Citrus Sinensis ID: 006922

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-----
Protein Sequence
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESSTPPPPVAGEN
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccccccccccccEEccccccccEEEEEEcccccccccccHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHcccccccccEEcccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHccccccccccccccccccccccccEEEEccccccccHHHHHHHHccccccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHcccccccccccEEEEEcccEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEccccccHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHccccccccccccccccccEEEEEccccccEEEEEEcccccccccccHHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccccccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHcccccccEEEEccccccccccHHHccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEcccccEccHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHccccEEEEEEEEccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHcHEEEccccccEEccccHHHHcccccccccccccccccHHHcccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MKALCVFTLIFNLGLifskvnaepvedkEALLDFVnnlphsrslnwnestsvcnhwtgvkcsedgkRVVAvrlpgvgfsglippntiSRLSALKILSLRSnvitgyfpsdfINLKSLCYLYLQFnnfsgtlpdfsvwknltiinlsdngfngtiprslsnlTQLEALYLANNslsgkipdlnlpnlqqlnlannnlsgsipqslkrfpssafvgnsisfdenlapraspdvaprgeshlrpksgrrigeTTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGtlqkrgmspekvvsrnqdasNRLFffegcnyafDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLkdvnvgkrDFEQQMEIVGSIRHENVVELKAYyyskdeklmVYDYYSLGSVSAMLhsergegripldwdTRMRIAIGAARGIARIHAanggklvhgnikssniflnsqqygcvsdlglTTITSALAPVIAraagyrapevtdsrkatqasdvySFGVVLLEIltgkspihttggdELVHLVRWVHSVVREEWTAEVFDvellrypnIEEEMVEMLQIAMSCVvrmpdqrpkmpdVVRVIEnvrpndsenrpssgnksesstppppvagen
Flexible Loop (DISEMBL)
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPgvgfsglippntISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLapraspdvaprgeshlrpksgrrigETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFagtlqkrgmspekvvSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRlkdvnvgkrdfeqqmeivgsirhenvVELKAYYYSKDEKLMVYDYYSLGSVSAMLhsergegripldwdTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAgyrapevtdsrkatqasdvYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVreewtaevfdvELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEnvrpndsenrpssgnksesstppppvagen
Low Complexity Region (SEG)
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDlnlpnlqqlnlannnlSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTrmriaigaargiarihaanggKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESSTPPPPVAGEN
Disordered region (IsUnstruct)
**ALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQ*L*********************************************************IGETTLLGIVIAASVLGLLAFLFLIVACCVRKK***************************NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVT****ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRM*********************************************
Disordered Region (DISOPRED)
*KALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDEN*****************************LLGIVIAASVLGLLAFLFLIVACCVRK******************************LFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV**RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH*****ELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV********************************
Disordered Region (DISEMBL)
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR***********QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP**************************
Disordered Region (DISPRO)
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRAS******************IGETTLLGIVIAASVLGLLAFLFLIVACCVRKKR*************************SNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV****************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESSTPPPPVAGEN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	625	2.2.26 [Sep-21-2011]
Q9SUQ3	638	Probable inactive recepto	yes	no	0.96	0.940	0.661	0.0
Q9SH71	587	Putative inactive recepto	no	no	0.915	0.974	0.541	1e-177
Q9LVM0	654	Probable inactive recepto	no	no	0.968	0.925	0.508	1e-174
Q9C9Y8	640	Probable inactive recepto	no	no	0.974	0.951	0.499	1e-166
Q9FK10	601	Probable inactive recepto	no	no	0.910	0.946	0.503	1e-162
O48788	658	Probable inactive recepto	no	no	0.964	0.916	0.5	1e-162
Q9FL63	614	Inactive leucine-rich rep	no	no	0.928	0.944	0.488	1e-161
Q9FHK7	640	Probable leucine-rich rep	no	no	0.937	0.915	0.488	1e-157
Q9LP77	655	Probable inactive recepto	no	no	0.905	0.864	0.448	1e-136
Q9LVI6	647	Probable inactive recepto	no	no	0.908	0.877	0.443	1e-126

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/620 (66%), Positives = 489/620 (78%), Gaps = 20/620 (3%)

Query: 16  IFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPG 75
           I    N++P+EDK ALL+F+  +  +RSLNWNE++ VCN WTGV C++DG R++AVRLPG
Sbjct: 18  IIYGANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPG 77

Query: 76  VGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DF 134
           VG +G IPPNTISRLSAL++LSLRSN+I+G FP DF+ LK L +LYLQ NN SG LP DF
Sbjct: 78  VGLNGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDF 137

Query: 135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLN-LPNLQQLNLAN 193
           SVWKNLT +NLS+NGFNGTIP SLS L ++++L LANN+LSG IPDL+ L +LQ ++L+N
Sbjct: 138 SVWKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSN 197

Query: 194 N-NLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIG--ET 250
           N +L+G IP  L+RFP S++ G  I          +P   P  ++H +P   R +G  ET
Sbjct: 198 NYDLAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPP-PPSEQTHQKPSKARFLGLSET 256

Query: 251 TLLGIVIAASVLGLLAFLFLIVACCVRKK--REDEFAG--TLQKRG-MSPEKVVSRNQDA 305
             L IVIA S++ + A  F++  C VR+K  R D       LQK+G MSPEK VSR +D 
Sbjct: 257 VFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMSPEKFVSRMEDV 316

Query: 306 SNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD 365
           +NRL FFEGCNY+FDLEDLLRASAEVLGKGTFG  YKA+LED T+V VKRLKDV  GKRD
Sbjct: 317 NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRD 376

Query: 366 FEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDT 425
           FEQQMEI+G I+HENVVELKAYYYSKDEKLMVYDY+S GSV+++LH  RGE RIPLDW+T
Sbjct: 377 FEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWET 436

Query: 426 RMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIA 485
           RM+IAIGAA+GIARIH  N GKLVHGNIKSSNIFLNS+  GCVSDLGLT + S LAP I+
Sbjct: 437 RMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPIS 496

Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE 545
           R AGYRAPEVTD+RK++Q SDVYSFGVVLLE+LTGKSPIHTT GDE++HLVRWVHSVVRE
Sbjct: 497 RQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVRE 556

Query: 546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV-------R 598
           EWTAEVFD+ELLRY NIEEEMVEMLQIAMSCVV+  DQRPKM D+VR+IENV        
Sbjct: 557 EWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIE 616

Query: 599 PNDSENRPSSGN-KSESSTP 617
           P + E +P S N  SE+STP
Sbjct: 617 P-EPELKPKSENGASETSTP 635

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  622 bits (1603), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 331/611 (54%), Positives = 426/611 (69%), Gaps = 39/611 (6%)

Query: 6   VFTLIFNLGLIFSKVNAEPVED-KEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSED 64
           +F   F+L L F  ++++ +ED K+ALL F+++   SR L+WN+S+ VC+ WTGV C+E+
Sbjct: 3   IFLFFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNEN 61

Query: 65  GKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQF 124
           G R+V+VRLP VGF+GLIPP TISRLS+LK LSLR N  TG FPSDF NLKSL +LYLQ 
Sbjct: 62  GDRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQH 121

Query: 125 NNFSG-TLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNL 183
           N+ SG  L  FS  KNL +++LS+NGFNG+IP SLS LT L+ L LANNS SG+IP+L+L
Sbjct: 122 NHLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHL 181

Query: 184 PNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKS 243
           P L Q+NL+NN L G+IP+SL+RF SSAF GN      NL  R      P G S L    
Sbjct: 182 PKLSQINLSNNKLIGTIPKSLQRFQSSAFSGN------NLTERKKQRKTPFGLSQL---- 231

Query: 244 GRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMS--PEKVVSR 301
                    L I+ AA VL +    F+++ C  + +     +G L+KR  S  P    SR
Sbjct: 232 -------AFLLILSAACVLCVSGLSFIMITCFGKTR----ISGKLRKRDSSSPPGNWTSR 280

Query: 302 --NQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
             N +   ++ FF G N+ FDL+DLL +SAEVLGKG FG  YK  +ED +TVVVKRLK+V
Sbjct: 281 DDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEV 340

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-GR 418
            VG+R+FEQQMEI+G IRHENV ELKAYYYSKD+KL VY YY+ GS+  +LH  RG   R
Sbjct: 341 VVGRREFEQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHR 400

Query: 419 IPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS 478
           +PLDWD R+RIA GAARG+A+IH    GK +HGNIKSSNIFL+SQ YGC+ D+GLTTI  
Sbjct: 401 VPLDWDARLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMR 457

Query: 479 ALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT-----TGGDELV 533
           +L       +GY APE+TD+R++TQ SDVYSFGVVLLE+LTGKSP+       TGG+ + 
Sbjct: 458 SLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENM- 516

Query: 534 HLVRWVHSVVREEWTAEVFDVELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            L  W+ SVV +EWT EVFD+E+L +    EEEMVEMLQI ++CV     +RP +  V++
Sbjct: 517 DLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLK 576

Query: 593 VIENVRPNDSE 603
           +IE++R  D+E
Sbjct: 577 LIEDIRSVDAE 587

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  613 bits (1581), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 318/625 (50%), Positives = 430/625 (68%), Gaps = 20/625 (3%)

Query: 5   CVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSED 64
           C+ + +F      S   A+   D++ALL F  ++PH R LNWN +  +C  W GV C+ D
Sbjct: 26  CLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSD 85

Query: 65  GKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQF 124
           G  V A+RLPG+G  G IPPNT+ +L +L+ILSLRSN+++G  P D  +L SL Y+YLQ 
Sbjct: 86  GTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQH 145

Query: 125 NNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP 184
           NNFSG +P F V + L I++LS N F G IP +  NL QL  L L NN LSG +P+L+  
Sbjct: 146 NNFSGEVPSF-VSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTV 204

Query: 185 NLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL----- 239
           +L++LNL+NN+L+GSIP +L  FPSS+F GN++     L P A+    P    H+     
Sbjct: 205 SLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPL 264

Query: 240 -----RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKK--REDEFAGTLQKRG 292
                +  S R++  +T++ I    + L LL  + +I+ CC++KK  RED          
Sbjct: 265 PPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITV-IILCCCIKKKDKREDSIVKVKTLTE 323

Query: 293 MSPEKVVSRNQDA-SNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTV 351
            + ++  S  Q+   N+L FF GC+Y FDLEDLLRASAEVLGKG++G AYKA+LE+ TTV
Sbjct: 324 KAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTV 383

Query: 352 VVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAML 410
           VVKRLK+V  GKR+FEQQMEI+  +  H +VV L+AYYYSKDEKLMV DYY  G++S++L
Sbjct: 384 VVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLL 443

Query: 411 HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD 470
           H  RG  + PLDWD+R++I + AA+GIA +HAA G K  HGNIKSSN+ +  +   C+SD
Sbjct: 444 HGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISD 503

Query: 471 LGLTTITSA-LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG 529
            GLT + +  +AP+  R AGYRAPEV ++RK T  SDVYSFGV++LE+LTGKSP+ +   
Sbjct: 504 FGLTPLMAVPIAPM--RGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSR 561

Query: 530 DELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD 589
           D++V L RWV SVVREEWT+EVFD+EL+R+ NIEEEMV+MLQIAM+CV ++P+ RP M D
Sbjct: 562 DDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDD 621

Query: 590 VVRVIENVRPNDSE-NRPSSGNKSE 613
           VVR+IE +R +DSE  RPSS + S+
Sbjct: 622 VVRMIEEIRVSDSETTRPSSDDNSK 646

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  585 bits (1507), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 316/633 (49%), Positives = 414/633 (65%), Gaps = 24/633 (3%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           MK +  F  +     +   ++A+   DK+ALL+F + +PHSR LNWN +  +C  WTG+ 
Sbjct: 2   MKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGIT 61

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS++  RV A+RLPG G  G +P  T  +L AL+I+SLRSN + G  PS  ++L  +  L
Sbjct: 62  CSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSL 121

Query: 121 YLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD 180
           Y   NNFSGT+P   +   L  ++LS N  +G IP SL NLTQL  L L NNSLSG IP+
Sbjct: 122 YFHENNFSGTIPPV-LSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPN 180

Query: 181 LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL- 239
           L  P L+ LNL+ NNL+GS+P S+K FP+S+F GNS+     L P      AP       
Sbjct: 181 LP-PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTP 239

Query: 240 ----------RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKR--EDEFAGT 287
                     R  + + +    ++GI +  SVL L   L +I  CC +K+   +D  A  
Sbjct: 240 TEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVL-LFIILAIITLCCAKKRDGGQDSTAVP 298

Query: 288 LQKRGMS---PEKVVSRNQDA-SNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKA 343
             K G S    E+  S  Q+A  N+L FFEG +Y FDLEDLLRASAEVLGKG++G  YKA
Sbjct: 299 KAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKA 358

Query: 344 ILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYS 402
           ILE+GTTVVVKRLK+V  GKR+FEQQME VG I  H NV  L+AYY+SKDEKL+VYDYY 
Sbjct: 359 ILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQ 418

Query: 403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS 462
            G+ S +LH     GR  LDW+TR+RI + AARGI+ IH+A+G KL+HGNIKS N+ L  
Sbjct: 419 GGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQ 478

Query: 463 QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKS 522
           + + CVSD G+  + S    + +R+ GYRAPE  ++RK TQ SDVYSFGV+LLE+LTGK+
Sbjct: 479 ELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKA 538

Query: 523 PIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVRMP 581
              TTG +E+V L +WV SVVREEWT EVFDVEL++   N+EEEMV+MLQIAM+CV + P
Sbjct: 539 AGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHP 598

Query: 582 DQRPKMPDVVRVIENVRPNDSENRPSSGNKSES 614
           D RP M +VV ++E +RP+ S   P SGN++ S
Sbjct: 599 DSRPSMEEVVNMMEEIRPSGS--GPGSGNRASS 629

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1

 Score =  572 bits (1473), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 314/624 (50%), Positives = 409/624 (65%), Gaps = 55/624 (8%)

Query: 3   ALCVFTLIFNLGLIFSKVNAEPV-EDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKC 61
            L +  +IFN+      + AE + EDK  LL FVNN+ HS SLNW+ S S+C  WTGV C
Sbjct: 6   VLILIVVIFNVC-----IEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTC 60

Query: 62  SEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLY 121
           + D   V A+ L   G  G I  + I+RLS L+ L L SN I+G FP+    LK+L  L 
Sbjct: 61  NSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELK 120

Query: 122 LQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD 180
           L FN FSG LP D S W+ L +++LS+N FNG+IP S+  LT L +L LA N  SG+IPD
Sbjct: 121 LDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPD 180

Query: 181 LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLR 240
           L++P L+ LNLA+NNL+G++PQSL+RFP SAFVGN +     LAP           S LR
Sbjct: 181 LHIPGLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKV-----LAPV---------HSSLR 226

Query: 241 PKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVS 300
             +        +LGI  A SV   +  L  I+   +   RE++       R  S +K   
Sbjct: 227 KHTKHH--NHVVLGI--ALSVCFAILALLAILLVIIIHNREEQ-------RRSSKDKPSK 275

Query: 301 RNQDAS-------NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVV 353
           R +D+        N++ FFEG N  FDLEDLLRASAEVLGKG FG  YK  LED  T+VV
Sbjct: 276 RRKDSDPNVGEGDNKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVV 335

Query: 354 KRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSE 413
           KR+K+V+V +R+FEQQ+E +GSI+HENV  L+ Y+YSKDEKL+VYDYY  GS+S +LH +
Sbjct: 336 KRIKEVSVPQREFEQQIENIGSIKHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQ 395

Query: 414 RG-EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG 472
           +G   R  L+W+TR+ +  G ARG+A IH+ +GGKLVHGNIKSSNIFLN + YGC+S  G
Sbjct: 396 KGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCISGTG 455

Query: 473 LTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           + T+  +L      A GYRAPE+TD+RK TQ SDVYSFG+++ E+LTGKS        E+
Sbjct: 456 MATLMHSLP---RHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--------EV 504

Query: 533 VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            +LVRWV+SVVREEWT EVFD ELLR   +EEEMVEMLQ+ M C  R+P++RP M +VVR
Sbjct: 505 ANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVR 564

Query: 593 VIENVRPNDSENRPSSGNKSESST 616
           ++E +RP     + +SG +SE ST
Sbjct: 565 MVEEIRP----EKLASGYRSEVST 584

Arabidopsis thaliana (taxid: 3702)

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  572 bits (1473), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 325/650 (50%), Positives = 417/650 (64%), Gaps = 47/650 (7%)

Query: 6   VFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG 65
           V   +F++ L+  +VN+E   +K+ALL F+  +PH   L WNES S CN W GV+C+ + 
Sbjct: 7   VLNSLFSILLLTQRVNSESTAEKQALLTFLQQIPHENRLQWNESDSACN-WVGVECNSNQ 65

Query: 66  KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
             + ++RLPG G  G IP  ++ RL+ L++LSLRSN ++G  PSDF NL  L  LYLQ N
Sbjct: 66  SSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHN 125

Query: 126 NFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP 184
            FSG  P  F+   NL  +++S N F G+IP S++NLT L  L+L NN  SG +P ++L 
Sbjct: 126 EFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL- 184

Query: 185 NLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSG 244
            L   N++NNNL+GSIP SL RF + +F GN       L P  S  V+P     L   S 
Sbjct: 185 GLVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSN 244

Query: 245 RRIGET-----TLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
           R   +        +  +I AS L  L  L L++  C+RK+R    A T Q +   P  V 
Sbjct: 245 RLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPK---PAGVA 301

Query: 300 SRNQD-----------------------ASNRLFFFEGCNYAFDLEDLLRASAEVLGKGT 336
           +RN D                         N+L F EG  Y+FDLEDLLRASAEVLGKG+
Sbjct: 302 TRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGS 361

Query: 337 FGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLM 396
            G +YKA+LE+GTTVVVKRLKDV   K++FE QME+VG I+H NV+ L+AYYYSKDEKL+
Sbjct: 362 VGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLL 421

Query: 397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSS 456
           V+D+   GS+SA+LH  RG GR PLDWD RMRIAI AARG+A +H +   KLVHGNIK+S
Sbjct: 422 VFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS--AKLVHGNIKAS 479

Query: 457 NIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLE 516
           NI L+  Q  CVSD GL  + S  +P   R AGY APEV ++RK T  SDVYSFGV+LLE
Sbjct: 480 NILLHPNQDTCVSDYGLNQLFSNSSPP-NRLAGYHAPEVLETRKVTFKSDVYSFGVLLLE 538

Query: 517 ILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSC 576
           +LTGKSP   + G+E + L RWV SVVREEWTAEVFDVEL+RY NIEEEMV++LQIAM+C
Sbjct: 539 LLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMAC 598

Query: 577 VVRMPDQRPKMPDVVRVIENVRPND--------SENRPSSGNKSESSTPP 618
           V  +PDQRP M +V+R+IE+V  ++        S + PS G  SE  TPP
Sbjct: 599 VSTVPDQRPVMQEVLRMIEDVNRSETTDDGLRQSSDDPSKG--SEGQTPP 646

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1

 Score =  567 bits (1462), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 299/612 (48%), Positives = 402/612 (65%), Gaps = 32/612 (5%)

Query: 6   VFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG 65
           V  L F    ++S+V  +   D++ALLDF+NN+ H RSL WN S+ VC  W GV C  DG
Sbjct: 12  VLFLFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDG 71

Query: 66  KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
            RV A+ LPG    G+IPP TISRLS L+ILSLRSN + G FP DF+ LK L  + L  N
Sbjct: 72  TRVTALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNN 131

Query: 126 NFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP 184
            FSG LP D++ W NLT+++L  N FNG+IP   +NLT L +L LA NS SG+IPDLNLP
Sbjct: 132 RFSGPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLP 191

Query: 185 NLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSG 244
            L++LN +NNNL+GSIP SLKRF +SAF GN++ F EN  P   P V    E   + K+G
Sbjct: 192 GLRRLNFSNNNLTGSIPNSLKRFGNSAFSGNNLVF-ENAPP---PAVVSFKE---QKKNG 244

Query: 245 RRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQK----RGMSPEKVVS 300
             I E  +LGI I+   +       +I+ C V+++R+ E      K    + M  EK VS
Sbjct: 245 IYISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVS 304

Query: 301 R-----------NQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGT 349
           +           ++   N++ FFEG N AF+LEDLL ASAE LGKG FGM YKA+LED  
Sbjct: 305 KLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSK 364

Query: 350 TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM 409
            + VKRLKD+ V ++DF+ QMEIVG+I+HENV  L+AY  SK+EKLMVYDY S GS+S  
Sbjct: 365 VIAVKRLKDIVVSRKDFKHQMEIVGNIKHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLR 424

Query: 410 LHSERG-EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV 468
           LH +   EG +PL+W+TR+R  IG A+G+  IH  N   L HGNIKSSN+F+NS+ YGC+
Sbjct: 425 LHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQN---LAHGNIKSSNVFMNSEGYGCI 481

Query: 469 SDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           S+ GL  +T+ +    + A     YRAPEVTD+R++T  SD+YSFG+++LE LTG+S + 
Sbjct: 482 SEAGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMD 541

Query: 526 TTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
                E + LV WV+ V+ ++WT EVFD+EL++ PN+E ++++MLQ+  SC   +P +RP
Sbjct: 542 DR--KEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRP 599

Query: 586 KMPDVVRVIENV 597
            M  VV  +E +
Sbjct: 600 DMVKVVETLEEI 611

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  555 bits (1429), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 304/622 (48%), Positives = 409/622 (65%), Gaps = 36/622 (5%)

Query: 20  VNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG--KRVVAVRLPGVG 77
           V+A+   D++ALL+F  ++PH   LNWN++ S+C+ W G+ C E     RVVAVRLPGVG
Sbjct: 25  VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNPTSRVVAVRLPGVG 84

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG-----TLP 132
             G IPP T+ +L ALK+LSLRSN + G  PSD ++L SL YLYLQ NNFSG     +LP
Sbjct: 85  LYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSLP 144

Query: 133 DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLA 192
             S+ K L +++LS N  +G IP  L NL+Q+  LYL NNS  G I  L+LP+++ +NL+
Sbjct: 145 --SISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLS 202

Query: 193 NNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGE------SHLRPKSGRR 246
            NNLSG IP+ LK+ P  +F+GNS+     L   +   ++P          +L P   RR
Sbjct: 203 YNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENLHPVR-RR 261

Query: 247 IGETTLLGIVIAASVLGL-LAFLFLIVACCVRKKREDEFAGTLQKRGM------SPEKVV 299
             +  ++ IV+  SV  L L  +FL+  C V+K +++E  G   +  M       P+   
Sbjct: 262 QSKAYIIAIVVGCSVAVLFLGIVFLV--CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFG 319

Query: 300 SRNQD-ASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKD 358
           S  QD   N+LFFFE CN+ FDLEDLL+ASAEVLGKG+FG AYKA+LED T VVVKRL++
Sbjct: 320 SGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLRE 379

Query: 359 VNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG 417
           V   K++FEQQMEIVG I +H N V L AYYYSKDEKL+VY Y + GS+  ++H  RG+ 
Sbjct: 380 VVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDR 439

Query: 418 RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT 477
            +  DW+TRM+IA G ++ I+ +H+    K VHG+IKSSNI L      C+SD  L T+ 
Sbjct: 440 GV--DWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTEDLEPCLSDTSLVTLF 494

Query: 478 SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE---LVH 534
           + L     R  GY APEV ++R+ +Q SDVYSFGVV+LE+LTGK+P+   G ++   ++ 
Sbjct: 495 N-LPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVID 553

Query: 535 LVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI 594
           L RWV SVVREEWTAEVFDVELL++ NIEEEMV+MLQ+A++CV R P+ RPKM +V R+I
Sbjct: 554 LPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMI 613

Query: 595 ENVRPNDSENRPSSGNKSESST 616
           E+VR  D   +      S  +T
Sbjct: 614 EDVRRLDQSQQLQQNRTSSEAT 635

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  486 bits (1250), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 276/616 (44%), Positives = 365/616 (59%), Gaps = 50/616 (8%)

Query: 27  DKEALLDFVNNLPHSRSLNWN-ESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPN 85
           D+ ALL   + +   R+  WN + TS CN W GVKC  +  RV A+RLPGV  SG IP  
Sbjct: 36  DRTALLSLRSAV-GGRTFRWNIKQTSPCN-WAGVKC--ESNRVTALRLPGVALSGDIPEG 91

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTII 143
               L+ L+ LSLR N ++G  P D     +L +LYLQ N FSG +P+  FS+  +L  +
Sbjct: 92  IFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSL-SHLVRL 150

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQS 203
           NL+ N F G I    +NLT+L+ L+L NN LSG IPDL+LP L Q N++NN+L+GSIP++
Sbjct: 151 NLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSIPKN 209

Query: 204 LKRFPSSAFVGNSISF-------DENLAPRASPD----VAPRGESHLRPKSGRRIGETTL 252
           L+RF S +F+  S+         DE   P           P  E     K   ++    +
Sbjct: 210 LQRFESDSFLQTSLCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSGGAI 269

Query: 253 LGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPE---------------- 296
            GIVI   V   L  L L+V C  +  +          +   PE                
Sbjct: 270 AGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSV 329

Query: 297 ------------KVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI 344
                       K    N  A+ +L FF      FDLEDLLRASAEVLGKGTFG AYKA+
Sbjct: 330 SAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAV 389

Query: 345 LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG 404
           L+  T V VKRLKDV +  ++F++++E+VG++ HEN+V L+AYY+S+DEKL+VYD+  +G
Sbjct: 390 LDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMG 449

Query: 405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ 464
           S+SA+LH  RG GR PL+WD R RIAIGAARG+  +H + G    HGNIKSSNI L    
Sbjct: 450 SLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLH-SQGTSTSHGNIKSSNILLTKSH 508

Query: 465 YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
              VSD GL  +  + A    RA GYRAPEVTD ++ +Q  DVYSFGVVLLE++TGK+P 
Sbjct: 509 DAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPS 568

Query: 525 HTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMV-EMLQIAMSCVVRMPDQ 583
           ++   +E V L RWV SV R+EW  EVFD ELL     EEEM+ EM+Q+ + C  + PDQ
Sbjct: 569 NSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQ 628

Query: 584 RPKMPDVVRVIENVRP 599
           RP+M +VVR +EN+RP
Sbjct: 629 RPEMSEVVRKMENLRP 644

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1

 Score =  454 bits (1167), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 275/620 (44%), Positives = 371/620 (59%), Gaps = 52/620 (8%)

Query: 27  DKEALLDFVNNLPHSRSLNWN-ESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPN 85
           DK ALL F + +   R+L W+ + TS CN WTGV C  DG RV A+RLPG   SG IP  
Sbjct: 34  DKSALLSFRSAV-GGRTLLWDVKQTSPCN-WTGVLC--DGGRVTALRLPGETLSGHIPEG 89

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTII 143
               L+ L+ LSLR N +TG  P D  +   L  LYLQ N FSG +P+  FS+  NL  +
Sbjct: 90  IFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSL-SNLVRL 148

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQS 203
           NL++N F+G I     NLT+L+ LYL NN LS         +L Q N++NN L+GSIP+S
Sbjct: 149 NLAENEFSGEISSGFKNLTRLKTLYLENNKLS-GSLLDLDLSLDQFNVSNNLLNGSIPKS 207

Query: 204 LKRFPSSAFVGNS-------ISFDENLAPR---ASPDVAPRGESHLRPKSGRRIGETTLL 253
           L++F S +FVG S       +  +E   P    +  ++    E     K  +++    + 
Sbjct: 208 LQKFDSDSFVGTSLCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKKLSGGAIA 267

Query: 254 GIVIAASVLGLLAFLFLIVACCVRKK---------------REDEFAGT----------- 287
           GIVI   V+GL + + +I+    RKK                E E  G            
Sbjct: 268 GIVIGC-VVGL-SLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENRS 325

Query: 288 -LQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILE 346
            + +   S  K V  N     +L FF      FDLEDLLRASAEVLGKGTFG AYKA+L+
Sbjct: 326 YVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLD 385

Query: 347 DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV 406
             T V VKRLKDV +  R+F++++E+VG++ HEN+V L+AYYYS DEKL+VYD+  +GS+
Sbjct: 386 AVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSL 445

Query: 407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG 466
           SA+LH  +G GR PL+W+ R  IA+GAARG+  +H+ +     HGN+KSSNI L +    
Sbjct: 446 SALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLS-SHGNVKSSNILLTNSHDA 504

Query: 467 CVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT 526
            VSD GL  + SA +    RA GYRAPEVTD R+ +Q +DVYSFGVVLLE+LTGK+P ++
Sbjct: 505 RVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNS 564

Query: 527 TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP---NIEEEMVEMLQIAMSCVVRMPDQ 583
              +E + L RWVHSV REEW  EVFD EL+      ++EEEM EMLQ+ + C  + PD+
Sbjct: 565 VMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDK 624

Query: 584 RPKMPDVVRVIENVRPNDSE 603
           RP M +VVR I+ +R + ++
Sbjct: 625 RPVMVEVVRRIQELRQSGAD 644

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	625
224058409	626	predicted protein [Populus trichocarpa]	0.992	0.990	0.760	0.0
224072093	626	predicted protein [Populus trichocarpa]	0.992	0.990	0.747	0.0
359473900	716	PREDICTED: probable inactive receptor ki	0.990	0.864	0.72	0.0
449452263	628	PREDICTED: probable inactive receptor ki	0.996	0.992	0.744	0.0
449521705	628	PREDICTED: LOW QUALITY PROTEIN: probable	0.996	0.992	0.742	0.0
356511460	688	PREDICTED: probable inactive receptor ki	0.952	0.864	0.718	0.0
356528976	618	PREDICTED: probable inactive receptor ki	0.936	0.946	0.738	0.0
302143694	660	unnamed protein product [Vitis vinifera]	0.987	0.934	0.655	0.0
359490541	656	PREDICTED: probable inactive receptor ki	0.953	0.908	0.666	0.0
224118140	633	predicted protein [Populus trichocarpa]	0.984	0.971	0.647	0.0

>gi|224058409|ref|XP_002299495.1| predicted protein [Populus trichocarpa] gi|222846753|gb|EEE84300.1| predicted protein [Populus trichocarpa]

 Score =  972 bits (2512), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 473/622 (76%), Positives = 534/622 (85%), Gaps = 2/622 (0%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           M+A  +  LI  +  +F +VN++PVEDK+ALLDFVNNLPHSRSLNWNES+ VCN+WTGV 
Sbjct: 1   MEATHILCLILLVEFVFFQVNSDPVEDKQALLDFVNNLPHSRSLNWNESSPVCNNWTGVI 60

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS DG RV+AVRLPGVGF G IPPNT+SRLSAL+ILSLRSN I+G FP D  NLK+L +L
Sbjct: 61  CSGDGTRVIAVRLPGVGFHGPIPPNTLSRLSALQILSLRSNGISGEFPFDISNLKNLSFL 120

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQ+NN SG+LP DFS+W NLTI+NLS+N FNG+IP S SNL+ L AL LANNSLSG++P
Sbjct: 121 YLQYNNLSGSLPVDFSLWPNLTIVNLSNNRFNGSIPYSFSNLSHLAALNLANNSLSGEVP 180

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           D NL NL Q+NL+NNNLSGS+P+SL+RFP+S F GN+I F E   P ASP V P    + 
Sbjct: 181 DFNLSNLHQINLSNNNLSGSVPRSLRRFPNSVFSGNNIPF-ETFPPHASPVVTPSDTPYP 239

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
           R ++ R +GE TLLGI++A+ VLGLLAF+F I  CC RKK E +F G L K GMSPEK+V
Sbjct: 240 RSRNKRGLGEKTLLGIIVASCVLGLLAFVFFIAVCCSRKKGEAQFPGKLLKGGMSPEKMV 299

Query: 300 SRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
           SR+QDA+NRL FFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILED TTVVVKRLK+V
Sbjct: 300 SRSQDANNRLTFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDATTVVVKRLKEV 359

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
           +VGKRDFEQQME+VGSIR ENVVELKAYYYSKDEKLMVYDYY+ GS+S+MLH +RG  R+
Sbjct: 360 SVGKRDFEQQMEVVGSIRQENVVELKAYYYSKDEKLMVYDYYNQGSISSMLHGKRGGERV 419

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
           PLDWDTRMRIAIGAARGIA IHA NGGK VHGNIKSSNIFLNSQQYGCVSDLGL TITS 
Sbjct: 420 PLDWDTRMRIAIGAARGIACIHAENGGKFVHGNIKSSNIFLNSQQYGCVSDLGLATITSP 479

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV 539
           LAP IARAAGYRAPEV D+RKA Q SDVYSFGVVLLE+LTGKSPIHTTGGDE++HLVRWV
Sbjct: 480 LAPPIARAAGYRAPEVADTRKAAQPSDVYSFGVVLLELLTGKSPIHTTGGDEIIHLVRWV 539

Query: 540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP 599
           HSVVREEWTAEVFDVEL+RYPNIEEEMVEMLQIAMSCV RMPD+RPKM DVVR+IENVR 
Sbjct: 540 HSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIAMSCVARMPDKRPKMTDVVRMIENVRQ 599

Query: 600 NDSENRPSSGNKSESSTPPPPV 621
            D+EN  S  N+SESSTPPP V
Sbjct: 600 MDTENHQSPQNRSESSTPPPLV 621

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224072093|ref|XP_002303623.1| predicted protein [Populus trichocarpa] gi|222841055|gb|EEE78602.1| predicted protein [Populus trichocarpa]

 Score =  965 bits (2494), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/622 (74%), Positives = 536/622 (86%), Gaps = 2/622 (0%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           M+A  +   I  +G +  +VNA+PVEDK+ALLDFV+ LPHSRSLNW ES+ VCN+W+GV 
Sbjct: 1   MEAKHILCFILLVGFVLFQVNADPVEDKQALLDFVHYLPHSRSLNWKESSPVCNNWSGVI 60

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS DG RV++VRLPGVGF G IPPNT+SRLSAL++LSLRSN I+G FP +F NLK+L +L
Sbjct: 61  CSGDGTRVISVRLPGVGFHGPIPPNTLSRLSALQVLSLRSNGISGEFPFEFSNLKNLSFL 120

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQ+NN SG+LP DFSVW NLTI+NLS+N FNG+IP S SNL+ L  L LANNS SG++P
Sbjct: 121 YLQYNNLSGSLPFDFSVWPNLTIVNLSNNRFNGSIPYSFSNLSHLAVLNLANNSFSGEVP 180

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           D NLPNLQQ+N++NNNL+GS+P+SL+RFP+S F GN+I F E   P A P V P    + 
Sbjct: 181 DFNLPNLQQINMSNNNLTGSVPRSLRRFPNSVFSGNNIPF-EAFPPHAPPVVTPSATPYP 239

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
           R ++ R +GE  LLGI++AA VLGL+AF++LIV CC RKK EDEF+G LQK GMSPEKVV
Sbjct: 240 RSRNSRGLGEKALLGIIVAACVLGLVAFVYLIVVCCSRKKGEDEFSGKLQKGGMSPEKVV 299

Query: 300 SRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
           SR+QDA+NRL FFEGCNYAFDLEDLLRASAE+LGKGTFGMAYKAILED TTVVVKRLK+V
Sbjct: 300 SRSQDANNRLTFFEGCNYAFDLEDLLRASAEILGKGTFGMAYKAILEDATTVVVKRLKEV 359

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
           +VGKRDFEQQME+VGSIRHENVVELKAYYYSKDEKLMVYDY+S GSV++MLH +RG  RI
Sbjct: 360 SVGKRDFEQQMEVVGSIRHENVVELKAYYYSKDEKLMVYDYFSQGSVASMLHGKRGGERI 419

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
           PLDWDTRMRIAIGAARGIA IHA NGGK VHGNIKSSNIFLNS+ YGCVSDLGL TITS+
Sbjct: 420 PLDWDTRMRIAIGAARGIALIHAENGGKFVHGNIKSSNIFLNSRCYGCVSDLGLVTITSS 479

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV 539
           LAP IARAAGYRAPEV D+RKA Q SD+YSFGVVLLE+LTGKSPIHTTG DE++HLVRWV
Sbjct: 480 LAPPIARAAGYRAPEVADTRKAAQPSDIYSFGVVLLELLTGKSPIHTTGSDEIIHLVRWV 539

Query: 540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP 599
           HSVVREEWTAEVFDVEL+RYPNIEEEMVEMLQIAMSCVVRMPDQRPKM +VV++IENVR 
Sbjct: 540 HSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMTEVVKMIENVRQ 599

Query: 600 NDSENRPSSGNKSESSTPPPPV 621
            D+EN   S ++SESSTPPP V
Sbjct: 600 IDTENHQPSESRSESSTPPPLV 621

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473900|ref|XP_002271560.2| PREDICTED: probable inactive receptor kinase At4g23740-like [Vitis vinifera]

 Score =  938 bits (2425), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/625 (72%), Positives = 537/625 (85%), Gaps = 6/625 (0%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           MK L +F+ IF LGLIFS  NA+PV+DK+ALL+FV++LPH   +NW++ + VCN+WTGV 
Sbjct: 89  MKTLYIFSGIFLLGLIFSLGNADPVDDKQALLEFVSHLPHLHPINWDKDSPVCNNWTGVT 148

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS+D  +V++VRLPGVGF G IPPNT+SRLSAL+ILSLRSN I+G+FPSDF+NLK+L +L
Sbjct: 149 CSDDKSQVISVRLPGVGFQGAIPPNTLSRLSALQILSLRSNRISGFFPSDFVNLKNLTFL 208

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQ+N+F G+LP DFSVWKNLTIINLS+N FNG+IP S+SNLT L+AL LA NSLSG+IP
Sbjct: 209 YLQYNDFVGSLPSDFSVWKNLTIINLSNNRFNGSIPNSISNLTSLQALNLATNSLSGEIP 268

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDEN-LAPRASPDVAPRGESH 238
           DL L +LQQLNL++NNLSGS+P+SL RFP S F GN+I+F+ + L P  SP   P    +
Sbjct: 269 DLQLSSLQQLNLSHNNLSGSMPKSLLRFPPSVFSGNNITFETSPLPPALSPSFPP----Y 324

Query: 239 LRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKV 298
            +P++ R+IGE  LLGI++AA  LGL+AF FL++ CC ++K  D F+G LQK GMSPEK 
Sbjct: 325 PKPRNSRKIGEMALLGIIVAACALGLVAFAFLLIVCCSKRKGGDGFSGKLQKGGMSPEKG 384

Query: 299 VSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKD 358
           +  +QDA+NRL FF+GCN+ FDLEDLLRASAEVLGKGTFG  YKAILED TTVVVKRLK+
Sbjct: 385 IPGSQDANNRLIFFDGCNFVFDLEDLLRASAEVLGKGTFGTTYKAILEDATTVVVKRLKE 444

Query: 359 VNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGR 418
           V+VGKR+FEQQME+VG+IRHENVVEL+AYY+SKDEKLMVYDYYSLGSVS +LH +RG  R
Sbjct: 445 VSVGKREFEQQMEVVGNIRHENVVELRAYYHSKDEKLMVYDYYSLGSVSTILHGKRGGDR 504

Query: 419 IPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS 478
           +PLDWDTR+RIA+GAARGIARIHA NGGK VHGNIKSSNIFLN++ YGCVSDLGLTT+ S
Sbjct: 505 MPLDWDTRLRIALGAARGIARIHAENGGKFVHGNIKSSNIFLNARGYGCVSDLGLTTVMS 564

Query: 479 ALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW 538
            LAP I+RAAGYRAPEVTD+RKA+Q+SDVYSFGVVLLE+LTGKSPIH TGGDE++HLVRW
Sbjct: 565 PLAPPISRAAGYRAPEVTDTRKASQSSDVYSFGVVLLELLTGKSPIHATGGDEVIHLVRW 624

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
           VHSVVREEWTAEVFDVEL+RYPNIEEEMVEMLQIAM CV+RMPDQRPKMPDVVR+IENVR
Sbjct: 625 VHSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIAMGCVIRMPDQRPKMPDVVRLIENVR 684

Query: 599 PNDSENRPSSGNKSESSTPPPPVAG 623
             D++NR S   +SE STP P   G
Sbjct: 685 HTDTDNRSSFETRSEGSTPLPTTVG 709

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452263|ref|XP_004143879.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Cucumis sativus]

 Score =  934 bits (2415), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 466/626 (74%), Positives = 536/626 (85%), Gaps = 3/626 (0%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           M+AL +F  +  +GL+FS +N +PVEDK ALLDFV NLPHSRSLNWN ++ VC++WTG+ 
Sbjct: 1   MEALWIFRFVLVMGLVFSPINGDPVEDKLALLDFVKNLPHSRSLNWNAASPVCHYWTGIT 60

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS+D  RV+AVRLPGVGF G IPPNT+SRLSAL+ILSLRSN ITG FP DF  L +L YL
Sbjct: 61  CSQDESRVIAVRLPGVGFHGPIPPNTLSRLSALQILSLRSNRITGDFPLDFSKLSNLSYL 120

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQFNNFSG LP +FSVWKNL  +NLS+NGFNG IP SLSNLT L  L LANNSLSG+IP
Sbjct: 121 YLQFNNFSGPLPSNFSVWKNLVFVNLSNNGFNGQIPNSLSNLTSLTGLNLANNSLSGEIP 180

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           DL +P LQ L+L+NNNLSGS+P+SL+RFP S FVGN+ISF  +L+    P  AP   S+ 
Sbjct: 181 DLQIPRLQVLDLSNNNLSGSLPESLQRFPRSVFVGNNISFGNSLS-NNPPVPAPLPVSNE 239

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
           +PK    +GE  LLGI+IA  +LGLLAF FLI+ C  R+KREDE++G LQK GMSPEKV+
Sbjct: 240 KPKKSGGLGEAALLGIIIAGGILGLLAFGFLILVCFSRRKREDEYSGDLQKGGMSPEKVI 299

Query: 300 SRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
           SR QDA+NRL FFEGC+YAFDLEDLLRASAEVLGKGTFG AYKAILED T VVVKRLKDV
Sbjct: 300 SRTQDANNRLVFFEGCHYAFDLEDLLRASAEVLGKGTFGTAYKAILEDATIVVVKRLKDV 359

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
           + GKRDFEQQMEIVGSIRHENV ELKAYYYSKDEKLMVYD++  GSVSAMLH +RGE + 
Sbjct: 360 SAGKRDFEQQMEIVGSIRHENVAELKAYYYSKDEKLMVYDFFGQGSVSAMLHGKRGEEKT 419

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
           PLDWDTR+RIA+GAARGIAR+HA NGGKLVHGN+KSSNIFLNSQQYGCVSDLGL TITS+
Sbjct: 420 PLDWDTRLRIAVGAARGIARVHAENGGKLVHGNVKSSNIFLNSQQYGCVSDLGLATITSS 479

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV 539
           L+P I+RAAGYRAPEVTD+RKATQASDV+SFGVVLLE+LTGKSPIH TGG+E+VHLVRWV
Sbjct: 480 LSPPISRAAGYRAPEVTDTRKATQASDVFSFGVVLLELLTGKSPIHATGGEEIVHLVRWV 539

Query: 540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP 599
           HSVVREEWTAEVFDVEL+RYPNIEEEMVEMLQIA+SCV R+PDQRPKMP++V++IENVRP
Sbjct: 540 HSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIALSCVARIPDQRPKMPEIVKMIENVRP 599

Query: 600 NDSENRPSSGNKSESSTPPPPVAGEN 625
            ++ENRPS+ N+ ESS  P  V  EN
Sbjct: 600 MEAENRPST-NQLESSMLPQAVETEN 624

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449521705|ref|XP_004167870.1| PREDICTED: LOW QUALITY PROTEIN: probable inactive receptor kinase At4g23740-like [Cucumis sativus]

 Score =  932 bits (2410), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/626 (74%), Positives = 535/626 (85%), Gaps = 3/626 (0%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           M+AL +F  +  +GL+FS +N +PVEDK ALLDFV NLPHSRSLNWN ++ VC++WTG+ 
Sbjct: 1   MEALWIFRFVLVMGLVFSPINGDPVEDKLALLDFVKNLPHSRSLNWNAASPVCHYWTGIT 60

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS+D  RV+AVRLPGVGF G IPPNT+SRLSAL+ILSLRSN ITG FP DF  L +L YL
Sbjct: 61  CSQDESRVIAVRLPGVGFHGPIPPNTLSRLSALQILSLRSNRITGDFPLDFSKLSNLSYL 120

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQFNNFSG LP +FSVWKNL  +NLS+NGFNG IP SLSNLT L  L LANNSLSG+IP
Sbjct: 121 YLQFNNFSGPLPSNFSVWKNLVFVNLSNNGFNGQIPNSLSNLTSLTGLNLANNSLSGEIP 180

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           DL +P LQ L+L+NNNLSGS+P+SL+RFP S FVGN+ISF  +L+    P  AP   S+ 
Sbjct: 181 DLQIPRLQVLDLSNNNLSGSLPESLQRFPRSVFVGNNISFGNSLS-NNPPVPAPLPVSNE 239

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
           +PK    +GE  LLGI+IA  +LGLLAF FLI+ C  R+KREDE++G LQK GMSPEK +
Sbjct: 240 KPKKSGGLGEAALLGIIIAGGILGLLAFGFLILVCFSRRKREDEYSGDLQKGGMSPEKXI 299

Query: 300 SRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
           SR QDA+NRL FFEGC+YAFDLEDLLRASAEVLGKGTFG AYKAILED T VVVKRLKDV
Sbjct: 300 SRTQDANNRLVFFEGCHYAFDLEDLLRASAEVLGKGTFGTAYKAILEDATIVVVKRLKDV 359

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
           + GKRDFEQQMEIVGSIRHENV ELKAYYYSKDEKLMVYD++  GSVSAMLH +RGE + 
Sbjct: 360 SAGKRDFEQQMEIVGSIRHENVAELKAYYYSKDEKLMVYDFFGQGSVSAMLHGKRGEEKT 419

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
           PLDWDTR+RIA+GAARGIAR+HA NGGKLVHGN+KSSNIFLNSQQYGCVSDLGL TITS+
Sbjct: 420 PLDWDTRLRIAVGAARGIARVHAENGGKLVHGNVKSSNIFLNSQQYGCVSDLGLATITSS 479

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV 539
           L+P I+RAAGYRAPEVTD+RKATQASDV+SFGVVLLE+LTGKSPIH TGG+E+VHLVRWV
Sbjct: 480 LSPPISRAAGYRAPEVTDTRKATQASDVFSFGVVLLELLTGKSPIHATGGEEIVHLVRWV 539

Query: 540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP 599
           HSVVREEWTAEVFDVEL+RYPNIEEEMVEMLQIA+SCV R+PDQRPKMP++V++IENVRP
Sbjct: 540 HSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIALSCVARIPDQRPKMPEIVKMIENVRP 599

Query: 600 NDSENRPSSGNKSESSTPPPPVAGEN 625
            ++ENRPS+ N+ ESS  P  V  EN
Sbjct: 600 MEAENRPST-NQLESSMLPQAVETEN 624

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356511460|ref|XP_003524444.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Glycine max]

 Score =  907 bits (2343), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/614 (71%), Positives = 511/614 (83%), Gaps = 19/614 (3%)

Query: 1   MKALCVFTLI-FNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGV 59
           M+ L +F+ I   L L+  +V+ EPVEDKEALLDFV+  P SR LNWNES+ +C+ WTGV
Sbjct: 88  MEFLPIFSFISLLLCLVLWQVSGEPVEDKEALLDFVSKFPPSRPLNWNESSPMCDSWTGV 147

Query: 60  KCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCY 119
            C+ D  +V+A+RLPGVGF G IPP+TISRLSAL+ LSLRSNVITG+FPSDF NLK+L +
Sbjct: 148 TCNVDKSKVIAIRLPGVGFHGTIPPDTISRLSALQTLSLRSNVITGHFPSDFSNLKNLSF 207

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           LYLQFNN SG LPDFS WKNLT++NLS+N FNGTIP SL+NLTQL  L LANNSLSG+IP
Sbjct: 208 LYLQFNNISGPLPDFSAWKNLTVVNLSNNHFNGTIPSSLNNLTQLAGLNLANNSLSGEIP 267

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           DLNL  LQ LNL+NN+L GS+P SL RFP SAF+GN+ISF       + P    RG    
Sbjct: 268 DLNLSRLQVLNLSNNSLQGSVPNSLLRFPESAFIGNNISFG------SFPTSRKRG---- 317

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDE--FAGTLQKRGMSPEK 297
                 R+ E  LLG++IAA VLGL+ F+ L+  CC R+  EDE  F+G L K  MSPEK
Sbjct: 318 ------RLSEAALLGVIIAAGVLGLVCFVSLVFVCCSRRVDEDEETFSGKLHKGEMSPEK 371

Query: 298 VVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLK 357
            VSRNQDA+N+L FFEGCNYA+DLEDLLRASAEVLGKGTFG AYKAILED T VVVKRLK
Sbjct: 372 AVSRNQDANNKLVFFEGCNYAYDLEDLLRASAEVLGKGTFGTAYKAILEDATMVVVKRLK 431

Query: 358 DVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG 417
           +V  GK+DFEQ MEIVGS++HENVVELKAYYYSKDEKLMVYDY+S GS+S+MLH +RGE 
Sbjct: 432 EVAAGKKDFEQHMEIVGSLKHENVVELKAYYYSKDEKLMVYDYHSQGSISSMLHGKRGED 491

Query: 418 RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT 477
           R+PLDWDTR++IA+GAARGIARIH  NGGKLVHGNIKSSNIFLN++QYGCVSDLGL TI+
Sbjct: 492 RVPLDWDTRLKIALGAARGIARIHVENGGKLVHGNIKSSNIFLNTKQYGCVSDLGLATIS 551

Query: 478 SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
           S+LA  I+RAAGYRAPEVTD+RKA Q SDVYSFGVVLLE+LTGKSPIHTTGGDE++HLVR
Sbjct: 552 SSLALPISRAAGYRAPEVTDTRKAAQPSDVYSFGVVLLELLTGKSPIHTTGGDEIIHLVR 611

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           WVHSVVREEWTAEVFD+EL+RYPNIEEEMVEMLQIAMSCVVRMPDQRPKM +VV++IENV
Sbjct: 612 WVHSVVREEWTAEVFDLELMRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMSEVVKMIENV 671

Query: 598 RPNDSENRPSSGNK 611
           R  D++   SSGN+
Sbjct: 672 RQIDADTHSSSGNQ 685

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528976|ref|XP_003533073.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Glycine max]

 Score =  905 bits (2338), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/589 (73%), Positives = 497/589 (84%), Gaps = 4/589 (0%)

Query: 27  DKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNT 86
           DKEALLDFVN  P SR LNWNES+ +C+ WTGV C+ D  +V+A+RLPGVGF G IPP+T
Sbjct: 8   DKEALLDFVNKFPPSRPLNWNESSPLCDSWTGVTCNVDKSKVIAIRLPGVGFHGSIPPDT 67

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ISRLSAL+ LSLRSNVITG+FPSDF NLK+L +LYLQFNN SG LPDFS WKNLT++NLS
Sbjct: 68  ISRLSALQTLSLRSNVITGHFPSDFFNLKNLSFLYLQFNNISGPLPDFSAWKNLTVVNLS 127

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKR 206
           DN FNGTIP SLS LTQL  L LANN+LSG+IPDLNL  LQ LNL+NNNL GS+P+SL R
Sbjct: 128 DNHFNGTIPSSLSKLTQLAGLNLANNTLSGEIPDLNLSRLQVLNLSNNNLQGSVPKSLLR 187

Query: 207 FPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLA 266
           F  SAF GN+ISF     P  SP   P  E   + +   R+ E  LLG+++AA VL L+ 
Sbjct: 188 FSESAFSGNNISFGS--FPTVSPAPQPAYEPSFKSRKHGRLSEAALLGVIVAAGVLVLVC 245

Query: 267 FLFLIVACCVRKKREDE--FAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDL 324
           F+ L+  CC R+  EDE  F+G L K  MSPEK VSRNQDA+N+L FFEGCNYAFDLEDL
Sbjct: 246 FVSLMFVCCSRRGDEDEETFSGKLHKGEMSPEKAVSRNQDANNKLVFFEGCNYAFDLEDL 305

Query: 325 LRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           LRASAEVLGKGTFG AYKAILED TTVVVKRLK+V VGK+DFEQ MEIVGS++HENVVEL
Sbjct: 306 LRASAEVLGKGTFGTAYKAILEDATTVVVKRLKEVAVGKKDFEQHMEIVGSLKHENVVEL 365

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           KAYYYSKDEKLMVYDY+S GS+S+MLH +RGE R+PLDWDTR++IA+GAARGIARIH  N
Sbjct: 366 KAYYYSKDEKLMVYDYHSQGSISSMLHGKRGEDRVPLDWDTRLKIALGAARGIARIHVEN 425

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
           GGKLVHGNIK SNIFLNS+QYGCVSDLGL TI+S+LA  I+RAAGYRAPEVTD+RKA Q 
Sbjct: 426 GGKLVHGNIKCSNIFLNSKQYGCVSDLGLATISSSLALPISRAAGYRAPEVTDTRKAAQP 485

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           SDVYSFGVVLLE+LTGKSPIHTTGGDE++HLVRWVHSVVREEWTAEVFD+EL+RYPNIEE
Sbjct: 486 SDVYSFGVVLLELLTGKSPIHTTGGDEIIHLVRWVHSVVREEWTAEVFDLELMRYPNIEE 545

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSE 613
           EMVEMLQIAMSCVVRMPDQRPKM +VV++IENVR  D++   SSGN++E
Sbjct: 546 EMVEMLQIAMSCVVRMPDQRPKMSEVVKMIENVRQTDAQTHSSSGNQAE 594

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143694|emb|CBI22555.3| unnamed protein product [Vitis vinifera]

 Score =  831 bits (2147), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/627 (65%), Positives = 502/627 (80%), Gaps = 10/627 (1%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           M    +F++IF LG I  +  AEPVEDK+ALLDF+NN+ HSR+LNWNE +SVCN WTGV 
Sbjct: 1   MGVKSIFSIIFLLGTISFQGFAEPVEDKQALLDFLNNINHSRTLNWNEYSSVCNTWTGVT 60

Query: 61  CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
           CS D  RV+A+ LPG+GF G IPPNT+ +LSA++ILSLRSN IT  FPSDF  L++L  L
Sbjct: 61  CSGDHSRVIALHLPGIGFRGEIPPNTLGQLSAVQILSLRSNAITSPFPSDFSKLENLTAL 120

Query: 121 YLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           YLQ+N FSG LP DFSVWKNLTIINLS+NGFNG+IP S+S LT L AL LANNSLSG+IP
Sbjct: 121 YLQYNKFSGPLPIDFSVWKNLTIINLSNNGFNGSIPSSISKLTHLAALDLANNSLSGEIP 180

Query: 180 DLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHL 239
           DLN  +LQ +NL+NN L+G++PQSL+RFP+ AF GN+IS +  + P   P+  P  +S  
Sbjct: 181 DLNTSSLQHINLSNNLLNGTLPQSLRRFPNWAFSGNNISTENAIPPVFPPNNPPLRKS-- 238

Query: 240 RPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVV 299
                +++ E  LLGI++  SV+G + F  L++ C  ++ RE  F    QK   S +K V
Sbjct: 239 -----KKLSEPALLGIILGGSVVGFVLFALLMIVCYSKRDRETGFIVKSQKGEGSVKKTV 293

Query: 300 SRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDV 359
           S + D SNRL FFEGC++AFDLEDLLRASAEVLGKGTFG  YKA LED TT+VVKRLK+V
Sbjct: 294 SGSHDGSNRLVFFEGCSFAFDLEDLLRASAEVLGKGTFGTTYKAALEDATTLVVKRLKEV 353

Query: 360 NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
           ++ +RDFEQQM+IVG IRHENV  L+AYYYSKDEKLMVYD+Y  GSVS++LH  RG+GR+
Sbjct: 354 SLVRRDFEQQMQIVGQIRHENVAPLRAYYYSKDEKLMVYDFYGQGSVSSILHGRRGDGRV 413

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
            LDW+TR+RIA+GAARGIA IH  NGGKLVHGNIK+SNIFLNS++YGCVSDLGL T+ + 
Sbjct: 414 SLDWETRLRIALGAARGIAHIHTENGGKLVHGNIKASNIFLNSRRYGCVSDLGLGTLMTP 473

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV 539
               + RAAGYRAPEVTD+RKA+QASDVYSFGV+LLE+LTGKSPIH TGGDE++HLVRWV
Sbjct: 474 TPMPMTRAAGYRAPEVTDTRKASQASDVYSFGVLLLELLTGKSPIHNTGGDEVIHLVRWV 533

Query: 540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP 599
           +SVVREEWTAEVFDVELLRYPNIEEEMVEMLQI M+CVV+MP+QRPKM +VV+++E+++ 
Sbjct: 534 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIGMNCVVKMPEQRPKMAEVVKMMESIQQ 593

Query: 600 NDSENRPSSGNKSE--SSTPPPPVAGE 624
            ++ NRPSS  KSE  SSTP PP A E
Sbjct: 594 VNTGNRPSSETKSEVSSSTPTPPAAAE 620

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490541|ref|XP_002267446.2| PREDICTED: probable inactive receptor kinase At4g23740-like [Vitis vinifera]

 Score =  823 bits (2127), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/606 (66%), Positives = 491/606 (81%), Gaps = 10/606 (1%)

Query: 22  AEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGL 81
           AEPVEDK+ALLDF+NN+ HSR+LNWNE +SVCN WTGV CS D  RV+A+ LPG+GF G 
Sbjct: 50  AEPVEDKQALLDFLNNINHSRTLNWNEYSSVCNTWTGVTCSGDHSRVIALHLPGIGFRGE 109

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNL 140
           IPPNT+ +LSA++ILSLRSN IT  FPSDF  L++L  LYLQ+N FSG LP DFSVWKNL
Sbjct: 110 IPPNTLGQLSAVQILSLRSNAITSPFPSDFSKLENLTALYLQYNKFSGPLPIDFSVWKNL 169

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSI 200
           TIINLS+NGFNG+IP S+S LT L AL LANNSLSG+IPDLN  +LQ +NL+NN L+G++
Sbjct: 170 TIINLSNNGFNGSIPSSISKLTHLAALDLANNSLSGEIPDLNTSSLQHINLSNNLLNGTL 229

Query: 201 PQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAAS 260
           PQSL+RFP+ AF GN+IS +  + P   P+  P  +S       +++ E  LLGI++  S
Sbjct: 230 PQSLRRFPNWAFSGNNISTENAIPPVFPPNNPPLRKS-------KKLSEPALLGIILGGS 282

Query: 261 VLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFD 320
           V+G + F  L++ C  ++ RE  F    QK   S +K VS + D SNRL FFEGC++AFD
Sbjct: 283 VVGFVLFALLMIVCYSKRDRETGFIVKSQKGEGSVKKTVSGSHDGSNRLVFFEGCSFAFD 342

Query: 321 LEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN 380
           LEDLLRASAEVLGKGTFG  YKA LED TT+VVKRLK+V++ +RDFEQQM+IVG IRHEN
Sbjct: 343 LEDLLRASAEVLGKGTFGTTYKAALEDATTLVVKRLKEVSLVRRDFEQQMQIVGQIRHEN 402

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           V  L+AYYYSKDEKLMVYD+Y  GSVS++LH  RG+GR+ LDW+TR+RIA+GAARGIA I
Sbjct: 403 VAPLRAYYYSKDEKLMVYDFYGQGSVSSILHGRRGDGRVSLDWETRLRIALGAARGIAHI 462

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRK 500
           H  NGGKLVHGNIK+SNIFLNS++YGCVSDLGL T+ +     + RAAGYRAPEVTD+RK
Sbjct: 463 HTENGGKLVHGNIKASNIFLNSRRYGCVSDLGLGTLMTPTPMPMTRAAGYRAPEVTDTRK 522

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           A+QASDVYSFGV+LLE+LTGKSPIH TGGDE++HLVRWV+SVVREEWTAEVFDVELLRYP
Sbjct: 523 ASQASDVYSFGVLLLELLTGKSPIHNTGGDEVIHLVRWVNSVVREEWTAEVFDVELLRYP 582

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSE--SSTPP 618
           NIEEEMVEMLQI M+CVV+MP+QRPKM +VV+++E+++  ++ NRPSS  KSE  SSTP 
Sbjct: 583 NIEEEMVEMLQIGMNCVVKMPEQRPKMAEVVKMMESIQQVNTGNRPSSETKSEVSSSTPT 642

Query: 619 PPVAGE 624
           PP A E
Sbjct: 643 PPAAAE 648

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118140|ref|XP_002317741.1| predicted protein [Populus trichocarpa] gi|222858414|gb|EEE95961.1| predicted protein [Populus trichocarpa]

 Score =  809 bits (2089), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/624 (64%), Positives = 489/624 (78%), Gaps = 9/624 (1%)

Query: 4   LCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSE 63
           L +F+     G +   + A+PV+DK+ALLDF++N+ HS  +NW+E+TSVCN WTGV CS 
Sbjct: 8   LFIFSAFLFFGEVLLSITADPVDDKQALLDFLHNILHSHPVNWHENTSVCNSWTGVSCSN 67

Query: 64  DGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYL 122
           D  RV A+RLPGVGF G IPPNT+SRLSA++ILSLRSN I+G FP D F  L++L  L+L
Sbjct: 68  DNSRVTALRLPGVGFRGPIPPNTLSRLSAIQILSLRSNGISGSFPYDEFSKLRNLTILFL 127

Query: 123 QFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL 181
           Q NNFSG LP DFS+W  LTI+NLS+NGFNG IP S+SNLT L AL LANNSLSG IPD+
Sbjct: 128 QSNNFSGPLPSDFSIWNYLTILNLSNNGFNGRIPPSISNLTHLTALSLANNSLSGNIPDI 187

Query: 182 NLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRP 241
           N+P+LQ L+L NNN +GS+P+SL+RFPSSAF GN++S  EN  P A P       S    
Sbjct: 188 NVPSLQHLDLTNNNFTGSLPKSLQRFPSSAFSGNNLS-SENALPPALPI---HPPSSQPS 243

Query: 242 KSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSR 301
           K   ++ E  +L I I   VLG +   F+IV C  +K+RE   A   + + +S +K  S+
Sbjct: 244 KKSSKLSEPAILAIAIGGCVLGFVVLAFMIVVCHSKKRREGGLA--TKNKEVSLKKTASK 301

Query: 302 NQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV 361
           +Q+ +NRLFFFE C+ AFDLEDLLRASAEVLGKGTFG+AYKA LE+ TTVVVKRLK+V V
Sbjct: 302 SQEQNNRLFFFEHCSLAFDLEDLLRASAEVLGKGTFGIAYKAALEEATTVVVKRLKEVAV 361

Query: 362 GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPL 421
            K++FEQQM  VGSIRH NV  L+AYYYSKDE+LMVYD+Y  GSVSAMLH +RGEG  P+
Sbjct: 362 PKKEFEQQMIAVGSIRHVNVSPLRAYYYSKDERLMVYDFYEEGSVSAMLHVKRGEGHTPM 421

Query: 422 DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA 481
           DW+TR++IAIGAARGIA IH  NGGKLVHGNIKSSNIFLNSQ +GCVSD+GL ++ S + 
Sbjct: 422 DWETRLKIAIGAARGIAHIHTQNGGKLVHGNIKSSNIFLNSQGHGCVSDIGLASLMSPMP 481

Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS 541
           P + RAAGYRAPEVTD+RKAT ASDVYS+GV LLE+LTGKSP+HTTGGDE+VHLVRWV+S
Sbjct: 482 PPVMRAAGYRAPEVTDTRKATHASDVYSYGVFLLELLTGKSPMHTTGGDEVVHLVRWVNS 541

Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           VVREEWTAEVFD+ELLRYPNIEEEMVEMLQI +SCVVRMP+QRPKMPDVV+++E +R   
Sbjct: 542 VVREEWTAEVFDLELLRYPNIEEEMVEMLQIGLSCVVRMPEQRPKMPDVVKMVEEIRQVS 601

Query: 602 SENRPSSGNKSE-SSTPPPPVAGE 624
           +EN PSS +K E S   P P A E
Sbjct: 602 TENPPSSDSKLEISVATPSPQAAE 625

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	625
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.985	0.965	0.616	1.8e-197
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.968	0.925	0.483	2.1e-148
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.494	0.469	0.588	1.4e-142
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.940	0.918	0.469	3.8e-133
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.974	0.951	0.459	2.1e-132
TAIR|locus:2178712	614	AT5G24100 [Arabidopsis thalian	0.928	0.944	0.464	2.7e-132
TAIR|locus:2024517	587	AT1G64210 [Arabidopsis thalian	0.916	0.976	0.452	1.5e-120
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.494	0.477	0.501	2.9e-114
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.483	0.461	0.513	2.6e-113
TAIR|locus:2174190	625	LRR1 [Arabidopsis thaliana (ta	0.497	0.497	0.466	1.3e-105

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1912 (678.1 bits), Expect = 1.8e-197, P = 1.8e-197
 Identities = 392/636 (61%), Positives = 469/636 (73%)

Query:     1 MKALCVF--TLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTG 58
             M+AL ++  +L  +L LI    N++P+EDK ALL+F+  +  +RSLNWNE++ VCN WTG
Sbjct:     1 MEALRIYLWSLCLSLCLIIYGANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTG 60

Query:    59 VKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLC 118
             V C++DG R++AVRLPGVG +G IPPNTISRLSAL++LSLRSN+I+G FP DF+ LK L 
Sbjct:    61 VTCNQDGSRIIAVRLPGVGLNGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLA 120

Query:   119 YLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK 177
             +LYLQ NN SG LP DFSVWKNLT +NLS+NGFNGTIP SLS L ++++L LANN+LSG 
Sbjct:   121 FLYLQDNNLSGPLPLDFSVWKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGD 180

Query:   178 IPDXXXXXXXXXXXXXXXX--SGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRG 235
             IPD                  +G IP  L+RFP S++ G  I          +P   P  
Sbjct:   181 IPDLSVLSSLQHIDLSNNYDLAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPP-PPSE 239

Query:   236 ESHLRPKSGRRIG--ETTLLGIVIAASVLGLLAFLFLIVACCVRKK--REDEFAGT--LQ 289
             ++H +P   R +G  ET  L IVIA S++ + A  F++  C VR+K  R D       LQ
Sbjct:   240 QTHQKPSKARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQ 299

Query:   290 KRG-MSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDG 348
             K+G MSPEK VSR +D +NRL FFEGCNY+FDLEDLLRASAEVLGKGTFG  YKA+LED 
Sbjct:   300 KKGGMSPEKFVSRMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDA 359

Query:   349 TTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA 408
             T+V VKRLKDV  GKRDFEQQMEI+G I+HENVVELKAYYYSKDEKLMVYDY+S GSV++
Sbjct:   360 TSVAVKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVAS 419

Query:   409 MLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCV 468
             +LH  RGE RIPLDW+T                     KLVHGNIKSSNIFLNS+  GCV
Sbjct:   420 LLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCV 479

Query:   469 SDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG 528
             SDLGLT + S LAP I+R AGYRAPEVTD+RK++Q SDVYSFGVVLLE+LTGKSPIHTT 
Sbjct:   480 SDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTA 539

Query:   529 GDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMP 588
             GDE++HLVRWVHSVVREEWTAEVFD+ELLRY NIEEEMVEMLQIAMSCVV+  DQRPKM 
Sbjct:   540 GDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMS 599

Query:   589 DVVRVIENV---RPN---DSENRPSSGN-KSESSTP 617
             D+VR+IENV   R +   + E +P S N  SE+STP
Sbjct:   600 DLVRLIENVGNRRTSIEPEPELKPKSENGASETSTP 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1449 (515.1 bits), Expect = 2.1e-148, P = 2.1e-148
 Identities = 302/625 (48%), Positives = 400/625 (64%)

Query:     5 CVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSED 64
             C+ + +F      S   A+   D++ALL F  ++PH R LNWN +  +C  W GV C+ D
Sbjct:    26 CLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSD 85

Query:    65 GKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQF 124
             G  V A+RLPG+G  G IPPNT+ +L +L+ILSLRSN+++G  P D  +L SL Y+YLQ 
Sbjct:    86 GTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQH 145

Query:   125 NNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDXXXX 184
             NNFSG +P F V + L I++LS N F G IP +  NL QL  L L NN LSG +P+    
Sbjct:   146 NNFSGEVPSF-VSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTV 204

Query:   185 XXXXXXXXXXXXSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESH-----L 239
                         +GSIP +L  FPSS+F GN++     L P A+    P    H     L
Sbjct:   205 SLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPL 264

Query:   240 RP---KSG--RRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKK--REDEFAGTLQKRG 292
              P   K G  R++  +T++ I    + L LL    +I+ CC++KK  RED          
Sbjct:   265 PPFPHKEGSKRKLHVSTIIPIAAGGAAL-LLLITVIILCCCIKKKDKREDSIVKVKTLTE 323

Query:   293 MSPEKVVSRNQDAS-NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTV 351
              + ++  S  Q+   N+L FF GC+Y FDLEDLLRASAEVLGKG++G AYKA+LE+ TTV
Sbjct:   324 KAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTV 383

Query:   352 VVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAML 410
             VVKRLK+V  GKR+FEQQMEI+  +  H +VV L+AYYYSKDEKLMV DYY  G++S++L
Sbjct:   384 VVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLL 443

Query:   411 HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSD 470
             H  RG  + PLDWD+                     K  HGNIKSSN+ +  +   C+SD
Sbjct:   444 HGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISD 503

Query:   471 LGLTTITSA-LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG 529
              GLT + +  +AP+  R AGYRAPEV ++RK T  SDVYSFGV++LE+LTGKSP+ +   
Sbjct:   504 FGLTPLMAVPIAPM--RGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSR 561

Query:   530 DELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD 589
             D++V L RWV SVVREEWT+EVFD+EL+R+ NIEEEMV+MLQIAM+CV ++P+ RP M D
Sbjct:   562 DDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDD 621

Query:   590 VVRVIENVRPNDSEN-RPSSGNKSE 613
             VVR+IE +R +DSE  RPSS + S+
Sbjct:   622 VVRMIEEIRVSDSETTRPSSDDNSK 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 905 (323.6 bits), Expect = 1.4e-142, Sum P(2) = 1.4e-142
 Identities = 187/318 (58%), Positives = 230/318 (72%)

Query:   307 NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDF 366
             N+L F EG  Y+FDLEDLLRASAEVLGKG+ G +YKA+LE+GTTVVVKRLKDV   K++F
Sbjct:   332 NKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEF 391

Query:   367 EQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTX 426
             E QME+VG I+H NV+ L+AYYYSKDEKL+V+D+   GS+SA+LH  RG GR PLDWD  
Sbjct:   392 ETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNR 451

Query:   427 XXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR 486
                                 KLVHGNIK+SNI L+  Q  CVSD GL  + S  +P   R
Sbjct:   452 MRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPP-NR 508

Query:   487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE 546
              AGY APEV ++RK T  SDVYSFGV+LLE+LTGKSP   + G+E + L RWV SVVREE
Sbjct:   509 LAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREE 568

Query:   547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN-- 604
             WTAEVFDVEL+RY NIEEEMV++LQIAM+CV  +PDQRP M +V+R+IE+V  +++ +  
Sbjct:   569 WTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDDG 628

Query:   605 -RPSSGNKSESS---TPP 618
              R SS + S+ S   TPP
Sbjct:   629 LRQSSDDPSKGSEGQTPP 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1305 (464.4 bits), Expect = 3.8e-133, P = 3.8e-133
 Identities = 291/620 (46%), Positives = 382/620 (61%)

Query:    20 VNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG--KRVVAVRLPGVG 77
             V+A+   D++ALL+F  ++PH   LNWN++ S+C+ W G+ C E     RVVAVRLPGVG
Sbjct:    25 VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNPTSRVVAVRLPGVG 84

Query:    78 FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFS-- 135
               G IPP T+ +L ALK+LSLRSN + G  PSD ++L SL YLYLQ NNFSG L   S  
Sbjct:    85 LYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSLP 144

Query:   136 -VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDXXXXXXXXXXXXXX 194
              + K L +++LS N  +G IP  L NL+Q+  LYL NNS  G I                
Sbjct:   145 SISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLSYN 204

Query:   195 XXSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGE------SHLRPKSGRRIG 248
               SG IP+ LK+ P  +F+GNS+     L   +   ++P          +L P   RR  
Sbjct:   205 NLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENLHPVR-RRQS 263

Query:   249 ETTLLGIVIAASVLGL-LAFLFLIVACCVRKKREDEFAGT---LQKRGMS---PEKVVSR 301
             +  ++ IV+  SV  L L  +FL+  C V+K +++E  G     Q  G++   P+   S 
Sbjct:   264 KAYIIAIVVGCSVAVLFLGIVFLV--CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSG 321

Query:   302 NQDAS-NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVN 360
              QD   N+LFFFE CN+ FDLEDLL+ASAEVLGKG+FG AYKA+LED T VVVKRL++V 
Sbjct:   322 VQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVV 381

Query:   361 VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
               K++FEQQMEIVG I +H N V L AYYYSKDEKL+VY Y + GS+  ++H  RG+  +
Sbjct:   382 ASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRGV 441

Query:   420 PLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
               DW+T                     K VHG+IKSSNI L      C+SD  L T+ + 
Sbjct:   442 --DWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTEDLEPCLSDTSLVTLFN- 495

Query:   480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG-GDE--LVHLV 536
             L     R  GY APEV ++R+ +Q SDVYSFGVV+LE+LTGK+P+   G  DE  ++ L 
Sbjct:   496 LPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLP 555

Query:   537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
             RWV SVVREEWTAEVFDVELL++ NIEEEMV+MLQ+A++CV R P+ RPKM +V R+IE+
Sbjct:   556 RWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIED 615

Query:   597 VRPNDSENRPSSGNKSESST 616
             VR  D   +      S  +T
Sbjct:   616 VRRLDQSQQLQQNRTSSEAT 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
 Identities = 291/633 (45%), Positives = 383/633 (60%)

Query:     1 MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
             MK +  F  +     +   ++A+   DK+ALL+F + +PHSR LNWN +  +C  WTG+ 
Sbjct:     2 MKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGIT 61

Query:    61 CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL 120
             CS++  RV A+RLPG G  G +P  T  +L AL+I+SLRSN + G  PS  ++L  +  L
Sbjct:    62 CSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSL 121

Query:   121 YLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD 180
             Y   NNFSGT+P   +   L  ++LS N  +G IP SL NLTQL  L L NNSLSG IP+
Sbjct:   122 YFHENNFSGTIPPV-LSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPN 180

Query:   181 XXXXXXXXXXXXXXXXSG------SIPQSLKRFPSSAFVGNSIS-FDENL-APRASPDVA 232
                                     S P S  +  +S   G  ++   EN  AP  SP   
Sbjct:   181 LPPRLKYLNLSFNNLNGSVPSSVKSFPASSFQ-GNSLLCGAPLTPCPENTTAPSPSPTTP 239

Query:   233 PRGE--SHLRPKSGRRIGET-TLLGIVIAASVLGLLAFLFLIVACCVRKKR--EDEFAGT 287
               G   +++   + +++  T  ++GI +  SVL L   L +I  CC +K+   +D  A  
Sbjct:   240 TEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVL-LFIILAIITLCCAKKRDGGQDSTAVP 298

Query:   288 LQKRGMSPEKVV---SRNQDAS-NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKA 343
               K G S  K     S  Q+A  N+L FFEG +Y FDLEDLLRASAEVLGKG++G  YKA
Sbjct:   299 KAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKA 358

Query:   344 ILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYS 402
             ILE+GTTVVVKRLK+V  GKR+FEQQME VG I  H NV  L+AYY+SKDEKL+VYDYY 
Sbjct:   359 ILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQ 418

Query:   403 LGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNS 462
              G+ S +LH     GR  LDW+T                     KL+HGNIKS N+ L  
Sbjct:   419 GGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQ 478

Query:   463 QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKS 522
             + + CVSD G+  + S    + +R+ GYRAPE  ++RK TQ SDVYSFGV+LLE+LTGK+
Sbjct:   479 ELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKA 538

Query:   523 PIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVRMP 581
                TTG +E+V L +WV SVVREEWT EVFDVEL++   N+EEEMV+MLQIAM+CV + P
Sbjct:   539 AGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHP 598

Query:   582 DQRPKMPDVVRVIENVRPNDSENRPSSGNKSES 614
             D RP M +VV ++E +RP+ S   P SGN++ S
Sbjct:   599 DSRPSMEEVVNMMEEIRPSGSG--PGSGNRASS 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2178712 AT5G24100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1297 (461.6 bits), Expect = 2.7e-132, P = 2.7e-132
 Identities = 284/612 (46%), Positives = 380/612 (62%)

Query:     6 VFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG 65
             V  L F    ++S+V  +   D++ALLDF+NN+ H RSL WN S+ VC  W GV C  DG
Sbjct:    12 VLFLFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDG 71

Query:    66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
              RV A+ LPG    G+IPP TISRLS L+ILSLRSN + G FP DF+ LK L  + L  N
Sbjct:    72 TRVTALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNN 131

Query:   126 NFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDXXXX 184
              FSG LP D++ W NLT+++L  N FNG+IP   +NLT L +L LA NS SG+IPD    
Sbjct:   132 RFSGPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLP 191

Query:   185 XXXXXXXXXXXXSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSG 244
                         +GSIP SLKRF +SAF GN++ F EN  P   P V    E   + K+G
Sbjct:   192 GLRRLNFSNNNLTGSIPNSLKRFGNSAFSGNNLVF-ENAPP---PAVVSFKE---QKKNG 244

Query:   245 RRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQK----RGMSPEKVVS 300
               I E  +LGI I+   +       +I+ C V+++R+ E      K    + M  EK VS
Sbjct:   245 IYISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVS 304

Query:   301 R-----N----QDAS--NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGT 349
             +     N    +D S  N++ FFEG N AF+LEDLL ASAE LGKG FGM YKA+LED  
Sbjct:   305 KLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSK 364

Query:   350 TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM 409
              + VKRLKD+ V ++DF+ QMEIVG+I+HENV  L+AY  SK+EKLMVYDY S GS+S  
Sbjct:   365 VIAVKRLKDIVVSRKDFKHQMEIVGNIKHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLR 424

Query:   410 LHSERG-EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCV 468
             LH +   EG +PL+W+T                      L HGNIKSSN+F+NS+ YGC+
Sbjct:   425 LHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQ---NLAHGNIKSSNVFMNSEGYGCI 481

Query:   469 SDLGLTTITSAL--APVIARAA-GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
             S+ GL  +T+ +  A   AR+   YRAPEVTD+R++T  SD+YSFG+++LE LTG+S + 
Sbjct:   482 SEAGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMD 541

Query:   526 TTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
                  E + LV WV+ V+ ++WT EVFD+EL++ PN+E ++++MLQ+  SC   +P +RP
Sbjct:   542 DR--KEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRP 599

Query:   586 KMPDVVRVIENV 597
              M  VV  +E +
Sbjct:   600 DMVKVVETLEEI 611

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1186 (422.6 bits), Expect = 1.5e-120, P = 1.5e-120
 Identities = 276/610 (45%), Positives = 365/610 (59%)

Query:     6 VFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDG 65
             +F   F+L L F  ++++ +ED +  L    +  +S  L+WN+S+ VC+ WTGV C+E+G
Sbjct:     3 IFLFFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSRLHWNQSSDVCHSWTGVTCNENG 62

Query:    66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
              R+V+VRLP VGF+GLIPP TISRLS+LK LSLR N  TG FPSDF NLKSL +LYLQ N
Sbjct:    63 DRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHN 122

Query:   126 NFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDXXXXX 185
             + SG L   +++  L  + + D   NG      ++L+ L +L + N  L+          
Sbjct:   123 HLSGPL--LAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLN--LANNSFSGEIPN 178

Query:   186 XXXXXXXXXXXSGSIPQSLKRFPSSAFVGNSISFD-ENLAPRASPDVAPRGESHLRPKSG 244
                        S +  + +   P S     S +F   NL  R      P G S L     
Sbjct:   179 LHLPKLSQINLSNN--KLIGTIPKSLQRFQSSAFSGNNLTERKKQRKTPFGLSQL----- 231

Query:   245 RRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMS--PEKVVSR- 301
                     L I+ AA VL +    F+++ C   K R    +G L+KR  S  P    SR 
Sbjct:   232 ------AFLLILSAACVLCVSGLSFIMITC-FGKTR---ISGKLRKRDSSSPPGNWTSRD 281

Query:   302 -NQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVN 360
              N +   ++ FF G N+ FDL+DLL +SAEVLGKG FG  YK  +ED +TVVVKRLK+V 
Sbjct:   282 DNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEVV 341

Query:   361 VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-GRI 419
             VG+R+FEQQMEI+G IRHENV ELKAYYYSKD+KL VY YY+ GS+  +LH  RG   R+
Sbjct:   342 VGRREFEQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHRV 401

Query:   420 PLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
             PLDWD                      K +HGNIKSSNIFL+SQ YGC+ D+GLTTI  +
Sbjct:   402 PLDWDARLRIATGAARGLAKIHEG---KFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRS 458

Query:   480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT-----TGGDELVH 534
             L       +GY APE+TD+R++TQ SDVYSFGVVLLE+LTGKSP+       TGG+ +  
Sbjct:   459 LPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENM-D 517

Query:   535 LVRWVHSVVREEWTAEVFDVELLRYPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV 593
             L  W+ SVV +EWT EVFD+E+L      EEEMVEMLQI ++CV     +RP +  V+++
Sbjct:   518 LASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKL 577

Query:   594 IENVRPNDSE 603
             IE++R  D+E
Sbjct:   578 IEDIRSVDAE 587

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 774 (277.5 bits), Expect = 2.9e-114, Sum P(2) = 2.9e-114
 Identities = 157/313 (50%), Positives = 205/313 (65%)

Query:   294 SPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVV 353
             S  K V  N     +L FF      FDLEDLLRASAEVLGKGTFG AYKA+L+  T V V
Sbjct:   333 SAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAV 392

Query:   354 KRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSE 413
             KRLKDV +  R+F++++E+VG++ HEN+V L+AYYYS DEKL+VYD+  +GS+SA+LH  
Sbjct:   393 KRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGN 452

Query:   414 RGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGL 473
             +G GR PL+W+                         HGN+KSSNI L +     VSD GL
Sbjct:   453 KGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSS-HGNVKSSNILLTNSHDARVSDFGL 511

Query:   474 TTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
               + SA +    RA GYRAPEVTD R+ +Q +DVYSFGVVLLE+LTGK+P ++   +E +
Sbjct:   512 AQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGM 571

Query:   534 HLVRWVHSVVREEWTAEVFDVELLRYP---NIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
              L RWVHSV REEW  EVFD EL+      ++EEEM EMLQ+ + C  + PD+RP M +V
Sbjct:   572 DLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEV 631

Query:   591 VRVIENVRPNDSE 603
             VR I+ +R + ++
Sbjct:   632 VRRIQELRQSGAD 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 771 (276.5 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
 Identities = 156/304 (51%), Positives = 201/304 (66%)

Query:   297 KVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRL 356
             K    N  A+ +L FF      FDLEDLLRASAEVLGKGTFG AYKA+L+  T V VKRL
Sbjct:   342 KASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRL 401

Query:   357 KDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE 416
             KDV +  ++F++++E+VG++ HEN+V L+AYY+S+DEKL+VYD+  +GS+SA+LH  RG 
Sbjct:   402 KDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGA 461

Query:   417 GRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI 476
             GR PL+WD                         HGNIKSSNI L       VSD GL  +
Sbjct:   462 GRSPLNWDVRSRIAIGAARGLDYLHSQGTSTS-HGNIKSSNILLTKSHDAKVSDFGLAQL 520

Query:   477 TSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               + A    RA GYRAPEVTD ++ +Q  DVYSFGVVLLE++TGK+P ++   +E V L 
Sbjct:   521 VGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLP 580

Query:   537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMV-EMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
             RWV SV R+EW  EVFD ELL     EEEM+ EM+Q+ + C  + PDQRP+M +VVR +E
Sbjct:   581 RWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKME 640

Query:   596 NVRP 599
             N+RP
Sbjct:   641 NLRP 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)]

 Score = 682 (245.1 bits), Expect = 1.3e-105, Sum P(2) = 1.3e-105
 Identities = 147/315 (46%), Positives = 197/315 (62%)

Query:   296 EKVVSRNQDA-SNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVK 354
             E  VS+N  A S  L FF      FDL+ LL+ASAEVLGKGTFG +YKA  + G  V VK
Sbjct:   312 ENGVSKNPAAVSKDLTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVK 371

Query:   355 RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER 414
             RL+DV V +++F ++++++GSI H N+V L AYY+S+DEKL+V++Y S GS+SA+LH  +
Sbjct:   372 RLRDVVVPEKEFREKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNK 431

Query:   415 GEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT 474
             G GR PL+W+T                        HGNIKSSNI L+      VSD  L 
Sbjct:   432 GSGRSPLNWETRANIALGAARAISYLHSRDATTS-HGNIKSSNILLSESFEAKVSDYCLA 490

Query:   475 TITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH 534
              + S  +    R  GYRAPEVTD+RK +Q +DVYSFGV++LE+LTGKSP H    +E V 
Sbjct:   491 PMISPTSTP-NRIDGYRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQLHEEGVD 549

Query:   535 LVRWVHSVVREEWTAEVFDVELLRYPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV 593
             L RWV S+  ++  ++VFD EL RY +   E M+ +L I +SC  + PD RP MP+V R+
Sbjct:   550 LPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRL 609

Query:   594 IENVRPNDSENRPSS 608
             IE V  + +   P S
Sbjct:   610 IEEVSRSPASPGPLS 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009610 "response to symbiotic fungus" evidence=IEP

GO:0016020 "membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SUQ3	Y4374_ARATH	No assigned EC number	0.6612	0.96	0.9404	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	625
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-19
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-08
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-05
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	4e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-04
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.003
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.003
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  172 bits (437), Expect = 3e-45
 Identities = 147/549 (26%), Positives = 243/549 (44%), Gaps = 80/549 (14%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
           F G +P +       L+ L L  N  +G  P    +L  L  L L  N  SG +PD  S 
Sbjct: 464 FFGGLPDS--FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPN---LQQLNLAN 193
            K L  ++LS N  +G IP S S +  L  L L+ N LSG+IP  NL N   L Q+N+++
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK-NLGNVESLVQVNISH 580

Query: 194 NNLSGSIPQS--LKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRIGETT 251
           N+L GS+P +       +SA  GN      +              S L P   +R+ +T 
Sbjct: 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT------------SGLPP--CKRVRKTP 626

Query: 252 LLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFF 311
                I  +   L AFL L +           F     +   + E     N+D +  L F
Sbjct: 627 SWWFYITCT---LGAFLVLALVA---------FGFVFIRGRNNLELKRVENEDGTWELQF 674

Query: 312 FEG-CNYAFDLEDLLRASAE--VLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFE 367
           F+   + +  + D+L +  E  V+ +G  G +YK   +++G   VVK + DVN       
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 368 QQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRM 427
             M   G ++H N+V+L     S+    ++++Y    ++S +L +        L W+ R 
Sbjct: 735 ADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRR 783

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ--YGCVSDLGLTTITSALAPVIA 485
           +IAIG A+ +  +H      +V GN+    I ++ +   +  +S  GL    +       
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFI--- 840

Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP--IHTTGGDELV---------- 533
            ++ Y APE  +++  T+ SD+Y FG++L+E+LTGKSP          +V          
Sbjct: 841 -SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899

Query: 534 HLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV 593
           HL  W+   +R + +              + E+VE++ +A+ C    P  RP   DV++ 
Sbjct: 900 HLDMWIDPSIRGDVSVN------------QNEIVEVMNLALHCTATDPTARPCANDVLKT 947

Query: 594 IENVRPNDS 602
           +E+   + S
Sbjct: 948 LESASRSSS 956

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  132 bits (335), Expect = 1e-35
 Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 15/194 (7%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLK--DVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           LG+G FG  Y A   + G  V +K +K  D +    +  +++EI+  + H N+V+L   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             ++   +V +Y   GS+  +L    G     L  D  +RI +    G+  +H+     +
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNG---I 113

Query: 449 VHGNIKSSNIFLNSQQYGCV-SDLGLTTITSALAPVIARAAG---YRAPEV-TDSRKATQ 503
           +H ++K  NI L+S       +D GL+ + ++   ++    G   Y APEV       ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 504 ASDVYSFGVVLLEI 517
            SD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  119 bits (301), Expect = 2e-30
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 16/202 (7%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQ---MEIVGSIRHENVVELK 385
             LG G+FG  YKA     G  V VK LK  +   +  +     + I+  + H N+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +  KD   +V +Y   G +   L         PL  D   +IA+   RG+  +H+   
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVT-DSRKA 501
             ++H ++K  NI L+      ++D GL      +S+          Y APEV       
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 502 TQASDVYSFGVVLLEILTGKSP 523
               DV+S GV+L E+LTGK P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (289), Expect = 9e-29
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 41/278 (14%)

Query: 330 EVLGKGTFGMAYKAILEDG-----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           + LG+G FG  YK  L+         V VK LK+        +F ++  I+  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +L      ++  ++V +Y   G +   L   R +    L     +  A+  ARG+  + +
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLES 121

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------TITSALAPVIARAAGYRAPEV 495
            N    +H ++ + N  +       +SD GL+               +  R   + APE 
Sbjct: 122 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR---WMAPES 175

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
               K T  SDV+SFGV+L EI T G+ P       E++  ++                 
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK----------KGYR--- 222

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            L + PN   E+ +++     C    P+ RP   ++V 
Sbjct: 223 -LPKPPNCPPELYKLML---QCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 1e-28
 Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 50/282 (17%)

Query: 330 EVLGKGTFGMAYKAILED-----GTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           + LG+G FG  YK  L+         V VK LK+        +F ++  I+  + H NVV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +L      ++   +V +Y   G + + L   R +    L     +  A+  ARG+  + +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLES 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT---------TITSALAPVIARAAGYR-- 491
            N    +H ++ + N  +       +SD GL+                P+       R  
Sbjct: 121 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI-------RWM 170

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE     K T  SDV+SFGV+L EI T G+ P     G     ++ ++ +  R      
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYR------ 221

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                L + PN   E+     + + C    P+ RP   ++V 
Sbjct: 222 -----LPQPPNCPPELY---DLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  113 bits (286), Expect = 3e-28
 Identities = 63/269 (23%), Positives = 120/269 (44%), Gaps = 29/269 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK--DVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           E LG+G+FG  Y A   + G  V +K +K   +   +    ++++I+  ++H N+V L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +  +D+  +V +Y   G +  +L      GR+  D + R          +  +H+    
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSED-EAR-FYLRQILSALEYLHSKG-- 117

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSRKATQ 503
            +VH ++K  NI L+   +  ++D GL         L   +     Y APEV   +   +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVG-TPEYMAPEVLLGKGYGK 175

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
           A D++S GV+L E+LTGK P    G D+L+ L + +                     +I 
Sbjct: 176 AVDIWSLGVILYELLTGKPPFP--GDDQLLELFKKIGKPKPPFP---------PPEWDIS 224

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            E  ++++     +V+ P++R    + ++
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  113 bits (285), Expect = 3e-28
 Identities = 69/289 (23%), Positives = 111/289 (38%), Gaps = 59/289 (20%)

Query: 330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           + LG+G FG  YK  L        T V VK LK+      + +F ++  I+  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L       +   +V +Y   G +   L          L     +++A+  A+G+  + +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR----------- 491
            N    VH ++ + N  +       +SD GL       +  I     YR           
Sbjct: 121 KN---FVHRDLAARNCLVTENLVVKISDFGL-------SRDIYEDDYYRKRGGGKLPIKW 170

Query: 492 -APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR----E 545
            APE     K T  SDV+SFGV+L EI T G+ P     G     ++  +    R    E
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY---PGMSNEEVLELLEDGYRLPRPE 227

Query: 546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI 594
               E++++              MLQ    C    P+ RP   ++V  +
Sbjct: 228 NCPDELYEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 4e-28
 Identities = 69/285 (24%), Positives = 115/285 (40%), Gaps = 42/285 (14%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           + LG+G FG  YK  L+      T V VK LK+      ++DF ++  ++  + H NVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIAR 439
           L      ++   +V +Y   G +   L   R       +  L     +  AI  A+G+  
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYR 491
           + +      VH ++ + N  +       +SD GL+                +  R   + 
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---WM 174

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE       T  SDV+SFGV+L EI T G +P      +E++  +R             
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------------- 221

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
               +  R P  E    E+ ++ +SC    P+ RP   ++V  +E
Sbjct: 222 ----KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (277), Expect = 4e-25
 Identities = 82/234 (35%), Positives = 118/234 (50%), Gaps = 35/234 (14%)

Query: 4   LCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNL--PHSRSLNWNESTSVCNHWTGVKC 61
             +F L F L L FS ++AE +E    LL F +++  P     NWN S  VC  W G+ C
Sbjct: 11  YLIFMLFF-LFLNFSMLHAEELE---LLLSFKSSINDPLKYLSNWNSSADVCL-WQGITC 65

Query: 62  SEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYL 120
           + +  RVV++ L G   SG I      RL  ++ ++L +N ++G  P D F    SL YL
Sbjct: 66  N-NSSRVVSIDLSGKNISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123

Query: 121 YLQFNNFSGTLP-----------------------DFSVWKNLTIINLSDNGFNGTIPRS 157
            L  NNF+G++P                       D   + +L +++L  N   G IP S
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 158 LSNLTQLEALYLANNSLSGKIP-DL-NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
           L+NLT LE L LA+N L G+IP +L  + +L+ + L  NNLSG IP  +    S
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.8 bits (233), Expect = 7e-20
 Identities = 49/122 (40%), Positives = 75/122 (61%), Gaps = 3/122 (2%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTI 142
           PN+++ L++L+ L+L SN + G  P +   +KSL ++YL +NN SG +P +     +L  
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSGSI 200
           ++L  N   G IP SL NL  L+ L+L  N LSG IP    +L  L  L+L++N+LSG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 201 PQ 202
           P+
Sbjct: 301 PE 302

Length = 968

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 42/269 (15%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQME------IVGSIRHENVVE 383
             +GKG+FG+ +K + +    V    +K +++ K +  ++ E      ++  +    ++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 384 LKAYYYS--KDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
              YY S     KL +V +Y   G +  +L  +RG    PL  D   R  I    G+A +
Sbjct: 64  ---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHL 117

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVIARAAGYRAPEVTD 497
           H+    K++H +IKS N+FL++     + DLG+  + S     A  I     Y +PE+ +
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174

Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVVREEWTAEVFDVEL 556
            +   + SDV++ GVVL E  TGK P        L+  ++R V   V + ++        
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQ------- 227

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
                      ++ Q+   C+ +   QRP
Sbjct: 228 -----------QLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 32/267 (11%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVEL 384
           LGKG++G  YK   L D        LK+V++G      + D   ++ I+ S+ H N++  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           K  +   ++  +V +Y   G +S  + S+R + R  +      RI I   RG+  +H   
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-TSALAPVIARAAGYRAPEVTDSRKATQ 503
             K++H ++KS+NI L +     + DLG++ +    +A        Y APEV   R  + 
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            SD++S G +L E+ T   P       +L       + V R ++            P I 
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKVQRGKYP---------PIPPIY 225

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDV 590
            +  ++     S +   P  RP    +
Sbjct: 226 SQ--DLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
           E +GKG FG  YKA     G  V +K +K  +  K   E    +++I+   +H N+V+  
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             Y  KDE  +V ++ S GS+  +L S        L       +     +G+  +H+   
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNG- 118

Query: 446 GKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARA--AGYRAPEVTDSRKA 501
             ++H +IK++NI L S   G V   D GL+   S             + APEV + +  
Sbjct: 119 --IIHRDIKAANILLTSD--GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 502 TQASDVYSFGVVLLEILTGKSPIH 525
              +D++S G+  +E+  GK P  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.6 bits (218), Expect = 7e-19
 Identities = 66/314 (21%), Positives = 120/314 (38%), Gaps = 37/314 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHE-NVVEL 384
             LG+G+FG  Y A   D   V +K L      K      F ++++I+ S+ H  N+V+L
Sbjct: 6   RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             ++  +    +V +Y   GS+  +L     +G +       + I       +  +H+  
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121

Query: 445 GGKLVHGNIKSSNIFLNSQ-QYGCVSDLGL---------TTITSALAPVIARAAGYRAPE 494
              ++H +IK  NI L+   +   + D GL         T+   AL        GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 495 V---TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           V        A+ +SD++S G+ L E+LTG  P                  ++ E  T  +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSL 235

Query: 552 -FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKM-----PDVVRVIENVRPNDSENR 605
              +       I +   ++L      + + P  R         D++  ++    + S+  
Sbjct: 236 ASPLSPSNPELISKAASDLL---KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292

Query: 606 PSSGNKSESSTPPP 619
               +     + PP
Sbjct: 293 KPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 50/275 (18%)

Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQM---EIVGSIRHENVVELK 385
           E+LG+G+FG  Y A+ +D G  + VK ++     + + E       I+ S++H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63

Query: 386 AYYYSK--DEKLMVY---DYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIAR 439
            YY S+  +EK  +    +Y S GS+S++L      G++P   +  +R        G+A 
Sbjct: 64  -YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLP---EPVIRKYTRQILEGLAY 116

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI--TSALAPVIARAAG---YRA 492
           +H+     +VH +IK +NI ++S   G V  +D G                  G   + A
Sbjct: 117 LHSNG---IVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           PEV    +  +A+D++S G  ++E+ TGK P              W          A ++
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP--------------WSEL---GNPMAALY 214

Query: 553 DVELLRY-PNIEEEMVEMLQ-IAMSCVVRMPDQRP 585
            +      P I E + E  +     C+ R P +RP
Sbjct: 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.0 bits (218), Expect = 6e-18
 Identities = 59/154 (38%), Positives = 79/154 (51%), Gaps = 30/154 (19%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP------ 132
           SG IP   I  L++L  L L  N +TG  PS   NLK+L YL+L  N  SG +P      
Sbjct: 225 SGEIP-YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283

Query: 133 ------DFS-------------VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNS 173
                 D S               +NL I++L  N F G IP +L++L +L+ L L +N 
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343

Query: 174 LSGKIPDLNL---PNLQQLNLANNNLSGSIPQSL 204
            SG+IP  NL    NL  L+L+ NNL+G IP+ L
Sbjct: 344 FSGEIPK-NLGKHNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 50/206 (24%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELK 385
           +++G+G FG+ YK + LE G  V +K++    + +   +   Q+++++ +++H N+V+  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA---RGIARIHA 442
               + D   ++ +Y   GS+  ++      G  P        +A+      +G+A +H 
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKF---GPFP-----ESLVAVYVYQVLQGLAYLH- 116

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSR 499
                ++H +IK++NI         ++D G+ T  + ++   A   G   + APEV +  
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 500 KATQASDVYSFGVVLLEILTGKSPIH 525
            A+ ASD++S G  ++E+LTG  P +
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY 200

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 67/301 (22%), Positives = 125/301 (41%), Gaps = 62/301 (20%)

Query: 332 LGKGTFGMAYKA---ILEDGTT--VVVKRLK--DVNVGKRDFEQQMEIVGSIRHENVVEL 384
           LG+G FG         L D T   V VK L        + DFE+++EI+ ++ HEN+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           K        +   ++ +Y   GS+   L  H ++      ++    +  +    +G+  +
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ------INLKRLLLFSSQICKGMDYL 125

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----------LAPVIARAAG 489
            +    + +H ++ + NI + S+    +SD GL  +               +P+      
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----- 177

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT----GKSPI--------HTTGGDELVHLVR 537
           + APE   + K + ASDV+SFGV L E+ T     +SP            G   +  L+ 
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            +    R           L R P+  +E+ ++++    C    P  RP   D++ +++ +
Sbjct: 238 LLKEGER-----------LPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIVDRL 283

Query: 598 R 598
           R
Sbjct: 284 R 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVE 383
           +V+G G FG  ++ IL+        V +K LK     K+  DF  +  I+G   H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-GRIPLDWDTRMRIAIGAARGIAR-IH 441
           L+         +++ +Y   G++   L    GE     L         +G  RGIA  + 
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---------VGMLRGIAAGMK 121

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT---------TITSALAPVIARAAGYRA 492
             +    VH ++ + NI +NS     VSD GL+         T T++   +  R   + A
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR---WTA 178

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           PE    RK T ASDV+SFG+V+ E+++ G+ P       E++  +               
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------------- 224

Query: 552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
              +  R P   +    + Q+ + C  +   +RP+  D+V +++ +
Sbjct: 225 ---DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 81.0 bits (201), Expect = 5e-17
 Identities = 48/204 (23%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 330 EVLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVV 382
           + +GKG+FG  Y      DG   V+K    +++       + D   +++I+  + H N++
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKE---IDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +    +  K +  +V +Y   G +S  +  ++ +   P   +  +   +     +  +H+
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSR 499
               K++H +IK  NIFL S     + D G++ +   T  LA  +     Y +PE+  ++
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178

Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SD++S G VL E+ T K P
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
             LG+G FG  +           D   V VK LK+   N  ++DFE++ E++ + +HEN+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI---------PLDWDTRMRIAIG 432
           V+        D  +MV++Y   G ++  L S   +             L     ++IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT----------SALAP 482
            A G+  + +      VH ++ + N  +       + D G++               + P
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
           +      +  PE    RK T  SDV+SFGVVL EI T GK P +    +E++  +     
Sbjct: 188 I-----RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242

Query: 542 VVR-EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           + R     +EV+D+              ML     C  R P QR  + D+   ++ 
Sbjct: 243 LQRPRTCPSEVYDI--------------ML----GCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 51/261 (19%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENV 381
           E LG+G FG  YK  L         T+V +K LK+    K  ++F Q+ E++  ++H N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAML-----------HSERGEGRIPLDWDTRMRIA 430
           V L      +    M+++Y + G +   L            S     +  LD    + IA
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSAL 480
           I  A G+  + + +    VH ++ + N  +       +SD GL+            + +L
Sbjct: 131 IQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR-- 537
            PV      +  PE     K T  SD++SFGVVL EI + G  P +     E++ ++R  
Sbjct: 188 LPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242

Query: 538 -----------WVHSVVREEW 547
                       V++++ E W
Sbjct: 243 QLLPCPEDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVE 383
           +V+G G FG   +  L    +    V +K LK  +  K   DF  +  I+G   H N++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 384 LKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           L+    +K   +M + +Y   GS+   L    G+          + +  G A G+  +  
Sbjct: 70  LEGVV-TKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTD 497
            N    VH ++ + NI +NS     VSD GL+              G     + APE   
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSP 523
            RK T ASDV+SFG+V+ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 42/277 (15%)

Query: 322 EDLLRASAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQ----MEIVGSI 376
            DL R    VLG+G+ G+ YK      G    +K++     G  +F +Q    ++ + S 
Sbjct: 1   SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSC 56

Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
               VV+    +Y + E  +V +Y   GS++ +L          L       IA    +G
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKG 111

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARA------A 488
           +  +H      ++H +IK SN+ +NS+  G V  +D G   I+  L   + +        
Sbjct: 112 LDYLHTKR--HIIHRDIKPSNLLINSK--GEVKIADFG---ISKVLENTLDQCNTFVGTV 164

Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
            Y +PE       + A+D++S G+ LLE   GK P    G      L++ +         
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP 224

Query: 549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
           AE F            E  + +     C+ + P +RP
Sbjct: 225 AEEFS----------PEFRDFISA---CLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 18/213 (8%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
             +GKG FG         G  V VK LKD +   + F  +  ++ ++RH N+V+L     
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
             +   +V +Y + GS+   L   R  GR  +    ++  A+    G+  +   N    V
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLT-----TITSALAPVIARAAGYRAPEVTDSRKATQA 504
           H ++ + N+ ++      VSD GL         S   PV      + APE    +K +  
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-----KWTAPEALREKKFSTK 179

Query: 505 SDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           SDV+SFG++L EI + G+ P       ++V  V
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 45/286 (15%)

Query: 330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVV 382
           E LG+  FG  YK  L     +    V +K LKD+N  ++  +F+Q+  ++  + H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAML-----HS-------ERGEGRIPLDWDTRMRIA 430
            L      +    M+++Y + G +   L     HS       E G  +  LD    + IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSA----LAPVIA 485
           I  A G+  + +      VH ++ + NI +  Q +  +SDLGL+  I SA    + P   
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR 544
               +  PE     K +  SD++SFGVVL EI + G  P +     E++ +VR       
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR------- 240

Query: 545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                     +LL  P  E+    M  +   C    P +RP+  D+
Sbjct: 241 --------KRQLL--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 40/284 (14%)

Query: 332 LGKGTFGMAYKAILEDGTT---VVVKRLKD-VNVGKRD-FEQQMEIVGSIRHENVVELKA 386
           +G G FG         G +   VVVK L+      ++  F Q+++    + H NV++   
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
                   L+V ++  LG +   L S RG        D   R+A   A G+  +H A+  
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDS 498
             +H ++   N  L +     + D GL          IT     V  R   + APE+ + 
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR---WLAPELVEI 176

Query: 499 R-------KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           R         T+ S+++S GV + E+ T     +    DE V     +  VVRE+     
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ----- 226

Query: 552 FDVELLRYPNIEEEMVEM-LQIAMSCVVRMPDQRPKMPDVVRVI 594
            D++L + P ++ +  +   ++   C +  P+ RP   +V  ++
Sbjct: 227 -DIKLPK-PQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 48/289 (16%)

Query: 332 LGKGTFGMAYKA------ILEDGTTVVVKRLKDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LKD  +  R DF+++ E++ +++HE++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------MRIAIGA 433
                  D  +MV++Y   G ++  L +   +  I +D   R           + IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---- 489
           A G+  + + +    VH ++ + N  + +     + D G++      +    R  G    
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS--RDVYSTDYYRVGGHTML 187

Query: 490 ---YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVRE 545
              +  PE    RK T  SDV+SFGV+L EI T GK P       E++  +         
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-------- 239

Query: 546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI 594
                     +L  P +  +  E+  I + C  R P QR  + ++ +++
Sbjct: 240 -------QGRVLERPRVCPK--EVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 40/278 (14%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVK--RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E +GKG FG  YK +L+  T V VK  R       KR F Q+ EI+    H N+V+L   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
              K    +V +    GS+   L  ++      L     +++++ AA G+  + + N   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESKN--- 113

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
            +H ++ + N  +       +SD G++        T++  L  +  +   + APE  +  
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEALNYG 170

Query: 500 KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL-L 557
           + T  SDV+S+G++L E  + G +P                +   RE        +E   
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG-----------MSNQQTRER-------IESGY 212

Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           R P  +    E+ ++ + C    P+ RP   ++   ++
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 34/214 (15%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ---QMEIVGSIRHENVVELKAY 387
           +G GTFG  Y A+ L+ G  + VK ++  +   +  ++   +M+++  ++H N+V+    
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63

Query: 388 YYS---KDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           YY      EK+ ++ +Y S G++  +L      GRI LD        +    G+A +H+ 
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLE----HGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 444 NGGKLVHGNIKSSNIFLNSQ------QYGCVSDLGLTTITSALAPVIARAAG---YRAPE 494
               +VH +IK +NIFL+         +GC   L   T  + +   +   AG   Y APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT--TTMGEEVQSLAGTPAYMAPE 173

Query: 495 VTDSRKAT---QASDVYSFGVVLLEILTGKSPIH 525
           V    K     +A+D++S G V+LE+ TGK P  
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.1 bits (195), Expect = 4e-15
 Identities = 51/146 (34%), Positives = 76/146 (52%), Gaps = 4/146 (2%)

Query: 66  KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
           ++++++ L     SG IP   + +L  L+IL L SN  TG  P    +L  L  L L  N
Sbjct: 284 QKLISLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342

Query: 126 NFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP-DLNL 183
            FSG +P +     NLT+++LS N   G IP  L +   L  L L +NSL G+IP  L  
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402

Query: 184 PN-LQQLNLANNNLSGSIPQSLKRFP 208
              L+++ L +N+ SG +P    + P
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLP 428

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  +       T V VK LK   +    F Q+ +I+  +RH+ +V+L A    +
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
           +   +V +Y S GS+   L S  GEG+  L     + +A   A G+A + + N    +H 
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKS--GEGK-KLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127

Query: 452 NIKSSNIFLNSQQYGC-VSDLGL---------TTITSALAPVIARAAGYRAPEVTDSRKA 501
           ++ + NI L  +   C ++D GL         T    A  P+      + APE  +  + 
Sbjct: 128 DLAARNI-LVGENLVCKIADFGLARLIEDDEYTAREGAKFPI-----KWTAPEAANYGRF 181

Query: 502 TQASDVYSFGVVLLEILT-GKSP 523
           T  SDV+SFG++L EI+T G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           EV+G G FG   +  L+        V +K LK       +RDF  +  I+G   H N++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR-IHA 442
           L+         +++ ++   G++ + L    G+        T +++ +G  RGIA  +  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQF-------TVIQL-VGMLRGIAAGMKY 121

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYRA 492
            +    VH ++ + NI +NS     VSD GL+          T TS+L   I     + A
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP--IRWTA 179

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           PE    RK T ASDV+S+G+V+ E+++ G+ P       ++++ +               
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-------------- 225

Query: 552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
              +  R P   +    + Q+ + C  +  + RPK   +V  ++
Sbjct: 226 ---QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 16/211 (7%)

Query: 317 YAFDLEDLLRASAEVLGKGTFGMAYKAILED--GTTVVVKRLKDVNVGKRDFEQQMEIVG 374
           +A ++++L     + +GKG FG     +L D  G  V VK +K+ +   + F  +  ++ 
Sbjct: 1   WALNMKEL--KLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKN-DATAQAFLAEASVMT 54

Query: 375 SIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
            +RH N+V+L      +   L +V +Y + GS+   L   R  GR  L  D  ++ ++  
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDV 111

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAP 493
              +  + A N    VH ++ + N+ ++      VSD GLT   S+          + AP
Sbjct: 112 CEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 168

Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           E    +K +  SDV+SFG++L EI + G+ P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 40/276 (14%)

Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQM--EIV--GSIRHENVVELKA 386
           VLGKGT+G+ Y A   D +T V   +K++      + Q +  EI     ++H N+V+   
Sbjct: 15  VLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA--RGIARIHAAN 444
                    +  +    GS+SA+L S+ G    PL  + +  I        G+  +H   
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 445 GGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG---YRAPEVTDS-- 498
             ++VH +IK  N+ +N+      +SD G +   + + P      G   Y APEV D   
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
           R     +D++S G  ++E+ TGK P    G                 E  A +F V + +
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELG-----------------EPQAAMFKVGMFK 228

Query: 559 -YPNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVVR 592
            +P I E +  E     + C    PD+R    D+++
Sbjct: 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 42/274 (15%)

Query: 331 VLGKGTFGMA--YKAILEDGTTVVVKRLKDVNV------GKRDFEQQMEIVGSIRHENVV 382
           VLGKG FG A  Y+   ED + VV    K+VN+       +RD   ++ I+  ++H N++
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVV---WKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62

Query: 383 ELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
              AYY  +  D  L++   Y+ G         +       +        I +A  ++ I
Sbjct: 63  ---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYI 117

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALAPVIARAAGYRAPEVTD 497
           H A    ++H +IK+ NIFL       + D G++ I     ++A  +     Y +PE+  
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174

Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             K    SD+++ G VL E+LT K    T      ++L   V  +V+  +T       + 
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLK---RTFDATNPLNL---VVKIVQGNYT-----PVVS 223

Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV 591
            Y +      E++ +  S + + P++RP   +V+
Sbjct: 224 VYSS------ELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 12/198 (6%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E LG+G++G  YKAI  E G  V +K +  V    ++  +++ I+       +V+    Y
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
           +   +  +V +Y   GSVS ++          L  +    I     +G+  +H+    K 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSN---KK 120

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSRKATQAS 505
           +H +IK+ NI LN +    ++D G++     T A    +     + APEV         +
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G+  +E+  GK P
Sbjct: 181 DIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 62/301 (20%)

Query: 332 LGKGTFG---MAYKAILEDGT--TVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   +     L+D T   V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 386 AYYYSKDEKLM--VYDYYSLGSVSAML--HSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
              YS   + +  V +Y   GS+   L  H ER + R  L + +++       +G+  + 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYLG 125

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----------TSALAPVIARAAGY 490
           +    + VH ++ + NI + S+    + D GLT +               +P+      +
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----W 177

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDE-----LVHLVR 537
            APE     K + ASDV+SFGVVL E+ T      SP    +   G D+     + HL+ 
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI- 236

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
               +++             R P       E+  I   C    P QRP   ++   +E +
Sbjct: 237 ---ELLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Query: 598 R 598
           R
Sbjct: 284 R 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 49/212 (23%), Positives = 101/212 (47%), Gaps = 22/212 (10%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ +++  + H  +V+L      +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
               +V+++   G +S  L ++RG+       +T + + +    G+A + ++N   ++H 
Sbjct: 72  SPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDSRKAT 502
           ++ + N  +   Q   VSD G+T           T    PV      + +PEV    K +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWSSPEVFSFSKYS 179

Query: 503 QASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
             SDV+SFGV++ E+ + GK+P       E+V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 53/287 (18%)

Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LK+ +   R DF+++ E++  ++H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI----------PLDWDTRMRIAIGAA 434
                     LMV++Y   G ++  L S   + +I           L     + IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 435 RG---IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-- 489
            G   +A +H       VH ++ + N  +       + D G++      +    R  G  
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRT 184

Query: 490 -----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
                +  PE    RK T  SD++SFGVVL EI T GK P +     E +  +       
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR--- 241

Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                      EL R      E+  ++Q    C  R P QR  + D+
Sbjct: 242 -----------ELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 34/273 (12%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  +     + T V VK LK   +  + F ++  ++ +++H+ +V L A    +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRI--PLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           +   ++ +Y + GS+   L S+ G G++  P   D   +I    A G+A I   N    +
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI----AEGMAYIERKN---YI 125

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQAS 505
           H +++++N+ ++      ++D GL  +           A +     APE  +    T  S
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 506 DVYSFGVVLLEILT-GKSPI-HTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
           DV+SFG++L EI+T GK P    +  D +  L R                    R P +E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG------------------YRMPRME 227

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
               E+  I  +C     ++RP    +  V+++
Sbjct: 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 38/264 (14%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  ++ +  + T V VK LK   +  +DF  + +I+  +RH  +++L A    +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
           +   +V +    GS+   L    G GR  L     + +A   A G+A + A N    +H 
Sbjct: 74  EPIYIVTELMKYGSLLEYLQ--GGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDSRKAT 502
           ++ + N+ +       V+D GL  +           A  P+      + APE     + +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI-----KWTAPEAALYNRFS 182

Query: 503 QASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
             SDV+SFG++L EI+T G+ P       E++  V                  +  R P 
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-----------------QGYRMPC 225

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRP 585
                 E+  I + C    PD RP
Sbjct: 226 PPGCPKELYDIMLDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 58/158 (36%), Positives = 81/158 (51%), Gaps = 20/158 (12%)

Query: 129 GTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPN 185
           G +P D S  ++L  INLS N   G IP SL ++T LE L L+ NS +G IP+    L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 186 LQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGR 245
           L+ LNL  N+LSG +P +L           S +F +N      P +   G  HL    G 
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL---LHRASFNFTDNAGLCGIPGLRACG-PHL--SVGA 545

Query: 246 RIGETTLLGIVIAASVLGLLAFLFLIV-ACCVRKKRED 282
           +IG        IA  V   +AFLFL++ A C  K+R++
Sbjct: 546 KIG--------IAFGV--SVAFLFLVICAMCWWKRRQN 573

Length = 623

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 29/270 (10%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  + A     T V VK +K  ++    F  +  ++ +++H+ +V+L A   +K
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 72

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
           +   ++ ++ + GS+   L S+ G  + PL     +  +   A G+A I   N    +H 
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGS-KQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++NI +++     ++D GL  +           A +     APE  +    T  SDV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 508 YSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM 566
           +SFG++L+EI+T G+ P       E++  +   + + R E   E                
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE---------------- 230

Query: 567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
            E+  I M C    P++RP    +  V+++
Sbjct: 231 -ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 45/289 (15%)

Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDV-NVGKRDFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LKD  +  ++DF ++ E++ +++HE++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSE------RGEGRIP--LDWDTRMRIAIGAARG 436
                  D  +MV++Y   G ++  L +         EG  P  L     + IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------- 489
           +  + + +    VH ++ + N  +       + D G++      +    R  G       
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPIR 187

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           +  PE    RK T  SDV+S GVVL EI T GK P +    +E++  +            
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT----------- 236

Query: 549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                  +L+ P    +  E+  + + C  R P  R  + ++  +++N+
Sbjct: 237 ----QGRVLQRPRTCPK--EVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 48/223 (21%), Positives = 98/223 (43%), Gaps = 20/223 (8%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ---QMEIVGSIRHENVVELK 385
           E +GKG+FG   K     DG  +V K +   N+ +++ +Q   ++ I+  ++H N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63

Query: 386 AYYYSKD-----EKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
             YY +      + L +  +Y   G ++ ++   + E +  ++ +   RI       +  
Sbjct: 64  --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-YIEEEFIWRILTQLLLALYE 120

Query: 440 IH--AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPE 494
            H  +  G  ++H ++K +NIFL++     + D GL       S+ A        Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
             +     + SD++S G ++ E+     P       +L   ++
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTRMRIAIGAARGIARIHAANGGKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D   +I    A G+A +   N    VH
Sbjct: 73  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI----ASGMAYVERMN---YVH 125

Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A +     APE     + T  SD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.0 bits (179), Expect = 2e-13
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 4/129 (3%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSV 136
           FSG IP N + + + L +L L +N +TG  P    +  +L  L L  N+  G +P     
Sbjct: 344 FSGEIPKN-LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANN 194
            ++L  + L DN F+G +P   + L  +  L ++NN+L G+I     ++P+LQ L+LA N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462

Query: 195 NLSGSIPQS 203
              G +P S
Sbjct: 463 KFFGGLPDS 471

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.0 bits (179), Expect = 2e-13
 Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 4/135 (2%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
           F+G IP   ++ L  L++L L SN  +G  P +     +L  L L  NN +G +P+    
Sbjct: 320 FTGKIP-VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
             NL  + L  N   G IP+SL     L  + L +NS SG++P     LP +  L+++NN
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438

Query: 195 NLSGSIPQSLKRFPS 209
           NL G I       PS
Sbjct: 439 NLQGRINSRKWDMPS 453

Length = 968

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 29/259 (11%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  +       T V VK LK   +    F ++ +I+  +RH+ +V+L A   S+
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
           +   +V +Y S GS+   L  + GEGR  L     + +A   A G+A I   N    +H 
Sbjct: 73  EPIYIVTEYMSKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++S+NI +       ++D GL  +         + A +     APE     + T  SDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 508 YSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM 566
           +SFG++L E++T G+ P       E++  V   +                 R P  ++  
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-----------------RMPCPQDCP 229

Query: 567 VEMLQIAMSCVVRMPDQRP 585
           + + ++ + C  + P++RP
Sbjct: 230 ISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 70.2 bits (173), Expect = 2e-13
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)

Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFEQQME----IVGSIRHENVVELKA 386
           LGKG+FG        + G    +K LK   + KR   +       I+  I H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 387 YYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHAAN 444
           Y +  +EKL +V +Y   G + + L  E   GR   +   R   A I  A  +  +H+  
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEER-ARFYAAEIVLA--LEYLHSLG 113

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSRKA 501
              +++ ++K  NI L++  +  ++D GL        +          Y APEV   +  
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
            +A D +S GV+L E+LTGK P +     E+   +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 30/225 (13%)

Query: 331 VLGKGTFG---MAY-KAILEDG--TTVVVKRL--KDVNVGKRDFEQQMEIVGSIRHENVV 382
            LG+G FG   +A  K I E+G  T V+VK L        + +F +++++   + H+NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI----PLDWDTRMRIAIGAARGIA 438
            L       +   M+ +Y  LG +   L + + +       PL    ++ +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---------SALAPVIARAAG 489
             H +N  + VH ++ + N  ++SQ+   VS L L+            +AL P+      
Sbjct: 132 --HLSN-ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL-----R 183

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
           + APE       +  SDV+SFGV++ E+ T G+ P +    +E++
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 70/298 (23%), Positives = 119/298 (39%), Gaps = 53/298 (17%)

Query: 331 VLGKGTFGMAYKAI------LEDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
            LG+G FG   KA           TTV VK LK+   +   RD   +  ++  + H +V+
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER-------------------GEGRIPLDW 423
           +L          L++ +Y   GS+ + L   R                         L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 424 DTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV 483
              +  A   +RG+  +      KLVH ++ + N+ +   +   +SD GL+         
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 484 IARAAG-----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           + R+ G     + A E       T  SDV+SFGV+L EI+T G +P      + L +L++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
             + + R E  +E                 EM  + ++C  + PD+RP   D+ + +E
Sbjct: 244 TGYRMERPENCSE-----------------EMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 27/204 (13%)

Query: 332 LGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGKRDFEQ---QMEIVGSIRHENVVEL 384
           +G+G+FG   KAIL    EDG   V+K +    +  ++ E+   ++ ++ +++H N+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARI 440
           +  +       +V DY   G +   ++++RG    E +I LDW  ++ +A+        +
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQICLAL------KHV 117

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTD 497
           H     K++H +IKS NIFL       + D G+  +   T  LA        Y +PE+ +
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 498 SRKATQASDVYSFGVVLLEILTGK 521
           +R     SD+++ G VL E+ T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFEQ---QMEIVGS 375
           DLE L       LG G  G+  K      G  + VK ++ + + +   +Q   +++I+  
Sbjct: 2   DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHK 55

Query: 376 IRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
                +V     +Y+  +  +  +Y   GS+  +L  +  +GRIP       +IA+   +
Sbjct: 56  CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLK 111

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPE 494
           G+  +H     K++H ++K SNI +NS+    + D G++  + ++LA      + Y APE
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPI 524
                  +  SD++S G+ L+E+ TG+ P 
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 62/265 (23%), Positives = 116/265 (43%), Gaps = 40/265 (15%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G FG  ++ + ++   V +K LK  ++ K +DF+++++ +  +RH++++ L A    
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVH 450
            +   ++ +    GS+ A L S   EG++ L   + + +A   A G+A +   N    +H
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSP--EGQV-LPVASLIDMACQVAEGMAYLEEQN---SIH 127

Query: 451 GNIKSSNIFLNSQQYGC-VSDLGLTTI--------TSALAPVIARAAGYRAPEVTDSRKA 501
            ++ + NI L  +   C V+D GL  +        +    P       + APE       
Sbjct: 128 RDLAARNI-LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY-----KWTAPEAASHGTF 181

Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           +  SDV+SFG++L E+ T G+ P       E+   +                     R P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-----------------TAGYRMP 224

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRP 585
              +   E+ +I + C    P+ RP
Sbjct: 225 CPAKCPQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 47/225 (20%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM--EI--VGSIRHENVVELKA 386
           +G+GT+G  YKA   + G  V +K+++  N  K  F      EI  +  +RH N+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 387 YYYSKDEK--LMVYDYYS--LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR------- 435
              SK +    MV++Y    L   + +L S              ++      +       
Sbjct: 66  IVTSKGKGSIYMVFEYMDHDL---TGLLDS------------PEVKFTESQIKCYMKQLL 110

Query: 436 -GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAP-----VIARAA 488
            G+  +H+     ++H +IK SNI +N+     ++D GL    T   +      VI    
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL-- 165

Query: 489 GYRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
            YR PE+   + +     D++S G +L E+  GK      G  EL
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ--GSTEL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 3e-12
 Identities = 44/128 (34%), Positives = 59/128 (46%), Gaps = 28/128 (21%)

Query: 56  WTGVKCSED---GKRVV-AVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDF 111
           W+G  C  D   GK  +  + L   G  G IP N IS+L  L+ ++L  N I G  P   
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP-NDISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 112 INLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLAN 171
            ++ SL                        +++LS N FNG+IP SL  LT L  L L  
Sbjct: 463 GSITSL-----------------------EVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499

Query: 172 NSLSGKIP 179
           NSLSG++P
Sbjct: 500 NSLSGRVP 507

Length = 623

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 41/280 (14%)

Query: 331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVEL 384
           V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR--IHA 442
           +         ++V +Y   GS+ A L    G+        T +++ +G  RGIA    + 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF-------TVIQL-VGMLRGIASGMKYL 122

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVT 496
           ++ G  VH ++ + NI +NS     VSD GL+ +            G      + APE  
Sbjct: 123 SDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
             RK T ASDV+S+G+V+ E+++ G+ P       +++  +                  E
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-----------------E 224

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
             R P   +    + Q+ + C  +  ++RPK   +V +++
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 6e-12
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 58/221 (26%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIR 377
           E LG+GT+G+ YKA   + G  V +K+++         + + E           ++  ++
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIR--------LDNEEEGIPSTALREISLLKELK 56

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           H N+V+L    +++ +  +V++Y  +  +   L    G    PL  +    I     RG+
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGL 111

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG------ 489
           A  H+     ++H ++K  NI +N    G +  +D GL           ARA G      
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINR--DGVLKLADFGL-----------ARAFGIPLRTY 155

Query: 490 --------YRAPEVT-DSRKATQASDVYSFGVVLLEILTGK 521
                   YRAPE+   S+  + A D++S G +  E++TGK
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 33/274 (12%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + LG G FG  +       T V +K LK  ++    F  +  ++  ++H  +V L A   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           +++   ++ +Y   GS+   L +  G   I L  +  + +A   A G+A I   N    +
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YI 124

Query: 450 HGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQA 504
           H +++++NI L S+   C ++D GL  +           A +     APE  +    T  
Sbjct: 125 HRDLRAANI-LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 505 SDVYSFGVVLLEILT-GKSPIHTTGGDELV-HLVRWVHSVVREEWTAEVFDVELLRYPNI 562
           SDV+SFG++L EI+T G+ P       E++ +L R                    R P  
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER------------------GYRMPRP 225

Query: 563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           +    E+ ++   C    P++RP    +  V+E+
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 30/212 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
           E+LG G+FG  Y+ + L+DG    VK +   + G+      +  EQ++ ++  ++H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 383 ELKAYYYSK--DEKLMVY-DYYSLGSVSAMLHSERGEGRIPL-DWDTRMRIAIGAARGIA 438
           +   Y  ++  ++ L ++ +    GS++ +L  + G    P+    TR  +      G+ 
Sbjct: 66  Q---YLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILL-----GLE 116

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPV--IARAAGYRAPE 494
            +H  N    VH +IK +NI +++   G V  +D G+       +       +  + APE
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTN--GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171

Query: 495 VTDSRKA-TQASDVYSFGVVLLEILTGKSPIH 525
           V   +     A+D++S G  +LE+ TGK P  
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 29/221 (13%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFE-QQMEIV--GSIRHENVVELK 385
           + +G+G+FG  Y A  + D    V+K +    +  ++ E  + E++    ++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARIH 441
           A +       +V +Y   G +   ++ +RG    E +I L W  ++      + G+  IH
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFVQI------SLGLKHIH 118

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI------TSALAPVIARAAGYRAPEV 495
                K++H +IKS NIFL+    G V+ LG   I      +  LA        Y +PE+
Sbjct: 119 DR---KILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             +R     +D++S G VL E+ T K P     G+ L  LV
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 38/286 (13%)

Query: 317 YAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVV-VKRL----KDVNVGKRDFEQQME 371
           Y  D E++     E+ G G+FG  Y A       VV VK++    K  N   +D  ++++
Sbjct: 15  YKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 372 IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI 431
            +  ++H N +E K  Y  +    +V +Y  LGS S +L   +     PL       I  
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK----PLQEVEIAAITH 128

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR 491
           GA +G+A +H+ N   ++H +IK+ NI L       ++D G  + +S     +     + 
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-WM 184

Query: 492 APEV---TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVRE-E 546
           APEV    D  +     DV+S G+  +E+   K P+        L H+ +     ++  E
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244

Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           WT                  V+       C+ ++P +RP   +++R
Sbjct: 245 WTDSF------------RGFVDY------CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)

Query: 330 EVLGKGTFGMAYKAILED---GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           E++G+G FG    A+L+    G  V VK +K  +V  + F ++  ++  + H+N+V L  
Sbjct: 12  EIIGEGEFG----AVLQGEYTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
                   + V +  S G++   L   R  GR  +     ++ ++  A G+  + +    
Sbjct: 67  VILHNGLYI-VMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK--- 119

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASD 506
           KLVH ++ + NI ++      VSD GL  + S           + APE    +K +  SD
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179

Query: 507 VYSFGVVLLEILT-GKSP 523
           V+S+GV+L E+ + G++P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 68/283 (24%), Positives = 105/283 (37%), Gaps = 62/283 (21%)

Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVE 383
           + LG G+FG+     +         V VK LK   +     DF ++  I+ S+ HEN++ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 384 LKAYYYSKDEKLM-VYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARGIARIH 441
           L  Y       LM V +   LGS+   L  +  G   I    D  ++IA     G+  + 
Sbjct: 61  L--YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLE 114

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YR----- 491
           +      +H ++ + NI L S     + D GL            RA       Y      
Sbjct: 115 SKR---FIHRDLAARNILLASDDKVKIGDFGLM-----------RALPQNEDHYVMEEHL 160

Query: 492 -------APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
                  APE   +R  + ASDV+ FGV L E+ T G+ P     G +++  +       
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI------- 213

Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK 586
                    D E  R    E    ++  + + C    P  RP 
Sbjct: 214 ---------DKEGERLERPEACPQDIYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 39/287 (13%)

Query: 325 LRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHE 379
           L +    +G G+FG  Y A  + +   V +K++    K  N   +D  +++  +  +RH 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           N ++ +  Y  +    +V +Y  LGS S +L   +     PL       +  GA +G+A 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAY 130

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV---T 496
           +H+ N   ++H ++K+ NI L+      + D G  +I +     +     + APEV    
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY-WMAPEVILAM 186

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFDVE 555
           D  +     DV+S G+  +E+   K P+        L H+ +     ++    +E F   
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF--- 243

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV---RVIENVRP 599
                      V+      SC+ ++P  RP   +V+   R +   RP
Sbjct: 244 --------RNFVD------SCLQKIPQDRP-TSEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 37/213 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           + +G GT+G  YKA  +  G  V +K +K +        +Q++ ++   RH N+V   AY
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AY 65

Query: 388 Y--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           +  Y + +KL +V +Y   GS+  +        R PL       +     +G+A +H   
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLSELQIAYVCRETLKGLAYLHET- 120

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTT-ITSALA--------PVIARAAGYRAP 493
               +H +IK +NI L     G V  +D G++  +T+ +A        P       + AP
Sbjct: 121 --GKIHRDIKGANILLTED--GDVKLADFGVSAQLTATIAKRKSFIGTPY------WMAP 170

Query: 494 EVTDSRKA---TQASDVYSFGVVLLEILTGKSP 523
           EV    +        D+++ G+  +E+   + P
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 58/297 (19%), Positives = 115/297 (38%), Gaps = 74/297 (24%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR---------HENV 381
           +G+GT+G+ YKA     G  V +K++      K  FE +     ++R         H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           ++L   +  K +  +V+++        +   +R      L             +G+A  H
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCH 115

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------------ 489
           +     ++H ++K  N+ +N++    ++D GL           AR+ G            
Sbjct: 116 SHG---ILHRDLKPENLLINTEGVLKLADFGL-----------ARSFGSPVRPYTHYVVT 161

Query: 490 --YRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE 546
             YRAPE+    +  +   D++S G +  E+L+ + P+   G  E+            ++
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-PLF-PGKSEI------------DQ 207

Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE 603
              ++F    L  P+  E   +   +A +     P +   MP     +  + PN S 
Sbjct: 208 LF-KIFRT--LGTPD-PEVWPKFTSLARNYKFSFPKK-AGMP-----LPKLFPNASP 254

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 57/266 (21%), Positives = 124/266 (46%), Gaps = 30/266 (11%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKA 386
           +G+G F   Y+A  L DG  V +K+++  ++     + D  ++++++  + H NV++  A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +   +E  +V +    G +S M+   + + R+ +   T  +  +     +  +H+    
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMHSR--- 125

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
           +++H +IK +N+F+ +     + DLGL    S+         G   Y +PE         
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            SD++S G +L E+   +SP +   GD++      ++S+ ++        +E   YP + 
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFY---GDKMN-----LYSLCKK--------IEQCDYPPLP 229

Query: 564 EEMV--EMLQIAMSCVVRMPDQRPKM 587
            +    E+ Q+   C+   P++RP +
Sbjct: 230 SDHYSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 4e-11
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 55/222 (24%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVELK 385
            +G G +G+   A+    G  V +K++     D+   KR   ++++++  +RHEN++ L 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLL 65

Query: 386 AYYYSKD----EKL-MVYDYYS--LGSVSAMLHSERGEGRIPLDWDTRMR-IAIGAARGI 437
                        + +V +     L  V   + S +     PL  D  ++       RG+
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETDLHKV---IKSPQ-----PLT-DDHIQYFLYQILRGL 116

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------- 489
             +H+AN   ++H ++K SNI +NS     + D GL           AR           
Sbjct: 117 KYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL-----------ARGVDPDEDEKGF 162

Query: 490 ---------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                    YRAPE+   S + T+A D++S G +  E+LT K
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +I+  +RH+ +V L A   S+
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
           +   +V ++   GS+   L  + G+G+  L     + +A   A G+A I   N    +H 
Sbjct: 73  EPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++NI +       ++D GL  +         + A +     APE     + T  SDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 508 YSFGVVLLEILT-GKSP 523
           +SFG++L E++T G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 51/290 (17%)

Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+ +       E  T V +K + +  ++ +R +F  +  ++      +VV 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIA 438
           L     +    L+V +  + G + + L S R E     G  P      +++A   A G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAA 488
            + A    K VH ++ + N  +       + D G+T               L PV  R  
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV--R-- 186

Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + APE       T  SDV+SFGVVL E+ T  + P      +E++              
Sbjct: 187 -WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF------------ 233

Query: 548 TAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
              V D   L  P N  ++++E++++   C    P  RP   ++V  +++
Sbjct: 234 ---VIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 54/295 (18%)

Query: 330 EVLGKGTFGMAYKAIL--EDGTT--VVVKRLKDVNVGKRDFEQQMEIVGSIR---HENVV 382
           ++LG+G FG   +  L  +DG+   V VK +K       + E+ +     ++   H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 383 ELKAYYYSKDEK------LMVYDYYSLGSVSAMLHSERGEG---RIPLDWDTRMRIAIGA 433
           +L    +           +++  +   G + + L   R  G   ++PL   T ++  +  
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDI 122

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITS---------ALAPV 483
           A G+  +   N    +H ++ + N  L      CV+D GL+  I S         A  PV
Sbjct: 123 ALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSV 542
                 + A E    R  T  SDV++FGV + EI T G++P       E+   +R  +  
Sbjct: 180 -----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR- 233

Query: 543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         L+ P  E+ + E+  +  SC    P  RP    +  V+EN+
Sbjct: 234 --------------LKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E+LGKG FG  +K  L+D T V VK  K+      K  F  +  I+    H N+V+L   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
              +    +V +    G   + L  ++ E    L     ++ A+ AA G+A + + N   
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLESKN--- 113

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTT-------ITSALAPVIARAAGYRAPEVTDSRK 500
            +H ++ + N  +       +SD G++         +S L  +  +   + APE  +  +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---WTAPEALNYGR 170

Query: 501 ATQASDVYSFGVVLLEILT 519
            +  SDV+S+G++L E  +
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.6 bits (154), Expect = 7e-11
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 28/226 (12%)

Query: 309 LFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTT---VVVKRL----KDVNV 361
           LFF E      D E L     E+ G G+FG  Y A   D  T   V +K++    K  N 
Sbjct: 17  LFFKE------DPEKLFTDLREI-GHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNE 67

Query: 362 GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPL 421
             +D  ++++ +  I+H N +E K  Y  +    +V +Y  LGS S +L   +     PL
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKK----PL 122

Query: 422 DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA 481
                  I  GA +G+A +H+ N   ++H +IK+ NI L       ++D G  +I S   
Sbjct: 123 QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179

Query: 482 PVIARAAGYRAPEV---TDSRKATQASDVYSFGVVLLEILTGKSPI 524
             +     + APEV    D  +     DV+S G+  +E+   K P+
Sbjct: 180 SFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 331 VLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVV 382
           VLG G FG  YK + + +G      V +K L++     +  +    +  ++ S+ H +VV
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVDHPHVV 72

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARI 440
            L     S   +L +     LG +   + + +     +  L+W  ++      A+G++ +
Sbjct: 73  RLLGICLSSQVQL-ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEV 495
                 +LVH ++ + N+ + + Q+  ++D GL  +            G     + A E 
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSP 523
              R  T  SDV+S+GV + E++T G  P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 56/264 (21%), Positives = 117/264 (44%), Gaps = 34/264 (12%)

Query: 335 GTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEK 394
           GT  MA K +     + V K++           ++++I+   R   +V     + +++  
Sbjct: 30  GTV-MAKKVVHIGAKSSVRKQIL----------RELQIMHECRSPYIVSFYGAFLNENNI 78

Query: 395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIK 454
            M  ++   GS+  +    +  G IP++     +IA+    G+  ++  N  +++H +IK
Sbjct: 79  CMCMEFMDCGSLDRIY---KKGGPIPVE--ILGKIAVAVVEGLTYLY--NVHRIMHRDIK 131

Query: 455 SSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVV 513
            SNI +NS+    + D G++  + +++A      + Y +PE     K T  SDV+S G+ 
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191

Query: 514 LLEILTGK-----SPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVE 568
           ++E+  GK     S I   G D+ + ++  +  +V+E             +P    + V+
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS----DFPEDLRDFVD 247

Query: 569 MLQIAMSCVVRMPDQRPKMPDVVR 592
                  C+++ P +RP    +  
Sbjct: 248 A------CLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 44/197 (22%), Positives = 85/197 (43%), Gaps = 26/197 (13%)

Query: 341 YKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL- 395
           YK I  +   V+++  K       V     E +++ +  I   N++++  +     + L 
Sbjct: 37  YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 396 ---MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGN 452
              ++ +Y + G +  +L  E+      L + T++ +AI   +G+  ++        + N
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 453 IKSSNIFLNSQQY----GCVSDLGLTTITSALAPVIARAAGYRAPEVTDS--RKATQASD 506
           + +S  FL ++ Y     C    GL  I S+          Y + ++ +    + T   D
Sbjct: 149 L-TSVSFLVTENYKLKIIC---HGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204

Query: 507 VYSFGVVLLEILTGKSP 523
           +YS GVVL EI TGK P
Sbjct: 205 IYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 25/227 (11%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK-DVNVGKRDFEQQM--EIVGSIRHEN--VVE 383
           +VLGKG+FG    A L+  G    VK LK DV +   D E  M  + V ++  EN  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L   + +K+    V ++ + G +  M H +  +GR  L      R    AA  +  +   
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFHIQD-KGRFDL-----YRATFYAAEIVCGLQFL 112

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRK 500
           +   +++ ++K  N+ L+   +  ++D G+          A        Y APE+    K
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWV 539
            T + D +SFGV+L E+L G+SP H    DEL         H  RW+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 55/245 (22%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS--------------- 375
           LG+GT+G   KA     G  V +K++K +     D  +  ++VG                
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 376 -IRHENVVELKAYYYSKDEKLMVYDY--YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG 432
            I+HEN++ L   Y   D   +V D     L  V         + +I L       I + 
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV--------DRKIRLTESQVKCILLQ 127

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
              G+  +H       +H ++  +NIF+NS+    ++D GL        P  +       
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA--RRYGYPPYSDTLSKDE 182

Query: 490 ----------------YRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                           YRAPE +  + K   A D++S G +  E+LTGK      G +E+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--PGENEI 240

Query: 533 VHLVR 537
             L R
Sbjct: 241 DQLGR 245

Length = 335

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 58/299 (19%)

Query: 332 LGKGTFGMAYKA----ILED----GTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A    I +D      TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIP---LDWDTRMRI 429
           ++ L           ++ +Y S G++   L + R  G        ++P   L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
           A   ARG+  + +    K +H ++ + N+ +       ++D GL             T+ 
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW 538
             PV      + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++ 
Sbjct: 197 RLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            H + +                       E+  I   C   +P QRP    +V  ++ V
Sbjct: 252 GHRMDKPANCTH-----------------ELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 43/204 (21%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQ----QMEIVGSIRHENVVELKA 386
           V+G+G FG+ +    +    +V+ +   V    +D       + +++  + H N++E   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE--- 63

Query: 387 YYYS--KDEKLMVYDYYSLGSVSAMLHSERGEGRIP----LDWDTRMRIAIGAARGIARI 440
           YY +  +D+ LM+   Y+ G   A    +R    +     L +  ++ +A+        +
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHV 117

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTI--TSALAPVIARAAGYRAPEVTD 497
           H      ++H ++K+ NI L+  +    + D G++ I  + + A  +     Y +PE+ +
Sbjct: 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174

Query: 498 SRKATQASDVYSFGVVLLEILTGK 521
            +   Q SD+++ G VL E+ + K
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V + K +    +    ++ + RH  +
Sbjct: 1   KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTRMRIAIGAARGIAR 439
             LK  + +KD    V +Y + G +   L  ER   E R      TR       A  ++ 
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR------TRFY----GAEIVSA 107

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--IT-SALAPVIARAAGYRAPEVT 496
           +   + GK+V+ ++K  N+ L+   +  ++D GL    IT +A          Y APEV 
Sbjct: 108 LDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 49/250 (19%)

Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE--- 367
           F GC+   D E L       LG+GTFG  YKA  ++ G  V +K++  ++  K  F    
Sbjct: 1   FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITA 54

Query: 368 -QQMEIVGSIRHENVVEL--KAYYYSKDEK------LMVYDYYSLGSVSAMLHSER---G 415
            ++++I+  ++H NVV L   A       K       MV  Y     +S +L +      
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLT 113

Query: 416 EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT 475
           E +I           +    GI  +H      ++H +IK++NI +++Q    ++D GL  
Sbjct: 114 ESQIKC-------YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Query: 476 ITSALAPVIARAAG--------------YRAPE-VTDSRKATQASDVYSFGVVLLEILTG 520
                 P      G              YR PE +   R+ T A D++  G V  E+ T 
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Query: 521 KSPIHTTGGD 530
           + PI     D
Sbjct: 224 R-PILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 58/305 (19%)

Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG   +A          +   TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIP---LDWDTRMRI 429
           ++ L      +    ++ +Y + G++   L + R  G        ++P   L +   +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
           A   ARG+  + +    + +H ++ + N+ +       ++D GL             ++ 
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW 538
             PV      + APE    R  T  SDV+SFG+++ EI T G SP      +EL  L+R 
Sbjct: 197 RLPV-----KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
            H + +                N   E+  +++    C   +P QRP    +V  ++ V 
Sbjct: 252 GHRMDKP--------------SNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVL 294

Query: 599 PNDSE 603
              SE
Sbjct: 295 AAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRD--FEQQM--EI--VGSIRHENVVEL 384
           +G+G  G+ +KA   E G TV +K+   V + + +     Q   EI  + + +H  VV+L
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKK---VALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +       ++   Y    +S +L  E      PL             +G+A +HA  
Sbjct: 65  LDVF-PHGSGFVLVMEYMPSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP------VIARAAGYRAPEVT-D 497
              ++H ++K +N+ +++     ++D GL  + S   P      V  R   YRAPE+   
Sbjct: 120 ---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW--YRAPELLYG 174

Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGD 530
           +RK     D+++ G +  E+L G SP+     D
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNG-SPLFPGEND 206

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 15/205 (7%)

Query: 352 VVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLH 411
           + KR+K  +      E ++  +G + HEN+++++    S+    M+   Y     S M  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 412 SERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL 471
                   PL   TR  I       +  IH     KL+H +IK  NIFLN      + D 
Sbjct: 256 EAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 472 GLTTITSALAPVIARAAGY------RAPEVTDSRKATQASDVYSFGVVLLEILTGK-SPI 524
           G  T         A   G+       +PE+       + +D++S G++LL++L+    PI
Sbjct: 312 G--TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369

Query: 525 HTTGGDELVHLVRWVH--SVVREEW 547
              GG     L++ +   SV  EE+
Sbjct: 370 GDGGGKPGKQLLKIIDSLSVCDEEF 394

Length = 501

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 58/299 (19%)

Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIP---LDWDTRMRI 429
           ++ L           ++ +Y S G++   L + R  G        R+P   + +   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
               ARG+  + +    K +H ++ + N+ +       ++D GL             T+ 
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW 538
             PV      + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++ 
Sbjct: 200 RLPV-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            H + +                N   E+  M++    C   +P  RP    +V  ++ +
Sbjct: 255 GHRMDKP--------------ANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 28/177 (15%)

Query: 376 IRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
           + H +V+ +K    S     MV  +YS    + +    R     PL  D  + I      
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILE 168

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA----AG-- 489
           G+  +HA    +++H ++K+ NIF+N     C+ DLG     +A  PV+A A    AG  
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG-----AAQFPVVAPAFLGLAGTV 220

Query: 490 -YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT---TGGDELV-----HLVR 537
              APEV    K    +D++S G+VL E+L   S I     +  +E V     HL++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Length = 357

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 44/292 (15%)

Query: 330 EVLGKGTFGMAYKAIL------EDGT--TVVVKRLKDVN--VGKRDFEQQMEIVGSIRHE 379
            VLG+G FG   K  L       DGT   V VK LK          +++++ I+ ++ HE
Sbjct: 10  RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 380 NVVELKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           N+V+ K     +  K   ++ +Y  LGS+   L   +      L+    +  A     G+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGM 120

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YR 491
           A +H+      +H ++ + N+ L++ +   + D GL   +         R  G     + 
Sbjct: 121 AYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTA 549
           A E     K + ASDV+SFGV L E+LT      +     +E++   +   +VVR     
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL---- 233

Query: 550 EVFDVELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
               +ELL    R P  +    E+  +  +C       RP    ++ +++ +
Sbjct: 234 ----IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK-DVNVGKRDFEQQM--EIVGSI--RHENVVE 383
           ++LGKG+FG  + A L+       +K LK DV +   D E  M  + V S+   H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L   + +K+    V +Y + G +  M H +    +  L      R    AA  I  +   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCH-KFDLP-----RATFYAAEIICGLQFL 112

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRK 500
           +   +V+ ++K  NI L++  +  ++D G+     +  A          Y APE+   +K
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
              + D +SFGV+L E+L G+SP H    +EL   +R
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 31/232 (13%)

Query: 334 KGTFGMAYKA------------ILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV 381
           KG FG  Y A            +L+    +   ++ +V   +     Q E         V
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE------SPYV 59

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
            +L   + SKD   +V +Y + G  ++++   +  G +P DW  +  IA     G+  +H
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIA-EVVLGVEDLH 114

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKA 501
                 ++H +IK  N+ ++   +  ++D GL+               Y APE       
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-GLENKKFVGTPDYLAPETILGVGD 170

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
            + SD +S G V+ E L G  P H    D +      +   +   W  EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDNILSRRI--NWPEEVKE 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 57/272 (20%), Positives = 121/272 (44%), Gaps = 30/272 (11%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKA 386
           +G+G F   Y+A  L D   V +K+++   +     ++D  ++++++  + H NV++   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +   +E  +V +    G +S M+   + + R+ +   T  +  +     +  +H+    
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSR--- 125

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
           +++H +IK +N+F+ +     + DLGL    S+         G   Y +PE         
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            SD++S G +L E+   +SP +   GD++ +L                  +E   YP + 
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFY---GDKM-NLFSLCQK------------IEQCDYPPLP 229

Query: 564 EEMV--EMLQIAMSCVVRMPDQRPKMPDVVRV 593
            E    ++ ++   C+   PDQRP +  V ++
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRL----KDVNVGKRDFEQQMEIVG---SIRHENVV 382
           EVLGKG +G  Y  +   G  + VK++     +V   ++++E+  E V    S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +        +   +  ++   GS+S++L+             T+  +      G+A +H 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQ------QYGCVSDLGLTTITSALAPVIARAAG---YRAP 493
                +VH +IK +N+ L          +GC   L    +    + ++    G   + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
           EV +     + SD++S G  + E+ TGK P+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 61/300 (20%)

Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVE 383
           +G+G FG  ++A        E  T V VK LK+      + DF+++  ++    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSER-----------------GEGRIPLDWDTR 426
           L           ++++Y + G ++  L                     G   +PL    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 427 MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSA------ 479
           + IA   A G+A +   +  K VH ++ + N  +       ++D GL+  I SA      
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 480 ---LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL 535
                P+      +  PE     + T  SDV+++GVVL EI + G  P +    +E+++ 
Sbjct: 190 ENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244

Query: 536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           VR               D  +L  P  +   +E+  +   C  ++P  RP    + R+++
Sbjct: 245 VR---------------DGNVLSCP--DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.7 bits (143), Expect = 2e-09
 Identities = 47/225 (20%), Positives = 93/225 (41%), Gaps = 67/225 (29%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ---------QMEIVGSIRHENV 381
           LG+GT+ + YKA   E G  V +K++K   +G+R   +         +++++  ++H N+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRM-----RIAIGAA-- 434
           + L   +  K    +V+++                    ++ D         I +  A  
Sbjct: 65  IGLLDVFGHKSNINLVFEF--------------------METDLEKVIKDKSIVLTPADI 104

Query: 435 --------RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAP-- 482
                   RG+  +H+     ++H ++K +N+ + S   G +  +D GL       +P  
Sbjct: 105 KSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD--GVLKLADFGLARSFG--SPNR 157

Query: 483 -----VIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGK 521
                V+ R   YRAPE+   +R      D++S G +  E+L   
Sbjct: 158 KMTHQVVTRW--YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 71/287 (24%), Positives = 111/287 (38%), Gaps = 59/287 (20%)

Query: 332 LGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-------GKRDFEQQME---IVGSIRHEN 380
           LG+GTF   YK +L       +V   ++V+V         RD     E   ++  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           +V+L      +DE +MV +Y   G +   LH E+    + L W  ++ +A   A  +   
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASAL--- 114

Query: 441 HAANGGKLVHGNIKSSNIFL--NSQQYGCVSDLGLTTITSALAPVIARAAGYR------- 491
           H     KLVHGN+   NI +       G V  + L+       P I      R       
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD------PGIPITVLSREERVERI 168

Query: 492 ---APEV--TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVRE 545
              APE         T A+D +SFG  LLEI + G+ P+ T    E     +  H +   
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP 228

Query: 546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           +  AE+    L+                  C    P +RP    ++R
Sbjct: 229 DC-AELA--NLI----------------NQCWTYDPTKRPSFRAILR 256

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 34/217 (15%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFE-----QQMEIVGSIRHENVVEL 384
           EV+G G   + Y AI       V   +K +++ K         ++++ +    H NVV  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVA--IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV-- 62

Query: 385 KAYYYS---KDEKLMVYDYYSLGSV-SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
             YY S    DE  +V  Y S GS+   M  S    G   LD      +     +G+  +
Sbjct: 63  -KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLKGLEYL 118

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR--------- 491
           H+ NG   +H +IK+ NI L       ++D G   ++++LA    R    R         
Sbjct: 119 HS-NG--QIHRDIKAGNILLGEDGSVKIADFG---VSASLADGGDRTRKVRKTFVGTPCW 172

Query: 492 -APEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHT 526
            APEV +        +D++SFG+  +E+ TG +P   
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 58/299 (19%)

Query: 332 LGKGTFG--MAYKAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG  +  +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIP---LDWDTRMRI 429
           ++ L           ++ +Y S G++   L + R  G        ++P   L +   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
           A   ARG+  + +    K +H ++ + N+ +       ++D GL             T+ 
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW 538
             PV      + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++ 
Sbjct: 203 RLPV-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            H + +                N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 258 GHRMDKPS--------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 39/274 (14%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++  + HE +V+L      +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
               +V +Y S G +   L     E          + +      G+A + +    + +H 
Sbjct: 72  RPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALA---PVIARAAGYRAPEVTDSRKAT 502
           ++ + N  ++ Q    VSD GL+        TS++    PV      +  PEV    K +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-----RWSPPEVLLYSKFS 179

Query: 503 QASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
             SDV++FGV++ E+ + GK P       E V  V     + R               P+
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------------PH 224

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           +  E V    I  SC     ++RP    ++  IE
Sbjct: 225 LASEKV--YAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 57/274 (20%), Positives = 125/274 (45%), Gaps = 39/274 (14%)

Query: 331 VLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVVELKA 386
           V+GKG++G ++      DG   V+K+L   N  +R+    EQ+ +++  ++H N+V  + 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 387 YYYSKDEKL-MVYDYYSLGSVSAMLHSERGE---GRIPLDWDTRMRIAIGAARGIARIHA 442
            +  +D  L +V  +   G +   L  ++G+       ++W  ++ +A+        +H 
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVIARAAGYRAPEVTDSR 499
            +   ++H ++K+ N+FL       V DLG+  +      +A  +     Y +PE+  ++
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
                SDV++ G  + E+ T K   +    + LV+                + + +L   
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY---------------RIIEGKLPPM 222

Query: 560 P-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           P +   E+ E++   +S   + P++RP +  ++R
Sbjct: 223 PKDYSPELGELIATMLS---KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +    TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVH 450
           +    ++ ++ + G+   +L   R   R  ++    + +A   +  +  +   N    +H
Sbjct: 74  EPPFYIITEFMTYGN---LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVIAR-AAGYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +     A   A+    + APE     K +  SD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 507 VYSFGVVLLEILT-GKSP 523
           V++FGV+L EI T G SP
Sbjct: 188 VWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 61/273 (22%), Positives = 127/273 (46%), Gaps = 32/273 (11%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKA 386
           +GKG F + YKAI L DG  V +K+++   +     ++D  ++++++  + H NV++  A
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +   +E  +V +    G +S M+   + + R  +   T  +  +     +  +H+    
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMHSK--- 125

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
           +++H +IK +N+F+ +     + DLGL    S+         G   Y +PE         
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT---AEVFDVELLRYP 560
            SD++S G +L E+   +SP +   GD++ +L      + + ++    A+ +  EL    
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFY---GDKM-NLYSLCKKIEKCDYPPLPADHYSEEL---- 237

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV 593
               ++V        C+   P++RP +  V++V
Sbjct: 238 ---RDLVSR------CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 14/209 (6%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE 379
           D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  +   
Sbjct: 1   DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 380 NVVELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           +   +  YY  Y KD KL +   Y LG  SA+   E G    PLD      I     +G+
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEY-LGGGSALDLLEPG----PLDETQIATILREILKGL 114

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPE 494
             +H+    K +H +IK++N+ L+      ++D G+    T T            + APE
Sbjct: 115 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSP 523
           V         +D++S G+  +E+  G+ P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 19/205 (9%)

Query: 331 VLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFE----QQMEIVGSIRHENVVELK 385
           VLGKG FG +    +   G     K+L+   + KR  E     + +I+  +    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR---GIARIHA 442
             Y +KD   +V    + G +   ++   GE           R    AA    G+  +H 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE-----EGRAVFYAAEICCGLEDLHQ 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRK 500
               ++V+ ++K  NI L+   +  +SDLGL         +  R    GY APEV  + +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177

Query: 501 ATQASDVYSFGVVLLEILTGKSPIH 525
            T + D ++ G +L E++ G+SP  
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 17/216 (7%)

Query: 331 VLGKGTFGMAYKAILEDGTTV-VVKRLK-DVNVGKRDFEQQM---EIVG-SIRHENVVEL 384
           VLGKG+FG    A L+       +K LK DV +   D E  M    ++  +  H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              + +K+    V +Y + G +  M H +   GR         R    AA  I  +   +
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL--MFHIQS-SGRFDEA-----RARFYAAEIICGLQFLH 113

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGL--TTIT-SALAPVIARAAGYRAPEVTDSRKA 501
              +++ ++K  N+ L+   +  ++D G+    +     A        Y APE+   +K 
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
            ++ D +SFGV+L E+L G+SP H    DEL   + 
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 22/212 (10%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+ +         V +K +++  + + DF ++ +++  + H N+V+L      +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
               +V +Y + G +   L   +G+       +  + +       +  + +      +H 
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 452 NIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPEVTDSRKAT 502
           ++ + N  +       VSD GL         T+      PV      +  PEV D  + +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-----KWAPPEVFDYSRFS 179

Query: 503 QASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
             SDV+SFGV++ E+ + GK P       E+V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 59/273 (21%), Positives = 113/273 (41%), Gaps = 39/273 (14%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+ +         V +K + +  + + DF ++ +++  + H  +V+L      +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHG 451
               +V ++   G +   L   +G+    L  D  + +      G+  +   +    +H 
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 452 NIKSSNIFLNSQQYGCVSDLGLTT-------ITSALA--PVIARAAGYRAPEVTDSRKAT 502
           ++ + N  ++S     VSD G+T         +S+ A  PV      +  PEV +  K +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV-----KWSPPEVFNFSKYS 179

Query: 503 QASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
             SDV+SFGV++ E+ T GK P       E+V ++     + R               P 
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------------PK 224

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI 594
           +    V   ++  SC    P+ RP   +++R I
Sbjct: 225 LASMTV--YEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 56/293 (19%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           + LG+G FG   KA         + +TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTR---MRI 429
           ++ L      +    +V +Y + G++   L + R  G        R P +  T+   +  
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
           A   ARG+  + +    K +H ++ + N+ +       ++D GL             T+ 
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW 538
             PV      + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++ 
Sbjct: 195 RLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249

Query: 539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV 591
            +   R E           +  N  +E+  ++     C   +P QRP    +V
Sbjct: 250 GY---RME-----------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 72/288 (25%), Positives = 115/288 (39%), Gaps = 40/288 (13%)

Query: 331 VLGKGTFGMAYKAIL--EDGT--TVVVKRLKDVNVGKRDFEQQMEIVGSIR---HENVVE 383
           +LGKG FG   +A L  EDG+   V VK LK       D E+ +     ++   H NV++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 384 LKAYYYSKDEK------LMVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARG 436
           L         K      +++  +   G +   L   R GE    L   T +R  I  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSA----LAPVIARAAGYR 491
           +  + + N    +H ++ + N  LN     CV+D GL+  I S               + 
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           A E       T  SDV++FGV + EI+T G++P     G E   +  ++    R      
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY---AGVENSEIYNYLIKGNR------ 233

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
                L + P+  E++ E++     C    P  RP    +   +E + 
Sbjct: 234 -----LKQPPDCLEDVYELMC---QCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 53/296 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVEL 384
            ++G+G++GM  K    E G  V +K+      D  V K    +++ ++  +RHEN+V L
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRHENLVNL 65

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +  K    +V+++     +  +     G     LD     +      RGI   H+ N
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHN 120

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARAAG---YRAPE--VTD 497
              ++H +IK  NI L SQ  G V   D G     +A   V         YRAPE  V D
Sbjct: 121 ---IIHRDIKPENI-LVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 498 SRKATQASDVYSFGVVLLEILTGK------SPIHTTGGDELVHLVRWVHSVVREEWT--- 548
           + K  +A D+++ G ++ E+LTG+      S I     D+L H+++ + +++        
Sbjct: 176 T-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYHIIKCLGNLIPRHQEIFQ 229

Query: 549 ----------AEVFDVELL--RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                      EV ++E L  R+P +   ++++ +    C+   PD RP    ++ 
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK---QCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 60/234 (25%), Positives = 111/234 (47%), Gaps = 50/234 (21%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQ--------QMEIVGSIRHENV 381
           E LG+GT+   YK    + TT  +  LK++++   D E+        ++ ++  ++HEN+
Sbjct: 6   EKLGEGTYATVYKG--RNRTTGEIVALKEIHL---DAEEGTPSTAIREISLMKELKHENI 60

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAM-LHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           V L    +++++ ++V++Y        M  H  RG     LD +T         +GIA  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFC 116

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----------- 489
           H     +++H ++K  N+ +N +    ++D GL           ARA G           
Sbjct: 117 HE---NRVLHRDLKPQNLLINKRGELKLADFGL-----------ARAFGIPVNTFSNEVV 162

Query: 490 ---YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVR 537
              YRAP+V   SR  + + D++S G ++ E++TG+ P+   T   D+L+ + R
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 331 VLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFE----QQMEIVGSIRHENVVELK 385
           VLGKG FG +    +   G     K+L+   + KR  E     + +I+  +    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR---GIARIHA 442
             Y +KD   +V    + G +   +++  G            R    AA    G+  +H 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFD-----EERAVFYAAEITCGLEDLHR 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRK 500
                +V+ ++K  NI L+   +  +SDLGL         +  R    GY APEV  + +
Sbjct: 121 ER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER 177

Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
            T + D +  G ++ E++ GKSP
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 37/223 (16%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQ---MEIVGS 375
           DL+DL       +G+G FG   K + +  GT + VKR++     K   EQ+   M++   
Sbjct: 5   DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK---EQKRLLMDLDVV 56

Query: 376 IRHENVVELKAYY---YSKDEKLMVYDYY--SLGSVSAMLHSERGEGRIPLDWDTRMRIA 430
           +R  +   +  +Y   + + +  +  +    SL      ++ E  +  IP      +   
Sbjct: 57  MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-EVLKSVIP----EEILGK 111

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARA- 487
           I  A   A  +     K++H ++K SNI L+    G +   D G   I+  L   IA+  
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRN--GNIKLCDFG---ISGQLVDSIAKTR 166

Query: 488 -AG---YRAPEVTDSRKATQ---ASDVYSFGVVLLEILTGKSP 523
            AG   Y APE  D          SDV+S G+ L E+ TGK P
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 37/216 (17%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVG-------SIRHENV 381
           +V+GKG+FG    A  + DG+   VK L+   + K+  ++Q  I+        +++H  +
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK--KEQNHIMAERNVLLKNLKHPFL 58

Query: 382 VELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIAR 439
           V L  Y +   EKL  V DY + G +   L  ER         + R R  A   A  I  
Sbjct: 59  VGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGY 111

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGY 490
           +H+ N   +++ ++K  NI L+SQ +  ++D GL         TT T    P       Y
Sbjct: 112 LHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP------EY 162

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT 526
            APEV       +  D +  G VL E+L G  P ++
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 33/207 (15%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           +G G +G    A+    G  V +K+L    +     KR + +++ ++  ++HENV+ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGL-L 80

Query: 387 YYYSKDEKLMVY-DYY--------SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
             ++ D  L  + D+Y         LG +  M H +  E RI         +     +G+
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKL--MKHEKLSEDRIQF-------LVYQMLKGL 131

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT--TITSALAPVIARAAGYRAPEV 495
             IHAA    ++H ++K  N+ +N      + D GL   T +     V+ R   YRAPEV
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--WYRAPEV 186

Query: 496 TDS-RKATQASDVYSFGVVLLEILTGK 521
             +    TQ  D++S G ++ E+LTGK
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 330 EVLGKGTFGMAYKA-ILEDGTTVVVKRLKDV---NVGKRDFEQQMEIVGSIRHENVVELK 385
            V+G+G +G+  K      G  V +K+ K+       K+   ++++++  +RHEN+V LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +  K    +V++Y     V   L          L  D          + IA  H+ N 
Sbjct: 67  EAFRRKGRLYLVFEY-----VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN- 120

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAP-----VIARAAGYRAPEV-TDS 498
             ++H +IK  NI ++      + D G    + +  A      V  R   YRAPE+    
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--WYRAPELLVGD 176

Query: 499 RKATQASDVYSFGVVLLEILTG 520
               +  DV++ G ++ E+L G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 330 EVLGKGTFGMAYK-AILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAY 387
           E +GKGT+G  YK    +DG+   VK L  ++    + E +  I+ S+  H NVV+    
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 388 YYSKDEKL-----MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +Y  D+ +     +V +  + GSV+ ++      G+  LD      I  GA  G+  +H 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQHLH- 145

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSR 499
               +++H ++K +NI L ++    + D G++   ++       + G   + APEV    
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 500 KATQAS-----DVYSFGVVLLEILTGKSPI 524
           +    S     DV+S G+  +E+  G  P+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 64/278 (23%)

Query: 331 VLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGKRD-FEQQM------EIVGSIRHE 379
           VLG+G FG   K +L    + G    +K LK  ++  RD  E  M      E   S RH 
Sbjct: 6   VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            +V L A + ++D    V +Y + G +  M+H       I  D  +  R    AA  +  
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDL--MMH-------IHTDVFSEPRAVFYAACVVLG 113

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGY 490
           +   +  K+V+ ++K  N+ L+++ +  ++D GL          T T    P       +
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTP------EF 167

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
            APEV      T+A D +  GV++ E+L G+SP     GD+             EE   E
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP---GDD-------------EE---E 208

Query: 551 VFDVEL---LRYP-NIEEEMVEMLQIAMSCVVRMPDQR 584
           VFD  +   +RYP  +  E + +++  +    R P++R
Sbjct: 209 VFDSIVNDEVRYPRFLSREAISIMRRLLR---RNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 48/241 (19%)

Query: 309 LFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFE- 367
            +  EGC                +G+GT+G  YKA  ++G       +K     K  +  
Sbjct: 1   KYEIEGC----------------IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG 44

Query: 368 ------QQMEIVGSIRHENVVELKAYYYSKDEKL--MVYDY--YSLGSVSAMLHSERGEG 417
                 +++ ++  ++HENVV L   +    +K   +++DY  + L  +   +   R   
Sbjct: 45  ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI---IKFHRQAK 101

Query: 418 RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--GCV--SDLGL 473
           R+ +       +      G+  +H+     ++H ++K +NI +  +    G V   DLGL
Sbjct: 102 RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Query: 474 TTITSALAPVIARAAG--------YRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPI 524
             + +  AP+   A          YRAPE+   +R  T+A D+++ G +  E+LT +   
Sbjct: 159 ARLFN--APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Query: 525 H 525
            
Sbjct: 217 K 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 64/301 (21%)

Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENV 381
           LG+G FG   K  L          G  V VK LK  + G    D ++++EI+ ++ HEN+
Sbjct: 12  LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 382 VELKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           V+ K            ++ ++   GS+   L   R + +I L    +++ A+   +G+  
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLK--QQLKYAVQICKGMDY 124

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSAL-APVIARAA 488
           + +      VH ++ + N+ + S+    + D GLT          T+   L +PV     
Sbjct: 125 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---- 177

Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT----GKSPIH--------TTGGDELVHLV 536
            + APE     K   ASDV+SFGV L E+LT      SP+         T G   +  LV
Sbjct: 178 -WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236

Query: 537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           R    V+ E          L R PN  EE+ ++++    C    P +R    +++   E 
Sbjct: 237 R----VLEEG-------KRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEA 282

Query: 597 V 597
           +
Sbjct: 283 I 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-------IVGSIRHENV 381
           + LG G F   Y+A  ++ GT + VK++  V     + E+ +E       ++  + H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           + +           +  ++ + GSVS +L                +       RG++ +H
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH 120

Query: 442 AANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGL-----TTITSA------LAPVIARAAG 489
                +++H ++K +N+ ++S  Q   ++D G         T A      L   IA    
Sbjct: 121 E---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA---- 173

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           + APEV    +  ++ DV+S G V++E+ T K P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 331 VLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFE----QQMEIVGSIRHENVVELK 385
           VLGKG FG +    +   G     KRL+   + KR  E     + +I+  +  + VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR---GIARIHA 442
             Y +KD   +V    + G +   +++    G          R    AA    G+  +H 
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF------EEERALFYAAEILCGLEDLHR 120

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRK 500
            N    V+ ++K  NI L+   +  +SDLGL         +  R    GY APEV ++++
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR 177

Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
            T + D +  G ++ E++ G+SP
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 50.0 bits (120), Expect = 2e-08
 Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 3/40 (7%)

Query: 26 EDKEALLDF---VNNLPHSRSLNWNESTSVCNHWTGVKCS 62
          +D++ALL F   +N  P     +WN S+S    WTGV C 
Sbjct: 3  DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 330 EVLGKGTFGMAY---KAILED-GTTVVVKRLKDVNVGKRD-FEQQME--IVGSIRHENVV 382
           +VLG+G+FG  +   K    D G    +K LK   +  RD    +ME  I+  + H  +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 383 ELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           +L  Y +  + KL ++ D+   G +   L  E     +  + D +  +A   A  +  +H
Sbjct: 62  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLA-ELALALDHLH 115

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAPVIARAAGYRAPEVTDS 498
           +     +++ ++K  NI L+ + +  ++D GL+  +      A        Y APEV + 
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIH 525
           R  TQ++D +SFGV++ E+LTG  P  
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 60/227 (26%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM---------EIVGSIRHE 379
             +G+G +GM   A     G  V +K++         FE Q          +I+   +HE
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISP-------FEHQTFCQRTLREIKILRRFKHE 63

Query: 380 NVVELKA------YYYSKD----EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI 429
           N++ +        +    D    ++LM  D Y L      + ++       L  D     
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKL------IKTQ------HLSNDHIQYF 111

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP---- 482
                RG+  IH+AN   ++H ++K SN+ LN+    C   + D GL  I          
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGF 165

Query: 483 ----VIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPI 524
               V  R   YRAPE+  +S+  T+A D++S G +L E+L+ + P+
Sbjct: 166 LTEYVATR--WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 21/203 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E +G+G  G  YKA     G  V +K+++     K     ++ I+   +H N+V+    Y
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 389 YSKDEKLMVYDYYSLGSVSAML---HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
              DE  +V +Y   GS++ ++        E +I         +     +G+  +H+ N 
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-------YVCREVLQGLEYLHSQN- 136

Query: 446 GKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG---YRAPEVTDSRK 500
             ++H +IKS NI L+    G V  +D G     +          G   + APEV   + 
Sbjct: 137 --VIHRDIKSDNILLSKD--GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192

Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
                D++S G++ +E+  G+ P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRL-KDVNVGKRDFEQQME----IVGSIRHENVVE 383
           +V+GKG+FG    A  + DG    VK L K + + +++ +  M     ++ +++H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA-ARGIARIHA 442
           L   + + ++   V D+ + G +   L  ER     P   + R R      A  +  +H+
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS---FP---EPRARFYAAEIASALGYLHS 114

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSR 499
            N   +V+ ++K  NI L+SQ +  ++D GL     A +       G   Y APEV   +
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                 D +  G VL E+L G  P +     E+
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 32/257 (12%)

Query: 332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A  +  G  V VK++      +R+    ++ I+    HENVV++   Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             DE  +V ++   G+++ ++ H+   E +I         + +   R ++ +H      +
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQG---V 139

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L S     +SD G     S   P      G   + APEV          
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVR-----------WVHSVVREEWTAEVFDV 554
           D++S G++++E++ G+ P       + +  +R            V SV+R        D+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-----GFLDL 254

Query: 555 ELLRYPNIEEEMVEMLQ 571
            L+R P+      E+LQ
Sbjct: 255 MLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 45/205 (21%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+  K   +    ++ ++L  + +    +    ++++++       +V     +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
           YS  E  +  ++   GS+  +L   +   RIP +   ++ IA+   RG+A +   +  ++
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAV--LRGLAYLREKH--QI 125

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 186 WSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.2 bits (121), Expect = 3e-08
 Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNL 196
           NL  ++LS+N        +   L  L+ L L+ N+L+   P+    LP+L+ L+L+ NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 62/290 (21%), Positives = 125/290 (43%), Gaps = 55/290 (18%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIR-------- 377
           E++GKGT+G  Y A+  + TT  +  +K V +      R   +Q ++V ++R        
Sbjct: 7   ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 378 --HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
             H N+V+   +  +++   +  +Y   GS+ + L   R  GR   +             
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGR--FEEQLVRFFTEQVLE 119

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-----SALAPVIARAAGY 490
           G+A +H+     ++H ++K+ N+ +++     +SD G++  +     +     +  +  +
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 491 RAPEV--TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
            APEV  + S+  +   D++S G V+LE+  G+ P              W      EE  
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------W----SDEEAI 218

Query: 549 AEVFDV-ELLRYPNIEEEMVEML-QIAM----SCVVRMPDQRPKMPDVVR 592
           A +F +      P I  ++   L  +A+    +C    PD RP   ++++
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 33/211 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-----QQMEIVGSIRHENVVE 383
           E++G+G +G  Y+   +  G  V    LK +N+   D +     +++ ++  +R      
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVA---LKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 384 LKAYY--YSKDEKL-MVYDYYSLGSVSAMLH----SERGEGRIPLDWDTRMRIAIGAARG 436
           +  YY  Y K  +L ++ +Y   GSV  ++     +E+    I       +R  + A   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI-------IREVLVA--- 113

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG---LTTITSALAPVIARAAGYRAP 493
           +  IH      ++H +IK++NI + +     + D G   L    S+          + AP
Sbjct: 114 LKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Query: 494 EV-TDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV T+ +     +D++S G+ + E+ TG  P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 45/198 (22%), Positives = 90/198 (45%), Gaps = 16/198 (8%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK-DVNVG-KRDFEQQMEIVGSIRHENVVELKA 386
           E+LG G  G  YKA  L     + VK +  D+ V  ++    ++EI+       ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            ++ ++   +  ++   GS+           +IP       RIA+   +G+  +      
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY-------RKIP--EHVLGRIAVAVVKGLTYLW---SL 114

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           K++H ++K SN+ +N++    + D G++T + +++A        Y APE     +    S
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 506 DVYSFGVVLLEILTGKSP 523
           DV+S G+  +E+  G+ P
Sbjct: 175 DVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 3/127 (2%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
            + +  L+ L  L L +N IT   P   +   +L  L L  N             NL  +
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNL 168

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPN-LQQLNLANNNLSGSIPQ 202
           +LS N  +  +P+ LSNL+ L  L L+ N +S   P++ L + L++L+L+NN++   +  
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLS 226

Query: 203 SLKRFPS 209
           SL    +
Sbjct: 227 SLSNLKN 233

Length = 394

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 16/198 (8%)

Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A ++  G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             DE  +V ++   G+++ ++ H+   E +I         + +   + ++ +HA     +
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQG---V 137

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 13/200 (6%)

Query: 331 VLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFE----QQMEIVGSIRHENVVELK 385
           VLGKG FG +    +   G     K+L+   + KR  E     +  I+  +    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             Y +KD   +V    + G +   +++    G    D    +  A     G+  +     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRKATQ 503
            ++V+ ++K  NI L+ + +  +SDLGL         V  R    GY APEV ++ K T 
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 504 ASDVYSFGVVLLEILTGKSP 523
           + D +  G ++ E++ G+SP
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 331 VLGKGTFGMAY--KAILEDGTTVVVK-RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           V+G+G+FG A   + +  D    + + RL   +    D  ++  ++  ++H N+V  K  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARIHAA 443
           + +     +V +Y   G +   +  +RG    E  I L W  +M +      G+  IH  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMCL------GVQHIHEK 119

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALAPVIARAAGYRAPEVTDSRK 500
              +++H +IKS NIFL       + D G   + +   A A        Y  PE+ ++  
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
               SD++S G +L E+ T K P        L+
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKNLI 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 24/206 (11%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQ-----MEIVGSIRHENVVELKA 386
           LG+G  G   K  L++   +    LK +        Q+     +EI  S +   +V+   
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFA--LKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 387 YYYSKDEKL--MVYDYYSLGSVSAMLHS--ERGEGRI---PLDWDTRMRIAIGAARGIAR 439
            +  +      +  +Y   GS+ ++     +RG GRI    L      +IA    +G++ 
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG-GRIGEKVLG-----KIAESVLKGLSY 120

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDS 498
           +H+    K++H +IK SNI L  +    + D G++  + ++LA      + Y APE    
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQG 177

Query: 499 RKATQASDVYSFGVVLLEILTGKSPI 524
           +  +  SDV+S G+ LLE+   + P 
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 53/263 (20%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENV 381
           E LG+  FG  YK  L      E    V +K LKD   G  + +F+ +  +   ++H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAML-----HSERGEGRIPLDWDTRMRIAIGAA-- 434
           V L      +    M++ Y S   +   L     HS+ G      D D  ++  +  A  
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS----TDDDKTVKSTLEPADF 126

Query: 435 -RGIARIHAA----NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL----------TTITSA 479
              + +I A     +   +VH ++ + N+ +  +    +SDLGL            + ++
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR- 537
           L P+      + +PE     K +  SD++S+GVVL E+ + G  P       +++ ++R 
Sbjct: 187 LLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Query: 538 ------------WVHSVVREEWT 548
                       WV++++ E W 
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWN 264

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 33/208 (15%)

Query: 332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LG G FG      ++    T  +K +K  ++ +   ++ +    EI+    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 387 YYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
            +  KD+K   M+ +Y   G +  +L      G    ++  R  IA         +H   
Sbjct: 61  TF--KDKKYIYMLMEYCLGGELWTILRDR---GLFD-EYTARFYIA-CVVLAFEYLHNRG 113

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA---------GYRAPEV 495
              +++ ++K  N+ L+S  Y  + D G        A  +              Y APE+
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGF-------AKKLKSGQKTWTFCGTPEYVAPEI 163

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
             ++    + D +S G++L E+LTG+ P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 32/222 (14%)

Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK-------RDFEQQMEIVGSIRHENVVE 383
           V+GKG FG     I++   T  +  +K +N  K       R+   +  I+  + H  +V 
Sbjct: 7   VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 384 LKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIA 438
           L  Y +  +E + +V D    G +    H  +     E ++                 + 
Sbjct: 65  LW-YSFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKF-------WICEIVLALE 114

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--TSALAPVIARAAGYRAPEVT 496
            +H+     ++H +IK  NI L+ Q +  ++D  + T      L    +   GY APEV 
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIH---TTGGDELVHL 535
             +  + A D +S GV   E L GK P      T  D++   
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----IVGSIRHENVVEL 384
           V+GKG+FG    A    DG    VK L+   + K+  ++ +      ++ +++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIARIHAA 443
              + + D+   V DY + G +   L  ER     P   + R R  A   A  +  +H+ 
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLHSL 115

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPE 494
           N   +++ ++K  NI L+SQ +  ++D GL         TT T    P       Y APE
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP------EYLAPE 166

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHT 526
           V   +   +  D +  G VL E+L G  P ++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 15/200 (7%)

Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQ----QMEIVGSIRHENVVELKA 386
           LGKG FG      ++  G     K+L    + KR  EQ    + +I+  +    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIARIHAANG 445
            + +KD+  +V    + G +   +    GE   P   + R    A     G+  +H    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHI-YNVGEPGFP---EARAIFYAAQIICGLEHLHQRR- 115

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRKATQ 503
             +V+ ++K  N+ L+      +SDLGL         +  RA   GY APEV        
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 504 ASDVYSFGVVLLEILTGKSP 523
           + D ++ G  L E++ G+SP
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAY 387
           E +GKGT+G  +K +  ++G+   VK L  ++    + E +  I+ ++  H NVV+    
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 388 YYSKDEK-----LMVYDYYSLGSVSAMLHS--ERGEGRIPLDWDTRMR------IAIGAA 434
           YY KD K      +V +  + GSV+ ++    +RGE         RM       I   A 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---------RMEEPIIAYILHEAL 134

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YR 491
            G+  +H     K +H ++K +NI L ++    + D G++   ++       + G   + 
Sbjct: 135 MGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 492 APEVTDSRKATQAS-----DVYSFGVVLLEILTGKSPI 524
           APEV    +   ++     DV+S G+  +E+  G  P+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 70/298 (23%), Positives = 123/298 (41%), Gaps = 52/298 (17%)

Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIA 438
           L          L+V +  + G + + L S R E     GR P      +++A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT----------SALAPVIARAA 488
            +   N  K VH ++ + N  +       + D G+T               L PV     
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV----- 185

Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + APE       T +SD++SFGVVL EI +  + P      ++++              
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------ 233

Query: 548 TAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI-ENVRPNDSE 603
              V D   L  P N  E + +++++   C    P  RP   ++V ++ +++ P+  E
Sbjct: 234 ---VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVELKAYYY 389
           LG G FG  YKA  ++   +   ++ D    +   D+  +++I+ S  H N+V+L   +Y
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 390 SKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            ++   ++ ++ + G+V A ML  ER     PL   T  +I +   + +  ++  +  K+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER-----PL---TEPQIRVVCKQTLEALNYLHENKI 124

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPEV-----TDSRK 500
           +H ++K+ NI         ++D G++   T T            + APEV     +  R 
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 501 ATQASDVYSFGVVLLEILTGKSPIH 525
               +DV+S G+ L+E+   + P H
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---------QQMEIVGSIRHE 379
           EV+GKG++G+   AI    G  V +K++ DV      FE         ++++++  +RH 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV------FEHVSDATRILREIKLLRLLRHP 59

Query: 380 NVVELKAYYY--SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           ++VE+K      S+ E   +Y  + L  + + LH         L  +          R +
Sbjct: 60  DIVEIKHIMLPPSRREFKDIYVVFEL--MESDLHQVIKAND-DLTPEHHQFFLYQLLRAL 116

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--------VIARAAG 489
             IH AN   + H ++K  NI  N+     + D GL  +     P        V  R   
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR--W 171

Query: 490 YRAPEVTDS--RKATQASDVYSFGVVLLEILTGK 521
           YRAPE+  S   K T A D++S G +  E+LTGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 46/282 (16%)

Query: 330 EVLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHEN 380
           E LG+GTF   +K I  +         T V++K L   +      F +   ++  + H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           +V         DE +MV +Y   GS+   L  ++ +  I + W   +   +  A     +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWA-----L 113

Query: 441 HAANGGKLVHGNIKSSNIFL--------NSQQYGCVSDLGLTTITSALAPVIARAAGYRA 492
           H      L HGN+ + N+ L         +  +  +SD G++        ++ R   +  
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVP 172

Query: 493 PE-VTDSRKATQASDVYSFGVVLLEILTG-KSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           PE + + +  + A+D +SFG  L EI +G   P+      + +      H +   +WT  
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT-- 230

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                            E+  +   C+   PD RP    ++R
Sbjct: 231 -----------------ELANLINQCMDYEPDFRPSFRAIIR 255

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 51/213 (23%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD----------FEQQMEIVGSIRHE 379
           ++G G+FG  Y  +    G  + VK+++  +V                +++ ++  ++HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           N+V+        D   +  +Y   GSV+A+L +  G     L  +   +I     +G+  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQIL----KGLNY 121

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG---------LTTITSALAPVIARAAGY 490
           +H      ++H +IK +NI ++++    +SD G         L+T T+   P +  +  +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APEV      T+ +D++S G +++E+LTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 45/205 (21%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    ++ ++L  + +    +    ++++++       +V     +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
           YS  E  +  ++   GS+  +L   +  GRIP     ++ IA+   +G+  +   +  K+
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLREKH--KI 125

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 33/212 (15%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAY 387
           LG G FG  YKA  +   T +    K + +       DF  +++I+   +H N+V L   
Sbjct: 13  LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 388 YYSKDEKLMVYDYYSLGSV-SAMLHSERG--EGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           Y+ +++  ++ ++   G++ S ML  ERG  E +I         +       +  +H+  
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHSH- 122

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY------RAPEV--- 495
             K++H ++K+ NI L       ++D G   +++     + +   +       APEV   
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 496 -TDSRKATQA-SDVYSFGVVLLEILTGKSPIH 525
            T         +D++S G+ L+E+   + P H
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 17/161 (10%)

Query: 81  LIPPNTISRLS--------ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP 132
            +  N I+ +          LK L L  N I    PS   NL +L  L L FN+ S    
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPK 180

Query: 133 DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLN 190
             S   NL  ++LS N  +  +P  +  L+ LE L L+NNS+  ++     NL NL  L 
Sbjct: 181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238

Query: 191 LANNNLSGSIPQSLKRFPSSAFVGNS---ISFDENLAPRAS 228
           L+NN L   +P+S+    +   +  S   IS   +L    +
Sbjct: 239 LSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTN 278

Length = 394

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 54/234 (23%), Positives = 106/234 (45%), Gaps = 34/234 (14%)

Query: 309 LFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFE- 367
           LF +EGC                +G+GT+G  YKA  +DG       LK +         
Sbjct: 1   LFEYEGCK---------------VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA 45

Query: 368 -QQMEIVGSIRHENVVELKAYYYSKDEK--LMVYDY--YSLGSVSAMLHSERGEGRIPLD 422
            +++ ++  ++H NV+ L+  + S  ++   +++DY  + L  +    H      + P+ 
Sbjct: 46  CREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHI-IKFHRASKANKKPMQ 104

Query: 423 WDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ--QYGCV--SDLGLTTI-T 477
               M  ++   + +  IH  +   ++H ++K +NI +  +  + G V  +D+G   +  
Sbjct: 105 LPRSMVKSL-LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 478 SALAPV-----IARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIH 525
           S L P+     +     YRAPE+   +R  T+A D+++ G +  E+LT +   H
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGKRDFEQQME-----IVGSIRHEN 380
           +V+GKG+FG   K +L     +     VK L+   + K+  E+ +      ++ +++H  
Sbjct: 1   KVIGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIAR 439
           +V L   + + D+   V DY + G +   L  ER         + R R  A   A  +  
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGY 111

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGY 490
           +H+ N   +V+ ++K  NI L+SQ +  ++D GL         TT T    P       Y
Sbjct: 112 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP------EY 162

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
            APEV   +   +  D +  G VL E+L G  P ++    E+
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 16/196 (8%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           +G G FG+   A     G  V +K++        + KR + ++++++  +RHEN++ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            + S  E +    Y+    +   LH        PL+            RG+  +H+A   
Sbjct: 77  IFISPLEDI----YFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG-- 128

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDS-RKATQAS 505
            +VH ++K SNI +N      + D GL  I             YRAPE+  + +K     
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV 187

Query: 506 DVYSFGVVLLEILTGK 521
           D++S G +  E+L GK
Sbjct: 188 DIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 59/222 (26%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS-----------IR 377
           E +G+GT+G+ YKA     G  V +K+++         E + E V S           + 
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA---IGAA 434
           H N+V L    +S+++  +V+++  L     M          PL       I        
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDS-------SPLTGLDPPLIKSYLYQLL 109

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----- 489
           +GIA  H     +++H ++K  N+ ++ +    ++D GL           ARA G     
Sbjct: 110 QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGL-----------ARAFGVPVRT 155

Query: 490 ---------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                    YRAPE+   SR+ +   D++S G +  E++  +
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 45/238 (18%)

Query: 332 LGKGTFGMAY----KAILEDGT---TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           LG G FG  Y      IL  G+    V VK L+    +  K++F ++  ++ +  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIP--LDWDTRMRIAIGAARG---I 437
           +L       + + ++ +    G + + L   R E   P  L     + I +  A+G   +
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAAGYR- 491
            ++H       +H ++ + N  ++ + Y       + D GL       A  I ++  YR 
Sbjct: 123 EQMH------FIHRDLAARNCLVSEKGYDADRVVKIGDFGL-------ARDIYKSDYYRK 169

Query: 492 -----------APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
                      APE     K T  SDV+SFGV++ EILT G+ P       E++  V 
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE 379
           D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  +   
Sbjct: 1   DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 380 NVVELKAYY--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           +   +  YY  Y K  KL ++ +Y   GS   +L +       P D      +     +G
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKG 113

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAP 493
           +  +H+    K +H +IK++N+ L+ Q    ++D G+    T T            + AP
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV         +D++S G+  +E+  G+ P
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 36/235 (15%)

Query: 309 LFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTT---VVVKRLKDVNVGKRD 365
           LF +EGC                +G+GT+G  YKA  +DG       +K+++   +    
Sbjct: 1   LFEYEGCK---------------VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA 45

Query: 366 FEQQMEIVGSIRHENVVELKAYYYSK-DEKL-MVYDY--YSLGSVSAMLHSERGEGRIPL 421
             +++ ++  ++H NV+ L+  + S  D K+ +++DY  + L  +    H      + P+
Sbjct: 46  C-REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHI-IKFHRASKANKKPV 103

Query: 422 DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ--QYGCV--SDLGLTTI- 476
                M  ++   + +  IH  +   ++H ++K +NI +  +  + G V  +D+G   + 
Sbjct: 104 QLPRGMVKSL-LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 477 TSALAPV-----IARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIH 525
            S L P+     +     YRAPE+   +R  T+A D+++ G +  E+LT +   H
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 75/294 (25%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAY 387
           EV+G+GT+G  YKA   + G  V +K +  +   + + +++  I+     H N+      
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 388 YYSK------DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTRMRIAI---GAARGI 437
           +  K      D+  +V +    GSV+ ++   R +G R+  +W     IA       RG+
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------ 491
           A +H     K++H +IK  NI L       + D G+    SA    +    G R      
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV----SAQ---LDSTLGRRNTFIGT 176

Query: 492 ----APEVT---DSRKAT--QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV 542
               APEV    +   A+    SDV+S G+  +E+  GK P+     D  +H +R +  +
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL----CD--MHPMRALFKI 230

Query: 543 VR---------EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKM 587
            R         E W+ +  D        I E           C+++  +QRP M
Sbjct: 231 PRNPPPTLKSPENWSKKFNDF-------ISE-----------CLIKNYEQRPFM 266

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 13/102 (12%)

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIARAAG-----YRAPEV 495
           G   VH ++ + N+ L +Q Y  +SD GL+    AL        AR+AG     + APE 
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLS---KALGADDSYYKARSAGKWPLKWYAPEC 169

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
            + RK +  SDV+S+G+ + E  + G+ P     G E++  +
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTV---VVKRLKDVNVGKR---DFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK I + +G TV   V  ++ +   G +   +F  +  I+ S+ H ++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARI 440
            L     S   +L V      G +   +H  +     ++ L+W       +  A+G+  +
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEV 495
                 +LVH ++ + N+ + S  +  ++D GL  +            G     + A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSP 523
              RK T  SDV+S+GV + E++T G  P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY- 388
           E +GKG+FG  YK I      VV  ++ D+   + + E   + +  +   +   +  YY 
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 389 -YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
            Y K  KL +   Y LG  SA+   + G    PL+      I     +G+  +H+    +
Sbjct: 70  SYLKGTKLWIIMEY-LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---R 121

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPEVTDSRKATQA 504
            +H +IK++N+ L+ Q    ++D G+    T T            + APEV         
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 505 SDVYSFGVVLLEILTGKSP 523
           +D++S G+  +E+  G+ P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 32/207 (15%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK-RD-----FEQQMEIVGSIRHENVVELK 385
           +G+GT+G+ Y+A   D T+  +  LK V +   RD       +++ ++ ++RH N+VELK
Sbjct: 15  IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 386 AYYYSK--DEKLMVYDY--YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
                K  D   +V +Y    L S+   + +   E ++         + +   RG+  +H
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYLH 125

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITS----ALAPVIARAAGYRAPEV 495
                 ++H ++K SN+ L     GC  ++D GL          + P +     YRAPE+
Sbjct: 126 ENF---IIHRDLKVSNLLLT--DKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPEL 179

Query: 496 T-DSRKATQASDVYSFGVVLLEILTGK 521
                  T A D+++ G +L E+L  K
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 38/219 (17%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-------RHENVV 382
           EV+G GT+G  YK     G  V   +L  + V     +++ EI   I        H N+ 
Sbjct: 22  EVVGNGTYGQVYK-----GRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 383 ELKAYYYSK------DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
                +  K      D+  +V ++   GSV+ ++ + +G   +  DW   +   I   RG
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREI--LRG 133

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY------ 490
           +A +HA    K++H +IK  N+ L       + D G   +++ L   + R   +      
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYW 187

Query: 491 RAPEVTDSRKATQA-----SDVYSFGVVLLEILTGKSPI 524
            APEV    +   A     SD++S G+  +E+  G  P+
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 42/257 (16%)

Query: 351 VVVKRLK-DVNVGKR-DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA 408
           V VK L+ D +   R DF ++++I+  +   N+  L           M+ +Y   G ++ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 409 MLHSERGE------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS 462
            L     E          L + T + +A   A G+  + + N    VH ++ + N  +  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165

Query: 463 QQYGCVSDLGLTTITSALAPVIARAAGYRAP--------EVTDSRKATQASDVYSFGVVL 514
                ++D G++   +  +    R  G RAP        E     K T  SDV++FGV L
Sbjct: 166 NYTIKIADFGMSR--NLYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Query: 515 LEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD-----VELLRYPNIEEEMVE 568
            EILT  +   +    + L         V+  E     F      + L R PN  +++ E
Sbjct: 223 WEILTLCREQPY----EHLTD-----QQVI--ENAGHFFRDDGRQIYLPRPPNCPKDIYE 271

Query: 569 MLQIAMSCVVRMPDQRP 585
           +    + C  R  + RP
Sbjct: 272 L---MLECWRRDEEDRP 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 50.6 bits (122), Expect = 8e-07
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKR--DFEQQMEI--VGSIR----HEN 380
           + LG GTFG  Y A   E G  V +K++K     K+   +E+ M +  V S+R    H N
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           +V+LK  +   DE   V++Y   G++  ++   +G    P        I     +G+A I
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHI 115

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIARAAGYRAPEVT 496
           H        H ++K  N+ ++  +   ++D GL     +  P    V  R   YRAPE+ 
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR--WYRAPEIL 170

Query: 497 -DSRKATQASDVYSFGVVLLEILTGK 521
             S   +   D+++ G ++ E+ T +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 331 VLGKGTFGMAYKAILEDGTTVV--VKRL-KDVNVGKRDFEQQM------EIVGSIRHENV 381
           VLGKG+FG    A L+ GT  +  VK L KDV +   D E  M       + G  +H  +
Sbjct: 2   VLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGAARGIARI 440
            +L + + +KD    V +Y + G +  M H +R  GR     + R R  A     G+  +
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFL 112

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR 491
           H      +++ ++K  N+ L+S+ +  ++D G+         TT T    P       Y 
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP------DYI 163

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
           APE+   +    A D ++ GV+L E+L G+SP      DEL   + 
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +    +    ++ + RH  +
Sbjct: 1   KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
             LK  + + D    V +Y + G +   L  ER          T  R     A  ++ + 
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRER--------VFTEERARFYGAEIVSALE 109

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--ITS-ALAPVIARAAGYRAPEVTDS 498
             +   +V+ +IK  N+ L+   +  ++D GL    I+  A          Y APEV + 
Sbjct: 110 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 38/226 (16%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +    +    ++ + RH  +
Sbjct: 1   KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTRMRIAIGAARGIAR 439
             LK  + + D    V +Y + G +   L  ER   E R       R       A  ++ 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARFY----GAEIVSA 107

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGY 490
           +   +   +V+ ++K  N+ L+   +  ++D GL         T  T    P       Y
Sbjct: 108 LGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP------EY 161

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
            APEV +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 36/209 (17%)

Query: 393 EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGN 452
           E +MV ++   G +   L  E+G  R+P+ W  ++ +A   A  ++ +   N   LVHGN
Sbjct: 90  ENIMVEEFVEHGPLDVCLRKEKG--RVPVAW--KITVAQQLASALSYLEDKN---LVHGN 142

Query: 453 IKSSNIFL-------NSQQYGCVSDLGLTTITSALAPVIARAAGYRAPE-VTDSRKATQA 504
           + + NI L        +  +  +SD G++    +    + R   + APE V      + A
Sbjct: 143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIP-WIAPECVPGGNSLSTA 201

Query: 505 SDVYSFGVVLLEI-LTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
           +D +SFG  LLEI   G+ P+                   R     E F  +  R P  E
Sbjct: 202 ADKWSFGTTLLEICFDGEVPLKE-----------------RTPSEKERFYEKKHRLP--E 242

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
               E+  +   C+   P QRP    ++R
Sbjct: 243 PSCKELATLISQCLTYEPTQRPSFRTILR 271

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL----------KDVNVGKRDFEQQMEIVGSIRHEN 380
           LG+G FG  Y    ++ G  + VK++          K+VN      E +++++ +++HE 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA----LECEIQLLKNLQHER 65

Query: 381 VVELKAYYY---SKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           +V+    YY     DE L ++ +Y   GSV   L   +  G   L      +       G
Sbjct: 66  IVQ----YYGCLRDDETLSIFMEYMPGGSVKDQL---KAYG--ALTETVTRKYTRQILEG 116

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG----LTTI---TSALAPVIARAAG 489
           +  +H+     +VH +IK +NI  +S     + D G    L TI    + +  V      
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG-TPY 172

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           + +PEV       + +DV+S G  ++E+LT K P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 327 ASAEVLGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENV 381
            S + +G G +G    AI    G  V +K+L    +     KR + +++ ++  ++HENV
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENV 76

Query: 382 VELKAYYYSKDEKLMVYDYY-SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           + L   + S        D+Y  +  +   L    G    PL  D    +      G+  I
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH---PLSEDKVQYLVYQMLCGLKYI 133

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDS 498
           H+A    ++H ++K  N+ +N      + D GL     A     V+ R   YRAPEV  +
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--WYRAPEVILN 188

Query: 499 -RKATQASDVYSFGVVLLEILTGKS 522
                Q  D++S G ++ E+LTGK+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV---------- 381
           +GKGTFG  Y+   +D   +   ++    + K++   + E+  +I   N+          
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV----LSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 382 --VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA-ARGIA 438
             V LK  + +  +  +V DY S G +   L  E   GR   D   R +  I      + 
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFSED---RAKFYIAELVLALE 110

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEV 495
            +H  +   +V+ ++K  NI L++  +  + D GL+      +           Y APEV
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 496 T-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             D +  T+  D +S GV++ E+  G SP +     ++   +
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 16/203 (7%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKA 386
           E +G+G FG  +   L  D T V VK  ++      K  F Q+  I+    H N+V L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
               K    +V +    G     L +E    ++       +++   AA G+  + + +  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV----KELIQMVENAAAGMEYLESKH-- 114

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARAAGYRAPEVTDSRKA 501
             +H ++ + N  +  +    +SD G++      + ++   +      + APE  +  + 
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 502 TQASDVYSFGVVLLEILT-GKSP 523
           +  SDV+SFG++L E  + G  P
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LG G FG  +K I + +G +    V +K ++D   G++ F++    M  +GS+ H  +
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG--EGRIPLDWDTRMRIAIGAARGIAR 439
           V L         +L V     LGS+   +   R   + +  L+W       +  A+G+  
Sbjct: 72  VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--------VIARAAGYR 491
           +      ++VH N+ + NI L S     ++D G   +   L P               + 
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFG---VADLLYPDDKKYFYSEHKTPIKWM 178

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           A E     + T  SDV+S+GV + E+++ G  P
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 22/170 (12%)

Query: 370 MEIVGSIRHENVVELKAY--------------YYSKDEKLMVYDYYSLGSVSAMLHSERG 415
           +EI  +IR++ + ELK                +YS  E  +  ++   GS+  +L   + 
Sbjct: 36  LEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KK 92

Query: 416 EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT- 474
            GRIP +   ++ IA+   RG+  +   +  K++H ++K SNI +NS+    + D G++ 
Sbjct: 93  AGRIPENILGKISIAV--LRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 148

Query: 475 TITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
            +  ++A        Y +PE       T  SD++S G+ L+E+  G+ PI
Sbjct: 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELKAY 387
           +G GT+G  YKA  +  G    +K +K +  G+ DF   +Q++ ++   +H N+V     
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIK-LEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           Y  +D+  +  ++   GS+  + H        PL       ++    +G+  +H  + GK
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLH--SKGK 127

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY------RAPEVTD-SRK 500
           + H +IK +NI L    +  ++D G++   +A    IA+   +       APEV    RK
Sbjct: 128 M-HRDIKGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 501 A--TQASDVYSFGVVLLEILTGKSPI 524
               Q  D+++ G+  +E+   + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
           E +GKG+FG  YKAI       V +K + D+   + + E   Q+++ +   R   + +  
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITK-- 63

Query: 386 AYY--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            YY  + K  KL ++ +Y   GS   +L          LD      I      G+  +H 
Sbjct: 64  -YYGSFLKGSKLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH- 115

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALA--------PVIARAAGYRAP 493
                 +H +IK++NI L+ +    ++D G++  +TS ++        P       + AP
Sbjct: 116 --EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF------WMAP 167

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV       + +D++S G+  +E+  G+ P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 63/294 (21%)

Query: 328 SAEVLGKGTFGMAYKAILEDGTT-----VVVKRLKD------VNVGKRDFEQQMEIVGSI 376
            +++L +GTFG  +  IL D        V VK +KD      V +      Q+  ++  +
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL----LLQESCLLYGL 65

Query: 377 RHENVVELKAYYYSKDEKLMV-YDYYSLGSVSAMLHSER-GEGRIPLDWDTR--MRIAIG 432
            H+N++ +        E   V Y Y + G++   L   R GE   P    T+  + +AI 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-------- 484
            A G++ +H      ++H +I + N  ++ +    ++D       +AL+  +        
Sbjct: 126 IACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD-------NALSRDLFPMDYHCL 175

Query: 485 ----ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWV 539
                R   + A E   +++ + ASDV+SFGV+L E++T G++P       E+   ++  
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-- 233

Query: 540 HSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVR-MPDQRPKMPDVV 591
                        D   L  P N  +E+  +    M+C     P++RP    +V
Sbjct: 234 -------------DGYRLAQPINCPDELFAV----MACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 49/289 (16%)

Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+ I       E  T V +K + +  ++ +R +F  +  ++      +VV 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIA 438
           L          L++ +  + G + + L S R E      + P      +++A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT----------SALAPVIARAA 488
            +   N  K VH ++ + N  +       + D G+T               L PV     
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV----- 185

Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + +PE       T  SDV+SFGVVL EI T  + P      ++++              
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------ 233

Query: 548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
              V +  LL  P+   +M  + ++   C    P  RP   +++  I+ 
Sbjct: 234 ---VMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 22/101 (21%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLT-TITS--------ALAP 482
           + +  IH+ N   ++H ++K SNI LNS    C   ++D GL  +++          L  
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTD 171

Query: 483 VIA-RAAGYRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
            +A R   YRAPE+   S + T+  D++S G +L E+L GK
Sbjct: 172 YVATR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 53/220 (24%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS--IR--------- 377
           E +G+GT+G+ YKA     G  V +K+++         + + E V S  IR         
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIR--------LDTETEGVPSTAIREISLLKELN 57

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           H N+V+L    +++++  +V+++        M  S      +PL      ++     +G+
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL----LQGL 113

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------- 489
           A  H+    +++H ++K  N+ +N++    ++D GL           ARA G        
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL-----------ARAFGVPVRTYTH 159

Query: 490 ------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKS 522
                 YRAPE+    +  + A D++S G +  E++T ++
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD--FEQ-QMEIVGSIRHENV----VEL 384
           LGKG +G  YK +     T V   +K++ +   +  F Q  ME+   I H+ V    V+ 
Sbjct: 9   LGKGNYGSVYKVLHR--PTGVTMAMKEIRLELDESKFNQIIMELD--ILHKAVSPYIVDF 64

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              ++ +    M  +Y   GS+  +         IP   D   RI     +G+  +   +
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP--EDVLRRITYAVVKGLKFLKEEH 122

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQ 503
              ++H ++K +N+ +N      + D G++  + ++LA        Y APE   S    Q
Sbjct: 123 --NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 504 A------SDVYSFGVVLLEILTGKSP 523
                  SDV+S G+ +LE+  G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 71/290 (24%), Positives = 133/290 (45%), Gaps = 49/290 (16%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           ++G G+FG+ Y+AI ++    V +K+ L+D     R    ++ I+ ++ H N++ LK YY
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYY 128

Query: 389 YS----KDEKLM----VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           Y+    K+EK +    V ++        M H  R    +PL         +   R +A I
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLG----LTTITSALAPVIARAAGYRAPEV 495
           H+     + H ++K  N+ ++   +   + D G    L     +++ + +R   YRAPE+
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPEL 241

Query: 496 T-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
              +   T   D++S G ++ E++ G  PI  +G   +  LVR                +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG-YPIF-SGQSSVDQLVRI---------------I 284

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN 604
           ++L  P  E+++ EM        ++ PD +PK  D+ +V     P+D+ N
Sbjct: 285 QVLGTPT-EDQLKEMNPNYAD--IKFPDVKPK--DLKKVFPKGTPDDAIN 329

Length = 440

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 38/214 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR--LKDVNVGKRDFE-QQMEIVGSIRHENVVELK 385
           E +G+GT+G  +KA   E    V +KR  L D + G      +++ ++  ++H+N+V L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
              +S  +  +V++Y     +     S  G+    +D +          +G+A  H+ N 
Sbjct: 66  DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSHN- 119

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
             ++H ++K  N+ +N      ++D GL           ARA G              YR
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGL-----------ARAFGIPVRCYSAEVVTLWYR 166

Query: 492 APEVTDSRKATQAS-DVYSFGVVLLEILTGKSPI 524
            P+V    K    S D++S G +  E+     P+
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 332 LGKGTFGMAYKAI--LEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVELK 385
           LG G FG   K +  ++ G    V VK LK   +  GK++F ++  ++  + H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 386 AYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIP----LDWDTRMRIAIGAARGIARI 440
                K E LM V +   LG +   L   +    IP     +   +  +A+G       +
Sbjct: 63  GV--CKGEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQ--VAMG-------M 108

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIARAAG-----YR 491
                   VH ++ + N+ L ++    +SD G++    AL        A  AG     + 
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMS---RALGAGSDYYRATTAGRWPLKWY 165

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           APE  +  K +  SDV+S+GV L E  + G  P     G E++ ++
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)

Query: 331 VLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE----QQMEIVGSIRHENVVELK 385
            +G+GT+G  YKA  +D G  V +K+++  N  K  F     ++++I+  + H N+V LK
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 386 AYYYSKDEKL----------MVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIG 432
                K + L          +V++Y        M H   G    G +    D        
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEY--------MDHDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAG- 489
              G+   H  N    +H +IK SNI LN++    ++D GL  + ++    P   +    
Sbjct: 125 LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 490 -YRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPI 524
            YR PE +    +   A DV+S G +L E+ T K PI
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 48.3 bits (116), Expect = 4e-06
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSI-RHENVVE 383
           +++G+G+F     A   E      +K L    + K    + +    E++  +  H  +++
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 384 LKAYYYSKDE-KL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARI 440
           L  YY  +DE  L  V +Y   G    +L   R  G +     TR   A I     +  +
Sbjct: 67  L--YYTFQDEENLYFVLEYAPNGE---LLQYIRKYGSLDEKC-TRFYAAEI--LLALEYL 118

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG-----------------LTTITSALAPV 483
           H+     ++H ++K  NI L+   +  ++D G                  T I S +   
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 484 IARA------AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
             R       A Y +PE+ + + A ++SD+++ G ++ ++LTGK P  
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 36/223 (16%)

Query: 327 ASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHEN 380
           A  + LG+G FG   +  L    +++   +K + +         DF  +   +    H N
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 381 VVELKAYYYSKDEK------LMVYDYYSLGSV-SAMLHSERGEGRIPLDWDTRMRIAIGA 433
           V+ L        E       +++  +   G + S +L+S  G+    L     ++     
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-- 491
           A G+  + + +    +H ++ + N  LN     CV+D GL+         I     YR  
Sbjct: 122 ASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSK-------KIYNGDYYRQG 171

Query: 492 ----------APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
                     A E    R  T  SDV+SFGV + EI T G++P
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.2 bits (114), Expect = 5e-06
 Identities = 46/214 (21%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAY 387
           E++G GT+G  YK   ++ G    +K +      + + +Q++ ++     H N+      
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 388 YYSK------DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           +  K      D+  +V ++   GSV+ ++ + +G   +  +W   +   I   RG++ +H
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREI--LRGLSHLH 128

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY------RAPEV 495
                K++H +IK  N+ L       + D G   +++ L   + R   +       APEV
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 496 TDSRKATQA-----SDVYSFGVVLLEILTGKSPI 524
               +   A     SD++S G+  +E+  G  P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 23/136 (16%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAG 489
           RG+  IH+AN   ++H ++K SN+ LN+     + D GL   TS         V+ R   
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-- 173

Query: 490 YRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV---RE 545
           YRAPE+  +  + T A DV+S G +  E+L  K P+    G + VH ++ +  ++    E
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFP--GKDYVHQLKLITELLGSPSE 230

Query: 546 EWTAEVFDVELLRYPN 561
           E      D+  +R   
Sbjct: 231 E------DLGFIRNEK 240

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.4 bits (116), Expect = 6e-06
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 31/208 (14%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVEL 384
             +G G +G    A   + G  V +K+L    +     KR + +++ ++  + HENV+ L
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79

Query: 385 KAYYYSKDEKLMVYDYY--------SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
              +          D Y         L ++              L  D    +     RG
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---------KLSDDHIQFLVYQILRG 130

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--VIARAAGYRAPE 494
           +  IH+A    ++H ++K SNI +N      + D GL   T       V  R   YRAPE
Sbjct: 131 LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR--WYRAPE 185

Query: 495 VTDSR-KATQASDVYSFGVVLLEILTGK 521
           +  +     Q  D++S G ++ E+LTGK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 23/209 (11%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVE 383
             +G+G FG  Y+ +      +   V VK  K+      +  F Q+  I+    H ++V+
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L     +++   +V +   LG + + L   +      LD  + +  +   +  +A + + 
Sbjct: 72  LIGVI-TENPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLESK 126

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA----LAPVIARAAGYRAPEVTD 497
                VH +I + N+ ++S    CV   D GL+          A        + APE  +
Sbjct: 127 R---FVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIH 525
            R+ T ASDV+ FGV + EIL  G  P  
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 55/266 (20%), Positives = 114/266 (42%), Gaps = 30/266 (11%)

Query: 369 QMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMR 428
           ++  + +  H  +V+    + S D+ L++ +Y S G ++  +  +R +  +P        
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVGL 173

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-----TITSALAPV 483
           +       +  +H+    K++H ++KS+NIFL       + D G +     +++  +A  
Sbjct: 174 LFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW----- 538
                 Y APE+ + ++ ++ +D++S GV+L E+LT   P       E++  V +     
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290

Query: 539 ----VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIA-MSCVVRMPDQRPKMPDVVRV 593
               V S ++      + D  L + P +     ++L    +  V  +        D+VR 
Sbjct: 291 FPCPVSSGMK-----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANL------FQDIVRH 339

Query: 594 IENVRPNDSENRPSSGNKSESSTPPP 619
            E + P+D E       +S    PPP
Sbjct: 340 SETISPHDREEILRQLQESGERAPPP 365

Length = 478

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 29/217 (13%)

Query: 330 EVLGKGTFGMAYKAILE-DGT--TVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHENVVE 383
           +V+G+G FG   +A+++ DG      +K LK+       RDF  ++E++  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIP-----------LDWDTRMRIAIG 432
           L     ++    +  +Y   G++   L   R     P           L     ++ A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARA 487
            A G+      +  + +H ++ + N+ +       ++D GL+      +   +  +  R 
Sbjct: 128 VATGM---QYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
             + A E  +    T  SDV+SFGV+L EI++ G +P
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)

Query: 330 EVLGKGTFGMAYKAILED---------GTTVVVKR-LKDVNVGKRD----FEQQMEIVGS 375
           E LG+GT    Y  IL                +K  LK ++   RD    F +   ++  
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 376 IRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
           + H+++V L        E +MV ++   G +   +H +       L    + ++A   A 
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLAS 116

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQ----QYGC---VSDLGLTTITSALAPVIARAA 488
            ++ +       LVHGN+ + NI L  +    + G    +SD G+     +    + R  
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP 173

Query: 489 GYRAPE-VTDSRKATQASDVYSFGVVLLEI-LTGKSPI 524
            + APE V DS+  + A+D +SFG  L EI   G+ P+
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 74/341 (21%), Positives = 115/341 (33%), Gaps = 93/341 (27%)

Query: 330 EVLGKGTFGMAYKAILED------GTTVVVKRLKDVNVGKRDFEQ-----QMEIVGSI-R 377
           + LG+G FG   +A            TV VK LK+   G    E      +++I+  I  
Sbjct: 13  KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE---GATASEYKALMTELKILIHIGH 69

Query: 378 HENVVELKAYYYSKDEKLMV-YDYYSLGSVSAMLHSERGE---GRIPLDWDTRMRIAIGA 433
           H NVV L          LMV  +Y   G++S  L S+R      R        M+   G 
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129

Query: 434 ARGIARIHAANGG----------------------------------------------- 446
            + +  + ++                                                  
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189

Query: 447 ---KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVTD 497
              K +H ++ + NI L+      + D GL        P   R    R      APE   
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLPLKWMAPESIF 248

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            +  T  SDV+SFGV+L EI + G SP      D              EE+   + +   
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------------EEFCRRLKEGTR 294

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +R P  E    E+  I + C    P+ RP   ++V ++ ++
Sbjct: 295 MRAP--EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-------GKRDFEQQME--------IVG 374
           E LG G FG  YK   ++    ++  LK++NV        KR+ ++ +         I  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLA-LKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHS--ERG----EGRIPLDWDTRMR 428
            +RH N+V     +   D   +V D      +    +S  E+     E RI   W+  ++
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQ 121

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL-------TTITSALA 481
           + + A R    +H     ++VH ++  +NI L       ++D GL       + +TS + 
Sbjct: 122 MVL-ALR---YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG 175

Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTT 527
            ++     Y  PE+  +    + +DV++FG +L ++ T + P ++T
Sbjct: 176 TIL-----YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 40/114 (35%), Positives = 52/114 (45%), Gaps = 3/114 (2%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
           P  I  LSAL+ L L +N I     S   NLK+L  L L  N             NL  +
Sbjct: 202 PPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETL 260

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +LS+N    +   SL +LT L  L L+ NSLS  +P + L  L    L N  L+
Sbjct: 261 DLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312

Length = 394

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 1   KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA--ARGIAR 439
             LK  + + D    V +Y + G +   L  ER      +  + R R   GA     +  
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARF-YGAEIVSALDY 110

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVT 496
           +H+     +V+ ++K  N+ L+   +  ++D GL        A          Y APEV 
Sbjct: 111 LHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 24/82 (29%), Positives = 32/82 (39%), Gaps = 23/82 (28%)

Query: 93  LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNG 152
           LK L L +N +T      F  L +L  L L  N             NLT I+        
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGN-------------NLTSIS-------- 40

Query: 153 TIPRSLSNLTQLEALYLANNSL 174
             P + S L  L +L L+ N+L
Sbjct: 41  --PEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 5/100 (5%)

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-----TITSALAPVIARAAGYRAPE 494
           +H  +   ++H +IKS+NI L S     + D G +     T++  +         Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH 534
           +   +  ++ +D++S GV+L E+LT K P      +E++H
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Length = 496

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 40/280 (14%)

Query: 332 LGKGTFGMAYKAILEDG---TTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELK 385
           +G G FG      +  G     VVVK L+ V+     +  F ++ +   S++H N+++  
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
                    L+V ++  LG +   L S R    +  D  T  R+A   A G+  +H  N 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--------ITSALAPVIARAAGYRAPEVTD 497
              +H ++   N  L +     + D GL+         +T     V  R   + APE+ D
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---WIAPELVD 175

Query: 498 SRKA-------TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
                      T+ S+V+S GV + E+    S  +    DE V     +   VRE+    
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-----LTYTVREQQLK- 229

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                 L+ P + +   E++Q    C ++ P+QRP   +V
Sbjct: 230 -LPKPRLKLP-LSDRWYEVMQ---FCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 32/222 (14%)

Query: 324 LLRASAEVLGKGTFGMAYKAIL--EDGTT----VVVKRLKDVNVGKR--DFEQQMEIVGS 375
           LLRA    LG G FG  Y+ +    DG      V VK L +    +   DF  +  I+  
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 376 IRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
             H+N+V L    + +  + ++ +  + G + + L   R     P      M+  +  AR
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS--LTMKDLLFCAR 123

Query: 436 GIAR-IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR--- 491
            +A+          +H +I + N  L  +  G V+ +        +A  I RA+ YR   
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA----DFGMARDIYRASYYRKGG 179

Query: 492 ---------APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
                     PE       T  +DV+SFGV+L EI + G  P
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)

Query: 387 YYYSKDEKL-MVYDYYSLGSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           Y +  D KL ++ DY + G +   L   E          ++ +R+ I     +  +   +
Sbjct: 72  YAFQTDTKLHLILDYVNGGELFTHLYQREHFT-------ESEVRVYIAEI--VLALDHLH 122

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEV--T 496
              +++ +IK  NI L+S+ +  ++D GL+     LA    RA        Y APEV   
Sbjct: 123 QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGG 529
            S    +A D +S GV+  E+LTG SP    G 
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELKA 386
           V+G+G +G+  K    E    V +K+ KD    +   E   ++++++ +++ EN+VELK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +  + +  +V++Y     +   L  E   G  P     ++R  I   + I  IH  +  
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP----EKVRSYI--YQLIKAIHWCHKN 119

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAGYRAPEVTDSRKAT 502
            +VH +IK  N+ ++      + D G    L+  ++A          YR+PE+       
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 503 QASDVYSFGVVLLEILTGK 521
           +A D++S G +L E+  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELKAY 387
           +G GT+G  YKA  L  G    VK +K +  G  DF   +Q++ +V   +H N+V     
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIK-LEPGD-DFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           Y S+++  +  +Y   GS+  + H       + + +  R  +     +G+A +H+   GK
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK--GK 127

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPEVTDSRKA--- 501
           + H +IK +NI L       ++D G+    T T A          + APEV    K    
Sbjct: 128 M-HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 502 TQASDVYSFGVVLLEILTGKSPI 524
            Q  D+++ G+  +E+   + P+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 30/202 (14%)

Query: 341 YKAILEDGTTVVV-----KRLKDVNVGKRDFEQQME---------IVGSIRHENVVELKA 386
           +  I E  T +V         + V V K D  +Q           I+   +H N+VE+ +
Sbjct: 24  FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            Y   DE  +V ++   G+++ ++   R      ++ +    + +   + ++ +HA    
Sbjct: 84  SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLHAQ--- 134

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRK--A 501
            ++H +IKS +I L S     +SD G     S   P      G   + APEV  SR    
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYG 193

Query: 502 TQASDVYSFGVVLLEILTGKSP 523
           T+  D++S G++++E++ G+ P
Sbjct: 194 TEV-DIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 13/199 (6%)

Query: 332 LGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFEQ----QMEIVGSIRHENVVELKA 386
           LGKG FG +    +   G     K+L    + K+  E+    + EI+  +    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            + SK    +V    + G +   +++    G   L+ +  +  +     GI  +H+    
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSM--- 114

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRKATQA 504
            +V+ ++K  N+ L+ Q    +SDLGL         +  RA   GY APE+      +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 505 SDVYSFGVVLLEILTGKSP 523
            D ++ G  + E++ G++P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 64/286 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR--------------LKDVNVGKRDFEQQMEIVG 374
           E +G+GT+G  YKA     G  V +K+              L+++++ +    + + IV 
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQM-LSESIYIVR 65

Query: 375 SIRHENVVEL--KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG 432
            +  E+V E   K   Y      +V++Y        M  + RG GR PL   T       
Sbjct: 66  LLDVEHVEEKNGKPSLY------LVFEYLDSDLKKFMDSNGRGPGR-PLPAKTIKSFMYQ 118

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG-- 489
             +G+A  H      ++H ++K  N+ ++ Q+    ++DLGL    S   PV +      
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIV 173

Query: 490 ---YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD----ELVHLVRWVHS 541
              YRAPEV   S   +   D++S G +  E+   K P+    GD    +L+H+ + + +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFP--GDSELQQLLHIFKLLGT 230

Query: 542 VVREEWTAEVFDVELLR----------------YPNIEEEMVEMLQ 571
              + W      V  LR                 P++  E +++LQ
Sbjct: 231 PTEQVWPG----VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQ 272

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 49/217 (22%)

Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVEL 384
           + LG G+FG       +  G    +K L    + K    + +     I+ SIRH  +V L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
              +  +D+    +V +Y   G    +    R  GR P                 AR +A
Sbjct: 67  YGSF--QDDSNLYLVMEYVPGGE---LFSHLRKSGRFPEPV--------------ARFYA 107

Query: 443 AN---------GGKLVHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAG 489
           A             +V+ ++K  N+ L+S  Y  ++D G    +   T  L        G
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-------G 160

Query: 490 ---YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
              Y APE+  S+   +A D ++ G+++ E+L G  P
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 330 EVLGKGTFGMAY-------KAILEDGTT--------VVVKRLK-DVNVGKR-DFEQQMEI 372
           E LG+G FG  +          L +G          V VK L+ DV    R DF ++++I
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGR------IP-LDWDT 425
           +  +++ N++ L     S D   M+ +Y   G ++  L     E        IP +    
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 426 RMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--ITSALAPV 483
            + +A+  A G+  + + N    VH ++ + N  + +     ++D G++    +     +
Sbjct: 131 LLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 484 IARAA---GYRAPEVTDSRKATQASDVYSFGVVLLEILT 519
             RA     + A E     K T ASDV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 26/102 (25%), Positives = 52/102 (50%), Gaps = 8/102 (7%)

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVI-A 485
           +IA+   + +  +H+     ++H ++K SN+ +N      + D G++  +  ++A  I A
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 486 RAAGYRAPEVTDSRKATQA----SDVYSFGVVLLEILTGKSP 523
               Y APE  +     +     SDV+S G+ ++E+ TG+ P
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 29/217 (13%)

Query: 330 EVLGKGTFGMAYKA-ILEDGTTV--VVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVE 383
           +V+G+G FG   KA I +DG  +   +KR+K+       RDF  ++E++  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIP-----------LDWDTRMRIAIG 432
           L      +    +  +Y   G++   L   R     P           L     +  A  
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARA 487
            ARG+  +      + +H ++ + NI +       ++D GL+      +   +  +  R 
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
             + A E  +    T  SDV+S+GV+L EI++ G +P
Sbjct: 189 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELKAYYY 389
           LG G FG  YKA   E G     K ++  +  +  D+  ++EI+ +  H  +V+L   +Y
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 390 SKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
              +  ++ ++   G+V A ML  +RG         T  +I +   + +  +   +  K+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL--------TEPQIQVICRQMLEALQYLHSMKI 131

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPEVT--DSRKATQ 503
           +H ++K+ N+ L       ++D G++     T            + APEV   ++ K T 
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 504 ---ASDVYSFGVVLLEILTGKSPIH 525
               +D++S G+ L+E+   + P H
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHH 216

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 3e-05
 Identities = 18/46 (39%), Positives = 20/46 (43%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF 127
           IP      L  LK+L L  N +T   P  F  L SL  L L  NN 
Sbjct: 15  IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 32/214 (14%)

Query: 332 LGKGTFGMAYKAILE-DGTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIRHENVVELKA 386
           + KG +G  + A  +  G    +K + K   + K   +Q +   +I+   +   VV+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 387 YYYS--KDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHA 442
            YYS    + L +V +Y   G ++++L +    G +  D   R+ IA I  A  +  +H+
Sbjct: 59  -YYSFQGKKNLYLVMEYLPGGDLASLLENV---GSLDEDV-ARIYIAEIVLA--LEYLHS 111

Query: 443 ANGGKLVHGNIKSSNIFLNSQ-----------QYGCVSDLGLTTITSALAPVIARAAGYR 491
                ++H ++K  NI ++S            + G V               I     Y 
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           APEV   +  ++  D +S G +L E L G  P H
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 55/226 (24%)

Query: 329 AEVLGKGTFGMAYKAILED-GTTVVVKRL----------KDVNVGKRDFEQQMEIVGSIR 377
            ++LG+G FG  Y     D G  + VK++          K+VN      E +++++ ++R
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA----LECEIQLLKNLR 62

Query: 378 HENVVELKAYYYS-----KDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI 431
           H+ +V+    YY      +++KL ++ +Y   GS+   L +        L  +   R   
Sbjct: 63  HDRIVQ----YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-----LTENVTRRYTR 113

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQ--------------QYGCVSDLGLTTIT 477
              +G++ +H      +VH +IK +NI  +S               Q  C+S  G+ ++T
Sbjct: 114 QILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 478 SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
               P       + +PEV       + +DV+S    ++E+LT K P
Sbjct: 171 GT--PY------WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 28/96 (29%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+  + +      A+  G     + APE  +  K 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G+E+  ++
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 40.9 bits (97), Expect = 4e-05
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 2/37 (5%)

Query: 162 TQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           T LE L L+NN ++  +P L NLPNL+ L+L+ N ++
Sbjct: 1   TNLETLDLSNNQIT-DLPPLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 13/121 (10%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSA-------LAPVIAR 486
           RG+  IH+AN   ++H ++K +N+F+N++     + D GL  I          L+  +  
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 487 AAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE 545
              YR+P +  S    T+A D+++ G +  E+LTGK         E + L+     VVRE
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 546 E 546
           E
Sbjct: 241 E 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSA 177

Query: 506 DVYSFGVVLLEILTGKSP 523
           D +S G +L ++L G SP
Sbjct: 178 DWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 43/197 (21%), Positives = 89/197 (45%), Gaps = 14/197 (7%)

Query: 332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A  +  G  V VK +      +R+    ++ I+   +H+NVVE+   Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
             +E  ++ ++   G+++ ++   R      L+ +    +     + +  +H+     ++
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQASD 506
           H +IKS +I L       +SD G     S   P      G   + APEV          D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 507 VYSFGVVLLEILTGKSP 523
           ++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 24/158 (15%)

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVTDSRK 500
           K +H ++ + NI L+      + D GL        P   R    R      APE    + 
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 501 ATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            T  SDV+SFGV+L EI + G SP              +    + EE+   + D   +R 
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASP--------------YPGVQINEEFCQRLKDGTRMRA 298

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           P  E    E+ +I ++C    P +RP    +V ++ ++
Sbjct: 299 P--ENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 28/236 (11%)

Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVELKA 386
           +G+G +G  + A  +D G  V +KR+K   + K +       + +I+ + + E +V+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-L 67

Query: 387 YYYSKDEKL---MVY----DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           Y +  DE L   M Y    D+ +L +   +L  +    R  +     M  A+ A   +  
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYM---AEMFEAVDALHELGY 122

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSR 499
           IH          ++K  N  +++  +  ++D GL+      A  +  +  Y APEV   +
Sbjct: 123 IHR---------DLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGK 173

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDE-LVHLVRWVHSVVREEWTAEVFDV 554
                 D +S G +L E L G  P   +  +E   +L  W  ++ R  +    F++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 31/212 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFE--QQMEIVGSIRHENVV 382
           +VLG G FG  YK + + +G      V +K L++    K + E   +  ++ S+ + +V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAML-----HSERGEGRIPLDWDTRMRIAIGAARGI 437
            L     +   +L+      L     +L     H +    +  L+W       +  A+G+
Sbjct: 73  RLLGICLTSTVQLIT----QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 122

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRA 492
             +      +LVH ++ + N+ + + Q+  ++D GL  +  A         G     + A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
            E    R  T  SDV+S+GV + E++T G  P
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 28/222 (12%)

Query: 331 VLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVEL 384
           +LG G FG   +  L+        V +  L+     K  R F  +   +G   H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           +      +  ++V +Y S G++ + L    G+    L     M +  G A G+  +    
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEMG 127

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLG---------LTTITSALAPVIARAAGYRAPEV 495
               VH  + +  + +NS     +S            + T  S  +PV+     + APE 
Sbjct: 128 ---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEA 179

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
                 + ASDV+SFG+V+ E+++ G+ P     G +++  V
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 23/214 (10%)

Query: 330 EVLGKGTFGMAYKAILE-DG--TTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHENVVE 383
           +V+G+G FG   KA ++ DG      +KR+K+       RDF  ++E++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI--H 441
           L      +    +  +Y   G++   L   R     P         +  +++ +      
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 442 AANG------GKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARAAGY 490
            A G       + +H ++ + NI +       ++D GL+      +   +  +  R   +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR---W 177

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
            A E  +    T  SDV+S+GV+L EI++ G +P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 363 KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLD 422
           +R   +++EI+  + H NVV+    +    E  ++ ++   GS+         EG    D
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIAD 166

Query: 423 WDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP 482
                 +A     GIA +H      +VH +IK SN+ +NS +   ++D G++ I +    
Sbjct: 167 EQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223

Query: 483 VIARAAG---YRAPE-----VTDSRKATQASDVYSFGVVLLEILTGKSP 523
               + G   Y +PE     +        A D++S GV +LE   G+ P
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIR-HENVVE 383
            VLGKG+FG    A L E G    VK LK DV +   D E  M    I+   R H  + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L   + + D    V ++ + G +  M H ++       D     R    AA   + +   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSR---RFDEA---RARFYAAEITSALMFL 112

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPE 494
           +   +++ ++K  N+ L+ + +  ++D G+         TT T    P       Y APE
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP------DYIAPE 166

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           +        + D ++ GV+L E+L G +P      D+L
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 177

Query: 506 DVYSFGVVLLEILTGKSP 523
           D +S G +L ++L G SP
Sbjct: 178 DWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 42/239 (17%)

Query: 331 VLGKGTFGMAYKAILED--GTT--VVVKRLK-DVNVGKRDFEQQME----IVGSIRHENV 381
           VLGKG+FG   K +L +  GT     +K LK DV +   D E  M     +  S +   +
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARGIARI 440
            +L + + + D    V +Y + G +  M   ++ G  + P        IAIG    +  +
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIG----LFFL 117

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR 491
           H+     +++ ++K  N+ L+S+ +  ++D G+         TT T    P       Y 
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP------DYI 168

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-----HLVRWVHSVVRE 545
           APE+   +   ++ D ++FGV+L E+L G++P      DEL      H V +  S+ +E
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 47/218 (21%), Positives = 92/218 (42%), Gaps = 39/218 (17%)

Query: 329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLK------DVNVGKRDFEQQMEIVGSIRHENV 381
            ++LG+G FG  Y    ++ G  +  K+++      + +      E +++++ +++HE +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 382 VELKAYYYSKDEKLMV--YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           V+       + EK +    +Y   GSV   L +        L      +       G++ 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSY 121

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQ--------------QYGCVSDLGLTTITSALAPVIA 485
           +H      +VH +IK +NI  +S               Q  C+S  G+ ++T    P   
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT--PY-- 174

Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
               + +PEV       + +DV+S G  ++E+LT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 39/199 (19%), Positives = 88/199 (44%), Gaps = 14/199 (7%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAY 387
           E +G+G  G  + AI +  G  V +K++      K++    ++ ++  +++ N+V     
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           +   DE  +V +Y + GS++ ++     +           +IA      +  +   +  +
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTETCMD---------EAQIAAVCRECLQALEFLHANQ 135

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRKATQA 504
           ++H +IKS N+ L       ++D G     T   +    +     + APEV   +     
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 505 SDVYSFGVVLLEILTGKSP 523
            D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 16/200 (8%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y AI +  G  V +K++      K++    ++ ++   ++ N+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 388 YYSKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
           Y   DE  +V +Y + GS++ ++  +   EG+I          A      +  +   +  
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----------AAVCRECLQALDFLHSN 134

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H +IKS NI L       ++D G     T   +    +     + APEV   +    
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 504 ASDVYSFGVVLLEILTGKSP 523
             D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 58/218 (26%), Positives = 86/218 (39%), Gaps = 40/218 (18%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVGKRDFEQQME------IVGSIRHE 379
            V+GKG FG  Y   L D         VK L  +     D E+  +      I+    H 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHP 56

Query: 380 NVVELKAYYYSKD-EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIA 438
           NV+ L       +   L+V  Y   G +    +  R E   P   D  +   +  A+G+ 
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDL-IGFGLQVAKGME 112

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIAR 486
            + +    K VH ++ + N  L+      V+D GL               T A  PV   
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV--- 166

Query: 487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
              + A E   ++K T  SDV+SFGV+L E++T G  P
Sbjct: 167 --KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 42/200 (21%), Positives = 89/200 (44%), Gaps = 16/200 (8%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y A+ +  G  V ++++      K++    ++ ++   ++ N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 388 YYSKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
           Y   DE  +V +Y + GS++ ++  +   EG+I          A      +  +   +  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----------AAVCRECLQALEFLHSN 135

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
           +++H +IKS NI L       ++D G     +      +   G   + APEV   +    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 504 ASDVYSFGVVLLEILTGKSP 523
             D++S G++ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 36/268 (13%)

Query: 369 QMEIVGS--IRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR 426
           Q E+V S   RH N++     + +     ++  + + GS +++L +   EG   +     
Sbjct: 47  QNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG---MSEALI 103

Query: 427 MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR 486
             I  GA RG+  +H  NG   +H NIK+S+I ++    G VS  GL+ + S +      
Sbjct: 104 GNILFGALRGLNYLHQ-NG--YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKA 158

Query: 487 AAGYRAPEVT--------------DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
              Y  P+ +              D       SD+YS G+   E+ TG+ P       ++
Sbjct: 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218

Query: 533 VHLVRWVHSVVREEWTAEVFDVELLRYPN--------IEEEMV--EMLQIAMSCVVRMPD 582
             L++ +            F  E  R  N        I E +V   M Q   S  +R P 
Sbjct: 219 --LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276

Query: 583 QRPKMPDVVRVIENVRPNDSENRPSSGN 610
            +   P    ++E     D E RPS+ +
Sbjct: 277 SKTFSPAFQNLVELCLQQDPEKRPSASS 304

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 71/255 (27%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS-----------IRH 378
           E +G+GT+G+ YKA   D  T     LK + +     EQ+ E V S           ++H
Sbjct: 8   EKIGEGTYGVVYKA--RDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKEMQH 60

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA----IGAA 434
            N+V L+   +S+    +V++Y  L     M  S         D+    R+         
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSP--------DFAKNPRLIKTYLYQIL 112

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG---- 489
           RGIA  H+    +++H ++K  N+ ++ +     ++D GL           ARA G    
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL-----------ARAFGIPVR 158

Query: 490 ----------YRAPEV-TDSRKATQASDVYSFGVVLLEILT------GKSPIHTTGGDEL 532
                     YRAPE+   SR  +   D++S G +  E++       G S I     DEL
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-----DEL 213

Query: 533 VHLVRWVHSVVREEW 547
             + R + +   E W
Sbjct: 214 FKIFRILGTPNEETW 228

Length = 294

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPE 494
           RG+  IH+A+   ++H ++K SN+ +N      + D GL   T            YRAPE
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 187

Query: 495 VT-DSRKATQASDVYSFGVVLLEILTGKS 522
           +  +     Q  D++S G ++ E+LTG++
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 13/199 (6%)

Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVEL 384
           E LG G+FG    A  +  G    +K LK   + K    +   Q+  I+  + H  +V +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +  ++    + ++   G +   L   R  GR P D        +  A     +H+ +
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA--FEYLHSKD 138

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
              +++ ++K  N+ L+++ +  V+D G           +     Y APEV  S+   +A
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKA 195

Query: 505 SDVYSFGVVLLEILTGKSP 523
            D ++ GV+L E + G  P
Sbjct: 196 VDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 42/194 (21%), Positives = 77/194 (39%), Gaps = 26/194 (13%)

Query: 346 EDGTTVVVKRLKDVNV-GKRD---FEQQMEIVGSIRHENVVELKAYYYSKDEKLM-VYDY 400
             G  V +K L+      +     F ++  +   + H N+V L     +    L  V++Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL 460
               ++  +L ++       L      R+ +     +A  H      +VH ++K  NI +
Sbjct: 61  VPGRTLREVLAADG-----ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112

Query: 461 NS---QQYGCVSDLGLTTITS----ALAPVIARAA------GYRAPEVTDSRKATQASDV 507
           +    + +  V D G+ T+      A    + R         Y APE       T  SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 508 YSFGVVLLEILTGK 521
           Y++G++ LE LTG+
Sbjct: 173 YAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTV-VVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVEL 384
           +V+G+G FG      L++   V  +K L    + KR     F ++ +++ +  ++ +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLD----WDTRMRIAIGAARGIARI 440
              +  ++   +V DYY  G +  +L   + E R+P D    +   M IAI +   + ++
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDS---VHQL 121

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAGYRAPEVT 496
           H       VH +IK  NI ++   +  ++D G    L    +  + V      Y +PE+ 
Sbjct: 122 H------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 497 DSRKATQAS-----DVYSFGVVLLEILTGKSPIH 525
            + +  +       D +S GV + E+L G++P +
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 331 VLGKGTFGMAYKAILEDGTTV-------VVKRLKDVNVGKRDFEQQME--IVGSIRHENV 381
           VLGKG +G  ++     G          V+K+   V   K     + E  I+ +++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 382 VELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLD----WDTRMRIAIGAARG 436
           V+L  Y +    KL ++ +Y S G +   +H ER EG    D    + + + +A+     
Sbjct: 63  VDL-IYAFQTGGKLYLILEYLSGGEL--FMHLER-EGIFMEDTACFYLSEISLALE---- 114

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAP 493
               H    G +++ ++K  NI L++Q +  ++D GL   +     V     G   Y AP
Sbjct: 115 ----HLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           E+       +A D +S G ++ ++LTG  P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 24/158 (15%)

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVTDSRK 500
           K +H ++ + NI L+      + D GL        P   R    R      APE    R 
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 501 ATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            T  SDV+SFGV+L EI + G SP      D              EE+   + +   +R 
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRA 303

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           P  +    EM Q  + C    P QRP   ++V  + N+
Sbjct: 304 P--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 41/218 (18%)

Query: 331 VLGKGTFG-----MAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQ--------MEIVGSI 376
            LG G FG      AY     D    V VK LK         E++        M  +G+ 
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMSELKIMSHLGN- 97

Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
            HEN+V L          L++ +Y   G +   L  +R      L  +  +  +   A+G
Sbjct: 98  -HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKG 153

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIAR 486
           +A + + N    +H ++ + N+ L   +   + D GL              +A  PV   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
              + APE   +   T  SDV+S+G++L EI + G +P
Sbjct: 208 --KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 50/243 (20%)

Query: 331 VLGKGTFGMAYKAILED----GTTVVVKRLK-DVNVGKRDFEQQM--EIVGSIRHEN--V 381
           VLGKG+FG   K +L +         +K LK DV +   D E  M  + V +++ +   +
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGA----ARG 436
            +L + + + D    V +Y + G +  M H ++ G+ + P        I++G      RG
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARA 487
           I           ++ ++K  N+ L+S+ +  ++D G+         TT T    P     
Sbjct: 122 I-----------IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP----- 165

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-----HLVRWVHSV 542
             Y APE+   +   ++ D +++GV+L E+L G+ P      DEL      H V +  S+
Sbjct: 166 -DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224

Query: 543 VRE 545
            +E
Sbjct: 225 SKE 227

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 330 EVLGKGTFG-----------------MAYKAILEDGTTVVVKRLK-DVNVGKR-DFEQQM 370
           E LG+G FG                  +          V VK L+ D N   R DF +++
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 371 EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG------RIPLDWD 424
           +I+  ++  N++ L A   + D   M+ +Y   G ++  L     +        + + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 425 TRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--ITSALAP 482
           T + +A   A G+  + + N    VH ++ + N  +       ++D G++    +     
Sbjct: 131 TLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187

Query: 483 VIARAA---GYRAPEVTDSRKATQASDVYSFGVVLLEILT 519
           +  RA     + + E     K T ASDV++FGV L EILT
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 18/103 (17%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAA 488
           RG+  +H+A    ++H +IK  N+ +NS     + D GL  +            V+ +  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 489 GYRAPEV-TDSRKATQASDVYSFGVVLLEILTGK------SPI 524
            YRAPE+   SR  T A D++S G +  E+L  +      SPI
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 70/230 (30%)

Query: 332 LGKGTFGM---AYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR----------H 378
           LG+G +G+   A  A   +  TV +K++ +V      F +++    ++R          H
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNV------FSKKILAKRALRELKLLRHFRGH 61

Query: 379 ENVVEL------------KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR 426
           +N+  L            + Y Y   E+LM  D      +  ++ S +     PL  D  
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLY---EELMEAD------LHQIIRSGQ-----PLT-DAH 106

Query: 427 MRIAI-GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP 482
            +  I     G+  IH+AN   ++H ++K  N+ +N+    C   + D GL       + 
Sbjct: 107 FQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNA---DCELKICDFGLA---RGFSE 157

Query: 483 VIARAAG----------YRAPEVTDS-RKATQASDVYSFGVVLLEILTGK 521
                AG          YRAPE+  S +  T+A DV+S G +L E+L  K
Sbjct: 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 16/94 (17%)

Query: 448 LVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIA--RAAG---YRAPEVTDSRK 500
           ++H ++K SNI L++   G V   D G   I+  L    A  R+AG   Y APE  D   
Sbjct: 136 VIHRDVKPSNILLDAS--GNVKLCDFG---ISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 501 ATQA----SDVYSFGVVLLEILTGKSPIHTTGGD 530
                   +DV+S G+ L+E+ TG+ P      +
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 20/199 (10%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL---KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           +G+G++G+ +K    E G  V +K+    +D  V K+   +++ ++  ++H N+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           +  K +  +V++Y     ++ +  + RG     +      +I     + +   H  N   
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAGYRAPE--VTDSRKA 501
            +H ++K  NI +  Q    + D G    LT         +A    YRAPE  V D++  
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDTQYG 179

Query: 502 TQASDVYSFGVVLLEILTG 520
               DV++ G V  E+LTG
Sbjct: 180 P-PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 39/185 (21%), Positives = 74/185 (40%), Gaps = 20/185 (10%)

Query: 346 EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS 405
           E    V+VK       G +   ++++I+ +I H  ++ L   Y  K    MV   Y    
Sbjct: 117 EQRKKVIVK----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172

Query: 406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY 465
            + +      +   PL  +  + I       +A +H   G  ++H ++K+ NIFL+  + 
Sbjct: 173 FTYV------DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPEN 223

Query: 466 GCVSDLGLTTITSALAPVIARAAGY------RAPEVTDSRKATQASDVYSFGVVLLEILT 519
             + D G      A  P   +  G+       +PE+         +D++S G+VL E+  
Sbjct: 224 AVLGDFGAACKLDA-HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 520 GKSPI 524
               +
Sbjct: 283 KNVTL 287

Length = 392

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 19/118 (16%)

Query: 426 RMRIAIGAARGIAR-----IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL 480
           +  IAI     I R     I   +  +++H +IK+ NIF+N     C+ D G     +A 
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-----AAC 230

Query: 481 APVIARAAGY---------RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG 529
            PV   A  Y          APE+        A D++S G+VL E+ T    +    G
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 5e-04
 Identities = 21/50 (42%), Positives = 31/50 (62%), Gaps = 4/50 (8%)

Query: 163 QLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
            L++L L+NN L+  IPD     LPNL+ L+L+ NNL+   P++    PS
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPS 49

Length = 60

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 47/222 (21%)

Query: 329 AEVLGKGTFGMAYKAILED-GTTVVVKRL----------KDVNVGKRDFEQQMEIVGSIR 377
            ++LG+G FG  Y     D G  + VK++          K+VN      E +++++ ++ 
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA----LECEIQLLKNLL 62

Query: 378 HENVVELKAYYYSKDEKLM--VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
           HE +V+         E+ +    ++   GS+   L S        L  +   +       
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILE 117

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQ--------------QYGCVSDLGLTTITSALA 481
           G++ +H+     +VH +IK +NI  +S               Q  C+S  G+ ++T    
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT-- 172

Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           P       + +PEV       + +D++S G  ++E+LT K P
Sbjct: 173 PY------WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 31/205 (15%)

Query: 332 LGKGTFGM---AYKAILEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           +G G  G+   A+  +L  G  V VK+L    ++    KR + +++ ++  + H+N++ L
Sbjct: 29  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85

Query: 385 KAYYYSKDEKLMVYDYYSL-----GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
              +  +       D Y +      ++  ++H E       LD +    +      GI  
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKH 138

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAP-VIARAAGYRAPEV 495
           +H+A    ++H ++K SNI + S     + D GL         + P V+ R   YRAPEV
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY--YRAPEV 193

Query: 496 TDSRKATQASDVYSFGVVLLEILTG 520
                  +  D++S G ++ E++ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALAPVIARAAGYR 491
           RG+  +HA     +VH ++K  NI + S     ++D GL  I S   AL PV+     YR
Sbjct: 119 RGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYR 174

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREEWTA 549
           APEV          D++S G +  E+   K P+    +  D+L  +   +     ++W  
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGLPPEDDWPR 233

Query: 550 EV 551
           +V
Sbjct: 234 DV 235

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 46/272 (16%)

Query: 351 VVVKRLK-DVNVGKR-DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA 408
           V VK L+ D N   R DF ++++I+  ++  N++ L      +D   M+ +Y   G ++ 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 409 MLHS-------ERGEGRIPLD-------WDTRMRIAIGAARGIARIHAANGGKLVHGNIK 454
            L S       E G   +P         + + + +A+  A G+  + + N    VH ++ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165

Query: 455 SSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAA---GYRAPEVTDSRKATQASDVYS 509
           + N  +       ++D G++    A     +  RA     + A E     K T ASDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 510 FGVVLLEILT--GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF-----DVELLRYPNI 562
           FGV L EIL    + P      ++++            E   E F      V L R P  
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVI------------ENAGEFFRDQGRQVYLFRPPPC 273

Query: 563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI 594
            + + E++   + C  R   +RP   D+   +
Sbjct: 274 PQGLYELM---LQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 50/243 (20%)

Query: 331 VLGKGTFGMAYKAILED--GTTVV--VKRLK-DVNVGKRDFEQQME----IVGSIRHENV 381
           VLGKG+FG   K +L +  GT  +  +K LK DV +   D E  M     +    +   +
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGA----ARG 436
            +L + + + D    V +Y + G +  M H ++ G+ + P        IAIG     ++G
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARA 487
           I           ++ ++K  N+ L+++ +  ++D G+         TT T    P     
Sbjct: 122 I-----------IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP----- 165

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-----HLVRWVHSV 542
             Y APE+   +   ++ D ++FGV+L E+L G+ P      DEL      H V +  S+
Sbjct: 166 -DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224

Query: 543 VRE 545
            +E
Sbjct: 225 SKE 227

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y AI +  G  V +K++      K++    ++ ++   +H N+V     
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA------RGIARIH 441
           Y   DE  +V +Y + GS++ ++             +T M     AA      + +  +H
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVT------------ETCMDEGQIAAVCRECLQALEFLH 132

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
           +    +++H +IKS NI L       ++D G     +      +   G   + APEV   
Sbjct: 133 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 499 RKATQASDVYSFGVVLLEILTGKSP 523
           +      D++S G++ +E++ G+ P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 330 EVLGKGTFGMAY---KAILED-GTTVVVKRLKDVNVGKR-----DFEQQMEIVGSIRHEN 380
           +VLG G +G  +   K    D G    +K LK   + ++         + +++  IR   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 381 VVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            +    Y +  D KL ++ DY + G +   L S+R   +     +  ++I  G    +A 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-----EQEVQIYSGEIV-LAL 118

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----TITSALAPVIARAAGYRAPEV 495
            H    G +++ +IK  NI L+S  +  ++D GL+          A        Y AP++
Sbjct: 119 EHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 496 TDSRKA--TQASDVYSFGVVLLEILTGKSPIHTTGGDE 531
                    +A D +S GV++ E+LTG SP  T  G++
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEK 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 44/204 (21%), Positives = 83/204 (40%), Gaps = 22/204 (10%)

Query: 332 LGKGTFGMAYKAILEDGT--TVVVKRLKDVNVGKRD-----FEQQMEIVGSIRHENVVEL 384
           LG G+FG    A  ++     V +KR +   + K+      F ++ +I+  I H   V L
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNL 96

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG---AARGIARIH 441
              +  +    +V ++   G     L   R   R P D        +G   AA+ +    
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPND--------VGCFYAAQIVLIFE 145

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKA 501
                 +V+ ++K  N+ L+   +  ++D G   +       +     Y APE+  +   
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGH 205

Query: 502 TQASDVYSFGVVLLEILTGKSPIH 525
            +A+D ++ G+ + EIL G  P +
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 86/231 (37%)

Query: 335 GTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIRHENVV 382
           GT+G+ Y+A   + G  V +K+LK         E++ E           I+  ++H N+V
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLK--------MEKEKEGFPITSLREINILLKLQHPNIV 67

Query: 383 ELKAYYYSK--DEKLMVYDY---------------YSLGSVSAMLHSERGEGRIPLDWDT 425
            +K        D+  MV +Y               +    V  ++               
Sbjct: 68  TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ------------- 114

Query: 426 RMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIA 485
                     G+A +H      ++H ++K+SN+ LN++    + D GL           A
Sbjct: 115 -------LLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGL-----------A 153

Query: 486 RAAG--------------YRAPEVT-DSRKATQASDVYSFGVVLLEILTGK 521
           R  G              YRAPE+   +++ + A D++S G +  E+LT K
Sbjct: 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPE 494
           RG+  IH+A    ++H ++K SN+ +N      + D GL                YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185

Query: 495 VT-DSRKATQASDVYSFGVVLLEILTGKS 522
           +  +     Q  D++S G ++ E+L GK+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 19/200 (9%)

Query: 332 LGKGTFGM---AYKAILEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           +G G  G+   AY AILE    V +K+L    ++    KR + +++ ++  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTRMRIAIGAARGIARIHAA 443
              +  +       D Y    V  ++ +   +  ++ LD +    +      GI  +H+A
Sbjct: 89  LNVFTPQKSLEEFQDVYI---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL--TTITSALAPVIARAAGYRAPEVTDSRKA 501
               ++H ++K SNI + S     + D GL  T  TS +         YRAPEV      
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202

Query: 502 TQASDVYSFGVVLLEILTGK 521
            +  D++S G ++ E++ G 
Sbjct: 203 KENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 22/212 (10%)

Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVN----VGKRDFEQQME---IVGSIRHENVVEL 384
           +GKG+FG   +    D  T  +  LK +     V + +    +    ++  +    +V L
Sbjct: 1   IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR-GIARIHAA 443
           K  + S ++  +V  + + G    + H  + EGR  L   +R R         +  +H  
Sbjct: 59  KFSFQSPEKLYLVLAFINGGE---LFHHLQREGRFDL---SRARFYTAELLCALENLHKF 112

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRK 500
           N   +++ ++K  NI L+ Q +  + D GL  +            G   Y APE+     
Sbjct: 113 N---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
            T+A D ++ GV+L E+LTG  P +    +E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLN 182
            NL  ++LS+N     +P  LSNL  LE L L+ N ++  +  L+
Sbjct: 1   TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKIT-DLSPLS 42

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 9/117 (7%)

Query: 413 ERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG 472
           E  E   PLD D  +R +   A+G+  + + N    +H ++ + N+ L   +   + D G
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFG 257

Query: 473 LT-TITSALAPVI---AR-AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           L   I +    V+   AR    + APE       T  SDV+S+G++L EI + GKSP
Sbjct: 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 33/205 (16%)

Query: 332 LGKGTFGMAY-----KAILEDGTTVVVKRLKDVNVGKRD------FEQQMEIVGSIRHEN 380
           LGKG+FG  Y     KA+ E+     +K LK++ VG+ +        Q+ +++  + H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI-----PLDWDTRMRIAIGAAR 435
           +V+  A +  +D   ++ +Y     +   L   +  G+        +W  ++ +      
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRA 492
           G+  +H     +++H ++K+ NIFL +     + D G++ +   +  LA        Y +
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 493 PEVTDSRKATQASDVYSFGVVLLEI 517
           PE    +     SD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA--- 386
           +V+G+G FG    A+++   T  +  +K +N  K +  ++ E     R E  V +     
Sbjct: 7   KVIGRGAFGEV--AVVKMKHTERIYAMKILN--KWEMLKRAE-TACFREERNVLVNGDCQ 61

Query: 387 -----YYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
                +Y  +DE    +V DYY  G +  +L   + E R+P D   R  IA      +  
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPEDM-ARFYIA----EMVLA 114

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------TITSALAPVIARAAGYRA 492
           IH+ +    VH +IK  N+ L+   +  ++D G         T+ S++A        Y +
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYIS 171

Query: 493 PEVTDSR-----KATQASDVYSFGVVLLEILTGKSPIH 525
           PE+  +      K     D +S GV + E+L G++P +
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVV--VKRLKDVNVGKRD----FEQQMEIVGSIRHENVVE 383
           +V+G+G FG   + +    +  V  +K L    + KR     F ++ +I+     E +V+
Sbjct: 49  KVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107

Query: 384 LKAYYYSKDEK--LMVYDYYSLGS-VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           L  +Y  +D+K   MV +Y   G  V+ M + +     IP  W  R   A      +  I
Sbjct: 108 L--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKW-ARFYTA-EVVLALDAI 158

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVT 496
           H+      +H ++K  N+ L+   +  ++D G      A   V    A     Y +PEV 
Sbjct: 159 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215

Query: 497 DSRKAT----QASDVYSFGVVLLEILTGKSP 523
            S+       +  D +S GV L E+L G +P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 27/102 (26%), Positives = 46/102 (45%), Gaps = 8/102 (7%)

Query: 420 PLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-- 477
           PL      ++   A + ++ I   +G  ++H +IK+ N+ +N  +  C+ D G       
Sbjct: 256 PLG---LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312

Query: 478 SALAPV---IARAAGYRAPEVTDSRKATQASDVYSFGVVLLE 516
           S   P    IA      APEV      T + D++S G+V+ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 40/199 (20%), Positives = 83/199 (41%), Gaps = 17/199 (8%)

Query: 332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           +G GTFG  +            +K +    V +   EQ +     ++  + H  ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 387 YYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           ++   D++   M+ +Y   G + + L   R  GR      +       A+  +  +   +
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRF-----SNSTGLFYASEIVCALEYLH 118

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
             ++V+ ++K  NI L+ + +  ++D G           +     Y APEV  S+   +A
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKA 178

Query: 505 SDVYSFGVVLLEILTGKSP 523
            D ++ G+++ E+L G  P
Sbjct: 179 VDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 50/280 (17%)

Query: 331 VLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFE--QQMEIVGSIRHENVVE 383
           VLG G FG  YK I + DG      V +K L++    K + E   +  ++  +    V  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAML-HSERGEGRIP----LDWDTRMRIAIGAARGIA 438
           L     +   +L+      L     +L +    + RI     L+W       +  A+G++
Sbjct: 74  LLGICLTSTVQLVT----QLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMS 123

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAP----- 493
            +      +LVH ++ + N+ + S  +  ++D GL  +   +      A G + P     
Sbjct: 124 YLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMA 179

Query: 494 -EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
            E    R+ T  SDV+S+GV + E++T G  P       E+  L+             E 
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE----------KGE- 228

Query: 552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV 591
                 R P      +++  I + C +   + RP+  ++V
Sbjct: 229 ------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 73/295 (24%)

Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVV 382
           + LG G FG   +A K  ++      +K L+  +V  R+     + + +I+    +E VV
Sbjct: 7   KTLGIGAFGEVCLARK--VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L   +  KD    V DY   G + ++L       R+ +  +   R  I  A     + +
Sbjct: 65  RLYYSFQDKDNLYFVMDYIPGGDMMSLLI------RMGIFPEDLARFYI--AELTCAVES 116

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT--------------------------- 475
            +    +H +IK  NI ++   +  ++D GL T                           
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 476 --------ITSALAPVIARAA---------------GYRAPEVTDSRKATQASDVYSFGV 512
                       L P+  RAA                Y APEV      TQ  D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 513 VLLEILTGKSP-IHTTGGDELVHLVRW---VHSVVREEWTAEVFD--VELLRYPN 561
           +L E+L G+ P +  T  +  + ++ W   +H   + + + E  D  ++L R P 
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 26/152 (17%)

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLD----WDTRMRIAIGAAR 435
           N+V L  Y  S+D   +V  +   G + + +        IP +    W   M +A+ A  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDA-- 100

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT--SALAPVIARAA---GY 490
               +H      +V  ++  +NI L+ + +     + LT  +  S +       A    Y
Sbjct: 101 ----LHREG---IVCRDLNPNNILLDDRGH-----IQLTYFSRWSEVEDSCDGEAVENMY 148

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKS 522
            APEV    + T+A D +S G +L E+LTGK+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 54/235 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS-----------IR 377
           E +G+GT+G+ YK    + G  V +K+++         E + E V S           ++
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIR--------LESEEEGVPSTAIREISLLKELQ 57

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           H N+V L+     +    +++++ S+  +   L S      +  +        I   +GI
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI--LQGI 114

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------- 489
              H+    +++H ++K  N+ ++++    ++D GL           ARA G        
Sbjct: 115 LFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL-----------ARAFGIPVRVYTH 160

Query: 490 ------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
                 YRAPEV   S + +   D++S G +  E+ T K   H  G  E+  L R
Sbjct: 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH--GDSEIDQLFR 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 20/54 (37%), Positives = 33/54 (61%), Gaps = 2/54 (3%)

Query: 159 SNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS 210
           +N +++ ++ L+  ++SGKI      LP +Q +NL+NN LSG IP  +    SS
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS 119

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	625
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PLN03150	623	hypothetical protein; Provisional	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
PRK10345	210	hypothetical protein; Provisional	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.54
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.38
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.26
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.26
PLN03150	623	hypothetical protein; Provisional	99.26
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.24
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.18
KOG1243	690	consensus Protein kinase [General function predict	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.95
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.93
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.93
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.92
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.86
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.81
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.81
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.76
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.74
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.73
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.72
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.71
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.69
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.65
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.64
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.63
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.62
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.62
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.54
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.53
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.39
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.39
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.35
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.35
PRK09902	216	hypothetical protein; Provisional	98.34
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.23
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.23
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.19
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.18
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.03
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.03
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	97.97
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-60  Score=566.32  Aligned_cols=494  Identities=26%  Similarity=0.412  Sum_probs=342.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLS  146 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls  146 (625)
                      +..|+|.+|.+.|.+|.  ...+++|+.|+|++|++++.+|..|.++++|+.|+|++|++.+.+| .+..+++|++|+|+
T Consensus       454 L~~L~L~~n~~~~~~p~--~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  531 (968)
T PLN00113        454 LQMLSLARNKFFGGLPD--SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS  531 (968)
T ss_pred             CcEEECcCceeeeecCc--ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence            45556666666655553  2245677777777777777777778888888888888888887777 57778888888888


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccc--cccCCCCcccCCCCCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQS--LKRFPSSAFVGNSISFDEN  222 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~--l~~~~~~~~~~n~~~~~~~  222 (625)
                      +|.+++.+|..+..+++|+.|+|++|+++|.+|..  .+++|+.|++++|+++|.+|..  +..+....+.||+..|+.+
T Consensus       532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  611 (968)
T PLN00113        532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD  611 (968)
T ss_pred             CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence            88888888888888888888888888888877763  6778888888888888888853  3445566778888888653


Q ss_pred             CCCCCCCCCCCCCCccCCCCCCCccccceeeehhhhHHHHHHHHHHHHHhhhhhccccchhhccccccCCCCCccccccc
Q 006922          223 LAPRASPDVAPRGESHLRPKSGRRIGETTLLGIVIAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSPEKVVSRN  302 (625)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (625)
                      .....    +     .+...  .+ .....+.+++++++++++++++++++++++|++.+. +......+. .+      
T Consensus       612 ~~~~~----~-----~c~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~------  671 (968)
T PLN00113        612 TTSGL----P-----PCKRV--RK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL-KRVENEDGT-WE------  671 (968)
T ss_pred             cccCC----C-----CCccc--cc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccc-ccccccccc-cc------
Confidence            21100    0     00000  01 111112222222222222222222222333222111 000000000 00      


Q ss_pred             cCCCCceeeecCCCcccCHHHHHHHH--HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCC
Q 006922          303 QDASNRLFFFEGCNYAFDLEDLLRAS--AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE  379 (625)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~  379 (625)
                           ...+.......+..+++....  .++||+|+||+||+|.. .+|..||||+++....   ....|++++++++||
T Consensus       672 -----~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~Hp  743 (968)
T PLN00113        672 -----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHP  743 (968)
T ss_pred             -----ccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCC
Confidence                 000000111224444443332  35799999999999996 5799999999875432   224568899999999


Q ss_pred             ceecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 006922          380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIF  459 (625)
Q Consensus       380 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIl  459 (625)
                      |||+++|+|.+.+..++||||+++|+|.++++.        ++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+
T Consensus       744 nIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil  815 (968)
T PLN00113        744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII  815 (968)
T ss_pred             CcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence            999999999999999999999999999999962        899999999999999999999776667999999999999


Q ss_pred             eCCCCCeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 006922          460 LNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       460 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~  539 (625)
                      ++.++.+++. ||.+...... ....++..|+|||++.+..++.++|||||||++|||+||+.||+... .......+|+
T Consensus       816 ~~~~~~~~~~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~  892 (968)
T PLN00113        816 IDGKDEPHLR-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWA  892 (968)
T ss_pred             ECCCCceEEE-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHH
Confidence            9999988875 6655443222 12356788999999999999999999999999999999999995432 2334566677


Q ss_pred             HHHhhcccccccccccccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          540 HSVVREEWTAEVFDVELLR-YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                      +..........++|+.... .+...++..++.+++.+||+.+|++||+|.||++.|+++....+
T Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             HHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            6655554455556655432 23345667789999999999999999999999999999876443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-55  Score=456.47  Aligned_cols=283  Identities=37%  Similarity=0.652  Sum_probs=251.4

Q ss_pred             CCcccCHHHHHHHH-----HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEE
Q 006922          315 CNYAFDLEDLLRAS-----AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYY  388 (625)
Q Consensus       315 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~  388 (625)
                      ....|+++++..||     .++||+|+||.||+|.+.+|+.||||++...... .++|..|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34668999999998     3689999999999999999999999999876554 67799999999999999999999999


Q ss_pred             EecC-ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          389 YSKD-EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       389 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                      .+.+ +.+||||||++|+|.++|+.....   +++|.+|++||.++|+||+|||+...++|||||||++|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998 499999999999999999976432   689999999999999999999999988999999999999999999999


Q ss_pred             Eecccccccccc-ccccc---ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 006922          468 VSDLGLTTITSA-LAPVI---ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       468 l~DfGla~~~~~-~~~~~---~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                      |+|||+|+.... .....   .||.+|+|||++.....+.|+|||||||+|+||+||+.+.+.........+++|+...+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999987764 33222   78999999999999999999999999999999999999988655445556899999999


Q ss_pred             hcccccccccccccCCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          544 REEWTAEVFDVELLRYPNIE-EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       544 ~~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ......+++|+.+....... +++..+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            99899999999986433332 6888899999999999999999999999999776654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=401.93  Aligned_cols=262  Identities=30%  Similarity=0.477  Sum_probs=214.3

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC-c
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD-E  393 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  393 (625)
                      .++.+++.  ..+.||+|+||+||+|.+.....||||++.....+   .++|.+|+.+|.+++|||||+++|+|.... .
T Consensus        37 ~i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   37 EIDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ecChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            34555543  34569999999999999874444999999876443   358999999999999999999999999887 7


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLG  472 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfG  472 (625)
                      .++|||||++|+|.++++..   ....++|..+++++.|||+||.|||+++.  |||||||++|||++.++ ++||+|||
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence            99999999999999999874   12359999999999999999999999873  99999999999999997 99999999


Q ss_pred             ccccccc---cccccccCCCcCCccccC--CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          473 LTTITSA---LAPVIARAAGYRAPEVTD--SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       473 la~~~~~---~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      +++....   ......||..|||||++.  ...|+.|+|||||||++|||+||+.||...........      ....+ 
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~------v~~~~-  262 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA------VVVGG-  262 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhcC-
Confidence            9987653   334468999999999999  66999999999999999999999999987654221111      11111 


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                               .+.+....+...+..++.+||..||..||+|.|++..|+.+.....
T Consensus       263 ---------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  263 ---------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             ---------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                     1112223355678888889999999999999999999998877544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=399.95  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=222.9

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEE
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ++.+++  ...+.||+|-||.||.|.++....||+|.++......++|.+|+++|.+++|+|||+++|+|..++.++|||
T Consensus       203 i~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  203 IPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             ecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            444444  456789999999999999987789999999998888899999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      |||+.|+|.++|+...   ...++..+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+...
T Consensus       281 E~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence            9999999999999732   234888999999999999999999998   9999999999999999999999999999654


Q ss_pred             cccccc-cc---CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          479 ALAPVI-AR---AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       479 ~~~~~~-~~---~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      +..+.. .+   ..-|.|||++...+++.|||||||||+||||+| |+.||......+..+.++                
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le----------------  418 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE----------------  418 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh----------------
Confidence            433321 11   224999999999999999999999999999999 999999887766665554                


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                       +..+.|.++.+..++.++|..||..+|++||||+.+...|+.+....
T Consensus       419 -~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  419 -RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             -ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence             12234556667789999999999999999999999999999886643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=376.50  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccc--cCChHHHHHHHHHHHcCCCCceecceeEEEecCc-
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-  393 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  393 (625)
                      .+.++|+.  ..+.||+|+.|+|||++++ +++.+|+|.+...  ...+++..+|++++++.+||+||.++|.|+..+. 
T Consensus        75 ~i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            35566664  3578999999999999965 6889999999432  2235789999999999999999999999999984 


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      ..++||||++|+|+.++....     .+++...-+|+.++++||.|||+..  +||||||||+|||++..|++||+|||.
T Consensus       153 isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccc
Confidence            999999999999999998653     3889999999999999999999743  399999999999999999999999999


Q ss_pred             ccccc-ccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--CcchhhHHHHHHHHhhcccccc
Q 006922          474 TTITS-ALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG--GDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       474 a~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ++.+- ......+||..|||||.+.+..|+.++||||||++++|+++|+.||....  ...+.+++.++           
T Consensus       226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I-----------  294 (364)
T KOG0581|consen  226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI-----------  294 (364)
T ss_pred             cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH-----------
Confidence            98764 34567789999999999999999999999999999999999999997641  22344444332           


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .+..-.+.|.. ....++..++..|+++||.+||+..|+++
T Consensus       295 -v~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  295 -VDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -hcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             12111111211 24567778888999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-47  Score=410.64  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=218.9

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|+..      +.+.||||.+++....  +.+|++|+++++.++|||||+|+|+|..++..++|+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            467999999999999842      3468999999986543  57899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCC---------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          401 YSLGSVSAMLHSERGEG---------RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      |..|||.++|.......         ..+|+..+.+.||.|||.||.||.++.   +|||||..+|+||.++..+||+||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEeccc
Confidence            99999999997654321         234889999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccc-----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhc
Q 006922          472 GLTTITSALAPVIAR-----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVRE  545 (625)
Q Consensus       472 Gla~~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  545 (625)
                      |+++..-...+...+     ...||+||.+..++++++||||||||+|||++| |+.||.+...+|+.+.++.       
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-------  720 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-------  720 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-------
Confidence            999977554443322     235999999999999999999999999999999 9999999988888776651       


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                              ..+  .+.++.+..+++.||..||+.+|++||+|.||-..|+.....
T Consensus       721 --------g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  721 --------GQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --------CCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                    111  355677888999999999999999999999999999887554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=400.20  Aligned_cols=251  Identities=25%  Similarity=0.454  Sum_probs=222.0

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||.|.||.||+|+++-    ...||||.||....  .+++|..|+.||++++||||++|.|+.......+||.|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            5789999999999999642    35799999997643  45789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|+.+|+.+.++    +.+.+...++.+||.|++||.+++   .|||||.++|||++.+..+|++|||+++.+.+...
T Consensus       714 NGsLDsFLR~~DGq----ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  714 NGSLDSFLRQNDGQ----FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             CCcHHHHHhhcCCc----eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            99999999987643    899999999999999999999998   99999999999999999999999999998865543


Q ss_pred             ccccC------CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 VIARA------AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ~~~~~------~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ....|      ..|.|||++..++++.++|||||||+|||.++ |+.||.+++..+..+.++                 .
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-----------------~  849 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------Q  849 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-----------------h
Confidence            32222      24999999999999999999999999999998 999999998877766554                 2


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                      ..+.|.+.++...+.+||+.||++|-.+||+|.||+..|+++..+...
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            235577788999999999999999999999999999999999887553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-45  Score=377.49  Aligned_cols=238  Identities=23%  Similarity=0.403  Sum_probs=207.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|||+.||+++. ..|..||+|++.+.    ...++...+|++|.+.++|||||+++++|++.++.|||.|+|++
T Consensus        23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~  102 (592)
T KOG0575|consen   23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR  102 (592)
T ss_pred             eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence            36799999999999996 78999999999874    33346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      ++|.++++..+     ++++.++..+..||+.||.|||+.+   |+|||||..|+||+++.++||+|||+|..+.   ..
T Consensus       103 ~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen  103 GSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             ccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            99999998433     5999999999999999999999998   9999999999999999999999999999886   44


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..+.+||+.|+|||++....++..+||||+||+||-|+.|++||+...-.++...+....                  +.
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------------Y~  236 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------------YS  236 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC------------------cc
Confidence            567899999999999999999999999999999999999999998765555555443211                  12


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.....+..+++.+.++.+|.+|||.++|+.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22233445567777999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=359.70  Aligned_cols=198  Identities=25%  Similarity=0.406  Sum_probs=176.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..||+|+||+||+|++. ++..||||.+......   .+.+..|+++|++++|||||+++++++.++..++|||||.+||
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD   95 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD   95 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence            34999999999999954 6899999999876433   3557899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC------CCeeEecccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ------QYGCVSDLGLTTITSA  479 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~------~~~kl~DfGla~~~~~  479 (625)
                      |.++++...     .+++.....++.|+|.||++||+++   ||||||||.||||+..      -.+||+|||+|+.+..
T Consensus        96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            999999764     3899999999999999999999998   9999999999999875      4579999999999865


Q ss_pred             c--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhH
Q 006922          480 L--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL  535 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~  535 (625)
                      .  ..+.+|++-|||||++..++|+.|+|+||.|+++||+++|+.||+.....|....
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            3  3567899999999999999999999999999999999999999987665555443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-45  Score=360.33  Aligned_cols=242  Identities=23%  Similarity=0.405  Sum_probs=197.7

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC--------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG--------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||.|-+|. ..+|+.||||++++....        ..+..+|+++|.+++|||||+++++|...+..|||||
T Consensus       177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE  256 (475)
T KOG0615|consen  177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE  256 (475)
T ss_pred             eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence            4679999999999999 568999999999865221        2345799999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEeccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTI  476 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~  476 (625)
                      ||+||+|.+.+-.+..     +.+.....++.|++.|+.|||+++   |+||||||+|||+..+   ..+||+|||+|+.
T Consensus       257 ~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  257 YVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999876542     677778899999999999999998   9999999999999877   6789999999998


Q ss_pred             cc--ccccccccCCCcCCccccCCCCC---CCccchhhhHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHHhhcccccc
Q 006922          477 TS--ALAPVIARAAGYRAPEVTDSRKA---TQASDVYSFGVVLLEILTGKSPIHTTGGDE-LVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       477 ~~--~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  550 (625)
                      ..  ....+.+||+.|.|||++.+..+   ..|+|+||+||+||-+++|.+||.+...+. ..+.+.      ++.    
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~------~G~----  398 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL------KGR----  398 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh------cCc----
Confidence            84  34456799999999999976543   348899999999999999999998765443 222221      110    


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       +.   ...+...+..++..+++.+++..||++|||++|+++
T Consensus       399 -y~---f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  399 -YA---FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cc---ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             00   011223444556777888999999999999999985

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=394.40  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=213.8

Q ss_pred             HhHcccCCceeEEEEEEcC--Cc----EEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILED--GT----TVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~--g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||.|...+  |.    .||||.++....  ...+|.+|..+|++++|||||+++|+|.+....+|++||
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley  776 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY  776 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence            4679999999999999543  43    499999987633  347899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          401 YSLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      |++|+|..+|++.+..  +...++-...+.++.|||+|+.||++++   +|||||.++|+||+....+||+|||+|+.+.
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            9999999999987432  2345888999999999999999999998   9999999999999999999999999999654


Q ss_pred             cccccccc-----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          479 ALAPVIAR-----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       479 ~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ...+...+     ...|||||.+....++.|+|||||||++||++| |..||...+..++...+.      .+       
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~g-------  920 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EG-------  920 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hC-------
Confidence            43333222     235999999999999999999999999999999 999998877665544322      11       


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                          .+.+.++.+...++++|..||+.+|++||+|..+++.+..+....
T Consensus       921 ----gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  921 ----GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                133455667778999999999999999999999999998886654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-43  Score=331.60  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             HHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeE-EEecCc-eEEEEEec
Q 006922          328 SAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAY-YYSKDE-KLMVYDYY  401 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~e~~  401 (625)
                      +.++||+|.||+|||+. +.+|..+|.|.+.-...+   +++...|+.+|++++|||||+++++ +..+++ .+|||||+
T Consensus        23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c  102 (375)
T KOG0591|consen   23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC  102 (375)
T ss_pred             HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence            46789999999999999 678999999999855443   3568899999999999999999994 444444 78999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG-GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      ..|+|...++..+.+ +..+++..+.+++.|+++||.++|++-. ..|+||||||.||+++.+|.+||+|||++++++..
T Consensus       103 ~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~  181 (375)
T KOG0591|consen  103 DAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK  181 (375)
T ss_pred             cccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence            999999999876643 4458999999999999999999999431 13999999999999999999999999999998754


Q ss_pred             c---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          481 A---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      .   ...+||+.||+||.+.+..|+.|+||||+||++|||..=++||.+.+-.+....+.       .+           
T Consensus       182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-------qg-----------  243 (375)
T KOG0591|consen  182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-------QG-----------  243 (375)
T ss_pred             hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-------cC-----------
Confidence            3   45789999999999999999999999999999999999999998753322222221       11           


Q ss_pred             CCC-Cc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          558 RYP-NI-EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       558 ~~~-~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      ..+ .+ +--..++..|+..|+..||+.||+...++..+
T Consensus       244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            112 12 33356788888999999999999854444444

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=355.94  Aligned_cols=250  Identities=23%  Similarity=0.416  Sum_probs=210.7

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEE
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .+.++++..  .+-||.|+.|.||+|+++ ++.||||+++.      .-+.+|+-|++++||||+.+.|+|....-+|||
T Consensus       120 eiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  120 EIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             cCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            344555432  467999999999999986 78999998764      234578999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ||||..|-|...|+..+     ++.-.....|..+||.|+.|||.+.   |||||||.-||||..+..+||+|||-++..
T Consensus       191 MEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999998754     4777788999999999999999987   999999999999999999999999999887


Q ss_pred             ccccc--ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          478 SALAP--VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       478 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      +...+  ..+||..|||||++..+++++|+||||||||||||+||+.||.+.+...+.    |            -+..+
T Consensus       263 ~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w------------GVGsN  326 (904)
T KOG4721|consen  263 SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W------------GVGSN  326 (904)
T ss_pred             hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E------------eccCC
Confidence            65433  468999999999999999999999999999999999999999765443221    0            01122


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ....+.++.+...+.-++++||+..|.+||+|.+|+..|+-..++
T Consensus       327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            334566677777888888999999999999999999999766554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=339.75  Aligned_cols=231  Identities=24%  Similarity=0.367  Sum_probs=192.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .++||+|+||+||.++.. .++.+|+|++++...    +.+....|..+|.+++||.||.+.-.|++.+..|+|+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            478999999999999954 589999999987643    235678999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      |.|..+|.+..     .+++..+..++..|+.||.|||+++   ||||||||+|||||.+|+++|+|||+++..-   ..
T Consensus       110 GeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  110 GELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             ccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999998654     2889999999999999999999998   9999999999999999999999999998542   23


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      +...+||+.|||||++.+..|+.++|+||+||++|||++|.+||...+..+..+.+.      .+.         +...+
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~------~~k---------~~~~p  246 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL------KGK---------LPLPP  246 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh------cCc---------CCCCC
Confidence            445689999999999999999999999999999999999999998765433332221      111         11112


Q ss_pred             C-cHHHHHHHHHHHHHccCCCCCCCC
Q 006922          561 N-IEEEMVEMLQIAMSCVVRMPDQRP  585 (625)
Q Consensus       561 ~-~~~~~~~l~~l~~~Cl~~~P~~RP  585 (625)
                      . ...   +..+++...+..+|++|-
T Consensus       247 ~~ls~---~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  247 GYLSE---EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ccCCH---HHHHHHHHHhccCHHHhc
Confidence            1 233   345556688999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=326.64  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=198.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ...+|+|+||+|||++.+ .|+.||||++.....+   ++-..+|+++|.+++|+|+|.++.+|......++|+||++..
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT   86 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT   86 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence            356999999999999965 5999999999876554   356889999999999999999999999999999999999985


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      -|.++=+...     .++.....++++|+++|+.|+|+++   +|||||||+|||++.++.+||||||+|+.+....   
T Consensus        87 vL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   87 VLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             HHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            5554443332     2888899999999999999999998   9999999999999999999999999999886322   


Q ss_pred             cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH-HHHHhhc--------cccccc
Q 006922          482 PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW-VHSVVRE--------EWTAEV  551 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~  551 (625)
                      +..+.|..|+|||.+.+ ..|...+||||.||++.||++|.+-|.+.+.-+....+.. +...++.        .....+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            23567888999999877 6899999999999999999999999877654333222221 1111111        111111


Q ss_pred             ccccccCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 FDVELLRYPNIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 ~d~~~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .-++.......+    ....-+++++..|+..||.+|++.+|++.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111111111111    11234688999999999999999999873

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.5e-42  Score=347.72  Aligned_cols=257  Identities=18%  Similarity=0.309  Sum_probs=206.2

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEe---
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYS---  390 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~---  390 (625)
                      .++.+++.......||+|++|.||+|.. +|+.||||+++......    +.+.+|++++.+++||||++++|++.+   
T Consensus        14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            3556666544456799999999999998 58999999998654332    567799999999999999999999877   


Q ss_pred             -cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe
Q 006922          391 -KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS  469 (625)
Q Consensus       391 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~  469 (625)
                       ....++||||+++|+|.+++....     .++|....+++.+++.||+|||...  .++||||||+||++++++.+||+
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence             346789999999999999997643     4889999999999999999999852  28899999999999999999999


Q ss_pred             cccccccccccccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          470 DLGLTTITSALAPVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       470 DfGla~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      |||+++..........++..|+|||++.+  ..++.++|||||||++|||++|+.||......+....+      ...+.
T Consensus       166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~  239 (283)
T PHA02988        166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN  239 (283)
T ss_pred             ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC
Confidence            99999876554444567888999999876  68899999999999999999999999865433322211      11110


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                                ..+........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       240 ----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 ----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                      00111123346778888999999999999999999998865

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=356.65  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=203.4

Q ss_pred             hHcccCCceeEEEEEEcC--C---cEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILED--G---TTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~--g---~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||.||+|.+..  +   ..||||..+..    .....+|.+|+++|++++|||||+++|++......++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            679999999999999543  2   23899999852    22347899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      |.||+|.++|.+..+    .++..++.+++.+.|+||+|||+++   +|||||.++|+|++.++.+||+|||+++.....
T Consensus       243 ~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            999999999998754    3899999999999999999999998   999999999999999999999999998876421


Q ss_pred             ccc---cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          481 APV---IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       481 ~~~---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                      ...   -.-...|+|||.+....|+.++|||||||++||+++ |..||.+....+....+.      ..+.         
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~~---------  380 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNGY---------  380 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcCc---------
Confidence            111   112345999999999999999999999999999999 899998765443322221      1111         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                       +.+.......++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       381 -r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 -RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             111112233456667779999999999999999999999876643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=347.93  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=202.1

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccCCh-HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..||+|+.|.||.+. ..+++.||||++......+ +-..+|+.+|+..+|+|||.+++.|...++.++|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            569999999999999 5578999999998766555 45789999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +.+....      +++.++..|+.++++||+|||.++   |+|||||.+|||++.++.+||+|||++......   ....
T Consensus       359 DvVt~~~------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  359 DVVTKTR------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             hhhhccc------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence            9998654      899999999999999999999998   999999999999999999999999999887543   3456


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||+.|||||++....|++|+||||+|++++||+.|++||-....-....+       +...        ........+.
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~n--------g~P~lk~~~k  494 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATN--------GTPKLKNPEK  494 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------Hhhc--------CCCCcCCccc
Confidence            899999999999999999999999999999999999999975332111111       1111        1112223334


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.++..+|++.|+++||++.|+++
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            4456667777999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-41  Score=337.85  Aligned_cols=256  Identities=22%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  402 (625)
                      .++||+|+||.||+|+ ..+|+.||+|+++-....   ..-..+||.||++++||||++|.+...+.  ..+|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            3679999999999999 668999999999865422   35678999999999999999999998876  68999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      . ||..++....-    .++..++..++.|++.||+|+|+++   |+|||||.+|||||.+|.+||+|||+|++..... 
T Consensus       202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            8 88888876432    3899999999999999999999998   9999999999999999999999999999775433 


Q ss_pred             ---cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc--cccccc
Q 006922          482 ---PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA--EVFDVE  555 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~d~~  555 (625)
                         +..+-|..|+|||++.+ ..|+.++|+||.||||.||++|++.|.+..+-+..+.+-.+-....++.+.  .+-...
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence               23455778999999875 479999999999999999999999998765433333222111111122222  000001


Q ss_pred             ccCC-----CCcHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRY-----PNIEE----EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~-----~~~~~----~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....     ....+    .....++|+..++..||.+|.|+.++++
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1110     00111    1234567788999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=342.56  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=208.8

Q ss_pred             HHhHcccCCceeEEEEEEcCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..+.||+|-||.|..+....+..||||.++....  .+++|.+|+++|.+++|||||+++|+|..++..++|+|||++|+
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD  621 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD  621 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence            3678999999999999998889999999997643  35789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc-c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-I  484 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~  484 (625)
                      |..++......   .++-....+|+.|||.||+||.+.+   +||||+.++|+|+|.++++||+|||+++-+-...+. .
T Consensus       622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999876432   1345567889999999999999998   999999999999999999999999999966433322 2


Q ss_pred             cc----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          485 AR----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT--GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       485 ~~----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      .|    ...|||+|.+.-.++++++|||+|||++||+++  .+.||.....+.+.   +-.....+..... ++      
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~-~~------  765 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQ-VV------  765 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcc-ee------
Confidence            22    346999999999999999999999999999888  88999876654433   2222233222111 11      


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .+.+.-+...+++++.+||..+-++||+|+++...|++..
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            1223445667889999999999999999999999997653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-40  Score=311.40  Aligned_cols=255  Identities=20%  Similarity=0.376  Sum_probs=200.7

Q ss_pred             HHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..+.||+|.||.||+|+ ...|+.||||+++..+..   .....+|++.|+.++|+||+.++++|.+.+...+|+|||+.
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t   85 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT   85 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence            35779999999999999 567999999999876433   36789999999999999999999999999999999999987


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  482 (625)
                       +|+..++...    ..++-.+...++.++.+|++|+|.+.   |+||||||.|+|++++|.+||+|||+|+....... 
T Consensus        86 -dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   86 -DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             -cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence             8998887643    46899999999999999999999998   99999999999999999999999999998764322 


Q ss_pred             --ccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh----hcccc--ccccc
Q 006922          483 --VIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV----REEWT--AEVFD  553 (625)
Q Consensus       483 --~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~d  553 (625)
                        ..+-|..|+|||.+. .+.|+..+||||.|||+.||+-|.+-|.+.++  +.++.. +-..+    .+.|.  ..+-|
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~-If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSK-IFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHH-HHHHcCCCCcccCcccccccc
Confidence              235677899999875 46799999999999999999999988866443  222222 11111    12221  11111


Q ss_pred             ccccC-CC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          554 VELLR-YP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       554 ~~~~~-~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ..-.. .|      -...+..+.++++..++..||.+|++++|++++
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111 11      112234456889999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=342.55  Aligned_cols=238  Identities=18%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||+|+|++||+|+ ...++.||||++.+...    ..+...+|-+.|.++ .||.|++|+-.|++...+|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            4679999999999999 55799999999987532    224577888899999 89999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|+|.+++++..     .+++.-...++.+|+.||+|||+.+   ||||||||+|||||.|+++||.|||.|+.+++.  
T Consensus       158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            999999999764     3899889999999999999999998   999999999999999999999999999876421  


Q ss_pred             ----------c----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc
Q 006922          481 ----------A----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE  546 (625)
Q Consensus       481 ----------~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  546 (625)
                                .    ...+||..|++||++.....+..+|+|+||||+|+|+.|++||.+.++--+.+.+..+.      
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~------  303 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD------  303 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc------
Confidence                      1    23678889999999999999999999999999999999999998765433333332211      


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                             ...  .+...   ..+.+|+.+.+..||.+|++.+||.+
T Consensus       304 -------y~f--p~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  304 -------YEF--PEGFP---EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -------ccC--CCCCC---HHHHHHHHHHHccCccccccHHHHhh
Confidence                   111  11222   34556666999999999999988875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=338.03  Aligned_cols=264  Identities=18%  Similarity=0.321  Sum_probs=206.7

Q ss_pred             HHHHHHHHHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHH--HHHHHHHHHcCC-CCceecceeEEEecC-ceE
Q 006922          321 LEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD--FEQQMEIVGSIR-HENVVELKAYYYSKD-EKL  395 (625)
Q Consensus       321 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  395 (625)
                      +.+.+. +.+.||.|+||.||+|+ ...|..||||+++.....-++  -.+|++-|++++ |||||++..++.+.+ ..+
T Consensus         8 ~m~RY~-~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYT-VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHH-HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            344443 45789999999999999 567999999999987554443  578999999998 999999999999888 899


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +|||||+. +|+++++..    ..++++..++.|+.||.+||+|+|.++   +.|||+||+|||+.....+||+|||+|+
T Consensus        87 fVfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence            99999976 999999865    346999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccc--cccccCCCcCCcccc-CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhhccccc--
Q 006922          476 ITSALA--PVIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD-ELVHLVRWVHSVVREEWTA--  549 (625)
Q Consensus       476 ~~~~~~--~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--  549 (625)
                      ......  +..+.|..|+|||++ ....|+.+.||||+|||++|+.+=++-|-+.++- ++..+.+.+..-..+.|..  
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            876543  345789999999986 4667899999999999999999999999776532 2223222222111122211  


Q ss_pred             ---ccccccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          550 ---EVFDVELLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       550 ---~~~d~~~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                         ..........+.      ...+..+.++++.+|++.||.+|||++|+++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               111111111110      12245677888999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-40  Score=347.71  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecC-ceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKD-EKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  398 (625)
                      .+.||+|+||.||+|..      .+++.||+|+++....  ..+.+.+|++++.++ +||||++++++|...+ ..++||
T Consensus        12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~   91 (338)
T cd05102          12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV   91 (338)
T ss_pred             eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence            46799999999999973      2356899999975432  235688999999999 8999999999987654 578999


Q ss_pred             EeccCCChhhhhccccCC---------------------------------------------------------CCccC
Q 006922          399 DYYSLGSVSAMLHSERGE---------------------------------------------------------GRIPL  421 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~l  421 (625)
                      ||+++|+|.+++......                                                         ...++
T Consensus        92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  171 (338)
T cd05102          92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL  171 (338)
T ss_pred             ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence            999999999998753210                                                         02358


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-----cccccCCCcCCcccc
Q 006922          422 DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVT  496 (625)
Q Consensus       422 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~  496 (625)
                      ++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......     ....++..|+|||++
T Consensus       172 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  248 (338)
T cd05102         172 TMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI  248 (338)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence            88999999999999999999987   9999999999999999999999999998653221     112345679999999


Q ss_pred             CCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHH
Q 006922          497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMS  575 (625)
Q Consensus       497 ~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  575 (625)
                      .+..++.++|||||||++|||++ |+.||......+..  ..    .+..+..        ..  ........+.+++.+
T Consensus       249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~----~~~~~~~--------~~--~~~~~~~~l~~li~~  312 (338)
T cd05102         249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQ----RLKDGTR--------MR--APENATPEIYRIMLA  312 (338)
T ss_pred             hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HH----HHhcCCC--------CC--CCCCCCHHHHHHHHH
Confidence            98899999999999999999997 99999765432211  11    1111100        00  011223467788899


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          576 CVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       576 Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ||+.||++|||+.|+++.|+++..+
T Consensus       313 cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         313 CWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=346.38  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=203.8

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceE
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKL  395 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  395 (625)
                      +.++++.  ..+.||+|+||+||+|++.  ..||||.++......   +.|..|+..+++=||.||+-+.|||..+.. .
T Consensus       389 Ip~~ev~--l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVL--LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhh--ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3444443  4678999999999999975  459999998764433   679999999999999999999999988776 9


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      ||+.+|+|-+|+.++|..+.    .++..+...|+.|||+|+.|||.++   |||||||..||++.+++.+||+|||++.
T Consensus       464 IiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             eeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence            99999999999999998653    3888899999999999999999998   9999999999999999999999999986


Q ss_pred             ccccc-----ccccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          476 ITSAL-----APVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       476 ~~~~~-----~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      .-.-.     .....+..-|||||++..   .+|+.++||||||+++|||+||..||.....+.+.-++.      ++  
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG------rG--  608 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG------RG--  608 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec------cc--
Confidence            53211     112234556999999853   478999999999999999999999998444333221111      11  


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       ...-|..    .....+.+++.+|+..||..++++||.+.+|+..|+++.+.
T Consensus       609 -~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  609 -YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence             0011111    11234455777788899999999999999999999888774

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=316.69  Aligned_cols=202  Identities=20%  Similarity=0.329  Sum_probs=183.0

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEecCc
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYSKDE  393 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  393 (625)
                      +.++|..  ....||.|+||.|..++. .+|..+|+|++++...-+    +...+|..+|..+.||.++++.+.|.+...
T Consensus        41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            4555553  356799999999999995 468999999998754321    346789999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      .+|||||++||.|..++++.+.     ++...+..++.+|+.||+|||+.+   |++||+||+|||+|.+|.+||.|||+
T Consensus       119 lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence            9999999999999999997653     899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc
Q 006922          474 TTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD  530 (625)
Q Consensus       474 a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~  530 (625)
                      |+.......+.+||+.|+|||.+++..|..++|+|||||++|||+.|.+||......
T Consensus       191 AK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~  247 (355)
T KOG0616|consen  191 AKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI  247 (355)
T ss_pred             eEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence            999999888899999999999999999999999999999999999999999876653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=332.91  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=195.4

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecC--ceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKD--EKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  403 (625)
                      ..+.||+|+||.||++... +|...|||........ .+.+.+|+.+|.+++|||||+++|......  ..+++|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            4578999999999999955 4999999998765322 356899999999999999999999865555  58999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEecccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSA---  479 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~---  479 (625)
                      |+|.+++....+    .+++..+.+++.|+++||+|||+++   ||||||||+|||++. ++.+||+|||+++....   
T Consensus       101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen  101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999987643    3899999999999999999999998   999999999999999 79999999999987653   


Q ss_pred             ---cccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          480 ---LAPVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       480 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                         ......||+.|||||++... ....++||||+||++.||+||+.||... . +   ...++-....+...       
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-~---~~~~~~~ig~~~~~-------  241 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F-E---EAEALLLIGREDSL-------  241 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c-c---hHHHHHHHhccCCC-------
Confidence               12235789999999999853 3345999999999999999999999763 1 1   11111111111111       


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                       +.  .+.....+..+++..|+..+|++|||++++++.--.
T Consensus       242 -P~--ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 -PE--IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -CC--CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence             11  112233455677779999999999999999986543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=325.35  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=194.4

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHH--cCCCCceecceeEEEecC----ceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVG--SIRHENVVELKAYYYSKD----EKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~~~  402 (625)
                      .+++|+|+||.||||.+. ++.||||++....  ++.|..|-+|..  .++|+||++++++-....    +..||+||.+
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            467999999999999986 5999999997543  456777776665  468999999999987665    7899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN------GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      .|+|.++|..+.      ++|....+|+..+++||+|||+..      +|+|+|||||++||||.+|+.+.|+|||+|..
T Consensus       292 kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  292 KGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             CCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            999999998764      999999999999999999999864      67899999999999999999999999999988


Q ss_pred             cccc-----ccccccCCCcCCccccCCCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCc--------chhh--H
Q 006922          477 TSAL-----APVIARAAGYRAPEVTDSRK------ATQASDVYSFGVVLLEILTGKSPIHTTGGD--------ELVH--L  535 (625)
Q Consensus       477 ~~~~-----~~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvil~elltG~~p~~~~~~~--------~~~~--~  535 (625)
                      +...     ....+||..|||||++.+..      .-.+.||||+|.+||||+++-.-++.....        |+..  -
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            7532     22367999999999986542      124799999999999999965433210000        1100  0


Q ss_pred             HHHHHHHh-hcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          536 VRWVHSVV-REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       536 ~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ++.++..+ ++.....+-| ...    ....+..+.+.+..||..||+.|-|+.=|.+.+.++....
T Consensus       446 ~e~mq~~VV~kK~RP~~p~-~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPD-AWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHHhhccCCCChh-hhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            11111111 1111011111 000    1134556778888999999999999999998888876544

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=349.35  Aligned_cols=254  Identities=21%  Similarity=0.355  Sum_probs=215.6

Q ss_pred             HHHHHHHHhHcccCCceeEEEEE-EcCC----cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCce
Q 006922          322 EDLLRASAEVLGKGTFGMAYKAI-LEDG----TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEK  394 (625)
Q Consensus       322 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  394 (625)
                      +|.+....++||.|+||+||||. .+.|    .+||||++.....  ...++.+|+-+|.+++|||+++++|+|.... .
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            34444456789999999999998 4444    4789999976543  3578999999999999999999999998766 8


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      .||++||+.|+|.++++..++    .+..+..+.|..|||+||.|||.+.   +|||||.++||||..-..+||.|||+|
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            899999999999999998664    4888889999999999999999887   999999999999999999999999999


Q ss_pred             cccccccccccc-----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALAPVIAR-----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +.+.........     ...|||-|.+....|+.++|||||||++||++| |..||++...+|+.++++.          
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----------  915 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----------  915 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----------
Confidence            998765433221     223999999999999999999999999999999 9999999888887766651          


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                             ..+.+.++-+..+++.++.+||..|+..||+|+++...+.++...
T Consensus       916 -------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  916 -------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             -------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                   112355566778999999999999999999999999988877554

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=341.90  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=214.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ...||.|-||.||.|.++ -...||||.++...+.-++|..|+.+|..++|||+|+|+|+|.....+|||+|||.+|+|.
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            467999999999999965 4678999999998888899999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc-cc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-AR  486 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~  486 (625)
                      +||++....   .++--..+.++.||+.|+.||..++   +|||||.++|+|+.++..+||+|||+++++....+.. .|
T Consensus       352 dYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  352 DYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             HHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            999987543   4666678899999999999999998   9999999999999999999999999999998765432 22


Q ss_pred             C---CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          487 A---AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       487 ~---~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      .   .-|.|||-+....++.|+|||+|||+||||.| |..||.+.+...+..+++       .+       .++   ..+
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kg-------yRM---~~P  488 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KG-------YRM---DGP  488 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------cc-------ccc---cCC
Confidence            2   23999999999999999999999999999999 999997765433333332       11       122   234


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      +.|...++++|+.||+.+|.+||+|.|+-+.+|.+-.+.
T Consensus       489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            556678999999999999999999999999998876553

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=323.89  Aligned_cols=246  Identities=18%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ++||.|..++||+|+ .+.+..||||++.-..+.  -+.+.+|+..|+.++||||++++..|..+.+.++||.||.+|++
T Consensus        32 e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~  111 (516)
T KOG0582|consen   32 EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSL  111 (516)
T ss_pred             EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcH
Confidence            569999999999999 567899999999865443  36789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-----
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-----  481 (625)
                      .++++..-..+   +++..+..|..++++||.|||.++   -||||||+.||||+++|.+||+|||.+..+....     
T Consensus       112 ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~  185 (516)
T KOG0582|consen  112 LDIIKTYYPDG---LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT  185 (516)
T ss_pred             HHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence            99998775543   889999999999999999999998   9999999999999999999999999976553211     


Q ss_pred             --cccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc---cccccc
Q 006922          482 --PVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT---AEVFDV  554 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~  554 (625)
                        ....|++.|||||++..  ..|+.|+||||||++..||++|..||.........  ..    .+.....   ....|.
T Consensus       186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~----tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LL----TLQNDPPTLLTSGLDK  259 (516)
T ss_pred             eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HH----HhcCCCCCcccccCCh
Confidence              34578899999999643  46999999999999999999999999876543221  11    1111111   001111


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +     ........+.+++..|+++||.+|||++++++
T Consensus       260 d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  260 D-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             H-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1     11112236777888999999999999999985

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.8e-40  Score=333.86  Aligned_cols=240  Identities=23%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +..+||+|+||.||.++.+ .|..+|+|+|++...-.    +....|-++|...++|+||+|+-.|++.++.||||||++
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            4578999999999999955 69999999999875432    457889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc----
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS----  478 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~----  478 (625)
                      ||++..+|....     .|++..+..++.+++-|+..+|..+   +|||||||+|+|||..|++||+|||++.-+.    
T Consensus       225 GGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  225 GGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             CccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            999999998654     4889999999999999999999998   9999999999999999999999999984210    


Q ss_pred             ----------------------c------------------------cccccccCCCcCCccccCCCCCCCccchhhhHH
Q 006922          479 ----------------------A------------------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGV  512 (625)
Q Consensus       479 ----------------------~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gv  512 (625)
                                            .                        .....+||+.|||||++.+..|+..+|+||+||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                                  0                        001235889999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HH
Q 006922          513 VLLEILTGKSPIHTTGGDELVH-LVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK---MP  588 (625)
Q Consensus       513 il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~  588 (625)
                      |+|||+.|.+||......++.. ++.|....               ..|...+...+..+++.+|+. ||++|--   ++
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            9999999999999887766554 33343221               112222223466677779998 9999975   55


Q ss_pred             HHH
Q 006922          589 DVV  591 (625)
Q Consensus       589 ev~  591 (625)
                      ||.
T Consensus       441 EIK  443 (550)
T KOG0605|consen  441 EIK  443 (550)
T ss_pred             HHh
Confidence            554

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-39  Score=323.46  Aligned_cols=242  Identities=22%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||.||++...++..+|+|.++......+++.+|++++++++||||+++++++...+..++||||+++|+|.++
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~   89 (256)
T cd05114          10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY   89 (256)
T ss_pred             eEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHH
Confidence            56999999999999988888999999886666677899999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----ccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~~  485 (625)
                      ++....    .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.++.......    ...
T Consensus        90 ~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          90 LRQRQG----KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            875432    3889999999999999999999988   99999999999999999999999999886532211    112


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..+.   ....   ...        ...
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~---~~i~---~~~~---~~~--------~~~  225 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV---EMIS---RGFR---LYR--------PKL  225 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH---CCCC---CCC--------CCC
Confidence            3456999999988889999999999999999999 99999765432222   2111   1110   000        111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ...++.+++.+||+.+|++||++.|+++.|.
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            2346788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=335.09  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccc----cC--ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV----NV--GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||.|.. .+|..||+|.+...    ..  ..+...+|+.++++++ ||||++++.++......++||||+
T Consensus        23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~  102 (370)
T KOG0583|consen   23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC  102 (370)
T ss_pred             eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence            5699999999999984 46899999977653    11  2345678999999999 999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccc--
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITS--  478 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~--  478 (625)
                      .+|+|.+++....     .+.+..+.+++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++....  
T Consensus       103 ~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen  103 SGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE  174 (370)
T ss_pred             CCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence            9999999998732     3888999999999999999999998   9999999999999999 999999999999872  


Q ss_pred             -ccccccccCCCcCCccccCCCC-CC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          479 -ALAPVIARAAGYRAPEVTDSRK-AT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       479 -~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                       ......+|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||++..   ...+...   ..+..         
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~k---i~~~~---------  239 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRK---IRKGE---------  239 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHH---HhcCC---------
Confidence             3445678999999999999877 86 78999999999999999999998732   2222221   11111         


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       ...|..-. ..++..++.+|+..+|.+|+++.||+ .-.-++.
T Consensus       240 -~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  240 -FKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             -ccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence             01111100 34566777899999999999999998 4444444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.1e-40  Score=334.64  Aligned_cols=238  Identities=21%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..+.||+|+||.||||+.+ +.+.||+|.+.+.....   +.+.+|++++++++|||||.++++|+...+.++|.||+.+
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            3467999999999999954 68899999998765444   4588999999999999999999999999999999999988


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                       +|..++....     .+.++.+..|+.+++.||.|||+..   |+|||+||.|||++..+.+|++|||+|+.++...  
T Consensus        86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence             9999998654     3899999999999999999999997   9999999999999999999999999999887543  


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       +.+.||+-|||||+..++.|+..+|+||+||++||+++|++||...   ++.++++.+.   .+.            .+
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~---~d~------------v~  218 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSIL---KDP------------VK  218 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHh---cCC------------CC
Confidence             3467899999999999999999999999999999999999999753   3444443322   111            01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+......+..++...+.+||..|.+-.+++.
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            12244456677777999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-39  Score=331.72  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=196.1

Q ss_pred             hHcccCCceeEEEEEEcC-----------------CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe
Q 006922          330 EVLGKGTFGMAYKAILED-----------------GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS  390 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~  390 (625)
                      +.||+|+||.||++...+                 +..||+|.+.....  ...++.+|++++.+++||||+++++++..
T Consensus        11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   90 (304)
T cd05096          11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD   90 (304)
T ss_pred             eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence            569999999999997532                 34799999876432  23578999999999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhccccC--------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 006922          391 KDEKLMVYDYYSLGSVSAMLHSERG--------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSS  456 (625)
Q Consensus       391 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~  456 (625)
                      .+..++||||+++|+|.+++.....              .....++|....+++.|++.||+|||+.+   |+||||||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~  167 (304)
T cd05096          91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATR  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchh
Confidence            9999999999999999998865321              11234788999999999999999999998   999999999


Q ss_pred             CEEeCCCCCeeEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh--CCCCCCCCCC
Q 006922          457 NIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT--GKSPIHTTGG  529 (625)
Q Consensus       457 NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~  529 (625)
                      |||++.++.+||+|||+++.......     ...++..|+|||++....++.++||||||+++|||++  +..||.....
T Consensus       168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  247 (304)
T cd05096         168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD  247 (304)
T ss_pred             heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence            99999999999999999986533211     1233567999999988889999999999999999987  6678876543


Q ss_pred             cchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          530 DELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .+.   ...+....+.... ...   ...   ...+...+.+++.+||+.+|++|||+.||.+.|++
T Consensus       248 ~~~---~~~~~~~~~~~~~-~~~---~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         248 EQV---IENAGEFFRDQGR-QVY---LFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHH---HHHHHHHhhhccc-ccc---ccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            322   2222222211110 000   001   11223467888899999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.2e-39  Score=324.96  Aligned_cols=245  Identities=22%  Similarity=0.382  Sum_probs=197.1

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|...    .+..||+|.++.....  .+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS   89 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence            467999999999999753    3678999999865322  3568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++....    ..++|..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+........
T Consensus        90 ~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          90 NGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            999999987543    24899999999999999999999987   99999999999999999999999998765422111


Q ss_pred             ----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                          ...++..|+|||.+.+..++.++|||||||++||+++ |+.||......+..+   .+    .+..          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~---~~----~~~~----------  225 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK---AV----EDGF----------  225 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HH----HCCC----------
Confidence                1123457999999998999999999999999999876 999997654332221   11    1110          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ..+........+.+++.+||+.+|.+||++.||.+.|+++
T Consensus       226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0111222345677888899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=336.10  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             HHHhHcccCCceeEEEEEEc---CC--cEEEEEEeccc--cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          327 ASAEVLGKGTFGMAYKAILE---DG--TTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       327 ~~~~~lg~G~~g~Vy~~~~~---~g--~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      ...++||+|-||.||+|...   .|  ..||||.-+..  ..+.+.|..|..+|+.++|||||+++|+|.+ ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            34678999999999999842   23  45889988864  2345789999999999999999999999976 46899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      .++.|.|.++|..++.    .|+......++.|+..||+|||+..   +|||||.++|||+.+...+|++|||+++.+..
T Consensus       471 L~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             cccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            9999999999987654    3888899999999999999999998   99999999999999999999999999999877


Q ss_pred             ccccccc----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          480 LAPVIAR----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       480 ~~~~~~~----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      .......    ..-|||||.+..++++.++|||.|||.+||+++ |..||.+....+..-.++                 
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-----------------  606 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-----------------  606 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-----------------
Confidence            6543222    123999999999999999999999999999999 999998876554432221                 


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ...+.|.++.+...++.++.+||..+|.+||++.|+...|+++..+
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            2234566777888999999999999999999999999999888764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-39  Score=336.63  Aligned_cols=236  Identities=23%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +||+|+||+||++.. .+|+.||+|+++....    ....+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999999985 4789999999985421    12457789999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---ccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~~  482 (625)
                      |.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ...
T Consensus        82 L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          82 LFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            999887543     4899999999999999999999998   99999999999999999999999999875422   122


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||...........+      ..+.       .   ..+  
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~-------~---~~p--  215 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE-------I---RFP--  215 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------HcCC-------C---CCC--
Confidence            346889999999999999999999999999999999999999764332221111      1110       0   001  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      .....++.+++.+|++.||++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            11233566778899999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.9e-39  Score=321.80  Aligned_cols=246  Identities=24%  Similarity=0.423  Sum_probs=201.1

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++..++|+||+++++++...+..++||||+++++|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD   90 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence            36799999999999998888899999988655556789999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      +++....   ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++......    ...
T Consensus        91 ~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          91 FLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            9875432   24789999999999999999999987   9999999999999999999999999998764322    112


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||++....++.++|||||||++|||+| |+.||......+..   ..+.    ...          ..+...
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~----------~~~~~~  227 (261)
T cd05072         165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQ----RGY----------RMPRME  227 (261)
T ss_pred             ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHH----cCC----------CCCCCC
Confidence            33456999999988889999999999999999999 99999654322211   1111    110          001111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ....++.+++.+|+..+|++||+++++.+.|+++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1234577888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=338.50  Aligned_cols=232  Identities=22%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ..+||+|+||+|+++..+ +++.+|||++++...    +-+....|-+|+... +||.++.++..|+..++.+.||||+.
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            468999999999999954 688999999998643    235577788887777 59999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc---cc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SA  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~---~~  479 (625)
                      ||++..+.+..      .+++..+..++..|+.||.|||+++   ||+||||.+|||||.+|++||+|||+++..   ..
T Consensus       453 Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  453 GGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             CCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            99966555533      3899999999999999999999998   999999999999999999999999999864   34


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .+.+.+||+.|||||++.+..|+.++|+|||||+||||+.|+.||.+.+++|..+-+..      ++       +     
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------d~-------~-----  585 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------DE-------V-----  585 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------CC-------C-----
Confidence            55678999999999999999999999999999999999999999998776665544321      11       1     


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                      ..+.....+.+.|+.+.+.++|++|--+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1122234567788889999999999866

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-40  Score=328.38  Aligned_cols=242  Identities=30%  Similarity=0.535  Sum_probs=189.1

Q ss_pred             hHcccCCceeEEEEEEc-----CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-----DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||.|+||.||+|.+.     .+..|+||.++.....  .+.+.+|++.+.+++||||++++|++...+..++||||++
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~   84 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP   84 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence            56999999999999965     3678999999764332  4789999999999999999999999998888999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....   ...+++.++..|+.|+++||+|||+.+   |+|+||+++||++++++.+||+|||++....... 
T Consensus        85 ~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   85 GGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999998762   224899999999999999999999987   9999999999999999999999999998763211 


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ........|+|||.+....++.++||||||+++|||++ |+.||......+....+   .   ....         
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---~---~~~~---------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---K---QGQR---------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---H---TTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---cccc---------
Confidence                11234456999999988889999999999999999999 78998765433222111   1   1110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                        .+........+.+++..||..+|++||+|.++++.|
T Consensus       224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              111122334677888999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-38  Score=323.80  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=199.7

Q ss_pred             HhHcccCCceeEEEEEEcC-C-----cEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILED-G-----TTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|.... +     ..||+|.++.....  ...+.+|++++.+++||||+++++++...+..+++|||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   89 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY   89 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence            4679999999999998542 2     57999998754322  35688999999999999999999999998999999999


Q ss_pred             ccCCChhhhhccccCCC-----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe
Q 006922          401 YSLGSVSAMLHSERGEG-----------RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS  469 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~  469 (625)
                      +++|+|.+++.......           ...+++.....++.|++.||+|||+.+   |+||||||+||++++++.++|+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEEC
Confidence            99999999987643211           135889999999999999999999998   9999999999999999999999


Q ss_pred             cccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 006922          470 DLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       470 DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                      |||+++......     ....++..|+|||.+....++.++|||||||++|||++ |..||......+....   +.   
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~---i~---  240 (283)
T cd05048         167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM---IR---  240 (283)
T ss_pred             CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH---
Confidence            999997653221     12234567999999988889999999999999999998 9999986554333221   11   


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       544 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       .....          +.......++.+++.+||+.+|.+||++.||++.|+.+
T Consensus       241 -~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 -SRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -cCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence             11100          11123345778888999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-38  Score=338.06  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=197.5

Q ss_pred             HHhHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          328 SAEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ..+.||+|+||+||+|..      ..+..||||+++....  ..+.+.+|++++..+ +||||++++++|...+..++||
T Consensus        39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~  118 (375)
T cd05104          39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT  118 (375)
T ss_pred             hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence            357899999999999963      2356899999975432  235688999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhhccccCC--------------------------------------------------------------
Q 006922          399 DYYSLGSVSAMLHSERGE--------------------------------------------------------------  416 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~--------------------------------------------------------------  416 (625)
                      ||+++|+|.++++.....                                                              
T Consensus       119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (375)
T cd05104         119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD  198 (375)
T ss_pred             hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence            999999999998653210                                                              


Q ss_pred             --------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-----c
Q 006922          417 --------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----V  483 (625)
Q Consensus       417 --------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----~  483 (625)
                              ....++|..+.+++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......     .
T Consensus       199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence                    1124789999999999999999999987   99999999999999999999999999986543221     1


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ...+.+.    .+...       .. +  
T Consensus       276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~~-------~~-~--  339 (375)
T cd05104         276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYRM-------LS-P--  339 (375)
T ss_pred             CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCccC-------CC-C--
Confidence            123456999999999999999999999999999998 899997643221  1122211    11100       00 0  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      .....++.+++..||+.||++||++.||++.|++.
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            11123677888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-38  Score=330.50  Aligned_cols=249  Identities=20%  Similarity=0.374  Sum_probs=197.5

Q ss_pred             HhHcccCCceeEEEEEEc-CCc----EEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE-DGT----TVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|... +|.    .||+|+++....  ..+++.+|+.++..++||||++++|+|... ..++|+||+
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~   90 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   90 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence            367999999999999853 344    489999875432  236788999999999999999999999764 578999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.+++.....    .+++..+.+++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          91 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCC
Confidence            99999999986432    3889999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cc-----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 PV-----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ..     ...+..|+|||.+....++.++|||||||++|||++ |+.||.+....+.....       ....        
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~--------  228 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE--------  228 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------hCCC--------
Confidence            11     122456999999999999999999999999999998 99999764332221111       1110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                        ..+....+..++.+++.+||..+|.+||++.+++..|..+.....
T Consensus       229 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         229 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence              011111223467888999999999999999999999988866543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=330.51  Aligned_cols=237  Identities=18%  Similarity=0.252  Sum_probs=194.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||+|++.....    ..+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   86 (291)
T cd05612           7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG   86 (291)
T ss_pred             eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence            56999999999999964 689999999975321    2346788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        87 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  158 (291)
T cd05612          87 ELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL  158 (291)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence            9999987543     3889999999999999999999998   9999999999999999999999999998776554455


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..+.+      ....         . ..+  ..
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~---------~-~~~--~~  220 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGK---------L-EFP--RH  220 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC---------c-CCC--cc
Confidence            7888999999999989999999999999999999999999765432222111      1110         0 001  11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ....+.+++.+|++.||.+||+     ++|+++
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            1235667888999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-38  Score=325.62  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=193.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++.. .+|+.||+|.+.....    ....+.+|++++.+++|+||+++++++...+..++||||+++|
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g   85 (285)
T cd05631           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence            5699999999999995 5799999999875422    1245778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      +|..++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          86 DLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             cHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            9988876432   224899999999999999999999998   9999999999999999999999999998754322  2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||...........+   ...+....        .   ...
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~--------~---~~~  225 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQ--------E---EYS  225 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhccc--------c---cCC
Confidence            346788999999999999999999999999999999999999865432221111   11111100        0   001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      .....++.+++.+||+.||++||+     ++|+++
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            112235667888999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-39  Score=308.08  Aligned_cols=267  Identities=20%  Similarity=0.297  Sum_probs=201.6

Q ss_pred             ecCCCcccCHHHHHHHHHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeE
Q 006922          312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAY  387 (625)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~  387 (625)
                      ..+|...-+++.+     +.|++|+||+||+|+ .++++.||+|+++-....   .-.-.+|+.+|.+++|||||.+..+
T Consensus        69 l~gCrsv~efe~l-----nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEV  143 (419)
T KOG0663|consen   69 LGGCRSVEEFEKL-----NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEV  143 (419)
T ss_pred             ccCcccHHHHHHH-----hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence            4556544444444     679999999999999 457899999999864321   1346899999999999999999988


Q ss_pred             EEec--CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          388 YYSK--DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       388 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      ....  +..|+|||||+. +|..+++...    .++...+...+..|+++|++|||...   |+|||||++|+|++..|.
T Consensus       144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  144 VVGSNMDKIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             EeccccceeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCc
Confidence            7654  579999999998 9999998754    35888899999999999999999998   999999999999999999


Q ss_pred             eeEeccccccccccc---ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 006922          466 GCVSDLGLTTITSAL---APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       466 ~kl~DfGla~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      +||+|||+|+.+...   .+..+-|..|+|||++.+ ..|+++.||||+|||+.||+++++-|.+.+.-+..+.+-.+-.
T Consensus       216 lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG  295 (419)
T KOG0663|consen  216 LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG  295 (419)
T ss_pred             EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence            999999999988654   334566788999998865 5699999999999999999999999987654322222211111


Q ss_pred             Hhhccccccccccc------ccCC---------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWTAEVFDVE------LLRY---------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~~~~~d~~------~~~~---------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+..+..+....      ....         +... ....-++++...+..||.+|.|++|.++
T Consensus       296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence            11112121111111      0000         1010 1234567778999999999999999986

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=331.66  Aligned_cols=233  Identities=19%  Similarity=0.286  Sum_probs=187.9

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||+||++... +++.||+|+++...    .....+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999964 58899999997532    1234577899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~~~  483 (625)
                      .+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence            99987542     3889999999999999999999998   99999999999999999999999999886422   1223


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..      ........            ....
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~~~~~~~~------------~~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RKILQEPL------------RFPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC------------CCCC
Confidence            46888999999999999999999999999999999999999764322211      11111100            0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDV  590 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev  590 (625)
                      ....++.+++.+||..||++||++..+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            122356677889999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-38  Score=337.73  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             HHhHcccCCceeEEEEEE------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          328 SAEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ..+.||+|+||.||+|..      .++..||+|+++.....  ...+.+|+++++.+ +|+|||+++++|...+..++||
T Consensus        42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~  121 (374)
T cd05106          42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT  121 (374)
T ss_pred             ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence            457899999999999873      22457999999764322  34678999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhhccccC---------------------------------------------------------------
Q 006922          399 DYYSLGSVSAMLHSERG---------------------------------------------------------------  415 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~---------------------------------------------------------------  415 (625)
                      ||+++|+|.+++.....                                                               
T Consensus       122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (374)
T cd05106         122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE  201 (374)
T ss_pred             hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence            99999999998864321                                                               


Q ss_pred             --CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-----ccccCC
Q 006922          416 --EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAA  488 (625)
Q Consensus       416 --~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~~~  488 (625)
                        ....++++.++.+++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......     ...++.
T Consensus       202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~  278 (374)
T cd05106         202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV  278 (374)
T ss_pred             ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence              01124788999999999999999999987   99999999999999999999999999986533221     112345


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMV  567 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  567 (625)
                      .|+|||++....++.++|||||||++|||++ |+.||......+.  ...    ......     ....   +  .....
T Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~----~~~~~~-----~~~~---~--~~~~~  342 (374)
T cd05106         279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK----MVKRGY-----QMSR---P--DFAPP  342 (374)
T ss_pred             ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH----HHHccc-----CccC---C--CCCCH
Confidence            6999999988899999999999999999998 9999976433221  111    111110     0000   0  01124


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          568 EMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       568 ~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            6778888999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-39  Score=334.92  Aligned_cols=238  Identities=18%  Similarity=0.278  Sum_probs=195.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||+|... +|+.||+|+++....    ..+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  102 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG  102 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence            367999999999999964 689999999975421    235688999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  174 (329)
T PTZ00263        103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT  174 (329)
T ss_pred             ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence            99999987543     3788889999999999999999998   999999999999999999999999999887655555


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....      . .....         ..+.  
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------i-~~~~~---------~~p~--  236 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK------I-LAGRL---------KFPN--  236 (329)
T ss_pred             ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH------H-hcCCc---------CCCC--
Confidence            6788999999999999999999999999999999999999975432221111      1 11100         0010  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ....++.+++.+||+.||.+||+     ++|++.
T Consensus       237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            01234567888999999999997     677763

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=317.65  Aligned_cols=246  Identities=25%  Similarity=0.415  Sum_probs=201.8

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||+|...+++.||+|.++......+++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE   90 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence            36799999999999998778899999998766666789999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-cccc-
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-VIAR-  486 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~-  486 (625)
                      ++....   ...++|..+..++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||+++....... ...+ 
T Consensus        91 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          91 YLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             HHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            987543   224899999999999999999999987   99999999999999999999999999987643211 1122 


Q ss_pred             --CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          487 --AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       487 --~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                        +..|+|||.+.+..++.++||||||+++|||+| |+.||......+...   .+    ....          ..+...
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~----~~~~----------~~~~~~  227 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---QV----DQGY----------RMPCPP  227 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH----HcCC----------CCCCCC
Confidence              246999999998899999999999999999999 999997543222211   11    1110          001112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      .....+.+++.+|++.+|.+||++.++++.|+++
T Consensus       228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            2335678888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=300.12  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=210.2

Q ss_pred             cccCHHHHHHHHHhHcccCCceeEEEEE-EcCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEec
Q 006922          317 YAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSK  391 (625)
Q Consensus       317 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  391 (625)
                      ..+.++++.  ..+.||+|.||.||.|+ .+++-.||+|++.+...    -..++.+|+++-+.++||||+++++||.+.
T Consensus        17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            345566653  46789999999999999 45688999999976532    246789999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       392 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      ...|+++||...|.+...|...+.   ..++......+..|+|.|+.|+|.++   ||||||||+|+|++.++..||+||
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            999999999999999999985432   24777888889999999999999998   999999999999999999999999


Q ss_pred             ccccccc-ccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          472 GLTTITS-ALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       472 Gla~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      |-+...+ ......+||..|.+||...+..++..+|+|++||+.||++.|.+||.....++....+..++          
T Consensus       169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~----------  238 (281)
T KOG0580|consen  169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD----------  238 (281)
T ss_pred             CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc----------
Confidence            9987663 34456789999999999999999999999999999999999999998877666655554322          


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      +.++        +.......+++++|+..+|.+|.+..|+++.
T Consensus       239 ~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 LKFP--------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCC--------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1121        2223355677889999999999999999763

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.3e-39  Score=333.76  Aligned_cols=253  Identities=19%  Similarity=0.307  Sum_probs=196.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||++... +|..||+|.+.....  ....+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   90 (331)
T cd06649          11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL   90 (331)
T ss_pred             EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence            56999999999999965 688999999875422  235689999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-cccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-LAPVIA  485 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~~~  485 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+  .|+||||||+|||++.++.+||+|||+++.... ......
T Consensus        91 ~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (331)
T cd06649          91 DQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  163 (331)
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCC
Confidence            99987543     3889999999999999999999864  499999999999999999999999999876533 223346


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc---cc--------------
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE---WT--------------  548 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--------------  548 (625)
                      ++..|+|||++.+..++.++|||||||++|||+||+.||......+......   ......   ..              
T Consensus       164 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG---RPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             CCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc---ccccccccCCccccCcccccccccc
Confidence            7889999999999899999999999999999999999997544332221111   000000   00              


Q ss_pred             -----------------cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          549 -----------------AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       549 -----------------~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                                       ..+........+ ......++.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                             000000000000 00123467888899999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-39  Score=335.02  Aligned_cols=239  Identities=23%  Similarity=0.355  Sum_probs=200.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccc-cC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV-NV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ++.||+|+.|.|..|++ ..|+.+|||++.+. ..   ....+++|+-+|+.+.||||++++++++++.+.|+|.||+++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            46799999999999995 57999999999765 22   235689999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LA  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--~~  481 (625)
                      |.|.+++....     ++.+.++.+++.||..|+.|+|..+   |+|||+||+|+|||.++++||+|||+|..-.+  .-
T Consensus        97 GELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   97 GELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             chhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            99999998654     4889999999999999999999998   99999999999999999999999999986543  23


Q ss_pred             cccccCCCcCCccccCCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKAT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .+.+|++.|.|||++.+.+|+ .++||||+|||||-|+||+.||++.   .+..++..|..   +            .+.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~---G------------~f~  230 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQR---G------------VFE  230 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHc---C------------ccc
Confidence            456899999999999999985 7999999999999999999999853   34444433321   1            111


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .+.....+.-+++.+++..||+.|.|++||++.
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            122233345566679999999999999999884

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-38  Score=318.07  Aligned_cols=245  Identities=21%  Similarity=0.368  Sum_probs=199.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||.||+|... .++.||+|+++.......++.+|++++..++|+||+++++++...+..++||||+++++|.+
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (263)
T cd05052          12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD   91 (263)
T ss_pred             eecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHH
Confidence            56999999999999954 58899999998665556788999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc----c
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV----I  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----~  484 (625)
                      ++....   ...+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........    .
T Consensus        92 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          92 YLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             HHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            987543   224899999999999999999999987   999999999999999999999999999876432211    1


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+..|+|||.+.+..++.++|||||||++|||++ |..||......+....   .    .....     .     +...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~----~~~~~-----~-----~~~~  228 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L----EKGYR-----M-----ERPE  228 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H----HCCCC-----C-----CCCC
Confidence            23456999999998899999999999999999998 9999975433222111   1    11100     0     1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ....++.+++.+|++.+|++||++.|+++.|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1234677888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=316.73  Aligned_cols=243  Identities=21%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             HHhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          328 SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..+.||+|+||.||++...++..+|+|.+........++.+|++++..++||||+++++++...+..++||||+++++|.
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL   87 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence            35679999999999999877788999998766555678899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc-c--
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-I--  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~--  484 (625)
                      +++.....    .++|..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+++........ .  
T Consensus        88 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          88 NYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             HHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence            99875432    4899999999999999999999998   999999999999999999999999998765432111 1  


Q ss_pred             -ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          485 -ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       485 -~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                       .++..|+|||.+.+..++.++||||||+++||+++ |+.||......+..   ..+.    ..     ...     +..
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~----~~-----~~~-----~~~  223 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVS----AG-----YRL-----YRP  223 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHH----cC-----CcC-----CCC
Confidence             12346999999998899999999999999999999 89999754432221   1111    11     000     011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      .....++.+++.+||..+|++|||+.|+++.|
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            11234678889999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-38  Score=331.59  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=191.3

Q ss_pred             CHHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEE
Q 006922          320 DLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       320 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  396 (625)
                      .++++.  ..+.||+|+||+||+|... +|+.||||++......  .+.+.+|+++++.++|+||+++++++...+..++
T Consensus        72 ~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         72 SLSELE--RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CHHHHh--hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            344442  3467999999999999954 6899999999654322  3568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ||||+++|+|....         ..++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       150 v~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        150 LLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             EEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999986432         2566778899999999999999998   99999999999999999999999999987


Q ss_pred             ccccc---cccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          477 TSALA---PVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       477 ~~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      .....   ....|+..|+|||.+..     ...+.++|||||||++|||++|+.||......+.........   ...  
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~--  292 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQ--  292 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---ccC--
Confidence            64321   23467889999998743     234568999999999999999999997443333322222111   000  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                               ..........++.+++.+||+.+|++||++.|+++.
T Consensus       293 ---------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ---------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     000111223467788889999999999999999873

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=333.23  Aligned_cols=246  Identities=17%  Similarity=0.245  Sum_probs=199.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||+|... +++.||+|+++....    ..+.+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~   86 (333)
T cd05600           7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG   86 (333)
T ss_pred             EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence            56999999999999965 589999999975421    2356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~  158 (333)
T cd05600          87 DFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV  158 (333)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence            9999997543     4889999999999999999999998   9999999999999999999999999998766544556


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.....        ....+...  .....
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~~~~~~~--~~~~~  228 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--------TLQRPVYD--DPRFN  228 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--------cccCCCCC--ccccc
Confidence            788999999999988999999999999999999999999976544333222111000        00000000  00012


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ...++.+++.+|+..+|.+||++.|+++.
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            23456778889999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-38  Score=331.38  Aligned_cols=237  Identities=22%  Similarity=0.339  Sum_probs=192.3

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +||+|+||.||++.. .+|+.||+|+++....    ....+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            589999999999995 4689999999975421    23567889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---ccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~~  482 (625)
                      |..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ...
T Consensus        82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          82 LFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            998886543     4899999999999999999999998   99999999999999999999999999876422   122


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+      ....       ...     .
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~~~-------~~~-----p  215 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMED-------IKF-----P  215 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------ccCC-------ccC-----C
Confidence            346888999999999889999999999999999999999999764332222111      1110       000     1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~~  593 (625)
                      .....++.+++.+|++.||++||     ++.|+++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11223566777899999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-38  Score=330.47  Aligned_cols=236  Identities=23%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +||+|+||.||++.. .+|..||+|+++....    ....+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            589999999999995 4689999999975421    22456789999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ..
T Consensus        82 L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          82 LFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            998886543     4899999999999999999999998   999999999999999999999999998753221   12


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+      ....    .      ..+  
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~----~------~~p--  215 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEE----I------RFP--  215 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC----C------CCC--
Confidence            345788999999999889999999999999999999999999765432222111      1110    0      001  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      .....++.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            11223566777899999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.9e-38  Score=316.02  Aligned_cols=242  Identities=21%  Similarity=0.328  Sum_probs=197.8

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...++..+|+|.++.......++.+|+.++.+++||||+++++++...+..++||||+++|+|.++
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   89 (256)
T cd05113          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY   89 (256)
T ss_pred             eEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence            56999999999999987777899999987666667899999999999999999999999988899999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----ccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~~  485 (625)
                      +.....    .++|..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.++.......    ...
T Consensus        90 i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          90 LREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             HHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            875432    4899999999999999999999987   99999999999999999999999999876533211    112


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++|||||||++|||++ |+.||......+...   .+   ......           .....
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~---~~~~~~-----------~~~~~  225 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---KV---SQGLRL-----------YRPHL  225 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HH---hcCCCC-----------CCCCC
Confidence            3456999999988889999999999999999999 999997544322211   11   111100           00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ....+.+++.+||+.+|.+||++.++++.|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            2356788889999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6e-38  Score=318.71  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=200.3

Q ss_pred             HHhHcccCCceeEEEEEEcC------CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          328 SAEVLGKGTFGMAYKAILED------GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      ..+.||+|+||.||+|...+      +..||+|.++.....  .+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus         9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   88 (280)
T cd05049           9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE   88 (280)
T ss_pred             HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence            34779999999999998633      478999999865433  4679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccC---------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          400 YYSLGSVSAMLHSERG---------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                      |+++++|.+++.....         .....+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence            9999999999976432         12334889999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          471 LGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       471 fGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      ||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+...   .+.    
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~---~~~----  238 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE---CIT----  238 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH----
Confidence            99997643221     12234567999999999999999999999999999999 999997654433221   111    


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .+...          .........+.+++.+||+.+|++||++.||++.|++
T Consensus       239 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 QGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11000          0011223467788889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.3e-38  Score=314.68  Aligned_cols=247  Identities=23%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             HHhHcccCCceeEEEEEEcCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          328 SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ..+.||+|+||.||+|...++..+|+|.++.... ...++.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (261)
T cd05148          10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL   89 (261)
T ss_pred             HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence            4578999999999999987899999999986644 456789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---V  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~  483 (625)
                      .+++.....   ..+++.++.+++.|++.|++|||+.+   |+||||||+||++++++.+||+|||.+........   .
T Consensus        90 ~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~  163 (261)
T cd05148          90 LAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD  163 (261)
T ss_pred             HHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence            999986432   24899999999999999999999987   99999999999999999999999999977643221   1


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||......+....   +..   ..           ..+..
T Consensus       164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~---~~-----------~~~~~  226 (261)
T cd05148         164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---ITA---GY-----------RMPCP  226 (261)
T ss_pred             CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHh---CC-----------cCCCC
Confidence            234556999999988889999999999999999999 8999976543322221   110   00           00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ......+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            22334677888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.3e-38  Score=314.05  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=194.3

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .||+|+||.||+|.. .+++.||+|.+.....  ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            589999999999995 4789999998875432  2356899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc----
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV----  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----  483 (625)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.........    
T Consensus        82 ~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          82 TFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9986532    24889999999999999999999987   999999999999999999999999998765432111    


Q ss_pred             -cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          484 -IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       484 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                       ...+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.       ...          ..+.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~~----------~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QGV----------RLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC----------CCCC
Confidence             112345999999998889999999999999999998 999996543322211111       000          0011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .......+.+++.+|++.+|++||++.|+.++|+.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11223467788889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=324.39  Aligned_cols=238  Identities=21%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||||.. ..++.||+|++.-..  ...++.++|+.++..++++||.++++.|..+...+++||||.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            5799999999999994 468999999997653  3347899999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+.+....     .+++....-|+.++..|+.|||.++   .+|||||+.|||+..+|.+|++|||++..+...   ...
T Consensus        99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             hhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99998653     3477778889999999999999998   999999999999999999999999999877543   245


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..||+.|||||++.+..|+.|+||||+|++.+||++|.+|+..........++       ....     -|.+.     .
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~-----PP~L~-----~  233 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSA-----PPRLD-----G  233 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCC-----CCccc-----c
Confidence            68999999999999999999999999999999999999999876653222111       1110     00110     1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....+.+++..|+.++|++||++.++++
T Consensus       234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            22345667777999999999999999985

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=313.67  Aligned_cols=250  Identities=22%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEe-----cCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYS-----KDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~  400 (625)
                      +.||+|+||.|+++. ..+|..||||++...-   ...+...+|+++++.++|+||+.+++.+..     -+..|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            569999999999999 4579999999998542   234678899999999999999999999865     2468999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc--
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS--  478 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~--  478 (625)
                      |+ .+|...++...     .|+......+.+|+++||+|+|+.+   |+||||||+|+|++.+...||+|||+|+...  
T Consensus       108 Me-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  108 ME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             Hh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence            95 49999998654     3889999999999999999999999   9999999999999999999999999999884  


Q ss_pred             ---ccccccccCCCcCCcccc-CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH----------------
Q 006922          479 ---ALAPVIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW----------------  538 (625)
Q Consensus       479 ---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~----------------  538 (625)
                         ...+....|..|+|||++ ....|+.+.||||.|||+.||++|++-|.+.+.-+..+++..                
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~  258 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE  258 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence               233455678889999986 466899999999999999999999999977543332222211                


Q ss_pred             -HHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          539 -VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       539 -~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ++..++......-.... ..++...   ...++++.+++..||.+|+|++|+++
T Consensus       259 ~ar~yi~slp~~p~~~f~-~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  259 KARPYIKSLPQIPKQPFS-SIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHHhCCCCCCCCHH-HHcCCCC---HHHHHHHHHHhccCccccCCHHHHhc
Confidence             11111111000000000 0112222   34566777999999999999999986

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-38  Score=331.05  Aligned_cols=239  Identities=17%  Similarity=0.234  Sum_probs=194.4

Q ss_pred             HhHcccCCceeEEEEEEc-C-CcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-D-GTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|... . +..||+|++....    ...+.+.+|++++..++||||+++++++.+.+..++||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            367999999999999854 3 3689999997532    123567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~  186 (340)
T PTZ00426        115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY  186 (340)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence            999999997543     3889999999999999999999998   99999999999999999999999999987765555


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.........+.      ......       ..  .+..
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~~~~-------~~--p~~~  251 (340)
T PTZ00426        187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILEGII-------YF--PKFL  251 (340)
T ss_pred             eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------HhcCCC-------CC--CCCC
Confidence            56789999999999988899999999999999999999999976433221111      111100       00  0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~~  593 (625)
                      .   ..+.+++.+|++.+|++|+     +++|+++.
T Consensus       252 ~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        252 D---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            2   2456777799999999995     78887653

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.6e-38  Score=332.66  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=198.9

Q ss_pred             HHhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEE
Q 006922          328 SAEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ..+.||+|+||+||+|...      .+..||||+++.....  .+.+.+|++++.++. ||||++++++|...+..++||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT  120 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence            3567999999999999842      1347999999754322  356889999999996 999999999999999999999


Q ss_pred             EeccCCChhhhhccccCC--------------------------------------------------------------
Q 006922          399 DYYSLGSVSAMLHSERGE--------------------------------------------------------------  416 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~--------------------------------------------------------------  416 (625)
                      ||+++|+|.++++.....                                                              
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (400)
T cd05105         121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY  200 (400)
T ss_pred             EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence            999999999988754210                                                              


Q ss_pred             -----------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          417 -----------------------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       417 -----------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                                                   ....+++..+.+++.|+++||+|||+.+   |+||||||+|||++.++.+|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k  277 (400)
T cd05105         201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK  277 (400)
T ss_pred             hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence                                         0124788899999999999999999987   99999999999999999999


Q ss_pred             Eecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 006922          468 VSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       468 l~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      |+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||.....++..  ..    
T Consensus       278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~----  351 (400)
T cd05105         278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YN----  351 (400)
T ss_pred             EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HH----
Confidence            99999998653221     11234567999999988899999999999999999997 99999754322211  11    


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .+..+.          ..+.......++.+++.+||+.+|++||++.+|.++|+++.+
T Consensus       352 ~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 KIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            111110          001112233567888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.1e-38  Score=320.89  Aligned_cols=255  Identities=17%  Similarity=0.258  Sum_probs=191.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|... +++.||+|+++....  ....+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus        11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l   89 (288)
T cd07871          11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DL   89 (288)
T ss_pred             eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CH
Confidence            56999999999999954 689999999975432  235678999999999999999999999998899999999985 88


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ..
T Consensus        90 ~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          90 KQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            88886432    23788999999999999999999998   9999999999999999999999999997653221   22


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc---------
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD---------  553 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---------  553 (625)
                      ..++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+....+.........+.+..+.+         
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF  242 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence            356778999998865 5689999999999999999999999976544333222211110000011111000         


Q ss_pred             ccccCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPN---IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.....+.   ......+..+++.+|+..||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000   0011234667888999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4e-38  Score=321.38  Aligned_cols=255  Identities=17%  Similarity=0.238  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+++.. +++.||+|+++....   ..+.+.+|++++..++||||+++++++...+..++||||++++.
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   86 (287)
T cd07848           7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM   86 (287)
T ss_pred             EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence            56999999999999965 688999999976432   23567899999999999999999999999999999999999987


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      +..+....     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    
T Consensus        87 l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          87 LELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            76554321     24889999999999999999999987   9999999999999999999999999998754321    


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc---------cccccc
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE---------WTAEVF  552 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  552 (625)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+..........         ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            22457888999999988889999999999999999999999997654322221111111000000         000000


Q ss_pred             cccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPN-----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.......     ......++.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000     0012345788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=311.40  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=197.3

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHc--CCCCceecceeEEEecC----ceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS--IRHENVVELKAYYYSKD----EKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~~  402 (625)
                      .+.||+|.||.||+|.++ |..||||++....  .+...+|.+|.+.  ++|+||..+++.-..++    ..+||.||.+
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            357999999999999996 8999999998643  4567777777765  49999999998865443    5789999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-----NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      .|+|+++|...      .++-...++++..+|.||++||..     ++|.|.|||||+.|||+.+++.+.|+|+|+|...
T Consensus       293 ~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  293 HGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             CCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            99999999875      389999999999999999999974     6889999999999999999999999999999765


Q ss_pred             ccc-------ccccccCCCcCCccccCCCCC------CCccchhhhHHHHHHHHhC----------CCCCCCCCCcchhh
Q 006922          478 SAL-------APVIARAAGYRAPEVTDSRKA------TQASDVYSFGVVLLEILTG----------KSPIHTTGGDELVH  534 (625)
Q Consensus       478 ~~~-------~~~~~~~~~y~aPE~~~~~~~------~~~~DvwS~Gvil~elltG----------~~p~~~~~~~~~~~  534 (625)
                      ...       .+..+||..|||||++.+.--      -..+||||||+|+||++.+          +.||.+.-..+-. 
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-  445 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-  445 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-
Confidence            443       234578999999999865421      2469999999999999863          3577653221100 


Q ss_pred             HHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          535 LVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       .+-++.++-.+..+    +.....=...+++..+.++|..||..+|.-|-|+--|-+.|.++...
T Consensus       446 -~eeMrkVVCv~~~R----P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 -FEEMRKVVCVQKLR----PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             -HHHHhcceeecccC----CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence             00111111111111    11111112456788899999999999999999999999999888753

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-38  Score=329.86  Aligned_cols=236  Identities=23%  Similarity=0.340  Sum_probs=190.9

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||++.. .+|+.||+|+++....    ....+.+|++++..++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999999985 4789999999976421    22456789999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      |..++....     .+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          82 LFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            998886543     48999999999999999999997 56   99999999999999999999999999875321   12


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||+||+.||......+....+.      ...       .   ..+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~~~-------~---~~p-  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEE-------I---RFP-  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------cCC-------C---CCC-
Confidence            23468889999999998899999999999999999999999997654332222111      000       0   001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                       .....++.+++.+|++.||++|+     ++.++++
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             11223566778899999999996     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-37  Score=310.64  Aligned_cols=241  Identities=22%  Similarity=0.372  Sum_probs=195.6

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +||+|+||.||+|...+++.+|+|.++.....  ...+.+|++++.+++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            58999999999999888999999998764322  3468899999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----cc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~  484 (625)
                      ++.....    .+++..+..++.|++.||.|+|..+   ++||||||+||+++.++.+||+|||++........    ..
T Consensus        82 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          82 FLRKKKD----ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            8865432    3789999999999999999999987   99999999999999999999999999876533211    11


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||++.+..++.++||||||+++||+++ |..||......+...   .+    ......          ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~----~~~~~~----------~~~~  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QV----EKGYRM----------SCPQ  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HH----HcCCCC----------CCCC
Confidence            23456999999998899999999999999999999 999997543222111   11    111000          0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ....++.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            22346788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-37  Score=313.53  Aligned_cols=244  Identities=24%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||+|...+++.||+|.+........++.+|++++++++|+||+++++++. .+..++||||+++++|.+
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   89 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVD   89 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHH
Confidence            4679999999999999888999999999877666788999999999999999999999864 467899999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      ++.....   ..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......    ...
T Consensus        90 ~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          90 FLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             HHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            9875432   24899999999999999999999987   9999999999999999999999999997664221    112


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||.+....++.++||||||+++||+++ |+.||......+...   .+.    ....          .+...
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~----~~~~----------~~~~~  226 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NLE----RGYR----------MPRPD  226 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHH----cCCC----------CCCCC
Confidence            34557999999988889999999999999999999 999997654322221   111    1000          01111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ....++.+++.+|+..+|++||+++++...|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            123467888889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-37  Score=311.92  Aligned_cols=241  Identities=22%  Similarity=0.383  Sum_probs=191.6

Q ss_pred             cccCCceeEEEEEEc---CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE---DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||.||+|...   ++..||+|++......  .+.+.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   3567999999765322  356889999999999999999999885 4578999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----  482 (625)
                      .+++....    ..+++..+.+++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.......    
T Consensus        82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99987532    24899999999999999999999987   99999999999999999999999999976532211    


Q ss_pred             --ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          483 --VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       483 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                        ...++..|+|||.+....++.++|||||||++||+++ |+.||......+....+.      ....           .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------~~~~-----------~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE------QGKR-----------L  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH------CCCC-----------C
Confidence              1112356999999988889999999999999999997 999997654333221111      1100           0


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      +.......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11112234677788899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-38  Score=328.85  Aligned_cols=234  Identities=22%  Similarity=0.354  Sum_probs=189.4

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+++.    .+|+.||+|+++....   ....+.+|++++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999874    3588999999986432   23457789999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|+|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            999999986532     4899999999999999999999998   999999999999999999999999998765332  


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..   .   .......          ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~---~i~~~~~----------~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T---MILKAKL----------GM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H---HHHcCCC----------CC
Confidence             22346788899999999888999999999999999999999999764322221   1   1111100          00


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPD  589 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  589 (625)
                      +  .....++.+++.+|++.||++||++.+
T Consensus       218 p--~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 P--QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C--CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1  112235667888999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-37  Score=311.44  Aligned_cols=245  Identities=26%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             HHhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          328 SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..+.||+|+||.||+|...++..+|+|.++......+.+.+|++++++++|+|++++++++. .+..++||||+++++|.
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~   88 (260)
T cd05070          10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL   88 (260)
T ss_pred             hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence            35679999999999999888889999999876666678999999999999999999999875 45689999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----c
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----V  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~  483 (625)
                      ++++...   ...+++.++..++.+++.||+|||+.+   |+||||||+||++++++.++|+|||++........    .
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05070          89 DFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence            9987542   224899999999999999999999987   99999999999999999999999999986543221    1


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   +...   . ..          ..+..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~---~-~~----------~~~~~  225 (260)
T cd05070         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQVE---R-GY----------RMPCP  225 (260)
T ss_pred             CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH---c-CC----------CCCCC
Confidence            123456999999988889999999999999999999 99999754332222   1111   1 00          00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ......+.+++.+|+..+|++|||+.++.+.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2223467888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-37  Score=312.45  Aligned_cols=241  Identities=23%  Similarity=0.371  Sum_probs=192.7

Q ss_pred             HcccCCceeEEEEEE---cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAIL---EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||.||+|..   .++..+|+|+++.....   .+++.+|+.++..++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            489999999999964   35789999998754332   356889999999999999999999885 45678999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc--
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~--  482 (625)
                      +|.+++....     .+++..+.+++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999986532     3889999999999999999999988   99999999999999999999999999986643221  


Q ss_pred             ----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                          ...++..|+|||.+....++.++|||||||++|||++ |+.||......+..+.++       .+...        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~~--------  217 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGERM--------  217 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC--------
Confidence                1122357999999988889999999999999999998 999997654333222221       11100        


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                        +.......++.+++.+||+.+|++||++++|++.|++.
T Consensus       218 --~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 --ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              00111234567888899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=313.16  Aligned_cols=245  Identities=25%  Similarity=0.450  Sum_probs=198.2

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|....    ...||||.++.....  ..++.+|+.++.+++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   88 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME   88 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence            4679999999999998642    457999998754332  3578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +++|.+++.....    .+++..+.+++.|++.|++|||+.+   |+||||||+||++++++.++|+|||+++.......
T Consensus        89 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          89 NGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            9999999976432    4899999999999999999999987   99999999999999999999999999987642111


Q ss_pred             -----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          483 -----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       483 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                           ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+..   ..+.    ...         
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~~---------  225 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAVE----DGY---------  225 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHHH----cCC---------
Confidence                 1123456999999998899999999999999999998 99999654432221   1111    110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       ..+........+.+++.+|++.+|++||++.||++.|+++
T Consensus       226 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 -RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0011122334678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=315.50  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=190.8

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---------------hHHHHHHHHHHHcCCCCceecceeEEEec-
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---------------KRDFEQQMEIVGSIRHENVVELKAYYYSK-  391 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  391 (625)
                      ...||+|.||.|-+|+ ..+++.||||++.+....               -+...+|+.+|.+++|||||+|+.+..+. 
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~  181 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE  181 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence            4569999999999999 457999999999653211               14678999999999999999999999875 


Q ss_pred             -CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          392 -DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       392 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                       +..|||+|||..|.+...-...     ..++..++.+++.+++.||+|||.++   ||||||||+|+||+++|++||+|
T Consensus       182 s~~~YlVley~s~G~v~w~p~d~-----~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  182 SDKLYLVLEYCSKGEVKWCPPDK-----PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             cCceEEEEEeccCCccccCCCCc-----ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence             5789999999988865433221     22899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccc--------ccccccCCCcCCccccCCCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 006922          471 LGLTTITSAL--------APVIARAAGYRAPEVTDSRK----ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW  538 (625)
Q Consensus       471 fGla~~~~~~--------~~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~  538 (625)
                      ||.+......        .....||+.|+|||...+..    .+.+.||||+||+||.|+.|+.||.+...-+..+.+. 
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv-  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV-  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh-
Confidence            9999866211        12257899999999987632    3578999999999999999999997643322222111 


Q ss_pred             HHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       539 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                                    ... ..+|...+...++-+++.+++.+||+.|.+..||....
T Consensus       333 --------------n~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  333 --------------NDP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             --------------cCc-ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                          111 12233334556677788899999999999999987654

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-37  Score=318.29  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=200.4

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||++...      ++..+|+|.+..... ..+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   89 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            467999999999999842      345689999875432 2457899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccC--------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          402 SLGSVSAMLHSERG--------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       402 ~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      ++++|.+++.....        .....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  166 (288)
T cd05093          90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGM  166 (288)
T ss_pred             CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCc
Confidence            99999999875431        12234899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          474 TTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       474 a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      ++.......     ...++..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+       ..+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-------~~~~  239 (288)
T cd05093         167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-------TQGR  239 (288)
T ss_pred             cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC
Confidence            986533221     1223557999999998899999999999999999999 99999765432221111       1111


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ..          +.......++.+++.+||+.+|.+|||+.|+.+.|+.+...
T Consensus       240 ~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         240 VL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             cC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            00          00011223578888899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.7e-38  Score=325.36  Aligned_cols=237  Identities=21%  Similarity=0.339  Sum_probs=190.6

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC-----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||.||+++.    ..++.||+|+++....     ....+.+|++++..++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4699999999999985    3578999999975321     224567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-  479 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-  479 (625)
                      +++|+|.+++....     .+.+..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            99999999887543     3788888999999999999999998   99999999999999999999999999875322 


Q ss_pred             --cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          480 --LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       480 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+..      .......         ..
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~~~~---------~~  218 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKILKGK---------LN  218 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHHcCC---------CC
Confidence              122346888999999999888999999999999999999999999764322211      1111111         00


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ..+   ....++.+++.+|++.+|++||     ++.++++
T Consensus       219 ~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LPP---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCC---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            001   1123567788899999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-37  Score=311.24  Aligned_cols=245  Identities=27%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||+||+|...++..||+|+++......+.+.+|++++.+++||||+++++++. .+..++||||+++|+|.+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~   89 (262)
T cd05071          11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD   89 (262)
T ss_pred             eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHH
Confidence            3569999999999999777778999999876555678999999999999999999999874 456799999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----cc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~  484 (625)
                      ++.....   ..++|..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||.++.......    ..
T Consensus        90 ~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          90 FLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             HHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            9975421   24789999999999999999999987   99999999999999999999999999986543221    12


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||+..+..++.++||||||+++|||+| |+.||......+......       ...          ..+...
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~----------~~~~~~  226 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY----------RMPCPP  226 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cCC----------CCCCcc
Confidence            34456999999988889999999999999999999 888987554332221110       000          011122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      +....+.+++.+|++.+|++||++.++++.|++.
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            3445678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-37  Score=315.01  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=196.8

Q ss_pred             HHhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          328 SAEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      ..+.||+|+||+||+|...      ++..||+|+++.....  .+.+.+|+.++..++||||+++++++...+..++++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e   88 (283)
T cd05091           9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS   88 (283)
T ss_pred             HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence            3577999999999999853      2578999999854322  3568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeE
Q 006922          400 YYSLGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV  468 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl  468 (625)
                      |+++++|.+++.....           .....+++..+.+++.|++.||+|+|+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl  165 (283)
T cd05091          89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence            9999999998853211           11234889999999999999999999998   999999999999999999999


Q ss_pred             ecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 006922          469 SDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       469 ~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                      +|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+..   +.+.  
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~i~--  240 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIR--  240 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH--
Confidence            9999988653221     11234567999999988889999999999999999998 88898764432222   1111  


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       543 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                       ... .          .+...+....+.+++.+||+.+|++||++.||+..|+.
T Consensus       241 -~~~-~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 -NRQ-V----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -cCC-c----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             111 0          01112234467788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.7e-37  Score=316.13  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=196.3

Q ss_pred             HhHcccCCceeEEEEEE-----cCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|..     .++..||+|.++.....  ...+.+|++++++++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   89 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL   89 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence            35799999999999984     24678999999754332  256889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccC------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe
Q 006922          402 SLGSVSAMLHSERG------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS  469 (625)
Q Consensus       402 ~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~  469 (625)
                      ++++|.+++.....            .....+++.+...++.|++.||+|||+.+   |+||||||+|||+++++.+||+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEec
Confidence            99999999853321            11234789999999999999999999998   9999999999999999999999


Q ss_pred             ccccccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 006922          470 DLGLTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       470 DfGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                      |||+++.....     .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..+.+.      
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~------  240 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR------  240 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence            99999765322     112234556999999988889999999999999999999 999997654332222221      


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       544 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                       .....          +.......++.+++.+|++.+|++||++.+|.+.|..
T Consensus       241 -~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 -KRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -cCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             11000          1111123456778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.9e-38  Score=325.55  Aligned_cols=236  Identities=20%  Similarity=0.330  Sum_probs=189.6

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||+||+|... +++.||+|+++...    ...+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5899999999999964 58899999997642    1224567788888866 7999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|...+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          82 DLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            9998886543     3889999999999999999999998   99999999999999999999999999875421   12


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+....      ......    .      .+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~~~~----~------~p-  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILHDDV----L------YP-  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCC----C------CC-
Confidence            234578899999999988999999999999999999999999976543222211      111110    0      01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRP-------KMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RP-------s~~ev~~  592 (625)
                       .....++.+++..|++.+|++||       +++++++
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             01123566788899999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.8e-38  Score=323.72  Aligned_cols=235  Identities=25%  Similarity=0.367  Sum_probs=188.1

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||+|... +++.||+|+++...    ...+.+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5899999999999965 57899999997642    2234566777777764 8999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~~  481 (625)
                      +|..++....     .+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ...
T Consensus        82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          82 DLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            9999987542     3889999999999999999999997   9999999999999999999999999987532   122


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..+.+.      ...       +.   .+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~~-------~~---~~-  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------MDN-------PC---YP-  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC-------CC---CC-
Confidence            33467889999999999899999999999999999999999997654322222111      000       00   01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMP-DVV  591 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-ev~  591 (625)
                       .....++.+++.+|++.+|++||++. ++.
T Consensus       217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 -RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence             11123456778899999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-37  Score=314.81  Aligned_cols=246  Identities=21%  Similarity=0.339  Sum_probs=193.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCc----EEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGT----TVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|.. .+++    .+++|.+.....  ...++..|+..+.+++||||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence            46799999999999985 3454    477787754322  12467778888999999999999998754 4578899999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.+++.....    .++|..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            99999999975432    4899999999999999999999987   9999999999999999999999999998653221


Q ss_pred             -----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 -----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                           ....++..|+|||.+.+..++.++|||||||++||+++ |+.||.+....+..+.+.       .+.  ....  
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~--~~~~--  232 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE--RLAQ--  232 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC--cCCC--
Confidence                 12235567999999988899999999999999999998 999997654332222211       110  0000  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                            ......++.+++.+||..+|++|||+.|+++.|+.+..
T Consensus       233 ------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  11122356778889999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.1e-37  Score=310.13  Aligned_cols=243  Identities=24%  Similarity=0.376  Sum_probs=197.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||.||++...++..+|+|++.......+.+.+|++++.+++|||++++++++. .+..++||||+++++|.++
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~   90 (260)
T cd05069          12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDF   90 (260)
T ss_pred             eeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHH
Confidence            569999999999999877778999998866555678899999999999999999999875 4568899999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----ccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~~  485 (625)
                      ++...   ...++|..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||+++.......    ...
T Consensus        91 ~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05069          91 LKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK  164 (260)
T ss_pred             HhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCc
Confidence            97543   224789999999999999999999987   99999999999999999999999999976533211    123


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||...+..++.++|||||||++|||+| |+.||......+..   .+..    ....          .+....
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~----~~~~----------~~~~~~  227 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVE----RGYR----------MPCPQG  227 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----cCCC----------CCCCcc
Confidence            4557999999988889999999999999999999 99999764432221   1111    1100          011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ....+.+++.+||..+|++||+++++++.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34567788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.1e-38  Score=325.53  Aligned_cols=243  Identities=17%  Similarity=0.293  Sum_probs=191.3

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||+||++... +++.||+|+++....    ..+.+.+|..++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5899999999999954 689999999986422    124577899999888 7999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...   ...
T Consensus        82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            9998886542     3899999999999999999999998   9999999999999999999999999987532   222


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE--LVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+  .....++....+.....         ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  224 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------RI  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------CC
Confidence            33568889999999999999999999999999999999999996432211  11111222222222110         01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPK------MPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~ev~~  592 (625)
                      +  .....++.+++.+|++.||.+||+      ++|+++
T Consensus       225 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 P--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             C--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1  112235677888999999999997      567753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-38  Score=340.80  Aligned_cols=243  Identities=20%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             HhHcccCCceeEEEEEEc-C-CcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-D-GTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||.||+|... + +..||+|.+...... ...+.+|++++..++|||||++++++...+..++||||+++|+
T Consensus        72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~  151 (478)
T PTZ00267         72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD  151 (478)
T ss_pred             EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence            357999999999999843 4 678888876543322 2457789999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----  480 (625)
                      |.+++..... ...++++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     
T Consensus       152 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        152 LNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             HHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            9998865322 2345889999999999999999999987   999999999999999999999999999876432     


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||.+|+|||++.+..++.++|||||||++|||++|+.||......+...      .......     +      +
T Consensus       228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~-----~------~  290 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLYGKY-----D------P  290 (478)
T ss_pred             ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC-----C------C
Confidence            223458889999999999999999999999999999999999997543322211      1111110     0      0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......++.+++..||..+|++||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11112245777888999999999999999874

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.2e-38  Score=325.11  Aligned_cols=231  Identities=22%  Similarity=0.331  Sum_probs=186.8

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||+|... +++.||+|+++...    ...+.+..|.+++... +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5899999999999954 68999999997532    2234567788888776 6999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          82 DLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             hHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            9998887543     3889999999999999999999998   99999999999999999999999999875421   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+      ....    ..      .+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~----~~------~~-  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE----VV------YP-  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcCC----CC------CC-
Confidence            3346888999999999889999999999999999999999999765432222111      1111    00      01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                       .....++.+++.+|++.||++||++
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 -TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence             1122356678889999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-37  Score=313.05  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEEEcC-Cc--EEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec------CceEE
Q 006922          329 AEVLGKGTFGMAYKAILED-GT--TVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLM  396 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  396 (625)
                      .+.||+|+||.||+|...+ +.  .||+|.++.....   .+.+.+|++++..++|+||+++++++...      ...++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            3679999999999999654 33  6899988764322   35688899999999999999999987542      24689


Q ss_pred             EEEeccCCChhhhhccccC-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          397 VYDYYSLGSVSAMLHSERG-EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +|||+++|+|.+++...+. .....+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCccc
Confidence            9999999999988754322 12334899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ......     ....++..|+|||...+..++.++||||||+++|||++ |+.||......+.   .+.+    ..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YDYL----RQGNRL  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HcCCCC
Confidence            764321     11234556999999998899999999999999999999 8999975432221   1111    111100


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                                +........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       234 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 ----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      01112234577888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=328.57  Aligned_cols=238  Identities=26%  Similarity=0.426  Sum_probs=199.4

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +||+|.||+||-|+. .+...+|||.+..... ..+.+..|+.+-+.++|.|||+++|.+..++..-|.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999994 4567899999976432 33568899999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccccccccc---cccc
Q 006922          409 MLHSERGEGRIPL--DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLTTITS---ALAP  482 (625)
Q Consensus       409 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~~---~~~~  482 (625)
                      +|+...+    |+  ++.+.-.+..||++||.|||+..   |||||||-+|||++ -.|.+||+|||-++.+.   +.+.
T Consensus       662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             HHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            9997654    35  77788889999999999999997   99999999999996 57899999999998864   4455


Q ss_pred             ccccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc--C
Q 006922          483 VIARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL--R  558 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~  558 (625)
                      +..||..|||||++..+  .|..++|||||||++.||.||++||.........                 +|...+.  .
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----------------MFkVGmyKvH  797 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----------------MFKVGMYKVH  797 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----------------hhhhcceecC
Confidence            67899999999999643  5899999999999999999999999865532211                 1111111  2


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.+++...+...++.+|+..+|.+||++.++++
T Consensus       798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            3445666677888999999999999999999986

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-37  Score=323.60  Aligned_cols=236  Identities=25%  Similarity=0.402  Sum_probs=186.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHH---HcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIV---GSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||.||+|... +|+.||||+++....    ..+.+.+|++++   ..++||||+++++++...+..++||||+
T Consensus         5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~   84 (324)
T cd05589           5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA   84 (324)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence            56999999999999854 689999999975421    124456666554   5678999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--  479 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--  479 (625)
                      ++|+|...++..      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....  
T Consensus        85 ~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          85 AGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999998887642      3899999999999999999999998   99999999999999999999999999875322  


Q ss_pred             -cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          480 -LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       480 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                       ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....      ......          .
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~~~~~----------~  219 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVNDEV----------R  219 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC----------C
Confidence             22334688899999999999999999999999999999999999976443222211      111110          0


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      .+  ......+.+++.+|++.||.+||     ++.++++
T Consensus       220 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 YP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11  11234567788899999999999     4556554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-37  Score=324.68  Aligned_cols=238  Identities=18%  Similarity=0.300  Sum_probs=187.3

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||++... +++.||+|+++....    ....+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5999999999999954 688999999986422    124467888888776 7999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            9988886542     3889999999999999999999998   99999999999999999999999999875321   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE--LVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ......++...+.....         ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~~  224 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------RI  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------CC
Confidence            33468889999999999999999999999999999999999996432211  11112222222211110         01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                      +  ......+.+++.+|++.||++||+.
T Consensus       225 p--~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         225 P--RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             C--CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1  1123456778889999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-37  Score=322.78  Aligned_cols=235  Identities=23%  Similarity=0.337  Sum_probs=186.2

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||+|... +++.||+|+++...    ...+.+..|.+++... +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999964 58899999997542    1223455666776654 8999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            9998887542     3888999999999999999999987   99999999999999999999999999975422   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+      ....          ...+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~----------~~~~-  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LNDR----------PHFP-  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC----------CCCC-
Confidence            3346888999999999889999999999999999999999999765432222111      1110          0001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMP-DVV  591 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-ev~  591 (625)
                       .....++.+++.+||..+|++||++. ++.
T Consensus       217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             11223456777899999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=328.42  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=205.1

Q ss_pred             HHhHcccCCceeEEEEEEc--CCc--EEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          328 SAEVLGKGTFGMAYKAILE--DGT--TVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      ..++||+|.||+|++|.+.  .|+  .||||.++.....  ..+|.+|+.+|.+++|+|+++|+|+..+ ....||||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4678999999999999964  343  6899999876543  4789999999999999999999999887 6789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      +.|+|.+.|++..   ...+-......++.|||.||.||.+++   +|||||.++|+||-....+||+|||+.+.+....
T Consensus       193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999732   234777888999999999999999998   9999999999999999999999999999886544


Q ss_pred             ccccc------CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 PVIAR------AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ~~~~~------~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      ..+.-      .+.|.|||.+...+++.++|||+|||++|||+| |+.||-+..+-.+.+.++                 
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-----------------  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-----------------  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-----------------
Confidence            33222      345999999999999999999999999999999 999998766544443332                 


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      +..+.+..+.+.+++++++..||..+|++||||.+|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1223455667888999999999999999999999998433

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.9e-37  Score=311.64  Aligned_cols=245  Identities=26%  Similarity=0.476  Sum_probs=197.0

Q ss_pred             HhHcccCCceeEEEEEEc-CC---cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DG---TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|... ++   ..+|+|.++....  ..+++..|++++.+++||||+++++++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            357999999999999964 33   3799999875432  23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +++|.+++.....    .+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          90 NGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999999875432    4899999999999999999999998   99999999999999999999999999876643211


Q ss_pred             c------cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 V------IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      .      ...+..|+|||++....++.++|||||||++||+++ |+.||......+....+   .    ..         
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~----~~---------  226 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---N----DG---------  226 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---h----cC---------
Confidence            1      112345999999988889999999999999999998 99999764432222111   1    10         


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       ...+...+...++.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             01111222345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-37  Score=309.47  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||+|... |+.||+|.++......+.+.+|+.++.+++|+||+++++++...+..++||||+++++|.+
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   89 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD   89 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence            467999999999999865 8899999998765445778999999999999999999999999899999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccCC
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA  488 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  488 (625)
                      ++.....   ..++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.++...........+.
T Consensus        90 ~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  163 (256)
T cd05039          90 YLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV  163 (256)
T ss_pred             HHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence            9875432   24899999999999999999999998   99999999999999999999999999987754333333455


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMV  567 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  567 (625)
                      .|+|||.+....++.++||||||+++||+++ |+.||......+..   ..+    ......          ........
T Consensus       164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~~----------~~~~~~~~  226 (256)
T cd05039         164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PHV----EKGYRM----------EAPEGCPP  226 (256)
T ss_pred             cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----hcCCCC----------CCccCCCH
Confidence            7999999988889999999999999999998 99999754332221   111    111100          00111234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          568 EMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       568 ~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      .+.+++.+|+..+|++||++.|+++.|+.+
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            677888999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-37  Score=311.36  Aligned_cols=237  Identities=24%  Similarity=0.358  Sum_probs=186.6

Q ss_pred             HcccCCceeEEEEEEcC-------------CcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecCceEE
Q 006922          331 VLGKGTFGMAYKAILED-------------GTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  396 (625)
                      .||+|+||+||+|...+             ...|++|.+...... ...+.+|+.++..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998532             235889988754332 3568889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC-------eeEe
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY-------GCVS  469 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~-------~kl~  469 (625)
                      ||||+++|+|..++....    ..+++..+.+++.|+++||+|||+.+   |+||||||+|||++.++.       ++++
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999998886532    24899999999999999999999987   999999999999987664       8999


Q ss_pred             cccccccccccccccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHH-hCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          470 DLGLTTITSALAPVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEIL-TGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       470 DfGla~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      |||++....... ...++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+....       .....
T Consensus       155 d~g~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~~~~  226 (262)
T cd05077         155 DPGIPITVLSRQ-ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------YEGQC  226 (262)
T ss_pred             CCCCCccccCcc-cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------HhcCc
Confidence            999987654322 235677899999886 567899999999999999998 58888865432221111       00000


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                                  ........++.+++.+||+.||.+||++.||++.|
T Consensus       227 ------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         227 ------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                        00011124577888899999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-37  Score=311.86  Aligned_cols=249  Identities=23%  Similarity=0.337  Sum_probs=189.9

Q ss_pred             HcccCCceeEEEEEEcC---CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILED---GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||.||+|...+   +..+|+|.++.....  ...+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998543   457999998765432  3468889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++...........++..+..++.|+++|++|||+.+   ++||||||+||+++.++.+||+|||+++......    
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997654333334678888999999999999999988   9999999999999999999999999987543221    


Q ss_pred             -cccccCCCcCCccccCCC-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          482 -PVIARAAGYRAPEVTDSR-------KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~-------~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                       ....++..|+|||++...       .++.++||||||+++|||++ |+.||......+.....      .... .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~-~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT------VREQ-QLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH------hhcc-cCCCC
Confidence             122356679999988542       35789999999999999997 99999764433221110      1111 01111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ++...     ......+.+++..|| .+|++|||++||++.|+
T Consensus       232 ~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111     011234667778998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-37  Score=322.56  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             HHhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEec-CceEEE
Q 006922          328 SAEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSK-DEKLMV  397 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv  397 (625)
                      ..+.||+|+||.||+|...      .++.||+|+++.....  .+.+.+|++++.++ +|+||++++++|... ...+++
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v   90 (337)
T cd05054          11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (337)
T ss_pred             hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence            3477999999999999632      2478999999754322  24577899999999 899999999988754 567899


Q ss_pred             EEeccCCChhhhhccccCC--------------------------------------------------------CCccC
Q 006922          398 YDYYSLGSVSAMLHSERGE--------------------------------------------------------GRIPL  421 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l  421 (625)
                      |||+++++|.+++......                                                        ...++
T Consensus        91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (337)
T cd05054          91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL  170 (337)
T ss_pred             EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence            9999999999988643210                                                        01258


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-----cccccCCCcCCcccc
Q 006922          422 DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVT  496 (625)
Q Consensus       422 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~  496 (625)
                      +|..+.+++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||+++......     ....++..|+|||++
T Consensus       171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            99999999999999999999987   9999999999999999999999999998753221     112345579999999


Q ss_pred             CCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHH
Q 006922          497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMS  575 (625)
Q Consensus       497 ~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  575 (625)
                      .+..++.++|||||||++|||++ |+.||......+..  ..    .+......          ........++.+++.+
T Consensus       248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~----~~~~~~~~----------~~~~~~~~~~~~l~~~  311 (337)
T cd05054         248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CR----RLKEGTRM----------RAPEYATPEIYSIMLD  311 (337)
T ss_pred             cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HH----HHhccCCC----------CCCccCCHHHHHHHHH
Confidence            99999999999999999999998 99999764332211  11    11111000          0011223467888999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          576 CVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       576 Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ||+.+|++||++.|+++.|+++.+
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-37  Score=309.40  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=194.7

Q ss_pred             HcccCCceeEEEEEEc--C--CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE--D--GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||.||+|...  +  +..+|+|.+.....  ..+++.+|++++..++|+||+++++++. .+..++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            5999999999999742  2  26899999986554  3467889999999999999999999876 45689999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc-
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  483 (625)
                      +|.+++....     .+++..+..++.|++.||+|||..+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          81 PLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             cHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999997543     4899999999999999999999987   999999999999999999999999999866432211 


Q ss_pred             -----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          484 -----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       484 -----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                           ..++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.   ..++.    ....         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~----~~~~---------  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLE----SGER---------  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH----cCCc---------
Confidence                 112346999999998899999999999999999998 9999976543222   22221    1100         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                       .+........+.+++.+||..+|++||++.++++.|+++.
T Consensus       217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             0111122346778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.5e-37  Score=313.89  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|...      .+..||+|+++....  ...++.+|+.++..++||||+++++++......++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            357999999999998743      256799999865332  235688999999999999999999999998999999999


Q ss_pred             ccCCChhhhhccccCC-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +++|+|.+++......     ....++|..+..++.|+++||+|||+.+   ++||||||+||++++++.++|+|||+++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcc
Confidence            9999999998754321     1234688999999999999999999987   9999999999999999999999999987


Q ss_pred             ccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      .......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   .    .....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~---~----~~~~~  240 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---M----EGGLL  240 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----cCCcC
Confidence            6532211     1233567999999998889999999999999999999 78999765432222111   1    11000


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                              .  ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus       241 --------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         241 --------D--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --------C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                    0  011223467888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=311.70  Aligned_cols=248  Identities=22%  Similarity=0.376  Sum_probs=194.3

Q ss_pred             HcccCCceeEEEEEEc-CCc--EEEEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGT--TVVVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||.||+|... ++.  .+++|.++...  ...+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            5899999999999964 344  46888887532  2235788999999999 7999999999999999999999999999


Q ss_pred             ChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          405 SVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       405 ~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      +|.++++....           .....+++.++..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence            99999876431           11224789999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccccc--ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          474 TTITSALAP--VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       474 a~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      +........  ....+..|+|||++....++.++|||||||++|||++ |..||......+..   +.+    ...... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~~~-  230 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKL----PQGYRL-  230 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH---HHH----hCCCCC-
Confidence            864322111  1122456999999988899999999999999999997 99999654322211   111    111000 


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                               +.......++.+++.+||..+|.+|||+.|+++.|+++.
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         231 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     001112346778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3e-37  Score=315.53  Aligned_cols=251  Identities=26%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|...      ....+++|.+......  .+.+.+|++++..++||||+++++.+...+..++|+||
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            367999999999999842      2357888888754322  35688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccC-------------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 006922          401 YSLGSVSAMLHSERG-------------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~  461 (625)
                      +++++|.+++.....                   .....+++..+..++.|++.||+|||+.+   |+||||||+||+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEc
Confidence            999999998865321                   11235889999999999999999999987   99999999999999


Q ss_pred             CCCCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhH
Q 006922          462 SQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL  535 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~  535 (625)
                      +++.+||+|||+++......     ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+..+ 
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-  240 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-  240 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence            99999999999997653221     11234557999999988889999999999999999999 999996544322222 


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                        .+.    ...          ..+.......++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       241 --~~~----~~~----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         241 --LLK----TGY----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             --HHh----CCC----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence              111    110          001111223467788899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-37  Score=313.83  Aligned_cols=244  Identities=20%  Similarity=0.282  Sum_probs=191.7

Q ss_pred             cccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||+||++.. .+|+.||+|++.....    ..+.+..|++++.+++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 4689999999975322    123456799999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--PVI  484 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~~~  484 (625)
                      .+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence            98886432   234889999999999999999999988   9999999999999999999999999987664322  224


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||........  ............     ...   ...   .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-----~~~---~~~---~  221 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-----VKF---EHQ---N  221 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-----ccc---ccc---c
Confidence            577889999999888899999999999999999999999975432211  111111111111     000   001   1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      ...++.+++.+|++.||++||++.|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            223567788899999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=310.45  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=201.5

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||+||+|..++++.||+|.+.......+++.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   90 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD   90 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence            46799999999999998888899999998776677889999999999999999999999998889999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----cc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~  484 (625)
                      ++.....   ..+++.++..++.+++.|++|||+.+   |+|+||||+||++++++.+|++|||+++.......    ..
T Consensus        91 ~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          91 FLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             HHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            9976432   24899999999999999999999998   99999999999999999999999999887643211    11


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+..|+|||.+.+..++.++|||||||++||+++ |+.||......+.   .+...   ...           ..+...
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~---~~~-----------~~~~~~  227 (261)
T cd05034         165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVE---RGY-----------RMPRPP  227 (261)
T ss_pred             CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---cCC-----------CCCCCC
Confidence            23456999999998889999999999999999999 9999965433221   11111   100           001111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ....++.+++.+|+..+|++||++.++++.|+.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            123467888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-37  Score=312.81  Aligned_cols=248  Identities=20%  Similarity=0.360  Sum_probs=196.6

Q ss_pred             HhHcccCCceeEEEEEE-cCCc----EEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGT----TVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|.. .+|.    .||+|+++.....  .+++.+|+.++..++||||+++++++.. ...+++|||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence            36799999999999984 4454    4899998754322  3568899999999999999999999975 4578999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.++++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          91 PYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             CCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            99999999876432    4899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cc-----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 PV-----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ..     ..++..|+|||...+..++.++|||||||++|||++ |..||......+...   ++.    ...        
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~----~~~--------  228 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---LLE----KGE--------  228 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHH----CCC--------
Confidence            11     123456999999988899999999999999999998 999997543322221   111    100        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                        ..+.......++.+++.+||..||++||++.|+++.|+.+....
T Consensus       229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence              00111123346778889999999999999999999998886554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-37  Score=322.27  Aligned_cols=235  Identities=24%  Similarity=0.337  Sum_probs=187.5

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||.||+|... +|+.||+|+++...    ...+....|..++... +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            5999999999999965 68999999997642    2234566777777654 8999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~~  481 (625)
                      +|..++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ...
T Consensus        82 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          82 DLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            9998886532     3789999999999999999999998   9999999999999999999999999987532   222


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..+.   +.    ..      .+.   .+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~---~~----~~------~~~---~~-  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES---IR----VD------TPH---YP-  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HH----hC------CCC---CC-
Confidence            345688899999999999999999999999999999999999976443222211   11    10      000   01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMP-DVV  591 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-ev~  591 (625)
                       .....++.+++.+|+..||++||++. ++.
T Consensus       217 -~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 -RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             01123566777899999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-37  Score=315.68  Aligned_cols=250  Identities=25%  Similarity=0.430  Sum_probs=199.9

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||.||+|...      ++..+++|.++..... .+.+.+|++++.+++|+||+++++++...+..++||||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   90 (291)
T cd05094          11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK   90 (291)
T ss_pred             eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence            56999999999999742      3567899998764432 3578999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          403 LGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       403 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      +++|.+++.....           .....++|..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCC
Confidence            9999999875421           11224899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhc
Q 006922          472 GLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVRE  545 (625)
Q Consensus       472 Gla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  545 (625)
                      |+++......     ....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+..   +..    ..
T Consensus       168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~----~~  240 (291)
T cd05094         168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---ECI----TQ  240 (291)
T ss_pred             CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----hC
Confidence            9997653321     12234567999999998899999999999999999999 99999765433221   111    11


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .....          ........+.+++.+||+.+|++||++.+|+++|+++..
T Consensus       241 ~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         241 GRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11100          011123467788889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-37  Score=310.54  Aligned_cols=249  Identities=23%  Similarity=0.381  Sum_probs=196.7

Q ss_pred             HhHcccCCceeEEEEEEc-C---CcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCc------eE
Q 006922          329 AEVLGKGTFGMAYKAILE-D---GTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDE------KL  395 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  395 (625)
                      .+.||+|+||+||+|... +   +..||+|+++......   ..+.+|++.+..++||||+++++++.....      .+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            357999999999999854 2   3679999998643332   468899999999999999999999876554      78


Q ss_pred             EEEEeccCCChhhhhccccCC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGE-GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      +||||+++|+|..++...... ....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccce
Confidence            999999999999988654321 2235899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +.......     ....+..|+|||.+.+..++.++|||||||++|||++ |..||......+.   .+++.   .... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~---~~~~-  233 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLR---HGNR-  233 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---cCCC-
Confidence            87543221     1123457999999988889999999999999999999 9999976443222   22111   1110 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                                .+.......++.+++.+||+.||.+||++.|+++.|+++
T Consensus       234 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      011122345778888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-38  Score=312.12  Aligned_cols=263  Identities=19%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCc-----eEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-----KLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~~~~  403 (625)
                      +++|+|+||.||+|... .+..||||+.-...   +.-.+|+++|++++|||||+++-+|....+     ..+|||||+.
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~  106 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE  106 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence            67999999999999954 57999999886532   344579999999999999999998876432     3589999997


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~  482 (625)
                       +|.+.++.... .+..++.-.+.-+..|+.+||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+....+
T Consensus       107 -tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  107 -TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             -HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence             89888875321 1223666677889999999999999987   9999999999999987 8999999999998865443


Q ss_pred             c--cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHHhhccc----c--cccc
Q 006922          483 V--IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL-VRWVHSVVREEW----T--AEVF  552 (625)
Q Consensus       483 ~--~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~----~--~~~~  552 (625)
                      .  ..=+..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.++.+.... ++.+...-+++.    .  .+.-
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~  261 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK  261 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence            2  234567999998865 5799999999999999999999999987554332211 111110001100    0  0111


Q ss_pred             cccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCCC
Q 006922          553 DVELLRYP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPN  600 (625)
Q Consensus       553 d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~~  600 (625)
                      .+.+...+    .......+.++++.++++.+|.+|.++.|++.  ..++++..
T Consensus       262 ~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  262 FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            11111111    11223356788888999999999999999985  55666555

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-37  Score=313.89  Aligned_cols=238  Identities=24%  Similarity=0.378  Sum_probs=186.2

Q ss_pred             HcccCCceeEEEEEEcC-------------------------CcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecc
Q 006922          331 VLGKGTFGMAYKAILED-------------------------GTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVEL  384 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l  384 (625)
                      .||+|+||.||+|....                         ...||+|++...... ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            48999999999997421                         135889988754322 3567888999999999999999


Q ss_pred             eeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 006922          385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ  464 (625)
Q Consensus       385 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~  464 (625)
                      +++|......++||||+++|+|..++.....    .+++..+.+++.|+++||+|||+.+   |+||||||+|||++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence            9999999999999999999999998865322    3789999999999999999999987   99999999999997654


Q ss_pred             -------CeeEecccccccccccccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHH-hCCCCCCCCCCcchhhH
Q 006922          465 -------YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEIL-TGKSPIHTTGGDELVHL  535 (625)
Q Consensus       465 -------~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~ell-tG~~p~~~~~~~~~~~~  535 (625)
                             .+|++|||++....... ...++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+....
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSRE-ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cccCccceeeecCCcccccccccc-ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                   37999999986543322 2346677999998865 56899999999999999995 69999976543322211


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ..       ...          ..+  .....++.+++.+||+.+|++||++.++++.|+
T Consensus       234 ~~-------~~~----------~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 YE-------KKH----------RLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-------hcc----------CCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11       000          001  111235778888999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-37  Score=319.84  Aligned_cols=193  Identities=20%  Similarity=0.331  Sum_probs=168.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||.||++... ++..+|+|.++....  ....+.+|++++.+++||||++++++|...+..++||||+++|+
T Consensus        10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (333)
T cd06650          10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (333)
T ss_pred             eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence            467999999999999965 688899998875422  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-cccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVI  484 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~~  484 (625)
                      |.+++....     .+++.....++.+++.||+|||+.+  +|+||||||+|||++.++.+||+|||++...... ....
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  162 (333)
T cd06650          90 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (333)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence            999987532     3788999999999999999999853  3999999999999999999999999999765332 2334


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            67888999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-37  Score=322.55  Aligned_cols=236  Identities=25%  Similarity=0.355  Sum_probs=190.2

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||++... +++.||+|+++...    .....+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999965 58899999998642    1234567888888877 6999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          82 DLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            9998887543     3899999999999999999999998   99999999999999999999999999875321   12


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+..   .   .......          ..+ 
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~---~i~~~~~----------~~~-  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---Q---SILEDEV----------RYP-  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---H---HHHcCCC----------CCC-
Confidence            2345788899999999999999999999999999999999999754422211   1   1111100          001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKM-----PDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~ev~~  592 (625)
                       ......+.+++.+||..||.+||++     .++++
T Consensus       217 -~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 -RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             1122356788889999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-37  Score=308.68  Aligned_cols=244  Identities=24%  Similarity=0.381  Sum_probs=196.6

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+|++++++++.. .+..++||||+++++|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~   88 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence            467999999999999865 7889999987533 34678999999999999999999998654 45789999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccC
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA  487 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  487 (625)
                      +++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...........+
T Consensus        89 ~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  162 (256)
T cd05082          89 DYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  162 (256)
T ss_pred             HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCccc
Confidence            99875432   24889999999999999999999987   9999999999999999999999999988765443333445


Q ss_pred             CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHH
Q 006922          488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM  566 (625)
Q Consensus       488 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  566 (625)
                      ..|+|||++.+..++.++|||||||++|||++ |+.||......+   ....+.    .+....          ......
T Consensus       163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~~----------~~~~~~  225 (256)
T cd05082         163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYKMD----------APDGCP  225 (256)
T ss_pred             eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCCCCC----------CCCCCC
Confidence            67999999998889999999999999999998 999996543222   222111    111110          011223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       567 ~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            4677888899999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=314.93  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=196.0

Q ss_pred             HhHcccCCceeEEEEE-----EcCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAI-----LEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-----~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  399 (625)
                      .+.||+|+||+||++.     ..++..||+|.++....  ....+.+|++++++++||||+++++++...  ...++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME   88 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence            4679999999998764     24678999999976432  346788999999999999999999998764  35789999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++...      .+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.++|+|||+++....
T Consensus        89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999998753      3899999999999999999999998   99999999999999999999999999986643


Q ss_pred             ccc------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 LAP------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ...      ...++..|+|||.+....++.++||||||+++|||+||+.||...... ..+...............+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence            211      112345599999998888999999999999999999999998653321 1111110000000000001111


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ... ..+.......++.+++..||+.+|++|||++++++.|+++.
T Consensus       239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            100 11111223457788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8e-37  Score=308.19  Aligned_cols=252  Identities=20%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-C---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-G---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||+|.. .+++.||||.++.... .   ...+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            35699999999999995 4789999998865322 1   24678899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      |+|.+++..... ....+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||++.......  
T Consensus        87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~  162 (267)
T cd08228          87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence            999988864322 2234788999999999999999999987   9999999999999999999999999988764322  


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......+.   ....      +.    .
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~---~~~~------~~----~  228 (267)
T cd08228         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIE---QCDY------PP----L  228 (267)
T ss_pred             HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHh---cCCC------CC----C
Confidence             1235677899999998888999999999999999999999999653221 111121111   1000      00    0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ........+.+++.+||..+|++||++.||++.+++++
T Consensus       229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            11223356788888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.4e-37  Score=326.69  Aligned_cols=252  Identities=21%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             HHhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEE
Q 006922          328 SAEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ..+.||+|+||.||+|...      .+..||+|+++.....  .+.+.+|++++.++. |||||+++++|...+..++||
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            4678999999999999853      2468999999864322  246889999999997 999999999999999999999


Q ss_pred             EeccCCChhhhhccccC---------------------------------------------------------------
Q 006922          399 DYYSLGSVSAMLHSERG---------------------------------------------------------------  415 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~---------------------------------------------------------------  415 (625)
                      ||+++|+|.++++....                                                               
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            99999999999975431                                                               


Q ss_pred             ------------------------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          416 ------------------------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       416 ------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                                                    .....++|....+++.|++.||+|||+.+   |+||||||+|||+++++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCE
Confidence                                          01124788889999999999999999887   999999999999999999


Q ss_pred             eeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 006922          466 GCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       466 ~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  539 (625)
                      +||+|||+++......     ....++..|+|||.+....++.++|||||||++|||++ |+.||......+..  .   
T Consensus       278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~--~---  352 (401)
T cd05107         278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF--Y---  352 (401)
T ss_pred             EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--H---
Confidence            9999999998643211     11234567999999988889999999999999999998 89998654322211  1   


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                       ..+..+..          .+.......++.+++.+||..+|.+||+++||++.|+++.
T Consensus       353 -~~~~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 -NAIKRGYR----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             11111100          0011112346778888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-37  Score=312.84  Aligned_cols=243  Identities=16%  Similarity=0.253  Sum_probs=190.6

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||+||++... +|+.||+|.+......    .+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999854 6899999999754322    24567899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      ..++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......   ..
T Consensus        81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            888754322 2235899999999999999999999998   9999999999999999999999999997654322   23


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||..........  .........         ..   ....
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~---------~~---~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILND---------SV---TYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhccc---------CC---CCcc
Confidence            467888999999999999999999999999999999999997643321111  101111000         00   1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ....++.+++.+|++.||++||     +++|+++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2234567788899999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.1e-38  Score=326.49  Aligned_cols=251  Identities=22%  Similarity=0.361  Sum_probs=187.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecC-----ceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  400 (625)
                      +.||+|+||.||+|.. .+|..||||+++...   .....+.+|++++++++||||+++++++...+     ..++||||
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~   85 (338)
T cd07859           6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL   85 (338)
T ss_pred             EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence            5699999999999995 468999999987532   22346889999999999999999999886432     47999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +. ++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          86 ME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             CC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            96 68888886532     3899999999999999999999998   999999999999999999999999999764321


Q ss_pred             c------cccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh--------
Q 006922          481 A------PVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR--------  544 (625)
Q Consensus       481 ~------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------  544 (625)
                      .      ....++..|+|||++.+  ..++.++|||||||++|||+||+.||..........   .+.....        
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~  233 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD---LITDLLGTPSPETIS  233 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCCHHHHH
Confidence            1      22457888999999865  678999999999999999999999997644322111   1111100        


Q ss_pred             ---cccccccccccccCCCC-cH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          545 ---EEWTAEVFDVELLRYPN-IE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       545 ---~~~~~~~~d~~~~~~~~-~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         .....+.++......+. ..    .....+.+++.+|++.+|++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               00000000000000000 00    11234678888999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-37  Score=326.58  Aligned_cols=192  Identities=22%  Similarity=0.320  Sum_probs=167.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|+++....    ....+.+|++++.+++|+||+++++++.+.+..++||||+++|
T Consensus         7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (363)
T cd05628           7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG   86 (363)
T ss_pred             EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence            57999999999999854 689999999975421    1245778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          87 DMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999997542     4899999999999999999999998   999999999999999999999999998754211    


Q ss_pred             ----------------------------------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          481 ----------------------------------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       481 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                                                        .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                              0123688899999999999999999999999999999999999976


Q ss_pred             CCC
Q 006922          527 TGG  529 (625)
Q Consensus       527 ~~~  529 (625)
                      ...
T Consensus       239 ~~~  241 (363)
T cd05628         239 ETP  241 (363)
T ss_pred             CCH
Confidence            543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-37  Score=322.47  Aligned_cols=238  Identities=16%  Similarity=0.273  Sum_probs=188.8

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||++... +++.||+|+++....    ..+.+.+|+.++.++ +||||+.+++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999954 678999999986422    124577899998888 6999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---ALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ...
T Consensus        82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            9998886542     3899999999999999999999998   9999999999999999999999999987532   122


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||............+++...+.....         ..+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p-  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIP-  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCC-
Confidence            3356888999999999999999999999999999999999999754333222222222222221110         011 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                       ......+.+++.+|++.||++|+++
T Consensus       224 -~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 -RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCC
Confidence             1112345677789999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.7e-37  Score=307.89  Aligned_cols=243  Identities=21%  Similarity=0.434  Sum_probs=198.2

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||++...++..+|+|.++.......++.+|++++++++|||++++++++......++||||+++++|.+
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD   88 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence            35699999999999997778899999998766666789999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----cc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~  484 (625)
                      ++.....    .+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.++|+|||+++.......    ..
T Consensus        89 ~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          89 YLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             HHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            9875432    4789999999999999999999988   99999999999999999999999999876532211    11


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+.+|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ....    ....  ....+.        
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~--~~~~~~--------  224 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VETI----NAGF--RLYKPR--------  224 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH----hCCC--CCCCCC--------
Confidence            23457999999988889999999999999999998 9999975432221   1111    1110  001111        


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      .....+.+++.+||+.+|++||++.|+++.|.
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            12346788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-37  Score=322.75  Aligned_cols=232  Identities=24%  Similarity=0.356  Sum_probs=184.4

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHH-HHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQME-IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||+||+|... +|+.||+|++.....    ..+.+..|.. ++..++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5899999999999964 689999999975321    1234445544 467789999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            9999887532     4889999999999999999999998   99999999999999999999999999875321   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..+      ......         ....+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~---------~~~~~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILNKP---------LRLKPN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHcCC---------CCCCCC
Confidence            23467889999999999999999999999999999999999997643322211      111110         000111


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMP  588 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~  588 (625)
                      .   ...+.+++.+|++.||.+||++.
T Consensus       219 ~---~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 I---SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C---CHHHHHHHHHHhhcCHHhCCCCC
Confidence            2   33566778899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-37  Score=328.75  Aligned_cols=241  Identities=24%  Similarity=0.321  Sum_probs=187.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+++.||+|+++....    ..+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg   86 (381)
T cd05626           7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG   86 (381)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            5699999999999985 4689999999976432    1245788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----  479 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-----  479 (625)
                      +|.+++....     .+++..+..++.|++.||+|||..+   |+||||||+|||++.++.+||+|||+++....     
T Consensus        87 ~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          87 DMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999987543     3788889999999999999999988   99999999999999999999999999753210     


Q ss_pred             ---------------------------------------------cccccccCCCcCCccccCCCCCCCccchhhhHHHH
Q 006922          480 ---------------------------------------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVL  514 (625)
Q Consensus       480 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil  514 (625)
                                                                   ......||..|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                         00123588899999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 006922          515 LEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMS--CVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       515 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPs~~ev~~  592 (625)
                      |||+||+.||......+....+      ..  +...   ...........   ++.+++.+  |+..+|..||++.|++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i------~~--~~~~---~~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKV------IN--WENT---LHIPPQVKLSP---EAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHH------Hc--cccc---cCCCCCCCCCH---HHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999765432221111      00  0000   00111111222   34445545  66777778999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.9e-37  Score=311.76  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=195.6

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|...      .+..||+|.+......  ...+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            357999999999999964      3568999988754322  35689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccccc
Q 006922          401 YSLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~  475 (625)
                      +++++|.+++......  ....++|..+.+++.|++.||+|||+.+   ++||||||+||+++.++   .+||+|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccc
Confidence            9999999998765421  1235899999999999999999999998   99999999999998765   58999999998


Q ss_pred             ccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      .......     ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      ..... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------~~~~~-  240 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------GGGRL-  240 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------cCCcC-
Confidence            7632211     1122346999999988899999999999999999997 999997654333222111      11000 


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                                .........+.+++.+|++.+|++||++.+|++.|++
T Consensus       241 ----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         241 ----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                      0011123467788899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-37  Score=316.42  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=199.8

Q ss_pred             HHhHcccCCceeEEEEEE--------cCCcEEEEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEE
Q 006922          328 SAEVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  396 (625)
                      ..+.||+|+||.||++..        .++..||+|.++...  ...+++.+|+.++..+ +||||+++++++...+..++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   98 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   98 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence            346799999999999973        124579999987542  2236788999999999 89999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          397 VYDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      ||||+++|+|.+++......           ....++|.++..++.|+++||+|||+.+   |+||||||+||+++.++.
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~  175 (304)
T cd05101          99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNV  175 (304)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCc
Confidence            99999999999999764321           1234789999999999999999999997   999999999999999999


Q ss_pred             eeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 006922          466 GCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       466 ~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  539 (625)
                      +||+|||+++......     ....++..|+|||++.+..++.++||||||+++|||++ |..||......+....   +
T Consensus       176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~  252 (304)
T cd05101         176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---L  252 (304)
T ss_pred             EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---H
Confidence            9999999998764321     11234456999999988889999999999999999999 8888865433222211   1


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                          ......          .........+.+++.+||..+|.+||++.|+++.|+++..-
T Consensus       253 ----~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         253 ----KEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ----HcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                111100          01112334677788899999999999999999999887553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.2e-37  Score=307.73  Aligned_cols=242  Identities=25%  Similarity=0.390  Sum_probs=196.0

Q ss_pred             HcccCCceeEEEEEEcC--C--cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILED--G--TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|++|+||+|...+  +  ..||+|.+.....  ..+.+.+|++++.+++||||+++++++.. ...++||||++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            58999999999998543  3  3699999987644  24678999999999999999999999988 8899999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++.....   ..++|.....++.|++.||+|||..+   ++||||||+||+++.++.+||+|||+++.....    
T Consensus        81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999976532   35899999999999999999999997   999999999999999999999999999876431    


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                        .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.   .   ...          
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~----------  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---EGE----------  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---cCC----------
Confidence              112345667999999998899999999999999999999 999997544332222111   0   000          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ..+........+.+++.+|++.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00111122346778889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=333.27  Aligned_cols=249  Identities=19%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             HhHcccCCceeEEEEEEcCC-cEEEEEEeccccC-ChHHHHHHHHHHHcCC-CCceeccee-EEEe------cCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILEDG-TTVVVKRLKDVNV-GKRDFEQQMEIVGSIR-HENVVELKA-YYYS------KDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~~lv~  398 (625)
                      .++|.+|||+.||.|....+ ..||+|++-.... .-+...+|+++|++++ |+|||.+++ ....      .-+.+|+|
T Consensus        42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            46799999999999996655 9999999876532 2367899999999996 999999999 3322      13678999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      |||.+|.|-+++......   .|++.++++|+.|+++|+++||.. +|||||||||-+||||+.+++.||||||.|.-.-
T Consensus       122 EyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~  197 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI  197 (738)
T ss_pred             hhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence            999999999999865432   299999999999999999999987 5789999999999999999999999999986421


Q ss_pred             ccc--c----------ccccCCCcCCcccc---CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 006922          479 ALA--P----------VIARAAGYRAPEVT---DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       479 ~~~--~----------~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                      ...  .          ....|+.|+|||.+   .+...++|+||||+||+||-|+....||+....-.+.          
T Consensus       198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----------  267 (738)
T KOG1989|consen  198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----------  267 (738)
T ss_pred             CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----------
Confidence            111  0          11357789999986   4677899999999999999999999999765332221          


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       544 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                               +.. ..+|........+.+|+..||+.+|.+||++-+|+..+.++....
T Consensus       268 ---------ng~-Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  268 ---------NGN-YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ---------ecc-ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                     111 123434456667888888999999999999999999998886653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-37  Score=300.22  Aligned_cols=260  Identities=18%  Similarity=0.273  Sum_probs=198.6

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCc-eecceeEEEecC------ceEEEE
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHEN-VVELKAYYYSKD------EKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv~  398 (625)
                      +.||+|+||+||+|+ ..+|+.||+|+++-...   ......+|+.++.+++|+| ||.+++++...+      ..++||
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            569999999999999 55799999999986543   2356789999999999999 999999998877      788999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||++. +|..++....... ..++-..+..++.|+++||+|||+++   |+||||||.|||++++|.+||+|||+|+...
T Consensus        97 e~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   97 EFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             Eeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            99976 9999988765321 23566789999999999999999998   9999999999999999999999999999765


Q ss_pred             cc---ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---ccccccc
Q 006922          479 AL---APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEV  551 (625)
Q Consensus       479 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  551 (625)
                      -.   -+....|..|+|||++.+. .|+...||||+|||++||++++.-|.+..+.+   ....+-..+.   +..+..+
T Consensus       172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCccCCCCc
Confidence            22   1234567789999998776 79999999999999999999999997765422   2222222221   1112211


Q ss_pred             c---ccc--ccCCCCcHHH-------HHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          552 F---DVE--LLRYPNIEEE-------MVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       552 ~---d~~--~~~~~~~~~~-------~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                      .   +..  ....+.....       ..+..+++.+|++.+|.+|.|+..++.+  +..+
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            1   111  1111101111       1357788889999999999999999875  4444

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=304.24  Aligned_cols=239  Identities=21%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             HHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCCh-H---HHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          328 SAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK-R---DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~-~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ..+.||+|.||.|-+|. +..|+.||||.+++..... +   .+.+|++||+.++||||+.++.+|+..+..+|||||..
T Consensus        57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS  136 (668)
T KOG0611|consen   57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS  136 (668)
T ss_pred             HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence            34679999999999999 5789999999998765433 2   37899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|.|++++.+.+     .|++..+..++.||+.|+.|+|.+.   ++|||||.+|||+|.++++||+|||++..+...  
T Consensus       137 ~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  137 GGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             CccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            999999998765     3999999999999999999999987   999999999999999999999999999876533  


Q ss_pred             ccccccCCCcCCccccCCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 APVIARAAGYRAPEVTDSRKAT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ..+.+|++-|.+||++.+.+|. +.+|-||+||+||.|+.|..||++.+-   ..+++   +..++.    .+.+     
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---QIs~Ga----YrEP-----  273 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---QISRGA----YREP-----  273 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---Hhhccc----ccCC-----
Confidence            3456888899999999999884 689999999999999999999987542   22332   222221    1111     


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      +.+.    +..-+++.++..+|++|.|..+|...
T Consensus       274 ~~PS----dA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 ETPS----DASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             CCCc----hHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1122    23446668888999999999999753

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-37  Score=311.51  Aligned_cols=251  Identities=22%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             HhHcccCCceeEEEEEEcC-----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILED-----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  400 (625)
                      .++||+|+||.||+|...+     +..|++|+++....  ..+.+.+|+.++.+++|+||+++++++.. ....++++||
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~   90 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY   90 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence            3679999999999999765     68899999875432  23568899999999999999999999876 4678999999


Q ss_pred             ccCCChhhhhccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          401 YSLGSVSAMLHSERGE---GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +++++|.+++......   ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            9999999998764321   1245899999999999999999999987   999999999999999999999999999865


Q ss_pred             cccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 006922          478 SALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV  551 (625)
Q Consensus       478 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  551 (625)
                      ....     ....++..|+|||++....++.++||||||+++||+++ |+.||......+   ...++.    .+.    
T Consensus       168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~----  236 (280)
T cd05043         168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK----DGY----  236 (280)
T ss_pred             cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----cCC----
Confidence            3221     11234567999999988889999999999999999999 999997643322   222111    110    


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       552 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                            ..+.......++.+++.+||..+|++|||+.|+++.|+.+..
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 ------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  001111123467888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.5e-37  Score=316.30  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=197.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCc--EEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGT--TVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|... ++.  .+|+|.++....  ..+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            356999999999999954 454  457777764322  235688999999999 89999999999999999999999999


Q ss_pred             CCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          403 LGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       403 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      +++|.++++....           .....+++.++..++.|++.|++|||+.+   |+||||||+|||++.++.+||+||
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df  168 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  168 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence            9999999975431           11235889999999999999999999987   999999999999999999999999


Q ss_pred             ccccccccccc--ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          472 GLTTITSALAP--VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       472 Gla~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      |+++.......  ....+..|+|||.+.+..++.++|||||||++|||+| |..||......+...   .+    .....
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~~----~~~~~  241 (303)
T cd05088         169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KL----PQGYR  241 (303)
T ss_pred             ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH---HH----hcCCc
Confidence            99874322111  1123456999999988889999999999999999998 999997544332211   11    11100


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                      .          ........++.+++.+||+.+|++||+++++++.|+.+.....
T Consensus       242 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         242 L----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            0          0011122356788889999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-37  Score=314.23  Aligned_cols=252  Identities=21%  Similarity=0.370  Sum_probs=196.9

Q ss_pred             hHcccCCceeEEEEEEc-CCc--EEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGT--TVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|... ++.  .+++|.++....  ..+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~   87 (297)
T cd05089           8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY   87 (297)
T ss_pred             eeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence            56999999999999864 343  478888874322  235788999999999 799999999999998999999999999


Q ss_pred             CChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccc
Q 006922          404 GSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG  472 (625)
Q Consensus       404 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG  472 (625)
                      ++|.++++.....           ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  164 (297)
T cd05089          88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFG  164 (297)
T ss_pred             CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcC
Confidence            9999999764311           1124889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccccccc--cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          473 LTTITSALAPV--IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       473 la~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ++.........  ...+..|+|||.+.+..++.++|||||||++|||++ |..||......+....      . ..+.  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~------~-~~~~--  235 (297)
T cd05089         165 LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK------L-PQGY--  235 (297)
T ss_pred             CCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------H-hcCC--
Confidence            98754322111  122446999999988889999999999999999998 9999976543222111      1 1110  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                              ..+........+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus       236 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         236 --------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                    00011112346778888999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.3e-37  Score=313.48  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=198.5

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||.||++...      ....+|+|.++.....  ..++.+|++++.++ +|+||+++++++...+..+++||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            457999999999999853      2368999998764322  24588899999999 79999999999999999999999


Q ss_pred             eccCCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeE
Q 006922          400 YYSLGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV  468 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl  468 (625)
                      |+++|+|..++.....           .....+++..+++++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence            9999999999875321           12335899999999999999999999987   999999999999999999999


Q ss_pred             ecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 006922          469 SDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       469 ~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                      +|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.....      
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------  247 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL------  247 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH------
Confidence            9999998764321     11123456999999988899999999999999999998 99999754432222111      


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       543 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                       .....          .........++.+++.+|+..+|++|||+.|+++.|+.+.
T Consensus       248 -~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         248 -KEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -HcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             11100          0111122346778899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-37  Score=306.18  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=200.2

Q ss_pred             HcccCCceeEEEEEEcC----CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILED----GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||.||+|....    +..|++|.++.....  .+.+.+|++++..++|+||+++++++......++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            58999999999999653    889999999876443  477899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          405 SVSAMLHSERGE----GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       405 ~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +|.+++......    ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999865211    0235899999999999999999999987   999999999999999999999999999876543


Q ss_pred             -----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 -----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                           .....++..|+|||.+....++.++||||+|+++|||++ |+.||......+..   +.+.    ...       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~----~~~-------  224 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLR----KGY-------  224 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH----cCC-------
Confidence                 222345677999999988889999999999999999999 69999765332222   1111    110       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                         ..+.......++.+++.+|+..+|++||++.|+++.|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               00111222457788889999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=319.27  Aligned_cols=242  Identities=22%  Similarity=0.381  Sum_probs=205.2

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecCc-eEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-KLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~~  403 (625)
                      .+++|+|+||.++..++ .+++.+++|.+.-..   ..++...+|+.++++++|||||.+.+.|..++. .+|||+|++|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            46799999999999985 468899999997543   234578999999999999999999999999887 8999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |++.+.+.+.++   ..++++++.+++.|++.|+.|||+..   |+|||||+.||+++.+..+||+|||+|+.+...   
T Consensus        89 g~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   89 GDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             CCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            999999988763   34889999999999999999999887   999999999999999999999999999998654   


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||+.||.||.+.+..|..|+||||+||++|||++=+++|...+..+....+   .   +.     .      -.|
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---~---~~-----~------~~P  225 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---N---RG-----L------YSP  225 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---h---hc-----c------CCC
Confidence            34578999999999999999999999999999999999999999765543332211   1   11     1      113


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .......++..++..|++.+|..||++.+++..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            334445577778889999999999999999974

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.5e-37  Score=307.13  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=190.0

Q ss_pred             hHcccCCceeEEEEEEc----CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|...    ++..||+|++.....  ..+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            35899999999999853    245799999864322  23578889999999999999999998764 456789999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++.....    ..++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            9999999875432    3678888999999999999999987   9999999999999999999999999987653211 


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTG-KSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....++..|+|||.+.+..++.++|||||||++|||++| .+||.....   .+....+   .....       
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~~~~~-------  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---LQGRR-------  220 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---hcCCC-------
Confidence                  112345579999999888899999999999999999995 566654322   1222211   11110       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                          .+........+.+++.+||..+|++||++.|+++.|+++.
T Consensus       221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                0111112346778899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-37  Score=307.62  Aligned_cols=237  Identities=26%  Similarity=0.434  Sum_probs=190.6

Q ss_pred             HcccCCceeEEEEEEcC-C----------cEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          331 VLGKGTFGMAYKAILED-G----------TTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~-g----------~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .||+|+||.||+|...+ +          ..+++|.+.........+.+|+.++++++||||+++++++.. +..++|||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e   80 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE   80 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence            58999999999999654 3          257888877654446788999999999999999999999988 78899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-------CeeEeccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-------YGCVSDLG  472 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~DfG  472 (625)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++       .+||+|||
T Consensus        81 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          81 YVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999976432    4889999999999999999999987   99999999999999888       79999999


Q ss_pred             ccccccccccccccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          473 LTTITSALAPVIARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       473 la~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ++...... ....++..|+|||++...  .++.++|||||||++|||++ |..||......+......      ..    
T Consensus       154 ~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------~~----  222 (259)
T cd05037         154 IPITVLSR-EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------DQ----  222 (259)
T ss_pred             cccccccc-cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------cC----
Confidence            99876542 223456679999998776  78999999999999999999 678886654222111110      00    


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                           .....+.    ...+.+++.+||..+|.+||++.|+++.|+
T Consensus       223 -----~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 -----HRLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----CCCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0000111    156778889999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=312.83  Aligned_cols=243  Identities=23%  Similarity=0.280  Sum_probs=193.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++.. .+++.||+|++......    ...+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05605           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence            5699999999999995 46899999999754221    245678999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||+++......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          86 DLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             cHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            9998886432   224899999999999999999999998   9999999999999999999999999998764322  2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||++.+..++.++||||+||++|||++|+.||...........+   ...+....         .  ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~---------~--~~~  225 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKEDQ---------E--EYS  225 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhcc---------c--ccC
Confidence            235778899999998888999999999999999999999999865432221111   11111100         0  001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ......+.+++.+||..||++||     ++.++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            12234567888899999999999     6767654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.9e-37  Score=308.07  Aligned_cols=245  Identities=26%  Similarity=0.467  Sum_probs=196.2

Q ss_pred             HhHcccCCceeEEEEEEc-C---CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-D---GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|... +   +..+|+|.++.....  .+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            467999999999999853 2   347999998754322  3578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +++|.+++.....    .+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||++........
T Consensus        89 ~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          89 NGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            9999999975432    4899999999999999999999988   99999999999999999999999999987643221


Q ss_pred             c------cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 V------IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      .      ...+..|+|||.+.+..++.++||||||+++||+++ |+.||......+..   ..+.    +..        
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~----~~~--------  226 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIE----EGY--------  226 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHh----CCC--------
Confidence            1      112346999999998889999999999999999887 99999765432221   1111    110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                        ..+........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              0111112234567888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8e-37  Score=308.72  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=186.8

Q ss_pred             HcccCCceeEEEEEEcC---CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILED---GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||+|...+   ...+|+|.+......  ...+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   356888887654322  3567889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++...........++.....++.|++.|++|||+.+   |+||||||+|||++.++.+||+|||+++......    
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997765332334578888999999999999999997   9999999999999999999999999987542211    


Q ss_pred             -cccccCCCcCCccccC-------CCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          482 -PVIARAAGYRAPEVTD-------SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~-------~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                       ....++..|+|||++.       ...++.++|||||||++|||++ |..||......+...      ....... ..+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~~~-~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK------QVVREQD-IKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH------HHhhccC-ccCC
Confidence             1123455699999864       3456889999999999999999 888886543222111      1111110 0111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ++..     .......+.+++..|| .||++||+++||++.|.
T Consensus       232 ~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111     1122234556777888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.6e-37  Score=314.80  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=198.7

Q ss_pred             HhHcccCCceeEEEEEEc--------CCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAILE--------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .+.||+|+||.||++...        ++..+|+|.++....  ...++.+|++++.++ +||||+++++++...+..++|
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  102 (307)
T cd05098          23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  102 (307)
T ss_pred             eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467999999999999742        235799999985422  235688899999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          398 YDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |||+++|+|.+++......           ....++|.++.+++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus       103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~  179 (307)
T cd05098         103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  179 (307)
T ss_pred             EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcE
Confidence            9999999999999765321           1124899999999999999999999987   9999999999999999999


Q ss_pred             eEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ||+|||.++......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+    
T Consensus       180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~----  255 (307)
T cd05098         180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL----  255 (307)
T ss_pred             EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----
Confidence            999999987654211     11123356999999988889999999999999999999 88998654322222111    


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                         .....          .+.......++.+++.+|+..+|.+||++.|+++.|+++...
T Consensus       256 ---~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         256 ---KEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ---HcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence               11110          011122234677888899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-36  Score=313.30  Aligned_cols=253  Identities=17%  Similarity=0.275  Sum_probs=189.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|... +++.||+|+++....  ....+.+|+++++.++||||+++++++...+..++||||++ ++|
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l   89 (303)
T cd07869          11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL   89 (303)
T ss_pred             eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence            56999999999999965 689999999975432  23467889999999999999999999999999999999996 578


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        90 ~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          90 CQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            77776532    23788899999999999999999998   999999999999999999999999998754321   123


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccccc-----cccc
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAE-----VFDV  554 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~d~  554 (625)
                      ..++..|+|||++.+ ..++.++||||+||++|||++|+.||.+...  ....+..+......   .....     .+++
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            456788999998765 4578999999999999999999999976432  11222211111100   00000     0000


Q ss_pred             ccc---CCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELL---RYPNIEE------EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~---~~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...   .......      ...++.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000   0000000      1134667888999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.8e-37  Score=335.32  Aligned_cols=242  Identities=23%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC--------ceEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD--------EKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv  397 (625)
                      +.||+|+||+||++.. .+|+.||||++......   ...+.+|+..+..++|+||+++.+.+...+        ..++|
T Consensus        38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV  117 (496)
T PTZ00283         38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV  117 (496)
T ss_pred             EEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence            5699999999999984 57999999999765333   245788999999999999999988775432        35799


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~  193 (496)
T PTZ00283        118 LDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMY  193 (496)
T ss_pred             EeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence            999999999999875432 2345889999999999999999999987   999999999999999999999999999865


Q ss_pred             ccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          478 SAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       478 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ...     .....||..|+|||++.+..++.++|||||||++|||++|+.||......+..      .......     .
T Consensus       194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~------~~~~~~~-----~  262 (496)
T PTZ00283        194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM------HKTLAGR-----Y  262 (496)
T ss_pred             cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHhcCC-----C
Confidence            322     22346888999999999999999999999999999999999999754322211      1111111     0


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +      +.......++.+++.+||+.+|.+||++.++++
T Consensus       263 ~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        263 D------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             C------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            0      011122345777888999999999999999976

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-37  Score=321.56  Aligned_cols=236  Identities=23%  Similarity=0.317  Sum_probs=185.2

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHH-HHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQME-IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||++... +++.||+|++.....    ....+..|.. ++..++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5899999999999954 678999999975421    1233444443 567789999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|.+++....     .+.+.....++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          82 ELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            9999887543     3778888899999999999999998   99999999999999999999999999875421   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++||||+||++|||++|+.||......+.   ...+   ....         ....+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i---~~~~---------~~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI---LNKP---------LQLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHH---HhCC---------cCCCCC
Confidence            334688899999999999999999999999999999999999976443222   1111   1110         000111


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .   ...+.+++.+|++.+|.+||++.+.+.
T Consensus       219 ~---~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         219 I---TNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             C---CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            2   234566777999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-36  Score=303.84  Aligned_cols=241  Identities=24%  Similarity=0.434  Sum_probs=196.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|.||++... +++.|++|.+.....   ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08529           6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD   85 (256)
T ss_pred             EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence            56999999999999954 689999999875432   34678899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.++++....   ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||+++......   .
T Consensus        86 L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          86 LHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             HHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            9999986422   24889999999999999999999987   9999999999999999999999999988654322   2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||+..+..++.++|||||||++|||++|+.||......+   ....   .... ...          +..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~-~~~----------~~~  222 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK---IIRG-VFP----------PVS  222 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcC-CCC----------CCc
Confidence            2356778999999998889999999999999999999999997544211   1111   1111 000          111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....++.+++.+||+.+|++||++.|+++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1234567888899999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-37  Score=311.14  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             HhHcccCCceeEEEEEEcC------CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILED------GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|...+      +..||+|.+.....  ....+.+|+.++..++||||+++++++......++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            4679999999999998542      36899999875432  235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCC-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +++|+|.+++......     ....++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccch
Confidence            9999999998754321     1224789999999999999999999987   9999999999999999999999999987


Q ss_pred             cccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ......     ....++..|+|||.+.+..++.++|||||||++||++| |+.||......+..   ....    .....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~----~~~~~  240 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVI----DGGHL  240 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHHh----cCCCC
Confidence            653221     12234667999999988889999999999999999998 99999764433322   2111    11000


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                                +.......++.+++.+||+.+|++|||+.|++..|++
T Consensus       241 ----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         241 ----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                      0111124567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.3e-37  Score=309.01  Aligned_cols=245  Identities=25%  Similarity=0.480  Sum_probs=196.0

Q ss_pred             HhHcccCCceeEEEEEEc-CC---cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DG---TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|... ++   ..||+|.++....  ..+++..|+.+++.++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            467999999999999954 33   3699999875422  23578999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +++|.+++.....    .+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||++........
T Consensus        89 ~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          89 NGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             CCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            9999999875432    3899999999999999999999987   99999999999999999999999999876532211


Q ss_pred             --c----ccc--CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          483 --V----IAR--AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       483 --~----~~~--~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                        .    ..+  +..|+|||.+.+..++.++|||||||++||+++ |..||......+.   ..++.    ...      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~----~~~------  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE----QDY------  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH----cCC------
Confidence              0    111  235999999998899999999999999999887 9999976543222   22221    110      


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                          ..+...+....+.+++.+||+.+|.+||++.+++..|+++
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0111122334577888899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=326.29  Aligned_cols=241  Identities=19%  Similarity=0.323  Sum_probs=194.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||+|+++...    .....+.+|++++..++||||+++++++.+.+..++||||++++
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (350)
T cd05573           7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG   86 (350)
T ss_pred             EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence            56999999999999965 68999999997542    22356888999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus        87 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          87 DLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999997652     4889999999999999999999987   9999999999999999999999999997654322   


Q ss_pred             -----------------------------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcch
Q 006922          482 -----------------------------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL  532 (625)
Q Consensus       482 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~  532 (625)
                                                   ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                         234578889999999999999999999999999999999999976543222


Q ss_pred             hhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006922          533 VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK-MPDVVRV  593 (625)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~ev~~~  593 (625)
                      ...+      ..  +....      ..+.......++.+++.+|+. +|.+||+ +.|+++.
T Consensus       239 ~~~i------~~--~~~~~------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKI------IN--WKESL------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH------hc--cCCcc------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1111      10  00000      011111123456677789997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-37  Score=324.05  Aligned_cols=249  Identities=20%  Similarity=0.312  Sum_probs=188.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||.||++.. ..++.||+|...     ...+.+|++++++++||||+++++++......++|+|++. ++|..
T Consensus        98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~  171 (391)
T PHA03212         98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC  171 (391)
T ss_pred             EEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence            5699999999999995 468999999654     2457889999999999999999999999999999999986 68888


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc----ccccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA----LAPVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~----~~~~~  484 (625)
                      ++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....    .....
T Consensus       172 ~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        172 YLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence            876532     3889999999999999999999997   99999999999999999999999999975422    12234


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHHhh---cccc-------cc
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE----LVHLVRWVHSVVR---EEWT-------AE  550 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~----~~~~~~~~~~~~~---~~~~-------~~  550 (625)
                      .||..|+|||++.+..++.++|||||||++|||+||+.||.......    ....+..+.....   .+..       ..
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~  323 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE  323 (391)
T ss_pred             cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence            68899999999999899999999999999999999998875432110    0011111100000   0000       00


Q ss_pred             cc-------cccccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VF-------DVELLRYP---NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~-------d~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+       .......+   .......++.+++.+|++.||++|||+.|+++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00       00000000   01123446788999999999999999999985

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=299.87  Aligned_cols=248  Identities=20%  Similarity=0.389  Sum_probs=207.3

Q ss_pred             HHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          321 LEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       321 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+++.. +.+.||+|+||.|||+.++ .|+.+|||.+.. ..+-++...|+.+|++++.|++|+++|.|......++|||
T Consensus        31 PEEVFD-i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   31 PEEVFD-IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             hHHHHH-HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            344433 3467999999999999854 699999998764 3345788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ||.-|+..+.++..+    .+|++..+..++.+.++||+|||...   -||||||+.|||++.+|.+|++|||.|..+.+
T Consensus       109 YCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             hcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            999999999998654    36999999999999999999999987   89999999999999999999999999988754


Q ss_pred             c---ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          480 L---APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       480 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                      .   .+.+.||+.|||||++..-.|+.++||||+|++..||..|++||.+.......-+       ++...        -
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~P--------P  246 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKP--------P  246 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCC--------C
Confidence            3   3567899999999999999999999999999999999999999986543221100       00000        0


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..+..++....++-+++++|+.++|++|-|+.++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            122345667778899999999999999999988775

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-36  Score=311.36  Aligned_cols=256  Identities=19%  Similarity=0.277  Sum_probs=187.6

Q ss_pred             hHcccCCceeEEEEEE-c-CCcEEEEEEeccccC---ChHHHHHHHHHHHcC---CCCceecceeEEEe-----cCceEE
Q 006922          330 EVLGKGTFGMAYKAIL-E-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSI---RHENVVELKAYYYS-----KDEKLM  396 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~l  396 (625)
                      +.||+|+||+||+|.. . +|+.||+|+++....   ....+.+|++++..+   +||||++++++|..     ....++
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l   86 (290)
T cd07862           7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   86 (290)
T ss_pred             eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence            5699999999999985 3 468899999875432   124566777777665   69999999999853     346899


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ||||++ ++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          87 VFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             EEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            999997 589888875432   24889999999999999999999998   99999999999999999999999999986


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhhccccccccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH-LVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d  553 (625)
                      ....  .....++..|+|||.+.+..++.++|||||||++|||++|++||......+... ..+.........+..+...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            5432  223457888999999988889999999999999999999999998654332221 1111100001111110000


Q ss_pred             c-c-cc-CCC-Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 V-E-LL-RYP-NI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~-~-~~-~~~-~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      + . .. ... ..    ......+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0 0 00 000 00    011234567888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=292.02  Aligned_cols=243  Identities=19%  Similarity=0.310  Sum_probs=197.3

Q ss_pred             HHhHcccCCceeEEEEEE-cCCcEEEEEEeccc---cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV---NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..++||+|.|+.||+..+ ..|+.+|+|.+...   ..+.+++.+|+.|-+.++|||||+|.+.+......++|+|+|.|
T Consensus        15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G   94 (355)
T KOG0033|consen   15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG   94 (355)
T ss_pred             HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence            457899999999999874 57999999988643   23567889999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEeccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTITSAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~  480 (625)
                      ++|..-+-..     ...++..+-....||+++|.|+|..+   |||||+||.|+++-+.   .-+|++|||+|..+++.
T Consensus        95 ~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   95 GELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             hHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            9997765432     23677788889999999999999998   9999999999999543   45899999999988743


Q ss_pred             c--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 A--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      .  ....||++|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.....+.+.           ...+|.....
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-----------~g~yd~~~~~  235 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-----------AGAYDYPSPE  235 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-----------ccccCCCCcc
Confidence            2  24678999999999999999999999999999999999999998755444333222           2223333333


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ++...++.+   +++.+|+..||.+|.|+.|+++
T Consensus       236 w~~is~~Ak---~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  236 WDTVTPEAK---SLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCcCCHHHH---HHHHHHhccChhhhccHHHHhC
Confidence            344455554   4556999999999999998873

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.7e-36  Score=305.90  Aligned_cols=252  Identities=21%  Similarity=0.366  Sum_probs=201.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||++.. .++..+|||.+.....    ...++.+|++++..++||||+++++++...+..+++|||+++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA   86 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence            46799999999999994 5799999998875322    225688999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      ++|.+++..... ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd08229          87 GDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence            999998875322 2235899999999999999999999988   9999999999999999999999999987664322  


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....++..|+|||.+.+..++.++||||||+++|||++|..||.....+ .......+.   ...      .+..    
T Consensus       163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---~~~------~~~~----  228 (267)
T cd08229         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE---QCD------YPPL----  228 (267)
T ss_pred             cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh---cCC------CCCC----
Confidence             2235677899999998888999999999999999999999999653321 111111111   000      0000    


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ........+.+++.+||..+|++||||.+|++.++++.
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            01123346778888999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-37  Score=320.06  Aligned_cols=232  Identities=23%  Similarity=0.340  Sum_probs=183.0

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHH-HHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQME-IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +||+|+||+||+|+.. +|+.||+|++.....    ....+.+|.. ++..++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999964 689999999975421    1234455554 577889999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|...+....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          82 ELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            9988876432     3788888999999999999999987   99999999999999999999999999875321   12


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.||...+..+.   .+.   ....         .. ..+ 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~---i~~~---------~~-~~~-  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YDN---ILHK---------PL-QLP-  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HHH---HhcC---------CC-CCC-
Confidence            234578899999999988999999999999999999999999976432221   111   1111         00 001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMP  588 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~  588 (625)
                       ......+.+++.+|++.+|.+||+..
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             11233567788899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.5e-37  Score=333.27  Aligned_cols=260  Identities=18%  Similarity=0.277  Sum_probs=191.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCC------CceecceeEEEec-CceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH------ENVVELKAYYYSK-DEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~-~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|.. ..++.||||+++......+++..|++++.+++|      .+++.+++++... +..++|||+
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~  213 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK  213 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence            35799999999999995 468899999997643334556778877777654      4588899988765 467899998


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCC---------------
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQ---------------  464 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~---------------  464 (625)
                      + +++|.+++....     .+++..+..|+.|++.||+|||++ +   ||||||||+|||++.++               
T Consensus       214 ~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        214 Y-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             c-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            7 668888876532     489999999999999999999984 6   99999999999998765               


Q ss_pred             -CeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 006922          465 -YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       465 -~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                       .+||+|||.+...........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+......+
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence             4999999998765555556678999999999999999999999999999999999999998655433333322211111


Q ss_pred             hccccc--------cccccccc--------------CCCCcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006922          544 REEWTA--------EVFDVELL--------------RYPNIE--EEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENV  597 (625)
Q Consensus       544 ~~~~~~--------~~~d~~~~--------------~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~  597 (625)
                      ..++..        ++++....              ......  .....+.+++..||+.||++|||+.|+++  .+.+.
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            111100        00100000              000000  01235678999999999999999999987  44443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-37  Score=323.21  Aligned_cols=196  Identities=26%  Similarity=0.380  Sum_probs=174.4

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcCC-C-----CceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-H-----ENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .++||+|+||.|.||. ..+++.||||+++....-..+...|+.+|..++ |     -|+|++++||...++.|||+|.+
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL  270 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL  270 (586)
T ss_pred             EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence            4679999999999999 456999999999986655567788999999886 4     48999999999999999999988


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC--CeeEecccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ--YGCVSDLGLTTITSA  479 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~--~~kl~DfGla~~~~~  479 (625)
                      .. +|+++++.++-   ..++......++.||+.||.+||+.+   |||+||||+||||.+-.  .+||+|||.|.....
T Consensus       271 ~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  271 ST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             hh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            65 99999998754   35899999999999999999999998   99999999999997644  799999999999887


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE  531 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~  531 (625)
                      .......+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+
T Consensus       344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            7777788899999999999999999999999999999999988887765443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-37  Score=324.20  Aligned_cols=241  Identities=20%  Similarity=0.302  Sum_probs=191.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++.. .+|+.||+|+++....    ..+.+.+|++++..++|+||+++++++.+.+..++||||+++|
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (330)
T cd05601           7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG   86 (330)
T ss_pred             EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence            5699999999999995 4689999999986432    2356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......   
T Consensus        87 ~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          87 DLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            99999976522    4899999999999999999999998   9999999999999999999999999998764322   


Q ss_pred             -cccccCCCcCCccccC------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 -PVIARAAGYRAPEVTD------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                       ....++..|+|||++.      ...++.++|||||||++|||++|+.||......+...      ......   ..   
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~---~~---  227 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQ---RF---  227 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCC---Cc---
Confidence             1235788899999986      4567899999999999999999999997644322211      111110   00   


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ...+.......++.+++..|+. +|++||++.++++
T Consensus       228 --~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 --LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              0111111122355667778997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.3e-37  Score=318.82  Aligned_cols=232  Identities=21%  Similarity=0.309  Sum_probs=185.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCC-ceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHE-NVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|... +++.||+|+++...    ...+.+..|.+++..++|+ +|+.+++++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (324)
T cd05587           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (324)
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence            56999999999999954 57899999997542    2235677889999999764 688899999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ..
T Consensus        86 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          86 GDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999886543     3789999999999999999999998   9999999999999999999999999987532   12


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....|+..|+|||++.+..++.++||||+||++|||+||+.||......+....   +.   ...       .   ..+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---i~---~~~-------~---~~~  221 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS---IM---EHN-------V---SYP  221 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HH---cCC-------C---CCC
Confidence            2234688899999999999999999999999999999999999976543222211   11   100       0   001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                        .....++.+++.+|+..+|.+|++.
T Consensus       222 --~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 --KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1122356678889999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-36  Score=305.02  Aligned_cols=244  Identities=24%  Similarity=0.422  Sum_probs=197.6

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||++...++..+|+|.++......+.+.+|++++++++|+||+++.+++.. ...+++|||+++++|.+
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~   89 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD   89 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence            35699999999999997778889999988655455778999999999999999999999887 77899999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----cc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~  484 (625)
                      ++....   ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.+........    ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          90 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             HHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            997643   224789999999999999999999987   99999999999999999999999999876542211    12


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||++....++.++|||||||++||++| |+.||......+.   ..+..    .....          +...
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~----~~~~~----------~~~~  226 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALE----RGYRM----------PRPE  226 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh----CCCCC----------CCcc
Confidence            23456999999988889999999999999999999 9999975432222   11111    11100          1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ....++.+++.+|++.+|++||++.++.+.|+.
T Consensus       227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            223467788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-37  Score=322.02  Aligned_cols=235  Identities=23%  Similarity=0.333  Sum_probs=186.0

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHH-HHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQME-IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||++.. .+|+.||+|++.....    ....+..|.. ++..++||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            589999999999995 4789999999975421    2234555554 467789999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            9988886532     4889999999999999999999998   99999999999999999999999999875321   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..+      ......         ....+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~~~---------~~~~~~  218 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILHKP---------LVLRPG  218 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHcCC---------ccCCCC
Confidence            33468889999999999999999999999999999999999997654322211      111110         001111


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                         ....+.+++.+|++.+|.+||++.+.+
T Consensus       219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         219 ---ASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ---CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence               223556778899999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-37  Score=309.96  Aligned_cols=238  Identities=22%  Similarity=0.410  Sum_probs=186.9

Q ss_pred             HcccCCceeEEEEEEcC--------CcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILED--------GTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .||+|+||+||+|....        ...||+|.+..... ..+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            58999999999998532        23488888765432 2356888999999999999999999999989999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC--------eeEecccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--------GCVSDLGL  473 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DfGl  473 (625)
                      ++|+|..+++....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||+
T Consensus        82 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          82 KFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999976432    4889999999999999999999987   999999999999988765        58999999


Q ss_pred             cccccccccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhhccccccc
Q 006922          474 TTITSALAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGK-SPIHTTGGDELVHLVRWVHSVVREEWTAEV  551 (625)
Q Consensus       474 a~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  551 (625)
                      +...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||...........   .    ...     
T Consensus       155 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~----~~~-----  221 (258)
T cd05078         155 SITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---Y----EDR-----  221 (258)
T ss_pred             ccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---H----Hcc-----
Confidence            8765432 23457778999999876 45789999999999999999984 66654322211110   0    000     


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       552 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                           ...+  .....++.+++.+||+.+|++|||++|+++.|+
T Consensus       222 -----~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -----HQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----ccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0011  111245778888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=302.18  Aligned_cols=241  Identities=24%  Similarity=0.418  Sum_probs=196.6

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .||+|+||.||++...+++.||+|.++.....  .+.+.+|++++++++|+||+++++++...+..++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            58999999999999777999999998765432  4578999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-----c
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----V  483 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----~  483 (625)
                      ++.....    .+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||++........     .
T Consensus        82 ~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          82 FLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9865422    4789999999999999999999988   99999999999999999999999999986542211     1


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...+..|+|||.+.+..++.++|||||||++|||+| |+.||...........+.       ...          ..+..
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~~----------~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGY----------RMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cCC----------CCCCC
Confidence            122446999999988899999999999999999999 899996654322221111       100          01111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      .....++.+++.+|+..+|.+||++.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            223346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-36  Score=311.10  Aligned_cols=248  Identities=23%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||++...      ++..||+|+++....  ..+++.+|++++.+++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY   89 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence            356999999999999853      467899999875432  235688999999999999999999999998999999999


Q ss_pred             ccCCChhhhhccccC-----------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC
Q 006922          401 YSLGSVSAMLHSERG-----------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ  463 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~  463 (625)
                      +++|+|.+++.....                 .....+++..++.++.|++.||+|||..+   ++||||||+||+++.+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~  166 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGEN  166 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCC
Confidence            999999999975321                 11234789999999999999999999987   9999999999999999


Q ss_pred             CCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 006922          464 QYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       464 ~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~  537 (625)
                      +.++|+|||++.......     .....+..|+|||.+.+..++.++|||||||++|||++ |..||......+...   
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~---  243 (288)
T cd05050         167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY---  243 (288)
T ss_pred             CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence            999999999987643221     11223456999999988899999999999999999998 888987544332221   


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .+   ....         ..  +.......++.+++.+|++.+|++|||+.|+++.|++
T Consensus       244 ~~---~~~~---------~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 YV---RDGN---------VL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HH---hcCC---------CC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            11   1111         00  1111223467888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.6e-37  Score=319.26  Aligned_cols=241  Identities=20%  Similarity=0.286  Sum_probs=188.9

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC-----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      +.||+|+||+||+++.    .+++.||+|+++....     ..+.+..|++++..+ +||||+++++++...+..++|||
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (332)
T cd05614           6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD   85 (332)
T ss_pred             EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence            5699999999999885    3588999999975321     224577899999999 59999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          86 YVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            999999999987543     3889999999999999999999998   99999999999999999999999999976432


Q ss_pred             c----ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          480 L----APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       480 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      .    .....|+..|+|||++.+. .++.++|||||||++|||+||+.||...........+  .......       ++
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~-------~~  228 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC-------DP  228 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcC-------CC
Confidence            1    2234688899999998765 4788999999999999999999999754332221111  1111110       01


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ..     .......+.+++.+|++.||++||     +++|+++
T Consensus       229 ~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 PF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            00     111223456778899999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.6e-37  Score=318.50  Aligned_cols=232  Identities=21%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|... +++.||+|+++....    ..+.+..|..++..+ +|++|+.+++++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (323)
T cd05616           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (323)
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence            56999999999999955 578999999976421    123466777887777 589999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---L  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~  480 (625)
                      |+|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   .
T Consensus        86 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          86 GDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99998886543     3889999999999999999999987   99999999999999999999999999875421   2


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....|+..|+|||++.+..++.++|||||||++|||+||+.||......+....+   .   ...         . ..+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---~---~~~---------~-~~p  221 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---M---EHN---------V-AYP  221 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH---H---hCC---------C-CCC
Confidence            22346888999999999999999999999999999999999999765433222111   1   110         0 001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                        .....++.+++.+|++.+|.+|++.
T Consensus       222 --~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 --KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CcCCHHHHHHHHHHcccCHHhcCCC
Confidence              1123456778889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.2e-37  Score=311.59  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=193.7

Q ss_pred             HhHcccCCceeEEEEEE-----cCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  400 (625)
                      .+.||+|+||+||++..     .++..||+|+++..... .+.+.+|++++.+++||||+++++++...  ...++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            36799999999999974     25789999998765332 35788999999999999999999987543  467899999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++|+|.+++.....    .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          89 LPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             cCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            999999999875432    3899999999999999999999998   999999999999999999999999999876432


Q ss_pred             ccc------cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhh----------HHHHHHHHhh
Q 006922          481 APV------IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH----------LVRWVHSVVR  544 (625)
Q Consensus       481 ~~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~----------~~~~~~~~~~  544 (625)
                      ...      ..++..|+|||.+.+..++.++|||||||++|||++|..|+...... ...          ..........
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHHHh
Confidence            211      11223499999998888999999999999999999988776432211 000          0000001111


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ..          ...+.......++.+++.+||..+|++|||+.||++.|+.++
T Consensus       241 ~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         241 NN----------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cC----------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            00          011111223346788888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-36  Score=316.34  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             HHhHcccCCceeEEEEEEc--------CCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEE
Q 006922          328 SAEVLGKGTFGMAYKAILE--------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  396 (625)
                      ..+.||+|+||.||++...        .+..||+|.++.....  .+++.+|++++.++ +||||++++++|...+..++
T Consensus        16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (334)
T cd05100          16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   95 (334)
T ss_pred             ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence            3567999999999999742        1236899988754322  35788999999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          397 VYDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      +|||+++|+|.+++......           ....++|.++..++.|++.||+|||+.+   |+||||||+||+++.++.
T Consensus        96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~  172 (334)
T cd05100          96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence            99999999999998764311           1234889999999999999999999987   999999999999999999


Q ss_pred             eeEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 006922          466 GCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       466 ~kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  539 (625)
                      +||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+   
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---  249 (334)
T cd05100         173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---  249 (334)
T ss_pred             EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence            99999999986543211     1122356999999999899999999999999999999 89999654432222111   


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      .    .....          +.......++.+++.+||+.+|.+||++.|+++.|+++....
T Consensus       250 ~----~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         250 K----EGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             H----cCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1    11000          011122346778889999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-36  Score=307.65  Aligned_cols=246  Identities=24%  Similarity=0.402  Sum_probs=194.3

Q ss_pred             HcccCCceeEEEEEEcC-------CcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILED-------GTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .||+|+||.||+|...+       +..+|+|.+....  .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999998542       2579999886543  23467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-----CeeEeccccc
Q 006922          402 SLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-----YGCVSDLGLT  474 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DfGla  474 (625)
                      ++++|.+++......  ....++|.+++.++.|++.||+|||+.+   ++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999754321  1234789999999999999999999987   99999999999999887     8999999998


Q ss_pred             ccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +......     .....+..|+|||.+.+..++.++|||||||++|||+| |+.||......+.   ...+.   ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~~---~~~--  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHVT---AGG--  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHHh---cCC--
Confidence            7553221     11233567999999998899999999999999999998 9999965432221   11111   000  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                               ...........+.+++.+||+.+|.+||++.++++.|++
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     001111223467788889999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-37  Score=323.96  Aligned_cols=242  Identities=18%  Similarity=0.253  Sum_probs=190.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||++... +++.||+|+++...    ...+.+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence            357999999999999954 68999999997532    1234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |+|.+++...      .++...+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            9999998653      2777888899999999999999988   999999999999999999999999999865432   


Q ss_pred             -ccccccCCCcCCccccCCC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          481 -APVIARAAGYRAPEVTDSR----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                       .....|+..|+|||.+.+.    .++.++|||||||++|||++|+.||......+...      .......  .     
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~~--~-----  265 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHKN--S-----  265 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCCC--c-----
Confidence             1234688899999998653    47889999999999999999999997654322111      1111100  0     


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQ--RPKMPDVVRV  593 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~ev~~~  593 (625)
                       ...+.......++.+++.+|++.+|.+  ||++.|+++.
T Consensus       266 -~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 -LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             011111112345667778999999987  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-36  Score=310.84  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             HhHcccCCceeEEEEEEcC-----------------CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEE
Q 006922          329 AEVLGKGTFGMAYKAILED-----------------GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYY  389 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  389 (625)
                      .+.||+|+||.||++...+                 +..||+|++.....  ..+.+.+|++++.+++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4679999999999988542                 24689999876432  2357889999999999999999999999


Q ss_pred             ecCceEEEEEeccCCChhhhhccccCC------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC
Q 006922          390 SKDEKLMVYDYYSLGSVSAMLHSERGE------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ  463 (625)
Q Consensus       390 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~  463 (625)
                      ..+..++||||+++++|.+++......      ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCC
Confidence            999999999999999999999765422      1225899999999999999999999987   9999999999999999


Q ss_pred             CCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCcchhhHH
Q 006922          464 QYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT--GKSPIHTTGGDELVHLV  536 (625)
Q Consensus       464 ~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~~~~~  536 (625)
                      +.++|+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++  |..||......+   ..
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~  243 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VI  243 (296)
T ss_pred             CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HH
Confidence            999999999987653221     12234567999999988889999999999999999998  778886543322   22


Q ss_pred             HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       537 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ..+....+........       +.......++.+++.+|++.+|++|||+.|+++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            2222211111101000       1111123468889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-36  Score=310.95  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||.||++..      ..+..||+|+++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  119 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE  119 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence            46799999999999973      13458999998764322  35688999999999 79999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++|+|.++++....   ..+++.+...++.|++.||+|||+.+   |+|+||||+||+++.++.++++|||+++....
T Consensus       120 ~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         120 YCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             cCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            9999999999975432   23899999999999999999999987   99999999999999999999999999986543


Q ss_pred             ccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 LAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ...     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..  ...    .......    
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~~~~----  263 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEGYRM----  263 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcCCcC----
Confidence            211     1234556999999988889999999999999999998 99999765432221  111    1111000    


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                            ........++.+++.+|+..+|++||++.|+++.|++.
T Consensus       264 ------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 ------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  00011124677888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=326.40  Aligned_cols=241  Identities=20%  Similarity=0.288  Sum_probs=187.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++.. .+|+.||||++.....    ..+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg   86 (377)
T cd05629           7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG   86 (377)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence            5699999999999985 4789999999875421    1245788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        87 ~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          87 DLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999987542     3788899999999999999999998   999999999999999999999999998632110    


Q ss_pred             ----------------------------------------------ccccccCCCcCCccccCCCCCCCccchhhhHHHH
Q 006922          481 ----------------------------------------------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVL  514 (625)
Q Consensus       481 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil  514 (625)
                                                                    .....||..|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                          0013578889999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHH
Q 006922          515 LEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQR---PKMPDVV  591 (625)
Q Consensus       515 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~ev~  591 (625)
                      |||+||+.||......+....+      ..  +....      ..+.......++.+++.+|+. +|.+|   +++.|++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i------~~--~~~~~------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKI------IN--WRETL------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHH------Hc--cCCcc------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999765432221111      10  00000      011111112345667778887 66665   6999988


Q ss_pred             HH
Q 006922          592 RV  593 (625)
Q Consensus       592 ~~  593 (625)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=285.50  Aligned_cols=253  Identities=21%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~  402 (625)
                      +.||+|||+-||.++ ..++..+|+|++.... .+.+...+|++..++++|||+++++++...+     .+.|+++.|..
T Consensus        27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~  106 (302)
T KOG2345|consen   27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK  106 (302)
T ss_pred             eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence            569999999999999 6789999999998765 4457789999999999999999999987543     35899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      .|+|.+.+.....+ ...+++.+.+.|+.++.+||++||+.. ++.+||||||.|||+.+++.+++.|||.++...-.  
T Consensus       107 ~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~  184 (302)
T KOG2345|consen  107 RGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE  184 (302)
T ss_pred             cccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence            99999998876543 335899999999999999999999985 57999999999999999999999999998765311  


Q ss_pred             --c--------cccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          481 --A--------PVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       481 --~--------~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                        .        ....-|..|+|||.+.-   ...++++|||||||++|+|+.|..||+....              +++.
T Consensus       185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------------~GgS  250 (302)
T KOG2345|consen  185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------------QGGS  250 (302)
T ss_pred             chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------------cCCe
Confidence              0        01123566999999864   4567899999999999999999999964221              1111


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ..-.+...-...|........+.+++..|++.||.+||+..|++..++.+.
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111111111122322234456777888999999999999999999987653

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=324.98  Aligned_cols=240  Identities=19%  Similarity=0.282  Sum_probs=189.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +|+.||||+++....    ....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g   86 (364)
T cd05599           7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG   86 (364)
T ss_pred             EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence            57999999999999954 689999999975421    1245778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus        87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          87 DMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             HHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999987542     3899999999999999999999998   9999999999999999999999999987542110   


Q ss_pred             --------------------------------------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCC
Q 006922          482 --------------------------------------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP  523 (625)
Q Consensus       482 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p  523 (625)
                                                            ....||..|+|||++....++.++|||||||++|||++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                  113578899999999998999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 006922          524 IHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK---MPDVVR  592 (625)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~ev~~  592 (625)
                      |......+..   ..   ....  ....   .........   .++.+++.+|+. +|.+|++   +.|+++
T Consensus       239 f~~~~~~~~~---~~---i~~~--~~~~---~~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQETY---RK---IINW--KETL---QFPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHHHHH---HH---HHcC--CCcc---CCCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9765432221   11   1100  0000   000001112   244566668885 8999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.6e-37  Score=311.16  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=195.6

Q ss_pred             HHHhHcccCCceeEEEEEE-----cCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEE
Q 006922          327 ASAEVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMV  397 (625)
Q Consensus       327 ~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  397 (625)
                      ...+.||+|+||.||++..     .++..||+|.++.....  .+.+.+|+++++.++||||+++.+++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            3456799999999999973     35789999998754322  35789999999999999999999998875  567899


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+++++|.+++....    ..++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+++..
T Consensus        87 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          87 MEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999986532    24899999999999999999999998   999999999999999999999999999865


Q ss_pred             cccc------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc---------hhhHHHHHHHH
Q 006922          478 SALA------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE---------LVHLVRWVHSV  542 (625)
Q Consensus       478 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~---------~~~~~~~~~~~  542 (625)
                      ....      ....++..|+|||.+.+..++.++|||||||++|||+|++.|+.......         .......+. .
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence            4321      12334556999999988889999999999999999999877653321100         000011111 1


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       543 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      .....          ..+........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110          1111122345788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=310.36  Aligned_cols=255  Identities=21%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             HhHcccCCceeEEEEEEcC---------------CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEec
Q 006922          329 AEVLGKGTFGMAYKAILED---------------GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSK  391 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  391 (625)
                      .+.||+|+||.||++....               ...||+|.++....  ....+.+|++++.+++|+|++++++++...
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   89 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD   89 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            3679999999999987532               23589999875422  235688999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhccccCC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 006922          392 DEKLMVYDYYSLGSVSAMLHSERGE-------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ  464 (625)
Q Consensus       392 ~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~  464 (625)
                      +..++||||+++++|.+++......       ....++|..+.+++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~  166 (295)
T cd05097          90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHY  166 (295)
T ss_pred             CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCC
Confidence            9999999999999999998653211       1124789999999999999999999998   99999999999999999


Q ss_pred             CeeEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCcchhhHHH
Q 006922          465 YGCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT--GKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       465 ~~kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~~~~~~  537 (625)
                      .+||+|||++........     ...++..|+|||.+....++.++|||||||++|||++  |..||.....++....  
T Consensus       167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~--  244 (295)
T cd05097         167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN--  244 (295)
T ss_pred             cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH--
Confidence            999999999976532211     1123457999999988889999999999999999998  6778876543332221  


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                       ..............    ...+   .....+.+++.+||+.+|++||++++|++.|++
T Consensus       245 -~~~~~~~~~~~~~~----~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         245 -TGEFFRNQGRQIYL----SQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHhhhhccccccC----CCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             11111111000000    0001   122468889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-36  Score=308.58  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=195.8

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||.||++...      ++..+|+|.++.... ...++.+|++++..++|+||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM   89 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence            367999999999999732      356899998875432 2467999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          402 SLGSVSAMLHSERGE----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      ++++|.+++......          ....+++..+..++.|++.|++|||+.+   |+||||||+|||+++++.+||+||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~df  166 (280)
T cd05092          90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDF  166 (280)
T ss_pred             CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCC
Confidence            999999998764321          1124889999999999999999999988   999999999999999999999999


Q ss_pred             cccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhc
Q 006922          472 GLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVRE  545 (625)
Q Consensus       472 Gla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  545 (625)
                      |+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.....      ...
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------~~~  240 (280)
T cd05092         167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI------TQG  240 (280)
T ss_pred             CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH------HcC
Confidence            9987653221     11223567999999998899999999999999999999 99999654432222111      111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      ..   .        .........+.+++.+||+.+|.+||++.||++.|+.
T Consensus       241 ~~---~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         241 RE---L--------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cc---C--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            00   0        0011122456788889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-36  Score=311.42  Aligned_cols=248  Identities=23%  Similarity=0.382  Sum_probs=195.2

Q ss_pred             HhHcccCCceeEEEEEE-cCCc----EEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGT----TVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||.||+|.. .+|.    .||+|.+......  ..++.+|+.++..++||||++++++|... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            46799999999999985 3444    5788988754322  24688999999999999999999998754 467999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        91 ~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          91 PHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcc
Confidence            99999999875432    4789999999999999999999987   9999999999999999999999999998654322


Q ss_pred             c-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 P-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      .     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   .    ...        
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~---~----~~~--------  228 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---E----KGE--------  228 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----CCC--------
Confidence            1     1223557999999998899999999999999999998 99999754322222211   1    110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                        ..+.......++.+++..||..+|++||++.|+++.|+++....
T Consensus       229 --~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         229 --RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence              00111112346778899999999999999999999999875543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-36  Score=309.32  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=196.5

Q ss_pred             HhHcccCCceeEEEEEEc-----------------CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-----------------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYY  389 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  389 (625)
                      .+.||+|+||+||++...                 ++..||+|+++....  ...++.+|++++.+++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            356999999999998532                 244689999975432  2357899999999999999999999999


Q ss_pred             ecCceEEEEEeccCCChhhhhccccCC------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC
Q 006922          390 SKDEKLMVYDYYSLGSVSAMLHSERGE------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ  463 (625)
Q Consensus       390 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~  463 (625)
                      ..+..++||||+++|+|.+++......      ....+++.++..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCC
Confidence            999999999999999999998764321      1234788999999999999999999998   9999999999999999


Q ss_pred             CCeeEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCcchhhHH
Q 006922          464 QYGCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT--GKSPIHTTGGDELVHLV  536 (625)
Q Consensus       464 ~~~kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~~~~~  536 (625)
                      +.++|+|||+++.......     ....+..|+|||......++.++|||||||++|||++  |..||......+...  
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~--  244 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE--  244 (296)
T ss_pred             CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH--
Confidence            9999999999986533211     1122456999999888889999999999999999998  778887654333221  


Q ss_pred             HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       537 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                       ............. .      .+....+...+.+++.+||+.+|.+||++.||++.|++
T Consensus       245 -~~~~~~~~~~~~~-~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         245 -NTGEFFRDQGRQV-Y------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHhhccccc-c------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             1111111111000 0      01111223567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7e-37  Score=325.33  Aligned_cols=192  Identities=26%  Similarity=0.339  Sum_probs=166.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+++.||+|++.....    ....+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (382)
T cd05625           7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG   86 (382)
T ss_pred             EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence            5699999999999995 4688999999975422    1246788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----  479 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-----  479 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....     
T Consensus        87 ~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          87 DMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999987542     3788889999999999999999998   99999999999999999999999999753210     


Q ss_pred             ---------------------------------------------cccccccCCCcCCccccCCCCCCCccchhhhHHHH
Q 006922          480 ---------------------------------------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVL  514 (625)
Q Consensus       480 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil  514 (625)
                                                                   ......||..|+|||++.+..++.++||||+||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                         00123578889999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCC
Q 006922          515 LEILTGKSPIHTTGG  529 (625)
Q Consensus       515 ~elltG~~p~~~~~~  529 (625)
                      |||++|+.||.....
T Consensus       239 ~elltG~~Pf~~~~~  253 (382)
T cd05625         239 YEMLVGQPPFLAQTP  253 (382)
T ss_pred             HHHHhCCCCCCCCCH
Confidence            999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-36  Score=308.08  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=195.9

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|...      .+..||+|.++.....  ...+.+|+.++..++||||+++++++...+..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            467999999999999743      2458999988754322  24578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCC-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +++|+|.+++......     .....++..+.+++.|++.||+|||+.+   |+||||||+||++++++.++|+|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccc
Confidence            9999999999754321     1234678889999999999999999987   9999999999999999999999999988


Q ss_pred             ccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      .......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..+   .   ....+.  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~---~---~~~~~~--  239 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK---F---VMDGGY--  239 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H---HHcCCC--
Confidence            6532211     1123456999999988889999999999999999999 888997644322211   1   111110  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                             .  +........+.+++.+|++.+|++|||+.|+++.|++.
T Consensus       240 -------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         240 -------L--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -------C--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                   0  01112234678888999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=315.29  Aligned_cols=239  Identities=24%  Similarity=0.402  Sum_probs=196.3

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||-|+ ..+...||||++.....    .-.++..|+..|.+++|||+|.+.|+|......++|||||-|
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG  110 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG  110 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence            4669999999999999 45788999999975422    126799999999999999999999999999999999999965


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                       +..+++.-.+.    ++.+..+..|+.+.+.||+|||+.+   .||||||+.|||+++.|.+|++|||.|....+. ..
T Consensus       111 -SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-ns  181 (948)
T KOG0577|consen  111 -SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-NS  181 (948)
T ss_pred             -cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-hc
Confidence             77777765543    5889999999999999999999998   999999999999999999999999999887654 45


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .+||+.|||||++.   .+.|+-|+||||+|++..||...++|+..++.......+.      ..+       +-...  
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA------QNe-------sPtLq--  246 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE-------SPTLQ--  246 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH------hcC-------CCCCC--
Confidence            68999999999874   6789999999999999999999999997765432222111      010       00111  


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ..+....+..++..|+++-|.+|||.+++++
T Consensus       247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             2344556777777999999999999998764

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-36  Score=316.30  Aligned_cols=254  Identities=28%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             HHhHcccCCceeEEEEEE------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEec-CceEEE
Q 006922          328 SAEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSK-DEKLMV  397 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv  397 (625)
                      ..+.||+|+||+||+|..      .+++.||||+++.....  ...+.+|++++.++ +||||+++++++... ...++|
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence            456799999999999973      34789999999754322  34678999999999 689999999988764 467899


Q ss_pred             EEeccCCChhhhhccccCC-------------------------------------------------------------
Q 006922          398 YDYYSLGSVSAMLHSERGE-------------------------------------------------------------  416 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~-------------------------------------------------------------  416 (625)
                      |||+++|+|.+++......                                                             
T Consensus        91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T cd05103          91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED  170 (343)
T ss_pred             EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence            9999999999998653210                                                             


Q ss_pred             -CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-----ccccCCCc
Q 006922          417 -GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAGY  490 (625)
Q Consensus       417 -~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~y  490 (625)
                       ....++|.++.+++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.......     ...++..|
T Consensus       171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         171 LYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence             0123788899999999999999999987   99999999999999999999999999986532211     12234569


Q ss_pred             CCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHH
Q 006922          491 RAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEM  569 (625)
Q Consensus       491 ~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  569 (625)
                      +|||.+.+..++.++||||||+++|||++ |..||......+.  ...    .+..+...        ..+  .....++
T Consensus       248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~--------~~~--~~~~~~~  311 (343)
T cd05103         248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRM--------RAP--DYTTPEM  311 (343)
T ss_pred             ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCC--------CCC--CCCCHHH
Confidence            99999988899999999999999999997 9999975432211  111    11111100        001  0112357


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          570 LQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       570 ~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .+++..||+.+|++||++.||++.|+.+.+.
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            8889999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-36  Score=297.01  Aligned_cols=250  Identities=19%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEEcC-CcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEecCc
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYSKDE  393 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  393 (625)
                      +.++.+.  ..+.||+|.-|+||.+++.+ +..+|+|++.+.....    ...+.|-+||+.++||.+++|++.++.++.
T Consensus        74 l~l~~f~--llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   74 LGLRHFR--LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             cCHHHHH--HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            4455542  35779999999999999764 5899999998754332    456788899999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      .++|||||+||+|..+++++.+.   -++...+..++..++-||+|||-.+   ||.|||||+||||.++|++.|+||.+
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccc
Confidence            99999999999999999876543   4888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccc----------------------------------c-c------------------------ccccccCCCcCCcc
Q 006922          474 TTITS----------------------------------A-L------------------------APVIARAAGYRAPE  494 (625)
Q Consensus       474 a~~~~----------------------------------~-~------------------------~~~~~~~~~y~aPE  494 (625)
                      +....                                  . .                        ....+||-.|+|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            74320                                  0 0                        00123566699999


Q ss_pred             ccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHH
Q 006922          495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAM  574 (625)
Q Consensus       495 ~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  574 (625)
                      ++.+...+.++|+|+|||++|||+.|+.||.+.+.+++...+-      ..       +.   .+|...+....+.++++
T Consensus       306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv------~~-------~l---~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV------GQ-------PL---KFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh------cC-------CC---cCCCCCcchhHHHHHHH
Confidence            9999999999999999999999999999999887766543221      11       11   22323344456677788


Q ss_pred             HccCCCCCCCCC----HHHHHH
Q 006922          575 SCVVRMPDQRPK----MPDVVR  592 (625)
Q Consensus       575 ~Cl~~~P~~RPs----~~ev~~  592 (625)
                      ..+.+||.+|--    +.||-+
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHhccChhhhhccccchHHhhc
Confidence            999999999998    666653

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-36  Score=308.12  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=200.0

Q ss_pred             HhHcccCCceeEEEEEEc-----CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-----DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  399 (625)
                      .+.||+|+||.||++...     .+..+|+|+++.....  .+.+.+|++++..++|+||+++++++..  ....++|||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            367999999999999853     3689999999876553  5679999999999999999999999887  557899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++.....    .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            9999999999976532    3899999999999999999999987   99999999999999999999999999987652


Q ss_pred             ccc------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHHhhc
Q 006922          480 LAP------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWVHSVVRE  545 (625)
Q Consensus       480 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~  545 (625)
                      ...      ...++..|+|||.+.+..++.++||||||+++|||+||+.|+.........        .........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            211      112344599999998888999999999999999999999998654322110        001111111111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .          ...+.......++.+++.+||+.+|++||++.||+++|+.++
T Consensus       242 ~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         242 G----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             C----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1          011111223356888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-36  Score=321.74  Aligned_cols=241  Identities=18%  Similarity=0.248  Sum_probs=187.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++... +++.+|+|++.+..    ...+.+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus        49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg  128 (370)
T cd05621          49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG  128 (370)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence            56999999999999965 58899999997532    12345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......   
T Consensus       129 ~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         129 DLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            999998643      2788889999999999999999998   9999999999999999999999999998764321   


Q ss_pred             -cccccCCCcCCccccCCC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 -PVIARAAGYRAPEVTDSR----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                       ....||..|+|||++.+.    .++.++||||+||++|||++|+.||......+...      ........        
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~~~--------  265 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHKNS--------  265 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCcc--------
Confidence             234688999999998654    37889999999999999999999997644322111      11111000        


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPD--QRPKMPDVVRV  593 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPs~~ev~~~  593 (625)
                      ...+........+.+++..|+..++.  .||++.|+++.
T Consensus       266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            01111111223455666688875554  38999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-37  Score=326.14  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=187.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++. .+++.||+|++.....    ....+.+|++++.+++||||+++++.+.+.+..++||||+++|
T Consensus         7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g   86 (376)
T cd05598           7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG   86 (376)
T ss_pred             EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence            5699999999999995 4689999999975321    2356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----  479 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-----  479 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....     
T Consensus        87 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          87 DMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999997542     3788888999999999999999998   99999999999999999999999999752210     


Q ss_pred             -----------------------------------------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHH
Q 006922          480 -----------------------------------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEIL  518 (625)
Q Consensus       480 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ell  518 (625)
                                                               ......||..|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                     001235888999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 006922          519 TGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP---KMPDVVRV  593 (625)
Q Consensus       519 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---s~~ev~~~  593 (625)
                      +|+.||......+....+.      .  +....   .........   .++.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~------~--~~~~~---~~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQLKVI------N--WETTL---HIPSQAKLS---REASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHh------c--cCccc---cCCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999997654333221110      0  00000   000011112   23445555655 5999999   88888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-36  Score=312.06  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             HHhHcccCCceeEEEEEEc--------CCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEE
Q 006922          328 SAEVLGKGTFGMAYKAILE--------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  396 (625)
                      ..+.||+|+||.||++...        .+..+|+|.++.....  ..++.+|++++.++ +||||+++++++...+..++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            3567999999999999742        2457999998754322  35678899999999 69999999999999899999


Q ss_pred             EEEeccCCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          397 VYDYYSLGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      ||||+++|+|.+++.....           .....++|.+..+++.|++.||+|||+.+   |+||||||+||+++.++.
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~  172 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV  172 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence            9999999999999976431           11234899999999999999999999987   999999999999999999


Q ss_pred             eeEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 006922          466 GCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       466 ~kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  539 (625)
                      +||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---  249 (314)
T cd05099         173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL---  249 (314)
T ss_pred             EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence            99999999986543211     1123346999999988889999999999999999999 89999665433322211   


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                          ......          ........++.+++.+|+..+|++||++.|+++.|+++...
T Consensus       250 ----~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         250 ----REGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ----HcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                111100          00112233667888899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.7e-36  Score=305.08  Aligned_cols=250  Identities=21%  Similarity=0.355  Sum_probs=199.1

Q ss_pred             HHhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          328 SAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ..+.||+|+||+||++.. .+|+.||+|++.....  ..+.+.+|++++..++||||+++++++...+..++||||++++
T Consensus         9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (284)
T cd06620           9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG   88 (284)
T ss_pred             HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence            457899999999999995 4689999998865432  2467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-cccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-LAPV  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~  483 (625)
                      +|.+++....     ++++.....++.+++.||.|||+..  +|+||||||+||++++++.++|+|||++..... ....
T Consensus        89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~  161 (284)
T cd06620          89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT  161 (284)
T ss_pred             CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence            9999887532     4899999999999999999999742  399999999999999999999999999876532 2233


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-----chhhHHHHHHHHhhcccccccccccccC
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD-----ELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ..++..|+|||++.+..++.++|||||||++||++||+.||......     ......++......+..         ..
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  232 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---------PR  232 (284)
T ss_pred             cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---------CC
Confidence            46788899999998888999999999999999999999999764432     11112222222222110         01


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      .+ ..+...++.+++.+|++.||++||++.|+++..
T Consensus       233 ~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            01 112334677888899999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.8e-36  Score=305.70  Aligned_cols=245  Identities=20%  Similarity=0.301  Sum_probs=192.8

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L   93 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL   93 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence            46799999999999995 5789999999975432 335678899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .++++...     .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||+++......   ..
T Consensus        94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            99886432     4889999999999999999999987   9999999999999999999999999998654221   22


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+.....      ....    ...+   ...
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~~~~----~~~~---~~~  232 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------SKSN----FQPP---KLK  232 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------ecCC----CCCC---CCc
Confidence            35677899999874   345788999999999999999999999654322111000      0000    0000   001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      ........+.+++.+||..+|++||+++++++.|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1112234677888899999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-36  Score=304.99  Aligned_cols=242  Identities=19%  Similarity=0.338  Sum_probs=190.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+++.||+|++.....  ..+.+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l   86 (279)
T cd06619           7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL   86 (279)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence            5799999999999984 5789999999865422  235688999999999999999999999999999999999999998


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVIA  485 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~~~  485 (625)
                      ..+.         .+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++...... .....
T Consensus        87 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          87 DVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             HHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            6542         2678889999999999999999998   999999999999999999999999999765432 23346


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. .............      ....   + ...
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~-~~~  224 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL---P-VGQ  224 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC---C-CCc
Confidence            788899999999889999999999999999999999999753322111 1111111110000      0000   0 011


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ...++.+++.+|++.+|++||+++|+++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            22356788889999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-36  Score=304.15  Aligned_cols=242  Identities=20%  Similarity=0.355  Sum_probs=191.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEec------CceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSK------DEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|... +++.||+|++.........+.+|+.++.++ +|+||+++++++...      ...++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            467999999999999954 688999999987655567789999999998 699999999998753      357899999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++....   ...++|..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus        91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            99999999987643   234889999999999999999999987   999999999999999999999999998765322


Q ss_pred             ---ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 ---APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                         .....++..|+|||++.     ...++.++|||||||++|||++|+.||..........      . .......   
T Consensus       165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~-~~~~~~~---  234 (272)
T cd06637         165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRNPAP---  234 (272)
T ss_pred             cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------H-HhcCCCC---
Confidence               22345778899999985     3467889999999999999999999996533211110      0 0000000   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ...    ......++.+++.+||..+|.+|||+.|+++
T Consensus       235 --~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         235 --RLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --CCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              000    1112345778888999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-35  Score=299.95  Aligned_cols=251  Identities=22%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||+|... +|+.||+|.++....    ..+.+.+|++++++++|+|++++++++...+..++||||++++
T Consensus         8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (267)
T cd08224           8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG   87 (267)
T ss_pred             eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence            56999999999999965 799999999874321    2457889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|..++..... ....+++.++..++.++++||+|||+.+   |+||||+|+||+++.++.++|+|||++.......   
T Consensus        88 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  163 (267)
T cd08224          88 DLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence            99998865432 2335899999999999999999999987   9999999999999999999999999987654321   


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+   ... .+.    .    ...+ 
T Consensus       164 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~---~~~-~~~----~----~~~~-  229 (267)
T cd08224         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCK---KIE-KCD----Y----PPLP-  229 (267)
T ss_pred             ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHh---hhh-cCC----C----CCCC-
Confidence            223567789999999888899999999999999999999999964321 1111111   111 100    0    0001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .......+.+++.+||..+|++||++.+|++.|+++.
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1133446778889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-36  Score=304.94  Aligned_cols=248  Identities=21%  Similarity=0.372  Sum_probs=196.9

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|...+    ...||+|.......  ..+.+.+|+.++.+++||||+++++++.+ +..++||||++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            4679999999999998543    34689998875432  23578899999999999999999999875 55789999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++.....    .+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        90 ~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          90 LGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             CCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            9999999975432    3899999999999999999999987   99999999999999999999999999986543211


Q ss_pred             ----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                          ...++..|+|||.+....++.++||||||+++||+++ |+.||......+..   .++.   ....          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~---~~~~----------  226 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIE---NGER----------  226 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH---cCCc----------
Confidence                1123356999999988889999999999999999997 99999765433222   1111   1110          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                       .+.......++.+++.+|+..+|.+|||+.++++.|+++..+.
T Consensus       227 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         227 -LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence             0111122346778888999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=301.97  Aligned_cols=241  Identities=19%  Similarity=0.291  Sum_probs=193.2

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|++|.||++.. .+++.||+|.+......      .+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            46799999999999985 46899999998754221      246788999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++++|.+++....     .+++..+.+++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||+++......
T Consensus        87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            9999999887543     3788999999999999999999998   9999999999999999999999999987653321


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                            ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+..   ..   .......       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~---~~~~~~~-------  225 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FK---IATQPTN-------  225 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HH---HhccCCC-------
Confidence                  1234567799999999888999999999999999999999999754322111   11   1111000       


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                         ..........+.+++.+||..+|.+||++.|+++.
T Consensus       226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               01111223456778889999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.6e-36  Score=303.93  Aligned_cols=238  Identities=19%  Similarity=0.331  Sum_probs=193.9

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||.||+|... ++..||+|.++....  ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence            467999999999999854 588999999875432  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++...      .+++..+..++.|+++|++|||+.+   ++|+||+|+||++++++.++++|||++.......   .
T Consensus        89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          89 ALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            99988642      3889999999999999999999987   9999999999999999999999999997654322   1


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||......+....       +....     .+     ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~~-----~~-----~~~  222 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------IPKNS-----PP-----TLE  222 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-------hhcCC-----CC-----CCC
Confidence            23467789999999988899999999999999999999999975433221110       01100     00     011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+|++.+|.+||++.|+++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            123346778888999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4e-36  Score=306.45  Aligned_cols=243  Identities=24%  Similarity=0.295  Sum_probs=192.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++.. .+++.||+|.+......    ...+.+|++++..++|+||+.+.+++..++..++||||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            5699999999999985 46899999999764322    234778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          86 DLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            9998886432   224899999999999999999999988   9999999999999999999999999987654322  2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++|+|||||++|||++|+.||......+....+.   .......  ..      .   .
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~~~--~~------~---~  225 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLETE--EV------Y---S  225 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhccc--cc------c---C
Confidence            3457888999999988899999999999999999999999997644322221111   1111110  00      0   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ......+.+++..|++.+|++||+     +.|++.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            112235667888999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.1e-36  Score=307.27  Aligned_cols=243  Identities=22%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|.+......    .+.+.+|+.++.+++|+|++.+++.+...+..++||||++++
T Consensus         6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~   85 (285)
T cd05630           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence            56999999999999954 6899999998754322    234678999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      +|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          86 DLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             cHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            99998864321   24889999999999999999999987   9999999999999999999999999987654322  2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||.....................         .     ..
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~-----~~  225 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE---------E-----YS  225 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---------h-----cC
Confidence            246788899999999889999999999999999999999999764322111111110000000         0     00


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      .....++.+++.+||+.||++|||     +.|+++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            112235667888999999999999     778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-36  Score=337.25  Aligned_cols=253  Identities=20%  Similarity=0.251  Sum_probs=198.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||+|... +|+.||+|+++....    ..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus         8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG   87 (932)
T PRK13184          8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY   87 (932)
T ss_pred             EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence            57999999999999954 689999999975422    1356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccC------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          405 SVSAMLHSERG------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       405 ~L~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      +|.+++.....      .....+++..+.+++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~  164 (932)
T PRK13184         88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKK  164 (932)
T ss_pred             CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecc
Confidence            99998865321      11234678888999999999999999997   9999999999999999999999999997652


Q ss_pred             cc---------------------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 006922          479 AL---------------------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       479 ~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~  537 (625)
                      ..                     .....||..|+|||.+.+..++.++|||||||++|||+||+.||......+....  
T Consensus       165 ~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--  242 (932)
T PRK13184        165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--  242 (932)
T ss_pred             cccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--
Confidence            10                     0123578899999999999999999999999999999999999976433221110  


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCC
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP-KMPDVVRVIENVRPN  600 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~ev~~~L~~~~~~  600 (625)
                        ..         ..++...  ....+....+.+++.+|+..||++|| +++++.+.|+.....
T Consensus       243 --~~---------i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        243 --DV---------ILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             --hh---------ccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence              00         0000000  00112234567888899999999995 678888888877554

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.1e-36  Score=299.60  Aligned_cols=241  Identities=22%  Similarity=0.391  Sum_probs=196.3

Q ss_pred             HhHcccCCceeEEEEEEcC-CcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||.||+|...+ ++.+++|.++.... .+++.+|++++++++||||+++++++......++++||+++++|.
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   86 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS   86 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence            4569999999999999664 88999999976433 678999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~  484 (625)
                      +++....    ..++|..+..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++.......   ...
T Consensus        87 ~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          87 DIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            9986533    24899999999999999999999987   9999999999999999999999999988764322   233


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+       .....        ........
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~--------~~~~~~~~  224 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNKPP--------PTLSDPEK  224 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccCCC--------CCCCchhh
Confidence            4677899999999889999999999999999999999999754322111100       00000        00111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+++.+|++.+|++|||+.|+++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2346778888999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.9e-36  Score=307.48  Aligned_cols=239  Identities=18%  Similarity=0.316  Sum_probs=193.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus        26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~  105 (296)
T cd06654          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (296)
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence            5699999999999984 4689999999876433 3466889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~  484 (625)
                      +++...      .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ...
T Consensus       106 ~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            998643      3789999999999999999999998   9999999999999999999999999987654321   223


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+..  ..    ..... ..        ..+....
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~----~~~~~-~~--------~~~~~~~  241 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL----IATNG-TP--------ELQNPEK  241 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH----HhcCC-CC--------CCCCccc
Confidence            5677899999998888999999999999999999999999754321111  11    00000 00        0011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+||..+|++||++.|+++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            3345778888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.9e-37  Score=328.90  Aligned_cols=263  Identities=18%  Similarity=0.254  Sum_probs=187.9

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEec--------CceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK--------DEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv~e  399 (625)
                      .+.||+|+||+||+|... +++.||||++...   .....+|+.+++.++|||||++++++...        ...++|||
T Consensus        71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE  147 (440)
T PTZ00036         71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME  147 (440)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence            357999999999999964 6899999988643   23456799999999999999999987532        13568999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITS  478 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~  478 (625)
                      |+++ ++.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+|+...
T Consensus       148 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        148 FIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             cCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            9985 67666654321 2235889999999999999999999998   99999999999999665 69999999998764


Q ss_pred             cc--ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc----cc
Q 006922          479 AL--APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA----EV  551 (625)
Q Consensus       479 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  551 (625)
                      ..  .....++..|+|||++.+ ..++.++|||||||++|||++|++||.+....+....+..+......+...    ..
T Consensus       223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~  302 (440)
T PTZ00036        223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY  302 (440)
T ss_pred             CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence            32  223467888999998765 468999999999999999999999997654332221111100000000000    00


Q ss_pred             ccccccCCC-------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006922          552 FDVELLRYP-------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRP  599 (625)
Q Consensus       552 ~d~~~~~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~  599 (625)
                      .+.......       .......++.+++.+||+.+|.+|||+.|+++  .++.++.
T Consensus       303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            000000000       00112246778888999999999999999984  4555543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-36  Score=303.75  Aligned_cols=246  Identities=21%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCc----EEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE-DGT----TVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|... +|.    .+|+|.++.....  ...+.+|+.++.+++||||+++++++.. ...++||||+
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   90 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM   90 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence            467999999999999854 343    6899988765432  3568899999999999999999999987 7889999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.+++.....    .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        91 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          91 PLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999999976432    3899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cc-----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 PV-----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ..     ...+..|+|||.+....++.++||||||+++||+++ |+.||......+....+.      ...         
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------~~~---------  228 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGE---------  228 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh------CCC---------
Confidence            11     112456999999988889999999999999999999 999997654333222111      100         


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                        ..+.......++.+++.+||..+|.+||++.++++.|+++..
T Consensus       229 --~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 --RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              001111123467788889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-36  Score=312.11  Aligned_cols=255  Identities=16%  Similarity=0.265  Sum_probs=191.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|... +++.||+|+++....  ....+.+|++++.+++||||+++++++...+..++||||+++ +|
T Consensus        12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l   90 (309)
T cd07872          12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DL   90 (309)
T ss_pred             EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CH
Confidence            56999999999999854 688999999975432  234678899999999999999999999999999999999985 78


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ...
T Consensus        91 ~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          91 KQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            87776542    23788999999999999999999987   999999999999999999999999998764322   122


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc------cccccc
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE------VFDVEL  556 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~d~~~  556 (625)
                      ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+....+.........+....      ..+...
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            356778999998754 5688999999999999999999999976554333222221110000000000      000000


Q ss_pred             cCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          557 LRYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       557 ~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....      .......++.+++.+|++.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000      00011235667888999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-37  Score=289.03  Aligned_cols=242  Identities=21%  Similarity=0.356  Sum_probs=196.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---------hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---------KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .++||+|..++|.++.+ ..|...|+|++......         .+.-.+|+.||+++ .||+|+.+.++|+.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            46799999999998874 57899999999643211         13456799999998 699999999999999999999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +|.|+.|.|.++|...-     .+++....+|+.|+.+|+.|||..+   ||||||||+|||+|++.++||+|||+|..+
T Consensus       102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999998643     4899999999999999999999998   999999999999999999999999999988


Q ss_pred             cccc--cccccCCCcCCccccCC------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SALA--PVIARAAGYRAPEVTDS------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ....  ...+||+||+|||.+..      ..|+..+|+||+|||||.|+.|.+||....   ..   -.++....+.   
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Qm---lMLR~ImeGk---  244 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QM---LMLRMIMEGK---  244 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HH---HHHHHHHhcc---
Confidence            6543  45789999999998853      468889999999999999999999996431   11   1122222211   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        +..   +.|...+...+.-+++.+|++.||.+|.|..|++.
T Consensus       245 --yqF---~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 --YQF---RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --ccc---CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence              111   12333444455667788999999999999999985

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.9e-36  Score=300.27  Aligned_cols=242  Identities=24%  Similarity=0.407  Sum_probs=193.7

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||.||++.. .++.||+|.++.. .....+.+|+.++.+++|||++++++++... ..++||||+++++|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~   87 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVN   87 (254)
T ss_pred             eeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHH
Confidence            46799999999999975 5788999998653 2346788999999999999999999998654 5799999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccCC
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA  488 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  488 (625)
                      ++....   ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++............+.
T Consensus        88 ~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (254)
T cd05083          88 FLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV  161 (254)
T ss_pred             HHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCc
Confidence            987543   224789999999999999999999987   99999999999999999999999999876543322233445


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMV  567 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  567 (625)
                      .|+|||.+.+..++.++|||||||++|||++ |+.||......+.....       ......          +.......
T Consensus       162 ~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~----------~~~~~~~~  224 (254)
T cd05083         162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGYRM----------EPPEGCPA  224 (254)
T ss_pred             eecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCCCC----------CCCCcCCH
Confidence            6999999988889999999999999999998 99999765432221111       111100          01112234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          568 EMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       568 ~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .+.+++.+||+.+|++||++.++++.|++
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            66788889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-36  Score=317.52  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=190.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC-----ceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  399 (625)
                      .+.||+|+||+||++.. .+|+.||+|++.....   ..+.+.+|+++++.++||||+++++++...+     ..++|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            36799999999999995 4799999999875422   2356889999999999999999999998776     7899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+. ++|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            997 57777775432     4899999999999999999999998   99999999999999999999999999986532


Q ss_pred             cc----cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc----
Q 006922          480 LA----PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE----  550 (625)
Q Consensus       480 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  550 (625)
                      ..    ....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.   .........+    
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEAMRSA  232 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHHHHHh
Confidence            21    123467789999998764 57899999999999999999999997654332222111   1000000000    


Q ss_pred             ------cccccccCCC-------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          551 ------VFDVELLRYP-------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       551 ------~~d~~~~~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                            .+.......+       .......++.+++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  0000000000       001113457788889999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-35  Score=308.28  Aligned_cols=194  Identities=22%  Similarity=0.403  Sum_probs=159.1

Q ss_pred             hHcccCCceeEEEEEEc---CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE---DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  404 (625)
                      ..||+|+||+||+|...   +++.||+|.++.... ...+.+|++++.+++||||+++++++..  ....++||||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            46999999999999854   467899999975432 3567889999999999999999998865  3467899999865 


Q ss_pred             ChhhhhccccC----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCCeeEeccccccc
Q 006922          405 SVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL----NSQQYGCVSDLGLTTI  476 (625)
Q Consensus       405 ~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla~~  476 (625)
                      +|.+++.....    .....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            78777654321    11234889999999999999999999998   9999999999999    4567899999999987


Q ss_pred             cccc------ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          477 TSAL------APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       477 ~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      ....      .....+|..|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            5432      123457888999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-35  Score=301.87  Aligned_cols=243  Identities=21%  Similarity=0.337  Sum_probs=191.5

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++++..++||||+++++++...+..++||||+++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            4577999999999999965 578889999865432 23568889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |..++....    .++++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++......   ..
T Consensus        89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            998876432    24899999999999999999999987   999999999999999999999999998765322   12


Q ss_pred             ccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 VIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ...++..|+|||++.     ...++.++|||||||++|||++|+.||......+.  ...    .......      .. 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~~~~~------~~-  228 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAKSEPP------TL-  228 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----HhhcCCC------CC-
Confidence            345778899999874     34577899999999999999999999975432211  111    1111100      00 


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ........++.+++.+||+.+|.+||++.++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              001112235677888999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=309.74  Aligned_cols=240  Identities=22%  Similarity=0.354  Sum_probs=201.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|.||+||++..+ +|+.+|+|.+.+...    +...+.+|+++|+++. |||||.+.++|++.+..++|||++.|
T Consensus        41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G  120 (382)
T KOG0032|consen   41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG  120 (382)
T ss_pred             hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence            67999999999999965 599999999987543    2368999999999998 99999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CCeeEecccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ----QYGCVSDLGLTTITSA  479 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~~~~~  479 (625)
                      |.|.+.+...      .+++..+..++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++|||++.....
T Consensus       121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            9999999865      1889999999999999999999988   9999999999999654    4799999999998876


Q ss_pred             --cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          480 --LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       480 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                        .....+||+.|+|||++....|+..+||||.||++|.|++|.+||.+....+....+      ...++     +....
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~~~~-----~f~~~  260 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LRGDF-----DFTSE  260 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------HcCCC-----CCCCC
Confidence              345678999999999999999999999999999999999999999887654444322      11211     22222


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .++...+   .+-+++..++..||..|+|+.++++
T Consensus       261 ~w~~is~---~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  261 PWDDISE---SAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CccccCH---HHHHHHHHhcccCcccCCCHHHHhc
Confidence            2333333   4455666999999999999999998

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.6e-36  Score=300.01  Aligned_cols=241  Identities=22%  Similarity=0.338  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||++... ++..+|+|.++...  ...+.+.+|+.+++.++|+||+++++++...+..++||||+++|+|
T Consensus         6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   85 (255)
T cd08219           6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL   85 (255)
T ss_pred             EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence            56999999999999954 68999999986432  2346788899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++.....   ..+++.....++.|++.||+|||+.+   |+|+||||+||++++++.++++|||.+.......   ..
T Consensus        86 ~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          86 MQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             HHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            998865432   24788999999999999999999988   9999999999999999999999999987664322   23


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||++.+..++.++||||||+++|+|++|+.||........   ...+   . .+...          +...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~---~-~~~~~----------~~~~  222 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKV---C-QGSYK----------PLPS  222 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHH---h-cCCCC----------CCCc
Confidence            4577789999999888899999999999999999999999975432211   1111   1 11000          0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....+.+++.+||+.+|++||++.|++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            123356788889999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-36  Score=302.90  Aligned_cols=244  Identities=25%  Similarity=0.456  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChH---HHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKR---DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||++... +++.+|+|++........   ...+|+.++.+++||||+++++++......++||||+++++
T Consensus         5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~   84 (260)
T PF00069_consen    5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS   84 (260)
T ss_dssp             EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred             EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence            56999999999999965 567899999987654433   23559999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc---ccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~---~~~~~  482 (625)
                      |.+++....     .+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||.+...   .....
T Consensus        85 L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   85 LQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             HHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999998332     4899999999999999999999998   999999999999999999999999999753   22223


Q ss_pred             ccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...++..|+|||++. +..++.++||||+|+++|+|++|+.||......+..........   ...     ....   ..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~~-----~~~~---~~  225 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RPL-----PSSS---QQ  225 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---THH-----HHHT---TS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---ccc-----cccc---cc
Confidence            446777899999998 88899999999999999999999999986522222222211110   000     0000   00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......+.+++..|++.+|++||++.|+++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0011257788888999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.8e-36  Score=313.17  Aligned_cols=232  Identities=20%  Similarity=0.292  Sum_probs=185.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|.. .+|+.||+|+++...    ...+.+..|.+++..+. |++|+.+.+++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~   85 (323)
T cd05615           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG   85 (323)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence            5699999999999995 468999999997532    12245777888888885 57788899999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |+|.+++....     .+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          86 GDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            99999886542     3899999999999999999999998   999999999999999999999999998754221   


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..   ..   ......          ..+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~---i~~~~~----------~~p  221 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---QS---IMEHNV----------SYP  221 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HH---HHhCCC----------CCC
Confidence            22345788999999999889999999999999999999999999765432221   11   111100          001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                        .....++.+++.+|++.+|.+|++.
T Consensus       222 --~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 --KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --ccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1122356778889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-37  Score=318.54  Aligned_cols=240  Identities=21%  Similarity=0.397  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccc---cC--ChHHHHHHHHHHHcCCCCceecceeEEEecCc--eEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDV---NV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE--KLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~~  401 (625)
                      .+||+|+|-+||||... +|..||--.++..   ..  ..+.|..|+.+|..++|||||+++.++.+...  ..+|+|.|
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            56999999999999954 6888886544422   11  22678999999999999999999999988665  77899999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~  480 (625)
                      ..|+|..|+++.+.     ++......|+.||++||.|||++. |||||||||-+||+|+.+ |.+||+|.|+|+.....
T Consensus       126 TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999998764     788899999999999999999985 789999999999999865 89999999999987654


Q ss_pred             c-cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 A-PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      . ..+.||+.|||||... ..|++.+||||||++|+||+|+..||..-..  -.++.+.|-.-++...+..+-|      
T Consensus       200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~d------  270 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKD------  270 (632)
T ss_pred             ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCC------
Confidence            3 3468999999999987 7899999999999999999999999965322  2223333322222222222222      


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                             .++.+|+.+|+.. .++|||+.|+++
T Consensus       271 -------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                   2455677799998 999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.6e-36  Score=307.48  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=193.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||++... ++..+|+|.++....  ...++.+|++++.+++||||+++++++..++..++||||+++++|
T Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L   86 (308)
T cd06615           7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL   86 (308)
T ss_pred             eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence            56999999999999954 688899998875422  135688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVIA  485 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~~~  485 (625)
                      .+++....     .+++..+..++.|+++||+|||+..  +++||||||+||+++.++.+||+|||++...... .....
T Consensus        87 ~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (308)
T cd06615          87 DQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  159 (308)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence            99997542     3889999999999999999999842  3999999999999999999999999998765322 23345


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc-c-----------------
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE-W-----------------  547 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~-----------------  547 (625)
                      ++..|+|||.+.+..++.++|||||||++|||++|+.||...................... .                 
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06615         160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI  239 (308)
T ss_pred             CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence            7788999999988889999999999999999999999996543222111110000000000 0                 


Q ss_pred             ---ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          548 ---TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       548 ---~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                         ............+. .....++.+++.+|+..+|++||++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         240 FELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             HHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000000000000 0123357788999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-36  Score=310.95  Aligned_cols=262  Identities=19%  Similarity=0.275  Sum_probs=192.8

Q ss_pred             HhHcccC--CceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKG--TFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||+|  +|++||++.. .+|+.||+|+++.....   .+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            3579999  7899999985 57899999999764322   2457789999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+........  
T Consensus        83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999865432   23889999999999999999999988   999999999999999999999999865433110  


Q ss_pred             --------ccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh------
Q 006922          481 --------APVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR------  544 (625)
Q Consensus       481 --------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------  544 (625)
                              .....++..|+|||++.+  ..++.++|||||||++|||++|+.||.........  .........      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcccccccc
Confidence                    111234566999999875  46899999999999999999999999754322111  110000000      


Q ss_pred             ----cc----ccccccccccc----------------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          545 ----EE----WTAEVFDVELL----------------RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       545 ----~~----~~~~~~d~~~~----------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                          ++    ......+....                ..+.......++.+++.+|++.||++|||++|+++  .++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                00    00000000000                00011122346778999999999999999999986  344443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-35  Score=300.16  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=185.4

Q ss_pred             HcccCCceeEEEEEEcCC---cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILEDG---TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||+|...++   ..+++|.++....  ..+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985443   3456676654332  24678999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-----c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----L  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-----~  480 (625)
                      |.+++...... ....++.....++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++.....     .
T Consensus        82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999764321 224677778899999999999999987   99999999999999999999999999864321     1


Q ss_pred             ccccccCCCcCCccccCC-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 APVIARAAGYRAPEVTDS-------RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+...      ....+. .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~~-~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKDQ-QVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhhc-ccccC
Confidence            122346678999998743       245789999999999999997 677886543322211      111111 11222


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ++....  ..   ...+.+++..|| .+|++||+++||++.|.
T Consensus       231 ~~~~~~--~~---~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL--PY---SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC--CC---cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222211  11   234566777999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.8e-35  Score=298.85  Aligned_cols=239  Identities=19%  Similarity=0.327  Sum_probs=195.5

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||.|+||.||+|... ++..||+|+++....  ....+.+|++++.+++||||+++++++.+.+..++||||+++++
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence            466999999999999954 588999999875432  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++...      ++++.+...++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            99988643      3788899999999999999999987   9999999999999999999999999997654321   2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++|||||||++|||+||+.||......+.....       ....          .....
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~----------~~~~~  222 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNN----------PPTLT  222 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcCC----------CCCCc
Confidence            234667799999998888999999999999999999999999754432221111       0000          01112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ......+.+++.+||+.+|++||++.|+++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            3345677889999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-35  Score=304.82  Aligned_cols=239  Identities=19%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||.|+||+||+|.. .+|+.||+|.+..... ..+.+.+|+++++.++||||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  104 (296)
T cd06655          25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT  104 (296)
T ss_pred             EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence            4699999999999984 5789999999875433 3466889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~  484 (625)
                      .++...      .+++.++..++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||++.......   ...
T Consensus       105 ~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655         105 DVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence            988643      3899999999999999999999998   9999999999999999999999999987654322   223


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+....   ..   .. ....        ......
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~~-~~~~--------~~~~~~  240 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---TN-GTPE--------LQNPEK  240 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hc-CCcc--------cCCccc
Confidence            567789999999988899999999999999999999999976443221111   10   00 0000        011112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+||..+|.+||++.++++
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            2335677888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-36  Score=315.83  Aligned_cols=251  Identities=20%  Similarity=0.274  Sum_probs=188.8

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEec------CceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  398 (625)
                      .+.||+|+||+||+|.. .+++.||||++.....   ..+.+.+|++++.+++||||+++++++...      ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            46799999999999985 4688999999975422   235577899999999999999999987543      3568999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      |++ +++|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878         100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence            987 67888877532      3899999999999999999999998   9999999999999999999999999998876


Q ss_pred             ccccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccccccc--
Q 006922          479 ALAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVF--  552 (625)
Q Consensus       479 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--  552 (625)
                      .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .+......   +....+.  
T Consensus       170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK---RIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCCHHHHHhcchh
Confidence            55555678889999999876 568899999999999999999999997543222111   11110000   0000000  


Q ss_pred             -----cccccCCCCc------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 -----DVELLRYPNI------EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 -----d~~~~~~~~~------~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           ...+...+..      ......+.+++.+|+..||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000000000      001123568888999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=315.57  Aligned_cols=236  Identities=21%  Similarity=0.271  Sum_probs=182.0

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcC---CCCceecceeEEEecCceEEEEEeccC
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSI---RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ||+|+||+||+|+.. +|+.||+|++......    ...+..|..++...   +||||+.+++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999954 6899999999753221    12344566666555   699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---L  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~  480 (625)
                      |+|..++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....   .
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            99998886532     3889999999999999999999998   99999999999999999999999999875422   1


Q ss_pred             ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .....|+..|+|||++.+. .++.++|||||||++|||++|+.||......+....+      ....       ..... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~-------~~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGK-------VRFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCC-------CCCCC-
Confidence            2234688899999998654 4799999999999999999999999764332221111      1110       00000 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRP----KMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RP----s~~ev~~  592 (625)
                      ..   ...++.+++.+|++.+|.+||    ++.|+++
T Consensus       219 ~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            01   123456777899999999998    4555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.6e-36  Score=317.12  Aligned_cols=242  Identities=18%  Similarity=0.249  Sum_probs=187.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.++..++||||+++++++...+..++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  127 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            357999999999999965 68899999987532    1234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |+|.+++...      .++...+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            9999998653      2778888999999999999999998   999999999999999999999999999876432   


Q ss_pred             -ccccccCCCcCCccccCCC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          481 -APVIARAAGYRAPEVTDSR----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                       .....||..|+|||++...    .++.++|||||||++|||++|+.||...+..+...      ........       
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~-------  265 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMNHKNS-------  265 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHHcCCCc-------
Confidence             1234688899999998654    37899999999999999999999997643221111      11111000       


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQ--RPKMPDVVRV  593 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~ev~~~  593 (625)
                       ...+........+.+++..|+..++.+  ||++.|+++.
T Consensus       266 -~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         266 -LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence             011111122334556677899744433  7889888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.6e-36  Score=318.28  Aligned_cols=193  Identities=22%  Similarity=0.329  Sum_probs=168.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|+++....    ....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (360)
T cd05627           7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG   86 (360)
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence            56999999999999954 689999999975321    2346788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          87 DMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999987543     3889999999999999999999998   999999999999999999999999998754211    


Q ss_pred             ----------------------------------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          481 ----------------------------------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       481 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                                                        .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                              1123578899999999999999999999999999999999999976


Q ss_pred             CCCc
Q 006922          527 TGGD  530 (625)
Q Consensus       527 ~~~~  530 (625)
                      ....
T Consensus       239 ~~~~  242 (360)
T cd05627         239 ETPQ  242 (360)
T ss_pred             CCHH
Confidence            5443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-35  Score=296.10  Aligned_cols=241  Identities=24%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||.|+||.||.++ ..++..+++|.+.....   ..+.+.+|++++++++|+||+++++++.+.+..++||||+++++
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (256)
T cd08221           6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT   85 (256)
T ss_pred             eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence            579999999999998 45689999999875432   23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++....   ...+++..+..++.|+++|++|||+.+   ++|+||+|+||++++++.+||+|||++.......   .
T Consensus        86 L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          86 LYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            999987643   224889999999999999999999987   9999999999999999999999999988664322   2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+..      .........           +..
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~~~~~-----------~~~  222 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIVQGNYT-----------PVV  222 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCCCC-----------CCc
Confidence            345778899999998888899999999999999999999999654322211      111111110           011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....++.+++.+||..+|.+||++.|+++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1223457778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-35  Score=297.94  Aligned_cols=244  Identities=19%  Similarity=0.314  Sum_probs=192.1

Q ss_pred             HHhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.++..++||||+++++++...+..++||||+++++
T Consensus        13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~   92 (267)
T cd06645          13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS   92 (267)
T ss_pred             HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence            456799999999999985 4689999999875432 23567889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |.+++....     .+++.+...++.|++.|++|||+.+   |+|+||||+||+++.++.++|+|||++......   ..
T Consensus        93 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          93 LQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999886542     4889999999999999999999998   999999999999999999999999998765322   12


Q ss_pred             ccccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          483 VIARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ...++..|+|||++.   ...++.++|||||||++|||++|+.||............      ........    .... 
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~~~~~~~----~~~~-  233 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TKSNFQPP----KLKD-  233 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hccCCCCC----cccc-
Confidence            345788899999874   456889999999999999999999998654322211110      00110000    0000 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .......+.+++.+|++.+|++||+++++++
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              0011234667888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-35  Score=298.80  Aligned_cols=241  Identities=22%  Similarity=0.358  Sum_probs=192.3

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC-------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG-------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|...+|+.+|+|.++.....       ...+.+|++++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            3569999999999999888999999998753211       145788999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--  479 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--  479 (625)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....  
T Consensus        85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999996532     3789999999999999999999987   99999999999999999999999999876421  


Q ss_pred             -------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          480 -------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       480 -------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                             ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+..  .....   .....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~~---~~~~~----  227 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FYIGA---HRGLM----  227 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HHhhh---ccCCC----
Confidence                   111234677899999999888999999999999999999999999754322111  11000   00000    


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       +..     ......++.+++.+|+..+|.+||++.|+++
T Consensus       228 -~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 -PRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -CCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000     1112345677888999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=316.93  Aligned_cols=251  Identities=17%  Similarity=0.239  Sum_probs=190.1

Q ss_pred             hHcccCCceeEEEEEEc---CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE---DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||++...   .+..||+|.+...    +...+|++++.+++||||+++++++...+..++|||++. ++|
T Consensus        98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l  172 (392)
T PHA03207         98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDL  172 (392)
T ss_pred             EeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence            56999999999999743   3578999988652    356789999999999999999999999999999999986 588


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-----
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-----  481 (625)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||+++......     
T Consensus       173 ~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        173 FTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence            8887432     24899999999999999999999998   9999999999999999999999999997654321     


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc-----------
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE-----------  550 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  550 (625)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+...........           
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  324 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH  324 (392)
T ss_pred             cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence            234688899999999999999999999999999999999999976543322222211111111100000           


Q ss_pred             c--cccc-ccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          551 V--FDVE-LLRYPNI-----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       551 ~--~d~~-~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .  +... .......     .....++.+++.+|+..||++|||+.|++..
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0  0000 0000000     0012356678889999999999999999864

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-35  Score=311.74  Aligned_cols=183  Identities=26%  Similarity=0.370  Sum_probs=157.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||.||+|... .+..||+|....     .....|+.++.+++||||+++++++...+..++||||+. ++|.
T Consensus        71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~  144 (357)
T PHA03209         71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY  144 (357)
T ss_pred             EEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHH
Confidence            357999999999999965 578899997543     234568999999999999999999999999999999995 5888


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--cccccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIA  485 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--~~~~~~  485 (625)
                      +++....    ..++|..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....  ......
T Consensus       145 ~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        145 TYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence            8876532    24899999999999999999999998   99999999999999999999999999975432  223346


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCC
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI  524 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~  524 (625)
                      |+..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            888999999999999999999999999999999955444

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-35  Score=299.22  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceE
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKL  395 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  395 (625)
                      .+.||+|+||+||+|...    .++.||+|+++.....   .+++.+|++++++++||||+++++++....      ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            357999999999999853    3688999999764322   356889999999999999999999886532      237


Q ss_pred             EEEEeccCCChhhhhccccC-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERG-EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      +++||+++|+|..++..... .....+++....+++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccccc
Confidence            88999999999888754321 12234789999999999999999999987   999999999999999999999999999


Q ss_pred             ccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +......     ....++..|++||.+....++.++||||||+++|||++ |+.||......+.   ..+..   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~---~~~~~  234 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI---KGNRL  234 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH---cCCcC
Confidence            8653221     11223456999999988889999999999999999999 8999875433221   11111   11100


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                                 .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       235 -----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         235 -----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       00112234788899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-35  Score=300.46  Aligned_cols=247  Identities=20%  Similarity=0.350  Sum_probs=193.9

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ..+.||+|+||.||++... +|..||+|.++.....  ...+.+|++++.+++||||+++++++...+..++||||++++
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (286)
T cd06622           5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG   84 (286)
T ss_pred             hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence            3467999999999999965 7899999998753222  356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-cccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-LAPV  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~  483 (625)
                      +|..++.....  ...+++..+..++.+++.||.|||+..  +|+||||||+||+++.++.++|+|||++..... ....
T Consensus        85 ~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (286)
T cd06622          85 SLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT  160 (286)
T ss_pred             CHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence            99998875421  224899999999999999999999742  399999999999999999999999999876532 2223


Q ss_pred             cccCCCcCCccccCCC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          484 IARAAGYRAPEVTDSR------KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ..++..|+|||.+.+.      .++.++|||||||++|||++|+.||.............   ......         ..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~---------~~  228 (286)
T cd06622         161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGD---------PP  228 (286)
T ss_pred             CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HHhhcC---------CC
Confidence            4567789999998544      34789999999999999999999996543322221111   111110         00


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ........++.+++.+|++.+|++||++.+++.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 --TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              111223456778888999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=332.42  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             HHHhHcccCCceeEEEEEEc----C----CcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceE
Q 006922          327 ASAEVLGKGTFGMAYKAILE----D----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKL  395 (625)
Q Consensus       327 ~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  395 (625)
                      +..+.||+|+||.|++|...    .    ...||||.++....  +.+.+..|+++|..+ +|+||+.++|+|...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            34458999999999999842    1    45799999987543  357899999999999 5999999999999999999


Q ss_pred             EEEEeccCCChhhhhcccc---------CCCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 006922          396 MVYDYYSLGSVSAMLHSER---------GEGR--IPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ  464 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~  464 (625)
                      +|+||++.|+|.++++..+         ....  ..++....+.++.|||.|++||++..   +|||||.++|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCC
Confidence            9999999999999999877         1111  23888999999999999999999997   99999999999999999


Q ss_pred             CeeEeccccccccccccccc-cc-----CCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 006922          465 YGCVSDLGLTTITSALAPVI-AR-----AAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       465 ~~kl~DfGla~~~~~~~~~~-~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~  537 (625)
                      .+||+|||+|+......... .+     ...|||||.+....|+.|+|||||||+||||+| |..||.+....  .++.+
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~  533 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLE  533 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHH
Confidence            99999999999755433322 11     234999999999999999999999999999999 99999763311  12222


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      +++    ++          .+...+..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus       534 ~l~----~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  534 FLK----EG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHh----cC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            222    11          12233445567899999999999999999999999999885

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-36  Score=306.26  Aligned_cols=244  Identities=19%  Similarity=0.388  Sum_probs=194.0

Q ss_pred             HHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEe
Q 006922          325 LRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       325 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .....+.||+||.+.||++...+.+.+|+|++.....+.   ..|..|++.|.+++ |.+||+|++|-..++..||||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            334567899999999999998888999999887554433   56999999999995 99999999999999999999997


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      = ..+|..+|.....   ...+| .++.+..|++.|+.++|.++   |||.||||.|+|+- .|.+||+|||+|..+...
T Consensus       442 G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             c-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            4 4599999987643   23556 67889999999999999998   99999999999884 588999999999988665


Q ss_pred             cc-----ccccCCCcCCccccCCC-----------CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          481 AP-----VIARAAGYRAPEVTDSR-----------KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       481 ~~-----~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      ++     ..+||+.||+||++...           +.++++||||+|||||+|+.|+.||..     ..+.+..+.    
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----~~n~~aKl~----  583 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----IINQIAKLH----  583 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----HHHHHHHHH----
Confidence            43     35799999999998533           256899999999999999999999953     333333332    


Q ss_pred             cccccccccccc-cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          545 EEWTAEVFDVEL-LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       545 ~~~~~~~~d~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           .+.|+.. ..++...+ -.+++++|..|+..||++||+..|+++
T Consensus       584 -----aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 -----AITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----hhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 3333322 11121111 113788999999999999999999986

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-35  Score=311.46  Aligned_cols=189  Identities=22%  Similarity=0.345  Sum_probs=160.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  398 (625)
                      .+.||+|+||.||++.. .+|..||+|++.....   ....+.+|+.++..++||||+++++++...+      ..++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            35799999999999985 4689999999975422   2356788999999999999999999986543      469999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++ ++...++.       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99976 55555532       2788889999999999999999998   9999999999999999999999999997653


Q ss_pred             cc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          479 AL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       479 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      ..  .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            22  223467888999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-35  Score=300.84  Aligned_cols=243  Identities=19%  Similarity=0.315  Sum_probs=191.7

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+++++.++||||+++++++..++..++||||+++++
T Consensus        16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            3467999999999999965 589999999975432 23568889999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |..++.....    .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++......   ..
T Consensus        96 l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          96 VDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            9888764322    4899999999999999999999987   999999999999999999999999998754322   12


Q ss_pred             ccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 VIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ...++..|+|||.+.     ...++.++|||||||++|||++|+.||......+.  ..    .......      +.  
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~------~~--  234 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAKSEP------PT--  234 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHhcCCC------cc--
Confidence            335677899999984     34567899999999999999999999965432111  11    1111100      00  


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .........++.+++.+||..+|++||++.|+++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0111222346778888999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-35  Score=303.01  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=187.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcC---CCCceecceeEEEec-----CceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSI---RHENVVELKAYYYSK-----DEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~~~~lv  397 (625)
                      +.||+|+||+||+|... +|+.||+|.++....   ....+.+|++++..+   +||||+++++++...     ...++|
T Consensus         6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv   85 (288)
T cd07863           6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV   85 (288)
T ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence            56999999999999954 689999999875422   124566777776655   799999999988652     357899


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+++ +|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          86 FEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             Eccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccc
Confidence            999985 88888865432   24899999999999999999999998   999999999999999999999999999876


Q ss_pred             cccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhccccccc---
Q 006922          478 SALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVVREEWTAEV---  551 (625)
Q Consensus       478 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---  551 (625)
                      ....  ....++..|+|||++.+..++.++||||+||++|||++|++||......+.. .............+....   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            4322  2345678899999998888999999999999999999999999764432221 111111000001111000   


Q ss_pred             ---ccccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 ---FDVELLRY--PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 ---~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         +.......  ....+....+.+++.+|++.||++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00000000  000112235678888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=298.41  Aligned_cols=239  Identities=20%  Similarity=0.336  Sum_probs=194.8

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||.|+||.||+|... +++.||+|++.....  ....+.+|++++++++|+||+++++++.+....++|+||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS   85 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence            357999999999999954 689999999875432  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |.+++...      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.....   ..
T Consensus        86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            99998753      4899999999999999999999987   999999999999999999999999999876533   22


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++|||||||++|||+||+.||......+..   ..    +......     ......  
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~---~~----~~~~~~~-----~~~~~~--  222 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---FL----IPKNNPP-----SLEGNK--  222 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH---HH----hhhcCCC-----CCcccc--
Confidence            345677899999998888999999999999999999999999754322111   11    1111111     000000  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ...++.+++.+|+..+|++||+++++++
T Consensus       223 --~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         223 --FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              2335677888999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-35  Score=309.13  Aligned_cols=244  Identities=19%  Similarity=0.266  Sum_probs=186.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +++.||+|++....    .....+.+|..++..++|+||+.+++++...+..++||||+++|
T Consensus         7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg   86 (331)
T cd05624           7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG   86 (331)
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence            56999999999999954 68899999997532    12245788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus        87 ~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          87 DLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             cHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            99999976322    3888999999999999999999988   9999999999999999999999999997654322   


Q ss_pred             -cccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 -PVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                       ....|+..|+|||++.+     ..++.++|||||||++|||++|+.||......+...      .......   ...  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~---~~~--  228 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEE---RFQ--  228 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCC---ccc--
Confidence             22458889999999865     467889999999999999999999997543322111      1111100   000  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQ--RPKMPDVVRV  593 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~ev~~~  593 (625)
                      .  .+...+...++.+++.+|+..++.+  |++++++++.
T Consensus       229 ~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0  0111112235566667887765543  5688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-35  Score=318.46  Aligned_cols=250  Identities=19%  Similarity=0.282  Sum_probs=187.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||.||++... .++.||||...     ...+.+|++++++++|+|||++++++...+..++|||++. ++|..
T Consensus       175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~  248 (461)
T PHA03211        175 RALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYT  248 (461)
T ss_pred             EEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHH
Confidence            56999999999999965 57899999643     2356789999999999999999999999999999999995 68888


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----APV  483 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~~~  483 (625)
                      ++....    ..++|.++..|+.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     ...
T Consensus       249 ~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        249 YLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            876432    24899999999999999999999998   999999999999999999999999999865432     123


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc--------chhhHHHHHHHHhhccccc----cc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD--------ELVHLVRWVHSVVREEWTA----EV  551 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~  551 (625)
                      ..||..|+|||++.+..++.++|||||||++|||++|..|+......        ...+.++...... .+...    ++
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~~~~l  400 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHAGSRL  400 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCcchHH
Confidence            45888999999999999999999999999999999988765432211        1122222111100 00000    00


Q ss_pred             c----c----ccccCC--CCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          552 F----D----VELLRY--PNIE---EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       552 ~----d----~~~~~~--~~~~---~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .    +    ......  +...   .....+.+++.+|++.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0    0    000000  0000   111256678889999999999999999863

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-35  Score=297.64  Aligned_cols=238  Identities=21%  Similarity=0.362  Sum_probs=191.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      ..||+|+||.||+|.. .+++.||+|.+......          .+.+.+|++++.+++||||+++++++...+..++||
T Consensus         6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (267)
T cd06628           6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL   85 (267)
T ss_pred             ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence            5699999999999985 46899999988754221          145788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++...
T Consensus        86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          86 EYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999997542     4888999999999999999999987   9999999999999999999999999988664


Q ss_pred             ccc---------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          479 ALA---------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       479 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ...         ....++..|+|||.+.+..++.++|||||||++|||++|+.||........   +..+..    .   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~----~---  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IFKIGE----N---  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HHHHhc----c---
Confidence            211         123466779999999888899999999999999999999999975432111   111000    0   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ..+.     ........+.+++.+||+.+|.+||++.|+++
T Consensus       228 --~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 --ASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --CCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              0000     11122345677888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=304.85  Aligned_cols=242  Identities=21%  Similarity=0.315  Sum_probs=191.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|.+......    .+.+.+|++++..++|+||+++++++...+..++||||+.++
T Consensus         7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (316)
T cd05574           7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG   86 (316)
T ss_pred             eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence            56999999999999965 5899999999765332    256888999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....   ..+++..+..++.|+++||+|||..+   ++|+||||+||+++.++.++|+|||++.......   
T Consensus        87 ~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          87 ELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99999875422   24899999999999999999999987   9999999999999999999999999987543211   


Q ss_pred             -----------------------------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcch
Q 006922          482 -----------------------------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL  532 (625)
Q Consensus       482 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~  532 (625)
                                                   ....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                         112467779999999988899999999999999999999999976543221


Q ss_pred             hhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          533 VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ..  .    .....          ...+.......++.+++.+|+..+|++||++...++.
T Consensus       241 ~~--~----~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         241 FS--N----ILKKE----------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             HH--H----HhcCC----------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            11  1    11100          0111111134567788889999999999994443333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-35  Score=305.64  Aligned_cols=252  Identities=16%  Similarity=0.288  Sum_probs=190.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||+|... +++.||+|.++....  ....+.+|++++.+++||||+++++++...+..++||||++ ++|
T Consensus        12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l   90 (301)
T cd07873          12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   90 (301)
T ss_pred             eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence            56999999999999854 688999999875432  23567889999999999999999999999999999999998 588


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ..
T Consensus        91 ~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          91 KQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            888865422    3789999999999999999999987   9999999999999999999999999987643221   12


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---ccccccccc------
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEVFD------  553 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d------  553 (625)
                      ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+...   .+.....   ...+..+.+      
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhccccccc
Confidence            345778999998765 457889999999999999999999997654332221   1111110   000111100      


Q ss_pred             ccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........      .......+.+++.+|+..||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000      0011234667888999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-35  Score=304.21  Aligned_cols=240  Identities=18%  Similarity=0.307  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            3699999999999985 4689999999865432 3456889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      .++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   ....
T Consensus       107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         107 DIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            877542      3889999999999999999999998   999999999999999999999999998765432   2234


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+.   ...+.    ......     ...   ...
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~~~~~-----~~~---~~~  242 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----DSPPPK-----LKN---AHK  242 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----ccCCCC-----ccc---cCC
Confidence            577889999999888899999999999999999999999975432221   11111    110000     000   011


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ....+.+++.+|++.+|++||++.|+++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            12356678889999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-35  Score=295.87  Aligned_cols=242  Identities=26%  Similarity=0.451  Sum_probs=195.8

Q ss_pred             hHcccCCceeEEEEEEcC-----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILED-----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||.||++...+     +..||+|+++....  ..+.+..|++++..++|+||+++++++...+..+++|||++
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~   84 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME   84 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence            569999999999999653     38899999976544  34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +++|.+++......   .+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.......
T Consensus        85 ~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       85 GGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             CCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            99999998764321   1899999999999999999999997   99999999999999999999999999987654321


Q ss_pred             c----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 V----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ~----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      .    ..++..|+|||.+.+..++.++||||+|++++||++ |+.||......+.   .+.+.   ... .         
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~---~~~-~---------  222 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLK---KGY-R---------  222 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh---cCC-C---------
Confidence            1    125567999999988889999999999999999999 8888875332222   22111   110 0         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                       .+.......++.+++.+|+..+|++|||+.|+++.|
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             011111344677888999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-35  Score=312.60  Aligned_cols=254  Identities=18%  Similarity=0.251  Sum_probs=188.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEec------CceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  398 (625)
                      .+.||+|+||.||++... .++.||||++.....   ..+.+.+|+.+++.++||||+++++++...      ...++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            357999999999999954 688999999975422   235678899999999999999999987643      3469999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++ +|...+..       .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            99975 66666642       2788899999999999999999987   9999999999999999999999999998764


Q ss_pred             cc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHH-H-----------H----HH
Q 006922          479 AL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV-R-----------W----VH  540 (625)
Q Consensus       479 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~-~-----------~----~~  540 (625)
                      ..  .....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+ .           .    +.
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            32  22346788899999999999999999999999999999999999765432211111 0           0    00


Q ss_pred             HHhhcccc------cccccccccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          541 SVVREEWT------AEVFDVELLR--YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       541 ~~~~~~~~------~~~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ........      ...+......  .........++.+++.+|++.||.+|||+.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000      0000000000  00000112356788889999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=289.38  Aligned_cols=250  Identities=21%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ...||.|+||+|+|-.+ +.|+..|||+++....  +++++..|.+...+- +.||||+++|.+...+..++.||.|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            36799999999999885 4799999999987644  456788888865555 689999999999999999999999965 


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      ++..+-+.-..-....+++.-.-.|....++||.||-...  .|||||+||+|||+|..|.+||||||++..+...  .+
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT  225 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT  225 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence            6555433322222334788888888889999999999876  5999999999999999999999999999877543  23


Q ss_pred             ccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          483 VIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..+|...|||||.+..  ..|+.++||||+|++|+|++||+.||...     ....+.+..++.++...-..+.+.    
T Consensus       226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gdpp~l~~~~~~----  296 (361)
T KOG1006|consen  226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGDPPILLFDKEC----  296 (361)
T ss_pred             hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCCCCeecCcccc----
Confidence            4578888999999853  35899999999999999999999999654     334455555555543332222221    


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .+....+.+++..|+.+|-..||+..++.+
T Consensus       297 --~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  297 --VHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              122346777888999999999999998875

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-35  Score=300.53  Aligned_cols=255  Identities=18%  Similarity=0.303  Sum_probs=192.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..||+|+||.||+|... +|+.||+|++.....   ..+.+.+|++++.+++|||++++++++......++||||++++.
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (286)
T cd07847           7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV   86 (286)
T ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence            56999999999999965 689999999875432   23567899999999999999999999999999999999999988


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      +..+.....     .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......   .
T Consensus        87 l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          87 LNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             HHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence            887765432     3899999999999999999999987   9999999999999999999999999998764432   2


Q ss_pred             ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHHhh--------cccccccc
Q 006922          483 VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR-WVHSVVR--------EEWTAEVF  552 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~  552 (625)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+....+. .......        ..+.....
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            2346677999999865 567899999999999999999999997654332221111 1000000        00000000


Q ss_pred             cccccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+........    ......+.+++.+||+.+|++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000    011345778899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-35  Score=301.55  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=190.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe-----cCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS-----KDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||++.. .+++.+|+|+++........+.+|+.++.++ +||||+++++++..     .+..++||||++
T Consensus        24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~  103 (286)
T cd06638          24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN  103 (286)
T ss_pred             eeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecC
Confidence            5699999999999985 4688999999876544456788999999999 69999999998853     346899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +++|.+++..... ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus       104 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         104 GGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             CCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence            9999998764321 1234789999999999999999999987   999999999999999999999999998765432  


Q ss_pred             -ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 -APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                       .....++..|+|||++.     ...++.++|||||||++|||++|+.||......+  ....    .. ........+ 
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~----~~-~~~~~~~~~-  251 (286)
T cd06638         180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK----IP-RNPPPTLHQ-  251 (286)
T ss_pred             ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh----cc-ccCCCcccC-
Confidence             12345788899999875     3457889999999999999999999997543211  1111    00 000000101 


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                             ......++.+++.+||+.+|++||++.|+++.
T Consensus       252 -------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         252 -------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                   11112357788889999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-35  Score=304.61  Aligned_cols=194  Identities=22%  Similarity=0.402  Sum_probs=158.4

Q ss_pred             hHcccCCceeEEEEEEc---CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE---DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  404 (625)
                      ..||+|+||+||+|...   ++..||+|.++.... ...+.+|++++.+++||||+++++++..  ....++||||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            46999999999999964   357899999875432 3467889999999999999999999854  4567899999875 


Q ss_pred             ChhhhhccccC----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCCeeEeccccccc
Q 006922          405 SVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL----NSQQYGCVSDLGLTTI  476 (625)
Q Consensus       405 ~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla~~  476 (625)
                      +|.+++.....    .....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            77776643221    12235889999999999999999999998   9999999999999    5667899999999987


Q ss_pred             ccccc------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          477 TSALA------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       477 ~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      .....      ....++..|+|||.+.+ ..++.++|||||||++|||+||++||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            54321      22356788999999876 457999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=293.74  Aligned_cols=243  Identities=21%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||.||+|... +++.+++|.+..... ..+.+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus         9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~   88 (262)
T cd06613           9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ   88 (262)
T ss_pred             EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence            56999999999999954 578999999976533 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++......   ....
T Consensus        89 ~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          89 DIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             HHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            9887642    24889999999999999999999987   999999999999999999999999998765432   1234


Q ss_pred             ccCCCcCCccccCCC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          485 ARAAGYRAPEVTDSR---KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      .++..|+|||.+...   .++.++||||||+++|||+||+.||......+......      ...     +.+.  ....
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------~~~-----~~~~--~~~~  228 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------KSN-----FPPP--KLKD  228 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcc-----CCCc--cccc
Confidence            567789999998776   78999999999999999999999997644322111110      000     0000  0011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+||..+|.+||+++||+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2223456788899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-35  Score=303.38  Aligned_cols=240  Identities=20%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence            35699999999999995 5799999999975433 345678899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++...      .+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ..
T Consensus       104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656         104 TDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            9998643      3789999999999999999999987   9999999999999999999999999987654322   22


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++|||||||++||+++|+.||............      ...+         ........
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~~---------~~~~~~~~  239 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG---------TPELQNPE  239 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccCC---------CCCCCCcc
Confidence            35677899999999888999999999999999999999999654322111000      0000         00001112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....+.+++.+||..+|++||++.++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22345667888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-35  Score=302.43  Aligned_cols=241  Identities=20%  Similarity=0.326  Sum_probs=192.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ...||+|+||.||++.. .++..||||++..... ..+.+.+|+.++..++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            35699999999999985 4689999999865432 235688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++...      .+++.....++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.......   ..
T Consensus       107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            9988542      3789999999999999999999997   9999999999999999999999999987653221   22


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||......+..   ..+....         ......   ..
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~---------~~~~~~---~~  242 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRDNL---------PPRVKD---SH  242 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcC---------CCcccc---cc
Confidence            35677899999998888999999999999999999999999754322211   1111100         111101   11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....+.+++..|+..+|.+|||+.|+++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            122345677779999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.1e-35  Score=296.90  Aligned_cols=241  Identities=23%  Similarity=0.379  Sum_probs=188.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            3699999999999995 4678999999876533 3457889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccccc---c
Q 006922          408 AMLHSERGEGRIPL--DWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       408 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~---~  481 (625)
                      +++.....    ++  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||++......   .
T Consensus        94 ~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          94 ALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             HHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            99875422    24  78888999999999999999987   999999999999986 679999999998765321   1


Q ss_pred             cccccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 PVIARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ....++..|+|||.+...  .++.++|||||||++|||++|+.||.........   .+.......       .+   . 
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~-------~~---~-  232 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI-------HP---E-  232 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc-------CC---C-
Confidence            223467789999998654  3788999999999999999999999653321111   000000000       00   0 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .......++.+++.+||..+|.+|||+.|+++
T Consensus       233 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         233 -IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             01122345677888999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=298.64  Aligned_cols=244  Identities=19%  Similarity=0.339  Sum_probs=193.1

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..+.||.|+||+||++... ++..+|+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (280)
T cd06611           9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA   88 (280)
T ss_pred             HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence            4567999999999999964 689999999875432 23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |.+++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++......   ..
T Consensus        89 L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          89 LDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999987542    24899999999999999999999998   999999999999999999999999998765322   12


Q ss_pred             ccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 VIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ...++..|+|||.+.     ...++.++||||||+++|||++|+.||......+..  .    .......         .
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~~---------~  226 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----KILKSEP---------P  226 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----HHhcCCC---------C
Confidence            335777899999874     345678999999999999999999999764322211  1    1111100         0


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ..........++.+++..||..+|.+||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            001111123356778889999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.8e-36  Score=313.39  Aligned_cols=254  Identities=17%  Similarity=0.243  Sum_probs=188.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  398 (625)
                      .+.||+|+||.||++... .++.||||++......   .+.+.+|+.++..++||||+++++++....      ..++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            357999999999999854 6899999999764322   356778999999999999999999886543      468999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++ ++.+.+..       .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874         102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            99976 56665542       2788899999999999999999998   9999999999999999999999999998754


Q ss_pred             cc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh-hHHH---------------HHH
Q 006922          479 AL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVR---------------WVH  540 (625)
Q Consensus       479 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~-~~~~---------------~~~  540 (625)
                      ..  .....++..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.               .+.
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            32  22346788899999999989999999999999999999999999764322111 1100               000


Q ss_pred             HHhhcccc-cccccccc-----c--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          541 SVVREEWT-AEVFDVEL-----L--RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       541 ~~~~~~~~-~~~~d~~~-----~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ........ .....+..     .  ..........++.+++.+|++.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000000 00000000     0  000001113456788889999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=281.06  Aligned_cols=256  Identities=21%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             CCCcccCHHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCC-CCceecceeEEE
Q 006922          314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIR-HENVVELKAYYY  389 (625)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~  389 (625)
                      +..+..++.|+.  ....||+|+.|+|++++.. .|..+|||.+....-  +.+.+...++++.+-+ .|+||+.+|||.
T Consensus        84 g~r~~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   84 GQRYQADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             CcccccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            344556777764  3567999999999999955 689999999986532  2345666777776654 899999999999


Q ss_pred             ecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe
Q 006922          390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS  469 (625)
Q Consensus       390 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~  469 (625)
                      .+....+.||.|.. .+..+++...    .++++.-+-++...+.+||.||.+++  .|+|||+||+|||+|+.|++|++
T Consensus       162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            99999999999865 4455555443    25888888899999999999999987  69999999999999999999999


Q ss_pred             ccccccccccc--ccccccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          470 DLGLTTITSAL--APVIARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       470 DfGla~~~~~~--~~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      |||++.++-+.  .+..+|.+.|||||.+.   ...|+.++||||||++++||+||+.||.+...+  .+.+.   .++.
T Consensus       235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~lt---kvln  309 (391)
T KOG0983|consen  235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLT---KVLN  309 (391)
T ss_pred             cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHH---HHHh
Confidence            99999877443  23457888899999985   457899999999999999999999999764322  22222   1222


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ++.         ...+.......++.++...|+.+|+.+||.-.++++
T Consensus       310 ~eP---------P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 EEP---------PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCC---------CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            221         111222223456778888999999999999998875

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-35  Score=300.60  Aligned_cols=255  Identities=18%  Similarity=0.287  Sum_probs=189.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|+||+|... ++..||+|+++....   ..+.+.+|+.++.+++||||+++++++..++..++||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            56999999999999964 689999999875422   23568899999999999999999999999999999999998 58


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++.....  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus        85 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          85 LKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             HHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            8888765432  235899999999999999999999987   9999999999999999999999999987653221   1


Q ss_pred             ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh--hccccc---cccc--c
Q 006922          483 VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV--REEWTA---EVFD--V  554 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~d--~  554 (625)
                      ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+  ..........  ....+.   ..-+  .
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            2245677999998765 457889999999999999999999997543211  1111111000  000000   0000  0


Q ss_pred             cccCC--C----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRY--P----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~--~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....  .    .......++.+++.+|+..||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000  0    00012245668888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3e-35  Score=298.13  Aligned_cols=248  Identities=23%  Similarity=0.405  Sum_probs=195.0

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      ..||+|+||+||+|+..      +.+.|++|.+......  .+.+.+|++++.+++|+||+++++++...+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT   90 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence            56999999999999853      2467999988764433  357899999999999999999999999988999999999


Q ss_pred             cCCChhhhhccccCCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          402 SLGSVSAMLHSERGEG----RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ++|+|.+++.......    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||+++..
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccccc
Confidence            9999999997654211    125899999999999999999999998   999999999999999999999999998754


Q ss_pred             cccc----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          478 SALA----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       478 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ....    ....++..|+|||.+.+..++.++||||||+++|||++ |..||........   .....    .....   
T Consensus       168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~~----~~~~~---  237 (275)
T cd05046         168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQ----AGKLE---  237 (275)
T ss_pred             CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHHH----cCCcC---
Confidence            3211    11233456999999988888999999999999999999 8889965432221   11111    00000   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                            .+........+.+++.+|++.+|++||++.|+++.|.+
T Consensus       238 ------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 ------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                  00111123467788889999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=298.72  Aligned_cols=238  Identities=20%  Similarity=0.328  Sum_probs=202.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|.|++|-.|++ -.|..||||++.+...+   ...+.+|++-|..++|||||+|+.+...+...|+|+|.-.+|+
T Consensus        24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD  103 (864)
T KOG4717|consen   24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD  103 (864)
T ss_pred             hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence            5699999999999984 57999999999887654   3668899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-CCCCCeeEeccccccccccc--cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL-NSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      |++++.+...+    +++..+.+++.||+.|+.|+|+.+   +|||||||+||.+ ..-|-+||.|||++-.+.+.  .+
T Consensus       104 l~DyImKHe~G----l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen  104 LFDYIMKHEEG----LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             HHHHHHhhhcc----ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            99999877543    899999999999999999999998   9999999999965 45688999999999776543  34


Q ss_pred             ccccCCCcCCccccCCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKAT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ..+|+..|-|||++.+..|+ +++||||+|||||.|++|++||+..+..|...++-               |.   .+..
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------DC---KYtv  238 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------DC---KYTV  238 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------cc---cccC
Confidence            56788889999999999987 57899999999999999999999877766554332               22   2233


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.....++.+++.+|+..||++|.+.+||+.
T Consensus       239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            4445566777788999999999999999874

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=308.16  Aligned_cols=192  Identities=21%  Similarity=0.335  Sum_probs=165.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|++....    ...+.+.+|+.++..++|+||+++++++...+..++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (331)
T cd05597           7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG   86 (331)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence            56999999999999954 68999999997532    12345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......   
T Consensus        87 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          87 DLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             cHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            99999975322    3888999999999999999999998   9999999999999999999999999987653321   


Q ss_pred             -cccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          482 -PVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                       ....|+..|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence             12358889999999863     457889999999999999999999997543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-35  Score=306.60  Aligned_cols=244  Identities=18%  Similarity=0.254  Sum_probs=186.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... .++.+|+|++.+..    .....+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus         7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g   86 (332)
T cd05623           7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG   86 (332)
T ss_pred             EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence            56999999999999965 57889999996532    12245788999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......    
T Consensus        87 ~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          87 DLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            99999976322    3889999999999999999999998   999999999999999999999999998764322    


Q ss_pred             ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          481 APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      .....|+..|+|||++.     ...++.++|||||||++|||++|+.||...+..+...      .......  ..   .
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~--~~---~  228 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKE--RF---Q  228 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCc--cc---c
Confidence            12246888999999985     3467899999999999999999999997643222211      1111100  00   0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVR--MPDQRPKMPDVVRV  593 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPs~~ev~~~  593 (625)
                      ..  ........++.+++.+|+..  ++..|+++.|+++.
T Consensus       229 ~p--~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FP--AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CC--CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00  00111223455566676644  44447899999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-35  Score=294.10  Aligned_cols=240  Identities=21%  Similarity=0.409  Sum_probs=194.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||++.. .+|+.||+|++.....   ..+++.+|++++++++||||+++++++...+..++||||+++++
T Consensus         6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08218           6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD   85 (256)
T ss_pred             EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence            5699999999999985 4689999999875422   23578899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++.....   ..+++.++.+++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        86 l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          86 LYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            9998875432   24789999999999999999999987   9999999999999999999999999997654322   1


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||++.+..++.++|||||||+++||++|+.||......+   .   +.....+..           .+..
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~---~~~~~~~~~-----------~~~~  222 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L---VLKIIRGSY-----------PPVS  222 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H---HHHHhcCCC-----------CCCc
Confidence            2346778999999998889999999999999999999999996532221   1   111111110           0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+||+.+|.+||++.||++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            222346778888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-35  Score=330.04  Aligned_cols=252  Identities=19%  Similarity=0.343  Sum_probs=192.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||++... .+..||+|.+......   ...+..|+.++.+++|||||+++++|...  ...++||||+++
T Consensus        19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g   98 (1021)
T PTZ00266         19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA   98 (1021)
T ss_pred             EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence            56999999999999954 5788999998754332   35688999999999999999999988653  468999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCC----CCceecCCCCCCEEeCCC----------------
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG----GKLVHGNIKSSNIFLNSQ----------------  463 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivHrDlk~~NIll~~~----------------  463 (625)
                      |+|.+++..... ....+++..+..|+.||+.||+|||..+.    .+||||||||+||||+.+                
T Consensus        99 GSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         99 GDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            999999875432 12358999999999999999999998542    349999999999999642                


Q ss_pred             -CCeeEeccccccccccc--ccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 006922          464 -QYGCVSDLGLTTITSAL--APVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW  538 (625)
Q Consensus       464 -~~~kl~DfGla~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~  538 (625)
                       ..+||+|||++......  .....+++.|+|||++.+  ..++.++|||||||++|||+||+.||.....  ...++..
T Consensus       178 ~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--~~qli~~  255 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--FSQLISE  255 (1021)
T ss_pred             CCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--HHHHHHH
Confidence             34899999999876432  233468889999999854  4588999999999999999999999975432  1111111


Q ss_pred             HHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHhhCC
Q 006922          539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV--RVIENVRP  599 (625)
Q Consensus       539 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~--~~L~~~~~  599 (625)
                      +    ....       ..   + ......++.+|+..||..+|.+||++.|++  ..+..+.+
T Consensus       256 l----k~~p-------~l---p-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        256 L----KRGP-------DL---P-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             H----hcCC-------CC---C-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            1    1110       00   0 011134677888899999999999999998  45555543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.3e-35  Score=298.98  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=190.9

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEec-----CceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSK-----DEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e~~~  402 (625)
                      +.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++ +|||++++++++...     +..++||||++
T Consensus        28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~  107 (291)
T cd06639          28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN  107 (291)
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence            4699999999999995 4689999999976554456788899999998 799999999998754     35799999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +++|.++++.... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus       108 ~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  183 (291)
T cd06639         108 GGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  183 (291)
T ss_pred             CCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence            9999998864321 1234899999999999999999999987   999999999999999999999999998865422  


Q ss_pred             -ccccccCCCcCCccccCCC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 -APVIARAAGYRAPEVTDSR-----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                       .....++..|+|||.+...     .++.++|||||||++|||++|+.||......+.  ...+    .+ .....+   
T Consensus       184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~----~~-~~~~~~---  253 (291)
T cd06639         184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKI----PR-NPPPTL---  253 (291)
T ss_pred             cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHH----hc-CCCCCC---
Confidence             1233567789999987543     368899999999999999999999975432111  1111    01 101111   


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           ...+.....+.+++.+|++.+|++||++.|+++
T Consensus       254 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         254 -----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 111223346778889999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.9e-35  Score=295.57  Aligned_cols=239  Identities=19%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||.||+|.. .++..||+|.+.....  ..+.+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS   88 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence            45699999999999985 4688999999865432  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++...      .+++..+..++.+++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        89 l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          89 ALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            99988642      3889999999999999999999987   9999999999999999999999999987654321   2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||.........   ..+    ......          ...
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~----~~~~~~----------~~~  222 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL---FLI----PKNNPP----------TLE  222 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH---HHH----hcCCCC----------CCC
Confidence            235677899999998888899999999999999999999999654322111   111    111000          001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....++.+++.+|+..+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1223456778889999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=309.87  Aligned_cols=250  Identities=20%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             CHHHHHHHHHhHcccCCceeEEEEEEcC-CcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEE
Q 006922          320 DLEDLLRASAEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       320 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  397 (625)
                      +..|.. .+...||.|+||.||+|..++ +-..|.|++..... .-+++.-|++||..+.||+||.|++.|+..+..+|+
T Consensus        29 nP~d~W-eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   29 NPRDHW-EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             CHHHHH-HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            344443 344568999999999999654 45567787765432 347899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      .|||.||-....+-.-.    .+|...++..++++++.||.|||++.   |||||||+.|||++-+|.++|+|||.+...
T Consensus       108 iEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence            99999999988876543    25999999999999999999999998   999999999999999999999999998654


Q ss_pred             c---ccccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 S---ALAPVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~---~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      .   .......||+.|||||+..     ..+|+.++||||||++|.||..+.+|.+..+...+      +-.+-..+.  
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSeP--  252 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEP--  252 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcCC--
Confidence            3   2334578999999999874     46899999999999999999999999876543221      111111111  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                             +..-.+......+.+++.+|+.++|..||++.++++
T Consensus       253 -------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 -------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                   111223455667888888999999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7e-35  Score=292.19  Aligned_cols=240  Identities=21%  Similarity=0.383  Sum_probs=191.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEec-CceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSK-DEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g  404 (625)
                      +.||+|++|.||++... +++.||+|++.....   ..+.+.+|++++++++|+|++++++.+... ...++||||++++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (257)
T cd08223           6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG   85 (257)
T ss_pred             EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence            56999999999999954 578999999975432   235688899999999999999999987654 4578999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~  481 (625)
                      +|.+++.....   ..+++.++..++.+++.|++|||+.+   |+||||||+||+++.++.++|+|||++......   .
T Consensus        86 ~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          86 DLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            99999876432   24899999999999999999999998   999999999999999999999999999766432   1


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++||||||++++||++|+.||......+.      ...... +...          +.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~-~~~~----------~~  222 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIE-GKLP----------PM  222 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cCCC----------CC
Confidence            233567789999999988999999999999999999999999975332111      111111 1110          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+|++.+|++||++.|+++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1223346778888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.8e-35  Score=294.53  Aligned_cols=248  Identities=20%  Similarity=0.344  Sum_probs=192.9

Q ss_pred             HhHcccCCceeEEEEEEcC--CcEEEEEEeccccC-----------ChHHHHHHHHHHHc-CCCCceecceeEEEecCce
Q 006922          329 AEVLGKGTFGMAYKAILED--GTTVVVKRLKDVNV-----------GKRDFEQQMEIVGS-IRHENVVELKAYYYSKDEK  394 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~~-----------~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~  394 (625)
                      .+.||+|+||.||+|....  ++.+|+|.+.....           ...++.+|+.++.+ ++||||+++++++...+..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            4679999999999999654  78899998863211           11346678887765 7999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      ++||||+++++|.+++..... ....+++..+.+++.|++.||.|||+..  +++|+||+|+||+++.++.+||+|||.+
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccce
Confidence            999999999999988854321 1234889999999999999999999632  3999999999999999999999999999


Q ss_pred             ccccccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          475 TITSALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       475 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      .......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||........   ..   .......     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~---~~~~~~~-----  230 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT---KIVEAVY-----  230 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH---HHhhccC-----
Confidence            8754332  234567789999999988899999999999999999999999965432211   11   1111110     


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      .+     .........+.+++.+||+.||++||++.|+..+++
T Consensus       231 ~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EP-----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             Cc-----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00     000112346778888999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.4e-35  Score=293.14  Aligned_cols=239  Identities=20%  Similarity=0.346  Sum_probs=185.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC------hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  399 (625)
                      .+.||+|+||.||+|... +++.||+|+++.....      ...+.+|+.++++++||||+++++++...  +..++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            357999999999999854 6899999998643211      24578899999999999999999988753  56789999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++....     .+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            999999999987532     3788999999999999999999987   99999999999999999999999999876532


Q ss_pred             cc------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 LA------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ..      ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.      +.......     ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----~~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----TN  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----CC
Confidence            11      123467789999999988899999999999999999999999975422111      11111000     00


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +..   +  ......+.+++ +||..+|++||+++||++
T Consensus       228 ~~~---~--~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQL---P--SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC---c--hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111   1  11122333444 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-35  Score=300.76  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=191.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|... +++.||+|++.....   ..+.+.+|++++..++||||+++++++...+..++||||+++++
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (286)
T cd07846           7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV   86 (286)
T ss_pred             eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence            57999999999999965 589999999875432   23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      +..+.....     .++|..+..++.|+++||+|||+.+   |+|+||+|+||++++++.++|+|||++.......   .
T Consensus        87 l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          87 LDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            888765432     3899999999999999999999987   9999999999999999999999999988653321   1


Q ss_pred             ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc---------cccccc
Q 006922          483 VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE---------WTAEVF  552 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  552 (625)
                      ...++..|+|||++.+ ..++.++|||||||++|||++|++||......+....+..........         ....+.
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            2346778999999865 457889999999999999999999997543222111111000000000         000000


Q ss_pred             cccccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPN----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.......    .......+.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000    0112345778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-35  Score=297.35  Aligned_cols=242  Identities=21%  Similarity=0.385  Sum_probs=189.8

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe------cCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS------KDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|.. .+++.+|+|++........++..|+.++.++ +|+||+++++++..      .+..+++|||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            35799999999999995 4689999999876554556788899999998 69999999999853      3567999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++|+|.+++.....   ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus       101 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         101 CGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             CCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            999999999875432   24788889999999999999999998   999999999999999999999999998765321


Q ss_pred             ---ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 ---APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                         .....++..|+|||.+.     ...++.++|||||||++|||++|+.||......+.....      .+..      
T Consensus       175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~------~~~~------  242 (282)
T cd06636         175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI------PRNP------  242 (282)
T ss_pred             ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH------hhCC------
Confidence               12345777899999875     346788999999999999999999999654321111100      0000      


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....    .......++.+++.+||..+|.+||++.|+++
T Consensus       243 ~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         243 PPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0000    01122346788888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-34  Score=298.13  Aligned_cols=240  Identities=23%  Similarity=0.380  Sum_probs=190.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-C---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-G---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|... +|+.||+|++..... .   .+++.+|++++..++||||+++.++|...+..++||||++ 
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence            367999999999999954 689999999864322 1   2468899999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |++.+.+....    ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++...... ..
T Consensus        99 g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~  170 (307)
T cd06607          99 GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NS  170 (307)
T ss_pred             CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-CC
Confidence            57766665432    24899999999999999999999988   999999999999999999999999998766433 23


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..++..|+|||.+.   ...++.++||||||+++|||+||+.||.........   .   .......      +   . .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~---~~~~~~~------~---~-~  234 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y---HIAQNDS------P---T-L  234 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---H---HHhcCCC------C---C-C
Confidence            45777899999874   456889999999999999999999999654321111   1   0000000      0   0 0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ........+.+++.+||..+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            112234567888899999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.5e-35  Score=292.11  Aligned_cols=246  Identities=21%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  403 (625)
                      +.||.|+||.||++.. .+|+.+|+|++......   .+.+..|++++++++||||+++++++..  ....+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            5699999999999984 46899999999754332   3457889999999999999999998864  3457899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|.+++..... ....+++..+..++.|+++||+|||..+  ..+|+|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  164 (265)
T cd08217          86 GDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS  164 (265)
T ss_pred             CCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence            999999876432 2335899999999999999999999332  2239999999999999999999999999998765432


Q ss_pred             ---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 ---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                         ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+   ..+.+.    .....         
T Consensus       165 ~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~---------  228 (265)
T cd08217         165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIK----EGKFR---------  228 (265)
T ss_pred             ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHh----cCCCC---------
Confidence               23457788999999998889999999999999999999999997654221   122111    11100         


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                       ........++.+++.+|++.+|++||++.||++.
T Consensus       229 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             1112233567888889999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-34  Score=291.39  Aligned_cols=247  Identities=21%  Similarity=0.347  Sum_probs=195.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||.|+||+||+|.. .++..+|+|++.....  ..+.+.+|+++++.++|+||+++++.+...+..++||||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            35699999999999995 4688999999975432  34678999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++.....  ...+++.....++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++.......    
T Consensus        86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            9999976432  124899999999999999999999987   9999999999999999999999999987664322    


Q ss_pred             ---cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          482 ---PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                         ....++..|+|||.+... .++.++|||||||++|||++|+.||......+..  .+.    .....      ....
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~----~~~~~------~~~~  228 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLT----LQNDP------PSLE  228 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHH----hcCCC------CCcC
Confidence               223567789999998776 7899999999999999999999999754332211  111    11110      0000


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...........+.+++.+|+..+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00001122346678888999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-34  Score=290.37  Aligned_cols=240  Identities=20%  Similarity=0.387  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||++.. .+++.+|+|++.....   ..+.+.+|+++++.++||||+++++.+...+..++||||+++++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08220           6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT   85 (256)
T ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence            5699999999999985 4688999999875432   23568899999999999999999999998899999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccccc--c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~--~  482 (625)
                      |.+++....   ...+++..+.+++.++++|++|||+++   |+|+||||+||+++.++ .+||+|||++.......  .
T Consensus        86 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          86 LAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            999997643   234889999999999999999999987   99999999999998654 57999999998765332  2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+.   ....   ..... .          +..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~---~~~~~-~----------~~~  222 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI---MSGTF-A----------PIS  222 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH---HhcCC-C----------CCC
Confidence            34567789999999988899999999999999999999999975433221   1111   11100 0          011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+||..+|.+|||+.|+++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            112346778888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-34  Score=294.83  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=194.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~g  404 (625)
                      +.||.|++|.||++... +++.+|+|.+.....  ....+.+|++++++++||||++++++|...  +..++||||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            56999999999999964 689999999875433  236688999999999999999999998654  3689999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APV  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~  483 (625)
                      +|.+++..... ....+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus        87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  162 (287)
T cd06621          87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT  162 (287)
T ss_pred             CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccccc
Confidence            99988764322 2234788999999999999999999988   999999999999999999999999998764322 223


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG--DELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ..++..|+|||.+.+..++.++||||+|+++|||++|+.||.....  ....+...++...   . .....+.    ...
T Consensus       163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~----~~~  234 (287)
T cd06621         163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---P-NPELKDE----PGN  234 (287)
T ss_pred             ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---C-chhhccC----CCC
Confidence            3567789999999988999999999999999999999999976532  1112222222210   0 0000000    000


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......+.+++.+||..+|.+|||+.|+++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1112346788999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-34  Score=295.97  Aligned_cols=239  Identities=20%  Similarity=0.358  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|++|.||++.. .+++.+++|+++.... ..+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            5799999999999985 4789999999865432 2356889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~  484 (625)
                      +++...      .+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||.+.......   ...
T Consensus       105 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648         105 DIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             HHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            998752      3889999999999999999999998   9999999999999999999999999887654321   223


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+..   ....    .....     ..   .....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~~----~~~~~-----~~---~~~~~  240 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRIR----DNLPP-----KL---KNLHK  240 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHH----hcCCC-----CC---ccccc
Confidence            5777899999998888999999999999999999999999754322211   1111    11000     00   00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+||..+|++||++.|+++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2346788888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-34  Score=290.92  Aligned_cols=239  Identities=22%  Similarity=0.370  Sum_probs=192.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... ++..|++|.+.....      ..+.+.+|+++++.++|+||+++++++......++||||++
T Consensus         6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (258)
T cd06632           6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP   85 (258)
T ss_pred             ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence            56999999999999965 799999999865431      22568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +++|.+++....     .+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||++....... 
T Consensus        86 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          86 GGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence            999999987542     3889999999999999999999987   9999999999999999999999999987654322 


Q ss_pred             -cccccCCCcCCccccCCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 -PVIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       ....++..|+|||.+.... ++.++|+|||||++|||++|+.||......+  ....    ........        ..
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~----~~~~~~~~--------~~  223 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFK----IGRSKELP--------PI  223 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHH----HHhcccCC--------Cc
Confidence             3345677899999987766 8999999999999999999999997543111  1111    11100000        00


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .......+.+++.+||..+|.+||++.|+++
T Consensus       224 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 --PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              1112245667888999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2e-34  Score=290.60  Aligned_cols=239  Identities=18%  Similarity=0.266  Sum_probs=186.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---C---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---G---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  399 (625)
                      .+.||+|+||.||+|.. .+|..||+|.+.....   .   .+.+.+|++++.+++||||+++++++.+.  ...++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            35799999999999995 4689999999864321   1   24678899999999999999999988764  45789999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++....     .+++....+++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            999999999987532     3788889999999999999999998   99999999999999999999999999876432


Q ss_pred             ------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 ------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                            ......++..|+|||.+.+..++.++|||||||++|||++|+.||........  ..    ......       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~-------  225 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQP-------  225 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcCC-------
Confidence                  11223577789999999888899999999999999999999999975422111  11    111000       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .  ...........+.+++.+|+. +|++||+++|+++
T Consensus       226 -~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -T--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -C--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             0  001112233456677778884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-34  Score=291.58  Aligned_cols=243  Identities=19%  Similarity=0.350  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||++.. .+++.||+|++.....       ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            35699999999999984 5789999999975331       125688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSA  479 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~  479 (625)
                      +++++|.+++....     ++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999987542     4889999999999999999999998   99999999999998776 589999999876643


Q ss_pred             cc-------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          480 LA-------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       480 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ..       ....++..|+|||.+.+..++.++||||+|+++|||++|+.||............   .......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~------  227 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASAT------  227 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhccC------
Confidence            21       1234677899999998888999999999999999999999999654322221111   1110000      


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          ...........++.+++.+|+..+|.+||++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                001111223456778889999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-34  Score=296.88  Aligned_cols=236  Identities=18%  Similarity=0.277  Sum_probs=192.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++... +++.+|+|+++....    ..+.+.+|++++.+++||||+++++++...+..++||||++++
T Consensus         7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (290)
T cd05580           7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG   86 (290)
T ss_pred             EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence            56999999999999954 689999999975422    2356888999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||+++.........
T Consensus        87 ~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  158 (290)
T cd05580          87 ELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL  158 (290)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence            9999987642     4889999999999999999999987   9999999999999999999999999998876555555


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||......+..   .   ......         .   +....
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~~~---------~---~~~~~  220 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---E---KILEGK---------V---RFPSF  220 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHhcCC---------c---cCCcc
Confidence            6788899999998888899999999999999999999999754421111   1   111110         0   00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRP-----KMPDVV  591 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~  591 (625)
                      ....+.+++.+||..+|.+||     +..|++
T Consensus       221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            124566778899999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-34  Score=297.60  Aligned_cols=255  Identities=17%  Similarity=0.286  Sum_probs=191.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||.||+|... +|+.||+|+++.....      ...+..|++++.+++|+||+++++++.+.+..++||||+ 
T Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   84 (298)
T cd07841           6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-   84 (298)
T ss_pred             eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence            46999999999999954 6899999999765332      245678999999999999999999999999999999999 


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....    ..+++..+..++.|+++||+|||+++   |+|+||||+||+++.++.++|+|||+++...... 
T Consensus        85 ~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          85 ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            899999997543    24899999999999999999999998   9999999999999999999999999998764322 


Q ss_pred             --cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHHhhccc-----ccccc
Q 006922          482 --PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV-RWVHSVVREEW-----TAEVF  552 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~  552 (625)
                        ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+..... +.........+     .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence              12234567999998854 46789999999999999999998888654432211111 10000000000     00000


Q ss_pred             cccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........    .......++.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000000    01122356778899999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-34  Score=292.64  Aligned_cols=241  Identities=22%  Similarity=0.369  Sum_probs=196.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||.||+|... ++..|++|+++......+.+.+|++++..++|+|++++++++...+..++|+||+++++|.+
T Consensus        25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  104 (286)
T cd06614          25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD  104 (286)
T ss_pred             HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence            56999999999999965 68999999998654445678899999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVIA  485 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~~  485 (625)
                      ++....    ..+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||++.......   ....
T Consensus       105 ~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  177 (286)
T cd06614         105 IITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV  177 (286)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcccc
Confidence            998653    24899999999999999999999987   9999999999999999999999999987654321   2234


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE  565 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  565 (625)
                      ++..|+|||.+.+..++.++|||||||++|||++|+.||......+...  ..    .... ..        ..+.....
T Consensus       178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~----~~~~-~~--------~~~~~~~~  242 (286)
T cd06614         178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LI----TTKG-IP--------PLKNPEKW  242 (286)
T ss_pred             CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH----HhcC-CC--------CCcchhhC
Confidence            6678999999988889999999999999999999999997543221111  10    0000 00        01111112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          566 MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       566 ~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+.+++.+|++.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            346777888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=297.10  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=192.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|... +++.||+|+++....   ..+.+.+|++++++++|+||+++++++...+..++||||++++.
T Consensus         7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   86 (288)
T cd07833           7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL   86 (288)
T ss_pred             EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence            56999999999999965 588999999875432   23678899999999999999999999999999999999999877


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      +..+....     ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|||++.......    
T Consensus        87 l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          87 LELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            76655432     23889999999999999999999997   9999999999999999999999999988765432    


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---------cccc--
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---------EWTA--  549 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~--  549 (625)
                      ....++..|+|||++.+. .++.++||||||+++|||++|+.||......+..............         ....  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            223567779999999887 8899999999999999999999999754322211111100000000         0000  


Q ss_pred             ---ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 ---EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ---~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ...+..............++.+++.+||..+|++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               0000000000000112456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-34  Score=294.43  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=187.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||++... +++.||+|.+.....  ....+.+|+.++.++. |+||+++++++...+..+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            467999999999999954 689999999875432  2356889999999996 99999999999998899999999874 


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      ++.++...........+++.....++.+++.||+|||+..  .|+||||||+||+++.++.++|+|||+++.....  ..
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  165 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT  165 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence            5444332111111235899999999999999999999752  2999999999999999999999999999765332  12


Q ss_pred             ccccCCCcCCccccCCC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          483 VIARAAGYRAPEVTDSR---KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ...++..|+|||.+...   .++.++|||||||++|||++|+.||....  .   ....+........      +.+.. 
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~---~~~~~~~~~~~~~------~~~~~-  233 (288)
T cd06616         166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--S---VFDQLTQVVKGDP------PILSN-  233 (288)
T ss_pred             cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--h---HHHHHhhhcCCCC------CcCCC-
Confidence            33567789999998765   68999999999999999999999996533  1   1111111111110      00100 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........++.+++.+|++.+|++|||+.||++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011123346778888999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-34  Score=293.58  Aligned_cols=240  Identities=20%  Similarity=0.259  Sum_probs=184.1

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHH---HcCCCCceecceeEEEecCceEEEEEecc
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIV---GSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +||+|+||.||++.. .+++.+|+|.+......    ...+.+|..++   ...+||||+.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999995 46899999998754321    12334444333   33479999999999999899999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            999998887542     4899999999999999999999998   9999999999999999999999999987653322 


Q ss_pred             cccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....++..|+|||.+. +..++.++|||||||++|||++|+.||............. ..   ..      .+..     
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~---~~------~~~~-----  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MT---LT------VNVE-----  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hh---hc------CCcC-----
Confidence            2335788899999886 4568999999999999999999999997644322221111 10   00      0000     


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~~  593 (625)
                      .......++.+++.+|+..||++||     +++|+++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1112234667788899999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-34  Score=298.57  Aligned_cols=244  Identities=19%  Similarity=0.277  Sum_probs=192.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++... .++.||+|.+.....    ....+.+|++++..++||||+++++.+...+..++||||++++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (305)
T cd05609           7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG   86 (305)
T ss_pred             eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            56999999999999964 578999999875432    1246778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-----  479 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-----  479 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+++....     
T Consensus        87 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          87 DCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999996542     4889999999999999999999987   99999999999999999999999999864210     


Q ss_pred             -------------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc
Q 006922          480 -------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE  546 (625)
Q Consensus       480 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  546 (625)
                                   ......++..|+|||.+....++.++|+|||||++|||++|+.||.+....+....      .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~------~~~~~  232 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VISDD  232 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcc
Confidence                         00112456779999999888899999999999999999999999975433222111      11110


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                          ...+.     .......++.+++.+||+.+|++||++.++.+.|+.
T Consensus       233 ----~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 ----IEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----cCCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                00000     000123456788889999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8e-35  Score=296.46  Aligned_cols=253  Identities=19%  Similarity=0.301  Sum_probs=187.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|... +|..||+|+++.....   ...+.+|++++.+++||||+++++++.+.+..++|+||+++ +
T Consensus         6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   84 (284)
T cd07839           6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-D   84 (284)
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-C
Confidence            56999999999999964 6899999999754222   25678899999999999999999999999999999999974 7


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .
T Consensus        85 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          85 LKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            877776432    24899999999999999999999998   9999999999999999999999999998654321   1


Q ss_pred             ccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc----c--cccccccc
Q 006922          483 VIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE----W--TAEVFDVE  555 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~d~~  555 (625)
                      ...++..|+|||.+.+. .++.++|||||||++|||+||+.|+......  ....+.+.......    +  .....+..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            23456789999988664 4789999999999999999999887543321  11111111111000    0  00000000


Q ss_pred             -ccCCC-------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 -LLRYP-------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 -~~~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ....+       .......++.+++.+|++.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             00000       00112245667888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-34  Score=289.36  Aligned_cols=246  Identities=20%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||.||++... +++.+|+|++.....  ..+.+.+|++++++++||||+++++++...+..++|+||+++++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS   85 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence            467999999999999965 689999999876532  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APV  483 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~  483 (625)
                      |.+++....    ..+++....+++.|++.|++|||+ .+   ++|+||||+||++++++.++|+|||.+...... ...
T Consensus        86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            999987643    248889999999999999999999 76   999999999999999999999999998765322 112


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.+........         ...+ ..
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~-~~  227 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP---------PRLP-SG  227 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC---------CCCC-hh
Confidence            456778999999999899999999999999999999999997543211 111222222111110         0001 01


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....++.+++.+||..+|++|||+.|++.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            13445778888999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=292.29  Aligned_cols=244  Identities=20%  Similarity=0.383  Sum_probs=190.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--C---------hHHHHHHHHHHHcCCCCceecceeEEEecCceEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--G---------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  396 (625)
                      .+.||+|+||.||+|.. .+|+.||+|.++....  .         .+.+.+|++++..++|||++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            35799999999999985 4689999999864211  0         1357789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++++|||+++.
T Consensus        86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999987642     4889999999999999999999987   99999999999999999999999999876


Q ss_pred             cccc-----ccccccCCCcCCccccCCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          477 TSAL-----APVIARAAGYRAPEVTDSRK--ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       477 ~~~~-----~~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ....     .....++..|+|||.+....  ++.++||||||+++||+++|+.||......+  ...+    ..... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~~~~-~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK----LGNKR-SA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH----hhccc-cC
Confidence            5422     12234677899999987654  7899999999999999999999996432211  1111    10000 00


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..++...     ..+....+.+++.+|+..+|.+||++.|+++
T Consensus       231 ~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0111110     0112346677888999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-34  Score=289.43  Aligned_cols=241  Identities=24%  Similarity=0.407  Sum_probs=193.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|... +++.|++|.++.....   .+.+.+|+++++.++|+||+++++++...+..++|+||+++++
T Consensus         6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06626           6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT   85 (264)
T ss_pred             eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence            56999999999999854 6899999999866443   3678899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---  482 (625)
                      |.+++....     .+++..+..++.++++|++|||+.+   |+|+||+|+||++++++.+||+|||++........   
T Consensus        86 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          86 LEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             HHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            999987532     3788899999999999999999988   99999999999999999999999999887643221   


Q ss_pred             ----ccccCCCcCCccccCCCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                          ...++..|+|||++.+..   ++.++||||||+++||+++|+.||.......  .......    ..     ..+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~-----~~~~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVG----AG-----HKPP  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHh----cC-----CCCC
Confidence                234567899999988766   8899999999999999999999997543211  1111110    00     0001


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         .+........+.+++.+|++.+|.+||++.|++.
T Consensus       227 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 ---IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               1111112345667888999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.4e-34  Score=295.30  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=192.7

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||++.. .++..||+|++......    ...+.+|++++++++|||++++++++...+..++||||+++
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g  109 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG  109 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence            46799999999999995 46899999998754221    24688899999999999999999999999999999999974


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                       ++.+.+....    .+++|.++..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++...... ..
T Consensus       110 -~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~  180 (317)
T cd06635         110 -SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-NS  180 (317)
T ss_pred             -CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-cc
Confidence             7777765432    24899999999999999999999988   999999999999999999999999998765432 23


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+...  .    ......         .. .
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~----~~~~~~---------~~-~  244 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H----IAQNES---------PT-L  244 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--H----HHhccC---------CC-C
Confidence            45777899999973   4568899999999999999999999997543221111  1    111110         00 1


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ........+.+++.+|++.+|.+||++.|+++.+-...
T Consensus       245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            11122345778888999999999999999998654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=291.76  Aligned_cols=245  Identities=23%  Similarity=0.370  Sum_probs=192.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecC------ceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKD------EKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~e~  400 (625)
                      .+.||+|+||.||+|... +++.+++|++.......+.+.+|++++.++ +|+||+++++++....      ..++||||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            357999999999999964 678999999987665567899999999999 6999999999997654      37999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            999999998875431 1235899999999999999999999987   999999999999999999999999998765322


Q ss_pred             ---ccccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 ---APVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                         .....++..|+|||.+..     ..++.++|||||||++|||++|+.||......+  ....    .... ...   
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~-~~~---  236 (275)
T cd06608         167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK----IPRN-PPP---  236 (275)
T ss_pred             hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH----hhcc-CCC---
Confidence               123356778999998753     346789999999999999999999997533211  1111    1110 000   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           ..........++.+++.+|+..||++|||+.|+++
T Consensus       237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 11111223446778888999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=295.95  Aligned_cols=252  Identities=18%  Similarity=0.296  Sum_probs=188.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|++|.||+|... +++.||+|.+.....  ....+.+|++++++++|+||+++++++...+..++||||+++ +|
T Consensus        11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L   89 (291)
T cd07844          11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DL   89 (291)
T ss_pred             EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CH
Confidence            56999999999999965 689999999875432  234567899999999999999999999999999999999985 89


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++.....    .+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ...
T Consensus        90 ~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          90 KQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             HHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            888875432    4889999999999999999999998   999999999999999999999999998754321   112


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---ccccccc------cc
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEV------FD  553 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------~d  553 (625)
                      ..++..|+|||.+.+ ..++.++||||+||++|||++|+.||......  .+..........   ++....+      ..
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            235667999998865 45789999999999999999999999654311  111111111110   0000000      00


Q ss_pred             ccccC---------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLR---------YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~---------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....         .+.. ....++.+++.+|++.+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000         0000 01145678889999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2e-34  Score=295.05  Aligned_cols=241  Identities=20%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||++.. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence            35699999999999984 468899999986533 2345688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++...      .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   ..
T Consensus       104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647         104 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9998753      2789999999999999999999998   9999999999999999999999999887554322   22


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+....++.++|||||||++||+++|+.||......+....+      ...+         ....+...
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~---------~~~~~~~~  239 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG---------TPELQNPE  239 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC---------CCCCCCcc
Confidence            35667799999998888999999999999999999999999754322111100      0000         00011112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....+.+++.+||..+|++||++.+++..
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            223457788889999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=291.89  Aligned_cols=239  Identities=18%  Similarity=0.338  Sum_probs=191.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc--CChHHHHHHHHHHHcCC---CCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIR---HENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|.. .+++.||+|.++...  ....++.+|++++++++   |||++++++++......++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            36799999999999995 578999999987542  23356889999999986   9999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +++|.+++...      .+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||++....... 
T Consensus        86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999988643      4899999999999999999999998   9999999999999999999999999987764322 


Q ss_pred             --cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 --PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ....    ...     ..+....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~----~~~-----~~~~~~~  224 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLI----PKS-----KPPRLED  224 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcc----ccC-----CCCCCCc
Confidence              22356778999998865 4568999999999999999999999965432111   1100    000     0001100


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          .....++.+++.+||+.+|++||++.|+++
T Consensus       225 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 ----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                112346778888999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3e-34  Score=288.68  Aligned_cols=239  Identities=20%  Similarity=0.313  Sum_probs=192.6

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||.|+||.||++... +++.+|+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999965 589999999975432    235688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--APVI  484 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~~~  484 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||+++.....  ....
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~  152 (262)
T cd05572          81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF  152 (262)
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence            99997643     3889999999999999999999987   999999999999999999999999999876543  2234


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+....++.++|+||||+++|||++|+.||.....+. .   +.........        .....+  ..
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~~~~~~--------~~~~~~--~~  218 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M---EIYNDILKGN--------GKLEFP--NY  218 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H---HHHHHHhccC--------CCCCCC--cc
Confidence            56778999999988889999999999999999999999997654211 1   1111111100        000111  11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ...++.+++.+||..+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1346788888999999999999     566654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-34  Score=292.70  Aligned_cols=243  Identities=21%  Similarity=0.379  Sum_probs=186.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHH-HHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEI-VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||++... +|+.||+|+++.....  ...+..|+.+ ++..+||||+++++++...+..++||||++ |+
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (283)
T cd06617           7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS   85 (283)
T ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence            56999999999999954 6999999999765332  3455566665 556689999999999999999999999997 68


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      |.+++...... ...+++..+..++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        86 l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (283)
T cd06617          86 LDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT  161 (283)
T ss_pred             HHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            88877654322 24589999999999999999999986 5   9999999999999999999999999998654321  2


Q ss_pred             ccccCCCcCCccccCC----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          483 VIARAAGYRAPEVTDS----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ...++..|+|||.+.+    ..++.++|+|||||++|||++|+.||...... ....    ........      +.   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~------~~---  227 (283)
T cd06617         162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVEEPS------PQ---  227 (283)
T ss_pred             cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHhcCC------CC---
Confidence            2456778999998864    45688999999999999999999999643211 1111    11111100      00   


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+ ......++.+++.+|+..+|++||++.|+++
T Consensus       228 ~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 LP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 0112345778888999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-34  Score=292.32  Aligned_cols=251  Identities=17%  Similarity=0.245  Sum_probs=188.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCC-CCceecceeEEEec--CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIR-HENVVELKAYYYSK--DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|.. .+++.||+|+++....  ......+|+.++.++. |+|++++++++.+.  +..++||||++ 
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-   83 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-   83 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence            5699999999999995 4689999999976432  2334567888888885 99999999999987  88999999997 


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      +++.+.+....    ..++|.++..++.|++.||+|||+.+   |+||||||+||+++. +.+||+|||+++......  
T Consensus        84 ~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          84 MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            47877776532    24899999999999999999999998   999999999999999 999999999998764322  


Q ss_pred             cccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc--------ccccc
Q 006922          482 PVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW--------TAEVF  552 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  552 (625)
                      ....++..|+|||.+. +..++.++|||||||++|||++|+.||...+..+.   +.+.........        .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccc
Confidence            2234677899999764 45678899999999999999999999976543222   222221111000        00000


Q ss_pred             cccccCC------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRY------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +......      .........+.+++.+|++.+|++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000      001123467888999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-34  Score=287.83  Aligned_cols=241  Identities=22%  Similarity=0.371  Sum_probs=198.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|++|.||++... +++.|++|++.....  ..+.+.+|++.+.+++|+||+++++++...+..++||||+++++|
T Consensus         7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (264)
T cd06623           7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL   86 (264)
T ss_pred             eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence            67999999999999965 599999999976543  346799999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---  482 (625)
                      .+++...     ..+++..+..++.|+++|++|||+ .+   ++||||+|+||+++.++.++|+|||.+........   
T Consensus        87 ~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          87 ADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            9999754     248999999999999999999999 87   99999999999999999999999999887643222   


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++||||||+++|||+||+.||.........+...++.   .... .          ...
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~-~----------~~~  224 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPP-P----------SLP  224 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCC-C----------CCC
Confidence            2356778999999998889999999999999999999999997654323333333222   1100 0          001


Q ss_pred             HH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EE-EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~-~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .. ....+.+++.+|+..+|++||++.|+++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11 2346777888999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.2e-34  Score=293.53  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=190.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  402 (625)
                      .+.||+|+||.||+|... +++.+|+|.++.....   ...+.+|++++.+++||||+++++++...  +..++||||++
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~   89 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE   89 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence            467999999999999965 6899999999754322   23567899999999999999999999877  78999999998


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      + +|.+++.....    .+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++....... 
T Consensus        90 ~-~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          90 H-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             c-CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            5 88888865432    4899999999999999999999998   9999999999999999999999999988764321 


Q ss_pred             --cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccc-------
Q 006922          482 --PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWT-------  548 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-------  548 (625)
                        ....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+....+   ......   ..+       
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI---FKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCchHHHHHhhccc
Confidence              223456779999998654 4688999999999999999999999765432222111   110000   000       


Q ss_pred             -------cccccccc-cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 -------AEVFDVEL-LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 -------~~~~d~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                             ........ ...+.. .....+.+++.+|++.+|++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                   00000000 001110 01345677888999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-34  Score=289.07  Aligned_cols=240  Identities=21%  Similarity=0.377  Sum_probs=192.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||++... +|..+|+|.+....   ...+.+.+|++++++++|+||+++++.+...+..++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (257)
T cd08225           6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD   85 (257)
T ss_pred             EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence            56999999999999954 68999999987542   234568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccccc---
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSALA---  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~---  481 (625)
                      |.+++.....   ..+++..+..++.|+++||+|||+.+   ++|+||||+||++++++ .+||+|||.+.......   
T Consensus        86 L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          86 LMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            9999875432   24799999999999999999999987   99999999999999886 46999999987664322   


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||......++.++|||||||++|||++|+.||......+      ++....... .    ...   .+ 
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~----~~~---~~-  224 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQGY-F----API---SP-  224 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhccc-C----CCC---CC-
Confidence            12346778999999988889999999999999999999999996543211      111111111 1    100   01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ....++.+++.+|+..+|++|||+.|+++
T Consensus       225 --~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         225 --NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              11235677788999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-34  Score=294.08  Aligned_cols=254  Identities=17%  Similarity=0.261  Sum_probs=188.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|.||+|... +|+.||||+++....   ....+.+|++++.+++||||+++++++.+.+..++||||+. ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (284)
T cd07860           6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD   84 (284)
T ss_pred             eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence            56899999999999854 689999999875432   22568899999999999999999999999999999999996 58


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |..++.....   ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.+||+|||++.......   .
T Consensus        85 l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          85 LKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             HHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            8888865432   34899999999999999999999987   9999999999999999999999999987654221   1


Q ss_pred             ccccCCCcCCccccCCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc-c-cc---cccc--c
Q 006922          483 VIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE-W-TA---EVFD--V  554 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~-~~---~~~d--~  554 (625)
                      ...++..|+|||.+.+.. ++.++|||||||++|||+||+.||......  ....+.....-... . ..   .+.+  .
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            223567799999876544 688999999999999999999999754321  11111111100000 0 00   0000  0


Q ss_pred             cccC--CCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLR--YPNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~--~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....  ....    .....++.+++.+|++.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000  0000    011234667888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.7e-34  Score=283.87  Aligned_cols=241  Identities=25%  Similarity=0.406  Sum_probs=197.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|++|.||++... ++..+++|++..... ..+.+.+|++++++++|+|++++++++...+..++++||+++++|.
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   85 (253)
T cd05122           6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK   85 (253)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence            56999999999999965 689999999987543 4467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--PVIA  485 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~~~~  485 (625)
                      +++....    ..+++..+..++.+++.|++|||..+   ++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        86 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          86 DLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             HHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            9987642    24899999999999999999999987   9999999999999999999999999998775543  3456


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE  565 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  565 (625)
                      ++..|+|||.+.+..++.++||||||++++||++|+.||...+..+.....   ..    ......        +.....
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~----~~~~~~--------~~~~~~  223 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---AT----NGPPGL--------RNPEKW  223 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hh----cCCCCc--------Cccccc
Confidence            778899999998888999999999999999999999999754322211111   10    000100        111111


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          566 MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       566 ~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..++.+++.+|++.+|++|||+.|+++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            346778888999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-34  Score=292.25  Aligned_cols=239  Identities=20%  Similarity=0.358  Sum_probs=192.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..||+|+||.||++.. .+|..||+|++..... ....+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5699999999999986 4789999999864332 3456889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~~  484 (625)
                      +++...      .+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus       106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            887532      3789999999999999999999987   9999999999999999999999999987654321   224


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+.   ........+.         ..   .....
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~~~---------~~---~~~~~  241 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLPP---------KL---KNLHK  241 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhCCc---------cc---CCccc
Confidence            567889999999888889999999999999999999999975432222   1111111110         00   01111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+|+..+|.+||++.|+++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2235667788999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-34  Score=289.11  Aligned_cols=240  Identities=21%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||.||++... +|+.+++|++.....    ..+.+.+|++++.+++||||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 499999999976533    235688899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc------
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL------  480 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~------  480 (625)
                      .+++....     .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++......      
T Consensus        81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            99997543     4899999999999999999999987   999999999999999999999999998764322      


Q ss_pred             -----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          481 -----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       481 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                           .....++..|+|||......++.++||||||+++||+++|+.||......+.....      ....     .   
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~-----~---  218 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------LNGK-----I---  218 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC-----c---
Confidence                 12234567799999998888999999999999999999999999754432221111      1100     0   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                        ..+........+.+++.+|++.+|++|||+.++.+.|+
T Consensus       219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence              01111111346678888999999999999966665553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.6e-34  Score=290.76  Aligned_cols=257  Identities=20%  Similarity=0.313  Sum_probs=192.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||.|++|+||+|... +|..||+|+++....  ....+.+|++++++++|+||+++++++...+..++||||+++ +|
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l   84 (284)
T cd07836           6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DL   84 (284)
T ss_pred             eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cH
Confidence            56999999999999964 689999999976432  235677899999999999999999999999999999999985 88


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++++|||+++......   ..
T Consensus        85 ~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          85 KKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             HHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            888765432  235899999999999999999999988   9999999999999999999999999997653221   22


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc-----cccc
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD-----VELL  557 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----~~~~  557 (625)
                      ..++..|++||.+.+ ..++.++|||||||++|||++|+.||......+....+...........+..+.+     ....
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            345678999998765 4578899999999999999999999986554332221110000000000000000     0000


Q ss_pred             CCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...      ..+.....+.+++..|++.+|.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000      00112345678888999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.8e-34  Score=291.94  Aligned_cols=253  Identities=19%  Similarity=0.262  Sum_probs=186.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||.||+|.. .+|..||+|++......  ...+.+|+++++.++|+||+++.+++...+..++||||+. +++
T Consensus        11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l   89 (291)
T cd07870          11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL   89 (291)
T ss_pred             EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence            5699999999999985 46899999999754322  2467889999999999999999999999999999999996 677


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+.+....    ..+.+..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+++.....   ...
T Consensus        90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          90 AQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            76665432    13778889999999999999999997   999999999999999999999999998764321   122


Q ss_pred             cccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh-------------ccccc
Q 006922          484 IARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR-------------EEWTA  549 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~  549 (625)
                      ..++..|+|||.+.+. .++.++|||||||++|||++|+.||......  .+.+........             .....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            3457789999998653 5788999999999999999999999754321  111111111000             00000


Q ss_pred             ccccccccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLR----YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ++.......    ..........+.+++.+|+..||++|||+.|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000    0000011245667888999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-34  Score=292.59  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=192.9

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|.. .+|+.||+|++.....   ....+.+|+.++++++||||+++++++......++||||+ +++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~   84 (286)
T cd07832           6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD   84 (286)
T ss_pred             eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence            5699999999999995 4689999999976532   2367899999999999999999999999999999999999 999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++....    .++++.++..++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||++.......    
T Consensus        85 L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          85 LSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            999987543    34899999999999999999999998   9999999999999999999999999988764332    


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc----ccc--cccccc
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE----EWT--AEVFDV  554 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~d~  554 (625)
                      ....++..|+|||.+.+. .++.++||||+|+++|||+||++||......+.   ..++......    .+.  .+..+.
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchh
Confidence            223567789999998654 468999999999999999999888865432221   1111111100    000  000000


Q ss_pred             cccCCC---------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYP---------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~---------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....+         ...+....+.+++.+|+..+|.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000         00112356778888999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=291.09  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=191.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|... +|+.+|+|++....   .....+.+|++++.+++|+|++++++++...  +..++||||+++
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07840           5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH   84 (287)
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence            56899999999999965 58999999998653   1235688999999999999999999999988  789999999985


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                       +|.+++....    ..+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++.......  
T Consensus        85 -~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          85 -DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             -cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence             8888876542    24899999999999999999999987   9999999999999999999999999998765432  


Q ss_pred             --cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---cccccccccc-
Q 006922          482 --PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEVFDV-  554 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~-  554 (625)
                        ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||..........   .+.....   ......+.+. 
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccch
Confidence              22345667999997754 457899999999999999999999997654322221   1111110   0000000000 


Q ss_pred             ---ccc-CCC---C----cHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ---ELL-RYP---N----IEE-EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ---~~~-~~~---~----~~~-~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ... ...   .    ... ....+.+++.+|+..+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               000 000   0    001 1456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=288.80  Aligned_cols=242  Identities=20%  Similarity=0.269  Sum_probs=186.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHH-HcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIV-GSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|.. .+|+.||+|+++.....    ...+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            3589999999999985 46899999999754321    12344454444 445899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++.... ...
T Consensus        82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~  152 (260)
T cd05611          82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKK  152 (260)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-ccc
Confidence            99999987542     4788999999999999999999987   99999999999999999999999999886543 223


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..||......+......      ... ..  ...     ....
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~-~~--~~~-----~~~~  218 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------SRR-IN--WPE-----EVKE  218 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcc-cC--CCC-----cccc
Confidence            457788999999988888999999999999999999999997544322211110      000 00  000     0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                      ....++.+++.+||+.+|++||++.++.+.|
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            2234677888899999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-34  Score=293.06  Aligned_cols=257  Identities=18%  Similarity=0.244  Sum_probs=189.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCC-CCceecceeEEEecCc-----eEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDE-----KLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~e  399 (625)
                      +.||+|+||.||+|... +|+.||+|+++....   ....+.+|++++.+++ ||||+++++++...+.     .++|||
T Consensus         7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e   86 (295)
T cd07837           7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE   86 (295)
T ss_pred             eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence            56999999999999954 689999999875422   2356888999999995 6999999999987665     799999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITS  478 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~  478 (625)
                      |+++ +|.+++..........+++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.+||+|||+++...
T Consensus        87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~  162 (295)
T cd07837          87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS  162 (295)
T ss_pred             ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecC
Confidence            9986 8888887654332346899999999999999999999998   999999999999998 8899999999987653


Q ss_pred             ccc---cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh--cccccccc
Q 006922          479 ALA---PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR--EEWTAEVF  552 (625)
Q Consensus       479 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  552 (625)
                      ...   ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+  ...........  ........
T Consensus       163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCChhhCcchh
Confidence            221   12245667999998754 457899999999999999999999997543221  11111110000  00000000


Q ss_pred             ccc----ccCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVE----LLRYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~----~~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +..    .....      .......++.+++.+|+..+|.+||++.|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000    00000      00112345778889999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=300.97  Aligned_cols=255  Identities=20%  Similarity=0.315  Sum_probs=188.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecC-----ceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~  401 (625)
                      +.||+|+||+||+|.. .+|+.||+|+++....  ....+.+|+.++.+++||||+++++++....     ..++|+||+
T Consensus        11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~   90 (336)
T cd07849          11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM   90 (336)
T ss_pred             EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence            5799999999999984 5789999999974322  2356788999999999999999999876543     579999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++ ++...+...      .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        91 ~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          91 ET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             cc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            75 777777542      3899999999999999999999998   9999999999999999999999999987653221


Q ss_pred             ------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc---cccc
Q 006922          482 ------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW---TAEV  551 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  551 (625)
                            ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......   ....+........   ...+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHh
Confidence                  12356778999998654 568899999999999999999999996543211   1111111111100   0000


Q ss_pred             cccc-------ccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          552 FDVE-------LLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       552 ~d~~-------~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                      .+..       ....+.      ......++.+++.+||+.+|++|||+.|+++.  ++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0000       000000      01123457889999999999999999999875  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.3e-34  Score=298.43  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             HHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---------------HHHHHHHHHHHcCCCCceecceeEEEe
Q 006922          327 ASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---------------RDFEQQMEIVGSIRHENVVELKAYYYS  390 (625)
Q Consensus       327 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l~~~~~~  390 (625)
                      ...+.||+|+||+||+|... +++.||+|+++......               ..+.+|++++..++|+||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            34567999999999999954 68999999987542211               246789999999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       391 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                      .+..++||||+. |+|.+++....     .+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECC
Confidence            999999999997 58888886432     3889999999999999999999987   99999999999999999999999


Q ss_pred             cccccccccc-----------------ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcch
Q 006922          471 LGLTTITSAL-----------------APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDEL  532 (625)
Q Consensus       471 fGla~~~~~~-----------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~  532 (625)
                      ||+++.....                 .....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998765410                 0112346679999998654 468999999999999999999999976543222


Q ss_pred             hhHHHHHHHHhhc----ccccccc----cccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          533 VHLVRWVHSVVRE----EWTAEVF----DVELLRYPN-----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       533 ~~~~~~~~~~~~~----~~~~~~~----d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .   ..+......    .+.....    .+.....+.     ......++.+++.+|++.+|++||+++|++.
T Consensus       243 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 L---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1   111111110    0000000    000000000     0111345778889999999999999999985

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-34  Score=289.01  Aligned_cols=239  Identities=20%  Similarity=0.249  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||.|+||.||++... ++..||+|.+.....    ..+.+.+|++++++++||||+++++++...+..++|+||++++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (258)
T cd05578           6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG   85 (258)
T ss_pred             EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence            56999999999999965 589999999975432    2367889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +|.+++...     .++++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++......  ..
T Consensus        86 ~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          86 DLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence            999998754     24889999999999999999999987   999999999999999999999999998876433  22


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+....++.++|+||||+++|+|++|+.||.............    .....           .....
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~-----------~~~~~  222 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQETA-----------DVLYP  222 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhccc-----------cccCc
Confidence            3456677999999988889999999999999999999999998665432221111    11100           00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKM--PDVV  591 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~--~ev~  591 (625)
                      ......+.+++.+||..+|.+||++  +|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1223567788889999999999999  5553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.4e-34  Score=288.23  Aligned_cols=239  Identities=21%  Similarity=0.292  Sum_probs=183.9

Q ss_pred             HcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHH---HHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQM---EIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +||+|+||+||++.. .+++.||+|.+......    ...+..|.   +.+....||||+.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999985 46899999998754322    12233343   34445579999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-c
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-A  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~  481 (625)
                      +|+|..++....     .+++..+..++.|+++|++|||+.+   |+||||||+||+++.++.++|+|||++...... .
T Consensus        81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            999998886432     4899999999999999999999987   999999999999999999999999998755322 2


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....++..|+|||.+.+. .++.++||||+||++|||++|+.||.............    ....      .+...   +
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~------~~~~~---~  219 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------MAVEL---P  219 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hhhc------cCCCC---C
Confidence            234678889999998744 68999999999999999999999997653322211111    0000      00011   1


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                        .....++.+++.+|+..+|.+||     ++.|+++
T Consensus       220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              11234677788899999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=296.28  Aligned_cols=196  Identities=23%  Similarity=0.394  Sum_probs=163.5

Q ss_pred             hHcccCCceeEEEEEEc---CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE---DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  400 (625)
                      +.||+|+||.||+|...   +++.||+|.+....    ...+.+.+|++++.+++||||+++++++...  +..++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            46999999999999954   47999999998632    1235678899999999999999999999988  789999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC----CCCeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS----QQYGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DfGla~~  476 (625)
                      +++ ++.+++..........+++..+..++.|++.||+|||+.+   |+||||||+||+++.    ++.+||+|||+++.
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            985 6766665443333336889999999999999999999998   999999999999999    89999999999886


Q ss_pred             ccccc------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 006922          477 TSALA------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGG  529 (625)
Q Consensus       477 ~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~  529 (625)
                      .....      ....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            53321      12346778999998765 4578999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-33  Score=292.10  Aligned_cols=261  Identities=17%  Similarity=0.208  Sum_probs=191.1

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.+|.|+++.||++.. +++.||+|+++....   ..+.+.+|++++..++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34456666666666655 689999999976422   23578999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----  480 (625)
                      |.+++.....   ..+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+......     
T Consensus        86 l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          86 CEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999976432   23788899999999999999999998   999999999999999999999999988654221     


Q ss_pred             -----ccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc----ccc-
Q 006922          481 -----APVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE----EWT-  548 (625)
Q Consensus       481 -----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-  548 (625)
                           .....++..|+|||++..  ..++.++|||||||++|||++|+.||......  ....+........    ... 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence                 112345667999999865  35889999999999999999999999764321  1112211110000    000 


Q ss_pred             ---cc-------cccccc---cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          549 ---AE-------VFDVEL---LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       549 ---~~-------~~d~~~---~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                         ..       ..+...   ...........++.+++.+||..+|++|||+.|+++  .++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence               00       000000   000111223356788999999999999999999986  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.3e-34  Score=288.46  Aligned_cols=238  Identities=20%  Similarity=0.269  Sum_probs=186.7

Q ss_pred             cccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||+||++.. .+|+.||+|.+.....    ..+.+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999984 4689999999875321    234567899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--PVI  484 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~~~  484 (625)
                      .+++.....   ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+.......  ...
T Consensus        81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence            999875432   24899999999999999999999998   9999999999999999999999999987654321  223


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||...........+.   ......        ..   .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~--------~~---~~~~~  220 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLEM--------AV---EYPDK  220 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hccccc--------cc---cCCcc
Confidence            45677999999988889999999999999999999999997644311111111   000000        00   00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPD  589 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~e  589 (625)
                      ...++.+++.+||+.+|.+||++.|
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCc
Confidence            2335677888999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-33  Score=293.58  Aligned_cols=262  Identities=20%  Similarity=0.294  Sum_probs=193.0

Q ss_pred             hHcccC--CceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKG--TFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..||+|  +||+||++.. .+|+.||+|++......   .+.+.+|+.++..++||||+++++++...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            357777  9999999995 47999999998754332   25678899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      +++.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+......   
T Consensus        84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999998876432   23889999999999999999999987   999999999999999999999999865432111   


Q ss_pred             c-------cccccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH---------
Q 006922          481 A-------PVIARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV---------  542 (625)
Q Consensus       481 ~-------~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~---------  542 (625)
                      .       ....++..|+|||++.+.  .++.++|||||||++|||++|+.||......+.  ........         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence            0       011234569999998763  478999999999999999999999976432211  11110000         


Q ss_pred             -----------------------hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006922          543 -----------------------VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENV  597 (625)
Q Consensus       543 -----------------------~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~  597 (625)
                                             ........+.+.. ...+........+.+++.+||+.||++|||+.|+++  .++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER-LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhcccccccccccc-ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                   0000000000000 011122334567889999999999999999999985  44555


Q ss_pred             CCC
Q 006922          598 RPN  600 (625)
Q Consensus       598 ~~~  600 (625)
                      +..
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-33  Score=294.51  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=190.6

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcC-CCCceecceeEEEecC--ceEEEEEe
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKD--EKLMVYDY  400 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--~~~lv~e~  400 (625)
                      ..+.||+|+||.||+|... +|+.+|+|++....   .....+.+|+.++.++ +||||+++++++...+  ..++||||
T Consensus        11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~   90 (337)
T cd07852          11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY   90 (337)
T ss_pred             HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence            3467999999999999964 68899999986432   2234577899999999 9999999999986543  67999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      ++ ++|..++...      .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            97 5888887643      3889999999999999999999987   999999999999999999999999999865322


Q ss_pred             c--------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------h
Q 006922          481 A--------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV--------V  543 (625)
Q Consensus       481 ~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------~  543 (625)
                      .        ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+......        +
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            1        12356778999998754 46788999999999999999999999754432221111110000        0


Q ss_pred             hccccccccccccc-CCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          544 REEWTAEVFDVELL-RYPNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       544 ~~~~~~~~~d~~~~-~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                      .......+.+.... .....    .....++.+++.+||+.+|++|||+.++++.  ++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            00000001100000 00000    0123467888999999999999999999974  4443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-34  Score=294.38  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=188.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||+|... +|+.||+|+++.....   ...+.+|++++.+++|+||+++++++...  +..++||||+++
T Consensus        13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   92 (309)
T cd07845          13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ   92 (309)
T ss_pred             eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence            56999999999999964 6899999999754322   23467899999999999999999998765  468999999975


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                       +|.+++....    ..+++.++..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        93 -~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          93 -DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             -CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence             7888876543    24899999999999999999999998   9999999999999999999999999998765321  


Q ss_pred             -cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccccccc----
Q 006922          482 -PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVF----  552 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----  552 (625)
                       ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.   .....   .....+.    
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhchhhhcccc
Confidence             11234567999998865 557899999999999999999999997654333222111   11110   0000000    


Q ss_pred             --cccccCC--CCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 --DVELLRY--PNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 --d~~~~~~--~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .......  ...    ......+.+++.+|++.||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              0000000  000    011345678888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.8e-34  Score=293.27  Aligned_cols=255  Identities=19%  Similarity=0.285  Sum_probs=186.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC--------ceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD--------EKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv  397 (625)
                      +.||+|+||.||+|... +++.||||++......   ...+.+|++++++++||||+++++++...+        ..++|
T Consensus        18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv   97 (310)
T cd07865          18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV   97 (310)
T ss_pred             EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence            56999999999999954 6899999998653221   235678999999999999999999987654        34999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+.+ ++.+.+....    ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        98 ~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          98 FEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            999975 7877775432    24899999999999999999999997   999999999999999999999999999765


Q ss_pred             cccc-------cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SALA-------PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ....       ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..+......+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            3221       122456679999987654 47889999999999999999999997654433332222222111111110


Q ss_pred             cc-----ccc-cccCCC--CcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EV-----FDV-ELLRYP--NIE------EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~-----~d~-~~~~~~--~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..     ++. ......  ...      .....+.+++.+|+..+|.+|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00     000 000000  000      01234568899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-34  Score=300.33  Aligned_cols=261  Identities=22%  Similarity=0.327  Sum_probs=190.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||.||+|.. .+|+.||+|+++....   ....+.+|++++++++||||+++++++....      ..++|+|
T Consensus        21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e  100 (342)
T cd07879          21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP  100 (342)
T ss_pred             EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence            5699999999999995 4689999999875322   2356789999999999999999999987543      4589999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+.. ++..+...       .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       101 ~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879         101 YMQT-DLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             cccc-CHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            9864 66655421       3889999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc-----
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD-----  553 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  553 (625)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+................+     
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (342)
T cd07879         170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS  249 (342)
T ss_pred             CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence            4444456778999999865 4688999999999999999999999976432221111110000000000000000     


Q ss_pred             --ccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCCCC
Q 006922          554 --VELLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPND  601 (625)
Q Consensus       554 --~~~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~~~  601 (625)
                        ......+.      ......++.+++.+|++.||++||+++|++.  .++..++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence              00000000      0012235678888999999999999999995  477776543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-34  Score=291.52  Aligned_cols=245  Identities=15%  Similarity=0.212  Sum_probs=174.3

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccCCh--H----------HHHHHHHHHHcCCCCceecceeEEEecC
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNVGK--R----------DFEQQMEIVGSIRHENVVELKAYYYSKD  392 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~--~----------~~~~e~~~l~~l~h~niv~l~~~~~~~~  392 (625)
                      .++||+|+||+||+|...+    +..+|+|+........  +          ....+...+..++|+|++++++++....
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   96 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR   96 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence            3569999999999999654    3456666543221110  0          1122334455678999999999776543


Q ss_pred             ----ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeE
Q 006922          393 ----EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV  468 (625)
Q Consensus       393 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl  468 (625)
                          ..++++|++.. ++.+.+....     ..++..+..|+.|+++||+|||+.+   |+||||||+|||++.++.++|
T Consensus        97 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         97 CRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             CCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence                34677776543 5555554321     2567888999999999999999987   999999999999999999999


Q ss_pred             ecccccccccc----------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc-hhhHH-
Q 006922          469 SDLGLTTITSA----------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE-LVHLV-  536 (625)
Q Consensus       469 ~DfGla~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~~~~-  536 (625)
                      +|||+|+....          ......||..|+|||+..+..++.++|||||||++|||++|+.||....... ..... 
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999976521          1122358888999999999999999999999999999999999998763322 11111 


Q ss_pred             -HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          537 -RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       537 -~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                       ++.......         .. ..+   .....+.+++..|+..+|++||++.++++.|+
T Consensus       248 ~~~~~~~~~~---------~~-~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        248 CDFIKRLHEG---------KI-KIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHhhhh---------hh-ccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             111111111         00 011   12356778888999999999999999998763

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=289.79  Aligned_cols=255  Identities=18%  Similarity=0.271  Sum_probs=190.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|++|+||+|.. .+|..||+|++.....   ..+.+.+|++++++++|||++++++++.+.+..++||||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            35699999999999985 4799999999875432   22568889999999999999999999999999999999995 6


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....   ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++......   
T Consensus        83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            89988875432   24899999999999999999999987   9999999999999999999999999997653221   


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc--ccc-c--ccccc-
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE--EWT-A--EVFDV-  554 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-~--~~~d~-  554 (625)
                      ....++..|+|||++.+. .++.++|||||||++|||++|+.||......  .............  ... .  .+-+. 
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            122456779999987654 5788999999999999999999999754321  1111111110000  000 0  00000 


Q ss_pred             -cccCC--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 -ELLRY--PN----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 -~~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....  +.    ......++.+++.+|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00000  00    0111245678888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-33  Score=283.88  Aligned_cols=234  Identities=19%  Similarity=0.271  Sum_probs=183.0

Q ss_pred             cccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          332 LGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       332 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      ||+|+||.||++.. .++..+|+|.+........    |+.....+ +||||+++++++...+..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            69999999999995 4688999999875432211    22222222 799999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccccccccccCC
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSALAPVIARAA  488 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~  488 (625)
                      +....     .++|..+..++.|+++||+|||+.+   ++||||||+||+++.++ .++|+|||+++...... ...++.
T Consensus       100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~  170 (267)
T PHA03390        100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-CYDGTL  170 (267)
T ss_pred             HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-cCCCCC
Confidence            97643     4899999999999999999999998   99999999999999998 99999999988765332 335778


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVE  568 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  568 (625)
                      .|+|||++.+..++.++|||||||++|||++|+.||......+ .....+.... ..         .   .+........
T Consensus       171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~---------~---~~~~~~~~~~  236 (267)
T PHA03390        171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK---------K---LPFIKNVSKN  236 (267)
T ss_pred             cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc---------c---CCcccccCHH
Confidence            8999999998889999999999999999999999998543322 2222221111 00         0   0111123345


Q ss_pred             HHHHHHHccCCCCCCCCC-HHHHHH
Q 006922          569 MLQIAMSCVVRMPDQRPK-MPDVVR  592 (625)
Q Consensus       569 l~~l~~~Cl~~~P~~RPs-~~ev~~  592 (625)
                      +.+++.+|++.+|.+||+ ++|+++
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhc
Confidence            677888999999999995 688874

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.6e-34  Score=291.26  Aligned_cols=245  Identities=20%  Similarity=0.358  Sum_probs=186.1

Q ss_pred             HHhHcccCCceeEEEEEEcC-CcEEEEEEeccccC--ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..+.||+|+||+||+|...+ ++.||||+++....  ....+.+|++++.+.. ||||+++++++......++||||+.+
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   98 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST   98 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence            34679999999999999764 89999999976432  2345667777777664 99999999999999999999999864


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                       ++.+++....    ..+++..+.+++.|+++|++|||+..  +|+||||+|+||++++++.+||+|||++.......  
T Consensus        99 -~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          99 -CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             -CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence             6666665432    25899999999999999999999742  39999999999999999999999999987654322  


Q ss_pred             cccccCCCcCCccccCCCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          482 PVIARAAGYRAPEVTDSRK----ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......  .+.   ......+.         ..
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~---~~~~~~~~---------~~  237 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV---LTKILQEE---------PP  237 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH---HHHHhcCC---------CC
Confidence            2224567899999987654    788999999999999999999999643211  111   11111111         00


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ..+.......++.+++.+||..+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111111123467788889999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=289.10  Aligned_cols=252  Identities=16%  Similarity=0.269  Sum_probs=193.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|.||++... +|+.+++|+++.....   ...+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            46999999999999954 6899999998765433   45788899999999999999999999999999999999985 8


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      +.+++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||.+.......   .
T Consensus        84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            888776532    24899999999999999999999998   9999999999999999999999999987765432   1


Q ss_pred             ccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---cccccccc-----
Q 006922          483 VIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVFD-----  553 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-----  553 (625)
                      ...++..|+|||.+.+. .++.++||||+|+++|||+||+.||...+..+..   .........   .......+     
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhh
Confidence            23456679999998776 7899999999999999999999999765432211   111111100   00000000     


Q ss_pred             -ccccC--CC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 -VELLR--YP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 -~~~~~--~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....  ..    .......++.+++.+||+.+|.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00000  00    01123456889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-34  Score=298.46  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=192.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  400 (625)
                      +.||+|+||+||++.. .+++.||||.++...   .....+.+|+.++..++|+||+++++++...     ...++||||
T Consensus        11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~   90 (337)
T cd07858          11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL   90 (337)
T ss_pred             EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence            5699999999999995 468999999987532   2235677899999999999999999988654     347999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +. ++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          91 MD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            96 68888876432     4899999999999999999999997   999999999999999999999999999876432


Q ss_pred             ---ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc-
Q 006922          481 ---APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE-  555 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-  555 (625)
                         .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+..+.......+...........+.+.. 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence               122346777999998764 468899999999999999999999997543222111111000000000000000000 


Q ss_pred             ------ccCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006922          556 ------LLRYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENVRPN  600 (625)
Q Consensus       556 ------~~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~~~~  600 (625)
                            ....+      .......++.+++.+|++.+|++|||+.|+++.  ++.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                  00000      001233567788999999999999999999976  6665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-33  Score=289.20  Aligned_cols=242  Identities=21%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||+|... ++..+|+|.+.....    ..+++.+|+++++.++|+|++++.+++...+..++||||+. 
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence            467999999999999954 688999999864321    12467789999999999999999999999999999999997 


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |++.+.+....    .++++.++..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++...... ..
T Consensus        99 ~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~  170 (308)
T cd06634          99 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NX  170 (308)
T ss_pred             CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-cc
Confidence            58877765432    24889999999999999999999987   999999999999999999999999998766443 23


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+....      ......         .. .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~---------~~-~  234 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNES---------PA-L  234 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH------HhhcCC---------CC-c
Confidence            45778899999874   35678899999999999999999999865432221111      111100         00 0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      ........+.+++.+||..+|++||++.++++.--
T Consensus       235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            01123345678888999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-34  Score=313.91  Aligned_cols=260  Identities=19%  Similarity=0.273  Sum_probs=180.0

Q ss_pred             HhHcccCCceeEEEEEEcC--CcEEEEE------------------EeccccCChHHHHHHHHHHHcCCCCceecceeEE
Q 006922          329 AEVLGKGTFGMAYKAILED--GTTVVVK------------------RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY  388 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  388 (625)
                      .+.||+|+||+||++..+.  +..++.|                  .++........+.+|++++.+++||||+++++++
T Consensus       153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  232 (501)
T PHA03210        153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL  232 (501)
T ss_pred             EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence            4679999999999987432  2222222                  1111111234578999999999999999999999


Q ss_pred             EecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeE
Q 006922          389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV  468 (625)
Q Consensus       389 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl  468 (625)
                      ...+..++|+|++.+ ++.+++..................++.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus       233 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL  308 (501)
T PHA03210        233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL  308 (501)
T ss_pred             EECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            999999999999864 6766665432211112345567789999999999999998   999999999999999999999


Q ss_pred             ecccccccccccc----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHHh
Q 006922          469 SDLGLTTITSALA----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP-IHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       469 ~DfGla~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~  543 (625)
                      +|||+++......    ....|+..|+|||++.+..++.++|||||||++|||++|+.+ +.........++.+.+....
T Consensus       309 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~  388 (501)
T PHA03210        309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLS  388 (501)
T ss_pred             EeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcc
Confidence            9999998764321    234688899999999999999999999999999999998754 44333333333322222110


Q ss_pred             --hccccc---ccccc----cccCCC-CcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          544 --REEWTA---EVFDV----ELLRYP-NIEE------EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       544 --~~~~~~---~~~d~----~~~~~~-~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .++...   .+++.    .....+ ....      ...++.+++.+|++.||++|||+.|++.
T Consensus       389 ~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        389 VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000000   00000    000000 0000      1124566788999999999999999986

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-33  Score=282.44  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=196.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||++.. .++..+|+|.+......   ...+.+|++++++++|+||+++++++......++||||+++++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd08530           6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD   85 (256)
T ss_pred             eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence            5699999999999984 46889999999764322   3467789999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-cccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVI  484 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~~  484 (625)
                      |.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+|++|||+++..... ....
T Consensus        86 L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  161 (256)
T cd08530          86 LSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ  161 (256)
T ss_pred             HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccc
Confidence            9999876332 2235899999999999999999999998   999999999999999999999999999876443 2223


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+..+...   .+    ......          +....
T Consensus       162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~---~~----~~~~~~----------~~~~~  224 (256)
T cd08530         162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KV----QRGKYP----------PIPPI  224 (256)
T ss_pred             cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----hcCCCC----------CCchh
Confidence            46778999999998889999999999999999999999997654322111   11    111000          11123


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+++.+|+..+|++||++.|+++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            3456888999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-33  Score=288.48  Aligned_cols=255  Identities=19%  Similarity=0.283  Sum_probs=186.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|+||+|... +|+.||+|++.....   ..+.+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus         8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   86 (294)
T PLN00009          8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD   86 (294)
T ss_pred             EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence            56899999999999954 689999999875432   23568899999999999999999999999999999999996 47


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEecccccccccccc---
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~---  481 (625)
                      +.+++....   ...+++.....++.|++.||+|||+.+   |+||||+|+||+++. ++.+||+|||++.......   
T Consensus        87 l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         87 LKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             HHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            777765432   123578888899999999999999987   999999999999985 5578999999997653221   


Q ss_pred             cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHHhhccccccc---cccc-
Q 006922          482 PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL-VHLVRWVHSVVREEWTAEV---FDVE-  555 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~d~~-  555 (625)
                      ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+. .+........ .+..+...   .+.. 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP-NEETWPGVTSLPDYKS  239 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-Chhhccccccchhhhh
Confidence            22345678999998865 4578999999999999999999999976433221 1111110000 00000000   0000 


Q ss_pred             -ccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 -LLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 -~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ....+.      ......++.+++.+|++.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000000      0111235677888999999999999999986

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.7e-34  Score=297.94  Aligned_cols=252  Identities=19%  Similarity=0.287  Sum_probs=187.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||+|++.....   ....+.+|++++.+++||||+++++++....      ..++|||
T Consensus        22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  101 (353)
T cd07850          22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME  101 (353)
T ss_pred             EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence            5699999999999995 4789999999875322   2245778999999999999999999986542      4699999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+.+ +|.+.+...       +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       102 ~~~~-~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850         102 LMDA-NLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             ccCC-CHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            9965 777777532       788899999999999999999998   99999999999999999999999999987643


Q ss_pred             cc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHH-H-----------H----HHH
Q 006922          480 LA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV-R-----------W----VHS  541 (625)
Q Consensus       480 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~-~-----------~----~~~  541 (625)
                      ..  ....++..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+ .           .    ...
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            22  2235677899999999999999999999999999999999999754321111000 0           0    000


Q ss_pred             Hhhccc------ccccccccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEW------TAEVFDVELLRY---PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~------~~~~~d~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......      ....+.......   .........+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000000      000000000000   001112345678889999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.5e-33  Score=278.58  Aligned_cols=240  Identities=24%  Similarity=0.369  Sum_probs=196.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  403 (625)
                      +.||+|++|.||+|... +++.|++|++.....   ..+.+.+|++++++++||||+++++.+...  +..++|+||+++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   85 (260)
T cd06606           6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG   85 (260)
T ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence            56999999999999965 689999999976543   346788999999999999999999999988  889999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      ++|.+++....     .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        86 ~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          86 GSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            99999987643     4899999999999999999999987   9999999999999999999999999988765432  


Q ss_pred             ---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 ---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                         ....++..|+|||.+.+..++.++||||||++++||++|+.||.....  ...   .+..........         
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~---~~~~~~~~~~~~---------  223 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMA---ALYKIGSSGEPP---------  223 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHH---HHHhccccCCCc---------
Confidence               234567789999999888899999999999999999999999976541  111   111111000000         


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .........+.+++.+|+..+|.+||++.|+++
T Consensus       224 -~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 -EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             111122456788888999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=284.72  Aligned_cols=256  Identities=20%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +++.|++|++.....  ......+|+..+.+++ |+||+++++++...+..++||||+ +|+
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   83 (283)
T cd07830           5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN   83 (283)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence            56999999999999965 578999999876433  2234567899999998 999999999999999999999999 889


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--PV  483 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~~  483 (625)
                      |.+.+....   ...++|..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++......  ..
T Consensus        84 l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          84 LYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             HHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            998887643   124899999999999999999999988   9999999999999999999999999998764322  22


Q ss_pred             cccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhhccc-----ccccccccc
Q 006922          484 IARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH-LVRWVHSVVREEW-----TAEVFDVEL  556 (625)
Q Consensus       484 ~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~d~~~  556 (625)
                      ..++..|+|||.+. ...++.++||||||+++|||++|+.||......+... ..........+.+     .....+...
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            35677899999874 4567899999999999999999999997654322211 1110000000000     000000000


Q ss_pred             cCCC-C-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          557 LRYP-N-----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       557 ~~~~-~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .... .     ......++.+++.+||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000 0     0011356788999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.8e-34  Score=296.83  Aligned_cols=254  Identities=20%  Similarity=0.322  Sum_probs=188.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  401 (625)
                      +.||+|+||.||+|.. .+|..||+|++.....   ..+.+.+|+.++.+++||||+++++++..    ....++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~   90 (334)
T cd07855          11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM   90 (334)
T ss_pred             eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence            5699999999999995 4699999999975422   23567789999999999999999998764    34679999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      . ++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        91 ~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          91 E-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             h-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            6 58888886432     3899999999999999999999987   9999999999999999999999999987653211


Q ss_pred             -------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hhc
Q 006922          482 -------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV--------VRE  545 (625)
Q Consensus       482 -------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~  545 (625)
                             ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+......        ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence                   12356778999998765 46889999999999999999999999765432221111110000        000


Q ss_pred             ccccccccccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          546 EWTAEVFDVELLRYPN-----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +...+..+......+.     ......++.+++.+|++.+|.+||++.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0000000000000000     0112456788889999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.8e-33  Score=287.66  Aligned_cols=240  Identities=24%  Similarity=0.401  Sum_probs=188.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|.. .+|+.|++|++......    .+.+.+|+++++.++|||++++++++.+.+..++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            35699999999999995 46899999998754221    2457889999999999999999999999999999999996 


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |++.+++....    .++++.++..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||++...... ..
T Consensus       105 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-~~  176 (313)
T cd06633         105 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-NS  176 (313)
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-CC
Confidence            57777775432    24899999999999999999999998   999999999999999999999999998754332 23


Q ss_pred             cccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||..........      ....... ..     ..   
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~-~~-----~~---  241 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDS-PT-----LQ---  241 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCC-CC-----CC---
Confidence            45777899999974   4568889999999999999999999997643222111      1111110 00     00   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                       .......+.+++.+|++.+|.+||++.+++..
T Consensus       242 -~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             01112346678889999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.1e-33  Score=288.68  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=187.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecC----------ce
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD----------EK  394 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~  394 (625)
                      .+.||+|+||.||+|... +|+.||+|+++...   .....+.+|+++++.++||||+++++++....          ..
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            467999999999999965 68999999997542   22356788999999999999999999987654          78


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      ++|+||+++ ++...+....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccc
Confidence            999999986 6666665432    24899999999999999999999997   999999999999999999999999999


Q ss_pred             ccccccc----cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc--
Q 006922          475 TITSALA----PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW--  547 (625)
Q Consensus       475 ~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--  547 (625)
                      .......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+   ....+........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~  240 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLCGSPCPA  240 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChh
Confidence            8664322    11234567999998754 457889999999999999999999997543222   2222222111110  


Q ss_pred             -ccccc--------cccccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          548 -TAEVF--------DVELLRY----PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       548 -~~~~~--------d~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ...+.        +......    .........+.+++..||+.+|.+||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00000        0000000    000011345778888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=324.54  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ...||.|.||.||.|. ..+|...|+|.++-....+   ....+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            3579999999999998 5679999999997543323   56789999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+.+...+     .+++.....+..|++.|++|||+.+   ||||||||.||+|+.+|.+|++|||.|.......   
T Consensus      1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999997543     2566666778899999999999998   9999999999999999999999999998775432   


Q ss_pred             ----cccccCCCcCCccccCCCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                          ....||+.|||||++.+..   ...+.||||+|||+.||+||+.||...+.+ + +++-+|               
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~-aIMy~V--------------- 1454 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-W-AIMYHV--------------- 1454 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-h-HHHhHH---------------
Confidence                2357899999999997643   457999999999999999999999765432 1 111111               


Q ss_pred             cccCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          555 ELLRYPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       555 ~~~~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ..+..|. ++....+-.+++.+|++.||++|.++.|+++.
T Consensus      1455 ~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1222232 22233445677779999999999988877653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=273.54  Aligned_cols=258  Identities=19%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             CHHHHHHHHHhHcccCCceeEEEEE-EcCCcEEEEEEecccc-CChHHHHHHHHHHHcCC-CCceecceeEEEecCceEE
Q 006922          320 DLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       320 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  396 (625)
                      .++|+++-+.++||+|+|+.|--+. +.+|.++|||++.+.. ..+....+|++++...+ |+||+.|++||+++...|+
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            5788888899999999999999887 7789999999998763 34577889999999995 9999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGL  473 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGl  473 (625)
                      |||-|.||.|...+++.+     -+++.++.++..+||.||.|||.++   |.|||+||+|||-.+..   -+||+||.+
T Consensus       154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence            999999999999998754     3889999999999999999999998   99999999999987655   479999988


Q ss_pred             cccccc----------cccccccCCCcCCcccc-----CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-------c
Q 006922          474 TTITSA----------LAPVIARAAGYRAPEVT-----DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD-------E  531 (625)
Q Consensus       474 a~~~~~----------~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-------~  531 (625)
                      ......          ...+..|+..|||||+.     ....|+.++|.||+|||+|-|++|.+||.+.-+.       |
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            754321          11123566679999976     2447899999999999999999999999865432       2


Q ss_pred             hhhHH-HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          532 LVHLV-RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       532 ~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..... ..+-..+.++. .++-|.   .+....++   .-+++...+..++.+|-++.+++.
T Consensus       306 ~Cr~CQ~~LFesIQEGk-YeFPdk---dWahIS~e---akdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGK-YEFPDK---DWAHISSE---AKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHHHHHHHHHHHhccC-CcCChh---hhHHhhHH---HHHHHHHHHhccHHhhhhhhhccC
Confidence            22111 11222222221 111111   01112233   344555677799999999988886

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=288.37  Aligned_cols=192  Identities=24%  Similarity=0.361  Sum_probs=171.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ++||+|+||.||-++.+ .|+.+|.|.+.+...    +..-...|-.++.+++.+.||.+--.|+..+..++|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            57999999999999854 699999999876433    2344778999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc--
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~--  482 (625)
                      +|.-++.....   ..+++..+..++.+|+-||.+||...   ||.||+||+|||||++|+++|+|.|+|..+.....  
T Consensus       271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            99988876542   34899999999999999999999998   99999999999999999999999999998865433  


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTT  527 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~  527 (625)
                      ..+||.||||||++....|+...|+||+||++|||+.|+.||...
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            357999999999999999999999999999999999999999654

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-33  Score=293.80  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=188.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++.. .+++.||+|++....   ...+.+.+|++++.+++||||+++.+++.. .+..++|+||+ ++
T Consensus        16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~   94 (328)
T cd07856          16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT   94 (328)
T ss_pred             EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence            5699999999999984 479999999986532   223567889999999999999999999876 45788999998 45


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|..++...      ++++.....++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||++..........
T Consensus        95 ~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (328)
T cd07856          95 DLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY  165 (328)
T ss_pred             CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence            888887642      3788888899999999999999998   9999999999999999999999999998765443444


Q ss_pred             ccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc-------c
Q 006922          485 ARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE-------L  556 (625)
Q Consensus       485 ~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-------~  556 (625)
                      .++..|+|||.+.+ ..++.++|||||||++|||+||+.||...........+........+++...+.+..       .
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence            56778999998765 578999999999999999999999997543211111110000000000000000000       0


Q ss_pred             c-CCC-CcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          557 L-RYP-NIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       557 ~-~~~-~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      . ..+ ...    .....+.+++.+|++.+|++||++.+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0 000 001    112467788889999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=279.47  Aligned_cols=238  Identities=23%  Similarity=0.451  Sum_probs=194.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|++|.||++... +++.|++|.+.....   ....+.+|++++.+++|+|++++++++...+..++||||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (254)
T cd06627           6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS   85 (254)
T ss_pred             eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence            56999999999999854 688999999987653   23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---  482 (625)
                      |.+++....     .+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||++........   
T Consensus        86 L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          86 LRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             HHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999987542     4899999999999999999999987   99999999999999999999999999987654332   


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||...+..++.++||||+|+++|||++|+.||.....  .......    .... ..          +..
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~~----~~~~-~~----------~~~  220 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFRI----VQDD-HP----------PLP  220 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHH----hccC-CC----------CCC
Confidence            33567789999999888889999999999999999999999975432  1111111    0000 00          011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......+.+++.+|+..+|++||++.|++.
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            112346677888999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-34  Score=273.36  Aligned_cols=196  Identities=22%  Similarity=0.375  Sum_probs=165.7

Q ss_pred             HhHcccCCceeEEEEEEc---C--CcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE---D--GTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  399 (625)
                      ...||+|.||.||+|...   +  ...+|+|+++.....   .....+|+.+++.++||||+.|..++.. +...++++|
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd  108 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD  108 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence            456999999999999632   2  237999999865332   2567899999999999999999999877 678899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CCeeEecccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ----QYGCVSDLGLTT  475 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~  475 (625)
                      |.+. +|...++-.+......++-.....|+.||..|++|||++-   |+||||||.|||+..+    |.+||+|||+++
T Consensus       109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR  184 (438)
T KOG0666|consen  109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLAR  184 (438)
T ss_pred             hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence            9988 8998887776555557888899999999999999999998   9999999999999988    899999999999


Q ss_pred             ccccc------ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          476 ITSAL------APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       476 ~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      .....      ...++-|..|+|||++.+. .|+.+.||||.|||+.||+|-++-|.+..
T Consensus       185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            87432      2234567789999998765 68999999999999999999998887643

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=295.16  Aligned_cols=258  Identities=20%  Similarity=0.307  Sum_probs=190.9

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||++. ..+|..||||++......   ...+.+|++++.+++||||+++++++....      ..++|||
T Consensus        21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  100 (343)
T cd07880          21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP  100 (343)
T ss_pred             EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence            569999999999998 457999999998653222   346789999999999999999999987653      3589999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+ +++|..++...      .+++..+..++.|+++||+|||..+   |+||||||+||+++.++.++|+|||++.....
T Consensus       101 ~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         101 FM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            98 67888877532      3889999999999999999999988   99999999999999999999999999987765


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh--hcccccccccc--
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV--REEWTAEVFDV--  554 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~--  554 (625)
                      ......++..|+|||.+.+ ..++.++||||+||++|++++|+.||.........  ........  .......+...  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL--MEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHHHHhhcchhH
Confidence            4444567788999998865 45889999999999999999999999754321111  11000000  00000000000  


Q ss_pred             -----cccCC--C----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006922          555 -----ELLRY--P----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRP  599 (625)
Q Consensus       555 -----~~~~~--~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~  599 (625)
                           .+...  .    .......++.+++.+|++.||++|||+.+++.  .++....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                 00000  0    00112235678888999999999999999983  4555443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-33  Score=282.36  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=189.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcC---CCCceecceeEEEecCc-----eEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSI---RHENVVELKAYYYSKDE-----KLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~lv  397 (625)
                      +.||+|+||.||+|... +++.||+|+++.....   ...+.+|++++.++   +|+|++++++++...+.     .+++
T Consensus         5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~   84 (287)
T cd07838           5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV   84 (287)
T ss_pred             EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence            56999999999999976 5899999999754222   24566777776655   69999999999988776     8999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+.+ +|.+++.....   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          85 FEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             ehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence            999975 78888865432   24899999999999999999999998   999999999999999999999999998776


Q ss_pred             cccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh---hccccccc-
Q 006922          478 SALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV---REEWTAEV-  551 (625)
Q Consensus       478 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-  551 (625)
                      ....  ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+...  .......   ...+.... 
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHhcCCCcc
Confidence            4322  22346677999999998889999999999999999999999997644322211  1111100   00000000 


Q ss_pred             -----ccccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 -----FDVELLRY--PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 -----~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           +.......  ....+....+.+++.+||+.||.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 00000000  001122356678899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-33  Score=294.00  Aligned_cols=236  Identities=22%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ..||+|.|++|..|++. .+..||||.+.+.....   +.+.+|+++|..++|||||+++++.......|+||||+.+|.
T Consensus        62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge  141 (596)
T KOG0586|consen   62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE  141 (596)
T ss_pred             eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence            56999999999999954 69999999998764432   458899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--cccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPV  483 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--~~~~  483 (625)
                      +++++.....     .....+..++.|+..|++|+|+++   |+|||||++||||+.+.++||+|||++..+..  ....
T Consensus       142 ~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  142 LFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             hHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccccc
Confidence            9999987653     455788889999999999999998   99999999999999999999999999988753  3345


Q ss_pred             cccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC-C
Q 006922          484 IARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP-N  561 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~  561 (625)
                      .+|++.|.|||++.+..| .+.+|+||+||++|-|+.|..||++..-.+....+-      +.         .. +.+ .
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl------~g---------k~-rIp~~  277 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL------RG---------KY-RIPFY  277 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe------ee---------ee-cccce
Confidence            689999999999998887 478999999999999999999998765443322111      00         00 111 1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...   ++-+++++.+..+|.+|++++++.+
T Consensus       278 ms~---dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  278 MSC---DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eec---hhHHHHHHhhccCccccCCHHHhhh
Confidence            222   3345566899999999999999975

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=277.99  Aligned_cols=232  Identities=22%  Similarity=0.299  Sum_probs=189.8

Q ss_pred             cccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          332 LGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      ||+|+||.||++... +++.+|+|+++....    ....+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 589999999976533    234688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++....     .+++.....++.|+++|+.|+|+.+   ++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence            99997543     3899999999999999999999987   999999999999999999999999998876442   233


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||...+...+.++|+||||+++||+++|+.||...+.   ......+   ....            .+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~~------------~~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---LKDP------------LRFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---hcCC------------CCCCC
Confidence            4567789999999888889999999999999999999999965432   1111111   1100            01111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPD  589 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~e  589 (625)
                      .....+.+++.+||..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            11346678888999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.1e-33  Score=277.64  Aligned_cols=242  Identities=22%  Similarity=0.414  Sum_probs=196.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||++... ++..+++|++.....   ..+.+.+|+++++.++|||++++++.+...+..++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~   85 (258)
T cd08215           6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD   85 (258)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence            56999999999999954 689999999986543   34568899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++..... ....+++..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   .
T Consensus        86 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  161 (258)
T cd08215          86 LSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK  161 (258)
T ss_pred             HHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence            9999976531 1235899999999999999999999997   9999999999999999999999999998764432   2


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||......++.++||||+|+++++|++|+.||......+   ...   ......     .    ...+  
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~~~-----~----~~~~--  224 (258)
T cd08215         162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KILKGQ-----Y----PPIP--  224 (258)
T ss_pred             ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---HHhcCC-----C----CCCC--
Confidence            2356677999999988889999999999999999999999996543211   111   111111     0    0011  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+||..+|++||++.|+++
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            122346778888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=297.33  Aligned_cols=265  Identities=23%  Similarity=0.317  Sum_probs=195.9

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~  400 (625)
                      +.||+|+||.||+|+ ...|+.||||.++...  ...+.-.+|+++|++++|+|||++++.-.+..      ..++||||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            569999999999999 5679999999998753  33466789999999999999999999876544      56899999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCC--CeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN--SQQ--YGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~--~~~--~~kl~DfGla~~  476 (625)
                      |.+|||...|.+..  +...|++...+.+..+++.||.|||+++   |+||||||.||++-  .+|  .-||+|||.|+.
T Consensus        99 C~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             cCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999998653  3445999999999999999999999988   99999999999873  333  358999999998


Q ss_pred             ccccc--cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          477 TSALA--PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       477 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ++...  ....||..|.+||.... ..|+..+|.|||||++||.+||..||.......-...+.|.-..-...-..-..+
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            86554  45689999999999984 7889999999999999999999999976544321111112111101000000001


Q ss_pred             cccc-------CCCC----cHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHhhCC
Q 006922          554 VELL-------RYPN----IEEEMVEMLQIAMSCVVRMPDQRP--KMPDVVRVIENVRP  599 (625)
Q Consensus       554 ~~~~-------~~~~----~~~~~~~l~~l~~~Cl~~~P~~RP--s~~ev~~~L~~~~~  599 (625)
                      .+..       ..|.    .......+-++....+..+|++|-  .+.+....+..|..
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1100       0111    122234455566667778888888  66666666655543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-33  Score=293.77  Aligned_cols=254  Identities=20%  Similarity=0.300  Sum_probs=186.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec------CceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  399 (625)
                      +.||+|+||.||+|.. .+|+.||+|+++.....   .+.+.+|++++.+++||||+++++++...      ...+++++
T Consensus        23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~  102 (345)
T cd07877          23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  102 (345)
T ss_pred             EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence            4699999999999984 57899999999754322   35677899999999999999999988643      23677887


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ++ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus       103 ~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877         103 LM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             hc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            76 77888877542      3899999999999999999999998   99999999999999999999999999987655


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc-----
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD-----  553 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  553 (625)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..............+.+     
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence            4444567788999998765 5678899999999999999999999965433221111100000000000000000     


Q ss_pred             --ccccCCCC--cH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          554 --VELLRYPN--IE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       554 --~~~~~~~~--~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                        ..+...+.  ..    ....++.+++.+|++.+|.+||++.+++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              00000000  00    112356788889999999999999998863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.8e-33  Score=284.05  Aligned_cols=246  Identities=20%  Similarity=0.285  Sum_probs=191.9

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC-----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      +.||+|+||.||++..    .+++.||||.++....     ..+.+.+|++++.++ +||||+++++.+......++|||
T Consensus         6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e   85 (288)
T cd05583           6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD   85 (288)
T ss_pred             EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence            5699999999999874    3578899999975321     235678899999999 59999999999999889999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++|+|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||+++....
T Consensus        86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          86 YVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             cCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            999999999887532     3889999999999999999999987   99999999999999999999999999876533


Q ss_pred             cc----cccccCCCcCCccccCCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 LA----PVIARAAGYRAPEVTDSRK--ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~~----~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ..    ....++..|+|||.+.+..  .+.++||||||+++|||++|+.||.........  ....+......       
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~-------  228 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKSK-------  228 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHccC-------
Confidence            22    1234677899999987655  788999999999999999999999643221111  11111111110       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                           .+........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       229 -----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 -----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                 011111223567788899999999999999888877553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=280.93  Aligned_cols=257  Identities=21%  Similarity=0.312  Sum_probs=206.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCC--C----ceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH--E----NVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      ...+|+|.||.|.++... .+..||+|+++....-++...-|++++.++.+  |    -+|.+.+||...++.++|+|.+
T Consensus        94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell  173 (415)
T KOG0671|consen   94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL  173 (415)
T ss_pred             hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence            457999999999999843 57899999999877667778889999999942  2    4788999999999999999987


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------------------
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-------------------  462 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-------------------  462 (625)
                       |-++.+++..+.   ..+++...+..++.|+.++++|||+..   ++|.||||+|||+.+                   
T Consensus       174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence             448999998753   456888999999999999999999997   999999999999842                   


Q ss_pred             -CCCeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 006922          463 -QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       463 -~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  541 (625)
                       +..++|+|||.|+......+.++.|..|+|||++.+-.++.++||||+||||.|+.||..-|+..+..|...+++.+-.
T Consensus       247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG  326 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG  326 (415)
T ss_pred             CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence             2357899999999988777888999999999999999999999999999999999999999998776665555443332


Q ss_pred             Hhhccccccc----------cc-cc--ccC---------------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWTAEV----------FD-VE--LLR---------------YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~~~~----------~d-~~--~~~---------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .++.......          +| ++  ..+               ......+..++++++..++..||.+|+|+.|+++
T Consensus       327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            2211111100          00 00  000               0123456778999999999999999999999975

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=292.29  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecC-----ceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  400 (625)
                      +.||+|+||.||+|... .+..||+|++....   ...+.+.+|++++..++||||+++++++...+     ..++||||
T Consensus         6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~   85 (330)
T cd07834           6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL   85 (330)
T ss_pred             eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence            56999999999999965 58999999997643   23467889999999999999999999988765     78999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++ +|.+++....     .+++..+..++.+++.||+|||+.+   |+||||||+||+++.++.++|+|||++......
T Consensus        86 ~~~-~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          86 MET-DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             hhh-hHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            984 8888886532     5899999999999999999999998   999999999999999999999999999876543


Q ss_pred             c------cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc------
Q 006922          481 A------PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW------  547 (625)
Q Consensus       481 ~------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------  547 (625)
                      .      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...........      
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            2      223456779999999877 789999999999999999999999976653322211110000000000      


Q ss_pred             --ccccccccccCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006922          548 --TAEVFDVELLRYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENVRPN  600 (625)
Q Consensus       548 --~~~~~d~~~~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~~~~  600 (625)
                        ..+.+.. .....      ........+.+++.+||+.+|.+||++.++++.  ++.++..
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         237 EKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             cchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence              0000000 00000      001123457788899999999999999999973  6665553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=277.53  Aligned_cols=239  Identities=19%  Similarity=0.302  Sum_probs=185.9

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc------CChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN------VGKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  399 (625)
                      .+.||+|+||.||+|.. .++..||+|.+....      .....+.+|++++++++|+||+++++++.+.  +..++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            35799999999999995 468999999875321      1124688899999999999999999998764  45789999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++....     .+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            999999999887532     3788899999999999999999988   99999999999999999999999999986532


Q ss_pred             c------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 L------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      .      .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+  ...+    ..... ...   
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~-~~~---  228 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFK----IATQP-TKP---  228 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHH----HHcCC-CCC---
Confidence            1      112356778999999988889999999999999999999999997542211  1111    11000 000   


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                            .........+.+++.+|+. +|..||+..+++.
T Consensus       229 ------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 ------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  0111222456677779998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=271.89  Aligned_cols=230  Identities=23%  Similarity=0.364  Sum_probs=189.5

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccC-ChH---HHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV-GKR---DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .++||+|.||+|-.++ ...|+.+|+|++++.-. .+.   .-..|-++|...+||.+..+.-.|+..+..|.||||..|
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            4789999999999998 56799999999987532 222   245678899999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc---ccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~---~~~  480 (625)
                      |.|.-+|...+     .+++.....+...|+.||.|||+.+   ||.||+|.+|.|+|.||++||+|||+++.-   ...
T Consensus       253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            99998887654     3888888889999999999999998   999999999999999999999999999853   334


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....+||+.|+|||++....|..++|+|.+||+||||++|+.||...+.+...+++-.          .++      ++|
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------ed~------kFP  388 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------EDL------KFP  388 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh----------hhc------cCC
Confidence            4567899999999999999999999999999999999999999987665555444431          111      111


Q ss_pred             -CcHHHHHHHHHHHHHccCCCCCCCC
Q 006922          561 -NIEEEMVEMLQIAMSCVVRMPDQRP  585 (625)
Q Consensus       561 -~~~~~~~~l~~l~~~Cl~~~P~~RP  585 (625)
                       ...++.+   .+..-.+.+||.+|-
T Consensus       389 r~ls~eAk---tLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  389 RTLSPEAK---TLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCHHHH---HHHHHHhhcChHhhc
Confidence             1223333   444477889999995

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=295.59  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=188.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCc------eEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE------KLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e  399 (625)
                      ..||+|+||+||+|... +++.||+|++.....   ..+.+.+|+.++++++||||+++.+++...+.      .++|+|
T Consensus        21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  100 (343)
T cd07851          21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH  100 (343)
T ss_pred             EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence            56999999999999964 688999999875422   22457789999999999999999998876554      899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus       101 ~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851         101 LM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            98 56898888642      3899999999999999999999987   99999999999999999999999999987755


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---cccccccccc-
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEVFDV-  554 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~-  554 (625)
                      ......++..|+|||.+.+ ..++.++|||||||++||+++|+.||......+...   .+.....   +.....+.+. 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK---RIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCCCHHHHhhccchh
Confidence            4444567778999998754 467899999999999999999999997543322111   1111100   0000000000 


Q ss_pred             --------cccCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 --------ELLRYPNIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 --------~~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                              .....+...    ....++.+++.+|++.+|++|||+.||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                    000000000    11346778889999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=273.30  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=201.5

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEec-CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSK-DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  400 (625)
                      .++-+|.||.||+|.+.      +.+.|.+|.++.....  -..+..|.-++..+.|||+..+.+++..+ +..+++|.+
T Consensus       290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~  369 (563)
T KOG1024|consen  290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA  369 (563)
T ss_pred             hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence            46789999999999643      3456777877754322  24467777788888999999999998765 467899999


Q ss_pred             ccCCChhhhhccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          401 YSLGSVSAMLHSERGE---GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +.-|+|..+|...++.   ..+.++-.+...++.|++.|++|||..+   |||.||.++|+++|+...+||+|=.+++.+
T Consensus       370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDL  446 (563)
T ss_pred             cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcccc
Confidence            9999999999855532   2345777788999999999999999998   999999999999999999999999999977


Q ss_pred             cccccc-----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 006922          478 SALAPV-----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV  551 (625)
Q Consensus       478 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  551 (625)
                      -+..+.     ..+...||+||.+....|+.++|||||||+||||+| |+.||...+..|....+.       ++     
T Consensus       447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-------dG-----  514 (563)
T KOG1024|consen  447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-------DG-----  514 (563)
T ss_pred             CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-------cc-----
Confidence            544332     234456999999999999999999999999999999 999998777665544332       11     


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       552 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                           .+..++..+..+++.+|.-||+..|++||+++|++.-|.++.
T Consensus       515 -----yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  515 -----YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             -----ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                 122334566778999999999999999999999999888764

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.4e-33  Score=286.68  Aligned_cols=255  Identities=24%  Similarity=0.324  Sum_probs=184.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC--------ceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD--------EKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv  397 (625)
                      +.||+|+||.||+|... +++.+|+|++.....   ....+.+|++++.+++||||+++++++....        ..++|
T Consensus        14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv   93 (311)
T cd07866          14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV   93 (311)
T ss_pred             EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence            56999999999999954 689999999865422   1246788999999999999999999875543        35899


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +||+.. ++...+....    ..+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||+++..
T Consensus        94 ~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          94 TPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            999875 6666665432    24899999999999999999999998   999999999999999999999999999765


Q ss_pred             cccc--------------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 006922          478 SALA--------------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       478 ~~~~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                      ....              ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            3211              11234667999998764 45789999999999999999999999765433222221111000


Q ss_pred             hhcccc------ccccc-ccccCCC-CcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          543 VREEWT------AEVFD-VELLRYP-NIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       543 ~~~~~~------~~~~d-~~~~~~~-~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..+...      ....+ ......+ ...    .....+.+++.+|++.+|++|||+.|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000      00000 0000000 001    11245778889999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-32  Score=281.28  Aligned_cols=241  Identities=20%  Similarity=0.315  Sum_probs=186.6

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC-----ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      +.||+|+||.||++..    .+|..||+|+++....     ..+.+.+|++++.++ +|+||+++++++......++|||
T Consensus         6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (290)
T cd05613           6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD   85 (290)
T ss_pred             eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence            5699999999999985    3689999999975321     235678899999999 59999999999999889999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++....     .+++.....++.|+++||+|||+.+   ++||||+|+|||++.++.+||+|||++.....
T Consensus        86 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          86 YINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            999999999987542     3788899999999999999999987   99999999999999999999999999876543


Q ss_pred             cc----cccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 LA----PVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 ~~----~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ..    ....++..|+|||.+..  ..++.++||||||+++|||++|+.||.........  ...........       
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~-------  228 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-------  228 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhccC-------
Confidence            21    12346778999999865  34678999999999999999999999643221111  11111111110       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                           .+........+.+++.+|++.+|++||     +..+++.
T Consensus       229 -----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 -----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 011111233566788899999999997     5566654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.4e-33  Score=278.19  Aligned_cols=241  Identities=20%  Similarity=0.314  Sum_probs=187.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||++... .+..+++|.++....      ....+.+|+.++.+++||||+++++++.+....++||||++
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (260)
T cd08222           6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE   85 (260)
T ss_pred             eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence            56999999999999854 345566666654221      22356788999999999999999999999889999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +++|.+++..... ....+++..+..++.|++.|++|||+.+   ++|+||||+||++++ +.++|+|||+++...... 
T Consensus        86 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          86 GRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             CCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            9999998875432 2235899999999999999999999987   999999999999975 569999999987653321 


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ....   .......         ..  
T Consensus       161 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~---~~~~~~~---------~~--  223 (260)
T cd08222         161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVV---LRIVEGP---------TP--  223 (260)
T ss_pred             cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHH---HHHHcCC---------CC--
Confidence              223467789999999888889999999999999999999999964321   1111   1111110         00  


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........++.+++.+|+..+|++||++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111223356778889999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.2e-33  Score=282.78  Aligned_cols=237  Identities=17%  Similarity=0.313  Sum_probs=191.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||++... +|+.||+|++.....    ..+.+.+|++++.+++ ||||+++++++...+..++||||+++
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd05581           7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN   86 (280)
T ss_pred             eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence            46999999999999954 799999999976322    2356788999999998 99999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  482 (625)
                      ++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++........ 
T Consensus        87 ~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          87 GELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999997643     4899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             ----------------------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 006922          483 ----------------------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       483 ----------------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  540 (625)
                                            ...++..|+|||......++.++||||||++++|+++|+.||........   ...+ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~-  234 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQKI-  234 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH-
Confidence                                  12356779999999888899999999999999999999999976542111   1111 


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKM----PDVVR  592 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~ev~~  592 (625)
                        ....            ..........+.+++.+|+..+|.+||++    +|+++
T Consensus       235 --~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         235 --LKLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HhcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              1100            01111123467788889999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=268.47  Aligned_cols=248  Identities=18%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             HHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe----cCceEEEE
Q 006922          325 LRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS----KDEKLMVY  398 (625)
Q Consensus       325 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~  398 (625)
                      +..+.++||-|-.|.|..+.++ .|+.+|+|++.+.    ...++|+++--.. .|||||.++++|.+    ....++||
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            3345689999999999999854 6899999999863    4566778775555 69999999999865    34568999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEecccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTT  475 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~  475 (625)
                      |+|+||.|.+.+....   ...+++.++-.|..||+.|+.|||+.+   |.||||||+|+|...   +..+||+|||+|+
T Consensus       139 E~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             ecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccc
Confidence            9999999999998654   346899999999999999999999999   999999999999965   4568999999999


Q ss_pred             cccc--cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          476 ITSA--LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       476 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ....  .....+-|+.|.|||++..++|+..+|+||+||++|-|++|.+||....+..+-.   -++..++.+.    ++
T Consensus       213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp---gMk~rI~~gq----y~  285 (400)
T KOG0604|consen  213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKRRIRTGQ----YE  285 (400)
T ss_pred             ccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh---hHHhHhhccC----cc
Confidence            8763  2233455778999999999999999999999999999999999998766533221   1122222211    00


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        . ..+......++.-++++..+..+|.+|-|+.|++.
T Consensus       286 --F-P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  286 --F-PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             --C-CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence              0 01222333455566777888999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-33  Score=280.62  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=192.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||.||+|... +++.+|+|++....   ...+.+..|++++++++|+|++++++++...+..++||||++ ++
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence            56999999999999965 58999999998653   223567889999999999999999999999999999999998 58


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++....    ..+++..+.+++.++++||+|||+.+   |+||||+|+||++++++.++|+|||+++......   .
T Consensus        84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            999997642    24899999999999999999999997   9999999999999999999999999988664322   1


Q ss_pred             ccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---ccccccc-----cc
Q 006922          483 VIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEV-----FD  553 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~d  553 (625)
                      ...++..|+|||.+.+. .++.++|||||||++|||++|+.||......+.   ...+.....   +.....+     ++
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccccc
Confidence            22345669999998766 789999999999999999999999966432211   111111110   0000000     01


Q ss_pred             ccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........      .......+.+++.+|+..+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            01111000      0011346788899999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.9e-33  Score=274.67  Aligned_cols=221  Identities=19%  Similarity=0.198  Sum_probs=176.6

Q ss_pred             CCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhhhccc
Q 006922          335 GTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSE  413 (625)
Q Consensus       335 G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  413 (625)
                      |.||.||++.. .+++.+|+|+++...    .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            89999999995 478999999997642    3344555555667999999999999999999999999999999998754


Q ss_pred             cCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccCCCcCCc
Q 006922          414 RGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAP  493 (625)
Q Consensus       414 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aP  493 (625)
                      .     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||.+...........++..|+||
T Consensus        80 ~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aP  151 (237)
T cd05576          80 L-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAP  151 (237)
T ss_pred             c-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCC
Confidence            2     3899999999999999999999987   9999999999999999999999999887665544344456679999


Q ss_pred             cccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHH
Q 006922          494 EVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIA  573 (625)
Q Consensus       494 E~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  573 (625)
                      |...+..++.++||||+|+++|||++|+.|+...... ..           .     ....   ..+  .....++.+++
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~-----------~-----~~~~---~~~--~~~~~~~~~li  209 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN-----------T-----HTTL---NIP--EWVSEEARSLL  209 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc-----------c-----cccc---CCc--ccCCHHHHHHH
Confidence            9998888999999999999999999999887532110 00           0     0000   001  11223567788


Q ss_pred             HHccCCCCCCCCCHHH
Q 006922          574 MSCVVRMPDQRPKMPD  589 (625)
Q Consensus       574 ~~Cl~~~P~~RPs~~e  589 (625)
                      .+|++.||++||++.+
T Consensus       210 ~~~l~~dp~~R~~~~~  225 (237)
T cd05576         210 QQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHccCCHHHhcCCCc
Confidence            8999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5e-33  Score=306.39  Aligned_cols=247  Identities=23%  Similarity=0.335  Sum_probs=177.0

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecC--
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD--  392 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  392 (625)
                      .-+++++     ++||+||||.|||++.+ ||+.||||++....  .......+|+..+++++|||||+++..+.+..  
T Consensus       478 ~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  478 LNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            3355555     67999999999999954 89999999998653  22356789999999999999999987651100  


Q ss_pred             --------------------------------------------------------------------------------
Q 006922          393 --------------------------------------------------------------------------------  392 (625)
Q Consensus       393 --------------------------------------------------------------------------------  392 (625)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------------ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHH
Q 006922          393 -------------------------------------EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR  435 (625)
Q Consensus       393 -------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  435 (625)
                                                           ..||=||||+...+.++++.+.-.    -.-....+++.+|+.
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILE  708 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHH
Confidence                                                 123455666666666665544311    024566789999999


Q ss_pred             HHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---------------------ccccccccCCCcCCcc
Q 006922          436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---------------------ALAPVIARAAGYRAPE  494 (625)
Q Consensus       436 ~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---------------------~~~~~~~~~~~y~aPE  494 (625)
                      ||+|+|+++   ||||||||.||++|++..+||+|||+|+...                     ...+..+||.-|+|||
T Consensus       709 GLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            999999998   9999999999999999999999999998621                     0123356788899999


Q ss_pred             ccCCC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHH
Q 006922          495 VTDSR---KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQ  571 (625)
Q Consensus       495 ~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  571 (625)
                      ++.+.   +|+.|+||||+|||++||+.   ||..     .++.+..+...- ......--       ....+.+..-.+
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~LR-~g~iP~~~-------~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTNLR-KGSIPEPA-------DFFDPEHPEEAS  849 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHhcc-cCCCCCCc-------ccccccchHHHH
Confidence            98754   49999999999999999996   4532     222233222221 11111100       011222334457


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 006922          572 IAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       572 l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ++.++++.||.+|||+.|+++
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            788999999999999999875

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-32  Score=287.13  Aligned_cols=254  Identities=21%  Similarity=0.265  Sum_probs=183.3

Q ss_pred             hHcccCCceeEEEEEEc-C--CcEEEEEEeccccC---ChHHHHHHHHHHHcC-CCCceecceeEEEec----CceEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-D--GTTVVVKRLKDVNV---GKRDFEQQMEIVGSI-RHENVVELKAYYYSK----DEKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lv~  398 (625)
                      +.||+|+||.||++... .  +..||+|++.....   ..+.+.+|++++.++ +||||+++++++...    ...++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~   85 (332)
T cd07857           6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE   85 (332)
T ss_pred             EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence            56999999999999954 4  78999999875322   235678899999999 599999999875432    3567888


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+. ++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          86 ELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             eccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            8886 58888886432     4899999999999999999999998   9999999999999999999999999998653


Q ss_pred             cc-------ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          479 AL-------APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       479 ~~-------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ..       .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.........+....
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            21       122356778999998765 5689999999999999999999999976442221111000000000000000


Q ss_pred             cccc-------cccCCC--Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDV-------ELLRYP--NI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~-------~~~~~~--~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.+.       .....+  ..    ......+.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000       000000  00    011346778888999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=304.91  Aligned_cols=193  Identities=22%  Similarity=0.295  Sum_probs=170.4

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.++||+|+||.|..++++ .++.||+|++++..    ....-|..|-++|..-+.+.||.++-.|++.++.|+|||||+
T Consensus        79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p  158 (1317)
T KOG0612|consen   79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP  158 (1317)
T ss_pred             HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence            4578999999999999964 68899999998743    234568999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      ||+|-.++.+..     .+++.-+..++..|+-||.-+|+.+   +|||||||+|||||..|++||+|||.+..+.... 
T Consensus       159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            999999998754     3777778889999999999999998   9999999999999999999999999998776432 


Q ss_pred             ---cccccCCCcCCccccC----C-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          482 ---PVIARAAGYRAPEVTD----S-RKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~----~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                         ...+||+.|++||++.    + +.|+..+|+||+||++|||+.|..||+..+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence               2357999999999984    2 578999999999999999999999997643

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.5e-33  Score=289.43  Aligned_cols=253  Identities=24%  Similarity=0.323  Sum_probs=182.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEec--------------Cc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSK--------------DE  393 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~~  393 (625)
                      +.||+|+||.||+|.. .+|+.||+|++...... .+.+.+|++++++++||||+++++++...              ..
T Consensus        11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (342)
T cd07854          11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS   90 (342)
T ss_pred             EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence            5699999999999995 46899999998765432 35688999999999999999999876543              34


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLG  472 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfG  472 (625)
                      .++||||++ ++|.+++...      .+++.....++.|++.||+|||+.+   |+||||||+||+++. ++.+|++|||
T Consensus        91 ~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          91 VYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             EEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence            689999997 5888877532      3889999999999999999999988   999999999999985 5578999999


Q ss_pred             ccccccccc------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc
Q 006922          473 LTTITSALA------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE  545 (625)
Q Consensus       473 la~~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  545 (625)
                      +++......      ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            997653211      12245667999997654 56788999999999999999999999765432211111000000000


Q ss_pred             ccccc--------cc-cccccCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          546 EWTAE--------VF-DVELLRYPN---IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       546 ~~~~~--------~~-d~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +...+        .. +......+.   ......++.+++.+|++.||.+|||++|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000        00 000000000   0012245678888999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=287.86  Aligned_cols=231  Identities=21%  Similarity=0.231  Sum_probs=187.3

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      ..+|.|+|+.|-++. ..+++..+||++.+.   ..+..+|+.++... +||||+++.+.+.+..+.++|||.+.++-+.
T Consensus       328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell  404 (612)
T KOG0603|consen  328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL  404 (612)
T ss_pred             cccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence            359999999999988 456899999999875   34566778777766 6999999999999999999999999999888


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-CCCCCeeEeccccccccccccccccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL-NSQQYGCVSDLGLTTITSALAPVIAR  486 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~~~~~~~  486 (625)
                      +.+...+      .....+..|+.+|+.|+.|||.++   |||||+||+|||+ ++.++++|+|||.++........-+-
T Consensus       405 ~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~  475 (612)
T KOG0603|consen  405 RRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL  475 (612)
T ss_pred             HHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence            7776554      222667789999999999999988   9999999999999 69999999999999988766333355


Q ss_pred             CCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhhcccccccccccccCCCCcHHH
Q 006922          487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD-ELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE  565 (625)
Q Consensus       487 ~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  565 (625)
                      |..|.|||+.....|++++|+||+|++||||++|+.||.....+ ++...+.       ..             +..+..
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~-------~~-------------~~s~~v  535 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ-------MP-------------KFSECV  535 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc-------CC-------------cccccc
Confidence            67899999999999999999999999999999999999877655 2221111       11             111222


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          566 MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       566 ~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..+..+++.+|++.||.+||+|.++..
T Consensus       536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  536 SDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CHHHHHHHHHhccCChhhCcChhhhcc
Confidence            234455666999999999999999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.8e-32  Score=270.60  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=188.3

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCCh--------HHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK--------RDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  398 (625)
                      ..+||+|+|+.||||. +...+.||||+-.-...++        +...+|.+|-..+.||.||++++|+.- .+.+|-|+
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            4679999999999999 5568889999754322111        346789999999999999999999975 46789999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEecccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTT  475 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~  475 (625)
                      |||+|.+|.-+|+..+     .+++..+..|+.||+.||.||.+. ++||||-||||.||||-+   .|.+||.|||+++
T Consensus       548 EYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             eecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            9999999999998765     489999999999999999999987 578999999999999954   4789999999999


Q ss_pred             ccccccc----------ccccCCCcCCccccC----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 006922          476 ITSALAP----------VIARAAGYRAPEVTD----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       476 ~~~~~~~----------~~~~~~~y~aPE~~~----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      .+.+...          ...||+.|++||.+.    -.+.+.|+||||.|||+|..+.|+.||.....  ..++++    
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq----  695 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ----  695 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh----
Confidence            9865432          246888999999874    23578899999999999999999999965322  111111    


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ++..-.......+..|....+...   ++++|++..-++|....++..
T Consensus       696 ---eNTIlkAtEVqFP~KPvVsseAka---FIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ---ENTILKATEVQFPPKPVVSSEAKA---FIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ---hhchhcceeccCCCCCccCHHHHH---HHHHHHHhhhhhhhhHHHHcc
Confidence               111111111122233444444444   556999999999998877754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=8.4e-32  Score=303.99  Aligned_cols=138  Identities=18%  Similarity=0.316  Sum_probs=123.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +++.||+|+++.....    ...+.+|++++..++||||+++++++...+..++||||++++
T Consensus        10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~   89 (669)
T cd05610          10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG   89 (669)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence            56999999999999965 6899999999754322    256888999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +|.+++....     .+++..+..|+.||+.||+|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          90 DVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999987542     3788899999999999999999987   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.3e-33  Score=271.92  Aligned_cols=200  Identities=22%  Similarity=0.325  Sum_probs=169.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh----HHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK----RDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ..+||+|+||.|..|..+ ....+|||++++...-+    +--..|-++|+.- +-|.++++..+|+..+..|.||||+.
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn  433 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN  433 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence            357999999999999865 45789999998753221    2234566666655 57899999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc---cc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SA  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~---~~  479 (625)
                      +|+|.-.+.....     +.+..+..+|..||-||-+||+++   ||.||||.+|||||.+|++||+|||+++.-   ..
T Consensus       434 GGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  434 GGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             CchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            9999988876542     677788999999999999999998   999999999999999999999999999753   22


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHH
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV  536 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~  536 (625)
                      .+....||+.|+|||++..++|+..+|+|||||+||||+.|++||++.+++|..+.+
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI  562 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI  562 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            234568999999999999999999999999999999999999999987766655433

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=5.8e-32  Score=244.22  Aligned_cols=206  Identities=19%  Similarity=0.317  Sum_probs=166.6

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC--hHHHHHHHHHHH-cCCCCceecceeEEEecCce
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG--KRDFEQQMEIVG-SIRHENVVELKAYYYSKDEK  394 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~  394 (625)
                      |+...-.......||+|+||.|-+-++ .+|+..|+|+++..-..  ++...+|+++.. ....|.+|+++|.+......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444433334567799999999999884 57999999999875433  456777777654 45799999999999999999


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      ++.||.|.. +|..+-++--. ....+++...-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|+||||++
T Consensus       121 wIcME~M~t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            999999975 66655443322 2234788889999999999999999987  5999999999999999999999999999


Q ss_pred             ccccccc--cccccCCCcCCccccCC----CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          475 TITSALA--PVIARAAGYRAPEVTDS----RKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       475 ~~~~~~~--~~~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      ..+.+..  +...|...|||||.+..    ..|+.|+||||+|+++.||++++.||....
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            8775442  22467788999998853    378999999999999999999999997643

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=277.80  Aligned_cols=250  Identities=20%  Similarity=0.329  Sum_probs=195.9

Q ss_pred             cCHHHHHHHH-HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCc
Q 006922          319 FDLEDLLRAS-AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE  393 (625)
Q Consensus       319 ~~~~~~~~~~-~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  393 (625)
                      .++..+++.. .++||+|-||+||-|.+ ++|+.||||++.+...   ....+.+|+.||++++||.||.+...|+..+.
T Consensus       558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER  637 (888)
T ss_pred             hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence            4455555443 57899999999999995 4799999999987643   23568999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEec
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSD  470 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~D  470 (625)
                      .++|||-+.|--|.-.|...++    .|++.....+..||+.||.|||.++   |+|+||||+|||+.+..   .+||+|
T Consensus       638 vFVVMEKl~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  638 VFVVMEKLHGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             EEEEehhhcchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecc
Confidence            9999999876555555554332    3888888889999999999999998   99999999999997653   689999


Q ss_pred             cccccccccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          471 LGLTTITSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       471 fGla~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      ||+|++....  ...+.||+.|+|||++....|...-||||.|||+|--++|..||...  +++.+.++-+.-+.+.+. 
T Consensus       711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~P-  787 (888)
T KOG4236|consen  711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNP-  787 (888)
T ss_pred             ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCc-
Confidence            9999998654  34578999999999999999999999999999999999999999642  344444443322222222 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                                   ..+...+.++++...++..-.+|-|.++.+
T Consensus       788 -------------W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 -------------WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                         223333455556666667777777776544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=236.15  Aligned_cols=256  Identities=19%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|.||+||||+. ..+..||+|+.+-...+   .....+|+-+++.++|.|||++++....++..-+|+|||.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            36799999999999994 46889999999754332   35688999999999999999999999999999999999975 


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|..+.....+.    ++-+....++.|+.+||.|+|+++   +.|||+||.|.|++.+|+.|++|||+++...-..   
T Consensus        86 dlkkyfdslng~----~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   86 DLKKYFDSLNGD----LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHHHHHhcCCc----CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            788887766543    888899999999999999999998   9999999999999999999999999998765322   


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccc---ccccc
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEV---FDVEL  556 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~~  556 (625)
                      ....-|..|++|.++.+. -|++..|+||-||++.|+.. |++-|.+.+.++....+-|+-....++.+..+   -|...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            112346679999998665 58999999999999999998 88778766554444444343333333322222   22211


Q ss_pred             c-CCCCc---HHHHHH----HHHHHHHccCCCCCCCCCHHHHHH
Q 006922          557 L-RYPNI---EEEMVE----MLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       557 ~-~~~~~---~~~~~~----l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      . .++..   ......    =.++....+.-+|.+|.++++.++
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1 11111   111111    134555666678999999988765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=283.62  Aligned_cols=243  Identities=20%  Similarity=0.358  Sum_probs=201.6

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe-----cCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS-----KDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~~  401 (625)
                      .++||.|.+|.||+++ .++++..|+|++.......++.+.|.+++... .|||++.++|+|.-     ++.+++|||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC  103 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC  103 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence            3679999999999999 56799999999988777778899999999888 69999999999864     46789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--  479 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--  479 (625)
                      .+|+..++++...+   ..+.|..+..|+..+++|+.+||...   ++|||||-.|||++.++.+|+.|||++..+..  
T Consensus       104 ~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  104 GGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             CCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            99999999987762   34899999999999999999999987   99999999999999999999999999987753  


Q ss_pred             -cccccccCCCcCCccccCCC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          480 -LAPVIARAAGYRAPEVTDSR-----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       480 -~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                       ......||+.|||||++...     .|+..+|+||+|++..||.-|.+|+.++......  ..     +..+.     -
T Consensus       178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL--F~-----IpRNP-----P  245 (953)
T KOG0587|consen  178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL--FL-----IPRNP-----P  245 (953)
T ss_pred             ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--cc-----CCCCC-----C
Confidence             23456789999999998543     5778999999999999999999999876542111  00     00000     0


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +   .....+...+++.+++..|+.+|-+.||++.++++
T Consensus       246 P---kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 P---KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             c---cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1   11234567788999999999999999999998874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.3e-31  Score=259.16  Aligned_cols=235  Identities=23%  Similarity=0.362  Sum_probs=190.8

Q ss_pred             CceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhhhcc
Q 006922          336 TFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHS  412 (625)
Q Consensus       336 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  412 (625)
                      +||.||+|... +|+.+|+|++......  .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 4899999999865433  47899999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--ccccccCCCc
Q 006922          413 ERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--APVIARAAGY  490 (625)
Q Consensus       413 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~~~~~~~~y  490 (625)
                      ..     .+++..+..++.+++++++|||..+   ++|+||+|+||+++.++.++++|||.+......  .....++..|
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence            43     2789999999999999999999987   999999999999999999999999999877542  3344567789


Q ss_pred             CCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHH
Q 006922          491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEML  570 (625)
Q Consensus       491 ~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  570 (625)
                      ++||......++.++||||||++++|+++|..||.....  .....+...    .....        ..........++.
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~  218 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG----KPKPP--------FPPPEWKISPEAK  218 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh----ccCCC--------CccccccCCHHHH
Confidence            999999888889999999999999999999999965321  122222111    10000        0000000234678


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 006922          571 QIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       571 ~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            8888999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.5e-32  Score=253.32  Aligned_cols=256  Identities=20%  Similarity=0.340  Sum_probs=192.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccc--cCC-hHHHHHHHHHHHcCCCCceecceeEEEec--------CceEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV--NVG-KRDFEQQMEIVGSIRHENVVELKAYYYSK--------DEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv  397 (625)
                      ..||+|.||.||+|+. +.|+.||+|+.--.  ..+ .....+|++++..++|+|++.++..|...        ...++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            5799999999999995 45888888765321  222 36788999999999999999999988542        347999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |++|+. +|..+|....    ..++..++.+++.++..||.|+|...   |+|||+|+.|+|++.++.+||+|||+++..
T Consensus       103 f~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             HHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccce
Confidence            999987 8888886543    23888899999999999999999987   999999999999999999999999999766


Q ss_pred             ccccc-------ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SALAP-------VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      +....       ..+-|..|++||.+.+ +.|+++.|||.-|||+.||+||.+-+++........++..+-..+..+.+.
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            43221       1233677999998765 568999999999999999999999998766555545444333323233222


Q ss_pred             ccccccccC-----------CCCcHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          550 EVFDVELLR-----------YPNIEEEMV------EMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       550 ~~~d~~~~~-----------~~~~~~~~~------~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ++....+..           ....++.+.      +.++++...+..||.+|+++++++..
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            222111110           001122222      45677789999999999999998753

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-30  Score=268.08  Aligned_cols=196  Identities=26%  Similarity=0.346  Sum_probs=167.6

Q ss_pred             hHcccCCceeEEEEEEcC-CcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||-|+||+|.+++..| ...+|.|.|++...-.    .....|-+||...+.+.||+|+-.|++++.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            459999999999999554 6678999998653321    34678999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc------
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------  478 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~------  478 (625)
                      ++..+|-+..     .+.+..+..++..++.|+++.|..+   +|||||||+|||||.||++||.|||+++-+.      
T Consensus       715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            9999987643     3777778888889999999999998   9999999999999999999999999974210      


Q ss_pred             ---c------------------------------------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh
Q 006922          479 ---A------------------------------------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT  519 (625)
Q Consensus       479 ---~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt  519 (625)
                         .                                    .....+||..|+|||++....|+.-+|+||.|||||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence               0                                    0112457888999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcchh
Q 006922          520 GKSPIHTTGGDELV  533 (625)
Q Consensus       520 G~~p~~~~~~~~~~  533 (625)
                      |++||......+..
T Consensus       867 g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQ  880 (1034)
T ss_pred             CCCCccCCCCCcce
Confidence            99999877665544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.3e-29  Score=279.24  Aligned_cols=255  Identities=16%  Similarity=0.182  Sum_probs=159.8

Q ss_pred             HhHcccCCceeEEEEEEc-C----CcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeE------EEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-D----GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY------YYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~~lv  397 (625)
                      .+.||+|+||+||+|... +    +..||+|++...... +....+  .+....+.+++.++..      +....+.++|
T Consensus       137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV  213 (566)
T PLN03225        137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV  213 (566)
T ss_pred             eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence            367999999999999964 4    689999988643211 111111  1122222233322221      2345678999


Q ss_pred             EEeccCCChhhhhccccCC---------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 006922          398 YDYYSLGSVSAMLHSERGE---------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS  462 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~  462 (625)
                      |||+++++|.+++......               .........+..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus       214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~  290 (566)
T PLN03225        214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSE  290 (566)
T ss_pred             EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeC
Confidence            9999999999988753210               0001123345679999999999999987   999999999999986


Q ss_pred             -CCCeeEeccccccccccc----ccccccCCCcCCccccCCC----------------------CCCCccchhhhHHHHH
Q 006922          463 -QQYGCVSDLGLTTITSAL----APVIARAAGYRAPEVTDSR----------------------KATQASDVYSFGVVLL  515 (625)
Q Consensus       463 -~~~~kl~DfGla~~~~~~----~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwS~Gvil~  515 (625)
                       ++.+||+|||+|+.....    .....+++.|+|||.+...                      .++.++|||||||++|
T Consensus       291 ~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~  370 (566)
T PLN03225        291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL  370 (566)
T ss_pred             CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence             579999999999865322    2234678889999965322                      2345679999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHHhhc-cccccccccc----cc-CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006922          516 EILTGKSPIHTTGGDELVHLVRWVHSVVRE-EWTAEVFDVE----LL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD  589 (625)
Q Consensus       516 elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~----~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  589 (625)
                      ||+++..|+..    +.......+...-.+ ..+.......    .. .............+++.+|++.||++|||+.|
T Consensus       371 el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        371 QMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            99998776532    111111111100000 0000000000    00 00000011123457888999999999999999


Q ss_pred             HHHH
Q 006922          590 VVRV  593 (625)
Q Consensus       590 v~~~  593 (625)
                      +++.
T Consensus       447 ~L~H  450 (566)
T PLN03225        447 ALAH  450 (566)
T ss_pred             HhCC
Confidence            9873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=270.23  Aligned_cols=255  Identities=17%  Similarity=0.244  Sum_probs=170.8

Q ss_pred             HhHcccCCceeEEEEEE-----------------cCCcEEEEEEeccccCC-hHH--------------HHHHHHHHHcC
Q 006922          329 AEVLGKGTFGMAYKAIL-----------------EDGTTVVVKRLKDVNVG-KRD--------------FEQQMEIVGSI  376 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~-~~~--------------~~~e~~~l~~l  376 (625)
                      .++||+|+||+||+|..                 .+++.||||+++..... .++              ...|+.++.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            36799999999999963                 24578999998753221 122              33466777777


Q ss_pred             CCCce-----ecceeEEEe--------cCceEEEEEeccCCChhhhhccccCC-------------------CCccCCHH
Q 006922          377 RHENV-----VELKAYYYS--------KDEKLMVYDYYSLGSVSAMLHSERGE-------------------GRIPLDWD  424 (625)
Q Consensus       377 ~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~  424 (625)
                      +|.++     ++++++|..        .+..++||||+++++|.++++.....                   ....++|.
T Consensus       230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~  309 (507)
T PLN03224        230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN  309 (507)
T ss_pred             hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence            66554     678888753        35689999999999999998753210                   01235788


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----ccccCCCcCCccccCCCC
Q 006922          425 TRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIARAAGYRAPEVTDSRK  500 (625)
Q Consensus       425 ~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~~~~~~y~aPE~~~~~~  500 (625)
                      .+..++.|++.||+|+|+.+   |+||||||+|||++.++.+||+|||+++.......    ....++.|+|||.+....
T Consensus       310 ~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            89999999999999999987   99999999999999999999999999976532211    122367899999875332


Q ss_pred             --------------------C--CCccchhhhHHHHHHHHhCCC-CCCCCCCcc-hhhHHHHHHHHhhcccccccccccc
Q 006922          501 --------------------A--TQASDVYSFGVVLLEILTGKS-PIHTTGGDE-LVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       501 --------------------~--~~~~DvwS~Gvil~elltG~~-p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                                          |  ..+.||||+||+++||++|.. ||....... ...........++.. ....++.  
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~~~~~~--  463 (507)
T PLN03224        387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KGQKYDF--  463 (507)
T ss_pred             CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-cccCCCc--
Confidence                                1  134799999999999999875 765321110 000000000000000 0001111  


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMP---DQRPKMPDVVR  592 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPs~~ev~~  592 (625)
                         +..........+++.+++..+|   .+|+|++|+++
T Consensus       464 ---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        464 ---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence               1111122345667778888765   68999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=277.06  Aligned_cols=238  Identities=22%  Similarity=0.355  Sum_probs=181.3

Q ss_pred             HhHcccCCce-eEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+++|.|+.| .||+|... |+.||||++-...  ..-..+|+..++.- +|||||++++.-.++...||..|.|.- +|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence            5679999887 57899885 8999999986533  23567899999887 599999999999999999999999864 99


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---C--CCeeEecccccccccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---Q--QYGCVSDLGLTTITSALA  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~--~~~kl~DfGla~~~~~~~  481 (625)
                      .+++.....+ .....-.....+..|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.+....
T Consensus       590 ~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  590 QDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999874111 111111345678889999999999987   999999999999976   3  468999999999876432


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....||.||+|||++....-+.++||||+||++|+.++ |..||.+....+ .++       +.++.       
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI-------l~~~~-------  730 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI-------LTGNY-------  730 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh-------hcCcc-------
Confidence                  23468889999999999888899999999999999999 699997543221 111       11110       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                      .+.......++  +..+++.+++..+|..||++.+|+
T Consensus       731 ~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  731 TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            01111111222  556777799999999999999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-31  Score=264.35  Aligned_cols=233  Identities=17%  Similarity=0.264  Sum_probs=189.8

Q ss_pred             hHcccCCceeEEEEEEcCC-cEEEEEEeccccC-C---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDG-TTVVVKRLKDVNV-G---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ..||-|+||.|=.+..+.. ..+|+|.+++... +   .+....|-.+|.+.+.|.||+++-.|.+....|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            4699999999999986543 3489999987532 2   234677889999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      .+...|+...     .++..+...++..+.+|++|||.++   ||.|||||+|.+||.+|.+||.|||+|+.....  +-
T Consensus       506 ElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  506 ELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             hhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence            9999998653     3788888899999999999999998   999999999999999999999999999988643  34


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      +.+||+.|.|||++.....+.++|.||+|+++|||++|.+||.+.+.-.+.+++-  +..       +.     ..+  +
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL--kGi-------d~-----i~~--P  641 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL--KGI-------DK-----IEF--P  641 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH--hhh-------hh-----hhc--c
Confidence            5789999999999999999999999999999999999999998876544443332  100       00     011  1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPK  586 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs  586 (625)
                      ....+...+++++.+..+|.+|--
T Consensus       642 r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  642 RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cccchhHHHHHHHHHhcCcHhhhc
Confidence            222334455666777899999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=243.52  Aligned_cols=238  Identities=17%  Similarity=0.298  Sum_probs=185.6

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh----HHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ..+||+|+|++|..+++ +..+.+|+|++++.-...    .=.+.|-.+.... +||.+|.+..+|+.....++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            46799999999999995 467889999998752221    2245566666665 79999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc---cc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SA  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~---~~  479 (625)
                      +|+|.-.+..+++     ++++.+..+...|.-||.|||+.+   ||.||+|.+|||+|..|++|+.|||+++.-   ..
T Consensus       335 ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  335 GGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             Ccceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            9999888776553     899999999999999999999998   999999999999999999999999999853   33


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhhcccccccccccccC
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD-ELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      .+.+.+||+.|+|||.+.+..|...+|+|++||+|+||+.|+.||+-...+ ...+--+++-.++-+...         +
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---------r  477 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---------R  477 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---------c
Confidence            455678999999999999999999999999999999999999999753321 111222233333322211         1


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRP  585 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP  585 (625)
                      .|  .........+...-+++||.+|-
T Consensus       478 ip--rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 IP--RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cc--ceeehhhHHHHHHhhcCCcHHhc
Confidence            11  11122334455678889999885

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-28  Score=245.87  Aligned_cols=258  Identities=17%  Similarity=0.284  Sum_probs=189.8

Q ss_pred             HhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcCC-----C---CceecceeEEEec----CceE
Q 006922          329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-----H---ENVVELKAYYYSK----DEKL  395 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~----~~~~  395 (625)
                      .+.||-|.|++||++. ..+.+.||+|+.+....-.+....||++|++++     |   .+||+|+++|...    .+.+
T Consensus        83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC  162 (590)
T KOG1290|consen   83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC  162 (590)
T ss_pred             EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence            3579999999999999 557889999999987665677889999999884     2   4799999999764    4789


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-----------C
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-----------Q  464 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-----------~  464 (625)
                      ||+|++- -+|..++....   ...++.....+|+.||+.||.|||.++  +|||.||||+|||+-.+           +
T Consensus       163 MVfEvLG-dnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  163 MVFEVLG-DNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             EEehhhh-hHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhc
Confidence            9999874 47777776543   234888899999999999999999998  69999999999998311           0


Q ss_pred             --------------------------------------------------------------------------------
Q 006922          465 --------------------------------------------------------------------------------  464 (625)
Q Consensus       465 --------------------------------------------------------------------------------  464 (625)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             ---------------------------------------------------------------------------CeeEe
Q 006922          465 ---------------------------------------------------------------------------YGCVS  469 (625)
Q Consensus       465 ---------------------------------------------------------------------------~~kl~  469 (625)
                                                                                                 .+||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                                                                       01111


Q ss_pred             cccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc-------hhhHHHHHHHH
Q 006922          470 DLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE-------LVHLVRWVHSV  542 (625)
Q Consensus       470 DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-------~~~~~~~~~~~  542 (625)
                      |||-|.....--+.-..|..|+|||++.+..|++.+|||||+|++|||+||..-|+..+++.       +..+++.+..+
T Consensus       397 DlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~i  476 (590)
T KOG1290|consen  397 DLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKI  476 (590)
T ss_pred             eccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhc
Confidence            22211111110011123556999999999999999999999999999999999997654332       22333322221


Q ss_pred             -----hhccccccccccccc------------------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          543 -----VREEWTAEVFDVELL------------------RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       543 -----~~~~~~~~~~d~~~~------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           +.+...+++|+....                  .+...+++..++.+++.-+++.+|++|||+.+.++
T Consensus       477 Pr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  477 PRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             cHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence                 122334445543321                  23456788999999999999999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=9.8e-28  Score=231.23  Aligned_cols=206  Identities=26%  Similarity=0.483  Sum_probs=181.2

Q ss_pred             cccCCceeEEEEEEcC-CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      ||+|++|.||++...+ ++.+++|++......  .+.+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999876542  4679999999999999999999999999899999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccccc---cccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      ++....    ..+++..+..++.+++++++|||+.+   ++|+||+|.||+++. ++.++|+|||.+......   ....
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            987642    24889999999999999999999997   999999999999999 899999999999876543   2334


Q ss_pred             ccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .+...|++||..... .++.+.|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            566779999998877 888999999999999998                                              


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                         ..+.+++..|+..+|++||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               256677889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-30  Score=240.32  Aligned_cols=253  Identities=21%  Similarity=0.326  Sum_probs=186.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecC-----ceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  400 (625)
                      +-||-|+||+||.+.. ++|+.||.|++....   ...+.+.+|++++..++|.|+...++..+..+     +.|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            3499999999999985 479999999987642   23477889999999999999999999887653     56788888


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      |.. +|...+-..     .+++-....-+.+||.+||+|||+.+   |.||||||.|.|++++...||+|||+++.-...
T Consensus       139 mQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  139 MQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence            865 666666543     25888889999999999999999998   999999999999999999999999999875432


Q ss_pred             c----cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc--------
Q 006922          481 A----PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW--------  547 (625)
Q Consensus       481 ~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  547 (625)
                      .    +...-|..|+|||.+.+ +.|+.+.||||.|||+.|++-++.-|+..+.-+..+++.   ..+....        
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt---dLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII---DLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH---HHhCCCcHHHHHHHh
Confidence            2    12234556999999876 468999999999999999999999987655433332222   1111100        


Q ss_pred             -------ccccc-c---ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          548 -------TAEVF-D---VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       548 -------~~~~~-d---~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                             ++.-. .   +.+.........-.+.+.+.+.++..||..|.+..+.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                   00000 0   00111111111222345566788899999999999988754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-29  Score=253.77  Aligned_cols=191  Identities=21%  Similarity=0.359  Sum_probs=165.1

Q ss_pred             HHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----h-----HHHHHHHHHHHcCC---CCceecceeEEEecCce
Q 006922          328 SAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----K-----RDFEQQMEIVGSIR---HENVVELKAYYYSKDEK  394 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~-----~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~  394 (625)
                      +.+.+|+|+||.|+.+.++ +...|+||.+.+.+.-    .     ...-.|++||..++   |+||++++++|++++..
T Consensus       565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y  644 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY  644 (772)
T ss_pred             eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence            4578999999999999965 5678999999765321    1     22557999999997   99999999999999999


Q ss_pred             EEEEEec-cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          395 LMVYDYY-SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       395 ~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      ||+||-. ++.+|.+++....     .+++..+..|+.|++.|+++||+++   |||||||-+||.++.+|-+||+|||.
T Consensus       645 yl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  645 YLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             EEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence            9999976 4568999987654     3899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccc-cccccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCC
Q 006922          474 TTITSA-LAPVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       474 a~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                      |..... .-....||.+|.|||++.+.+| ...-|||++|++||.++..+.||..
T Consensus       717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            877643 3345689999999999999988 4567999999999999999999863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=4.7e-28  Score=222.09  Aligned_cols=188  Identities=16%  Similarity=0.312  Sum_probs=158.8

Q ss_pred             HHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEecC--ceEEEEEeccC
Q 006922          328 SAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKD--EKLMVYDYYSL  403 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~~~  403 (625)
                      ..+.+|+|.|+.||.|. ..+...++||+++...  ++...+|++++..++ ||||+.+++...++.  ...+|+||+.+
T Consensus        42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n  119 (338)
T KOG0668|consen   42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN  119 (338)
T ss_pred             HHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence            35679999999999999 5578899999999754  567899999999997 999999999988754  56799999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSALAP  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~  482 (625)
                      .+...+...        ++-..+.....++++||.|+|+++   |.|||+||.|+++|... ..+|+|+|+|-+..+...
T Consensus       120 ~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  120 TDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             ccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            887766543        666778889999999999999998   99999999999999754 689999999998865443


Q ss_pred             c--cccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          483 V--IARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       483 ~--~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                      .  ...+..|.-||.+- -+.|+..-|+|||||++..|+..+.||....
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            2  23455688999874 4668889999999999999999999986543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=3.5e-28  Score=246.12  Aligned_cols=257  Identities=19%  Similarity=0.282  Sum_probs=198.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC------CCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR------HENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ...|+|=|++|.+|.. ..|..||||++.......+.=..|+++|.+++      --|+++|+-.|...+++|||||-+.
T Consensus       438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls  517 (752)
T KOG0670|consen  438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS  517 (752)
T ss_pred             eccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh
Confidence            3579999999999994 45889999999988777788889999999985      3589999999999999999999765


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSALA  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~  481 (625)
                      . +|.++|++....  ..|.......++.|+.-||..|-.++   |+|.||||+|||+++.. .+||||||.|...+...
T Consensus       518 l-NLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene  591 (752)
T KOG0670|consen  518 L-NLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENE  591 (752)
T ss_pred             c-hHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccc
Confidence            4 899999887543  34778888999999999999999988   99999999999999765 57999999998875432


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-----HHhhccc-ccccccc
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH-----SVVREEW-TAEVFDV  554 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~d~  554 (625)
                       +.+.-+..|.|||++.+-+|+...|+||.||+||||.||+.-|.+........+.--+.     .+++.+. ...-||.
T Consensus       592 itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~  671 (752)
T KOG0670|consen  592 ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQ  671 (752)
T ss_pred             ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhccc
Confidence             11223445999999999999999999999999999999999998766554433322111     1111111 1111111


Q ss_pred             ccc--------------------------------C---CCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELL--------------------------------R---YPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~--------------------------------~---~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.                                .   .+. ......++.+|+..|+..||++|.|..++++
T Consensus       672 d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  672 DLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             ccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            110                                0   111 1223566888999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.4e-26  Score=226.44  Aligned_cols=190  Identities=26%  Similarity=0.430  Sum_probs=167.7

Q ss_pred             hHcccCCceeEEEEEEcC-CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|++|+||++...+ ++.+|+|.+.....  ..+.+.+|++.+.+++|+|++++++++......++++||+++++|
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   84 (225)
T smart00221        5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL   84 (225)
T ss_pred             eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence            568999999999999764 89999999986544  356788999999999999999999999998999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----P  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~  482 (625)
                      .+++.....    .+++.....++.++++++.|||..+   ++|+||+++||+++.++.++|+|||.+.......    .
T Consensus        85 ~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       85 FDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            999876532    1789999999999999999999987   9999999999999999999999999998775432    3


Q ss_pred             ccccCCCcCCcccc-CCCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          483 VIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       483 ~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                      ...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34566779999998 677788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=228.99  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=184.0

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      ..+|.|+- .|..+. .-.++.||+|++.....   ..+...+|...+..++|+||++++.++.-..      +.|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            34777777 565555 23589999999865422   2367889999999999999999999997543      5689999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ||.. +|...++.       .++-.+...|..|+..|++|||+.+   |+||||||+||+++.+..+||.|||+|+....
T Consensus       102 ~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen  102 LMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCc
Confidence            9975 88887773       2777889999999999999999998   99999999999999999999999999987654


Q ss_pred             c--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCC-cchh---------------hHHHHHHH
Q 006922          480 L--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELV---------------HLVRWVHS  541 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~-~~~~---------------~~~~~~~~  541 (625)
                      .  .+....+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+... +.+.               ++...++.
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            3  3345677789999999998899999999999999999999998864321 1111               11111222


Q ss_pred             Hhhc--ccc----cccc-cccccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVRE--EWT----AEVF-DVELLR-YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~--~~~----~~~~-d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +++.  +..    .+.+ |..... .....-......+++.+++..+|++|.+++++++
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            2111  000    0001 000000 0011122344667888999999999999999976

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=220.97  Aligned_cols=255  Identities=20%  Similarity=0.337  Sum_probs=186.8

Q ss_pred             ccCHHHHHHHHHhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceeccee-EEEecCce
Q 006922          318 AFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKA-YYYSKDEK  394 (625)
Q Consensus       318 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~  394 (625)
                      ..++.|.+. +.+.||+|.||.+-.+.++ ..+.+++|.+.......++|.+|..---.+ .|.||+.-++ .|+..+..
T Consensus        19 kv~l~d~y~-I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   19 KVDLEDVYT-INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             ccchhhhhh-HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            345666543 5678999999999999965 578899999988777789999998765555 4899998776 46667888


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CC-CCeeEeccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQ-QYGCVSDLG  472 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~-~~~kl~DfG  472 (625)
                      +.++||++.|+|.+.+....      +.+....+++.|++.|+.|+|+++   +||||||.+|||+- .| ..+|++|||
T Consensus        98 vF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             EEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            89999999999998887542      777788999999999999999999   99999999999983 33 479999999


Q ss_pred             ccccccccccccccCCCcCCccccCCC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          473 LTTITSALAPVIARAAGYRAPEVTDSR-----KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       473 la~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                      +.+...........+..|-|||.....     .+.+.+|||.||++++.++||+.|++.... ......+|....-+.. 
T Consensus       169 ~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~-  246 (378)
T KOG1345|consen  169 LTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKN-  246 (378)
T ss_pred             cccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccC-
Confidence            998876655555566679999976432     346789999999999999999999984322 2223333333221111 


Q ss_pred             ccccccccccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          548 TAEVFDVELLR-YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       548 ~~~~~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                       .     .+++ +....+   .+.++-++-+..+|++|=...++.++
T Consensus       247 -~-----~~P~~F~~fs~---~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  247 -P-----ALPKKFNPFSE---KALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -c-----cCchhhcccCH---HHHHHHHHhcCCcccccchhHHHHHH
Confidence             1     1111 111122   23333447778888888544444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=248.83  Aligned_cols=240  Identities=21%  Similarity=0.323  Sum_probs=192.8

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.+|.|+||.|||++ ...+...|+|+++-.. .+....++|+-+++..+|||||.++|.|...+..++.|||+.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            569999999999999 5578999999998653 34466788999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +.-+...     ++++.++..++....+|++|||+++   -+|||||-.||++++.+.+|++|||.+..+...   ....
T Consensus       101 diy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen  101 DIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             ceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence            8877543     6899999999999999999999998   899999999999999999999999998776532   2345


Q ss_pred             ccCCCcCCcccc---CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc-cccCCC
Q 006922          485 ARAAGYRAPEVT---DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV-ELLRYP  560 (625)
Q Consensus       485 ~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~  560 (625)
                      .||+.|||||+.   ....|..++|||+.|++..|+-.-++|..+........+..           ...+++ .+... 
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----------kS~~qpp~lkDk-  240 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----------KSGFQPPTLKDK-  240 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----------ccCCCCCcccCC-
Confidence            799999999976   35578999999999999999999888875543322221111           111222 11111 


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                        ......+-.+++.|+.++|++||+++.++
T Consensus       241 --~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  241 --TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             --ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence              22233566677799999999999998765

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-27  Score=218.66  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             cCHHHHHHHHHhHcccCCceeEEEEEEcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceE
Q 006922          319 FDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL  395 (625)
Q Consensus       319 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  395 (625)
                      +++.++..  ...|.+...|..|+|+++ |..+++|+++....   ..++|..|.-.++.+.||||..++|.|....+..
T Consensus       187 id~~~lnl--~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  187 IDVSSLNL--ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             cchhhhhh--hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            45555533  345889999999999987 66778888875543   3478999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe--cccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS--DLGL  473 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DfGl  473 (625)
                      ++..||+.|+|+..||+...   ...+-.++.+++.++|+|++|||+.. +-|..--+.+..|++|++.+++|+  |--+
T Consensus       264 ~isq~mp~gslynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             EeeeeccchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence            99999999999999997643   35678899999999999999999986 224445688999999999998874  3222


Q ss_pred             cccccccccccccCCCcCCccccCCCCCC---CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          474 TTITSALAPVIARAAGYRAPEVTDSRKAT---QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       474 a~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      +-+.    ....-.+.||+||.++..+.+   .++|+|||++++||+.|.+.||.+.+..|....+..            
T Consensus       340 sfqe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------------  403 (448)
T KOG0195|consen  340 SFQE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------------  403 (448)
T ss_pred             eeec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------------
Confidence            2211    112334569999999876544   589999999999999999999988776554332210            


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                          +..+...+......+.+++..|+..||.+||.++.|+-.||++.
T Consensus       404 ----eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 ----EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                11111112233456778888999999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=4.8e-26  Score=263.41  Aligned_cols=191  Identities=18%  Similarity=0.216  Sum_probs=137.9

Q ss_pred             cCCC-CceecceeEE-------EecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006922          375 SIRH-ENVVELKAYY-------YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG  446 (625)
Q Consensus       375 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  446 (625)
                      .++| .||+.++++|       ......+.++||+ +++|.+++....    ..+++.+++.++.||++||+|||+++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4455 5888888887       2234567788887 559999997432    34899999999999999999999998  


Q ss_pred             CceecCCCCCCEEeCC-------------------CCCeeEeccccccccccc-------------------ccccccCC
Q 006922          447 KLVHGNIKSSNIFLNS-------------------QQYGCVSDLGLTTITSAL-------------------APVIARAA  488 (625)
Q Consensus       447 ~ivHrDlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~-------------------~~~~~~~~  488 (625)
                       |+||||||+||||+.                   ++.+|++|||+++.....                   .....+|.
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             999999999999954                   455677777777642110                   00124677


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVE  568 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  568 (625)
                      .|||||++.+..|+.++|||||||+||||++|..|+....     .........        ...+.      ......+
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~--------~~~~~------~~~~~~~  240 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR--------VLPPQ------ILLNWPK  240 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh--------hcChh------hhhcCHH
Confidence            7999999999999999999999999999999998874211     111101000        00100      0111234


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 006922          569 MLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       569 l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+||+.+|.+||+|.|+++
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhh
Confidence            457778999999999999999985

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.5e-25  Score=223.63  Aligned_cols=188  Identities=25%  Similarity=0.418  Sum_probs=158.6

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|.|++||++...    ..+.||+|.+..... ......|+++|..+. +.||+.+.+++...+...+|+||++.
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            467999999999999843    467899999976543 345889999999994 99999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccc----
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITS----  478 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~----  478 (625)
                      ....++...        ++...+..++..+.+||+++|+++   ||||||||+|+|.+.. +.-.|.|||+|....    
T Consensus       120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            998888764        678889999999999999999998   9999999999999764 567899999986210    


Q ss_pred             -------------c------------------------------cccccccCCCcCCccccC-CCCCCCccchhhhHHHH
Q 006922          479 -------------A------------------------------LAPVIARAAGYRAPEVTD-SRKATQASDVYSFGVVL  514 (625)
Q Consensus       479 -------------~------------------------------~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil  514 (625)
                                   .                              ......||+||+|||++. .+..++++||||.|||+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0                              001235899999999875 45678899999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 006922          515 LEILTGKSPIHTTG  528 (625)
Q Consensus       515 ~elltG~~p~~~~~  528 (625)
                      +-+++++.||....
T Consensus       269 Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAK  282 (418)
T ss_pred             ehhhccccccccCc
Confidence            99999999996543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=6e-25  Score=207.17  Aligned_cols=168  Identities=20%  Similarity=0.288  Sum_probs=126.4

Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |+|.++++...    ..++|.++..|+.|+++||+|||+.+         ||+|||++.++.+|+  ||+++....... 
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~-   64 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQS-   64 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccC-
Confidence            68888887532    24999999999999999999999875         999999999999999  999987654332 


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                       .++..|||||++.+..++.++|||||||++|||+||+.||.....  .......+.......      ++.  ..+...
T Consensus        65 -~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~------~~~--~~~~~~  133 (176)
T smart00750       65 -RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD------DPR--DRSNLE  133 (176)
T ss_pred             -CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC------Ccc--ccccHH
Confidence             578899999999999999999999999999999999999965432  111111111111110      000  001111


Q ss_pred             HHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          564 EEM--VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       564 ~~~--~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ...  .++.+++.+||..+|.+||++.|+++.+..+.
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            222  25888999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.88  E-value=1.4e-22  Score=240.82  Aligned_cols=180  Identities=38%  Similarity=0.685  Sum_probs=124.5

Q ss_pred             ChhHHHHHHHHHHhCCC--CCCCCCCCCCCCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCC
Q 006922           24 PVEDKEALLDFVNNLPH--SRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSN  101 (625)
Q Consensus        24 ~~~~~~~ll~~~~~~~~--~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N  101 (625)
                      .+.|+.+|+.||+.+..  ....+|+...++| .|.||+|++. .+|+.|+|++++++|.+++ .|..+++|+.|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNNS-SRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCCC-CcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCC
Confidence            45789999999999843  3344897655555 8999999864 5899999999999998876 4899999999999999


Q ss_pred             CCCccCCcccc-cccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCC
Q 006922          102 VITGYFPSDFI-NLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD  180 (625)
Q Consensus       102 ~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~  180 (625)
                      ++++.+|..+. ++++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|.
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  182 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN  182 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc-cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence            99988887655 788888888888877766553 2345555555555555555555555555555555555555554443


Q ss_pred             C--CCCCCcEEEcccCCCccccccccccC
Q 006922          181 L--NLPNLQQLNLANNNLSGSIPQSLKRF  207 (625)
Q Consensus       181 ~--~l~~L~~L~l~~N~l~g~~p~~l~~~  207 (625)
                      .  .+++|++|+|++|++++.+|..++++
T Consensus       183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l  211 (968)
T PLN00113        183 SLTNLTSLEFLTLASNQLVGQIPRELGQM  211 (968)
T ss_pred             hhhhCcCCCeeeccCCCCcCcCChHHcCc
Confidence            2  44455555555555554444444433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=4.7e-22  Score=205.44  Aligned_cols=161  Identities=16%  Similarity=0.206  Sum_probs=123.0

Q ss_pred             hHcccCCceeEEEEEEc--CCcEEEEEEeccccC------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE--DGTTVVVKRLKDVNV------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|...  +++.||||++.....      ..+.+.+|++++.+++|+|+++.+..   .+..++||||+
T Consensus        24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~  100 (365)
T PRK09188         24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWT  100 (365)
T ss_pred             cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEcc
Confidence            56999999999999854  577889998763311      13568999999999999999863322   25689999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCEEeCCCCCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNI-KSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      ++++|... ..        ..   ...++.++++||+|||+.+   |+|||| ||+|||++.++.+||+|||+|+.....
T Consensus       101 ~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188        101 EGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             CCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            99999632 11        11   1457889999999999998   999999 999999999999999999999865432


Q ss_pred             c-----------cccccCCCcCCccccCCCC------CCCccchh
Q 006922          481 A-----------PVIARAAGYRAPEVTDSRK------ATQASDVY  508 (625)
Q Consensus       481 ~-----------~~~~~~~~y~aPE~~~~~~------~~~~~Dvw  508 (625)
                      .           ....+++.|+|||.+....      .+..+|-|
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            1           2345677799999986432      23446666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=2.8e-20  Score=191.75  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=190.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCC-ceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHE-NVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||.|+||.||++...  ..+++|.+......    ...+.+|+.++..+.|+ +++++.+++......+++++|+.++
T Consensus         6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~   83 (384)
T COG0515           6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG   83 (384)
T ss_pred             EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence            45899999999999976  88999999865332    46789999999999988 7999999997777789999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSAL---  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~---  480 (625)
                      ++.+++......  ..+.......+..|++.++.|+|..+   ++|||+||+||+++..+ .++++|||.++.....   
T Consensus        84 ~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          84 SLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999666654211  24788899999999999999999998   99999999999999998 7999999999755432   


Q ss_pred             ------ccccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhhcccccc
Q 006922          481 ------APVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGD-ELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       481 ------~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  550 (625)
                            .....++..|+|||.+.+   ..+....|+||+|++++++++|..||...... ......+.+......     
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence                  244578889999999987   57889999999999999999999997654431 112222222211111     


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ........ .........+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000 0001122456677789999999999999887764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.5e-20  Score=192.99  Aligned_cols=266  Identities=16%  Similarity=0.166  Sum_probs=193.2

Q ss_pred             HhHcccCCceeEEEEEEcCC--cEEEEEEeccccCC-hHHHHHHHHHHHcCCC----CceecceeEE-EecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILEDG--TTVVVKRLKDVNVG-KRDFEQQMEIVGSIRH----ENVVELKAYY-YSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||.+.....  ..+|+|........ ...+..|..++..+..    +++..+++.. ......++||+.
T Consensus        23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l  102 (322)
T KOG1164|consen   23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL  102 (322)
T ss_pred             eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence            35799999999999996543  47888887664322 2268888888888863    5888888888 467788999986


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-----CCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-----QYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DfGla~  475 (625)
                      + |.+|.++.....   ...++..+..+|+.|+..+|.++|+.+   ++||||||.|+++...     ..+.+.|||+++
T Consensus       103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            5 669998876554   224888999999999999999999998   9999999999999865     358899999998


Q ss_pred             --ccc-cc----------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 006922          476 --ITS-AL----------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       476 --~~~-~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                        ... ..          .....||..|.++.+..+...+.+.|+||++.++.|+..|..|+................  
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~--  253 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP--  253 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh--
Confidence              321 10          112348888999999999999999999999999999999999997654332221111111  


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCCCC
Q 006922          543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSES  614 (625)
Q Consensus       543 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~~~  614 (625)
                       ...    ....   .......   ++.++...+-..+..++|....+...|++..........+.++|...
T Consensus       254 -~~~----~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~  314 (322)
T KOG1164|consen  254 -RKL----LTDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK  314 (322)
T ss_pred             -hhh----cccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence             110    0000   0111222   34444455556899999999999999988877655444455566543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-20  Score=181.30  Aligned_cols=253  Identities=15%  Similarity=0.184  Sum_probs=190.0

Q ss_pred             HHhHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCC
Q 006922          328 SAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.+.||+|+||+.+.|. +-+++.||||.- ....+.-++..|.+....+ ..+.|...+-|..+..+-.||+|.+ |-+
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            35779999999999999 668999999954 3333445677888777777 4688888887777777889999976 558


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-----CeeEeccccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-----YGCVSDLGLTTITSAL  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DfGla~~~~~~  480 (625)
                      |++++.-+..    .++..+...||.|+..-++|+|+++   +|.|||||+|+||..-+     .+.++|||+|+...+.
T Consensus       110 LEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  110 LEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             HHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            9988877653    3899999999999999999999998   99999999999997543     4779999999986432


Q ss_pred             c----------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          481 A----------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       481 ~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      .          ....||..||+-....++..+.+.|+-|+|-++++.+-|..||++.......+..+.+....+.-...+
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence            2          235688999999998999999999999999999999999999998776555544443322211111111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      +       ..+.++++...+..++.   .+-.+-|.-+-+...+..+..
T Consensus       263 L-------c~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  263 L-------CEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             H-------HhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHH
Confidence            0       12234555556665555   566777877766665555533

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.6e-20  Score=178.48  Aligned_cols=138  Identities=12%  Similarity=0.166  Sum_probs=107.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC----------hHH-----------------HHHHHHHHHcCCCCcee
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG----------KRD-----------------FEQQMEIVGSIRHENVV  382 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------~~~-----------------~~~e~~~l~~l~h~niv  382 (625)
                      ..||+|+||.||+|...+|+.||||+++.....          ...                 ...|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            469999999999999878999999999754211          011                 23488999999887764


Q ss_pred             cceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCCCCEEeC
Q 006922          383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI-HAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       383 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrDlk~~NIll~  461 (625)
                      ....+..  ...++||||++++++.......     ..+++.....++.|++.+|.|+ |+.+   |+||||||+|||++
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            4333322  2348999999998766543221     1488899999999999999999 5776   99999999999998


Q ss_pred             CCCCeeEeccccccccc
Q 006922          462 SQQYGCVSDLGLTTITS  478 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~  478 (625)
                       ++.++|+|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.2e-21  Score=213.50  Aligned_cols=247  Identities=18%  Similarity=0.215  Sum_probs=178.3

Q ss_pred             HHhHcccCCceeEEEEEE-cCCcEEEEEEec----cccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          328 SAEVLGKGTFGMAYKAIL-EDGTTVVVKRLK----DVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~----~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      ..+++|.|++|.|+.... ......+.|..+    ......   ..+..|+-+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            356799999998877763 334445555433    111111   124556777778899999998888777666666699


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++ +|..++....     .+.-..+..+..|+..|++|+|+.+   |.|||+|++|++++.++.+||+|||.+....-
T Consensus       402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            9999 9999998652     2677788899999999999999998   99999999999999999999999999865421


Q ss_pred             -------cccccccCCCcCCccccCCCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 006922          480 -------LAPVIARAAGYRAPEVTDSRKATQ-ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV  551 (625)
Q Consensus       480 -------~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  551 (625)
                             ......|+-+|+|||.+....|++ ..||||.||++..|.+|+.||......+... .+    .....    .
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~----~~~~~----~  543 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT----NNYSD----Q  543 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh----hcccc----c
Confidence                   223456777899999999988875 6899999999999999999997544332211 00    00000    0


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ++...+..........+...++.++++.+|.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00001111112233445567888999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=3.3e-20  Score=172.01  Aligned_cols=199  Identities=18%  Similarity=0.253  Sum_probs=162.3

Q ss_pred             hHcccCCceeEEEEE-EcCCcEEEEEEeccccCChHHHHHHHHHHHcCCC-CceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH-ENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||.|+||.+|.|. ..+|..||||.-+. ....-++..|.++...+++ ..|..+..|..+.+...+|||.. +-+|.
T Consensus        21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE   98 (341)
T KOG1163|consen   21 RKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE   98 (341)
T ss_pred             EeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence            569999999999999 66899999997654 3344578889999988875 67777888888888999999976 55888


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEecccccccccccc---
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~---  481 (625)
                      +++.-...    .++-.+.+-.+-|+..-++|+|..+   +|||||||+|+|..-+   ..+.++|||+|+...+..   
T Consensus        99 dLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   99 DLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            88876543    3788899999999999999999998   9999999999998654   356799999998764322   


Q ss_pred             -------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 006922          482 -------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       482 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~  537 (625)
                             ....||..|.+-.+..+-..+.+.|+-|+|.+|.++--|..||++.....-.+..+
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence                   23568888988887777777889999999999999999999999876544443333

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1e-19  Score=173.53  Aligned_cols=138  Identities=17%  Similarity=0.239  Sum_probs=109.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---------------------------hHHHHHHHHHHHcCCCCcee
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---------------------------KRDFEQQMEIVGSIRHENVV  382 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~niv  382 (625)
                      ..||+|+||+||+|...+|+.||||+++.....                           ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            469999999999999778999999999864211                           01235788999999999886


Q ss_pred             cceeEEEecCceEEEEEeccCCChhhh-hccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEe
Q 006922          383 ELKAYYYSKDEKLMVYDYYSLGSVSAM-LHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFL  460 (625)
Q Consensus       383 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll  460 (625)
                      ....+...  ..++||||++++++... +..      ..++.....+++.+++.++.++|+ .+   |+||||||+||++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll  151 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY  151 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence            55544433  34899999998865433 322      136778889999999999999999 77   9999999999999


Q ss_pred             CCCCCeeEecccccccccc
Q 006922          461 NSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       461 ~~~~~~kl~DfGla~~~~~  479 (625)
                      + ++.++|+|||+++....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            8 89999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4e-20  Score=177.80  Aligned_cols=163  Identities=14%  Similarity=0.154  Sum_probs=127.9

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHH----------HHHHHHHHHcCCCCceecceeEEEec-------
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD----------FEQQMEIVGSIRHENVVELKAYYYSK-------  391 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~h~niv~l~~~~~~~-------  391 (625)
                      .+++|.|+||.||.+.. ++..+|+|.++......+.          +++|++.+.+++|++|....+++...       
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~  114 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY  114 (232)
T ss_pred             EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence            46799999999999765 5778999999865433222          57899999999999999999886643       


Q ss_pred             -CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          392 -DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       392 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                       +..++||||++|.+|.++..         ++.    ....+++.++..+|..+   ++|||+||+||+++.++ ++++|
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence             35789999999999977632         222    24568999999999998   99999999999999988 99999


Q ss_pred             ccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHH
Q 006922          471 LGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEIL  518 (625)
Q Consensus       471 fGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ell  518 (625)
                      ||..+........         ..+...+.|..++|+|||||++..+.
T Consensus       178 fg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            9988765332111         11345556778999999999987643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=191.23  Aligned_cols=215  Identities=24%  Similarity=0.378  Sum_probs=164.0

Q ss_pred             HHcCCCCceecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 006922          373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGN  452 (625)
Q Consensus       373 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrD  452 (625)
                      |+.+.|.|+.+++|.+.+....++|.+|+..|+|.+.+....    ..++|.....+..+++.||+|+|.-.  -..|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence            356789999999999999999999999999999999998632    34999999999999999999999864  239999


Q ss_pred             CCCCCEEeCCCCCeeEeccccccccccc-----ccccccCCCcCCccccCCCC-------CCCccchhhhHHHHHHHHhC
Q 006922          453 IKSSNIFLNSQQYGCVSDLGLTTITSAL-----APVIARAAGYRAPEVTDSRK-------ATQASDVYSFGVVLLEILTG  520 (625)
Q Consensus       453 lk~~NIll~~~~~~kl~DfGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwS~Gvil~elltG  520 (625)
                      ++++|+++|..+.+|++|||+.......     ........-|.|||.+....       .+.++||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998776431     11111223399999986531       46789999999999999999


Q ss_pred             CCCCCCCCCcch-hhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          521 KSPIHTTGGDEL-VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       521 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      +.||......+. .+++.++..     .....+-+.+..   ..+...++..++..||..+|.+||++.+|-..++.+..
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCChHHHHHHHHh-----cCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999986443322 233333332     011111111111   11223368888999999999999999999999988877


Q ss_pred             CC
Q 006922          600 ND  601 (625)
Q Consensus       600 ~~  601 (625)
                      ..
T Consensus       227 ~~  228 (484)
T KOG1023|consen  227 GG  228 (484)
T ss_pred             cc
Confidence            54

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.6e-19  Score=168.44  Aligned_cols=178  Identities=13%  Similarity=0.099  Sum_probs=137.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChH-----HHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR-----DFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..|++|+||+||.+.. ++.+++.+.+.......+     -+.+|+++|.++. |+++++++++    +..+++|||+++
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            5699999999997766 688899888886654322     5789999999995 5889888886    457999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCEEeCCCCCeeEeccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNI-KSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      .+|......            ....+..|++++|+++|..+   |+|||| ||+|||++.++.++|+|||+|........
T Consensus        83 ~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         83 AAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            888654321            11346788999999999998   999999 79999999999999999999985543221


Q ss_pred             ----------------ccccCCCcCCccccCCC-CCC-CccchhhhHHHHHHHHhCCCCCCCC
Q 006922          483 ----------------VIARAAGYRAPEVTDSR-KAT-QASDVYSFGVVLLEILTGKSPIHTT  527 (625)
Q Consensus       483 ----------------~~~~~~~y~aPE~~~~~-~~~-~~~DvwS~Gvil~elltG~~p~~~~  527 (625)
                                      ....++.|++|+...-. ..+ ...++++-|.-+|.++||..++...
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                            11235667777754221 223 5779999999999999999887543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.4e-20  Score=197.39  Aligned_cols=185  Identities=23%  Similarity=0.320  Sum_probs=155.7

Q ss_pred             HcccCCceeEEEEE----EcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEecc
Q 006922          331 VLGKGTFGMAYKAI----LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ++|+|+||.|+.++    .+.|.-+|.|++++.....   .....|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999765    2347889999998653221   23556778888886 9999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|++...+....     ..+......+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-....
T Consensus        81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            999988876543     2566666777888999999999998   99999999999999999999999999987643332


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                      . +||.-|||||++.  ....++|.||||++++||+||-.||..
T Consensus       153 ~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 A-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             c-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            2 7889999999988  578899999999999999999999975

>PLN03150 hypothetical protein; Provisional

Probab=99.79  E-value=7.5e-19  Score=196.30  Aligned_cols=134  Identities=31%  Similarity=0.593  Sum_probs=93.4

Q ss_pred             CCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCC----CCCceEeCCCC----CeEEEEEcCCCCcccccCcccccCCCCc
Q 006922           22 AEPVEDKEALLDFVNNLPHSRSLNWNESTSVCN----HWTGVKCSEDG----KRVVAVRLPGVGFSGLIPPNTISRLSAL   93 (625)
Q Consensus        22 ~~~~~~~~~ll~~~~~~~~~~~~~w~~~~~~c~----~w~gv~C~~~~----~~v~~l~l~~~~l~g~~~~~~~~~l~~L   93 (625)
                      ...+.|..||+.+|..+......+|+.  ++|+    .|.||.|+.+.    .+|+.|+|+++++.|.+|+. |+.|++|
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~~L  444 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRHL  444 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCCCC
Confidence            445678999999999886443458964  4553    79999996321    24777888888888877764 7777788


Q ss_pred             cEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCc
Q 006922           94 KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSL  158 (625)
Q Consensus        94 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l  158 (625)
                      +.|+|++|.|.|.+|..++++++|+.|+|++|+++|.+| .++.+++|+.|+|++|+++|.+|..+
T Consensus       445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l  510 (623)
T PLN03150        445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL  510 (623)
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence            888887777777777777777777777777666666655 35555666666666666655555544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=4.9e-19  Score=194.52  Aligned_cols=237  Identities=24%  Similarity=0.332  Sum_probs=168.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEecccc--CChHHHH---HHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVN--VGKRDFE---QQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||++.|=+|.+|+.+.|. |+||++-+..  .+-+.|.   .|++ ...++|||++++.-+-.....-|||=+|... 
T Consensus        29 ~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-  105 (1431)
T KOG1240|consen   29 ENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-  105 (1431)
T ss_pred             cccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence            56999999999999988787 8999986543  2334444   4444 5566899999988776666667788888766 


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc--ccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT--SALAP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~--~~~~~  482 (625)
                      +|++.+....     -+...+.+-|+.|+..|+.-+|..+   |+|+|||.+|||+++=.-+.|+||..-+..  ....+
T Consensus       106 nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  106 NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            8888886532     3667778889999999999999998   999999999999999999999999765432  11111


Q ss_pred             --------ccccCCCcCCccccCCC-----------CCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 006922          483 --------VIARAAGYRAPEVTDSR-----------KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       483 --------~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                              +..+...|+|||.+...           ..+++-||||.||+++||++ |++||.      .-++..+-.. 
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~~-  250 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRSG-  250 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhcc-
Confidence                    11222349999987431           14578899999999999999 899984      2222221110 


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006922          543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVI  594 (625)
Q Consensus       543 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L  594 (625)
                             .-.|++..- ...+  -..+..++..|++.||+.|-++++.++.-
T Consensus       251 -------~~~~~e~~L-e~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  251 -------NADDPEQLL-EKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -------CccCHHHHH-HhCc--CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence                   001111000 0000  01456778899999999999999998873

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=8.3e-18  Score=161.36  Aligned_cols=132  Identities=13%  Similarity=0.146  Sum_probs=102.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEecccc-CChHHHHHHHHHHHcC-----CCCceecceeEEEecC---ceE-EEEE
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSI-----RHENVVELKAYYYSKD---EKL-MVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~e  399 (625)
                      +.||+|+||.||. ...++.. +||++.... ...+++.+|++++..+     .||||++++|++.++.   ..+ +|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5799999999996 3334444 789887542 2346799999999999     5799999999998863   333 7899


Q ss_pred             e--ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCCEEeCC----CCCeeEeccc
Q 006922          400 Y--YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI-ARIHAANGGKLVHGNIKSSNIFLNS----QQYGCVSDLG  472 (625)
Q Consensus       400 ~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DfG  472 (625)
                      |  +++|+|.+++....      +++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        86 ~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         86 FDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             CCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            9  56899999996531      4444  35577888777 9999998   999999999999974    3479999954


Q ss_pred             cc
Q 006922          473 LT  474 (625)
Q Consensus       473 la  474 (625)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.73  E-value=1.1e-17  Score=165.85  Aligned_cols=228  Identities=17%  Similarity=0.284  Sum_probs=140.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCC----------CCceecceeEEE-----
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIR----------HENVVELKAYYY-----  389 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~----------h~niv~l~~~~~-----  389 (625)
                      +.||.|+++.||.+... .|+.+|+|+.......    .+++.+|.-....+.          |-.++--++...     
T Consensus        18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~   97 (288)
T PF14531_consen   18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP   97 (288)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred             cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence            56999999999999965 5899999998643321    245555554443322          212222222221     


Q ss_pred             ----ecC--------ceEEEEEeccCCChhhhhcc---ccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006922          390 ----SKD--------EKLMVYDYYSLGSVSAMLHS---ERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIK  454 (625)
Q Consensus       390 ----~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk  454 (625)
                          ...        ..+++|.-+ -+||..++..   .... ...+....++.+..|+.+.+++||+.+   ++|+|||
T Consensus        98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~  172 (288)
T PF14531_consen   98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK  172 (288)
T ss_dssp             SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred             cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence                111        235666666 3477776543   2111 223445566778899999999999998   9999999


Q ss_pred             CCCEEeCCCCCeeEecccccccccccccccccCCCcCCccccCC--------CCCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          455 SSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDS--------RKATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       455 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                      |+|++++.+|.+.|+||+.....+........+..|.+||....        -.++.+.|.|++|+++|.|++|+.||..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            99999999999999999987766554332344567999997643        2468899999999999999999999975


Q ss_pred             CCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 006922          527 TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQR  584 (625)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  584 (625)
                      .........                 +..  ...   +..+.+-.++...++.+|.+|
T Consensus       253 ~~~~~~~~~-----------------~f~--~C~---~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW-----------------DFS--RCR---DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG-----------------GGT--TSS------HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc-----------------cch--hcC---CcCHHHHHHHHHHccCCcccC
Confidence            432211100                 111  111   233345566679999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=8.4e-17  Score=156.32  Aligned_cols=133  Identities=17%  Similarity=0.339  Sum_probs=113.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|++|.||+|.. +|..+++|+.......         ...+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 6788999987643211         13477899999999999998888888888888999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      +++++|.+++...        .+ .+..++.+++.+|+++|..+   ++|+|++|.|||++ ++.++|+|||.++.
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988642        22 78889999999999999998   99999999999999 78999999998875

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.1e-16  Score=157.54  Aligned_cols=138  Identities=13%  Similarity=0.189  Sum_probs=106.0

Q ss_pred             HhHcccCCceeEEEEE--EcCCcEEEEEEeccccCC-------------------------hHHHHHHHHHHHcCCCCc-
Q 006922          329 AEVLGKGTFGMAYKAI--LEDGTTVVVKRLKDVNVG-------------------------KRDFEQQMEIVGSIRHEN-  380 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~h~n-  380 (625)
                      .+.||+|+||.||+|.  ..+|+.||+|+++.....                         ...+.+|++.+.++.+.. 
T Consensus        33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i  112 (237)
T smart00090       33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV  112 (237)
T ss_pred             CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4679999999999998  568999999998753210                         022568999999987533 


Q ss_pred             -eecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 006922          381 -VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIF  459 (625)
Q Consensus       381 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIl  459 (625)
                       +..++++    ...++||||++++++........     .+.......++.|++.++++||+.+  .|+||||||+||+
T Consensus       113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl  181 (237)
T smart00090      113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL  181 (237)
T ss_pred             CCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence             3333332    24589999999988876543221     2455567889999999999999886  4999999999999


Q ss_pred             eCCCCCeeEeccccccccc
Q 006922          460 LNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       460 l~~~~~~kl~DfGla~~~~  478 (625)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999887654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=2.4e-17  Score=185.03  Aligned_cols=184  Identities=18%  Similarity=0.321  Sum_probs=148.0

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCC---CCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR---HENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      ...||+|+||+||+|...+|+.||+|+-+......  |.--.+++.+++   -+-|+.+...+.-.+.-++|+||.+.|+
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            35699999999999998889999999988765442  222233344444   3455666666666778899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------CCCeeEeccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-------QQYGCVSDLGLTTITS  478 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-------~~~~kl~DfGla~~~~  478 (625)
                      |.+++...+     .++|.-.+.+..|+++.+++||..+   |||+||||+|+||..       ..-++|+|||.+..+.
T Consensus       781 lld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  781 LLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             HHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            999998433     4899999999999999999999998   999999999999953       2357999999987653


Q ss_pred             cc--c---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCC
Q 006922          479 AL--A---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKS  522 (625)
Q Consensus       479 ~~--~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~  522 (625)
                      -.  .   ....+|-++-.+|...++.++.++|-|.++-+++-|+.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            21  1   22345667899999999999999999999999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=1.4e-16  Score=153.35  Aligned_cols=130  Identities=19%  Similarity=0.318  Sum_probs=107.6

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccC--C-------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--G-------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .||+|+||.||+|.. +|..+++|+......  .       ...+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 578999998654321  1       144678999999999988776666666777789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ++++|.+.+....            ..++.+++++|+++|..+   ++|+|++|.||+++ ++.++++|||+++..
T Consensus        80 ~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988875321            178999999999999998   99999999999999 899999999988764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.7e-16  Score=157.31  Aligned_cols=194  Identities=18%  Similarity=0.261  Sum_probs=132.7

Q ss_pred             CCCCceecceeEEEec---------------------------CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHH
Q 006922          376 IRHENVVELKAYYYSK---------------------------DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMR  428 (625)
Q Consensus       376 l~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~  428 (625)
                      .+|||||+++++|.+.                           ...|+||.-++. +|.+++..+.      .+.....-
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~  345 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRV  345 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHH
Confidence            3699999999887331                           234678876654 8888887653      45556677


Q ss_pred             HHHHHHHHHHHHHhcCCCCceecCCCCCCEEe--CCCC--CeeEecccccccccc---------cccccccCCCcCCccc
Q 006922          429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFL--NSQQ--YGCVSDLGLTTITSA---------LAPVIARAAGYRAPEV  495 (625)
Q Consensus       429 i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll--~~~~--~~kl~DfGla~~~~~---------~~~~~~~~~~y~aPE~  495 (625)
                      ++.|+.+|+.|||.++   |.|||+|++|||+  |+|+  ...|+|||++-....         ......|....||||+
T Consensus       346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            8899999999999998   9999999999998  4444  357899998754321         1122345556999999


Q ss_pred             cCCCCC------CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHH
Q 006922          496 TDSRKA------TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEM  569 (625)
Q Consensus       496 ~~~~~~------~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  569 (625)
                      ....+-      -.|+|.|+.|-+.||+++...||...... ..+.-.     .++..+.          +..+.+...+
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qLP----------alp~~vpp~~  486 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQLP----------ALPSRVPPVA  486 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhCC----------CCcccCChHH
Confidence            864321      35999999999999999999999873321 111111     1111111          1122223345


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          570 LQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       570 ~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      .+++...++.||++|++..-....|.
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHH
Confidence            66777888999999999876665553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=1.9e-16  Score=152.14  Aligned_cols=132  Identities=14%  Similarity=0.171  Sum_probs=104.4

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC-----------------------hHHHHHHHHHHHcCCCCc--eec
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG-----------------------KRDFEQQMEIVGSIRHEN--VVE  383 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------------------~~~~~~e~~~l~~l~h~n--iv~  383 (625)
                      .+.||+|+||.||++...+|+.||||+++.....                       ...+..|+.++.++.|++  +..
T Consensus        20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~   99 (198)
T cd05144          20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK   99 (198)
T ss_pred             CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence            4679999999999999888999999987643210                       123567888888887774  344


Q ss_pred             ceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC
Q 006922          384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ  463 (625)
Q Consensus       384 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~  463 (625)
                      .++    ....++||||+++++|......           .....++.+++.++.++|+.+   |+||||||+||+++.+
T Consensus       100 ~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~  161 (198)
T cd05144         100 PID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD  161 (198)
T ss_pred             eee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence            333    2456899999999998765421           234678889999999999987   9999999999999999


Q ss_pred             CCeeEeccccccccc
Q 006922          464 QYGCVSDLGLTTITS  478 (625)
Q Consensus       464 ~~~kl~DfGla~~~~  478 (625)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2.7e-16  Score=173.89  Aligned_cols=131  Identities=19%  Similarity=0.273  Sum_probs=107.7

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEe-ccccC--------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRL-KDVNV--------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l-~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|...+. .+++|+. .+...        ..+.+.+|++++..++|++++....++...+..++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            46799999999999987544 3444432 22111        12457899999999999999988888888778899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |+++++|.+++.             ....++.+++++|+|||+.+   |+||||||+|||+ +++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999988775             34678999999999999998   9999999999999 6789999999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=8.2e-17  Score=177.20  Aligned_cols=198  Identities=22%  Similarity=0.320  Sum_probs=134.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .++|..|+||.||..+++ ..+.+|+| +.+..    .+.+.  ++.....|.+|                     |+-.
T Consensus        88 IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc--cccccCCccee---------------------chhh
Confidence            467899999999999865 46778884 43321    11111  33333344443                     4444


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--------
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--------  479 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--------  479 (625)
                      ..++...     ++.-        +++.+++|+|+.+   |+|||+||+|.+++.-|++|+.|||+++....        
T Consensus       140 tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  140 TLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             hhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence            4444321     1221        2378999999998   99999999999999999999999999875311        


Q ss_pred             ----------cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          480 ----------LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       480 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                                ....++||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||.+...+|....+-....    .|.+
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----~wpE  279 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----EWPE  279 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----cccc
Confidence                      11234789999999999999999999999999999999999999988766654432211110    1111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP  585 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  585 (625)
                      +  |         +....+..+++.+.++.+|.+|-
T Consensus       280 ~--d---------ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 E--D---------EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             c--C---------cCCCHHHHHHHHHHHHhChHhhc
Confidence            1  1         11122444555577889999885

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=1.3e-15  Score=144.84  Aligned_cols=134  Identities=18%  Similarity=0.234  Sum_probs=96.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHH-------------------------HHHHHHHHHcCCCCc--ee
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD-------------------------FEQQMEIVGSIRHEN--VV  382 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-------------------------~~~e~~~l~~l~h~n--iv  382 (625)
                      +.||+|+||+||+|...+|+.||||+++.......+                         ...|.+.+.++.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            469999999999999878999999998754321111                         124555555554332  33


Q ss_pred             cceeEEEecCceEEEEEeccCCChhhh-hccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEe
Q 006922          383 ELKAYYYSKDEKLMVYDYYSLGSVSAM-LHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFL  460 (625)
Q Consensus       383 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll  460 (625)
                      +.+++    ...++||||++++.+... +....      .. .....++.+++.++.++|. .+   |+||||||+||++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            33332    346899999999654321 22111      11 4578899999999999999 76   9999999999999


Q ss_pred             CCCCCeeEeccccccccc
Q 006922          461 NSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       461 ~~~~~~kl~DfGla~~~~  478 (625)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=3e-15  Score=136.49  Aligned_cols=134  Identities=17%  Similarity=0.156  Sum_probs=113.4

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCC--CceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH--ENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++|  .++.++++++...+..+++|||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            458999999999999754 7899999876443 5678999999999976  58899998888878899999999987765


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      .+            ++.....++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+...
T Consensus        82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            44            44567788999999999999875456999999999999999899999999988754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=3.4e-16  Score=161.64  Aligned_cols=119  Identities=20%  Similarity=0.294  Sum_probs=103.6

Q ss_pred             ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccc
Q 006922          393 EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG  472 (625)
Q Consensus       393 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG  472 (625)
                      ..++.|+++.-.+|.+++...+.  ....+|...+.++.|++.|+.|   ++   .+|||+||.||+...+..+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence            46899999999999999975432  2246788899999999999999   55   9999999999999999999999999


Q ss_pred             ccccccccc---------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh
Q 006922          473 LTTITSALA---------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT  519 (625)
Q Consensus       473 la~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt  519 (625)
                      +........         +...||..||+||.+.++.|+.|+||||+|++|+|+++
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            987764332         34567888999999999999999999999999999998

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=2.6e-14  Score=140.88  Aligned_cols=136  Identities=15%  Similarity=0.207  Sum_probs=105.7

Q ss_pred             HHhHcc-cCCceeEEEEEEcCCcEEEEEEecccc--------------CChHHHHHHHHHHHcCCCCce--ecceeEEEe
Q 006922          328 SAEVLG-KGTFGMAYKAILEDGTTVVVKRLKDVN--------------VGKRDFEQQMEIVGSIRHENV--VELKAYYYS  390 (625)
Q Consensus       328 ~~~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~  390 (625)
                      ...+|| .|+.|+||.+... +..+++|++....              .....+.+|++++.+++|++|  +..+++...
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            356788 8999999999875 7789999885321              112457889999999998775  667776544


Q ss_pred             cC----ceEEEEEeccC-CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          391 KD----EKLMVYDYYSL-GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       391 ~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      ..    ..++||||+++ .+|.+++...      +++..    .+.++++++++||..+   |+||||||.|||++.++.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGK  180 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCC
Confidence            32    23599999997 6888887542      24433    3568999999999998   999999999999999999


Q ss_pred             eeEecccccccc
Q 006922          466 GCVSDLGLTTIT  477 (625)
Q Consensus       466 ~kl~DfGla~~~  477 (625)
                      ++|+|||.+...
T Consensus       181 v~LIDfg~~~~~  192 (239)
T PRK01723        181 FWLIDFDRGELR  192 (239)
T ss_pred             EEEEECCCcccC
Confidence            999999988764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.54  E-value=3.6e-16  Score=138.14  Aligned_cols=151  Identities=28%  Similarity=0.500  Sum_probs=131.2

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..++.|.|+.|.++ .+||+ +..|.+|+.|++++|+|+. +|.+++.+++|+.|+++-|++.-.+-.|+.++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhhcCccccCCCchhhhhhc
Confidence            35888999999998 56776 9999999999999999997 788999999999999999999844448999999999999


Q ss_pred             CCccCC-CCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCCC
Q 006922          146 SDNGFN-GTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFD  220 (625)
Q Consensus       146 s~N~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~  220 (625)
                      +.|+++ ..+|..|..++.|+.|+|++|.+.-.+|+. .+++|+.|.+..|.+- ++|.+++.+..   +...||.+..-
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence            999986 468999999999999999999999666675 8999999999999997 78988776654   56677775443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.52  E-value=6.9e-15  Score=145.98  Aligned_cols=177  Identities=27%  Similarity=0.397  Sum_probs=135.7

Q ss_pred             CCCCCCCCCCCCc--eEeCCCCC---------eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccc
Q 006922           46 WNESTSVCNHWTG--VKCSEDGK---------RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINL  114 (625)
Q Consensus        46 w~~~~~~c~~w~g--v~C~~~~~---------~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  114 (625)
                      -++..|-|..-+|  |.|+..+.         ..+.|+|..|+++ .||+++|+.+++|+.||||+|+|+.+-|..|.+|
T Consensus        36 ~CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL  114 (498)
T KOG4237|consen   36 ACPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL  114 (498)
T ss_pred             cCCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhh
Confidence            3556677754445  88987652         4788999999998 6899999999999999999999999889888888


Q ss_pred             cccccccccc-cccCCC---------------------------------------------------------------
Q 006922          115 KSLCYLYLQF-NNFSGT---------------------------------------------------------------  130 (625)
Q Consensus       115 ~~L~~L~L~~-N~l~~~---------------------------------------------------------------  130 (625)
                      .+|..|-+.+ |+|+..                                                               
T Consensus       115 ~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlh  194 (498)
T KOG4237|consen  115 ASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLH  194 (498)
T ss_pred             HhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHh
Confidence            7766666555 655500                                                               


Q ss_pred             ----------------------------------------------------------------------CC--Cccccc
Q 006922          131 ----------------------------------------------------------------------LP--DFSVWK  138 (625)
Q Consensus       131 ----------------------------------------------------------------------~p--~~~~l~  138 (625)
                                                                                            .|  -|..++
T Consensus       195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~  274 (498)
T KOG4237|consen  195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP  274 (498)
T ss_pred             hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence                                                                                  00  033466


Q ss_pred             ccceecCCCccCCCCCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCcccccccccc---CCCCccc
Q 006922          139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKR---FPSSAFV  213 (625)
Q Consensus       139 ~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~---~~~~~~~  213 (625)
                      +|+.|+|++|+|++.-+.+|..+..|++|+|..|+|.-.-.. + ++..|+.|+|.+|+|+-.-|.++..   +..+.+.
T Consensus       275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~  354 (498)
T KOG4237|consen  275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL  354 (498)
T ss_pred             cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence            788888888888888888888888888888888888633222 1 6889999999999999777766554   4557788


Q ss_pred             CCCCCCCCCC
Q 006922          214 GNSISFDENL  223 (625)
Q Consensus       214 ~n~~~~~~~~  223 (625)
                      +|++.|++-+
T Consensus       355 ~Np~~CnC~l  364 (498)
T KOG4237|consen  355 SNPFNCNCRL  364 (498)
T ss_pred             cCcccCccch
Confidence            9999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=1.1e-14  Score=160.68  Aligned_cols=243  Identities=19%  Similarity=0.249  Sum_probs=176.3

Q ss_pred             hHcccCCceeEEEEEEc--CCcEEEEEEeccccCCh---HHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE--DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+|+.|-.....  ....+|+|.+.......   .....|..+-..+. |+|++.+++...+.+..+++.+|..+
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g  105 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG  105 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence            34899999999888753  24556777665543222   23344666666676 99999999999999999999999999


Q ss_pred             CChhhhh-ccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCCEEeCCCC-CeeEecccccccccc-
Q 006922          404 GSVSAML-HSERGEGRIPLDWDTRMRIAIGAARGIARIH-AANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSA-  479 (625)
Q Consensus       404 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~-  479 (625)
                      +++.+.+ +....    ..+......+..|+..++.|+| ..+   +.||||||+|.+++..+ ..+++|||+|..... 
T Consensus       106 ~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  106 GSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccCCcc----CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9998888 43321    2445567788999999999999 776   99999999999999999 999999999987654 


Q ss_pred             cc-----ccccc-CCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          480 LA-----PVIAR-AAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       480 ~~-----~~~~~-~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ..     ....| +..|+|||...+. ......|+||.|+++.-+++|..|+........ ....|....          
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~----------  247 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK----------  247 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc----------
Confidence            11     22456 8889999998885 446789999999999999999999976543321 111111110          


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ................++..+++..+|..|.+.+++..
T Consensus       248 --~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 --GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence              00001111222234456666888899999999888754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=8e-13  Score=141.59  Aligned_cols=140  Identities=19%  Similarity=0.274  Sum_probs=98.4

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCCh-----------------------------------------HHHHH
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK-----------------------------------------RDFEQ  368 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------------------------------~~~~~  368 (625)
                      +.||.|++|.||+|++.+|+.||||+.+......                                         -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4599999999999999999999999986531000                                         02334


Q ss_pred             HHHHHHcC----CCCceecceeEEE-ecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHH-HHHHHHh
Q 006922          369 QMEIVGSI----RHENVVELKAYYY-SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR-GIARIHA  442 (625)
Q Consensus       369 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~  442 (625)
                      |++.+.++    +|.+-+.+-.++. .....++||||++|++|.+........    .+   +.+++..+++ .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG----LD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC----CC---HHHHHHHHHHHHHHHHHh
Confidence            44444443    2322233323332 245679999999999998876532111    22   3456666666 4678888


Q ss_pred             cCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       443 ~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      .+   ++|+|++|.||+++.++.++++|||++..++.
T Consensus       276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            87   99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.38  E-value=1.6e-14  Score=127.76  Aligned_cols=137  Identities=28%  Similarity=0.506  Sum_probs=119.4

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCC-CCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG-TLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p-~~~~l~~L~~L~  144 (625)
                      .+..|++.+|++. .+|. +++.|+.|+.|+++-|++. ..|..|+.++.|+.|||..|+++. .+| .|..+..|+.|+
T Consensus        57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly  133 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY  133 (264)
T ss_pred             hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence            3556778888877 5666 4999999999999999998 489999999999999999999976 567 688899999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFP  208 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~  208 (625)
                      |++|.|. .+|..++++++|+.|.+.+|.+-..+-+. .+..|+.|++.+|+++ .+|++++++.
T Consensus       134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~  196 (264)
T KOG0617|consen  134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD  196 (264)
T ss_pred             hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence            9999998 88999999999999999999987443344 7899999999999998 8888888753

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.33  E-value=1.7e-13  Score=142.13  Aligned_cols=130  Identities=26%  Similarity=0.303  Sum_probs=84.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      ....|+|..|+++. +..+.+-+|+.|+.|+||+|.|....++.|...++|++|+|++|+++...+ .|..+..|+.|+|
T Consensus       270 kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL  348 (873)
T KOG4194|consen  270 KMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL  348 (873)
T ss_pred             ccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence            46667777777763 445567777888888888888877777777777788888888887775444 4666666666666


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-----CCCCCcEEEcccCCCc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-----NLPNLQQLNLANNNLS  197 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~L~l~~N~l~  197 (625)
                      ++|.++..--..|..+++|++|||++|.|++.+.+.     .+++|+.|+|.+|+|.
T Consensus       349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk  405 (873)
T KOG4194|consen  349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK  405 (873)
T ss_pred             cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence            666665443445555666666666666666555542     3455555555555554

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=3.3e-12  Score=124.38  Aligned_cols=151  Identities=21%  Similarity=0.376  Sum_probs=115.9

Q ss_pred             HHHHcCCCCceecceeEEEecC-----ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006922          371 EIVGSIRHENVVELKAYYYSKD-----EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG  445 (625)
Q Consensus       371 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  445 (625)
                      .-+-.+-|.|||+++.|+.+..     +..++.|||..|++..+|++.+.. ...+....-.+|+.||..||.|||+. .
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445567999999999987643     467899999999999999876543 23466666788999999999999997 5


Q ss_pred             CCceecCCCCCCEEeCCCCCeeEecccccccc-------cccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHH
Q 006922          446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-------SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEIL  518 (625)
Q Consensus       446 ~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ell  518 (625)
                      |+|+|+++..+-|++..++-+|+.----...-       ........+..+|-|||.=.....+.++|||+||...+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            78999999999999998888887422111100       01111224567899999876667788999999999999999


Q ss_pred             hCCCC
Q 006922          519 TGKSP  523 (625)
Q Consensus       519 tG~~p  523 (625)
                      -++..
T Consensus       277 ilEiq  281 (458)
T KOG1266|consen  277 ILEIQ  281 (458)
T ss_pred             Hheec
Confidence            98765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=7.8e-12  Score=116.79  Aligned_cols=130  Identities=11%  Similarity=0.083  Sum_probs=97.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceec-ceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVE-LKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.|+.|.++.||++... +..|++|...........+.+|++++..+.+.++++ ++.+.  ....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            45789999999999875 788999988654333456788999998886655544 44332  334689999999988754


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      .-          .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            30          0   11345678999999999986  22369999999999999 67899999997764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.26  E-value=2.3e-13  Score=135.38  Aligned_cols=142  Identities=32%  Similarity=0.504  Sum_probs=100.2

Q ss_pred             EEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCc
Q 006922           69 VAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDN  148 (625)
Q Consensus        69 ~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N  148 (625)
                      +.+++++|.+. .+|++.+. ++.|+.||...|-++. +|.+++.+.+|..|||..|++. .+|+|.++..|+.|+++.|
T Consensus       163 ~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~t-lP~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N  238 (565)
T KOG0472|consen  163 SKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLET-LPPELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGEN  238 (565)
T ss_pred             HHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhc-CChhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhccc
Confidence            34455555555 34444343 7777777777777764 6777888888888888888877 5667778888888888888


Q ss_pred             cCCCCCCCCcc-ccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccC--CCCcccCCCC
Q 006922          149 GFNGTIPRSLS-NLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRF--PSSAFVGNSI  217 (625)
Q Consensus       149 ~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~--~~~~~~~n~~  217 (625)
                      +|+ .+|.... ++++|..|||.+|++.. .|+.  -+.+|..||+|+|.++ .+|.+++++  ..+++.|||+
T Consensus       239 ~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPl  309 (565)
T KOG0472|consen  239 QIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPL  309 (565)
T ss_pred             HHH-hhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCch
Confidence            877 6666554 78888888888888874 4543  5677888888888888 567777765  3456667764

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.26  E-value=4.5e-13  Score=139.76  Aligned_cols=146  Identities=28%  Similarity=0.451  Sum_probs=103.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccccccccc--CCCCCCccccccccee
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF--SGTLPDFSVWKNLTII  143 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l--~~~~p~~~~l~~L~~L  143 (625)
                      .+++.|.|...+|. .+|.+ ++.|.+|+.|.+++|++.. +-.++..|+.|+.+++..|++  +|.++++..+..|+.|
T Consensus        32 t~~~WLkLnrt~L~-~vPeE-L~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~l  108 (1255)
T KOG0444|consen   32 TQMTWLKLNRTKLE-QVPEE-LSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTIL  108 (1255)
T ss_pred             hheeEEEechhhhh-hChHH-HHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccccCCCCchhcccccceee
Confidence            35777777777766 45554 8888888888888888875 445677788888888888877  4555677788888888


Q ss_pred             cCCCccCCCCCCCCccccccccceecccccccccCCC-C--CCCCCcEEEcccCCCccccccccc---cCCCCcccCCCC
Q 006922          144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L--NLPNLQQLNLANNNLSGSIPQSLK---RFPSSAFVGNSI  217 (625)
Q Consensus       144 ~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~--~l~~L~~L~l~~N~l~g~~p~~l~---~~~~~~~~~n~~  217 (625)
                      |||+|+++ ..|..+..-.++-.|+||+|+|.. ||. .  ++..|-.||||+|+|. .+|+.+.   .+..+.+.+|++
T Consensus       109 DLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet-IPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  109 DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET-IPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             ecchhhhh-hcchhhhhhcCcEEEEcccCcccc-CCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence            88888887 667777777777788888888873 443 2  6777777888888876 4554433   334455566654

>PLN03150 hypothetical protein; Provisional

Probab=99.26  E-value=6.3e-12  Score=140.85  Aligned_cols=106  Identities=39%  Similarity=0.525  Sum_probs=92.0

Q ss_pred             cccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEccc
Q 006922          117 LCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN  193 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~  193 (625)
                      ++.|+|++|.++|.+| .+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|+.  .+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            7788999999998888 6888999999999999999999999999999999999999999988874  788999999999


Q ss_pred             CCCccccccccccC----CCCcccCCCCCCCCC
Q 006922          194 NNLSGSIPQSLKRF----PSSAFVGNSISFDEN  222 (625)
Q Consensus       194 N~l~g~~p~~l~~~----~~~~~~~n~~~~~~~  222 (625)
                      |+|+|.+|..+...    ..+.+.+|+.+|+.+
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            99999999887653    245678899888754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.25  E-value=7.5e-13  Score=138.13  Aligned_cols=139  Identities=26%  Similarity=0.386  Sum_probs=99.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCC----CCC----------
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG----TLP----------  132 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p----------  132 (625)
                      ..+.|+|+.|++. +||...+-+|..|-.||||+|++.. +|+.+..|..|+.|+|++|.+..    .+|          
T Consensus       127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm  204 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM  204 (1255)
T ss_pred             CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence            3555777777766 5777677788888888888888875 56677788888888888885531    122          


Q ss_pred             ------------CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccc
Q 006922          133 ------------DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       133 ------------~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~  199 (625)
                                  ++..+.+|..+|||.|.+. .+|..+-++.+|+.|+||+|+|+..--.. .+.+|++|+||.|+|+ .
T Consensus       205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~  282 (1255)
T KOG0444|consen  205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V  282 (1255)
T ss_pred             ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence                        3445667778888888887 67888888888888888888887432222 4667788888888887 6


Q ss_pred             cccccccCCC
Q 006922          200 IPQSLKRFPS  209 (625)
Q Consensus       200 ~p~~l~~~~~  209 (625)
                      +|..+..+++
T Consensus       283 LP~avcKL~k  292 (1255)
T KOG0444|consen  283 LPDAVCKLTK  292 (1255)
T ss_pred             chHHHhhhHH
Confidence            7777666553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.24  E-value=8.4e-12  Score=135.23  Aligned_cols=140  Identities=17%  Similarity=0.195  Sum_probs=88.3

Q ss_pred             hHcccCCceeEEEEEEcC-CcEEEEEEeccccC---------------------------C--------hH------HHH
Q 006922          330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNV---------------------------G--------KR------DFE  367 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---------------------------~--------~~------~~~  367 (625)
                      +-||+|++|+||+|++++ |+.||||+++....                           .        .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999887 99999999975310                           0        01      123


Q ss_pred             HHHHHHHcC----CCCceecceeEEEe-cCceEEEEEeccCCChhhhhccccCC-CCccCCHHHHHHHHHHHHHHHHHHH
Q 006922          368 QQMEIVGSI----RHENVVELKAYYYS-KDEKLMVYDYYSLGSVSAMLHSERGE-GRIPLDWDTRMRIAIGAARGIARIH  441 (625)
Q Consensus       368 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH  441 (625)
                      +|+.-+.++    .+.+.+.+-.++.+ ....++||||++|+.+.+.-.-...+ ....+.......++.|       +.
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence            333333333    23334444444433 35678999999999997742211110 0001222222222333       33


Q ss_pred             hcCCCCceecCCCCCCEEeCCCC----CeeEecccccccccc
Q 006922          442 AANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTITSA  479 (625)
Q Consensus       442 ~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~~~~  479 (625)
                      ..+   ++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            455   99999999999999988    899999999876643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.18  E-value=1.1e-11  Score=128.94  Aligned_cols=152  Identities=23%  Similarity=0.216  Sum_probs=104.5

Q ss_pred             CCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCC--------------
Q 006922           65 GKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT--------------  130 (625)
Q Consensus        65 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------------  130 (625)
                      +..++.|+|++|.++ ++..+.|.+|.+|..|.|++|+++...+..|.+|++|+.|+|..|++.-.              
T Consensus       172 ~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nl  250 (873)
T KOG4194|consen  172 KVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNL  250 (873)
T ss_pred             CCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhh
Confidence            345677777777765 34455577777777777777777766666666677777777777765421              


Q ss_pred             ----------CC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCc
Q 006922          131 ----------LP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLS  197 (625)
Q Consensus       131 ----------~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~  197 (625)
                                -. .|-.+.++++|+|+.|+++..--..+-+|++|+.|+||.|.|+..-++.  -.++|+.|+|++|+|+
T Consensus       251 klqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~  330 (873)
T KOG4194|consen  251 KLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT  330 (873)
T ss_pred             hhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence                      11 2455667788888888887655667788899999999999988766653  5678999999999998


Q ss_pred             ccccccc---ccCCCCcccCCCC
Q 006922          198 GSIPQSL---KRFPSSAFVGNSI  217 (625)
Q Consensus       198 g~~p~~l---~~~~~~~~~~n~~  217 (625)
                      ..-+.++   .++..+.+..|.+
T Consensus       331 ~l~~~sf~~L~~Le~LnLs~Nsi  353 (873)
T KOG4194|consen  331 RLDEGSFRVLSQLEELNLSHNSI  353 (873)
T ss_pred             cCChhHHHHHHHhhhhcccccch
Confidence            5555544   3444455666654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.17  E-value=1.6e-10  Score=123.25  Aligned_cols=162  Identities=17%  Similarity=0.233  Sum_probs=125.3

Q ss_pred             EcCCcEEEEEEeccccCCh-HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCH
Q 006922          345 LEDGTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDW  423 (625)
Q Consensus       345 ~~~g~~vavK~l~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~  423 (625)
                      ..++.+|.|..++...... ....+-++.|..+|||||++++..+...+..|+|+|-+.  .|..++.+.        .-
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence            5578999999988655422 346677889999999999999999999999999999875  355666542        23


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---ccccCCCcCCccccCCCC
Q 006922          424 DTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---VIARAAGYRAPEVTDSRK  500 (625)
Q Consensus       424 ~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~~~~~~~y~aPE~~~~~~  500 (625)
                      ......+.||+.||.|||+.+  .++|++|.-+-|+++..|+.||++|.++...+....   ...--.+|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            455667889999999999766  599999999999999999999999998765543321   111222466777654322


Q ss_pred             CCCccchhhhHHHHHHHHhC
Q 006922          501 ATQASDVYSFGVVLLEILTG  520 (625)
Q Consensus       501 ~~~~~DvwS~Gvil~elltG  520 (625)
                        -..|.|-||+++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=3.7e-11  Score=127.11  Aligned_cols=238  Identities=20%  Similarity=0.185  Sum_probs=165.3

Q ss_pred             HhHccc--CCceeEEEEEE---cCCcEEEEEEeccccC---ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGK--GTFGMAYKAIL---EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      ...+|+  |.+|.||.+..   .++..+|+|+-+....   ....-.+|+....++ .|+|.++....+...+..++-+|
T Consensus       119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE  198 (524)
T KOG0601|consen  119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTE  198 (524)
T ss_pred             ccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeec
Confidence            456899  99999999986   3688899998554322   223344566666666 49999999999999999999999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR----GIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLT  474 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla  474 (625)
                      ++. .++..+.+....    .+.......+..+..+    |+.++|+.+   |+|-|+||.||+...+ ...++.|||+.
T Consensus       199 ~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  199 LCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             ccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCccee
Confidence            876 577777665432    1333444555555556    999999998   9999999999999999 88999999998


Q ss_pred             ccccccc---cc-----cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc
Q 006922          475 TITSALA---PV-----IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE  546 (625)
Q Consensus       475 ~~~~~~~---~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  546 (625)
                      ..+....   ..     ..+..-|++||...+ .++.+.|+|++|.+..|..+|..+........+.++-.         
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---------  340 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---------  340 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---------
Confidence            8765432   00     123445999999764 67889999999999999999877765432222221110         


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          .+.+.    ...+.-..++.....+++..+|..|++.+.+..
T Consensus       341 ----~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 ----GYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----ccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                00000    001111123334677889999999998877653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=4.3e-10  Score=109.79  Aligned_cols=142  Identities=18%  Similarity=0.245  Sum_probs=110.2

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCC--CceecceeEEEec---CceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRH--ENVVELKAYYYSK---DEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  402 (625)
                      +.|+.|.++.||++...+|..+++|.......  ....+.+|++++..+++  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            35899999999999987778999999875433  34678999999999875  3456677776653   25689999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--------------------------------------  444 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  444 (625)
                      +.++.+.+..      ..++..+...++.+++++|++||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9988776542      12677778888888899998888531                                      


Q ss_pred             ---------------CCCceecCCCCCCEEeCC--CCCeeEecccccccc
Q 006922          445 ---------------GGKLVHGNIKSSNIFLNS--QQYGCVSDLGLTTIT  477 (625)
Q Consensus       445 ---------------~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~~  477 (625)
                                     ...++|+|+.+.||+++.  ++.+.|+||+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                           134799999999999998  566889999987654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=5.6e-11  Score=125.70  Aligned_cols=240  Identities=16%  Similarity=0.184  Sum_probs=167.9

Q ss_pred             hHcccCCceeEEEEEEc--CCcEEEEEEeccccCCh---HHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE--DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ..||.|.|+.|++...+  ++..|++|.+.+.....   ..-..|+.+...+ .|.++++....+......++--||+++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            45899999999998743  68899999987653322   2234555555555 589999988877777777899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~  482 (625)
                      +++.......     ..++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.++.+.....
T Consensus       351 ~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  351 GSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             cchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence            9887665321     23777788999999999999999988   9999999999999886 7889999999875433322


Q ss_pred             ccccCCCcC--CccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          483 VIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       483 ~~~~~~~y~--aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ...+.-.+.  +++......+..+.|+||||+.+.|.++|..--....  ...                .+........+
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--~~~----------------~i~~~~~p~~~  484 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--QSL----------------TIRSGDTPNLP  484 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcccCcccc--cce----------------eeecccccCCC
Confidence            223333344  4555555667889999999999999999875432211  110                01111111222


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      ...   .++..++......++..||.+.+.....+..+
T Consensus       485 ~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  485 GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             chH---HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            222   34445555777799999999988876655443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=8.6e-10  Score=104.09  Aligned_cols=136  Identities=14%  Similarity=0.172  Sum_probs=97.4

Q ss_pred             hHcccCCceeEEEEEEcC-------CcEEEEEEeccccC-----------C------------hHHH----HHHHHHHHc
Q 006922          330 EVLGKGTFGMAYKAILED-------GTTVVVKRLKDVNV-----------G------------KRDF----EQQMEIVGS  375 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~-----------~------------~~~~----~~e~~~l~~  375 (625)
                      ..||.|--+.||.|.-.+       +..+|||+.+....           +            .+.+    ++|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            358999999999998543       47999999853210           0            1122    378888888


Q ss_pred             CCC--CceecceeEEEecCceEEEEEeccCCChhh-hhccccCCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCceec
Q 006922          376 IRH--ENVVELKAYYYSKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTRMRIAIGAARGIARI-HAANGGKLVHG  451 (625)
Q Consensus       376 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHr  451 (625)
                      +..  -++...+++    ...++||||+.+..+.. .+...      .++..+...+..+++.+|.++ |..+   |||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            753  455555554    56789999998754422 22211      244456677889999999999 6776   9999


Q ss_pred             CCCCCCEEeCCCCCeeEecccccccccc
Q 006922          452 NIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       452 Dlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++.||+++ ++.+.|+|||.+.....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999996 46799999998876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.05  E-value=4.7e-12  Score=126.22  Aligned_cols=154  Identities=23%  Similarity=0.320  Sum_probs=128.2

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      .+.+++..|.++ .+|++ ++.+..++.|+.++|+++. +|.+++++.+|..|+.+.|.+...+++++.+..|+.|+..+
T Consensus        70 l~vl~~~~n~l~-~lp~a-ig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~  146 (565)
T KOG0472|consen   70 LTVLNVHDNKLS-QLPAA-IGELEALKSLNVSHNKLSE-LPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATN  146 (565)
T ss_pred             eeEEEeccchhh-hCCHH-HHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccc
Confidence            566788888888 45664 8999999999999999985 78889999999999999999998888899999999999999


Q ss_pred             ccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCCC---cccCCCCCCCCCC
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSISFDENL  223 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~~~~~~~  223 (625)
                      |+++ ++|..+.++.+|..|++.+|++...+|+. .++.|++||...|-+. .+|+.++.+.++   .+..|.+..-+..
T Consensus       147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPef  224 (565)
T KOG0472|consen  147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPEF  224 (565)
T ss_pred             cccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCCC
Confidence            9998 78999999999999999999999777764 7899999999999886 899988887764   4445666555444


Q ss_pred             CCC
Q 006922          224 APR  226 (625)
Q Consensus       224 ~~~  226 (625)
                      ..|
T Consensus       225 ~gc  227 (565)
T KOG0472|consen  225 PGC  227 (565)
T ss_pred             Ccc
Confidence            444

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=3.5e-09  Score=96.49  Aligned_cols=131  Identities=22%  Similarity=0.346  Sum_probs=99.3

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEE-eccccC----C----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKR-LKDVNV----G----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~----~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+++|+-+.+|.+... |..+++|. +++...    +    .....+|++++.+++--.|..-.=|..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999764 44455553 222211    1    134668999999887666666666677788889999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ++..|.+.+...            +..++..+-+-+.-||..+   |+|+||.++||++..+. +.++|||++....
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999998888653            2456666777777899998   99999999999997765 8899999988654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.95  E-value=9.7e-11  Score=128.20  Aligned_cols=125  Identities=28%  Similarity=0.400  Sum_probs=102.9

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .+..|.|.+|.|+...-| .|-++.+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+| .+..+..|++|..
T Consensus       360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            466677888888876655 3889999999999999998755567888999999999999998 455 6888899999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccc-cCCCC-CCCCCcEEEcccCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL-NLPNLQQLNLANNN  195 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~-~l~~L~~L~l~~N~  195 (625)
                      .+|++. ..| .+..+++|+.+|+|.|+|+- .+|.. ..++|++|||++|.
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            999998 667 88899999999999999974 44443 44889999999997

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.94  E-value=1.2e-09  Score=122.84  Aligned_cols=75  Identities=28%  Similarity=0.445  Sum_probs=53.0

Q ss_pred             cccceecCCCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccC
Q 006922          138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVG  214 (625)
Q Consensus       138 ~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~  214 (625)
                      .+|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+.+++.   +.+.+
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            357778888888773 5543   2468888888888885 5542 456888999999998 78887766654   45567


Q ss_pred             CCCCC
Q 006922          215 NSISF  219 (625)
Q Consensus       215 n~~~~  219 (625)
                      |++..
T Consensus       455 N~Ls~  459 (788)
T PRK15387        455 NPLSE  459 (788)
T ss_pred             CCCCc
Confidence            77653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.93  E-value=3.2e-10  Score=126.04  Aligned_cols=193  Identities=19%  Similarity=0.243  Sum_probs=139.4

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      -+-+|+++.++.+.-. .|...++|.......    ..+....+-.+.-..+||-+++...-+......++|++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            5678899998877633 344445554433211    11223333344444567877776666666778899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc-------
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-------  478 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~-------  478 (625)
                      |...++...     ..+..-.......+.++.+|||...   +.|||++|.|.+...+++.++.|||......       
T Consensus       891 ~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  891 LPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             chhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            999998654     2343344455666888999999986   9999999999999999999999998432110       


Q ss_pred             -----------------------cc----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc
Q 006922          479 -----------------------AL----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE  531 (625)
Q Consensus       479 -----------------------~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~  531 (625)
                                             ..    .....+|..|.|||...+......+|+|++|++++|.++|.+||.......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                                   00    112346778999999999999999999999999999999999998655433

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.93  E-value=2.8e-10  Score=105.29  Aligned_cols=123  Identities=28%  Similarity=0.402  Sum_probs=42.4

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccc-cccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCc-cccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSL-SNLTQL  164 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l-~~l~~L  164 (625)
                      +.+...+++|+|++|.|+. + ..++ .+.+|+.|+|++|.++ .++.+..+++|+.|++++|+|+ .++..+ ..+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-cccCccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            4455567888888888875 2 2455 4778888888888887 5667777888888888888887 344334 357888


Q ss_pred             cceecccccccccCCC---CCCCCCcEEEcccCCCcccccc----ccccCCCCcccC
Q 006922          165 EALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSGSIPQ----SLKRFPSSAFVG  214 (625)
Q Consensus       165 ~~L~l~~N~l~~~~p~---~~l~~L~~L~l~~N~l~g~~p~----~l~~~~~~~~~~  214 (625)
                      +.|+|++|+|...-.-   ..+++|+.|+|.+|+++.. +.    -+..+|++.+.+
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            8888888888642111   2678888888888888632 22    344566665544

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.92  E-value=1.3e-10  Score=127.31  Aligned_cols=126  Identities=33%  Similarity=0.496  Sum_probs=99.5

Q ss_pred             CCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--CcccccccceecCCCccCCCCCCCCccccccccce
Q 006922           90 LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL  167 (625)
Q Consensus        90 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  167 (625)
                      ++.|+.|++.+|.|+...-.-+.+..+|+.|+|++|+|. .+|  .+.+|..|+.|+||+|+++ .+|..+.++..|++|
T Consensus       358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL  435 (1081)
T KOG0618|consen  358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL  435 (1081)
T ss_pred             hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence            345777788888887554446778889999999999987 455  4788899999999999998 788889999999999


Q ss_pred             ecccccccccCCCC-CCCCCcEEEcccCCCc-cccccccc--cCCCCcccCCCCC
Q 006922          168 YLANNSLSGKIPDL-NLPNLQQLNLANNNLS-GSIPQSLK--RFPSSAFVGNSIS  218 (625)
Q Consensus       168 ~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~-g~~p~~l~--~~~~~~~~~n~~~  218 (625)
                      ...+|++.. .|+. .++.|+.+|++.|+|+ +.+|..+.  ++..+.+.||.++
T Consensus       436 ~ahsN~l~~-fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  436 RAHSNQLLS-FPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhcCCceee-chhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            999999984 4554 8999999999999997 34454433  5566788888853

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.88  E-value=2.8e-09  Score=120.47  Aligned_cols=117  Identities=26%  Similarity=0.429  Sum_probs=70.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .+..|+|++|+|+ .+|.. +  ..+|+.|+|++|++.. +|..+.  .+|+.|+|++|+|+. +| .+.  ++|+.|+|
T Consensus       221 nL~~L~Ls~N~Lt-sLP~~-l--~~~L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~L  290 (754)
T PRK15370        221 NIKTLYANSNQLT-SIPAT-L--PDTIQEMELSINRITE-LPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSV  290 (754)
T ss_pred             CCCEEECCCCccc-cCChh-h--hccccEEECcCCccCc-CChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEEC
Confidence            4677888888877 45543 3  2467777777777774 565553  467777777777773 44 232  46777777


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS  197 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~  197 (625)
                      ++|+|+ .+|..+.  ++|+.|+|++|+++. +|....++|+.|++++|.|+
T Consensus       291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt  338 (754)
T PRK15370        291 YDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALT  338 (754)
T ss_pred             CCCccc-cCcccch--hhHHHHHhcCCcccc-CCccccccceeccccCCccc
Confidence            777776 3454432  356666666666653 33322345555555555555

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.88  E-value=1.7e-09  Score=122.16  Aligned_cols=118  Identities=25%  Similarity=0.411  Sum_probs=67.6

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .+..|+|++|++. .+|.. +.  .+|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|++..+.+.  ++|+.|+++
T Consensus       242 ~L~~L~Ls~N~L~-~LP~~-l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls  312 (754)
T PRK15370        242 TIQEMELSINRIT-ELPER-LP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQ  312 (754)
T ss_pred             cccEEECcCCccC-cCChh-Hh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCcccch--hhHHHHHhc
Confidence            4677888888877 56654 32  478888888888875 566553  477888888887775322221  345556666


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCc
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS  197 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~  197 (625)
                      +|+++ .+|..+.  ++|+.|++++|.+++ +|..-.++|+.|+|++|+|+
T Consensus       313 ~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~L~  359 (754)
T PRK15370        313 SNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLPPELQVLDVSKNQIT  359 (754)
T ss_pred             CCccc-cCCcccc--ccceeccccCCcccc-CChhhcCcccEEECCCCCCC
Confidence            66655 2343322  345555555555543 23222234555555555554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.87  E-value=1.2e-08  Score=92.61  Aligned_cols=141  Identities=15%  Similarity=0.306  Sum_probs=101.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEE-eccc----c----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKR-LKDV----N----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~----~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      ..+-+|+-+.|+++... |+...||. ..+.    .    ..++...+|++.+.+++--.|.--.-++.+...-.++|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45778999999999875 66655553 2221    1    1235577899999998766666555567777778899999


Q ss_pred             ccC-CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEeccccccc
Q 006922          401 YSL-GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~~  476 (625)
                      +++ -++.+++...-...   -.-......+..+-+.+.-||..+   |+|+||..+||++..++.   +.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            987 36677766543221   111222577888889999999998   999999999999987663   47999998764


Q ss_pred             c
Q 006922          477 T  477 (625)
Q Consensus       477 ~  477 (625)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.86  E-value=5.2e-09  Score=117.71  Aligned_cols=93  Identities=20%  Similarity=0.328  Sum_probs=47.5

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      ++.|++.+|+++. +|.    .+++|++|+|++|+|+. +|..   .++|+.|+|++|.++. +|.  ...+|+.|+|++
T Consensus       224 L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~-Lp~--lp~~L~~L~Ls~  291 (788)
T PRK15387        224 ITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTH-LPA--LPSGLCKLWIFG  291 (788)
T ss_pred             CCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhh-hhh--chhhcCEEECcC
Confidence            3444444444442 332    13455555555555553 3321   2345555555555542 221  124566666666


Q ss_pred             ccCCCCCCCCccccccccceecccccccc
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSG  176 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~  176 (625)
                      |+|+ .+|..   +++|+.|+|++|+|++
T Consensus       292 N~Lt-~LP~~---p~~L~~LdLS~N~L~~  316 (788)
T PRK15387        292 NQLT-SLPVL---PPGLQELSVSDNQLAS  316 (788)
T ss_pred             Cccc-ccccc---ccccceeECCCCcccc
Confidence            6666 34432   3567777777777775

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.85  E-value=9.2e-10  Score=101.84  Aligned_cols=118  Identities=29%  Similarity=0.368  Sum_probs=50.3

Q ss_pred             eEEEEEcCCCCcccccCccccc-CCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCc-ccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTIS-RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF-SVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~  144 (625)
                      +...|+|.++.++- | + .++ .|.+|+.|+|++|.|+.. + .+..+++|+.|+|++|+++...+.+ ..+++|+.|+
T Consensus        20 ~~~~L~L~~n~I~~-I-e-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-I-E-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY   94 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-c-c-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence            57889999999984 3 2 366 589999999999999974 3 5888999999999999999543444 3689999999


Q ss_pred             CCCccCCCCCC-CCccccccccceecccccccccCCCC------CCCCCcEEE
Q 006922          145 LSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPDL------NLPNLQQLN  190 (625)
Q Consensus       145 ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~------~l~~L~~L~  190 (625)
                      |++|+|...-- ..+..+++|+.|+|.+|.++.. +..      .+|+|+.||
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            99999975321 3467789999999999999854 431      589999887

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.81  E-value=6.7e-08  Score=96.47  Aligned_cols=140  Identities=14%  Similarity=0.078  Sum_probs=99.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC------------ChHHHHHHHHHHHcCCCCc--eecceeEEEe-----
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV------------GKRDFEQQMEIVGSIRHEN--VVELKAYYYS-----  390 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  390 (625)
                      +.+-+-....|++... +|+.|.||+......            ....+.+|...+.++...+  +...+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444445667665 578899997754321            1124778988888875333  3445556543     


Q ss_pred             cCceEEEEEeccCC-ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------
Q 006922          391 KDEKLMVYDYYSLG-SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-------  462 (625)
Q Consensus       391 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-------  462 (625)
                      ...-++|+|++++. +|.+++.....   .+.+...+..++.++++.++-||..+   |+|+|++++|||++.       
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence            23468999999986 78888753211   12455667789999999999999998   999999999999975       


Q ss_pred             CCCeeEeccccccc
Q 006922          463 QQYGCVSDLGLTTI  476 (625)
Q Consensus       463 ~~~~kl~DfGla~~  476 (625)
                      +..+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46789999998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=4.1e-08  Score=92.39  Aligned_cols=125  Identities=19%  Similarity=0.285  Sum_probs=81.4

Q ss_pred             eEEEEEEcCCcEEEEEEeccccCC---------------------------hHHHHHHHHHHHcCCCC--ceecceeEEE
Q 006922          339 MAYKAILEDGTTVVVKRLKDVNVG---------------------------KRDFEQQMEIVGSIRHE--NVVELKAYYY  389 (625)
Q Consensus       339 ~Vy~~~~~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~--niv~l~~~~~  389 (625)
                      .||.|...+|..+|+|..+.....                           .....+|++.|.++...  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999889999999998532100                           02256799999999765  45555544  


Q ss_pred             ecCceEEEEEecc--CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          390 SKDEKLMVYDYYS--LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI-HAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       390 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                        ...++||||++  +..+..+....       ++......++.++...+..+ |..+   |+|+|+.+.||+++++ .+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence              24679999999  54554433321       11234566777777766654 6766   9999999999999887 99


Q ss_pred             eEeccccccccc
Q 006922          467 CVSDLGLTTITS  478 (625)
Q Consensus       467 kl~DfGla~~~~  478 (625)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PLN03210 Resistant to P

Probab=98.76  E-value=2.4e-08  Score=120.21  Aligned_cols=145  Identities=22%  Similarity=0.259  Sum_probs=108.0

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      +..|++.++.+. .+|.. | .+.+|+.|+|.+|.+.. +|..+..+++|+.|+|++|...+.+|+++.+++|+.|+|++
T Consensus       591 Lr~L~~~~~~l~-~lP~~-f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~  666 (1153)
T PLN03210        591 LRLLRWDKYPLR-CMPSN-F-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSD  666 (1153)
T ss_pred             cEEEEecCCCCC-CCCCc-C-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecC
Confidence            344444444443 34443 3 46788889999988875 66778889999999998877666788888889999999998


Q ss_pred             ccCCCCCCCCccccccccceecccccccccCCC-CCCCCCcEEEcccCCCccccccccccCCCCcccCCC
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNS  216 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~  216 (625)
                      |..-..+|..++++++|+.|++++|..-+.+|. ..+++|+.|+|++|...+.+|....++..+.+.+|.
T Consensus       667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~  736 (1153)
T PLN03210        667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETA  736 (1153)
T ss_pred             CCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCc
Confidence            876668888899999999999998654445664 378889999998887766777666666666555554

syringae 6; Provisional

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.74  E-value=7.2e-10  Score=115.51  Aligned_cols=127  Identities=24%  Similarity=0.396  Sum_probs=70.2

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      +++|..|++|||+.|+++- +|..+..|+ |+.|-+++|+++..+++++.+..|..||.+.|.+. .+|..++.+.+|+.
T Consensus       117 i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~  193 (722)
T KOG0532|consen  117 ICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD  193 (722)
T ss_pred             hhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH
Confidence            4555555555555555543 343343332 45555555555533334555556666666666665 55666666666666


Q ss_pred             eecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCCC---cccCCCC
Q 006922          167 LYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSI  217 (625)
Q Consensus       167 L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~  217 (625)
                      |.+..|++...+++...-.|..||++.|+++ .||-.+.++..|   .+.+|++
T Consensus       194 l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL  246 (722)
T KOG0532|consen  194 LNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL  246 (722)
T ss_pred             HHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence            6666666665444432234667777777776 677666665543   3445553

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.73  E-value=4.6e-07  Score=94.38  Aligned_cols=171  Identities=20%  Similarity=0.267  Sum_probs=127.3

Q ss_pred             CceeEEEEE-EcCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEeccC-CChhh
Q 006922          336 TFGMAYKAI-LEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYYSL-GSVSA  408 (625)
Q Consensus       336 ~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  408 (625)
                      .-.+.||+. ..||..|+.|+++-.. .....-..-+++..++.|+|+|++..++..    +...++||+|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446889999 4589999999994321 111223345778889999999999998863    4468999999987 46666


Q ss_pred             hhccccCC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          409 MLHSERGE----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       409 ~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      +-......          ......+.....++.|++.||.++|+.+   +.-+-|.+++|+++.+.+++|+..|..-.+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54433221          1223567888999999999999999998   8889999999999999999999888766654


Q ss_pred             ccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCC
Q 006922          479 ALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP  523 (625)
Q Consensus       479 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p  523 (625)
                      ....           |-+.+   ..+-|.=.||.+++-|.||..-
T Consensus       445 ~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT-----------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC-----------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3320           11211   3467899999999999999653

>PLN03210 Resistant to P

Probab=98.72  E-value=3.5e-08  Score=118.81  Aligned_cols=64  Identities=23%  Similarity=0.175  Sum_probs=37.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP  132 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  132 (625)
                      ++..|+|+++...+.+|.  ++.+++|+.|+|++|..-..+|..+.++++|+.|++++|..-+.+|
T Consensus       635 ~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp  698 (1153)
T PLN03210        635 GLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP  698 (1153)
T ss_pred             CCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence            356666666554445542  6666677777776665444566666666666666666654333344

syringae 6; Provisional

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.71  E-value=1.1e-09  Score=105.49  Aligned_cols=107  Identities=25%  Similarity=0.296  Sum_probs=44.5

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      ..-+|.++.|++|+|.|...  ..+..|++|+.||||+|.++..----..+.|+++|.|++|.|..  -+.++.+.+|.+
T Consensus       303 vKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvn  378 (490)
T KOG1259|consen  303 VKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVN  378 (490)
T ss_pred             hhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhhee
Confidence            44444444444444444421  12444444444444444444211111223344444444444431  123444444555


Q ss_pred             eeccccccccc--CCCC-CCCCCcEEEcccCCCc
Q 006922          167 LYLANNSLSGK--IPDL-NLPNLQQLNLANNNLS  197 (625)
Q Consensus       167 L~l~~N~l~~~--~p~~-~l~~L~~L~l~~N~l~  197 (625)
                      ||+++|++...  +... .++-|++|.|.+|+++
T Consensus       379 LDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  379 LDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             ccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            55555544421  1111 3444455555555554

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.69  E-value=1e-08  Score=77.96  Aligned_cols=58  Identities=38%  Similarity=0.482  Sum_probs=30.5

Q ss_pred             CccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCcc
Q 006922           92 ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNG  149 (625)
Q Consensus        92 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~  149 (625)
                      +|++|++++|+|+...+..|.++++|++|++++|+++...| .|..+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45556666666655444555555555555555555553333 34444555555555544

...

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.65  E-value=2.7e-09  Score=110.46  Aligned_cols=132  Identities=25%  Similarity=0.313  Sum_probs=91.4

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCC---ccEEEecCCCCCc----cCCcccccc-cccccccccccccCCCCC-----
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSA---LKILSLRSNVITG----YFPSDFINL-KSLCYLYLQFNNFSGTLP-----  132 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p-----  132 (625)
                      ..++.|+++++.+.+..++ .+..+.+   |++|++++|.+++    .+...+..+ ++|+.|+|++|.+++...     
T Consensus        81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            4688888888888765443 3555555   8888888888873    223345556 788888888888875322     


Q ss_pred             CcccccccceecCCCccCCCC----CCCCccccccccceecccccccccCC----C--CCCCCCcEEEcccCCCcc
Q 006922          133 DFSVWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKIP----D--LNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p----~--~~l~~L~~L~l~~N~l~g  198 (625)
                      .+..+++|+.|++++|.+++.    ++..+..+++|+.|+|++|.+++...    .  ..+++|+.|++++|.+++
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            355667888888888888742    23344455688888888888764322    1  156788888888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.64  E-value=6.8e-10  Score=115.68  Aligned_cols=145  Identities=28%  Similarity=0.408  Sum_probs=123.5

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      .+..+|+.|.++ .+|.+ ++.+..|+.|.|..|.|.. +|..+.+|..|.+|||+.|+++-.++.+..++ |+.|-+++
T Consensus        77 t~~aDlsrNR~~-elp~~-~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEE-ACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCchH-HHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEec
Confidence            456788888887 56654 8999999999999999985 88899999999999999999995555676666 99999999


Q ss_pred             ccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC--CcccCCCCC
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS--SAFVGNSIS  218 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~~~~~n~~~  218 (625)
                      |+++ .+|..++.+..|..||.+.|.+...++.. .+.+|..|++..|++. .+|+++..++-  +.|..|.++
T Consensus       153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis  224 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS  224 (722)
T ss_pred             Cccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee
Confidence            9998 88999999999999999999998766665 8999999999999998 78888887763  566666654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.63  E-value=6.1e-09  Score=104.23  Aligned_cols=158  Identities=27%  Similarity=0.347  Sum_probs=121.1

Q ss_pred             CCceEeCCCCCeEEEEEcCCCCcc---cccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC
Q 006922           56 WTGVKCSEDGKRVVAVRLPGVGFS---GLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP  132 (625)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~---g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  132 (625)
                      -.+.+|++..+..  ++=.+.+|+   ..+|++       -..++|..|.|+.+.|..|+.+++|+.||||+|+|+.+-|
T Consensus        38 P~pC~Cs~~~g~~--VdCr~~GL~eVP~~LP~~-------tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p  108 (498)
T KOG4237|consen   38 PAPCTCSDVEGGI--VDCRGKGLTEVPANLPPE-------TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAP  108 (498)
T ss_pred             CCCcccCCCCCce--EEccCCCcccCcccCCCc-------ceEEEeccCCcccCChhhccchhhhceecccccchhhcCh
Confidence            4677887743323  333444543   344443       4789999999999889999999999999999999998777


Q ss_pred             -CcccccccceecCCC-ccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcccccc-ccccC
Q 006922          133 -DFSVWKNLTIINLSD-NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQ-SLKRF  207 (625)
Q Consensus       133 -~~~~l~~L~~L~ls~-N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~-~l~~~  207 (625)
                       .|..+.+|..|-+.+ |+|+......|+.|.+|+.|.+.-|++.-...+.  .+++|..|.+-+|.+. .++. ++..+
T Consensus       109 ~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l  187 (498)
T KOG4237|consen  109 DAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGL  187 (498)
T ss_pred             HhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccch
Confidence             699999888776665 9999655567899999999999999998655553  7899999999999997 4554 44443


Q ss_pred             C---CCcccCCCCCCCCCC
Q 006922          208 P---SSAFVGNSISFDENL  223 (625)
Q Consensus       208 ~---~~~~~~n~~~~~~~~  223 (625)
                      .   .+-...|++.|++++
T Consensus       188 ~~i~tlhlA~np~icdCnL  206 (498)
T KOG4237|consen  188 AAIKTLHLAQNPFICDCNL  206 (498)
T ss_pred             hccchHhhhcCcccccccc
Confidence            3   345567888888876

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.62  E-value=3.3e-09  Score=102.33  Aligned_cols=129  Identities=22%  Similarity=0.271  Sum_probs=97.4

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      +.....|+.||||+|.|+. +..+..-++.++.|++|+|.+. .+..+..+++|+.||||+|.++ .+-..-..+-++++
T Consensus       280 ~dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             cchHhhhhhccccccchhh-hhhhhhhccceeEEecccccee-eehhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            4455679999999999986 5667778899999999999997 5556888999999999999998 34444456678899


Q ss_pred             eecccccccccCCCC-CCCCCcEEEcccCCCccc-cccccccCCC---CcccCCCCCC
Q 006922          167 LYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGS-IPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       167 L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~-~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      |.|+.|.+... ... .+-+|..||+++|+|.-. --..++++|-   +.+.+||+..
T Consensus       357 L~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  357 LKLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             eehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            99999988732 222 567889999999999521 1245667665   4566777543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.62  E-value=1.4e-08  Score=77.16  Aligned_cols=59  Identities=37%  Similarity=0.493  Sum_probs=32.5

Q ss_pred             ccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccc
Q 006922          116 SLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL  174 (625)
Q Consensus       116 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l  174 (625)
                      +|++|+|++|+++...+ .|..+++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            45556666665553333 355555555555555555544445555555555555555543

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.55  E-value=5.6e-07  Score=87.18  Aligned_cols=136  Identities=21%  Similarity=0.199  Sum_probs=97.9

Q ss_pred             HHHHhHcccCCceeEEEEEEcCCcEEEEEEecccc-----------------------CChHHHHHHHHHHHcCCCC--c
Q 006922          326 RASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVN-----------------------VGKRDFEQQMEIVGSIRHE--N  380 (625)
Q Consensus       326 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-----------------------~~~~~~~~e~~~l~~l~h~--n  380 (625)
                      .+.++.||-|--+.||.|..+.|.++|||.=+...                       ..+...++|+++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35578899999999999999999999999532110                       0113367889999888644  5


Q ss_pred             eecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe
Q 006922          381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL  460 (625)
Q Consensus       381 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll  460 (625)
                      +.+.+++    +...+||||+++-.|...--          +-.....|+..|.+-+...-..+   |||+|+++=||++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence            6666654    56789999999866654331          12223444555555555555666   9999999999999


Q ss_pred             CCCCCeeEeccccccccc
Q 006922          461 NSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       461 ~~~~~~kl~DfGla~~~~  478 (625)
                      ++||.+.++||--+...+
T Consensus       236 ~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         236 TEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ecCCCEEEEeCcccccCC
Confidence            999999999998666544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.54  E-value=1.1e-06  Score=89.32  Aligned_cols=259  Identities=14%  Similarity=0.146  Sum_probs=152.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEE----E--ecC-ceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYY----Y--SKD-EKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~----~--~~~-~~~lv~e~~  401 (625)
                      .-||+|+-+.+|-.---  ..-+.|++.......+  .+.++.|.+. .||-+-.-+.|=    .  +.. ...++|..+
T Consensus        17 r~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          17 RPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             ccccCCccceeeecchh--hchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            45999999999964311  1234577765433221  2223344444 566444322221    1  111 245666666


Q ss_pred             cCC-Chhhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          402 SLG-SVSAMLHSE-RGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       402 ~~g-~L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ++. ....+.... +.+.....+|...++++..+|.+.+.||..+   .+-+|+.++|+|+.+++.+.+.|-..-.....
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n  169 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN  169 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccC
Confidence            553 122222211 2223345799999999999999999999998   88899999999999999999987543222111


Q ss_pred             c--ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCc--c---hhhHHHHHHHHhhcc
Q 006922          480 L--APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTG-KSPIHTTGGD--E---LVHLVRWVHSVVREE  546 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~--~---~~~~~~~~~~~~~~~  546 (625)
                      .  .....|...|.+||.-.     +-..+...|-|.+||++++++.| +.||.+....  +   ....+..       +
T Consensus       170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-------g  242 (637)
T COG4248         170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-------G  242 (637)
T ss_pred             CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-------c
Confidence            1  11224566799999754     22346789999999999999995 9999864311  0   0001110       0


Q ss_pred             cccccccccccCC------C--CcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHHhhCCCCCCCC
Q 006922          547 WTAEVFDVELLRY------P--NIEEEMVEMLQIAMSCVVR--MPDQRPKMPDVVRVIENVRPNDSENR  605 (625)
Q Consensus       547 ~~~~~~d~~~~~~------~--~~~~~~~~l~~l~~~Cl~~--~P~~RPs~~ev~~~L~~~~~~~~~~~  605 (625)
                      .....-|...+..      |  ......+.++   .+|+..  .+.-|||.+..+..|..++.+-.+..
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF---~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~  308 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALF---QQAFTESGVATPRPTAKAWVAALDALRQQLKKCT  308 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHH---HHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence            0111111111111      1  1122333343   478755  35689999999999988877654443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.53  E-value=1.5e-08  Score=104.91  Aligned_cols=132  Identities=24%  Similarity=0.345  Sum_probs=98.6

Q ss_pred             CeEEEEEcCCCCcccccC---cccccCC-CCccEEEecCCCCCcc----CCcccccccccccccccccccCCC----CC-
Q 006922           66 KRVVAVRLPGVGFSGLIP---PNTISRL-SALKILSLRSNVITGY----FPSDFINLKSLCYLYLQFNNFSGT----LP-  132 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~---~~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p-  132 (625)
                      .+++.|++.+|.+++.-.   ...+..+ ++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++ 
T Consensus       108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~  187 (319)
T cd00116         108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE  187 (319)
T ss_pred             CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence            358999999998873211   1236677 8999999999999842    334566678899999999999852    11 


Q ss_pred             CcccccccceecCCCccCCCC----CCCCccccccccceecccccccccCC-CC------CCCCCcEEEcccCCCc
Q 006922          133 DFSVWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKIP-DL------NLPNLQQLNLANNNLS  197 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p-~~------~l~~L~~L~l~~N~l~  197 (625)
                      .+..+++|+.|+|++|.+++.    +...+..+++|++|++++|.+++... ..      ..+.|+.|++++|.++
T Consensus       188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence            345567999999999999743    33456678899999999999985211 11      2478999999999997

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=4.3e-08  Score=105.49  Aligned_cols=146  Identities=23%  Similarity=0.291  Sum_probs=98.3

Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc------------cccCCCcCCccccC
Q 006922          430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV------------IARAAGYRAPEVTD  497 (625)
Q Consensus       430 ~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~------------~~~~~~y~aPE~~~  497 (625)
                      +.+++.|+.|+|...  .+||++|.|++|.++..+..||+.|+.+....+....            ......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999865  6999999999999999999999999987655431110            11234599999999


Q ss_pred             CCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHc
Q 006922          498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSC  576 (625)
Q Consensus       498 ~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C  576 (625)
                      ....+.++|+||+||++|-+.. |+.-+...+..........            ..+.....  .......++.+=+.+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------------~~~~~~~~--~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------------LLNAGAFG--YSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------------cccccccc--ccccCcHHHHHHHHHH
Confidence            9888999999999999999995 5555544333222221110            00100001  1112223444445578


Q ss_pred             cCCCCCCCCCHHHHH
Q 006922          577 VVRMPDQRPKMPDVV  591 (625)
Q Consensus       577 l~~~P~~RPs~~ev~  591 (625)
                      +..++.-||++.++.
T Consensus       249 l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLL  263 (700)
T ss_pred             hcCCcccCcchhhhh
Confidence            889999999777664

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.39  E-value=1.7e-07  Score=100.08  Aligned_cols=121  Identities=31%  Similarity=0.375  Sum_probs=66.8

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccc-ccccccccccccCCCCCCcccccccceecCCCcc
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK-SLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG  149 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~  149 (625)
                      +++..+.+...+.  .+..++.++.|++.+|.++. +|.....+. +|+.|++++|++......+..+++|+.|++++|+
T Consensus        98 l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          98 LDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeccccccccCch--hhhcccceeEEecCCccccc-CccccccchhhcccccccccchhhhhhhhhccccccccccCCch
Confidence            4555555433332  24455666666666666664 444455553 6666666666665322355566666666666666


Q ss_pred             CCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCC
Q 006922          150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNN  195 (625)
Q Consensus       150 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~  195 (625)
                      ++ .+|...+.++.|+.|++++|+++...+.. ....|+.|.+++|+
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCc
Confidence            66 44544445566666666666666333332 33336666666664

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.39  E-value=1.9e-07  Score=95.03  Aligned_cols=131  Identities=26%  Similarity=0.343  Sum_probs=92.7

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCcc-CCcccccccccccccccccccCCC-CCCccccccccee
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGY-FPSDFINLKSLCYLYLQFNNFSGT-LPDFSVWKNLTII  143 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~l~~L~~L  143 (625)
                      .++..|+|+.|.|.-......-..+++|+.|.|+.+.|+.. +-......++|+.|+|..|..-+. --....+..|+.|
T Consensus       172 p~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L  251 (505)
T KOG3207|consen  172 PSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL  251 (505)
T ss_pred             ccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence            46888888888887655554455788899999999888732 111234568899999998852211 1134556788899


Q ss_pred             cCCCccCCCCCC--CCccccccccceeccccccccc-CCCC-------CCCCCcEEEcccCCCc
Q 006922          144 NLSDNGFNGTIP--RSLSNLTQLEALYLANNSLSGK-IPDL-------NLPNLQQLNLANNNLS  197 (625)
Q Consensus       144 ~ls~N~l~~~~p--~~l~~l~~L~~L~l~~N~l~~~-~p~~-------~l~~L~~L~l~~N~l~  197 (625)
                      ||++|++-. .+  ..++.++.|..|+++.+.++.. .|+.       .+++|++|+++.|++.
T Consensus       252 dLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  252 DLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             cccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            999998763 33  3567888888888888888742 3331       5788999999999885

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.37  E-value=2.8e-06  Score=81.97  Aligned_cols=122  Identities=20%  Similarity=0.263  Sum_probs=89.4

Q ss_pred             CcEEEEEEeccc-c-------CChHHHHHHHHHHHcCCC--CceecceeEEEecC----ceEEEEEeccCC-Chhhhhcc
Q 006922          348 GTTVVVKRLKDV-N-------VGKRDFEQQMEIVGSIRH--ENVVELKAYYYSKD----EKLMVYDYYSLG-SVSAMLHS  412 (625)
Q Consensus       348 g~~vavK~l~~~-~-------~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~  412 (625)
                      ++.+.+|.+... .       .......+|...+..+..  -.+.+.+++.....    .-++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            556666654321 1       223457788887777743  33555666665532    348999999984 78888875


Q ss_pred             ccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccccccc
Q 006922          413 ERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTTIT  477 (625)
Q Consensus       413 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~~  477 (625)
                      ...     .+......++.++++.++-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       112 ~~~-----~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WEQ-----LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hcc-----cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            321     445567889999999999999998   99999999999999887   7889999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.35  E-value=1.9e-07  Score=99.80  Aligned_cols=137  Identities=35%  Similarity=0.481  Sum_probs=103.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCC-CccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLS-ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      .+..+++.+++++ .+++. ...+. +|+.|++++|.+.. +|..+.++++|+.|++++|+++...+..+..++|+.|++
T Consensus       117 ~l~~L~l~~n~i~-~i~~~-~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         117 NLTSLDLDNNNIT-DIPPL-IGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             ceeEEecCCcccc-cCccc-cccchhhcccccccccchhh-hhhhhhccccccccccCCchhhhhhhhhhhhhhhhheec
Confidence            5788899988888 45553 66664 99999999999986 566789999999999999999955555558899999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCC-CCCCCCcEEEcccCCCccccccccccCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-LNLPNLQQLNLANNNLSGSIPQSLKRFP  208 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~l~~L~~L~l~~N~l~g~~p~~l~~~~  208 (625)
                      ++|+++ .+|.....+..|++|++++|.+...+.. ..++++..|.+++|++. .++..++.++
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~  255 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS  255 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhcccc
Confidence            999998 6777666677799999999954333332 36677777777777775 2244444433

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.35  E-value=6.8e-06  Score=80.36  Aligned_cols=141  Identities=13%  Similarity=0.159  Sum_probs=85.4

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc--eecceeEEEecCceEEEEEeccCCC-h
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN--VVELKAYYYSKDEKLMVYDYYSLGS-V  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-L  406 (625)
                      ..||+|..+.||+.   .|..+++|.... .....+..+|.+++..+..-.  +.+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   255677887765 334466789999998886433  4566777777777889999999963 2


Q ss_pred             hhh---------------------hccccCCCCccCC--HHHHHHHH-------HHHH-HHHHHHHhc-CCCCceecCCC
Q 006922          407 SAM---------------------LHSERGEGRIPLD--WDTRMRIA-------IGAA-RGIARIHAA-NGGKLVHGNIK  454 (625)
Q Consensus       407 ~~~---------------------l~~~~~~~~~~l~--~~~~~~i~-------~~ia-~~l~~LH~~-~~~~ivHrDlk  454 (625)
                      ...                     +|..... ...+.  +......+       ..+. ...++|... ..+.++|+|+.
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            111                     1111000 00110  00000000       0011 112222221 12357899999


Q ss_pred             CCCEEeCCCCCeeEeccccccc
Q 006922          455 SSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       455 ~~NIll~~~~~~kl~DfGla~~  476 (625)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999997664

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.34  E-value=8.1e-06  Score=77.44  Aligned_cols=137  Identities=15%  Similarity=0.177  Sum_probs=100.6

Q ss_pred             cccCCceeEEEEEEcCCcEEEEEEeccc-------cCChHHHHHHHHHHHcCCCC--ceecceeEEE-ec----CceEEE
Q 006922          332 LGKGTFGMAYKAILEDGTTVVVKRLKDV-------NVGKRDFEQQMEIVGSIRHE--NVVELKAYYY-SK----DEKLMV  397 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~~g~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv  397 (625)
                      -|+||-+-|++-... |..+-+|+-...       ..+...|.+|+..+.++...  .+.+.. ++. ..    ..-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367888889997765 457888887521       22457899999998888532  244444 332 21    135799


Q ss_pred             EEeccC-CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC--eeEeccccc
Q 006922          398 YDYYSL-GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--GCVSDLGLT  474 (625)
Q Consensus       398 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DfGla  474 (625)
                      +|-+++ -+|.+++....   ..+.+...+..+..++++.++-||..+   +.|+|+.+.||+++.++.  ++++||.-+
T Consensus       104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            997764 47888875432   123567778899999999999999998   999999999999986666  899999866


Q ss_pred             cc
Q 006922          475 TI  476 (625)
Q Consensus       475 ~~  476 (625)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            54

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=5.8e-06  Score=89.53  Aligned_cols=139  Identities=15%  Similarity=0.249  Sum_probs=89.2

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCCh-------------------------------H----------HHHH
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK-------------------------------R----------DFEQ  368 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------~----------~~~~  368 (625)
                      +-|+.++-|+||+|++++|+.||||+.+..-...                               +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            3467899999999999999999999986421100                               0          1223


Q ss_pred             HHHHHHcC----C-CCceecceeEE-EecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHH-HHHHH
Q 006922          369 QMEIVGSI----R-HENVVELKAYY-YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG-IARIH  441 (625)
Q Consensus       369 e~~~l~~l----~-h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH  441 (625)
                      |+.-+.++    + .+++. +=.+| .-....+|+|||++|-.+.+...-...    ..+   +..++..++++ +.-+-
T Consensus       211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d---~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GID---RKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence            33333332    2 23332 22333 335678999999999998887432221    144   23333333332 22222


Q ss_pred             hcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       442 ~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ..+   ++|.|..|-||+++.++.+.+.|||+....++
T Consensus       283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            344   99999999999999999999999999876653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=3.2e-07  Score=97.71  Aligned_cols=180  Identities=17%  Similarity=0.149  Sum_probs=130.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc-eecceeEEEecCceEEEEEeccCC-Chh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN-VVELKAYYYSKDEKLMVYDYYSLG-SVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~L~  407 (625)
                      .-+++|+++++||.+--..+....+.+...    ....-++++|.+++||| .++.++-++.++...++++++..+ +-.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            457899999999887322233334544432    45566889999999999 777777777777888999999877 221


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--ccccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--APVIA  485 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~~~~  485 (625)
                      .....    ....+...+...+...-+++++|+|+..   =+|||    ||+..+ +..+..||+....+...  .....
T Consensus       324 ~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  324 LEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             ccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence            11110    0011333445566677788999999864   58998    776644 78899999998877654  34456


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCC
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH  525 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~  525 (625)
                      ++..|+|||+.....+..+.|+|+.|+-..++.-|.+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            7888999999999999999999999998888887877754

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.23  E-value=4.5e-07  Score=92.33  Aligned_cols=132  Identities=26%  Similarity=0.284  Sum_probs=98.0

Q ss_pred             CeEEEEEcCCCCcccccCc-ccccCCCCccEEEecCCCCCccCCccc-ccccccccccccccccCCC-CC-Ccccccccc
Q 006922           66 KRVVAVRLPGVGFSGLIPP-NTISRLSALKILSLRSNVITGYFPSDF-INLKSLCYLYLQFNNFSGT-LP-DFSVWKNLT  141 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~  141 (625)
                      ..|+.|||+.|-+...-+- .....|++|+.|+|+.|++.-...... ..+++|+.|.|+.+.|+.. +- -...+++|+
T Consensus       146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~  225 (505)
T KOG3207|consen  146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE  225 (505)
T ss_pred             CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence            4689999999887755432 235679999999999999985433322 3578899999999998731 11 245679999


Q ss_pred             eecCCCccCCCCCCCCccccccccceecccccccccC--CC-CCCCCCcEEEcccCCCc
Q 006922          142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKI--PD-LNLPNLQQLNLANNNLS  197 (625)
Q Consensus       142 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~--p~-~~l~~L~~L~l~~N~l~  197 (625)
                      .|+|..|...+.--.....+..|+.|||++|++-...  +. ..++.|..|+++.+.++
T Consensus       226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcc
Confidence            9999999633333344566789999999999987443  22 27899999999999986

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.23  E-value=1.7e-06  Score=60.25  Aligned_cols=37  Identities=38%  Similarity=0.847  Sum_probs=26.1

Q ss_pred             hhHHHHHHHHHHhCCC---CCCCCCCCC--CCCCCCCCceEeC
Q 006922           25 VEDKEALLDFVNNLPH---SRSLNWNES--TSVCNHWTGVKCS   62 (625)
Q Consensus        25 ~~~~~~ll~~~~~~~~---~~~~~w~~~--~~~c~~w~gv~C~   62 (625)
                      ++|++||++||+.+..   ....+|+.+  .++| +|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence            5799999999999863   234499877  4666 79999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.19  E-value=2.1e-08  Score=107.42  Aligned_cols=122  Identities=28%  Similarity=0.327  Sum_probs=92.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCc--ccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF--SVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~l~~L~~L~l  145 (625)
                      +...+.+.|.|.-.  .+++.-++.|+.|||++|+++..-  .+..++.|++|||+.|.+. .+|.+  ..+. |+.|+|
T Consensus       166 L~~a~fsyN~L~~m--D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  166 LATASFSYNRLVLM--DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             HhhhhcchhhHHhH--HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            44445555665533  345888899999999999998632  6788999999999999998 56643  3344 999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccC---CCCCCCCCcEEEcccCCCc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKI---PDLNLPNLQQLNLANNNLS  197 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~---p~~~l~~L~~L~l~~N~l~  197 (625)
                      .+|.++.  -..+.+|.+|+.|||+.|-|++.-   |-+.+..|..|+|.+|++.
T Consensus       240 rnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            9999873  245788899999999999887632   2236778899999999884

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.18  E-value=4e-08  Score=105.23  Aligned_cols=127  Identities=27%  Similarity=0.281  Sum_probs=99.9

Q ss_pred             CCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCC-Cccccccccceec
Q 006922           91 SALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYL  169 (625)
Q Consensus        91 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~~L~l  169 (625)
                      ..|...+.++|.+.. ...++.-++.|+.|||++|++... ..+..++.|++|||+.|.+. .+|. ....+ .|..|.|
T Consensus       164 n~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  164 NKLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hhHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh-HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            357778899999985 556788899999999999999843 36778899999999999998 5554 23344 4999999


Q ss_pred             ccccccccCCCCCCCCCcEEEcccCCCccc---cc-cccccCCCCcccCCCCCCCC
Q 006922          170 ANNSLSGKIPDLNLPNLQQLNLANNNLSGS---IP-QSLKRFPSSAFVGNSISFDE  221 (625)
Q Consensus       170 ~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~---~p-~~l~~~~~~~~~~n~~~~~~  221 (625)
                      ++|.++...--.++++|..|||++|-|++-   .| -+++.+..+.+.|||+-|..
T Consensus       240 rnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            999998544334899999999999988742   12 24566677889999988864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=5.8e-05  Score=74.85  Aligned_cols=141  Identities=18%  Similarity=0.193  Sum_probs=84.7

Q ss_pred             cccCCc-eeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          332 LGKGTF-GMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       332 lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      |-.|.+ ..||+.... +..+.+|+.....  ..+..+|++++..+. +--+.+++++....+..++|||+++|.++...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444555 789999765 4778888876543  345778888888774 43455677777666678999999999877643


Q ss_pred             h-------------------ccccCCCCccCC--HHHHHHHHH--------------------HHHHHHHHHHh----cC
Q 006922          410 L-------------------HSERGEGRIPLD--WDTRMRIAI--------------------GAARGIARIHA----AN  444 (625)
Q Consensus       410 l-------------------~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~----~~  444 (625)
                      .                   |..... ..+..  +........                    .+...+..|-.    ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            2                   111100 00111  000000000                    01111222211    11


Q ss_pred             CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       445 ~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      .+.++|+|+.|.|||++.+....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            34589999999999999987788999997653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.03  E-value=5.7e-05  Score=72.75  Aligned_cols=135  Identities=17%  Similarity=0.227  Sum_probs=89.3

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCChHH-------------------------HHHHHHHHHcCC--CCceec
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD-------------------------FEQQMEIVGSIR--HENVVE  383 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-------------------------~~~e~~~l~~l~--h~niv~  383 (625)
                      .|..|.-+.||+|...++..+|||+++......+.                         ..+|+.-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            47788889999999888999999999754222111                         123444444432  222223


Q ss_pred             ceeEEEecCceEEEEEeccCCC-hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 006922          384 LKAYYYSKDEKLMVYDYYSLGS-VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS  462 (625)
Q Consensus       384 l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~  462 (625)
                      -+++.    ...|||||+.... -.-.|...      ++.......+..++++.+.-|....  .+||+||+.=|||+. 
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv------~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV------PLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcccC------CcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-
Confidence            33332    3579999997642 22222221      1222356667778888888888733  399999999999998 


Q ss_pred             CCCeeEeccccccccc
Q 006922          463 QQYGCVSDLGLTTITS  478 (625)
Q Consensus       463 ~~~~kl~DfGla~~~~  478 (625)
                      ++.+.|+|||-|....
T Consensus       202 ~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEECccccccC
Confidence            8999999999887654

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.03  E-value=1.3e-06  Score=93.90  Aligned_cols=107  Identities=30%  Similarity=0.365  Sum_probs=57.5

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      ++.+.+|+.|++.+|.|... ...+..+++|++|+|++|+|+ .+..+..++.|+.|++++|.|+.  -..+..+.+|+.
T Consensus        91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~-~i~~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~  166 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKIT-KLEGLSTLTLLKELNLSGNLISD--ISGLESLKSLKL  166 (414)
T ss_pred             cccccceeeeeccccchhhc-ccchhhhhcchheeccccccc-cccchhhccchhhheeccCcchh--ccCCccchhhhc
Confidence            55556666666666666542 222455566666666666665 33344444556666666666542  123444555666


Q ss_pred             eecccccccccCCC--CCCCCCcEEEcccCCCc
Q 006922          167 LYLANNSLSGKIPD--LNLPNLQQLNLANNNLS  197 (625)
Q Consensus       167 L~l~~N~l~~~~p~--~~l~~L~~L~l~~N~l~  197 (625)
                      +++++|.+...-+.  ..+.+|+.+++++|.+.
T Consensus       167 l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  167 LDLSYNRIVDIENDELSELISLEELDLGGNSIR  199 (414)
T ss_pred             ccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence            66666665544441  34555555666666553

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=97.97  E-value=1.7e-06  Score=92.94  Aligned_cols=131  Identities=33%  Similarity=0.330  Sum_probs=100.3

Q ss_pred             cCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccce
Q 006922           88 SRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL  167 (625)
Q Consensus        88 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  167 (625)
                      ..+..++.+++..|.+.. +-..+..+++|+.|++.+|++......+..+++|++|+|++|+|+...  .+..++.|+.|
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            456778888899999986 334588899999999999999854444888999999999999998543  46677789999


Q ss_pred             ecccccccccCCCC-CCCCCcEEEcccCCCccccc---cccccCCCCcccCCCCCCCCC
Q 006922          168 YLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIP---QSLKRFPSSAFVGNSISFDEN  222 (625)
Q Consensus       168 ~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p---~~l~~~~~~~~~~n~~~~~~~  222 (625)
                      ++++|.++. +... .+++|+.+++++|+++..-+   ..+.++..+...+|.+....+
T Consensus       146 ~l~~N~i~~-~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~  203 (414)
T KOG0531|consen  146 NLSGNLISD-ISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEG  203 (414)
T ss_pred             eeccCcchh-ccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccc
Confidence            999999985 4443 58999999999999985444   344444455566666554443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=3.6e-05  Score=72.75  Aligned_cols=105  Identities=14%  Similarity=0.192  Sum_probs=81.9

Q ss_pred             HHHHHHHHcCCC-CceecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006922          367 EQQMEIVGSIRH-ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG  445 (625)
Q Consensus       367 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  445 (625)
                      ..|.-++..+++ +++.+++|+|    ..++|.||...+++...-..-  .....-+|..|.+||.++++.+.++++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            347778888875 6999999999    347799999887664321000  011126899999999999999999998665


Q ss_pred             CCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       446 ~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ..+.-.|++++|+-+++++++|++|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            56888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	625
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-11
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-04
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 148/274 (54%), Gaps = 12/274 (4%)
Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYY 388
           +LG+G FG  YK  L DGT V VKRLK+     G+  F+ ++E++    H N++ L+ + 
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
            +  E+L+VY Y + GSV++ L  ER E + PLDW                       K+
Sbjct: 105 MTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 163
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQA 504
           +H ++K++NI L+ +    V D GL  +       +  A     G+ APE   + K+++ 
Sbjct: 164 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK 223
Query: 505 SDVYSFGVVLLEILTGKSPIHTT--GGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI 562
           +DV+ +GV+LLE++TG+          D+ V L+ WV  +++E+    + DV+L    N 
Sbjct: 224 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNY 281
Query: 563 EEEMVEML-QIAMSCVVRMPDQRPKMPDVVRVIE 595
           ++E VE L Q+A+ C    P +RPKM +VVR++E
Sbjct: 282 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYY 388
           +LG+G FG  YK  L DG  V VKRLK+     G+  F+ ++E++    H N++ L+ + 
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
            +  E+L+VY Y + GSV++ L  ER E + PLDW                       K+
Sbjct: 97  MTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQA 504
           +H ++K++NI L+ +    V D GL  +       +  A     G+ APE   + K+++ 
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK 215
Query: 505 SDVYSFGVVLLEILTGKSP--IHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI 562
           +DV+ +GV+LLE++TG+    +     D+ V L+ WV  +++E+    + DV+L    N 
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNY 273
Query: 563 EEEMVEML-QIAMSCVVRMPDQRPKMPDVVRVIEN 596
           ++E VE L Q+A+ C    P +RPKM +VVR++E 
Sbjct: 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLK---DVNVG--KRDFEQQMEIVGSIRHENVVELKA 386
           +G+G FG+ YK  + + TTV VK+L    D+     K+ F+Q+++++   +HEN+VEL  
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    D+  +VY Y   GS+   L     +G  PL W                       
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI--ARAAG---YRAPEVTDSRKA 501
             +H +IKS+NI L+      +SD GL   +   A  +  +R  G   Y APE     + 
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG-EI 211
Query: 502 TQASDVYSFGVVLLEILTG 520
           T  SD+YSFGVVLLEI+TG
Sbjct: 212 TPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLK---DVNVG--KRDFEQQMEIVGSIRHENVVELKA 386
           +G+G FG+ YK  + + TTV VK+L    D+     K+ F+Q+++++   +HEN+VEL  
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    D+  +VY Y   GS+   L     +G  PL W                       
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAGYRAPEVTDSRKA 501
             +H +IKS+NI L+      +SD GL   +   A       I     Y APE     + 
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG-EI 211
Query: 502 TQASDVYSFGVVLLEILTG 520
           T  SD+YSFGVVLLEI+TG
Sbjct: 212 TPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLK---DVNVG--KRDFEQQMEIVGSIRHENVVELKA 386
           +G+G FG+ YK  + + TTV VK+L    D+     K+ F+Q+++++   +HEN+VEL  
Sbjct: 33  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    D+  +VY Y   GS+   L     +G  PL W                       
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAGYRAPEVTDSRKA 501
             +H +IKS+NI L+      +SD GL   +   A       I     Y APE     + 
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EI 205
Query: 502 TQASDVYSFGVVLLEILTG 520
           T  SD+YSFGVVLLEI+TG
Sbjct: 206 TPKSDIYSFGVVLLEIITG 224

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 331 VLGKGTFGMAYKAILEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           ++G G FG  YK +L DG  V +KR   + + G  +FE ++E +   RH ++V L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
            ++E +++Y Y   G++   L+       + + W+                       ++
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRA---II 161
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQA 504
           H ++KS NI L+      ++D G++   + L       V+    GY  PE     + T+ 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEK 221
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE- 563
           SDVYSFGVVL E+L  +S I  +   E+V+L  W           ++ D      PN+  
Sbjct: 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLAD 275
Query: 564 ----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
               E + +    A+ C+    + RP M DV+  +E
Sbjct: 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 331 VLGKGTFGMAYKAILEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           ++G G FG  YK +L DG  V +KR   + + G  +FE ++E +   RH ++V L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
            ++E +++Y Y   G++   L+       + + W+                       ++
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRA---II 161
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRKATQA 504
           H ++KS NI L+      ++D G++        + L  V+    GY  PE     + T+ 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEK 221
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE- 563
           SDVYSFGVVL E+L  +S I  +   E+V+L  W           ++ D      PN+  
Sbjct: 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLAD 275
Query: 564 ----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
               E + +    A+ C+    + RP M DV+  +E
Sbjct: 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 333 GKGTFGMAYKAILEDGTTVVVKRLK---DVNVG--KRDFEQQMEIVGSIRHENVVELKAY 387
           G+G FG+ YK  + + TTV VK+L    D+     K+ F+Q++++    +HEN+VEL  +
Sbjct: 31  GEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               D+  +VY Y   GS+   L     +G  PL W                        
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCL--DGTPPLSWHXRCKIAQGAANGINFLHENHH-- 145
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI--ARAAG---YRAPEVTDSRKAT 502
            +H +IKS+NI L+      +SD GL   +   A  +  +R  G   Y APE     + T
Sbjct: 146 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG-EIT 203
Query: 503 QASDVYSFGVVLLEILTG 520
             SD+YSFGVVLLEI+TG
Sbjct: 204 PKSDIYSFGVVLLEIITG 221

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 83/162 (51%), Gaps = 7/162 (4%)
Query: 26  EDKEALLDFVNNLPHSRSLN-WNESTSVCNH-WTGVKCSEDGK--RVVAVRLPGVGFSGL 81
           +DK+ALL    +L +  +L+ W  +T  CN  W GV C  D +  RV  + L G+     
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 82  IP-PNTISRLSALKILSLRS-NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF-SVWK 138
            P P++++ L  L  L +   N + G  P     L  L YLY+   N SG +PDF S  K
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD 180
            L  ++ S N  +GT+P S+S+L  L  +    N +SG IPD
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 39/288 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGT-----TVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVV 382
           +V+G G FG  YK +L+  +      V +K LK     K+  DF  +  I+G   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
            L+         +++ +Y   G++   L  + GE  +                       
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-------LQLVGMLRGIAAGMKY 162
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVT 496
                 VH ++ + NI +NS     VSD GL+ +           +G      + APE  
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
             RK T ASDV+SFG+V+ E++T G+ P       E++  +                  +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----------------D 265
Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDS 602
             R P   +    + Q+ M C  +   +RPK  D+V +++  +R  DS
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 127
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H N+ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 238
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 239 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 293

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKD-VNVGKRDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 126
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 237
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 238 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ +Y   GS+   L  H+ER +    L + +                
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS---------QICKGME 131
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 240
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 241 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 133
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 244
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 245 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 299

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 126
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 237
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 238 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 131
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 242
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 243 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 297

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 132
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 243
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 244 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 298

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 129
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 240
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 241 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ +Y   GS+   L  H ER +    L + +                
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKGME 128
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 237
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 238 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKD-VNVGKRDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ +Y   GS+   L  H ER +    L + +                
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKGME 127
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 128 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 236
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 237 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 291

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 144
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 255
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 256 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 310

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ +Y   GS+   L  H ER +    L + +                
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKGME 132
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 133 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 241
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 242 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 296

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 144
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 255
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 256 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 310

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR---DFEQQMEIVGSIRHENVVELKA 386
           E +G G+FG  ++A    G+ V VK L + +       +F +++ I+  +RH N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
                    +V +Y S GS+  +LH  +   R  LD +                      
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLD-ERRRLSMAYDVAKGMNYLHNRNP 158
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
            +VH N+KS N+ ++ +    V D GL+ + ++       AAG   + APEV     + +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 504 ASDVYSFGVVLLEILTGKSP 523
            SDVYSFGV+L E+ T + P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ ++   GS+   L  H ER +    L + +                
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS---------QICKGME 131
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 240
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R N
Sbjct: 241 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRL--KDVNVGK-RDFEQQMEIVGSIRHENVVELKA 386
           E +G G+FG  ++A    G+ V VK L  +D +  +  +F +++ I+  +RH N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
                    +V +Y S GS+  +LH  +   R  LD +                      
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLD-ERRRLSMAYDVAKGMNYLHNRNP 158
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
            +VH ++KS N+ ++ +    V D GL+ + ++       AAG   + APEV     + +
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 504 ASDVYSFGVVLLEILTGKSP 523
            SDVYSFGV+L E+ T + P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 330 EVLGKGTFG---MAYKAILED--GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVE 383
           + LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            K   YS   +   ++ +Y   GS+   L  H ER +    L + +              
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKG 157
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAP 493
                  + +H ++ + NI + ++    + D GLT +          +  G     + AP
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVRE 545
           E     K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++         
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--------- 268
Query: 546 EWTAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
                VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R
Sbjct: 269 -----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 52/296 (17%)
Query: 332 LGKGTFG---MAYKAILED--GTTVVVKRLKD-VNVGKRDFEQQMEIVGSIRHENVVELK 385
           LGKG FG   M     L+D  G  V VK+L+       RDFE+++EI+ S++H+N+V+ K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
              YS   +   ++ +Y   GS+   L  H ER +    L + +                
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---------QICKGME 126
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEV 495
                + +H ++ + NI + ++    + D GLT +          +  G     + APE 
Sbjct: 127 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 496 TDSRKATQASDVYSFGVVLLEILT----GKSP----IHTTGGDELVHLVRWVHSVVREEW 547
               K + ASDV+SFGVVL E+ T     KSP    +   G D+   ++           
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI----------- 235
Query: 548 TAEVFD-VELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
              VF  +ELL    R P  +    E+  I   C     +QRP   D+   ++ +R
Sbjct: 236 ---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 37/283 (13%)
Query: 331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVEL 384
           V+G G FG      L+  G   V   +K + VG     +RDF  +  I+G   H NVV L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           +         ++V ++   G++ A L    G+        T                   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF-------TVIQLVGMLRGIAAGMRYLA 162
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTDS 498
               VH ++ + NI +NS     VSD GL+ +       +    G      + APE    
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
           RK T ASDV+S+G+V+ E+++ G+ P       +++  +                  E  
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EGY 265
Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
           R P   +    + Q+ + C  +   +RPK   +V +++ +  N
Sbjct: 266 RLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 41/287 (14%)
Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDV-NVGKRDFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LKD  +  ++DF ++ E++ +++HE++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSE------RGEGRIPLDWDTXXXXXXXXXXXXX 438
                  D  +MV++Y   G ++  L +         EG  P +  T             
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL-TQSQMLHIAQQIAA 139
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------YR 491
                     VH ++ + N  +       + D G++      +    R  G       + 
Sbjct: 140 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPIRWM 197
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
            PE    RK T  SDV+S GVVL EI T GK P +    +E++  +              
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT------------- 244
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                +L+ P    +  E+ ++ + C  R P  R  +  +  +++N+
Sbjct: 245 --QGRVLQRPRTCPQ--EVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 331 VLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYY 388
           VLGKGT+G+ Y    L +   + +K + + +    +   +++ +   ++H+N+V+    +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
                  +  +    GS+SA+L S+ G    PL  D                      ++
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWG----PLK-DNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 449 VHGNIKSSNIFLNSQQYGCV---SDLGLTTITSALAPVIARAAG---YRAPEVTDS--RK 500
           VH +IK  N+ +N+  Y  V   SD G +   + + P      G   Y APE+ D   R 
Sbjct: 144 VHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR-Y 559
             +A+D++S G  ++E+ TGK P +  G                 E  A +F V + + +
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELG-----------------EPQAAMFKVGMFKVH 244
Query: 560 PNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVV 591
           P I E M  E     + C    PD+R    D++
Sbjct: 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 34/272 (12%)
Query: 331 VLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYY 388
           VLGKGT+G+ Y    L +   + +K + + +    +   +++ +   ++H+N+V+    +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
                  +  +    GS+SA+L S+ G    PL  D                      ++
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWG----PLK-DNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 449 VHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG---YRAPEVTDS--RKA 501
           VH +IK  N+ +N+   G   +SD G +   + + P      G   Y APE+ D   R  
Sbjct: 130 VHRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR-YP 560
            +A+D++S G  ++E+ TGK P +  G                 E  A +F V + + +P
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELG-----------------EPQAAMFKVGMFKVHP 231
Query: 561 NIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVV 591
            I E M  E     + C    PD+R    D++
Sbjct: 232 EIPESMSAEAKAFILKCFEPDPDKRACANDLL 263

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H NV+ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         +++ ++   GS+ + L    G+        T                  
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-------TVIQLVGMLRGIAAGMKYL 151
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYRAP 493
                VH ++ + NI +NS     VSD GL+          T TSAL   I     + AP
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP--IRWTAP 209
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E    RK T ASDV+S+G+V+ E+++ G+ P       ++++ +                
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--------------- 254
Query: 553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
             +  R P   +    + Q+ + C  +  + RPK   +V  ++ +  N
Sbjct: 255 --QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 300

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 37/297 (12%)
Query: 317 YAFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQM 370
           +A ++E        V+G G FG      L+  G   +   +K + VG     +RDF  + 
Sbjct: 15  FAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 371 EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXX 430
            I+G   H N++ L+         ++V +Y   GS+   L    G+        T     
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF-------TVIQLV 127
Query: 431 XXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG- 489
                             VH ++ + NI +NS     VSD GL+ +            G 
Sbjct: 128 GMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 187
Query: 490 -----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
                + APE    RK T ASDV+S+G+V+ E+++ G+ P       +++  V       
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE------ 241
Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
                      E  R P+  +    + Q+ + C  +  + RPK  ++V +++ +  N
Sbjct: 242 -----------EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 116/266 (43%), Gaps = 31/266 (11%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  + A     T V VK +K  ++    F  +  ++ +++H+ +V+L A   +K
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 248
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
           +   ++ ++ + GS+   L S+ G  + PL                           +H 
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEG-SKQPL-----PKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFG 511
           +++++NI +++     ++D GL  + +   P+      + APE  +    T  SDV+SFG
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKF-PI-----KWTAPEAINFGSFTIKSDVWSFG 356
Query: 512 VVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEML 570
           ++L+EI+T G+ P       E++  +   + + R E   E                 E+ 
Sbjct: 357 ILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE-----------------ELY 399
Query: 571 QIAMSCVVRMPDQRPKMPDVVRVIEN 596
            I M C    P++RP    +  V+++
Sbjct: 400 NIMMRCWKNRPEERPTFEYIQSVLDD 425

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 137
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V  GK    ++++I+  + H N+V L+ ++Y
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 138
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREE 546
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 138
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 139 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 257
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 258 FKFPQIK 264

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 137
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 156
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 157 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 275
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 276 FKFPQIK 282

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 172
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 232
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 292 KFPQIK 297

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/106 (42%), Positives = 62/106 (58%), Gaps = 4/106 (3%)
Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK-SLCYLYLQFNNFSG-TLPDFS 135
           FSG +P +T+ ++  LK+L L  N  +G  P    NL  SL  L L  NNFSG  LP+  
Sbjct: 327 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 386
Query: 136 VWKNLTI--INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
                T+  + L +NGF G IP +LSN ++L +L+L+ N LSG IP
Sbjct: 387 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 432

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN 144
           T     ++  L +  N+++GY P +  ++  L  L L  N+ SG++PD     + L I++
Sbjct: 624 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 683
Query: 145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDXXXXXXXXXXXXXXXXSGSIPQSL 204
           LS N  +G IP+++S LT L  + L+NN+LSG IP+                        
Sbjct: 684 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM--------------------GQF 723
Query: 205 KRFPSSAFVGNSISFDENLAPRASPDVAPRGESHLRPKSGRRI 247
           + FP + F+ N       L PR  P  A  G +H +   GRR+
Sbjct: 724 ETFPPAKFLNNPGLCGYPL-PRCDPSNA-DGYAHHQRSHGRRL 764

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 141
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 142 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 260
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 261 FKFPQIK 267

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 146
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 147 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 206
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 265
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 266 KFPQIK 271

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 21/278 (7%)
Query: 299 VSRNQDASNRLFFFEGCNYAFDL-EDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLK 357
           VSR++D S             D  +++     +V+G G+FG+ Y+A L D   +V   +K
Sbjct: 32  VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVA--IK 89
Query: 358 DVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL------MVYDYYSLGSVSAMLH 411
            V   KR   ++++I+  + H N+V L+ ++YS  EK       +V DY          H
Sbjct: 90  KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 149
Query: 412 SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGC-VSD 470
             R +  +P+ +                        + H +IK  N+ L+       + D
Sbjct: 150 YSRAKQTLPVIY-----VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 204
Query: 471 LGLTTITSALAPVIARAAG--YRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPIHT- 526
            G         P ++      YRAPE +  +   T + DV+S G VL E+L G+ PI   
Sbjct: 205 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPG 263
Query: 527 -TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            +G D+LV +++ + +  RE+      +    ++P I+
Sbjct: 264 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 301

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 149
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 268
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 269 FKFPQIK 275

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         +++ +Y   GS+ A L   + +GR      T                  
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF-----TVIQLVGMLRGIGSGMKYL 147
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTD 497
                VH ++ + NI +NS     VSD G++ +            G      + APE   
Sbjct: 148 SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            RK T ASDV+S+G+V+ E+++ G+ P       +++  +                  E 
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 250
Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            R P   +  + + Q+ + C  +    RPK   +V +++ +  N
Sbjct: 251 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN 294

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 137
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 332 LGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGKRDFEQ---QMEIVGSIRHENVVEL 384
           +G+G+FG   KAIL    EDG   V+K +    +  ++ E+   ++ ++ +++H N+V+ 
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXX 440
           +  +       +V DY   G +   +++++G    E +I LDW                 
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDW---------FVQICLAL 138
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTD 497
                 K++H +IKS NIFL       + D G+  +   T  LA        Y +PE+ +
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
           ++     SD+++ G VL E+ T K          LV
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 150
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 269
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 270 KFPQIK 275

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           EV+G G FG   +  L+      + V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+    +    +++ ++   G++ + L    G+        T                  
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF-------TVIQLVGMLRGIASGMRYL 132
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYRAP 493
                VH ++ + NI +NS     VSD GL+          T TS+L   I     + AP
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP--IRWTAP 190
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E    RK T ASD +S+G+V+ E+++ G+ P       ++++ +                
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE--------------- 235
Query: 553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             +  R P   +    + Q+ + C  +  + RP+ P VV  ++ +
Sbjct: 236 --QDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 21/278 (7%)
Query: 299 VSRNQDASNRLFFFEGCNYAFDL-EDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLK 357
           VSR++D S             D  +++     +V+G G+FG+ Y+A L D   +V   +K
Sbjct: 73  VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVA--IK 130
Query: 358 DVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL------MVYDYYSLGSVSAMLH 411
            V   KR   ++++I+  + H N+V L+ ++YS  EK       +V DY          H
Sbjct: 131 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 190
Query: 412 SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGC-VSD 470
             R +  +P+ +                        + H +IK  N+ L+       + D
Sbjct: 191 YSRAKQTLPVIY-----VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 245
Query: 471 LGLTTITSALAPVIARAAG--YRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPIHT- 526
            G         P ++      YRAPE +  +   T + DV+S G VL E+L G+ PI   
Sbjct: 246 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPG 304
Query: 527 -TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            +G D+LV +++ + +  RE+      +    ++P I+
Sbjct: 305 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 342

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 21/278 (7%)
Query: 299 VSRNQDASNRLFFFEGCNYAFDL-EDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLK 357
           VSR++D S             D  +++     +V+G G+FG+ Y+A L D   +V   +K
Sbjct: 30  VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVA--IK 87
Query: 358 DVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL------MVYDYYSLGSVSAMLH 411
            V   KR   ++++I+  + H N+V L+ ++YS  EK       +V DY          H
Sbjct: 88  KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 147
Query: 412 SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGC-VSD 470
             R +  +P+ +                        + H +IK  N+ L+       + D
Sbjct: 148 YSRAKQTLPVIY-----VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 202
Query: 471 LGLTTITSALAPVIARAAG--YRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPIHT- 526
            G         P ++      YRAPE +  +   T + DV+S G VL E+L G+ PI   
Sbjct: 203 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPG 261
Query: 527 -TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            +G D+LV +++ + +  RE+      +    ++P I+
Sbjct: 262 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 299

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 42/287 (14%)
Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LKD  +  R DF+++ E++ +++HE++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXX--------XXXXXXXX 436
                  D  +MV++Y   G ++  L +   +  I +D                      
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 437 XXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------- 489
                       VH ++ + N  + +     + D G++      +    R  G       
Sbjct: 143 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPIR 200
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           +  PE    RK T  SDV+SFGV+L EI T GK P       E++  +            
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT----------- 249
Query: 549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
                  +L  P +  +  E+  + + C  R P QR  + ++ +++ 
Sbjct: 250 ----QGRVLERPRVCPK--EVYDVMLGCWQREPQQRLNIKEIYKILH 290

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 38/293 (12%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         +++ +Y   GS+ A L   + +GR      T                  
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF-----TVIQLVGMLRGIGSGMKYL 126
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTD 497
                VH ++ + NI +NS     VSD G++ +            G      + APE   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            RK T ASDV+S+G+V+ E+++ G+ P       +++  +                  E 
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 229
Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSENRPSS 608
            R P   +  + + Q+ + C  +    RPK   +V +++  +R  +S  R  S
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGS 282

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/106 (42%), Positives = 62/106 (58%), Gaps = 4/106 (3%)
Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK-SLCYLYLQFNNFSG-TLPDFS 135
           FSG +P +T+ ++  LK+L L  N  +G  P    NL  SL  L L  NNFSG  LP+  
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 136 VWKNLTI--INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
                T+  + L +NGF G IP +LSN ++L +L+L+ N LSG IP
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 150
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 151 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 269
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 270 FKFPQIK 276

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 137
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            +V+G G+FG+ Y+A L D   +V   +K V  GK    ++++I+  + H N+V L+ ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           YS  EK       +V DY          H  R +  +P+ +                   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAY 137
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAPE +  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
              T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 557 LRYPNIE 563
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 35/292 (11%)
Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFE---QQMEI 372
           +Y +++E      +  +G G+FG  YK        V VK LK V+     F+    ++ +
Sbjct: 28  SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAV 85
Query: 373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXX 432
           +   RH N++ L   Y +KD   +V  +    S+   LH +  + ++             
Sbjct: 86  LRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQM-------FQLIDI 137
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--PVIARAAG- 489
                          ++H ++KS+NIFL+      + D GL T+ S  +    + +  G 
Sbjct: 138 ARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 490 --YRAPEV---TDSRKATQASDVYSFGVVLLEILTGKSPI-HTTGGDELVHLVRWVHSVV 543
             + APEV    D+   +  SDVYS+G+VL E++TG+ P  H    D+++ +V   ++  
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP 257
Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
                    D+  L Y N  + M  ++     CV ++ ++RP  P ++  IE
Sbjct: 258 ---------DLSKL-YKNCPKAMKRLV---ADCVKKVKEERPLFPQILSSIE 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK-----DVNVGKRDFEQQMEIVGSIRHENVVEL 384
           E++G G FG  Y+A    G  V VK  +     D++    +  Q+ ++   ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           +     +    +V ++   G ++ +L  +R    I ++W                     
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEA 125
Query: 445 XXKLVHGNIKSSNIFLN--------SQQYGCVSDLGL------TTITSALAPVIARAAGY 490
              ++H ++KSSNI +         S +   ++D GL      TT  SA     A A  +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-----AGAYAW 180
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG 529
            APEV  +   ++ SDV+S+GV+L E+LTG+ P     G
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 172
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 292 KFPQIK 297

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK  N+    F Q+ +++  +RHE +V+L A   S+
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 251
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-------MAAQIASGMAYVERMNYVH 304
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 365 VWSFGILLTELTTKGRVP 382

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         +++ +Y   GS+ A L   + +GR      T                  
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF-----TVIQLVGMLRGIGSGMKYL 132
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTD 497
                VH ++ + NI +NS     VSD G++ +            G      + APE   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            RK T ASDV+S+G+V+ E+++ G+ P       +++  +                  E 
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 235
Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            R P   +  + + Q+ + C  +    RPK   +V +++ +  N
Sbjct: 236 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN 279

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 327 ASAEVLGKGTFGMAYKAILEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELK 385
            + +V+G G+FG+ ++A L +   V +K+ L+D    KR   ++++I+  ++H NVV+LK
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLK 98
Query: 386 AYYYS----KDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
           A++YS    KDE    +V +Y       A  H  + +  +P+                  
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM-----LLIKLYMYQLLRS 153
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARAAG--YRAPE- 494
                   + H +IK  N+ L+    G +   D G   I  A  P ++      YRAPE 
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGEPNVSXICSRYYRAPEL 212
Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREE 546
           +  +   T   D++S G V+ E++ G+ P+    +G D+LV +++ + +  RE+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQ 265

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 143
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 144 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 203
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 262
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 263 KFPQIK 268

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V   KR   ++++I+  + H N+V L+ ++Y
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 166
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 167 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 226
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+      +    
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 285
Query: 558 RYPNIE 563
           ++P I+
Sbjct: 286 KFPQIK 291

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 74
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 75  EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 127
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 188 VWSFGILLTELTTKGRVP 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  IRHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 114/270 (42%), Gaps = 29/270 (10%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  + A     T V VK +K  ++    F  +  ++ +++H+ +V+L A   +K
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 81
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
           +   ++ ++ + GS+   L S+ G  + PL                           +H 
Sbjct: 82  EPIYIITEFMAKGSLLDFLKSDEG-SKQPLP-----KLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++NI +++     ++D GL  +           A +     APE  +    T  SDV
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 508 YSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM 566
           +SFG++L+EI+T G+ P       E++  +   + + R E   E                
Sbjct: 196 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE---------------- 239
Query: 567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
            E+  I M C    P++RP    +  V+++
Sbjct: 240 -ELYNIMMRCWKNRPEERPTFEYIQSVLDD 268

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L+  G   +   +K +  G     +RDF  +  I+G   H NV+ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         +++ ++   GS+ + L    G+        T                  
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-------TVIQLVGMLRGIAAGMKYL 125
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYRAP 493
                VH  + + NI +NS     VSD GL+          T TSAL   I     + AP
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP--IRWTAP 183
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E    RK T ASDV+S+G+V+ E+++ G+ P       ++++ +                
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--------------- 228
Query: 553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
             +  R P   +    + Q+ + C  +  + RPK   +V  ++ +  N
Sbjct: 229 --QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 274

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ Y+A L D   +V   +K V  GK    ++++I+  + H N+V L+ ++Y
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           S  EK       +V DY          H  R +  +P+ +                    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQLFRSLAYI 138
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--YRAPE-VTDSR 499
               + H +IK  N+ L+       + D G         P ++      YRAPE +  + 
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHT--TGGDELVHLVRWVHSVVREE 546
             T + DV+S G VL E+L G+ PI    +G D+LV +++ + +  RE+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 118/297 (39%), Gaps = 48/297 (16%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVTDSR 499
             +++H +IK  N+ L S     ++D G     S  AP   RAA      Y  PE+ + R
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
              +  D++S GV+  E L GK P       E          + R E+T   F  E  R 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR- 237
Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
                +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 238 -----DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 73
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 126
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 187 VWSFGILLTELTTKGRVP 204

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           EV+G G FG   +  L+      + V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+    +    +++ ++   G++ + L    G+        T                  
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF-------TVIQLVGMLRGIASGMRYL 134
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYRAP 493
                VH ++ + NI +NS     VSD GL+          T TS+L   I     + AP
Sbjct: 135 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP--IRWTAP 192
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E    RK T ASD +S+G+V+ E+++ G+ P       ++++ +                
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE--------------- 237
Query: 553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             +  R P   +    + Q+ + C  +  + RP+ P VV  ++ +
Sbjct: 238 --QDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 75
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 128
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 189 VWSFGILLTELTTKGRVP 206

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 77
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 130
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 191 VWSFGILLTELTTKGRVP 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 114/270 (42%), Gaps = 29/270 (10%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  + A     T V VK +K  ++    F  +  ++ +++H+ +V+L A   +K
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 254
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
           +   ++ ++ + GS+   L S+ G  + PL                           +H 
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEG-SKQPL-----PKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++NI +++     ++D GL  +           A +     APE  +    T  SDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 508 YSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM 566
           +SFG++L+EI+T G+ P       E++  +   + + R E   E                
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE---------------- 412
Query: 567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
            E+  I M C    P++RP    +  V+++
Sbjct: 413 -ELYNIMMRCWKNRPEERPTFEYIQSVLDD 441

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 126
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    ++    Y  PE+ + R   +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDE 186
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 235
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++S+N+ S+  +S
Sbjct: 236 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESASKQS 281

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 105
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 158
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 159 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 262
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 263 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 131
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 235
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 236 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 95
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 148
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 149 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 252
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 253 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL  +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------MAAQIASGMAYVERMNYVH 303
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------MAAQIASGMAYVERMNYVH 303
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A +     APE     + T  SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 333
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------MAAQIASGMAYVERMNYVH 386
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A +     APE     + T  SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 447 VWSFGILLTELTTKGRVP 464

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 26/205 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  ++   ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVTDSR 499
             K++H +IK  N+ L S     ++D G     S  AP   RAA      Y  PE+ + R
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 500 KATQASDVYSFGVVLLEILTGKSPI 524
              +  D++S GV+  E L GK P 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +Y   GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL  +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y + GS+   L  E G+  R+P   D                        VH
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM-------SAQIASGMAYVERMNYVH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 195 VWSFGILLTELTTKGRVP 212

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 251 EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD-------MAAQIASGMAYVERMNYVH 303
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S G +   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S GS+   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ ++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y + GS+   L  E G+  R+P   D                        VH
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM-------SAQIASGMAYVERMNYVH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 195 VWSFGILLTELTTKGRVP 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +   +V +Y S G +   L  E G+  R+P   D                        VH
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM-------AAQIASGMAYVERMNYVH 137
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            +++++NI +       V+D GL  +         + A     + APE     + T  SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L E+ T G+ P
Sbjct: 198 VWSFGILLTELTTKGRVP 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 234
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 235 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 280

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 151
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 211
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 260
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 261 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 306

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 237
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 238 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 283

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 152 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 212 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 270
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 271 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 130
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE  + R   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDE 190
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 239
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 240 -DLISRL------LKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 49/300 (16%)
Query: 329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHE 379
            + LG+G FG   KA           TTV VK LK+ N      RD   +  ++  + H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNHP 86
Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIP---------LDWD---- 424
           +V++L          L++ +Y   GS+   L   R  G G +          LD      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 425 -TXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV 483
            T                     KLVH ++ + NI +   +   +SD GL+         
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 484 IARAAG-----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           + R+ G     + A E       T  SDV+SFGV+L EI+T G +P      + L +L++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             H + R +  +E                 EM ++ + C  + PD+RP   D+ + +E +
Sbjct: 267 TGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 130
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 190
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 239
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 240 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVTDSR 499
             +++H +IK  N+ L S     ++D G     S  AP   RAA      Y  PE+ + R
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDE 531
              +  D++S GV+  E L GK P       E
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 150 TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 210 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA 269
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 270 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 49/300 (16%)
Query: 329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHE 379
            + LG+G FG   KA           TTV VK LK+ N      RD   +  ++  + H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNHP 86
Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIP---------LDWD---- 424
           +V++L          L++ +Y   GS+   L   R  G G +          LD      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 425 -TXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV 483
            T                     KLVH ++ + NI +   +   +SD GL+         
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 484 IARAAG-----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           + R+ G     + A E       T  SDV+SFGV+L EI+T G +P      + L +L++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             H + R +  +E                 EM ++ + C  + PD+RP   D+ + +E +
Sbjct: 267 TGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           EV+G+G FG+  KA       V +K+++  +  ++ F  ++  +  + H N+V+L  Y  
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKL--YGA 69
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK-- 447
             +   +V +Y   GS+  +LH     G  PL + T                     +  
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLH-----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 448 -LVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQAS 505
            L+H ++K  N+ L +      + D G              +A + APEV +    ++  
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW-VHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+S+G++L E++T + P    GG      + W VH+  R               P + +
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTR---------------PPLIK 227
Query: 565 EMVEMLQIAMS-CVVRMPDQRPKMPDVVRVIENV 597
            + + ++  M+ C  + P QRP M ++V+++ ++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAP 482
                         K +H ++ + N+ +       ++D GL             T+   P
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
           V      + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H 
Sbjct: 223 V-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +                N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 278 MDKP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAP 482
                         K +H ++ + N+ +       ++D GL             T+   P
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
           V      + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H 
Sbjct: 269 V-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 323
Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +                N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 324 MDKPA--------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           EV+G+G FG+  KA       V +K+++  +  ++ F  ++  +  + H N+V+L  Y  
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKL--YGA 70
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK-- 447
             +   +V +Y   GS+  +LH     G  PL + T                     +  
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLH-----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 448 -LVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQAS 505
            L+H ++K  N+ L +      + D G              +A + APEV +    ++  
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW-VHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+S+G++L E++T + P    GG      + W VH+  R               P + +
Sbjct: 186 DVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTR---------------PPLIK 228
Query: 565 EMVEMLQIAMS-CVVRMPDQRPKMPDVVRVIENV 597
            + + ++  M+ C  + P QRP M ++V+++ ++
Sbjct: 229 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 142
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 202
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 203 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 251
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 252 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 297

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 127
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE 187
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 236
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 237 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 282

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 155 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 215 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 273
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 274 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 234
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 235 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 151
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDE 211
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 260
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 261 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 306

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +    GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 38/277 (13%)
Query: 320 DLEDLLRASAEV---LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI 376
           D+ ++ R S ++   LG G FG  +       T V +K LK   +    F ++ +I+  +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGR---IPLDWDTXXXXXXXX 433
           +H+ +V+L A   S++   +V +Y + GS+   L    GEGR   +P             
Sbjct: 62  KHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKD--GEGRALKLP-------NLVDMA 111
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----G 489
                          +H +++S+NI + +     ++D GL  +         + A     
Sbjct: 112 AQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK 171
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           + APE     + T  SDV+SFG++L E++T G+ P       E++  V   +        
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------- 223
Query: 549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
                    R P  ++  + + ++ + C  + P++RP
Sbjct: 224 ---------RMPCPQDCPISLHELMIHCWKKDPEERP 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +    GS+ + L     +        T               
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 160
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 264
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHEN 380
           +V+G G FG      L+       +V +K LK   VG     +RDF  +  I+G   H N
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           ++ L+         ++V +    GS+ + L     +        T               
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-------TVIQLVGMLRGIASGM 131
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                   VH ++ + NI +NS     VSD GL+ +            G      + +PE
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
               RK T ASDV+S+G+VL E+++ G+ P       +++  V                 
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------------- 235
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            E  R P   +    + Q+ + C  +  + RPK   +V +++ +  N
Sbjct: 236 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++  Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 127
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     +++ G +    S+    +     Y  PE+ + R   +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 187
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 236
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 237 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 282

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    K   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++  Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG    A          ++  TV VK LKD    +   D   +ME++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G        R+P +  T       
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL    + +        G   
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV++ EI T G SP      +EL  L++  H + +  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP- 281
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 282 -------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 126
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDE 186
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 235
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESST 616
            +++  L      +   P QRP + +   V+E+     + ++PS+    ES++
Sbjct: 236 -DLISRL------LKHNPSQRPMLRE---VLEHPWITANSSKPSNCQNKESAS 278

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 49/300 (16%)
Query: 329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHE 379
            + LG+G FG   KA           TTV VK LK+ N      RD   +  ++  + H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNHP 86
Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIP---------LDWD---- 424
           +V++L          L++ +Y   GS+   L   R  G G +          LD      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 425 -TXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV 483
            T                      LVH ++ + NI +   +   +SD GL+         
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 484 IARAAG-----YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           + R+ G     + A E       T  SDV+SFGV+L EI+T G +P      + L +L++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             H + R +  +E                 EM ++ + C  + PD+RP   D+ + +E +
Sbjct: 267 TGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 73
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 127
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQAS 505
           H N++++NI ++      ++D GL  +           A +     APE  +    T  S
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 233
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 234 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 20/219 (9%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM-- 370
           G    + LED        LGKG FG  Y A  +    ++ +K L    + K   E Q+  
Sbjct: 4   GSKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 371 --EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTX 426
             EI   +RH N++ L  Y++      ++ +Y  LG+V   L   S+  E R        
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------- 114
Query: 427 XXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIA 485
                               +++H +IK  N+ L S     ++D G +    S+    + 
Sbjct: 115 ---ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 171
Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
               Y  PE+ + R   +  D++S GV+  E L GK P 
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 124
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 184
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 185 KVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 40/290 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 234
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSG 609
            +++  L      +   P QRP + +V+        + +P++ +N+ S+ 
Sbjct: 235 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAA 277

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +K+ ++ + DF ++ E++  + H  +V+L      +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V+++   G +S  L ++RG    E  + +  D                       
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----------- 143
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 198
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 234

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y   G V   L   S+  E R                          
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT----------ATYITELANALSYCH 130
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 190
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 239
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 240 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 41/284 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
            L   Y +K +  +V  +    S+   LH+   +  +    D                  
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS-- 128
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 129 -----IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             DS   +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSK 237
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           V      N  + M  ++     C+ +  D+RP  P ++  IE +
Sbjct: 238 VR----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 274

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+      +    V VK +K+ ++ + +F Q+ + +  + H  +V+       +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               +V +Y S G +   L S  G+G  P                          + +H 
Sbjct: 76  YPIYIVTEYISNGCLLNYLRS-HGKGLEP------SQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTDSRKATQAS 505
           ++ + N  ++      VSD G+T     L      + G      + APEV    K +  S
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV++FG+++ E+ + GK P       E+V  V   H + R               P++  
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---------------PHLAS 231
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE 603
           + +   QI  SC   +P++RP    ++  IE +R  D  
Sbjct: 232 DTI--YQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 126
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 235
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESST 616
            +++  L      +   P QRP + +   V+E+     + ++PS+    ES++
Sbjct: 236 -DLISRL------LKHNPSQRPMLRE---VLEHPWITANSSKPSNCQNKESAS 278

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  +     + T V VK LK   +  + F ++  ++ +++H+ +V L A    +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
           +   ++ +Y + GS+   L S+ G G++ L                           +H 
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEG-GKVLL-----PKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++N+ ++      ++D GL  +           A +     APE  +    T  SDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 508 YSFGVVLLEILT-GKSP 523
           +SFG++L EI+T GK P
Sbjct: 195 WSFGILLYEIVTYGKIP 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE 188
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 130
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE 190
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 239
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESST 616
            +++  L      +   P QRP + +   V+E+     + ++PS+    ES++
Sbjct: 240 -DLISRL------LKHNPSQRPMLRE---VLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 122
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 182
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 183 KVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE 185
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 86
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 140
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 246
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 247 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 275

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 311 FFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------- 363
           F E  +  FD  ++LRA    +GKG+FG     I++   T  +  +K +N  K       
Sbjct: 6   FDENEDVNFDHFEILRA----IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEV 59
Query: 364 RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHS--ERGEGRIPL 421
           R+  ++++I+  + H  +V L   +  +++  MV D    G +   L       E  + L
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL 119
Query: 422 DWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA 481
                                    +++H ++K  NI L+   +  ++D  +  +     
Sbjct: 120 ----------FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 482 PVIARAAG--YRAPEVTDSRKA---TQASDVYSFGVVLLEILTGKSPIH---TTGGDELV 533
            +   A    Y APE+  SRK    + A D +S GV   E+L G+ P H   +T   E+V
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 534 HLVRWVHSVVREEWTAEVFDVELLRYPNI-EEEMVEMLQIAMSCVVRMPDQR 584
           H                 F+  ++ YP+   +EMV +L+  +      PDQR
Sbjct: 230 H----------------TFETTVVTYPSAWSQEMVSLLKKLLE---PNPDQR 262

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----------TATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDE 188
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG+G++G  YKAI ++   +V  +   V    ++  +++ I+      +VV+    Y+
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
              +  +V +Y   GSVS ++       R+     T                     + +
Sbjct: 95  KNTDLWIVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAP--VIARAAGYRAPEVTDSRKATQASD 506
           H +IK+ NI LN++ +  ++D G+   +T  +A    +     + APEV         +D
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 507 VYSFGVVLLEILTGKSP 523
           ++S G+  +E+  GK P
Sbjct: 208 IWSLGITAIEMAEGKPP 224

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/278 (21%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKA 386
           +G+G F   Y+A  L DG  V +K+++  ++     + D  ++++++  + H NV++  A
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 387 YYYSKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
            +   +E  +V +    G +S M+ H ++ +  IP                         
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP-----ERTVWKYFVQLCSALEHMHS 154
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKAT 502
            +++H +IK +N+F+ +     + DLGL    S+         G   Y +PE        
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI 562
             SD++S G +L E+   +SP +   GD++      ++S+ ++        +E   YP +
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFY---GDKMN-----LYSLCKK--------IEQCDYPPL 258
Query: 563 EEEMV--EMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             +    E+ Q+   C+   P++RP +  V  V + + 
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 131
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 85
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 139
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 245
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 246 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 274

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L      +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V+++   G +S  L ++RG    E  + +  D                       
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV-----------CEGMAYLEEAS 123
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 178
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 79
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 133
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 239
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 240 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 131
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L      +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V+++   G +S  L ++RG    E  + +  D                       
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----------- 123
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 178
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L      +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V+++   G +S  L ++RG    E  + +  D                       
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----------- 121
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 176
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L      +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V+++   G +S  L ++RG    E  + +  D                       
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----------- 126
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 181
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 217

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 78
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 132
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 238
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 239 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 137
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 243
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 244 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 272

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y   G V   L   S+  E R                          
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT----------ATYITELANALSYCH 130
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDE 190
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E          + R E+T   F  E  R     
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR----- 239
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR----VIENVRPNDSENRPSSGNKS 612
            +++  L      +   P QRP + +V+        + +P++ +N+ S+  +S
Sbjct: 240 -DLISRL------LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 114/287 (39%), Gaps = 38/287 (13%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL-----DWDTXXXXXXXXXXX 436
            L          LMV  ++   G++S  L S+R E  +P      D+ T           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLICYSFQV 153
Query: 437 XXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YR 491
                     K +H ++ + NI L+ +    + D GL          + +        + 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE    R  T  SDV+SFGV+L EI + G SP      D              EE+   
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRR 259
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 260 LKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 131
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 82
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 136
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 242
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 243 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 271

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLH--SERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
           Y++      ++ +Y  LG+V   L   S+  E R                          
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----------ATYITELANALSYCH 128
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
             +++H +IK  N+ L S     +++ G +    S+    +     Y  PE+ + R   +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDE 531
             D++S GV+  E L GK P       E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 87
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 141
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 247
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 248 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 276

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 137
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A     + APE  +    T  S
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 243
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 244 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 272

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 72
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 126
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +           A +     APE  +    T  S
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +              N  E
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 232
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           E+ +++++   C    P+ RP    +  V+E+
Sbjct: 233 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 261

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 330 EVLGKGTFGMAYKAILED--GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           + +GKG FG     +L D  G  V VK +K+ +   + F  +  ++  +RH N+V+L   
Sbjct: 12  QTIGKGEFG---DVMLGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 388 YYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
              +   L +V +Y + GS+   L   R  GR  L  D                      
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASD 506
             VH ++ + N+ ++      VSD GLT   S+          + APE    +K +  SD
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 507 VYSFGVVLLEILT-GKSP 523
           V+SFG++L EI + G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 144
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 250
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSENR 605
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N ++ N  ++R
Sbjct: 251 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 144
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 250
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSENR 605
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N ++ N  ++R
Sbjct: 251 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 305 ASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILED--GTTVVVKRLKDVNVG 362
           A+   F+  G  +A ++++L     + +GKG FG     +L D  G  V VK +K+ +  
Sbjct: 178 AAQDEFYRSG--WALNMKEL--KLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKN-DAT 229
Query: 363 KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPL 421
            + F  +  ++  +RH N+V+L      +   L +V +Y + GS+   L   R  GR  L
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVL 286
Query: 422 DWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA 481
             D                        VH ++ + N+ ++      VSD GLT   S+  
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343
Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
                   + APE    +K +  SDV+SFG++L EI + G+ P
Sbjct: 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 115/289 (39%), Gaps = 40/289 (13%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL-------DWDTXXXXXXXXX 434
            L          LMV  ++   G++S  L S+R E  +P        D+ T         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKPEDLYKDFLTLEHLIXYSF 155
Query: 435 XXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----- 489
                       K +H ++ + NI L+ +    + D GL          + +        
Sbjct: 156 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           + APE    R  T  SDV+SFGV+L EI + G SP      D              EE+ 
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFC 261
Query: 549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 262 RRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 115/287 (40%), Gaps = 38/287 (13%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL-----DWDTXXXXXXXXXXX 436
            L          LMV  ++   G++S  L S+R E  +P      D+ T           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIXYSFQV 153
Query: 437 XXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YR 491
                     K +H ++ + NI L+ +    + D GL          + +        + 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE    R  T  SDV+SFGV+L EI + G SP      D              EE+   
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFXRR 259
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 260 LKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 114/290 (39%), Gaps = 41/290 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL--------DWDTXXXXXXXX 433
            L          LMV  ++   G++S  L S+R E  +P         D+ T        
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKTPEDLYKDFLTLEHLICYS 154
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---- 489
                        K +H ++ + NI L+ +    + D GL          + +       
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 490 -YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + APE    R  T  SDV+SFGV+L EI + G SP      D              EE+
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEF 260
Query: 548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
              + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 261 CRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 144
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 250
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSENR 605
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N ++ N  ++R
Sbjct: 251 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILED--GTTVVVKRLKDVNVGKRDFEQQ 369
           F    +A ++++L     + +GKG FG     +L D  G  V VK +K+ +   + F  +
Sbjct: 11  FYRSGWALNMKEL--KLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKN-DATAQAFLAE 64
Query: 370 MEIVGSIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXX 428
             ++  +RH N+V+L      +   L +V +Y + GS+   L   R  GR  L  D    
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLK 121
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA 488
                               VH ++ + N+ ++      VSD GLT   S+         
Sbjct: 122 FSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 178
Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
            + APE    +K +  SDV+SFG++L EI + G+ P
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRKATQA 504
           +V+ ++K  NI L+   +  ++D G+     +  A          Y APE+   +K   +
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHS 198
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
            D +SFGV+L E+L G+SP H    +EL H +R
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 144
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 250
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSENR 605
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N ++ N  ++R
Sbjct: 251 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 153
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 259
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 260 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 16/217 (7%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM-- 370
           G    + LED        LGKG FG  Y A       ++ +K L    + K   E Q+  
Sbjct: 4   GSKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 371 --EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXX 428
             EI   +RH N++ L  Y++      ++ +Y  LG+V   L          L       
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSRFDEQR 113
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARA 487
                             +++H +IK  N+ L S     ++D G +    S+    +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGT 173
Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
             Y  PE+ + R   +  D++S GV+  E L G  P 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGL---TTITSALAPVIARAAGYRAPEVTDSRKATQA 504
           +V+ ++K  NI L+   +  ++D G+     +  A          Y APE+   +K   +
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHS 199
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
            D +SFGV+L E+L G+SP H    +EL H +R
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 232

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 16/217 (7%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM-- 370
           G    + LED        LGKG FG  Y A       ++ +K L    + K   E Q+  
Sbjct: 4   GSKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 371 --EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXX 428
             EI   +RH N++ L  Y++      ++ +Y  LG+V   L          L       
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSRFDEQR 113
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT-SALAPVIARA 487
                             +++H +IK  N+ L S     ++D G +    S+    +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGT 173
Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
             Y  PE+ + R   +  D++S GV+  E L G  P 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 41/284 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
            L   Y +K +  +V  +    S+   LH+   +  +    D                  
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS-- 140
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T  S  +       ++ +  + APEV  
Sbjct: 141 -----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             DS   +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSK 249
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           V      N  + M  ++     C+ +  D+RP  P ++  IE +
Sbjct: 250 VR----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRL--------KDVNVGKRDFEQQMEIVGSIRHENVV 382
           +GKG FG+ +K  +++D + V +K L         ++    ++F++++ I+ ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L  Y    +   MV ++   G +   L  +      P+ W +                 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKW-SVKLRLMLDIALGIEYMQ 139
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAAGYRAPEV-- 495
                +VH +++S NIFL S          V+D GL+  +      +     + APE   
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPI--HTTGGDELVHLVR 537
            +    T+ +D YSF ++L  ILTG+ P   ++ G  + ++++R
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 153
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 259
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 260 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 31/273 (11%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G  G  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLV 449
           +++   ++ +Y   GS+   L +  G   I L   T                       +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKL---TINKLLDMAAQIAEGMAFIEERNYI 131
Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKATQA 504
           H +++++NI ++      ++D GL  +    A   AR        + APE  +    T  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED-AEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 505 SDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
           SDV+SFG++L EI+T G+ P       E++  +   + +VR +              N  
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCP 236
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           EE+ +++++   C    P+ RP    +  V+E+
Sbjct: 237 EELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 153
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 259
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 260 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKEAPEDLYKDFLTLEHLICY 155
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 156 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 261
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 262 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAYKA----ILEDGT--TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-NVV 382
           LG+G FG   +A    I +  T  TV VK LK+   +   R    +++I+  I H  NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 383 ELKAYYYSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPL---------DWDTXXXXXXX 432
            L          LMV  ++   G++S  L S+R E  +P          D+ T       
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLICY 190
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + NI L+ +    + D GL          + +      
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI + G SP      D              EE
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 296
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +   + +   +R P+      EM Q  + C    P QRP   ++V  + N+
Sbjct: 297 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L      +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 392 DEKLMVYDYYSLGSVSAMLHSERG----EGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
               +V ++   G +S  L ++RG    E  + +  D                       
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----------- 124
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYRAPEVTDS 498
           ++H ++ + N  +   Q   VSD G+T           T    PV      + +PEV   
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 179
Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELV 533
            + +  SDV+SFGV++ E+ + GK P       E+V
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/309 (22%), Positives = 112/309 (36%), Gaps = 49/309 (15%)
Query: 307 NRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVN 360
           N  +F + C +     D++      LG+G FG  + A        +D   V VK LK+ +
Sbjct: 26  NPQYFSDACVHHIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS 83
Query: 361 VGKR-DFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI 419
              R DF+++ E++  ++H+++V            LMV++Y   G ++  L S   + ++
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 420 ----------PLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVS 469
                     PL                           VH ++ + N  +       + 
Sbjct: 144 LAGGEDVAPGPLG---LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200
Query: 470 DLGLTTITSALAPVIARAAG-------YRAPEVTDSRKATQASDVYSFGVVLLEILT-GK 521
           D G++      +    R  G       +  PE    RK T  SDV+SFGVVL EI T GK
Sbjct: 201 DFGMS--RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 522 SPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMP 581
            P +     E +  +     + R                       E+  I   C  R P
Sbjct: 259 QPWYQLSNTEAIDCITQGRELERPRACPP-----------------EVYAIMRGCWQREP 301
Query: 582 DQRPKMPDV 590
            QR  + DV
Sbjct: 302 QQRHSIKDV 310

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 41/284 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 84  LFMGY--STAPQLAIVTQWCEGS-SLYHHLHASETKFEM-----KKLIDIARQTARGMDY 135
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T  S  +       ++ +  + APEV  
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             DS   +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSK 249
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           V      N  + M  ++     C+ +  D+RP  P ++  IE +
Sbjct: 250 VR----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 16/214 (7%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILED--GTTVVVKRLKDVNVGKRDFEQQME 371
           G  +A ++++L     + +GKG FG     +L D  G  V VK +K+ +   + F  +  
Sbjct: 4   GSGWALNMKEL--KLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKN-DATAQAFLAEAS 57
Query: 372 IVGSIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXX 430
           ++  +RH N+V+L      +   L +V +Y + GS+   L   R  GR  L  D      
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFS 114
Query: 431 XXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY 490
                             VH ++ + N+ ++      VSD GLT   S+          +
Sbjct: 115 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW 171
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
            APE       +  SDV+SFG++L EI + G+ P
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 103/240 (42%), Gaps = 12/240 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG  +     + T V VK LK   +  + F ++  ++ +++H+ +V L A    +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
           +   ++ ++ + GS+   L S+ G G++ L                           +H 
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEG-GKVLLP-----KLIDFSAQIAEGMAYIERKNYIHR 133
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY----RAPEVTDSRKATQASDV 507
           +++++N+ ++      ++D GL  +           A +     APE  +    T  S+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 508 YSFGVVLLEILT-GKSPI-HTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           +SFG++L EI+T GK P    T  D +  L +       E    E++D+  + +    EE
Sbjct: 194 WSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKAEE 253

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 37/279 (13%)
Query: 330 EVLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +++G G  G + Y  +   G   V   +K +  G     +RDF  +  I+G   H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         ++V +Y   GS+   L +  G+        T                  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF-------TIMQLVGMLRGVGAGMRYL 167
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTD 497
                VH ++ + N+ ++S     VSD GL+ +            G      + APE   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            R  + ASDV+SFGVV+ E+L  G+ P       +++  V                  E 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-----------------EG 270
Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
            R P        + Q+ + C  +   QRP+   +V V++
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 37/279 (13%)
Query: 330 EVLGKGTFG-MAYKAILEDGTTVVVKRLKDVNVG-----KRDFEQQMEIVGSIRHENVVE 383
           +++G G  G + Y  +   G   V   +K +  G     +RDF  +  I+G   H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+         ++V +Y   GS+   L +  G+        T                  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF-------TIMQLVGMLRGVGAGMRYL 167
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPEVTD 497
                VH ++ + N+ ++S     VSD GL+ +            G      + APE   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            R  + ASDV+SFGVV+ E+L  G+ P       +++  V                  E 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-----------------EG 270
Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
            R P        + Q+ + C  +   QRP+   +V V++
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 30/230 (13%)
Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LK+ +   R DF+++ E++  ++H+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI----------PLDWDTXXXXXXXXX 434
                     LMV++Y   G ++  L S   + ++          PL             
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG---LGQLLAVAS 142
Query: 435 XXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----- 489
                         VH ++ + N  +       + D G++      +    R  G     
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTMLP 200
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
             +  PE    RK T  SDV+SFGVVL EI T GK P +     E +  +
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 250

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 30/230 (13%)
Query: 332 LGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           LG+G FG  + A        +D   V VK LK+ +   R DF+++ E++  ++H+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI----------PLDWDTXXXXXXXXX 434
                     LMV++Y   G ++  L S   + ++          PL             
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG---LGQLLAVAS 136
Query: 435 XXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----- 489
                         VH ++ + N  +       + D G++      +    R  G     
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTMLP 194
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
             +  PE    RK T  SDV+SFGVVL EI T GK P +     E +  +
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 244

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRL--------KDVNVGKRDFEQQMEIVGSIRHENVV 382
           +GKG FG+ +K  +++D + V +K L         ++    ++F++++ I+ ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L  Y    +   MV ++   G +   L  +      P+ W +                 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKW-SVKLRLMLDIALGIEYMQ 139
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAAGYRAPEV-- 495
                +VH +++S NIFL S          V+D G +  +      +     + APE   
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPI--HTTGGDELVHLVR 537
            +    T+ +D YSF ++L  ILTG+ P   ++ G  + ++++R
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRL--------KDVNVGKRDFEQQMEIVGSIRHENVV 382
           +GKG FG+ +K  +++D + V +K L         ++    ++F++++ I+ ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L  Y    +   MV ++   G +   L  +      P+ W +                 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKW-SVKLRLMLDIALGIEYMQ 139
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAAGYRAPEV-- 495
                +VH +++S NIFL S          V+D  L+  +      +     + APE   
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPI--HTTGGDELVHLVR 537
            +    T+ +D YSF ++L  ILTG+ P   ++ G  + ++++R
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTV----VVKRLKDVNVGKRD---FEQQMEIVGSIRHENVV 382
           +VLG+G+FG  +      G+       +K LK   +  RD    + + +I+  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L   + ++ +  ++ D+   G +   L  E           T                 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALALDH 141
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAPVIARAAGYRAPEVTDSR 499
                +++ ++K  NI L+ + +  ++D GL+  +      A        Y APEV + R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             TQ++D +SFGV++ E+LTG  P       E + ++
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 68  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 119
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 233
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 234 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 73  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 124
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 238
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 239 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 273

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVIARAAG-----YRAPEVTDSRKA 501
            VH N+ + N+ L ++ Y  +SD GL+    A  +   AR+AG     + APE  + RK 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+S+GV + E L+ G+ P     G E++  +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 70  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 121
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 235
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 236 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 270

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP 215
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 275
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 276 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 73  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 124
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 238
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 239 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTV----VVKRLKDVNVGKRD---FEQQMEIVGSIRHENVV 382
           +VLG+G+FG  +      G+       +K LK   +  RD    + + +I+  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L   + ++ +  ++ D+   G +   L  E           T                 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALALDH 141
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAPVIARAAGYRAPEVTDSR 499
                +++ ++K  NI L+ + +  ++D GL+  +      A        Y APEV + R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             TQ++D +SFGV++ E+LTG  P       E + ++
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTV----VVKRLKDVNVGKRD---FEQQMEIVGSIRHENVV 382
           +VLG+G+FG  +      G+       +K LK   +  RD    + + +I+  + H  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L   + ++ +  ++ D+   G +   L  E           T                 
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALALDH 142
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAPVIARAAGYRAPEVTDSR 499
                +++ ++K  NI L+ + +  ++D GL+  +      A        Y APEV + R
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             TQ++D +SFGV++ E+LTG  P       E + ++
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKA 386
            EVLGKG FG A K    E G  +V+K L   +   +R F ++++++  + H NV++   
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 387 YYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
             Y KD++L  + +Y   G++  ++ S   +      W                      
Sbjct: 75  VLY-KDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQ---RVSFAKDIASGMAYLHS 126
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLT--TITSALAPVIARAAG-------------- 489
             ++H ++ S N  +   +   V+D GL    +     P   R+                
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 490 -YRAPEVTDSRKATQASDVYSFGVVLLEIL 518
            + APE+ + R   +  DV+SFG+VL EI+
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 68  LFMGY--STAPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 119
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 233
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 234 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 332 LGKGTFG----MAYKAILED-GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG      Y  + ++ G  V VK+L+     + RDF+++++I+ ++  + +V+ +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 386 AYYYS--KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              Y   + E  +V +Y   G +   L   R      LD                     
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR----LD---ASRLLLYSSQICKGMEYL 127
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAG-----YRAP 493
              + VH ++ + NI + S+ +  ++D GL    + L P+     + R  G     + AP
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGL----AKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT 519
           E       ++ SDV+SFGVVL E+ T
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 22/210 (10%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    +V +K L    + K   E Q+    EI   + H N++ L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           Y+Y +    ++ +Y   G +   L            +D                      
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-------CTFDEQRTATIMEELADALMYCHGK- 142
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVTDSRKA 501
           K++H +IK  N+ L  +    ++D G     S  AP + R        Y  PE+ + R  
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGW----SVHAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDE 531
            +  D++  GV+  E+L G  P  +   +E
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APVIARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L ++ Y  +SD GL+    A  +   AR+AG     + APE  + RK 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+S+GV + E L+ G+ P     G E++  +
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 316
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 317 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 96  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 147
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 261
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 262 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 296

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 95  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 146
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV  
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 260
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 261 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 295

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 21/247 (8%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFE-----QQMEIVGSIRHENVVEL 384
           E LG GT+   YK +  + TT V   LK+V +   +       +++ ++  ++HEN+V L
Sbjct: 11  EKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
               +++++  +V+++        M    R  G  P   +                    
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYM--DSRTVGNTPRGLE-LNLVKYFQWQLLQGLAFCH 125
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARAAGYRAPEV-TDS 498
             K++H ++K  N+ +N +    + D GL       + +  + V+     YRAP+V   S
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT--LWYRAPDVLMGS 183
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
           R  + + D++S G +L E++TGK     T  +E + L+  +     E     V   +L +
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--TKLPK 241
Query: 559 Y-PNIEE 564
           Y PNI++
Sbjct: 242 YNPNIQQ 248

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 260
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 261 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 275
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 276 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 47/259 (18%)
Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENV 381
           E LG+  FG  YK  L      E    V +K LKD   G  + +F  +  +   ++H NV
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 382 VELKAYYYSKDEKL-MVYDYYSLGSVSAML-----HSERG---EGRIPLDWDTXXXXXXX 432
           V L     +KD+ L M++ Y S G +   L     HS+ G   + R              
Sbjct: 92  VCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGL----------TTITSALAP 482
                          +VH ++ + N+ +  +    +SDLGL            + ++L P
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR---- 537
           +      + APE     K +  SD++S+GVVL E+ + G  P       ++V ++R    
Sbjct: 211 I-----RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 265
Query: 538 ---------WVHSVVREEW 547
                    WV++++ E W
Sbjct: 266 LPCPDDCPAWVYALMIECW 284

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 145 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 204
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 205 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 264
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 265 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 47/259 (18%)
Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENV 381
           E LG+  FG  YK  L      E    V +K LKD   G  + +F  +  +   ++H NV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 382 VELKAYYYSKDEKL-MVYDYYSLGSVSAML-----HSERG---EGRIPLDWDTXXXXXXX 432
           V L     +KD+ L M++ Y S G +   L     HS+ G   + R              
Sbjct: 75  VCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGL----------TTITSALAP 482
                          +VH ++ + N+ +  +    +SDLGL            + ++L P
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR---- 537
           +      + APE     K +  SD++S+GVVL E+ + G  P       ++V ++R    
Sbjct: 194 I-----RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248
Query: 538 ---------WVHSVVREEW 547
                    WV++++ E W
Sbjct: 249 LPCPDDCPAWVYALMIECW 267

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQ 369
           +E      + ED      E LG G FG  YKA  ++ + +   ++ D    +   D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 370 MEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTXXX 428
           ++I+ S  H N+V+L   +Y ++   ++ ++ + G+V A ML  ER     PL   T   
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TESQ 136
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIA 485
                             K++H ++K+ NI         ++D G++   T T        
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 196
Query: 486 RAAGYRAPEV-----TDSRKATQASDVYSFGVVLLEILTGKSPIH 525
               + APEV     +  R     +DV+S G+ L+E+   + P H
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 148 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 207
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 208 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 267
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 268 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 112/296 (37%), Gaps = 52/296 (17%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAP 482
                         K +H ++ + N+ +       ++D GL             T+   P
Sbjct: 149 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 208
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
           V      + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H 
Sbjct: 209 V-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 263
Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +                N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 264 MDKPS--------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 112/296 (37%), Gaps = 52/296 (17%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L + R  G          P +  +       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAP 482
                         K +H ++ + N+ +       ++D GL             T+   P
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
           V      + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H 
Sbjct: 216 V-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + +                N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 271 MDKPS--------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQ 369
           +E      + ED      E LG G FG  YKA  ++ + +   ++ D    +   D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 370 MEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTXXX 428
           ++I+ S  H N+V+L   +Y ++   ++ ++ + G+V A ML  ER     PL   T   
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TESQ 136
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA 488
                             K++H ++K+ NI         ++D G++   +          
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI 196
Query: 489 G---YRAPEV-----TDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           G   + APEV     +  R     +DV+S G+ L+E+   + P H
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQ 369
           +E      + ED      E LG G FG  YKA  ++ + +   ++ D    +   D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 370 MEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTXXX 428
           ++I+ S  H N+V+L   +Y ++   ++ ++ + G+V A ML  ER     PL   T   
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TESQ 136
Query: 429 XXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA 488
                             K++H ++K+ NI         ++D G++   +          
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI 196
Query: 489 G---YRAPEV-----TDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           G   + APEV     +  R     +DV+S G+ L+E+   + P H
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/283 (19%), Positives = 120/283 (42%), Gaps = 26/283 (9%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 93  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 145
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 205
Query: 508 YSFGVVLLEILTGKSPIHT-TGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM 566
           +S G+ L+E+  G+ PI + +G   +  L+ ++ +    +  + VF +E   + N     
Sbjct: 206 WSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN----- 260
Query: 567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSG 609
                    C+++ P +R  +  ++ V   ++ +D+E    +G
Sbjct: 261 --------KCLIKNPAERADLKQLM-VHAFIKRSDAEEVDFAG 294

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 68  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 119
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T  S  +       ++ +  + APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 233
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 234 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 332 LGKGTFG----MAYKAILED-GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG      Y  + ++ G  V VK+L+     + RDF+++++I+ ++  + +V+ +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              Y    +   +V +Y   G +   L   R      LD                     
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LD---ASRLLLYSSQICKGMEYL 130
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAG-----YRAP 493
              + VH ++ + NI + S+ +  ++D GL    + L P+     + R  G     + AP
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGL----AKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT 519
           E       ++ SDV+SFGVVL E+ T
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 332 LGKGTFGMAYKAILE---DGT--TVVVKRLK-DVNVGKRD-FEQQMEIVGSIRHENVVEL 384
           LG+G FG       +   DGT   V VK LK D     R  ++Q+++I+ ++ HE++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           K     + EK   +V +Y  LGS+   L         P                      
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---------PRHSIGLAQLLLFAQQICEGMAY 132
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEVT 496
                 +H N+ + N+ L++ +   + D GL   +         R  G     + APE  
Sbjct: 133 LHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 497 DSRKATQASDVYSFGVVLLEILT----GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
              K   ASDV+SFGV L E+LT     +SP   T   EL+ + +   +V+R        
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRL------- 243
Query: 553 DVELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             ELL    R P  ++   E+  +  +C       RP   +++ +++ V 
Sbjct: 244 -TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 332 LGKGTFG----MAYKAILED-GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG      Y  + ++ G  V VK+L+     + RDF+++++I+ ++  + +V+ +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              Y    +   +V +Y   G +   L   R      LD                     
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LD---ASRLLLYSSQICKGMEYL 131
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAG-----YRAP 493
              + VH ++ + NI + S+ +  ++D GL    + L P+     + R  G     + AP
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGL----AKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT 519
           E       ++ SDV+SFGVVL E+ T
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 332 LGKGTFGMAYKAILE---DGT--TVVVKRLK-DVNVGKRD-FEQQMEIVGSIRHENVVEL 384
           LG+G FG       +   DGT   V VK LK D     R  ++Q+++I+ ++ HE++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           K     + EK   +V +Y  LGS+   L         P                      
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---------PRHSIGLAQLLLFAQQICEGMAY 132
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEVT 496
                 +H N+ + N+ L++ +   + D GL   +         R  G     + APE  
Sbjct: 133 LHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 497 DSRKATQASDVYSFGVVLLEILT----GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
              K   ASDV+SFGV L E+LT     +SP   T   EL+ + +   +V+R        
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRL------- 243
Query: 553 DVELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             ELL    R P  ++   E+  +  +C       RP   +++ +++ V 
Sbjct: 244 -TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 88  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 139
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T  S  +       ++ +  + APEV  
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 253
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 254 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 288

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 39/287 (13%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 135
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT------SALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 239
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           E  R P  E+   ++  + + C    P+ RP    +   +   +P D
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 39/287 (13%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 129
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 233
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           E  R P  E+   ++  + + C    P+ RP    +   +   +P D
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 280

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 332 LGKGTFG----MAYKAILED-GTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELK 385
           LGKG FG      Y  + ++ G  V VK+L+     + RDF+++++I+ ++  + +V+ +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 386 AYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              Y    +   +V +Y   G +   L   R      LD                     
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LD---ASRLLLYSSQICKGMEYL 143
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-----IARAAG-----YRAP 493
              + VH ++ + NI + S+ +  ++D GL    + L P+     + R  G     + AP
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGL----AKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT 519
           E       ++ SDV+SFGVVL E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 41/282 (14%)
Query: 329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
            + +G G+FG  YK        V     K +NV        + F+ ++ ++   RH N++
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
               Y  S   +L +   +  GS S   H    E +  +                     
Sbjct: 96  LFMGY--STKPQLAIVTQWCEGS-SLYHHLHIIETKFEM-----IKLIDIARQTAQGMDY 147
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEV-- 495
                ++H ++KS+NIFL+      + D GL T  S  +       ++ +  + APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG-DELVHLVRWVHSVVREEWTAEVFD 553
             D    +  SDVY+FG+VL E++TG+ P       D+++ +V       R   + ++  
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSK 261
Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           V      N  + M  ++     C+ +  D+RP  P ++  IE
Sbjct: 262 VR----SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 296

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 39/287 (13%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 125
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 229
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           E  R P  E+   ++  + + C    P+ RP    +   +   +P D
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 276

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 39/287 (13%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 135
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 239
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           E  R P  E+   ++  + + C    P+ RP    +   +   +P D
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 126
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 126
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 126
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/302 (21%), Positives = 118/302 (39%), Gaps = 59/302 (19%)
Query: 332 LGKGTFGMAYKA------ILEDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVE 383
           +G+G FG  ++A        E  T V VK LK+      + DF+++  ++    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 384 LKAYYYSKDEKLMVYDYYSLG------------SVSAMLHSE-------RGEGRIPLDWD 424
           L           ++++Y + G            +V ++ HS+          G  PL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL--- 171
Query: 425 TXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPV 483
           +                     K VH ++ + N  +       ++D GL+  I SA    
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA---D 228
Query: 484 IARAAG-------YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL 535
             +A G       +  PE     + T  SDV+++GVVL EI + G  P +    +E+++ 
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288
Query: 536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           VR               D  +L  P  E   +E+  +   C  ++P  RP    + R+++
Sbjct: 289 VR---------------DGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
Query: 596 NV 597
            +
Sbjct: 332 RM 333

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 146
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 207 DIWSLGIMVIEMVDGEPP 224

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 330 EVLGKGTFGMAY---KAILED-GTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVV 382
           +VLG+G+FG  +   K    D G    +K LK   +  RD    + + +I+  + H  VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           +L   + ++ +  ++ D+   G +   L  E           T                 
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALGLDH 145
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT---SALAPVIARAAGYRAPEVTDSR 499
                +++ ++K  NI L+ + +  ++D GL+         A        Y APEV + +
Sbjct: 146 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
             + ++D +S+GV++ E+LTG  P       E + L+
Sbjct: 206 GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 148
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 209 DIWSLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 137
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 126
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 136 YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 188
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 248
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 249 WSMGLSLVEMAVGRYPIPPPDAKEL 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 288 EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----YRAPEVTDSRKATQASD 506
            N+ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 447
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 448 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 476

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 327 EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 380
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----YRAPEVTDSRKATQASD 506
            N+ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 441 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 486
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 487 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 153
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 213
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 141
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 202 DIWSLGIMVIEMVDGEPP 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 268
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 329 DIWSLGIMVIEMVDGEPP 346

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 109/291 (37%), Gaps = 42/291 (14%)
Query: 332 LGKGTFGMAY--KAILEDG------TTVVVKRLKDVNVGK--RDFEQQMEIVGSI-RHEN 380
           LG+G FG     +AI  D       T V VK LK     K   D   +ME++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG--------RIPLDWDTXXXXXXX 432
           ++ L           ++ +Y S G++   L +    G          P +  +       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         K +H ++ + N+ +       ++D GL      +        G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H + +  
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 275
Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                         N   E+  M++    C   +P QRP    +V  ++ +
Sbjct: 276 --------------NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A +   G  V VK++      +R+    ++ I+   +HENVVE+   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------AAVCLAVLQALSVLHAQGV 191
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L       +SD G     S   P      G   + APE+          
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 252 DIWSLGIMVIEMVDGEPP 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/271 (21%), Positives = 102/271 (37%), Gaps = 39/271 (14%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 125
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT------SALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 229
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
           E  R P  E+   ++  + + C    P+ RP
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 327 ASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVEL 384
           A  E +GKG +G  ++ +   G +V VK     +  ++ + ++ EI  ++  RH+N++  
Sbjct: 11  ALVECVGKGRYGEVWRGLWH-GESVAVKIFSSRD--EQSWFRETEIYNTVLLRHDNILGF 67
Query: 385 KAYYY----SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
            A       S  +  ++  Y+  GS+   L  +  E  + L                   
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL-AVSAACGLAHLHVEIF 126
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-------ARAAGYRAP 493
                  + H + KS N+ + S    C++DLGL  + S  +  +            Y AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 494 EV------TDSRKATQASDVYSFGVVLLEI 517
           EV      TD  ++ + +D+++FG+VL EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRKATQA 504
           ++V+ ++K  NI L+   +  +SDLGL         +  R    GY APEV  + + T +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 505 SDVYSFGVVLLEILTGKSPIH 525
            D ++ G +L E++ G+SP  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ 386

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA--GYRAPEVTDSRKATQA 504
           ++V+ ++K  NI L+   +  +SDLGL         +  R    GY APEV  + + T +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 505 SDVYSFGVVLLEILTGKSPIH 525
            D ++ G +L E++ G+SP  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ 386

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/197 (20%), Positives = 84/197 (42%), Gaps = 11/197 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 126
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 508 YSFGVVLLEILTGKSPI 524
           +S G+ L+E+  G+ PI
Sbjct: 187 WSMGLSLVEMAVGRYPI 203

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 136
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVIAR-AAGYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +     AP  A+    + APE     K +  SD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 242
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 243 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 330 EVLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFE---QQMEIVGSIRHENV 381
           +VLG G FG  +K + + +G +    V +K ++D + G++ F+     M  +GS+ H ++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHI 95
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTXXXXXXXXXXXXXX 439
           V L         +L V  Y  LGS+   +   RG    ++ L+W                
Sbjct: 96  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 153
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI----------TSALAPVIARAAG 489
                   +VH N+ + N+ L S     V+D G+  +          + A  P+      
Sbjct: 154 --------MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI-----K 200
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           + A E     K T  SDV+S+GV + E++T G  P
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 82  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 135
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVIAR-AAGYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +     AP  A+    + APE     K +  SD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 241
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 242 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 330 EVLGKGTFGMAYKAI-LEDGTT----VVVKRLKDVNVGKRDFE---QQMEIVGSIRHENV 381
           +VLG G FG  +K + + +G +    V +K ++D + G++ F+     M  +GS+ H ++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHI 77
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTXXXXXXXXXXXXXX 439
           V L         +L V  Y  LGS+   +   RG    ++ L+W                
Sbjct: 78  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI----------TSALAPVIARAAG 489
                   +VH N+ + N+ L S     V+D G+  +          + A  P+      
Sbjct: 136 --------MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI-----K 182
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           + A E     K T  SDV+S+GV + E++T G  P
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G FG  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 79  EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------KDYRMERPEGCPEK 238
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 239 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 332 LGKGTFGMAYKAILEDGTT---VVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           +G G +G    A+  DG T   V +K+L    +     KR + +++ ++  +RHENV+ L
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 385 KAYYYSKDEKLMVY-DYY--------SLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXX 435
              + + DE L  + D+Y         LG +  M H + GE RI                
Sbjct: 90  LDVF-TPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQF----------LVYQ 136
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV 495
                       ++H ++K  N+ +N      + D GL     +          YRAPEV
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEV 196
Query: 496 T-DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL 535
             +  + TQ  D++S G ++ E++TGK+     G D L  L
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQL 235

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/271 (21%), Positives = 102/271 (37%), Gaps = 39/271 (14%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 129
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 233
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
           E  R P  E+   ++  + + C    P+ RP
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/271 (21%), Positives = 102/271 (37%), Gaps = 39/271 (14%)
Query: 330 EVLGKGTFGMA----YKAILEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+     + A      +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           + L     +   K MV +   LGS+   L   +G   +                      
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL-------GTLSRYAVQVAEGMG 125
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS------ALAPVIARAAGYRAPEV 495
                + +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 229
Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
           E  R P  E+   ++  + + C    P+ RP
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA    G  V +KR++    D  +      +++ ++  + H N+V L 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI-REISLLKELHHPNIVSLI 85
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERG--EGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              +S+    +V+++        +  ++ G  + +I +                      
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI----------YLYQLLRGVAHC 135
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARAAGYRAPEV-TD 497
              +++H ++K  N+ +NS     ++D GL       + S    V+     YRAP+V   
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT--LWYRAPDVLMG 193
Query: 498 SRKATQASDVYSFGVVLLEILTGK 521
           S+K + + D++S G +  E++TGK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 332 LGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAYYY 389
           +G+G+ G+   A  +  G  V VK++      +R+    ++ I+    H+NVV++ + Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 390 SKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
             DE  +V ++   G+++ ++ H+   E +I                            +
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI----------ATVCLSVLRALSYLHNQGV 162
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQAS 505
           +H +IKS +I L S     +SD G     S   P      G   + APEV          
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 506 DVYSFGVVLLEILTGKSP 523
           D++S G++++E++ G+ P
Sbjct: 223 DIWSLGIMVIEMIDGEPP 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA    G  V +KR++    D  +      +++ ++  + H N+V L 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI-REISLLKELHHPNIVSLI 85
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERG--EGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
              +S+    +V+++        +  ++ G  + +I +                      
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI----------YLYQLLRGVAHC 135
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARAAGYRAPEV-TD 497
              +++H ++K  N+ +NS     ++D GL       + S    V+     YRAP+V   
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT--LWYRAPDVLMG 193
Query: 498 SRKATQASDVYSFGVVLLEILTGK 521
           S+K + + D++S G +  E++TGK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 16  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 124
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED 184
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 192 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 186 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 26/216 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG FG  Y A  +    ++ +K L    + K   E Q+    EI   +RH N++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           Y++ +    ++ ++   G +   L      GR                            
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKH---GRF-----DEQRSATFMEELADALHYCHER 134
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR-----AAGYRAPEVTDSRKA 501
           K++H +IK  N+ +  +    ++D G     S  AP + R        Y  PE+ + +  
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCGTLDYLPPEMIEGKTH 190
Query: 502 TQASDVYSFGVVLLEILTG----KSPIHTTGGDELV 533
            +  D++  GV+  E L G     SP HT     +V
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 330 EVLGKGTFGMAYKAI-LEDGTTV---VVKRLKDVNVGKR---DFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK I + +G TV   V  ++ +   G +   +F  +  I+ S+ H ++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTXXXXXXXXXXXXXXX 440
            L     S   +L V      G +   +H  +     ++ L+W                 
Sbjct: 104 RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW---------CVQIAKGM 153
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEV 495
                 +LVH ++ + N+ + S  +  ++D GL  +            G     + A E 
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 496 TDSRKATQASDVYSFGVVLLEILT 519
              RK T  SDV+S+GV + E++T
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 330 EVLGKGTFGMAYKAI-LEDGTTV---VVKRLKDVNVGKR---DFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK I + +G TV   V  ++ +   G +   +F  +  I+ S+ H ++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTXXXXXXXXXXXXXXX 440
            L     S   +L V      G +   +H  +     ++ L+W                 
Sbjct: 81  RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW---------CVQIAKGM 130
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEV 495
                 +LVH ++ + N+ + S  +  ++D GL  +            G     + A E 
Sbjct: 131 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 496 TDSRKATQASDVYSFGVVLLEILT 519
              RK T  SDV+S+GV + E++T
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 206 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 119
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED 179
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 30/232 (12%)
Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQM---- 370
            +  D  D++R     LGKG FG  Y A  +    ++ +K L    + K   E Q+    
Sbjct: 10  KFTIDDFDIVRP----LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 371 EIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXX 430
           EI   +RH N++ +  Y++ +    ++ ++   G +   L      GR            
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GRF-----DEQRSA 117
Query: 431 XXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR---- 486
                           K++H +IK  N+ +  +    ++D G     S  AP + R    
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMC 173
Query: 487 -AAGYRAPEVTDSRKATQASDVYSFGVVLLEILTG----KSPIHTTGGDELV 533
               Y  PE+ + +   +  D++  GV+  E L G     SP HT     +V
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 119
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED 179
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 33/278 (11%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIV 373
           G ++  D +DL     + LG G FG+           V +K +K+ ++ + +F ++ +++
Sbjct: 1   GGSWEIDPKDL--TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVM 58
Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXX 433
            ++ HE +V+L      +    ++ +Y + G +   L   R   +               
Sbjct: 59  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMC 111
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGY--- 490
                        + +H ++ + N  +N Q    VSD GL+          +R + +   
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR 171
Query: 491 -RAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT 548
              PEV    K +  SD+++FGV++ EI + GK P       E                T
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------T 215
Query: 549 AEVFDVELLRY-PNIEEEMVEMLQIAMSCVVRMPDQRP 585
           AE     L  Y P++  E V    I  SC     D+RP
Sbjct: 216 AEHIAQGLRLYRPHLASEKV--YTIMYSCWHEKADERP 251

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 119
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED 179
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 192 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 119
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 79  EPPFYIIIEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----YRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------KDYRMERPEGCPEK 238
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 239 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 14  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 122
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 182
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQ---QMEIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K L K+V + K +      +  ++ + RH  +
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
             LK  + + D    V +Y + G +   L  ER          T                
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALE 119
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
                 +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV + 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
               +A D +  GVV+ E++ G+ P +    + L  L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 139
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 245
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 246 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           +G G+FG  Y A  + +   V +K++    K  N   +D  +++  +  +RH N ++ + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
            Y  +    +V +Y  LGS S +L   +     PL                         
Sbjct: 83  CYLREHTAWLVMEY-CLGSASDLLEVHKK----PL---QEVEIAAVTHGALQGLAYLHSH 134
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV---TDSRKATQ 503
            ++H ++K+ NI L+      + D G  +I  A A        + APEV    D  +   
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-APANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 504 ASDVYSFGVVLLEILTGKSPI 524
             DV+S G+  +E+   K P+
Sbjct: 194 KVDVWSLGITCIELAERKPPL 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRL----KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           +G G+FG  Y A  + +   V +K++    K  N   +D  +++  +  +RH N ++ + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
            Y  +    +V +Y  LGS S +L   +     PL                         
Sbjct: 122 CYLREHTAWLVMEY-CLGSASDLLEVHKK----PLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV---TDSRKATQ 503
            ++H ++K+ NI L+      + D G  +I  A A        + APEV    D  +   
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-APANXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 504 ASDVYSFGVVLLEILTGKSPI 524
             DV+S G+  +E+   K P+
Sbjct: 233 KVDVWSLGITCIELAERKPPL 253

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSSKS 202
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 246
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
            E V    I  SC     D+RP    ++  I +V   +S
Sbjct: 247 SEKV--YTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 452 NIKSSNIFLNSQQYGCVSDLGLTTI------TSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP--VRWSPPEVLMYSKFSSKS 202
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 246
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
            E V    I  SC     D+RP    ++  I +V   +S
Sbjct: 247 SEKV--YTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 82  EPPFYIIIEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 135
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 241
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 242 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 270

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/202 (19%), Positives = 82/202 (40%), Gaps = 13/202 (6%)
Query: 331 VLGKGTFGMAYKA-ILEDGTTVVVKRLK-DVNVGKRDFEQQME---IVGSIRHENVVELK 385
            LG G+FG  +      +G    +K LK ++ V  +  E   +   ++  + H  ++ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
             +    +  M+ DY   G + ++L   R   R P                         
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP-----NPVAKFYAAEVCLALEYLHS 124
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQAS 505
             +++ ++K  NI L+   +  ++D G       +   +     Y APEV  ++   ++ 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 506 DVYSFGVVLLEILTGKSPIHTT 527
           D +SFG+++ E+L G +P + +
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDS 206

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 319 FDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSI 376
           +D  D+L    E LG G FG+ ++ + +    V V +  +    + K   + ++ I+  +
Sbjct: 50  YDYYDIL----EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL 105
Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWD-TXXXXXXXXXX 435
            H  ++ L   +  K E +++ ++ S G +   + +E        D+  +          
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQ 157
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITS--ALAPVIARAAGYR 491
                       +VH +IK  NI   +++   V   D GL T  +   +  V    A + 
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 217
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW 547
           APE+ D       +D+++ GV+   +L+G SP    G D+L  L     +V R +W
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--AGEDDLETL----QNVKRCDW 267

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 76  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSSKS 186
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 230
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
            E V    I  SC     D+RP    ++  I +V   +S
Sbjct: 231 SEKV--YTIMYSCWHEKADERPTFKILLSNILDVMDEES 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 86  EPPFYIIIEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 139
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 245
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 246 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 139
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 245
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 246 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/296 (20%), Positives = 118/296 (39%), Gaps = 31/296 (10%)
Query: 310 FFFEGC-NY-AFDLEDLLRASAEVLGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDF 366
            +F+G  NY  +++E         LG G +G  Y+ + +  + TV VK LK+  +   +F
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 69
Query: 367 EQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTX 426
            ++  ++  I+H N+V+L      +    ++ ++ + G++   L   R   R  ++    
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVN---A 123
Query: 427 XXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR 486
                                 +H ++ + N  +       V+D GL+ + +        
Sbjct: 124 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 183
Query: 487 AA----GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
            A     + APE     K +  SDV++FGV+L EI T G SP       ++  L+     
Sbjct: 184 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---- 239
Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                      D  + R     E++ E+++   +C    P  RP   ++ +  E +
Sbjct: 240 ----------KDYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETM 282

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 83  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSSKS 193
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 237
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
            E V    I  SC     D+RP    ++  I +V   +S
Sbjct: 238 SEKV--YTIMYSCWHEKADERPTFKILLSNILDVMDEES 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 85  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 138
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 244
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 245 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 332 LGKGTFGMAYKAILE---DGT--TVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVE 383
           LG+G FG       +   DGT   V VK LK+   G   +  +++++EI+ ++ HE++V+
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE-GCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
            K     + EK   +V +Y  LGS+   L         P                     
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRHCVGLAQLLLFAQQICEGMA 126
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEV 495
                  +H  + + N+ L++ +   + D GL   +         R  G     + APE 
Sbjct: 127 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 496 TDSRKATQASDVYSFGVVLLEILT 519
               K   ASDV+SFGV L E+LT
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSSKS 182
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 226
Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
            E V    I  SC     D+RP    ++  I +V   +S
Sbjct: 227 SEKV--YTIMYSCWHEKADERPTFKILLSNILDVMDEES 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 245
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 246 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 274

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 550 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 332 LGKGTFGMAYKAILE---DGT--TVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVE 383
           LG+G FG       +   DGT   V VK LK+   G   +  +++++EI+ ++ HE++V+
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE-GCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
            K     + EK   +V +Y  LGS+   L         P                     
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRHCVGLAQLLLFAQQICEGMA 125
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEV 495
                  +H  + + N+ L++ +   + D GL   +         R  G     + APE 
Sbjct: 126 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 496 TDSRKATQASDVYSFGVVLLEILT 519
               K   ASDV+SFGV L E+LT
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 329 AEVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDF----EQQMEIVGSIRHENV 381
            + LG+G+FG   +AY      G  V +K +    + K D     E+++  +  +RH ++
Sbjct: 9   VKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           ++L     SKDE +MV +Y           +E  +  +  D  +                
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAG---------NELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDSR 499
                K+VH ++K  N+ L+      ++D GL+ I +          +  Y APEV   +
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 500 -KATQASDVYSFGVVLLEILTGKSP 523
             A    DV+S GV+L  +L  + P
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 139
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 245
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 246 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 329 AEVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDF----EQQMEIVGSIRHENV 381
            + LG+G+FG   +AY      G  V +K +    + K D     E+++  +  +RH ++
Sbjct: 13  VKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           ++L     SKDE +MV +Y           +E  +  +  D  +                
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAG---------NELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDSR 499
                K+VH ++K  N+ L+      ++D GL+ I +          +  Y APEV   +
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 500 -KATQASDVYSFGVVLLEILTGKSP 523
             A    DV+S GV+L  +L  + P
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI-ARAAG-----YRAPEVTDSRKA 501
            VH ++ + N+ L +Q Y  +SD GL+    A      A+  G     + APE  +  K 
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           +  SDV+SFGV++ E  + G+ P     G E+  ++
Sbjct: 551 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E++G G FG  +KA    DG T V+KR+K  N      E++++ +  + H N+V     +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 389 ---------------YSKDEKLMV-YDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXX 432
                           SK + L +  ++   G++   +   RGE    LD          
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLD---KVLALEL 127
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--- 489
                         KL++ ++K SNIFL   +   + D GL T          R+ G   
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-XRSKGTLR 186
Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEIL 518
           Y +PE   S+   +  D+Y+ G++L E+L
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 331 VLGKGTFGMAYKAILED-GTTVVVKRL---KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           ++G+G++GM  K   +D G  V +K+     D  + K+   ++++++  +RHEN+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
               K    +V+++     +  +     G     LD+                       
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQV---VQKYLFQIINGIGFCHSH 143
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPE-VTDSRKAT 502
            ++H +IK  NI ++      + D G     +A   V         YRAPE +    K  
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 503 QASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREEWT------------ 548
           +A DV++ G ++ E+  G+ P+    +  D+L H++  + +++                 
Sbjct: 204 KAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 549 -AEVFDVELL--RYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
             E+ + E L  RYP + E ++++   A  C+   PD+RP
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDL---AKKCLHIDPDKRP 299

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 22/157 (14%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKA 501
           K +H ++ + NI L+ +    + D GL          + +        + APE    R  
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 270
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           T  SDV+SFGV+L EI + G SP      D              EE+   + +   +R P
Sbjct: 271 TIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRAP 316
Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +      EM Q  + C    P QRP   ++V  + N+
Sbjct: 317 DYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 22/157 (14%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKA 501
           K +H ++ + NI L+ +    + D GL          + +        + APE    R  
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           T  SDV+SFGV+L EI + G SP      D              EE+   + +   +R P
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRAP 318
Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +      EM Q  + C    P QRP   ++V  + N+
Sbjct: 319 DYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 329 AEVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDF----EQQMEIVGSIRHENV 381
            + LG+G+FG   +AY      G  V +K +    + K D     E+++  +  +RH ++
Sbjct: 19  VKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 76
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           ++L     SKDE +MV +Y           +E  +  +  D  +                
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAG---------NELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDSR 499
                K+VH ++K  N+ L+      ++D GL+ I +          +  Y APEV   +
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 500 -KATQASDVYSFGVVLLEILTGKSP 523
             A    DV+S GV+L  +L  + P
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 329 AEVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDF----EQQMEIVGSIRHENV 381
            + LG+G+FG   +AY      G  V +K +    + K D     E+++  +  +RH ++
Sbjct: 18  VKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 75
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXX 441
           ++L     SKDE +MV +Y           +E  +  +  D  +                
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAG---------NELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDSR 499
                K+VH ++K  N+ L+      ++D GL+ I +          +  Y APEV   +
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 500 -KATQASDVYSFGVVLLEILTGKSP 523
             A    DV+S GV+L  +L  + P
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 31/273 (11%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 79  EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKATQAS 505
            ++ + N  +       V+D GL+ + +      A A       + APE     K +  S
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV++FGV+L EI T G SP       ++  L+                D  + R     E
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------KDYRMERPEGCPE 237
Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           ++ E+++   +C    P  RP   ++ +  E +
Sbjct: 238 KVYELMR---ACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 17/204 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELK 385
           E LGKG F +  + + +  G     K +    +  RDF   E++  I   ++H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
                +    +V+D  + G        E  E  +  ++ +                    
Sbjct: 72  DSIQEESFHYLVFDLVTGG--------ELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 446 XKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTIT--SALAPVIARAAGYRAPEVTDSRK 500
             +VH N+K  N+ L S+  G    ++D GL      S      A   GY +PEV     
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 501 ATQASDVYSFGVVLLEILTGKSPI 524
            ++  D+++ GV+L  +L G  P 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 17/204 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELK 385
           E LGKG F +  + + +  G     K +    +  RDF   E++  I   ++H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
                +    +V+D  + G        E  E  +  ++ +                    
Sbjct: 72  DSIQEESFHYLVFDLVTGG--------ELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 446 XKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTIT--SALAPVIARAAGYRAPEVTDSRK 500
             +VH N+K  N+ L S+  G    ++D GL      S      A   GY +PEV     
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 501 ATQASDVYSFGVVLLEILTGKSPI 524
            ++  D+++ GV+L  +L G  P 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 25/220 (11%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 157 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 213
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXX 439
             LK  + + D    V +Y + G +   L  ER   E R                     
Sbjct: 214 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---------YGAEIVSAL 264
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVT 496
                   +V+ ++K  N+ L+   +  ++D GL        A          Y APEV 
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 22/157 (14%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKA 501
           K +H ++ + NI L+ +    + D GL          + +        + APE    R  
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 279
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           T  SDV+SFGV+L EI + G SP      D              EE+   + +   +R P
Sbjct: 280 TIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRAP 325
Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +      EM Q  + C    P QRP   ++V  + N+
Sbjct: 326 DY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 25/220 (11%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 154 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXX 439
             LK  + + D    V +Y + G +   L  ER   E R                     
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---------YGAEIVSAL 261
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVT 496
                   +V+ ++K  N+ L+   +  ++D GL        A          Y APEV 
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 17/204 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELK 385
           E LGKG F +  + + +  G     K +    +  RDF   E++  I   ++H N+V L 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
                +    +V+D  + G        E  E  +  ++ +                    
Sbjct: 71  DSIQEESFHYLVFDLVTGG--------ELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 446 XKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTIT--SALAPVIARAAGYRAPEVTDSRK 500
             +VH N+K  N+ L S+  G    ++D GL      S      A   GY +PEV     
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 501 ATQASDVYSFGVVLLEILTGKSPI 524
            ++  D+++ GV+L  +L G  P 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPF 206

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 22/157 (14%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAPEVTDSRKA 501
           K +H ++ + NI L+ +    + D GL          + +        + APE    R  
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 277
Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
           T  SDV+SFGV+L EI + G SP      D              EE+   + +   +R P
Sbjct: 278 TIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRAP 323
Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +      EM Q  + C    P QRP   ++V  + N+
Sbjct: 324 DY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 136
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 242
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 243 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  ++                          +H
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVN---AVVLLYMATQISSAMEYLEKKNFIH 136
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 242
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 243 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 18/217 (8%)
Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEI 372
            +  + EDL+    E +G+G FG  +   L  D T V VK  ++      K  F Q+  I
Sbjct: 108 KWVLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXX 432
           +    H N+V L      K    +V +    G     L +E    R+             
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV-------KTLLQM 218
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-----ITSALAPVIARA 487
                           +H ++ + N  +  +    +SD G++      + +A   +    
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVP 278
Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
             + APE  +  + +  SDV+SFG++L E  + G SP
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 105 D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 164 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 17/204 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDF---EQQMEIVGSIRHENVVELK 385
           E LGKG F +  + + +  G     K +    +  RDF   E++  I   ++H N+V L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
                +    +V+D  + G        E  E  +  ++ +                    
Sbjct: 95  DSIQEESFHYLVFDLVTGG--------ELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 446 XKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTIT--SALAPVIARAAGYRAPEVTDSRK 500
             +VH N+K  N+ L S+  G    ++D GL      S      A   GY +PEV     
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 501 ATQASDVYSFGVVLLEILTGKSPI 524
            ++  D+++ GV+L  +L G  P 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPF 230

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 14/213 (6%)
Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS 375
           N   D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  
Sbjct: 15  NLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 376 IRHENVVELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXX 433
           +   +   +  YY  Y KD KL +   Y LG  SA+   E G    PLD           
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEY-LGGGSALDLLEPG----PLD---ETQIATIL 125
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGY 490
                        K +H +IK++N+ L+      ++D G+    T T            +
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APEV         +D++S G+  +E+  G+ P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 14/211 (6%)
Query: 318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR 377
           + D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  + 
Sbjct: 2   SLDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 378 HENVVELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXX 435
             +   +  YY  Y KD KL +   Y LG  SA+   E G    PLD             
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEY-LGGGSALDLLEPG----PLD---ETQIATILRE 112
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRA 492
                      K +H +IK++N+ L+      ++D G+    T T            + A
Sbjct: 113 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 172
Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           PEV         +D++S G+  +E+  G+ P
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y+ + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    ++ ++ + G++   L   R   R  +   +                       +H
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEV---SAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE     K +  SD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 507 VYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           V++FGV+L EI T G SP       ++  L+                D  + R     E+
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 240
Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           + E+++   +C    P  RP   ++ +  E +
Sbjct: 241 VYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 25/220 (11%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 14  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 70
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXX 439
             LK  + + D    V +Y + G +   L  ER   E R                     
Sbjct: 71  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---------YGAEIVSAL 121
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVT 496
                   +V+ ++K  N+ L+   +  ++D GL          +    G   Y APEV 
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 82/196 (41%), Gaps = 11/196 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+ +K   +    V+ ++L  + +    +    ++++++       +V     +
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +  GRIP                          K+
Sbjct: 77  YSDGEISICMEHMDGGSLDQVL---KKAGRIP----EQILGKVSIAVIKGLTYLREKHKI 129
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +   +A        Y +PE       +  SD+
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDI 189
Query: 508 YSFGVVLLEILTGKSP 523
           +S G+ L+E+  G+ P
Sbjct: 190 WSMGLSLVEMAVGRYP 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 25/220 (11%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 15  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 71
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXX 439
             LK  + + D    V +Y + G +   L  ER   E R                     
Sbjct: 72  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---------YGAEIVSAL 122
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVT 496
                   +V+ ++K  N+ L+   +  ++D GL          +    G   Y APEV 
Sbjct: 123 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 291 RGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKA-ILEDGT 349
           RG + E + S   D S    FF+        +   R S   LG G++G  +K    EDG 
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQ--------QSFQRLSR--LGHGSYGEVFKVRSKEDGR 83
Query: 350 TVVVKRLKDVNVGKRDFEQQMEIVGSI----RHENVVELKAYYYSKDEKLMVYDYYSLGS 405
              VKR      G +D  +++  VGS     +H   V L+  +   +E  ++Y    L  
Sbjct: 84  LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW---EEGGILYLQTELCG 140
Query: 406 VSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQY 465
            S   H E     +P                           LVH ++K +NIFL  +  
Sbjct: 141 PSLQQHCEAWGASLP-----EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR 195
Query: 466 GCVSDLGLTTI--TSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEI 517
             + D GL     T+    V      Y APE+      T A+DV+S G+ +LE+
Sbjct: 196 CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGT-AADVFSLGLTILEV 248

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 25/220 (11%)
Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIRHENV 381
           ++LGKGTFG   K IL      G    +K LK +V V K +    +    ++ + RH  +
Sbjct: 16  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 72
Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXX 439
             LK  + + D    V +Y + G +   L  ER   E R                     
Sbjct: 73  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---------YGAEIVSAL 123
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVT 496
                   +V+ ++K  N+ L+   +  ++D GL          +    G   Y APEV 
Sbjct: 124 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
           +     +A D +  GVV+ E++ G+ P +    ++L  L+
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 14/211 (6%)
Query: 318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR 377
           + D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  + 
Sbjct: 2   SLDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 378 HENVVELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXX 435
             +   +  YY  Y KD KL +   Y LG  SA+   E G    PLD             
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEY-LGGGSALDLLEPG----PLD---ETQIATILRE 112
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRA 492
                      K +H +IK++N+ L+      ++D G+    T T            + A
Sbjct: 113 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 172
Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           PEV         +D++S G+  +E+  G+ P
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/262 (21%), Positives = 101/262 (38%), Gaps = 35/262 (13%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK 391
           LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L      +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHG 451
               ++ +Y + G +   L   R   +                            + +H 
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 452 NIKSSNIFLNSQQYGCVSDLGLT------TITSALAPVIARAAGYRAPEVTDSRKATQAS 505
           ++ + N  +N Q    VSD GL+        TS++         +  PEV    K +  S
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSSKS 187
Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-PNIE 563
           D+++FGV++ EI + GK P       E                TAE     L  Y P++ 
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 231
Query: 564 EEMVEMLQIAMSCVVRMPDQRP 585
            E V    I  SC     D+RP
Sbjct: 232 SEKV--YTIMYSCWHEKADERP 251

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 66  D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 125 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 92  D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 151 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 67  D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 126 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 29/230 (12%)
Query: 331 VLGKGTFGMAYKA-ILEDGTTVVVKRLK-DVNVGKRDFEQQM---EIVGSIR-HENVVEL 384
           VLGKG+FG    A + E G    VK LK DV +   D E  M    I+   R H  + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
              + + D    V ++ + G +   +   R   E R                        
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR----------ARFYAAEIISALMF 139
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSR 499
                +++ ++K  N+ L+ + +  ++D G+           A   G   Y APE+    
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV--------RWVHS 541
               A D ++ GV+L E+L G +P      D+L   +         W+H 
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 12  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 69  D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 128 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAY 387
           E +GKG FG  ++     G  V VK        +R + ++ EI  ++  RHEN++   A 
Sbjct: 15  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 388 YYSKD-----EKLMVYDYYSLGSVSAML--HSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
             +KD     +  +V DY+  GS+   L  ++   EG I L   T               
Sbjct: 72  D-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------AP 493
                  + H ++KS NI +      C++DLGL     +    I  A  +R       AP
Sbjct: 131 GKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 494 EVTDSR------KATQASDVYSFGVVLLEI 517
           EV D        ++ + +D+Y+ G+V  EI
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 14/211 (6%)
Query: 318 AFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR 377
           + D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  + 
Sbjct: 22  SMDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 80
Query: 378 HENVVELKAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXX 435
             +   +  YY  Y KD KL +   Y LG  SA+   E G    PLD             
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEY-LGGGSALDLLEPG----PLD---ETQIATILRE 132
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRA 492
                      K +H +IK++N+ L+      ++D G+    T T            + A
Sbjct: 133 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 192
Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           PEV         +D++S G+  +E+  G+ P
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 22/219 (10%)
Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEI 372
            +  + EDL+    E +G+G FG  +   L  D T V VK  ++      K  F Q+  I
Sbjct: 108 KWVLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXX 432
           +    H N+V L      K    +V +    G     L +E    R+             
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV-------KTLLQM 218
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR- 491
                           +H ++ + N  +  +    +SD G++        V A + G R 
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQ 276
Query: 492 ------APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
                 APE  +  + +  SDV+SFG++L E  + G SP
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/239 (20%), Positives = 102/239 (42%), Gaps = 42/239 (17%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA    G T  +K+++    D  +      +++ I+  ++H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSNIVKLY 66
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              ++K   ++V+++        +   E G   +                          
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--------TAKSFLLQLLNGIAYCHD 118
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N +    ++D GL           ARA G              YR
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGL-----------ARAFGIPVRKYTHEIVTLWYR 167
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREEW 547
           AP+V   S+K +   D++S G +  E++ G +P+    +  D+L+ + R + +   + W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/239 (20%), Positives = 102/239 (42%), Gaps = 42/239 (17%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA    G T  +K+++    D  +      +++ I+  ++H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSNIVKLY 66
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              ++K   ++V+++        +   E G   +                          
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--------TAKSFLLQLLNGIAYCHD 118
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N +    ++D GL           ARA G              YR
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGL-----------ARAFGIPVRKYTHEVVTLWYR 167
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREEW 547
           AP+V   S+K +   D++S G +  E++ G +P+    +  D+L+ + R + +   + W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/239 (20%), Positives = 102/239 (42%), Gaps = 42/239 (17%)
Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA    G T  +K+++    D  +      +++ I+  ++H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSNIVKLY 66
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              ++K   ++V+++        +   E G   +                          
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--------TAKSFLLQLLNGIAYCHD 118
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N +    ++D GL           ARA G              YR
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGL-----------ARAFGIPVRKYTHEVVTLWYR 167
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVRWVHSVVREEW 547
           AP+V   S+K +   D++S G +  E++ G +P+    +  D+L+ + R + +   + W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG-APLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/282 (20%), Positives = 114/282 (40%), Gaps = 46/282 (16%)
Query: 330 EVLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVGKRD-FEQQMEIVGSIRHEN 380
           E LG+GTF   +K +  +         T V++K L   +    + F +   ++  + H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           +V      +  DE ++V ++   GS+   L  ++ +  I + W                 
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEE 131
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQ--------YGCVSDLGLTTITSALAPVIARAAGYRA 492
                  L+HGN+ + NI L  ++        +  +SD G++ IT     ++     +  
Sbjct: 132 NT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIPWVP 185
Query: 493 PEVTDSRKATQ-ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           PE  ++ K    A+D +SFG  L EI         +GGD+ +       S +  +   + 
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEI--------CSGGDKPL-------SALDSQRKLQF 230
Query: 552 F-DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           + D   L  P    +  E+  +  +C+   PD RP    ++R
Sbjct: 231 YEDRHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIR 268

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 37/174 (21%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIA--RAAG---YRAPEVTDSRKA 501
           K++H +IK SNI L+      + D G   I+  L   IA  R AG   Y APE  D   +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 502 TQA----SDVYSFGVVLLEILTGKSPIHTTGG--DELVHLVR------------------ 537
            Q     SDV+S G+ L E+ TG+ P        D+L  +V+                  
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 538 --WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSC-VVRMPDQRPKMP 588
             +V+  + ++ +      ELL++P I   M E   + ++C V ++ DQ P  P
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFI--LMYEERAVEVACYVCKILDQMPATP 314

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T          V+     Y APEV   +  + 
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             DV+S G ++  +L GK P  T+
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T          V+     Y APEV   +  + 
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             DV+S G ++  +L GK P  T+
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T          V+     Y APEV   +  + 
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             DV+S G ++  +L GK P  T+
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 43/222 (19%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E++G G FG  +KA    DG T V++R+K  N      E++++ +  + H N+V     +
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN---EKAEREVKALAKLDHVNIVHYNGCW 74
Query: 389 -------YSKDEKLMVYDY----------------------YSLGSVSAMLHSERGEGRI 419
                   + D+ L   DY                         G++   +   RGE   
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--- 131
Query: 420 PLDWDTXXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA 479
            LD                        KL+H ++K SNIFL   +   + D GL T    
Sbjct: 132 KLD---KVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 480 LAPVIARAAG---YRAPEVTDSRKATQASDVYSFGVVLLEIL 518
                 R+ G   Y +PE   S+   +  D+Y+ G++L E+L
Sbjct: 189 DGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 42/299 (14%)
Query: 332 LGKGTFGMAYKAILE---DGT--TVVVKRLK-DVNVGKRD-FEQQMEIVGSIRHENVVEL 384
           LG+G FG       +   DGT   V VK LK D     R  ++Q+++I+ ++ HE++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           K            +V +Y  LGS+   L         P                      
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL---------PRHSIGLAQLLLFAQQICEGMAY 149
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEVT 496
                 +H ++ + N+ L++ +   + D GL   +         R  G     + APE  
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 497 DSRKATQASDVYSFGVVLLEILT----GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
              K   ASDV+SFGV L E+LT     +SP   T   EL+ + +   +V+R        
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRL------- 260
Query: 553 DVELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPS 607
             ELL    R P  ++   E+  +  +C       RP   +++ +++ V        PS
Sbjct: 261 -TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 147
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 148 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV-----KW 202
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 84/205 (40%), Gaps = 11/205 (5%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYY 388
           LG G  G+  K        ++ ++L  + +    +    ++++++       +V     +
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
           YS  E  +  ++   GS+  +L   +   RIP +                        ++
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAK---RIPEE----ILGKVSIAVLRGLAYLREKHQI 136
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           +H ++K SNI +NS+    + D G++  +  ++A        Y APE       +  SD+
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDI 196
Query: 508 YSFGVVLLEILTGKSPIHTTGGDEL 532
           +S G+ L+E+  G+ PI      EL
Sbjct: 197 WSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 149
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 150 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV-----KW 204
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 148
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 149 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 203
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 148
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 149 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 203
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 146
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 147 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 201
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 145
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 200
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 167
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 168 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 222
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 153
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 154 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 208
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 148
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 149 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 203
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 149
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 150 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 204
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 12/198 (6%)
Query: 332 LGKGTFGMAYKAILEDGT-TVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           LG G +G  Y  + +  + TV VK LK+  +   +F ++  ++  I+H N+V+L      
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKLVH 450
           +    +V +Y   G++   L     E        T                       +H
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEV------TAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 451 GNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA----GYRAPEVTDSRKATQASD 506
            ++ + N  +       V+D GL+ + +         A     + APE       +  SD
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 507 VYSFGVVLLEILT-GKSP 523
           V++FGV+L EI T G SP
Sbjct: 214 VWAFGVLLWEIATYGMSP 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 140
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 141 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 195
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 166
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 167 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 221
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 146
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 147 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 201
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 143
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 198
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 366 FEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDT 425
           FE+++     + H+N+V +       D   +V +Y    ++S  +     E   PL  DT
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDT 112
Query: 426 XXXXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV-- 483
                                ++VH +IK  NI ++S +   + D G+    S  +    
Sbjct: 113 AINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 484 --IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
             +     Y +PE        + +D+YS G+VL E+L G+ P
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
           ++SD+++ G ++ +++ G  P    G + L+
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFR-AGNEYLI 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
           ++SD+++ G ++ +++ G  P    G + L+
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFR-AGNEYLI 219

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 148
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 149 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 203
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
           ++SD+++ G ++ +++ G  P    G + L+
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFR-AGNEYLI 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELV 533
           ++SD+++ G ++ +++ G  P    G + L+
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFR-AGNEYLI 217

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 506 DVYSFGVVLLEILTGKSPI 524
           D +S G +L ++L G SP 
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 506 DVYSFGVVLLEILTGKSPI 524
           D +S G +L ++L G SP 
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 506 DVYSFGVVLLEILTGKSPI--HTT 527
           D +S G +L ++L G SP   H T
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-GYRAPEVTDSRKATQAS- 505
           +V+ ++K +NI L+   +  +SDLGL    S   P  +    GY APEV     A  +S 
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 371
Query: 506 DVYSFGVVLLEILTGKSPI--HTT 527
           D +S G +L ++L G SP   H T
Sbjct: 372 DWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 384 LKAYYY-SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKF 207
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KW 262
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPF 216

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 330 EVLGKGTFGMAYKAIL--EDGTTV--VVKRLKDV-NVGK-RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L   DG  +   VK L  + ++G+   F  +  I+    H NV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 384 LKAY-YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           L      S+   L+V  Y   G +   +   R E   P    T                 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP----TVKDLIGFGLQVAKGMKY 147
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV      +
Sbjct: 148 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KW 202
Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            A E   ++K T  SDV+SFGV+L E++T  +P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 89/234 (38%), Gaps = 19/234 (8%)
Query: 329 AEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDV-------NVGKRDFEQQMEIVGSIRHEN 380
            EV+GKG F +  + I  E G    VK + DV        +   D +++  I   ++H +
Sbjct: 29  CEVIGKGAFSVVRRCINRETGQQFAVK-IVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           +VEL   Y S     MV+++     +   +      G +     +               
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY----SEAVASHYMRQILEAL 143
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------YRAPE 494
                  ++H ++K  N+ L S++      LG   +   L      A G      + APE
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           V       +  DV+  GV+L  +L+G  P + T       +++  + +   +W+
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS 257

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A+
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/282 (20%), Positives = 113/282 (40%), Gaps = 46/282 (16%)
Query: 330 EVLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVGKRD-FEQQMEIVGSIRHEN 380
           E LG+GTF   +K +  +         T V++K L   +    + F +   ++  + H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXX 440
           +V         DE ++V ++   GS+   L  ++ +  I + W                 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 441 XXXXXXKLVHGNIKSSNIFLNSQQ--------YGCVSDLGLTTITSALAPVIARAAGYRA 492
                  L+HGN+ + NI L  ++        +  +SD G++ IT     ++     +  
Sbjct: 132 NT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIPWVP 185
Query: 493 PEVTDSRKATQ-ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           PE  ++ K    A+D +SFG  L EI         +GGD+ +       S +  +   + 
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEI--------CSGGDKPL-------SALDSQRKLQF 230
Query: 552 F-DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           + D   L  P    +  E+  +  +C+   PD RP    ++R
Sbjct: 231 YEDRHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIR 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 122
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPF 239

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF 231

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 106/278 (38%), Gaps = 43/278 (15%)
Query: 329 AEVLGKGTFGMAYKAIL--EDGTT--VVVKRLKDVNVGKRDFEQQMEIVGSIR---HENV 381
            ++LG+G FG   +  L  EDGT+  V VK +K  N  +R+ E+ +     ++   H NV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 382 VELKAYYYSKDEK-----LMVYDYYSLGSV-SAMLHS--ERGEGRIPLDWDTXXXXXXXX 433
           + L         +     +++  +   G + + +L+S  E G   IPL            
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ-----TLLKFM 153
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAG--- 489
                          +H ++ + N  L      CV+D GL+  I S       R A    
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 490 -YRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + A E    R  T  SDV++FGV + EI T G +P       E+   +   H       
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH------- 266
Query: 548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
                     R    E+ + E+ +I  SC    P  RP
Sbjct: 267 ----------RLKQPEDCLDELYEIMYSCWRTDPLDRP 294

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 19/204 (9%)
Query: 331 VLGKGTFGMAYKAILE----DGTTVVVKRLK-DVNV-GKRDFEQQMEIVGSIRHENVVEL 384
           +LG+G FG  Y+ +      +   V VK  K D  +  K  F  +  I+ ++ H ++V+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
                 ++   ++ + Y  G +   L   +   ++                         
Sbjct: 75  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV-------LTLVLYSLQICKAMAYLE 126
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS----ALAPVIARAAGYRAPEVTDSRK 500
               VH +I   NI + S +   + D GL+          A V      + +PE  + R+
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 501 ATQASDVYSFGVVLLEILT-GKSP 523
            T ASDV+ F V + EIL+ GK P
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQP 210

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPF 235

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/77 (27%), Positives = 38/77 (49%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +A    Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 124
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 21/221 (9%)
Query: 314 GCNYAFDLEDLLRASAEVLGKGTFGMAYKAILE----DGTTVVVKRLK-DVNV-GKRDFE 367
           G  Y    ED++     +LG+G FG  Y+ +      +   V VK  K D  +  K  F 
Sbjct: 4   GPQYGIAREDVVLN--RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM 61
Query: 368 QQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXX 427
            +  I+ ++ H ++V+L      ++   ++ + Y  G +   L   +   ++        
Sbjct: 62  SEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV-------L 113
Query: 428 XXXXXXXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS----ALAPV 483
                                VH +I   NI + S +   + D GL+          A V
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
                 + +PE  + R+ T ASDV+ F V + EIL+ GK P
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 19/204 (9%)
Query: 331 VLGKGTFGMAYKAILE----DGTTVVVKRLK-DVNV-GKRDFEQQMEIVGSIRHENVVEL 384
           +LG+G FG  Y+ +      +   V VK  K D  +  K  F  +  I+ ++ H ++V+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
                 ++   ++ + Y  G +   L   +   ++                         
Sbjct: 91  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV-------LTLVLYSLQICKAMAYLE 142
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS----ALAPVIARAAGYRAPEVTDSRK 500
               VH +I   NI + S +   + D GL+          A V      + +PE  + R+
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 501 ATQASDVYSFGVVLLEILT-GKSP 523
            T ASDV+ F V + EIL+ GK P
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE------NVV 382
           +V+GKG+FG   KA        V +K +++     R   +++ I+  +R +      NV+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXX 441
            +   +  ++   M ++  S+ ++  ++   + +G  +PL                    
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPL-------VRKFAHSILQCLD 214
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARAAGYRAPEVTDSR 499
                +++H ++K  NI L  Q    +   D G +           ++  YRAPEV    
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 500 KATQASDVYSFGVVLLEILTG 520
           +     D++S G +L E+LTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE------NVV 382
           +V+GKG+FG   KA        V +K +++     R   +++ I+  +R +      NV+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXX 441
            +   +  ++   M ++  S+ ++  ++   + +G  +PL                    
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPL-------VRKFAHSILQCLD 214
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARAAGYRAPEVTDSR 499
                +++H ++K  NI L  Q    +   D G +           ++  YRAPEV    
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 500 KATQASDVYSFGVVLLEILTG 520
           +     D++S G +L E+LTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPF 237

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSF 221
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             D++S G +L  +L GK P  T+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             DV+S G ++  +L GK P  T+
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF 231

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             DV+S G ++  +L GK P  T+
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/77 (27%), Positives = 38/77 (49%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D GL          +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQA 504
           +++ ++K  N+ L+S+ +  ++D G+                   Y APE+   +   ++
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELV-----HLVRWVHSVVRE 545
            D ++FGV+L E+L G++P      DEL      H V +  S+ +E
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/77 (27%), Positives = 38/77 (49%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D GL          +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVK--RLKDVNVGKRD---FEQQMEIVGSIRHENVVELKA 386
           +G+G+F   YK  L+  TTV V    L+D  + K +   F+++ E +  ++H N+V    
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 387 YYYS--KDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
            + S  K +K  ++V +  + G++   L       R  +                     
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLK------RFKVXKIKVLRSWCRQILKGLQFLH 146
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSA-LAPVIARAAGYRAPEVTDSRK 500
                ++H ++K  NIF+        + DLGL T+  A  A  +     + APE  +  K
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEE-K 205
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             ++ DVY+FG   LE  T + P
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYP 228

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 20/206 (9%)
Query: 332 LGKGTFGMAYKAILEDGTT-------VVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           LGKG F   ++  + D  T       +V K L      +     ++ I  S+ H++VV  
Sbjct: 29  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXX 444
             ++   D   +V +     S+   LH  R          T                   
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE-LHKRR-------KALTEPEARYYLRQIVLGCQYLH 138
Query: 445 XXKLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKA 501
             +++H ++K  N+FLN      + D GL T           +     Y APEV   +  
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 502 TQASDVYSFGVVLLEILTGKSPIHTT 527
           +   DV+S G ++  +L GK P  T+
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             D++S G +L  +L GK P  T+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITS-----ALAPVIARAAGYRAPEVTDSRKAT 502
           ++H ++K  NI LN   +  ++D G   + S     A A      A Y +PE+   + A 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 503 QASDVYSFGVVLLEILTGKSPI 524
           ++SD+++ G ++ +++ G  P 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPF 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 25/214 (11%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G FG+ ++A  + D     +KR++  N  + +    ++++ +  + H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 387 YYYSKD--EKLM-----VYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
            +  K+  EKL      VY Y  +         +   GR  ++                 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 440 XXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---------ALAPVIARAAG- 489
                   L+H ++K SNIF        V D GL T               P  AR  G 
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 490 -----YRAPEVTDSRKATQASDVYSFGVVLLEIL 518
                Y +PE       +   D++S G++L E+L
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 41/285 (14%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 142
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAP 493
                   K VH N+ + N  +       + D G+T              G     + AP
Sbjct: 143 GMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E       T +SD++SFGVVL EI +  + P      ++++                 V 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---------------VM 247
Query: 553 DVELLRYP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           D   L  P N  E + +++++   C    P+ RP   ++V ++++
Sbjct: 248 DGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 289

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 22/224 (9%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 141
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAP 493
                   K VH ++ + N  +       + D G+T      A       G     + AP
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           E       T +SD++SFGVVL EI +  + P      ++++  V
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 19/217 (8%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVK-RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++      G     K  +      K    ++++ +  +RH  +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
           +   +E +M+Y++ S G +   +  E  +        +                      
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDEAVEYMRQVCKGLCHMHENN 275
Query: 448 LVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAP-----VIARAAGYRAPEVTDSRK 500
            VH ++K  NI   +++   +   D GLT   + L P     V    A + APEV + + 
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
               +D++S GV+   +L+G SP      DE +  V+
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 24/158 (15%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVTDSRK 500
           K +H ++ + NI L+      + D GL        P   R    R      APE    + 
Sbjct: 219 KCIHRDLAARNILLSENNVVKICDFGLARDIYK-NPDYVRKGDTRLPLKWMAPESIFDKI 277
Query: 501 ATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            +  SDV+S+GV+L EI + G SP      D              E++ + + +   +R 
Sbjct: 278 YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMD--------------EDFCSRLREGMRMRA 323
Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           P  E    E+ QI + C  R P +RP+  ++V  + ++
Sbjct: 324 P--EYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 51/290 (17%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 141
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT----------SALAPVIARAA 488
                   K VH N+ + N  +       + D G+T               L PV     
Sbjct: 142 GMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV----- 196
Query: 489 GYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEW 547
            + APE       T +SD++SFGVVL EI +  + P      ++++              
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------ 244
Query: 548 TAEVFDVELLRYP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
              V D   L  P N  E + +++++   C    P+ RP   ++V ++++
Sbjct: 245 ---VMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/92 (23%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQA 504
           +++ ++K  N+ L+S+ +  ++D G+                   Y APE+   +   ++
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
            D ++FGV+L E+L G++P      DEL   +
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 18/216 (8%)
Query: 330 EVLGKGTFGMAY--KAILEDGTTVVVKRLKDVNVGKRD--FEQQMEIVGSIRHENVVELK 385
           EVLG G F   +  K  L  G    +K +K  +   RD   E ++ ++  I+HEN+V L+
Sbjct: 15  EVLGSGAFSEVFLVKQRL-TGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
             Y S     +V    S G +   +  ERG         T                    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRI-LERGVY-------TEKDASLVIQQVLSAVKYLHE 124
Query: 446 XKLVHGNIKSSNI-FLNSQQYG--CVSDLGLTTI-TSALAPVIARAAGYRAPEVTDSRKA 501
             +VH ++K  N+ +L  ++     ++D GL+ +  + +        GY APEV   +  
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
           ++A D +S GV+   +L G  P +     +L   ++
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 65/297 (21%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA  +  G  V +K+++   +         +++ ++  + H N+V+L 
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              +++++  +V+++ S+     M  S      +PL                        
Sbjct: 72  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-------IKSYLFQLLQGLAFCHS 124
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N++    ++D GL           ARA G              YR
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGL-----------ARAFGVPVRTYXHEVVTLWYR 173
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE+    +  + A D++S G +  E++T ++     G  E+  L R    + R   T +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFR----IFRTLGTPD 227
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPNDSENR 605
                               ++    V  MPD +P  P   R    + V P D + R
Sbjct: 228 --------------------EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 264

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             D++S G +L  +L GK P  T+
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETS 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 19/217 (8%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVK-RLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++      G     K  +      K    ++++ +  +RH  +V L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXK 447
           +   +E +M+Y++ S G +   +  E  +        +                      
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDEAVEYMRQVCKGLCHMHENN 169
Query: 448 LVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAP-----VIARAAGYRAPEVTDSRK 500
            VH ++K  NI   +++   +   D GLT   + L P     V    A + APEV + + 
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
               +D++S GV+   +L+G SP      DE +  V+
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 263

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 65/297 (21%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA  +  G  V +K+++   +         +++ ++  + H N+V+L 
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              +++++  +V+++ S+     M  S      +PL                        
Sbjct: 72  DVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-------IKSYLFQLLQGLAFCHS 124
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N++    ++D GL           ARA G              YR
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGL-----------ARAFGVPVRTYXHEVVTLWYR 173
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE+    +  + A D++S G +  E++T ++     G  E+  L R    + R   T +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFR----IFRTLGTPD 227
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPNDSENR 605
                               ++    V  MPD +P  P   R    + V P D + R
Sbjct: 228 --------------------EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 264

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 65/297 (21%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA  +  G  V +K+++   +         +++ ++  + H N+V+L 
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              +++++  +V+++ S+     M  S      +PL                        
Sbjct: 71  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-------IKSYLFQLLQGLAFCHS 123
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N++    ++D GL           ARA G              YR
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGL-----------ARAFGVPVRTYXHEVVTLWYR 172
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE+    +  + A D++S G +  E++T ++     G  E+  L R    + R   T +
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFR----IFRTLGTPD 226
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPNDSENR 605
                               ++    V  MPD +P  P   R    + V P D + R
Sbjct: 227 --------------------EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 263

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDW 207
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 208 WALGVLIYEMAAGYPPF 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 65/297 (21%)
Query: 330 EVLGKGTFGMAYKAILE-DGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA  +  G  V +K+++   +         +++ ++  + H N+V+L 
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXX 445
              +++++  +V+++ S+     M  S      +PL                        
Sbjct: 70  DVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-------IKSYLFQLLQGLAFCHS 122
Query: 446 XKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG--------------YR 491
            +++H ++K  N+ +N++    ++D GL           ARA G              YR
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGL-----------ARAFGVPVRTYXHEVVTLWYR 171
Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
           APE+    +  + A D++S G +  E++T ++     G  E+  L R    + R   T +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFR----IFRTLGTPD 225
Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPNDSENR 605
                               ++    V  MPD +P  P   R    + V P D + R
Sbjct: 226 --------------------EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 262

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 24/219 (10%)
Query: 330 EVLGKGTFGMAYKAILED----GTTVVVKRL--KDVNVGKRDFEQQMEIVGSIRHENVVE 383
           E LG G F    + +L +    G    VK +  K +   +   E ++ ++  I+HEN+V 
Sbjct: 28  ETLGTGAFS---EVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L+  Y S +   +V    S G +   +  E+G       + T                  
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRI-VEKG-------FYTEKDASTLIRQVLDAVYYL 136
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG---YRAPEVTD 497
               +VH ++K  N+   SQ       +SD GL+ +      V++ A G   Y APEV  
Sbjct: 137 HRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK-GDVMSTACGTPGYVAPEVLA 195
Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV 536
            +  ++A D +S GV+   +L G  P +     +L   +
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQI 234

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 18/201 (8%)
Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE------NVV 382
           +V+GKG FG   KA        V +K +++     R   +++ I+  +R +      NV+
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG-RIPLDWDTXXXXXXXXXXXXXXXX 441
            +   +  ++   M ++  S+ ++  ++   + +G  +PL                    
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPL-------VRKFAHSILQCLD 214
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVS--DLGLTTITSALAPVIARAAGYRAPEVTDSR 499
                +++H ++K  NI L  Q    +   D G +           ++  YRAPEV    
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGA 274
Query: 500 KATQASDVYSFGVVLLEILTG 520
           +     D++S G +L E+LTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 41/285 (14%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 141
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAP 493
                   K VH ++ + N  +       + D G+T              G     + AP
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF 552
           E       T +SD++SFGVVL EI +  + P      ++++                 V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---------------VM 246
Query: 553 DVELLRYP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           D   L  P N  E + +++++   C    P+ RP   ++V ++++
Sbjct: 247 DGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT---ITSALAPVIARAAGYRAPEVTDSRKATQ 503
           +++H ++K  N+FLN      + D GL T           +     Y APEV   +  + 
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 504 ASDVYSFGVVLLEILTGKSPIHTT 527
             D++S G +L  +L GK P  T+
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 332 LGKGTFGMAYKAILE-----DGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVEL 384
           LG+G FG       +      G  V VK LK  + G    D ++++EI+ ++ HEN+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           K            ++ ++   GS+   L   + + +I L                     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINL-----KQQLKYAVQICKGMDY 129
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----------APVIARAAGYR 491
               + VH ++ + N+ + S+    + D GLT                 +PV      + 
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-----WY 184
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT 519
           APE     K   ASDV+SFGV L E+LT
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 215 WALGVLIYEMAAGYPPF 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 215 WALGVLIYEMAAGYPPF 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 16/210 (7%)
Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE 379
           D E+L     E +GKG+FG  +K I      VV  ++ D+   + + E   + +  +   
Sbjct: 20  DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 78
Query: 380 NVVELKAYY--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXX 436
           +   +  YY  Y K  KL ++ +Y   GS   +L +       P D              
Sbjct: 79  DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG------PFD---EFQIATMLKEI 129
Query: 437 XXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAP 493
                     K +H +IK++N+ L+ Q    ++D G+    T T            + AP
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV         +D++S G+  +E+  G+ P
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 216
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 217 WALGVLIYEMAAGYPPF 233

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 22/224 (9%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 141
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAP 493
                   K VH ++ + N  +       + D G+T              G     + AP
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           E       T +SD++SFGVVL EI +  + P      ++++  V
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 208
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 209 WALGVLIYEMAAGYPPF 225

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/200 (21%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE-QQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y A+ +  G  V ++++      K++    ++ ++   ++ N+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 388 YYSKDEKLMVYDYYSLGSVSAML-HSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           Y   DE  +V +Y + GS++ ++  +   EG+I                           
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----------AAVCRECLQALEFLHSN 136
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
           +++H NIKS NI L       ++D G     +      +   G   + APEV   +    
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 504 ASDVYSFGVVLLEILTGKSP 523
             D++S G++ +E++ G+ P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 332 LGKGTFGMAYKAILE-----DGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVEL 384
           LG+G FG       +      G  V VK LK  + G    D ++++EI+ ++ HEN+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 385 KAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXX 442
           K            ++ ++   GS+   L   + + +I L                     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINL-----KQQLKYAVQICKGMDY 141
Query: 443 XXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----------APVIARAAGYR 491
               + VH ++ + N+ + S+    + D GLT                 +PV      + 
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-----WY 196
Query: 492 APEVTDSRKATQASDVYSFGVVLLEILT 519
           APE     K   ASDV+SFGV L E+LT
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVELKAYYY 389
           LG G FG  YKA  ++   +   ++ +    +   D+  ++EI+ +  H  +V+L   YY
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 390 SKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
              +  ++ ++   G+V A ML  +RG         T                     ++
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGL--------TEPQIQVVCRQMLEALNFLHSKRI 130
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVT--DSRKA 501
           +H ++K+ N+ +  +    ++D G++     L  +  R +      + APEV   ++ K 
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 502 T---QASDVYSFGVVLLEILTGKSPIH 525
           T     +D++S G+ L+E+   + P H
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHH 215

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 22/224 (9%)
Query: 332 LGKGTFGMAYKAILED------GTTVVVKRLKD-VNVGKR-DFEQQMEIVGSIRHENVVE 383
           LG+G+FGM Y+    D       T V VK + +  ++ +R +F  +  ++      +VV 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTXXXXXXXXXXXXX 438
           L          L+V +  + G + + L S R E     GR P    T             
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 138
Query: 439 XXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YRAP 493
                   K VH ++ + N  +       + D G+T              G     + AP
Sbjct: 139 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 494 EVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           E       T +SD++SFGVVL EI +  + P      ++++  V
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 28/279 (10%)
Query: 330 EVLGKGTFGM---AYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           EV+G G   +   AY A  ++   +    L+       +  ++++ +    H N+V    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHS--ERGEGRIP-LDWDTXXXXXXXXXXXXXXXXXX 443
            +  KDE  +V    S GSV  ++     +GE +   LD  T                  
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--------LAPVIARAAGYRAPEV 495
                +H ++K+ NI L       ++D G++   +         +         + APEV
Sbjct: 136 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 496 TDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
            +  R     +D++SFG+  +E+ TG +P H     +++ L         E     V D 
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---TGVQDK 249
Query: 555 ELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           E+L +Y     +M+ +      C+ + P++RP   +++R
Sbjct: 250 EMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 282

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/77 (25%), Positives = 37/77 (48%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDV 507
           L++ ++K  N+ ++ Q Y  V+D G           +     Y APE+  S+   +A D 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 508 YSFGVVLLEILTGKSPI 524
           ++ GV++ E+  G  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR--DFEQQMEIVGSIRHENVVELKAYYY 389
           LG G FG  YKA  ++   +   ++ +    +   D+  ++EI+ +  H  +V+L   YY
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 390 SKDEKLMVYDYYSLGSVSA-MLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXXKL 448
              +  ++ ++   G+V A ML  +RG         T                     ++
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGL--------TEPQIQVVCRQMLEALNFLHSKRI 138
Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVT--DSRKA 501
           +H ++K+ N+ +  +    ++D G++     L  +  R +      + APEV   ++ K 
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 502 T---QASDVYSFGVVLLEILTGKSPIH 525
           T     +D++S G+ L+E+   + P H
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHH 223

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 32/212 (15%)
Query: 330 EVLGKGTFGMAYKAILEDGTT---VVVKRL-KDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           +VLG G F     A  ED  T   V +K + K+   GK    E ++ ++  I+H N+V L
Sbjct: 24  DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 385 KAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
              Y S     ++    S G      V    ++ER   R+                    
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF-------------QVLDA 128
Query: 440 XXXXXXXKLVHGNIKSSNIF---LNSQQYGCVSDLGLTTITSALAPVIARAA---GYRAP 493
                   +VH ++K  N+    L+      +SD GL+ +      V++ A    GY AP
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAP 187
Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           EV   +  ++A D +S GV+   +L G  P +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 28/279 (10%)
Query: 330 EVLGKGTFGM---AYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           EV+G G   +   AY A  ++   +    L+       +  ++++ +    H N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHS--ERGEGRIP-LDWDTXXXXXXXXXXXXXXXXXX 443
            +  KDE  +V    S GSV  ++     +GE +   LD  T                  
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--------LAPVIARAAGYRAPEV 495
                +H ++K+ NI L       ++D G++   +         +         + APEV
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 496 TDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
            +  R     +D++SFG+  +E+ TG +P H     +++ L         E     V D 
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---TGVQDK 254
Query: 555 ELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           E+L +Y     +M+ +      C+ + P++RP   +++R
Sbjct: 255 EMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 330 EVLGKGTFG---MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G  G   +A   + E+   V +  +K       + ++++ I   + HENVV+   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
           +    + + +  +Y S G +   +  + G   +P                          
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIG---MP-----EPDAQRFFHQLMAGVVYLHGI 123
Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSRK- 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+   R+ 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  DV+S G+VL  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSRKATQA 504
           ++H ++K +N+FL+ +Q   + D GL  I    ++ A        Y +PE  +     + 
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
           SD++S G +L E+     P       EL   +R
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 39/230 (16%)
Query: 321 LEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIR 377
            ED+ + ++E+LG+G +     A+ L++G    VK ++    +   R F +   +     
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLH-----SERGEGRIPLDWDTXXXXXXX 432
           ++N++EL  ++       +V++    GS+ A +      +ER   R+  D          
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD---------- 119
Query: 433 XXXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYG-----CVSDLG--------LTTITSA 479
                          + H ++K  NI   S +       C  DLG         T IT+ 
Sbjct: 120 ---VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 480 LAPVIARAAGYRAPEVTD--SRKAT---QASDVYSFGVVLLEILTGKSPI 524
                  +A Y APEV +  + +AT   +  D++S GVVL  +L+G  P 
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDSRKATQA 504
           ++H ++K +N+FL+ +Q   + D GL  I    ++ A        Y +PE  +     + 
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 196
Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
           SD++S G +L E+     P       EL   +R
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 53/289 (18%)
Query: 332 LGKGTFGMAYKAILEDGTTVVVKRLKDVN-----VGKRDFEQQMEIVGSIRHENVVELKA 386
           LG G FG  +  ++E+ ++ + + +K +N     V     E ++E++ S+ H N++++  
Sbjct: 30  LGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXXXXX 446
            +       +V +    G +   + S +  G+      +                     
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQ 143
Query: 447 KLVHGNIKSSNI-FLNSQQYGCVS--DLGLTTI--TSALAPVIARAAGYRAPEVTDSRKA 501
            +VH ++K  NI F ++  +  +   D GL  +  +   +   A  A Y APEV   R  
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDV 202
Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
           T   D++S GVV+  +LTG  P   T  +E           V+++ T         + PN
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-----------VQQKAT--------YKEPN 243
Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGN 610
                      A+ C       RP  P  V +++ +   D E RPS+  
Sbjct: 244 ----------YAVEC-------RPLTPQAVDLLKQMLTKDPERRPSAAQ 275

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 35/212 (16%)
Query: 331 VLGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVV 382
           VLGKG+FG   + IL        E    V+ KR       K    ++++++  + H N++
Sbjct: 39  VLGKGSFG---EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 383 ELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTXXXXXXXXXXXX 437
           +L  ++  K    +V + Y+ G      +S    SE    RI                  
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-------------IRQVL 142
Query: 438 XXXXXXXXXKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIAR--AAGYRA 492
                    K+VH ++K  N+ L S+       + D GL+T   A   +  +   A Y A
Sbjct: 143 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
           PEV       +  DV+S GV+L  +L+G  P 
Sbjct: 203 PEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 28/226 (12%)
Query: 330 EVLGKGTFGMA-----YKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVEL 384
           E LG+G+FG       YK   +     + ++L   +      E+++  +  +RH ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSER---GEGRIPLDWDTXXXXXXXXXXXXXXXX 441
                +  + +MV +Y        ++  +R    EGR                       
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGR------------RFFQQIICAIE 122
Query: 442 XXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--LAPVIARAAGYRAPEVTDSR 499
                K+VH ++K  N+ L+      ++D GL+ I +          +  Y APEV + +
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 500 -KATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVV 543
             A    DV+S G+VL  +L G+ P      DE + +L + V+S V
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNSCV 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 18/205 (8%)
Query: 329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVE 383
            + LG GTFG       E  G  V VK L    +   D      ++++ +   RH ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXXXXXX 443
           L     +  +  MV +Y S G +   +      GR+                        
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKN---GRL-----DEKESRRLFQQILSGVDYC 132
Query: 444 XXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSR- 499
               +VH ++K  N+ L++     ++D GL+ + S     +  + G   Y APEV   R 
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRXSCGSPNYAAPEVISGRL 191
Query: 500 KATQASDVYSFGVVLLEILTGKSPI 524
            A    D++S GV+L  +L G  P 
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 323 DLLRASAEVLGKGTFGMAYKAILEDGTTV-------VVKRLKDVNVGKRDFEQQME--IV 373
           +LLR    VLGKG +G  ++     G          V+K+   V   K     + E  I+
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXX 433
             ++H  +V+L   + +  +  ++ +Y S G +   L  ER EG    D           
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--ER-EGIFMED-----TACFYL 127
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------TITSALAPVIAR 486
                         +++ ++K  NI LN Q +  ++D GL        T+T      I  
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE- 186
Query: 487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
              Y APE+       +A D +S G ++ ++LTG  P 
Sbjct: 187 ---YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
           ++H ++K +NI +++     V D G+         ++T   A  +   A Y +PE     
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGD 211
Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SDVYS G VL E+LTG+ P
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 32/212 (15%)
Query: 330 EVLGKGTFGMAYKAILEDGTT---VVVKRL-KDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           +VLG G F     A  ED  T   V +K + K+   GK    E ++ ++  I+H N+V L
Sbjct: 24  DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 385 KAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
              Y S     ++    S G      V    ++ER   R+                    
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF-------------QVLDA 128
Query: 440 XXXXXXXKLVHGNIKSSNIF---LNSQQYGCVSDLGLTTITSALAPVIARAA---GYRAP 493
                   +VH ++K  N+    L+      +SD GL+ +      V++ A    GY AP
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAP 187
Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           EV   +  ++A D +S GV+   +L G  P +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
           ++H ++K +NI +++     V D G+         ++T   A  +   A Y +PE     
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGD 194
Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SDVYS G VL E+LTG+ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 323 DLLRASAEVLGKGTFGMAYKAILEDGTTV-------VVKRLKDVNVGKRDFEQQME--IV 373
           +LLR    VLGKG +G  ++     G          V+K+   V   K     + E  I+
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTXXXXXXXX 433
             ++H  +V+L   + +  +  ++ +Y S G +   L  ER EG    D           
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--ER-EGIFMED-----TACFYL 127
Query: 434 XXXXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------TITSALAPVIAR 486
                         +++ ++K  NI LN Q +  ++D GL        T+T      I  
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE- 186
Query: 487 AAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPI 524
              Y APE+       +A D +S G ++ ++LTG  P 
Sbjct: 187 ---YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
           ++H ++K +NI +++     V D G+         ++T   A  +   A Y +PE     
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGD 194
Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SDVYS G VL E+LTG+ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
           ++H ++K +NI +++     V D G+         ++T   A  +   A Y +PE     
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGD 194
Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SDVYS G VL E+LTG+ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT--------TITSALAPVIARAAGYRAPEVTDSR 499
           ++H ++K +NI +++     V D G+         ++T   A  +   A Y +PE     
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGD 194
Query: 500 KATQASDVYSFGVVLLEILTGKSP 523
                SDVYS G VL E+LTG+ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 74/326 (22%), Positives = 129/326 (39%), Gaps = 80/326 (24%)
Query: 330 EVLGKGTFGMAYKA-ILEDGTTVVVKRLKDVNVGKRDFEQQMEIVG--SIRHENVVEL-- 384
           EV  +G FG  +KA +L +   V +  ++D    K+ ++ + E+     ++HEN+++   
Sbjct: 30  EVKARGRFGCVWKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 385 -KAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDW-------DTXXXXXXXXXX 435
            +    S D  L ++  ++  GS+S  L +        + W       +T          
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHE 139
Query: 436 XXXXXXXXXXXKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------ 489
                       + H +IKS N+ L +    C++D GL     AL     ++AG      
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-----ALKFEAGKSAGDTHGQV 194
Query: 490 ----YRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH 540
               Y APEV +      R A    D+Y+ G+VL E+ +       T  D  V       
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-----RCTAADGPV------- 242
Query: 541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD----------V 590
               +E+    F+ E+ ++P++E+         M  VV    +RP + D          +
Sbjct: 243 ----DEYMLP-FEEEIGQHPSLED---------MQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 591 VRVIENVRPNDSENRPSSGNKSESST 616
              IE    +D+E R S+G   E  T
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERIT 314

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 32/212 (15%)
Query: 330 EVLGKGTFGMAYKAILEDGTT---VVVKRL-KDVNVGKR-DFEQQMEIVGSIRHENVVEL 384
           +VLG G F     A  ED  T   V +K + K+   GK    E ++ ++  I+H N+V L
Sbjct: 24  DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 385 KAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTXXXXXXXXXXXXXX 439
              Y S     ++    S G      V    ++ER   R+                    
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF-------------QVLDA 128
Query: 440 XXXXXXXKLVHGNIKSSNIF---LNSQQYGCVSDLGLTTITSALAPVIARAA---GYRAP 493
                   +VH ++K  N+    L+      +SD GL+ +      V++ A    GY AP
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAP 187
Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           EV   +  ++A D +S GV+   +L G  P +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR----AAGYRAPEVTDSRKATQ 503
           +++ ++K  N+ L+S+ +  ++D G+      +  V  R       Y APE+   +   +
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAYQPYGK 199
Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELV-----HLVRWVHSVVRE 545
           + D +++GV+L E+L G+ P      DEL      H V +  S+ +E
Sbjct: 200 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 246

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	625
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-77
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-70
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-52
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-32
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-51
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-28
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-40
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-31
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-10
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-25
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-20
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-06
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-22
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-14
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-17
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-17
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-05
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-16
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-07
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-14
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-12
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-11
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-11
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-10
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-10
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-10
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-10
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-10
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-09
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-07
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-06
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-06
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-04
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-05
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (637), Expect = 1e-77
 Identities = 105/295 (35%), Positives = 173/295 (58%), Gaps = 25/295 (8%)

Query: 319 FDLEDLLRA-----SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQME 371
           F L +L  A     +  +LG+G FG  YK  L DGT V VKRLK+     G+  F+ ++E
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 372 IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI 431
           ++    H N++ L+ +  +  E+L+VY Y + GSV++ L  ER E + PLDW  R RIA+
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIAL 138

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL--------TTITSALAPV 483
           G+ARG+A +H     K++H ++K++NI L+ +    V D GL        T +T+A+   
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTG--GDELVHLVRWVHS 541
           I    G+ APE   + K+++ +DV+ +GV+LLE++TG+          D+ V L+ WV  
Sbjct: 199 I----GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 542 VVREEWTAEVFDVELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
           +++E+    + DV+L   Y   +EE+ +++Q+A+ C    P +RPKM +VVR++E
Sbjct: 255 LLKEKKLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  229 bits (585), Expect = 4e-70
 Identities = 89/324 (27%), Positives = 145/324 (44%), Gaps = 34/324 (10%)

Query: 292 GMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRA-----SAEVLGKGTFGMAYKAILE 346
           G    K  +   DA +  +     +Y   L DL  A        ++G G FG  YK +L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 347 DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS 405
           DG  V +KR    +  G  +FE ++E +   RH ++V L  +   ++E +++Y Y   G+
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY 465
           +   L+       + + W+ R+ I IGAARG+  +H      ++H ++KS NI L+    
Sbjct: 122 LKRHLY-GSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177

Query: 466 GCVSDLGLTTITSALAP---------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLE 516
             ++D G+    S             V+    GY  PE     + T+ SDVYSFGVVL E
Sbjct: 178 PKITDFGI----SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 517 ILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE-----EEMVEMLQ 571
           +L  +S I  +   E+V+L  W           ++ D      PN+      E + +   
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLRKFGD 287

Query: 572 IAMSCVVRMPDQRPKMPDVVRVIE 595
            A+ C+    + RP M DV+  +E
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  209 bits (534), Expect = 8e-63
 Identities = 89/295 (30%), Positives = 140/295 (47%), Gaps = 33/295 (11%)

Query: 319 FDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-----GKRDFEQQMEIV 373
           FD E  +      +G+G FG+ YK  + + TTV VK+L  +        K+ F+Q+++++
Sbjct: 27  FD-ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
              +HEN+VEL  +    D+  +VY Y   GS+   L    G    PL W  R +IA GA
Sbjct: 85  AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGA 142

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVI 484
           A GI  +H       +H +IKS+NI L+      +SD GL         T +TS     I
Sbjct: 143 ANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR----I 195

Query: 485 ARAAGYRAPE-VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV 543
                Y APE +    + T  SD+YSFGVVLLEI+TG   +      +   L+     + 
Sbjct: 196 VGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIE 251

Query: 544 REEWT-AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            EE T  +  D ++         +  M  +A  C+    ++RP +  V ++++ +
Sbjct: 252 DEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  180 bits (458), Expect = 7e-52
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 10/189 (5%)

Query: 26  EDKEALLDFVNNLPHSRSL-NWNESTSVC-NHWTGVKCSEDGK--RVVAVRLPGVGFSGL 81
           +DK+ALL    +L +  +L +W  +T  C   W GV C  D +  RV  + L G+     
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 82  IP-PNTISRLSALKILSLRS-NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF-SVWK 138
            P P++++ L  L  L +   N + G  P     L  L YLY+   N SG +PDF S  K
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQ-LNLANNN 195
            L  ++ S N  +GT+P S+S+L  L  +    N +SG IPD   +   L   + ++ N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 196 LSGSIPQSL 204
           L+G IP + 
Sbjct: 186 LTGKIPPTF 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  149 bits (379), Expect = 9e-41
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 5/135 (3%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLC-YLYLQFNNFSGTLPDFSV 136
            SG +PP +IS L  L  ++   N I+G  P  + +   L   + +  N  +G +P  + 
Sbjct: 137 LSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP-TF 194

Query: 137 WK-NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANN 194
              NL  ++LS N   G       +    + ++LA NSL+  +  +    NL  L+L NN
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254

Query: 195 NLSGSIPQSLKRFPS 209
            + G++PQ L +   
Sbjct: 255 RIYGTLPQGLTQLKF 269

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  135 bits (343), Expect = 9e-36
 Identities = 47/145 (32%), Positives = 65/145 (44%), Gaps = 9/145 (6%)

Query: 78  FSGLIPPNTISRLSAL-KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FS 135
            SG IP  +    S L   +++  N +TG  P  F NL +L ++ L  N   G     F 
Sbjct: 161 ISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFG 218

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
             KN   I+L+ N     +   +     L  L L NN + G +P     L  L  LN++ 
Sbjct: 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 194 NNLSGSIPQS--LKRFPSSAFVGNS 216
           NNL G IPQ   L+RF  SA+  N 
Sbjct: 278 NNLCGEIPQGGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  126 bits (318), Expect = 2e-32
 Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 3/125 (2%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW 137
            +G IPP T + L+ L  + L  N++ G     F + K+   ++L  N+ +  L    + 
Sbjct: 186 LTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
           KNL  ++L +N   GT+P+ L+ L  L +L ++ N+L G+IP   NL        ANN  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303

Query: 197 SGSIP 201
               P
Sbjct: 304 LCGSP 308

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  179 bits (455), Expect = 2e-51
 Identities = 64/311 (20%), Positives = 112/311 (36%), Gaps = 40/311 (12%)

Query: 319 FDLEDLLRAS-----AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIV 373
              E+L   S      EV  +G FG  +KA L     V VK     +      E ++  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 374 GSIRHENVVELKAY----YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI 429
             ++HEN+++             +  ++  ++  GS+S  L +        + W+    I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126

Query: 430 AIGAARGIARIHAANGGKL-------VHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSA 479
           A   ARG+A +H    G          H +IKS N+ L +    C++D GL        +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 480 LAPVIARA--AGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                 +     Y APEV +      R A    D+Y+ G+VL E+ +  +       + +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 533 VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE------MVEMLQIAMSCVVRMPDQRPK 586
           +     +      E   EV   +  R P + +       M  + +    C     + R  
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 587 MPDVVRVIENV 597
              V   I  +
Sbjct: 306 AGCVGERITQM 316

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  162 bits (413), Expect = 2e-42
 Identities = 49/242 (20%), Positives = 84/242 (34%), Gaps = 63/242 (26%)

Query: 26  EDKEALLDFVNNLPHSRSL-NWNESTSVCNHWTGVKCSEDGKRVVAVR------------ 72
            +   L+ F + LP    L +W+ + + C  + GV C     +V ++             
Sbjct: 12  REIHQLISFKDVLPDKNLLPDWSSNKNPCT-FDGVTC--RDDKVTSIDLSSKPLNVGFSA 68

Query: 73  --------------------------------------LPGVGFSGLIPPN-TISRLSAL 93
                                                 L     SG +    ++   S L
Sbjct: 69  VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128

Query: 94  KILSLRSNVITGYFP-SDFINLKSLCYLYLQFNNFSGTLPD----FSVWKNLTIINLSDN 148
           K L++ SN +      S  + L SL  L L  N+ SG              L  + +S N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188

Query: 149 GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRF 207
             +G +   +S    LE L +++N+ S  IP L +   LQ L+++ N LSG   +++   
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTC 246

Query: 208 PS 209
             
Sbjct: 247 TE 248

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  155 bits (394), Expect = 5e-40
 Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 4/134 (2%)

Query: 73  LPGVGFSGLIPPN--TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT 130
           L     SG              LK L++  N I+G          +L +L +  NNFS  
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215

Query: 131 LPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLN 190
           +P       L  +++S N  +G   R++S  T+L+ L +++N   G IP L L +LQ L+
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 275

Query: 191 LANNNLSGSIPQSL 204
           LA N  +G IP  L
Sbjct: 276 LAENKFTGEIPDFL 289

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  149 bits (379), Expect = 4e-38
 Identities = 50/136 (36%), Positives = 69/136 (50%), Gaps = 4/136 (2%)

Query: 78  FSGLIPPN-TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFS 135
           FSG I PN   +  + L+ L L++N  TG  P    N   L  L+L FN  SGT+P    
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLAN 193
               L  + L  N   G IP+ L  +  LE L L  N L+G+IP    N  NL  ++L+N
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499

Query: 194 NNLSGSIPQSLKRFPS 209
           N L+G IP+ + R  +
Sbjct: 500 NRLTGEIPKWIGRLEN 515

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  148 bits (377), Expect = 8e-38
 Identities = 51/139 (36%), Positives = 75/139 (53%), Gaps = 8/139 (5%)

Query: 77  GFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSV 136
             SG      IS  + LK+L++ SN   G  P     LKSL YL L  N F+G +PDF  
Sbjct: 234 KLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLS 290

Query: 137 --WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNL 191
                LT ++LS N F G +P    + + LE+L L++N+ SG++P    L +  L+ L+L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 192 ANNNLSGSIPQSLKRFPSS 210
           + N  SG +P+SL    +S
Sbjct: 351 SFNEFSGELPESLTNLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  143 bits (363), Expect = 4e-36
 Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 6/144 (4%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
           F G+     ++RLS     ++ S V  G+    F N  S+ +L + +N  SG +P     
Sbjct: 596 FQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANN 194
              L I+NL  N  +G+IP  + +L  L  L L++N L G+IP     L  L +++L+NN
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714

Query: 195 NLSGSIPQS--LKRFPSSAFVGNS 216
           NLSG IP+    + FP + F+ N 
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNP 738

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (357), Expect = 3e-35
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 7/138 (5%)

Query: 78  FSGLIPPNTISRLSA-LKILSLRSNVITGYFPSDFIN--LKSLCYLYLQFNNFSGTLPD- 133
           FSG +P  +++ LSA L  L L SN  +G    +       +L  LYLQ N F+G +P  
Sbjct: 355 FSGELPE-SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

Query: 134 FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNL 191
            S    L  ++LS N  +GTIP SL +L++L  L L  N L G+IP   + +  L+ L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473

Query: 192 ANNNLSGSIPQSLKRFPS 209
             N+L+G IP  L    +
Sbjct: 474 DFNDLTGEIPSGLSNCTN 491

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (344), Expect = 1e-33
 Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 9/139 (6%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTLPD-FS 135
           F G IPP     L +L+ LSL  N  TG  P        +L  L L  N+F G +P  F 
Sbjct: 259 FVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315

Query: 136 VWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPD--LNL-PNLQQLNL 191
               L  + LS N F+G +P  +L  +  L+ L L+ N  SG++P+   NL  +L  L+L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375

Query: 192 ANNNLSGSIPQSLKRFPSS 210
           ++NN SG I  +L + P +
Sbjct: 376 SSNNFSGPILPNLCQNPKN 394

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (323), Expect = 5e-31
 Identities = 42/146 (28%), Positives = 63/146 (43%), Gaps = 7/146 (4%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSV 136
             G IP   +  +  L+ L L  N +TG  PS   N  +L ++ L  N  +G +P     
Sbjct: 454 LEGEIPQ-ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL 196
            +NL I+ LS+N F+G IP  L +   L  L L  N  +G IP   +       +A N +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA-AMFKQSGK-IAANFI 570

Query: 197 SGSIPQSLKRFPSSAFV---GNSISF 219
           +G     +K           GN + F
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEF 596

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (302), Expect = 2e-28
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
            +G IP   +S  + L  +SL +N +TG  P     L++L  L L  N+FSG +P     
Sbjct: 478 LTGEIPS-GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
            ++L  ++L+ N FNGTIP ++   +      +A N ++GK      N    ++ + A N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGN 592

Query: 195 --NLSGSIPQSLKRFPS 209
                G   + L R  +
Sbjct: 593 LLEFQGIRSEQLNRLST 609

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  119 bits (300), Expect = 3e-28
 Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 26/152 (17%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP----- 132
            +G IP   I RL  L IL L +N  +G  P++  + +SL +L L  N F+GT+P     
Sbjct: 502 LTGEIPK-WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 133 ----------------DFSVWKNLTIINLSDNG--FNGTIPRSLSNLTQLEALYLANNSL 174
                                      + + N   F G     L+ L+      + +   
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620

Query: 175 SGKIPDL--NLPNLQQLNLANNNLSGSIPQSL 204
            G       N  ++  L+++ N LSG IP+ +
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (383), Expect = 2e-41
 Identities = 62/306 (20%), Positives = 126/306 (41%), Gaps = 36/306 (11%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE 379
           D +++     EV+G+G FG+  KA       V +K+++  +  ++ F  ++  +  + H 
Sbjct: 6   DYKEIEVE--EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE-RKAFIVELRQLSRVNHP 61

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
           N+V+L       +   +V +Y   GS+  +LH               M   +  ++G+A 
Sbjct: 62  NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG---YRAPEV 495
           +H+     L+H ++K  N+ L +      + D G           +    G   + APEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEV 174

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
            +    ++  DV+S+G++L E++T + P      DE+      +   V            
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNG--------- 220

Query: 556 LLRYP---NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS 612
             R P   N+ + +  ++     C  + P QRP M ++V+++ ++               
Sbjct: 221 -TRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276

Query: 613 ESSTPP 618
           + S PP
Sbjct: 277 QHSLPP 282

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  149 bits (377), Expect = 3e-40
 Identities = 61/323 (18%), Positives = 109/323 (33%), Gaps = 48/323 (14%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEI--VGSIRHENVVEL--- 384
           E++G+G +G  YK  L D   V VK     N  +++F  +  I  V  + H+N+      
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 385 --KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
             +     + E L+V +YY  GS+   L           DW +  R+A    RG+A +H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHT 129

Query: 443 ANGG------KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-------- 488
                      + H ++ S N+ + +     +SD GL+   +    V             
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 489 ---GYRAPEV-------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV-- 536
               Y APEV        D   A +  D+Y+ G++  EI    + +          +   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 537 RWVHSVVREEWTAEVFDVELLR------YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
             V +    E    +   E  R      +      +  + +    C  +  + R      
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309

Query: 591 VRVIENVRPNDSENRPSSGNKSE 613
              +  +      N+  S     
Sbjct: 310 EERMAELMMIWERNKSVSPTAHH 332

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  144 bits (365), Expect = 7e-39
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 28/275 (10%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKA 386
           E +G G+FG  ++A    G+ V VK L + +       +F +++ I+  +RH N+V    
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
                    +V +Y S GS+  +LH  +   R  LD   R+ +A   A+G+  +H     
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKATQ 503
            +VH N+KS N+ ++ +    V D GL+ + ++       AAG   + APEV     + +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            SDVYSFGV+L E+ T + P         ++  + V +V  +            R   I 
Sbjct: 219 KSDVYSFGVILWELATLQQPWGN------LNPAQVVAAVGFKC----------KR-LEIP 261

Query: 564 EEM-VEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
             +  ++  I   C    P +RP    ++ ++  +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (355), Expect = 1e-37
 Identities = 65/300 (21%), Positives = 126/300 (42%), Gaps = 47/300 (15%)

Query: 317 YAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK--------RDFE 367
                 ++     + +GKG FG+ +K   ++D + V +K L   +           ++F+
Sbjct: 14  PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 368 QQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRM 427
           +++ I+ ++ H N+V+L       +   MV ++   G +   L  +      P+ W  ++
Sbjct: 72  REVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKL 125

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAP 482
           R+ +  A GI  +       +VH +++S NIFL S          V+D GL+  +     
Sbjct: 126 RLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV- 183

Query: 483 VIARAAG---YRAPEV--TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
             +   G   + APE    +    T+ +D YSF ++L  ILTG+ P       +    ++
Sbjct: 184 --SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IK 237

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEML-QIAMSCVVRMPDQRPKMPDVVRVIEN 596
           +++ +  E           LR P I E+    L  +   C    P +RP    +V+ +  
Sbjct: 238 FINMIREEG----------LR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  141 bits (358), Expect = 1e-37
 Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 33/293 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAY-- 387
           + +GKG +G  +      G  V VK            E ++     +RHEN++   A   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 388 --YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
               S  +  ++ DY+  GS+   L S        LD  + +++A  +  G+  +H    
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 446 G-----KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------YRAP 493
                  + H ++KS NI +      C++DLGL     +    +            Y  P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 494 EV------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL-VRWVHSVVREE 546
           EV       +  ++   +D+YSFG++L E+             +L +  +        + 
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 547 WTAEVFDVELLRYPN---IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
                       +PN    +E + +M ++   C    P  R     V + +  
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (347), Expect = 1e-36
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 49/297 (16%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLK-----DVNVGKRDFEQQMEIVG 374
           D  +L     E++G G FG  Y+A    G  V VK  +     D++    +  Q+ ++  
Sbjct: 5   DFAELTLE--EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA 434
            ++H N++ L+     +    +V ++   G ++ +L  +R      +  D  +  A+  A
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIA 115

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--------VSDLGL------TTITSAL 480
           RG+  +H      ++H ++KSSNI +  +            ++D GL      TT  SA 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH 540
                    + APEV  +   ++ SDV+S+GV+L E+LTG+ P         +  +   +
Sbjct: 176 GAY-----AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG------IDGLAVAY 224

Query: 541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            V   +          L  P          ++   C    P  RP   +++  +  +
Sbjct: 225 GVAMNK----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  135 bits (341), Expect = 3e-35
 Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 39/296 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKA--- 386
           E +GKG FG  ++     G  V VK            E ++     +RHEN++   A   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 387 -YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
               +  +  +V DY+  GS+   L+         +  +  +++A+  A G+A +H    
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 446 G-----KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-------YRAP 493
           G      + H ++KS NI +      C++DLGL     +    I  A         Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 494 EVTDSR------KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH-LVRWVHSVVREE 546
           EV D        ++ + +D+Y+ G+V  EI    S        +L +  +      V E 
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 547 WTAEVFDVELLRYPNIEEE------MVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
                     LR PNI         +  M +I   C       R     + + +  
Sbjct: 281 RKVVCEQK--LR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (330), Expect = 4e-34
 Identities = 64/297 (21%), Positives = 110/297 (37%), Gaps = 41/297 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E +GKG +G  ++     G  V VK     +      E ++     +RHEN++   A   
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 390 SKDEKLMVY----DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
           +             Y+ +GS+   L          LD  + +RI +  A G+A +H    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 446 G-----KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA----AG---YRAP 493
           G      + H ++KS NI +      C++DLGL  + S     +        G   Y AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 494 EV------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL--VHLVRWVHSVVRE 545
           EV       D   + +  D+++FG+VL E+             +     +V    S   E
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF--E 244

Query: 546 EWTAEVFDVELLRYPNIEEE------MVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           +    V  V+  R PNI         +  + ++   C  + P  R     + + +  
Sbjct: 245 DMRKVVC-VDQQR-PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  128 bits (323), Expect = 2e-33
 Identities = 55/291 (18%), Positives = 109/291 (37%), Gaps = 41/291 (14%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSI 376
           D + L       L +   G  +K     G  +VVK LK  +      RDF ++   +   
Sbjct: 8   DFKQLNFL--TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 377 RHENVVELKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA 434
            H NV+ +     S       ++  +   GS+  +LH         +D    ++ A+  A
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMA 121

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YR 491
           RG+A +H      +    + S ++ ++      +S   +     +             + 
Sbjct: 122 RGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-----RMYAPAWV 175

Query: 492 APEVTDSRKA---TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
           APE    +      +++D++SF V+L E++T + P         +  +     V  E   
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD------LSNMEIGMKVALEG-- 227

Query: 549 AEVFDVELLRYPNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
                   LR P I   +   + ++   C+   P +RPK   +V ++E ++
Sbjct: 228 --------LR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  131 bits (332), Expect = 2e-32
 Identities = 34/137 (24%), Positives = 58/137 (42%), Gaps = 4/137 (2%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FS 135
              +   +    L  L  L +        F   F  L SL  L +  N+F        F+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
             +NLT ++LS        P + ++L+ L+ L +++N+           L +LQ L+ + 
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 194 NNLSGSIPQSLKRFPSS 210
           N++  S  Q L+ FPSS
Sbjct: 528 NHIMTSKKQELQHFPSS 544

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (308), Expect = 2e-29
 Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 4/145 (2%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +   +      L++L L    I       + +L  L  L L  N         FS   +L
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL-SGKIPDL--NLPNLQQLNLANNNLS 197
             +   +          + +L  L+ L +A+N + S K+P+   NL NL+ L+L++N + 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 198 GSIPQSLKRFPSSAFVGNSISFDEN 222
                 L+       +  S+    N
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLN 187

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  120 bits (303), Expect = 7e-29
 Identities = 33/133 (24%), Positives = 53/133 (39%), Gaps = 6/133 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
               +    ++LK L L  N +     S+F+ L+ L +L  Q +N         F   +N
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKI-PDL--NLPNLQQLNLANNNL 196
           L  +++S            + L+ LE L +A NS      PD+   L NL  L+L+   L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 197 SGSIPQSLKRFPS 209
               P +     S
Sbjct: 483 EQLSPTAFNSLSS 495

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  111 bits (280), Expect = 7e-26
 Identities = 24/123 (19%), Positives = 44/123 (35%), Gaps = 5/123 (4%)

Query: 84  PNTISRLSALKILSLRSNVIT--GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
             +   L +L+ L L  N ++  G          SL YL L FN       +F   + L 
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE 399

Query: 142 IINLSDNGFNGTIPRS-LSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
            ++   +        S   +L  L  L +++         +   L +L+ L +A N+   
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 199 SIP 201
           +  
Sbjct: 460 NFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  106 bits (266), Expect = 3e-24
 Identities = 30/130 (23%), Positives = 48/130 (36%), Gaps = 7/130 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +     S LS+L+ L      +         +LK+L  L +  N          FS   N
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEA----LYLANNSLSGKIPD-LNLPNLQQLNLANN 194
           L  ++LS N         L  L Q+      L L+ N ++   P       L +L L NN
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

Query: 195 NLSGSIPQSL 204
             S ++ ++ 
Sbjct: 211 FDSLNVMKTC 220

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  103 bits (258), Expect = 3e-23
 Identities = 27/137 (19%), Positives = 50/137 (36%), Gaps = 6/137 (4%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
           F     P+  + L  L  L L    +    P+ F +L SL  L +  NNF       +  
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNL-TQLEALYLANNSLSGKIPDL----NLPNLQQLNL 191
             +L +++ S N    +  + L +  + L  L L  N  +           + + +QL +
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576

Query: 192 ANNNLSGSIPQSLKRFP 208
               +  + P   +  P
Sbjct: 577 EVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 2e-21
 Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 3/97 (3%)

Query: 116 SLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL 174
           S   L L FN         F  +  L +++LS          +  +L+ L  L L  N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 175 SGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
                     L +LQ+L     NL+      +    +
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 91.6 bits (228), Expect = 1e-19
 Identities = 30/166 (18%), Positives = 50/166 (30%), Gaps = 19/166 (11%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL----CYLYLQFNNFSGTLPD 133
                 P   S L+ L+ L L SN I   + +D   L  +      L L  N  +   P 
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 134 FSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSG-----KIPDLNLPNLQ 187
                 L  + L +N  +  + +  +  L  LE   L            K     L  L 
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 188 QLNLANNNLS------GSIPQSLKRFPS---SAFVGNSISFDENLA 224
            L +    L+        I        +    + V  +I   ++ +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 27/148 (18%), Positives = 41/148 (27%), Gaps = 12/148 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSG----TLPDFSV 136
           I P     +  L  L+LR+N  +       I  L  L    L    F         D S 
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 137 WKNLTIINLSDNGFN------GTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLN 190
            + L  + + +            I    + LT + +  L + ++            Q L 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 191 LANNNLSGSIPQSLKRFPSSAFVGNSIS 218
           L N          LK      F  N   
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGG 338

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 29/133 (21%), Positives = 47/133 (35%), Gaps = 9/133 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYF---PSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
              + +  L  L I   R   +  Y       F  L ++    L        + DFS   
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF 304

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS- 197
               + L +  F       L +L +L      +N       +++LP+L+ L+L+ N LS 
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 198 -GSIPQSLKRFPS 209
            G   QS     S
Sbjct: 362 KGCCSQSDFGTTS 374

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  126 bits (318), Expect = 2e-32
 Identities = 68/324 (20%), Positives = 123/324 (37%), Gaps = 57/324 (17%)

Query: 319 FDLEDLLRASAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSI 376
           F   DL+    EVLGKG FG A K    E G  +V+K L   +   +R F ++++++  +
Sbjct: 7   FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 377 RHENVVELKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
            H NV++     Y KD++L  + +Y   G++  ++ S          W  R+  A   A 
Sbjct: 65  EHPNVLKFIGVLY-KDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIAS 119

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAGYR--- 491
           G+A +H+ N   ++H ++ S N  +        V+D GL  +              +   
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 492 --------------APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
                         APE+ + R   +  DV+SFG+VL EI+   +               
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-------------- 221

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVE-----MLQIAMSCVVRMPDQRPKMPDVVR 592
                   ++     D  L     ++             I + C    P++RP    +  
Sbjct: 222 ------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

Query: 593 VIENVRPNDSENRPSSGNKSESST 616
            +E +R + + + P      +   
Sbjct: 276 WLETLRMHLAGHLPLGPQLEQLDR 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  123 bits (311), Expect = 1e-31
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 39/281 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKR---DFEQQMEIVGSIRHENVVELKA 386
           + +G G+FG  YK        V VK L       +    F+ ++ ++   RH N++    
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 387 YYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
           Y  S   +L +V  +    S+   LH+         +    + IA   ARG+  +HA + 
Sbjct: 88  Y--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKS- 140

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS--ALAPVIARAAG---YRAPEV---TD 497
             ++H ++KS+NIFL+      + D GL T  S  + +    + +G   + APEV    D
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 498 SRKATQASDVYSFGVVLLEILTGKSP-IHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
           S   +  SDVY+FG+VL E++TG+ P  +    D+++ +V                    
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV--------------GRGSLS 244

Query: 557 LRYPNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
                +       M ++   C+ +  D+RP  P ++  IE 
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  122 bits (307), Expect = 6e-31
 Identities = 57/306 (18%), Positives = 121/306 (39%), Gaps = 51/306 (16%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKA 386
           E++GKG FG  Y         V ++ +      +   + F++++      RHENVV    
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
              S     ++       ++ +++   +    I LD +   +IA    +G+  +HA    
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG-- 150

Query: 447 KLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAP-----VIARAAG---YRAPEV-- 495
            ++H ++KS N+F ++ +    ++D GL +I+  L        +    G   + APE+  
Sbjct: 151 -ILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 496 -------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
                   D    ++ SDV++ G +  E+   + P  T   + ++  +            
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG----------- 256

Query: 549 AEVFDVELLRYPNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVVRVIENV-RPNDSENRP 606
                   ++    +  M  E+  I + C     ++RP    ++ ++E + + N   + P
Sbjct: 257 ------TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

Query: 607 SSGNKS 612
               KS
Sbjct: 311 GHFWKS 316

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  122 bits (307), Expect = 2e-29
 Identities = 40/226 (17%), Positives = 80/226 (35%), Gaps = 24/226 (10%)

Query: 19  KVNAEPVEDKEALLDFVNNL----------PHSRSLNWNESTSVCNH--WTGVKCSEDGK 66
              AE ++D  AL +  + L                NWN +  +       GV  + +G 
Sbjct: 23  SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG- 81

Query: 67  RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITG----YFPSDFINLKSLCYLYL 122
           RV  + L G G SG +P   I +L+ L++L+L S+        + P       S      
Sbjct: 82  RVTGLSLEGFGASGRVPDA-IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQK 140

Query: 123 QFNNFSGTLPD---FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
              ++  T  D      + +L    ++ +    +I +S     +   +   +N+++  + 
Sbjct: 141 MRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VS 199

Query: 180 D--LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENL 223
              + L  L+Q  + N+              +S +     + D   
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (278), Expect = 1e-25
 Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 20/144 (13%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITG-------YFPSDFINLKSLCYLYLQFNNFSGT 130
            S   P    S  S L  ++L  N++T            +F N   L  + L+FN  +  
Sbjct: 445 ISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL 503

Query: 131 LPDFSVWK--NLTIINLSDNGFNGTIPRSLSNLTQLEALYL------ANNSLSGKIPDL- 181
             DF       L  I+LS N F+   P    N + L+   +        N    + P+  
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI 562

Query: 182 -NLPNLQQLNLANNNLSGSIPQSL 204
              P+L QL + +N++   + + +
Sbjct: 563 TLCPSLTQLQIGSNDIR-KVNEKI 585

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (276), Expect = 2e-25
 Identities = 24/143 (16%), Positives = 50/143 (34%), Gaps = 7/143 (4%)

Query: 73  LPGVGFSGLIPPNTISRLSALKILSLRSNVI-TGYFPSDFINLKSLCYLYLQFNNFSGTL 131
              +        +       ++I+ +  N + T    +    +K L  L   +N   G L
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL----NLPNLQ 187
           P F     L  +NL+ N              Q+E L  A+N L   IP++    ++  + 
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMS 405

Query: 188 QLNLANNNLSGSIPQSLKRFPSS 210
            ++ + N +     ++      +
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPT 428

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (275), Expect = 3e-25
 Identities = 26/146 (17%), Positives = 44/146 (30%), Gaps = 21/146 (14%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGY-------FPSDFINLKSLCYLYLQFNNFSGT 130
              +        +S +  +    N I                   ++  + L  N  S  
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448

Query: 131 LPD-FSVWKNLTIINLSDNGFNG-------TIPRSLSNLTQLEALYLANNSLSGKIPD-- 180
             + FS    L+ INL  N               +  N   L ++ L  N L+  + D  
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDF 507

Query: 181 --LNLPNLQQLNLANNNLSGSIPQSL 204
               LP L  ++L+ N+ S   P   
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQP 532

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (275), Expect = 3e-25
 Identities = 20/144 (13%), Positives = 47/144 (32%), Gaps = 14/144 (9%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
                   ++ ++  L +L    N + G     F +   L  L L +N  +    +    
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGF 375

Query: 137 WKNLTIINLSDNGFNGTIPRSLS--NLTQLEALYLANNSLSGKIPDL---------NLPN 185
            + +  ++ + N     IP      +++ + A+  + N +                   N
Sbjct: 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434

Query: 186 LQQLNLANNNLSGSIPQSLKRFPS 209
           +  +NL+NN +S    +       
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSP 458

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (272), Expect = 6e-25
 Identities = 27/144 (18%), Positives = 46/144 (31%), Gaps = 13/144 (9%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW 137
             G +P         L  L+L  N IT    +     + +  L    N        F   
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399

Query: 138 K--NLTIINLSDNGFNG-------TIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNL 186
               ++ I+ S N            +  +      + ++ L+NN +S    +L      L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459

Query: 187 QQLNLANNNLSGSIPQSLKRFPSS 210
             +NL  N L+     SLK    +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENEN 483

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  106 bits (266), Expect = 3e-24
 Identities = 31/155 (20%), Positives = 51/155 (32%), Gaps = 22/155 (14%)

Query: 73  LPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG--- 129
           + G  F  L    T  +   +  ++L +N I+ +    F     L  + L  N  +    
Sbjct: 417 VDGKNFDPL--DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474

Query: 130 -----TLPDFSVWKNLTIINLSDNGFNGTIPRSL--SNLTQLEALYLANNSLSGKIPD-- 180
                   +F     LT I+L  N     +      + L  L  + L+ NS S   P   
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532

Query: 181 LNLPNLQQL------NLANNNLSGSIPQSLKRFPS 209
           LN   L+        +   N      P+ +   PS
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  103 bits (259), Expect = 3e-23
 Identities = 24/141 (17%), Positives = 45/141 (31%), Gaps = 19/141 (13%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTL--------P 132
           IP N       ++ LS   N +          ++  +  +   +N              P
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

Query: 133 DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---------NL 183
                 N++ INLS+N  +       S  + L ++ L  N L+    +          N 
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 184 PNLQQLNLANNNLSGSIPQSL 204
             L  ++L  N L+  +    
Sbjct: 488 YLLTSIDLRFNKLT-KLSDDF 507

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (256), Expect = 7e-23
 Identities = 21/150 (14%), Positives = 46/150 (30%), Gaps = 33/150 (22%)

Query: 84  PNTISRLSALKILSLRSNVITGY-------------------FPSDFINLKSLCYLYLQF 124
              + RL+ L+   + ++                            + NLK L  + +  
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258

Query: 125 NNFSGTLPDFSVW--KNLTIINLSDNGF--------NGTIPRSLSNLTQLEALYLANNSL 174
                 LP   +     + +IN++ N          +           +++ +Y+  N+L
Sbjct: 259 CPNLTKLPT-FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317

Query: 175 -SGKIPDL--NLPNLQQLNLANNNLSGSIP 201
            +  +      +  L  L    N L G +P
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (255), Expect = 8e-23
 Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 12/140 (8%)

Query: 73  LPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI--NLKSLCYLYLQFNNFS-- 128
           +P                  L  + LR N +T     DF    L  L  + L +N+FS  
Sbjct: 472 IPKNSLKDE--NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF 528

Query: 129 ----GTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP 184
                       +      +   N      P  ++    L  L + +N +   + +   P
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587

Query: 185 NLQQLNLANNNLSGSIPQSL 204
           N+  L++ +N         +
Sbjct: 588 NISVLDIKDNPNISIDLSYV 607

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 18/117 (15%), Positives = 39/117 (33%), Gaps = 11/117 (9%)

Query: 78  FSGLIPPNTISRLSALKILSLR------SNVITGYFPSDFINLKSLCYLYLQFNNFSGTL 131
           FS    P      S LK   +R       N     +P       SL  L +  N+    +
Sbjct: 525 FSKF--PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KV 581

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQ 188
            +  +  N++++++ DN         +    +     L  +     I   +  ++++
Sbjct: 582 NE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DIRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 6/93 (6%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL------NLPNLQQLNLA 192
            +T ++L   G +G +P ++  LT+LE L L ++                  + +Q    
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 193 NNNLSGSIPQSLKRFPSSAFVGNSISFDENLAP 225
             +   +      R   S  + + I+ D     
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  118 bits (298), Expect = 5e-28
 Identities = 40/145 (27%), Positives = 55/145 (37%), Gaps = 8/145 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +P    +R S L  L +  N I+   P     L  L  L LQ N  S      F+   NL
Sbjct: 40  LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
           T ++L  N               L  L L++N LS         L NLQ+L L+NN +  
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 199 SIPQSLKRFPSSAFV-----GNSIS 218
              + L  F +S+        N I 
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIK 184

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (294), Expect = 2e-27
 Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 8/136 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKN-- 139
           I   +   L  L+ L++  N I G   + F  L +L YL L  +  S        + +  
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

Query: 140 ---LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLAN 193
              L I+NL+ N  +     + S L  LE L L  N +  ++       L N+ ++ L+ 
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 194 NNLSGSIPQSLKRFPS 209
           N        S    PS
Sbjct: 440 NKYLQLTRNSFALVPS 455

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  111 bits (279), Expect = 9e-26
 Identities = 28/137 (20%), Positives = 52/137 (37%), Gaps = 8/137 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKN- 139
           I  N   +   L  L L  N ++       + L++L  L L  N        +  ++ N 
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171

Query: 140 -LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-----LNLPNLQQLNLAN 193
            L  + LS N      P     + +L  L+L N  L   + +     L   +++ L+L+N
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231

Query: 194 NNLSGSIPQSLKRFPSS 210
           + LS +   +      +
Sbjct: 232 SQLSTTSNTTFLGLKWT 248

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (278), Expect = 1e-25
 Identities = 34/138 (24%), Positives = 55/138 (39%), Gaps = 11/138 (7%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFS---------GTLPDF 134
           P+    L  L IL L +N I          L+ L  L LQ NN +         G +   
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532

Query: 135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLA 192
               +L I+NL  NGF+        +L +L+ + L  N+L+     +  N  +L+ LNL 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 193 NNNLSGSIPQSLKRFPSS 210
            N ++    +       +
Sbjct: 593 KNLITSVEKKVFGPAFRN 610

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  109 bits (275), Expect = 3e-25
 Identities = 31/145 (21%), Positives = 49/145 (33%), Gaps = 13/145 (8%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW 137
               +       L  +  + L  N       + F  + SL  L L+           S +
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 138 KN---LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLS--------GKIPDL--NLP 184
           +    LTI++LS+N         L  L +LE L L +N+L+        G        L 
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536

Query: 185 NLQQLNLANNNLSGSIPQSLKRFPS 209
           +L  LNL +N       +  K    
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFE 561

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (270), Expect = 1e-24
 Identities = 28/131 (21%), Positives = 56/131 (42%), Gaps = 6/131 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +P +     + + +L+L  N +     ++F     L  L + FN  S   P+       L
Sbjct: 19  VPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
            ++NL  N  +    ++ +  T L  L+L +NS+     +      NL  L+L++N LS 
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135

Query: 199 SIPQSLKRFPS 209
           +   +  +  +
Sbjct: 136 TKLGTQVQLEN 146

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (269), Expect = 2e-24
 Identities = 32/139 (23%), Positives = 58/139 (41%), Gaps = 6/139 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD-FSVWKN 139
           I  +  S L  L++L L  N I        +  L+++  +YL +N +     + F++  +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 140 LTIINLSDNGFNG--TIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNN 195
           L  + L         + P     L  L  L L+NN+++    D+   L  L+ L+L +NN
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 196 LSGSIPQSLKRFPSSAFVG 214
           L+     +    P     G
Sbjct: 516 LARLWKHANPGGPIYFLKG 534

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (263), Expect = 9e-24
 Identities = 35/142 (24%), Positives = 53/142 (37%), Gaps = 9/142 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDF---INLKSLCYLYLQFNNFSGTLPD-FS-- 135
             P     +  L  L L +  +           +   S+  L L  +  S T    F   
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
            W NLT+++LS N  N     S + L QLE  +L  N++          L N++ LNL  
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 194 NNLSGSIPQ-SLKRFPSSAFVG 214
           +    SI   SL +    +F  
Sbjct: 306 SFTKQSISLASLPKIDDFSFQW 327

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  103 bits (260), Expect = 3e-23
 Identities = 30/132 (22%), Positives = 48/132 (36%), Gaps = 12/132 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVIT--------GYFPSDFINLKSLCYLYLQFNNFSGTLPD 133
           I  + +  L  L+IL L+ N +         G        L  L  L L+ N F     +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554

Query: 134 -FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQL 189
            F     L II+L  N  N       +N   L++L L  N ++     +      NL +L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614

Query: 190 NLANNNLSGSIP 201
           ++  N    +  
Sbjct: 615 DMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.9 bits (247), Expect = 8e-22
 Identities = 23/120 (19%), Positives = 44/120 (36%), Gaps = 6/120 (5%)

Query: 93  LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFN 151
            ++       +T   P D     ++  L L  N        +F+ +  LT +++  N  +
Sbjct: 6   HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 152 GTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
              P     L  L+ L L +N LS           NL +L+L +N++         +  +
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.5 bits (238), Expect = 1e-20
 Identities = 32/151 (21%), Positives = 57/151 (37%), Gaps = 20/151 (13%)

Query: 82  IPPNTIS--RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF----- 134
               T    + + L +L L  N +       F  L  L Y +L++NN             
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 135 -----SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQ 187
                ++ ++ T  ++S          S   L  LE L + +N + G   ++   L NL+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 188 QLNLANNNLSGSIPQSLKRFPSSAFVGNSIS 218
            L+L+N+        SL+   +  FV  + S
Sbjct: 357 YLSLSNSFT------SLRTLTNETFVSLAHS 381

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.8 bits (148), Expect = 9e-10
 Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 5/73 (6%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNL 196
           +  + + S       +P  L   T +  L L +N L             L  L++  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 197 SGSIPQSLKRFPS 209
           S   P+  ++ P 
Sbjct: 62  SKLEPELCQKLPM 74

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  115 bits (289), Expect = 5e-27
 Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 4/136 (2%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FS 135
              +   +    L  L  L +        F   F+ L SL  L +  N+F        F+
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
              NLT ++LS              L +L+ L +++N+L          L +L  L+ + 
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530

Query: 194 NNLSGSIPQSLKRFPS 209
           N +  S         S
Sbjct: 531 NRIETSKGILQHFPKS 546

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  111 bits (280), Expect = 6e-26
 Identities = 32/145 (22%), Positives = 52/145 (35%), Gaps = 4/145 (2%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +   + S  S L+ L L    I       +  L  L  L L  N      P  FS   +L
Sbjct: 47  LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL--NLPNLQQLNLANNNLS 197
             +   +          +  L  L+ L +A+N +   K+P    NL NL  ++L+ N + 
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166

Query: 198 GSIPQSLKRFPSSAFVGNSISFDEN 222
                 L+    +  V  S+    N
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLN 191

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (256), Expect = 5e-23
 Identities = 27/135 (20%), Positives = 44/135 (32%), Gaps = 8/135 (5%)

Query: 82  IPPNTISRL--SALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVW 137
               + S L  ++L+ L L  N       ++F+ L+ L +L  Q +          F   
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
           + L  +++S              LT L  L +A NS           N  NL  L+L+  
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483

Query: 195 NLSGSIPQSLKRFPS 209
            L             
Sbjct: 484 QLEQISWGVFDTLHR 498

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 30/132 (22%), Positives = 49/132 (37%), Gaps = 7/132 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +P + I   S+ K + L  N +       F N   L +L L            +    +L
Sbjct: 26  VPDD-IP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
           + + L+ N      P S S LT LE L      L+         L  L++LN+A+N +  
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

Query: 199 -SIPQSLKRFPS 209
             +P       +
Sbjct: 143 CKLPAYFSNLTN 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 92.4 bits (230), Expect = 9e-20
 Identities = 23/126 (18%), Positives = 46/126 (36%), Gaps = 5/126 (3%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLK--SLCYLYLQFNNFSGTLPDFSVWKNLT 141
                 L +L  L L  N ++      + +L   SL +L L FN       +F   + L 
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQ 402

Query: 142 IINLSDNGFNGTIPRS-LSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
            ++   +        S   +L +L  L ++  +       +   L +L  L +A N+   
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462

Query: 199 SIPQSL 204
           +   ++
Sbjct: 463 NTLSNV 468

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 86.2 bits (214), Expect = 7e-18
 Identities = 25/132 (18%), Positives = 42/132 (31%), Gaps = 6/132 (4%)

Query: 81  LIPPNTISRLSALKI--LSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
           +  P+ +  L  + I    L            F  L ++  + L   +    L D     
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF 307

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG 198
               +++            L  L  L    L  N  S     + LP+L  L+L+ N LS 
Sbjct: 308 KWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGSISFKKVALPSLSYLDLSRNALSF 364

Query: 199 SIPQSLKRFPSS 210
           S   S     ++
Sbjct: 365 SGCCSYSDLGTN 376

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.9 bits (208), Expect = 5e-17
 Identities = 23/122 (18%), Positives = 38/122 (31%), Gaps = 3/122 (2%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
           F      N  +  + L  L L    +       F  L  L  L +  NN        ++ 
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL 196
             +L+ ++ S N    +          L    L NNS++  I +     LQ +      L
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEH-QKFLQWVKEQKQFL 577

Query: 197 SG 198
             
Sbjct: 578 VN 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 5e-17
 Identities = 27/145 (18%), Positives = 44/145 (30%), Gaps = 23/145 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-------------------FINLKSLCYLYL 122
                   L+ +  +SL    I                           ++L  L  L L
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL 335

Query: 123 QFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNL--TQLEALYLANNSLSGKIPD 180
             N  S          +L+ ++LS N  + +   S S+L    L  L L+ N       +
Sbjct: 336 TMNKGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSAN 394

Query: 181 L-NLPNLQQLNLANNNLSGSIPQSL 204
              L  LQ L+  ++ L      S 
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSA 419

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 80.1 bits (198), Expect = 6e-16
 Identities = 24/134 (17%), Positives = 43/134 (32%), Gaps = 12/134 (8%)

Query: 77  GFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFIN---LKSLC-----YLYLQFNNFS 128
             S  I    +  L+ L +  L           +      ++ LC        L + N  
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274

Query: 129 GTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQ 187
                 F    N++ ++L+           +    + ++L +    L    P L+LP L+
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ-FPTLDLPFLK 331

Query: 188 QLNLANNNLSGSIP 201
            L L  N  S S  
Sbjct: 332 SLTLTMNKGSISFK 345

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 27/165 (16%), Positives = 44/165 (26%), Gaps = 18/165 (10%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLC----YLYLQFNNFSGTLPD 133
                 P   S L+ L  + L  N I     +D   L+        L +  N        
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199

Query: 134 FSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSG--KIPDL------NLP 184
                 L  + L  N  +  I +  L NL  L    L          +          L 
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259

Query: 185 NLQ--QLNLANNNLSGSIPQSLKRFPSSA---FVGNSISFDENLA 224
           ++   +  L   N             + +     G SI + E++ 
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP 304

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 23/135 (17%), Positives = 37/135 (27%), Gaps = 11/135 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSG----TLPDFSV 136
           I       +  L  L+LR N  +       + NL  L    L    F       + + S+
Sbjct: 196 IQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 137 WKNLT-----IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNL 191
            + L         L+              L  + A+ LA  S+            Q L++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314

Query: 192 ANNNLSGSIPQSLKR 206
               L       L  
Sbjct: 315 IRCQLKQFPTLDLPF 329

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 13/71 (18%), Positives = 25/71 (35%), Gaps = 5/71 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT--LPDFSVW-- 137
           +  +  ++L +L  L    N I           KSL +  L  N+ +       F  W  
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVK 571

Query: 138 -KNLTIINLSD 147
            +   ++N+  
Sbjct: 572 EQKQFLVNVEQ 582

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (275), Expect = 2e-26
 Identities = 58/317 (18%), Positives = 123/317 (38%), Gaps = 39/317 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
           + +G+G+FG A      EDG   V+K +    +  ++ E   +++ ++ +++H N+V+ +
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +       +V DY   G +   +++++G        D  +   +     +  +H    
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDR-- 144

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKAT 502
            K++H +IKS NIFL       + D G+  + ++   +     G   Y +PE+ +++   
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203

Query: 503 QASDVYSFGVVLLEILTGKSPIHTTGGDELVHL-VRWVHSVVREEWTAEVFDV------- 554
             SD+++ G VL E+ T K          LV   +      V   ++ ++  +       
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263

Query: 555 ---------ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENR 605
                     +L    I + + + L          P    +   +    +         R
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLS---------PQLIAEEFCLKTFSKFGSQPIPAKR 314

Query: 606 PSSGNKSESSTPPPPVA 622
           P+SG  S S  P   + 
Sbjct: 315 PASGQNSISVMPAQKIT 331

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  112 bits (282), Expect = 5e-26
 Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 68/255 (26%)

Query: 21  NAEPVEDKEALLDFVNNL-------------PHSRSLNWNESTSVC--NHWTGVKCSEDG 65
            AE ++D +AL      L                 SLNWN +  +       GV    +G
Sbjct: 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323

Query: 66  KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN 125
            RV  + L G G  G +P   I +L+ LK+LS  ++  T           +      + +
Sbjct: 324 -RVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381

Query: 126 NFSGTLPDFSVW--KNLTIINLSDNGFNG----------------------------TIP 155
                     +   + L + +L  +  N                              I 
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441

Query: 156 RSLSNLTQLEALYLANNSLSGKIPDL---------------------NLPNLQQLNLANN 194
           +++  LT+L+ +Y AN+  +     +                     NL +L  + L N 
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501

Query: 195 NLSGSIPQSLKRFPS 209
                +P  L   P 
Sbjct: 502 PNMTQLPDFLYDLPE 516

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  104 bits (260), Expect = 2e-23
 Identities = 24/135 (17%), Positives = 38/135 (28%), Gaps = 14/135 (10%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG---------TLP 132
               + S L  L  + L +       P    +L  L  L +  N              L 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 133 D-FSVWKNLTIINLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQL 189
           D       + I  +  N         SL  + +L  L   +N +   +        L  L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDL 600

Query: 190 NLANNNLSGSIPQSL 204
            L  N +   IP+  
Sbjct: 601 KLDYNQIE-EIPEDF 614

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  101 bits (253), Expect = 2e-22
 Identities = 23/157 (14%), Positives = 47/157 (29%), Gaps = 17/157 (10%)

Query: 73  LPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTL 131
              +        +       ++I  +  N +  +  S  +  +  L  L    N     L
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL 588

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL----NLPNL 186
             F     LT + L  N     IP    +   Q+E L  ++N L   IP++    ++  +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVM 646

Query: 187 QQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENL 223
             ++ + N +             +           N 
Sbjct: 647 GSVDFSYNKIGS--------EGRNISCSMDDYKGINA 675

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  101 bits (252), Expect = 2e-22
 Identities = 18/143 (12%), Positives = 43/143 (30%), Gaps = 15/143 (10%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FS 135
                   ++ ++  L +L    N +       F     L  L L +N     +P+   +
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCA 616

Query: 136 VWKNLTIINLSDNGFNGTIPR--SLSNLTQLEALYLANNSLSG-------KIPDLNLPNL 186
               +  +  S N     IP   +  ++  + ++  + N +          + D    N 
Sbjct: 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675

Query: 187 QQLNLANNNLSGSIPQSLKRFPS 209
             + L+ N +     +       
Sbjct: 676 STVTLSYNEIQKFPTELFATGSP 698

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 4e-21
 Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 18/133 (13%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTI 142
              I RL+ L+I+   ++  T                   +          +S  K+LT 
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG---------KIPDL--NLPNLQQLNL 191
           + L +      +P  L +L +L++L +A N             ++ D     P +Q   +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 192 ANNNLSGSIPQSL 204
             NNL    P S 
Sbjct: 556 GYNNLE-EFPASA 567

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.1 bits (239), Expect = 9e-21
 Identities = 23/141 (16%), Positives = 49/141 (34%), Gaps = 21/141 (14%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDF--INLKSLCYLYLQFNNFSGTLPDFSV--- 136
           IP +  +    ++ L    N +    P+ F   ++  +  +   +N       + S    
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

Query: 137 ---WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD----------LNL 183
                N + + LS N          +  + +  + L+NN ++  IP+           N 
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727

Query: 184 PNLQQLNLANNNLSGSIPQSL 204
             L  ++L  N L+ S+    
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDF 747

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.1 bits (239), Expect = 9e-21
 Identities = 30/133 (22%), Positives = 45/133 (33%), Gaps = 10/133 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I  ++   L   +I +L +N IT         L  L  +Y   + F+          +  
Sbjct: 417 IKKDSRISLKDTQIGNL-TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV----DWE 470

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG- 198
             N            S SNL  L  + L N     ++PD   +LP LQ LN+A N     
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 199 -SIPQSLKRFPSS 210
             +     R    
Sbjct: 531 AQLKADWTRLADD 543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 94.9 bits (236), Expect = 2e-20
 Identities = 25/147 (17%), Positives = 46/147 (31%), Gaps = 15/147 (10%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSD--FINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
                    L  + LR N +T     D     L  L  + + +N FS + P        L
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQL 778

Query: 141 TIINL------SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANN 194
               +        N      P  ++    L  L + +N +  K+ +   P L  L++A+N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837

Query: 195 NL-SGSIPQSLKRFPSSA--FVGNSIS 218
              S  +        +     + +   
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 93.4 bits (232), Expect = 6e-20
 Identities = 24/150 (16%), Positives = 47/150 (31%), Gaps = 22/150 (14%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD----- 133
             +       +      ++L  N I  +    F     +  + L  N  + ++P+     
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKP 719

Query: 134 ----FSVWKNLTIINLSDNGFNGTIPRSL--SNLTQLEALYLANNSLSGKIPD--LNLPN 185
               +     LT I+L  N    ++      + L  L  + ++ N  S   P   LN   
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777

Query: 186 LQQLNL------ANNNLSGSIPQSLKRFPS 209
           L+   +        N +    P  +   PS
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPS 807

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 19/139 (13%), Positives = 38/139 (27%), Gaps = 12/139 (8%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---FSVWKNL 140
                    L  L L  N I             +  L    N     +P+         +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646

Query: 141 TIINLSDNGFNGTIPR-----SLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
             ++ S N                       + L+ N +     +L      +  + L+N
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706

Query: 194 NNLSGSIPQSLKRFPSSAF 212
           N ++ SIP++  +     +
Sbjct: 707 NLMT-SIPENSLKPKDGNY 724

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 11/74 (14%), Positives = 26/74 (35%), Gaps = 2/74 (2%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNL--QQLNLANNNL 196
            +T ++L+  G  G +P ++  LT+L+ L    +S +          L         + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383

Query: 197 SGSIPQSLKRFPSS 210
                +    +   
Sbjct: 384 RMHYKKMFLDYDQR 397

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (263), Expect = 3e-25
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVVELK 385
             +G+G+F   YK +  E    V    L+D  + K +   F+++ E++  ++H N+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 386 AYYYSKDEK----LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
             + S  +     ++V +  + G++   L   +      +             +G+  +H
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA-LAPVIARAAGYRAPEVTDS 498
                 ++H ++K  NIF+     G V   DLGL T+  A  A  +     + APE+ + 
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 203

Query: 499 RKATQASDVYSFGVVLLEILTGKSP 523
            K  ++ DVY+FG+ +LE+ T + P
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP 228

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  105 bits (264), Expect = 3e-25
 Identities = 57/289 (19%), Positives = 125/289 (43%), Gaps = 34/289 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVEL 384
           + +G+G F   Y+A  L DG  V +K+++  ++     + D  ++++++  + H NV++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
            A +   +E  +V +    G +S M+     + +  +   T  +  +     +  +H+  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG---YRAPEVTDSR 499
             +++H +IK +N+F+ +   G V   DLGL    S+         G   Y +PE     
Sbjct: 156 --RVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
                SD++S G +L E+   +SP +     + ++L      + + +            Y
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCD------------Y 255

Query: 560 PNIEEEMV--EMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRP 606
           P +  +    E+ Q+   C+   P++RP +  V  V + +    + +  
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  107 bits (268), Expect = 2e-24
 Identities = 33/146 (22%), Positives = 51/146 (34%), Gaps = 10/146 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW--KN 139
           I   T SRL  L  L L    I       F +   L  L L  N     + + ++   K 
Sbjct: 48  IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKA 106

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLS 197
           L  +     G +      L N   LE+LYL +N +S            L+ L+  NN + 
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166

Query: 198 GSIPQSLKRFPSSAFV-----GNSIS 218
               + +     +  +     GN I+
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIA 192

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  105 bits (263), Expect = 9e-24
 Identities = 31/157 (19%), Positives = 60/157 (38%), Gaps = 10/157 (6%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---- 133
                  +    L  LK+L+L  +++       F  L +L +L LQ N+F          
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 134 FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNL 191
                 L I+ LS    +     + ++L  +  + L++N L+    +   +L  +  LNL
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530

Query: 192 ANNNLSGSIPQSLKRFPSSAFV---GNSISFDENLAP 225
           A+N++S  +P  L        +    N +    +   
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (252), Expect = 2e-22
 Identities = 34/135 (25%), Positives = 54/135 (40%), Gaps = 7/135 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           +   + S   +L  LS++ N       +    NL++L  L L  ++   +       +NL
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 141 T---IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
           +    +NLS N        +     QLE L LA   L  K       NL  L+ LNL+++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 195 NLSGSIPQSLKRFPS 209
            L  S  Q     P+
Sbjct: 436 LLDISSEQLFDGLPA 450

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.9 bits (247), Expect = 8e-22
 Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 7/135 (5%)

Query: 82  IPPNTISRLSA--LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKN 139
           I P     L    ++ ++L+ +       + F     L  L L   + S           
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLST 302

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  + LS N F      S SN   L  L +  N+   ++      NL NL++L+L+++++
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362

Query: 197 --SGSIPQSLKRFPS 209
             S      L+    
Sbjct: 363 ETSDCCNLQLRNLSH 377

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 95.9 bits (239), Expect = 7e-21
 Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 6/131 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           IP       ++ + L    NV+     + F  L +L +L L          D F     L
Sbjct: 27  IPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG 198
             + L+ N        +LS    L+ L+     +S        N   L+ L L +N++S 
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 199 SIPQSLKRFPS 209
                      
Sbjct: 144 IKLPKGFPTEK 154

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 24/135 (17%), Positives = 45/135 (33%), Gaps = 9/135 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-----FINLKSLCYLYLQFNNFSGTLPDFSV 136
           I P      +  + L+                    +L    +  +   + S  + +   
Sbjct: 194 IEPG-AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
             ++  INL  + F      +    + L+ L L    LS ++P   + L  L++L L+ N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311

Query: 195 NLSGSIPQSLKRFPS 209
                   S   FPS
Sbjct: 312 KFENLCQISASNFPS 326

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 84.3 bits (209), Expect = 3e-17
 Identities = 22/152 (14%), Positives = 41/152 (26%), Gaps = 11/152 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNL 140
           I    +     L+ L L SN I+          + L  L  Q N        D S  +  
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 141 TIINLSDNG-FNGTIPRSLSNLTQLEALYLANNSLSGKIPD----LNLPNLQQLNLANNN 195
           T ++L+ NG     I     +    ++L          I        + +L      + +
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239

Query: 196 LSGSIPQSLKRFPSSAFV-----GNSISFDEN 222
                P   +     +        +      +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISS 271

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 28/139 (20%), Positives = 52/139 (37%), Gaps = 22/139 (15%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           +   N++  L  L+IL L    ++      F +LK + ++ L  N  + +  +       
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG----------------KIPDLN-- 182
             +NL+ N  +  +P  L  L+Q   + L  N L                  K+ D    
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDT 585

Query: 183 ----LPNLQQLNLANNNLS 197
                P L+ + L++  LS
Sbjct: 586 LCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 18/95 (18%), Positives = 27/95 (28%), Gaps = 10/95 (10%)

Query: 120 LYLQFNNFS---GTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG 176
              +    +   GTLP      +   +  S N        + S L  L  L L    +  
Sbjct: 17  YNCENLGLNEIPGTLP-----NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 177 KIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
              D   +   L  L L  N L      +L    +
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  100 bits (251), Expect = 9e-24
 Identities = 50/275 (18%), Positives = 107/275 (38%), Gaps = 31/275 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
             +G G++G   K     DG  +V K L   ++ + + +    ++ ++  ++H N+V   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 386 AYYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
                +      +V +Y   G +++++     E +  LD +  +R+       +   H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRR 130

Query: 444 N--GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDS 498
           +  G  ++H ++K +N+FL+ +Q   + D GL  I +          G   Y +PE  + 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
               + SD++S G +L E+     P       EL   +R                    +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------------EGK 232

Query: 559 YPNIEEEM-VEMLQIAMSCVVRMPDQRPKMPDVVR 592
           +  I      E+ +I    +      RP + +++ 
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  100 bits (250), Expect = 3e-23
 Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 7/128 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
              +       +K L L  N ++    +D      L  L L  N       D      L 
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLR 83

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            ++L++N       + L     +E L+ ANN++S ++        + + LANN ++    
Sbjct: 84  TLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRD 137

Query: 202 QSLKRFPS 209
                   
Sbjct: 138 LDEGCRSR 145

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 24/126 (19%), Positives = 45/126 (35%), Gaps = 6/126 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           +        S ++ L L+ N I     ++   +  +L +L LQ+N     +    V+  L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSG 198
             ++LS N     +     +   +  + L NN L   I        NL+  +L  N    
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

Query: 199 SIPQSL 204
              +  
Sbjct: 252 GTLRDF 257

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 22/127 (17%), Positives = 46/127 (36%), Gaps = 8/127 (6%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTII 143
            +    +++ L   +N I+    S     K++   YL  N  +  L D        +  +
Sbjct: 94  ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKIT-MLRDLDEGCRSRVQYL 149

Query: 144 NLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQ 202
           +L  N  +        ++   LE L L  N +      +    L+ L+L++N L+  +  
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGP 208

Query: 203 SLKRFPS 209
             +    
Sbjct: 209 EFQSAAG 215

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 13/123 (10%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSD 147
            +  KI  +  + +     S   +  ++  L L  N  S  +     + +  L ++NLS 
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSS 67

Query: 148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP----QS 203
           N         L +L+ L  L L NN +  ++     P+++ L+ ANNN+S  +     Q 
Sbjct: 68  NVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNIS-RVSCSRGQG 121

Query: 204 LKR 206
            K 
Sbjct: 122 KKN 124

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 25/118 (21%), Positives = 44/118 (37%), Gaps = 16/118 (13%)

Query: 111 FINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYL 169
             N        +  ++    L        N+  ++LS N  +      L+  T+LE L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 170 ANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQ------------SLKRFPSSAFVG 214
           ++N L  +  DL +L  L+ L+L NN +   +              ++ R   S   G
Sbjct: 66  SSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRGQG 121

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 14/106 (13%), Positives = 29/106 (27%), Gaps = 2/106 (1%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
                  + +  +SLR+N +           ++L +  L+ N F          KN  + 
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQL 189
            ++       +         +  L          +P      L  L
Sbjct: 266 TVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 2/58 (3%)

Query: 154 IPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
           I     N  + +   + ++SL   +  L  +  N+++L+L+ N LS      L  F  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  101 bits (254), Expect = 4e-23
 Identities = 24/128 (18%), Positives = 43/128 (33%), Gaps = 7/128 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
              +       +K L L  N ++    +D      L  L L  N       D      L 
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLR 83

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            ++L++N         L     +E L+ ANN++S ++        + + LANN ++    
Sbjct: 84  TLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRD 137

Query: 202 QSLKRFPS 209
                   
Sbjct: 138 LDEGCRSR 145

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 97.2 bits (242), Expect = 2e-21
 Identities = 24/126 (19%), Positives = 45/126 (35%), Gaps = 6/126 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           +        S ++ L L+ N I     ++   +  +L +L LQ+N     +    V+  L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSG 198
             ++LS N     +     +   +  + L NN L   I        NL+  +L  N    
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

Query: 199 SIPQSL 204
              +  
Sbjct: 252 GTLRDF 257

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 28/122 (22%), Positives = 50/122 (40%), Gaps = 11/122 (9%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDN 148
            +  KI  +  + +     S   +  ++  L L  N  S       + +  L ++NLS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 149 GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP----QSL 204
                    L +L+ L  L L NN +  ++     P+++ L+ ANNN+S  +     Q  
Sbjct: 69  VL--YETLDLESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNIS-RVSCSRGQGK 122

Query: 205 KR 206
           K 
Sbjct: 123 KN 124

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 22/128 (17%), Positives = 46/128 (35%), Gaps = 8/128 (6%)

Query: 85  NTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTI 142
             +    +++ L   +N I+    S     K++   YL  N  +  L D        +  
Sbjct: 93  QELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKIT-MLRDLDEGCRSRVQY 148

Query: 143 INLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
           ++L  N  +        ++   LE L L  N +      +    L+ L+L++N L+  + 
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMG 207

Query: 202 QSLKRFPS 209
              +    
Sbjct: 208 PEFQSAAG 215

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 25/118 (21%), Positives = 43/118 (36%), Gaps = 16/118 (13%)

Query: 111 FINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYL 169
             N        +  ++    L        N+  ++LS N  +      L+  T+LE L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 170 ANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQ------------SLKRFPSSAFVG 214
           ++N L     DL +L  L+ L+L NN +   +              ++ R   S   G
Sbjct: 66  SSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRGQG 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 19/127 (14%), Positives = 41/127 (32%), Gaps = 6/127 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +    +   + LK L L SN +  +   +F +   + ++ L+ N     +       +NL
Sbjct: 184 VKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 141 TIINLSDNGFN-GTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGS 199
              +L  NGF+ GT+    S   +++ +            +         +         
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299

Query: 200 IPQSLKR 206
                 R
Sbjct: 300 PAPFADR 306

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 16/133 (12%), Positives = 34/133 (25%), Gaps = 2/133 (1%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
                  + +  +SLR+N +           ++L +  L+ N F          KN  + 
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQS 203
            ++         ++    T     +         +P      L  L    + L       
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSE 324

Query: 204 LKRFPSSAFVGNS 216
            +R          
Sbjct: 325 TERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 2/58 (3%)

Query: 154 IPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
           I     N  + +   + ++SL   +  L  +  N+++L+L+ N LS      L  F  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 10/123 (8%), Positives = 24/123 (19%), Gaps = 9/123 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFI------NLKSLCYLYLQFNNFSGTLPDFS 135
           +        +   +    +       P+ F         K    L  Q +       +  
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN 193
                  I+     +   I +          L     +L  ++ +       L       
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393

Query: 194 NNL 196
              
Sbjct: 394 VGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 9/141 (6%), Positives = 25/141 (17%), Gaps = 11/141 (7%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LPDFSV 136
           F      +  S+    ++ ++    +      +          +           P    
Sbjct: 249 FHCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 137 WKNLTIINLS----DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQL 189
              L     +           +     N  +   +          + D   L       L
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITL 365

Query: 190 NLANNNLSGSIPQSLKRFPSS 210
                 L   +    +     
Sbjct: 366 EQKKKALDEQVSNGRRAHAEL 386

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (255), Expect = 7e-23
 Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 6/146 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +   +      L++L L    I       + +L  L  L L  N    +L    FS   +
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSS 101

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL-SGKIPDL--NLPNLQQLNLANNNL 196
           L  +   +          + +L  L+ L +A+N + S K+P+   NL NL+ L+L++N +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 197 SGSIPQSLKRFPSSAFVGNSISFDEN 222
                  L+       +  S+    N
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLN 187

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  100 bits (250), Expect = 2e-22
 Identities = 35/158 (22%), Positives = 59/158 (37%), Gaps = 26/158 (16%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW---K 138
               +    ++LK L L  N +     S+F+ L+ L +L  Q +N    + +FSV+   +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 421

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
           NL  +++S            + L+ LE L +A NS            L NL  L+L+   
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 196 LSGSIPQS-----------------LKRFPSSAFVGNS 216
           L   +  +                 LK  P   F   +
Sbjct: 482 LE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 93.2 bits (232), Expect = 5e-20
 Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 6/129 (4%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FS 135
              +   +    L  L  L +        F   F  L SL  L +  N+F        F+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLA 192
             +NLT ++LS        P + ++L+ L+ L +A+N L   +PD     L +LQ++ L 
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLH 526

Query: 193 NNNLSGSIP 201
            N    S P
Sbjct: 527 TNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 28/133 (21%), Positives = 54/133 (40%), Gaps = 9/133 (6%)

Query: 84  PNTISRLSALKILSLRSNVITGYFP-SDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNL 140
            +    L  L+ L  + + +      S F++L++L YL +   +      +  F+   +L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 447

Query: 141 TIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
            ++ ++ N F         + L  L  L L+   L  ++      +L +LQ LN+A+N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506

Query: 197 SGSIPQSLKRFPS 209
                    R  S
Sbjct: 507 KSVPDGIFDRLTS 519

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 29/133 (21%), Positives = 53/133 (39%), Gaps = 9/133 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP N +    + K L L  N +       F +   L  L L       T+ D  +    +
Sbjct: 22  IPDN-LP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNL- 196
           L+ + L+ N        + S L+ L+ L     +L+        +L  L++LN+A+N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 197 SGSIPQSLKRFPS 209
           S  +P+      +
Sbjct: 138 SFKLPEYFSNLTN 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 23/155 (14%)

Query: 72  RLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDF-INLKSLCYLYLQFNNFS-- 128
           RL  + +      +  + L+ +   SL S  I       +    + L  +  +F  F   
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 129 ---------------GTLPDFSVWKNLTIINLSDNGFN--GTIPRSLSNLTQLEALYLAN 171
                          G         +L  ++LS NG +  G   +S    T L+ L L+ 
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 172 NSLSGKIPD--LNLPNLQQLNLANNNLSGSIPQSL 204
           N +   +    L L  L+ L+  ++NL      S+
Sbjct: 383 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 13/138 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGY---FPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
              + +  L  L I   R   +  Y       F  L ++    L        + DFS   
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF 304

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG 198
               + L +  F       L +L +L      +N       +++LP+L+ L+L+ N L  
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEVDLPSLEFLDLSRNGL-- 359

Query: 199 SIPQSLKRFPSSAFVGNS 216
               S K   S +  G +
Sbjct: 360 ----SFKGCCSQSDFGTT 373

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 70.1 bits (172), Expect = 9e-13
 Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 4/103 (3%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
                 + LS+L++L +  N     F  D F  L++L +L L        L    F+   
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 494

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL 181
           +L ++N++ N            LT L+ ++L  N      P +
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 31/157 (19%), Positives = 48/157 (30%), Gaps = 19/157 (12%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL----CYLYLQFNNFSGTLPDFSV 136
              P   S L+ L+ L L SN I   + +D   L  +      L L  N  +   P    
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 137 WKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSG-----KIPDLNLPNLQQLN 190
              L  + L +N  +  + +  +  L  LE   L            K     L  L  L 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 191 LANNNLSG---------SIPQSLKRFPSSAFVGNSIS 218
           +    L+           +   L    S + V  +I 
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 26/148 (17%), Positives = 40/148 (27%), Gaps = 12/148 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSG----TLPDFSV 136
           I P     +  L  L+LR+N  +          L  L    L    F         D S 
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 137 WKNLTIINLSDNGFNG------TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLN 190
            + L  + + +            I    + LT + +  L + ++            Q L 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 191 LANNNLSGSIPQSLKRFPSSAFVGNSIS 218
           L N          LK      F  N   
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGG 338

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 3/70 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---FSVWK 138
           + P   + LS+L++L++ SN +       F  L SL  ++L  N +  + P     S W 
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544

Query: 139 NLTIINLSDN 148
           N        +
Sbjct: 545 NKNSQKEQGS 554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E++G G FG  +KA    DG T V+KR   V       E++++ +  + H N+V     +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCW 73

Query: 389 YSKDEKL----------------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG 432
              D                   +  ++   G++   +   RGE    LD    + +   
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFEQ 130

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG- 489
             +G+  IH+    KL++ ++K SNIFL       V   D GL T          R+ G 
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKN-DGKRTRSKGT 184

Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
             Y +PE   S+   +  D+Y+ G++L E+L     
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 31/218 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVEL 384
           + LG+G F        L DG    +KR   +   ++   ++     ++     H N++ L
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKR---ILCHEQQDREEAQREADMHRLFNHPNILRL 91

Query: 385 KAYYYSKDEK----LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
            AY   +        ++  ++  G++   +     +    L  D  + + +G  RG+  I
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----------- 489
           HA       H ++K +NI L  +    + DLG             +A             
Sbjct: 151 HAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 490 -YRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSP 523
            YRAPE+   +      + +DV+S G VL  ++ G+ P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.7 bits (243), Expect = 3e-22
 Identities = 43/280 (15%), Positives = 94/280 (33%), Gaps = 30/280 (10%)

Query: 330 EVLGKGTFGMAYKAI------LEDGTTVVVKRLKDVNVGKRDFEQQM-EIVGSIRHENVV 382
            +LG+G F   Y+A        ++    V+K  K  N  +     Q+ E +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +  + +  ++  ++V + YS G++   ++  +      +     +  A+     I ++H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYG-----------CVSDLGLTTITSALAPVIARAA--- 488
                ++HG+IK  N  L +                + DLG +             A   
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 489 --GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE 546
             G++  E+  ++      D +     +  +L G        G E      +      + 
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM 307

Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK 586
           W  E F V L          +++L+  +    ++  Q   
Sbjct: 308 WN-EFFHVMLNIPDCHHLPSLDLLRQKLK---KVFQQHYT 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 97.2 bits (243), Expect = 4e-22
 Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 9/124 (7%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
           + + P   +S L  L  L + +N IT    S   NL +L  LYL  +N S  +   +   
Sbjct: 79  TDISP---LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD-ISPLANLT 132

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
            +  +NL  N  N +    LSN+T L  L +  + +   +  + NL +L  L+L  N + 
Sbjct: 133 KMYSLNLGAN-HNLSDLSPLSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIE 190

Query: 198 GSIP 201
              P
Sbjct: 191 DISP 194

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 3/111 (2%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ LS L  L + +N I+    +   +L  L  L +  N  S  +   +    L  + L+
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLN 295

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +N         +  LT L  L+L+ N ++   P  +L  +   + AN  + 
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.8 bits (234), Expect = 6e-21
 Identities = 33/125 (26%), Positives = 59/125 (47%), Gaps = 10/125 (8%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
           + + P   ++ ++ L  L + +N IT    S   NL  L +L +  N  S  +       
Sbjct: 212 TDITP---VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS-DINAVKDLT 265

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNL 196
            L ++N+  N    +    L+NL+QL +L+L NN L  +  ++   L NL  L L+ N++
Sbjct: 266 KLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

Query: 197 SGSIP 201
           +   P
Sbjct: 324 TDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 27/120 (22%), Positives = 50/120 (41%), Gaps = 6/120 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I P  ++ L+ +  L+L +N       S   N+  L YL +  +     +   +   +L 
Sbjct: 125 ISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLY 180

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            ++L+ N      P  L++LT L       N ++   P  N+  L  L + NN ++   P
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 6/116 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           I  L+ L+ L+L  N IT    S   NL  L  LY+  N  +  +       NL  + L+
Sbjct: 62  IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLN 118

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIP 201
           ++  +   P  L+NLT++ +L L  N     +  L N+  L  L +  + +    P
Sbjct: 119 EDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 29/124 (23%), Positives = 53/124 (42%), Gaps = 7/124 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L++L   +   N IT    +   N+  L  L +  N  +  L   +    LT + + 
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIG 251

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLK 205
            N    +   ++ +LT+L+ L + +N +S  I  L NL  L  L L NN L     + + 
Sbjct: 252 TNQI--SDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308

Query: 206 RFPS 209
              +
Sbjct: 309 GLTN 312

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 31/117 (26%), Positives = 51/117 (43%), Gaps = 7/117 (5%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
             + L+      L+   +T         L+S+  L +     + ++       NL  +NL
Sbjct: 17  PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNL 73

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIP 201
           + N      P  LSNL +L  LY+  N ++  I  L NL NL++L L  +N+S   P
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 5/115 (4%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
            + +S ++ L  L++  + +     +   NL  L  L L +N     +   +   +L   
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYF 204

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG 198
               N      P  ++N+T+L +L + NN ++   P  NL  L  L +  N +S 
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 22/105 (20%), Positives = 40/105 (38%), Gaps = 5/105 (4%)

Query: 93  LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNG 152
              L+     I   FP    +L       LQ  + +  +      +++T + ++      
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVA- 57

Query: 153 TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +I   +  LT LE L L  N ++   P  NL  L  L +  N ++
Sbjct: 58  SIQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 16/83 (19%), Positives = 27/83 (32%), Gaps = 5/83 (6%)

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           L       +   PD +         L        +      L  +  L +A   ++  I 
Sbjct: 5   LATLPAPINQIFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ 60

Query: 180 DL-NLPNLQQLNLANNNLSGSIP 201
            +  L NL+ LNL  N ++   P
Sbjct: 61  GIEYLTNLEYLNLNGNQITDISP 83

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 44/221 (19%), Positives = 88/221 (39%), Gaps = 34/221 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI----RHENVVEL 384
           E +G G FG  +K +   DG    +KR K    G  D +  +  V +     +H +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75

Query: 385 KAYY--YSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
             Y+  +++D+ +++  +Y + GS++  + SE               + +   RG+  IH
Sbjct: 76  --YFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA------------- 488
           + +   LVH +IK SNIF++       +         A   V+ +               
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 489 --G---YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSP 523
             G   + A EV  ++      +D+++  + ++     +  
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 54/245 (22%), Positives = 87/245 (35%), Gaps = 36/245 (14%)

Query: 291 RGMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGT 349
           RG + E + S   D S    FF+     F            LG G++G  +K    EDG 
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQS---FQRL-------SRLGHGSYGEVFKVRSKEDGR 83

Query: 350 TVVVKRLKDVNVGKRDFEQQMEIVGSI----RHENVVELKAYYYS--KDEKLMVYDYYSL 403
              VKR      G +D  +++  VGS     +H   V       +  +   L +      
Sbjct: 84  LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---LEQAWEEGGILYLQTELCG 140

Query: 404 GSVSAMLHSERG---EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL 460
            S+     +      E ++                 +A +H+     LVH ++K +NIFL
Sbjct: 141 PSLQQHCEAWGASLPEAQV-------WGYLRDTLLALAHLHSQG---LVHLDVKPANIFL 190

Query: 461 NSQQYGCVSDLGLTTITSALAPVIARA--AGYRAPEVTDSRKATQASDVYSFGVVLLEIL 518
             +    + D GL            +     Y APE+        A+DV+S G+ +LE+ 
Sbjct: 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVA 249

Query: 519 TGKSP 523
                
Sbjct: 250 CNMEL 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
             LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           S++   +V +Y S GS+   L  E G+    L     + +A   A G+A +   N    V
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YV 302

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPEVTDSRK 500
           H +++++NI +       V+D GL         T    A  P+      + APE     +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEAALYGR 357

Query: 501 ATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            T  SDV+SFG++L E+ T G+ P       E++  V   +                 R 
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------------RM 400

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN 604
           P   E    +  +   C  + P++RP    +   +E+   +    
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 22/204 (10%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + LG G FG  + A     T V VK +K  ++    F  +  ++ +++H+ +V+L A   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 252

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           +K+   ++ ++ + GS+   L S+ G           +  +   A G+A I   N    +
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRN---YI 306

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPEVTDSRK 500
           H +++++NI +++     ++D GL         T    A  P+      + APE  +   
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAINFGS 361

Query: 501 ATQASDVYSFGVVLLEILT-GKSP 523
            T  SDV+SFG++L+EI+T G+ P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 4/129 (3%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTI 142
           P +I+ L  LK L +R++ ++        +L  L  L L+        P  F     L  
Sbjct: 199 PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSI 200
           + L D     T+P  +  LTQLE L L       ++P L   LP    + +  +  +   
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 201 PQSLKRFPS 209
                  P+
Sbjct: 318 QHRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 5/135 (3%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSV 136
            +          L  L+ L L    I    P+   NL++L  L ++ +  S  L      
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
              L  ++L         P        L+ L L + S    +P     L  L++L+L   
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287

Query: 195 NLSGSIPQSLKRFPS 209
                +P  + + P+
Sbjct: 288 VNLSRLPSLIAQLPA 302

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 28/133 (21%), Positives = 53/133 (39%), Gaps = 16/133 (12%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTI 142
           P+   RLS L+ +++ +  +    P        L  L L  N     LP   +    L  
Sbjct: 97  PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154

Query: 143 INLSDNGFNGTIPRSLSN---------LTQLEALYLANNSLSGKIPD--LNLPNLQQLNL 191
           +++        +P  L++         L  L++L L    +   +P    NL NL+ L +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213

Query: 192 ANNNLSGSIPQSL 204
            N+ LS ++  ++
Sbjct: 214 RNSPLS-ALGPAI 225

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 22/142 (15%), Positives = 45/142 (31%), Gaps = 9/142 (6%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS--LCYLYLQFNNFSGTLPD-FS 135
           +        +  +  +I +     +         +        L L+        PD   
Sbjct: 44  NRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLAN 193
              +L  + +   G    +P ++     LE L LA N L   +P    +L  L++L++  
Sbjct: 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159

Query: 194 NNLSGSIPQSLKRFPSSAFVGN 215
                 +P+ L    +S     
Sbjct: 160 CPELTELPEPLASTDASGEHQG 181

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 17/142 (11%), Positives = 37/142 (26%), Gaps = 27/142 (19%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFS----------- 135
               S  + L  + +     +       +          + +    + +           
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 136 -----------VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LN 182
                             + L         P     L+ L+ + +    L  ++PD    
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125

Query: 183 LPNLQQLNLANNNLSGSIPQSL 204
              L+ L LA N L  ++P S+
Sbjct: 126 FAGLETLTLARNPLR-ALPASI 146

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 57/303 (18%), Positives = 111/303 (36%), Gaps = 58/303 (19%)

Query: 330 EVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHEN 380
           E LG+GTF   +K +            T V++K L   +      F +   ++  + H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           +V         DE ++V ++   GS+   L   +      ++   ++ +A   A  +  +
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHFL 129

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC--------VSDLGLTTITSALAPVIARAAGYR- 491
                  L+HGN+ + NI L  ++           +SD G+       +  +      + 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKDILQE 179

Query: 492 -----APE-VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR 544
                 PE + + +    A+D +SFG  L EI + G  P+        +           
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE------- 232

Query: 545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN 604
                   D   L  P    +  E+  +  +C+   PD RP    ++R + ++   D   
Sbjct: 233 --------DRHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

Query: 605 RPS 607
           R S
Sbjct: 281 RGS 283

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 95.7 bits (238), Expect = 6e-21
 Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
             LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           S++   +V +Y S GS+   L  E G+    L     + +A   A G+A +   N    V
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YV 385

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPEVTDSRK 500
           H +++++NI +       V+D GL         T    A  P+      + APE     +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEAALYGR 440

Query: 501 ATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            T  SDV+SFG++L E+ T G+ P       E++  V   +                 R 
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------------RM 483

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN 604
           P   E    +  +   C  + P++RP    +   +E+   +    
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 95.2 bits (237), Expect = 7e-21
 Identities = 59/285 (20%), Positives = 112/285 (39%), Gaps = 41/285 (14%)

Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             LG G +G  Y+ + +    TV VK LK+  +   +F ++  ++  I+H N+V+L    
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             +    ++ ++ + G++   L     +    +     + +A   +  +  +   N    
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKN---F 339

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPEVTDSR 499
           +H N+ + N  +       V+D GL         T    A  P+      + APE     
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPESLAYN 394

Query: 500 KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR-EEWTAEVFDVELL 557
           K +  SDV++FGV+L EI T G SP       ++  L+   + + R E    +V+++   
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--- 451

Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
                      M      C    P  RP   ++ +  E +    S
Sbjct: 452 -----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESS 481

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 8e-21
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           +++   ++ +Y   GS+   L +  G     L  +  + +A   A G+A I   N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--APEVTDS 498
           H +++++NI ++      ++D GL         T    A  P+       +  APE  + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-------KWTAPEAINY 184

Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
              T  SDV+SFG++L EI+T G+ P       E++  + 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 26/220 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + LG G FG+      +    V VK +K+ ++ + +F Q+ + +  + H  +V+      
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
            +    +V +Y S G +   L S        L+    + +      G+A + +      +
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESHQ---FI 126

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--APEVTDS 498
           H ++ + N  ++      VSD G+          +      PV       +  APEV   
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV-------KWSAPEVFHY 179

Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
            K +  SDV++FG+++ E+ + GK P       E+V  V 
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + +GKG FG         G  V VK +K+ +   + F  +  ++  +RH N+V+L     
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 390 SKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            +   L  V +Y + GS+   L   R  GR  L  D  ++ ++     +  +   N    
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGL-----TTITSALAPVIARAAGYR--APEVTDSRKA 501
           VH ++ + N+ ++      VSD GL     +T  +   PV       +  APE    +K 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-------KWTAPEALREKKF 191

Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           +  SDV+SFG++L EI + G+ P       ++V  V 
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 29/228 (12%), Positives = 57/228 (25%), Gaps = 37/228 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKR----DFEQQMEIVGSIRHENVVEL 384
           E L  G   + +    +E      +K         R       +       +  E+  E 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 385 KAYY--------------------YSKDEKLMVYDYYSL-----GSVSAMLH--SERGEG 417
           +                           +   V +Y  L       +  +          
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 418 RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT 477
           R          +     R  A + +     LVHG+    N+F+       + D+      
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 478 SALAPVIARAAGYRAPEVTDSRKA--TQASDVYSFGVVLLEILTGKSP 523
               P  +    Y   E  ++  A  T A + +  G+ +  +     P
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 36/133 (27%), Positives = 56/133 (42%), Gaps = 11/133 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I       L  L  L L +N I+   P  F  L  L  LYL  N     LP+  + K L 
Sbjct: 67  IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE-KMPKTLQ 124

Query: 142 IINLSDNGFNGTIPR-SLSNLTQLEALYLANNSL-SGKIPD---LNLPNLQQLNLANNNL 196
            + + +N     + +   + L Q+  + L  N L S  I +     +  L  + +A+ N+
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 197 SGSIPQSLKRFPS 209
           + +IPQ L   PS
Sbjct: 184 T-TIPQGL--PPS 193

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 21/125 (16%), Positives = 42/125 (33%), Gaps = 14/125 (11%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +   ++  L+ L  L L  N I+        N   L  L+L  N     +P   +  K +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 141 TIINLSDNGFNGTIPRS-------LSNLTQLEALYLANNSLS-GKIPD---LNLPNLQQL 189
            ++ L +N  +  I  +        +       + L +N +   +I       +     +
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324

Query: 190 NLANN 194
            L N 
Sbjct: 325 QLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 28/131 (21%), Positives = 54/131 (41%), Gaps = 16/131 (12%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP        +L  L L  N IT    +    L +L  L L FN+ S  + +   +   +
Sbjct: 186 IPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPH 241

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLS--------GKIPDLNLPNLQQLNL 191
           L  ++L++N     +P  L++   ++ +YL NN++S            +    +   ++L
Sbjct: 242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300

Query: 192 ANNNLS-GSIP 201
            +N +    I 
Sbjct: 301 FSNPVQYWEIQ 311

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 34/129 (26%), Positives = 51/129 (39%), Gaps = 10/129 (7%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSV 136
           S  I       +  L  + +    IT   P       SL  L+L  N  +  +       
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKG 214

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
             NL  + LS N  +     SL+N   L  L+L NN L  K+P    +   +Q + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273

Query: 195 NLSGSIPQS 203
           N+S +I  +
Sbjct: 274 NIS-AIGSN 281

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 36/138 (26%), Positives = 55/138 (39%), Gaps = 23/138 (16%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +PP+T        +L L++N IT     DF NLK+L  L L  N  S  +    F+    
Sbjct: 50  LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  + LS N     +P  +     L+ L +  N ++ K+       L  +  + L  N L
Sbjct: 102 LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157

Query: 197 SGSIPQSLKRFPSSAFVG 214
             S         + AF G
Sbjct: 158 KSS------GIENGAFQG 169

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 55/272 (20%), Positives = 110/272 (40%), Gaps = 62/272 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK-RDFEQQMEIVGSIRHENVVELKAY 387
            VLGKGT+G+ Y    L +   + +K + + +    +   +++ +   ++H+N+V+   Y
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---Y 84

Query: 388 Y--YSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +S++  + ++ +    GS+SA+L      G +  +  T          G+  +H   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG---YRAPEV--TD 497
              +VH +IK  N+ +N+   G +  SD G +   + + P      G   Y APE+    
Sbjct: 143 ---IVHRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 498 SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
            R   +A+D++S G  ++E+ TGK P                                  
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP---------------------------------- 224

Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD 589
            +  + E    M ++ M          P++P+
Sbjct: 225 -FYELGEPQAAMFKVGMF------KVHPEIPE 249

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 33/115 (28%), Positives = 52/115 (45%), Gaps = 5/115 (4%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L+ L+ L + SN ++    S    L +L  L    N  S  +    +  NL  ++L+
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLN 229

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            N        +L++LT L  L LANN +S   P   L  L +L L  N +S   P
Sbjct: 230 GN--QLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 93.5 bits (233), Expect = 2e-20
 Identities = 34/118 (28%), Positives = 52/118 (44%), Gaps = 5/118 (4%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
            + +++L+ L+ L   +N I+   P     L +L  L L  N     +   +   NLT +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDL 248

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
           +L++N  +   P  LS LT+L  L L  N +S   P   L  L  L L  N L    P
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 92.7 bits (231), Expect = 4e-20
 Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 5/119 (4%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L+AL  L L  N +     S   NLK+L YL L FNN S  +   S    L  +   
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFY 339

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLK 205
           +N    +   SL+NLT +  L   +N +S   P  NL  + QL L +   + +      
Sbjct: 340 NNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKA 396

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 88.9 bits (221), Expect = 8e-19
 Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 5/116 (4%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           T + L+      L    +T        +L  +  L         ++       NLT IN 
Sbjct: 19  TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINF 75

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
           S+N      P  L NLT+L  + + NN ++   P  NL NL  L L NN ++   P
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 84.6 bits (210), Expect = 2e-17
 Identities = 38/140 (27%), Positives = 56/140 (40%), Gaps = 26/140 (18%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I P  +  L+ L  + + +N I     +   NL +L  L L  N  +  +       NL 
Sbjct: 83  ITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLN 137

Query: 142 IINLSDN-------------------GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL- 181
            + LS N                   G   T  + L+NLT LE L +++N +S  I  L 
Sbjct: 138 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLA 196

Query: 182 NLPNLQQLNLANNNLSGSIP 201
            L NL+ L   NN +S   P
Sbjct: 197 KLTNLESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 22/113 (19%), Positives = 36/113 (31%), Gaps = 7/113 (6%)

Query: 89  RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDN 148
            L +  I       I   F      L       L   N + T+   +    +T +     
Sbjct: 2   PLGSATITQ--DTPINQIFT--DTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRL 56

Query: 149 GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
           G        +  L  L  +  +NN L+   P  NL  L  + + NN ++   P
Sbjct: 57  GI--KSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 25/151 (16%), Positives = 52/151 (34%), Gaps = 29/151 (19%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW 137
            S + P   +S L+ L+ L   +N ++    S   NL ++ +L    N  S  L   +  
Sbjct: 321 ISDISP---VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANL 374

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL- 196
             +T + L+D  +        +N++    +     +L       +  +  + ++  N   
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434

Query: 197 ----------------------SGSIPQSLK 205
                                 SG++ Q LK
Sbjct: 435 YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 46/222 (20%), Positives = 94/222 (42%), Gaps = 28/222 (12%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVV-VKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             LG G +G  Y+ + +  +  V VK LK+  +   +F ++  ++  I+H N+V+L    
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 389 YSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
            +++     + ++ + G++   L     +    +     + +A   +  +  +   N   
Sbjct: 79  -TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKN--- 131

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAGYR--APEVT 496
            +H ++ + N  +       V+D GL+ +           A  P+       +  APE  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-------KWTAPESL 184

Query: 497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
              K +  SDV++FGV+L EI T G SP       ++  L+ 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 24/113 (21%), Positives = 54/113 (47%), Gaps = 4/113 (3%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LPDFSVWKNLTIINL 145
           I     +K L++ +   T Y  +    L +L  L +   + +   +P+ S   +LT++++
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           S +  + +I   ++ L ++ ++ L+ N     I  L  LP L+ LN+  + + 
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 4/114 (3%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LPDFSVWKNLTIINL 145
           IS LS L+ L +    +T     +   L SL  L +  +    + L   +    +  I+L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSG 198
           S NG    I   L  L +L++L +  + +      + + P L QL   +  + G
Sbjct: 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 19/117 (16%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           T +++++L  ++L +  +T    +      ++  L +   + +      S   NL  + +
Sbjct: 39  TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRI 95

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL-NLPNLQQLNLANNNLSGSI 200
                      +LS LT L  L +++++     +  +  LP +  ++L+ N     I
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.7 bits (179), Expect = 7e-15
 Identities = 23/122 (18%), Positives = 46/122 (37%), Gaps = 8/122 (6%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
             A     L  +       +   +L  +    L   N +  L       N+  + +++  
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVT-DLTGIEYAHNIKDLTINNIH 77

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL-NLPNLQQLNLANNNLSGSIPQSLKRF 207
                P  +S L+ LE L +    ++  KIP+L  L +L  L+++++    SI   +   
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 208 PS 209
           P 
Sbjct: 136 PK 137

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 14/95 (14%), Positives = 35/95 (36%), Gaps = 2/95 (2%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
                +S L++L +L +  +       +    L  +  + L +N     +        L 
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELK 162

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG 176
            +N+  +G +      + +  +L  LY  + ++ G
Sbjct: 163 SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 11/69 (15%), Positives = 27/69 (39%), Gaps = 6/69 (8%)

Query: 130 TLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQ 188
            +PD               G + T   + + +  L  + LAN +++  +  +    N++ 
Sbjct: 16  NIPD----STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKD 70

Query: 189 LNLANNNLS 197
           L + N + +
Sbjct: 71  LTINNIHAT 79

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 26/206 (12%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L     
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
            +    ++ +Y + G +   L   R            + +       +  + +      +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQ---FL 142

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--APEVTDS 498
           H ++ + N  +N Q    VSD GL         T+   +  PV       R   PEV   
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-------RWSPPEVLMY 195

Query: 499 RKATQASDVYSFGVVLLEILT-GKSP 523
            K +  SD+++FGV++ EI + GK P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 49/220 (22%), Positives = 99/220 (45%), Gaps = 26/220 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L     
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
            +    +V ++   G +S  L ++RG        +T + + +    G+A +  A    ++
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEAC---VI 126

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--APEVTDS 498
           H ++ + N  +   Q   VSD G+         T+ T    PV       +  +PEV   
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-------KWASPEVFSF 179

Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
            + +  SDV+SFGV++ E+ + GK P       E+V  + 
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 2/117 (1%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           L     +     L  + L  N +       F+ ++ L  LY+  N              L
Sbjct: 238 LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTL 297

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            +++LS N     + R+     +LE LYL +NS+   +       L+ L L++N+  
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 34/129 (26%), Positives = 59/129 (45%), Gaps = 10/129 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P   +     +++L+L    I       F    ++  LY+ FN     LP   F     
Sbjct: 60  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           LT++ L  N  + ++PR +  N  +L  L ++NN+L  +I D       +LQ L L++N 
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176

Query: 196 LSGSIPQSL 204
           L+  +  SL
Sbjct: 177 LT-HVDLSL 184

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 20/136 (14%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I  +T    ++L+ L L SN +T +       + SL +  + +N     L   ++   + 
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----LSTLAIPIAVE 208

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSI 200
            ++ S N  N  +   +    +L  L L +N+L+     L N P L +++L+ N L    
Sbjct: 209 ELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE--- 261

Query: 201 PQSLKRFPSSAFVGNS 216
                +     FV   
Sbjct: 262 -----KIMYHPFVKMQ 272

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 11/100 (11%)

Query: 113 NLKSLCYLY-----LQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL 167
           NL+  C  Y     +Q  +      D ++  N  I+   ++         L +  Q+E L
Sbjct: 16  NLQYDCVFYDVHIDMQTQDVYFGFEDITL-NNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 168 YLANNSLSGKIPD---LNLPNLQQLNLANNNLSGSIPQSL 204
            L +  +  +I          +Q+L +  N +   +P  +
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 112

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + +GKG FG         G  V VK +K+ +   + F  +  ++  +RH N+V+L     
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 390 SKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            +   L  V +Y + GS+   L   R  GR  L  D  ++ ++     +  +   N    
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGL-----TTITSALAPVIARAAGYR--APEVTDSRKA 501
           VH ++ + N+ ++      VSD GL     +T  +   PV       +  APE    +K 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-------KWTAPEALREKKF 363

Query: 502 TQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           +  SDV+SFG++L EI + G+ P       ++V  V 
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 36/126 (28%), Positives = 52/126 (41%), Gaps = 9/126 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P  +      L IL L SNV+     + F  L  L  L L  N    ++    F     
Sbjct: 47  VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGR 106

Query: 140 LTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
           L  ++L   G    +       L  L+ LYL +N+L   +PD    +L NL  L L  N 
Sbjct: 107 LHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164

Query: 196 LSGSIP 201
           +S S+P
Sbjct: 165 IS-SVP 169

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 40/128 (31%), Positives = 53/128 (41%), Gaps = 8/128 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           + P T   L  L  L L    +    P  F  L +L YLYLQ N     LPD  F    N
Sbjct: 96  VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGN 154

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           LT + L  N  +    R+   L  L+ L L  N ++  +      +L  L  L L  NNL
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNL 213

Query: 197 SGSIPQSL 204
           S ++P   
Sbjct: 214 S-ALPTEA 220

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 9/121 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           + P     L+AL+ L L+ N +    P D F +L +L +L+L  N  S ++P+  F    
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLH 177

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
           +L  + L  N      P +  +L +L  LYL  N+LS  +P      L  LQ L L +N 
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236

Query: 196 L 196
            
Sbjct: 237 W 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 16/126 (12%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP  +       + + L  N I+    + F   ++L  L+L  N  +  +    F+    
Sbjct: 30  IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 140 LTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
           L  ++LSDN    ++   +   L +L  L+L    L  ++       L  LQ L L +N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140

Query: 196 LSGSIP 201
           L  ++P
Sbjct: 141 LQ-ALP 145

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 27/129 (20%), Positives = 53/129 (41%), Gaps = 7/129 (5%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           +   +    L  L  L +        F   F  L SL  L +  N+F        F+  +
Sbjct: 116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           NLT ++LS        P + ++L+ L+ L +++N+    +       L +LQ L+ + N+
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234

Query: 196 LSGSIPQSL 204
           +  +  +  
Sbjct: 235 IM-TSKKQE 242

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 17/130 (13%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG---TLPDFSVWK 138
           IP +          L L SN +       F  L  L  L L  N  S             
Sbjct: 26  IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL----NLPNLQQLNLANN 194
           +L  ++LS NG   T+  +   L QLE L   +++L  ++ +     +L NL  L++++ 
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136

Query: 195 NLSGSIPQSL 204
           +        +
Sbjct: 137 HTR-VAFNGI 145

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 9/123 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
                 + LS+L++L +  N     F  D F  L++L +L L        L    F+   
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLP-NLQQLNLANN 194
           +L ++N+S N F          L  L+ L  + N +          + P +L  LNL  N
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

Query: 195 NLS 197
           + +
Sbjct: 259 DFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 17/75 (22%), Positives = 29/75 (38%), Gaps = 5/75 (6%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD----LNLPNLQQLNLANN 194
           + T + L  N            LTQL  L L++N LS K           +L+ L+L+ N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 195 NLSGSIPQSLKRFPS 209
            +  ++  +      
Sbjct: 89  GVI-TMSSNFLGLEQ 102

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.5 bits (230), Expect = 5e-20
 Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +  +  +    L+ L L  N+++   P  F NL +L  L L+ N     +P   F+   N
Sbjct: 47  LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSN 105

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           LT +++S+N     +     +L  L++L + +N L   I       L +L+QL L   NL
Sbjct: 106 LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164

Query: 197 SGSIP 201
           + SIP
Sbjct: 165 T-SIP 168

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 8/128 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I   +  RL  LK+L +           + +   +L  L +   N +  +P         
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  +NLS N  +      L  L +L+ + L    L+  +       L  L+ LN++ N L
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308

Query: 197 SGSIPQSL 204
           + ++ +S+
Sbjct: 309 T-TLEESV 315

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 85.9 bits (213), Expect = 7e-18
 Identities = 33/139 (23%), Positives = 52/139 (37%), Gaps = 13/139 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTL-PDFSVWKNL 140
           IP   +S L  L +L LR   I       F  L  L  L +    +  T+ P+     NL
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLS 197
           T ++++          ++ +L  L  L L+ N +S  I       L  LQ++ L    L+
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285

Query: 198 GSIPQSLKRFPSSAFVGNS 216
                        AF G +
Sbjct: 286 --------VVEPYAFRGLN 296

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 22/138 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP  T       ++L L  N I      +F +   L  L L  N  S  +    F+   N
Sbjct: 30  IPTET-------RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNL 196
           L  + L  N          + L+ L  L ++ N +   + D    +L NL+ L + +N+L
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140

Query: 197 SGSIPQSLKRFPSSAFVG 214
                         AF G
Sbjct: 141 V--------YISHRAFSG 150

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 26/121 (21%), Positives = 43/121 (35%), Gaps = 7/121 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
                      L  LS+    +T        +L  L +L L +N  S T+          
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLR 273

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  I L         P +   L  L  L ++ N L+  + +    ++ NL+ L L +N L
Sbjct: 274 LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

Query: 197 S 197
           +
Sbjct: 333 A 333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 41/231 (17%), Positives = 84/231 (36%), Gaps = 41/231 (17%)

Query: 330 EVLGKGTFGMAYKAILEDG-----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK +           V +K L++       ++   +  ++ S+ + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 383 ELKAYYY---SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            L              ++      G +   +   +      +     +   +  A+G+  
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------- 491
           +       LVH ++ + N+ + + Q+  ++D GL       A ++               
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGL-------AKLLGAEEKEYHAEGGKVP 182

Query: 492 ----APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
               A E    R  T  SDV+S+GV + E++T G  P       E+  ++ 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 46/226 (20%), Positives = 93/226 (41%), Gaps = 33/226 (14%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
             +G+G FG  ++ I          V +K  K+   +  +  F Q+   +    H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L     +++   ++ +  +LG + + L   +      LD  + +  A   +  +A + + 
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLESK 135

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--A 492
                VH +I + N+ ++S     + D GL            +    P+       +  A
Sbjct: 136 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-------KWMA 185

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           PE  + R+ T ASDV+ FGV + EIL  G  P      ++++  + 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 59/286 (20%), Positives = 103/286 (36%), Gaps = 49/286 (17%)

Query: 330 EVLGKGTFGMAYKAILEDGTT-VVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVELKA 386
           E +G+G FG  +   L    T V VK  ++      K  F Q+  I+    H N+V L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
               K    +V +    G     L +E       L   T +++   AA G+  + +    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLESKC-- 233

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIARAAGYR--APE 494
             +H ++ + N  +  +    +SD G++          +      PV       +  APE
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV-------KWTAPE 285

Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
             +  + +  SDV+SFG++L E  + G SP       +    V                 
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------------KG 331

Query: 554 VELLRYPNIEEEMVE-MLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             L       + +   M Q    C    P QRP    + + ++++R
Sbjct: 332 GRLPCPELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIR 373

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 9/135 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I    +   + L++L L+S+ I       F +L SL +L L  N+ S +L    F    +
Sbjct: 41  IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSS 99

Query: 140 LTIINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
           L  +NL  N +  T+  +    NLT L+ L + N     +I       L +L +L +   
Sbjct: 100 LKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158

Query: 195 NLSGSIPQSLKRFPS 209
           +L     QSLK    
Sbjct: 159 SLRNYQSQSLKSIRD 173

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 11/132 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYF---PSDFINLKSLCYLYLQFNNFSGTLPD----F 134
           +P +    L +L+ L L  N++   +    +      SL  L L  N+   ++       
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEIL 383

Query: 135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANN 194
              KNLT +++S N F+  +P S     ++  L L++  +   +       L+ L+++NN
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNN 441

Query: 195 NLSGSIPQSLKR 206
           NL  S    L R
Sbjct: 442 NLD-SFSLFLPR 452

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 87.5 bits (217), Expect = 3e-18
 Identities = 30/148 (20%), Positives = 48/148 (32%), Gaps = 19/148 (12%)

Query: 81  LIPPNTISRLSALKILSLRSNVIT--GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
           L          +L+ L L  N +          + LK+L  L +  N F          +
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPE 410

Query: 139 NLTIINLSDNG---FNGTIPRSL--------------SNLTQLEALYLANNSLSGKIPDL 181
            +  +NLS  G       IP++L                L +L+ LY++ N L       
Sbjct: 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDAS 470

Query: 182 NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
             P L  + ++ N L         R  S
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTS 498

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 83.2 bits (206), Expect = 6e-17
 Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 11/128 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP       +A+K L L  N IT     D     +L  L L+ +  + T+    F    +
Sbjct: 20  IPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD----LNLPNLQQLNLANNN 195
           L  ++LSDN  +         L+ L+ L L  N     +       NL NLQ L + N  
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVE 134

Query: 196 LSGSIPQS 203
               I + 
Sbjct: 135 TFSEIRRI 142

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 18/132 (13%), Positives = 45/132 (34%), Gaps = 7/132 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +        +   +     +          +   ++  L++        L   +S+ + +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-----NLPNLQQLNLANNN 195
             I + ++           +L  LE L L+ N +  +           P+LQ L L+ N+
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372

Query: 196 LSGSIPQSLKRF 207
           L  S+ ++ +  
Sbjct: 373 LR-SMQKTGEIL 383

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 22/136 (16%), Positives = 44/136 (32%), Gaps = 27/136 (19%)

Query: 83  PPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTI 142
               +  L  L  L +  N      P      + + +L L        +    + + L +
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT-CIPQTLEV 435

Query: 143 INLSDNGFNGTIPRSLSNLT-------------------QLEALYLANNSLSGKIPD--- 180
           +++S+N  + +    L  L                     L  + ++ N L   +PD   
Sbjct: 436 LDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK-SVPDGIF 493

Query: 181 LNLPNLQQLNLANNNL 196
             L +LQ++ L  N  
Sbjct: 494 DRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 22/153 (14%), Positives = 50/153 (32%), Gaps = 9/153 (5%)

Query: 78  FSGLIPPNTISRLSALKILSL-RSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--F 134
           +  L   +    L+ L+ L +      +     DF  L SL  L ++  +          
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSL 168

Query: 135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL-----SGKIPDLNLPNLQQL 189
              +++  + L  +     +      L+ +  L L + +L     S    D     +++L
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228

Query: 190 NLANNNLSGSIPQSLKRFPSSAFVGNSISFDEN 222
               + L+      L +        + + FD+ 
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 20/144 (13%), Positives = 46/144 (31%), Gaps = 22/144 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQ-----------FNNFSGT 130
           +       LS+++ L LR   +  +  S     +    +              FN     
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 131 LPDFSVWKNLTIINLSDNG---FNGTIPRSLSNLTQLEALYLANNSLSG----KIPD--- 180
           L        +   + + NG   FN +    +S L ++E + +    +             
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306

Query: 181 LNLPNLQQLNLANNNLSGSIPQSL 204
             L  ++++ + N+ +   +P S 
Sbjct: 307 SLLEKVKRITVENSKVF-LVPCSF 329

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 19/92 (20%), Positives = 42/92 (45%), Gaps = 7/92 (7%)

Query: 116 SLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLS 175
           +      +  +F+ ++P   +   +  ++LS N         L     L+ L L ++ ++
Sbjct: 6   ASGVCDGRSRSFT-SIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63

Query: 176 GKIPD---LNLPNLQQLNLANNNLSGSIPQSL 204
             I      +L +L+ L+L++N+LS S+  S 
Sbjct: 64  -TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 5/70 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---FSVWK 138
           +P  ++     L ++ +  N +       F  L SL  ++L  N +  + P     S W 
Sbjct: 466 LPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 523

Query: 139 NLTIINLSDN 148
           N        +
Sbjct: 524 NKNSQKEQGS 533

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 91.5 bits (227), Expect = 2e-19
 Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 2/117 (1%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           L     +     L  + L  N +       F+ ++ L  LY+  N              L
Sbjct: 244 LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTL 303

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            +++LS N     + R+     +LE LYL +NS+   +       L+ L L++N+  
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 85.0 bits (210), Expect = 2e-17
 Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 4/118 (3%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I     +    ++ L +  N I    P  F N+  L  L L+ N+ S +LP   F     
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 148

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           LT +++S+N        +    T L+ L L++N L+  +    +P+L   N++ N LS
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 84.2 bits (208), Expect = 3e-17
 Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 8/116 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           +P         L  LS+ +N +       F    SL  L L  N  +  +   S+  +L 
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-LSLIPSLF 195

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
             N+S N  +     +L+    +E L  ++NS++  +       L  L L +NNL+
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT 245

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 81.5 bits (201), Expect = 2e-16
 Identities = 26/143 (18%), Positives = 49/143 (34%), Gaps = 15/143 (10%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSV 136
             +        L+  KI++ +++ +     +   + + +  L L        +    F+ 
Sbjct: 39  QDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAY 97

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLAN 193
              +  + +  N      P    N+  L  L L  N LS  +P     N P L  L+++N
Sbjct: 98  AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 156

Query: 194 NNLSGSIPQSLKRFPSSAFVGNS 216
           NNL         R     F   +
Sbjct: 157 NNLE--------RIEDDTFQATT 171

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.4 bits (180), Expect = 7e-14
 Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 15/138 (10%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLT 141
            + +        + +       YF  + I L +   +  + +     LP      ++ + 
Sbjct: 20  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSG 198
           ++NL+D         + +    ++ LY+  N++   +P     N+P L  L L  N+LS 
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 199 SIPQSLKRFPSSAFVGNS 216
                    P   F    
Sbjct: 137 -------SLPRGIFHNTP 147

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 62/318 (19%), Positives = 108/318 (33%), Gaps = 66/318 (20%)

Query: 330 EVLGKGTFGMAYKAILEDG-----TTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVV 382
           +VLG G FG  +K +           V +K ++D +     +     M  +GS+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 383 ELKAYYY---SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            L              +V  Y  LGS+   +   RG     L     +   +  A+G+  
Sbjct: 79  RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYY 130

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR-------- 491
           +       +VH N+ + N+ L S     V+D G+       A ++               
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGV-------ADLLPPDDKQLLYSEAKTP 180

Query: 492 ----APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR-- 544
               A E     K T  SDV+S+GV + E++T G  P       E+  L+       R  
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLA 237

Query: 545 --EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
             +  T +V+ V              M++    C +   + RP   ++      +  +  
Sbjct: 238 QPQICTIDVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDPP 279

Query: 603 ENRPSSGNKSESSTPPPP 620
                         P P 
Sbjct: 280 RYLVIKRESGPGIAPGPE 297

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 68/318 (21%), Positives = 114/318 (35%), Gaps = 57/318 (17%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
             LG+G+FGM Y+ +       E  T V +K + +      + +F  +  ++      +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-----GRIPLDWDTRMRIAIGAARG 436
           V L          L++ +  + G + + L S R          P      +++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIAR 486
           +A ++A    K VH ++ + N  +       + D G+T               L PV   
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV--- 204

Query: 487 AAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
               R  +PE       T  SDV+SFGVVL EI T  + P      ++++  V       
Sbjct: 205 ----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-- 258

Query: 544 REEWTAEVFDVELLRYPNIEEEMVE-MLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
                       L +  N  + + E M      C    P  RP   +++  I+       
Sbjct: 259 ------------LDKPDNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKEEMEPGF 302

Query: 603 ENRPSSGNKSESSTPPPP 620
                S   SE +  P P
Sbjct: 303 RE--VSFYYSEENKLPEP 318

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 59/317 (18%), Positives = 99/317 (31%), Gaps = 56/317 (17%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
             LG G FG  Y+  +           V VK L +V     + DF  +  I+    H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR--MRIAIGAARGIAR 439
           V           + ++ +  + G + + L   R     P        + +A   A G   
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYG---CVSDLGLT----------TITSALAPVIAR 486
           +   N    +H +I + N  L     G    + D G+               A+ PV   
Sbjct: 197 L-EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV--- 250

Query: 487 AAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
               +   PE       T  +D +SFGV+L EI + G  P  +    E++  V       
Sbjct: 251 ----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 303

Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE 603
                         R    +     + +I   C    P+ RP    ++  IE    +   
Sbjct: 304 --------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349

Query: 604 NRPSSGNKSESSTPPPP 620
              +         P   
Sbjct: 350 INTAL---PIEYGPLVE 363

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 88.2 bits (219), Expect = 5e-19
 Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 37/303 (12%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L    +   +V +K LK       +RDF  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L+         ++V +Y   GS+ + L     +          + +  G A G+  +   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSDM 166

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPEVTD 497
                VH ++ + NI +NS     VSD GL   +            G     + +PE   
Sbjct: 167 G---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            RK T ASDV+S+G+VL E+++ G+ P       +++  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESST 616
            R P   +    + Q+ + C  +  + RPK   +V +++ +  N    +  +   +  S 
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSN 326

Query: 617 PPP 619
              
Sbjct: 327 LLL 329

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 5e-19
 Identities = 33/153 (21%), Positives = 60/153 (39%), Gaps = 23/153 (15%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD----FSV 136
           ++     S++S    L   +N++T     +  +L  L  L LQ N     L       + 
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372

Query: 137 WKNLTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNN 195
            K+L  +++S N  +    +   S    L +L +++N L+  I     P ++ L+L +N 
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432

Query: 196 LSGSIPQS----------------LKRFPSSAF 212
           +  SIP+                 LK  P   F
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.1 bits (200), Expect = 3e-16
 Identities = 36/154 (23%), Positives = 56/154 (36%), Gaps = 7/154 (4%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           +  + I  LS L+IL +  N I     S F   + L YL L  N     +       NL 
Sbjct: 36  LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS-CHPTVNLK 93

Query: 142 IINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGS 199
            ++LS N F+  +P      N++QL+ L L+   L  K   L + +L    +        
Sbjct: 94  HLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLLVLGETY 151

Query: 200 I-PQSLKRFPSSAFVGNSISFDENLAPRASPDVA 232
              +  +           I F  N       DV+
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 76.4 bits (188), Expect = 9e-15
 Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 7/112 (6%)

Query: 89  RLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD 147
           ++ +L+ L +  N ++           KSL  L +  N  + T+    +   + +++L  
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLHS 430

Query: 148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           N    +IP+ +  L  L+ L +A+N L   +PD     L +LQ++ L  N  
Sbjct: 431 NKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 22/132 (16%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +   T        IL++  N I+  + SD ++L  L  L +  N     L    F   + 
Sbjct: 19  LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70

Query: 140 LTIINLSDNGFNGTIPRSLS--NLTQLEALYLANNSLSGKIPDL----NLPNLQQLNLAN 193
           L  ++LS N         +S      L+ L L+ N+    +P      N+  L+ L L+ 
Sbjct: 71  LEYLDLSHNKL-----VKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLST 124

Query: 194 NNLSGSIPQSLK 205
            +L  S    + 
Sbjct: 125 THLEKSSVLPIA 136

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 25/134 (18%), Positives = 53/134 (39%), Gaps = 7/134 (5%)

Query: 83  PPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LPDFSVWKNLT 141
              + + L AL I  + S+V        +    ++       +      +   S      
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-----NLPNLQQLNLANNNL 196
            ++ S+N    T+  +  +LT+LE L L  N L  ++  +      + +LQQL+++ N++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386

Query: 197 SGSIPQSLKRFPSS 210
           S    +    +  S
Sbjct: 387 SYDEKKGDCSWTKS 400

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 22/140 (15%), Positives = 41/140 (29%), Gaps = 7/140 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---FSVWK 138
           +  +       L+ L L  N +            +L +L L FN F   LP    F    
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMS 115

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG 198
            L  + LS      +    +++L   + L +   +   K     L +    +L     + 
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175

Query: 199 SIPQSLKRFPSSAFVGNSIS 218
                +            +S
Sbjct: 176 KEFHFILDVSVKTVANLELS 195

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 36/230 (15%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L D         VK L  +        F  +  I+    H NV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 384 LKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           L       +   + V  Y   G +   + +E             +   +  A+G+  + +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLAS 146

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV       
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV------- 196

Query: 491 R--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           +  A E   ++K T  SDV+SFGV+L E++T G  P       ++   + 
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 62/323 (19%), Positives = 102/323 (31%), Gaps = 60/323 (18%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENV 381
             LG G FG  Y+  +           V VK L +V     + DF  +  I+    H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIP--LDWDTRMRIAIGAARGIAR 439
           V           + ++ +  + G + + L   R     P  L     + +A   A G   
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYG---CVSDLGLT----------TITSALAPVIAR 486
           +   N    +H +I + N  L     G    + D G+               A+ PV   
Sbjct: 156 L-EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV--- 209

Query: 487 AAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
               +   PE       T  +D +SFGV+L EI + G  P  +    E++  V       
Sbjct: 210 ----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 259

Query: 544 REEWTAEVFDVELLRYP-NIEEEMVE-MLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
                        +  P N    +   M Q    C    P+ RP    ++  IE    + 
Sbjct: 260 ---------SGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDP 306

Query: 602 SENRPSSGNKSESSTPPPPVAGE 624
                +         P      +
Sbjct: 307 DVINTAL---PIEYGPLVEEEEK 326

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 88.7 bits (220), Expect = 6e-19
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 7/127 (5%)

Query: 82  IPPNTISRLSALKILSL-RSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           IP    +R+ +L+ L L     ++      F  L +L YL L   N    +P+ +    L
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKL 209

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLS 197
             ++LS N  +   P S   L  L+ L++  + +   I      NL +L ++NLA+NNL+
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268

Query: 198 GSIPQSL 204
             +P  L
Sbjct: 269 -LLPHDL 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 14/137 (10%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I     + L+ L  L L  N +T      F+ L  L  L+L+ N    ++P   F+   +
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS 161

Query: 140 LTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           L  ++L +      I   +   L+ L  L LA  +L  +IP+L  L  L +L+L+ N+LS
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS 220

Query: 198 GSIPQSLKRFPSSAFVG 214
                        +F G
Sbjct: 221 --------AIRPGSFQG 229

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 36/138 (26%), Positives = 57/138 (41%), Gaps = 21/138 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I  NT       ++L+L  N I     + F +L+ L  L L  N+   T+    F+   N
Sbjct: 62  ISTNT-------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  + L DN        +   L++L+ L+L NN +   IP      +P+L++L+L     
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171

Query: 197 SGSIPQSLKRFPSSAFVG 214
                  L      AF G
Sbjct: 172 ------RLSYISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 7/119 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I       LS L+ L+L    +      +   L  L  L L  N+ S  +    F    +
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMH 232

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNL 196
           L  + +  +        +  NL  L  + LA+N+L+    DL   L +L++++L +N  
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 31/129 (24%), Positives = 47/129 (36%), Gaps = 8/129 (6%)

Query: 76  VGFSGLIPPNTISRLSALKILSLRSN---VITGYFPSDFINLKSLCYLYLQFNNFSGTLP 132
           +G  GLI      +   L++L+LR+      +G   +       L  L L  N+      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 133 D--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLN 190
                    L  +NLS  G    +P+ L    +L  L L+ N L        LP +  L+
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDELPQVGNLS 302

Query: 191 LANNNLSGS 199
           L  N    S
Sbjct: 303 LKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 33/162 (20%), Positives = 59/162 (36%), Gaps = 15/162 (9%)

Query: 64  DGKRVVAVRLPGVGFSGLIPPNTIS-RLSALKILSLRSNVITG--YFPSDFINL--KSLC 118
               +  + L  +  +G  PP  +      L IL+LR+        + ++        L 
Sbjct: 93  GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152

Query: 119 YLYLQFNNFSG-TLPDFSVWKNLTIINLSDNGFNGTIPRSLS----NLTQLEALYLANN- 172
            L +   +    +     V+  L+ ++LSDN   G      +        L+ L L N  
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212

Query: 173 --SLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS 210
             + SG    L      LQ L+L++N+L  +       +PS 
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 30/155 (19%), Positives = 48/155 (30%), Gaps = 19/155 (12%)

Query: 71  VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT 130
            R+P     G +    IS L  L   +L +  +TG  P   +         L   N S  
Sbjct: 78  ARIPSRILFGALRVLGISGLQEL---TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

Query: 131 -----LPDFSVW--KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLN- 182
                L +   W    L +++++           +     L  L L++N   G+   ++ 
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 183 -----LPNLQQLNLANNN---LSGSIPQSLKRFPS 209
                 P LQ L L N      SG           
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.5 bits (222), Expect = 8e-19
 Identities = 46/224 (20%), Positives = 93/224 (41%), Gaps = 29/224 (12%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
             +G+G FG  ++ I          V +K  K+   +  +  F Q+   +    H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L     +++   ++ +  +LG + + L   +      LD  + +  A   +  +A + + 
Sbjct: 456 LIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLESK 510

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPE 494
                VH +I + N+ ++S     + D GL            +    P+      + APE
Sbjct: 511 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-----KWMAPE 562

Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
             + R+ T ASDV+ FGV + EIL  G  P      ++++  + 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 38/308 (12%)

Query: 330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           +V+G G FG  YK +L     +    V +K LK       + DF  +  I+G   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L+         +++ +Y   G++   L  + GE          + +  G A G+  +  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 165

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVT 496
            N    VH ++ + NI +NS     VSD GL+ +           +G +      APE  
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 497 DSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
             RK T ASDV+SFG+V+ E++T G+ P       E++  +                  +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----------------D 265

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESS 615
             R P   +    + Q+ M C  +   +RPK  D+V +++ +       +  +      S
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVS 325

Query: 616 TPPPPVAG 623
              P  +G
Sbjct: 326 IRLPSTSG 333

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 7/127 (5%)

Query: 82  IPPNTISRLSALKILSL-RSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           IP    +R+ +L  L L     +       F  L +L YL L   N    +P+ +    L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGL 220

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLS 197
             + +S N F    P S   L+ L+ L++ N+ +S  I       L +L +LNLA+NNLS
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279

Query: 198 GSIPQSL 204
            S+P  L
Sbjct: 280 -SLPHDL 285

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 35/138 (25%), Positives = 53/138 (38%), Gaps = 21/138 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP NT       + L+L  N I       F +L  L  L L  N+    +    F+   +
Sbjct: 73  IPSNT-------RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  + L DN        +   L++L  L+L NN +   IP      +P+L +L+L     
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK- 182

Query: 197 SGSIPQSLKRFPSSAFVG 214
                  L+     AF G
Sbjct: 183 ------KLEYISEGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 9/120 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I       L  LK L+L    I      +   L  L  L +  N+F   +    F    +
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSS 243

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           L  + + ++  +     +   L  L  L LA+N+LS  +P      L  L +L+L +N  
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 51/311 (16%), Positives = 106/311 (34%), Gaps = 52/311 (16%)

Query: 330 EVLGKGTFGMAYKAILEDG-----TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK +           V +K L++       ++   +  ++ S+ + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L           ++      G +   +   +      +     +   +  A+G+  +  
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLED 135

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR----------- 491
                LVH ++ + N+ + + Q+  ++D GL       A ++                  
Sbjct: 136 RR---LVHRDLAARNVLVKTPQHVKITDFGL-------AKLLGAEEKEYHAEGGKVPIKW 185

Query: 492 -APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA 549
            A E    R  T  SDV+S+GV + E++T G  P       E+  ++             
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------- 236

Query: 550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSG 609
                   R P      +++  I + C +   D RPK  +++     +  +        G
Sbjct: 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

Query: 610 NKSESSTPPPP 620
           ++      P  
Sbjct: 289 DERMHLPSPTD 299

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 66/309 (21%), Positives = 118/309 (38%), Gaps = 58/309 (18%)

Query: 330 EVLGKGTFGMAYKAILED-----GTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVV 382
             LG+G FG       +      G  V VK LK     +    ++Q+++I+ ++ HE+++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 383 ELKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           + K            +V +Y  LGS+   L          +     +  A     G+A +
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YR---- 491
           HA +    +H ++ + N+ L++ +   + D GL           A+A       YR    
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGL-----------AKAVPEGHEYYRVRED 196

Query: 492 --------APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV 543
                   APE     K   ASDV+SFGV L E+LT                 +++  + 
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH-------CDSSQSPPTKFLELIG 249

Query: 544 REEWTAEVFDV-ELL----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             +    V  + ELL    R P  ++   E+  +  +C       RP   +++ +++ V 
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

Query: 599 PNDSENRPS 607
                  PS
Sbjct: 310 EKYQGQAPS 318

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 60/331 (18%), Positives = 107/331 (32%), Gaps = 77/331 (23%)

Query: 330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVE 383
             LGKG FG              G  V VK+L+      +RDF+++++I+ ++  + +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
            +   Y    +   +V +Y   G +   L   R      LD    +  +    +G+  + 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG-----YR----- 491
           +      VH ++ + NI + S+ +  ++D GL           A+        Y      
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGL-----------AKLLPLDKDYYVVREPG 190

Query: 492 -------APEVTDSRKATQASDVYSFGVVLLEILT-GKSP-----------IHTTGGDEL 532
                  APE       ++ SDV+SFGVVL E+ T                        L
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 533 VHLVRWVHSVVR----EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMP 588
             L+  +    R        AEV ++              M      C    P  RP   
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHEL--------------MKL----CWAPSPQDRPSFS 292

Query: 589 DVVRVIENVRPNDSENRPSSGNKSESSTPPP 619
            +   ++ +          +           
Sbjct: 293 ALGPQLDMLWSGSRGCETHAFTAHPEGKHHS 323

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 52/327 (15%), Positives = 111/327 (33%), Gaps = 59/327 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIR-HENVVELKA 386
            VL +G F   Y+A  +  G    +KR L +     R   Q++  +  +  H N+V+  +
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 387 YYYSKDEK-------LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
                 E+        ++      G +   L      G +  D  T ++I     R +  
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD--TVLKIFYQTCRAVQH 151

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---------- 489
           +H      ++H ++K  N+ L++Q    + D G  T  S        A            
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 490 -----YRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS 541
                YR PE+ D        +  D+++ G +L  +   + P                  
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----------KLR 260

Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
           +V  +++       +  +         +++   + +   P++R  + +VV  ++ +    
Sbjct: 261 IVNGKYS-------IPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAAR 310

Query: 602 SENRPS--------SGNKSESSTPPPP 620
           + N  S        +G    ++    P
Sbjct: 311 NVNPKSPITELLEQNGGYGSATLSRGP 337

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 31/122 (25%), Positives = 45/122 (36%), Gaps = 10/122 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P      L+  + L L  N I     S F  L+ L  L L       T+    F    N
Sbjct: 19  VPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD----LNLPNLQQLNLANNN 195
           L I++L  +      P +   L  L  L L    LS  +       NL  L +L+L+ N 
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 196 LS 197
           + 
Sbjct: 135 IR 136

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 34/143 (23%), Positives = 53/143 (37%), Gaps = 14/143 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +       L  LK+L+L  N I       F  L +L  L L +N     L    F     
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPK 339

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGS 199
           +  I+L  N       ++   L +L+ L L +N+L+  I    +P++  + L+ N L   
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIH--FIPSIPDIFLSGNKLV-- 394

Query: 200 IPQSLKRFPSSAFVGNSISFDEN 222
                   P      N I   EN
Sbjct: 395 ------TLPKINLTANLIHLSEN 411

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 31/141 (21%), Positives = 52/141 (36%), Gaps = 10/141 (7%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
              I       L  L+IL L S+ I    P  F  L  L  L L F   S  +     ++
Sbjct: 61  PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

Query: 139 ---NLTIINLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPD-----LNLPNLQQL 189
               LT ++LS N      +  S   L  L+++  ++N +   + +     L    L   
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFF 179

Query: 190 NLANNNLSGSIPQSLKRFPSS 210
           +LA N+L   +     +  + 
Sbjct: 180 SLAANSLYSRVSVDWGKCMNP 200

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.1 bits (208), Expect = 5e-17
 Identities = 45/262 (17%), Positives = 80/262 (30%), Gaps = 26/262 (9%)

Query: 31  LLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRL 90
            L  ++ +P    +  +      N    +        ++   L       L     + R+
Sbjct: 373 ALTTIHFIPSIPDIFLS-----GNKLVTLPKINLTANLI--HLSENRLENLDILYFLLRV 425

Query: 91  SALKILSLRSNVITGYFPSD--FINLKSLCYLYLQFNNFSGTLPD------FSVWKNLTI 142
             L+IL L  N  +     D       SL  L+L  N              F    +L +
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQ 202
           + L+ N  N   P   S+LT L  L L +N L+    +    NL+ L+++ N L    P 
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPD 544

Query: 203 SLKRFPSSAFVGNSISFDENLAP-----RASPDVAPRGESHLR-----PKSGRRIGETTL 252
                       N    +  L+        +        + +        SG  +   + 
Sbjct: 545 VFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLST 604

Query: 253 LGIVIAASVLGLLAFLFLIVAC 274
            G      +  L   LF++   
Sbjct: 605 EGCDEEEVLKSLKFSLFIVCTV 626

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.2 bits (198), Expect = 8e-16
 Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 11/131 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I       L  L++L+L  N++   + S+F  L  + Y+ LQ N+ +  + D  F   + 
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEK 363

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG- 198
           L  ++L DN        ++  +  +  ++L+ N L   +P +NL     ++L+ N L   
Sbjct: 364 LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINL-TANLIHLSENRLENL 416

Query: 199 SIPQSLKRFPS 209
            I   L R P 
Sbjct: 417 DILYFLLRVPH 427

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 32/139 (23%), Positives = 47/139 (33%), Gaps = 19/139 (13%)

Query: 89  RLSALKILSLRSNVITGYFPSDFIN------------LKSLCYLYLQFNNFSGTLPDF-- 134
           R   L+IL +  N  T     +F N               +      F+N      +   
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261

Query: 135 -SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLN 190
                ++  ++LS         R    L  L+ L LA N ++ KI D     L NLQ LN
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLN 320

Query: 191 LANNNLSGSIPQSLKRFPS 209
           L+ N L      +    P 
Sbjct: 321 LSYNLLGELYSSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 24/152 (15%), Positives = 56/152 (36%), Gaps = 26/152 (17%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINL--KSLCYLYLQFNNFSGTLP--- 132
              L    +  +L++LK +   SN I      +   L  K+L +  L  N+    +    
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 133 --DFSVWKN--LTIINLSDNGFN------------GTIPRSLSNLTQLEALYLANNSLSG 176
               + ++N  L I+++S NG+              +   SL     +       +++  
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254

Query: 177 KIPD----LNLPNLQQLNLANNNLSGSIPQSL 204
              +    L   +++ L+L++  +  S+   +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV 285

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 22/100 (22%), Positives = 34/100 (34%), Gaps = 14/100 (14%)

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
            + +F N +      +       + LS N        S   L QL+ L L +      I 
Sbjct: 9   AFYRFCNLTQVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 180 D---LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNS 216
                NLPNL+ L+L ++ +              AF G  
Sbjct: 66  KEAFRNLPNLRILDLGSSKIY--------FLHPDAFQGLF 97

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 86.6 bits (215), Expect = 4e-18
 Identities = 29/122 (23%), Positives = 48/122 (39%), Gaps = 15/122 (12%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
           P     L +L + +     ++   P        L YL +  N     LP+      L II
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPELQNSSFLKII 158

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQ 202
           ++ +N     +P    +L  +      NN L  ++P+L NLP L  +   NN+L   +P 
Sbjct: 159 DVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPD 212

Query: 203 SL 204
             
Sbjct: 213 LP 214

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 22/132 (16%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
             +L+ +   +N++      +  NL  L  +Y   N    TLPD     +L  +N+ DN 
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNY 268

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---------------NLPNLQQLNLANN 194
               +P    +LT L+      + LS   P+L                 P+L++LN++NN
Sbjct: 269 LT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 327

Query: 195 NLSGSIPQSLKR 206
            L   +P    R
Sbjct: 328 KLI-ELPALPPR 338

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 24/152 (15%), Positives = 43/152 (28%), Gaps = 35/152 (23%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINL-------------KSLCYLYLQFNNFSGT 130
           P     + +        +      P                   +    L L     S +
Sbjct: 27  PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85

Query: 131 LPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG-------------- 176
           LP+     +L  +  S N     +P    +L  L        +LS               
Sbjct: 86  LPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 142

Query: 177 --KIPDL-NLPNLQQLNLANNNLSGSIPQSLK 205
             K+P+L N   L+ +++ NN+L   +P    
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP 173

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 25/118 (21%), Positives = 51/118 (43%), Gaps = 15/118 (12%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
                +L+ L++ +N +    P+    L+    L   FN+ +  +P+    +NL  +++ 
Sbjct: 313 CDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELP--QNLKQLHVE 365

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSL 204
            N      P    ++  L      N+ L+ ++P+L   NL+QL++  N L    P   
Sbjct: 366 YNPLR-EFPDIPESVEDLRM----NSHLA-EVPEL-PQNLKQLHVETNPLR-EFPDIP 415

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 15/110 (13%), Positives = 38/110 (34%), Gaps = 14/110 (12%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
              LK L +  N +   FP    +++ L     + N+    +P+    +NL  +++  N 
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELP--QNLKQLHVETNP 407

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSG--KIPDLNLPNLQQLNLANNNLS 197
                P    ++  L    + +  +    +        L+     +++  
Sbjct: 408 LR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 20/109 (18%), Positives = 33/109 (30%), Gaps = 35/109 (32%)

Query: 111 FINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA 170
           FIN +++   +LQ      +        NLT            +P    N+      Y A
Sbjct: 2   FINPRNVSNTFLQEPLRHSS--------NLT-----------EMPVEAENVKSKTEYYNA 42

Query: 171 NNSLSG---------------KIPDLNLPNLQQLNLANNNLSGSIPQSL 204
            +                   ++ D       +L L N  LS S+P+  
Sbjct: 43  WSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELP 90

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.3 bits (213), Expect = 4e-18
 Identities = 33/261 (12%), Positives = 76/261 (29%), Gaps = 54/261 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME----------------- 371
            VLG+       +A   E G +  V           +  +QM+                 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 372 ------------IVGSIRHENVVELKA----YYYSKDEKLMVYDYYSLGSVSAMLHSERG 415
                       +V   + + ++ ++      +      L      +L +   +L S   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 416 EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL-- 473
             +  L    R+++ +   R +A +H      LVH  ++  +I L+ +    ++      
Sbjct: 204 THK-SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 474 ----TTITSALAPVIARAAGYRAPEVTDSRKA-----TQASDVYSFGVVLLEILTGKSPI 524
               + ++              A  +    +      T A D ++ G+ +  I     P 
Sbjct: 260 RDGASAVSPIGRGFAPPE--TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 525 HTTGGDELVHLVRWVHSVVRE 545
                D  +    W+    + 
Sbjct: 318 T---DDAALGGSEWIFRSCKN 335

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 55/296 (18%), Positives = 105/296 (35%), Gaps = 60/296 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK--RLKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G FG+ ++A    D     +K  RL +  + +    ++++ +  + H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 387 YYYSKDE---------KLMVY---DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA 434
            +  K+          K+ +Y         ++   +           +    + I +  A
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIA 128

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI---TSALAPVIARAAG 489
             +  +H+     L+H ++K SNIF        V   D GL T          V+     
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 490 ------------YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
                       Y +PE       +   D++S G++L E+L    P  T    E V  + 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QMERVRTLT 238

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVE-MLQIAMSCVVRMPDQRPKMPDVVR 592
                VR      +F     +    E  MV+ ML  +       P +RP+  +++ 
Sbjct: 239 ----DVRNLKFPPLFT----QKYPCEYVMVQDMLSPS-------PMERPEAINIIE 279

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 27/127 (21%), Positives = 51/127 (40%), Gaps = 8/127 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           +  +    L  L  L L +N I+      F  L+ L  LY+  N+    +P  ++  +L 
Sbjct: 69  LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLV 126

Query: 142 IINLSDNGFNGTIPR-SLSNLTQLEALYLANNSL-SGKIPD--LNLPNLQQLNLANNNLS 197
            + + DN     +P+   S L  +  + +  N L +        +   L  L ++   L+
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

Query: 198 GSIPQSL 204
             IP+ L
Sbjct: 186 -GIPKDL 191

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 27/143 (18%), Positives = 47/143 (32%), Gaps = 21/143 (14%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IP +       L  L L  N I      D +    L  L L  N     + +   S    
Sbjct: 187 IPKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPT 242

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLS--------GKIPDLNLPNLQQLNL 191
           L  ++L +N  +  +P  L +L  L+ +YL  N+++             +       ++L
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301

Query: 192 ANNNLSGSIPQSLKRFPSSAFVG 214
            NN +             + F  
Sbjct: 302 FNNPV------PYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 23/125 (18%), Positives = 37/125 (29%), Gaps = 14/125 (11%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           I    + R S L  L L  N I          L +L  L+L  N  S  +P      K L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 141 TIINLSDNGFNGTIP-------RSLSNLTQLEALYLANNSLS-GKIPD---LNLPNLQQL 189
            ++ L  N     +                   + L NN +   ++       + +   +
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325

Query: 190 NLANN 194
              N 
Sbjct: 326 QFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 23/138 (16%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I P+T        +L L++N I+     DF  L+ L  L L  N  S  + +  FS  + 
Sbjct: 52  ISPDT-------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNL 196
           L  + +S N     IP +L   + L  L + +N +  K+P      L N+  + +  N L
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159

Query: 197 SGSIPQSLKRFPSSAFVG 214
             S       F   AF G
Sbjct: 160 ENS------GFEPGAFDG 171

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 31/133 (23%), Positives = 51/133 (38%), Gaps = 12/133 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I     S L  L+ L +  N +    P +     SL  L +  N     +P   FS  +N
Sbjct: 93  IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRN 148

Query: 140 LTIINLSDNGFNGTI--PRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +  I +  N    +   P +   L  L  L ++   L+  IP      L +L+L +N + 
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQ 206

Query: 198 GSIPQ-SLKRFPS 209
            +I    L R+  
Sbjct: 207 -AIELEDLLRYSK 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 330 EVLGKGTFGMAYKAILE-----DGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVV 382
             LG+G FG       +      G  V VK LK  + G    D ++++EI+ ++ HEN+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 383 ELKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           + K            ++ ++   GS+   L   + +    ++   +++ A+   +G+  +
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG-----YRAPE 494
            +      VH ++ + N+ + S+    + D GLT  I +       +        + APE
Sbjct: 143 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 495 VTDSRKATQASDVYSFGVVLLEILT 519
                K   ASDV+SFGV L E+LT
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 62/318 (19%), Positives = 105/318 (33%), Gaps = 89/318 (27%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVV 382
           ++LG+G FG   +  L+        V VK +K  N       +F  +   +    H NV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 383 EL-----KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-GRIPLDWDTRMRIAIGAARG 436
            L     +       + +++  +   G +   L   R E G   +   T ++  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR----- 491
           +  + +      +H ++ + N  L      CV+D GL       +  I     YR     
Sbjct: 160 MEYL-SNR--NFLHRDLAARNCMLRDDMTVCVADFGL-------SKKIYSGDYYRQGRIA 209

Query: 492 -------APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVV 543
                  A E    R  T  SDV++FGV + EI T G +P                    
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-------------------- 249

Query: 544 REEWTAEVFDVELLRYPNIE-EEMVEML-----------------QIAMSCVVRMPDQRP 585
                          YP ++  EM + L                 +I  SC    P  RP
Sbjct: 250 ---------------YPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRP 294

Query: 586 KMPDVVRVIENVRPNDSE 603
               +   +E +  +  +
Sbjct: 295 TFSVLRLQLEKLLESLPD 312

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 20/207 (9%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
           +++G G  G      L    +    V +K LK       +RDF  +  I+G   H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L+         ++V +Y   GS+   L +  G+          + +  G   G+  +   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSDL 170

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-TITSALAPVIARAAG---YR--APEVTD 497
                VH ++ + N+ ++S     VSD GL+  +            G    R  APE   
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSP 523
            R  + ASDV+SFGVV+ E+L  G+ P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 70/309 (22%)

Query: 330 EVLGKGTFGMAYKAILE-----DGTTVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVE 383
           + LGKG FG       +      G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
            K   YS   +   ++ +Y   GS+   L   +      +D    ++      +G+  + 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR---------- 491
                  +H ++ + NI + ++    + D GLT +      +      ++          
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKV------LPQDKEFFKVKEPGESPIF 182

Query: 492 --APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA 549
             APE     K + ASDV+SFGVVL E+ T      +   + +  +              
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN------------ 230

Query: 550 EVFDVELLRYPNIE-EEMVEML-----------------QIAMSCVVRMPDQRPKMPDVV 591
                   +   +    ++E+L                  I   C     +QRP   D+ 
Sbjct: 231 -------DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

Query: 592 RVIENVRPN 600
             ++ +R N
Sbjct: 284 LRVDQIRDN 292

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 14/123 (11%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           +P +T        IL L  N++  +  +  +    L  L L     +  L        L 
Sbjct: 29  LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLG 80

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSG 198
            ++LS N    ++P     L  L  L ++ N L+  +P      L  LQ+L L  N L  
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137

Query: 199 SIP 201
           ++P
Sbjct: 138 TLP 140

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 11/125 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
               T+   + L  L+L    +T         L  L  L L  N    +LP        L
Sbjct: 46  FSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL 102

Query: 141 TIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL 196
           T++++S N    ++P      L +L+ LYL  N L   +P       P L++L+LANNNL
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160

Query: 197 SGSIP 201
           +  +P
Sbjct: 161 T-ELP 164

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 36/119 (30%), Positives = 50/119 (42%), Gaps = 9/119 (7%)

Query: 88  SRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINL 145
             L  L  L L  N +    P     L +L  L + FN  + +LP         L  + L
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSGSIP 201
             N      P  L+   +LE L LANN+L+ ++P      L NL  L L  N+L  +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 33/116 (28%), Positives = 45/116 (38%), Gaps = 8/116 (6%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLT 141
           P     L AL +L +  N +T         L  L  LYL+ N    TLP    +    L 
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151

Query: 142 IINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANN 194
            ++L++N     +P  L + L  L+ L L  NSL   IP        L    L  N
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 65/308 (21%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVV 382
             LG+G FG  + A        +D   V VK LK+ +   ++DF+++ E++  ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA------IGAARG 436
                       LMV++Y   G ++  L S   + ++    +            +  A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 437 IARIHAANGG-------KLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSA 479
           +A       G         VH ++ + N  +       + D G++               
Sbjct: 167 VAA------GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 480 LAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           + P+       R   PE    RK T  SDV+SFGVVL EI T GK P +     E +  +
Sbjct: 221 MLPI-------RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273

Query: 537 RWVHSVVR-EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
                + R      EV+ +              M      C  R P QR  + DV   ++
Sbjct: 274 TQGRELERPRACPPEVYAI--------------MRG----CWQREPQQRHSIKDVHARLQ 315

Query: 596 NVRPNDSE 603
            +      
Sbjct: 316 ALAQAPPV 323

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 63/309 (20%), Positives = 116/309 (37%), Gaps = 70/309 (22%)

Query: 330 EVLGKGTFGMAYKAILE-----DGTTVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVE 383
           + LGKG FG       +      G  V VK+L+       RDFE+++EI+ S++H+N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 384 LKAYYYSKDEK--LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
            K   YS   +   ++ +Y   GS+   L   +      +D    ++      +G+  + 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR---------- 491
                  +H ++ + NI + ++    + D GLT +      +      Y+          
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKV------LPQDKEYYKVKEPGESPIF 213

Query: 492 --APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA 549
             APE     K + ASDV+SFGVVL E+ T      +   + +  +              
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN------------ 261

Query: 550 EVFDVELLRYPNIE-EEMVEML-----------------QIAMSCVVRMPDQRPKMPDVV 591
                   +   +    ++E+L                  I   C     +QRP   D+ 
Sbjct: 262 -------DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314

Query: 592 RVIENVRPN 600
             ++ +R  
Sbjct: 315 LRVDQIRDQ 323

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 36/230 (15%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVE 383
           EV+G+G FG  Y   L D         VK L  +        F  +  I+    H NV+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 384 LKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           L       +   + V  Y   G +   + +E             +   +  A+G+  + +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLAS 210

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
               K VH ++ + N  L+ +    V+D GL               T A  PV       
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV------- 260

Query: 491 R--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           +  A E   ++K T  SDV+SFGV+L E++T G  P       ++   + 
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 37/261 (14%), Positives = 77/261 (29%), Gaps = 53/261 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM------------------ 370
            VLG+       +A   E G +  V           +  +QM                  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 371 -----------EIVGSIRHENVVELKAYYYSKDEK----LMVYDYYSLGSVSAMLHSERG 415
                      ++V   + + ++ ++             L      +L +   +L S   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 416 EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT 475
             +  L    R+++ +   R +A +H      LVH  ++  +I L+ +    ++      
Sbjct: 199 THK-SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 476 ITSALAPVIARAAGYRAPEVTDSR-----------KATQASDVYSFGVVLLEILTGKSPI 524
              A          +  PE+   R             T + D ++ G+V+  I     PI
Sbjct: 255 RDGARVVSSVSRG-FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 525 HTTGGDELVHLVRWVHSVVRE 545
                D  +    W+    + 
Sbjct: 314 T---KDAALGGSEWIFRSCKN 331

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 36/230 (15%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVVE 383
            V+GKG FG+ Y     D         +K L  +   +    F ++  ++  + H NV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 384 LKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           L       +     +  Y   G +   + S +            +   +  ARG+  +  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYLAE 142

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT------------TITSALAPVIARAAGY 490
                 VH ++ + N  L+      V+D GL                 A  PV       
Sbjct: 143 QK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV------- 192

Query: 491 R--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
           +  A E   + + T  SDV+SFGV+L E+LT G  P       +L H + 
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 33/212 (15%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVE 383
            +LG+G FG  Y+ +      +   V VK  K       K  F  +  I+ ++ H ++V+
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L      ++   ++ + Y  G +   L   +      L   T +  ++   + +A + + 
Sbjct: 78  LIGII-EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLESI 132

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYR--A 492
           N    VH +I   NI + S +   + D GL            +    P+       +  +
Sbjct: 133 N---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-------KWMS 182

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           PE  + R+ T ASDV+ F V + EIL+ GK P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 10/127 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD---FSVWK 138
           I  ++ S L +L+ L L  N ++    S F  L SL +L L  N +  TL +   FS   
Sbjct: 91  IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLT 149

Query: 139 NLTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
            L I+ + +      I  +  + LT LE L +  + L          ++ N+  L L   
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208

Query: 195 NLSGSIP 201
                + 
Sbjct: 209 QHI-LLL 214

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 23/134 (17%), Positives = 50/134 (37%), Gaps = 13/134 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I     + L+ L+ L + ++ +  Y P    +++++ +L L        L +    V  +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSS 223

Query: 140 LTIINLSDNGFNGT--------IPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLN 190
           +  + L D   +             SL        + + + SL   +  L  +  L +L 
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283

Query: 191 LANNNLSGSIPQSL 204
            + N L  S+P  +
Sbjct: 284 FSRNQLK-SVPDGI 296

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 21/139 (15%), Positives = 50/139 (35%), Gaps = 7/139 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           +  +    LS+L  L+L  N       +  F +L  L  L +   +    +    F+   
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
            L  + +  +      P+SL ++  +  L L        + ++      +++ L L + +
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233

Query: 196 LSGSIPQSLKRFPSSAFVG 214
           L       L    +++ + 
Sbjct: 234 LDTFHFSELSTGETNSLIK 252

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 38/128 (29%), Positives = 58/128 (45%), Gaps = 12/128 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           I  + + R   L+ L L SN I      D F +L SL +L L +N  S  L    F    
Sbjct: 67  ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124

Query: 139 NLTIINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLAN 193
           +LT +NL  N +  T+  +   S+LT+L+ L + N     KI       L  L++L +  
Sbjct: 125 SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183

Query: 194 NNLSGSIP 201
           ++L  S  
Sbjct: 184 SDLQ-SYE 190

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 20/127 (15%), Positives = 41/127 (32%), Gaps = 14/127 (11%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF---------SGTLP 132
             P ++  +  +  L L                 S+  L L+  +          +G   
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248

Query: 133 DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQL 189
                     + ++D      + + L+ ++ L  L  + N L   +PD     L +LQ++
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKI 306

Query: 190 NLANNNL 196
            L  N  
Sbjct: 307 WLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 31/127 (24%), Positives = 47/127 (37%), Gaps = 17/127 (13%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +           K L L +N IT    SD     +L  L L  N  + T+ +  FS   +
Sbjct: 50  LTEAV-------KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL----NLPNLQQLNLANN 194
           L  ++LS N     +  S    L+ L  L L  N     + +     +L  LQ L + N 
Sbjct: 102 LEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159

Query: 195 NLSGSIP 201
           +    I 
Sbjct: 160 DTFTKIQ 166

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 54/285 (18%), Positives = 105/285 (36%), Gaps = 18/285 (6%)

Query: 311 FFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQ- 368
             +        +D  +     LG G  G+ +K      G  +  K +  + +      Q 
Sbjct: 22  TQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQI 78

Query: 369 QME--IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR 426
             E  ++       +V     +YS  E  +  ++   GS+  +L   +  GRIP      
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQI--L 133

Query: 427 MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIA 485
            +++I   +G+  +      K++H ++K SNI +NS+    + D G++  +  ++A    
Sbjct: 134 GKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191

Query: 486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE 545
               Y +PE       +  SD++S G+ L+E+  G+ PI      EL  +          
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 546 EWTAEVFDVELLRYPNIEEEMVEMLQIA-MSCVVRMPDQRPKMPD 589
           E                 +    M     +  +V   +  PK+P 
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN--EPPPKLPS 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 56/306 (18%)

Query: 330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVV 382
            +LGKG FG   +A L+        V VK LK   +      +F ++   +    H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 383 EL------KAYYYSKDEKLMVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAAR 435
           +L                +++  +   G + A L + R GE    L   T +R  +  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALAPVIA 485
           G+  + ++     +H ++ + N  L      CV+D GL+             ++  PV  
Sbjct: 149 GMEYL-SSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV-- 203

Query: 486 RAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSV 542
                +  A E       T  SDV++FGV + EI+T G++P       E+ + +   +  
Sbjct: 204 -----KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257

Query: 543 VREEWTAEVFDVELLRYPNIEEEMVE-MLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
                        L + P   EE+ + M Q    C    P QRP    +   +EN+  + 
Sbjct: 258 -------------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGHL 300

Query: 602 SENRPS 607
           S    S
Sbjct: 301 SVLSTS 306

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 43/240 (17%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVV 382
             LG+G FG  + A        +D   V VK LKD  +  ++DF+++ E++ +++HE++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------MRIAI 431
           +        D  +MV++Y   G ++  L +   +  I +D   R           + IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLT----------TITSAL 480
             A G+  + A+     VH ++ + N  L        + D G++               +
Sbjct: 141 QIASGMVYL-ASQ--HFVHRDLATRNC-LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 481 APVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
            P+       R   PE    RK T  SDV+SFGV+L EI T GK P       E++  + 
Sbjct: 197 LPI-------RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 31/157 (19%), Positives = 53/157 (33%), Gaps = 25/157 (15%)

Query: 52  VCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDF 111
            C+     + +   K +  +  P       +PP+T       + L L    +       F
Sbjct: 9   ECHQEEDFRVT--CKDIQRI--PS------LPPST-------QTLKLIETHLRTIPSHAF 51

Query: 112 INLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRS-LSNLTQLEALY 168
            NL ++  +Y+  +     L    F     +T I + +      I    L  L  L+ L 
Sbjct: 52  SNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111

Query: 169 LANNSLSGKIPDL----NLPNLQQLNLANNNLSGSIP 201
           + N  L    PDL    +      L + +N    SIP
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 28/129 (21%), Positives = 56/129 (43%), Gaps = 12/129 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD--FINLKSLCYLYLQFNNFSGTLPD--FSVW 137
           I P+ +  L  LK L + +  +   FP      +      L +  N +  ++P   F   
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154

Query: 138 KNLTI-INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPN-LQQLNLA 192
            N T+ + L +NGF  ++     N T+L+A+YL  N     I       + +    L+++
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213

Query: 193 NNNLSGSIP 201
             +++ ++P
Sbjct: 214 QTSVT-ALP 221

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 3e-17
 Identities = 49/227 (21%), Positives = 91/227 (40%), Gaps = 20/227 (8%)

Query: 322 EDLLRASAEVLGKGTFGMAYKAILEDG---TTVVVKRLKD--VNVGKRDFEQQMEIVGSI 376
            D L  +   LG G FG   + +         V +K LK         +  ++ +I+  +
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
            +  +V L       +  ++V +    G +   L  +R E    +       +    + G
Sbjct: 394 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 448

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR----- 491
           +  +   N    VH N+ + N+ L ++ Y  +SD GL+    A        +  +     
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505

Query: 492 -APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
            APE  + RK +  SDV+S+GV + E L+ G+ P     G E++  +
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 39/290 (13%)

Query: 332 LGKGTFGMAYKAILEDG---TTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVVELKA 386
           LG G FG   + +         V +K LK         +  ++ +I+  + +  +V L  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 387 YYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
               + E LM V +    G +   L  +R E    +       +    + G+  +   N 
Sbjct: 78  V--CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN- 130

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APEVTDSR 499
              VH ++ + N+ L ++ Y  +SD GL+    A        +  +      APE  + R
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 500 KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
           K +  SDV+S+GV + E L+ G+ P     G E++  +                  +  R
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----------------QGKR 231

Query: 559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSS 608
                E   E+  +   C +   + RP    V + +     + +      
Sbjct: 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 69/332 (20%), Positives = 120/332 (36%), Gaps = 80/332 (24%)

Query: 330 EVLGKGTFGMA--YKA---ILEDGTTVVVKRLK-----DVNVGKRDFEQQMEIVGSIRHE 379
           E+LG G  GM+  + A          V VK L+     D +   R F ++ +   ++ H 
Sbjct: 18  EILGFG--GMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHP 72

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLH----------------SERGEGRIPLDW 423
            +V              VYD     + +  L                    G    P+  
Sbjct: 73  AIVA-------------VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTP 115

Query: 424 DTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL--------TT 475
              + +   A + +   H      ++H ++K +NI +++     V D G+         +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172

Query: 476 ITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL 535
           +T   A VI  A  Y +PE          SDVYS G VL E+LTG+ P     GD  V  
Sbjct: 173 VTQT-AAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVS- 226

Query: 536 VRWVHSVVREEWTAEVFDVELLR--YPNIEEEMVEMLQIAMSCVVRMPDQRPK-MPDVVR 592
           V + H  VRE       D       +  +  ++  ++  A++   + P+ R +   ++  
Sbjct: 227 VAYQH--VRE-------DPIPPSARHEGLSADLDAVVLKALA---KNPENRYQTAAEMRA 274

Query: 593 VIENVRPNDSENRPSSGNKSESSTPPPPVAGE 624
            +  V   +    P     +E ++     AG 
Sbjct: 275 DLVRVHNGEPPEAPKVLTDAERTSLLSSAAGN 306

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 41/288 (14%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G+FG+  +           +V VK LK           DF +++  + S+ H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 382 VELKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           + L  Y       +  V +   LGS+   L   +G         T  R A+  A G+  +
Sbjct: 84  IRL--YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYL 137

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR------APE 494
            +      +H ++ + N+ L ++    + D GL                 +      APE
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 495 VTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
              +R  + ASD + FGV L E+ T G+ P     G +++H +                D
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------D 238

Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
            E  R P  E+   ++  + + C    P+ RP    +   +   +P D
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 11/127 (8%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           +   +      L++L L    I        + +L  L  L L  N    +L    FS   
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS 100

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD----LNLPNLQQLNLANN 194
           +L  +   +          + +L  L+ L +A+N +           NL NL+ L+L++N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159

Query: 195 NLSGSIP 201
            +  SI 
Sbjct: 160 KIQ-SIY 165

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 30/158 (18%), Positives = 55/158 (34%), Gaps = 25/158 (15%)

Query: 51  SVCN-HWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPS 109
            V        +C         +  P       +P +T       K L L  N +      
Sbjct: 3   CVEVVPNITYQCM--ELNFYKI--P----DN-LPFST-------KNLDLSFNPLRHLGSY 46

Query: 110 DFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL 167
            F +   L  L L       T+ D  +    +L+ + L+ N        + S L+ L+ L
Sbjct: 47  SFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105

Query: 168 YLANNSLSGKIPDL---NLPNLQQLNLANNNLSGSIPQ 202
                +L+  + +    +L  L++LN+A+N +  S   
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKL 141

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 13/123 (10%)

Query: 82  IPPNTISRLSALKILSLRSNVITGY-FPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWK 138
           +    I  L  LK L++  N+I  +  P  F NL +L +L L  N    ++   D  V  
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173

Query: 139 NLTIIN----LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNL 191
            + ++N    LS N  N  I        +L+ L L  N L   +PD     L +LQ++ L
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 231

Query: 192 ANN 194
             N
Sbjct: 232 HTN 234

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 22/203 (10%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELK 385
            LGKG FG  Y A   +    + +K L    + K   E Q+    EI   +RH N++ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
            Y++      ++ +Y  LG+V   L   +   +   +  T        A  ++  H+   
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCHSKR- 129

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-----GYRAPEVTDSRK 500
             ++H +IK  N+ L S     ++D G     S  AP   R        Y  PE+ + R 
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  D++S GV+  E L GK P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 44/241 (18%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
           E LG+  FG  YK  L      E    V +K LKD      + +F  +  +   ++H NV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------MRIA 430
           V L           M++ Y S G +   L        +    D R           + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGL----------TTITSA 479
              A G+  + + +   +VH ++ + N+ L   +    +SDLGL            + ++
Sbjct: 135 AQIAAGMEYLSSHH---VVHKDLATRNV-LVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 480 LAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
           L P+       R  APE     K +  SD++S+GVVL E+ + G  P       ++V ++
Sbjct: 191 LLPI-------RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

Query: 537 R 537
           R
Sbjct: 244 R 244

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 5/112 (4%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           T + L  +  LS     +T         L +L  L L+ N  +  L        +T + L
Sbjct: 36  TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLAPLKNLTKITELEL 92

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           S N     +  +++ L  ++ L L +  ++   P   L NLQ L L  N ++
Sbjct: 93  SGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 5/111 (4%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ LS L++L L  N IT    S    L +L YL +     S  L   +    LT +   
Sbjct: 125 LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKAD 181

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           DN  +  I   L++L  L  ++L NN +S   P  N  NL  + L N  ++
Sbjct: 182 DNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 24/129 (18%), Positives = 48/129 (37%), Gaps = 11/129 (8%)

Query: 81  LIPPNTISR------LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF 134
           +  P  I+       L+    ++   + +T        +L  +  L       + T+   
Sbjct: 3   ITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEGV 59

Query: 135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANN 194
               NL  + L DN     +   L NLT++  L L+ N L        L +++ L+L + 
Sbjct: 60  QYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117

Query: 195 NLSGSIPQS 203
            ++   P +
Sbjct: 118 QITDVTPLA 126

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 6/115 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L+ L+ LS+ +  ++    +   NL  L  L    N  S  +   +   NL  ++L 
Sbjct: 147 LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLK 203

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
           +N  +   P  L+N + L  + L N +++   P     NL   N+        I 
Sbjct: 204 NNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIA 255

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 22/119 (18%), Positives = 46/119 (38%), Gaps = 8/119 (6%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ LS L  L    N I+    S   +L +L  ++L+ N  S  +   +   NL I+ L+
Sbjct: 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLT 225

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLK 205
           +           +NL     +   + +    I    + +      A+ NL+ ++   + 
Sbjct: 226 NQTITNQPVFYNNNLVVPNVVKGPSGAP---IAPATISDN--GTYASPNLTWNLTSFIN 279

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 53/294 (18%)

Query: 330 EVLGKGTFGMA--YKAILED---GTTVVVKRLK-----DVNVGKRDFEQQMEIVGSIRHE 379
           + LG G  GM+  Y A  ED      V +K +           KR FE+++     + H+
Sbjct: 17  DKLGGG--GMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQ 71

Query: 380 NVVELKAYYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           N+V +      +++    +V +Y    ++S  +    G    PL  DT +        GI
Sbjct: 72  NIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG----PLSVDTAINFTNQILDGI 124

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL------TTITSALAPVIARAAGYR 491
              H      +VH +IK  NI ++S +   + D G+      T++T     V+     Y 
Sbjct: 125 KHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQ-YF 179

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           +PE        + +D+YS G+VL E+L G+ P +   G+  V  +   H  +++      
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN---GETAVS-IAIKH--IQDSVPNVT 233

Query: 552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVRVIENVRPN 600
            DV      +I + +  ++  A     +    R K       D+  V+   R N
Sbjct: 234 TDVR----KDIPQSLSNVILRATE---KDKANRYKTIQEMKDDLSSVLHENRAN 280

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 51/237 (21%), Positives = 99/237 (41%), Gaps = 32/237 (13%)

Query: 311 FFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ- 368
              G  Y  ++ DL       +G GT G  +K    + G  + VK++   +  K + ++ 
Sbjct: 14  TIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRI 70

Query: 369 QMEI---VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDT 425
            M++   + S     +V+    + +  +  +  +   +G+ +  L      G IP     
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL--MGTCAEKLKKRMQ-GPIPERI-- 125

Query: 426 RMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPV 483
             ++ +   + +  +   +   ++H ++K SNI L+ +  G +   D G   I+  L   
Sbjct: 126 LGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDER--GQIKLCDFG---ISGRLVDD 178

Query: 484 IARA--AG---YRAPEVTDSRKATQA-----SDVYSFGVVLLEILTGKSPIHTTGGD 530
            A+   AG   Y APE  D    T+      +DV+S G+ L+E+ TG+ P      D
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 42/212 (19%), Positives = 80/212 (37%), Gaps = 31/212 (14%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQ-QMEI---VGSIRHENVVELK 385
           +VLG G  G      + D   V VKR+         F     E+     S  H NV+   
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRYF 84

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
                +  + +  +  +  ++   +  ++    + L+  T ++       G+A +H+ N 
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQ---QTTSGLAHLHSLN- 138

Query: 446 GKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAA------GYRAPE 494
             +VH ++K  NI ++           +SD GL    +      +R +      G+ APE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 495 V---TDSRKATQASDVYSFGVVLLEILTGKSP 523
           +         T   D++S G V   +++  S 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 37/235 (15%)

Query: 330 EVLGKGTFGMAYKAILEDG---TTVVVKRLKD--VNVGKRDFEQQMEIVGSI-RHENVVE 383
           +V+G+G FG   KA ++         +KR+K+       RDF  ++E++  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------MRIAIG 432
           L      +    +  +Y   G++   L   R     P                 +  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------TITSALAPVIA 485
            ARG+  +      + +H ++ + NI +       ++D GL+         T    PV  
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-- 205

Query: 486 RAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
                R  A E  +    T  SDV+S+GV+L EI++ G +P       EL   + 
Sbjct: 206 -----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 44/240 (18%), Positives = 90/240 (37%), Gaps = 44/240 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
            VLG+G FG   KA    D     +K+++           ++ ++ S+ H+ VV   A +
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 389 YSKDEKL-------------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
             +   +             +  +Y   G++  ++H       +    D   R+      
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQILE 127

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG------ 489
            ++ IH+     ++H ++K  NIF++  +   + D GL         ++   +       
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 490 -----------YRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
                      Y A EV D      +  D+YS G++  E++   S      G E V++++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-----GMERVNILK 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 22/203 (10%)

Query: 331 VLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELK 385
            LGKG FG  Y A   ++   + +K L    + K   E Q+    EI   +RH N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
            Y++ +    ++ ++   G +   L   +  GR   +  +        A  +   H    
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSA-TFMEELADALHYCHERK- 134

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR--AAG---YRAPEVTDSRK 500
             ++H +IK  N+ +  +    ++D G     S  AP + R    G   Y  PE+ + + 
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRTMCGTLDYLPPEMIEGKT 188

Query: 501 ATQASDVYSFGVVLLEILTGKSP 523
             +  D++  GV+  E L G  P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 8/116 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
               +  +L+ L  L   ++ IT    +    L  L  L    NN +    D S   NLT
Sbjct: 33  TDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITT--LDLSQNTNLT 88

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            +    N     +   ++ LT+L  L    N L+ K+     P L  LN A N L+
Sbjct: 89  YLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 29/117 (24%), Positives = 43/117 (36%), Gaps = 9/117 (7%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
            I    ++  + L  L    N IT     D    K L  L    NN   T  D +    L
Sbjct: 160 KITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI--TKLDLNQNIQL 214

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           T ++ S N     I   ++ LTQL     + N L+ ++    L  L  L+    +L 
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 9/115 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +S+   L  L+   N +T     D  +   L  L    N    T  D +    LT ++ S
Sbjct: 123 VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCS 178

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            N     +   +S    L  L    N+++ K+       L  L+ ++N L+  I 
Sbjct: 179 FNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EID 228

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 9/115 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L+ L       N +T     D   L  L  L+    +      +  +  N  +I   
Sbjct: 229 VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL----EIDLTHNTQLIYFQ 281

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
             G        +++ TQL  L      ++ ++     P L  L L N  L+  + 
Sbjct: 282 AEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNNTELT-ELD 334

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 22/119 (18%), Positives = 37/119 (31%), Gaps = 6/119 (5%)

Query: 85  NTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIIN 144
           N              +  +          L +L  L    ++ +  +        LT + 
Sbjct: 12  NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLI 70

Query: 145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQS 203
            + N    T+   LS  T L  L   +N L+  +    L  L  LN   N L+  +  S
Sbjct: 71  CTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLT-KLDVS 124

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 8/111 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +S+ + L  L+  SN +T     D   L  L YL    N  +    D S    LT +N +
Sbjct: 81  LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCA 135

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            N     I   +S+ TQL  L    N    K+       L  L+ + N ++
Sbjct: 136 RNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.8 bits (179), Expect = 9e-14
 Identities = 19/120 (15%), Positives = 38/120 (31%), Gaps = 9/120 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++  + L                D  +   L  L  Q    +  L D S    L  + L+
Sbjct: 271 LTHNTQLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLN 326

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLK 205
           +      +   +S+ T+L++L   N  +      +  +P L     A         ++L 
Sbjct: 327 NTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLT 382

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 8/111 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +++   L  L   SN +T     D   L  L Y     N    T  D S    LT ++  
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL--TELDVSTLSKLTTLHCI 262

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
                  I   L++ TQL            ++   +   L  L+     ++
Sbjct: 263 QTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 22/116 (18%), Positives = 38/116 (32%), Gaps = 8/116 (6%)

Query: 81  LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
            I    ++  + L +L  ++  IT     D      L YLYL     +  L D S    L
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL-DVSHNTKL 341

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL 196
             ++  +         S+  +  L   + A       +P   L N       + +L
Sbjct: 342 KSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 8/102 (7%)

Query: 100 SNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLS 159
           +     +FP D  N  S   +   F   +           LT ++  ++     +   + 
Sbjct: 8   TQSFNDWFPDD--NFASE--VAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIE 61

Query: 160 NLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIP 201
            LT L  L   +N+++  +      NL  L   +N L+ ++ 
Sbjct: 62  KLTGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKLT-NLD 101

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 15/112 (13%), Positives = 33/112 (29%), Gaps = 6/112 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPS-DFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           +S+   L  L L +  +T      D  +   L  L     +             L     
Sbjct: 314 LSQNPKLVYLYLNNTELT----ELDVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFE 368

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           ++         +L+N +   A+        G   ++   +    + A N ++
Sbjct: 369 AEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 80.7 bits (199), Expect = 5e-16
 Identities = 51/325 (15%), Positives = 100/325 (30%), Gaps = 65/325 (20%)

Query: 330 EVLGKGTFGMA--YKA--ILEDGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVV 382
             +  G  G+   Y A     +G  VV+K L    D          + + +  + H ++V
Sbjct: 86  GCIAHG--GLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIV 142

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVS-------AM-------LHSERGEGRIPLDWDTRMR 428
           +             ++++               M       L   +G+    L     + 
Sbjct: 143 Q-------------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIA 186

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL-TTITSALAPVIARA 487
             +     ++ +H+     LV+ ++K  NI L  +Q   + DLG  + I S    +    
Sbjct: 187 YLLEILPALSYLHSIG---LVYNDLKPENIMLTEEQLK-LIDLGAVSRINSF-GYLYG-T 240

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW 547
            G++APE+  +   T A+D+Y+ G  L  +       +   G  +  L            
Sbjct: 241 PGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN---GRYVDGL----PEDDPVLK 292

Query: 548 TAEVFDVELL---------RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
           T + +   L          R+    EEM   L   +  VV      P+         +  
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTA-EEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRS 351

Query: 599 PNDSENRPSSGNKSESSTPPPPVAG 623
               +   +  +             
Sbjct: 352 TFGVDLLVAHTDVYLDGQVHAEKLT 376

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 37/208 (17%), Positives = 75/208 (36%), Gaps = 30/208 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQ-MEIVGSIRHENVVELKAY 387
             +G+G+FG  ++    + G    VK+     V    F  + +     +    +V     
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLSSPRIVP---L 115

Query: 388 Y--YSKDEKLMVY-DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           Y    +   + ++ +    GS+  ++          L  D  +     A  G+  +H   
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR 170

Query: 445 GGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAAG--------YRAPEV 495
              ++HG++K+ N+ L+S      + D G            +   G        + APEV
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
              +      D++S   ++L +L G  P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 34/172 (19%), Positives = 63/172 (36%), Gaps = 33/172 (19%)

Query: 51  SVCNHW-TGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPS 109
           S C+       C    + +  V  P       +P +          + L  N I     +
Sbjct: 6   SECSVIGYNAICI--NRGLHQV--PE------LPAHV-------NYVDLSLNSIAELNET 48

Query: 110 DFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIP-RSLSNLTQLEA 166
            F  L+ L +L ++       + +  F    +L I+ L  N F   +   + + L  LE 
Sbjct: 49  SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEV 107

Query: 167 LYLANNSL-SGKIPD---LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVG 214
           L L   +L    +       L +L+ L L +NN+     + ++  P+S F+ 
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKIQ--PASFFLN 152

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 33/143 (23%), Positives = 47/143 (32%), Gaps = 8/143 (5%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF-SGTLPD--FSVWK 138
           I  NT   LS+L IL L  N         F  L +L  L L   N     L    F    
Sbjct: 70  IRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

Query: 139 NLTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLS----GKIPDLNLPNLQQLNLAN 193
           +L ++ L DN      P S   N+ +   L L  N +       + +    +   L L++
Sbjct: 130 SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189

Query: 194 NNLSGSIPQSLKRFPSSAFVGNS 216
             L       L          N+
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNT 212

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 31/121 (25%), Positives = 49/121 (40%), Gaps = 9/121 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +  +  S  + L+ L+L  N I     + F  L  L  L L  N    ++    F     
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDK 348

Query: 140 LTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           L +++LS N     +  +S   L  L+ L L  N L   +PD     L +LQ++ L  N 
Sbjct: 349 LEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406

Query: 196 L 196
            
Sbjct: 407 W 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 39/134 (29%), Positives = 53/134 (39%), Gaps = 15/134 (11%)

Query: 73  LPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP 132
                F GL           +K   L  + I     S F +   L  L L  N  +  + 
Sbjct: 264 PDNFTFKGLEASG-------VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315

Query: 133 D--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQ 187
           D  F    +L  +NLS N       R   NL +LE L L+ N +   + D   L LPNL+
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLK 374

Query: 188 QLNLANNNLSGSIP 201
           +L L  N L  S+P
Sbjct: 375 ELALDTNQLK-SVP 387

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 27/140 (19%), Positives = 51/140 (36%), Gaps = 18/140 (12%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD--FINLKSLCYLYLQFNNFSGTLPD--FSVW 137
           +     + L+ L++L+L    + G   S   F  L SL  L L+ NN     P   F   
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLT--QLEALYLANNSLSGKIPDL-----------NLP 184
           +   +++L+ N         L N        L L++ +L   + +               
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNT 212

Query: 185 NLQQLNLANNNLSGSIPQSL 204
           ++  L+L+ N    S+ +  
Sbjct: 213 SITTLDLSGNGFKESMAKRF 232

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 24/149 (16%), Positives = 50/149 (33%), Gaps = 22/149 (14%)

Query: 73  LPGVGFSGLIPPN-TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTL 131
           +           + T+ RLS++ +  +    +      +     S+  L L  N F  ++
Sbjct: 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228

Query: 132 PD--FSVWKNLTIINLSDN-------GFNGTIPRSLSNLT-------QLEALYLANNSLS 175
               F       I +L  +        F  T  +   N T        ++   L+ + + 
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288

Query: 176 GKIPD---LNLPNLQQLNLANNNLSGSIP 201
             +      +  +L+QL LA N ++  I 
Sbjct: 289 -ALLKSVFSHFTDLEQLTLAQNEIN-KID 315

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 35/155 (22%), Positives = 55/155 (35%), Gaps = 25/155 (16%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C++   V C   GK +  +  P    +  +P            + L  N I    P  F 
Sbjct: 11  CSN-NIVDCR--GKGLTEI--P----TN-LPETI-------TEIRLEQNTIKVIPPGAFS 53

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA 170
             K L  + L  N  S  L    F   ++L  + L  N            L  L+ L L 
Sbjct: 54  PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112

Query: 171 NNSLSGKIPD---LNLPNLQQLNLANNNLSGSIPQ 202
            N ++  +      +L NL  L+L +N L  +I +
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 9/119 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           IPP   S    L+ + L +N I+   P  F  L+SL  L L  N  +  LP   F    +
Sbjct: 47  IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFS 105

Query: 140 LTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
           L ++ L+ N  N  +   +  +L  L  L L +N L   I       L  +Q ++LA N
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 19/69 (27%), Positives = 32/69 (46%), Gaps = 5/69 (7%)

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
            +T I L  N      P + S   +L  + L+NN +S ++       L +L  L L  N 
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91

Query: 196 LSGSIPQSL 204
           ++  +P+SL
Sbjct: 92  IT-ELPKSL 99

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 22/228 (9%)

Query: 323 DLLRASAEVLGKGTFGMAYKAILEDG---TTVVVKRLKD---VNVGKRDFEQQMEIVGSI 376
            LL    + LG G FG   K   +      TV VK LK+       K +   +  ++  +
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 377 RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
            +  +V +       +  ++V +   LG ++  L   R      +     + +    + G
Sbjct: 76  DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMG 129

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYR----- 491
           +  +  +N    VH ++ + N+ L +Q Y  +SD GL+    A           +     
Sbjct: 130 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 492 -APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVR 537
            APE  +  K +  SDV+SFGV++ E  + G+ P     G E+  ++ 
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 27/244 (11%)

Query: 302 NQDASNRLFFFEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN 360
           + ++S +L      ++ F  EDL       +G+G +G   K +    G  + VKR+    
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RST 58

Query: 361 VGKRDFEQ-QMEI---VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE 416
           V +++ +Q  M++   + S     +V+     + + +  +  +  S        +     
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118

Query: 417 GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLT 474
               +  +   +I +   + +  +      K++H +IK SNI L+    G +   D G  
Sbjct: 119 DD-VIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRS--GNIKLCDFG-- 171

Query: 475 TITSALAPVIARA--AG---YRAPEVTDSRKATQA----SDVYSFGVVLLEILTGKSPIH 525
            I+  L   IA+   AG   Y APE  D   + Q     SDV+S G+ L E+ TG+ P  
Sbjct: 172 -ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

Query: 526 TTGG 529
               
Sbjct: 231 KWNS 234

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 35/212 (16%)

Query: 330 EVLGKGTFGMA--YKAILED---GTTVVVKRLK-----DVNVGKRDFEQQMEIVGSIRHE 379
            ++G+G  GM   Y+A  ED      V +K +      D     R  +++    G ++  
Sbjct: 40  RLVGRG--GMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEP 94

Query: 380 NVVELKAYYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           +VV +  + + + +    +     +   ++AML   +G    PL     + I       +
Sbjct: 95  HVVPI--HDFGEIDGQLYVDMRLINGVDLAAMLR-RQG----PLAPPRAVAIVRQIGSAL 147

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL------TTITSALAPVIARAAGYR 491
              HAA      H ++K  NI +++  +  + D G+        +T      +     Y 
Sbjct: 148 DAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLY-YM 202

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           APE      AT  +D+Y+   VL E LTG  P
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPP 234

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 45/231 (19%), Positives = 93/231 (40%), Gaps = 28/231 (12%)

Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ-QMEI- 372
           +     +DL       LG+G +G+  K   +  G  + VKR+    V  ++ ++  M++ 
Sbjct: 1   SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLD 57

Query: 373 --VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA 430
             + ++     V      + + +  +  +                   IP D   +  IA
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IA 115

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARA- 487
           +   + +  +H  +   ++H ++K SN+ +N+   G V   D G   I+  L   +A+  
Sbjct: 116 VSIVKALEHLH--SKLSVIHRDVKPSNVLINAL--GQVKMCDFG---ISGYLVDDVAKDI 168

Query: 488 -AG---YRAPEVTDSRKATQA----SDVYSFGVVLLEILTGKSPIHTTGGD 530
            AG   Y APE  +     +     SD++S G+ ++E+   + P  + G  
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 44/245 (17%)

Query: 330 EVLGKGTFGMAYKAILEDG------TTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
             +G+G FG  ++A           T V VK LK+      + DF+++  ++    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           V+L           ++++Y + G ++  L S        L        A  ++ G   + 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 442 A----------ANG------GKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------T 475
                      A G       K VH ++ + N  +       ++D GL+           
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232

Query: 476 ITSALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDEL 532
             +   P+       R   PE     + T  SDV+++GVVL EI + G  P +    +E+
Sbjct: 233 DGNDAIPI-------RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

Query: 533 VHLVR 537
           ++ VR
Sbjct: 286 IYYVR 290

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 33/130 (25%), Positives = 56/130 (43%), Gaps = 12/130 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPDFSVWKNL 140
           +    IS LS L++L L  N I        F+  + L YL +  N     +       +L
Sbjct: 67  LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS-CCPMASL 123

Query: 141 TIINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPDLNLPNLQ----QLNLANN 194
             ++LS N F+  +P      NLT+L  L L+      ++  L + +L      L+L + 
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSY 181

Query: 195 NLSGSIPQSL 204
           ++ G   +SL
Sbjct: 182 HIKGGETESL 191

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 34/155 (21%), Positives = 52/155 (33%), Gaps = 23/155 (14%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVW 137
           +  I        S+   L+   NV T         LK L  L LQ N           + 
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQ----LEALYLANNSLSGKIPDLNLPNLQQLNLAN 193
           KN++ +   D   N     +          +  L L++N L+G +     P ++ L+L N
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHN 459

Query: 194 NNLSGSIPQ----------------SLKRFPSSAF 212
           N +  SIP+                 LK  P   F
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVF 493

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 23/119 (19%), Positives = 49/119 (41%), Gaps = 10/119 (8%)

Query: 84  PNTISRLSALKILSLRSNVIT----GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKN 139
                    +  L      +       +       +S+  L L  N  +G++    +   
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPK 451

Query: 140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNN 195
           + +++L +N    +IP+ +++L  L+ L +A+N L   +PD     L +LQ + L +N 
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 30/158 (18%), Positives = 48/158 (30%), Gaps = 41/158 (25%)

Query: 46  WNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITG 105
            + +       + V  S   + +  V          +PP T       K LSL  N I+ 
Sbjct: 23  GSMTPFSNELESMVDYS--NRNLTHV------PKD-LPPRT-------KALSLSQNSISE 66

Query: 106 YFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE 165
               D   L  L  L L  N    +L                                LE
Sbjct: 67  LRMPDISFLSELRVLRLSHNRIR-SLD----------------------FHVFLFNQDLE 103

Query: 166 ALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQS 203
            L +++N L   I    + +L+ L+L+ N+    +P  
Sbjct: 104 YLDVSHNRLQ-NISCCPMASLRHLDLSFNDFD-VLPVC 139

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 31/221 (14%), Positives = 78/221 (35%), Gaps = 13/221 (5%)

Query: 1   MKALCVFTLIFNLGLIFSKVNAEPVEDKEALLDFVNNLPHSRSLNWNESTSVCNHWTGVK 60
           ++       + +L L   K+N E  +     L  +   P   ++      +       + 
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270

Query: 61  CSEDGKRVVAVRLPGVGFSGLI----PPNTISRLSALKILSLRSNVITGYFPSDFINLKS 116
                + V  + +  +  +  I       + + L +L I  +++ V      + +     
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330

Query: 117 LCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL 174
           +    L  ++ +  +         + T +N + N F  ++ +  S L +L+ L L  N L
Sbjct: 331 MNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389

Query: 175 SGKIPDL-----NLPNLQQLNLANNNLSGSIPQSLKRFPSS 210
                 +     N+ +L+ L+++ N+L+         +  S
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 36/217 (16%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
            + G+GTFG          G +V +K+ ++D     R+  Q M+ +  + H N+V+L++Y
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSY 87

Query: 388 YYSKDEKLM--VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA----------R 435
           +Y+  E+    +Y    +  V   LH      R       R ++A              R
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPDTLH------RC-CRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV---SDLGLTTITSALAP----VIARAA 488
            I  +H  +   + H +IK  N+ +N           D G     S   P    + +R  
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEAD--GTLKLCDFGSAKKLSPSEPNVAYICSRY- 196

Query: 489 GYRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPI 524
            YRAPE+   ++  T A D++S G +  E++ G+ PI
Sbjct: 197 -YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.5 bits (190), Expect = 4e-15
 Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 7/112 (6%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           ++ L  L  L L  N I     S   +LK L  L L+ N  S  +        L  + L 
Sbjct: 83  LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 139

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           +N    T    LS LT+L+ L L +N +S  I  L  L  LQ L L+ N++S
Sbjct: 140 NN--KITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 75.5 bits (185), Expect = 2e-14
 Identities = 29/113 (25%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           T + L+++  +   ++ I          L ++  L+L  N  +  +   +  KNL  + L
Sbjct: 38  TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFL 94

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
            +N     +  SL +L +L++L L +N +S  I  L +LP L+ L L NN ++
Sbjct: 95  DENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 29/136 (21%), Positives = 46/136 (33%), Gaps = 3/136 (2%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +SRL+ L  LSL  N I+         L  L  LYL  N+ S  L   +  KNL ++ L 
Sbjct: 149 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELF 205

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKR 206
                       SNL     +   + SL       +  + ++ N+  +    +   S   
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIF 265

Query: 207 FPSSAFVGNSISFDEN 222
           +           F   
Sbjct: 266 YQPVTIGKAKARFHGR 281

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 20/105 (19%), Positives = 37/105 (35%), Gaps = 5/105 (4%)

Query: 93  LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNG 152
           +      S  I   FP D           L+  + +      +   ++  I  +++    
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK- 56

Query: 153 TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           ++   +  L  +  L+L  N L+   P  NL NL  L L  N + 
Sbjct: 57  SVQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK 100

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 50/279 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVVELK 385
           + LG G +G               +K ++  +V         +++ ++  + H N+++L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 386 AYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
            ++  K    +V + Y  G      +  M  +E     I       ++  +     +  +
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-------IKQVLSG---VTYL 152

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPEV 495
           H  N   +VH ++K  N+ L S++      + D GL+ +      +  R   A Y APEV
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
              +K  +  DV+S GV+L  +L G  P       E++  V               +  +
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-----------KGKYTFD 257

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRM----PDQRPKMPDV 590
              + N+ E        A   + +M      +R      
Sbjct: 258 SPEWKNVSEG-------AKDLIKQMLQFDSQRRISAQQA 289

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 35/227 (15%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           +V+G G+FG+ ++A L +   V +K+   V   KR   ++++I+  ++H NVV+LKA++Y
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 390 SKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA-----ARGIA 438
           S  +K       +V +Y       A  H  + +  +P+         I        R +A
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL-------IKLYMYQLLRSLA 155

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAP----VIARAAGYRAP 493
            IH+     + H +IK  N+ L+       + D G   I  A  P    + +R   YRAP
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--YRAP 210

Query: 494 EVT-DSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVR 537
           E+   +   T   D++S G V+ E++ G+ P+    +G D+LV +++
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIK 256

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 58/245 (23%), Positives = 92/245 (37%), Gaps = 44/245 (17%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENV 381
           + LG+G FG   KA           TTV VK LK+       RD   +  ++  + H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           ++L          L++ +Y   GS+   L   R  G   L        +         + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 442 A----------ANG------GKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------T 475
                      + G       KLVH ++ + NI +   +   +SD GL+           
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 476 ITSALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDEL 532
            +    PV       +  A E       T  SDV+SFGV+L EI+T G +P      + L
Sbjct: 209 RSQGRIPV-------KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261

Query: 533 VHLVR 537
            +L++
Sbjct: 262 FNLLK 266

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 73.2 bits (180), Expect = 8e-15
 Identities = 30/155 (19%), Positives = 59/155 (38%), Gaps = 26/155 (16%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-F 111
           C   T V CS   +++  +  P       IP  T         L L +N  T    +  F
Sbjct: 11  CE-GTTVDCS--NQKLNKI--P----EH-IPQYT-------AELRLNNNEFTVLEATGIF 53

Query: 112 INLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYL 169
             L  L  +    N  +  + +  F     +  I L+ N       +    L  L+ L L
Sbjct: 54  KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112

Query: 170 ANNSLSGKIPD---LNLPNLQQLNLANNNLSGSIP 201
            +N ++  + +   + L +++ L+L +N ++ ++ 
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVA 145

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 23/116 (19%), Positives = 37/116 (31%), Gaps = 27/116 (23%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I        S +  + L SN +       F  L+SL  L L+ N  +  +          
Sbjct: 72  IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVG--------- 121

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
                          S   L+ +  L L +N ++  +       L +L  LNL  N
Sbjct: 122 -------------NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 54/171 (31%), Positives = 71/171 (41%), Gaps = 36/171 (21%)

Query: 51  SVC---NHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYF 107
            VC   N+   V CS   K++ A+  P    S  IP +T       K L L+SN ++   
Sbjct: 10  GVCSCNNNKNSVDCS--SKKLTAI--P----SN-IPADT-------KKLDLQSNKLSSLP 53

Query: 108 PSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSL-SNLTQL 164
              F  L  L  LYL  N    TLP   F   KNL  + ++DN     +P  +   L  L
Sbjct: 54  SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNL 111

Query: 165 EALYLANN---SLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAF 212
             L L  N   SL  ++ D +L  L  L+L  N L     QSL   P   F
Sbjct: 112 AELRLDRNQLKSLPPRVFD-SLTKLTYLSLGYNEL-----QSL---PKGVF 153

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 37/126 (29%), Positives = 56/126 (44%), Gaps = 10/126 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P     RL+ L++L L  N +       F  LK+L  L++  N     LP   F    N
Sbjct: 52  LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVN 110

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           L  + L  N    ++P  +  +LT+L  L L  N L   +P      L +L++L L NN 
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQ 168

Query: 196 LSGSIP 201
           L   +P
Sbjct: 169 LK-RVP 173

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 36/126 (28%), Positives = 54/126 (42%), Gaps = 10/126 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P      L  L+ L +  N +       F  L +L  L L  N    +LP   F     
Sbjct: 76  LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK 134

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           LT ++L  N    ++P+ +   LT L+ L L NN L  ++P+     L  L+ L L NN 
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192

Query: 196 LSGSIP 201
           L   +P
Sbjct: 193 LK-RVP 197

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 35/120 (29%), Positives = 52/120 (43%), Gaps = 11/120 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           +P     +L  L  L L  N +    P   F +L  L YL L +N    +LP   F    
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157

Query: 139 NLTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
           +L  + L +N     +P      LT+L+ L L NN L  ++P+    +L  L+ L L  N
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 28/224 (12%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           +V+G G+FG+ Y+A L + G  V +K+   V   KR   ++++I+  + H N+V L+ ++
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 389 YSKDEKL------MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI-GAARGIARIH 441
           YS  EK       +V DY          H  R +  +P+     +++ +    R +A IH
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLFRSLAYIH 173

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYG---CVSDLGLTTITSALAPVIARAAG--YRAPEVT 496
           +     + H +IK  N+ L+        C  D G         P ++      YRAPE+ 
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 497 -DSRKATQASDVYSFGVVLLEILTGKSPIH--TTGGDELVHLVR 537
             +   T + DV+S G VL E+L G+ PI    +G D+LV +++
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIK 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 44/284 (15%), Positives = 105/284 (36%), Gaps = 50/284 (17%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRH--ENVVEL 384
           + +G G     ++ + E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             Y  +     MV +      +++ L  ++      +D   R          +  IH   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARA--AG---YRAPEV-- 495
              +VH ++K +N  +     G +   D G+          + +    G   Y  PE   
Sbjct: 176 ---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 496 ---------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE 546
                        K +  SDV+S G +L  +  GK+P       ++++ +  +H+++   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDP- 283

Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                 + E+      E+++ ++L+    C+ R P QR  +P++
Sbjct: 284 ------NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 6/111 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +  L+ L+ LS+  N +      + I    L  L+L  N            KNL I+++ 
Sbjct: 81  LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELR-DTDSLIHLKNLEILSIR 136

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +N    +I   L  L++LE L L  N ++       L  +  ++L      
Sbjct: 137 NNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 6/111 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
              L+     +L    +T         L  +       +N   +L     + NL  ++LS
Sbjct: 15  DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLS 71

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            N  +  +   L +LT+LE L +  N L   +  +    L +L L NN L 
Sbjct: 72  HNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 8/112 (7%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +   + LK L L  N I+    S   +L  L  L +  N     L        L+ + L 
Sbjct: 59  MQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLK-NLNGIP-SACLSRLFLD 114

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           +N        SL +L  LE L + NN L   I  L  L  L+ L+L  N ++
Sbjct: 115 NN--ELRDTDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT 163

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 28/134 (20%)

Query: 88  SRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD 147
           +    L+ L +  N +T   P     L  L        +    LP       L  + +  
Sbjct: 78  ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPS-----GLCKLWIFG 130

Query: 148 NGFNGTIPRSLSNLT-----------------QLEALYLANNSLSGKIPDLNLPNLQQLN 190
           N    ++P     L                  +L  L+  NN L+  +P L    LQ+L+
Sbjct: 131 NQLT-SLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPML-PSGLQELS 187

Query: 191 LANNNLSGSIPQSL 204
           +++N L+ S+P   
Sbjct: 188 VSDNQLA-SLPTLP 200

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 32/142 (22%), Positives = 55/142 (38%), Gaps = 17/142 (11%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTII 143
           P   S L  L   + R   +    P+    LK L    +  N  + +LP       L  +
Sbjct: 197 PTLPSELYKLWAYNNRLTSL----PALPSGLKEL---IVSGNRLT-SLPVL--PSELKEL 246

Query: 144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSGSIP 201
            +S N    ++P   S L  L    +  N L+ ++P+  ++L +   +NL  N LS    
Sbjct: 247 MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301

Query: 202 QSLKRFPSSAFVGNSISFDENL 223
           Q+L+   S+      I   +  
Sbjct: 302 QALREITSAPGYSGPIIRFDMA 323

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 23/116 (19%), Positives = 43/116 (37%), Gaps = 13/116 (11%)

Query: 89  RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDN 148
             +   +L++  + +T   P        +  L +  NN + +LP   +   L  + +S N
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA--LPPELRTLEVSGN 91

Query: 149 GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSL 204
               ++P     L +L         L    P L    L +L +  N L+ S+P   
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHL----PAL-PSGLCKLWIFGNQLT-SLPVLP 140

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 30/115 (26%), Positives = 52/115 (45%), Gaps = 14/115 (12%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
              L+ LS+  N +    P+    L  L   +   N  + +LP   +   L  +++SDN 
Sbjct: 140 PPGLQELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPM--LPSGLQELSVSDNQ 192

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSL 204
              ++P   S L +L A    NN L+  +P L    L++L ++ N L+ S+P   
Sbjct: 193 LA-SLPTLPSELYKLWAY---NNRLT-SLPAL-PSGLKELIVSGNRLT-SLPVLP 240

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 21/119 (17%), Positives = 34/119 (28%), Gaps = 6/119 (5%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDN 148
            S LK L +  N +T   P     L SL    +  N  +  LP+      + T +NL  N
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 149 GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRF 207
             +    ++L  +T                             A + L  +        
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 50/227 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR--LKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           EV+G G   +   A        V +KR  L+       +  ++++ +    H N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS--- 77

Query: 387 YY--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI---GAARGIARI 440
           YY  +   ++L +V    S GSV  ++     +G           IA        G+  +
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLG----LTTITSAL-------------- 480
           H       +H ++K+ NI L     G V  +D G    L T                   
Sbjct: 138 H---KNGQIHRDVKAGNILLGED--GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 481 -AP-VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
            AP V+ +  GY         KA    D++SFG+  +E+ TG +P H
Sbjct: 193 MAPEVMEQVRGY-------DFKA----DIWSFGITAIELATGAAPYH 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 44/287 (15%), Positives = 101/287 (35%), Gaps = 56/287 (19%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRH--ENVVEL 384
           + +G G     ++ + E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             Y  +     MV +      +++ L  ++      +D   R          +  IH   
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAA-----GYRAPEV-- 495
              +VH ++K +N  +     G +   D G+          + + +      Y  PE   
Sbjct: 148 ---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 496 ---------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG--DELVHLVRWVHSVVR 544
                        K +  SDV+S G +L  +  GK+P         +L  ++   H +  
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 259

Query: 545 EEWTAEVFDVELLRYPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                         +P+  E+++ ++L+    C+ R P QR  +P++
Sbjct: 260 -------------EFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 290

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 25/142 (17%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFP-SDFINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           +P  T        +L L  N ++          L +L  L L  N+ +  +    F    
Sbjct: 37  LPSYT-------ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 139 NLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
           NL  ++LS N  + T+     S+L  LE L L NN +   +      ++  LQ+L L+ N
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146

Query: 195 NLSGSIPQSLKRFPSSAFVGNS 216
            +S        RFP       +
Sbjct: 147 QIS--------RFPVELIKDGN 160

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 17/152 (11%)

Query: 82  IPPNTI-SRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPD--FSVW 137
           +      +RL+ L  L L  N +  +  S+ F+ + +L YL L  N+   TL +  FS  
Sbjct: 54  LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDL 111

Query: 138 KNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPD------LNLPNLQQLN 190
           + L ++ L +N     + R +  ++ QL+ LYL+ N +S + P         LP L  L+
Sbjct: 112 QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169

Query: 191 LANNNLSGSIPQSLKRFPSSAFVGNSISFDEN 222
           L++N L       L++ P+   V N +    N
Sbjct: 170 LSSNKLKKLPLTDLQKLPAW--VKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 33/126 (26%), Positives = 50/126 (39%), Gaps = 14/126 (11%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           I       +  L+ L L SN +       F +L++L  L L  N+    +    F     
Sbjct: 79  ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQ 137

Query: 140 LTIINLSDNGFNGTIP----RSLSNLTQLEALYLANNSLSGKIPD---LNLPNLQQ--LN 190
           L  + LS N  +   P    +  + L +L  L L++N L  K+P      LP   +  L 
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLY 195

Query: 191 LANNNL 196
           L NN L
Sbjct: 196 LHNNPL 201

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 44/287 (15%), Positives = 101/287 (35%), Gaps = 56/287 (19%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRH--ENVVEL 384
           + +G G     ++ + E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             Y  +     MV +      +++ L  ++      +D   R          +  IH   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAA-----GYRAPEV-- 495
              +VH ++K +N  +     G +   D G+          + + +      Y  PE   
Sbjct: 129 ---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 496 ---------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG--DELVHLVRWVHSVVR 544
                        K +  SDV+S G +L  +  GK+P         +L  ++   H +  
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 240

Query: 545 EEWTAEVFDVELLRYPN-IEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                         +P+  E+++ ++L+    C+ R P QR  +P++
Sbjct: 241 -------------EFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 51/280 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKR----DFEQQMEIVGSIRHENVVEL 384
            VLGKG+FG          G    VK +    V ++       ++++++  + H N+++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 385 KAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
             ++  K    +V + Y+ G      +S    SE    RI       +R  +     I  
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-------IRQVLSG---ITY 141

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPE 494
           +H      +VH ++K  N+ L S+       + D GL+T   A   +  +   A Y APE
Sbjct: 142 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
           V       +  DV+S GV+L  +L+G  P +     +++  V               +  
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-----------KGKYTF 246

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRM----PDQRPKMPDV 590
           EL ++  + E        A   + +M    P  R    D 
Sbjct: 247 ELPQWKKVSES-------AKDLIRKMLTYVPSMRISARDA 279

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 45/243 (18%)

Query: 330 EVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RH 378
           + LG+G FG    A          ++  TV VK LKD        D   +ME++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------M 427
           +N++ L           ++ +Y S G++   L + R  G        R           +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TIT 477
                 ARG+  + A+   K +H ++ + N+ +       ++D GL             T
Sbjct: 161 SCTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 478 SALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVH 534
           +   PV       +  APE    R  T  SDV+SFGV++ EI T G SP      +EL  
Sbjct: 218 NGRLPV-------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

Query: 535 LVR 537
           L++
Sbjct: 271 LLK 273

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 29/113 (25%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL 145
           T + L+++  +   ++ I          L ++  L+L  N  +  +   +  KNL  + L
Sbjct: 41  TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFL 97

Query: 146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
            +N     +  SL +L +L++L L +N +S  I  L +LP L+ L L NN ++
Sbjct: 98  DENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 7/112 (6%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +  L  LK LSL  N I+    +  ++L  L  LYL  N  +  +   S    L  ++L 
Sbjct: 108 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLE 164

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLS 197
           DN    +    L+ LT+L+ LYL+ N +S  +  L  L NL  L L +    
Sbjct: 165 DNQI--SDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 6/109 (5%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +  L  L+ L L +N IT    +    L  L  L L+ N  S  +   +    L  + LS
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLS 186

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNN 195
            N  + +  R+L+ L  L+ L L +       P  +  NL   N   N 
Sbjct: 187 KN--HISDLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNT 232

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 5/102 (4%)

Query: 96  LSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIP 155
                  I   F  D           L+  + +      +   ++  I  +++    ++ 
Sbjct: 7   TITVPTPIKQIFSDD--AFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQ 62

Query: 156 RSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
             +  L  +  L+L  N L+   P  NL NL  L L  N + 
Sbjct: 63  -GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK 103

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 27/111 (24%), Positives = 42/111 (37%), Gaps = 3/111 (2%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           +SRL+ L  LSL  N I+         L  L  LYL  N+ S  L   +  KNL ++ L 
Sbjct: 152 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELF 208

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
                       SNL     +   + SL       +  + ++ N+  +   
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 32/131 (24%), Positives = 52/131 (39%), Gaps = 12/131 (9%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLPDFS---VW 137
           I P     L  L+ L + +  I  + P    I+      L +Q N    T+   S   + 
Sbjct: 95  INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYL-ANNSLSGKIPD---LNLPNLQQLNLAN 193
               I+ L+ NG    I  S  N TQL+ L L  NN+L  ++P+           L+++ 
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211

Query: 194 NNLSGSIPQSL 204
             +  S+P   
Sbjct: 212 TRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 23/139 (16%), Positives = 45/139 (32%), Gaps = 21/139 (15%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P N          L      +       F     L  + +  N+    +    FS    
Sbjct: 28  LPRNA-------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 140 LTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNN 195
           L  I +        I   +  NL  L+ L ++N  +   +PD+   +      L++ +N 
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139

Query: 196 LSGSIPQSLKRFPSSAFVG 214
                  ++     ++FVG
Sbjct: 140 -------NIHTIERNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 32/117 (27%), Positives = 43/117 (36%), Gaps = 8/117 (6%)

Query: 82  IPPNTISRLSA-LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWK 138
           I  N+   LS    IL L  N I     +   N   L  L L  NN    LP+  F    
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANN 194
              I+++S    +      L NL +L A    N     K+P L  L  L + +L   
Sbjct: 203 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 3/92 (3%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           I  +  +     ++    +N +       F        L +       +LP     +NL 
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS-YGLENLK 226

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNS 173
            +          +P +L  L  L    L   S
Sbjct: 227 KLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 44/228 (19%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHEN 380
           + LG+G FG   +A            TV VK LK+   +   R    +++I+  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 381 VVELKAYYYSKDEKLMV-YDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------MR 428
           VV L          LMV  ++   G++S  L S+R E                     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITS 478
            +   A+G+  + +    K +H ++ + NI L+ +    + D GL               
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 479 ALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           A  P+       +  APE    R  T  SDV+SFGV+L EI + G SP
Sbjct: 210 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.3 bits (179), Expect = 9e-14
 Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 9/119 (7%)

Query: 83  PPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTI 142
                   + +++L L    +T         L  + +L L  N      P  +  + L +
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL----NLPNLQQLNLANNNLS 197
           +  SDN     +   ++NL +L+ L L NN L  +   +    + P L  LNL  N+L 
Sbjct: 491 LQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 45/243 (18%)

Query: 330 EVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RH 378
           + LG+G FG    A             T V VK LK         D   +ME++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-----------M 427
           +N++ L           ++ +Y S G++   L + R  G       +            +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI----------T 477
             A   ARG+  + A+   K +H ++ + N+ +       ++D GL             T
Sbjct: 195 SCAYQVARGMEYL-ASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 478 SALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVH 534
           +   PV       +  APE    R  T  SDV+SFGV+L EI T G SP      +EL  
Sbjct: 252 NGRLPV-------KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 535 LVR 537
           L++
Sbjct: 305 LLK 307

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 47/230 (20%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSI-RHEN 380
           + LG G FG   +A        +   TV VK LK       +     +++++  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-------------M 427
           +V L          L++ +Y   G +   L  +R                         +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIAR 486
             +   A+G+A + +      +H ++ + NI L +      + D GL       A  I  
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNI-LLTHGRITKICDFGL-------ARDIKN 197

Query: 487 AAGYR------------APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
            + Y             APE   +   T  SDV+S+G+ L E+ + G SP
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 54/290 (18%), Positives = 103/290 (35%), Gaps = 61/290 (21%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK--------------DVNVGKRDFEQQMEIVG 374
             LG G +G           +   +K +K              ++     +   ++ ++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRI 429
           S+ H N+++L   +  K    +V ++Y  G      ++     E     I       M+ 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-------MKQ 154

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIAR 486
            +     I  +H  N   +VH +IK  NI L ++       + D GL++  S    +  R
Sbjct: 155 ILSG---ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 487 A--AGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR 544
              A Y APEV   +K  +  DV+S GV++  +L G  P       +++  V        
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE------- 260

Query: 545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRM----PDQRPKMPDV 590
                  +  +   + NI +E       A   +  M     ++R    + 
Sbjct: 261 ----KGKYYFDFNDWKNISDE-------AKELIKLMLTYDYNKRCTAEEA 299

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 33/209 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR--LKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           E +GKG+FG  +K I       V +K   L++      D +Q++ ++       V +   
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK--- 84

Query: 387 YY--YSKDEKL-MVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARGIARIHA 442
           YY  Y KD KL ++ +Y   GS   +L      E +I         I     +G+  +H+
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLHS 137

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARA---AG---YRAPE 494
               K +H +IK++N+ L+    G V  +D G   +   L     +     G   + APE
Sbjct: 138 E---KKIHRDIKAANVLLSEH--GEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSP 523
           V         +D++S G+  +E+  G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 45/243 (18%)

Query: 330 EVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RH 378
           + LG+G FG    A          ++  TV VK LKD        D   +ME++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRI-----------PLDWDTRM 427
           +N++ L           ++ +Y S G++   L + R  G              + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TIT 477
                 ARG+  + A+   K +H ++ + N+ +       ++D GL             T
Sbjct: 207 SCTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 478 SALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVH 534
           +   PV       +  APE    R  T  SDV+SFGV++ EI T G SP      +EL  
Sbjct: 264 NGRLPV-------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

Query: 535 LVR 537
           L++
Sbjct: 317 LLK 319

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 14/133 (10%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
            ++L+ L    N ++   P    +LK   +L +  N  +  LP+  +   L  IN  +N 
Sbjct: 99  PASLEYLDACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPE--LPALLEYINADNNQ 151

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
               +P   ++L     L + NN L+  +P+L   +L+ L+++ N L  S+P    R   
Sbjct: 152 LT-MLPELPTSLEV---LSVRNNQLT-FLPEL-PESLEALDVSTNLLE-SLPAVPVRNHH 204

Query: 210 SAFVGNSISFDEN 222
           S          EN
Sbjct: 205 SEETEIFFRCREN 217

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 26/126 (20%), Positives = 52/126 (41%), Gaps = 14/126 (11%)

Query: 82  IPPNTISRLSALKILSLRS---NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWK 138
              +  S     +  +L     N            +     L L   N S +LPD ++  
Sbjct: 25  TYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPD-NLPP 80

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG 198
            +T++ ++ N    ++P   ++L  L      +N LS  +P+L   +L+ L++ NN L+ 
Sbjct: 81  QITVLEITQNAL-ISLPELPASLEYL---DACDNRLS-TLPEL-PASLKHLDVDNNQLT- 133

Query: 199 SIPQSL 204
            +P+  
Sbjct: 134 MLPELP 139

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 26/136 (19%), Positives = 54/136 (39%), Gaps = 27/136 (19%)

Query: 88  SRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD 147
             ++    L L    ++   P +      +  L +  N    +LP+     +L  ++  D
Sbjct: 56  CLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPELP--ASLEYLDACD 109

Query: 148 NGFNGTIPRSLSNLT-----------------QLEALYLANNSLSGKIPDLNLPNLQQLN 190
           N  + T+P   ++L                   LE +   NN L+  +P+L   +L+ L+
Sbjct: 110 NRLS-TLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLT-MLPEL-PTSLEVLS 166

Query: 191 LANNNLSGSIPQSLKR 206
           + NN L+  +P+  + 
Sbjct: 167 VRNNQLT-FLPELPES 181

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 17/122 (13%), Positives = 37/122 (30%), Gaps = 7/122 (5%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSL----CYLYLQFNNFSGTLPD-FSVWKNLTIIN 144
             +L+ L + +N++    P+  +          +   + N  +  +P+          I 
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236

Query: 145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSL 204
           L DN  +  I  SLS  T     +      S      N  +    +        +    +
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDV 296

Query: 205 KR 206
            +
Sbjct: 297 SQ 298

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 26/94 (27%), Positives = 35/94 (37%), Gaps = 5/94 (5%)

Query: 113 NLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLA 170
           N  SL      +N  SGT  D FS W       L     N  +       + Q   L L 
Sbjct: 9   NNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLN 67

Query: 171 NNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSL 204
             +LS  +PD   P +  L +  N L  S+P+  
Sbjct: 68  RLNLS-SLPDNLPPQITVLEITQNALI-SLPELP 99

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 13/75 (17%), Positives = 23/75 (30%), Gaps = 10/75 (13%)

Query: 142 IINLSDNGFNGTIP-------RSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANN 194
             +LS N F  TI         +     +        N     + +  +    +L L   
Sbjct: 10  NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRL 69

Query: 195 NLS---GSIPQSLKR 206
           NLS    ++P  +  
Sbjct: 70  NLSSLPDNLPPQITV 84

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 50/279 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
            +LGKG+FG   K           VK +   +   +D     +++E++  + H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 386 AYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
                     +V + Y+ G      +     SE    RI       ++        I  +
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFSG---ITYM 137

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPEV 495
           H  N   +VH ++K  NI L S++  C   + D GL+T       +  R   A Y APEV
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
                  +  DV+S GV+L  +L+G  P +     +++  V               +  +
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-----------TGKYAFD 242

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRM----PDQRPKMPDV 590
           L ++  I ++       A   + +M    P  R      
Sbjct: 243 LPQWRTISDD-------AKDLIRKMLTFHPSLRITATQC 274

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 44/232 (18%), Positives = 82/232 (35%), Gaps = 52/232 (22%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQ-QMEI---VGSIRHENVVELK 385
           ++LG G+ G         G  V VKR+          +   MEI     S  H NV+   
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR-------GIA 438
               +     +  +       +  L  +  E +   D + +++              G+A
Sbjct: 76  CSETTDRFLYIALEL-----CNLNLQ-DLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGC-------------VSDLGLTTI----TSALA 481
            +H+     ++H ++K  NI +++                  +SD GL        S+  
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 482 PVIARAAG---YRAPEV-------TDSRKATQASDVYSFGVVLLEILTGKSP 523
             +   +G   +RAPE+          R+ T++ D++S G V   IL+    
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 45/211 (21%), Positives = 80/211 (37%), Gaps = 16/211 (7%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVEL 384
             LGKG F   ++    +       K +    + K    ++M     I  S+ H++VV  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             ++   D   +V +     S+  +    +    +  + + R         G   +H   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT-EPEAR-YYLRQIVLGCQYLHRN- 160

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKA 501
             +++H ++K  N+FLN      + D GL T             G   Y APEV   +  
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           +   DV+S G ++  +L GK P  T+   E 
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 45/241 (18%), Positives = 87/241 (36%), Gaps = 58/241 (24%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR-LKDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           + LG G+FG+  +   +E G    +K+ L+D     R    +++I+  + H N+++L  Y
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDY 68

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR--------------------M 427
           +Y+  ++                 +                                  +
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 428 RIAIGAA----------------RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--- 468
           +  I +                 R +  IH+     + H +IK  N+ +NS+        
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD--NTLKL 183

Query: 469 SDLGLTTITSALAP----VIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSP 523
            D G         P    + +R   YRAPE+   + + T + D++S G V  E++ GK P
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-P 240

Query: 524 I 524
           +
Sbjct: 241 L 241

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 45/211 (21%), Positives = 79/211 (37%), Gaps = 16/211 (7%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVEL 384
             LGKG F   ++    +       K +    + K    ++M     I  S+ H++VV  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             ++   D   +V +     S+  +    +    +    + R         G   +H   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEP-EAR-YYLRQIVLGCQYLHRN- 134

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKA 501
             +++H ++K  N+FLN      + D GL T             G   Y APEV   +  
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           +   DV+S G ++  +L GK P  T+   E 
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 41/225 (18%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHEN 380
           + LG G FG   +A        +    V VK LK       K     +++I+  + +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSER---------GEGRIPLDWDTRMRIAI 431
           +V L          L++ +Y   G +   L  +                      +  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT----------TITSALA 481
             A+G+A + A+     +H ++ + N+ L +     + D GL              +A  
Sbjct: 172 QVAQGMAFL-ASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 482 PVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSP 523
           PV       +  APE       T  SDV+S+G++L EI + G +P
Sbjct: 229 PV-------KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 46/218 (21%), Positives = 77/218 (35%), Gaps = 36/218 (16%)

Query: 330 EVLGKG--TFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ-QMEIV--GSIRHENVVE 383
            V+GKG         A     G  V V+R+             Q E+       H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 384 LKAYY--YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI---GAARGI 437
              Y   +  D +L +V  + + GS   ++ +   +G +         IA    G  + +
Sbjct: 91  ---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELA-----IAYILQGVLKAL 141

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAGYR-- 491
             IH  + G  VH ++K+S+I ++      +S L     + +       V          
Sbjct: 142 DYIH--HMGY-VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 492 ----APEVTDSRKA--TQASDVYSFGVVLLEILTGKSP 523
               +PEV           SD+YS G+   E+  G  P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 46/217 (21%), Positives = 77/217 (35%), Gaps = 38/217 (17%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRD---FEQQM-------EI--VGSIR 377
             +  G++G     +  +G  V +KR+ +     R                EI  +    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 378 HENVVELKAYYYSKDEKLM--VYDYYSLGSVSAM---LHSERGEGRIPLDWDTRMRIAIG 432
           H N++ L+  +   +E  M  +Y    L     M   L     + RI +           
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYH 142

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP----VIA 485
              G+  +H A    +VH ++   NI L          + D  L    +A A     V  
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADN---NDITICDFNLAREDTADANKTHYVTH 196

Query: 486 RAAGYRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
           R   YRAPE+    +  T+  D++S G V+ E+   K
Sbjct: 197 RW--YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 63/224 (28%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EIV--GSIRHE 379
           + +G G  G+   A        V +K+L         F+ Q        E+V    + H+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG------RIPLDWDTRMRIAIGA 433
           N++ L   +  +       D Y        L  E  +       ++ LD +    +    
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVY--------LVMELMDANLCQVIQMELDHERMSYLLYQM 173

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG- 489
             GI  +H+A    ++H ++K SNI + S    C   + D GL           AR AG 
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSD---CTLKILDFGL-----------ARTAGT 216

Query: 490 ------------YRAPEVTDSRKATQASDVYSFGVVLLEILTGK 521
                       YRAPEV       +  D++S G ++ E++  K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 30/207 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E LG+G++G  YKAI  E G  V +K++  V    ++  +++ I+      +VV+   YY
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVK---YY 90

Query: 389 --YSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             Y K+  L +V +Y   GSVS ++          L  D    I     +G+  +H    
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHF--- 143

Query: 446 GKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA-LAPVIARAA---G---YRAPEVT 496
            + +H +IK+ NI LN++  G    +D G+    +  L   +A+     G   + APEV 
Sbjct: 144 MRKIHRDIKAGNILLNTE--GHAKLADFGV----AGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSP 523
                   +D++S G+  +E+  GK P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 55/251 (21%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHEN 380
           +VLG G FG    A             V VK LK+   +  +     +++++  +  HEN
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR-------------- 426
           +V L           ++++Y   G +   L S+R +                        
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 427 ----MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT-------- 474
               +  A   A+G+           VH ++ + N+ +   +   + D GL         
Sbjct: 171 FEDLLCFAYQVAKGME--FLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 475 --TITSALAPVIARAAGYR--APEVTDSRKATQASDVYSFGVVLLEILT-GKSP---IHT 526
                +A  PV       +  APE       T  SDV+S+G++L EI + G +P   I  
Sbjct: 228 YVVRGNARLPV-------KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280

Query: 527 TGGDELVHLVR 537
                   L++
Sbjct: 281 --DANFYKLIQ 289

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 42/215 (19%), Positives = 82/215 (38%), Gaps = 39/215 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKA 386
             LG G FG  YKA   E G     K + +        D+  ++EI+ +  H  +V+L  
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLG 83

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            YY   +  ++ ++   G+V A++          L       +       +  +H+    
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS---K 136

Query: 447 KLVHGNIKSSNIFLNSQQYGCV--SDLGLTT-ITSALAPVIARAAGYR----------AP 493
           +++H ++K+ N+ +  +  G +  +D G++      L          R          AP
Sbjct: 137 RIIHRDLKAGNVLMTLE--GDIRLADFGVSAKNLKTLQK--------RDSFIGTPYWMAP 186

Query: 494 EVTDSRKATQAS-----DVYSFGVVLLEILTGKSP 523
           EV               D++S G+ L+E+   + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 29/216 (13%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELKA 386
           LGKG+F   Y+A  +  G  V +K +    + K    Q++    +I   ++H +++EL  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR--MRIAIGA-----ARGIAR 439
           Y+   +   +V +    G ++  L +         + + R  M   I       + GI  
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFS-ENEARHFMHQIITGMLYLHSHGI-- 133

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVT 496
                    +H ++  SN+ L       ++D GL T             G   Y +PE+ 
Sbjct: 134 ---------LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                   SDV+S G +   +L G+ P  T      
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 46/222 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVE---- 383
           E++G GT+G  YK   ++ G    +K +      + + +Q++ ++     H N+      
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 384 -LKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI---GAARGIA 438
            +K      D++L +V ++   GSV+ ++ + +G   +  +W     IA       RG++
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEW-----IAYICREILRGLS 143

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAGYR----- 491
            +H     K++H +IK  N+ L       V   D G+    SA    + R  G R     
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTEN--AEVKLVDFGV----SAQ---LDRTVGRRNTFIG 191

Query: 492 -----APEVTDSRKATQAS-----DVYSFGVVLLEILTGKSP 523
                APEV    +   A+     D++S G+  +E+  G  P
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 32/208 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK-DVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y A+ +  G  V ++++       K     ++ ++   ++ N+V    Y
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---Y 82

Query: 388 Y--YSKDEKL-MVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARGIARIHAA 443
              Y   ++L +V +Y + GS++ ++      EG+I         +     + +  +H+ 
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHS- 134

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAA---G---YRAPEV 495
              +++H +IKS NI L     G V  +D G     + + P  ++ +   G   + APEV
Sbjct: 135 --NQVIHRDIKSDNILLGMD--GSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
              +      D++S G++ +E++ G+ P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 67/226 (29%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EIV--GSIRHE 379
           + +G G  G+   A        V +K+L         F+ Q        E+V    + H+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84

Query: 380 NVVELKAYYYSKDEKLMVYDYY--------SLGSVSAMLHSERGEGRIPLDWDTRMRIAI 431
           N++ L   +  +       D Y        +L  V           ++ LD +    +  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI----------QMELDHERMSYLLY 134

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAA 488
               GI  +H+A    ++H ++K SNI + S    C   + D GL           AR A
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSD---CTLKILDFGL-----------ARTA 177

Query: 489 G-------------YRAPEVTDSRKATQASDVYSFGVVLLEILTGK 521
           G             YRAPEV       +  D++S G ++ E++ G 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 63.2 bits (154), Expect = 1e-11
 Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 23/128 (17%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFI----NLKSLCYLYLQFNNFSGTLPDFSVWKNLTI 142
           +S L A K L+L +N I        I     +++L  L L  N         +V   L  
Sbjct: 44  LSTLKACKHLALSTNNIEK------ISSLSGMENLRILSLGRNLIKKIENLDAVADTLEE 97

Query: 143 INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-------NLPNLQQLNLANNN 195
           + +S N    ++   +  L  L  LY++NN    KI +         L  L+ L LA N 
Sbjct: 98  LWISYNQIA-SL-SGIEKLVNLRVLYMSNN----KITNWGEIDKLAALDKLEDLLLAGNP 151

Query: 196 LSGSIPQS 203
           L     ++
Sbjct: 152 LYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 7e-08
 Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 5/80 (6%)

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           L+             S  K    + LS N     I  SLS +  L  L L  N +  KI 
Sbjct: 30  LHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIE 86

Query: 180 DL--NLPNLQQLNLANNNLS 197
           +L      L++L ++ N ++
Sbjct: 87  NLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 5/65 (7%)

Query: 136 VWKNLTIINLSDNGFNG--TIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLA 192
           V      + L          +  +LS L   + L L+ N++  KI  L  + NL+ L+L 
Sbjct: 21  VATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLG 78

Query: 193 NNNLS 197
            N + 
Sbjct: 79  RNLIK 83

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 31/216 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRD-FEQQMEIVGSIRHENVVEL-- 384
           E LG G FG   + I  + G  V +K+  ++++   R+ +  +++I+  + H NVV    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 385 ----KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
                      D  L+  +Y   G +   L+       +  +   R  +    +  +  +
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIR-TLLSDISSALRYL 137

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTI---TSALA-----PVIARAAG 489
           H      ++H ++K  NI L          + DLG                         
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL------Q 188

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIH 525
           Y APE+ + +K T   D +SFG +  E +TG  P  
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++ +    G   V K +     + K   + ++ I+  + H  ++ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRM--RIAIGAAR----GIAR 439
           +  K E +++ ++ S G          GE   RI    D +M     I   R    G+  
Sbjct: 117 FEDKYEMVLILEFLS-G----------GELFDRI-AAEDYKMSEAEVINYMRQACEGLKH 164

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI--TSALAPVIARAAGYRAPEV 495
           +H  +   +VH +IK  NI   +++   V   D GL T      +  V    A + APE+
Sbjct: 165 MHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
            D       +D+++ GV+   +L+G SP
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 38/226 (16%), Positives = 74/226 (32%), Gaps = 45/226 (19%)

Query: 331 VLGKGTFGMAYKAILEDGTTVVVKRLK--------------DVNVGKRDFEQQM----EI 372
            L +G F        +D     +K+ +              +  +  +          +I
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 373 VGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG 432
           +  I++E  +  +    + DE  ++Y+Y    S+              LD +    I I 
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF-----VLDKNYTCFIPIQ 151

Query: 433 AARGIAR--------IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-- 482
             + I +        IH      + H ++K SNI ++      +SD G     S      
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE----SEYMVDK 205

Query: 483 VIARAAG---YRAPEVTDSRKAT--QASDVYSFGVVLLEILTGKSP 523
            I  + G   +  PE   +  +      D++S G+ L  +     P
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 27/207 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++      G     K +       K    ++++ +  +RH  +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIGAAR----GIARI 440
           +   +E +M+Y++ S G +   +  E     E             A+   R    G+  +
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----------DEAVEYMRQVCKGLCHM 271

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI--TSALAPVIARAAGYRAPEVT 496
           H  N    VH ++K  NI   +++   +   D GLT          V    A + APEV 
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSP 523
           + +     +D++S GV+   +L+G SP
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 48/216 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EIV--GSIRHE 379
             +G G +G    AI    G  V +K+L         F+ ++       E++    ++HE
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83

Query: 380 NVVELK-----AYYYSKDEKL-MVYDY--YSLGSVSAMLHSERGEGRIPLDWDTRMRIAI 431
           NV+ L      A          +V  +    L  +            +    +    +  
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM----------GLKFSEEKIQYLVY 133

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLT-TITSALAP-VIAR 486
              +G+  IH+A    +VH ++K  N+ +N     C   + D GL     + +   V+ R
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNED---CELKILDFGLARHADAEMTGYVVTR 187

Query: 487 AAGYRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
              YRAPEV        Q  D++S G ++ E+LTGK
Sbjct: 188 W--YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 47/166 (28%), Positives = 62/166 (37%), Gaps = 23/166 (13%)

Query: 53  CNHW-TGVKCSEDGKRVVAV-----------RLPGVGFSGLIPPNTISRLSALKILSLRS 100
           CN     V C   GK + +V            L   G + L    T   L+ L  L+L  
Sbjct: 12  CNEGKKEVDCQ--GKSLDSVPSGIPADTEKLDLQSTGLATL-SDATFRGLTKLTWLNLDY 68

Query: 101 NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSL 158
           N +       F +L  L  L L  N  + +LP   F     L  + L  N          
Sbjct: 69  NQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF 127

Query: 159 SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNLSGSIP 201
             LT+L+ L L  N L   IP      L NLQ L+L+ N L  S+P
Sbjct: 128 DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 33/119 (27%), Positives = 46/119 (38%), Gaps = 9/119 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +       L+ L  L L +N +       F +L  L  LYL  N    +LP   F     
Sbjct: 74  LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
           L  + L+ N    +IP      LT L+ L L+ N L   +P      L  LQ + L  N
Sbjct: 133 LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 27/114 (23%), Positives = 43/114 (37%), Gaps = 13/114 (11%)

Query: 89  RLSALKILSLRSNVIT-GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD 147
             S +K L L ++    G         + L +L       + ++ +      L  + LSD
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73

Query: 148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLN-------LPNLQQLNLANN 194
           N  +G +         L  L L+ N    KI DL+       L NL+ L+L N 
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGN----KIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 8e-09
 Identities = 30/114 (26%), Positives = 43/114 (37%), Gaps = 11/114 (9%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW-KNLTI 142
                    L+ LS  +  +T    ++   L  L  L L  N  SG L   +    NLT 
Sbjct: 35  EGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92

Query: 143 INLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPD------LNLPNLQQL 189
           +NLS N     +    L  L  L++L L N  ++  + D        LP L  L
Sbjct: 93  LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 18/74 (24%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 138 KNLTIINLSDNGFN-GTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNN 195
            ++  + L ++  N G +        +LE L   N  L+  I +L  L  L++L L++N 
Sbjct: 17  SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNR 75

Query: 196 LSGSIPQSLKRFPS 209
           +SG +    ++ P+
Sbjct: 76  VSGGLEVLAEKCPN 89

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 26/104 (25%), Positives = 47/104 (45%), Gaps = 14/104 (13%)

Query: 113 NLKSLCYLYLQFNNFS--GTLPDFSVWKNLTIINLSDNGFNGTIPR--SLSNLTQLEALY 168
           ++K L     + N     G   +F   + L  ++  + G    +    +L  L +L+ L 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEF---EELEFLSTINVG----LTSIANLPKLNKLKKLE 70

Query: 169 LANNSLSGKIPDL--NLPNLQQLNLANNNLSG-SIPQSLKRFPS 209
           L++N +SG +  L    PNL  LNL+ N +   S  + LK+  +
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 41/213 (19%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EIV--GSIRHE 379
           + +G G +G    A+    G  V +K+L         F+ ++       E+     +RHE
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHE 84

Query: 380 NVVELK---AYYYSKDEKLMVYDYYSL--GSVSAMLHSERGEGRIPLDWDTRMRIAIGAA 434
           NV+ L        + D+    Y         +  ++  E       L  D    +     
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------KLGEDRIQFLVYQML 138

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP--VIARAAG 489
           +G+  IHAA    ++H ++K  N+ +N     C   + D GL     +     V+ R   
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNED---CELKILDFGLARQADSEMTGYVVTRW-- 190

Query: 490 YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
           YRAPEV  +  + TQ  D++S G ++ E++TGK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 36/210 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIV--GSIRHENVVELKA 386
             +G+G+ G+   A     G  V VK + D+   +R      E+V     +H NVVE   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVE--- 106

Query: 387 YY--YSKDEKL-MVYDYYSLGSVSAMLHSER-GEGRIPLDWDTRMRIAIGAARGIARIHA 442
            Y  Y   E+L ++ ++   G+++ ++   R  E +I         +     + +A +HA
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-------ATVCEAVLQALAYLHA 159

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA-LAPVIARAA---G---YRAP 493
                ++H +IKS +I L     G V  SD G      A ++  + +     G   + AP
Sbjct: 160 ---QGVIHRDIKSDSILLTLD--GRVKLSDFGF----CAQISKDVPKRKSLVGTPYWMAP 210

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV          D++S G++++E++ G+ P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 42/207 (20%), Positives = 89/207 (42%), Gaps = 28/207 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E LG+G FG+ ++ +      T + K +K     +   ++++ I+   RH N++ L   +
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRM--RIAIGAAR----GIARI 440
            S +E +M++++ S G           +   RI       +  R  +         +  +
Sbjct: 71  ESMEELVMIFEFIS-G----------LDIFERI-NTSAFELNEREIVSYVHQVCEALQFL 118

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI--TSALAPVIARAAGYRAPEVT 496
           H+ N   + H +I+  NI   +++   +   + G            ++  A  Y APEV 
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSP 523
                + A+D++S G ++  +L+G +P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 42/147 (28%), Positives = 56/147 (38%), Gaps = 25/147 (17%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C   T V+CS   K +  +  P     G IP +          L L  N  T   P +  
Sbjct: 10  CLD-TVVRCS--NKGLKVL--P----KG-IPRDV-------TELYLDGNQFT-LVPKELS 51

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA 170
           N K L  + L  N  S TL +  FS    L  + LS N      PR+   L  L  L L 
Sbjct: 52  NYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110

Query: 171 NNSLSGKIPD---LNLPNLQQLNLANN 194
            N +S  +P+    +L  L  L +  N
Sbjct: 111 GNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 5/86 (5%)

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
           LYL  N F+    + S +K+LT+I+LS+N  +    +S SN+TQL  L L+ N L   IP
Sbjct: 36  LYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IP 94

Query: 180 DL---NLPNLQQLNLANNNLSGSIPQ 202
                 L +L+ L+L  N++S  +P+
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPE 119

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 6/64 (9%)

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNLS 197
           T + L  N F   +P+ LSN   L  + L+NN +S  + +    N+  L  L L+ N L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 198 GSIP 201
             IP
Sbjct: 92  -CIP 94

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 37/214 (17%), Positives = 77/214 (35%), Gaps = 26/214 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD--FEQQMEIVGSIRHENVVELKA 386
           ++LG+G     ++    + G    +K   +++  +      ++ E++  + H+N+V+L A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 387 YYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
                  +   ++ ++   GS+  +L        +P   +    +      G+  +    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLRENG 132

Query: 445 GGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAPVIARAAG---YRAPEV-- 495
              +VH NIK  NI     + G     ++D G                G   Y  P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYE 188

Query: 496 ------TDSRKATQASDVYSFGVVLLEILTGKSP 523
                    +K     D++S GV      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 13/112 (11%)

Query: 90  LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG 149
               + L LR   I     +    L     +    N     L  F + + L  + +++N 
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75

Query: 150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDLN-------LPNLQQLNLANN 194
                      L  L  L L NN     + +L        L +L  L +  N
Sbjct: 76  ICRIGEGLDQALPDLTELILTNN----SLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 3/73 (4%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
                ++L        I    + L Q +A+  ++N +  K+     L  L+ L + NN +
Sbjct: 19  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRI 76

Query: 197 SGSIPQSLKRFPS 209
                   +  P 
Sbjct: 77  CRIGEGLDQALPD 89

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 19/110 (17%), Positives = 33/110 (30%), Gaps = 29/110 (26%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
              L  LK L + +N I          L  L  L L  N+             L  ++  
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----------ELGDLD-- 107

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD------LNLPNLQQLN 190
                      L++L  L  L +  N ++             +P ++ L+
Sbjct: 108 ----------PLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 51/218 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EIV--GSIRHE 379
             +G G +G    A   + G  V VK+L         F+  +       E+     ++HE
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHE 88

Query: 380 NVVELKAYY---YSKDEKLMVYDYYSLGSVSAM---LHSERGEGRI----PLDWDTRMRI 429
           NV+ L   +    S +E   VY    L     M   L+       I     L  D    +
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN------NIVKCQKLTDDHVQFL 137

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP--VI 484
                RG+  IH+A+   ++H ++K SN+ +N     C   + D GL   T+      V 
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNED---CELKILDFGLARHTADEMTGYVA 191

Query: 485 ARAAGYRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
            R   YRAPE+  +     Q  D++S G ++ E+LTG+
Sbjct: 192 TRW--YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 39/228 (17%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVG 374
           + L+    +LGKGTFG   K IL      G    +K L K+V V K +    +    ++ 
Sbjct: 151 EYLK----LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGA 433
           + RH  +  LK  + + D    V +Y + G +    H  R E     D   R R      
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFSED---RARFYGAEI 257

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVI 484
              +  +H+     +V+ ++K  N+ L+   +  ++D GL         T  T    P  
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP-- 313

Query: 485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                Y APEV +     +A D +  GVV+ E++ G+ P +    ++L
Sbjct: 314 ----EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 29/208 (13%)

Query: 331 VLGKGTFGMAYKAILED-GTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIRHENVVELK 385
           VLGKG FG      +   G     K+L K     ++     +   +I+  +    VV L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLH-SERGEGRIPLDWDTRMRIAIG-AARGIARIHAA 443
             Y +KD   +V    + G +    H    G+   P     R          G+  +H  
Sbjct: 251 YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE 305

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL--------TTITSALAPVIARAAGYRAPEV 495
               +V+ ++K  NI L+   +  +SDLGL        T              GY APEV
Sbjct: 306 R---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV------GYMAPEV 356

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
             + + T + D ++ G +L E++ G+SP
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
            +LGKG+FG   K           VK +   +   +D     +++E++  + H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 386 AYYYSKDEKLMVYDYYSLG----SVSAMLH-SERGEGRIPLDWDTRMRIAIGAARGIARI 440
                     +V + Y+ G     +      SE    RI       ++        I  +
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFSG---ITYM 137

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPEV 495
           H  N   +VH ++K  NI L S++  C   + D GL+T       +  R   A Y APEV
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
                  +  DV+S GV+L  +L+G  P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 42/225 (18%), Positives = 76/225 (33%), Gaps = 44/225 (19%)

Query: 387 YYYSKDEKLMVY---DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
                  K+ +Y         ++   +   R       +    + I I  A  +  +H+ 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---------TSALAPVIARAAG----- 489
               L+H ++K SNIF        V D GL T               P  A   G     
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 490 -YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT 548
            Y +PE       +   D++S G++L E+L   S        E V ++            
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRIIT----------- 284

Query: 549 AEVFDVELLRYPNI-EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
               DV  L++P +  ++  +   +    +   P +RP+  D++ 
Sbjct: 285 ----DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 12/103 (11%), Positives = 35/103 (33%), Gaps = 3/103 (2%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKR--LKDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + +G+G FG+ ++A    D     +KR  L +  + +    ++++ +  + H  +V    
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI 429
            +     +    +   +                      ++R 
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 48/155 (30%), Positives = 64/155 (41%), Gaps = 27/155 (17%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C+  T V+C    +   +V  P    +G IP  T         L L +N +       F 
Sbjct: 7   CSG-TTVECY--SQGRTSV--P----TG-IPAQT-------TYLDLETNSLKSLPNGVFD 49

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA 170
            L SL  LYL  N    +LP+  F+   +LT +NLS N            LTQL+ L L 
Sbjct: 50  ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108

Query: 171 NNSLSGKIP----DLNLPNLQQLNLANNNLSGSIP 201
            N L   +P    D  L  L+ L L  N L  S+P
Sbjct: 109 TNQLQ-SLPDGVFD-KLTQLKDLRLYQNQLK-SVP 140

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 36/218 (16%)

Query: 323 DLLRASAEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRD------FEQQM-EIVG 374
            + R    ++G+G FG  Y     D G    +K L    +  +        E+ M  +V 
Sbjct: 192 SVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI-AIGA 433
           +     +V +   +++ D+   + D  + G      H  +  G         MR  A   
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQ-HGVFSEA---DMRFYAAEI 301

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL-------TTITSALAPVIAR 486
             G+  +H      +V+ ++K +NI L+   +  +SDLGL           S        
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH---- 354

Query: 487 AAGYRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSP 523
             GY APEV         ++D +S G +L ++L G SP
Sbjct: 355 --GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 47/218 (21%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK---DVNVGKRDF-EQQMEIVGSIRHENVVEL 384
             +G+G +GM   A    +   V +K++         +R   E  ++I+   RHEN++ +
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGI 90

Query: 385 KAYYYSKDEKLM--VYDYYSLGSVSAM---LHSERGEGRI----PLDWDTRMRIAIGAAR 435
                +   + M  VY    L     M   L+      ++     L  D          R
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDL-----METDLY------KLLKTQHLSNDHICYFLYQILR 139

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP--------VI 484
           G+  IH+AN   ++H ++K SN+ LN+    C   + D GL  +              V 
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 485 ARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGK 521
            R   YRAPE+  +S+  T++ D++S G +L E+L+ +
Sbjct: 194 TRW--YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 32/209 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           EVLG G F   +       G    +K + K         E ++ ++  I+HEN+V L+  
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 388 YYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIGAARGIARI 440
           Y S     +V    S G      +   +++E+         D    ++  + A   +  +
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEK---------DASLVIQQVLSA---VKYL 122

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG---YRAPE 494
           H      +VH ++K  N+   + +      ++D GL+ +      +++ A G   Y APE
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTACGTPGYVAPE 177

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSP 523
           V   +  ++A D +S GV+   +L G  P
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 52/225 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL--KDVNVGKRDFEQQMEIVGSIRHENVVELK- 385
           + LG G  G+ + A+  +    V +K++   D    K    ++++I+  + H+N+V++  
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFE 75

Query: 386 ----------AYYYSKDEKLMVYDYYSLGSVSAM---LHSERGEGRI----PLDWDTRMR 428
                         S  E   VY          M   L        +    PL  +    
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLA------NVLEQGPLLEEHARL 124

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP--- 482
                 RG+  IH+AN   ++H ++K +N+F+N++       + D GL  I         
Sbjct: 125 FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTED--LVLKIGDFGLARIMDPHYSHKG 179

Query: 483 -----VIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGK 521
                ++ +   YR+P +       T+A D+++ G +  E+LTGK
Sbjct: 180 HLSEGLVTKW--YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 41/213 (19%), Positives = 77/213 (36%), Gaps = 32/213 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-------RLKDVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G F +  K      G     K       R     V + + E+++ I+  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 382 VELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           + L   Y ++ + +++ +  S G            SE             ++  +    G
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-------IKQILD---G 127

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAPVIARA--AGY 490
           +  +H      + H ++K  NI L  +        + D GL                  +
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APE+ +       +D++S GV+   +L+G SP
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 32/213 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-------RLKDVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G F +  K      G     K       R     V + + E+++ I+  + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 382 VELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           + L   Y ++ + +++ +  S G            SE             ++  +    G
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-------IKQILD---G 127

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAPVIARA--AGY 490
           +  +H      + H ++K  NI L  +        + D GL                  +
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APE+ +       +D++S GV+   +L+G SP
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 58.2 bits (141), Expect = 4e-10
 Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 7/111 (6%)

Query: 89  RLSALKILSLRSNVIT-GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD 147
             +A++ L L +     G          +L +L L       ++ +      L  + LS+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80

Query: 148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL----NLPNLQQLNLANN 194
           N   G +      L  L  L L+ N L   I  L     L  L+ L+L N 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 13/115 (11%)

Query: 84  PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW-KNLTI 142
               +    L+ LSL +  +     S+   L  L  L L  N   G L   +    NLT 
Sbjct: 42  EGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99

Query: 143 INLSDNGFN--GTIPRSLSNLTQLEALYLANNSLSGKIPD------LNLPNLQQL 189
           +NLS N      T+   L  L  L++L L N  ++  + D        LP L  L
Sbjct: 100 LNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 5/75 (6%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNN 195
            NL  ++L + G   ++  +L  L +L+ L L+ N + G +  L   LPNL  LNL+ N 
Sbjct: 49  VNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106

Query: 196 LSG-SIPQSLKRFPS 209
           L   S  + LK+   
Sbjct: 107 LKDISTLEPLKKLEC 121

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 3/73 (4%)

Query: 139 NLTIINLSDNGFN-GTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
            +  + L +   N G I    +    LE L L N  L   + +L  LP L++L L+ N +
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRI 83

Query: 197 SGSIPQSLKRFPS 209
            G +    ++ P+
Sbjct: 84  FGGLDMLAEKLPN 96

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 41/206 (19%), Positives = 76/206 (36%), Gaps = 26/206 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
             +G+G++G    A+          K++ K        F+Q++EI+ S+ H N++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 388 YYSKDEKLMVYDYYSLG----SVSAMLH-SERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           +    +  +V +  + G     V       E    RI       M+  + A   +A  H 
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLSA---VAYCHK 124

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPEVTD 497
            N   + H ++K  N    +        + D GL         +  +     Y +P+V  
Sbjct: 125 LN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL- 180

Query: 498 SRKATQASDVYSFGVVLLEILTGKSP 523
                   D +S GV++  +L G  P
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPP 206

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 43/158 (27%), Positives = 55/158 (34%), Gaps = 23/158 (14%)

Query: 53  CNHWTGVKCSEDGKRVVAV-----------RLPGVGFSGLIPPNTISRLSALKILSLRSN 101
           C+  T V C    KR  +V            L     + L  P     L  LK L L SN
Sbjct: 19  CSG-TTVDCR--SKRHASVPAGIPTNAQILYLHDNQITKL-EPGVFDSLINLKELYLGSN 74

Query: 102 VITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLS 159
            +       F +L  L  L L  N  +  LP   F    +L  + +  N     +PR + 
Sbjct: 75  QLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132

Query: 160 NLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
            LT L  L L  N L   IP      L +L    L  N
Sbjct: 133 RLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 38/247 (15%), Positives = 78/247 (31%), Gaps = 56/247 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-----RLKDVNVGKR-DFEQQMEIVGSIRHENVV 382
             +G+G++G+   AI  +      +K     +++ +N       + ++ ++  + H N+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 383 ELKAYYYSKDEKLMVYDYYSLGS----VSAMLHSERGEGRIPLDWDTRMRIAIG------ 432
            L   Y  +    +V +    G     ++  +    G+  + +                 
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 433 -----------------AARGIAR--------IHAANGGKLVHGNIKSSNIFLNSQQYGC 467
                                I R        +H      + H +IK  N   ++ +   
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFE 208

Query: 468 V--SDLGLTTITSALAPVIARA-------AGYRAPEV--TDSRKATQASDVYSFGVVLLE 516
           +   D GL+     L                + APEV  T +       D +S GV+L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 517 ILTGKSP 523
           +L G  P
Sbjct: 269 LLMGAVP 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 31/211 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL--KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
             LG G FG  +       G   V+K +      V     E ++E++ S+ H N++++  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 387 YYYSKDEKLMVYDYYSLG--------SVSAMLH-SERGEGRIPLDWDTRMRIAIGAARGI 437
            +       +V +    G        + +     SE     +       M+  + A   +
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-------MKQMMNA---L 137

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRA 492
           A  H+ +   +VH ++K  NI            + D GL  +  +       A  A Y A
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           PEV   R  T   D++S GVV+  +LTG  P
Sbjct: 195 PEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 44/223 (19%)

Query: 323 DLLRASAEVLGKGTFGMAYKAILED-GTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIR 377
              R    VLG+G FG  +   ++  G     K+L K     ++ ++  M   +I+  + 
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLH---SERGEGRIPLDWDTRMR-----I 429
              +V L   + +K +  +V    + G +    H    +            R       I
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEP---RAIFYTAQI 298

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSAL 480
             G    +  +H  N   +++ ++K  N+ L+      +SDLGL          T   A 
Sbjct: 299 VSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351

Query: 481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            P      G+ APE+    +   + D ++ GV L E++  + P
Sbjct: 352 TP------GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 52/224 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK---DVNVGKRDF-EQQMEIVGSIRHENVVEL 384
            +LG+G +G+   A     G  V +K+++         R   E  ++I+   +HEN++ +
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE--IKILKHFKHENIITI 74

Query: 385 KAYYYSKDEKLM--VYDYYSLGSVSAM---LHSERGEGRI----PLDWDTRMR-IAIGAA 434
                    +    VY    L     M   LH      R+     L  D  ++       
Sbjct: 75  FNIQRPDSFENFNEVYIIQEL-----MQTDLH------RVISTQMLS-DDHIQYFIYQTL 122

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG-- 489
           R +  +H +N   ++H ++K SN+ +NS    C   V D GL  I    A   +   G  
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 490 -----------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                      YRAPEV   S K ++A DV+S G +L E+   +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 45/211 (21%), Positives = 84/211 (39%), Gaps = 27/211 (12%)

Query: 331 VLGKGTFGMAYKAILEDGTTVV-VKRL-KDVNVGKRDFEQQME---IVGSIRHENVVELK 385
           V+G+G F       ++    V  +K + K   + + +     E   ++ +     + +L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 386 AYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHAA 443
            + +  +  L +V +YY  G +  +    +   RIP +   R  +A I  A  I  +H  
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEM-ARFYLAEIVMA--IDSVHRL 181

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-G---YRAPEVTDSR 499
                VH +IK  NI L+   +  ++D G      A   V +  A G   Y +PE+  + 
Sbjct: 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 500 KATQASDVY-------SFGVVLLEILTGKSP 523
                +  Y       + GV   E+  G++P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 37/214 (17%), Positives = 77/214 (35%), Gaps = 26/214 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD--FEQQMEIVGSIRHENVVELKA 386
           ++LG+G     ++    + G    +K   +++  +      ++ E++  + H+N+V+L A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 387 YYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
                  +   ++ ++   GS+  +L        +P   +    +      G+  +    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLRENG 132

Query: 445 GGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAPVIARAAG---YRAPEV-- 495
              +VH NIK  NI     + G     ++D G                G   Y  P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYE 188

Query: 496 ------TDSRKATQASDVYSFGVVLLEILTGKSP 523
                    +K     D++S GV      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 39/213 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK----RLKDVNVGKRDFEQQMEIVGSIRHENVVEL 384
             +G G+FG  Y A  + +   V +K      K  N   +D  +++  +  +RH N ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ- 118

Query: 385 KAYY--YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI---GAARGIAR 439
             Y   Y ++    +   Y LGS S +L   +     PL       IA    GA +G+A 
Sbjct: 119 --YRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEV---EIAAVTHGALQGLAY 169

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGL-TTITSALAPVIARAAG---YRAP 493
           +H+     ++H ++K+ NI L+    G V   D G  + +  A + V     G   + AP
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEP--GLVKLGDFGSASIMAPANSFV-----GTPYWMAP 219

Query: 494 EVTDSRKATQ---ASDVYSFGVVLLEILTGKSP 523
           EV  +    Q     DV+S G+  +E+   K P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.1 bits (144), Expect = 9e-10
 Identities = 42/213 (19%), Positives = 81/213 (38%), Gaps = 32/213 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-------RLKDVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G F +  K      G     K             V + + E+++ I+  IRH N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 382 VELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           + L   + +K + +++ +  S G            +E    +        ++  +    G
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-------LKQILD---G 120

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAP--VIARAAGY 490
           +  +H+     + H ++K  NI L  +        + D G+     A      I     +
Sbjct: 121 VHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APE+ +       +D++S GV+   +L+G SP
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 44/222 (19%), Positives = 86/222 (38%), Gaps = 32/222 (14%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGS 375
           +  +    +++ LG+G F +  + I    G     K LK    G+        ++ ++  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 376 IRH-ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRM--RIA 430
            +    V+ L   Y +  E +++ +Y + G          GE       +    +     
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAA-G----------GEIFSLCLPELAEMVSENDV 133

Query: 431 IGAAR----GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAP- 482
           I   +    G+  +H  N   +VH ++K  NI L+S        + D G++         
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190

Query: 483 -VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
             I     Y APE+ +    T A+D+++ G++   +LT  SP
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 42/213 (19%), Positives = 79/213 (37%), Gaps = 32/213 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-------RLKDVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G F +  K      G     K       +     V + D E+++ I+  I+H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 382 VELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARG 436
           + L   Y +K + +++ +  + G            +E             ++  +     
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-------LKQILNG--- 126

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYG----CVSDLGLTTITSALAP--VIARAAGY 490
           +  +H+     + H ++K  NI L  +        + D GL            I     +
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
            APE+ +       +D++S GV+   +L+G SP
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 44/148 (29%), Positives = 64/148 (43%), Gaps = 26/148 (17%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C+  T ++C+   K + +V  P    +G IP +          L L SN +       F 
Sbjct: 7   CSG-TEIRCN--SKGLTSV--P----TG-IPSSA-------TRLELESNKLQSLPHGVFD 49

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSL-SNLTQLEALYL 169
            L  L  L L  N    +LPD  F     LTI+ L +N    ++P  +   LTQL+ L L
Sbjct: 50  KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107

Query: 170 ANNSLSGKIPDL---NLPNLQQLNLANN 194
             N L   +PD     L +LQ++ L  N
Sbjct: 108 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 35/210 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSI-----RHENV 381
             LG+G +   ++AI + +   VVVK LK V   K  R      EI   I        N+
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR------EI--KILENLRGGPNI 93

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAI-GAARGIARI 440
           + L         +     +  + +                  D  +R  +    + +   
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTD--FKQ-----LYQTLTDYDIRFYMYEILKALDYC 146

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG--YRAPEV 495
           H+     ++H ++K  N+ ++ +       + D GL            R A   ++ PE+
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201

Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPI 524
             D +    + D++S G +L  ++  K P 
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 35/220 (15%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME---IVG 374
           ++L+    V+G+G FG   +  +           +K L K   + + +     E   ++ 
Sbjct: 77  EILK----VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 375 SIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IG 432
           +   + +  L  Y +  D  L +V DYY  G +  +    + E R+P +   R  +A + 
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEM-ARFYLAEMV 185

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-G-- 489
            A  I  +H  +    VH +IK  NI ++   +  ++D G          V +  A G  
Sbjct: 186 IA--IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 490 -YRAPEVTDSRKA-----TQASDVYSFGVVLLEILTGKSP 523
            Y +PE+  + +          D +S GV + E+L G++P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 48/214 (22%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 332 LGKGTFGMAYKAILEDGTT---VVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELK-AY 387
           +G+GT+G  YKA  +DG       +K+++   +      +++ ++  ++H NV+ L+  +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-REIALLRELKHPNVISLQKVF 87

Query: 388 YYSKDEKL-MVYDYYS---LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
               D K+ +++DY        +     S+  +  + L       +      GI  +HA 
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147

Query: 444 NGGKLVHGNIKSSNIFLNSQ--QYGCV--SDLGL--------TTITSALAPVIARAAGYR 491
               ++H ++K +NI +  +  + G V  +D+G           +      V+     YR
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF--WYR 202

Query: 492 APEV-TDSRKATQASDVYSFGVVLLEILTGKSPI 524
           APE+   +R  T+A D+++ G +  E+LT + PI
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 38/119 (31%), Positives = 48/119 (40%), Gaps = 10/119 (8%)

Query: 89  RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLS 146
            L+ L  L L  N +       F  L +L  L L  N    +LPD  F    NLT +NL+
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP----DLNLPNLQQLNLANNNLSGSIP 201
            N            LT L  L L+ N L   +P    D  L  L+ L L  N L  S+P
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD-KLTQLKDLRLYQNQLK-SVP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 39/119 (32%), Positives = 55/119 (46%), Gaps = 9/119 (7%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKN 139
           +P     +L+ LK L L  N +       F  L +L YL L  N    +LP   F    N
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN 158

Query: 140 LTIINLSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANN 194
           LT ++LS N    ++P  +   LTQL+ L L  N L   +PD     L +LQ + L +N
Sbjct: 159 LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 28/149 (18%), Positives = 46/149 (30%), Gaps = 32/149 (21%)

Query: 59  VKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLC 118
           +  S           P           T          +L+   +T         L S+ 
Sbjct: 3   ITVS--TPIKQIF--P----DD-AFAET-------IKANLKKKSVTDAVT--QNELNSID 44

Query: 119 YLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLS---NLTQLEALYLANNSLS 175
            +    ++   ++       N+  + L  N         +S    LT L  L L  N L 
Sbjct: 45  QIIANNSDIK-SVQGIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ 98

Query: 176 GKIPD---LNLPNLQQLNLANNNLSGSIP 201
             +P+     L NL++L L  N L  S+P
Sbjct: 99  -SLPNGVFDKLTNLKELVLVENQLQ-SLP 125

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E+LG G FG  +K      G  +  K +       K + + ++ ++  + H N+++L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRM--RIAIGAAR----GIAR 439
           + SK++ ++V +Y   G          GE   RI +D    +     I   +    GI  
Sbjct: 155 FESKNDIVLVMEYVD-G----------GELFDRI-IDESYNLTELDTILFMKQICEGIRH 202

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTI--TSALAPVIARAAGYRAPEV 495
           +H      ++H ++K  NI   ++    +   D GL           V      + APEV
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSP 523
            +    +  +D++S GV+   +L+G SP
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 28/209 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL---KDVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E LGKG F +  + + +  G       +   K      +  E++  I   ++H N+V L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 386 AYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
                +    +++D  + G      V+   +SE             ++  + A   +   
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILEA---VLHC 126

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYG---CVSDLGLTTITSALAPVIARAAG---YRAPE 494
           H      +VH N+K  N+ L S+  G    ++D GL              AG   Y +PE
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSP 523
           V       +  D+++ GV+L  +L G  P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 56.4 bits (137), Expect = 7e-09
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 31/210 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
           E LGKG F +  + +    G     K +    +  RDF+   ++  I   ++H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 386 AYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIGAARGIA 438
                +    +V+D  + G      V+   +SE          D    ++  + +   IA
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DASHCIQQILES---IA 119

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAP 493
             H+     +VH N+K  N+ L S+  G    ++D GL    +        A   GY +P
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV      ++  D+++ GV+L  +L G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 32/304 (10%), Positives = 67/304 (22%), Gaps = 69/304 (22%)

Query: 330 EVLGKGTFGMAYKAILED---GTTVVVKRLKDVNVGKRDFEQQME----IVGSIRHENVV 382
              G       ++A   D      V +  +    V   D  Q+       +  I    V 
Sbjct: 37  IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGR-------IPLDWDTRMRIAIGAAR 435
                         V D     +   ++  E   G                +R     A 
Sbjct: 95  R-------------VLDVVHTRAGGLVVA-EWIRGGSLQEVADTSPSPVGAIRAMQSLAA 140

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV 495
                H A    +       S +                 ++     V+A          
Sbjct: 141 AADAAHRAG---VALSIDHPSRVR----------------VSIDGDVVLA-YPATMPD-- 178

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
                A    D+   G  L  +L  + P+   G    +       +    +   +  +  
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPA 226

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESS 615
            +   +I  ++     +A   V      R     ++ +++                    
Sbjct: 227 DID-RDIPFQISA---VAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPV 281

Query: 616 TPPP 619
           +  P
Sbjct: 282 SAAP 285

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 58/221 (26%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-----------R 377
            ++G+G++GM  K    + G  V +K+  +            ++V  I           R
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--------SDDDKMVKKIAMREIKLLKQLR 82

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           HEN+V L      K    +V+++     V   +  +       LD+    +       GI
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG------ 489
              H+ N   ++H +IK  NI ++    G V   D G            AR         
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQS--GVVKLCDFGF-----------ARTLAAPGEVY 181

Query: 490 --------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                   YRAPE+     K  +A DV++ G ++ E+  G+
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 6/85 (7%)

Query: 124 FNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSGKIPD-- 180
            +    +L      +NLT + + +      +    L  L +L  L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 181 -LNLPNLQQLNLANNNLSGSIPQSL 204
               P L +LNL+ N L  S+    
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 3/92 (3%)

Query: 108 PSDFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE 165
                  ++L  LY++       L          L  + +  +G     P +     +L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 166 ALYLANNSLSGKIPD-LNLPNLQQLNLANNNL 196
            L L+ N+L       +   +LQ+L L+ N L
Sbjct: 84  RLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 11/110 (10%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVG-----------FSGLIPPNTISRLSALKILSLRSN 101
            +  +G++C+ DG       LPG                 +    +  L  L+ L++  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 102 VITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFN 151
            +    P  F     L  L L FN             +L  + LS N  +
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 35/216 (16%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK------DVNVGKRDFEQQMEIVGSIRHENVV 382
           EV+GKG F +  + I  E G    VK +          +   D +++  I   ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 383 ELKAYYYSKDEKLMVYDYYSLG---------SVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
           EL   Y S     MV+++             + +  ++SE             MR  + A
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-------MRQILEA 142

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG- 489
              +   H  N   ++H ++K   + L S++      +   G+         V     G 
Sbjct: 143 ---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196

Query: 490 --YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
             + APEV       +  DV+  GV+L  +L+G  P
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 39/212 (18%), Positives = 83/212 (39%), Gaps = 28/212 (13%)

Query: 325 LRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVV 382
           L    + LG+G+F +  K +  +      VK +      + + ++++  +     H N+V
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIV 69

Query: 383 ELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           +L   ++ +    +V +  + G            SE     I       MR  + A   +
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-------MRKLVSA---V 119

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG---YR 491
           + +H      +VH ++K  N+    +       + D G   +       +        Y 
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           APE+ +     ++ D++S GV+L  +L+G+ P
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 30/215 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVG-SIRHENVVELKAY 387
           E +G G++ +  + I         VK +      KRD  +++EI+    +H N++ LK  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKDV 84

Query: 388 YYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           Y       +V +    G      +     SER    +       +         +  +HA
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-------LFTITKT---VEYLHA 134

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGC----VSDLGLTTITSALAPVIARAAG---YRAPEV 495
                +VH ++K SNI    +        + D G      A   ++        + APEV
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD 530
            + +    A D++S GV+L  +LTG +P      D
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 42/219 (19%), Positives = 82/219 (37%), Gaps = 41/219 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK---------RLKDVNVGKRDFEQQMEIVGSIRHE 379
           + LG G  G    A   +    V ++                   + E ++EI+  + H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIG 432
            ++++K ++ ++D   +V +    G      V      E            +      + 
Sbjct: 201 CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA---------TCKLYFYQMLL 250

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA-- 487
           A   +  +H      ++H ++K  N+ L+SQ+  C   ++D G + I    + +      
Sbjct: 251 A---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 488 AGYRAPEV---TDSRKATQASDVYSFGVVLLEILTGKSP 523
             Y APEV     +    +A D +S GV+L   L+G  P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.7 bits (133), Expect = 2e-08
 Identities = 41/220 (18%), Positives = 80/220 (36%), Gaps = 30/220 (13%)

Query: 29  EALLDFVNNLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTIS 88
           + +++      H   L W +        + ++   D   V+   +P +    +   N +S
Sbjct: 129 DGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQV-DLSPVLD-AMPLLNNLKIKGTNNLS 186

Query: 89  ----RLSALKILSLRSN-----VITGYFPSDFINLKSLCYLYLQFNNFSG--TLPDFSV- 136
                   LK L + S      V+     SD  NL+ L  LY+   ++     +  F   
Sbjct: 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPL 245

Query: 137 -----WKNLTIINLSDNGFNGTIPRSLSN---LTQLEALYLANNSLSGKIPDL------N 182
                + NL  + + D      +         L QLE + ++   L+ +   L       
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305

Query: 183 LPNLQQLNLANNNLSGSIPQSL-KRFPSSAFVGNSISFDE 221
           + +L+ +N+  N LS  + + L K  P    V +S  +D+
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 31/263 (11%)

Query: 292 GMSPEKVVSRNQDASNRLFFFEGCNYAFDLEDLLRASAEV---LGKGTFGMAYKAI-LED 347
           G++ +K        +N  +  +  +Y     D +    EV   +GKG+FG   KA   + 
Sbjct: 62  GLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121

Query: 348 GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH---------ENVVELKAYYYSKDEKLMVY 398
              V +K +++    KR   Q  E +  + H          NV+ +   +  ++   M +
Sbjct: 122 HQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178

Query: 399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNI 458
           +  S+ ++  ++   + +G   L    R + A    + +  +H      ++H ++K  NI
Sbjct: 179 ELLSM-NLYELIKKNKFQG-FSLP-LVR-KFAHSILQCLDALHKNR---IIHCDLKPENI 231

Query: 459 FLNSQQYG--CVSDLGLTTITS-ALAPVI-ARAAGYRAPEVTDSRKATQASDVYSFGVVL 514
            L  Q      V D G +      +   I +R   YRAPEV    +     D++S G +L
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPEVILGARYGMPIDMWSLGCIL 289

Query: 515 LEILTGKSPIHTTGGDELVHLVR 537
            E+LTG  P+   G DE   L  
Sbjct: 290 AELLTGY-PLL-PGEDEGDQLAC 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 38/221 (17%), Positives = 74/221 (33%), Gaps = 58/221 (26%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-----------R 377
             +G+G++G+ +K    + G  V +K+  +         +   ++  I           +
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--------SEDDPVIKKIALREIRMLKQLK 60

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           H N+V L   +  K    +V++Y         +  E    +  +       I     + +
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG------ 489
              H  N    +H ++K  NI +       +   D G            AR         
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKH--SVIKLCDFGF-----------ARLLTGPSDYY 159

Query: 490 --------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                   YR+PE+     +     DV++ G V  E+L+G 
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 63/223 (28%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIRH 378
           E +G+GT+G+ YKA    G  V +KR++         + + E           ++  + H
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDEGIPSTAIREISLLKELHH 78

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIGAAR 435
            N+V L    +S+    +V+++        M    +    E +  L             R
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEF--------MEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG---- 489
           G+A  H      ++H ++K  N+ +NS   G   ++D GL           ARA G    
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSD--GALKLADFGL-----------ARAFGIPVR 174

Query: 490 ----------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                     YRAP+V   S+K + + D++S G +  E++TGK
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 31/210 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFE---QQMEIVGSIRHENVVELK 385
           E LGKG F +  + +    G     K +    +  RDF+   ++  I   ++H N+V L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 386 AYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIGAARGIA 438
                +    +V+D  + G      V+   +SE          D    ++  + +   IA
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DASHCIQQILES---IA 142

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAP 493
             H+     +VH N+K  N+ L S+  G    ++D GL    +        A   GY +P
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           EV      ++  D+++ GV+L  +L G  P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 46/222 (20%), Positives = 83/222 (37%), Gaps = 36/222 (16%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH 378
            + D  + S +VLG G  G   +      G    +K L D    +++ +   +  G    
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---G 81

Query: 379 ENVVELKAYY----YSKDEKLMVYDYYSLG-------SVSAMLHSERGEGRIPLDWDTRM 427
            ++V +   Y    + K   L++ +    G              +ER    I       M
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI-------M 134

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVI 484
           R    A   I  +H+ N   + H ++K  N+   S++      ++D G    T+     +
Sbjct: 135 RDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NAL 186

Query: 485 ARAAG---YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
                   Y APEV    K  ++ D++S GV++  +L G  P
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 52/220 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM------EIVGSI----RH 378
           E LG GT+   YK +    G  V +K +K       D E+        EI  S+    +H
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVK------LDSEEGTPSTAIREI--SLMKELKH 62

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIA 438
           EN+V L    +++++  +V+++        M     G     L+ +          +G+A
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG------- 489
             H     K++H ++K  N+ +N +  G   + D GL           ARA G       
Sbjct: 123 FCHE---NKILHRDLKPQNLLINKR--GQLKLGDFGL-----------ARAFGIPVNTFS 166

Query: 490 -------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                  YRAP+V   SR  + + D++S G +L E++TGK
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 331 VLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVELK 385
           +LG+G+F     A          +K L+  ++ K +    +    +++  + H   V+L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 386 AYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHAA 443
            + +  DEKL     Y   G    +L   R  G       TR   A I +A  +  +H  
Sbjct: 97  -FTFQDDEKLYFGLSYAKNGE---LLKYIRKIGSFDET-CTRFYTAEIVSA--LEYLHGK 149

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA------AGYRAPEVTD 497
               ++H ++K  NI LN   +  ++D G   + S  +   ARA      A Y +PE+  
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFVGTAQYVSPELLT 205

Query: 498 SRKATQASDVYSFGVVLLEILTGKSP 523
            + A ++SD+++ G ++ +++ G  P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 45/219 (20%), Positives = 85/219 (38%), Gaps = 38/219 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQ-QMEI-------------VG 374
             LG G F   + A  + + T V +K ++     K   E  + EI               
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 375 SIRHENVVELKAYYYSKDEKL----MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA 430
           S+   ++++L  ++  K        MV++     ++ A++      G IPL    + +I+
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG-IPLI-YVK-QIS 137

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC------VSDLGLTT-ITSALAPV 483
                G+  +H   G  ++H +IK  N+ +             ++DLG            
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 484 I-ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGK 521
           I  R   YR+PEV         +D++S   ++ E++TG 
Sbjct: 196 IQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 29/207 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             LG+G   + Y+           +K LK   V K+    ++ ++  + H N+++LK  +
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 389 YSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIGAARGIARIH 441
            +  E  +V +  + G      V    +SER         D    ++  + A   +A +H
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSER---------DAADAVKQILEA---VAYLH 165

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRAPEVT 496
                 +VH ++K  N+   +        ++D GL+ I      +       GY APE+ 
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSP 523
                    D++S G++   +L G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.1 bits (131), Expect = 5e-08
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 323 DLLRASAEVLGKGTFG---MAYKAILED-GTTVVVKRL-KDVNVGKRDFEQQME--IVGS 375
           +LL+    VLG+G+FG   +  K    D      +K L K     +     +ME  I+  
Sbjct: 27  ELLK----VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82

Query: 376 IRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGA 433
           + H  +V+L  Y +  + KL ++ D+   G +       + E     + D +  +A +  
Sbjct: 83  VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSK-EVMFTEE-DVKFYLAELAL 137

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVI 484
           A  +  +H+     +++ ++K  NI L+ + +  ++D GL            +       
Sbjct: 138 A--LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV-- 190

Query: 485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                Y APEV + R  TQ++D +SFGV++ E+LTG  P       E 
Sbjct: 191 ----EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 7/88 (7%)

Query: 119 YLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG 176
            L L  N       D  F    +L  + L  N   G  P +    + ++ L L  N +  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 177 KIPD---LNLPNLQQLNLANNNLSGSIP 201
           +I +   L L  L+ LNL +N +S  + 
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 36/157 (22%), Positives = 53/157 (33%), Gaps = 43/157 (27%)

Query: 53  CNHWTGVKCSEDGKRVVAV-----------RLPGVGFSGLIPPNTISRLSALKILSLRSN 101
           C   T V C+  G+ +  +            L       +       RL  L  L L+ N
Sbjct: 8   CEG-TTVDCT--GRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64

Query: 102 VITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNG-FNGTIPRSLSN 160
            +TG  P+ F     +  L L  N     +                N  F G        
Sbjct: 65  QLTGIEPNAFEGASHIQELQLGENKIK-EIS---------------NKMFLG-------- 100

Query: 161 LTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANN 194
           L QL+ L L +N +S  +      +L +L  LNLA+N
Sbjct: 101 LHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVG 374
           D L+    +LGKGTFG   K IL      G    +K L K+V + K +    +    ++ 
Sbjct: 8   DYLK----LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 375 SIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIG-A 433
           + RH  +  LK  + + D    V +Y + G +    H  R E     +   R R      
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFTEE---RARFYGAEI 114

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVI 484
              +  +H+ +   +V+ +IK  N+ L+   +  ++D GL         T  T    P  
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-- 169

Query: 485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                Y APEV +     +A D +  GVV+ E++ G+ P +    + L
Sbjct: 170 ----EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 53.3 bits (129), Expect = 8e-08
 Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 63/223 (28%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIRH 378
           E +G+GT+G+ YKA    G T  +K+++         E++ E           I+  ++H
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDEGIPSTTIREISILKELKH 59

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIGAAR 435
            N+V+L    ++K   ++V+++        +    +         L+  T     +    
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEH--------LDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG---- 489
           GIA  H      ++H ++K  N+ +N +  G   ++D GL           ARA G    
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINRE--GELKIADFGL-----------ARAFGIPVR 155

Query: 490 ----------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                     YRAP+V   S+K +   D++S G +  E++ G 
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 41/245 (16%), Positives = 81/245 (33%), Gaps = 62/245 (25%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EI--VGSIRHE 379
            ++G+G++G  Y A        V +K++  +      FE  +       EI  +  ++ +
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85

Query: 380 NVVELKAYYYSKDEKLM--VYDYYSLGS--VSAMLHSERGEGRIPLDWDTRMR-IAIGAA 434
            ++ L       D      +Y    +    +  +  +      I L  +  ++ I     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-----PIFLT-EEHIKTILYNLL 139

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAG-- 489
            G   IH +    ++H ++K +N  LN     C   V D GL    ++            
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQD---CSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 490 -----------------------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPIH 525
                                  YRAPE+       T++ D++S G +  E+L       
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 526 TTGGD 530
               +
Sbjct: 254 NDPTN 258

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 44/226 (19%), Positives = 82/226 (36%), Gaps = 64/226 (28%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIR 377
             LG+GT+G  YKAI      TV +KR++         E + E           ++  ++
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQ 91

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG--EGRIPLDWDTRMRIAIGAAR 435
           H N++ELK+  +      ++++Y          +  +   +    +              
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEY--------AENDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-----VSDLGLTTITSALAPVIARAAG- 489
           G+   H+    + +H ++K  N+ L+           + D GL           ARA G 
Sbjct: 144 GVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-----------ARAFGI 189

Query: 490 -------------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                        YR PE+   SR  + + D++S   +  E+L   
Sbjct: 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 52.5 bits (127), Expect = 1e-07
 Identities = 43/227 (18%), Positives = 87/227 (38%), Gaps = 64/227 (28%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIR 377
           E +G+GT+G  +KA   E    V +KR++         +   E           ++  ++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREICLLKELK 59

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIGAA 434
           H+N+V L    +S  +  +V+++             +         LD +          
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEF--------CDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG--- 489
           +G+   H+ N   ++H ++K  N+ +N    G   +++ GL           ARA G   
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRN--GELKLANFGL-----------ARAFGIPV 155

Query: 490 -----------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPI 524
                      YR P+V   ++  + + D++S G +  E+     P+
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 39/183 (21%), Positives = 65/183 (35%), Gaps = 23/183 (12%)

Query: 354 KRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSE 413
                       F Q  + VG+I  +    L +   S+      +      S      + 
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

Query: 414 RGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL 473
               +  L  +  +  +   A+G+  + +      +H ++ + NI L+ +    + D GL
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGL 239

Query: 474 TTITSALAPVIARAAGYR------------APEVTDSRKATQASDVYSFGVVLLEILT-G 520
                  A  I +   Y             APE    R  T  SDV+SFGV+L EI + G
Sbjct: 240 -------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 521 KSP 523
            SP
Sbjct: 293 ASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 10/109 (9%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHEN 380
           + LG+G FG   +A            TV VK LK+   +   R    +++I+  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 381 VVELKAYYYSKDEKLMV-YDYYSLGSVSAMLHSERGEGRIPLDWDTRMR 428
           VV L          LMV  ++   G++S  L S+R E         R R
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 42/234 (17%), Positives = 87/234 (37%), Gaps = 81/234 (34%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQ---------MEIVGSIRHE 379
           + LG+G F   YKA        V +K++K   +G R   +          ++++  + H 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWD-----TRMRIAIGAA 434
           N++ L   +  K    +V+D+                    ++ D         + +  +
Sbjct: 73  NIIGLLDAFGHKSNISLVFDF--------------------METDLEVIIKDNSLVLTPS 112

Query: 435 ----------RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAP 482
                     +G+  +H  +   ++H ++K +N+ L+    G   ++D GL         
Sbjct: 113 HIKAYMLMTLQGLEYLH-QHW--ILHRDLKPNNLLLDEN--GVLKLADFGL--------- 158

Query: 483 VIARAAG--------------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
             A++ G              YRAPE+   +R      D+++ G +L E+L   
Sbjct: 159 --AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 38/218 (17%), Positives = 75/218 (34%), Gaps = 42/218 (19%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK-----RLKDVNVGKRDFEQQ----MEIVGSIRHE 379
             LG G FG  + A+  E    VVVK     ++ +    +     +    + I+  + H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAAR-- 435
           N++++   + ++    +V + +  G           +    I    D   R+    A   
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG----------LDLFAFI----DRHPRLDEPLASYI 135

Query: 436 ------GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG 489
                  +  +       ++H +IK  NI +       + D G          +     G
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFCG 191

Query: 490 ---YRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
              Y APEV           +++S GV L  ++  ++P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 72/239 (30%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR----------H 378
           + LGKG +G+ +K+I    G  V VK++ D       F+   +   + R          H
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68

Query: 379 ENVVELKAYYYSKDEK-------LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMR-IA 430
           EN+V L     + +++        M  D   L +V   + +        L+     + + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETD---LHAV---IRAN------ILE-PVHKQYVV 115

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA 487
               + I  +H+     L+H ++K SNI LN++   C   V+D GL+     +  V    
Sbjct: 116 YQLIKVIKYLHSGG---LLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVTNNI 169

Query: 488 AG------------------------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                                     YRAPE+   S K T+  D++S G +L EIL GK
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 32/230 (13%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVG 374
           ++LR     +GKG+FG   K  +    +      +K + K   V + +        +I+ 
Sbjct: 18  EILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70

Query: 375 SIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IG 432
            + H  +V L  Y +  +E + MV D    G +    H ++       +   ++ I  + 
Sbjct: 71  GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYHLQQ-NVHFKEE-TVKLFICELV 125

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA--AGY 490
            A  +  +       ++H ++K  NI L+   +  ++D  +  +      +   A    Y
Sbjct: 126 MA--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY 180

Query: 491 RAPEVTDSRKA---TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
            APE+  SRK    + A D +S GV   E+L G+ P H         +V 
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 26/208 (12%)

Query: 331 VLGKGTFGMAYKAILEDGTTVV-VKRL-KDVNVGKRDFEQQME---IVGSIRHENVVELK 385
           V+G+G FG       +    V  +K L K   + + D     E   I+       VV+L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 386 AYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHAA 443
            Y +  D  L MV +Y   G +  ++        +P  W  R   A +  A  +  IH+ 
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPEKW-ARFYTAEVVLA--LDAIHSM 187

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA-G---YRAPEVTDSR 499
                +H ++K  N+ L+   +  ++D G     +    V    A G   Y +PEV  S+
Sbjct: 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 500 KA----TQASDVYSFGVVLLEILTGKSP 523
                  +  D +S GV L E+L G +P
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 45/255 (17%), Positives = 83/255 (32%), Gaps = 77/255 (30%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM-------EI--VGSIRHE 379
            ++G G++G   +A    +   V +K++  V      FE  +       EI  +  + H+
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112

Query: 380 NVVELKAYYYSKDEK----------LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI 429
           +VV++      KD +          +   D+  L        +      + L       +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL------FRT-----PVYLTELHIKTL 161

Query: 430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIAR 486
                 G+  +H+A    ++H ++K +N  +N     C   V D GL           ++
Sbjct: 162 LYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD---CSVKVCDFGLARTVDYPENGNSQ 215

Query: 487 AAG------------------------------YRAPEV-TDSRKATQASDVYSFGVVLL 515
                                            YRAPE+       T+A DV+S G +  
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275

Query: 516 EILTGKSPIHTTGGD 530
           E+L           D
Sbjct: 276 ELLNMIKENVAYHAD 290

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 53/278 (19%)

Query: 276 VRKKREDEFAGTLQKRGMSPEKVVSRNQDASNRLFFFEGCNYAFDLED--LLRASAEVLG 333
           + + +E E          +P + ++    ++                D   L+    V+G
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHA----------KPSDFHFLK----VIG 47

Query: 334 KGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME----IVGSIRHENVVEL 384
           KG+FG   K +L     +     VK L K   + K++ +  M     ++ +++H  +V L
Sbjct: 48  KGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARIHAA 443
              + + D+   V DY + G +    H +R E         R   A I +A  +  +H+ 
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL--FYHLQR-ERCFLEP-RARFYAAEIASA--LGYLHSL 158

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPVIARAAGYRAPE 494
           N   +V+ ++K  NI L+SQ +  ++D GL         TT T    P       Y APE
Sbjct: 159 N---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP------EYLAPE 209

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           V   +   +  D +  G VL E+L G  P ++    E+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 53/225 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK---------RLKDVNVGKRDFEQQMEIVGSIRHE 379
           + LG G  G    A   +    V +K                   + E ++EI+  + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAIG 432
            ++++K ++ ++D   +V +    G      V      E            +      + 
Sbjct: 76  CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA---------TCKLYFYQMLL 125

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTI--------TSALA 481
           A   +  +H      ++H ++K  N+ L+SQ+  C   ++D G + I        T    
Sbjct: 126 A---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 482 PVIARAAGYRAPEV---TDSRKATQASDVYSFGVVLLEILTGKSP 523
           P       Y APEV     +    +A D +S GV+L   L+G  P
Sbjct: 180 P------TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 38/233 (16%), Positives = 70/233 (30%), Gaps = 70/233 (30%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQ-----MEIV------GSIR 377
            +LGKG FG  +    L D   V +K +    V             +E+           
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--------GRIPLDWDTRMRI 429
           H  V+ L  ++ +++  ++V +                +        G +          
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPA----------QDLFDYITEKGPLGEG------- 139

Query: 430 AIGAARGIAR--IHAAN---GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTIT--SAL 480
               +R      + A        +VH +IK  NI ++ ++ GC    D G   +      
Sbjct: 140 ---PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR-GCAKLIDFGSGALLHDEPY 195

Query: 481 ----------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
                      P       Y A              V+S G++L +++ G  P
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPA----------TVWSLGILLYDMVCGDIP 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME----IV 373
           + L     VLGKG+FG   K +L           VK L KDV +   D E  M     + 
Sbjct: 344 NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
              +   + +L + + + D    V +Y + G +  M H ++  GR               
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP---HAVFYAAE 450

Query: 434 -ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPV 483
            A G+  + +     +++ ++K  N+ L+S+ +  ++D G+         TT T    P 
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP- 506

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                 Y APE+   +   ++ D ++FGV+L E+L G++P      DEL
Sbjct: 507 -----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 44/216 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME----IVGSIRHENVVEL 384
           + LG GTFG          G  V VK L    +   D   +++     +   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR--------G 436
                +  +  MV +Y S G +   +  + G            R+    AR         
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI-CKHG------------RVEEMEARRLFQQILSA 123

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--------TSALAPVIARAA 488
           +   H      +VH ++K  N+ L++     ++D GL+ +        TS  +P      
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP------ 174

Query: 489 GYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
            Y APEV   R  A    D++S GV+L  +L G  P
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 37/210 (17%)

Query: 331 VLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVGSIRHENVV 382
            LG G+FG   + +L    E G    +K L K   V  +  E  +    I+ ++    +V
Sbjct: 48  TLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 383 ELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IGAARGIARI 440
           +L+ + +  +  L MV +Y + G + + L   R  GR       R   A I        +
Sbjct: 105 KLE-FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH-ARFYAAQIVLT--FEYL 157

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL----TTITSALAPVIARAAG---YRAP 493
           H+ +   L++ ++K  N+ ++ Q Y  V+D G        T  L        G     AP
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GTPEALAP 207

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           E+  S+   +A D ++ GV++ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 33/211 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           +VLG G  G   +           +K L+D    +R+ E            ++V +   Y
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVDVY 124

Query: 389 ----YSKDEKLMVYDYYSLG-------SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
                 +   L+V +    G              +ER    I       M+    A   I
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA---I 174

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA--AGYRA 492
             +H+ N   + H ++K  N+   S++      ++D G    T++   +        Y A
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 493 PEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           PEV    K  ++ D++S GV++  +L G  P
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 49/239 (20%), Positives = 84/239 (35%), Gaps = 77/239 (32%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----------IVGSIR 377
             +G+GTFG  +KA   + G  V +K++          E + E           I+  ++
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALREIKILQLLK 74

Query: 378 HENVVELK-------AYYYSKDEKL-MVYDYYSLGSVSAMLHSERG---EGRIPLDWDTR 426
           HENVV L        + Y      + +V+D+          H   G      +       
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDF--------CEHDLAGLLSNVLVKFTLSEI 126

Query: 427 MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVI 484
            R+      G+  IH      ++H ++K++N+ +     G   ++D GL           
Sbjct: 127 KRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD--GVLKLADFGL----------- 170

Query: 485 ARAAG------------------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGKSPI 524
           ARA                    YR PE+    R      D++  G ++ E+ T   PI
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 45/230 (19%), Positives = 85/230 (36%), Gaps = 39/230 (16%)

Query: 320 DLEDLLRASAEVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIR 377
             ED+ +   +VLG+G        I L       VK + K     +    +++E++   +
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 378 -HENVVELKAYYYSKDEKLMVYDYYSLGS----VSAMLH-SERGEGRIPLDWDTRMRIAI 431
            H NV+EL  ++  +D   +V++    GS    +    H +E     +       ++   
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-------VQDVA 121

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARA- 487
            A   +  +H      + H ++K  NI            + D  L +           + 
Sbjct: 122 SA---LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 488 ---------AGYRAPEV-----TDSRKATQASDVYSFGVVLLEILTGKSP 523
                    A Y APEV      ++    +  D++S GV+L  +L+G  P
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 41/212 (19%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVK-----RLKDVNVGKRDFEQQMEIVGSIRHENVVELK 385
           +GKG F     A  +  G  V +K     +L   ++ K    +++ I+  + H N+V+L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKLF 80

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR--IHAA 443
               ++    ++ +Y S G V   L    G            R+    AR   R  + A 
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL-VAHG------------RMKEKEARSKFRQIVSAV 127

Query: 444 N---GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--------TSALAPVIARAAGYRA 492
                 ++VH ++K+ N+ L++     ++D G +              AP       Y A
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP------PYAA 181

Query: 493 PEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
           PE+   +K      DV+S GV+L  +++G  P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 46/221 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQME----IVGSIRHENVVE 383
           ++LG+G++G   + +  E      VK L K       + E  ++    ++  +RH+NV++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 384 LK--AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR------ 435
           L    Y   K +  MV +Y   G     +     E R P+            A       
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVC----------QAHGYFCQL 118

Query: 436 --GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIAR------A 487
             G+  +H+     +VH +IK  N+ L +     +S LG+    +      A       +
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV----AEALHPFAADDTCRTS 171

Query: 488 AG---YRAPEVTDSRK--ATQASDVYSFGVVLLEILTGKSP 523
            G   ++ PE+ +     +    D++S GV L  I TG  P
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 42/221 (19%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK----------RLKDVNVGKRDFEQQMEIVGSI-R 377
           E+LG+G   +  + I         VK            ++V   +    ++++I+  +  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIA 430
           H N+++LK  Y +     +V+D    G         +  SE+         +TR  MR  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETRKIMRAL 133

Query: 431 IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA--A 488
           +     I  +H  N   +VH ++K  NI L+      ++D G +        +       
Sbjct: 134 LEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 489 GYRAPEV------TDSRKATQASDVYSFGVVLLEILTGKSP 523
            Y APE+       +     +  D++S GV++  +L G  P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 41/223 (18%), Positives = 82/223 (36%), Gaps = 63/223 (28%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM------EIVGSI----RH 378
           + LG+GT+   YK         V +K ++       + E+        E+  S+    +H
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREV--SLLKDLKH 59

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG---EGRIPLDWDTRMRIAIGAAR 435
            N+V L    +++    +V++Y        +    +    +    ++            R
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEY--------LDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSALAPVIARAAG---- 489
           G+A  H      ++H ++K  N+ +N +  G +  +D GL           ARA      
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINER--GELKLADFGL-----------ARAKSIPTK 155

Query: 490 ----------YRAPEV-TDSRKATQASDVYSFGVVLLEILTGK 521
                     YR P++   S   +   D++  G +  E+ TG+
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 47.5 bits (114), Expect = 6e-06
 Identities = 46/218 (21%), Positives = 93/218 (42%), Gaps = 41/218 (18%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM---EIVG 374
            +LR     LG G+FG   +  L     +G    +K L K++ V  +  E       ++ 
Sbjct: 9   QILR----TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61

Query: 375 SIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IG 432
            + H  ++ +    +   +++ M+ DY   G +       +   R P     +   A + 
Sbjct: 62  IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRK-SQRFPNP-VAKFYAAEVC 116

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL----TTITSALAPVIARAA 488
            A  +  +H+ +   +++ ++K  NI L+   +  ++D G       +T  L        
Sbjct: 117 LA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-------C 164

Query: 489 G---YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
           G   Y APEV  ++   ++ D +SFG+++ E+L G +P
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 56/225 (24%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK---RLKDVNVGKRDFEQQ--MEIV--GSIRHE-- 379
            +LG G FG  Y  I + D   V +K   + +  + G+     +  ME+V    +     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPL-DW-DTRMRIAIGAARGI 437
            V+ L  ++   D  +++           +   ER E    L D+   R  +    AR  
Sbjct: 109 GVIRLLDWFERPDSFVLI-----------L---ERPEPVQDLFDFITERGALQEELARSF 154

Query: 438 AR--IHAAN---GGKLVHGNIKSSNIFLNSQQYGCV--SDLGLTTIT--SAL-------- 480
               + A        ++H +IK  NI ++  + G +   D G   +   +          
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKDTVYTDFDGTRV 213

Query: 481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP 523
              P   R   Y                V+S G++L +++ G  P
Sbjct: 214 YSPPEWIRYHRYHGRSA----------AVWSLGILLYDMVCGDIP 248

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 46/242 (19%), Positives = 87/242 (35%), Gaps = 73/242 (30%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVK-----------------------RLKDVNVGKRDFE 367
           +GKG++G+   A    D T   +K                             +  R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 368 QQME----IVGSIRHENVVEL--------KAYYYSKDEKLMVYDYYSLGSVSAMLHSERG 415
           +Q+     I+  + H NVV+L        + + Y      MV++  + G V         
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY------MVFELVNQGPV--------- 125

Query: 416 EGRIPLDWDTRMRIAIGAAR--------GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC 467
                ++  T   ++   AR        GI  +H      ++H +IK SN+ +    +  
Sbjct: 126 -----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIK 177

Query: 468 VSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKAT---QASDVYSFGVVLLEILTGK 521
           ++D G++        +++   G   + APE     +     +A DV++ GV L   + G+
Sbjct: 178 IADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

Query: 522 SP 523
            P
Sbjct: 238 CP 239

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 47.2 bits (113), Expect = 9e-06
 Identities = 54/260 (20%), Positives = 106/260 (40%), Gaps = 54/260 (20%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME----IV 373
           DLLR    V+G+G++    K +L    +      +K + K++     D +          
Sbjct: 12  DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IG 432
            +  H  +V L + + ++     V +Y + G +  M H +R + ++P +   R   A I 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEEH-ARFYSAEIS 120

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPV 483
            A  +  +H      +++ ++K  N+ L+S+ +  ++D G+         TT T    P 
Sbjct: 121 LA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP- 174

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV 543
                 Y APE+        + D ++ GV++ E++ G+SP    G  +            
Sbjct: 175 -----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NP 219

Query: 544 REEWTAEVFDVEL---LRYP 560
            +     +F V L   +R P
Sbjct: 220 DQNTEDYLFQVILEKQIRIP 239

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 57/285 (20%), Positives = 118/285 (41%), Gaps = 58/285 (20%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME----IV 373
           DLLR    V+G+G++    K +L    +      ++ + K++     D +          
Sbjct: 55  DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-IG 432
            +  H  +V L + + ++     V +Y + G +  M H +R + ++P +   R   A I 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEE-HARFYSAEIS 163

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPV 483
            A  +  +H      +++ ++K  N+ L+S+ +  ++D G+         TT T    P 
Sbjct: 164 LA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP- 217

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV 543
                 Y APE+        + D ++ GV++ E++ G+SP    G  +            
Sbjct: 218 -----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NP 262

Query: 544 REEWTAEVFDVEL---LRYP-NIEEEMVEMLQIAMSCVVRMPDQR 584
            +     +F V L   +R P ++  +   +L+   S + + P +R
Sbjct: 263 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLK---SFLNKDPKER 304

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 50/209 (23%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           +VLG G  G   +           +K L+D    +R+ E            ++V +   Y
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVDVY 80

Query: 389 ----YSKDEKLMVYDYYSLG-------SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
                 +   L+V +    G              +ER    I       M+    A   I
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA---I 130

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC---VSDLGLTTITSALAPVIARAAGYRAPE 494
             +H+ N   + H ++K  N+   S++      ++D G                   A E
Sbjct: 131 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF------------------AKE 169

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSP 523
            T   K  ++ D++S GV++  +L G  P
Sbjct: 170 TT-GEKYDKSCDMWSLGVIMYILLCGYPP 197

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 40/230 (17%)

Query: 323 DLLRASAEVLGKGTFG---MAYKAILED-GTTVVVKRL-KDVNVGK-RDFEQQM---EIV 373
           +LLR    VLGKG +G      K    + G    +K L K + V   +D         I+
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 374 GSIRHENVVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIA-I 431
             ++H  +V+L  Y +    KL ++ +Y S G +   +  ER EG    D      +A I
Sbjct: 76  EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLER-EGIFMED-TACFYLAEI 130

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAP 482
             A  +  +H      +++ ++K  NI LN Q +  ++D GL          T T     
Sbjct: 131 SMA--LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                  Y APE+       +A D +S G ++ ++LTG  P       + 
Sbjct: 186 ------EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 45/231 (19%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM-E---IV 373
           + +R    VLGKG+FG   K +L    E G    VK L KDV +   D E  M E   + 
Sbjct: 26  EFIR----VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
            +  H  + +L   + + D    V ++ + G +  M H ++   R         R    A
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQK-SRRFDEA-----RARFYA 130

Query: 434 AR---GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALA 481
           A     +  +H      +++ ++K  N+ L+ + +  ++D G+         TT T    
Sbjct: 131 AEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187

Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
           P       Y APE+        A D ++ GV+L E+L G +P      D+L
Sbjct: 188 P------DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 41/229 (17%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQME----IV 373
            L +    +LGKG+FG   K  L    +      +K L KDV +   D E  M     + 
Sbjct: 20  ILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
            +  H  +  +   + +K+    V +Y + G +  M H +    +  L    R       
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQS-CHKFDLS---RATFYAAE 126

Query: 434 -ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPV 483
              G+  +H+     +V+ ++K  NI L+   +  ++D G+          T T    P 
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP- 182

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                 Y APE+   +K   + D +SFGV+L E+L G+SP H    +EL
Sbjct: 183 -----DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 50/222 (22%), Positives = 80/222 (36%), Gaps = 50/222 (22%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVK--RLKDVNVGKRDFEQQM--EI-----VGSIRHE 379
             +G G +G  YKA     G  V +K  R+ +   G          E+     + +  H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 380 NVVELK----AYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAA 434
           NVV L          ++ K+ +V+++     +   L      G   L  +T   +     
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG---LPAETIKDLMRQFL 130

Query: 435 RGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVIARAAG--- 489
           RG+  +HA     +VH ++K  NI + S   G   ++D GL           AR      
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSG--GTVKLADFGL-----------ARIYSYQM 174

Query: 490 ----------YRAPEVTDSRKATQASDVYSFGVVLLEILTGK 521
                     YRAPEV          D++S G +  E+   K
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 22/139 (15%)

Query: 81  LIPPNTISRLSALKILSLRSNVITG----YFPSDFINLKSLCYLYLQFNNF-----SGTL 131
           L           L+ +    N +       +   F + + L  + +  N          L
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208

Query: 132 PD-FSVWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGK--------I 178
            +  +  + L +++L DN F       +  +L +   L  L L +  LS +         
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268

Query: 179 PDLNLPNLQQLNLANNNLS 197
             L    LQ L L  N + 
Sbjct: 269 SKLENIGLQTLRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 31/164 (18%), Positives = 50/164 (30%), Gaps = 31/164 (18%)

Query: 87  ISRLSALKILSLRSNVIT-----GYFPSDFINLKSLCYLYLQFNNF--------SGTLPD 133
                 L  + +  N I                + L  L LQ N F        +  L  
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK- 241

Query: 134 FSVWKNLTIINLSDNGFNGT----IPRSLSNL--TQLEALYLANNSLS-------GKIPD 180
              W NL  + L+D   +      +  + S L    L+ L L  N +          + D
Sbjct: 242 --SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 181 LNLPNLQQLNLANNNLS--GSIPQSLKRFPSSAFVGNSISFDEN 222
             +P+L  L L  N  S    +   ++   S+   G     D+ 
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 68/230 (29%)

Query: 330 EVLGKGTFGMAYKA--ILEDGTTVVVKRLKDVNVGKRDFEQQMEIVG----SIR------ 377
             +G+G +G  +KA  +   G  V +KR++         +   E  G    +IR      
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR--------VQTGEE--GMPLSTIREVAVLR 66

Query: 378 ------HENVVELK----AYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTR 426
                 H NVV L          ++ KL +V+++     ++  L      G   +  +T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG---VPTETI 122

Query: 427 MRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITSALAPVI 484
             +     RG+  +H+     +VH ++K  NI + S   G   ++D GL           
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--GQIKLADFGL----------- 166

Query: 485 ARAAG-------------YRAPEVTDSRKATQASDVYSFGVVLLEILTGK 521
           AR                YRAPEV          D++S G +  E+   K
Sbjct: 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 39/123 (31%), Positives = 56/123 (45%), Gaps = 22/123 (17%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C+  T V C     R+ +V  P    +G IP +        + L L +N IT   P  F 
Sbjct: 12  CDQ-TLVNCQ--NIRLASV--P----AG-IPTDK-------QRLWLNNNQITKLEPGVFD 54

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYL 169
           +L +L  LY   N  +  +P   F     LT ++L+DN    +IPR +  NL  L  +YL
Sbjct: 55  HLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYL 112

Query: 170 ANN 172
            NN
Sbjct: 113 YNN 115

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 41/229 (17%)

Query: 323 DLLRASAEVLGKGTFGMAYKAIL----EDGTTVVVKRL-KDVNVGKRDFEQQM-E---IV 373
           + L     VLGKG+FG   K +L           VK L KDV +   D E  M E   + 
Sbjct: 23  NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
              +   + +L + + + D    V +Y + G +  M H ++  GR               
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP---HAVFYAAE 129

Query: 434 -ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL---------TTITSALAPV 483
            A G+  + +     +++ ++K  N+ L+S+ +  ++D G+         TT T    P 
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP- 185

Query: 484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL 532
                 Y APE+   +   ++ D ++FGV+L E+L G++P      DEL
Sbjct: 186 -----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 30/126 (23%)

Query: 490 YRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV----HLVRWV------ 539
           YR+ EV         +D++S   +  E+ TG        G+E      H+   +      
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

Query: 540 --HSVVREEWTAEVFD--VELLRYPNI----------------EEEMVEMLQIAMSCVVR 579
               +V  +++ E F    +L     +                +EE        +  +  
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 580 MPDQRP 585
           +P++R 
Sbjct: 379 IPEKRA 384

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 4e-05
 Identities = 73/586 (12%), Positives = 174/586 (29%), Gaps = 158/586 (26%)

Query: 81  LIPPNTISRLSAL--KILSLRSNVITGYFPS------DFI--------NLKSLCY-LYLQ 123
           ++  + +S    L   +LS +  ++  +          F+           S+   +Y++
Sbjct: 55  IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114

Query: 124 ----FNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE--ALY--------- 168
                 N +     ++V +    + L          ++L  L   +   +          
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLR---------QALLELRPAKNVLIDGVLGSGKTW 165

Query: 169 LANNSLSGKIPDLNLPNLQQ---LNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAP 225
           +A +          +    +   LNL N N   ++ + L++             D N   
Sbjct: 166 VALDVCLSYKVQCKMDF--KIFWLNLKNCNSPETVLEMLQKL--------LYQIDPNWTS 215

Query: 226 RASPDVAPR-----GESHLRPKSGRRIGETTLLGI---VIAASVLGLLAFLFLIVACCVR 277
           R+      +      ++ LR     +  E  LL +   V  A      AF     +C   
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-VLLNVQNAKAWN--AFNL---SC--- 266

Query: 278 KKREDEFAGTLQKRGMSPEKVVSRNQDASNRL-------FFFEGCNYAFDLEDLLRASAE 330
            K        L         + +R +  ++ L          +  +     +++     +
Sbjct: 267 -K-------IL---------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309

Query: 331 VLGKGTFGMAYKAILED--GTTVVVKRLKDV-----NVGKRDFEQQMEIVG-SIRHENVV 382
            L      +  + +  +    +++ + ++D      N    + ++   I+  S+      
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

Query: 383 ELKAYYYS-----KDEK-----LMVY----DYYSLGSVSAMLHS--------ERGEGRIP 420
           E +  +                L +         +  V   LH         +     IP
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429

Query: 421 -LDWDTRMRIAIGAARGIARIHAANGGKLV-HGNIKSSNIFLNSQQYGCVSDLGLTTITS 478
            +  + ++++          +H      +V H NI         + +    DL    +  
Sbjct: 430 SIYLELKVKL-----ENEYALHR----SIVDHYNIP--------KTF-DSDDLIPPYLDQ 471

Query: 479 ALAPVIARAAGYRAPEVTDSRKATQASDVY-SFGVVLLEILTGKSPIHTTGG--DELVHL 535
                I    G+    +    + T    V+  F  +  +I    +  + +G   + L  L
Sbjct: 472 YFYSHI----GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527

Query: 536 VRWVHSVVREEWTAEVFDVELLRY-PNIEEEMVE-----MLQIAMS 575
             +   +   +   E     +L + P IEE ++      +L+IA+ 
Sbjct: 528 KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 5e-04
 Identities = 70/403 (17%), Positives = 116/403 (28%), Gaps = 146/403 (36%)

Query: 11  FNLG---LIFSKVNAEPVEDKEALLDFVNNL--------PHSRSLNWNESTSVCNHWTGV 59
           FNL    L+ ++        K+ + DF++           HS +L  +E  S+   +   
Sbjct: 262 FNLSCKILLTTR-------FKQ-VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313

Query: 60  KCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCY 119
           +  +         LP                  L     R ++I      D +       
Sbjct: 314 RPQD---------LP---------------REVLTTNPRRLSII-AESIRDGLA------ 342

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE--ALYLANNSLSGK 177
               ++N          WK++    L+       I  SL+ L   E   ++   + LS  
Sbjct: 343 ---TWDN----------WKHVNCDKLTT-----IIESSLNVLEPAEYRKMF---DRLS-- 379

Query: 178 I--PDLNLPNLQQLNLANNNLSGSIPQ---------SL--KRFPSSAFVGNSISFD---- 220
           +  P  ++P    L+L   ++  S            SL  K+   S     SI  +    
Sbjct: 380 VFPPSAHIP-TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438

Query: 221 -ENLA------------PRASP--DVAPRGES---------HLRPKSGRRIGETTLLGIV 256
            EN              P+     D+ P             HL  K+       TL  +V
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL--KNIEHPERMTLFRMV 496

Query: 257 IAASVLGLLAFLFLIVACCVRKKREDEFAGTLQKRGMSP-------EKVVSRNQDASNRL 309
                   L F FL      +K R D  A       ++        +  +  N     RL
Sbjct: 497 -------FLDFRFL-----EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544

Query: 310 F-----FFEGCN---YAFDLEDLLRASAEVLGKGTFGMAYKAI 344
                 F              DLLR +     +  F  A+K +
Sbjct: 545 VNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 44/216 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME----IVGSIRHENVVEL 384
           + LG GTFG          G  V VK L    +   D   ++      +   RH ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR--------G 436
                +  +  MV +Y S G +   +  + G            R+    +R        G
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNG------------RLDEKESRRLFQQILSG 128

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--------TSALAPVIARAA 488
           +   H      +VH ++K  N+ L++     ++D GL+ +        TS  +P      
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP------ 179

Query: 489 GYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
            Y APEV   R  A    D++S GV+L  +L G  P
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 40/244 (16%), Positives = 82/244 (33%), Gaps = 50/244 (20%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQM---EIVGSIRHE-----N 380
             +G GTFG       +++     VK ++++   K+         +I+  I+++     N
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNN 97

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           +V+    +   D   ++++     S+  ++             +      I   + +  +
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGP-SLYEII---TRNNYNGFHIEDIKLYCIEILKALNYL 153

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG----------- 489
              +   L H ++K  NI L+   +                 +    +            
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 490 --------------YRAPEVTDSRKATQASDVYSFGVVLLEILTGKS--PIHTTGGDELV 533
                         YRAPEV  +     +SD++SFG VL E+ TG      H    + + 
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH----EHME 266

Query: 534 HLVR 537
           HL  
Sbjct: 267 HLAM 270

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 42/123 (34%), Positives = 56/123 (45%), Gaps = 22/123 (17%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
           C+  T V CS  GK + +V  P    +G IP  T       ++L L  N IT   P  F 
Sbjct: 9   CSG-TTVDCS--GKSLASV--P----TG-IPTTT-------QVLYLYDNQITKLEPGVFD 51

Query: 113 NLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYL 169
            L  L  L L  N  +  LP   F     LT ++L+DN    +IPR +  NL  L  ++L
Sbjct: 52  RLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWL 109

Query: 170 ANN 172
            NN
Sbjct: 110 LNN 112

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 46/222 (20%), Positives = 92/222 (41%), Gaps = 26/222 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH---------E 379
            ++GKG+FG   KA    +   V +K +K+    K    Q    V  +            
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            +V LK ++  ++   +V++  S  ++  +L   R      +  +   + A      +  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLL---RNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTITS-ALAPVIA-RAAGYRAPEV 495
           +       ++H ++K  NI L + +     + D G +      +   I  R   YR+PEV
Sbjct: 173 LATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--YRSPEV 229

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
                   A D++S G +L+E+ TG+ P+  +G +E+  + +
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE-PLF-SGANEVDQMNK 269

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 41/220 (18%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK---------DVNVGKRDFEQQMEIVGSIR-H 378
           +V+G+G   +  + +    G    VK ++          +   +    ++  I+  +  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGS-----VSAMLHSERGEGRIPLDWDTR--MRIAI 431
            +++ L   Y S     +V+D    G         +  SE+         +TR  MR  +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---------ETRSIMRSLL 210

Query: 432 GAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA--AG 489
            A   ++ +HA N   +VH ++K  NI L+      +SD G +        +       G
Sbjct: 211 EA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264

Query: 490 YRAPEV------TDSRKATQASDVYSFGVVLLEILTGKSP 523
           Y APE+             +  D+++ GV+L  +L G  P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 21/126 (16%), Positives = 43/126 (34%), Gaps = 21/126 (16%)

Query: 93  LKILSLRSNVIT----GYFPSDFINLKSLCYLYLQFNNFSGT----LPDF--SVWKNLTI 142
           ++ LSL++  +T    G   S    L +L  L+L  N         L +        L  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 143 INLSDNGFNGT----IPRSLSNLTQLEALYLANNSLS-------GKIPDLNLPNLQQLNL 191
           + L     +      +   L      + L ++NN ++        +    +   L+ L L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 192 ANNNLS 197
            +  ++
Sbjct: 207 ESCGVT 212

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 45/212 (21%), Positives = 80/212 (37%), Gaps = 42/212 (19%)

Query: 332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS 390
           +G G FG+A           V VK ++       + ++++    S+RH N+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR--------GIARIHA 442
                ++ +Y S G +   + +    GR   D           AR        G++  H+
Sbjct: 88  PTHLAIIMEYASGGELYERICN---AGRFSED----------EARFFFQQLLSGVSYCHS 134

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGC--VSDLGLTTI--------TSALAPVIARAAGYRA 492
                + H ++K  N  L+        + D G +          ++   P       Y A
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP------AYIA 185

Query: 493 PEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
           PEV   ++   + +DV+S GV L  +L G  P
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.6 bits (99), Expect = 3e-04
 Identities = 33/204 (16%), Positives = 55/204 (26%), Gaps = 50/204 (24%)

Query: 312 FEGCNYAFDLEDLLRASAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQME 371
           F  C     L+       E +G+G FG  ++ I  D T V +K +        +   Q  
Sbjct: 13  FSHCLPTEKLQRC-----EKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66

Query: 372 I------------------VGSIRHENVVELKAYYYSKDEK----LMVYDYYSLGSVSAM 409
                                  R E  + L + +  +       L  +D+Y+    SA 
Sbjct: 67  FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126

Query: 410 ------------LHSERGEGRIPL--------DWDTRMRIAIGAARGIARIHAANGGKLV 449
                       +  E   G I L           T   I       +A   A+      
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGL 473
           H ++   N+ L       +     
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLN 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 61/224 (27%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME----IVGSIRHENVVEL 384
           E LG+G+FG    A   +    V +K +    + K D   ++E     +  +RH ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE--------GRIPLDWDTRMRIAIGAAR- 435
                +  + +MV +Y              GE         R+  D            R 
Sbjct: 75  YDVITTPTDIVMVIEYAG------------GELFDYIVEKKRMTED----------EGRR 112

Query: 436 -------GIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--------TSAL 480
                   I   H      +VH ++K  N+ L+      ++D GL+ I        TS  
Sbjct: 113 FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG 169

Query: 481 APVIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSP 523
           +P       Y APEV + +  A    DV+S G+VL  +L G+ P
Sbjct: 170 SP------NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 56/239 (23%), Positives = 92/239 (38%), Gaps = 56/239 (23%)

Query: 323 DLLRASAEVLGKGTFG---MAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH 378
           +LL+    VLG G +G   +  K    D G    +K LK     K    Q+ +     R 
Sbjct: 57  ELLK----VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-----KATIVQKAKTTEHTRT 107

Query: 379 EN-----------VVELKAYYYSKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTR 426
           E            +V L  Y +  + KL ++ DY + G +    H  +   R     + +
Sbjct: 108 ERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQ-RERFTEH-EVQ 162

Query: 427 MRIA-IGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL--------TTIT 477
           + +  I  A  +  +H      +++ +IK  NI L+S  +  ++D GL        T   
Sbjct: 163 IYVGEIVLA--LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 478 SALAPVIARAAG---YRAPEV-TDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDE 531
                      G   Y AP++         +A D +S GV++ E+LTG SP    G   
Sbjct: 218 YDF-------CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 45/245 (18%), Positives = 82/245 (33%), Gaps = 56/245 (22%)

Query: 330 EVLGKGTFGMAYKAI--LEDGTTVVVKRLKDVNVGKRDFEQ-QMEIVGSI---------- 376
             LG+GTFG   + +      + V +K +++V    +  E  ++EI  ++          
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEI--NVLKKIKEKDKE 79

Query: 377 -RHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAAR 435
            +    V +  ++       + ++     +    L   +     P        +A     
Sbjct: 80  NKF-LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL---KENNFQPYPLPHVRHMAYQLCH 134

Query: 436 GIARIHAANGGKLVHGNIKSSNIFLNSQQYGC-------------------VSDLGLTTI 476
            +  +H      L H ++K  NI   + ++                     V+D G  T 
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 477 TS-ALAPVIA-RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKS--PIHTTGGDEL 532
                  ++A R   YR PEV       Q  DV+S G +L E   G +    H    +  
Sbjct: 192 DHEHHTTIVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH----ENR 245

Query: 533 VHLVR 537
            HLV 
Sbjct: 246 EHLVM 250

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 51/242 (21%), Positives = 87/242 (35%), Gaps = 50/242 (20%)

Query: 330 EVLGKGTFGMAYKAI--LEDGTTVVVKRLKDVNVGKRDFEQQM---EIVGSIRHE----- 379
           + LG+G FG   + I     G  V VK +K+V    R  E      +++  +        
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNST 76

Query: 380 -NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIA 438
              V++  ++       +V++   L S    +   +  G +P   D   ++A    + + 
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGL-STYDFI---KENGFLPFRLDHIRKMAYQICKSVN 132

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VI---------- 484
            +H+     L H ++K  NI      Y    +  +      L      V+          
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 485 -------ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKS--PIHTTGGDELVHL 535
                   R   YRAPEV  +   +Q  DV+S G +L+E   G +  P H    D   HL
Sbjct: 190 HHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH----DSKEHL 243

Query: 536 VR 537
             
Sbjct: 244 AM 245

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	625
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.88
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.82
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.82
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.76
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.76
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.74
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.73
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.71
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.71
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.7
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.7
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.7
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.69
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.68
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.68
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.67
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.67
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.67
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.66
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.65
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.65
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.65
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.64
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.64
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.64
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.64
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.64
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.63
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.63
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.63
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.63
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.62
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.62
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.62
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.61
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.61
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.59
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.59
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.58
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.58
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.57
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.57
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.56
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.55
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.55
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.55
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.54
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.54
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.53
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.53
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.53
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.53
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.52
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.52
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.52
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.52
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.52
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.51
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.51
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.49
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.49
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.48
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.48
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.48
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.48
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.47
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.47
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.47
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.47
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.46
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.46
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.45
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.45
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.45
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.45
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.45
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.44
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.44
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.44
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.43
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.41
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.4
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.39
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.39
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.39
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.39
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.38
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.38
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.36
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.34
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.32
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.22
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.21
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.21
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.19
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.19
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.18
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.16
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.11
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.05
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.95
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.9
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.8
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.65
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.61
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.44
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.42
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.36
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.3
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.29
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.28
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.26
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.12
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.98
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.98
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.95
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.81
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.75
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.74
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.67
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.66
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.61
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.3
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.29
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.27
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.92
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.85
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.79
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.38
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.24
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.22
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.16
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	95.94
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	95.74
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.35
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.0
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	94.82
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	94.67
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	94.58
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.55
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.39
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.99
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.01
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	90.95
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	90.55
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.86
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	85.13

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-54  Score=443.09  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=206.0

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|.+.      +++.||||+++....  ..++|.+|+.++++++|||||+++|+|.+.+..++|||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            56999999999999862      468899999976432  3478999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          402 SLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                      ++|+|.++|+.....           ....++|.++.+|+.|||+||+|||+++   ||||||||+||||++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECC
Confidence            999999999754321           1235899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          471 LGLTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       471 fGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      ||+|+.....     .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....   +.    
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~---i~----  261 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM---IR----  261 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH---HH----
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH----
Confidence            9999876432     223467888999999999999999999999999999999 8999987654333222   21    


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .+.          ..+.+.++..++.+++.+||+.||++||||.||++.|+...
T Consensus       262 ~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          262 NRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             cCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            111          11222334457888999999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-54  Score=444.48  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|++.      +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus        47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~  126 (329)
T 4aoj_A           47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR  126 (329)
T ss_dssp             EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            56999999999999864      478999999986532 24679999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccc
Q 006922          403 LGSVSAMLHSERGE----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG  472 (625)
Q Consensus       403 ~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG  472 (625)
                      +|+|.++++.....          ...+++|.++.+|+.|+|+||+|||+.+   ||||||||+||||++++.+||+|||
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccc
Confidence            99999999865421          1246999999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcc
Q 006922          473 LTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE  546 (625)
Q Consensus       473 la~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  546 (625)
                      +|+.....     .....||+.|||||++.+..|+.++|||||||++|||+| |+.||......+....   +.   .+.
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~---i~---~g~  277 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC---IT---QGR  277 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH---HH---HTC
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH---HH---cCC
Confidence            99876432     123467889999999999999999999999999999999 9999987654333222   21   111


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .           .+.+..+..++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus       278 ~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          278 E-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             C-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            0           111222345678889999999999999999999999998654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-54  Score=440.93  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|++.      +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus        19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~   98 (299)
T 4asz_A           19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK   98 (299)
T ss_dssp             EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCC
Confidence            56999999999999853      478899999986532 24679999999999999999999999999999999999999


Q ss_pred             CCChhhhhcccc--------CCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          403 LGSVSAMLHSER--------GEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       403 ~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      +|+|.++++...        ......++|.++.+|+.|+|+||+|||+++   ||||||||+|||+++++.+||+|||+|
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla  175 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS  175 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccc
Confidence            999999997642        122346999999999999999999999987   999999999999999999999999999


Q ss_pred             ccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +......     ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+   .   .+.. 
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~---~~~~-  248 (299)
T 4asz_A          176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---T---QGRV-  248 (299)
T ss_dssp             HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H---HTCC-
T ss_pred             eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H---cCCC-
Confidence            8764322     22357889999999999999999999999999999999 99999876543332222   1   1110 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                                .+.+..+..++.+++.+||+.||++||||+||++.|+++..
T Consensus       249 ----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          249 ----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                      11122234567888999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-53  Score=428.68  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=198.1

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||+|++.  ..||||+++.....   .+.|.+|++++++++|||||+++|+|.. +..+||||||++|+
T Consensus        41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            367999999999999865  36999999865433   3578999999999999999999998864 56899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----  480 (625)
                      |.++++....    .++|.++..|+.|+|+||+|||+++   ||||||||+||||++++.+||+|||+|+.....     
T Consensus       118 L~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          118 LYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             HHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            9999976432    4999999999999999999999987   999999999999999999999999999875421     


Q ss_pred             ccccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          481 APVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      .....||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+....+..  ...    +..+    ...+...
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~----~~~~----~~~p~~~  260 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFM----VGRG----YASPDLS  260 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHH----HHTT----CCCCCST
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHH----HhcC----CCCCCcc
Confidence            234578999999999853   46899999999999999999999999765433221  111    1111    1111111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .  ....+..++.+++.+||+.||++||||.||++.|+.++.
T Consensus       261 ~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          261 K--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             T--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             c--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1  112234567788899999999999999999999998864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.6e-53  Score=430.77  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecC----ceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKD----EKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||+++|+|...+    ..+||||||++|+
T Consensus         9 ~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gs   87 (303)
T 3hmm_A            9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS   87 (303)
T ss_dssp             EEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred             EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCc
Confidence            5699999999999998 5899999999764432233445666667889999999999998764    5799999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN-----GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      |.++++..      .++|..+.+++.|+++||+|||++.     .++||||||||+||||+.++++||+|||+|+.....
T Consensus        88 L~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           88 LFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            99999764      3899999999999999999999872     345999999999999999999999999999876432


Q ss_pred             c-------cccccCCCcCCccccCCC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--------hHHHHH
Q 006922          481 A-------PVIARAAGYRAPEVTDSR------KATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWV  539 (625)
Q Consensus       481 ~-------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--------~~~~~~  539 (625)
                      .       ....||+.|||||++.+.      .++.++|||||||++|||+||+.||......+..        .....+
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            2       234689999999998764      3678999999999999999998877543221110        001111


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ...+.++    ..++.........+....+.+++.+||+.||++||||.||++.|+++.++.
T Consensus       242 ~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          242 RKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            1111111    112222111122345667889999999999999999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-51  Score=423.82  Aligned_cols=239  Identities=20%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|... +|+.||||+++.... ..+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus        80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  159 (346)
T 4fih_A           80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  159 (346)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence            46999999999999964 699999999975433 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++...      .+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.....   ....
T Consensus       160 ~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          160 DIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             HHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence            999753      3899999999999999999999998   999999999999999999999999999876432   3456


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+..   ..+.    .....     .   .+....
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~~~~-----~---~~~~~~  295 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DNLPP-----R---LKNLHK  295 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSSCC-----C---CSCGGG
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cCCCC-----C---CCcccc
Confidence            8999999999999999999999999999999999999999765433222   2221    11100     0   111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+++.+||+.||++|||++|+++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2345677888999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-51  Score=423.64  Aligned_cols=241  Identities=20%  Similarity=0.391  Sum_probs=194.9

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++.....   .+.+.+|++++++++|||||++++++.+.+..|+|||||++|
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            35799999999999995 47999999999765433   356899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~  481 (625)
                      +|.+++...+   ...+++.++..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....   .
T Consensus       109 ~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          109 DLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             BHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             cHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999997543   234789999999999999999999998   999999999999999999999999999987543   2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+...      ........           +.
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~~~-----------~~  245 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIISGSFP-----------PV  245 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHTCCC-----------CC
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHcCCCC-----------CC
Confidence            34579999999999999999999999999999999999999997654322221      11122110           00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112235677888999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-51  Score=422.02  Aligned_cols=244  Identities=18%  Similarity=0.206  Sum_probs=201.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+|+.. +|+.||||+++...    ...+|++++++++|||||++++++.+.+..+||||||++|+|.+
T Consensus        64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~  139 (336)
T 4g3f_A           64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ  139 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             cEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence            46999999999999964 69999999997643    23479999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccc-------
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSAL-------  480 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~-------  480 (625)
                      +++...     .+++..+..++.|++.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.....       
T Consensus       140 ~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          140 LIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             HHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             HHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            998653     4999999999999999999999998   99999999999999987 6999999999876432       


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+....+.      .+...  .  ..  ..
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~--~--~~--~~  279 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPP--I--RE--IP  279 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCG--G--GG--SC
T ss_pred             cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCC--c--hh--cC
Confidence             123469999999999999999999999999999999999999998766555443222      11100  0  00  01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      +.   ...++.+++.+||++||++|||+.|+++.|.....+
T Consensus       280 ~~---~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          280 PS---CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cc---CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            11   223566777899999999999999999988776543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-50  Score=407.93  Aligned_cols=241  Identities=23%  Similarity=0.412  Sum_probs=193.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... ++..||+|++......   .+.|.+|++++++++|||||+++++|.+    .+..++|||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            45999999999999964 6899999999765433   3568999999999999999999999875    24579999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~  480 (625)
                      ++|+|.+++....     .+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+.....
T Consensus       112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            9999999998653     4899999999999999999999875 35999999999999985 789999999999865433


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....  ..+...+    ..+.....++    . 
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i----~~~~~~~~~~----~-  253 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV----TSGVKPASFD----K-  253 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH----TTTCCCGGGG----G-
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHH----HcCCCCCCCC----c-
Confidence             345679999999999875 6999999999999999999999999754322  1222211    1111110011    0 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .   ...++.+++.+||+.||++|||++|+++
T Consensus       254 -~---~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 -V---AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -C---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -c---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1   1124667888999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-51  Score=424.31  Aligned_cols=253  Identities=27%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             HhHcccCCceeEEEEEEcC------CcEEEEEEeccccC--ChHHHHHHHHHHHcCCC-CceecceeEEEec-CceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILED------GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRH-ENVVELKAYYYSK-DEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~lv~  398 (625)
                      .+.||+|+||+||+|....      ++.||||+++....  ..+.|.+|+++|.+++| ||||+++|+|... +..++||
T Consensus        69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~  148 (353)
T 4ase_A           69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  148 (353)
T ss_dssp             EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence            4679999999999998532      36899999986533  23679999999999965 8999999999765 5689999


Q ss_pred             EeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          399 DYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                      |||++|+|.++|+.....           ....++|.++..++.|||+||+|||+++   ||||||||+|||+++++.+|
T Consensus       149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK  225 (353)
T 4ase_A          149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  225 (353)
T ss_dssp             ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence            999999999999764321           1335899999999999999999999998   99999999999999999999


Q ss_pred             Eecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 006922          468 VSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       468 l~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      |+|||+|+......     ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+..  ...+. 
T Consensus       226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~--~~~i~-  302 (353)
T 4ase_A          226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK-  302 (353)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH-
T ss_pred             ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH--HHHHH-
Confidence            99999998764322     23457888999999999999999999999999999998 99999876543321  11111 


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                         .+.          +.+.++....++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus       303 ---~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          303 ---EGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             ---HTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence               111          1111122344678888999999999999999999999988653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=424.77  Aligned_cols=239  Identities=20%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|... +|+.||||++..... ..+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus       157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~  236 (423)
T 4fie_A          157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  236 (423)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence            56999999999999964 699999999976533 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++...      .+++.++..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....   ....
T Consensus       237 ~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          237 DIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             HHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            999753      2899999999999999999999998   999999999999999999999999999876432   3456


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      +||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+..   ..+.    ....     +........  
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~~~-----~~~~~~~~~--  373 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DNLP-----PRLKNLHKV--  373 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSCC-----CCCSCTTSS--
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cCCC-----CCCcccccC--
Confidence            7999999999999999999999999999999999999999765433222   2221    1110     111111122  


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ..++.+++.+||+.||++|||+.|+++
T Consensus       374 -s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          374 -SPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             235667778999999999999999976

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-50  Score=410.24  Aligned_cols=237  Identities=16%  Similarity=0.299  Sum_probs=198.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|+. .+|+.||||++.+..    ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g  116 (311)
T 4aw0_A           37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN  116 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            36799999999999995 479999999997532    2346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....   
T Consensus       117 G~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          117 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999998653     3899999999999999999999998   999999999999999999999999999876422   


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+....+      .....       ..  
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~~~~~-------~~--  253 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI------IKLEY-------DF--  253 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCC-------CC--
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCCC-------CC--
Confidence              23457999999999999999999999999999999999999999765433322211      11110       00  


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                       +  +....++.+++.+|++.||++|||++|+.
T Consensus       254 -p--~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 -P--EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -C--TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -C--cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             1  11123566778899999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-49  Score=398.80  Aligned_cols=236  Identities=20%  Similarity=0.314  Sum_probs=184.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+|+.||||++++...    ..+.+.+|++++++++|||||++++++.+.+..++||||+ +|
T Consensus        19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g   97 (275)
T 3hyh_A           19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN   97 (275)
T ss_dssp             EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence            5799999999999995 4799999999975432    2356899999999999999999999999999999999999 67


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....  ..
T Consensus        98 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           98 ELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            9999987643     4999999999999999999999998   999999999999999999999999999876432  23


Q ss_pred             ccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...||+.|||||++.+..| +.++||||+||++|||+||+.||.+.+..+.   .+.+.   ....       .   .+ 
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~---~~~i~---~~~~-------~---~p-  232 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL---FKNIS---NGVY-------T---LP-  232 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HTCC-------C---CC-
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHH---cCCC-------C---CC-
Confidence            4679999999999998876 5799999999999999999999976433222   22111   1110       0   01 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....++.+++.+|++.||++|||++|+++
T Consensus       233 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 -KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             111235667788999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.7e-50  Score=405.26  Aligned_cols=233  Identities=21%  Similarity=0.317  Sum_probs=187.3

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|+..    .++.||||+++....   ....+.+|++++.+++|||||++++++.+.+..++|||||
T Consensus        29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~  108 (304)
T 3ubd_A           29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL  108 (304)
T ss_dssp             EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred             EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence            367999999999999852    478999999976432   2346889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc--
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA--  479 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~--  479 (625)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+....  
T Consensus       109 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          109 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             TTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999998653     4899999999999999999999998   99999999999999999999999999986532  


Q ss_pred             -cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          480 -LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       480 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                       ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+....+      .....           
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~-----------  243 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAKL-----------  243 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC-----------
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCCC-----------
Confidence             233467999999999999999999999999999999999999999865443332221      11110           


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                       +.+.....++.+++.+||+.||++|||+
T Consensus       244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 -GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence             0011122356677889999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-47  Score=389.32  Aligned_cols=239  Identities=20%  Similarity=0.322  Sum_probs=182.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCc------------e
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE------------K  394 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------------~  394 (625)
                      +.||+|+||+||+|+. .+|+.||||+++....  ..+.+.+|+++|++++|||||++++++.+.+.            .
T Consensus        11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l   90 (299)
T 4g31_A           11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL   90 (299)
T ss_dssp             EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence            5799999999999995 4799999999975432  23568999999999999999999999876543            6


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      ++||||+++|+|.+++....  .....++..+..|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        91 ~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           91 YIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             EEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccc
Confidence            89999999999999997643  2234677888999999999999999998   999999999999999999999999999


Q ss_pred             ccccccc---------------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 006922          475 TITSALA---------------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV  539 (625)
Q Consensus       475 ~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~  539 (625)
                      +......               ....||+.|||||++.+..|+.++|||||||++|||++   ||...  .+....+.  
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~--  238 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLT--  238 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHH--
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHH--
Confidence            8764321               22468999999999999999999999999999999996   77531  11111111  


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .. .....          .+..........+++.+||+.||++|||+.|+++
T Consensus       239 -~~-~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 -DV-RNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HH-HTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HH-hcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11 11100          0111223345567888999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=389.25  Aligned_cols=254  Identities=21%  Similarity=0.305  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec------CceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+++|++++|||||++++++...      +..|+|||
T Consensus        60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE  139 (398)
T 4b99_A           60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD  139 (398)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred             EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence            5799999999999995 47999999999865433   24678999999999999999999997643      57899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      ||+ |+|.+++....     .+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+....
T Consensus       140 ~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          140 LME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             CCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            996 68999987543     4999999999999999999999998   99999999999999999999999999986532


Q ss_pred             -------cccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 006922          480 -------LAPVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV  551 (625)
Q Consensus       480 -------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  551 (625)
                             ......||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+..............+
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence                   22345799999999998765 5699999999999999999999999875543333222211100000000000


Q ss_pred             cc-------cccc-CCCCc-H----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 FD-------VELL-RYPNI-E----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 ~d-------~~~~-~~~~~-~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..       .... ..+.. .    ....++.+++.+||..||++|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00       0000 00000 0    01235677888999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-44  Score=376.13  Aligned_cols=187  Identities=25%  Similarity=0.418  Sum_probs=162.8

Q ss_pred             hHcccCCceeEEEEEEc----CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|+.+    .++.||+|++.... ....+.+|++++..+ +|||||++++++.+.+..++||||+++|
T Consensus        27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~  105 (361)
T 4f9c_A           27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE  105 (361)
T ss_dssp             EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred             EEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence            57999999999999843    46789999987643 345688999999988 6999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~---  480 (625)
                      +|.+++.        .+++.++..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.....   
T Consensus       106 ~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          106 SFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             cHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            9999984        2889999999999999999999998   9999999999999877 79999999999754321   


Q ss_pred             ----------------------------ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 006922          481 ----------------------------APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTG  528 (625)
Q Consensus       481 ----------------------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~  528 (625)
                                                  ....+||+.|||||++.+. .|+.++||||+||++|||+||+.||....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                        1224689999999998765 58999999999999999999999997544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2e-43  Score=365.08  Aligned_cols=266  Identities=29%  Similarity=0.519  Sum_probs=225.7

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+|...+|+.||||++...... .+.+.+|++++.+++||||+++++++...+..++||||+++|+|.+
T Consensus        45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (321)
T 2qkw_B           45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR  124 (321)
T ss_dssp             CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred             ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence            569999999999999888999999998765433 4678999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----APV  483 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~~~  483 (625)
                      ++..... ....++|..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....     ...
T Consensus       125 ~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  200 (321)
T 2qkw_B          125 HLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV  200 (321)
T ss_dssp             GSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred             HHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence            9976432 2335899999999999999999999998   999999999999999999999999999865322     123


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..|+..|+|||.+.+..++.++||||||+++|||+||+.||......+......|.............+++.... ....
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  279 (321)
T 2qkw_B          201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRP  279 (321)
T ss_dssp             CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CSCH
T ss_pred             cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-ccCH
Confidence            357888999999988889999999999999999999999998777666666777766555555555555554432 2346


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      +...++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            6778899999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-44  Score=394.98  Aligned_cols=240  Identities=20%  Similarity=0.254  Sum_probs=192.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHH---HHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQ---QMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      ++||+|+||+||+|+.. +|+.||||++++..    .......+   +++++..++|||||+++++|.+.+..|+|||||
T Consensus       195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~  274 (689)
T 3v5w_A          195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM  274 (689)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence            57999999999999965 69999999997542    12222333   456777889999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      +||+|.+++....     .+++..+..++.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+..... 
T Consensus       275 ~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          275 NGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             CSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            9999999998653     3899999999999999999999998   999999999999999999999999999876543 


Q ss_pred             ccccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 APVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ....+||+.|||||++. +..|+.++||||+||++|||++|+.||.+....+...+.....   ...         ..-.
T Consensus       347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~~~---------~~~p  414 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMA---------VELP  414 (689)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---HCC---------CCCC
T ss_pred             CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---CCC---------CCCC
Confidence            34568999999999996 4679999999999999999999999997654433333222111   110         0001


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ...   ..++.+++.+|++.||.+|++     ++||.+
T Consensus       415 ~~~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          415 DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             TTS---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ccC---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            112   235567777999999999998     577763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-44  Score=394.10  Aligned_cols=243  Identities=22%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|... +|+.||+|+++.... ..+.+.+|+++|+.++|||||++++++.+.+..++|||||++|+|
T Consensus       162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L  241 (573)
T 3uto_A          162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  241 (573)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence            357999999999999964 699999999976533 346788999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC--CCeeEecccccccccccc--c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ--QYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DfGla~~~~~~~--~  482 (625)
                      .+++.....    .+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+......  .
T Consensus       242 ~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          242 FEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             HHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             HHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            999865432    4899999999999999999999998   9999999999999865  899999999999875432  3


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+....+.      .....   ++..  ..+..
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~~~~~---~~~~--~~~~~  383 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCDWN---MDDS--AFSGI  383 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTCCC---CCSG--GGTTS
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------hCCCC---CCcc--cccCC
Confidence            4579999999999999999999999999999999999999998654433322221      11100   0000  01112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ..++.+|+.+||+.||.+|||+.|+++
T Consensus       384 ---s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          384 ---SEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               234567778999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.8e-43  Score=362.27  Aligned_cols=271  Identities=34%  Similarity=0.645  Sum_probs=223.2

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|...+|+.||||+++....  ....+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  114 (326)
T 3uim_A           35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV  114 (326)
T ss_dssp             TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred             ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence            357999999999999988899999999986532  234789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----AP  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----~~  482 (625)
                      .+++..... ...+++|..+..++.|++.||+|||+...++|+||||||+|||++.++.+||+|||+++.....    ..
T Consensus       115 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  193 (326)
T 3uim_A          115 ASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT  193 (326)
T ss_dssp             HHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEEC
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccc
Confidence            999987543 3345999999999999999999999993333999999999999999999999999999876432    22


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCC--CCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTT--GGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ...||..|+|||.+.+..++.++|||||||++|||+||+.||...  .........+|+...........+.+..... .
T Consensus       194 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  272 (326)
T 3uim_A          194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG-N  272 (326)
T ss_dssp             CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT-S
T ss_pred             cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc-c
Confidence            345788999999998888999999999999999999999999631  1122334556666666665555565554432 3


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ...+...++.+++.+||+.||.+|||+.||++.|+......
T Consensus       273 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            45677889999999999999999999999999998755443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-43  Score=364.74  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=201.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCc----eEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE----KLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|+.. ++.||||+++........+.+|+.++.+++||||+++++++.....    .++||||+++|+
T Consensus        30 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~  108 (322)
T 3soc_A           30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS  108 (322)
T ss_dssp             EEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred             heecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCC
Confidence            57999999999999875 8999999997655445567779999999999999999999987543    699999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc----------CCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA----------NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      |.+++...      .++|..+..++.|+++||+|||+.          +   |+||||||+|||++.++.+||+|||+++
T Consensus       109 L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          109 LSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             HHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCccc
Confidence            99999753      389999999999999999999998          6   9999999999999999999999999997


Q ss_pred             cccccc-----cccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHH---------
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLV---------  536 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~---------  536 (625)
                      ......     ....+|..|+|||++.+     ..++.++|||||||++|||+||+.||............         
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            654321     22467889999999876     35567899999999999999999999765433211111         


Q ss_pred             -HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          537 -RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       537 -~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       .+........ ..    +.............++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       260 ~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          260 EDMQEVVVHKK-KR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHTTSC-CC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccc-CC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             1111111110 00    1000000122345678899999999999999999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-42  Score=359.18  Aligned_cols=270  Identities=14%  Similarity=0.124  Sum_probs=216.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|++++.++ +||||+++++++...+..++||||+ +++|.
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (330)
T 2izr_A           15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE   92 (330)
T ss_dssp             EECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence            5699999999999995 579999999987543 235689999999999 9999999999999999999999999 99999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC-----eeEecccccccccccc-
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY-----GCVSDLGLTTITSALA-  481 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~~-  481 (625)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++...... 
T Consensus        93 ~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           93 DLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            9998642    24899999999999999999999998   999999999999999887     9999999998653321 


Q ss_pred             ---------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          482 ---------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       482 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                               ....||..|+|||++.+..++.++|||||||++|||++|+.||......+.......+..........   
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~---  242 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE---  242 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH---
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH---
Confidence                     24568899999999999999999999999999999999999998876555544444332211111000   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCCCCCCCCC
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESSTPPP  619 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~  619 (625)
                        ..  ....   . ++.+++..||+.+|.+||++++|.+.|+++............+|.....++|
T Consensus       243 --~~--~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~p  301 (330)
T 2izr_A          243 --VL--CENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTP  301 (330)
T ss_dssp             --HH--TTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTSCCCCC
T ss_pred             --HH--hccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCCCcCCC
Confidence              00  0011   1 6778888999999999999999999999887765555555666665443333

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-42  Score=349.92  Aligned_cols=247  Identities=21%  Similarity=0.401  Sum_probs=206.8

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...+++.||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||+++++|.++
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (269)
T 4hcu_A           16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   95 (269)
T ss_dssp             EEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             heecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHH
Confidence            56999999999999988899999999998777778899999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......    ....
T Consensus        96 l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A           96 LRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             HHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             HHhcCc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence            975432    4899999999999999999999998   9999999999999999999999999998764321    2234


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+   .   ...   ..        .....
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~---~---~~~---~~--------~~~~~  231 (269)
T 4hcu_A          169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S---TGF---RL--------YKPRL  231 (269)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H---TTC---CC--------CCCTT
T ss_pred             cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h---cCc---cC--------CCCCc
Confidence            5567999999988899999999999999999999 99999765433222111   1   110   00        00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ...++.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            234577888899999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-42  Score=356.95  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=197.7

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||+|.. +|+.||||++.......   +.+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            35799999999999987 58999999998654433   468899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |.+++....  ....+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.....   ..
T Consensus       121 L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          121 LYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             HHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             HHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            999997542  1224899999999999999999999874 34999999999999999999999999999865432   23


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+....+   ..   ...          ..+..
T Consensus       198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~~---~~~----------~~~~~  261 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GF---KCK----------RLEIP  261 (309)
T ss_dssp             ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HH---SCC----------CCCCC
T ss_pred             cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---cCC----------CCCCC
Confidence            356888999999999999999999999999999999999999765433222111   10   000          00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      .....++.+++.+||+.+|.+|||+.|+++.|+.+....
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            122345778888999999999999999999999987754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-42  Score=363.66  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=203.7

Q ss_pred             HhHcccCCceeEEEEEE--------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .+.||+|+||+||+|..        .++..||||+++.....  .+.+.+|++++.++ +||||++++++|...+..++|
T Consensus        86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  165 (370)
T 2psq_A           86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  165 (370)
T ss_dssp             EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence            35799999999999985        23567999999865322  35689999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          398 YDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |||+++|+|.+++......           ....+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  242 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM  242 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence            9999999999999865421           1224899999999999999999999998   9999999999999999999


Q ss_pred             eEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+....+.   
T Consensus       243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~---  319 (370)
T 2psq_A          243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK---  319 (370)
T ss_dssp             EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---
Confidence            999999998654321     22345667999999999999999999999999999999 999998765444332211   


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                          ....          .+.......++.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus       320 ----~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          320 ----EGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ----TTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                1100          01111223467788889999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=359.97  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|...    .+..||||+++....  ..+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME  133 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence            367999999999999964    355699999986432  23678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       134 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          134 NGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             TCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             CCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            9999999975432    4899999999999999999999998   99999999999999999999999999987643211


Q ss_pred             ------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 ------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                            ...++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.       ...        
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~--------  271 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EGY--------  271 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC--------
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cCC--------
Confidence                  1234557999999988889999999999999999999 999997654333222111       110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                        ..+........+.+++..||..||.+|||+.||++.|+.+......
T Consensus       272 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          272 --RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             --CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence              0111122334677888899999999999999999999999765443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=354.54  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus        16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~   95 (310)
T 3s95_A           16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR   95 (310)
T ss_dssp             EEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             ceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHH
Confidence            57999999999999964 68999999986543 23467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-----
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----  482 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----  482 (625)
                      +++.....    .++|..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......     
T Consensus        96 ~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           96 GIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             HHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            99986432    4899999999999999999999998   99999999999999999999999999986543211     


Q ss_pred             ------------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh---hHHHHHHHHhhccc
Q 006922          483 ------------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV---HLVRWVHSVVREEW  547 (625)
Q Consensus       483 ------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~  547 (625)
                                  ...||..|+|||++.+..++.++||||||+++|||++|..||.........   .........     
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-----  243 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-----  243 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-----
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-----
Confidence                        346888899999999999999999999999999999999998754332211   111111100     


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                              .     .......+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       244 --------~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          244 --------C-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             --------C-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                    0     011123567788899999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.3e-42  Score=371.57  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=204.4

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecC-ceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKD-EKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||+||+|... |+.||||+++... ..+.+.+|++++.+++||||+++++++...+ ..++||||+++|+|.
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~  275 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  275 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence            357999999999999875 7899999998654 4578999999999999999999999988765 789999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccC
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA  487 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  487 (625)
                      +++.....   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++..........++
T Consensus       276 ~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  349 (450)
T 1k9a_A          276 DYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  349 (450)
T ss_dssp             HHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred             HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence            99986532   24789999999999999999999998   9999999999999999999999999998765444344567


Q ss_pred             CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHH
Q 006922          488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM  566 (625)
Q Consensus       488 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  566 (625)
                      ..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+.       .+.          ..+......
T Consensus       350 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~----------~~~~p~~~~  412 (450)
T 1k9a_A          350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY----------KMDAPDGCP  412 (450)
T ss_dssp             TTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTC----------CCCCCTTCC
T ss_pred             cceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC----------CCCCCCcCC
Confidence            78999999999999999999999999999999 999998766554432221       110          011112233


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       567 ~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .++.+++.+||..||.+|||+.|+++.|+.+...
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            4677888899999999999999999999988654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.9e-42  Score=345.69  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=206.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...++..||+|+++......+++.+|++++.+++||||+++++++...+..++||||+++++|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (268)
T 3sxs_A           14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY   93 (268)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             eeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHH
Confidence            56999999999999988888999999988777778899999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----ccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----VIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~~~  485 (625)
                      +....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......    ...
T Consensus        94 l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           94 LRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             HHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             HHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence            97643    24899999999999999999999998   99999999999999999999999999986643321    223


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+      ....   ....        ...
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~---~~~~--------~~~  229 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGH---RLYR--------PHL  229 (268)
T ss_dssp             CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTC---CCCC--------CTT
T ss_pred             cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------HcCC---CCCC--------CCc
Confidence            4556999999988889999999999999999999 99999765433222111      1110   0000        111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ....+.+++..||+.+|++|||+.|+++.|+.+++..
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            1235777888999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-42  Score=374.23  Aligned_cols=247  Identities=25%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...++..||||+++......+.+.+|++++.+++||||+++++++. .+..++||||+++|+|.++
T Consensus       194 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~  272 (454)
T 1qcf_A          194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDF  272 (454)
T ss_dssp             EEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHH
T ss_pred             EEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHH
Confidence            579999999999999988899999999877667788999999999999999999999986 5678999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......    ....
T Consensus       273 l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  346 (454)
T 1qcf_A          273 LKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK  346 (454)
T ss_dssp             HHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSS
T ss_pred             HHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCc
Confidence            975431   23789999999999999999999998   9999999999999999999999999998764321    1223


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||++....++.++|||||||++|||+| |+.||.+....+....   +..   ..           ..+....
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~---~~-----------~~~~~~~  409 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LER---GY-----------RMPRPEN  409 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HHH---TC-----------CCCCCTT
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc---CC-----------CCCCCCC
Confidence            4567999999988899999999999999999999 9999976543332221   111   10           0111222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ...++.+++.+||..||++|||+.+|++.|+.+...
T Consensus       410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            334678888999999999999999999999998654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.1e-42  Score=350.02  Aligned_cols=239  Identities=19%  Similarity=0.319  Sum_probs=197.9

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.++.+++||||+++++++...+..++||||+++|+|.
T Consensus        26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (297)
T 3fxz_A           26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (297)
T ss_dssp             EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence            5699999999999994 579999999997543 34567899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......   ....
T Consensus       106 ~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence            999754      3899999999999999999999998   999999999999999999999999998876432   2334


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||..|+|||++.+..++.++|||||||++|||++|+.||......+....+      ..... ..        ......
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~-~~--------~~~~~~  241 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT-PE--------LQNPEK  241 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS-CC--------CSCGGG
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC-CC--------CCCccc
Confidence            6888999999999999999999999999999999999999764332211111      11110 00        111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2345778888999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-42  Score=366.97  Aligned_cols=247  Identities=26%  Similarity=0.444  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEEc----CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|+..    ++..||||+++....  ..+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        51 ~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (373)
T 2qol_A           51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN  130 (373)
T ss_dssp             EEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCC
Confidence            57999999999999854    577899999976432  235789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  482 (625)
                      |+|.++++...    ..+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       131 ~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          131 GSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            99999997543    24899999999999999999999998   99999999999999999999999999987643221 


Q ss_pred             -----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          483 -----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       483 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                           ...++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+   .    ...         
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---~----~~~---------  267 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---D----EGY---------  267 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH---H----TTE---------
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----cCC---------
Confidence                 1123567999999998899999999999999999998 99999765433222111   1    110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       ..+........+.+++.+||+.+|.+||++.||++.|+.+...
T Consensus       268 -~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 -RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence             0111122334678888999999999999999999999988654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-42  Score=366.86  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||+|... +++.||||+++.....  .+.+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            367999999999999975 7899999999864321  2468899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc--
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV--  483 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--  483 (625)
                      |.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........  
T Consensus       199 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          199 FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             HHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            999997643    24899999999999999999999998   999999999999999999999999999865432211  


Q ss_pred             ---cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          484 ---IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       484 ---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                         ..++..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+.       .+.          ..
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~----------~~  334 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGG----------RL  334 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTC----------CC
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC----------CC
Confidence               123556999999988889999999999999999999 999997654333222111       110          01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      +.......++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            1112223467788899999999999999999999998854

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-41  Score=349.23  Aligned_cols=238  Identities=19%  Similarity=0.316  Sum_probs=197.1

Q ss_pred             HcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          331 VLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .||+|+||+||+|... +|+.||||++..... ..+.+.+|+.++.+++||||+++++++...+..++||||+++++|.+
T Consensus        52 ~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  131 (321)
T 2c30_A           52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD  131 (321)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred             EeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHH
Confidence            6999999999999965 799999999976543 34678999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVIA  485 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~~  485 (625)
                      ++...      .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   .....
T Consensus       132 ~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          132 IVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             HHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             HHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            98643      3899999999999999999999998   999999999999999999999999999876432   23456


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE  565 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  565 (625)
                      ||..|+|||++.+..++.++|||||||++|||++|+.||......+   ....+..    ......        ......
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~----~~~~~~--------~~~~~~  267 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRD----SPPPKL--------KNSHKV  267 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH----SSCCCC--------TTGGGS
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhc----CCCCCc--------CccccC
Confidence            8889999999999999999999999999999999999997643222   2221111    110000        111112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          566 MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       566 ~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            235677888999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.3e-42  Score=353.73  Aligned_cols=237  Identities=21%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|.. .+|+.||||++......   .+.+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus        21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~  100 (328)
T 3fe3_A           21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE  100 (328)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence            5799999999999996 57999999999765433   2467899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--ccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--APV  483 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~~  483 (625)
                      |.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus       101 L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A          101 VFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             HHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            999997653     3899999999999999999999998   999999999999999999999999999865432  334


Q ss_pred             cccCCCcCCccccCCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKAT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ..||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....+....+      .....          ..+  
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~~----------~~p--  234 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRGKY----------RIP--  234 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC----------CCC--
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC----------CCC--
Confidence            5788999999999887775 7999999999999999999999765433222111      11110          011  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+|+..||.+|||++|+++
T Consensus       235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            112235667888999999999999999976

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.3e-42  Score=347.08  Aligned_cols=247  Identities=20%  Similarity=0.316  Sum_probs=203.6

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||++...++..||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||+++++|.++
T Consensus        30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  109 (283)
T 3gen_A           30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY  109 (283)
T ss_dssp             EECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHH
T ss_pred             hhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHH
Confidence            57999999999999998888999999998777778899999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    ....
T Consensus       110 l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (283)
T 3gen_A          110 LREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  182 (283)
T ss_dssp             HHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred             HHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence            976432    3899999999999999999999998   9999999999999999999999999998764321    1223


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||+|+++|||+| |+.||......+....+.      ...   ..        .....
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------~~~---~~--------~~~~~  245 (283)
T 3gen_A          183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGL---RL--------YRPHL  245 (283)
T ss_dssp             SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTC---CC--------CCCTT
T ss_pred             cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh------ccc---CC--------CCCCc
Confidence            4567999999988889999999999999999999 999997654332222111      110   00        00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ....+.+++.+||+.+|.+|||+.|+++.|+++..+
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            123577888899999999999999999999988654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.6e-42  Score=374.98  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             HhHcccCCceeEEEEEEcC-CcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||+||+|.... +..||||+++......+.+.+|++++.+++||||++++++|...+..++||||+++|+|.
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~  304 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL  304 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence            3579999999999999764 889999999877667788999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc----c
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP----V  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~----~  483 (625)
                      +++.....   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.......    .
T Consensus       305 ~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  378 (495)
T 1opk_A          305 DYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  378 (495)
T ss_dssp             HHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred             HHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence            99976432   34899999999999999999999998   99999999999999999999999999987643221    1


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ..++..|+|||++....++.++|||||||++|||+| |+.||......+....+.       ...          ..+..
T Consensus       379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~----------~~~~~  441 (495)
T 1opk_A          379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDY----------RMERP  441 (495)
T ss_dssp             CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTC----------CCCCC
T ss_pred             CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC----------CCCCC
Confidence            234567999999988889999999999999999999 999998765444332221       110          00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .....++.+++.+||+.||++|||+.||++.|+.+...
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            22234677888899999999999999999999988654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.2e-42  Score=355.83  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=198.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcE----EEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTT----VVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +++.    ||+|.+....  ...+.+.+|+.++.+++||||+++++++. .+..++||||++
T Consensus        19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   97 (325)
T 3kex_A           19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP   97 (325)
T ss_dssp             EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred             eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence            57999999999999954 4543    7888876442  22356789999999999999999999986 567899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           98 LGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             TCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             CCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            999999997643    24889999999999999999999998   9999999999999999999999999998764322 


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+....+.       ...  ..     
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--~~-----  236 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGE--RL-----  236 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTC--BC-----
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC--CC-----
Confidence                23356678999999998899999999999999999999 999998765544433222       100  00     


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                         ........++.+++.+||..||.+||++.|+++.|+.+....
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               001111224667888999999999999999999999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=348.38  Aligned_cols=252  Identities=23%  Similarity=0.408  Sum_probs=194.6

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|... ++.||+|++... ...+.+.+|++++.+++||||+++++++.  +..++||||+++|+|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~   89 (307)
T 2eva_A           14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV   89 (307)
T ss_dssp             EEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHH
T ss_pred             eEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHH
Confidence            57999999999999875 789999999753 23467899999999999999999999876  458999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC-eeEecccccccccccccccccCC
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY-GCVSDLGLTTITSALAPVIARAA  488 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DfGla~~~~~~~~~~~~~~  488 (625)
                      +....  ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++...........++.
T Consensus        90 l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~  167 (307)
T 2eva_A           90 LHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA  167 (307)
T ss_dssp             HHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCT
T ss_pred             HhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCC
Confidence            97643  1224789999999999999999999943234999999999999998887 79999999987665545557899


Q ss_pred             CcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHH
Q 006922          489 GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVE  568 (625)
Q Consensus       489 ~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  568 (625)
                      .|+|||.+.+..++.++||||||+++|||+||+.||........ ....   ...... ..          +........
T Consensus       168 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~~~~~-~~----------~~~~~~~~~  232 (307)
T 2eva_A          168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMW---AVHNGT-RP----------PLIKNLPKP  232 (307)
T ss_dssp             TSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHH---HHHTTC-CC----------CCBTTCCHH
T ss_pred             ceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHH---HHhcCC-CC----------CcccccCHH
Confidence            99999999999999999999999999999999999976543321 1111   111110 00          111112235


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          569 MLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       569 l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                      +.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            6778889999999999999999999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.6e-42  Score=369.11  Aligned_cols=247  Identities=27%  Similarity=0.399  Sum_probs=201.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...++..||||+++......+.+.+|++++.+++||||+++++++.. +..++||||+++|+|.++
T Consensus       190 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~  268 (452)
T 1fmk_A          190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF  268 (452)
T ss_dssp             EEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHH
T ss_pred             eeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHH
Confidence            5699999999999999888899999998766667889999999999999999999999876 678999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......    ....
T Consensus       269 l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  342 (452)
T 1fmk_A          269 LKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  342 (452)
T ss_dssp             HSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             HHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCc
Confidence            975421   24899999999999999999999998   9999999999999999999999999998764321    1223


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+....++.++|||||||++|||+| |+.||.+....+....+   .   ...           ..+....
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~---~~~-----------~~~~~~~  405 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E---RGY-----------RMPCPPE  405 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H---TTC-----------CCCCCTT
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H---cCC-----------CCCCCCC
Confidence            4567999999988899999999999999999999 99999765433322211   1   110           0111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ....+.+++.+||+.+|++|||++++++.|+.+...
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            334677888999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.6e-42  Score=354.68  Aligned_cols=246  Identities=20%  Similarity=0.379  Sum_probs=196.7

Q ss_pred             hHcccCCceeEEEEEEc-CCc----EEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGT----TVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +++    .||+|.++...  ...+.+.+|++++.+++||||++++++|... ..++|+||++
T Consensus        21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~   99 (327)
T 3poz_A           21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP   99 (327)
T ss_dssp             EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence            57999999999999953 444    46888886543  3346799999999999999999999999875 4789999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A          100 FGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             TCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            9999999986532    4899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             -----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          483 -----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       483 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                           ...++..|+|||++.+..++.++|||||||++|||+| |+.||......+....+.       ...         
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------  236 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---------  236 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC---------
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC---------
Confidence                 2234667999999999999999999999999999999 999998765544333222       100         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       ..+.......++.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence             0111122334677888999999999999999999999988764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-41  Score=346.42  Aligned_cols=249  Identities=23%  Similarity=0.415  Sum_probs=192.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHc--CCCCceecceeEEEec----CceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS--IRHENVVELKAYYYSK----DEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|.. +|+.||||++....  ...+.+|.+++..  ++||||+++++++...    ...++||||+++
T Consensus        14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~   90 (301)
T 3q4u_A           14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM   90 (301)
T ss_dssp             EEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred             EeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence            5799999999999987 68999999997542  3455666666665  7999999999997653    357899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH--------AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      |+|.+++...      .+++..+.+++.|++.||+|||        +.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           91 GSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             CBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            9999999643      3899999999999999999999        665   9999999999999999999999999997


Q ss_pred             cccccc-------cccccCCCcCCccccCCC------CCCCccchhhhHHHHHHHHhC----------CCCCCCCCCcch
Q 006922          476 ITSALA-------PVIARAAGYRAPEVTDSR------KATQASDVYSFGVVLLEILTG----------KSPIHTTGGDEL  532 (625)
Q Consensus       476 ~~~~~~-------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvil~elltG----------~~p~~~~~~~~~  532 (625)
                      ......       ....+|..|+|||++.+.      .++.++|||||||++|||+||          +.||........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            654322       123688899999999876      455799999999999999999          888865433221


Q ss_pred             -hhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          533 -VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       533 -~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       ....   .........    .+.............++.+++.+||+.||++|||+.||++.|+++
T Consensus       242 ~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          242 SFEDM---RKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CHHHH---HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhh---hHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             1111   111111100    001100001234567788999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.9e-41  Score=343.71  Aligned_cols=264  Identities=14%  Similarity=0.129  Sum_probs=212.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++......++||||+ +++|.
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   93 (298)
T 1csn_A           16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   93 (298)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence            5699999999999995 579999999986533 345788999999999 7999999999999999999999999 99999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC-----eeEeccccccccccc--
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY-----GCVSDLGLTTITSAL--  480 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~--  480 (625)
                      +++.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.     +||+|||+++.....  
T Consensus        94 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  166 (298)
T 1csn_A           94 DLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  166 (298)
T ss_dssp             HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence            99986432    4899999999999999999999998   999999999999988776     999999999876432  


Q ss_pred             --------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 --------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                              .....||..|+|||.+.+..++.++|||||||++|||++|+.||..............+............ 
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  245 (298)
T 1csn_A          167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-  245 (298)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-
T ss_pred             cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-
Confidence                    12345888999999999999999999999999999999999999876544433333322221111110000 


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS  612 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  612 (625)
                          .  +   ....++.+++.+||+.+|++||++++|++.|+++..+.........+|.
T Consensus       246 ----~--~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          246 ----C--A---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             ----T--T---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             ----H--h---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence                0  0   1124677888899999999999999999999999876665555555554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-40  Score=340.43  Aligned_cols=272  Identities=31%  Similarity=0.522  Sum_probs=215.6

Q ss_pred             cccCHHHHHHHHH-----------hHcccCCceeEEEEEEcCCcEEEEEEecccc-----CChHHHHHHHHHHHcCCCCc
Q 006922          317 YAFDLEDLLRASA-----------EVLGKGTFGMAYKAILEDGTTVVVKRLKDVN-----VGKRDFEQQMEIVGSIRHEN  380 (625)
Q Consensus       317 ~~~~~~~~~~~~~-----------~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~n  380 (625)
                      ..|.++++..++.           +.||+|+||+||+|.. +++.||||++....     ...+.+.+|++++.+++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            4466677766552           5699999999999986 58999999997532     12356889999999999999


Q ss_pred             eecceeEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe
Q 006922          381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL  460 (625)
Q Consensus       381 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll  460 (625)
                      |+++++++...+..++||||+++|+|.+++.....  ..+++|..+..++.|++.||+|||+.+   |+||||||+||++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            99999999999999999999999999999875432  235899999999999999999999998   9999999999999


Q ss_pred             CCCCCeeEeccccccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhH
Q 006922          461 NSQQYGCVSDLGLTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL  535 (625)
Q Consensus       461 ~~~~~~kl~DfGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~  535 (625)
                      +.++.+||+|||+++.....     .....++..|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999865432     123457888999998875 588999999999999999999999986554332221


Q ss_pred             HHHHHHHhhc-ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          536 VRWVHSVVRE-EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       536 ~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      +  ....... ....+.++....  .........+.+++.+||..+|.+|||+.|+++.|+++..
T Consensus       246 ~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 I--KEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             H--HHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             H--HHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1  1111111 112222333222  2245566788899999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=358.96  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             hHcccCCceeEEEEEEc--------CCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          330 EVLGKGTFGMAYKAILE--------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      +.||+|+||+||+|...        .+..||||+++.....  .+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  154 (382)
T 3tt0_A           75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV  154 (382)
T ss_dssp             EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEE
Confidence            56999999999999852        2468999999865332  25688999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          399 DYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                      ||+++|+|.+++......           ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  231 (382)
T 3tt0_A          155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMK  231 (382)
T ss_dssp             ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEE
Confidence            999999999999865421           1235899999999999999999999998   99999999999999999999


Q ss_pred             Eeccccccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 006922          468 VSDLGLTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       468 l~DfGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      |+|||+++.....     .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..   ..+. 
T Consensus       232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~---~~~~-  307 (382)
T 3tt0_A          232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLK-  307 (382)
T ss_dssp             ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH-
T ss_pred             EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH-
Confidence            9999999876432     122345677999999999999999999999999999999 99999765433222   2111 


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN  604 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~  604 (625)
                         .....          ........++.+++.+||+.+|++|||+.|+++.|+.+.......
T Consensus       308 ---~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          308 ---EGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             ---TTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             ---cCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence               11100          001112346778888999999999999999999999997654433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-41  Score=340.24  Aligned_cols=247  Identities=21%  Similarity=0.399  Sum_probs=205.8

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||.||++...+++.||+|+++......+.+.+|++++.+++||||+++++++...+..++||||+++++|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (267)
T 3t9t_A           14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY   93 (267)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHH
T ss_pred             eEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHH
Confidence            56999999999999988889999999998776778899999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    ....
T Consensus        94 ~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (267)
T 3t9t_A           94 LRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  166 (267)
T ss_dssp             HHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             HhhCcc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence            976432    4899999999999999999999998   9999999999999999999999999998764321    2234


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..+.    ....  .        .....
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i~----~~~~--~--------~~~~~  229 (267)
T 3t9t_A          167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDIS----TGFR--L--------YKPRL  229 (267)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH----TTCC--C--------CCCTT
T ss_pred             ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHHh----cCCc--C--------CCCcc
Confidence            5567999999988889999999999999999999 89999765432221   1111    1100  0        00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ....+.+++.+||..+|++||++.|+++.|+++..+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            223567788899999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-41  Score=348.51  Aligned_cols=237  Identities=23%  Similarity=0.336  Sum_probs=196.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +|+.||+|++++.    ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg   90 (337)
T 1o6l_A           11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   90 (337)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            57999999999999965 6999999999753    223466889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        91 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           91 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             BHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            9999987643     3899999999999999999999998   99999999999999999999999999986422   23


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+....+      .....          ..+ 
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~----------~~p-  225 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEI----------RFP-  225 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC----------CCC-
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH------HcCCC----------CCC-
Confidence            3457899999999999999999999999999999999999999764432222111      11110          011 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                       .....++.+++.+||+.||++||     ++.|+++
T Consensus       226 -~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence             11223566778899999999999     8999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=357.55  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=202.6

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|...      +++.||||+++....  ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  156 (367)
T 3l9p_A           77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM  156 (367)
T ss_dssp             EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence            56999999999999842      467899999975432  2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEeccccccc
Q 006922          402 SLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTTI  476 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~  476 (625)
                      ++|+|.+++......  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++   .+||+|||+++.
T Consensus       157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            999999999875431  2235899999999999999999999998   99999999999999555   599999999986


Q ss_pred             ccc-----cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          477 TSA-----LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       477 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ...     ......+|..|+|||++.+..++.++|||||||++|||+| |+.||......+....+   .   ....   
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i---~---~~~~---  304 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---T---SGGR---  304 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---H---TTCC---
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H---cCCC---
Confidence            422     1223456778999999988899999999999999999998 99999765433322211   1   1110   


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                              ..........+.+++.+||+.+|++||++.||++.|+.+....
T Consensus       305 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          305 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                    0111122345778888999999999999999999999887653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=352.58  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             hHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|...      +++.||||+++.....  .+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  132 (343)
T 1luf_A           53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM  132 (343)
T ss_dssp             EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence            56999999999999964      3488999999864322  357899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 006922          402 SLGSVSAMLHSERGE-------------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS  462 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~  462 (625)
                      ++|+|.+++......                   ....+++.++..++.|+++||+|||+.+   |+||||||+|||++.
T Consensus       133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~  209 (343)
T 1luf_A          133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE  209 (343)
T ss_dssp             TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred             CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECC
Confidence            999999999864321                   1145899999999999999999999998   999999999999999


Q ss_pred             CCCeeEeccccccccccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 006922          463 QQYGCVSDLGLTTITSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV  536 (625)
Q Consensus       463 ~~~~kl~DfGla~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~  536 (625)
                      ++.+||+|||+++.....     .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+.... 
T Consensus       210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-  288 (343)
T 1luf_A          210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY-  288 (343)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-
T ss_pred             CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHH-
Confidence            999999999999865322     122356778999999988889999999999999999999 9999976543322211 


Q ss_pred             HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       537 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                        +    ..+...          +.......++.+++.+||+.||++||++.|+++.|+++....
T Consensus       289 --~----~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          289 --V----RDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             --H----HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             --H----hCCCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence              1    111100          011122346778888999999999999999999999987754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-41  Score=339.72  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=189.4

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC-----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... |+.||||+++....     ..+.+.+|++++..++||||+++++++...+..++||||++++
T Consensus        13 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (271)
T 3dtc_A           13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG   91 (271)
T ss_dssp             EEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred             eeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence            56999999999999975 89999999875422     2367889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--------CCCeeEeccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS--------QQYGCVSDLGLTTI  476 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~--------~~~~kl~DfGla~~  476 (625)
                      +|.+++...      .+++..+..++.|+++||+|||+.+..+|+||||||+||+++.        ++.+||+|||+++.
T Consensus        92 ~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           92 PLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             EHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            999998643      3899999999999999999999987556899999999999986        67899999999986


Q ss_pred             cccc-ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          477 TSAL-APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       477 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+...      .......        
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~--------  231 (271)
T 3dtc_A          166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMNKL--------  231 (271)
T ss_dssp             ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTSCC--------
T ss_pred             cccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcCCC--------
Confidence            5432 223467889999999988889999999999999999999999997654322111      1111110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                        ..+........+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus       232 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 --ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence              0011112234677888899999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=349.33  Aligned_cols=242  Identities=20%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||++... +++.||+|.++........+.+|++++..++||||+++++++.+.+..++||||+++|+|.+
T Consensus        11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~   90 (321)
T 1tki_A           11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE   90 (321)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred             eEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHH
Confidence            56999999999999965 68999999998655455678999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCCeeEecccccccccccc--ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS--QQYGCVSDLGLTTITSALA--PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~--~~~  484 (625)
                      ++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++......  ...
T Consensus        91 ~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           91 RINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             HHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            997543    24899999999999999999999998   999999999999987  7899999999998764332  335


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .+++.|+|||++.+..++.++|||||||++|||++|+.||......+....      .......   ++...  .+   .
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------i~~~~~~---~~~~~--~~---~  229 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYT---FDEEA--FK---E  229 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCC---CCHHH--HT---T
T ss_pred             cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------HHcCCCC---CChhh--hc---c
Confidence            688899999999988899999999999999999999999976543322211      1111100   00000  01   1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+++.+|+..||.+|||+.|+++
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1245677888999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.4e-41  Score=345.99  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=194.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|...+|+.||+|+++.....   .+.+.+|++++.+++||||+++++++.+.+..++||||+++ +|
T Consensus        27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l  105 (311)
T 3niz_A           27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL  105 (311)
T ss_dssp             EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EH
T ss_pred             hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CH
Confidence            569999999999999888999999999754322   35688999999999999999999999999999999999985 78


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ...
T Consensus       106 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          106 KKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             HHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            88776543    24899999999999999999999998   999999999999999999999999999876422   223


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc---ccccc------
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT---AEVFD------  553 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d------  553 (625)
                      ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.   ........   ....+      
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF---SILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH---HHHCCCCTTTSGGGTTSHHHHS
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHHCCCChHHhhhhhccchhhh
Confidence            467889999999876 568999999999999999999999998765544332221   11111000   00000      


Q ss_pred             cccc--CCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELL--RYPNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~--~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....  .....    .....++.+++.+|++.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000  00000    011245678888999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.5e-41  Score=351.65  Aligned_cols=268  Identities=17%  Similarity=0.181  Sum_probs=201.4

Q ss_pred             hHcccCCceeEEEEEEcC------CcEEEEEEeccccCC------------hHHHHHHHHHHHcCCCCceecceeEEEec
Q 006922          330 EVLGKGTFGMAYKAILED------GTTVVVKRLKDVNVG------------KRDFEQQMEIVGSIRHENVVELKAYYYSK  391 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~  391 (625)
                      +.||+|+||+||+|....      ++.||||++......            ...+..|+..+..++||||+++++++...
T Consensus        41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  120 (364)
T 3op5_A           41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD  120 (364)
T ss_dssp             EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred             EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence            579999999999998754      478999998754211            11233455567778899999999999775


Q ss_pred             ----CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCC
Q 006922          392 ----DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN--SQQY  465 (625)
Q Consensus       392 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~--~~~~  465 (625)
                          ...++||||+ +++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++  .++.
T Consensus       121 ~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          121 KNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             ETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTC
T ss_pred             cCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCe
Confidence                3479999999 999999997642    24999999999999999999999998   99999999999999  8899


Q ss_pred             eeEecccccccccccc----------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhH
Q 006922          466 GCVSDLGLTTITSALA----------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHL  535 (625)
Q Consensus       466 ~kl~DfGla~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~  535 (625)
                      +||+|||+++......          ....||..|+|||++.+..++.++|||||||++|||+||+.||.........  
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~--  270 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--  270 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH--
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH--
Confidence            9999999997654321          2234888999999999999999999999999999999999999864333221  


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS  612 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  612 (625)
                      .......... ...++.+..+.. .   ....++.+++..||..+|.+||++.++++.|+++............+|.
T Consensus       271 ~~~~~~~~~~-~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  342 (364)
T 3op5_A          271 VRDSKIRYRE-NIASLMDKCFPA-A---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS  342 (364)
T ss_dssp             HHHHHHHHHH-CHHHHHHHHSCT-T---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred             HHHHHHHhhh-hHHHHHHHhccc-c---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence            1111111111 112222222111 1   1123677888899999999999999999999988776554444444554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-41  Score=344.76  Aligned_cols=237  Identities=19%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +|+.||+|+++...    ...+.+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus        12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg   91 (318)
T 1fot_A           12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG   91 (318)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence            57999999999999965 69999999997542    23456789999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~  163 (318)
T 1fot_A           92 ELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  163 (318)
T ss_dssp             BHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence            9999997643     3899999999999999999999998   9999999999999999999999999999877666667


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||..|+|||++.+..++.++||||+||++|||++|+.||......+...      .......          ..+  ..
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~~----------~~p--~~  225 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNAEL----------RFP--PF  225 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHCCC----------CCC--TT
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC----------CCC--CC
Confidence            89999999999999999999999999999999999999997643322211      1111110          011  11


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ...++.+++.+|+..||++||     +++|+++
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            123566777899999999999     8888874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-40  Score=338.60  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +++.||+|++......    .+.+.+|++++.+++||||+++++++...+..++||||++++
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~   96 (294)
T 4eqm_A           17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP   96 (294)
T ss_dssp             EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence            56999999999999954 6899999998654322    256889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++....     ++++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....    
T Consensus        97 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           97 TLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999997653     4899999999999999999999998   999999999999999999999999999876432    


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||..|+|||.+.+..++.++||||+|+++|||+||+.||......+..  ..    ...... ...   .....+
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~----~~~~~~-~~~---~~~~~~  238 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IK----HIQDSV-PNV---TTDVRK  238 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HH----HHSSCC-CCH---HHHSCT
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HH----HhhccC-CCc---chhccc
Confidence            22345889999999999999999999999999999999999999764422211  11    111110 000   000001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCCCCCC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRP-KMPDVVRVIENVRPNDSEN  604 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~ev~~~L~~~~~~~~~~  604 (625)
                         .....+.+++.+|++.||.+|| +++++.+.|+.+..+...+
T Consensus       239 ---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          239 ---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             ---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             ---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence               1224577788899999999998 9999999999987765443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-40  Score=337.46  Aligned_cols=247  Identities=25%  Similarity=0.438  Sum_probs=198.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh--------HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK--------RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||+||+|.. .+++.||+|++.......        +.+.+|++++.+++||||+++++++.+..  ++||||
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~  102 (287)
T 4f0f_A           25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF  102 (287)
T ss_dssp             EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred             hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence            5699999999999996 478999999997543211        56889999999999999999999986544  799999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC-----eeEecccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY-----GCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DfGla~  475 (625)
                      +++|+|.+.+....    ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.     +||+|||+++
T Consensus       103 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A          103 VPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             CTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             cCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            99999998887543    25899999999999999999999875 34999999999999988876     9999999998


Q ss_pred             cccccccccccCCCcCCcccc--CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          476 ITSALAPVIARAAGYRAPEVT--DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       476 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                      ..........++..|+|||.+  ....++.++|||||||++|||++|+.||......+... ....   .......    
T Consensus       178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~~~~~~~----  249 (287)
T 4f0f_A          178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMI---REEGLRP----  249 (287)
T ss_dssp             CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHH---HHSCCCC----
T ss_pred             cccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHH---hccCCCC----
Confidence            776665666789999999998  34567899999999999999999999998655433221 1111   1111100    


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                            ........++.+++.+||+.||.+|||+.|+++.|+++
T Consensus       250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          250 ------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  11112234677888899999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-41  Score=346.11  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=197.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||++... +|+.||+|+++....       ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   95 (326)
T 2y0a_A           16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   95 (326)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence            467999999999999965 689999999975432       246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----CeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~  476 (625)
                      +++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++.
T Consensus        96 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           96 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             CCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999997532     4899999999999999999999998   99999999999999887    799999999987


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      ....  .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+.   .   ...  . +..
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~---~~~--~-~~~  238 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A---VNY--E-FED  238 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H---TCC--C-CCH
T ss_pred             CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---h---cCC--C-cCc
Confidence            6432  234568899999999999999999999999999999999999997644322221111   1   000  0 000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...  +   .....+.+++.+||..||++|||+.|+++
T Consensus       239 ~~~--~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          239 EYF--S---NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHH--T---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc--c---cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000  0   11235677888999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-40  Score=349.32  Aligned_cols=241  Identities=20%  Similarity=0.319  Sum_probs=197.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||++... +|+.||+|+++....       ..+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~   97 (361)
T 2yab_A           18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV   97 (361)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence            56999999999999965 699999999976432       2367899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----CeeEecccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTIT  477 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~~  477 (625)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++..
T Consensus        98 ~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           98 SGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             CSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999997532     4899999999999999999999998   99999999999998877    7999999999876


Q ss_pred             ccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          478 SAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       478 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+      .....   -++..
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------~~~~~---~~~~~  240 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------TAVSY---DFDEE  240 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCC---CCCHH
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCC---CCCch
Confidence            543  23456899999999999999999999999999999999999999765433222111      11100   00100


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..  +.   ...++.+++.+|+..||.+|||+.|+++
T Consensus       241 ~~--~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          241 FF--SQ---TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HH--TT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hc--cC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00  11   1235667888999999999999999984

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=371.97  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||+||+|...++..||||+++......++|.+|+++|.+++||||+++++++.+ +..++||||+++|+|.+
T Consensus       272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~  350 (535)
T 2h8h_A          272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD  350 (535)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred             heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence            35799999999999999888899999998776667889999999999999999999999876 67899999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      ++.....   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++......    ...
T Consensus       351 ~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          351 FLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             HHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             HHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence            9975421   23899999999999999999999998   9999999999999999999999999998764321    122


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||++....++.++|||||||++|||+| |+.||......+....+   .    .+.          +.+...
T Consensus       425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i---~----~~~----------~~~~~~  487 (535)
T 2h8h_A          425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E----RGY----------RMPCPP  487 (535)
T ss_dssp             TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH---H----TTC----------CCCCCT
T ss_pred             cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----cCC----------CCCCCC
Confidence            34567999999988899999999999999999999 99999765433322211   1    110          011112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ....++.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            23346778889999999999999999999999886543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.4e-41  Score=343.89  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             hHcccCCceeEEEEEE-----cCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|+.     .+++.||||++...... .+.+.+|++++.+++||||+++++++...  ...++||||+
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   95 (295)
T 3ugc_A           16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL   95 (295)
T ss_dssp             EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred             heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence            5799999999999984     36889999999864322 36789999999999999999999998654  4689999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           96 PYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             TTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             CCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            99999999976532    4899999999999999999999998   9999999999999999999999999998764321


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHHhhcc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD---------ELVHLVRWVHSVVREE  546 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~~~  546 (625)
                            ....++..|+|||.+.+..++.++||||||+++|||+||..|+......         ........+...+...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence                  1223455699999999889999999999999999999999998642110         0000011111111111


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .          ..+.......++.+++.+||+.||++|||+.|+++.|++++.+
T Consensus       249 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          249 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0          1111222335677888899999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=340.84  Aligned_cols=238  Identities=21%  Similarity=0.333  Sum_probs=187.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---------------------------ChHHHHHHHHHHHcCCCCce
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---------------------------GKRDFEQQMEIVGSIRHENV  381 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~h~ni  381 (625)
                      +.||+|+||+||+|.. .+|+.||||++.....                           ..+.+.+|++++.+++||||
T Consensus        19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   98 (298)
T 2zv2_A           19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV   98 (298)
T ss_dssp             EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred             eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence            5699999999999995 4689999999975421                           12458899999999999999


Q ss_pred             ecceeEEEe--cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 006922          382 VELKAYYYS--KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIF  459 (625)
Q Consensus       382 v~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIl  459 (625)
                      +++++++.+  .+..++||||+++++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+|||
T Consensus        99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  169 (298)
T 2zv2_A           99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL  169 (298)
T ss_dssp             CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence            999999987  56789999999999998875432      4899999999999999999999998   999999999999


Q ss_pred             eCCCCCeeEecccccccccccc---cccccCCCcCCccccCCCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCcchh
Q 006922          460 LNSQQYGCVSDLGLTTITSALA---PVIARAAGYRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSPIHTTGGDELV  533 (625)
Q Consensus       460 l~~~~~~kl~DfGla~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~  533 (625)
                      ++.++.+||+|||+++......   ....+|..|+|||.+.+..   ++.++|||||||++|||++|+.||......+  
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--  247 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC--  247 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH--
Confidence            9999999999999998764322   2346888999999997665   3788999999999999999999997543211  


Q ss_pred             hHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          534 HLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ....+    .....         ..+.......++.+++.+||+.||++|||+.|+++
T Consensus       248 -~~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 -LHSKI----KSQAL---------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             -HHHHH----HHCCC---------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -HHHHH----hcccC---------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence             11111    11100         00111112235677888999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-40  Score=348.54  Aligned_cols=237  Identities=18%  Similarity=0.257  Sum_probs=199.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +|+.||+|+++...    ...+.+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus        47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg  126 (350)
T 1rdq_E           47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence            56999999999999965 69999999997542    23467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus       127 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~  198 (350)
T 1rdq_E          127 EMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence            9999998643     3899999999999999999999998   9999999999999999999999999999877666667


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||..|+|||++.+..++.++|||||||++|||++|+.||......+....      ......          ..+  ..
T Consensus       199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~~~~----------~~p--~~  260 (350)
T 1rdq_E          199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVSGKV----------RFP--SH  260 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCC----------CCC--TT
T ss_pred             cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH------HHcCCC----------CCC--CC
Confidence            899999999999999999999999999999999999999976543222211      111110          001  11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ...++.+++.+||+.||.+||+     ++|+++
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2235677888999999999998     888874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.2e-41  Score=347.15  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=192.1

Q ss_pred             HhHcccCCceeEEEEEEcC-C---cEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCce------E
Q 006922          329 AEVLGKGTFGMAYKAILED-G---TTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEK------L  395 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g---~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~  395 (625)
                      .+.||+|+||+||+|.... +   ..||||+++....   ..+.+.+|++++.+++||||+++++++...+..      +
T Consensus        28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  107 (323)
T 3qup_A           28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM  107 (323)
T ss_dssp             EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred             eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence            3679999999999999543 3   2799999976432   236789999999999999999999999887655      9


Q ss_pred             EEEEeccCCChhhhhccccCC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGE-GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      +||||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a  184 (323)
T 3qup_A          108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS  184 (323)
T ss_dssp             EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccc
Confidence            999999999999999765422 2235899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          475 TITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       475 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      +......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.      .... 
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~~~~-  257 (323)
T 3qup_A          185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI------GGNR-  257 (323)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC-
T ss_pred             ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh------cCCC-
Confidence            8754322     12235567999999998899999999999999999999 999998765444332211      1110 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                                .+.......++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       258 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          258 ----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                      01111223467788889999999999999999999999977643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=338.92  Aligned_cols=264  Identities=15%  Similarity=0.219  Sum_probs=205.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecC--ceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD--EKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||||+++...  ...+.+.+|++++.+++||||+++++++...+  ..++||||++++
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   94 (319)
T 4euu_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (319)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence            56999999999999965 58999999998643  23467889999999999999999999998765  679999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCCeeEeccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL----NSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla~~~~~~  480 (625)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.....
T Consensus        95 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           95 SLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             BHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            99999986542  223899999999999999999999998   9999999999999    78888999999999876443


Q ss_pred             c--cccccCCCcCCccccC--------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHHhhccccc
Q 006922          481 A--PVIARAAGYRAPEVTD--------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE-LVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       481 ~--~~~~~~~~y~aPE~~~--------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  549 (625)
                      .  ....++..|+|||++.        +..++.++|||||||++|||+||+.||....... ....+..+..........
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  249 (319)
T 4euu_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS  249 (319)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCE
T ss_pred             CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccch
Confidence            2  2346888999999875        5788999999999999999999999997544322 222222221111111111


Q ss_pred             cccc---------cccc-CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          550 EVFD---------VELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       550 ~~~d---------~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .+.+         .... ...........+.+++.+||+.||++|||++|+++...+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1100         0111 11223556667888999999999999999999999887654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-41  Score=353.95  Aligned_cols=256  Identities=19%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC-----CCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-----HENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|.. .+++.||||+++......+.+..|++++.+++     ||||+++++++...+..++||||+ +
T Consensus        41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~  119 (360)
T 3llt_A           41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-G  119 (360)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-C
T ss_pred             EEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-C
Confidence            5799999999999996 46899999999865444567888999999886     999999999999999999999999 8


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---------------------
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---------------------  462 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---------------------  462 (625)
                      ++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.                     
T Consensus       120 ~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          120 PSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             CCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            999999986542   24899999999999999999999998   999999999999976                     


Q ss_pred             ----CCCeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 006922          463 ----QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW  538 (625)
Q Consensus       463 ----~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~  538 (625)
                          ++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  273 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES  273 (360)
T ss_dssp             EEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence                7899999999999876666666789999999999999999999999999999999999999976544333322221


Q ss_pred             HHHHhhcccc--------cccccccc-----cCCCCcHH---------------HHHHHHHHHHHccCCCCCCCCCHHHH
Q 006922          539 VHSVVREEWT--------AEVFDVEL-----LRYPNIEE---------------EMVEMLQIAMSCVVRMPDQRPKMPDV  590 (625)
Q Consensus       539 ~~~~~~~~~~--------~~~~d~~~-----~~~~~~~~---------------~~~~l~~l~~~Cl~~~P~~RPs~~ev  590 (625)
                      ..........        ...++...     ........               ....+.+++.+||+.||++|||+.|+
T Consensus       274 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el  353 (360)
T 3llt_A          274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAEL  353 (360)
T ss_dssp             HTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             hcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHH
Confidence            1100000000        00000000     00000000               01456789999999999999999999


Q ss_pred             HH
Q 006922          591 VR  592 (625)
Q Consensus       591 ~~  592 (625)
                      ++
T Consensus       354 L~  355 (360)
T 3llt_A          354 LK  355 (360)
T ss_dssp             TT
T ss_pred             hc
Confidence            75

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-40  Score=338.36  Aligned_cols=252  Identities=19%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|...+|+.||+|+++....   ..+.+.+|++++.+++||||+++++++...+..++||||+++ +|
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l   86 (288)
T 1ob3_A            8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL   86 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred             hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence            56999999999999988899999999975432   236788999999999999999999999999999999999986 88


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ...
T Consensus        87 ~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           87 KKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             HHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            888875432    4899999999999999999999998   999999999999999999999999999875422   223


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc---ccc-----cccc
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW---TAE-----VFDV  554 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~d~  554 (625)
                      ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||......+..   ..+........   ...     .+++
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhccccccc
Confidence            467888999999865 45899999999999999999999999765432221   11111111100   000     0111


Q ss_pred             cccCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYP------NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......      .......++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            110000      00112245677888999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-40  Score=342.92  Aligned_cols=241  Identities=21%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|... +++.||||++.....  ..+.+.+|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus        13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L   92 (323)
T 3tki_A           13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL   92 (323)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence            57999999999999965 789999999975432  236789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~  481 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     .
T Consensus        93 ~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           93 FDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             GGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            99997542     4899999999999999999999998   999999999999999999999999999865321     2


Q ss_pred             cccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....||..|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+..    ..   .       ..+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~~---~-------~~~  229 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KK---T-------YLN  229 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----TC---T-------TST
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----cc---c-------cCC
Confidence            24568889999999987765 7799999999999999999999976543221 1111111    00   0       001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .......++.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111223456778889999999999999999863

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=372.49  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             HcccCCceeEEEEEEc---CCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILE---DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||+|...   ++..||||+++...  ...+++.+|++++.+++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5999999999999853   46789999998653  245789999999999999999999999976 56899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---  482 (625)
                      |.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......   
T Consensus       422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            999997543    24899999999999999999999998   99999999999999999999999999987643211   


Q ss_pred             ---ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          483 ---VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       483 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                         ...++..|+|||++.+..++.++|||||||++|||+| |+.||......+....+.      ...           .
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~------~~~-----------~  557 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK-----------R  557 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH------TTC-----------C
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------cCC-----------C
Confidence               1224567999999998899999999999999999998 999998766544332221      110           0


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .+.......++.+++..||..+|++||++.+|++.|+.+...
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            111122335678889999999999999999999999887543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-41  Score=343.88  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=202.9

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||.||+|..      .+++.||||+++....  ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  107 (314)
T 2ivs_A           28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY  107 (314)
T ss_dssp             EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence            35699999999999985      2458899999976432  235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 006922          401 YSLGSVSAMLHSERGE-------------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~  461 (625)
                      +++|+|.+++......                   ....+++..+..++.|+++||+|||+.+   |+||||||+||+++
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~  184 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVA  184 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEc
Confidence            9999999999865421                   1234899999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhH
Q 006922          462 SQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL  535 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~  535 (625)
                      .++.+||+|||+++......     ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....
T Consensus       185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  264 (314)
T 2ivs_A          185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL  264 (314)
T ss_dssp             TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999998664321     12245667999999988889999999999999999999 9999987654443322


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      +.       .....          +.......++.+++.+||+.||.+||++.|+++.|+++..
T Consensus       265 ~~-------~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          265 LK-------TGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HH-------TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hh-------cCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            21       11000          0111223467788889999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=354.74  Aligned_cols=242  Identities=18%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||++.. .+|+.||+|++......   .+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   95 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG   95 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence            35799999999999985 47899999999765432   356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCCeeEecccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN---SQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~  481 (625)
                      +|.+.+....     .+++..+..++.|++.||+|||+++   |+||||||+|||++   .++.+||+|||+++......
T Consensus        96 ~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           96 ELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             BHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            9999987643     3899999999999999999999998   99999999999998   46789999999998765432


Q ss_pred             ---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 ---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                         ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+   .   ...     .+.....
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i---~---~~~-----~~~~~~~  236 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---K---AGA-----YDFPSPE  236 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H---HTC-----CCCCTTT
T ss_pred             ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH---H---hCC-----CCCCccc
Confidence               2356889999999999999999999999999999999999999765433222211   1   111     0100011


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.   ...++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~---~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          237 WDT---VTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccc---CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111   2235667888999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=351.29  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=192.3

Q ss_pred             hHcccCCceeEEEEEEc--CC--cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE--DG--TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|...  ++  ..||||.++....  ..+.+.+|++++.+++||||+++++++.. .+..++||||++
T Consensus        95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~  174 (373)
T 3c1x_A           95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  174 (373)
T ss_dssp             EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred             cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence            56999999999999853  22  4689999875432  23678999999999999999999999765 457899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       175 ~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          175 HGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             TCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999975432    4789999999999999999999998   9999999999999999999999999998653221 


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....++..|+|||.+.+..++.++|||||||++|||+| |.+||......+....+.      ...   ..   
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------~~~---~~---  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR---RL---  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------TTC---CC---
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------cCC---CC---
Confidence                  12345567999999998899999999999999999999 788887655444332211      110   00   


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                           .........+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus       316 -----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                 0111123467788889999999999999999999999876544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-41  Score=352.85  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=200.3

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCc-eEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDE-KLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~  398 (625)
                      .+.||+|+||+||+|..      .+++.||||+++.....  .+.+.+|++++.++ +||||+++++++...+. .++||
T Consensus        27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~  106 (359)
T 3vhe_A           27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  106 (359)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence            35799999999999973      24689999999864322  35689999999999 79999999999988654 89999


Q ss_pred             EeccCCChhhhhccccCCC-------------------------------------------------------------
Q 006922          399 DYYSLGSVSAMLHSERGEG-------------------------------------------------------------  417 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~-------------------------------------------------------------  417 (625)
                      ||+++|+|.+++.......                                                             
T Consensus       107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3vhe_A          107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY  186 (359)
T ss_dssp             ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred             EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence            9999999999998654210                                                             


Q ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----ccccccCCCcCC
Q 006922          418 RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----APVIARAAGYRA  492 (625)
Q Consensus       418 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~~~~~~~~~y~a  492 (625)
                      ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     .....+|..|+|
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  263 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  263 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence            122899999999999999999999998   999999999999999999999999999865322     123356778999


Q ss_pred             ccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHH
Q 006922          493 PEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQ  571 (625)
Q Consensus       493 PE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  571 (625)
                      ||++.+..++.++|||||||++|||+| |+.||......+..  ...+.    .....          +.......++.+
T Consensus       264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~----~~~~~----------~~~~~~~~~l~~  327 (359)
T 3vhe_A          264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----EGTRM----------RAPDYTTPEMYQ  327 (359)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH----HTCCC----------CCCTTCCHHHHH
T ss_pred             hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHH----cCCCC----------CCCCCCCHHHHH
Confidence            999988899999999999999999999 99999775543321  11111    11000          011112235778


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          572 IAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       572 l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ++..||+.||.+|||+.|+++.|+++..
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            8889999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=351.31  Aligned_cols=237  Identities=22%  Similarity=0.316  Sum_probs=192.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|+.. +|+.||||+++...    ...+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus        29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g  108 (353)
T 3txo_A           29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG  108 (353)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence            57999999999999965 68999999997532    2335678899999988 699999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---L  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~  480 (625)
                      |+|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   .
T Consensus       109 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          109 GDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            99999997653     3899999999999999999999998   99999999999999999999999999986432   2


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+      .....          ..+
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~~----------~~p  244 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDEV----------VYP  244 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC----------CCC
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------HcCCC----------CCC
Confidence            33457899999999999888999999999999999999999999765433322211      11110          011


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM------PDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~ev~~  592 (625)
                        .....++.+++.+|++.||.+||++      .|+++
T Consensus       245 --~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          245 --TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              1122356677889999999999998      67764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-40  Score=333.99  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... ++.||||+++.....   .+.+.+|++++.+++||||+++++++...  +..++||||+++|
T Consensus        16 ~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   94 (271)
T 3kmu_A           16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG   94 (271)
T ss_dssp             EEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred             HHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence            57999999999999985 899999999865433   35689999999999999999999999887  6789999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....  ...
T Consensus        95 ~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--~~~  168 (271)
T 3kmu_A           95 SLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--PGR  168 (271)
T ss_dssp             BHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--TTC
T ss_pred             cHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--cCc
Confidence            9999998643   235899999999999999999999864 3599999999999999999999999988765433  234


Q ss_pred             ccCCCcCCccccCCCCCCC---ccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          485 ARAAGYRAPEVTDSRKATQ---ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~---~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      .+|..|+|||.+.+..++.   ++||||||+++|||++|+.||......+...      .........          ..
T Consensus       169 ~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~----------~~  232 (271)
T 3kmu_A          169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGLRP----------TI  232 (271)
T ss_dssp             BSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCCCC----------CC
T ss_pred             cCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCCCC----------CC
Confidence            6788999999998765554   8999999999999999999997654322211      111111100          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ......++.+++..||+.||++|||+.|+++.|+++..
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11123457788889999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-40  Score=338.70  Aligned_cols=248  Identities=21%  Similarity=0.358  Sum_probs=206.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+|... ++..||+|+++......+.+.+|++++.+++||||+++++++...+..++||||+++++|.+
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   98 (288)
T 3kfa_A           19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD   98 (288)
T ss_dssp             EESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred             eecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            56999999999999965 48899999998766666789999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      ++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......    ...
T Consensus        99 ~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A           99 YLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             HHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             HHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence            9976432   35899999999999999999999998   9999999999999999999999999998765332    123


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.   .    ..          ..+...
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~----~~----------~~~~~~  235 (288)
T 3kfa_A          173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K----DY----------RMERPE  235 (288)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---T----TC----------CCCCCT
T ss_pred             ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c----cC----------CCCCCC
Confidence            45667999999988899999999999999999999 999997755443332221   1    10          001111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ....++.+++.+|+..||.+|||+.|+++.|+.+..+
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            2234677888899999999999999999999887543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-40  Score=337.41  Aligned_cols=246  Identities=21%  Similarity=0.373  Sum_probs=189.8

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|....    +..||+|+++.....  .+.+.+|+.++.+++||||+++++++. .+..++||||++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~   98 (281)
T 1mp8_A           20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT   98 (281)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence            3569999999999998642    457999998764322  356889999999999999999999984 567899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        99 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           99 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            999999997543    24899999999999999999999998   9999999999999999999999999998764322 


Q ss_pred             ---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          482 ---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.      ....          
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~~~----------  235 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER----------  235 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC----------
T ss_pred             cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cCCC----------
Confidence               12245567999999988899999999999999999997 999998765443322211      1110          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       .+.......++.+++.+||..||++|||+.|+++.|+++..
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             01111223467788889999999999999999999988753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-40  Score=336.60  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=202.8

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|...++..||+|+++......+.+.+|++++.+++||||+++++++. .+..++||||+++++|.++
T Consensus        19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~   97 (279)
T 1qpc_A           19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDF   97 (279)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHH
T ss_pred             eeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHH
Confidence            569999999999999888889999999877666788999999999999999999999986 4568999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    ....
T Consensus        98 l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  171 (279)
T 1qpc_A           98 LKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (279)
T ss_dssp             TTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             HhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCC
Confidence            975421   24899999999999999999999998   9999999999999999999999999998764322    1223


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..+.    ....  .        .....
T Consensus       172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~----~~~~--~--------~~~~~  234 (279)
T 1qpc_A          172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE----RGYR--M--------VRPDN  234 (279)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH----TTCC--C--------CCCTT
T ss_pred             CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHh----cccC--C--------CCccc
Confidence            5667999999988889999999999999999999 99999765432222   1111    1100  0        00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ...++.+++.+|+..+|++|||+.++++.|+++...
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            224677888899999999999999999999988643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-40  Score=349.64  Aligned_cols=240  Identities=17%  Similarity=0.298  Sum_probs=191.5

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||+|+||+||+|+.. +++.||+|++++....    .+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            367999999999999965 5889999999865322    24578899999877 89999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---c
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---A  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~  479 (625)
                      +|+|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   .
T Consensus       137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            999999997653     3899999999999999999999998   9999999999999999999999999998632   2


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhhccccccccccccc
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--HLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  .....+...+.....         
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------  279 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------  279 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---------
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---------
Confidence            234457899999999999999999999999999999999999999754322111  111111111111100         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                      ..+  .....++.+++.+||+.||.+||++
T Consensus       280 ~~p--~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 RIP--RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCC--TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCC--CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            011  1122356778889999999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=347.46  Aligned_cols=241  Identities=20%  Similarity=0.291  Sum_probs=197.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||++... +++.||+|++....    ...+.+.+|++++..++|||||++++++.+.+..++||||+++
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   99 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG   99 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            367999999999999965 58999999997532    2346788999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--A  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~  481 (625)
                      |+|..++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  .
T Consensus       100 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A          100 GDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             EEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            99999997542     4899999999999999999999998   999999999999999999999999999876432  3


Q ss_pred             cccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 PVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ....||..|+|||++..   ..++.++|||||||++|||++|+.||..................   .          . 
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~----------~-  237 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---V----------V-  237 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---C----------C-
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---c----------c-
Confidence            34578999999999864   45899999999999999999999999865544443333322110   0          0 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPK-MPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~ev~~  592 (625)
                       ........++.+++.+||+.||.+||+ ++++.+
T Consensus       238 -~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 -TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             011112346677888999999999998 666653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.6e-41  Score=348.16  Aligned_cols=236  Identities=24%  Similarity=0.374  Sum_probs=194.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccc----cCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDV----NVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|+.. +|+.||+|+++..    ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus        23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g  102 (345)
T 1xjd_A           23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG  102 (345)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence            57999999999999965 6899999999764    22345678899998876 899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ..
T Consensus       103 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A          103 GDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            99999997643     3899999999999999999999998   9999999999999999999999999998642   22


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.      ...       ..   .+
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~-------~~---~p  238 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MDN-------PF---YP  238 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------CC---CC
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------hCC-------CC---CC
Confidence            344578999999999999999999999999999999999999997654333222111      111       00   01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMP-DVV  591 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-ev~  591 (625)
                        .....++.+++.+|+..||++||++. |+.
T Consensus       239 --~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              11123566778899999999999997 664

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-40  Score=348.38  Aligned_cols=244  Identities=19%  Similarity=0.265  Sum_probs=189.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+++.. +++.||+|++.......+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+
T Consensus        26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~  105 (361)
T 3uc3_A           26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE  105 (361)
T ss_dssp             EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence            56999999999999965 78999999998766666789999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC--eeEeccccccccc--cccccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--GCVSDLGLTTITS--ALAPVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DfGla~~~~--~~~~~~  484 (625)
                      ++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++...  ......
T Consensus       106 ~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (361)
T 3uc3_A          106 RICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  177 (361)
T ss_dssp             HHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence            987643     3899999999999999999999998   999999999999988775  9999999997542  222345


Q ss_pred             ccCCCcCCccccCCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          485 ARAAGYRAPEVTDSRKATQA-SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~-~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      .||..|+|||++.+..++.+ +||||+||++|||++|+.||......+..  ...+........          ..+...
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~----------~~~~~~  245 (361)
T 3uc3_A          178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY----------SIPDDI  245 (361)
T ss_dssp             ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC----------CCCTTS
T ss_pred             cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC----------CCCCcC
Confidence            68899999999988777655 89999999999999999999765432221  111111111110          001111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ....++.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            112356778889999999999999999873

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=343.42  Aligned_cols=258  Identities=22%  Similarity=0.351  Sum_probs=196.2

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC--CCCceecceeEEEec----CceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI--RHENVVELKAYYYSK----DEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|... |+.||||++....  ...+.+|.+++...  +||||+++++++...    ...++||||++
T Consensus        42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  118 (337)
T 3mdy_A           42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE  118 (337)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred             EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence            467999999999999875 8999999996543  34455566665554  899999999999887    67899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN-----GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +|+|.+++...      .+++..+..++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|||+++..
T Consensus       119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            99999999753      3899999999999999999999881     113999999999999999999999999999765


Q ss_pred             cccc-------cccccCCCcCCccccCCCCCCCc------cchhhhHHHHHHHHhC----------CCCCCCCCCcchhh
Q 006922          478 SALA-------PVIARAAGYRAPEVTDSRKATQA------SDVYSFGVVLLEILTG----------KSPIHTTGGDELVH  534 (625)
Q Consensus       478 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~------~DvwS~Gvil~elltG----------~~p~~~~~~~~~~~  534 (625)
                      ....       ....||..|+|||++.+..++.+      +|||||||++|||+||          +.||......... 
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-  271 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-  271 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-
Confidence            4322       13468889999999987766665      9999999999999999          6677553322211 


Q ss_pred             HHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          535 LVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                       ..............    +.........+...++.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus       272 -~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          272 -YEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             -HHHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             -hhhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence             01111111111111    111000112356677889999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-40  Score=346.74  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||+|... +|+.||+|+++......   +.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg  113 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG  113 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            467999999999999964 68999999997654332   56889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTTITSALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~~~~~~  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++......
T Consensus       114 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          114 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             BHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999887542     4899999999999999999999998   99999999999998654   59999999998765432


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                        ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.   ....     +..   .
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~i~---~~~~-----~~~---~  251 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIK---AGAY-----DYP---S  251 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH---HTCC-----CCC---T
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH---hCCC-----CCC---c
Confidence              2357889999999999999999999999999999999999999764432222   1111   1110     000   0


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.......++.+++.+||..||++||++.|+++
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            001112345677888999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.2e-40  Score=345.37  Aligned_cols=245  Identities=18%  Similarity=0.298  Sum_probs=195.5

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc------CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN------VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|... +|+.||||+++...      ...+.+.+|++++..++||||+++++++...+..++||||+
T Consensus        29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  108 (351)
T 3c0i_A           29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM  108 (351)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence            467999999999999964 68999999986421      23567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEeccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTTITS  478 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~~~~  478 (625)
                      ++|+|.+.+..... ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||+++...
T Consensus       109 ~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          109 DGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             SSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            99999888765432 1234899999999999999999999998   999999999999987655   9999999998765


Q ss_pred             ccc---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          479 ALA---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       479 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ...   ....||..|+|||++.+..++.++|||||||++|||++|+.||....    .....   ........   .++.
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~i~~~~~~---~~~~  254 (351)
T 3c0i_A          185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---GIIKGKYK---MNPR  254 (351)
T ss_dssp             TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---HHHHTCCC---CCHH
T ss_pred             CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---HHHcCCCC---CCcc
Confidence            432   23468889999999999999999999999999999999999997532    11111   11111100   0000


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .  .+   ....++.+++.+||..||++|||+.|+++
T Consensus       255 ~--~~---~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          255 Q--WS---HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             H--HT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c--cc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00   11235677888999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=344.44  Aligned_cols=248  Identities=27%  Similarity=0.465  Sum_probs=196.2

Q ss_pred             hHcccCCceeEEEEEEcC-----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILED-----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|....     +..||||+++....  ....+.+|++++.+++||||+++++++...+..++||||++
T Consensus        50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  129 (333)
T 1mqb_A           50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME  129 (333)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence            579999999999998542     24699999986432  23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       130 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          130 NGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             TEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             CCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            9999999976432    4899999999999999999999998   99999999999999999999999999987643211


Q ss_pred             ------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          483 ------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       483 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                            ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+...   .+.    ...        
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---~~~----~~~--------  267 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---AIN----DGF--------  267 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHH----TTC--------
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH---HHH----CCC--------
Confidence                  1234567999999998899999999999999999999 999997654332221   111    110        


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                        ..+........+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       268 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          268 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              01111122346778888999999999999999999999886543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-40  Score=340.23  Aligned_cols=263  Identities=19%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||+|.. .+|+.||+|+++....  ..+.+.+|++++.+++||||+++++++...+..++||||++ |+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~   88 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND   88 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence            46799999999999995 4689999999975432  34678899999999999999999999999999999999998 59


Q ss_pred             hhhhhccccCC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---c
Q 006922          406 VSAMLHSERGE-GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       406 L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~  481 (625)
                      |.+++...... ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF  165 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence            99988754321 1234899999999999999999999998   999999999999999999999999999876432   2


Q ss_pred             cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---cccccc-----c
Q 006922          482 PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEV-----F  552 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~  552 (625)
                      ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+   ......   .....+     +
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI---FDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCTTTCGGGGGCTTC
T ss_pred             CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCChhHhhhhhhhhhc
Confidence            23467889999999876 46899999999999999999999999865443322221   111110   000000     0


Q ss_pred             cccccCC--CCc---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          553 DVELLRY--PNI---------EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       553 d~~~~~~--~~~---------~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                      .+.....  ...         .....++.+++.+|++.||++|||+.|+++  .+.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            0000000  000         011235778888999999999999999986  344443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.4e-41  Score=340.18  Aligned_cols=247  Identities=22%  Similarity=0.384  Sum_probs=195.3

Q ss_pred             hHcccCCceeEEEEEEc-CC-------cEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE-DG-------TTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||+||+|... ++       ..||+|++.... ...+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   93 (289)
T 4fvq_A           14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEF   93 (289)
T ss_dssp             EEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             eeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEEC
Confidence            56999999999999854 33       579999997653 3346799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC--------eeEeccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--------GCVSDLG  472 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DfG  472 (625)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.        +||+|||
T Consensus        94 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           94 VKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             CTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            99999999998643    23899999999999999999999998   999999999999998887        9999999


Q ss_pred             ccccccccccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCC-CCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          473 LTTITSALAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKS-PIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       473 la~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|.. ||.......   ......   ....   
T Consensus       167 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~---~~~~---  236 (289)
T 4fvq_A          167 ISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQFYE---DRHQ---  236 (289)
T ss_dssp             SCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH---TTCC---
T ss_pred             ccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHHHhh---ccCC---
Confidence            99766443 23457888999999987 678999999999999999999554 444322111   111111   0000   


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                           ..  .   ....++.+++.+||+.||++|||+.|+++.|+++......
T Consensus       237 -----~~--~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          237 -----LP--A---PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             -----CC--C---CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             -----CC--C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence                 00  0   0122467788899999999999999999999998774433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-40  Score=343.59  Aligned_cols=236  Identities=22%  Similarity=0.302  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+|+.||+|++....    .....+.+|++++..++||||+++++++...+..++||||+ +|
T Consensus        15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g   93 (336)
T 3h4j_B           15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG   93 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence            5699999999999996 578999999997532    22357899999999999999999999999999999999999 68


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......  ..
T Consensus        94 ~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           94 ELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             EHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            9988887643     3899999999999999999999998   999999999999999999999999999876433  23


Q ss_pred             ccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+...               .+....   ...
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~~~---~~~  227 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNSCV---YVM  227 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCSSC---CCC
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHcCC---CCC
Confidence            4568899999999988776 689999999999999999999997654332211               000000   011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+|++.||.+|||++|+++
T Consensus       228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1112335677888999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=345.11  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|..      .++..||+|+++...  ...+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  129 (344)
T 1rjb_A           50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  129 (344)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence            46799999999999995      245689999997542  2346789999999999 89999999999999999999999


Q ss_pred             eccCCChhhhhccccCC------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 006922          400 YYSLGSVSAMLHSERGE------------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~  461 (625)
                      |+++|+|.+++......                  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~  206 (344)
T 1rjb_A          130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT  206 (344)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence            99999999999765321                  1124799999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhH
Q 006922          462 SQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL  535 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~  535 (625)
                      .++.+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+... 
T Consensus       207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-  285 (344)
T 1rjb_A          207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-  285 (344)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-
T ss_pred             CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH-
Confidence            99999999999998654322     12345677999999988889999999999999999998 999997765433221 


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                       ..+    .....          .+.......++.+++.+||..||.+|||+.|+++.|+.+......
T Consensus       286 -~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          286 -KLI----QNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             -HHH----HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             -HHH----hcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence             111    11100          011111234677888899999999999999999999998776543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-40  Score=373.18  Aligned_cols=242  Identities=23%  Similarity=0.354  Sum_probs=196.8

Q ss_pred             hHcccCCceeEEEEEE---cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL---EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|..   ..++.||||+++.....   .+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            3699999999999964   24688999999865332   3679999999999999999999999964 568899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      |+|.+++....     .+++..+..|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus       454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999997543     4899999999999999999999998   9999999999999999999999999998764322  


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.       .+.         
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~---------  589 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGE---------  589 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC---------
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------
Confidence                11234567999999998899999999999999999999 999998765433322221       110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       ..+.......++.+++..||+.||++||++.+|++.|+++
T Consensus       590 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          590 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             0011122335678888999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=348.18  Aligned_cols=242  Identities=21%  Similarity=0.344  Sum_probs=192.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||+|+++.... ..+.+.+|++++.+++||||+++++++...+..++||||+++|+|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            4699999999999995 4699999999986532 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe--CCCCCeeEecccccccccccc--cc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL--NSQQYGCVSDLGLTTITSALA--PV  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll--~~~~~~kl~DfGla~~~~~~~--~~  483 (625)
                      +++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++......  ..
T Consensus       175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            9887542    24899999999999999999999998   9999999999999  567889999999998765432  23


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+|..|+|||++.+..++.++|||||||++|||++|+.||......+..      .......+.  ..+..   .+.  
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~~--~~~~~---~~~--  314 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACRWD--LEDEE---FQD--  314 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCCC--SCSGG---GTT--
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccCC--CChhh---hcc--
Confidence            46889999999999889999999999999999999999999765432221      111111110  00000   011  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ...++.+++.+|++.||.+|||+.|+++
T Consensus       315 -~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 -ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             1235677888999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.3e-40  Score=334.38  Aligned_cols=265  Identities=15%  Similarity=0.142  Sum_probs=208.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEE-EecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY-YSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|++++..++|++++..+.++ ...+..++||||+ +++|.
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (296)
T 3uzp_A           15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE   92 (296)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHH
Confidence            5699999999999995 579999999987543 345789999999999998877777766 4556779999999 89999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEecccccccccccc---
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +++.....    .+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||+++......   
T Consensus        93 ~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           93 DLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence            99975432    4899999999999999999999998   9999999999999   488899999999998764321   


Q ss_pred             -------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 -------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                             ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.......+..........     
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  240 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----  240 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----
T ss_pred             ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----
Confidence                   23467888999999999999999999999999999999999998755433333222222111110000     


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSE  613 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~~  613 (625)
                      ...  +.   ...++.+++.+||+.||++|||+.|+++.|+++..+.........+|..
T Consensus       241 ~~~--~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          241 VLC--KG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             HHT--TT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             HHH--hh---CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence            000  01   1235778888999999999999999999999998776665555565543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=334.75  Aligned_cols=245  Identities=21%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             HcccCCceeEEEEEEc---CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILE---DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||+|...   ++..||+|+++....  ..+.+.+|++++.+++||||+++++++ ..+..++||||+++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence            6999999999999853   578899999986432  236788999999999999999999999 5567899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......    
T Consensus        96 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  168 (287)
T 1u59_A           96 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  168 (287)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence            999997532    24899999999999999999999998   9999999999999999999999999998764321    


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+   .   ....           
T Consensus       169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i---~---~~~~-----------  231 (287)
T 1u59_A          169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---E---QGKR-----------  231 (287)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---H---TTCC-----------
T ss_pred             ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---h---cCCc-----------
Confidence              12234677999999988889999999999999999999 99999775543332211   1   1100           


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .+.......++.+++..||..+|.+||++.|+++.|+.+..+
T Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            011112234677888899999999999999999999988554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3e-40  Score=336.59  Aligned_cols=265  Identities=15%  Similarity=0.141  Sum_probs=207.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEE-EecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY-YSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|.. .+++.||||++.... ....+.+|++++..++|++++..++++ ...+..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence            35799999999999995 578999999876533 235688999999999998888777766 4566789999999 9999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEecccccccccccc--
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      .+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++......  
T Consensus        92 ~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           92 EDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             HHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            999975432    4899999999999999999999998   9999999999999   788999999999998764322  


Q ss_pred             --------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          482 --------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       482 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                              ....++..|+|||.+.+..++.++|||||||++|||++|+.||..............+............  
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  242 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL--  242 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH--
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh--
Confidence                    2346788899999999999999999999999999999999999876544433333322211111000000  


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS  612 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  612 (625)
                          . ..   ...++.+++..||+.+|++|||++|+++.|+++..+...+.....+|.
T Consensus       243 ----~-~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          243 ----C-KG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             ----T-TT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             ----h-cc---CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence                0 00   123677888899999999999999999999999877665555555554

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-40  Score=339.73  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=203.8

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|..      .+++.||+|+++....  ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  107 (313)
T 1t46_A           28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (313)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence            35799999999999984      3468999999986532  236789999999999 89999999999999999999999


Q ss_pred             eccCCChhhhhccccCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          400 YYSLGSVSAMLHSERGE-------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |+++|+|.+++......             ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  184 (313)
T 1t46_A          108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (313)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence            99999999999865421             1234899999999999999999999998   9999999999999999999


Q ss_pred             eEeccccccccccccc-----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ||+|||+++.......     ...++..|+|||.+.+..++.++||||||+++|||+| |+.||......+..  ...+.
T Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~  262 (313)
T 1t46_A          185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--YKMIK  262 (313)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--HHHHH
T ss_pred             EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--HHHhc
Confidence            9999999987654321     2345667999999988899999999999999999999 99999765543221  11111


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                          ....          .........++.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus       263 ----~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          263 ----EGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ----HTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCC----------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                1100          000111234677888899999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-40  Score=354.08  Aligned_cols=240  Identities=18%  Similarity=0.230  Sum_probs=194.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|+.. +++.||+|++++..    ...+.+.+|++++..++|||||++++++.+.+..++||||+++|
T Consensus        75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  154 (410)
T 3v8s_A           75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG  154 (410)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            57999999999999965 58999999997532    22356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc----
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~----  480 (625)
                      +|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus       155 ~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          155 DLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             cHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            999998753      2889999999999999999999998   999999999999999999999999999876543    


Q ss_pred             ccccccCCCcCCccccCCCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          481 APVIARAAGYRAPEVTDSRK----ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                      .....||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+..+....+.      ....     ....
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~-----~~~~  294 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------NHKN-----SLTF  294 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------THHH-----HCCC
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH------hccc-----cccC
Confidence            22457899999999997665    7899999999999999999999997654332222111      1000     0000


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQ--RPKMPDVVR  592 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~ev~~  592 (625)
                      ......   ..++.+++.+|+..+|.+  ||+++||++
T Consensus       295 p~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          295 PDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CTTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCcccc---cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            111112   235567777999999988  999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-40  Score=342.82  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             HhHcccCCceeEEEEEE--------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAIL--------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .+.||+|+||+||+|..        .++..||+|+++....  ..+.+.+|++++.++ +||||+++++++...+..++|
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  119 (334)
T 2pvf_A           40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  119 (334)
T ss_dssp             EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred             eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence            36799999999999985        3467899999986432  235688999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          398 YDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |||+++|+|.+++......           ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+
T Consensus       120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  196 (334)
T 2pvf_A          120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM  196 (334)
T ss_dssp             EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence            9999999999999865421           1124899999999999999999999998   9999999999999999999


Q ss_pred             eEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ||+|||+++......     ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+..   ..+.
T Consensus       197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~  273 (334)
T 2pvf_A          197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---KLLK  273 (334)
T ss_dssp             EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH
T ss_pred             EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH---HHHh
Confidence            999999998764321     22345667999999988889999999999999999999 99999765433222   2111


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .    ....          +.......++.+++.+||..+|.+||++.|+++.|+.+...
T Consensus       274 ~----~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          274 E----GHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             H----TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----CCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1    1000          01112234677888899999999999999999999998654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.4e-40  Score=341.52  Aligned_cols=239  Identities=18%  Similarity=0.302  Sum_probs=190.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+++.. +++.||+|+++.....    .+.+.+|.+++.++ +||||+++++++.+.+..++||||+++
T Consensus        15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g   94 (345)
T 3a8x_A           15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   94 (345)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence            57999999999999965 6899999999865332    24577899999888 899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ..
T Consensus        95 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           95 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            99999997643     3899999999999999999999998   9999999999999999999999999998642   22


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhhcccccccccccccC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--HLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      .....||..|+|||++.+..++.++||||+||++|||++|+.||......+..  .....+...+.....         .
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~  237 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R  237 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---------C
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---------C
Confidence            33457899999999999999999999999999999999999999753321110  001111111111100         0


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                      .+  .....++.+++.+||+.||.+||++
T Consensus       238 ~p--~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IP--RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CC--TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CC--CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11  1122356778889999999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.2e-40  Score=338.95  Aligned_cols=238  Identities=19%  Similarity=0.338  Sum_probs=190.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCc-------------
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-------------  393 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------------  393 (625)
                      +.||+|+||+||+|+.. +|+.||||+++....  ..+.+.+|++++.+++||||++++++|.+...             
T Consensus        12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~   91 (332)
T 3qd2_B           12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLK   91 (332)
T ss_dssp             EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----
T ss_pred             eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhc
Confidence            57999999999999975 799999999975432  34679999999999999999999999866432             


Q ss_pred             --------------------------------------------eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHH
Q 006922          394 --------------------------------------------KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRI  429 (625)
Q Consensus       394 --------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i  429 (625)
                                                                  .++||||+++|+|.+++.....  .....+..+..+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~i  169 (332)
T 3qd2_B           92 DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLHI  169 (332)
T ss_dssp             ----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHHH
T ss_pred             cccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHHH
Confidence                                                        7999999999999999986532  334678889999


Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---------------cccccCCCcCCcc
Q 006922          430 AIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---------------PVIARAAGYRAPE  494 (625)
Q Consensus       430 ~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---------------~~~~~~~~y~aPE  494 (625)
                      +.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......               ....+|..|+|||
T Consensus       170 ~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            999999999999998   9999999999999999999999999998765321               2235788899999


Q ss_pred             ccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC-CcHHHHHHHHHHH
Q 006922          495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQIA  573 (625)
Q Consensus       495 ~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~l~~l~  573 (625)
                      ++.+..++.++|||||||++|||++|..|+.     +.........    ..           ..+ .......++.+++
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~----~~-----------~~~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVR----NL-----------KFPLLFTQKYPQEHMMV  306 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHH----TT-----------CCCHHHHHHCHHHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhh----cc-----------CCCcccccCChhHHHHH
Confidence            9999999999999999999999999877652     1111111111    10           001 1122334567888


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 006922          574 MSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       574 ~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+||+.||++|||+.|+++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=341.78  Aligned_cols=246  Identities=20%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             hHcccCCceeEEEEEEc-CCc----EEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGT----TVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +++    .||+|.+....  ...+.+.+|++++.+++||||+++++++.... .++|+||++
T Consensus        21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~   99 (327)
T 3lzb_A           21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP   99 (327)
T ss_dssp             EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred             EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence            57999999999999953 454    35777776432  24577999999999999999999999998754 889999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       100 ~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A          100 FGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             SCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            9999999986532    4899999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.       ...         
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~---------  236 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---------  236 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC---------
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC---------
Confidence                12234567999999999999999999999999999999 999998765544333221       100         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       ..+.......++.+++.+||..||.+||++.|+++.|+++...
T Consensus       237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence             0111112234677888899999999999999999999988654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-40  Score=335.81  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEec-CceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK-DEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||+||++... |+.||+|+++... ..+.+.+|++++.+++||||+++++++... +..++||||+++++|.
T Consensus        26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  103 (278)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence            357999999999999875 8999999997643 456789999999999999999999997654 4789999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccC
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA  487 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  487 (625)
                      +++....   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++...........++
T Consensus       104 ~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  177 (278)
T 1byg_A          104 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  177 (278)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred             HHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence            9997542   123789999999999999999999998   9999999999999999999999999998766554445677


Q ss_pred             CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHH
Q 006922          488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM  566 (625)
Q Consensus       488 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  566 (625)
                      ..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+       ....     .     ........
T Consensus       178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-----~-----~~~~~~~~  240 (278)
T 1byg_A          178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY-----K-----MDAPDGCP  240 (278)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTC-----C-----CCCCTTCC
T ss_pred             ccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC-----C-----CCCcccCC
Confidence            88999999988889999999999999999999 99999765443322211       1110     0     01111223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       567 ~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ..+.+++.+||+.||.+||++.|+++.|+.++..
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            4677788899999999999999999999988643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-40  Score=343.13  Aligned_cols=245  Identities=16%  Similarity=0.315  Sum_probs=177.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||++... +|+.||||++...  ....+.+|++++..++ ||||+++++++.+.+..++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            56999999999999965 6899999999753  2467889999999997 999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccccccccccc---
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTTITSALA---  481 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~~~~~~---  481 (625)
                      +++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++......   
T Consensus        95 ~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           95 ERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             HHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            9998643     4899999999999999999999998   99999999999998766   79999999998654322   


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....+|..|+|||++.+..++.++|||||||++|||++|+.||......... ...+.......... .  +..     +
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~--~~~-----~  238 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-S--FEG-----E  238 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-C--CCS-----H
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-C--CCc-----c
Confidence            2345788899999999999999999999999999999999999765432111 11111111111110 0  000     0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......++.+++.+|+..||.+|||++|+++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            00112346778888999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=345.26  Aligned_cols=267  Identities=11%  Similarity=0.102  Sum_probs=206.5

Q ss_pred             hHcccCCceeEEEEEEc---------CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceec---------------ce
Q 006922          330 EVLGKGTFGMAYKAILE---------DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVE---------------LK  385 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~---------------l~  385 (625)
                      +.||+|+||+||+|...         +++.||+|++...    +.+.+|++++.+++||||++               ++
T Consensus        48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~  123 (352)
T 2jii_A           48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM  123 (352)
T ss_dssp             EEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred             EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence            56999999999999965         3789999999753    57889999999999999988               67


Q ss_pred             eEEEe-cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 006922          386 AYYYS-KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ  464 (625)
Q Consensus       386 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~  464 (625)
                      +++.. .+..++||||+ +++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus       124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPED  196 (352)
T ss_dssp             EEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTE
T ss_pred             hccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCC
Confidence            77776 67889999999 999999998652   124999999999999999999999998   99999999999999998


Q ss_pred             --CeeEecccccccccccc----------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcch
Q 006922          465 --YGCVSDLGLTTITSALA----------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL  532 (625)
Q Consensus       465 --~~kl~DfGla~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~  532 (625)
                        .+||+|||+++......          ....++..|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-
Confidence              89999999997654321          22367889999999999899999999999999999999999998654221 


Q ss_pred             hhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006922          533 VHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS  612 (625)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  612 (625)
                      .......... ... .....+...    .......++.+++.+||..||++||+++|+++.|+++............+|.
T Consensus       276 ~~~~~~~~~~-~~~-~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~  349 (352)
T 2jii_A          276 EDIMKQKQKF-VDK-PGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP  349 (352)
T ss_dssp             HHHHHHHHHH-HHS-CCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred             HHHHHHHHhc-cCC-hhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence            1111111111 111 111111000    0001124577788899999999999999999999999887766666666665


Q ss_pred             CC
Q 006922          613 ES  614 (625)
Q Consensus       613 ~~  614 (625)
                      ..
T Consensus       350 ~~  351 (352)
T 2jii_A          350 MV  351 (352)
T ss_dssp             C-
T ss_pred             CC
Confidence            43

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8e-40  Score=338.99  Aligned_cols=237  Identities=21%  Similarity=0.313  Sum_probs=186.9

Q ss_pred             hHcccCCceeEEEEEE----cCCcEEEEEEeccccC-----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV-----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||+||+++.    .+|+.||+|+++....     ....+.+|++++.+++||||+++++++...+..++||||
T Consensus        23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  102 (327)
T 3a62_A           23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY  102 (327)
T ss_dssp             EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence            5799999999999996    4789999999986432     234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A          103 LSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             CCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            99999999997643     3889999999999999999999998   999999999999999999999999999764322


Q ss_pred             ---ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          481 ---APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                         .....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   ..   .....         . 
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~---i~~~~---------~-  238 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DK---ILKCK---------L-  238 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH---HHHTC---------C-
T ss_pred             CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HH---HHhCC---------C-
Confidence               23456889999999999999999999999999999999999999765432221   11   11111         0 


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ..+  .....++.+++.+||..||++||     ++.|+++
T Consensus       239 ~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 NLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            001  11223567788899999999999     6778765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=340.74  Aligned_cols=255  Identities=18%  Similarity=0.208  Sum_probs=192.4

Q ss_pred             hHcccCCceeEEEEEEc----CCcEEEEEEeccccC------------ChHHHHHHHHHHHcCCCCceecceeEEEe---
Q 006922          330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNV------------GKRDFEQQMEIVGSIRHENVVELKAYYYS---  390 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~---  390 (625)
                      +.||+|+||+||+|...    ++..+|+|++.....            ....+.+|+..+..++||||+++++++..   
T Consensus        43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~  122 (345)
T 2v62_A           43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK  122 (345)
T ss_dssp             EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred             eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence            57999999999999964    578899999875432            12346678888999999999999999988   


Q ss_pred             -cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC--Cee
Q 006922          391 -KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ--YGC  467 (625)
Q Consensus       391 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~--~~k  467 (625)
                       ....++||||+ +++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++  .+|
T Consensus       123 ~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          123 GRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             SCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEE
T ss_pred             CCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEE
Confidence             67889999999 999999998653     4899999999999999999999998   99999999999999887  999


Q ss_pred             Eecccccccccccc----------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 006922          468 VSDLGLTTITSALA----------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       468 l~DfGla~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~  537 (625)
                      |+|||+++......          ....++..|+|||++.+..++.++|||||||++|||+||+.||.........  ..
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~  271 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--VQ  271 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--HH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--HH
Confidence            99999997653221          2346788999999999989999999999999999999999999653322211  11


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .............+.+ ...    ......++.+++.+||..||++||++.||++.|+.....
T Consensus       272 ~~~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          272 TAKTNLLDELPQSVLK-WAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHHHTTTHHHHH-HSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHHhhcccccHHHHh-hcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            1111111111000000 000    001223677888899999999999999999999887653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.4e-40  Score=343.03  Aligned_cols=239  Identities=22%  Similarity=0.391  Sum_probs=193.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+|+.||||++......    .+.+.+|++++.+++||||+++++++...+..++||||+. |
T Consensus        60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g  138 (348)
T 1u5q_A           60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G  138 (348)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence            5699999999999995 57999999999754322    2468899999999999999999999999999999999998 5


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      ++.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       139 ~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~~  210 (348)
T 1u5q_A          139 SASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NSF  210 (348)
T ss_dssp             EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CCC
T ss_pred             CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-Ccc
Confidence            8888776443    24899999999999999999999998   999999999999999999999999999876543 345


Q ss_pred             ccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          485 ARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       485 ~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      .+|..|+|||++.   ...++.++|||||||++|||++|+.||......+..      ........ .     ... ...
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~-~-----~~~-~~~  277 (348)
T 1u5q_A          211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNES-P-----ALQ-SGH  277 (348)
T ss_dssp             CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC-C-----CCC-CTT
T ss_pred             cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCC-C-----CCC-CCC
Confidence            7889999999984   567899999999999999999999999764322211      11111110 0     000 011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                         ....+.+++.+||+.||++|||+.|+++.
T Consensus       278 ---~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          278 ---WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               12356678889999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-40  Score=340.34  Aligned_cols=254  Identities=21%  Similarity=0.330  Sum_probs=203.2

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|...      +++.||+|++......  ...+.+|++++.+++||||+++++++.+.+..++||||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  109 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  109 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence            357999999999999853      3788999999764332  34688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccC-----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERG-----EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +++|+|.+++.....     .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~  186 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  186 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccc
Confidence            999999999976421     11234789999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..+   ..... .
T Consensus       187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~---~~~~~-~  259 (322)
T 1p4o_A          187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFV---MEGGL-L  259 (322)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHH---HTTCC-C
T ss_pred             ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---HHH---HcCCc-C
Confidence            654322     12245677999999988889999999999999999999 89999765432222   111   11110 0


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                                +........+.+++.+||+.+|.+|||+.|+++.|+++....-
T Consensus       260 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~  302 (322)
T 1p4o_A          260 ----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  302 (322)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence                      0111223457778889999999999999999999999877543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.5e-40  Score=333.51  Aligned_cols=253  Identities=16%  Similarity=0.243  Sum_probs=191.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||+|+++.....   .+.+.+|++++.+++||||+++++++.+.+..++||||+++ +
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   86 (292)
T 3o0g_A            8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred             eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence            56999999999999964 6899999999765332   26688999999999999999999999999999999999986 5


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      +.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ..
T Consensus        87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           87 LKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            555554432    24899999999999999999999998   999999999999999999999999999876432   22


Q ss_pred             ccccCCCcCCccccCCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc---ccccccc---cc
Q 006922          483 VIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE---WTAEVFD---VE  555 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---~~  555 (625)
                      ...+|..|+|||++.+.. ++.++|||||||++|||++|..||.....  .......+.......   ....+.+   ..
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            346788899999987665 89999999999999999998888644322  222222222221110   0000000   00


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 --------LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 --------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                              ............++.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    0000001112345667888999999999999999976

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.2e-40  Score=343.37  Aligned_cols=237  Identities=20%  Similarity=0.305  Sum_probs=194.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|+.. +|+.||+|+++...    ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus        26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g  105 (353)
T 2i0e_A           26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG  105 (353)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence            57999999999999975 48899999997642    2345678899999888 799999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---AL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~~  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...   ..
T Consensus       106 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          106 GDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            99999997643     3899999999999999999999998   9999999999999999999999999998642   22


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..+.+      .....          ..+
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~~----------~~p  241 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEHNV----------AYP  241 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC----------CCC
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH------HhCCC----------CCC
Confidence            33457899999999999999999999999999999999999999765433222111      11110          011


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM-----PDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~ev~~  592 (625)
                        .....++.+++.+|+..||.+||++     +|+++
T Consensus       242 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          242 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              1122356778889999999999964     66653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=332.14  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             hHcccCCceeEEEEEEc-CC---cEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCce-EEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DG---TTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEK-LMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~~  402 (625)
                      +.||+|+||+||+|... ++   ..||+|+++.....  .+.+.+|++++.+++||||+++++++...+.. ++||||+.
T Consensus        27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~  106 (298)
T 3pls_A           27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC  106 (298)
T ss_dssp             EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred             ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence            56999999999999853 33   37999999864332  35788999999999999999999999876655 99999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus       107 ~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          107 HGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             TCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             CCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999997633    24899999999999999999999998   999999999999999999999999999765322  


Q ss_pred             -----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 -----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP-IHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                           .....++..|+|||.+.+..++.++||||||+++|||++|..| |......+....+   ..   ..        
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~---~~---~~--------  245 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---AQ---GR--------  245 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH---HT---TC--------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh---hc---CC--------
Confidence                 1223456779999999999999999999999999999995555 5443332222211   11   00        


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                         ..+........+.+++.+||+.+|.+|||+.|+++.|+++...-
T Consensus       246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence               00111112246778888999999999999999999999986654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=334.87  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC------ChHHHHHHHHHHHcCC---CCceecceeEEEecC-----ce
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV------GKRDFEQQMEIVGSIR---HENVVELKAYYYSKD-----EK  394 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-----~~  394 (625)
                      +.||+|+||+||+|.. .+|+.||+|+++....      ....+.+|++++.+++   ||||+++++++....     ..
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~   94 (308)
T 3g33_A           15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV   94 (308)
T ss_dssp             EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence            5699999999999995 5789999999974321      1346778888877764   999999999998765     47


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      ++||||+. ++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  167 (308)
T 3g33_A           95 TLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA  167 (308)
T ss_dssp             EEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred             EEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccc
Confidence            89999998 599999876532   23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh----cccc
Q 006922          475 TITSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR----EEWT  548 (625)
Q Consensus       475 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  548 (625)
                      +.....  .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+....   +.....    ..+.
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~  244 (308)
T 3g33_A          168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLIGLPPEDDWP  244 (308)
T ss_dssp             TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSC
T ss_pred             cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcc
Confidence            876432  2345688999999999999999999999999999999999999976543332221   111111    1111


Q ss_pred             ccccccc--cc-CCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 AEVFDVE--LL-RYPNI-----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 ~~~~d~~--~~-~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....+.  .. ..+..     .+...++.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1000000  00 00000     011245677888999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.5e-40  Score=347.63  Aligned_cols=262  Identities=18%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             hHcccC--CceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKG--TFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|  +||+||+|... +|+.||||+++......   +.+.+|++++++++|||||++++++...+..++||||+++
T Consensus        31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  110 (389)
T 3gni_B           31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY  110 (389)
T ss_dssp             EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence            579999  99999999965 69999999998654332   5678899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc----
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA----  479 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~----  479 (625)
                      |+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+.....    
T Consensus       111 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          111 GSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             CBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred             CCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence            999999976532   24899999999999999999999998   99999999999999999999999999865421    


Q ss_pred             ------cccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc------
Q 006922          480 ------LAPVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE------  545 (625)
Q Consensus       480 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------  545 (625)
                            ......+|..|+|||++.+  ..++.++|||||||++|||++|+.||.+....+...  .........      
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLLDTST  262 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC-------------
T ss_pred             ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCccccccc
Confidence                  1122357778999999987  679999999999999999999999998755433221  100000000      


Q ss_pred             ---cc-------------cccccc--------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006922          546 ---EW-------------TAEVFD--------VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENVRP  599 (625)
Q Consensus       546 ---~~-------------~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~~~  599 (625)
                         ..             ..+...        ......+.......++.+++.+||+.||++|||+.|+++.  ++++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence               00             000000        0000001111223457888999999999999999999864  555543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.1e-40  Score=334.60  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=195.0

Q ss_pred             HcccCCceeEEEEEE---cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAIL---EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .||+|+||+||+|..   ..++.||||+++.....   .+.+.+|++++..++||||+++++++ ..+..++||||++++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            699999999999963   34789999999865322   36789999999999999999999999 567789999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc--
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP--  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~--  482 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......  
T Consensus       103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A          103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            9999997643     3899999999999999999999998   99999999999999999999999999987643221  


Q ss_pred             ----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                          ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   .    ....         
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~----~~~~---------  238 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---E----KGER---------  238 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H----TTCC---------
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----cCCC---------
Confidence                1234567999999988889999999999999999999 99999765433222111   1    1100         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       .+.......++.+++.+||+.||.+||++.|+++.|+++-.
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             00111223467788889999999999999999999988743

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.4e-40  Score=332.34  Aligned_cols=249  Identities=26%  Similarity=0.435  Sum_probs=189.6

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|...  ..||+|+++......   +.+.+|++++.+++||||+++++++ ..+..++||||+++++|
T Consensus        30 ~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L  106 (289)
T 3og7_A           30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL  106 (289)
T ss_dssp             EEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred             eEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence            57999999999999854  469999998654332   5688999999999999999999965 45678999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~  481 (625)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....     .
T Consensus       107 ~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          107 YHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             HHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             HHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            99996543    24899999999999999999999998   999999999999999999999999999765421     1


Q ss_pred             cccccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 PVIARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ....++..|+|||.+.   +..++.++||||||+++|||++|+.||......+.  ....+..    ....    +....
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----~~~~----~~~~~  249 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR----GSLS----PDLSK  249 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH----TSCC----CCTTS
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc----cccC----cchhh
Confidence            2346788999999986   56788899999999999999999999976543221  1221111    1110    00000


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                        .......++.+++.+||+.+|.+|||+.|+++.|+++..+
T Consensus       250 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          250 --VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             --SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence              0112234677888899999999999999999999998753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.3e-40  Score=335.02  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=196.8

Q ss_pred             hHcccCCceeEEEEEE-----cCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  400 (625)
                      +.||+|+||.||+|..     .+++.||+|+++...  ...+.+.+|++++.+++||||+++++++...  +..++||||
T Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  106 (302)
T 4e5w_A           27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF  106 (302)
T ss_dssp             EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred             hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence            5699999999999983     468999999998543  2346789999999999999999999999876  568999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++|+|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       107 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          107 LPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             CTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            999999999965432    3899999999999999999999998   999999999999999999999999999876432


Q ss_pred             c------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc--------chhhHHHHHHHHhhcc
Q 006922          481 A------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD--------ELVHLVRWVHSVVREE  546 (625)
Q Consensus       481 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~~~  546 (625)
                      .      ....++..|+|||.+.+..++.++||||+|+++|||+||+.|+......        ........+.......
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            2      2234666799999998888999999999999999999999986432100        0000011111111111


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .          ..+.......++.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       260 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 K----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0          11111222346778888999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-39  Score=347.45  Aligned_cols=243  Identities=19%  Similarity=0.291  Sum_probs=187.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHH-cCCCCceecceeEEEe----cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVG-SIRHENVVELKAYYYS----KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  403 (625)
                      ++||+|+||+||++... +|+.||||+++.    ...+.+|++++. ..+||||+++++++..    .+..++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            46999999999999965 689999999974    356778888874 4589999999999876    5578999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~  480 (625)
                      |+|.+++....   ...+++..+..|+.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.....
T Consensus       144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999997643   234899999999999999999999998   999999999999998   789999999999876432


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhccccccccccccc
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV-HLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                        .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+.   ...     ++... 
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~-----~~~~~-  288 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ-----YEFPN-  288 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC-----CCCCT-
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc-----ccCCC-
Confidence              23456788999999999999999999999999999999999999765443221 1111111   010     00000 


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                        +.......++.+++.+||..||++|||+.|+++.
T Consensus       289 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          289 --PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0011123456778889999999999999999873

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-39  Score=334.43  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=192.0

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecC-----ceEE
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKD-----EKLM  396 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  396 (625)
                      .+.||+|+||+||+|...    .+..||+|+++......   +.+.+|++++.+++||||+++++++...+     ..++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  118 (313)
T 3brb_A           39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV  118 (313)
T ss_dssp             EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred             ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence            357999999999999853    34589999998654332   56889999999999999999999998755     3499


Q ss_pred             EEEeccCCChhhhhccccC-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          397 VYDYYSLGSVSAMLHSERG-EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      ||||+++|+|.+++..... .....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~  195 (313)
T 3brb_A          119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSK  195 (313)
T ss_dssp             EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred             EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcce
Confidence            9999999999999854321 22345899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   .   ....  
T Consensus       196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~---~~~~--  267 (313)
T 3brb_A          196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL---L---HGHR--  267 (313)
T ss_dssp             ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H---TTCC--
T ss_pred             ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---H---cCCC--
Confidence            654321     22345667999999999999999999999999999999 99999765544332211   1   1100  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                               .+.......++.+++.+||..+|.+|||+.|+++.|+++..
T Consensus       268 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          268 ---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             ---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     01112223467788889999999999999999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.7e-40  Score=353.45  Aligned_cols=243  Identities=18%  Similarity=0.259  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ++||+|+||+||+|+.. +++.||+|++++..    .....+.+|+.++..++||||++++++|.+.+..++||||+++|
T Consensus        80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg  159 (437)
T 4aw2_A           80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG  159 (437)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence            57999999999999965 58899999997532    22345889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus       160 ~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          160 DLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             BHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             cHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            99999976322    4899999999999999999999998   9999999999999999999999999997654322   


Q ss_pred             -cccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 -PVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                       ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....  .-.     + +.
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~-----~-p~  304 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQ-----F-PT  304 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCC-----C-CS
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--ccc-----C-Cc
Confidence             2357899999999986     56789999999999999999999999986543333222110000  000     0 00


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQ--RPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~ev~~  592 (625)
                        ..+...   .++.+++.+|+..+|++  ||+++|+++
T Consensus       305 --~~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          305 --QVTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             --SCCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             --ccccCC---HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              001122   34566777999888888  999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=344.78  Aligned_cols=243  Identities=22%  Similarity=0.367  Sum_probs=196.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|... +|+.||+|++..... ....+.+|++++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus        57 ~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~  136 (387)
T 1kob_A           57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF  136 (387)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred             EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHH
Confidence            57999999999999964 689999999976432 3457889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCCeeEeccccccccccc--ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS--QQYGCVSDLGLTTITSAL--APV  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~--~~~  483 (625)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.....  ...
T Consensus       137 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          137 DRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             HHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            9987542    24899999999999999999999998   999999999999974  467999999999876543  233


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+|..|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+   ....+.   ++..  .   ..
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i---~~~~~~---~~~~--~---~~  275 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNV---KRCDWE---FDED--A---FS  275 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH---HHCCCC---CCSS--T---TT
T ss_pred             eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHH---HhCCCC---CCcc--c---cc
Confidence            4688999999999999999999999999999999999999976433222   1111   111110   0100  0   11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ....++.+++.+||..||++|||+.|+++.
T Consensus       276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            122356778889999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.1e-40  Score=338.68  Aligned_cols=249  Identities=20%  Similarity=0.310  Sum_probs=190.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCce----EEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEK----LMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~  400 (625)
                      +.||+|+||+||++.. .+++.||||+++.....    ...+.+|++++.+++||||+++++++......    ++||||
T Consensus        18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~   97 (311)
T 3ork_A           18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY   97 (311)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence            5799999999999995 57899999999865332    24688999999999999999999998876543    999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           98 VDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             CCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            99999999997643     4899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 ------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            .....|+..|+|||++.+..++.++|||||||++|||+||+.||......+..      ..........    +
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~----~  239 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP----P  239 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC----H
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCC----c
Confidence                  12245788999999999999999999999999999999999999764432211      1111111000    0


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHHhhCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV-RVIENVRPN  600 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~-~~L~~~~~~  600 (625)
                      .. ..+.   ...++.+++.+||+.||++||+..+++ ..+..+...
T Consensus       240 ~~-~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          240 SA-RHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HH-HSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cc-ccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            00 0011   123567888899999999999666554 566555443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-40  Score=331.25  Aligned_cols=245  Identities=23%  Similarity=0.395  Sum_probs=196.1

Q ss_pred             hHcccCCceeEEEEEEcC----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILED----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|...+    +..||+|+++....  ..+.+.+|++++.+++||||+++++++.+ +..++||||+++
T Consensus        18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   96 (281)
T 3cc6_A           18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPY   96 (281)
T ss_dssp             EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCC
Confidence            569999999999998532    34699999986432  24678999999999999999999999865 457899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      ++|.+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......  
T Consensus        97 ~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           97 GELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             CBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            999999976432    4899999999999999999999998   9999999999999999999999999998764322  


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+.   .   ...           
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~---~~~-----------  232 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K---GDR-----------  232 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H---TCC-----------
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c---CCC-----------
Confidence              22345667999999988889999999999999999998 999997655444332221   1   100           


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .+........+.+++.+||..+|++||++.|+++.|+.+..
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            01111122457788889999999999999999999988743

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.1e-41  Score=355.80  Aligned_cols=236  Identities=15%  Similarity=0.185  Sum_probs=185.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHH---HHHHcCCCCceecce-------eEEEecCc-
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQM---EIVGSIRHENVVELK-------AYYYSKDE-  393 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~~-  393 (625)
                      +.||+|+||+||+|.. .+|+.||||+++...    ...+.+.+|+   +++++++|||||+++       +++...+. 
T Consensus        79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  158 (377)
T 3byv_A           79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK  158 (377)
T ss_dssp             EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred             ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence            5799999999999995 579999999997432    2236788999   455566899999998       66665532 


Q ss_pred             ----------------eEEEEEeccCCChhhhhccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 006922          394 ----------------KLMVYDYYSLGSVSAMLHSERG--EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKS  455 (625)
Q Consensus       394 ----------------~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~  455 (625)
                                      .++||||+ +|+|.+++.....  .....++|..+..|+.|++.||+|||+++   |+||||||
T Consensus       159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp  234 (377)
T 3byv_A          159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP  234 (377)
T ss_dssp             SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred             cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence                            78999999 6899999986431  11223557888999999999999999998   99999999


Q ss_pred             CCEEeCCCCCeeEecccccccccccccccccCCCcCCccccCCC-----------CCCCccchhhhHHHHHHHHhCCCCC
Q 006922          456 SNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSR-----------KATQASDVYSFGVVLLEILTGKSPI  524 (625)
Q Consensus       456 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvil~elltG~~p~  524 (625)
                      +|||++.++.+||+|||+++..........| ..|+|||++.+.           .++.++|||||||++|||++|+.||
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf  313 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI  313 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999976655555667 889999999877           8999999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          525 HTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......+...               .+.    ...+..   ..++.+++.+||+.||++|||+.|+++
T Consensus       314 ~~~~~~~~~~---------------~~~----~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          314 TKDAALGGSE---------------WIF----RSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             ------CCSG---------------GGG----SSCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             cccccccchh---------------hhh----hhccCC---CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            7543322111               010    011112   235677888999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.1e-40  Score=338.90  Aligned_cols=254  Identities=22%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEE--EEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTV--VVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~v--avK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|.. .+|..+  |+|+++...  ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  109 (327)
T 1fvr_A           30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP  109 (327)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence            35799999999999995 456654  999987532  2346789999999999 89999999999999999999999999


Q ss_pred             CCChhhhhccccC-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          403 LGSVSAMLHSERG-----------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       403 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      +|+|.+++.....           .....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df  186 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  186 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence            9999999976430           11235899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          472 GLTTITSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       472 Gla~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      |+++.....  .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+..   .   . +.....
T Consensus       187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~---~-~~~~~~  259 (327)
T 1fvr_A          187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---K-LPQGYR  259 (327)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---H-GGGTCC
T ss_pred             CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH---H---H-hhcCCC
Confidence            999754322  122345678999999988889999999999999999998 99999765432211   1   1 111100


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                                .+.......++.+++.+||..+|.+|||+.|+++.|+.+..+..
T Consensus       260 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          260 ----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                      01111122457788889999999999999999999998866544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.8e-40  Score=342.39  Aligned_cols=257  Identities=22%  Similarity=0.349  Sum_probs=198.8

Q ss_pred             hHcccCCceeEEEEEE-----cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  401 (625)
                      +.||+|+||+||++..     .+++.||||++..... ..+.+.+|++++.+++||||+++++++..  .+..++||||+
T Consensus        29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~  108 (327)
T 3lxl_A           29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL  108 (327)
T ss_dssp             EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred             hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence            5799999999999983     4688999999986533 23568999999999999999999999874  45688999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++++|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       109 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          109 PSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             TTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            99999999976432    4899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHHhhccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWVHSVVREEW  547 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~  547 (625)
                            ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........        .....+........
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ  261 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence                  1234566799999998888999999999999999999999998643211000        00011111111110


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          548 TAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       548 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                                ..+.......++.+++.+||+.||++|||+.|+++.|+.+......
T Consensus       262 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          262 ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             ----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence                      1111222334677888899999999999999999999998765543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-40  Score=339.72  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=198.9

Q ss_pred             hHcccCCceeEEEEEE-----cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEec--CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSK--DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  400 (625)
                      +.||+|+||+||++..     .+|+.||||+++....  ..+.+.+|++++.+++||||+++++++.+.  ...++||||
T Consensus        37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  116 (318)
T 3lxp_A           37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY  116 (318)
T ss_dssp             EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred             heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence            5799999999998864     2688999999986532  235689999999999999999999999884  567999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++|+|.+++....      +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       117 ~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          117 VPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             CTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             ccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999997542      899999999999999999999998   999999999999999999999999999876532


Q ss_pred             c------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc--------hhhHHHHHHHHhhcc
Q 006922          481 A------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDE--------LVHLVRWVHSVVREE  546 (625)
Q Consensus       481 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~~  546 (625)
                      .      ....++..|+|||.+.+..++.++||||||+++|||+||+.||.......        .......+...+...
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            2      22345667999999988889999999999999999999999996432110        000000111111111


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .          ..+.......++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       268 ~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          268 E----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            0          1111222335678888899999999999999999999988654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=339.48  Aligned_cols=244  Identities=15%  Similarity=0.222  Sum_probs=197.0

Q ss_pred             hHcccCCceeEEEEE------EcCCcEEEEEEeccccCChHHHHHHHHHHHcCC---CCceecceeEEEecCceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAI------LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR---HENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      +.||+|+||+||+|.      ..+++.||||+++..  ...++.+|++++..++   |+||+.+++++...+..++||||
T Consensus        71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~  148 (365)
T 3e7e_A           71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL  148 (365)
T ss_dssp             EEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred             EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence            579999999999993      456899999999754  3567888888888886   99999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----------CCCeeEe
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-----------QQYGCVS  469 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-----------~~~~kl~  469 (625)
                      +++|+|.+++..........++|..+..|+.|+++||+|||+.+   |+||||||+|||++.           ++.+||+
T Consensus       149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~  225 (365)
T 3e7e_A          149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI  225 (365)
T ss_dssp             CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred             cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence            99999999998654333446999999999999999999999988   999999999999998           8999999


Q ss_pred             cccccccccc-----cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          470 DLGLTTITSA-----LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       470 DfGla~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      |||+|+....     ......||.+|+|||++.+..++.++|||||||++|||+||+.||.........           
T Consensus       226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------  294 (365)
T 3e7e_A          226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----------  294 (365)
T ss_dssp             CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----------
T ss_pred             eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----------
Confidence            9999976431     123356899999999999999999999999999999999999999643221110           


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHhhCCC
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQR-PKMPDVVRVIENVRPN  600 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~ev~~~L~~~~~~  600 (625)
                             .+......+ ..+   .+.+++..|++.+|.+| |+++++.+.|++....
T Consensus       295 -------~~~~~~~~~-~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 -------PEGLFRRLP-HLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -------ECSCCTTCS-SHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -------echhccccC-cHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                   011111112 233   34456669999999998 6888888888876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-39  Score=329.00  Aligned_cols=237  Identities=22%  Similarity=0.360  Sum_probs=193.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... ++..||+|++....    .....+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   94 (279)
T 3fdn_A           15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG   94 (279)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence            56999999999999855 57899999996532    22456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APV  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~  483 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... ...
T Consensus        95 ~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  166 (279)
T 3fdn_A           95 TVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD  166 (279)
T ss_dssp             EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence            9999997653     3899999999999999999999987   999999999999999999999999998765432 234


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.   .   ..            .....
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~---~~------------~~~~~  228 (279)
T 3fdn_A          167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---R---VE------------FTFPD  228 (279)
T ss_dssp             -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---H---TC------------CCCCT
T ss_pred             cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---h---CC------------CCCCC
Confidence            568889999999999999999999999999999999999997644322221111   1   00            00011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....++.+++.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          229 FVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            12235667888999999999999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-40  Score=355.22  Aligned_cols=238  Identities=23%  Similarity=0.319  Sum_probs=188.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|.. .+|+.||||+++...    .....+.+|++++..++||||+++++++...+..++||||+++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  232 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG  232 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence            35799999999999995 468999999997532    2235677899999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---  479 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---  479 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....   
T Consensus       233 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          233 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            99999997643     48999999999999999999998 76   99999999999999999999999999986432   


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+.      ....          ..
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~~----------~~  368 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEEI----------RF  368 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC----------CC
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH------hCCC----------CC
Confidence            2234578999999999999999999999999999999999999997654332222111      1110          00


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      +  .....++.+++.+||+.||.+||     ++.|+++
T Consensus       369 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          369 P--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             C--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1  11223567788899999999999     9999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-39  Score=351.14  Aligned_cols=237  Identities=23%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||||+++...    ...+.+.+|++++..++||||+++++++...+..++||||+++|
T Consensus        22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg  101 (476)
T 2y94_A           22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG  101 (476)
T ss_dssp             EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            56999999999999965 79999999997542    22357889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       102 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A          102 ELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             EHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence            9999997532     4899999999999999999999998   999999999999999999999999999876432  23


Q ss_pred             ccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...||+.|+|||++.+..+ +.++||||+||++|||++|+.||......+....      .....     +     ..+ 
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------i~~~~-----~-----~~p-  236 (476)
T 2y94_A          174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK------ICDGI-----F-----YTP-  236 (476)
T ss_dssp             CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH------HHTTC-----C-----CCC-
T ss_pred             ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH------HhcCC-----c-----CCC-
Confidence            4568899999999988776 6899999999999999999999976543322211      11110     0     001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....++.+++.+||..||.+|||+.|+++
T Consensus       237 -~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 -QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             111235677888999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=339.35  Aligned_cols=241  Identities=19%  Similarity=0.324  Sum_probs=181.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+|... +++.||||+++... ..+.+.+|++++.+++||||+++++++...+..++||||+++|+|.+
T Consensus        59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  137 (349)
T 2w4o_A           59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD  137 (349)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             eEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHH
Confidence            56999999999999965 58899999998643 34678899999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccccccc--ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSAL--APV  483 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~--~~~  483 (625)
                      ++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.....  ...
T Consensus       138 ~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  209 (349)
T 2w4o_A          138 RIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT  209 (349)
T ss_dssp             HHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence            987542     4899999999999999999999998   999999999999975   889999999999876432  233


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..||..|+|||++.+..++.++|||||||++|||++|+.||......+.  ...   .......  ....      +...
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~~~~~--~~~~------~~~~  276 (349)
T 2w4o_A          210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RILNCEY--YFIS------PWWD  276 (349)
T ss_dssp             ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHHTTCC--CCCT------TTTT
T ss_pred             ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHHhCCC--ccCC------chhh
Confidence            5688899999999999999999999999999999999999976543221  111   1111110  0000      1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....++.+++.+|++.||++|||+.|+++
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22345677888999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.8e-40  Score=344.91  Aligned_cols=237  Identities=23%  Similarity=0.317  Sum_probs=185.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHH-HHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEI-VGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+++.. +++.||+|++++....    .+.+.+|..+ +..++||||+++++++.+.+..++||||++
T Consensus        43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  122 (373)
T 2r5t_A           43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN  122 (373)
T ss_dssp             EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence            367999999999999965 5889999999765322    2345666666 567899999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---c
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---A  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~  479 (625)
                      +|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++...   .
T Consensus       123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            999999997643     3889999999999999999999998   9999999999999999999999999998642   2


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+      ....         ..-.
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~---------~~~~  259 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNKP---------LQLK  259 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------HHSC---------CCCC
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hhcc---------cCCC
Confidence            234457899999999999999999999999999999999999999764432222111      1110         0001


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                      +..   ..++.+++.+|++.||.+||++.+.+
T Consensus       260 ~~~---~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          260 PNI---TNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             SSS---CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CCC---CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            112   23566777899999999999985433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-40  Score=347.24  Aligned_cols=190  Identities=28%  Similarity=0.435  Sum_probs=155.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCC-CCceecceeEEEecC--ceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIR-HENVVELKAYYYSKD--EKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|.. .+|+.||||++......   .+.+.+|+.++.++. ||||+++++++...+  ..++|||||+
T Consensus        15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~   94 (388)
T 3oz6_A           15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME   94 (388)
T ss_dssp             EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred             EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence            5699999999999995 46999999999754322   355778999999997 999999999998654  6899999998


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---  479 (625)
                       ++|..++...      .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus        95 -~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           95 -TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             -EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             -cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence             5898888753      3899999999999999999999998   99999999999999999999999999986532   


Q ss_pred             ---------------------cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 006922          480 ---------------------LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGG  529 (625)
Q Consensus       480 ---------------------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~  529 (625)
                                           ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                                 1122468888999999876 6789999999999999999999999986543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.8e-40  Score=341.37  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=200.5

Q ss_pred             HhHcccCCceeEEEEEEcC-C-----cEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILED-G-----TTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|.... +     ..||+|+++....  ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  130 (333)
T 2i1m_A           51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE  130 (333)
T ss_dssp             EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence            3679999999999999542 2     4799999986532  235688999999999 89999999999999999999999


Q ss_pred             eccCCChhhhhccccCC---------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          400 YYSLGSVSAMLHSERGE---------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                      |+++|+|.+++......         ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  207 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD  207 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence            99999999998754210         1234799999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhh
Q 006922          471 LGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVR  544 (625)
Q Consensus       471 fGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  544 (625)
                      ||+++......     ....++..|+|||.+.+..++.++|||||||++|||+| |..||......+..  ...+.    
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~~~~----  281 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YKLVK----  281 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HHHHH----
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HHHHh----
Confidence            99998653322     12345667999999988889999999999999999999 99999765443321  11111    


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          545 EEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       545 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .....          ........++.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       282 ~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          282 DGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            11000          0011112467788889999999999999999999988754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-39  Score=350.65  Aligned_cols=251  Identities=15%  Similarity=0.188  Sum_probs=200.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCC-CceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH-ENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+++.||||+++... ...++.+|++++..++| +++..+..++...+..++||||+ +++|.
T Consensus        13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~   90 (483)
T 3sv0_A           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE   90 (483)
T ss_dssp             CCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence            5699999999999995 579999999887543 23568899999999987 45555566666777889999999 99999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEeccccccccccccc--
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSALAP--  482 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~--  482 (625)
                      +++.....    .+++..+..|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        91 ~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           91 DLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            99975432    4999999999999999999999998   9999999999999   6889999999999987643221  


Q ss_pred             --------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          483 --------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       483 --------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                              ...||..|+|||.+.+..++.++|||||||++|||++|+.||..............+...........+.  
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~--  241 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC--  241 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH--
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh--
Confidence                    4568889999999999999999999999999999999999998766554444433322221111100000  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                        .      ....++.+++..||+.+|++||++.+|++.|+++..
T Consensus       242 --~------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          242 --R------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             --T------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --c------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              0      112467888889999999999999999999988844

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.2e-40  Score=351.84  Aligned_cols=194  Identities=21%  Similarity=0.312  Sum_probs=170.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC------CCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI------RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +++.||||+++......+.+.+|++++..+      +|+||+++++++...+..++||||+.
T Consensus       103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  182 (429)
T 3kvw_A          103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS  182 (429)
T ss_dssp             EEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred             EEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence            67999999999999854 589999999987544456778888888776      57799999999999999999999997


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC--eeEeccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY--GCVSDLGLTTITSAL  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DfGla~~~~~~  480 (625)
                       ++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus       183 -~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~  255 (429)
T 3kvw_A          183 -MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR  255 (429)
T ss_dssp             -CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             -CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence             589998876542   24899999999999999999999998   999999999999999987  999999999877666


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD  530 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~  530 (625)
                      .....+|..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       256 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            66667899999999999999999999999999999999999999765443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=334.44  Aligned_cols=255  Identities=17%  Similarity=0.288  Sum_probs=192.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||+|++......   .+.+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (311)
T 4agu_A            9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV   88 (311)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence            56999999999999965 5899999999765433   3567899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      |.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .
T Consensus        89 l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           89 LHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             HHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             HHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            998876543     3899999999999999999999998   9999999999999999999999999998765322   2


Q ss_pred             ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------Hh-hcccccccc
Q 006922          483 VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS--------VV-REEWTAEVF  552 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~  552 (625)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.....        .. ...+.....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            3467888999999865 6789999999999999999999999976554333222211100        00 000000000


Q ss_pred             cccccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+........    .....++.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000    112335778888999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.4e-40  Score=339.91  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=192.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHH--HHcCCCCceecceeEEEec-----CceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEI--VGSIRHENVVELKAYYYSK-----DEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|.. +++.||||+++...  ...+..|.++  +..++||||+++++++...     ...++||||++
T Consensus        19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   95 (336)
T 3g2f_A           19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP   95 (336)
T ss_dssp             EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred             eecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence            5799999999999976 58999999997543  2344444444  5568999999999876532     25689999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc---------CCCCceecCCCCCCEEeCCCCCeeEecccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA---------NGGKLVHGNIKSSNIFLNSQQYGCVSDLGL  473 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~ivHrDlk~~NIll~~~~~~kl~DfGl  473 (625)
                      +|+|.+++....      .++..+..++.|+++||+|||+.         +   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           96 NGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             TCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             CCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccc
Confidence            999999997543      68999999999999999999998         6   99999999999999999999999999


Q ss_pred             ccccccc-----------ccccccCCCcCCccccCC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCc-chhh
Q 006922          474 TTITSAL-----------APVIARAAGYRAPEVTDS-------RKATQASDVYSFGVVLLEILTGKSPIHTTGGD-ELVH  534 (625)
Q Consensus       474 a~~~~~~-----------~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~-~~~~  534 (625)
                      ++.....           .....||..|+|||++.+       ..++.++|||||||++|||++|+.||...... +...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9865421           112357889999999976       45677999999999999999997776543221 1110


Q ss_pred             HH----------HHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006922          535 LV----------RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN  604 (625)
Q Consensus       535 ~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~  604 (625)
                      ..          ...............+.   ...+.......++.+++.+||+.||++|||+.|+++.|+++...-..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFP---EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCC---TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCC---cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            00          00111111110000000   011122345567889999999999999999999999999987654433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=344.88  Aligned_cols=266  Identities=15%  Similarity=0.217  Sum_probs=206.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecC--ceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKD--EKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||||+++...  ...+.+.+|++++.+++||||+++++++...+  ..++||||+++|
T Consensus        15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g   94 (396)
T 4eut_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (396)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred             EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence            56999999999999965 58999999998643  23467889999999999999999999998765  679999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCCeeEeccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL----NSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla~~~~~~  480 (625)
                      +|.+++......  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.....
T Consensus        95 ~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           95 SLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             EHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            999999865422  23899999999999999999999998   9999999999999    77788999999999876543


Q ss_pred             c--cccccCCCcCCccccCC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHHhhccccc
Q 006922          481 A--PVIARAAGYRAPEVTDS--------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDE-LVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       481 ~--~~~~~~~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  549 (625)
                      .  ....+|..|+|||++.+        ..++.++|||||||++|||++|+.||....... ....+..+..........
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~  249 (396)
T 4eut_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS  249 (396)
T ss_dssp             GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCE
T ss_pred             CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccch
Confidence            2  23468889999998864        467889999999999999999999997544322 222222111111111111


Q ss_pred             ccc---------ccccc-CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          550 EVF---------DVELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       550 ~~~---------d~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .+.         ..... ...........+.+++..||+.||++||++.|+++.++.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000         00000 1122355667788999999999999999999999999887654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-39  Score=330.41  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=196.0

Q ss_pred             hHcccCCceeEEEEEEcC----CcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILED----GTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|...+    +..+|+|.++....  ..+.+.+|++++++++||||+++++++.. .+..++||||++
T Consensus        31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~  110 (298)
T 3f66_A           31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  110 (298)
T ss_dssp             EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCT
T ss_pred             ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCC
Confidence            569999999999998542    23689999886432  23568899999999999999999999754 557899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus       111 ~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          111 HGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             TCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            999999997543    24899999999999999999999998   9999999999999999999999999998654321 


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....++..|+|||.+.+..++.++||||+|+++|||++ |.+||......+......      ...   ..   
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------~~~---~~---  251 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR---RL---  251 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------TTC---CC---
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------cCC---CC---
Confidence                  22345667999999988899999999999999999999 666676544433322111      110   00   


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                           .........+.+++.+||+.+|.+|||+.|+++.|+++...-
T Consensus       252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                 001112235778888999999999999999999999986643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-40  Score=348.78  Aligned_cols=241  Identities=17%  Similarity=0.237  Sum_probs=193.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+++.. +|+.||+|++++...    ..+.+.+|.+++..++||||+++++++.+.+..++||||+++|
T Consensus        67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg  146 (412)
T 2vd5_A           67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG  146 (412)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence            57999999999999964 699999999975321    2245889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......   
T Consensus       147 ~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          147 DLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             BHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             cHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            99999976432    3899999999999999999999998   9999999999999999999999999998764332   


Q ss_pred             -cccccCCCcCCccccC-------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          482 -PVIARAAGYRAPEVTD-------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~-------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                       ....||..|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+.......          
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------  289 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----------  289 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----------
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----------
Confidence             2347899999999986       4578999999999999999999999997654333322211100000          


Q ss_pred             ccccCCCC-cHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 006922          554 VELLRYPN-IEEEMVEMLQIAMSCVVRMPDQR---PKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~-~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~ev~~  592 (625)
                          ..+. ......++.+++.+|+. +|.+|   |+++|+++
T Consensus       290 ----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          290 ----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                0010 01112356677789998 99998   68999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=331.61  Aligned_cols=236  Identities=20%  Similarity=0.243  Sum_probs=185.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|... +|+.||||++.......   ..+..|+..+.++ +||||++++++|.+.+..++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            357999999999999965 79999999987654333   3344555555554 8999999999999999999999999 6


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--A  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~  481 (625)
                      ++|.+++.....    .++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  .
T Consensus       141 ~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          141 PSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             CBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            689888876532    4999999999999999999999998   999999999999999999999999999876433  2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....||.+|+|||++.+ .++.++|||||||++|||++|..|+...   +..   .    .+....    ..+...    
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~---~----~~~~~~----~~~~~~----  274 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGW---Q----QLRQGY----LPPEFT----  274 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHH---H----HHTTTC----CCHHHH----
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHH---H----HHhccC----CCcccc----
Confidence            33458889999999876 7899999999999999999997776432   111   0    011110    011110    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....++.+++.+|++.||++|||+.|+++
T Consensus       275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 -AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             011246778888999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.3e-39  Score=349.82  Aligned_cols=252  Identities=18%  Similarity=0.252  Sum_probs=186.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||+|... +|+.||||++......   .+.+.+|++++..++||||+++++++...+      ..++|||
T Consensus        68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E  147 (464)
T 3ttj_A           68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME  147 (464)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence            57999999999999854 6899999999764322   356889999999999999999999997653      5699999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |++++ +.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       148 ~~~~~-l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          148 LMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CCCCC-HHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            99874 5555542       2889999999999999999999998   99999999999999999999999999987654


Q ss_pred             c--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH-H---------------HH
Q 006922          480 L--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW-V---------------HS  541 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~-~---------------~~  541 (625)
                      .  .....+|..|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.. .               ..
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            3  2345789999999999999999999999999999999999999976543222111110 0               00


Q ss_pred             Hhhcccc------cccccccccCCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWT------AEVFDVELLRYPN--IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~------~~~~d~~~~~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......      ...+.........  ......++.+++.+|+..||++|||++|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000      0000000000000  0112456788999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-39  Score=338.04  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHc--CCCCceecceeEEEecC----ceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGS--IRHENVVELKAYYYSKD----EKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|.. +|+.||||+++..  ..+.+.+|++++..  ++||||+++++++...+    ..++||||++
T Consensus        47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~  123 (342)
T 1b6c_B           47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE  123 (342)
T ss_dssp             EEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred             EeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence            35799999999999987 4899999999753  24567888888887  78999999999998876    7899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCCCCEEeCCCCCeeEeccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH--------AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLT  474 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla  474 (625)
                      +|+|.+++...      .+++..+..++.|++.||+|||        +.+   |+||||||+|||++.++.+||+|||++
T Consensus       124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            99999999753      3899999999999999999999        665   999999999999999999999999999


Q ss_pred             ccccccc-------cccccCCCcCCccccCCCC------CCCccchhhhHHHHHHHHhC----------CCCCCCCCCcc
Q 006922          475 TITSALA-------PVIARAAGYRAPEVTDSRK------ATQASDVYSFGVVLLEILTG----------KSPIHTTGGDE  531 (625)
Q Consensus       475 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvil~elltG----------~~p~~~~~~~~  531 (625)
                      +......       ....++..|+|||++.+..      ++.++|||||||++|||+||          +.||......+
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7664322       2346788899999987652      34689999999999999999          77886543221


Q ss_pred             hhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          532 LVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      .. ...+.. .+....    ..+.........+....+.+++.+||+.||++|||+.||++.|+++..+.
T Consensus       275 ~~-~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          275 PS-VEEMRK-VVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CC-HHHHHH-HHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cc-HHHHHH-HHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            11 111111 111111    11111100012355667889999999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-39  Score=325.66  Aligned_cols=241  Identities=20%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||+|++.......   +.+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   91 (284)
T 3kk8_A           12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   91 (284)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence            56999999999999964 68999999997654332   567899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEecccccccccccc-
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTTITSALA-  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~~-  481 (625)
                      |.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++....... 
T Consensus        92 l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           92 LFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            998887643     3899999999999999999999998   999999999999987665   9999999998765432 


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+   .   ....     ....... 
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~---~~~~-----~~~~~~~-  231 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---K---AGAY-----DYPSPEW-  231 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HTCC-----CCCTTTT-
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---H---hccc-----cCCchhh-
Confidence             2346788999999999999999999999999999999999999765432222111   1   1110     0000001 


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .....++.+++.+|++.||++|||+.|+++
T Consensus       232 --~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          232 --DTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              112235677888999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=338.41  Aligned_cols=233  Identities=18%  Similarity=0.264  Sum_probs=193.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC---------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.||+|+||+||+|.. .+++.||||+++....         ..+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  108 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM  108 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence            35799999999999995 5789999999986532         2245788999999999999999999999999999999


Q ss_pred             EeccCC-ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          399 DYYSLG-SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       399 e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ||+..| +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            999877 9999987543     3899999999999999999999998   999999999999999999999999999876


Q ss_pred             cccc--cccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          478 SALA--PVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       478 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      ....  ....||..|+|||++.+..+ +.++|||||||++|||++|+.||.....  .               ...    
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~---------------~~~----  239 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--T---------------VEA----  239 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--G---------------TTT----
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--H---------------Hhh----
Confidence            5432  33568899999999988777 7899999999999999999999964211  0               000    


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .......   ...++.+++..||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 AIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000011   12356778889999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-39  Score=327.03  Aligned_cols=251  Identities=21%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||++... +|+.||+|+++....       ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   89 (283)
T 3bhy_A           10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL   89 (283)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence            357999999999999965 689999999975422       246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----CeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~  476 (625)
                      +++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        90 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           90 VSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            99999999997543     4899999999999999999999998   99999999999999887    899999999987


Q ss_pred             ccccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          477 TSALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       477 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+      .....   ..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~---~~~~  232 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------SAVNY---DFDE  232 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTTCC---CCCH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh------Hhccc---CCcc
Confidence            64322  2345788899999999889999999999999999999999999765432221111      00000   0000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPND  601 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~~~  601 (625)
                      ...  +   .....+.+++.+|+..||++||++.|+++  .++.++...
T Consensus       233 ~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 EYF--S---NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHH--T---TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             hhc--c---cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            000  0   11235677888999999999999999997  566665544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-39  Score=344.66  Aligned_cols=257  Identities=18%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC--------CCceecceeEEE----ecCceE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR--------HENVVELKAYYY----SKDEKL  395 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~~~~  395 (625)
                      .+.||+|+||+||+|+. .+++.||||+++......+.+.+|++++.+++        |+||+++++++.    .....+
T Consensus        42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  121 (397)
T 1wak_A           42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC  121 (397)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred             EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence            35799999999999985 46899999999865444567889999999885        788999999987    455789


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCC----------
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQ----------  464 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~----------  464 (625)
                      +||||+ ++++.+.+....   ...+++..+..++.|++.||+|||++ +   |+||||||+|||++.++          
T Consensus       122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence            999999 556666655432   12489999999999999999999998 7   99999999999999775          


Q ss_pred             ---------------------------------------CeeEecccccccccccccccccCCCcCCccccCCCCCCCcc
Q 006922          465 ---------------------------------------YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQAS  505 (625)
Q Consensus       465 ---------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  505 (625)
                                                             .+||+|||+++..........+|..|+|||++.+..++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  274 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA  274 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence                                                   79999999998876655566789999999999999999999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH---HHHHhhc---------cccccccccc------------------
Q 006922          506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW---VHSVVRE---------EWTAEVFDVE------------------  555 (625)
Q Consensus       506 DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~d~~------------------  555 (625)
                      |||||||++|||+||+.||......+.......   +......         ....+.+...                  
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL  354 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence            999999999999999999987654432221111   1111110         0111111100                  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........+....+.+++.+||+.||++|||+.|+++
T Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0011224556678899999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=341.24  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=191.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||||++......   .+.+.+|++++..++||||+++++++...+      ..++|||
T Consensus        31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e  110 (367)
T 1cm8_A           31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP  110 (367)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence            5699999999999996 46999999999654332   356789999999999999999999997753      4599999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       111 ~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          111 FM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            99 78999998753      3899999999999999999999998   99999999999999999999999999998766


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccc-------
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV-------  551 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  551 (625)
                      ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.........+....+       
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            5556678899999999876 68999999999999999999999999765432222111100000000000000       


Q ss_pred             --------ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          552 --------FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       552 --------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                              .......  .......++.+++.+|+..||.+|||+.|+++  .++.+.
T Consensus       261 ~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          261 YMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhCCCCCCCCHHH--HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                    0000000  00112235677888999999999999999987  344443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-39  Score=338.82  Aligned_cols=254  Identities=17%  Similarity=0.223  Sum_probs=195.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc------CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN------VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|.. .++..||+|++....      ...+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  110 (345)
T 3hko_A           31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC  110 (345)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence            46799999999999996 468899999997531      22367899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC-----------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006922          402 SLGSVSAMLHSERGE-----------------------------------GRIPLDWDTRMRIAIGAARGIARIHAANGG  446 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  446 (625)
                      ++|+|.+++......                                   ....+++..+..++.|++.||+|||+.+  
T Consensus       111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--  188 (345)
T 3hko_A          111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--  188 (345)
T ss_dssp             CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            999999998632111                                   0112457778899999999999999998  


Q ss_pred             CceecCCCCCCEEeCCCC--CeeEeccccccccccc-------ccccccCCCcCCccccCC--CCCCCccchhhhHHHHH
Q 006922          447 KLVHGNIKSSNIFLNSQQ--YGCVSDLGLTTITSAL-------APVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLL  515 (625)
Q Consensus       447 ~ivHrDlk~~NIll~~~~--~~kl~DfGla~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~  515 (625)
                       |+||||||+||+++.++  .+||+|||+++.....       .....++..|+|||.+.+  ..++.++|||||||++|
T Consensus       189 -ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~  267 (345)
T 3hko_A          189 -ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH  267 (345)
T ss_dssp             -EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred             -ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence             99999999999998776  8999999999865321       123467888999999865  67899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--H
Q 006922          516 EILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--V  593 (625)
Q Consensus       516 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~  593 (625)
                      ||++|+.||......+...      ........  ...      +.......++.+++.+|++.+|.+||++.|+++  .
T Consensus       268 el~~g~~pf~~~~~~~~~~------~~~~~~~~--~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~  333 (345)
T 3hko_A          268 LLLMGAVPFPGVNDADTIS------QVLNKKLC--FEN------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW  333 (345)
T ss_dssp             HHHHSSCSSCCSSHHHHHH------HHHHCCCC--TTS------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred             HHHHCCCCCCCCChHHHHH------HHHhcccc--cCC------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence            9999999997654322211      11111100  000      111112245677888999999999999999987  4


Q ss_pred             HHhhCC
Q 006922          594 IENVRP  599 (625)
Q Consensus       594 L~~~~~  599 (625)
                      ++++..
T Consensus       334 ~~~~~~  339 (345)
T 3hko_A          334 ISQFSD  339 (345)
T ss_dssp             HHTTSS
T ss_pred             hccChH
Confidence            555443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.6e-39  Score=323.77  Aligned_cols=241  Identities=17%  Similarity=0.265  Sum_probs=195.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|... ++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL   93 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence            357999999999999965 57899999997653 3457899999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEeccccccccccc--c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSAL--A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~--~  481 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++......  .
T Consensus        94 ~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           94 FERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             HHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            99887643     3899999999999999999999998   9999999999999   78899999999999876432  2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+. ++.++||||||+++|||++|+.||......+....+   .   .... . ......   . 
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~---~~~~-~-~~~~~~---~-  232 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI---R---EGTF-T-FPEKDW---L-  232 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HCCC-C-CCHHHH---T-
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH---H---hCCC-C-CCchhh---h-
Confidence            334688899999998764 899999999999999999999999765432222111   1   1100 0 000000   0 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ....++.+++.+|++.||++|||+.|+++
T Consensus       233 --~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 --NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11346778888999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=329.23  Aligned_cols=238  Identities=22%  Similarity=0.375  Sum_probs=176.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|.. .+|+.||+|++....    ...+.+.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus        17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   96 (278)
T 3cok_A           17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG   96 (278)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence            5699999999999996 579999999997532    12367889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~  481 (625)
                      +|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++......   .
T Consensus        97 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           97 EMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            9999997542    24899999999999999999999998   999999999999999999999999999876422   2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+...      ....    .   +...   + 
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~----~---~~~~---~-  232 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVL----A---DYEM---P-  232 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS----S---CCCC---C-
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhh----c---ccCC---c-
Confidence            23467888999999998899999999999999999999999997654332211      0000    0   0011   1 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .....++.+++.+|++.||++|||+.|+++
T Consensus       233 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          233 -SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             112235677888999999999999999976

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.7e-39  Score=331.69  Aligned_cols=242  Identities=20%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|... +|+.||+|+++....       ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (321)
T 2a2a_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL   96 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence            467999999999999965 689999999976432       246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----CeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~  476 (625)
                      +++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||+++.
T Consensus        97 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             CCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            99999999997532     4899999999999999999999998   99999999999999888    799999999987


Q ss_pred             ccccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          477 TSALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       477 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+      ....   ..++.
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~---~~~~~  239 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------TSVS---YDFDE  239 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTC---CCCCH
T ss_pred             cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hhcc---cccCh
Confidence            65432  3346888999999999999999999999999999999999999764432222111      1100   00011


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...  +   .....+.+++.+|+..||++|||+.|+++
T Consensus       240 ~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          240 EFF--S---HTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHH--T---TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhh--c---ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000  0   11235677888999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-39  Score=329.09  Aligned_cols=244  Identities=22%  Similarity=0.318  Sum_probs=191.3

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||++.. .++..||+|++....  ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  106 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE  106 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence            46799999999999996 468999999997653  335789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEeccccccccccc--
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~--  480 (625)
                      |.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++.....  
T Consensus       107 L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~  182 (285)
T 3is5_A          107 LLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH  182 (285)
T ss_dssp             HHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             HHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence            9998865421 1134899999999999999999999998   9999999999999   45678999999999865432  


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....++..|+|||.+. ..++.++||||||+++|||++|+.||......+......      .....   ..  ....+
T Consensus       183 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~~~---~~--~~~~~  250 (285)
T 3is5_A          183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YKEPN---YA--VECRP  250 (285)
T ss_dssp             ----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCCC---CC--C--CC
T ss_pred             CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cCCcc---cc--cccCc
Confidence            23446788899999986 468899999999999999999999997654332221111      01000   00  00001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          ...++.+++.+|++.||++|||+.|+++
T Consensus       251 ----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          251 ----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1235667888999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=337.91  Aligned_cols=239  Identities=17%  Similarity=0.335  Sum_probs=188.2

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCC--CceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRH--ENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++...+++.||||++.......   +.+.+|++++.+++|  |||+++++++...+..++||| +.++
T Consensus        15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~   93 (343)
T 3dbq_A           15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI   93 (343)
T ss_dssp             EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred             EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCC
Confidence            5799999999999998889999999997654332   568899999999976  999999999999999999999 5678


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++......   
T Consensus        94 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           94 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             EHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            9999998643     4899999999999999999999998   99999999999997 6789999999998764322   


Q ss_pred             --cccccCCCcCCccccCC-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          482 --PVIARAAGYRAPEVTDS-----------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                        ....||..|+|||++.+           ..++.++|||||||++|||++|+.||......     .............
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~  239 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE  239 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSC
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcCCcc
Confidence              23468999999999854           67889999999999999999999999753321     1111111111110


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .        ..+  .....++.+++..||+.||.+|||+.|+++.
T Consensus       240 ~--------~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          240 I--------EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             C--------CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c--------CCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            0        001  1112356778889999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.3e-39  Score=353.60  Aligned_cols=242  Identities=23%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ++||+|+||+||+|... +|+.||+|++....    .....+.+|++++.+++|||||++++++.+.+..++||||+++|
T Consensus       190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg  269 (576)
T 2acx_A          190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG  269 (576)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence            56999999999999965 69999999997532    23456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +|.+++....   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       270 ~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~  343 (576)
T 2acx_A          270 DLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  343 (576)
T ss_dssp             BHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred             cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence            9999987543   224899999999999999999999998   999999999999999999999999999876533  23


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVH-LVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......... ....+.    ... .        ..+ 
T Consensus       344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~~-~--------~~p-  409 (576)
T 2acx_A          344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVP-E--------EYS-  409 (576)
T ss_dssp             CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HCC-C--------CCC-
T ss_pred             ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----ccc-c--------cCC-
Confidence            4578999999999999899999999999999999999999998754322211 111111    110 0        000 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                       .....++.+++.+|+..||.+||     +++|+++
T Consensus       410 -~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          410 -ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             11123567778899999999999     6788864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.5e-39  Score=329.39  Aligned_cols=248  Identities=20%  Similarity=0.270  Sum_probs=190.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            4699999999999994 4799999999976533 356789999999885 799999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEeccccccccccc---
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTTITSAL---  480 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~---  480 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+++.....   
T Consensus        99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            99997653     4899999999999999999999998   999999999999998876   999999998765321   


Q ss_pred             -------ccccccCCCcCCccccCC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHH
Q 006922          481 -------APVIARAAGYRAPEVTDS-----RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWVH  540 (625)
Q Consensus       481 -------~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--------~~~~~~~  540 (625)
                             .....+|..|+|||++..     ..++.++|||||||++|||++|+.||......+..        .....+.
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                   112347888999999864     45789999999999999999999999765432200        0000011


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..+..... ..-+...      .....++.+++.+|++.||++|||+.|+++
T Consensus       251 ~~i~~~~~-~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          251 ESIQEGKY-EFPDKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHCCC-CCCHHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhccCc-ccCchhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111100 0000000      011245778888999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.7e-39  Score=334.82  Aligned_cols=256  Identities=19%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             hHcccCCceeEEEEEE--cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc------eecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL--EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN------VVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|..  .+++.||||+++......+.+.+|++++..++|++      ++++++++...+..++||||+
T Consensus        20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   99 (339)
T 1z57_A           20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL   99 (339)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC
Confidence            5699999999999985  36899999999865444567889999999887664      999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------------------
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-------------------  462 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-------------------  462 (625)
                       +++|.+++....   ..++++..+..++.|+++||+|||+.+   |+||||||+|||++.                   
T Consensus       100 -~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A          100 -GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             -CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             -CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence             889999987643   235889999999999999999999998   999999999999987                   


Q ss_pred             CCCeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 006922          463 QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       463 ~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                      ++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+......
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  252 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP  252 (339)
T ss_dssp             CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCS
T ss_pred             CCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            66899999999988766556667899999999999999999999999999999999999999875544333322221110


Q ss_pred             hhccc-----cccccccc---------------------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          543 VREEW-----TAEVFDVE---------------------LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       543 ~~~~~-----~~~~~d~~---------------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....     ....+...                     ............++.+++.+||+.||.+|||+.|+++
T Consensus       253 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          253 LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            00000     00000000                     0001112234567889999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.8e-39  Score=331.17  Aligned_cols=256  Identities=21%  Similarity=0.357  Sum_probs=193.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||.||+|.. .+|+.||+|+++....    ..+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  116 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA  116 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence            35799999999999995 5799999999975322    235688999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      ++|.+++..... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......  
T Consensus       117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  192 (310)
T 2wqm_A          117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  192 (310)
T ss_dssp             CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence            999999875321 1234899999999999999999999998   9999999999999999999999999998764322  


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......+   .... ...     ..   
T Consensus       193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~---~~~~-~~~-----~~---  259 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI---EQCD-YPP-----LP---  259 (310)
T ss_dssp             ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHH---HTTC-SCC-----CC---
T ss_pred             ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHh---hccc-CCC-----Cc---
Confidence             2345788899999999999999999999999999999999999754322 11111111   1111 000     00   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                       ......++.+++.+||..||.+|||+.|+++.|+++.....
T Consensus       260 -~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          260 -SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence             01122357778889999999999999999999999976543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.8e-39  Score=329.29  Aligned_cols=252  Identities=18%  Similarity=0.278  Sum_probs=192.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +++.||+|++......    .+.+.+|++++.+++||||+++++++...+..++||||++++
T Consensus        40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  119 (309)
T 2h34_A           40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV  119 (309)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred             EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence            56999999999999964 6899999999765322    256889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......   
T Consensus       120 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          120 DLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            9999998643     4899999999999999999999998   9999999999999999999999999997664321   


Q ss_pred             -cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 -PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||......   ..    ...+.....    .... ..+
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~~~~~~~----~~~~-~~~  259 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM----GAHINQAIP----RPST-VRP  259 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH----HHHHHSCCC----CGGG-TST
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH----HHHhccCCC----Cccc-cCC
Confidence             2345788899999999999999999999999999999999999753221   11    111111110    0000 001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCCCCCC
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRP-KMPDVVRVIENVRPNDSEN  604 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~ev~~~L~~~~~~~~~~  604 (625)
                      .   ...++.+++.+||+.||++|| +++++++.|+.........
T Consensus       260 ~---~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          260 G---IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             T---CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             C---CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence            1   123566788899999999999 9999999999887766543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5e-39  Score=325.58  Aligned_cols=245  Identities=22%  Similarity=0.381  Sum_probs=197.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe----------------c
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS----------------K  391 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------------~  391 (625)
                      .+.||+|+||.||+|... +|+.||+|+++..   .+.+.+|++++.+++||||+++++++..                .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT   92 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECC---SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence            357999999999999975 7999999999754   2567899999999999999999999864                3


Q ss_pred             CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          392 DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       392 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      ...++||||+++|+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           93 KCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             ceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcc
Confidence            457899999999999999976432   24899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          472 GLTTITSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       472 Gla~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      |+++.....  .....++..|+|||.+.+..++.++||||||+++|||++|..|+...     .....   . .......
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~---~-~~~~~~~  237 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT---D-LRDGIIS  237 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH---H-HHTTCCC
T ss_pred             hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH---H-hhccccc
Confidence            999876432  23346788999999999999999999999999999999999887421     11111   1 1111110


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSEN  604 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~  604 (625)
                                ...   ..++.+++.+||..||.+|||+.|+++.|+.++.....+
T Consensus       238 ----------~~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          238 ----------DIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ----------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ----------ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                      111   124667888999999999999999999999998765443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7e-39  Score=339.92  Aligned_cols=238  Identities=17%  Similarity=0.319  Sum_probs=188.7

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCC--CCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIR--HENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++...+++.||||++......   .+.+.+|++++.+++  ||||+++++++...+..++||| +.++
T Consensus        62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~  140 (390)
T 2zmd_A           62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI  140 (390)
T ss_dssp             EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred             EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence            579999999999999878999999999765433   256889999999996  5999999999999999999999 6788


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++......   
T Consensus       141 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          141 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            9999997643     4889999999999999999999998   99999999999995 5899999999998764322   


Q ss_pred             --cccccCCCcCCccccCC-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          482 --PVIARAAGYRAPEVTDS-----------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                        ....||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ...+.........
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~~~~  286 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE  286 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCTTSC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCcccc
Confidence              23468899999999864           46889999999999999999999999754321     1112222211110


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                           ....  ...   ..++.+++.+||+.||.+|||+.|+++
T Consensus       287 -----~~~~--~~~---~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 -----IEFP--DIP---EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -----CCCC--CCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----CCCC--ccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                 0000  111   235677888999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=330.81  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=195.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  403 (625)
                      +.||+|+||.||++.. .+|+.||||++..... ..+.+.+|++++.+++||||+++++++..    ....++||||+++
T Consensus        35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~  114 (317)
T 2buj_A           35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR  114 (317)
T ss_dssp             EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred             EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence            6799999999999996 5799999999865432 34678899999999999999999999973    3467899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      |+|.+++..... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus       115 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~  190 (317)
T 2buj_A          115 GTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG  190 (317)
T ss_dssp             CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred             CcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence            999999976432 2235899999999999999999999998   9999999999999999999999999987653211  


Q ss_pred             ----------cccccCCCcCCccccCCCC---CCCccchhhhHHHHHHHHhCCCCCCCCC--CcchhhHHHHHHHHhhcc
Q 006922          482 ----------PVIARAAGYRAPEVTDSRK---ATQASDVYSFGVVLLEILTGKSPIHTTG--GDELVHLVRWVHSVVREE  546 (625)
Q Consensus       482 ----------~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~  546 (625)
                                ....++..|+|||.+.+..   ++.++||||||+++|||++|+.||....  .......   .    ...
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~----~~~  263 (317)
T 2buj_A          191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---V----QNQ  263 (317)
T ss_dssp             HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---H----HCC
T ss_pred             ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---h----hcc
Confidence                      1234688899999987654   6889999999999999999999995321  1111110   0    000


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       547 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                                ...+.......++.+++.+||+.||.+||++.|+++.|+.+...
T Consensus       264 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          264 ----------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             ----------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                      00111112234677888899999999999999999999998653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.3e-39  Score=334.36  Aligned_cols=251  Identities=21%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             hHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|..      .+++.||||++.....  ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (327)
T 2yfx_A           36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM  115 (327)
T ss_dssp             EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence            5699999999999983      3577899999975432  2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccc
Q 006922          402 SLGSVSAMLHSERGE--GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTI  476 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~  476 (625)
                      ++|+|.+++......  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.   +..+||+|||+++.
T Consensus       116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            999999999875421  1234899999999999999999999998   999999999999994   44699999999975


Q ss_pred             cccc-----ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          477 TSAL-----APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       477 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ....     .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+.   ...+.   ....   
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~---~~~~---  263 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVT---SGGR---  263 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH---TTCC---
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHh---cCCC---
Confidence            4322     122356778999999988889999999999999999999 9999976443222   22111   1110   


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                              ..........+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus       264 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          264 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                    001111234677888899999999999999999999988664

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.6e-39  Score=335.97  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=193.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEec--------CceEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSK--------DEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv  397 (625)
                      +.||+|+||+||+|.. .+|+.||+|++.....   ....+.+|++++.+++||||+++++++...        +..++|
T Consensus        23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv  102 (351)
T 3mi9_A           23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV  102 (351)
T ss_dssp             EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred             EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence            5799999999999996 5799999999865432   235788999999999999999999999873        467999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+++ +|.+.+.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          103 FDFCEH-DLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             EECCSE-EHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCC-CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            999986 77777765432    4899999999999999999999998   999999999999999999999999999865


Q ss_pred             ccc-------ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SAL-------APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~-------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ...       .....+|..|+|||++.+ ..++.++|||||||++|||+||+.||......+....+.............
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            421       123456888999998876 457999999999999999999999998755433333222221111111111


Q ss_pred             cccccccc--------CCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELL--------RYPNIEEE------MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~--------~~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+....        ......+.      ...+.+++.+|++.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11110000        00111111      234778899999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-39  Score=338.28  Aligned_cols=254  Identities=19%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||++... +|+.||+|+++....  ..+.+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus        39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  118 (360)
T 3eqc_A           39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL  118 (360)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence            56999999999999965 689999999976432  235688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEecccccccccc-ccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-LAPVI  484 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~~  484 (625)
                      .+++....     .+++..+..++.+++.||+|||+. +   |+||||||+|||++.++.+||+|||+++.... .....
T Consensus       119 ~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (360)
T 3eqc_A          119 DQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  190 (360)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence            99997653     389999999999999999999996 6   99999999999999999999999999976532 22345


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-hh---------ccc-------
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV-VR---------EEW-------  547 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~---------~~~-------  547 (625)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||......+........... ..         ...       
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence            7889999999999999999999999999999999999999765433322111000000 00         000       


Q ss_pred             ------ccccccc----cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          548 ------TAEVFDV----ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       548 ------~~~~~d~----~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                            ..+..+.    .....+ ......++.+++.+||+.||++|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCCCCCC-TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccchhhhhHHhccCCCCCC-cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  0000000    000000 0112335778888999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-39  Score=336.38  Aligned_cols=242  Identities=21%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||++... +|+.||+|+++...   ....+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            357999999999999965 68999999997643   2456788888887 799999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CCeeEeccccccccccc--
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ----QYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~~~~~~--  480 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.....  
T Consensus       104 ~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          104 LDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             HHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            99987543     4899999999999999999999998   9999999999998543    24999999999876432  


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....+|..|+|||++.+..++.++|||||||++|||++|+.||..............+..   ..     ++......
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~~-----~~~~~~~~  247 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---GK-----FSLSGGYW  247 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---CC-----CCCCSTTT
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---CC-----cccCcccc
Confidence             2334678899999999888899999999999999999999999986543333333322211   11     00000001


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +..   ..++.+++.+|+..||++||++.|+++
T Consensus       248 ~~~---s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          248 NSV---SDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             TTS---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            112   235667778999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-39  Score=332.93  Aligned_cols=253  Identities=27%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecC-ceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKD-EKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  398 (625)
                      .+.||+|+||+||+|..      .+++.||||+++.....  .+.+.+|++++.++ +||||+++++++...+ ..++||
T Consensus        32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~  111 (316)
T 2xir_A           32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  111 (316)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence            35799999999999984      34689999999865332  35688999999999 7999999999998755 589999


Q ss_pred             EeccCCChhhhhccccCCC-----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          399 DYYSLGSVSAMLHSERGEG-----------RIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                      ||+++|+|.+++.......           ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+|
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k  188 (316)
T 2xir_A          112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  188 (316)
T ss_dssp             ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence            9999999999998654210           123789999999999999999999998   99999999999999999999


Q ss_pred             Eecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 006922          468 VSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       468 l~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      |+|||+++......     ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+..  ...+. 
T Consensus       189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--~~~~~-  265 (316)
T 2xir_A          189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK-  265 (316)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--HHHHH-
T ss_pred             ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--HHHhc-
Confidence            99999998654321     22346678999999988899999999999999999999 99999765433221  11111 


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                         .....          +.......++.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus       266 ---~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          266 ---EGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             ---HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence               11000          00111223577888899999999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-38  Score=325.39  Aligned_cols=238  Identities=20%  Similarity=0.302  Sum_probs=195.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||++... +++.||+|++.....    ..+.+.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus        21 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  100 (294)
T 2rku_A           21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR  100 (294)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCC
Confidence            56999999999999965 588999999875432    2356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus       101 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A          101 SLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            9999887543     4899999999999999999999998   99999999999999999999999999987542   22


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....      ......            ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~------------~~  234 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEY------------SI  234 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTCC------------CC
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HhhccC------------CC
Confidence            334678889999999998999999999999999999999999976443222111      111100            00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .......+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            01112356778889999999999999999873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.9e-39  Score=328.60  Aligned_cols=238  Identities=19%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+++.||+|++....  ...+.+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  107 (303)
T 3a7i_A           28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA  107 (303)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence            5699999999999985 468999999997543  2347799999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      .+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   ...
T Consensus       108 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          108 LDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             HHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            9998642      4899999999999999999999998   999999999999999999999999999776432   223


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||......+..   ..+.    .....     ..     ..
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~~~~-----~~-----~~  241 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIP----KNNPP-----TL-----EG  241 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSCCC-----CC-----CS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhh----cCCCC-----CC-----cc
Confidence            46788899999999999999999999999999999999999764332211   1111    11100     00     01


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....+.+++.+||..+|.+|||+.|+++.
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            112356778889999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8e-39  Score=332.65  Aligned_cols=237  Identities=20%  Similarity=0.327  Sum_probs=195.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.++..++||||+++++++.+.+..++||||++++
T Consensus        47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  126 (335)
T 2owb_A           47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR  126 (335)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCC
Confidence            56999999999999965 588999999975432    2356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---A  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~  481 (625)
                      +|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   .
T Consensus       127 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          127 SLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            9999887543     3899999999999999999999998   999999999999999999999999999876422   2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....   +   .....       ..   + 
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~---~~~~~-------~~---~-  261 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---I---KKNEY-------SI---P-  261 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---H---HHTCC-------CC---C-
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---H---hcCCC-------CC---C-
Confidence            334678899999999998999999999999999999999999976443222111   1   11110       00   0 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ......+.+++.+||+.||++||++.|+++
T Consensus       262 -~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          262 -KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111235667888999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=335.71  Aligned_cols=260  Identities=17%  Similarity=0.279  Sum_probs=193.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|... +++.||+|+++.....  ...+.+|++++.+++||||+++++++...+..++||||++ |+|
T Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l   86 (324)
T 3mtl_A            8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   86 (324)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred             EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence            56999999999999965 7899999999754322  2345679999999999999999999999999999999998 488


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---PV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~~  483 (625)
                      .+++.....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   ..
T Consensus        87 ~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           87 KQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             HHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            888876432    4899999999999999999999998   9999999999999999999999999998654322   23


Q ss_pred             cccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---ccccccccccc----
Q 006922          484 IARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---EEWTAEVFDVE----  555 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~----  555 (625)
                      ..++..|+|||++.+ ..++.++||||+||++|||++|+.||......+....   +.....   ...+....+..    
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHhchhhhcchhhcc
Confidence            356888999999876 5689999999999999999999999977544332222   222111   11111111000    


Q ss_pred             --ccCC--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCCC
Q 006922          556 --LLRY--PN----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRPN  600 (625)
Q Consensus       556 --~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~~  600 (625)
                        ....  ..    ......++.+++.+|++.||++|||+.|+++  .+..+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence              0000  00    0011235678888999999999999999987  55665544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-38  Score=340.49  Aligned_cols=242  Identities=20%  Similarity=0.304  Sum_probs=184.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC---------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.||+|+||+||+|... +++.||||++.....         ....+.+|++++.+++||||+++++++.. +..++||
T Consensus       140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  218 (419)
T 3i6u_A          140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVL  218 (419)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEE
T ss_pred             EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEE
Confidence            356999999999999954 689999999975421         11358899999999999999999999754 5689999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDLGLTT  475 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~  475 (625)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++
T Consensus       219 e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          219 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             ECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence            9999999999887543     4899999999999999999999998   99999999999997554   59999999998


Q ss_pred             cccccc--cccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          476 ITSALA--PVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       476 ~~~~~~--~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ......  ....||..|+|||++.+   ..++.++|||||||++|||++|+.||.........  ...+.    ..... 
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~----~~~~~-  363 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SGKYN-  363 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHH----TTCCC-
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHh----cCCCC-
Confidence            765432  34568999999999853   57888999999999999999999999764432211  11111    11000 


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       +.+..     ......++.+++.+|++.||++|||+.|+++
T Consensus       364 -~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 -FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             00000     0011345778888999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.7e-39  Score=335.30  Aligned_cols=252  Identities=16%  Similarity=0.232  Sum_probs=186.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|.. .+++.||||+++.....   .+.+.+|++++.+++||||+++++++...+..++||||+++ +
T Consensus        40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~  118 (329)
T 3gbz_A           40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D  118 (329)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred             EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-C
Confidence            5799999999999995 47899999999754322   34578999999999999999999999999999999999985 9


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-----CCCCeeEeccccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-----SQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-----~~~~~kl~DfGla~~~~~~  480 (625)
                      |.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++     .++.+||+|||+++.....
T Consensus       119 L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          119 LKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             HHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            999987653     3899999999999999999999998   99999999999994     4455999999999876422


Q ss_pred             ---ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh--hcccccccc--
Q 006922          481 ---APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV--REEWTAEVF--  552 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--  552 (625)
                         .....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+..  .......-  .........  
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchhhhhhhhhh
Confidence               2234578889999998764 5899999999999999999999999764432221  11111110  000000000  


Q ss_pred             ---cccccC--CCCcHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 ---DVELLR--YPNIEE-----EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 ---d~~~~~--~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ......  ......     ...++.+++.+||+.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               000000  000011     1245678888999999999999999976

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-38  Score=320.40  Aligned_cols=241  Identities=21%  Similarity=0.326  Sum_probs=194.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .+.||+|+||+||+|... +++.||+|++.....  ..+.+.+|++++..++||||+++++++.+.+..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            357999999999999965 689999999975432  23678999999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----  480 (625)
                      |.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999987532     4899999999999999999999998   999999999999999999999999999765321     


Q ss_pred             ccccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 APVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .....++..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+..    ...   .       .
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~---~-------~  228 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---Y-------L  228 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----TCT---T-------S
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----ccc---c-------c
Confidence            223467888999999987665 7799999999999999999999976543221 1111111    000   0       0


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +........+.+++.+|++.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            011112235677888999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-39  Score=328.55  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=195.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||++... +|+.||+|++......   .+.+.+|++++.+++||||+++++++..  .+..++||||+++
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   91 (279)
T 2w5a_A           12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   91 (279)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred             hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence            56999999999999965 6899999999765433   3568899999999999999999998864  5678999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|.+++..... ....+++..+..++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        92 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~  170 (279)
T 2w5a_A           92 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  170 (279)
T ss_dssp             EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred             CCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence            999999976432 2234899999999999999999999986  2349999999999999999999999999998765332


Q ss_pred             ---cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 ---PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                         ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.   ...+    ..+....        
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i----~~~~~~~--------  235 (279)
T 2w5a_A          171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKI----REGKFRR--------  235 (279)
T ss_dssp             HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCCCC--------
T ss_pred             ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHH----hhccccc--------
Confidence               234678899999999988999999999999999999999999976543222   1111    1111100        


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN  596 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~  596 (625)
                      .  ......++.+++.+||+.||++||++.|+++.+..
T Consensus       236 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          236 I--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             C--CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            0  11122456778889999999999999999986643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=334.75  Aligned_cols=258  Identities=19%  Similarity=0.313  Sum_probs=190.7

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|...+  .||+|+++....   ..+.+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus        39 ~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L  116 (319)
T 2y4i_B           39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL  116 (319)
T ss_dssp             CBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred             eEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence            569999999999998753  499999975432   235678899999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc-------
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-------  479 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-------  479 (625)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ ++.+||+|||+++....       
T Consensus       117 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          117 YSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             HHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            99997643    24889999999999999999999998   99999999999998 68999999999875431       


Q ss_pred             -cccccccCCCcCCccccCC---------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          480 -LAPVIARAAGYRAPEVTDS---------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       480 -~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                       ......++..|+|||.+..         ..++.++||||||+++|||++|+.||......+...   .+    ......
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~----~~~~~~  261 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW---QM----GTGMKP  261 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH---HH----HTTCCC
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---Hh----ccCCCC
Confidence             1122347788999999864         457889999999999999999999997654322211   11    111100


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSE  613 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~~  613 (625)
                           .... .   ....++.+++.+||..+|++|||+.|+++.|+.+.........+...|..
T Consensus       262 -----~~~~-~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~  316 (319)
T 2y4i_B          262 -----NLSQ-I---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS  316 (319)
T ss_dssp             -----CCCC-S---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred             -----CCCc-C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence                 0000 0   01125677888999999999999999999999998876655444444443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.9e-39  Score=324.12  Aligned_cols=242  Identities=19%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +++.||+|++....    ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus        20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   99 (284)
T 2vgo_A           20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG   99 (284)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence            56999999999999965 68899999996532    22467899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-ccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-APV  483 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~~  483 (625)
                      +|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++...... ...
T Consensus       100 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (284)
T 2vgo_A          100 ELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT  171 (284)
T ss_dssp             EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence            9999997653     3899999999999999999999998   999999999999999999999999998765432 233


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||......+...      ......       ...  .+.  
T Consensus       172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~-------~~~--~~~--  234 (284)
T 2vgo_A          172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVNVD-------LKF--PPF--  234 (284)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTC-------CCC--CTT--
T ss_pred             ccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhccc-------cCC--CCc--
Confidence            467888999999999999999999999999999999999997644322211      111110       000  011  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENV  597 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~  597 (625)
                       ...++.+++.+|++.||.+||++.|+++  .++..
T Consensus       235 -~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          235 -LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             -SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence             1235677888999999999999999986  44443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=333.00  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=198.5

Q ss_pred             HhHcccCCceeEEEEEE-----cCCcEEEEEEeccccCC-hHHHHHHHHHHHcCCCCceecceeEEEecC--ceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVG-KRDFEQQMEIVGSIRHENVVELKAYYYSKD--EKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  400 (625)
                      .+.||+|+||.||++..     .+|+.||||++...... .+.+.+|++++.+++||||+++++++...+  ..++||||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  125 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY  125 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence            35799999999999983     36899999999865332 367899999999999999999999987654  68999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++.....    .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       126 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          126 LPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             CTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             CCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            999999999986532    4899999999999999999999998   999999999999999999999999999876433


Q ss_pred             cc------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHHhhc
Q 006922          481 AP------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD---------ELVHLVRWVHSVVRE  545 (625)
Q Consensus       481 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~~  545 (625)
                      ..      ...++..|+|||.+.+..++.++||||||+++|||+||+.|+......         ........+...+..
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            21      223455699999998888999999999999999999999998532100         000001111111111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          546 EWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       546 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ..          ..+.......++.+++.+||+.||++|||+.|+++.|++++.
T Consensus       279 ~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          279 NG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             TC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            10          011112233467788889999999999999999999998864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-39  Score=329.35  Aligned_cols=250  Identities=25%  Similarity=0.422  Sum_probs=189.1

Q ss_pred             hHcccCCceeEEEEEEc--CCc--EEEEEEeccccC----ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE--DGT--TVVVKRLKDVNV----GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|...  +++  .||+|+++....    ..+.+.+|++++.+++||||+++++++...+ .++||||+
T Consensus        24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~  102 (291)
T 1u46_A           24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA  102 (291)
T ss_dssp             EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred             eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence            56999999999999853  333  689999875422    2357889999999999999999999998754 88999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       103 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A          103 PLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             TTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             cCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            9999999997643    24899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...      .......       
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~-------  242 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGE-------  242 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCC-------
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccCC-------
Confidence                  12345667999999988889999999999999999999 999997654322221      1111110       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE  603 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~  603 (625)
                         ..+.......++.+++.+||..||++|||+.|+++.|+++.+....
T Consensus       243 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          243 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             ---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence               0111122234677888899999999999999999999998876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-39  Score=336.23  Aligned_cols=244  Identities=20%  Similarity=0.300  Sum_probs=193.9

Q ss_pred             HhHcccCCceeEEEEEE----cCCcEEEEEEecccc-----CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVN-----VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.||+|+||+||+++.    .+|+.||||+++...     ...+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            36799999999999996    368999999997532     2345678899999999 6999999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++|+|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999997643     3899999999999999999999998   9999999999999999999999999998653


Q ss_pred             cc----ccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          479 AL----APVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       479 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ..    .....||..|+|||++.+  ..++.++|||||||++|||++|+.||..........  ..........      
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~------  282 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKSE------  282 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHCC------
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhccC------
Confidence            22    223468999999999975  357899999999999999999999997644332221  1111111111      


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP-----KMPDVVRVI  594 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~~L  594 (625)
                            .+........+.+++.+||..||.+||     +++|+++..
T Consensus       283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  011111223567788899999999999     889987643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.8e-38  Score=329.43  Aligned_cols=255  Identities=21%  Similarity=0.331  Sum_probs=192.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||+|++......   .+.+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus        31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  110 (331)
T 4aaa_A           31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI  110 (331)
T ss_dssp             EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence            57999999999999965 5899999999765433   2457899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      |..++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ..
T Consensus       111 l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          111 LDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             HHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            988765432     3899999999999999999999998   999999999999999999999999999765432   22


Q ss_pred             ccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhh-cccccccc
Q 006922          483 VIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV--------HSVVR-EEWTAEVF  552 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~  552 (625)
                      ...++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...        ..... ........
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            34678889999998765 7899999999999999999999999765433222111100        00000 00001111


Q ss_pred             cccccCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.........    .....+.+++.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11111101000    12346778888999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-38  Score=335.94  Aligned_cols=256  Identities=18%  Similarity=0.247  Sum_probs=196.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC-----------CCceecceeEEEecC----c
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-----------HENVVELKAYYYSKD----E  393 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~----~  393 (625)
                      +.||+|+||+||+|.. .+++.||||++.......+.+.+|++++.+++           ||||+++++++...+    .
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  104 (373)
T 1q8y_A           25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH  104 (373)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred             EeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCce
Confidence            5699999999999995 57899999999865544567889999988876           899999999998654    6


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeC------CCCCe
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLN------SQQYG  466 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~------~~~~~  466 (625)
                      .++||||+ +++|.+++.....   ..+++..+..++.|++.||+|||++ +   |+||||||+|||++      ..+.+
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A          105 VVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             EEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             EEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceE
Confidence            89999999 8899999976432   2489999999999999999999998 7   99999999999994      44579


Q ss_pred             eEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH---HHHHh
Q 006922          467 CVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW---VHSVV  543 (625)
Q Consensus       467 kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~---~~~~~  543 (625)
                      ||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+||+.||..............   +....
T Consensus       178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (373)
T 1q8y_A          178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL  257 (373)
T ss_dssp             EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred             EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence            999999998876655566789999999999999999999999999999999999999986543221111111   11111


Q ss_pred             hcc---------cccccccc------------------cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          544 REE---------WTAEVFDV------------------ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       544 ~~~---------~~~~~~d~------------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..-         .....++.                  .............++.+++.+||+.||++|||+.|+++
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            000         00000000                  00111234556778889999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2e-38  Score=322.50  Aligned_cols=241  Identities=22%  Similarity=0.410  Sum_probs=191.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec----CceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK----DEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... ++..||+|++......   .+.+.+|++++.+++||||+++++++...    ...++||||+
T Consensus        32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  111 (290)
T 1t4h_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence            46999999999999964 6889999999865433   35688999999999999999999998763    4579999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~  480 (625)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ .++.+||+|||++......
T Consensus       112 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            9999999997643     3899999999999999999999874 3599999999999998 7899999999999765433


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....++..|+|||.+.+ .++.++||||+|+++|||++|+.||.......  ....   .. ........++    . 
T Consensus       186 ~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~---~~-~~~~~~~~~~----~-  253 (290)
T 1t4h_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR---RV-TSGVKPASFD----K-  253 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH---HH-TTTCCCGGGG----G-
T ss_pred             ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHH---HH-hccCCccccC----C-
Confidence             234568889999998874 58999999999999999999999997643221  1111   11 1111110000    0 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          ....++.+++..||+.||.+|||+.|+++
T Consensus       254 ----~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          254 ----VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                01135778888999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.7e-40  Score=344.50  Aligned_cols=245  Identities=10%  Similarity=0.018  Sum_probs=176.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC----hHHHHHHH---HHHHcCCCCceecce-------eEEEecC--
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG----KRDFEQQM---EIVGSIRHENVVELK-------AYYYSKD--  392 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~--  392 (625)
                      +.||+|+||+||+|... +|+.||||+++.....    .+.+.+|+   +++.. +||||++++       +++...+  
T Consensus        68 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSC
T ss_pred             eeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCC
Confidence            57999999999999954 7899999999875432    24567774   45555 799977754       5554332  


Q ss_pred             ---------------ceEEEEEeccCCChhhhhccccCCCCccCCHHHH------HHHHHHHHHHHHHHHhcCCCCceec
Q 006922          393 ---------------EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTR------MRIAIGAARGIARIHAANGGKLVHG  451 (625)
Q Consensus       393 ---------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ivHr  451 (625)
                                     ..++||||++ |+|.+++.....    .+.+..+      ..++.|+++||+|||+++   |+||
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr  218 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG  218 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence                           3799999999 899999986522    2445555      778899999999999998   9999


Q ss_pred             CCCCCCEEeCCCCCeeEecccccccccccccccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 006922          452 NIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIHTTGG  529 (625)
Q Consensus       452 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~  529 (625)
                      ||||+|||++.++.+||+|||+++..........++..|+|||++.+  ..++.++|||||||++|||+||+.||.....
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            99999999999999999999999987655544566788999999987  6799999999999999999999999986543


Q ss_pred             cchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          530 DELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......        ............ ...+........+.+++.+||+.||++|||+.|+++
T Consensus       299 ~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          299 GIKGSW--------KRPSLRVPGTDS-LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TCTTCC--------CBCCTTSCCCCS-CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccccch--------hhhhhhhccccc-cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            211100        000000000000 001111122346677888999999999999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-38  Score=329.55  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=194.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||+|+++....   ....+.+|+.++.+++ ||||+++++++...+..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            67999999999999965 699999999986432   2467899999999994 699999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEecccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~  481 (625)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++......
T Consensus       115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            9999986532   234899999999999999999999998   999999999999998   7899999999998765332


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                        ....++..|+|||++.+..++.++||||||+++|||++|+.||......+....+.   ..   .     .+...   
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~---~-----~~~~~---  254 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QV---N-----VDYSE---  254 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HT---C-----CCCCT---
T ss_pred             ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hc---c-----cccCc---
Confidence              23468889999999999999999999999999999999999997654332221111   10   0     00000   


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +........+.+++.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111122345677888999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-38  Score=348.59  Aligned_cols=239  Identities=19%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      ++||+|+||+||+++.. +|+.||+|+++...    .....+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            46999999999999965 69999999997542    23356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|..++..... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus       271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  346 (543)
T 3c4z_A          271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT  346 (543)
T ss_dssp             BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred             CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence            99999876432 2335899999999999999999999998   9999999999999999999999999998764332   


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDEL-VHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.+   ......         . ..+
T Consensus       347 ~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~---------~-~~p  413 (543)
T 3c4z_A          347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA---------V-TYP  413 (543)
T ss_dssp             CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCC---------C-CCC
T ss_pred             ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhcc---------c-CCC
Confidence            234789999999999999999999999999999999999999986543211 11111   111110         0 011


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKM  587 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~  587 (625)
                        ......+.+++.+|++.||.+||++
T Consensus       414 --~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          414 --DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --cccCHHHHHHHHHhccCCHhHCCCC
Confidence              1122356677889999999999976

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-39  Score=338.26  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=175.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec------CceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||||++......   .+.+.+|++++..++||||+++++++...      ...++|+|
T Consensus        35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e  114 (367)
T 2fst_X           35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  114 (367)
T ss_dssp             EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred             eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence            5799999999999995 46899999999764332   35678999999999999999999999754      56799999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       115 ~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          115 LM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             cc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            98 67998888642      3899999999999999999999998   99999999999999999999999999988765


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccccccccc-
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVFDV-  554 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~-  554 (625)
                      ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+   ......   +....+... 
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHTTCCCHH
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHHHhhhHH
Confidence            5555678999999999876 67899999999999999999999999765432222111   111110   000000000 


Q ss_pred             ------cccCCC--CcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ------ELLRYP--NIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ------~~~~~~--~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                            .+...+  ...    .....+.+++.+|+..||.+|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  000000  000    11235678888999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-38  Score=324.61  Aligned_cols=242  Identities=20%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||++... +|+.||+|+++.... ..+.+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL   93 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence            357999999999999964 799999999986532 345688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEeccccccccccc-cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSAL-AP  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~-~~  482 (625)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++..... ..
T Consensus        94 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  165 (304)
T 2jam_A           94 FDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS  165 (304)
T ss_dssp             HHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence            99987543     3899999999999999999999998   9999999999999   78899999999999765432 22


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|+.||......+..   ..+.    ....    ...   .+..
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~----~~~~----~~~---~~~~  231 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---EKIK----EGYY----EFE---SPFW  231 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HCCC----CCC---TTTT
T ss_pred             cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCC----CCC---cccc
Confidence            345888999999999999999999999999999999999999765432221   1111    1100    000   0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+|+..||++|||+.|+++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          232 DDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            112345677888999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=326.31  Aligned_cols=241  Identities=22%  Similarity=0.371  Sum_probs=193.1

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  112 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS  112 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence            357999999999999965 58999999997643 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   ....
T Consensus       113 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          113 DIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             HHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence            9987432    24899999999999999999999998   999999999999999999999999999766432   2234


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||......+..   ...    ........        .....
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~~~~~~~--------~~~~~  250 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---FMI----PTNPPPTF--------RKPEL  250 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH----HHSCCCCC--------SSGGG
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH----hcCCCccc--------CCccc
Confidence            6788899999999989999999999999999999999999764322111   111    11110000        01111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+.+++.+||..||.+|||+.|+++
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            2346778888999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-38  Score=319.93  Aligned_cols=237  Identities=22%  Similarity=0.309  Sum_probs=188.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||+|... +|+.||+|++....    ...+.+.+|++++..++||||+++++++...+..++||||++++
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   96 (276)
T 2h6d_A           17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG   96 (276)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence            56999999999999965 79999999997532    22457889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  .
T Consensus        97 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           97 ELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             cHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence            9999997643     3899999999999999999999998   9999999999999999999999999998765332  2


Q ss_pred             ccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          483 VIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ...++..|+|||.+.+..+ +.++||||||+++|||++|+.||......+.   .+.+.    ....         ..+ 
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----~~~~---------~~~-  231 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR----GGVF---------YIP-  231 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCC---------CCC-
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh----cCcc---------cCc-
Confidence            3457888999999987765 6899999999999999999999975432221   11111    1100         001 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ......+.+++.+|++.||.+|||+.|+++
T Consensus       232 -~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          232 -EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence             111235677888999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-38  Score=359.95  Aligned_cols=238  Identities=20%  Similarity=0.300  Sum_probs=195.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccc----cCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDV----NVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||+|+||+||+|... +++.||||+++..    ....+.+..|.+++..+ +||+|+.+++++.+.+..++||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            357999999999999964 6889999999753    22345678899999988 79999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc---c
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS---A  479 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~---~  479 (625)
                      +|+|..++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++++||+|||+++...   .
T Consensus       426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            999999998653     3899999999999999999999998   9999999999999999999999999998642   2


Q ss_pred             cccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          480 LAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+      ....         . ..
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~---------~-~~  561 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEHN---------V-AY  561 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSSC---------C-CC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhCC---------C-CC
Confidence            233457899999999999999999999999999999999999999865433322211      1111         0 01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKM-----PDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~ev~~  592 (625)
                        ......++.+++..||+.||++||++     +||++
T Consensus       562 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          562 --PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              11123456778889999999999998     66653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-39  Score=333.61  Aligned_cols=254  Identities=17%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCC------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+.||+|+||+||+|... +|+.||||+++.....      .+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   94 (346)
T 1ua2_A           15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   94 (346)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence            357999999999999964 6899999999753221      246889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      ++ +|..++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 ~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           95 ET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             SE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             CC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            86 8888886542    24888899999999999999999998   999999999999999999999999999876432 


Q ss_pred             --ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---ccccccc--
Q 006922          481 --APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVF--  552 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--  552 (625)
                        .....+|..|+|||.+.+ ..++.++|||||||++|||++|.+||......+..   ..+......   ..+....  
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhhhhhhccC
Confidence              233467889999999865 45899999999999999999999999765432221   111111111   0001000  


Q ss_pred             -ccc-ccCCCC-c-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          553 -DVE-LLRYPN-I-----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       553 -d~~-~~~~~~-~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                       +.. ....+. .     .....++.+++.+|+..||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             000 000000 0     1112467788889999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=324.12  Aligned_cols=243  Identities=22%  Similarity=0.376  Sum_probs=193.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+||+|+||+||+|.. .+++.||+|++..... ..+.+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            3699999999999995 4689999999976533 3467899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccccc---ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      +++.....  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.+||+|||+++.....   ...
T Consensus       108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            99976532  234678999999999999999999998   999999999999987 899999999999876432   233


Q ss_pred             cccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          484 IARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ..++..|+|||.+.+.  .++.++||||||+++|||++|+.||......... ...   .....      ..+..     
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~---~~~~~------~~~~~-----  247 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK---VGMFK------VHPEI-----  247 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH---HHHHC------CCCCC-----
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh---hcccc------ccccc-----
Confidence            4678889999998654  3789999999999999999999999754322111 111   00000      00000     


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+||+.||++||++.|+++
T Consensus       248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112235677888999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-38  Score=336.14  Aligned_cols=195  Identities=19%  Similarity=0.283  Sum_probs=166.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCC-CC-----ceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HE-----NVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +++.||||+++........+..|++++..++ |+     +|+++++++...+..++||||++
T Consensus        60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  139 (382)
T 2vx3_A           60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS  139 (382)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC
Confidence            57999999999999954 6889999999865444466778888888774 44     49999999999999999999996


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCCeeEeccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN--SQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~  480 (625)
                       |+|.+++.....   ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++.+||+|||+++.....
T Consensus       140 -~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~  214 (382)
T 2vx3_A          140 -YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR  214 (382)
T ss_dssp             -CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             -CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence             499999876532   2489999999999999999999952 12399999999999995  4778999999999887665


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGG  529 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~  529 (625)
                      .....+|..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            5666789999999999999999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-38  Score=346.18  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=197.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccc---cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDV---NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||++... +|+.||||++...   ......+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  106 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence            467999999999999964 7899999999643   234567899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCCeeEeccccccccccc-
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN---SQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~-  480 (625)
                      +|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||+++..... 
T Consensus       107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            9999887643     3899999999999999999999998   99999999999995   4567999999999876433 


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....||+.|+|||++.+ .++.++||||+||++|||++|+.||......+....+   .   .....     ...   
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~---~~~~~-----~~~---  243 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---E---TGKYA-----FDL---  243 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HTCCC-----SCS---
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---hCCCC-----CCC---
Confidence             233468889999999876 5899999999999999999999999765433322211   1   11100     000   


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                      +.......++.+++.+||+.||.+|||+.|+++.  ++..
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            1111122356778889999999999999999973  4443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.2e-38  Score=331.97  Aligned_cols=241  Identities=19%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---------hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---------KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      +.||+|+||+||+|... +|+.||||+++.....         .+.+.+|++++.++ +||||+++++++......++||
T Consensus       100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  179 (365)
T 2y7j_A          100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF  179 (365)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence            57999999999999975 7999999999754311         24578899999999 7999999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       180 e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          180 DLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999997543     4899999999999999999999998   9999999999999999999999999998765


Q ss_pred             cc--ccccccCCCcCCccccC------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          479 AL--APVIARAAGYRAPEVTD------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       479 ~~--~~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ..  .....||..|+|||++.      ...++.++|||||||++|||++|+.||......+   ....+.   .... . 
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~---~~~~-~-  323 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMIM---EGQY-Q-  323 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HTCC-C-
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hCCC-C-
Confidence            32  23456888999999885      3358899999999999999999999997643221   111111   1100 0 


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+..   .   .....+.+++.+|++.||++|||+.|+++
T Consensus       324 ~~~~~~---~---~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          324 FSSPEW---D---DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCHHHH---S---SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCccc---c---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000000   0   11235778888999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.9e-38  Score=332.14  Aligned_cols=252  Identities=18%  Similarity=0.255  Sum_probs=184.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||+|... +++.||||++......   .+.+.+|++++..++||||+++++++...+      ..++|||
T Consensus        31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e  110 (371)
T 2xrw_A           31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME  110 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred             eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence            56999999999999954 6899999999764332   256789999999999999999999997665      6799999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++ +|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       111 ~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          111 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            9985 77777752       2889999999999999999999998   99999999999999999999999999987643


Q ss_pred             c--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH----------------HHHH
Q 006922          480 L--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR----------------WVHS  541 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~----------------~~~~  541 (625)
                      .  .....+|..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.                .+..
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            2  233468889999999999999999999999999999999999997654322111100                0000


Q ss_pred             Hhhcccc------cccccccccCCC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWT------AEVFDVELLRYP--NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~------~~~~d~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......      ...+........  .......++.+++.+|+..||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            0000000      000000000000  01122456888999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-38  Score=343.97  Aligned_cols=181  Identities=22%  Similarity=0.341  Sum_probs=145.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  400 (625)
                      +.||+|+||+||+|... +|+.||||++......   .+.+.+|++++.+++|||||++++++...     +..++||||
T Consensus        59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  138 (458)
T 3rp9_A           59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI  138 (458)
T ss_dssp             CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred             eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence            57999999999999854 7899999999764333   35688999999999999999999999543     568999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +. ++|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       139 ~~-~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          139 AD-SDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             cc-cchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            85 68988887542     4899999999999999999999998   999999999999999999999999999875321


Q ss_pred             ------------------------------ccccccCCCcCCcccc-CCCCCCCccchhhhHHHHHHHHh
Q 006922          481 ------------------------------APVIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILT  519 (625)
Q Consensus       481 ------------------------------~~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvil~ellt  519 (625)
                                                    .....+|..|+|||++ ....++.++|||||||++|||+|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence                                          1234578889999976 56679999999999999999999

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=334.32  Aligned_cols=248  Identities=20%  Similarity=0.355  Sum_probs=180.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCC-CCceecceeEEEe--------cCceEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIR-HENVVELKAYYYS--------KDEKLMVY  398 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~~~~~lv~  398 (625)
                      +.||+|+||+||+|.. .+|+.||||++..... ..+.+.+|+.++.++. ||||+++++++..        ....++||
T Consensus        34 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~  113 (337)
T 3ll6_A           34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT  113 (337)
T ss_dssp             EEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEE
T ss_pred             EEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEE
Confidence            5799999999999995 4789999999865432 2356889999999996 9999999999953        33478999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+. |+|.+++.....  ...+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  189 (337)
T 3ll6_A          114 ELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS  189 (337)
T ss_dssp             ECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred             EecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence            9996 699988875432  224899999999999999999999874 349999999999999999999999999998764


Q ss_pred             cccc---------------ccccCCCcCCcccc---CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 006922          479 ALAP---------------VIARAAGYRAPEVT---DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       479 ~~~~---------------~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ....               ...++..|+|||++   .+..++.++|||||||++|||++|+.||......+..      .
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~  263 (337)
T 3ll6_A          190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------N  263 (337)
T ss_dssp             SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------c
Confidence            3211               23478889999998   5667899999999999999999999999653321110      0


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      .    .     ..     .+........+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus       264 ~----~-----~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          264 G----K-----YS-----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -----------CC-----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             C----c-----cc-----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            0    0     00     0000111124667888999999999999999999999886643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.9e-38  Score=325.77  Aligned_cols=248  Identities=18%  Similarity=0.258  Sum_probs=191.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEe--cCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYS--KDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|.. .+++.||||+++..  ..+.+.+|++++.+++ ||||+++++++..  ....++||||+++++
T Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~  119 (330)
T 3nsz_A           42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD  119 (330)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCC
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchh
Confidence            5799999999999985 57899999999753  3578999999999997 9999999999988  567899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccc--cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~--~~  482 (625)
                      |.+++..        +++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.....  ..
T Consensus       120 l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          120 FKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             HHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred             HHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence            9998853        788999999999999999999998   99999999999999777 8999999999876432  23


Q ss_pred             ccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc-------cc
Q 006922          483 VIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF-------DV  554 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------d~  554 (625)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+... ..........+..       ++
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRI-AKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHH-HHHHCHHHHHHHHHHTTCCCCT
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHH-HHhcCCchhhhHHHHhcccccc
Confidence            3467788999999876 67899999999999999999999999654322 1111111 1111000000000       00


Q ss_pred             ---------------cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ---------------ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ---------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                                     .............++.+++.+|++.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           00000111112346778888999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=339.30  Aligned_cols=259  Identities=18%  Similarity=0.298  Sum_probs=180.2

Q ss_pred             HhHcccCCceeEEEEEEc---CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE---DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  403 (625)
                      .++||+|+||+||+|...   +++.||||++..... ...+.+|++++.+++||||+++++++..  ....++||||+++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~  104 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH  104 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence            457999999999999965   578999999976433 3578899999999999999999999965  5678999999975


Q ss_pred             CChhhhhccccC----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCCeeEecccccc
Q 006922          404 GSVSAMLHSERG----EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL----NSQQYGCVSDLGLTT  475 (625)
Q Consensus       404 g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla~  475 (625)
                       +|.+++.....    .....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus       105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence             77777753321    11224899999999999999999999998   9999999999999    677899999999998


Q ss_pred             ccccc------ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcc------hhhHHHHHHHH
Q 006922          476 ITSAL------APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDE------LVHLVRWVHSV  542 (625)
Q Consensus       476 ~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~------~~~~~~~~~~~  542 (625)
                      .....      .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.....+.      ....+..+...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~  260 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  260 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence            76432      223567889999999877 458999999999999999999999997654321      01111111111


Q ss_pred             hhc---cccccccc------------ccccCCCCcHH--------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          543 VRE---EWTAEVFD------------VELLRYPNIEE--------EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       543 ~~~---~~~~~~~d------------~~~~~~~~~~~--------~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +..   ..+..+..            ...........        ...++.+++.+||..||.+|||+.|+++
T Consensus       261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            110   00000000            00000000000        0235678888999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=331.80  Aligned_cols=252  Identities=20%  Similarity=0.276  Sum_probs=188.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCc------eEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDE------KLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e  399 (625)
                      +.||+|+||+||+|... +|+.||||++......   .+.+.+|+.++.+++||||+++++++...+.      .++|||
T Consensus        30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  109 (353)
T 3coi_A           30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP  109 (353)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred             eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence            56999999999999964 6999999999765333   2568899999999999999999999987654      499999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |++ ++|.+++..       .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          110 FMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             ccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            998 588877742       2899999999999999999999998   99999999999999999999999999987765


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc----
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV----  554 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~----  554 (625)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.........++...+.+.    
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence            5555678899999999876 67899999999999999999999999865432222111100000000000000000    


Q ss_pred             ------c--ccCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ------E--LLRY-PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ------~--~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                            .  .... ........++.+++.+|+..||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0  0000 001122346777888999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-38  Score=345.07  Aligned_cols=241  Identities=19%  Similarity=0.310  Sum_probs=190.9

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||+|... ++..||+|+++...   .....+.+|++++..++||||++++++|.+.+..++||||+++|
T Consensus        42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  121 (494)
T 3lij_A           42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG  121 (494)
T ss_dssp             EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            367999999999999965 68999999997643   23467899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEeccccccccccc-
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~-  480 (625)
                      +|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++..   +.+||+|||+++..... 
T Consensus       122 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          122 ELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            9999887543     3899999999999999999999998   9999999999999764   45999999999876532 


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....||+.|+|||++. ..++.++||||+||++|||++|+.||......+....+.      ....  ....+.   .
T Consensus       194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~--~~~~~~---~  261 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------KGKY--TFDSPE---W  261 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCC--CCCSGG---G
T ss_pred             cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC--CCCchh---c
Confidence             23456899999999986 469999999999999999999999997654433222211      1110  000000   1


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.   ...++.+++.+||+.+|.+|||+.|+++
T Consensus       262 ~~---~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 KN---VSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cc---CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11   1235667788999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-38  Score=346.42  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc--------------CChHHHHHHHHHHHcCCCCceecceeEEEecCce
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--------------VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEK  394 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  394 (625)
                      +.||+|+||+||+|... +++.||+|+++...              ...+.+.+|++++.+++||||+++++++.+.+..
T Consensus        42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  121 (504)
T 3q5i_A           42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF  121 (504)
T ss_dssp             EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            57999999999999965 68899999997543              2235688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---CeeEecc
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ---YGCVSDL  471 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~Df  471 (625)
                      ++||||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+||
T Consensus       122 ~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          122 YLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999887643     3899999999999999999999998   99999999999998876   6999999


Q ss_pred             ccccccccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          472 GLTTITSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       472 Gla~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      |+++.....  .....||+.|+|||++.+ .++.++||||+||++|||++|+.||......+....+.      ....  
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~--  264 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE------KGKY--  264 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC--
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCCC--
Confidence            999876543  234568899999999874 69999999999999999999999998654433222221      1110  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                       .++..  ..+.   ...++.+++.+|+..||.+|||+.|+++  .+++..
T Consensus       265 -~~~~~--~~~~---~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          265 -YFDFN--DWKN---ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             -CCCHH--HHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             -CCCcc--ccCC---CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence             00000  0011   1235677888999999999999999986  344443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.6e-38  Score=347.31  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||++... +|+.||||++....    ...+.+.+|++++.+++||||+++++++...+..++||||+.+
T Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  110 (484)
T 3nyv_A           31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG  110 (484)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            357999999999999965 79999999996542    2356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCCeeEeccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL---NSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.....
T Consensus       111 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          111 GELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99999887543     3899999999999999999999998   9999999999999   56789999999999876543


Q ss_pred             c--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 A--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      .  ....||+.|+|||++.+ .++.++||||+||++|||++|+.||......+...   .+.   .....     ...  
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~---~~~~~-----~~~--  248 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK---KVE---KGKYT-----FEL--  248 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH---HCCCC-----CCS--
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH---cCCCC-----CCC--
Confidence            2  33468899999999876 68999999999999999999999997654332222   111   11100     000  


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVR  598 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~  598 (625)
                       +.......++.+++.+||+.+|.+|||+.|+++  .++...
T Consensus       249 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          249 -PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             -GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence             111122345677888999999999999999986  444443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-38  Score=334.19  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=188.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCce------EEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEK------LMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lv~e  399 (625)
                      +.||+|+||+||+|... +|+.||||+++.....   .+.+.+|++++..++||||+++++++...+..      ++|||
T Consensus        48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e  127 (371)
T 4exu_A           48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP  127 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence            56999999999999954 6899999999865433   35688999999999999999999999877654      99999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+. ++|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       128 ~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          128 FMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             ccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            998 588777742       2899999999999999999999998   99999999999999999999999999988766


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc-----
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD-----  553 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  553 (625)
                      ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+....+.+     
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 4exu_A          197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  276 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred             CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence            6566678999999999877 7889999999999999999999999976543222211110000000000000000     


Q ss_pred             --ccccCCC--Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 --VELLRYP--NI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 --~~~~~~~--~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ......+  ..    .....++.+++.+|++.||++|||+.|+++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              0000000  00    011346778888999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-38  Score=324.74  Aligned_cols=241  Identities=18%  Similarity=0.315  Sum_probs=190.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~  104 (302)
T 2j7t_A           25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD  104 (302)
T ss_dssp             EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred             ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence            56999999999999965 58999999997653 33577899999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---ccccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LAPVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~~~~  484 (625)
                      +++.....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....   .....
T Consensus       105 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (302)
T 2j7t_A          105 AIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF  177 (302)
T ss_dssp             HHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred             HHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence            98875432    3899999999999999999999998   99999999999999999999999999764321   12234


Q ss_pred             ccCCCcCCcccc-----CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          485 ARAAGYRAPEVT-----DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       485 ~~~~~y~aPE~~-----~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .++..|+|||++     ....++.++||||||+++|||++|+.||......+..      ........ ...        
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~-~~~--------  242 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSDP-PTL--------  242 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC-CCC--------
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccCC-ccc--------
Confidence            678889999988     4667899999999999999999999999765432211      11111111 000        


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ........++.+++.+||..||.+|||+.|+++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            011112345778888999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-38  Score=332.14  Aligned_cols=256  Identities=19%  Similarity=0.280  Sum_probs=197.8

Q ss_pred             hHcccCCceeEEEEEEc-CC-cEEEEEEeccccCChHHHHHHHHHHHcCCCCc------eecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DG-TTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN------VVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... ++ +.||+|+++......+.+.+|++++.+++|++      ++.+.+++...+..++||||+
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (355)
T 2eu9_A           25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL  104 (355)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC
T ss_pred             EEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc
Confidence            56999999999999964 34 78999999865444567889999999987766      899999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-------------------CC
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFL-------------------NS  462 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll-------------------~~  462 (625)
                       ++++.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+                   +.
T Consensus       105 -~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          105 -GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             -CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             -CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccC
Confidence             567777766543   124899999999999999999999998   9999999999999                   56


Q ss_pred             CCCeeEecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 006922          463 QQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV  542 (625)
Q Consensus       463 ~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  542 (625)
                      ++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+......
T Consensus       178 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP  257 (355)
T ss_dssp             CCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             CCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            78999999999988766656667899999999999999999999999999999999999999865443332222211110


Q ss_pred             hhcccc-----cccccc-cc--------------------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          543 VREEWT-----AEVFDV-EL--------------------LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       543 ~~~~~~-----~~~~d~-~~--------------------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......     ...+.. ..                    ...........++.+++.+||+.||++|||+.|+++
T Consensus       258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000     000000 00                    000112233457889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-38  Score=323.87  Aligned_cols=242  Identities=21%  Similarity=0.310  Sum_probs=188.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC---------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.||+|+||.||+|... +++.||||++.....         ....+.+|++++.+++||||+++++++...+ .++||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~   93 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL   93 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence            367999999999999964 689999999975421         1245889999999999999999999987654 89999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEecccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTT  475 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~  475 (625)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+++
T Consensus        94 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           94 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             ECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            9999999999887542     4899999999999999999999998   999999999999987665   9999999998


Q ss_pred             cccccc--cccccCCCcCCcccc---CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 006922          476 ITSALA--PVIARAAGYRAPEVT---DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE  550 (625)
Q Consensus       476 ~~~~~~--~~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (625)
                      ......  ....++..|+|||++   ....++.++|||||||++|||++|+.||........  ....+.    ..... 
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~----~~~~~-  238 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT----SGKYN-  238 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH----HTCCC-
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH----hCccc-
Confidence            765432  234688899999986   356789999999999999999999999976543321  111111    11000 


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ..+...     .....++.+++.+||..||++||++.|+++
T Consensus       239 -~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          239 -FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -cCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             000000     011246778888999999999999999984

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.8e-39  Score=326.91  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=178.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+++.||||++....  ...+.+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus        21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  100 (303)
T 2vwi_A           21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV  100 (303)
T ss_dssp             EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred             heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence            5799999999999984 478999999987542  2346788999999999999999999999999999999999999999


Q ss_pred             hhhhccccC---CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          407 SAMLHSERG---EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       407 ~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      .+++.....   .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  177 (303)
T 2vwi_A          101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI  177 (303)
T ss_dssp             HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred             HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence            999874211   11235899999999999999999999998   999999999999999999999999998765422   


Q ss_pred             -----ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc---ccc
Q 006922          481 -----APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT---AEV  551 (625)
Q Consensus       481 -----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  551 (625)
                           .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...  .    .......   ...
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~----~~~~~~~~~~~~~  251 (303)
T 2vwi_A          178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--L----TLQNDPPSLETGV  251 (303)
T ss_dssp             ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--H----HHTSSCCCTTC--
T ss_pred             cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--H----HhccCCCcccccc
Confidence                 123457888999999865 568999999999999999999999997654332211  1    1111100   000


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       552 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+...     ......++.+++.+||+.||.+||++.|+++
T Consensus       252 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          252 QDKEM-----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             ---CC-----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccchh-----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111     0111235677888999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-38  Score=318.59  Aligned_cols=239  Identities=21%  Similarity=0.300  Sum_probs=190.3

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccC---ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV---GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|... +++.||+|+++....   ....+.+|+..+.++ +||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            357999999999999965 799999999986432   235688899999999 899999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-------------------C
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-------------------Q  464 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-------------------~  464 (625)
                      ++|.+++..... ....+++..+..++.|++.||+|||+++   |+||||||+||+++.+                   .
T Consensus        96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred             CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            999999976431 1124899999999999999999999998   9999999999999844                   4


Q ss_pred             CeeEecccccccccccccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 006922          465 YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV  543 (625)
Q Consensus       465 ~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  543 (625)
                      .+||+|||.+....... ...++..|+|||.+.+. .++.++|||||||++|||++|++|+...   +..   ..    +
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~---~~----~  240 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQW---HE----I  240 (289)
T ss_dssp             CEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHH---HH----H
T ss_pred             EEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHH---HH----H
Confidence            79999999998775433 33588899999998765 5668999999999999999999877432   111   10    1


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       544 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......        ..+  .....++.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~--------~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          241 RQGRLP--------RIP--QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HTTCCC--------CCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCC--------CCC--cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111111        001  111235677888999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=327.32  Aligned_cols=241  Identities=20%  Similarity=0.356  Sum_probs=189.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe------cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS------KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e~~  401 (625)
                      +.||+|+||.||+|.. .+|+.||+|++.......+.+.+|++++.++ +||||+++++++..      .+..++||||+
T Consensus        30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~  109 (326)
T 2x7f_A           30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC  109 (326)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECC
T ss_pred             EEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcC
Confidence            5799999999999996 4789999999987666668899999999998 79999999999987      45789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      ++|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus       110 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  183 (326)
T 2x7f_A          110 GAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  183 (326)
T ss_dssp             TTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred             CCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence            9999999998643   224899999999999999999999998   999999999999999999999999999875432 


Q ss_pred             --ccccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          481 --APVIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                        .....++..|+|||++.     ...++.++|||||||++|||++|+.||......+..   ..   .... .....  
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~---~~~~-~~~~~--  254 (326)
T 2x7f_A          184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FL---IPRN-PAPRL--  254 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH---HHHS-CCCCC--
T ss_pred             cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---HH---hhcC-ccccC--
Confidence              22346788899999986     567899999999999999999999999764322111   11   1111 10000  


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         . ....   ...+.+++.+||..||.+||++.|+++
T Consensus       255 ---~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          255 ---K-SKKW---SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---S-CSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---C-cccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               0 0111   235677888999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.4e-38  Score=329.41  Aligned_cols=251  Identities=17%  Similarity=0.210  Sum_probs=195.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCCh------------------HHHHHHHHHHHcCCCCceecceeEEEec
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK------------------RDFEQQMEIVGSIRHENVVELKAYYYSK  391 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~------------------~~~~~e~~~l~~l~h~niv~l~~~~~~~  391 (625)
                      +.||+|+||.||+|.. +|+.||+|++.......                  +.+.+|++++.+++||||+++++++.+.
T Consensus        37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  115 (348)
T 2pml_X           37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY  115 (348)
T ss_dssp             EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred             EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            5699999999999999 89999999997542211                  7799999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhh------hccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCC
Q 006922          392 DEKLMVYDYYSLGSVSAM------LHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQ  464 (625)
Q Consensus       392 ~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~  464 (625)
                      +..++||||+++|+|.++      +...   ....+++..+..++.|++.||+|||+ .+   |+||||||+||+++.++
T Consensus       116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          116 DEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             SEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTS
T ss_pred             CeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCC
Confidence            999999999999999998      5432   13458999999999999999999999 77   99999999999999999


Q ss_pred             CeeEeccccccccccc-ccccccCCCcCCccccCCC-CCCC-ccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 006922          465 YGCVSDLGLTTITSAL-APVIARAAGYRAPEVTDSR-KATQ-ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       465 ~~kl~DfGla~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      .+||+|||++...... .....++..|+|||.+.+. .++. ++||||||+++|||++|+.||......  ......+  
T Consensus       190 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~i--  265 (348)
T 2pml_X          190 RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELFNNI--  265 (348)
T ss_dssp             CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHHHHH--
T ss_pred             cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH--
Confidence            9999999999875432 3345678889999999877 6666 999999999999999999999865431  1112111  


Q ss_pred             Hhhcccccc-----cccccccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWTAE-----VFDVELLR--YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~~~-----~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ........     ........  .........++.+++.+||+.||.+|||+.|+++
T Consensus       266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          266 -RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             11110000     00000000  0000112346778888999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-38  Score=331.78  Aligned_cols=253  Identities=19%  Similarity=0.294  Sum_probs=191.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... +++.||||++......  .+.+.+|++++.+++||||+++++++...     ...++||||+
T Consensus        33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  112 (364)
T 3qyz_A           33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM  112 (364)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred             EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence            57999999999999954 6889999999754322  25688999999999999999999999765     3689999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++ +|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       113 ~~-~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          113 ET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             SE-EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             Cc-CHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            85 899888653      3899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ------cccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.........+....+.+.
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                  23467888999998654 45899999999999999999999999876544433222110000000000000000


Q ss_pred             -------cccC-CC-Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 -------ELLR-YP-NI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 -------~~~~-~~-~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                             .... .. ..    .....++.+++.+|++.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   0000 00 00    011245678888999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.4e-38  Score=356.63  Aligned_cols=245  Identities=21%  Similarity=0.373  Sum_probs=196.4

Q ss_pred             HhHcccCCceeEEEEEEc----CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|...    .+..||||+++.....  .+.+.+|+.++.+++||||+++++++. .+..++||||++
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~  473 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT  473 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence            457999999999999863    2567999998764322  367899999999999999999999984 467899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP  482 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  482 (625)
                      +|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       474 ~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          474 LGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             TCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            999999997543    24899999999999999999999998   99999999999999999999999999987643321


Q ss_pred             ----ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 ----VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                          ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+..   ..+.   ....          
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~---~~~~----------  610 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE---NGER----------  610 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH---HTCC----------
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH---cCCC----------
Confidence                2245567999999988899999999999999999997 99999765433222   2111   1110          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                       .+........+.+++.+||..||.+|||+.|+++.|+.+.
T Consensus       611 -~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             0111122346778888999999999999999999998874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.3e-38  Score=329.99  Aligned_cols=252  Identities=17%  Similarity=0.278  Sum_probs=185.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC------------hHHHHHHHHHHHcCCCCceecceeEEEec-----C
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG------------KRDFEQQMEIVGSIRHENVVELKAYYYSK-----D  392 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  392 (625)
                      +.||+|+||.||+|...+|+.||||++......            .+.+.+|++++.+++||||+++++++...     .
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (362)
T 3pg1_A           28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH  107 (362)
T ss_dssp             EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred             EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence            579999999999999888999999999653221            15689999999999999999999998653     3


Q ss_pred             ceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccc
Q 006922          393 EKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLG  472 (625)
Q Consensus       393 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG  472 (625)
                      ..++||||++ |+|.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          108 KLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             EEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             eEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecC
Confidence            5799999998 58888887542    24899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccc--ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc-
Q 006922          473 LTTITSAL--APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT-  548 (625)
Q Consensus       473 la~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  548 (625)
                      +++.....  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....   +......... 
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~  256 (362)
T 3pg1_A          180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK---IVEVVGTPKIE  256 (362)
T ss_dssp             C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHH
T ss_pred             cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCChH
Confidence            99865332  233467888999999876 6789999999999999999999999976543222211   1111100000 


Q ss_pred             ----------cccccccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 ----------AEVFDVELLRYPN------IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 ----------~~~~d~~~~~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                                ...+.......+.      .......+.+++.+|++.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                      0000000000000      0011245778888999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.3e-38  Score=320.63  Aligned_cols=243  Identities=19%  Similarity=0.340  Sum_probs=178.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||++.. .+|+.||+|+++......   +.+.++...+..++||||+++++++...+..++||||+++ +
T Consensus        13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   91 (290)
T 3fme_A           13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-S   91 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-E
T ss_pred             HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-c
Confidence            5699999999999996 579999999997653322   2234445557788999999999999999999999999985 8


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      |.+++..... ....+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||+++......  .
T Consensus        92 l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           92 LDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             hHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            8777764321 123589999999999999999999998 7   9999999999999999999999999998764332  2


Q ss_pred             ccccCCCcCCcccc----CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          483 VIARAAGYRAPEVT----DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       483 ~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ...++..|+|||.+    .+..++.++||||||+++|||+||+.||...... ......    ........      .  
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~------~--  234 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQ----VVEEPSPQ------L--  234 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHH----HHHSCCCC------C--
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHH----HhccCCCC------c--
Confidence            34688899999996    5667899999999999999999999999753321 111111    11111000      0  


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       + ......++.+++.+|++.||++|||+.|+++
T Consensus       235 -~-~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          235 -P-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -C-TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -c-cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             0 0112235778888999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-38  Score=332.08  Aligned_cols=252  Identities=19%  Similarity=0.286  Sum_probs=186.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEec-----------------
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSK-----------------  391 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------------  391 (625)
                      +.||+|+||+||+|.. .+|+.||||++....   ....+|+++++.++||||+++++++...                 
T Consensus        13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~   89 (383)
T 3eb0_A           13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL   89 (383)
T ss_dssp             EEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred             EEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence            5799999999999995 579999999987542   2345799999999999999999998543                 


Q ss_pred             ---------------------CceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 006922          392 ---------------------DEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVH  450 (625)
Q Consensus       392 ---------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH  450 (625)
                                           ...++||||++ |+|.+.+..... ....+++..+..++.|+++||+|||+.+   |+|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H  164 (383)
T 3eb0_A           90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---ICH  164 (383)
T ss_dssp             --------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred             cccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---Ccc
Confidence                                 23789999999 488777764321 1235899999999999999999999998   999


Q ss_pred             cCCCCCCEEeC-CCCCeeEeccccccccccc--ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCC
Q 006922          451 GNIKSSNIFLN-SQQYGCVSDLGLTTITSAL--APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHT  526 (625)
Q Consensus       451 rDlk~~NIll~-~~~~~kl~DfGla~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~  526 (625)
                      |||||+|||++ .++.+||+|||+++.....  .....++..|+|||.+.+. .++.++||||+||++|||++|+.||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998 6889999999999876432  2344678889999998764 489999999999999999999999986


Q ss_pred             CCCcchhhHHHHHHHHhhcccccc-------cccccccC--CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          527 TGGDELVHLVRWVHSVVREEWTAE-------VFDVELLR--YPN-----IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~d~~~~~--~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+..  ...+. .........       ..+.....  ...     ......++.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~--~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          245 ETSIDQL--VRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             SSHHHHH--HHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CChHHHH--HHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            5433222  11111 100000000       00000000  000     0112235778888999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=318.09  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=188.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc-----CChHHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-----VGKRDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  401 (625)
                      +.||+|+||.||++.. .+++.||+|+++...     ...+.+.+|++++.+++||||+++++++..  .+..++||||+
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (305)
T 2wtk_C           11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC   90 (305)
T ss_dssp             CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred             eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence            5699999999999996 468999999997542     224678999999999999999999999853  45789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      +++ +.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        91 ~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           91 VCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             SEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             cCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            987 6666665432   24899999999999999999999998   999999999999999999999999999875421 


Q ss_pred             ----ccccccCCCcCCccccCCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 ----APVIARAAGYRAPEVTDSRK--ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 ----~~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                          .....++..|+|||++.+..  ++.++||||||+++|||++|+.||......+.   ...+.   ....       
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~---~~~~-------  230 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FENIG---KGSY-------  230 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH---HCCC-------
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHHh---cCCC-------
Confidence                12345788899999987644  37799999999999999999999976432221   11111   1100       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                           +........+.+++.+||..||.+|||+.|+++.
T Consensus       231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 0011122356778889999999999999999963

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.7e-38  Score=332.48  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=189.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCc------eEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE------KLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|....+..||+|++....   +...+|+++++.++||||+++++++...+.      .++||||+++
T Consensus        46 ~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~  122 (394)
T 4e7w_A           46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE  122 (394)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE
T ss_pred             EEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc
Confidence            5799999999999998777779999886532   223479999999999999999999976543      7899999998


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~--  480 (625)
                      +.+........  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++ .++.+||+|||+++.....  
T Consensus       123 ~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~  197 (394)
T 4e7w_A          123 TVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP  197 (394)
T ss_dssp             EHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             cHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC
Confidence            55444332221  1224899999999999999999999998   99999999999999 7899999999999876332  


Q ss_pred             ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH----------hhccccc
Q 006922          481 APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV----------VREEWTA  549 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~  549 (625)
                      .....+|..|+|||++.+. .++.++||||+||++|||++|+.||.+....+..  ...+...          .......
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHHhhChhhhh
Confidence            2345678889999998654 5899999999999999999999999865432221  1111110          0000000


Q ss_pred             ccccccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006922          550 EVFDVELLRYP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENVRP  599 (625)
Q Consensus       550 ~~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~~~  599 (625)
                      ..+. .....+    .......++.+++.+||+.||.+|||+.|+++.  +++++.
T Consensus       276 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          276 HKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             SCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            0000 000000    000122467788889999999999999999873  555543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.1e-38  Score=328.58  Aligned_cols=265  Identities=18%  Similarity=0.264  Sum_probs=183.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCc-------eEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-------KLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~e~~  401 (625)
                      +.||+|+||+||+|... +|+.||||++.........+.++++.+..++||||+++++++...+.       .++||||+
T Consensus        29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~  108 (360)
T 3e3p_A           29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV  108 (360)
T ss_dssp             ----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence            57999999999999964 68999999997655555677888888999999999999999976543       78999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hcCCCCceecCCCCCCEEeCC-CCCeeEeccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH--AANGGKLVHGNIKSSNIFLNS-QQYGCVSDLGLTTITS  478 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~  478 (625)
                      ++ +|...+..... ....+++..+..++.|++.||+|||  +.+   |+||||||+|||++. ++.+||+|||+++...
T Consensus       109 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~  183 (360)
T 3e3p_A          109 PD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS  183 (360)
T ss_dssp             SC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred             cc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence            87 44444332211 1234889999999999999999999  776   999999999999997 8999999999998765


Q ss_pred             ccc--cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHH---------HHHhhcc
Q 006922          479 ALA--PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWV---------HSVVREE  546 (625)
Q Consensus       479 ~~~--~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~  546 (625)
                      ...  ....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+....+...         .......
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3e3p_A          184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH  263 (360)
T ss_dssp             TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred             CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccch
Confidence            432  234678889999998654 4899999999999999999999999875433222211110         0000000


Q ss_pred             ccccccccccc-----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006922          547 WTAEVFDVELL-----RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRP  599 (625)
Q Consensus       547 ~~~~~~d~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~  599 (625)
                      ......+....     ..........++.+++.+||+.||.+|||+.|+++  .++++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             hhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            00000000000     00001113456788889999999999999999986  3555543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-38  Score=319.91  Aligned_cols=241  Identities=19%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC----------ChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV----------GKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  397 (625)
                      +.||+|+||+||+|... +|+.||||+++....          ..+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus        23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  102 (298)
T 1phk_A           23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV  102 (298)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence            56999999999999965 689999999975431          1245778999999995 99999999999999999999


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          103 FDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999997643     4899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccc--ccccccCCCcCCccccC------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SAL--APVIARAAGYRAPEVTD------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ...  .....++..|+|||.+.      ...++.++||||||+++|||++|+.||......+..   ..   ....... 
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~---~~~~~~~-  247 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RM---IMSGNYQ-  247 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH---HHHTCCC-
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---HH---HhcCCcc-
Confidence            432  22346788899999874      456889999999999999999999999764332211   11   1111100 


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       .      ..+.......++.+++.+||+.||.+|||+.|+++
T Consensus       248 -~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          248 -F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -c------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             0      00111122346778888999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.6e-38  Score=335.29  Aligned_cols=260  Identities=23%  Similarity=0.312  Sum_probs=188.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|... +|+.||||++....   +...+|++++++++|||||++++++....      ..++||||++
T Consensus        60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~  136 (420)
T 1j1b_A           60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  136 (420)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred             eEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence            57999999999999975 69999999987532   33457999999999999999999986532      3578999998


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEeccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~-  480 (625)
                      + ++.+.+..... ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.+ +.+||+|||+++..... 
T Consensus       137 ~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~  211 (420)
T 1j1b_A          137 E-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  211 (420)
T ss_dssp             E-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             c-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence            6 56555543211 1235899999999999999999999998   9999999999999965 56899999999875432 


Q ss_pred             -ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-------hhcc--ccc
Q 006922          481 -APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV-------VREE--WTA  549 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~~~--~~~  549 (625)
                       .....+|..|+|||++.+. .++.++|||||||++|||++|+.||.+....+  .+.+.+...       +...  ...
T Consensus       212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhh
Confidence             2335678899999998664 78999999999999999999999997654322  222222110       0000  000


Q ss_pred             ccccccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006922          550 EVFDVELLRYP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRP  599 (625)
Q Consensus       550 ~~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~  599 (625)
                      +...+.....+    .......++.+++.+||..||.+||++.|+++  .++++..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            00000000000    00111246778888999999999999999986  4555543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.5e-38  Score=337.17  Aligned_cols=186  Identities=20%  Similarity=0.326  Sum_probs=158.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  400 (625)
                      +.||+|+||+||+|... +|+.||||+++.....   .+.+.+|++++.+++||||+++++++...     +..++||||
T Consensus        32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  111 (432)
T 3n9x_A           32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI  111 (432)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred             EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence            57999999999999954 6889999999864333   35688999999999999999999999776     568999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      ++ |+|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       112 ~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          112 AD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             CC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            87 59999987542     4899999999999999999999998   999999999999999999999999999876432


Q ss_pred             -------------------------ccccccCCCcCCcccc-CCCCCCCccchhhhHHHHHHHHhCCCCC
Q 006922          481 -------------------------APVIARAAGYRAPEVT-DSRKATQASDVYSFGVVLLEILTGKSPI  524 (625)
Q Consensus       481 -------------------------~~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvil~elltG~~p~  524 (625)
                                               .....+|..|+|||++ ....++.++||||+||++|||++|..||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence                                     1345678899999986 5667999999999999999999855444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-37  Score=322.00  Aligned_cols=253  Identities=19%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             hHcccCCceeEEEEEE--cCCcEEEEEEeccccC---ChHHHHHHHHHHHcC---CCCceecceeEEE-----ecCceEE
Q 006922          330 EVLGKGTFGMAYKAIL--EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSI---RHENVVELKAYYY-----SKDEKLM  396 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~l  396 (625)
                      +.||+|+||+||+|..  .+|+.||+|+++....   ....+.+|++++..+   +||||+++++++.     .....++
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   96 (326)
T 1blx_A           17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   96 (326)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence            5699999999999996  4688999999975432   234677788777666   8999999999987     4567899


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ||||++ |+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        97 v~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  169 (326)
T 1blx_A           97 VFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI  169 (326)
T ss_dssp             EEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccccc
Confidence            999998 699999876532   24899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh----cccccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR----EEWTAE  550 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  550 (625)
                      ....  .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+..   ..+.....    ..+...
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCGGGSCTT
T ss_pred             ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCcccCccc
Confidence            6432  23346788899999999889999999999999999999999999765432221   11111111    111110


Q ss_pred             ccccc--ccC--CC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          551 VFDVE--LLR--YP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       551 ~~d~~--~~~--~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...+.  ...  ..    ........+.+++.+||..||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000  000  00    00112235667888999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-37  Score=334.39  Aligned_cols=244  Identities=20%  Similarity=0.286  Sum_probs=183.5

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      ++||+|+||+||.+...+|+.||||++....  .+.+.+|++++.++ +|||||++++++.+.+..++||||+. |+|.+
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~   97 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD   97 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence            5699999999987777789999999987532  35678999999876 89999999999999999999999996 69999


Q ss_pred             hhccccCCCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-------------CCeeEecccc
Q 006922          409 MLHSERGEGR--IPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-------------QYGCVSDLGL  473 (625)
Q Consensus       409 ~l~~~~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-------------~~~kl~DfGl  473 (625)
                      ++........  ...++..+..++.|++.||+|||+.+   |+||||||+|||++.+             +.+||+|||+
T Consensus        98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence            9976532111  01133456789999999999999998   9999999999999754             4899999999


Q ss_pred             cccccccc-------cccccCCCcCCccccCC-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 006922          474 TTITSALA-------PVIARAAGYRAPEVTDS-------RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRW  538 (625)
Q Consensus       474 a~~~~~~~-------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~  538 (625)
                      ++......       ....||.+|+|||++.+       ..++.++|||||||++|||+| |+.||......+ .   ..
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~---~i  250 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-S---NI  250 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-H---HH
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-H---HH
Confidence            98765321       23468899999999865       678999999999999999999 999997543222 1   11


Q ss_pred             HHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          539 VHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       539 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .    ...     .+..............++.+++.+||+.||.+|||+.|+++
T Consensus       251 ~----~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          251 I----RGI-----FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H----HTC-----CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             h----cCC-----CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1    111     11000011123345567888999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-37  Score=316.08  Aligned_cols=240  Identities=23%  Similarity=0.359  Sum_probs=184.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe-------------cCceE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS-------------KDEKL  395 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~~~~~  395 (625)
                      +.||+|+||+||+|.. .+|+.||||+++......+.+.+|++++.+++||||+++++++.+             .+..+
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (303)
T 1zy4_A           12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF   91 (303)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEE
T ss_pred             heeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceE
Confidence            5799999999999996 479999999997654445678999999999999999999998865             34678


Q ss_pred             EEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          396 MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       396 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +||||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           92 IQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             EEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             EEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchh
Confidence            9999999999999997532    24788999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccc-----------------ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 006922          476 ITSAL-----------------APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR  537 (625)
Q Consensus       476 ~~~~~-----------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~  537 (625)
                      .....                 .....++..|+|||.+.+. .++.++|||||||++|||++   ||...  .+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~~~~~~  239 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MERVNILK  239 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhHHHHHH
Confidence            65321                 1233577889999998754 78999999999999999998   55321  11111111


Q ss_pred             HHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       538 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.   ...   ..+.+     .........+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~---~~~---~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLR---SVS---IEFPP-----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH---STT---CCCCT-----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcc---ccc---cccCc-----cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111   100   00000     011122345677888999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-37  Score=324.19  Aligned_cols=244  Identities=18%  Similarity=0.264  Sum_probs=166.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g  404 (625)
                      ++||+|+||+||+|... +|+.||||++....   ....+....+..++||||+++++++..    ....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999965 69999999997532   222233344566799999999999976    34579999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEeccccccccccc-
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~-  480 (625)
                      +|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   +.+||+|||+++..... 
T Consensus       112 ~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~  185 (336)
T 3fhr_A          112 ELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA  185 (336)
T ss_dssp             EHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence            99999986432   35899999999999999999999998   9999999999999864   45999999999866432 


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.||.............   ..+...    ....   ..+
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~----~~~~---~~~  255 (336)
T 3fhr_A          186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLG----QYGF---PNP  255 (336)
T ss_dssp             ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC---CTT
T ss_pred             cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcc----cccc---Cch
Confidence            233467888999999988889999999999999999999999997654332211100   000000    0000   001


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......++.+++.+|++.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11122345677888999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.4e-37  Score=312.23  Aligned_cols=246  Identities=22%  Similarity=0.309  Sum_probs=195.7

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEecccc---CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||+|... +++.||+|++....   ...+.+.+|++++.+++||||+++++++...+..++||||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  106 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence            357999999999999965 68999999997543   23467899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CCeeEecccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ---QYGCVSDLGLTTITSALA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.+   +.+||+|||++.......
T Consensus       107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            9999887543     3899999999999999999999998   9999999999999764   469999999998764332


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                        ....++..|+|||.+.+ .++.++||||||+++|||++|+.||......+..   ..+   ......   .+  ... 
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~---~~~~~~---~~--~~~-  245 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRV---ETGKYA---FD--LPQ-  245 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---HHCCCC---CC--SGG-
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHH---HcCCCC---CC--chh-
Confidence              23356778999999876 4899999999999999999999999765432221   111   111100   00  000 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENV  597 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~  597 (625)
                        ......++.+++.+|+..||++|||+.|+++  .+++.
T Consensus       246 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          246 --WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             --GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             --hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence              0112235677888999999999999999997  45544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=323.92  Aligned_cols=250  Identities=20%  Similarity=0.289  Sum_probs=182.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEE--------------ecCc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYY--------------SKDE  393 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~~~  393 (625)
                      +.||+|+||+||+|... +|+.||+|++..... ..+.+.+|++++.+++||||+++++++.              ..+.
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~   96 (320)
T 2i6l_A           17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS   96 (320)
T ss_dssp             EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence            56999999999999965 589999999875432 2367889999999999999999999874              3357


Q ss_pred             eEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccc
Q 006922          394 KLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLG  472 (625)
Q Consensus       394 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfG  472 (625)
                      .++||||++ |+|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+||+++ .++.+||+|||
T Consensus        97 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           97 VYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             EEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             eeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence            799999998 5999988642      3889999999999999999999998   99999999999997 56799999999


Q ss_pred             cccccccc------ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc
Q 006922          473 LTTITSAL------APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE  545 (625)
Q Consensus       473 la~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  545 (625)
                      +++.....      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+   ......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~  243 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LESIPV  243 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHSCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCC
Confidence            99875421      122346778999998765 67899999999999999999999999765432221111   110000


Q ss_pred             ---ccccc-------cccccccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          546 ---EWTAE-------VFDVELLRYPNI-----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       546 ---~~~~~-------~~d~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         +...+       ............     .....++.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence               00000       000000000000     011345778888999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-37  Score=322.38  Aligned_cols=245  Identities=18%  Similarity=0.285  Sum_probs=171.8

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHH-HHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQME-IVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||||+++.....  ...+..|+. +++.++||||+++++++...+..++||||+++ +
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~  106 (327)
T 3aln_A           28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-S  106 (327)
T ss_dssp             CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-E
T ss_pred             heeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-C
Confidence            56999999999999964 7899999999765322  244556665 67778999999999999999999999999986 7


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--~  482 (625)
                      |.+++..........+++..+..++.|+++||+|||+. +   |+||||||+||+++.++.+||+|||+++......  .
T Consensus       107 l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  183 (327)
T 3aln_A          107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT  183 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence            77777642222223589999999999999999999998 7   9999999999999999999999999998764322  2


Q ss_pred             ccccCCCcCCcccc----CCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          483 VIARAAGYRAPEVT----DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       483 ~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ...++..|+|||++    .+..++.++||||||+++|||++|+.||.......     +.+         ..+.......
T Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~---------~~~~~~~~~~  249 (327)
T 3aln_A          184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL---------TQVVKGDPPQ  249 (327)
T ss_dssp             ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCCCCSCCCC
T ss_pred             cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH---------HHHhcCCCCC
Confidence            23678889999998    45678999999999999999999999997533210     000         0011100000


Q ss_pred             CC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YP--NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+  .......++.+++.+||..||++||++.|+++
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00  00112346778888999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=331.55  Aligned_cols=238  Identities=18%  Similarity=0.268  Sum_probs=180.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      ++||+|+||+||.....+|+.||||++....  ...+.+|++++.++ +|||||++++++.+.+..++||||+. |+|.+
T Consensus        30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~  106 (432)
T 3p23_A           30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE  106 (432)
T ss_dssp             EEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred             CeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence            5799999999766556679999999997533  23467899999999 79999999999999999999999997 59999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----CCCeeEeccccccccccc---
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-----QQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~---  480 (625)
                      ++.....    .+.+..+..++.|++.||+|||+.+   |+||||||+|||++.     ...+||+|||+++.....   
T Consensus       107 ~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          107 YVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             HHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             HHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            9876542    2344456789999999999999998   999999999999953     235789999999876422   


Q ss_pred             ---ccccccCCCcCCccccC---CCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 006922          481 ---APVIARAAGYRAPEVTD---SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD  553 (625)
Q Consensus       481 ---~~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  553 (625)
                         .....||..|+|||++.   ...++.++|||||||++|||+| |+.||.........       ...... ...   
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~-~~~---  248 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGAC-SLD---  248 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCC-CCT---
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccC-Ccc---
Confidence               23356899999999987   4567889999999999999999 99999643322111       011110 000   


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          ...........+.+++.+||+.||.+|||+.|+++
T Consensus       249 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 ----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                00111223345678888999999999999999983

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-37  Score=324.62  Aligned_cols=250  Identities=20%  Similarity=0.319  Sum_probs=189.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... +|+.||||+++.....  ...+.+|++++.+++||||+++++++...     ...++||||+
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   96 (353)
T 2b9h_A           17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM   96 (353)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred             eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence            56999999999999965 6899999999754322  35678999999999999999999998764     5789999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      . |+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        97 ~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           97 Q-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             S-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             C-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            8 5899888753      3899999999999999999999998   9999999999999999999999999998754211


Q ss_pred             -------------cccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc
Q 006922          482 -------------PVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW  547 (625)
Q Consensus       482 -------------~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  547 (625)
                                   ....+|..|+|||++. +..++.++|||||||++|||++|+.||......+...   .+........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCc
Confidence                         1235688899999875 4678999999999999999999999997654322211   1111111000


Q ss_pred             ----ccccccc-------cccCCC--Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          548 ----TAEVFDV-------ELLRYP--NI----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       548 ----~~~~~d~-------~~~~~~--~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          .......       .....+  ..    .....++.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0000000       000000  00    012245678888999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.2e-37  Score=314.68  Aligned_cols=239  Identities=17%  Similarity=0.307  Sum_probs=187.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCC--CCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIR--HENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||.||++...+++.||||++......   .+.+.+|++++.+++  ||||+++++++...+..++||| +.++
T Consensus        34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~  112 (313)
T 3cek_A           34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI  112 (313)
T ss_dssp             EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred             EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence            569999999999999888999999999765433   356889999999997  5999999999999999999999 6788


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---  481 (625)
                      +|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||++++ +.+||+|||+++......   
T Consensus       113 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          113 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            9999997643     4899999999999999999999998   999999999999964 899999999998764322   


Q ss_pred             --cccccCCCcCCccccCC-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          482 --PVIARAAGYRAPEVTDS-----------RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                        ....++..|+|||.+.+           ..++.++||||||+++|||++|+.||......     .............
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~  258 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE  258 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSC
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHHhcccc
Confidence              23457888999999865           46888999999999999999999999754321     1111111111110


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .     ...  ...   ..++.+++.+||..||.+||++.|+++.
T Consensus       259 ~-----~~~--~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          259 I-----EFP--DIP---EKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             C-----CCC--CCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c-----CCc--ccc---hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            0     000  111   2356778889999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-37  Score=320.48  Aligned_cols=231  Identities=16%  Similarity=0.336  Sum_probs=189.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC-------hHHHHHHHHHHHcCC--CCceecceeEEEecCceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG-------KRDFEQQMEIVGSIR--HENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+++.||||+++.....       .+.+.+|++++.+++  |+||+++++++...+..++|||
T Consensus        49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e  128 (320)
T 3a99_A           49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE  128 (320)
T ss_dssp             EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence            5699999999999985 57899999999765322       245778999999996  5999999999999999999999


Q ss_pred             eccC-CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEecccccccc
Q 006922          400 YYSL-GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLTTIT  477 (625)
Q Consensus       400 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~  477 (625)
                      |+.+ ++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++ +++.+||+|||+++..
T Consensus       129 ~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          129 RPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             CCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            9986 89999987643     4899999999999999999999998   99999999999999 7889999999999876


Q ss_pred             ccc-ccccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          478 SAL-APVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       478 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ... .....++..|+|||++.+..+ +.++||||||+++|||++|+.||....     ..       .....   .+   
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~-------~~~~~---~~---  262 (320)
T 3a99_A          201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IRGQV---FF---  262 (320)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HHCCC---CC---
T ss_pred             ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh-------hcccc---cc---
Confidence            543 233468888999999876665 688999999999999999999996421     10       01100   00   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ....   ..++.+++.+||+.||++|||+.|+++
T Consensus       263 ---~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          263 ---RQRV---SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0111   235677888999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=315.15  Aligned_cols=241  Identities=19%  Similarity=0.287  Sum_probs=170.9

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|... +|+.||||++.......   +.+.++..++..++||||+++++++...+..++||||+ ++.
T Consensus        31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~  109 (318)
T 2dyl_A           31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC  109 (318)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred             ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence            56999999999999965 78999999997653322   23344455678889999999999999999999999999 445


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      +..+.....    ..+++..+..++.|+++||+|||+. +   |+||||||+||+++.++.+||+|||++......  ..
T Consensus       110 ~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (318)
T 2dyl_A          110 AEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD  182 (318)
T ss_dssp             HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence            554444322    2489999999999999999999995 7   999999999999999999999999999765432  22


Q ss_pred             ccccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          483 VIARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                      ...++..|+|||.+.     ...++.++||||||+++|||++|+.||......  ....   .........      ...
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~~~------~~~  251 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL---TKVLQEEPP------LLP  251 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH---HHHHHSCCC------CCC
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH---HHHhccCCC------CCC
Confidence            346788999999984     557889999999999999999999999753321  1111   111111110      000


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....   ...++.+++.+||..||.+||++.|+++
T Consensus       252 ~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          252 GHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             SSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0011   1235677888999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=315.73  Aligned_cols=232  Identities=18%  Similarity=0.326  Sum_probs=184.1

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-------ChHHHHHHHHHHHcC----CCCceecceeEEEecCceEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSI----RHENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~l  396 (625)
                      .+.||+|+||+||+|.. .+++.||||+++....       ....+.+|++++.++    +||||+++++++...+..++
T Consensus        36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~  115 (312)
T 2iwi_A           36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML  115 (312)
T ss_dssp             EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred             eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence            35799999999999985 4789999999975432       123466789988888    89999999999999999999


Q ss_pred             EEEe-ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccccc
Q 006922          397 VYDY-YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLT  474 (625)
Q Consensus       397 v~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla  474 (625)
                      |||| +.+++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++ .++.+||+|||++
T Consensus       116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            9999 78999999997643     4899999999999999999999998   99999999999999 8899999999999


Q ss_pred             cccccc-ccccccCCCcCCccccCCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          475 TITSAL-APVIARAAGYRAPEVTDSRKAT-QASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       475 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      +..... .....++..|+|||++.+..+. .++||||||+++|||++|+.||....     ...       ...      
T Consensus       188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~-------~~~------  249 (312)
T 2iwi_A          188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL-------EAE------  249 (312)
T ss_dssp             EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-------HTC------
T ss_pred             hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh-------hhc------
Confidence            876543 2334678889999998766664 58999999999999999999996421     110       000      


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         .   ........++.+++.+||+.+|++|||+.|+++
T Consensus       250 ---~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 ---L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0   000112235677888999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-36  Score=307.45  Aligned_cols=227  Identities=11%  Similarity=0.067  Sum_probs=177.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh----HHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|... +|+.||||+++......    +.+.+|++++.+++||||+++++++...+..++||||++++
T Consensus        37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~  116 (286)
T 3uqc_A           37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG  116 (286)
T ss_dssp             EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred             EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence            56999999999999965 58999999998654332    67899999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|.+++...       ....++.+++.|++.||+|||+++   |+||||||+|||++.++.+||+++|            
T Consensus       117 ~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          117 SLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             CHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence            999998532       345578889999999999999998   9999999999999999999998543            


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                           |++|       ++.++|||||||++|||+||+.||......+......       ............. .+   .
T Consensus       175 -----~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~---~  231 (286)
T 3uqc_A          175 -----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADI-DR---D  231 (286)
T ss_dssp             -----CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------BCTTSCBCCHHHH-CT---T
T ss_pred             -----ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------HHhccCCCChhhc-cc---C
Confidence                 4443       6889999999999999999999998654332110000       0000000000000 01   1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS  602 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~  602 (625)
                      ...++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            12356788889999999999 99999999999987654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-37  Score=327.82  Aligned_cols=235  Identities=15%  Similarity=0.128  Sum_probs=175.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC----ChHHHHHHHHHHHcCCC-Cceecc---------eeE-------
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV----GKRDFEQQMEIVGSIRH-ENVVEL---------KAY-------  387 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h-~niv~l---------~~~-------  387 (625)
                      ++||+|+||+||+|.. .+|+.||||+++....    ..+.+.+|+.++..++| +|....         ...       
T Consensus        84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (413)
T 3dzo_A           84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK  163 (413)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred             cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence            5699999999999994 5799999999984322    24678999999999977 221111         111       


Q ss_pred             -----EEe-----cCceEEEEEeccCCChhhhhcccc--CCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 006922          388 -----YYS-----KDEKLMVYDYYSLGSVSAMLHSER--GEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKS  455 (625)
Q Consensus       388 -----~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~  455 (625)
                           +..     ....+++|++ .+++|.+++....  ......++|..+..++.|+++||+|||+++   |+||||||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp  239 (413)
T 3dzo_A          164 KMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP  239 (413)
T ss_dssp             -------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred             ccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCccc
Confidence                 111     1234566665 4679998885221  112335889999999999999999999998   99999999


Q ss_pred             CCEEeCCCCCeeEecccccccccccccccccCCCcCCcccc----------CCCCCCCccchhhhHHHHHHHHhCCCCCC
Q 006922          456 SNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVT----------DSRKATQASDVYSFGVVLLEILTGKSPIH  525 (625)
Q Consensus       456 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwS~Gvil~elltG~~p~~  525 (625)
                      +|||++.++.+||+|||+++..........| ..|+|||++          ....++.++|||||||++|||+||+.||.
T Consensus       240 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          240 VDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             ceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999877665555567 899999998          66678899999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006922          526 TTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVV  591 (625)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~  591 (625)
                      .....+...               .+    ....+...   .++.+++.+||+.||++||++.|++
T Consensus       319 ~~~~~~~~~---------------~~----~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          319 DDAALGGSE---------------WI----FRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             TTGGGSCSG---------------GG----GSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CcchhhhHH---------------HH----HhhcccCC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence            643322111               11    11111122   3577788899999999999976664

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-36  Score=343.99  Aligned_cols=231  Identities=18%  Similarity=0.255  Sum_probs=185.7

Q ss_pred             hHcccCCceeEEEEEEc--CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCc-----eEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILE--DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDE-----KLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~  400 (625)
                      +.||+|+||+||+|...  +|+.||||++.....  ....+.+|++++.+++||||+++++++...+.     .++||||
T Consensus        86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~  165 (681)
T 2pzi_A           86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY  165 (681)
T ss_dssp             EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred             EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence            56999999999999964  689999999875432  23568899999999999999999999988765     6999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++..       .++|.++..++.|++.||+|||+++   |+||||||+|||++.+ .+||+|||+++.....
T Consensus       166 ~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          166 VGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             CCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             CCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            999999887653       3899999999999999999999998   9999999999999885 8999999999877654


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                       ....||.+|+|||++.+. ++.++|||||||++|||++|..||.........                        ...
T Consensus       235 -~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------------~~~  288 (681)
T 2pzi_A          235 -GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------------EDD  288 (681)
T ss_dssp             -SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------------TTC
T ss_pred             -CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------------ccc
Confidence             445789999999998754 488999999999999999999988642211100                        000


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhh
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPK-MPDVVRVIENV  597 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~ev~~~L~~~  597 (625)
                      ........+.+++.+||+.||.+||+ ++++...|..+
T Consensus       289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            11122346778889999999999995 66666666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4e-36  Score=333.30  Aligned_cols=262  Identities=20%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe------cCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS------KDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|.. .+|+.||||+++....  ..+.+.+|++++.+++||||+++++++..      .+..++|||
T Consensus        19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE   98 (676)
T 3qa8_A           19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME   98 (676)
T ss_dssp             CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence            36799999999999995 4689999999876422  23568899999999999999999998765      567799999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC---eeEeccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY---GCVSDLGLTTI  476 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DfGla~~  476 (625)
                      |+++|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        99 y~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           99 YCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             eCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            9999999999986432  224888899999999999999999998   999999999999997765   89999999987


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccc-------
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEW-------  547 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  547 (625)
                      ....  .....++..|+|||.+.+..++.++|||||||++|||++|+.||......     ..|.........       
T Consensus       174 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          174 LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             TTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CCSCC
T ss_pred             cccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhhhh
Confidence            6533  23356888999999999999999999999999999999999999653211     111100000000       


Q ss_pred             -cccc--ccccccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHhhCCC
Q 006922          548 -TAEV--FDVELLR-YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPD-----VVRVIENVRPN  600 (625)
Q Consensus       548 -~~~~--~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e-----v~~~L~~~~~~  600 (625)
                       ....  +...... ..........+.+++..|+..||++|||+.|     ..+.++.+...
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence             0000  0000000 0112234567788888999999999999988     55666666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.3e-35  Score=299.47  Aligned_cols=222  Identities=18%  Similarity=0.298  Sum_probs=173.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHH-HcCCCCceecceeEEEe----cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIV-GSIRHENVVELKAYYYS----KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  403 (625)
                      ++||+|+||.||++.. .+++.||+|+++.    ...+.+|++++ ...+||||+++++++..    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            4699999999999996 4789999999975    35678888887 55689999999999987    6678999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~  480 (625)
                      |+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||++....  
T Consensus       100 ~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A          100 GELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             CBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            999999986432   24899999999999999999999998   999999999999998   7889999999887543  


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                                       +..++.++|||||||++|||+||+.||......+...           .....+.. .....+
T Consensus       172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~~~~~~-~~~~~~  222 (299)
T 3m2w_A          172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKTRIRM-GQYEFP  222 (299)
T ss_dssp             -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSCCSSCT-TCCSSC
T ss_pred             -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHHHHHhh-ccccCC
Confidence                             2346789999999999999999999997543321110           00000000 000001


Q ss_pred             Cc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NI--EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~--~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ..  .....++.+++.+||+.||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00  112346778888999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-34  Score=301.05  Aligned_cols=236  Identities=14%  Similarity=0.142  Sum_probs=176.5

Q ss_pred             HHhHcccCCceeEEEEEEcCCcEEEEEEeccccC---------ChHHHHHHHHHHHcCC---------CCceecceeEE-
Q 006922          328 SAEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---------GKRDFEQQMEIVGSIR---------HENVVELKAYY-  388 (625)
Q Consensus       328 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~---------h~niv~l~~~~-  388 (625)
                      ..+.||+|+||+||+|+. +|+.||||+++....         ..+.+.+|++++++++         |||||++.+.+ 
T Consensus        24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~  102 (336)
T 2vuw_A           24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC  102 (336)
T ss_dssp             TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred             heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence            457899999999999987 689999999976432         1267889999988885         66666665553 


Q ss_pred             ----------------Ee-------------cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHH
Q 006922          389 ----------------YS-------------KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR  439 (625)
Q Consensus       389 ----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~  439 (625)
                                      ..             .+..++||||+++|++.+.+...      .+++..+..++.|++.||+|
T Consensus       103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHHHHHH
Confidence                            32             67899999999999777666431      38999999999999999999


Q ss_pred             HH-hcCCCCceecCCCCCCEEeCCCC--------------------CeeEecccccccccccccccccCCCcCCccccCC
Q 006922          440 IH-AANGGKLVHGNIKSSNIFLNSQQ--------------------YGCVSDLGLTTITSALAPVIARAAGYRAPEVTDS  498 (625)
Q Consensus       440 LH-~~~~~~ivHrDlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~y~aPE~~~~  498 (625)
                      || +.+   |+||||||+|||++.++                    .+||+|||+|+.....  ...||..|+|||++.+
T Consensus       177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCC
T ss_pred             HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcC
Confidence            99 888   99999999999999887                    8999999999977543  3478999999999987


Q ss_pred             CCCCCccchhhhHHH-HHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHcc
Q 006922          499 RKATQASDVYSFGVV-LLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCV  577 (625)
Q Consensus       499 ~~~~~~~DvwS~Gvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl  577 (625)
                      .. +.++||||+|++ .+++++|..||.....  .....+   .........     .....+.......++.+++.+|+
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~---~~~~~~~~~-----~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTD---KMLKQMTFK-----TKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHH---HHHHTCCCS-----SCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHH---hhhhhhccC-----cccchhhhhhcCHHHHHHHHHHh
Confidence            66 889999998777 7778889999842100  000111   111000000     00001112345667889999999


Q ss_pred             CCCCCCCCCHHHHH
Q 006922          578 VRMPDQRPKMPDVV  591 (625)
Q Consensus       578 ~~~P~~RPs~~ev~  591 (625)
                      +.|     |+.|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.8e-29  Score=279.35  Aligned_cols=180  Identities=13%  Similarity=0.049  Sum_probs=128.5

Q ss_pred             cccCCceeEEEEE-EcCCcEEEEEEecccc-----------CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEE
Q 006922          332 LGKGTFGMAYKAI-LEDGTTVVVKRLKDVN-----------VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       332 lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.|++|.++.++ .--|+.+|+|++....           ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5667777776655 3358999999997541           1125689999999999 6999999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||++|++|.+++....     +++..   +|+.||+.||+|+|+++   ||||||||+|||++.++.+||+|||+|+...
T Consensus       322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999997643     35543   58899999999999998   9999999999999999999999999998765


Q ss_pred             cc---ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCC
Q 006922          479 AL---APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSP  523 (625)
Q Consensus       479 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p  523 (625)
                      ..   .....||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            33   234578999999999876 467789999999998887666544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.93  E-value=2.6e-26  Score=235.88  Aligned_cols=193  Identities=31%  Similarity=0.568  Sum_probs=169.3

Q ss_pred             CCChhHHHHHHHHHHhCCCCCC-CCCCCCCCCCCC--CCceEeCCCC--CeEEEEEcCCCCccc--ccCcccccCCCCcc
Q 006922           22 AEPVEDKEALLDFVNNLPHSRS-LNWNESTSVCNH--WTGVKCSEDG--KRVVAVRLPGVGFSG--LIPPNTISRLSALK   94 (625)
Q Consensus        22 ~~~~~~~~~ll~~~~~~~~~~~-~~w~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~~~~~l~~L~   94 (625)
                      .|.+.|++||++||+++.+... .+|+.+.++| .  |.||+|+...  .+|+.|+|+++++.|  .+|+ .|+++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence            5888999999999999854433 3898766666 6  9999998754  689999999999999  8887 499999999


Q ss_pred             EEEecC-CCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccc
Q 006922           95 ILSLRS-NVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANN  172 (625)
Q Consensus        95 ~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N  172 (625)
                      +|+|++ |.+.+.+|..|.++++|++|+|++|++++.+| .+..+++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 99999999999999999999999999998888 6999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCC-CCcEEEcccCCCccccccccccCC--CCcccCCC
Q 006922          173 SLSGKIPDL--NLP-NLQQLNLANNNLSGSIPQSLKRFP--SSAFVGNS  216 (625)
Q Consensus       173 ~l~~~~p~~--~l~-~L~~L~l~~N~l~g~~p~~l~~~~--~~~~~~n~  216 (625)
                      ++++.+|..  .++ +|+.|+|++|+++|.+|..+..+.  .+.+.+|.
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~  208 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM  208 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCc
Confidence            999988863  676 899999999999999998887754  33444444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.5e-26  Score=254.45  Aligned_cols=178  Identities=12%  Similarity=0.187  Sum_probs=146.8

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC---------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|.. .++.+++|+.......         .+.+.+|++++.+++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 5788999987543221         2347899999999999999988888888888899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+++++|.+++..             +..++.|+++||+|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999874             4579999999999999998   999999999999998  999999999998754


Q ss_pred             cc----------cccccCCCcCCccccCC--CCCCCccchhhhHHHHHHHHhCCCCCC
Q 006922          480 LA----------PVIARAAGYRAPEVTDS--RKATQASDVYSFGVVLLEILTGKSPIH  525 (625)
Q Consensus       480 ~~----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~  525 (625)
                      ..          ....||..|||||++..  ..|+.++|+|+..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            21          24578999999999976  668889999999999999888887773

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.89  E-value=6.4e-24  Score=244.54  Aligned_cols=181  Identities=20%  Similarity=0.322  Sum_probs=134.6

Q ss_pred             hcCCCChhHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCCCceEeCCCCCeEEEEEcCCCCcccc---cCc----------
Q 006922           19 KVNAEPVEDKEALLDFVNNLPHS-RSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGL---IPP----------   84 (625)
Q Consensus        19 ~~~~~~~~~~~~ll~~~~~~~~~-~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~~----------   84 (625)
                      ++.++.+.|++||++||+++.+. ...+|..+.++| .|.||+|+  .++|+.|+|+++++.|.   +|+          
T Consensus         5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~   81 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES   81 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred             ccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence            34455678999999999998533 333898665555 89999998  47999999999999987   553          


Q ss_pred             ------------ccccCCCCccEEEecCCCCCccCCc--ccccccccccccccccccCCCCCC--cccccccceecCCCc
Q 006922           85 ------------NTISRLSALKILSLRSNVITGYFPS--DFINLKSLCYLYLQFNNFSGTLPD--FSVWKNLTIINLSDN  148 (625)
Q Consensus        85 ------------~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~ls~N  148 (625)
                                  ..|+.+++|++|+|++|.++|.+|.  .++++++|++|+|++|.+++.+|.  +..+++|++|+|++|
T Consensus        82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n  161 (768)
T 3rgz_A           82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN  161 (768)
T ss_dssp             EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred             cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence                        3588899999999999999998888  899999999999999999888773  367888888888888


Q ss_pred             cCCCCCCCC---ccccccccceecccccccccCCCCCCCCCcEEEcccCCCcccccc
Q 006922          149 GFNGTIPRS---LSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQ  202 (625)
Q Consensus       149 ~l~~~~p~~---l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~  202 (625)
                      ++++..|..   +.++++|++|++++|.+++.+|...+++|++|+|++|++++.+|.
T Consensus       162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  218 (768)
T 3rgz_A          162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF  218 (768)
T ss_dssp             CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB
T ss_pred             ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc
Confidence            888766655   555556666666666555554444455555555555555544443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.88  E-value=1.2e-23  Score=237.01  Aligned_cols=185  Identities=28%  Similarity=0.434  Sum_probs=154.1

Q ss_pred             CCChhHHHHHHHHHHhCCCCC----------CCCCCCCCCCCCCC---CceEeCCCCCeEEEEEcCCCCcccccCccccc
Q 006922           22 AEPVEDKEALLDFVNNLPHSR----------SLNWNESTSVCNHW---TGVKCSEDGKRVVAVRLPGVGFSGLIPPNTIS   88 (625)
Q Consensus        22 ~~~~~~~~~ll~~~~~~~~~~----------~~~w~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~   88 (625)
                      +....|+.||.+++.++....          ..+|+.+.++| .|   .||+|+.. ++|+.|+|+++++.|.+|++ |+
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~-l~  102 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDA-IG  102 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECGG-GG
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCChH-Hh
Confidence            344569999999999874321          12698776666 89   99999876 69999999999999999975 99


Q ss_pred             CCCCccEEEecCCC------------------------------------------------------------------
Q 006922           89 RLSALKILSLRSNV------------------------------------------------------------------  102 (625)
Q Consensus        89 ~l~~L~~L~l~~N~------------------------------------------------------------------  102 (625)
                      +|++|++|+|++|.                                                                  
T Consensus       103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~  182 (636)
T 4eco_A          103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT  182 (636)
T ss_dssp             GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred             cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence            99999999999984                                                                  


Q ss_pred             ------------CCccCCcccccccccccccccccccCCC-----------------CC-Ccc--cccccceecCCCccC
Q 006922          103 ------------ITGYFPSDFINLKSLCYLYLQFNNFSGT-----------------LP-DFS--VWKNLTIINLSDNGF  150 (625)
Q Consensus       103 ------------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p-~~~--~l~~L~~L~ls~N~l  150 (625)
                                  ++| +|..|+++++|++|+|++|+++|.                 +| .++  .+++|++|+|++|++
T Consensus       183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l  261 (636)
T 4eco_A          183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN  261 (636)
T ss_dssp             CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred             hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence                        345 788899999999999999999983                 55 677  899999999999999


Q ss_pred             CCCCCCCccccccccceeccccc-ccc-cCCCC--CC------CCCcEEEcccCCCcccccc--ccccCCCCc
Q 006922          151 NGTIPRSLSNLTQLEALYLANNS-LSG-KIPDL--NL------PNLQQLNLANNNLSGSIPQ--SLKRFPSSA  211 (625)
Q Consensus       151 ~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~--~l------~~L~~L~l~~N~l~g~~p~--~l~~~~~~~  211 (625)
                      .+.+|..++++++|++|+|++|+ ++| .+|..  .+      ++|+.|+|++|+++ .+|.  .++.++.+.
T Consensus       262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~  333 (636)
T 4eco_A          262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG  333 (636)
T ss_dssp             CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred             CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence            99999999999999999999998 888 67752  33      88899999999998 7887  777766543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.88  E-value=1.2e-23  Score=241.96  Aligned_cols=193  Identities=26%  Similarity=0.403  Sum_probs=161.0

Q ss_pred             cCCCChhHHHHHHHHHHhCCCCCCCCCCCCC-----CC-CCCC------------CceEeCCCCCeEEEEEcCCCCcccc
Q 006922           20 VNAEPVEDKEALLDFVNNLPHSRSLNWNEST-----SV-CNHW------------TGVKCSEDGKRVVAVRLPGVGFSGL   81 (625)
Q Consensus        20 ~~~~~~~~~~~ll~~~~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~   81 (625)
                      .+++...|+.||++||+++...   +|+.+.     ++ ||.|            .||+|+.. ++|+.|+|+++++.|.
T Consensus       263 ~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~-~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          263 ETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN-GRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT-SCEEEEECTTTCCEEE
T ss_pred             ccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCC-CCEEEEECccCCCCCc
Confidence            3445567999999999998644   786554     44 2589            99999874 6899999999999999


Q ss_pred             cCcccccCCCCccEEEe-cCCCCCcc------------------------------------------------------
Q 006922           82 IPPNTISRLSALKILSL-RSNVITGY------------------------------------------------------  106 (625)
Q Consensus        82 ~~~~~~~~l~~L~~L~l-~~N~l~~~------------------------------------------------------  106 (625)
                      +|+. |++|++|+.|+| ++|.++|.                                                      
T Consensus       339 ip~~-l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i  417 (876)
T 4ecn_A          339 VPDA-IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI  417 (876)
T ss_dssp             ECGG-GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred             CchH-HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence            9975 999999999999 77765444                                                      


Q ss_pred             ----------------------CCcccccccccccccccccccCC-----------------CCC-Ccc--cccccceec
Q 006922          107 ----------------------FPSDFINLKSLCYLYLQFNNFSG-----------------TLP-DFS--VWKNLTIIN  144 (625)
Q Consensus       107 ----------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p-~~~--~l~~L~~L~  144 (625)
                                            +|..|+++++|++|+|++|+|+|                 .+| .++  .+++|++|+
T Consensus       418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~  497 (876)
T 4ecn_A          418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE  497 (876)
T ss_dssp             CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred             ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence                                  78889999999999999999998                 255 666  999999999


Q ss_pred             CCCccCCCCCCCCccccccccceeccccc-ccc-cCCCC---------CCCCCcEEEcccCCCcccccc--ccccCCCC-
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNS-LSG-KIPDL---------NLPNLQQLNLANNNLSGSIPQ--SLKRFPSS-  210 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~---------~l~~L~~L~l~~N~l~g~~p~--~l~~~~~~-  210 (625)
                      |++|++.+.+|..|+++++|+.|+|++|+ ++| .+|..         .+++|+.|+|++|+|+ .+|.  .+..++.+ 
T Consensus       498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~  576 (876)
T 4ecn_A          498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG  576 (876)
T ss_dssp             EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred             CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence            99999999999999999999999999998 988 66641         4569999999999999 8998  77777664 


Q ss_pred             --cccCCCCC
Q 006922          211 --AFVGNSIS  218 (625)
Q Consensus       211 --~~~~n~~~  218 (625)
                        .+.+|.+.
T Consensus       577 ~L~Ls~N~l~  586 (876)
T 4ecn_A          577 LLDCVHNKVR  586 (876)
T ss_dssp             EEECTTSCCC
T ss_pred             EEECCCCCcc
Confidence              44555544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.4e-22  Score=204.47  Aligned_cols=138  Identities=12%  Similarity=0.171  Sum_probs=114.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC-------------------ChHHHHHHHHHHHcCCCCceecceeEEEe
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-------------------GKRDFEQQMEIVGSIRHENVVELKAYYYS  390 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~  390 (625)
                      +.||+|+||.||+|...+|+.||+|+++....                   ....+.+|++++.+++  | +++.+++..
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~  172 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW  172 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence            67999999999999997799999999974321                   1345889999999999  5 777776544


Q ss_pred             cCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEec
Q 006922          391 KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSD  470 (625)
Q Consensus       391 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  470 (625)
                       +..++||||+++|+|.+ +..           .....++.|+++||+|||+.+   |+||||||+|||++ ++.+||+|
T Consensus       173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred             -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence             56699999999999988 421           124579999999999999998   99999999999999 99999999


Q ss_pred             ccccccccccccccccCCCcCCccccC
Q 006922          471 LGLTTITSALAPVIARAAGYRAPEVTD  497 (625)
Q Consensus       471 fGla~~~~~~~~~~~~~~~y~aPE~~~  497 (625)
                      ||+|+...          .|+|||++.
T Consensus       236 FG~a~~~~----------~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVEVG----------EEGWREILE  252 (282)
T ss_dssp             CTTCEETT----------STTHHHHHH
T ss_pred             CCCCeECC----------CCCHHHHHH
Confidence            99997543          378899874

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.82  E-value=7.9e-21  Score=218.72  Aligned_cols=162  Identities=32%  Similarity=0.561  Sum_probs=130.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccc-----------------------------------
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDF-----------------------------------  111 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-----------------------------------  111 (625)
                      .+..|+|++|.++|.+|.. ++.+++|+.|+|++|.++|.+|..+                                   
T Consensus       515 ~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (768)
T 3rgz_A          515 NLAILKLSNNSFSGNIPAE-LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL  593 (768)
T ss_dssp             TCCEEECCSSCCEEECCGG-GGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred             CCCEEECCCCcccCcCCHH-HcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence            3556677777777766653 7777777777777777766665433                                   


Q ss_pred             -----------------------------------ccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCC
Q 006922          112 -----------------------------------INLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIP  155 (625)
Q Consensus       112 -----------------------------------~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p  155 (625)
                                                         .++++|+.|||++|+++|.+| .++.+++|+.|+|++|+++|.+|
T Consensus       594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip  673 (768)
T 3rgz_A          594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP  673 (768)
T ss_dssp             EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred             cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence                                               234567788888888888887 68888899999999999999999


Q ss_pred             CCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccc--cccCCCCcccCCCCCCCCCCCCCCCC
Q 006922          156 RSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQS--LKRFPSSAFVGNSISFDENLAPRASP  229 (625)
Q Consensus       156 ~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~--l~~~~~~~~~~n~~~~~~~~~~~~~~  229 (625)
                      ..++++++|+.|||++|+++|.+|..  .+++|+.|+|++|+|+|.||..  +..++...|.||+.+||.++.+|...
T Consensus       674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred             hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence            99999999999999999999999874  7889999999999999999964  66778889999999999998888654

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.82  E-value=4.9e-21  Score=197.73  Aligned_cols=190  Identities=21%  Similarity=0.329  Sum_probs=153.3

Q ss_pred             CCCChhHHHHHHHHHHhCC-CC-C-CCCCC----CCCCCCCCCCceEeCC--------CCCeEEEEEcCCCCcccccCcc
Q 006922           21 NAEPVEDKEALLDFVNNLP-HS-R-SLNWN----ESTSVCNHWTGVKCSE--------DGKRVVAVRLPGVGFSGLIPPN   85 (625)
Q Consensus        21 ~~~~~~~~~~ll~~~~~~~-~~-~-~~~w~----~~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~~~~   85 (625)
                      .++..+|++||++||..+. +. . ..+|+    ...++| .|.|+.|+.        ...+|+.|+|+++++. .+|+.
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            3455678999999999762 22 2 22784    344555 799999952        2357999999999998 77775


Q ss_pred             cccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccc----
Q 006922           86 TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSN----  160 (625)
Q Consensus        86 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~----  160 (625)
                       ++++++|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+| .+..+++|++|+|++|++.+.+|..+..    
T Consensus       100 -l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~  176 (328)
T 4fcg_A          100 -AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS  176 (328)
T ss_dssp             -GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred             -hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence             888999999999999999 68999999999999999999999 555 7999999999999999998899988765    


Q ss_pred             -----cccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccccccCCCC---cccCCCC
Q 006922          161 -----LTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSI  217 (625)
Q Consensus       161 -----l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~  217 (625)
                           +++|++|+|++|+++ .+|. . .+++|+.|+|++|++++ +|..+..++++   .+.+|..
T Consensus       177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~  241 (328)
T 4fcg_A          177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA  241 (328)
T ss_dssp             CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred             hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence                 899999999999998 5664 3 78899999999999984 66667766654   4445554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.80  E-value=1.3e-19  Score=179.68  Aligned_cols=153  Identities=24%  Similarity=0.288  Sum_probs=130.5

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .++.|+|++|++.+..+ ..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+ .|..+++|++|+|
T Consensus        36 ~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            47789999999987554 469999999999999999999888889999999999999999997766 5788999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFD  220 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~  220 (625)
                      ++|+|++..+..|..+++|++|+|++|+|++..+. . .+++|+.|+|++|+|++..|..+..++.   +.+.+|++.|.
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            99999977666789999999999999999987774 3 7899999999999999777766665554   56778888776

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=1.4e-19  Score=175.63  Aligned_cols=154  Identities=21%  Similarity=0.267  Sum_probs=104.8

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL  117 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  117 (625)
                      ++..|.| .|..+.|++..         ..++.|+|++|++++..+++.|..+++|++|+|++|.|++..+..|.++++|
T Consensus         5 CP~~C~C-~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L   83 (220)
T 2v70_A            5 CPEKCRC-EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV   83 (220)
T ss_dssp             CCTTCEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCCCCEE-CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC
Confidence            3455666 68888886532         1345677777777766555556777777777777777777666667777777


Q ss_pred             ccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccC
Q 006922          118 CYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANN  194 (625)
Q Consensus       118 ~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N  194 (625)
                      ++|+|++|++++..+ .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..  .+++|+.|+|++|
T Consensus        84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  163 (220)
T 2v70_A           84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN  163 (220)
T ss_dssp             CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence            777777777776555 3666777777777777777666677777777777777777777665543  5667777777777


Q ss_pred             CCccccc
Q 006922          195 NLSGSIP  201 (625)
Q Consensus       195 ~l~g~~p  201 (625)
                      ++++..+
T Consensus       164 ~l~c~c~  170 (220)
T 2v70_A          164 PFNCNCY  170 (220)
T ss_dssp             CEECSGG
T ss_pred             CCcCCCc
Confidence            7765444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=3.6e-19  Score=173.90  Aligned_cols=153  Identities=24%  Similarity=0.242  Sum_probs=89.7

Q ss_pred             CCCCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccc
Q 006922           45 NWNESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK  115 (625)
Q Consensus        45 ~w~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  115 (625)
                      -|....+.| .|.+|.|++.+         ..++.|+|++|.+++..| ..|..+++|++|+|++|.|++..+..|.+++
T Consensus        11 ~~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~   88 (229)
T 3e6j_A           11 AACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVFDSLT   88 (229)
T ss_dssp             CCCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             ccCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence            355567778 79999998642         234556666666655333 3356666666666666666554444455666


Q ss_pred             ccccccccccccCCCCCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcc
Q 006922          116 SLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLA  192 (625)
Q Consensus       116 ~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~  192 (625)
                      +|++|+|++|+|++..+. |..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..  .+++|+.|+|+
T Consensus        89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  167 (229)
T 3e6j_A           89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF  167 (229)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence            666666666666544442 455666666666666665 45555566666666666666665444432  45566666666


Q ss_pred             cCCCcccc
Q 006922          193 NNNLSGSI  200 (625)
Q Consensus       193 ~N~l~g~~  200 (625)
                      +|++++..
T Consensus       168 ~N~~~c~c  175 (229)
T 3e6j_A          168 GNPWDCEC  175 (229)
T ss_dssp             TSCBCTTB
T ss_pred             CCCccCCc
Confidence            66665433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.79  E-value=4.4e-19  Score=170.48  Aligned_cols=152  Identities=26%  Similarity=0.339  Sum_probs=123.5

Q ss_pred             CCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccc
Q 006922           48 ESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLC  118 (625)
Q Consensus        48 ~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  118 (625)
                      +..|.| .|.+|.|+..+         .+++.|+|++|++++ +++..|..+++|++|+|++|.+++..+..|.++++|+
T Consensus         2 p~~C~C-~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~   79 (208)
T 2o6s_A            2 PSRCSC-SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT   79 (208)
T ss_dssp             CTTCEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             cCCCEE-CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcC
Confidence            456677 79999998643         257888999998884 5556688899999999999999887666778899999


Q ss_pred             cccccccccCCCCCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCC
Q 006922          119 YLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNN  195 (625)
Q Consensus       119 ~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~  195 (625)
                      +|+|++|++++..+. +..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..+..  .+++|+.|+|++|+
T Consensus        80 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  159 (208)
T 2o6s_A           80 YLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  159 (208)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred             EEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence            999999999876664 688899999999999998766667888899999999999998766652  68889999999988


Q ss_pred             Cccccc
Q 006922          196 LSGSIP  201 (625)
Q Consensus       196 l~g~~p  201 (625)
                      +++..|
T Consensus       160 ~~~~~~  165 (208)
T 2o6s_A          160 WDCTCP  165 (208)
T ss_dssp             BCCCTT
T ss_pred             eecCCC
Confidence            876554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1e-18  Score=169.52  Aligned_cols=149  Identities=26%  Similarity=0.344  Sum_probs=72.6

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL  117 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  117 (625)
                      ++..|.| .|..|.|++.+         ..++.|+|++|++.+ +++..|..+++|+.|+|++|.|++..|..|.++++|
T Consensus         5 CP~~C~C-~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L   82 (220)
T 2v9t_B            5 CPAACTC-SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL   82 (220)
T ss_dssp             SCTTSEE-ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC
T ss_pred             CCCCCEE-CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC
Confidence            4556666 68888887532         124444444444443 222334445555555555555544444444455555


Q ss_pred             ccccccccccCCCCCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccC
Q 006922          118 CYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANN  194 (625)
Q Consensus       118 ~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N  194 (625)
                      ++|+|++|+|+...+. |..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..  .+++|+.|+|++|
T Consensus        83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  162 (220)
T 2v9t_B           83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN  162 (220)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence            5555555554433332 344445555555555554444444444445555555555544443331  3444444444444


Q ss_pred             CCc
Q 006922          195 NLS  197 (625)
Q Consensus       195 ~l~  197 (625)
                      +++
T Consensus       163 ~~~  165 (220)
T 2v9t_B          163 PFI  165 (220)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=8.8e-19  Score=174.37  Aligned_cols=134  Identities=16%  Similarity=0.162  Sum_probs=102.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcE--EEEEEeccccCC-------------------------hHHHHHHHHHHHcCCCCce
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTT--VVVKRLKDVNVG-------------------------KRDFEQQMEIVGSIRHENV  381 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~h~ni  381 (625)
                      +.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|++.+.+++|+++
T Consensus        53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i  132 (258)
T 1zth_A           53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV  132 (258)
T ss_dssp             EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5699999999999997 68999  999997643211                         1257889999999988865


Q ss_pred             ecceeEEEecCceEEEEEeccC-C----ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCC
Q 006922          382 VELKAYYYSKDEKLMVYDYYSL-G----SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH-AANGGKLVHGNIKS  455 (625)
Q Consensus       382 v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrDlk~  455 (625)
                      ....-+..  +..++||||+.+ |    +|.+....        .++..+..++.|++.||.||| +.+   |+||||||
T Consensus       133 ~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp  199 (258)
T 1zth_A          133 SVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE  199 (258)
T ss_dssp             CCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred             CCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence            32222221  367899999953 4    55544322        223456789999999999999 887   99999999


Q ss_pred             CCEEeCCCCCeeEeccccccccc
Q 006922          456 SNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       456 ~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      +|||++.  .++|+|||+|....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETT
T ss_pred             HHEEEcC--cEEEEECcccccCC
Confidence            9999998  99999999997653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.76  E-value=4.1e-19  Score=182.08  Aligned_cols=158  Identities=30%  Similarity=0.463  Sum_probs=99.0

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccc-ccccccccccccCCCCC-C-----------
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK-SLCYLYLQFNNFSGTLP-D-----------  133 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p-~-----------  133 (625)
                      .++.|+|++|.+++.+|.. +..+++|++|+|++|.+++.+|..+.+++ +|++|+|++|++++.+| .           
T Consensus       126 ~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~L  204 (313)
T 1ogq_A          126 TLVTLDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL  204 (313)
T ss_dssp             TCCEEECCSSEEESCCCGG-GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred             CCCEEeCCCCccCCcCChH-HhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEEC
Confidence            4666777777777766653 77777777777777777766777777766 67777777776665444 2           


Q ss_pred             ------------cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccc
Q 006922          134 ------------FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       134 ------------~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~  199 (625)
                                  +..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..  .+++|+.|+|++|+++|.
T Consensus       205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  283 (313)
T 1ogq_A          205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence                        34445555555555555544333 455556666666666666655542  566677777777777766


Q ss_pred             cccc--cccCCCCcccCCCCCCCCCCCCC
Q 006922          200 IPQS--LKRFPSSAFVGNSISFDENLAPR  226 (625)
Q Consensus       200 ~p~~--l~~~~~~~~~~n~~~~~~~~~~~  226 (625)
                      +|..  +.++..+.+.+|+..|+.|+.+|
T Consensus       284 ip~~~~l~~L~~l~l~~N~~lc~~p~~~C  312 (313)
T 1ogq_A          284 IPQGGNLQRFDVSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             CCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred             CCCCccccccChHHhcCCCCccCCCCCCC
Confidence            6653  33344456667777777665544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.76  E-value=7.8e-19  Score=183.79  Aligned_cols=176  Identities=24%  Similarity=0.302  Sum_probs=148.8

Q ss_pred             CCCCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCccccc-CCCCccEEEecCCCCCccCCcccccc
Q 006922           45 NWNESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTIS-RLSALKILSLRSNVITGYFPSDFINL  114 (625)
Q Consensus        45 ~w~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l  114 (625)
                      .-|+..|.| .|..|.|++.+         ..++.|+|++|++++. ++..+. ++++|+.|+|++|+|++..|..|.++
T Consensus        10 ~~Cp~~C~C-~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l-~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   87 (361)
T 2xot_A           10 VSCPANCLC-ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRL-RAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV   87 (361)
T ss_dssp             TTCCTTCEE-ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEE-CTTSSSSCCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCCCCCEE-CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCcc-ChhhhhhcccccCEEECCCCcCCccChhhccCC
Confidence            346677777 68999998642         2467899999999875 445577 99999999999999999888889999


Q ss_pred             cccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC-----CCCCCcE
Q 006922          115 KSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-----NLPNLQQ  188 (625)
Q Consensus       115 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~  188 (625)
                      ++|++|+|++|+|++..+ .|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..     .+++|+.
T Consensus        88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~  167 (361)
T 2xot_A           88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML  167 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCE
T ss_pred             CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCE
Confidence            999999999999997766 5899999999999999999888999999999999999999999755442     4899999


Q ss_pred             EEcccCCCccccccccccCCC-----CcccCCCCCCCCC
Q 006922          189 LNLANNNLSGSIPQSLKRFPS-----SAFVGNSISFDEN  222 (625)
Q Consensus       189 L~l~~N~l~g~~p~~l~~~~~-----~~~~~n~~~~~~~  222 (625)
                      |+|++|+|++..+..+..++.     +.+.+|++.|++.
T Consensus       168 L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             EECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             EECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            999999999655566666653     6788999999864

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.74  E-value=1e-17  Score=167.87  Aligned_cols=173  Identities=24%  Similarity=0.344  Sum_probs=133.9

Q ss_pred             CCCCCCCCCC-CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccc
Q 006922           45 NWNESTSVCN-HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINL  114 (625)
Q Consensus        45 ~w~~~~~~c~-~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  114 (625)
                      .|....|.|. .|..|.|+..+         ..++.|+|++|++++ +++..|.++++|++|+|++|.++...+..|.++
T Consensus         6 ~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l   84 (270)
T 2o6q_A            6 KKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL   84 (270)
T ss_dssp             GGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC
T ss_pred             CCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCC
Confidence            4555555553 46667776432         247788999999885 555569999999999999999998666667899


Q ss_pred             cccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEc
Q 006922          115 KSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNL  191 (625)
Q Consensus       115 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l  191 (625)
                      ++|++|+|++|++++..+ .|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..  .+++|+.|+|
T Consensus        85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  164 (270)
T 2o6q_A           85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL  164 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence            999999999999987666 4688899999999999999877778889999999999999998766642  6888999999


Q ss_pred             ccCCCccccccccccCCC---CcccCCCCC
Q 006922          192 ANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       192 ~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      ++|++++..+..+..+++   +.+.+|.+.
T Consensus       165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (270)
T 2o6q_A          165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK  194 (270)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             cCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence            999998666655665554   344555543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.73  E-value=1.6e-17  Score=161.03  Aligned_cols=157  Identities=24%  Similarity=0.314  Sum_probs=133.2

Q ss_pred             CceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccc
Q 006922           57 TGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFS  135 (625)
Q Consensus        57 ~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~  135 (625)
                      .+..|...     .+++.+++++ .+|.. +.  ++|+.|+|++|.|++..+..|.++++|++|+|++|++++..| .|.
T Consensus         7 ~~C~C~~~-----~v~c~~~~l~-~iP~~-l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~   77 (220)
T 2v9t_B            7 AACTCSNN-----IVDCRGKGLT-EIPTN-LP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ   77 (220)
T ss_dssp             TTSEEETT-----EEECTTSCCS-SCCSS-CC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             CCCEECCC-----EEEcCCCCcC-cCCCc-cC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhh
Confidence            56778642     4778888887 46654 33  789999999999999888899999999999999999998766 699


Q ss_pred             cccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC---C
Q 006922          136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS---S  210 (625)
Q Consensus       136 ~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~  210 (625)
                      .+++|++|+|++|+|+...+..|..+++|++|+|++|+|++..|..  .+++|+.|+|++|+|++..+..+..++.   +
T Consensus        78 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  157 (220)
T 2v9t_B           78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM  157 (220)
T ss_dssp             TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE
Confidence            9999999999999999665566899999999999999999887764  7899999999999999777776766554   5


Q ss_pred             cccCCCCCCCCC
Q 006922          211 AFVGNSISFDEN  222 (625)
Q Consensus       211 ~~~~n~~~~~~~  222 (625)
                      .+.+|++.|++.
T Consensus       158 ~L~~N~~~c~c~  169 (220)
T 2v9t_B          158 HLAQNPFICDCH  169 (220)
T ss_dssp             ECCSSCEECSGG
T ss_pred             EeCCCCcCCCCc
Confidence            678999998764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.8e-18  Score=164.11  Aligned_cols=127  Identities=27%  Similarity=0.323  Sum_probs=108.2

Q ss_pred             EcCCCCcccccCcccccCCCCccEEEecCCCCCccCCc-ccccccccccccccccccCCCCC-CcccccccceecCCCcc
Q 006922           72 RLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPS-DFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNG  149 (625)
Q Consensus        72 ~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~  149 (625)
                      +++++++ +.+|.. +.  .+|++|+|++|.|++..+. .|.++++|++|+|++|++++..| .|..+++|++|+|++|+
T Consensus        14 ~~s~~~l-~~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   89 (192)
T 1w8a_A           14 DCTGRGL-KEIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             ECTTSCC-SSCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EcCCCCc-CcCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence            3444555 356654 33  3899999999999987664 48999999999999999998877 68999999999999999


Q ss_pred             CCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcccccc
Q 006922          150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQ  202 (625)
Q Consensus       150 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~  202 (625)
                      |++..|..|..+++|++|+|++|+|++.+|..  .+++|+.|+|++|++++..+.
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            99888888999999999999999999988864  789999999999999987663

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.73  E-value=1.5e-17  Score=161.39  Aligned_cols=158  Identities=19%  Similarity=0.229  Sum_probs=134.7

Q ss_pred             CCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC-cccccccccccccccccccCCCCC-C
Q 006922           56 WTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP-SDFINLKSLCYLYLQFNNFSGTLP-D  133 (625)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p-~  133 (625)
                      -.+..|...     .+++++++++. +|.. +  ...+++|+|++|.|++..| ..|.++++|+.|+|++|++++..+ .
T Consensus         6 P~~C~C~~~-----~l~~s~n~l~~-iP~~-~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~   76 (220)
T 2v70_A            6 PEKCRCEGT-----TVDCSNQKLNK-IPEH-I--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA   76 (220)
T ss_dssp             CTTCEEETT-----EEECCSSCCSS-CCSC-C--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTT
T ss_pred             CCCCEECCC-----EeEeCCCCccc-CccC-C--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHH
Confidence            356777642     68899999874 6654 3  3457899999999998755 458999999999999999998777 6


Q ss_pred             cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC--
Q 006922          134 FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS--  209 (625)
Q Consensus       134 ~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~--  209 (625)
                      |..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..  .+++|+.|+|++|+|++..|..+..+++  
T Consensus        77 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  156 (220)
T 2v70_A           77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLS  156 (220)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCC
T ss_pred             hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCC
Confidence            999999999999999999888888999999999999999999987763  7899999999999999888988877665  


Q ss_pred             -CcccCCCCCCCCC
Q 006922          210 -SAFVGNSISFDEN  222 (625)
Q Consensus       210 -~~~~~n~~~~~~~  222 (625)
                       +.+.+|++.|+++
T Consensus       157 ~L~L~~N~l~c~c~  170 (220)
T 2v70_A          157 TLNLLANPFNCNCY  170 (220)
T ss_dssp             EEECCSCCEECSGG
T ss_pred             EEEecCcCCcCCCc
Confidence             5677899988764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.71  E-value=5.1e-17  Score=162.93  Aligned_cols=153  Identities=24%  Similarity=0.258  Sum_probs=133.1

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      ..++.|+|++|.+.+.  + .+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+. +..+++|++|+
T Consensus        63 ~~L~~L~l~~n~l~~~--~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  139 (272)
T 3rfs_A           63 PNVRYLALGGNKLHDI--S-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN  139 (272)
T ss_dssp             TTCCEEECTTSCCCCC--G-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCCc--h-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence            3588999999999873  3 599999999999999999998887889999999999999999987774 78999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      |++|++++..+..+..+++|+.|+|++|++++..+..  .+++|+.|+|++|++++..|..+..++.   +.+.+|++.|
T Consensus       140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            9999999777777899999999999999999877753  7899999999999999877776666655   5667788776


Q ss_pred             CC
Q 006922          220 DE  221 (625)
Q Consensus       220 ~~  221 (625)
                      ..
T Consensus       220 ~~  221 (272)
T 3rfs_A          220 TC  221 (272)
T ss_dssp             CT
T ss_pred             cC
Confidence            54

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.71  E-value=2.9e-17  Score=164.57  Aligned_cols=162  Identities=26%  Similarity=0.357  Sum_probs=133.0

Q ss_pred             CCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCC
Q 006922           51 SVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT  130 (625)
Q Consensus        51 ~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  130 (625)
                      +.| .|.|+.|+... .+..+++++++++. +|.. +.  ++|+.|+|++|.+++..+..|.++++|++|+|++|+++..
T Consensus         3 ~~C-~~~~~~C~c~~-~~~~l~~~~~~l~~-ip~~-~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i   76 (270)
T 2o6q_A            3 ALC-KKDGGVCSCNN-NKNSVDCSSKKLTA-IPSN-IP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL   76 (270)
T ss_dssp             CCB-GGGTCSBEEET-TTTEEECTTSCCSS-CCSC-CC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred             ccC-CCCCCCCEeCC-CCCEEEccCCCCCc-cCCC-CC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence            455 89999987643 35678999999984 6654 33  6899999999999987777899999999999999999966


Q ss_pred             CCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccC
Q 006922          131 LPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRF  207 (625)
Q Consensus       131 ~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~  207 (625)
                      .+. |..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..  .+++|+.|+|++|++++..+..+..+
T Consensus        77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  156 (270)
T 2o6q_A           77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL  156 (270)
T ss_dssp             CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence            654 688999999999999999776777899999999999999999877753  78999999999999996655556665


Q ss_pred             CC---CcccCCCCC
Q 006922          208 PS---SAFVGNSIS  218 (625)
Q Consensus       208 ~~---~~~~~n~~~  218 (625)
                      ++   +.+.+|.+.
T Consensus       157 ~~L~~L~L~~n~l~  170 (270)
T 2o6q_A          157 TSLKELRLYNNQLK  170 (270)
T ss_dssp             TTCCEEECCSSCCS
T ss_pred             cccceeEecCCcCc
Confidence            55   445566543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.70  E-value=2.3e-17  Score=168.37  Aligned_cols=159  Identities=20%  Similarity=0.305  Sum_probs=95.5

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCcc--CCccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGY--FPSDFINLK  115 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~  115 (625)
                      ++..|.| .|.+|.|++.+         ..++.|+|++|++. .+|+..|.++++|++|+|++|.++..  .|..+..++
T Consensus         1 CP~~C~C-~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~   78 (306)
T 2z66_A            1 CPSRCSC-SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT   78 (306)
T ss_dssp             CCTTCEE-ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCS
T ss_pred             CcCCCee-CCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCccccccccc
Confidence            3455666 79999998643         36889999999998 67777789999999999999998732  244455555


Q ss_pred             ccccccccccccCCCCCCcccccccceecCCCccCCCCCC-CCccccccccceecccccccccCCCC--CCCCCcEEEcc
Q 006922          116 SLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLA  192 (625)
Q Consensus       116 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~  192 (625)
                      +|++|+|++|.++...+.+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..  .+++|+.|+|+
T Consensus        79 ~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  158 (306)
T 2z66_A           79 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA  158 (306)
T ss_dssp             CCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECT
T ss_pred             ccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECC
Confidence            6666666666555333344455555555555555543322 34445555555555555554444432  34455555555


Q ss_pred             cCCCcc-ccccccccC
Q 006922          193 NNNLSG-SIPQSLKRF  207 (625)
Q Consensus       193 ~N~l~g-~~p~~l~~~  207 (625)
                      +|.+++ .+|..+..+
T Consensus       159 ~n~l~~~~~~~~~~~l  174 (306)
T 2z66_A          159 GNSFQENFLPDIFTEL  174 (306)
T ss_dssp             TCEEGGGEECSCCTTC
T ss_pred             CCccccccchhHHhhC
Confidence            555543 334444333

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.70  E-value=1e-16  Score=156.39  Aligned_cols=156  Identities=26%  Similarity=0.367  Sum_probs=129.6

Q ss_pred             CCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Cc
Q 006922           56 WTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DF  134 (625)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~  134 (625)
                      |..-.|+..     .++..++++. .+|.. +  .++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+ .|
T Consensus        14 ~~~~~Cs~~-----~v~c~~~~l~-~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~   84 (229)
T 3e6j_A           14 PSQCSCSGT-----TVDCRSKRHA-SVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF   84 (229)
T ss_dssp             CTTCEEETT-----EEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             CCCCEEeCC-----EeEccCCCcC-ccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence            455678643     3777888876 56654 3  3899999999999999889999999999999999999986665 47


Q ss_pred             ccccccceecCCCccCCCCCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccccccCCC---
Q 006922          135 SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKRFPS---  209 (625)
Q Consensus       135 ~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---  209 (625)
                      ..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|. . .+++|+.|+|++|+|++..+..+..+++   
T Consensus        85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  163 (229)
T 3e6j_A           85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH  163 (229)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            89999999999999999777777899999999999999999 4554 3 7899999999999999666666665554   


Q ss_pred             CcccCCCCCCCC
Q 006922          210 SAFVGNSISFDE  221 (625)
Q Consensus       210 ~~~~~n~~~~~~  221 (625)
                      +.+.+|++.|.+
T Consensus       164 L~l~~N~~~c~c  175 (229)
T 3e6j_A          164 AYLFGNPWDCEC  175 (229)
T ss_dssp             EECTTSCBCTTB
T ss_pred             EEeeCCCccCCc
Confidence            567789988875

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.70  E-value=1.8e-17  Score=171.05  Aligned_cols=140  Identities=20%  Similarity=0.328  Sum_probs=109.5

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccc---------ccccccccccccccCCCCC-Cccc
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFIN---------LKSLCYLYLQFNNFSGTLP-DFSV  136 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p-~~~~  136 (625)
                      .++.|+|++|.+. .+|+. ++++++|++|+|++|++.+.+|..+..         +++|++|+|++|+++ .+| .+..
T Consensus       128 ~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~  204 (328)
T 4fcg_A          128 GLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN  204 (328)
T ss_dssp             TCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred             CCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence            5778888888888 67654 888888888888888888778877654         888888888888887 444 6777


Q ss_pred             ccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCC
Q 006922          137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS  210 (625)
Q Consensus       137 l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~  210 (625)
                      +++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..  .+++|+.|+|++|++.+.+|..+..++.+
T Consensus       205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L  279 (328)
T 4fcg_A          205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL  279 (328)
T ss_dssp             CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred             CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence            8888888888888874 5667788888888888888888777763  67788888888888888888777766654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.69  E-value=4.2e-17  Score=164.63  Aligned_cols=143  Identities=21%  Similarity=0.277  Sum_probs=103.8

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCC-CCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNV-ITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      .++.|+|++|.+++..+ ..|..+++|++|+|++|. ++...|..|.++++|++|+|++|.+++..| .+..+++|++|+
T Consensus        57 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  135 (285)
T 1ozn_A           57 NLTILWLHSNVLARIDA-AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY  135 (285)
T ss_dssp             TCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCccceeCH-hhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence            57777888877776544 357778888888888886 776667777778888888888888776655 467777788888


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccccccCCCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKRFPSS  210 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~~  210 (625)
                      |++|++++..+..+..+++|++|+|++|++++..+. . .+++|+.|+|++|++++..|..+..++.+
T Consensus       136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  203 (285)
T 1ozn_A          136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL  203 (285)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccc
Confidence            888887765556677777788888888877765554 2 57777777777777777667766655543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.68  E-value=1.4e-16  Score=160.89  Aligned_cols=170  Identities=26%  Similarity=0.336  Sum_probs=139.3

Q ss_pred             CCCCCCCC--CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccc
Q 006922           47 NESTSVCN--HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK  115 (625)
Q Consensus        47 ~~~~~~c~--~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  115 (625)
                      |+..|.|.  .+..|.|+..+         ..++.|+|+++++++ ++++.|..+++|++|+|++|.+++..|..|.+++
T Consensus         2 CP~~C~C~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~   80 (285)
T 1ozn_A            2 CPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLA   80 (285)
T ss_dssp             CCTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             cCCCceECCCCCeEEEcCcCCcccCCcCCCCCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence            34556663  22447786532         357889999999986 4555699999999999999999998899999999


Q ss_pred             ccccccccccc-cCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEc
Q 006922          116 SLCYLYLQFNN-FSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNL  191 (625)
Q Consensus       116 ~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l  191 (625)
                      +|++|+|++|. +....| .+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..  .+++|+.|+|
T Consensus        81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  160 (285)
T 1ozn_A           81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (285)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence            99999999997 776655 6889999999999999999888889999999999999999999877653  7899999999


Q ss_pred             ccCCCccccccccccCCCC---cccCCCC
Q 006922          192 ANNNLSGSIPQSLKRFPSS---AFVGNSI  217 (625)
Q Consensus       192 ~~N~l~g~~p~~l~~~~~~---~~~~n~~  217 (625)
                      ++|++++..+..+..++.+   .+.+|.+
T Consensus       161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  189 (285)
T 1ozn_A          161 HGNRISSVPERAFRGLHSLDRLLLHQNRV  189 (285)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCcccccCHHHhcCccccCEEECCCCcc
Confidence            9999996655567666554   4555553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.68  E-value=3.6e-17  Score=170.57  Aligned_cols=163  Identities=26%  Similarity=0.357  Sum_probs=133.3

Q ss_pred             CCCCCCCCCCCCCceEeCCCC-----------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccc
Q 006922           45 NWNESTSVCNHWTGVKCSEDG-----------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFIN  113 (625)
Q Consensus        45 ~w~~~~~~c~~w~gv~C~~~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  113 (625)
                      .|+...+.| .|.|+ |+..+           ..++.|+|++|++++ +++..|.++++|++|+|++|.+++..|..|.+
T Consensus        22 ~~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (353)
T 2z80_A           22 SSNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSS   98 (353)
T ss_dssp             -----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             CCCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCC
Confidence            455556667 79887 65321           368899999999986 55556999999999999999999988888999


Q ss_pred             ccccccccccccccCCCCCC-cccccccceecCCCccCCCCCCC--Cccccccccceeccccc-ccccCCCC--CCCCCc
Q 006922          114 LKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPR--SLSNLTQLEALYLANNS-LSGKIPDL--NLPNLQ  187 (625)
Q Consensus       114 l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~--~l~~l~~L~~L~l~~N~-l~~~~p~~--~l~~L~  187 (625)
                      +++|++|+|++|++++..+. +..+++|++|+|++|++++ +|.  .+..+++|++|++++|+ +++..+..  .+++|+
T Consensus        99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  177 (353)
T 2z80_A           99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE  177 (353)
T ss_dssp             CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred             CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence            99999999999999976654 8899999999999999995 554  78999999999999994 66655543  788999


Q ss_pred             EEEcccCCCccccccccccCCCCc
Q 006922          188 QLNLANNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       188 ~L~l~~N~l~g~~p~~l~~~~~~~  211 (625)
                      .|++++|++++..|..+..++.+.
T Consensus       178 ~L~l~~n~l~~~~~~~l~~l~~L~  201 (353)
T 2z80_A          178 ELEIDASDLQSYEPKSLKSIQNVS  201 (353)
T ss_dssp             EEEEEETTCCEECTTTTTTCSEEE
T ss_pred             EEECCCCCcCccCHHHHhccccCC
Confidence            999999999988888888777643

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.68  E-value=7.8e-17  Score=175.04  Aligned_cols=170  Identities=22%  Similarity=0.239  Sum_probs=143.4

Q ss_pred             CCCCCCCC-CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccc
Q 006922           47 NESTSVCN-HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS  116 (625)
Q Consensus        47 ~~~~~~c~-~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  116 (625)
                      |+..|.|. .|..|.|+..+         ..++.|+|++|++++..+ ..|.++++|++|+|++|.+++..|..|.++++
T Consensus         3 Cp~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~   81 (477)
T 2id5_A            3 CPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFN   81 (477)
T ss_dssp             CSTTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ccCCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCcc
Confidence            45667774 57899998642         357889999999997554 46999999999999999999988999999999


Q ss_pred             cccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEccc
Q 006922          117 LCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN  193 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~  193 (625)
                      |++|+|++|++++..+ .|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+..  .+++|+.|+|++
T Consensus        82 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  161 (477)
T 2id5_A           82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK  161 (477)
T ss_dssp             CCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred             CCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence            9999999999997666 4789999999999999999888999999999999999999999877753  789999999999


Q ss_pred             CCCccccccccccCCCC---cccCCCC
Q 006922          194 NNLSGSIPQSLKRFPSS---AFVGNSI  217 (625)
Q Consensus       194 N~l~g~~p~~l~~~~~~---~~~~n~~  217 (625)
                      |++++..+..+..++.+   .+.+|.+
T Consensus       162 n~l~~~~~~~l~~l~~L~~L~l~~n~i  188 (477)
T 2id5_A          162 CNLTSIPTEALSHLHGLIVLRLRHLNI  188 (477)
T ss_dssp             CCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred             CcCcccChhHhcccCCCcEEeCCCCcC
Confidence            99997666666665554   4445543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=1.8e-16  Score=148.08  Aligned_cols=137  Identities=28%  Similarity=0.357  Sum_probs=114.7

Q ss_pred             CCCCCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccccccccc
Q 006922           48 ESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF  127 (625)
Q Consensus        48 ~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  127 (625)
                      +..|.| +|.+|.|+..            ++. .+|..   ..++|+.|+|++|.+++..+..|.++++|++|+|++|++
T Consensus         2 p~~C~C-~~~~l~~~~~------------~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l   64 (177)
T 2o6r_A            2 PSRCSC-SGTEIRCNSK------------GLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI   64 (177)
T ss_dssp             CTTCEE-ETTEEECCSS------------CCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred             cCCCEe-CCCEEEecCC------------CCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcc
Confidence            445666 7999998753            222 34432   246899999999999987777789999999999999999


Q ss_pred             CCCCCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccc
Q 006922          128 SGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       128 ~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p  201 (625)
                      ++..+. +..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++.++..  .+++|+.|+|++|++++..|
T Consensus        65 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           65 QSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             eEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            977664 789999999999999999777777899999999999999999776653  68999999999999998776

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.67  E-value=2.5e-16  Score=159.46  Aligned_cols=148  Identities=25%  Similarity=0.226  Sum_probs=97.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|+|++|.+++..+ ..|..+++|++|+|++|.|++..+  ...+++|++|+|++|+++.....+..+++|++|+|+
T Consensus        32 ~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~  108 (290)
T 1p9a_G           32 DTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS  108 (290)
T ss_dssp             TCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECC
Confidence            56778888888876544 458888888888888888776433  266777777777777776433356667777777777


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC---CcccCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSI  217 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~  217 (625)
                      +|+|++..|..|..+++|++|+|++|++++.++..  .+++|+.|+|++|+|++..+..+..+++   +.+.+|.+
T Consensus       109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l  184 (290)
T 1p9a_G          109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL  184 (290)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence            77777555566777777777777777777655542  5667777777777776433333343333   34444443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.67  E-value=5.5e-17  Score=179.41  Aligned_cols=156  Identities=24%  Similarity=0.307  Sum_probs=135.6

Q ss_pred             CCCCCCceEeCCCC-----------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccc
Q 006922           52 VCNHWTGVKCSEDG-----------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYL  120 (625)
Q Consensus        52 ~c~~w~gv~C~~~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  120 (625)
                      .| .|.|| |+..+           ..++.|+|++|.+++..| ..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus         3 ~C-~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   79 (549)
T 2z81_A            3 SC-DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL   79 (549)
T ss_dssp             EE-CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cC-CCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEE
Confidence            35 79998 86532           368999999999987655 459999999999999999999888999999999999


Q ss_pred             cccccccCCCCCC-cccccccceecCCCccCCC-CCCCCccccccccceecccccccccCCC--C-CCCCCcEEEcccCC
Q 006922          121 YLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPD--L-NLPNLQQLNLANNN  195 (625)
Q Consensus       121 ~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~L~l~~N~  195 (625)
                      +|++|++++.+|. ++.+++|++|+|++|++++ .+|..++++++|++|++++|++.+.+|.  . .+++|+.|++++|+
T Consensus        80 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A           80 DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             ECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            9999999988875 9999999999999999986 4678899999999999999996555653  2 78999999999999


Q ss_pred             CccccccccccCCCC
Q 006922          196 LSGSIPQSLKRFPSS  210 (625)
Q Consensus       196 l~g~~p~~l~~~~~~  210 (625)
                      +++.+|..+..++.+
T Consensus       160 l~~~~~~~l~~l~~L  174 (549)
T 2z81_A          160 LRNYQSQSLKSIRDI  174 (549)
T ss_dssp             CCEECTTTTTTCSEE
T ss_pred             ccccChhhhhccccC
Confidence            999999888776653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.67  E-value=2.6e-16  Score=149.14  Aligned_cols=174  Identities=21%  Similarity=0.263  Sum_probs=133.9

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL  117 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  117 (625)
                      ++..|.| .|..+.|++.+         ..++.|+|++|.+.+..+...|+.+++|++|+|++|.|++..|..|.++++|
T Consensus         2 CP~~C~C-~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   80 (192)
T 1w8a_A            2 CPAMCHC-EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI   80 (192)
T ss_dssp             CCTTSEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             cCCCCEE-CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccC
Confidence            3456667 79999998642         2678899999999876655568999999999999999999889999999999


Q ss_pred             ccccccccccCCCCCC-cccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCCCC-CCCcEEEcccCC
Q 006922          118 CYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNL-PNLQQLNLANNN  195 (625)
Q Consensus       118 ~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l-~~L~~L~l~~N~  195 (625)
                      ++|+|++|++++..+. |..+++|++|+|++|+|++..|..+..+++|++|+|++|.+++..+...+ ..++...+..+.
T Consensus        81 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~  160 (192)
T 1w8a_A           81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGA  160 (192)
T ss_dssp             CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGG
T ss_pred             CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCC
Confidence            9999999999988774 88999999999999999999899999999999999999999876553211 112222334444


Q ss_pred             CccccccccccCCCCcccCCCCCCCC
Q 006922          196 LSGSIPQSLKRFPSSAFVGNSISFDE  221 (625)
Q Consensus       196 l~g~~p~~l~~~~~~~~~~n~~~~~~  221 (625)
                      .....|..+...+-..+..+.+.|..
T Consensus       161 ~~C~~P~~l~~~~l~~l~~~~~~C~~  186 (192)
T 1w8a_A          161 ARCGAPSKVRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             CBBCSSTTTTTSBGGGSCTTTCCCCC
T ss_pred             CCCCCChHHcCCChhhCcHhhcCcCC
Confidence            44455665555544444455555543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.66  E-value=2e-16  Score=170.58  Aligned_cols=124  Identities=22%  Similarity=0.248  Sum_probs=99.0

Q ss_pred             CCCCCCCC-CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccc
Q 006922           47 NESTSVCN-HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS  116 (625)
Q Consensus        47 ~~~~~~c~-~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  116 (625)
                      ++..|.|. .|..|.|++.+         ..++.|+|++|++++..+ ..|.++++|+.|+|++|.|++..|..|.++++
T Consensus        46 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  124 (452)
T 3zyi_A           46 CPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS  124 (452)
T ss_dssp             CCTTSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCCCCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCccc
Confidence            45566664 46889998643         358889999999997554 46999999999999999999988899999999


Q ss_pred             cccccccccccCCCCCC-cccccccceecCCCccCCCCCCCCccccccccceeccc
Q 006922          117 LCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLAN  171 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~  171 (625)
                      |++|+|++|++++..+. |..+++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus       125 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  180 (452)
T 3zyi_A          125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE  180 (452)
T ss_dssp             CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC
T ss_pred             CCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC
Confidence            99999999999976664 88899999999999999865554555555555555554

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.66  E-value=7.9e-17  Score=180.95  Aligned_cols=153  Identities=19%  Similarity=0.229  Sum_probs=132.9

Q ss_pred             CceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccccccccc
Q 006922           57 TGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF  127 (625)
Q Consensus        57 ~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  127 (625)
                      ..|.|+..+         ..++.|+|++|.+++ +++..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l  112 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI  112 (635)
T ss_dssp             TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence            457897643         358899999999985 6666799999999999999999998888899999999999999999


Q ss_pred             CCCCC-CcccccccceecCCCccCCCCCCCCccccccccceeccccccccc-CCCC--CCCCCcEEEcccCCCccccccc
Q 006922          128 SGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK-IPDL--NLPNLQQLNLANNNLSGSIPQS  203 (625)
Q Consensus       128 ~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~L~l~~N~l~g~~p~~  203 (625)
                      ++..+ .|..+++|++|+|++|+|++..+..|+++++|++|+|++|++++. +|..  .+++|+.|+|++|+|++..|..
T Consensus       113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence            97666 589999999999999999977777899999999999999999864 4543  6899999999999999888887


Q ss_pred             cccCCCC
Q 006922          204 LKRFPSS  210 (625)
Q Consensus       204 l~~~~~~  210 (625)
                      +..+..+
T Consensus       193 l~~L~~l  199 (635)
T 4g8a_A          193 LRVLHQM  199 (635)
T ss_dssp             GHHHHTC
T ss_pred             ccchhhh
Confidence            7765543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.65  E-value=2.3e-16  Score=176.67  Aligned_cols=165  Identities=20%  Similarity=0.192  Sum_probs=140.3

Q ss_pred             CCCCCCCCC-CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccc
Q 006922           46 WNESTSVCN-HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLK  115 (625)
Q Consensus        46 w~~~~~~c~-~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  115 (625)
                      |++..|.|. .+..|.|++.+         ..++.|+|++|.+++.. +..|+++++|++|+|++|.+++..|..|.+++
T Consensus         3 ~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~   81 (606)
T 3t6q_A            3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH   81 (606)
T ss_dssp             ---CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred             cccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCcc
Confidence            555566663 36678997642         36889999999999755 45699999999999999999999999999999


Q ss_pred             ccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceeccccccccc-CCCC-CCCCCcEEEcc
Q 006922          116 SLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK-IPDL-NLPNLQQLNLA  192 (625)
Q Consensus       116 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~-~l~~L~~L~l~  192 (625)
                      +|++|+|++|++++..| .|+.+++|++|+|++|++++..|..+.++++|++|+|++|++++. +|.. .+++|+.|+++
T Consensus        82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  161 (606)
T 3t6q_A           82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ  161 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECC
T ss_pred             ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcc
Confidence            99999999999998777 799999999999999999987788899999999999999999984 3543 78999999999


Q ss_pred             cCCCccccccccccCCCCc
Q 006922          193 NNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       193 ~N~l~g~~p~~l~~~~~~~  211 (625)
                      +|++++..|..++.++.+.
T Consensus       162 ~n~l~~~~~~~~~~l~~L~  180 (606)
T 3t6q_A          162 NNAIHYLSKEDMSSLQQAT  180 (606)
T ss_dssp             SSCCCEECHHHHHTTTTCC
T ss_pred             cCcccccChhhhhhhcccc
Confidence            9999988888777776543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.65  E-value=1.7e-16  Score=161.91  Aligned_cols=141  Identities=23%  Similarity=0.307  Sum_probs=90.5

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC-cccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP-SDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      .++.|+|++|.+.+ +|+. +..+++|++|+|++|.+++..+ ..+.++++|++|+|++|.+++..+ .+..+++|++|+
T Consensus        79 ~L~~L~Ls~n~i~~-l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  156 (306)
T 2z66_A           79 SLKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK  156 (306)
T ss_dssp             CCCEEECCSCSEEE-EEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred             ccCEEECCCCcccc-Chhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence            46667777777763 4433 6677777777777777766443 456667777777777777766555 356666777777


Q ss_pred             CCCccCCC-CCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC
Q 006922          145 LSDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS  209 (625)
Q Consensus       145 ls~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~  209 (625)
                      |++|.+++ .+|..+..+++|++|+|++|++++..|..  .+++|+.|+|++|++++..+..+..++.
T Consensus       157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  224 (306)
T 2z66_A          157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS  224 (306)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTT
T ss_pred             CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCccc
Confidence            77777665 45666666777777777777776655542  5666777777777776544444444433

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.65  E-value=2.4e-16  Score=176.20  Aligned_cols=149  Identities=20%  Similarity=0.226  Sum_probs=126.0

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLS  146 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls  146 (625)
                      +..+++.++.+. .+|+..+..+++|++|+|++|.|++..|..|.++++|++|+|++|.+++.+| .|+.+++|++|+|+
T Consensus        53 l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  131 (597)
T 3oja_B           53 QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE  131 (597)
T ss_dssp             CSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             ceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence            455677777765 5777778999999999999999999888899999999999999999998877 47999999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCCcccCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSI  217 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~~  217 (625)
                      +|.|++..+..|+++++|++|+|++|.+++.+|..  .+++|+.|+|++|.+++..+..+..+..+.+.+|.+
T Consensus       132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l  204 (597)
T 3oja_B          132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL  204 (597)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred             CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcc
Confidence            99999655556799999999999999999988863  789999999999999976555566665566666544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.64  E-value=5.7e-16  Score=153.32  Aligned_cols=133  Identities=23%  Similarity=0.275  Sum_probs=120.0

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      ..++.|+|++|.+.+. ++..|..+++|++|+|++|.|++..+..|..+++|++|+|++|++++..+. |..+++|+.|+
T Consensus        59 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  137 (251)
T 3m19_A           59 TKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR  137 (251)
T ss_dssp             TTCCEEECTTSCCCCC-CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             ccCCEEECCCCcCCcc-CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence            4688999999999975 455699999999999999999998888899999999999999999977764 78999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccc
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~  199 (625)
                      |++|+|++..+..|..+++|++|+|++|++++..+..  .+++|+.|+|++|++++.
T Consensus       138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            9999999777778999999999999999999877753  789999999999999876

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.64  E-value=1.5e-16  Score=156.19  Aligned_cols=167  Identities=16%  Similarity=0.250  Sum_probs=131.8

Q ss_pred             CCCCCCCCCCCCCce--EeCC------CCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCC-CCccCCccccccc
Q 006922           45 NWNESTSVCNHWTGV--KCSE------DGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNV-ITGYFPSDFINLK  115 (625)
Q Consensus        45 ~w~~~~~~c~~w~gv--~C~~------~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~  115 (625)
                      .|++..|.|..|.++  .|.+      -...++.|+|++|++++ +++..|.++++|++|+|++|. +++..+..|.+++
T Consensus         2 ~~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~   80 (239)
T 2xwt_C            2 GCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS   80 (239)
T ss_dssp             -CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCT
T ss_pred             CCCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCc
Confidence            367777888655664  4964      12358889999999985 555569999999999999997 8887777899999


Q ss_pred             ccccccccc-cccCCCCC-CcccccccceecCCCccCCCCCCCCcccccccc---ceecccc-cccccCCCC--CCCCCc
Q 006922          116 SLCYLYLQF-NNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE---ALYLANN-SLSGKIPDL--NLPNLQ  187 (625)
Q Consensus       116 ~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~---~L~l~~N-~l~~~~p~~--~l~~L~  187 (625)
                      +|++|+|++ |++++..+ .|..+++|++|++++|++++ +|. +..+++|+   .|++++| ++++..+..  .+++|+
T Consensus        81 ~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~  158 (239)
T 2xwt_C           81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET  158 (239)
T ss_dssp             TCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred             CCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcce
Confidence            999999998 99987665 58889999999999999986 676 88888888   9999999 898776652  688999


Q ss_pred             -EEEcccCCCcccccccccc---CCCCcccCC
Q 006922          188 -QLNLANNNLSGSIPQSLKR---FPSSAFVGN  215 (625)
Q Consensus       188 -~L~l~~N~l~g~~p~~l~~---~~~~~~~~n  215 (625)
                       .|++++|+++ .+|.....   +..+.+.+|
T Consensus       159 ~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n  189 (239)
T 2xwt_C          159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN  189 (239)
T ss_dssp             EEEECCSCCCC-EECTTTTTTCEEEEEECTTC
T ss_pred             eEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCC
Confidence             9999999998 66654322   233445555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.64  E-value=3.3e-16  Score=182.10  Aligned_cols=137  Identities=24%  Similarity=0.233  Sum_probs=120.1

Q ss_pred             ccCCCCccEEEecCCCCCccCCc-ccccccccccccccccccCCCC-----C-CcccccccceecCCCccCCCCCCCCcc
Q 006922           87 ISRLSALKILSLRSNVITGYFPS-DFINLKSLCYLYLQFNNFSGTL-----P-DFSVWKNLTIINLSDNGFNGTIPRSLS  159 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~-----p-~~~~l~~L~~L~ls~N~l~~~~p~~l~  159 (625)
                      +.++++|+.|+|++|.+++..+. .+..+++|+.|+|++|.+++..     + .|..+++|+.|+|++|+|++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            56899999999999999975443 4567899999999999997432     3 478899999999999999998888999


Q ss_pred             ccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCCCcccCCCCCCCCCC
Q 006922          160 NLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENL  223 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~~~~~~~~  223 (625)
                      .+++|+.|+|++|+|++.++..-.++|+.|+|++|+|++.+|..+.++..+.+.+|++.|++++
T Consensus       502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred             chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence            9999999999999999877765448999999999999999999999999999999999997754

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.64  E-value=2.1e-15  Score=144.69  Aligned_cols=156  Identities=26%  Similarity=0.294  Sum_probs=126.9

Q ss_pred             CceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cc
Q 006922           57 TGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FS  135 (625)
Q Consensus        57 ~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~  135 (625)
                      .+..|..     ..++..+++++. +|..   -.++|++|+|++|.+++..+..|.++++|++|+|++|++++..+. |.
T Consensus         3 ~~C~C~~-----~~v~c~~~~l~~-~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~   73 (208)
T 2o6s_A            3 SRCSCSG-----TTVECYSQGRTS-VPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN   73 (208)
T ss_dssp             TTCEEET-----TEEECCSSCCSS-CCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT
T ss_pred             CCCEECC-----CEEEecCCCccC-CCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcC
Confidence            3566754     246777888763 4533   356899999999999987777789999999999999999976664 78


Q ss_pred             cccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC---C
Q 006922          136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS---S  210 (625)
Q Consensus       136 ~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~  210 (625)
                      .+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..  .+++|+.|+|++|++++..+..+..+++   +
T Consensus        74 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  153 (208)
T 2o6s_A           74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI  153 (208)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEE
Confidence            9999999999999999776677899999999999999999877753  7899999999999999766655665554   5


Q ss_pred             cccCCCCCCCC
Q 006922          211 AFVGNSISFDE  221 (625)
Q Consensus       211 ~~~~n~~~~~~  221 (625)
                      .+.+|++.|..
T Consensus       154 ~l~~N~~~~~~  164 (208)
T 2o6s_A          154 WLHDNPWDCTC  164 (208)
T ss_dssp             ECCSCCBCCCT
T ss_pred             EecCCCeecCC
Confidence            66788877654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.64  E-value=1.9e-16  Score=180.28  Aligned_cols=179  Identities=22%  Similarity=0.294  Sum_probs=116.5

Q ss_pred             CChhHHHHHHHHHHhCC---CCCCCCCCCCCCCCCCCCceEeCCCCCeEEEEEcCCC------------------Cccc-
Q 006922           23 EPVEDKEALLDFVNNLP---HSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGV------------------GFSG-   80 (625)
Q Consensus        23 ~~~~~~~~ll~~~~~~~---~~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~------------------~l~g-   80 (625)
                      ....++++|+++.....   .....+|......+..|.++.++.  .+++.|+|.++                  .+.+ 
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~  206 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDED  206 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence            34557889999987652   222236754445555899888876  34555555333                  3322 


Q ss_pred             -------ccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCC
Q 006922           81 -------LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNG  152 (625)
Q Consensus        81 -------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~  152 (625)
                             .++++.+..++.|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+| .|..+++|++|+|++|+|+ 
T Consensus       207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-  283 (727)
T 4b8c_D          207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred             cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence                   134667899999999999999999 47888889999999999999999 555 7999999999999999999 


Q ss_pred             CCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccccccC
Q 006922          153 TIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQSLKRF  207 (625)
Q Consensus       153 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~l~~~  207 (625)
                      .+|..|+.|++|++|+|++|.|+ .+|. + .+++|+.|+|++|+|+|.+|..+..+
T Consensus       284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  339 (727)
T 4b8c_D          284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK  339 (727)
T ss_dssp             SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred             ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence            88999999999999999999998 5564 3 78999999999999999999877654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.63  E-value=3e-16  Score=165.88  Aligned_cols=150  Identities=20%  Similarity=0.233  Sum_probs=123.9

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l  145 (625)
                      .+..+++.++.+. .+|+..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|. +..+++|++|+|
T Consensus        46 ~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            4556777777765 57777789999999999999999998888999999999999999999988774 889999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCCcccCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSI  217 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~~  217 (625)
                      ++|+++...+..+..+++|++|+|++|++++..|..  .+++|+.|++++|++++.-...+..+..+.+.+|.+
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l  198 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL  198 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccc
Confidence            999999544445689999999999999999877763  789999999999999865445555555555555543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.63  E-value=6.1e-16  Score=166.22  Aligned_cols=155  Identities=25%  Similarity=0.323  Sum_probs=113.0

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcc-------------------------cccccccccc
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-------------------------FINLKSLCYL  120 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-------------------------~~~l~~L~~L  120 (625)
                      ..++.|+|++|.++ .+++..|..+++|++|+|++|.|++..+..                         |.++++|++|
T Consensus       112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  190 (440)
T 3zyj_A          112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL  190 (440)
T ss_dssp             SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred             ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence            35778888888887 455556888888888888888877655444                         4445556666


Q ss_pred             cccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcc
Q 006922          121 YLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG  198 (625)
Q Consensus       121 ~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g  198 (625)
                      +|++|+++ .+|.+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..  .+++|+.|+|++|+|++
T Consensus       191 ~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  269 (440)
T 3zyj_A          191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL  269 (440)
T ss_dssp             ECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred             cCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence            66666665 4556677777888888888888777778888888888888888888776653  67888888888888886


Q ss_pred             ccccccccCC---CCcccCCCCCCCCC
Q 006922          199 SIPQSLKRFP---SSAFVGNSISFDEN  222 (625)
Q Consensus       199 ~~p~~l~~~~---~~~~~~n~~~~~~~  222 (625)
                      ..+..+..++   .+.+.+|++.|++.
T Consensus       270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          270 LPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             cChhHhccccCCCEEEcCCCCccCCCC
Confidence            6555555544   45677888888775

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.63  E-value=5.1e-16  Score=155.88  Aligned_cols=150  Identities=20%  Similarity=0.240  Sum_probs=127.4

Q ss_pred             ceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccC
Q 006922           58 GVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFS  128 (625)
Q Consensus        58 gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  128 (625)
                      .|.|.+.+         ..++.|+|++|++++. ++..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++
T Consensus        11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   89 (276)
T 2z62_A           11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ   89 (276)
T ss_dssp             EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEE-CTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             eEEecCCCccccCCCCCCCccEEECCCCccccc-CHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence            46776532         2488999999999865 4446999999999999999999988888999999999999999999


Q ss_pred             CCCC-CcccccccceecCCCccCCCCCCCCccccccccceeccccccccc-CCCC--CCCCCcEEEcccCCCcccccccc
Q 006922          129 GTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK-IPDL--NLPNLQQLNLANNNLSGSIPQSL  204 (625)
Q Consensus       129 ~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~L~l~~N~l~g~~p~~l  204 (625)
                      +..+ .+..+++|++|++++|++++..+..+..+++|++|+|++|++++. +|..  .+++|+.|+|++|++++..+..+
T Consensus        90 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  169 (276)
T 2z62_A           90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  169 (276)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence            8776 689999999999999999977777899999999999999999873 4653  78999999999999997766666


Q ss_pred             ccCC
Q 006922          205 KRFP  208 (625)
Q Consensus       205 ~~~~  208 (625)
                      ..++
T Consensus       170 ~~l~  173 (276)
T 2z62_A          170 RVLH  173 (276)
T ss_dssp             HHHH
T ss_pred             hhhh
Confidence            5544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.63  E-value=9.6e-16  Score=153.62  Aligned_cols=135  Identities=27%  Similarity=0.343  Sum_probs=121.3

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      ..++.|+|++|.+++ +++..++.+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+. +..+++|+.|+
T Consensus        85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            468899999999996 4555689999999999999999998888899999999999999999977774 78999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccc
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p  201 (625)
                      |++|++++..+..+..+++|+.|+|++|++++.++..  .+++|+.|+|++|++++..|
T Consensus       164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            9999999877777899999999999999999887763  78999999999999987766

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.62  E-value=5.3e-16  Score=173.68  Aligned_cols=151  Identities=21%  Similarity=0.241  Sum_probs=133.0

Q ss_pred             CceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccccccccc
Q 006922           57 TGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNF  127 (625)
Q Consensus        57 ~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  127 (625)
                      ..|.|++.+         .+++.|+|++|.+++..+ ..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus        14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            458887532         468899999999987554 4699999999999999999998899999999999999999999


Q ss_pred             CCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccc-cCCCC--CCCCCcEEEcccCCCccccccc
Q 006922          128 SGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL--NLPNLQQLNLANNNLSGSIPQS  203 (625)
Q Consensus       128 ~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~--~l~~L~~L~l~~N~l~g~~p~~  203 (625)
                      ++..| .|..+++|++|+|++|++++..+..++++++|++|+|++|++++ .+|..  .+++|+.|+|++|++++..|..
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~  172 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND  172 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence            98877 69999999999999999998777889999999999999999986 55753  8999999999999999888877


Q ss_pred             cccCC
Q 006922          204 LKRFP  208 (625)
Q Consensus       204 l~~~~  208 (625)
                      ++.+.
T Consensus       173 ~~~l~  177 (606)
T 3vq2_A          173 LQFLR  177 (606)
T ss_dssp             THHHH
T ss_pred             hhhhh
Confidence            76554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.62  E-value=1.8e-15  Score=153.15  Aligned_cols=151  Identities=26%  Similarity=0.279  Sum_probs=121.6

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      .+++.|+|++|.+++. ++  .+.+++|++|+|++|.|+. +|..+..+++|++|+|++|++++..| .|..+++|+.|+
T Consensus        55 ~~L~~L~L~~n~l~~~-~~--~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~  130 (290)
T 1p9a_G           55 TRLTQLNLDRAELTKL-QV--DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY  130 (290)
T ss_dssp             TTCCEEECTTSCCCEE-EC--CSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCcc-cC--CCCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence            4578888999988864 32  3788899999999999985 77788889999999999999987766 588889999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCC---CCcccCCCCCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP---SSAFVGNSISF  219 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~---~~~~~~n~~~~  219 (625)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..  .+++|+.|+|++|+|+ .+|..+...+   .+.+.+|++.|
T Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            9999998766667788889999999999998665543  6888999999999998 6777665544   35667888888


Q ss_pred             CC
Q 006922          220 DE  221 (625)
Q Consensus       220 ~~  221 (625)
                      .+
T Consensus       210 ~c  211 (290)
T 1p9a_G          210 NC  211 (290)
T ss_dssp             SG
T ss_pred             cC
Confidence            65

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.62  E-value=3.6e-16  Score=175.08  Aligned_cols=154  Identities=21%  Similarity=0.207  Sum_probs=93.2

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCC-CC-CcccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LP-DFSVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~l  145 (625)
                      ++.|++++|.+.+..+...+..+++|++|++++|.+++..|..+.++++|++|+|++|++++. +| .+..+++|+.|+|
T Consensus       401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L  480 (606)
T 3vq2_A          401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL  480 (606)
T ss_dssp             CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEEC
Confidence            444555555555544434456666666666666666666666666666666666666666652 34 4566666666666


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCC----CCcccCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP----SSAFVGNSISF  219 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~----~~~~~~n~~~~  219 (625)
                      ++|++++..|..+..+++|+.|+|++|++++.+|..  .+++|+.|+|++|+|+ .+|..+..++    .+.+.+|++.|
T Consensus       481 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c  559 (606)
T 3vq2_A          481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVAC  559 (606)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred             CCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCccc
Confidence            666666666666666666666666666666655542  5666666666666666 5555554443    24556666666


Q ss_pred             CCC
Q 006922          220 DEN  222 (625)
Q Consensus       220 ~~~  222 (625)
                      +++
T Consensus       560 ~c~  562 (606)
T 3vq2_A          560 ICE  562 (606)
T ss_dssp             SST
T ss_pred             CCc
Confidence            554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.62  E-value=7.8e-16  Score=166.01  Aligned_cols=156  Identities=27%  Similarity=0.325  Sum_probs=116.7

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcc-------------------------cccccccccc
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-------------------------FINLKSLCYL  120 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-------------------------~~~l~~L~~L  120 (625)
                      ..+..|+|++|.+++ +++..|..+++|++|+|++|.|++..+..                         |.++++|++|
T Consensus       123 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  201 (452)
T 3zyi_A          123 ASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL  201 (452)
T ss_dssp             TTCCEEECCSSCCSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred             ccCCEEECCCCcCCc-cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence            357788888888884 55566888888888888888887655434                         4455666666


Q ss_pred             cccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcc
Q 006922          121 YLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG  198 (625)
Q Consensus       121 ~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g  198 (625)
                      +|++|++++ +|.+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..  .+++|+.|+|++|+|++
T Consensus       202 ~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  280 (452)
T 3zyi_A          202 NLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS  280 (452)
T ss_dssp             ECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             ECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence            666666663 466777778888888888888777888888888888888888888777653  67889999999999986


Q ss_pred             ccccccccCC---CCcccCCCCCCCCCC
Q 006922          199 SIPQSLKRFP---SSAFVGNSISFDENL  223 (625)
Q Consensus       199 ~~p~~l~~~~---~~~~~~n~~~~~~~~  223 (625)
                      ..+..+..++   .+.+.+|++.|++.+
T Consensus       281 ~~~~~~~~l~~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          281 LPHDLFTPLRYLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             CCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred             cChHHhccccCCCEEEccCCCcCCCCCc
Confidence            6655555544   456778988888753

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.62  E-value=3.9e-16  Score=168.37  Aligned_cols=152  Identities=25%  Similarity=0.354  Sum_probs=131.3

Q ss_pred             CCceEeCCCC--------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccC-Ccccccccccccccccccc
Q 006922           56 WTGVKCSEDG--------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYF-PSDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        56 w~gv~C~~~~--------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~  126 (625)
                      +..|.|+..+        .+++.|+|++|.+.+..| ..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+
T Consensus        12 ~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~   90 (455)
T 3v47_A           12 GYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ   90 (455)
T ss_dssp             TTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred             ccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence            4448898654        468999999999987655 46999999999999999998555 5679999999999999999


Q ss_pred             cCCCCC-CcccccccceecCCCccCCCCCCCC--ccccccccceecccccccccCCC--C-CCCCCcEEEcccCCCcccc
Q 006922          127 FSGTLP-DFSVWKNLTIINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPD--L-NLPNLQQLNLANNNLSGSI  200 (625)
Q Consensus       127 l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~L~l~~N~l~g~~  200 (625)
                      +++..| .|..+++|++|+|++|++++.+|..  +..+++|++|+|++|++++..|.  . .+++|+.|+|++|++++..
T Consensus        91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  170 (455)
T 3v47_A           91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC  170 (455)
T ss_dssp             TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCC
T ss_pred             cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccC
Confidence            998777 6999999999999999999865554  89999999999999999988776  2 7899999999999999988


Q ss_pred             ccccccCC
Q 006922          201 PQSLKRFP  208 (625)
Q Consensus       201 p~~l~~~~  208 (625)
                      |..+..+.
T Consensus       171 ~~~l~~l~  178 (455)
T 3v47_A          171 EEDLLNFQ  178 (455)
T ss_dssp             TTTSGGGT
T ss_pred             hhhhhccc
Confidence            88877653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=1.6e-15  Score=143.74  Aligned_cols=124  Identities=28%  Similarity=0.332  Sum_probs=105.4

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCcc
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNG  149 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~  149 (625)
                      ++++++++. .+|.. +  .++|++|+|++|.|+. +|..|.++++|+.|+|++|++++..+ .|..+++|+.|+|++|+
T Consensus        15 l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           15 VRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EECTTSCCS-SCCSC-C--CTTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            334445555 45543 3  3689999999999995 77899999999999999999998776 59999999999999999


Q ss_pred             CCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccc
Q 006922          150 FNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       150 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~  199 (625)
                      |++..|..|..+++|+.|+|++|+|++..+..  .+++|+.|+|++|+++..
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            99888889999999999999999999776653  789999999999999743

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.61  E-value=9.4e-16  Score=153.95  Aligned_cols=112  Identities=26%  Similarity=0.262  Sum_probs=79.4

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .++.|+|++|.+.+ +++..|..+++|++|+|++|.+++..|..|.++++|++|++++|++++..+ .+..+++|++|++
T Consensus        53 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  131 (276)
T 2z62_A           53 ELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (276)
T ss_dssp             TCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred             CCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence            46777777777764 344457777777777777777777666777777777777777777776555 5677777777777


Q ss_pred             CCccCCCC-CCCCccccccccceecccccccccCC
Q 006922          146 SDNGFNGT-IPRSLSNLTQLEALYLANNSLSGKIP  179 (625)
Q Consensus       146 s~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p  179 (625)
                      ++|++++. +|..+..+++|++|+|++|++++..+
T Consensus       132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A          132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             cCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            77777652 56677777777777777777765443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=3.5e-16  Score=162.05  Aligned_cols=134  Identities=11%  Similarity=0.099  Sum_probs=95.1

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC---------------hHH--------HHHHHHHHHcCCCCceecce
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---------------KRD--------FEQQMEIVGSIRHENVVELK  385 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------~~~--------~~~e~~~l~~l~h~niv~l~  385 (625)
                      .+.||+|+||.||+|...+|+.||||+++.....               ...        ..+|...|.++.+.++....
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~  179 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE  179 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            3579999999999999889999999998642110               111        12345555555433332211


Q ss_pred             eEEEecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCC
Q 006922          386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQY  465 (625)
Q Consensus       386 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~  465 (625)
                      -+..  ...++||||+++++|..+...           .....++.|++.+|.|||..+   ||||||||.|||+++++.
T Consensus       180 p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          180 PIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             EEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             eeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            1111  234799999999888665431           123567899999999999988   999999999999988773


Q ss_pred             ----------eeEeccccccccc
Q 006922          466 ----------GCVSDLGLTTITS  478 (625)
Q Consensus       466 ----------~kl~DfGla~~~~  478 (625)
                                +.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                      7899999876543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.61  E-value=5.6e-16  Score=167.12  Aligned_cols=132  Identities=26%  Similarity=0.245  Sum_probs=115.0

Q ss_pred             CCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceec
Q 006922           91 SALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYL  169 (625)
Q Consensus        91 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l  169 (625)
                      ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..| .|..+++|+.|+|++|++++..|..+..+++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            689999999999999899999999999999999999998777 6889999999999999999888888999999999999


Q ss_pred             ccccccccCCCC--CCCCCcEEEcccCCCccccccccccCC---CCcccCCCCCCCCC
Q 006922          170 ANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP---SSAFVGNSISFDEN  222 (625)
Q Consensus       170 ~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~---~~~~~~n~~~~~~~  222 (625)
                      ++|++++..|..  .+++|+.|+|++|+|++..+..+..++   .+.+.+|++.|..+
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            999999887763  789999999999999975555555554   46678899888764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.61  E-value=1.7e-15  Score=162.79  Aligned_cols=150  Identities=24%  Similarity=0.263  Sum_probs=114.5

Q ss_pred             CCCCCCCC-CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccc
Q 006922           47 NESTSVCN-HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS  116 (625)
Q Consensus        47 ~~~~~~c~-~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  116 (625)
                      ++..|.|. .|..|.|.+.+         ..++.|+|++|++.+..+ ..|.++++|++|+|++|.|++..+..|.++++
T Consensus        35 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~  113 (440)
T 3zyj_A           35 CPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN  113 (440)
T ss_dssp             CCSSSEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSS
T ss_pred             CCCCCEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCcc
Confidence            34556664 47789998642         346789999999986554 56999999999999999999988889999999


Q ss_pred             cccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCC--C-CCCCCcEEEcc
Q 006922          117 LCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--L-NLPNLQQLNLA  192 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~L~l~  192 (625)
                      |++|+|++|++++..+ .|..+++|+.|+|++|+|+...+..|..+++|++|+|++|+..+.++.  + .+++|+.|+|+
T Consensus       114 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  193 (440)
T 3zyj_A          114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA  193 (440)
T ss_dssp             CCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECT
T ss_pred             CCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCC
Confidence            9999999999997666 588899999999999999866666677777777777777443333332  1 55666666666


Q ss_pred             cCCCc
Q 006922          193 NNNLS  197 (625)
Q Consensus       193 ~N~l~  197 (625)
                      +|+++
T Consensus       194 ~n~l~  198 (440)
T 3zyj_A          194 MCNLR  198 (440)
T ss_dssp             TSCCS
T ss_pred             CCcCc
Confidence            66665

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.59  E-value=3.5e-15  Score=153.99  Aligned_cols=167  Identities=24%  Similarity=0.357  Sum_probs=129.7

Q ss_pred             CCCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccc
Q 006922           46 WNESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS  116 (625)
Q Consensus        46 w~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  116 (625)
                      +++..|.| +|..+.|++.+         ..++.|+|++|++.+. ++..|.++++|++|+|++|.+++..|..|.++++
T Consensus        26 ~cp~~c~c-~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  103 (332)
T 2ft3_A           26 MCPFGCHC-HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISEL-RKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK  103 (332)
T ss_dssp             CCCSSCEE-ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEE-CTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTT
T ss_pred             CCCCCCcc-cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCcc-CHhHhhCCCCCcEEECCCCccCccCHhHhhCcCC
Confidence            34555556 79999998532         3578899999999864 4556999999999999999999988999999999


Q ss_pred             cccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccc--cCCCC--CCCCCcEEEcc
Q 006922          117 LCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG--KIPDL--NLPNLQQLNLA  192 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~L~l~  192 (625)
                      |++|+|++|+++...+.+.  ++|++|++++|++++..+..+..+++|+.|++++|.++.  ..|..  .+ +|+.|+++
T Consensus       104 L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~  180 (332)
T 2ft3_A          104 LQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS  180 (332)
T ss_dssp             CCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCC
T ss_pred             CCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECc
Confidence            9999999999984444443  789999999999986656678899999999999999963  44442  34 78888888


Q ss_pred             cCCCcccccccc-ccCCCCcccCCCCC
Q 006922          193 NNNLSGSIPQSL-KRFPSSAFVGNSIS  218 (625)
Q Consensus       193 ~N~l~g~~p~~l-~~~~~~~~~~n~~~  218 (625)
                      +|++++ +|..+ ..+..+.+.+|.+.
T Consensus       181 ~n~l~~-l~~~~~~~L~~L~l~~n~i~  206 (332)
T 2ft3_A          181 EAKLTG-IPKDLPETLNELHLDHNKIQ  206 (332)
T ss_dssp             SSBCSS-CCSSSCSSCSCCBCCSSCCC
T ss_pred             CCCCCc-cCccccCCCCEEECCCCcCC
Confidence            888874 55433 34555556565543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.59  E-value=2.3e-15  Score=170.83  Aligned_cols=165  Identities=25%  Similarity=0.290  Sum_probs=138.7

Q ss_pred             CCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccc
Q 006922           51 SVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLY  121 (625)
Q Consensus        51 ~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~  121 (625)
                      |.| .+..|.|+..+         .+++.|+|++|++.+ +++..|+++++|++|+|++|.+++..|..|.++++|++|+
T Consensus         2 C~~-~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   79 (680)
T 1ziw_A            2 CTV-SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLN   79 (680)
T ss_dssp             --C-BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEE
T ss_pred             cee-ECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEE
Confidence            344 46678887532         468899999999987 5555699999999999999999999999999999999999


Q ss_pred             ccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcc
Q 006922          122 LQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSG  198 (625)
Q Consensus       122 L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g  198 (625)
                      |++|++++..+ .|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..  .+++|+.|++++|++++
T Consensus        80 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  159 (680)
T 1ziw_A           80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA  159 (680)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence            99999997666 5999999999999999999877789999999999999999999887763  79999999999999998


Q ss_pred             ccccccc-----cCCCCcccCCCC
Q 006922          199 SIPQSLK-----RFPSSAFVGNSI  217 (625)
Q Consensus       199 ~~p~~l~-----~~~~~~~~~n~~  217 (625)
                      ..|..+.     .+..+.+.+|.+
T Consensus       160 ~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          160 LKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             BCHHHHGGGTTCEESEEECTTCCC
T ss_pred             cCHHHhhccccccccEEECCCCcc
Confidence            7776543     344555666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.59  E-value=1.5e-15  Score=155.33  Aligned_cols=134  Identities=20%  Similarity=0.193  Sum_probs=64.3

Q ss_pred             eEEEEEcCCCCcccccC---cccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCC---CC--Cccccc
Q 006922           67 RVVAVRLPGVGFSGLIP---PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT---LP--DFSVWK  138 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~---~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p--~~~~l~  138 (625)
                      .++.|+|++|.+++..+   ...+..+++|++|+|++|.+++..|..|.++++|++|+|++|++.+.   .+  .+..++
T Consensus       118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~  197 (310)
T 4glp_A          118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP  197 (310)
T ss_dssp             CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred             CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence            34555555555554333   11233455555555555555555555555555555555555555431   11  123445


Q ss_pred             ccceecCCCccCCCCCCC----CccccccccceecccccccccCCCC--CC---CCCcEEEcccCCCcccccc
Q 006922          139 NLTIINLSDNGFNGTIPR----SLSNLTQLEALYLANNSLSGKIPDL--NL---PNLQQLNLANNNLSGSIPQ  202 (625)
Q Consensus       139 ~L~~L~ls~N~l~~~~p~----~l~~l~~L~~L~l~~N~l~~~~p~~--~l---~~L~~L~l~~N~l~g~~p~  202 (625)
                      +|++|+|++|+++ .++.    .++.+++|++|+|++|++++..|..  .+   ++|+.|+|++|+|+ .+|.
T Consensus       198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~  268 (310)
T 4glp_A          198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPK  268 (310)
T ss_dssp             CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred             CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhh
Confidence            5555555555554 1121    1234455555555555555543321  22   45555555555555 3443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.58  E-value=1.1e-15  Score=141.37  Aligned_cols=133  Identities=26%  Similarity=0.205  Sum_probs=109.3

Q ss_pred             CeEEEEEcCCCCcc-cccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-ccccccccee
Q 006922           66 KRVVAVRLPGVGFS-GLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTII  143 (625)
Q Consensus        66 ~~v~~l~l~~~~l~-g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L  143 (625)
                      ..++.|+|++|+++ +.+|.. +..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|. +..+++|++|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSC-CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             ccCCEEECCCCCCChhhHHHH-HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            35888999999988 777764 88899999999999999875  6788899999999999999887774 4558999999


Q ss_pred             cCCCccCCCCC-CCCccccccccceecccccccccCC----C-CCCCCCcEEEcccCCCcccccc
Q 006922          144 NLSDNGFNGTI-PRSLSNLTQLEALYLANNSLSGKIP----D-LNLPNLQQLNLANNNLSGSIPQ  202 (625)
Q Consensus       144 ~ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p----~-~~l~~L~~L~l~~N~l~g~~p~  202 (625)
                      +|++|+|++.. +..+..+++|+.|++++|.+++..+    . ..+++|+.|++++|.+. .+|.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99999998542 2678889999999999999987766    2 27889999999999886 4554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.58  E-value=1.2e-15  Score=170.68  Aligned_cols=143  Identities=22%  Similarity=0.204  Sum_probs=96.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcc-cccccccccccccccccCCCCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSD-FINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      .++.|++++|.+.+..|. .+..+++|+.|+|++|.+++..|.. +.++++|+.|+|++|.+++..| .+..+++|+.|+
T Consensus       377 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  455 (606)
T 3t6q_A          377 HLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN  455 (606)
T ss_dssp             TCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence            566777777777765443 4777777777777777777655443 6777777777777777776655 466677777777


Q ss_pred             CCCccCCCC---CCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCC
Q 006922          145 LSDNGFNGT---IPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS  210 (625)
Q Consensus       145 ls~N~l~~~---~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~  210 (625)
                      |++|++++.   .+..+..+++|++|+|++|++++.+|..  .+++|+.|+|++|++++..|..+..++.+
T Consensus       456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  526 (606)
T 3t6q_A          456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI  526 (606)
T ss_dssp             CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred             CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence            777777652   2345666777777777777777666543  56677777777777776666666665544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.58  E-value=1.3e-15  Score=165.76  Aligned_cols=146  Identities=21%  Similarity=0.170  Sum_probs=76.2

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccc-cccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFS-VWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~l  145 (625)
                      +..|+|++|.+++..+    ..+++|+.|+|++|.|++..|..|+++++|+.|+|++|.+++.+| .+. .+++|+.|+|
T Consensus       101 L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          101 IETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             CCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             cCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            4445555555554322    234555666666666665555555556666666666666655444 332 4555666666


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFD  220 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~  220 (625)
                      ++|.|++. |. +..+++|+.|+|++|.|++.+|.. .+++|+.|+|++|+|++ +|..+..++.   +.+.+|++.|+
T Consensus       177 s~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             CCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence            66665543 21 223555666666666665544443 45556666666666653 4544443332   34445555543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.57  E-value=4.6e-15  Score=152.94  Aligned_cols=147  Identities=22%  Similarity=0.310  Sum_probs=102.9

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL  117 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  117 (625)
                      ++..|.| +|+.+.|++.+         ..++.|+|++|++++. ++..|+++++|++|+|++|.+++..|..|.++++|
T Consensus        25 cp~~c~c-~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  102 (330)
T 1xku_A           25 CPFRCQC-HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL  102 (330)
T ss_dssp             CCTTCEE-ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             CCCCCcC-CCeEEEecCCCccccCccCCCCCeEEECCCCcCCEe-ChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCC
Confidence            3445556 79999998532         3577899999999864 45569999999999999999999889999999999


Q ss_pred             ccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccc--cCCCC--CCCCCcEEEccc
Q 006922          118 CYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG--KIPDL--NLPNLQQLNLAN  193 (625)
Q Consensus       118 ~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~L~l~~  193 (625)
                      ++|+|++|+++.....+.  ++|++|++++|++++..+..+..+++|+.|++++|.++.  ..+..  .+++|+.|++++
T Consensus       103 ~~L~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~  180 (330)
T 1xku_A          103 ERLYLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD  180 (330)
T ss_dssp             CEEECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred             CEEECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence            999999999984332332  566666666666665544455556666666666666542  22321  445555555555


Q ss_pred             CCCc
Q 006922          194 NNLS  197 (625)
Q Consensus       194 N~l~  197 (625)
                      |+++
T Consensus       181 n~l~  184 (330)
T 1xku_A          181 TNIT  184 (330)
T ss_dssp             SCCC
T ss_pred             Cccc
Confidence            5554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.57  E-value=4.8e-15  Score=164.42  Aligned_cols=153  Identities=24%  Similarity=0.305  Sum_probs=125.2

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCcc--CCcccccccccccccccccccCCCCC--Ccccccccc
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGY--FPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLT  141 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~  141 (625)
                      ..++.|+|++|.+++.+|. .++.+++|++|+|++|.+++.  +|..+.++++|++|+|++|++++.+|  .+..+++|+
T Consensus       353 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~  431 (562)
T 3a79_B          353 SSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL  431 (562)
T ss_dssp             CCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred             CCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence            4688899999999987765 489999999999999999973  34678899999999999999998566  378889999


Q ss_pred             eecCCCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccc-cccCCC---CcccCCC
Q 006922          142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQS-LKRFPS---SAFVGNS  216 (625)
Q Consensus       142 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~-l~~~~~---~~~~~n~  216 (625)
                      .|+|++|++++.+|..+.  ++|+.|+|++|+++...+.. .+++|+.|+|++|+|+ .+|.. +..++.   +.+.+|+
T Consensus       432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~  508 (562)
T 3a79_B          432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP  508 (562)
T ss_dssp             EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCC
T ss_pred             EEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCC
Confidence            999999999888877765  68999999999998543333 7889999999999999 56665 665554   5677888


Q ss_pred             CCCCCC
Q 006922          217 ISFDEN  222 (625)
Q Consensus       217 ~~~~~~  222 (625)
                      +.|+++
T Consensus       509 ~~c~c~  514 (562)
T 3a79_B          509 WDCTCP  514 (562)
T ss_dssp             BCCCHH
T ss_pred             cCCCcc
Confidence            888753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.56  E-value=3.6e-15  Score=167.39  Aligned_cols=156  Identities=22%  Similarity=0.249  Sum_probs=136.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCC-CCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG-TLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p-~~~~l~~L~~L~  144 (625)
                      .+..+++..++.....+...+..+.+|+.++++.|.+.+..|..+..+++|+.|+|++|++.. .+| .|..+++|++|+
T Consensus       421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~  500 (635)
T 4g8a_A          421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD  500 (635)
T ss_dssp             TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred             cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence            455667777777777777778999999999999999999999999999999999999998644 455 588999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccC----CCCcccCCCCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRF----PSSAFVGNSIS  218 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~----~~~~~~~n~~~  218 (625)
                      |++|+|++..|..|.++++|++|+|++|+|++..|..  .+++|+.|+|++|+|++..|..+..+    ..+.+.+|++.
T Consensus       501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~  580 (635)
T 4g8a_A          501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  580 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred             CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence            9999999998999999999999999999999887763  78999999999999999999888765    34678899999


Q ss_pred             CCCC
Q 006922          219 FDEN  222 (625)
Q Consensus       219 ~~~~  222 (625)
                      |++.
T Consensus       581 C~C~  584 (635)
T 4g8a_A          581 CTCE  584 (635)
T ss_dssp             CSGG
T ss_pred             ccCC
Confidence            9874

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.55  E-value=9.4e-15  Score=165.82  Aligned_cols=152  Identities=24%  Similarity=0.291  Sum_probs=119.0

Q ss_pred             EEEcCCCCcc--cccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCC----C-----Cccccc
Q 006922           70 AVRLPGVGFS--GLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTL----P-----DFSVWK  138 (625)
Q Consensus        70 ~l~l~~~~l~--g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----p-----~~~~l~  138 (625)
                      .|++.+|.+.  +.+| ..|..+++|+.|+|++|.|++..|..|.++++|++|+|++|++++..    |     .+..++
T Consensus       458 ~L~l~~n~l~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~  536 (680)
T 1ziw_A          458 RLMLRRVALKNVDSSP-SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS  536 (680)
T ss_dssp             EEECTTSCCBCTTCSS-CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCT
T ss_pred             cchhccccccccccCC-cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCC
Confidence            3344444433  3344 34888889999999999998877777888999999999999887532    1     378889


Q ss_pred             ccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccc----cccCCCCcc
Q 006922          139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQS----LKRFPSSAF  212 (625)
Q Consensus       139 ~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~----l~~~~~~~~  212 (625)
                      +|+.|+|++|+++...+..|..+++|+.|+|++|++++.++..  .+++|+.|+|++|+|++..|..    +.++..+.+
T Consensus       537 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l  616 (680)
T 1ziw_A          537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM  616 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEEC
T ss_pred             CCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEc
Confidence            9999999999998443446899999999999999999766653  7899999999999999877764    445667788


Q ss_pred             cCCCCCCCCC
Q 006922          213 VGNSISFDEN  222 (625)
Q Consensus       213 ~~n~~~~~~~  222 (625)
                      .+|++.|++.
T Consensus       617 ~~N~~~c~c~  626 (680)
T 1ziw_A          617 RFNPFDCTCE  626 (680)
T ss_dssp             TTCCCCBCCC
T ss_pred             cCCCcccCCc
Confidence            9999999875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.55  E-value=9.1e-16  Score=172.61  Aligned_cols=150  Identities=23%  Similarity=0.361  Sum_probs=127.3

Q ss_pred             CeEEEEEcCCCCcccc-----------------cCccccc--CCCCccEEEecCCCCCccCCcccccccccccccccccc
Q 006922           66 KRVVAVRLPGVGFSGL-----------------IPPNTIS--RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~  126 (625)
                      ..++.|+|++|.++|.                 +|+. ++  ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus       206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~  284 (636)
T 4eco_A          206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR  284 (636)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred             cCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence            3578899999999996                 8765 88  99999999999999999999999999999999999998


Q ss_pred             -cCC-CCC-Ccccc------cccceecCCCccCCCCCCC--CccccccccceecccccccccCCCC-CCCCCcEEEcccC
Q 006922          127 -FSG-TLP-DFSVW------KNLTIINLSDNGFNGTIPR--SLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANN  194 (625)
Q Consensus       127 -l~~-~~p-~~~~l------~~L~~L~ls~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N  194 (625)
                       ++| .+| .++.+      ++|++|+|++|+++ .+|.  .++++++|++|+|++|+++|.+|.. .+++|+.|+|++|
T Consensus       285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N  363 (636)
T 4eco_A          285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN  363 (636)
T ss_dssp             TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred             CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence             888 677 46655      89999999999999 8888  8999999999999999999888854 6788999999999


Q ss_pred             CCccccccccccCCC-C---cccCCCCC
Q 006922          195 NLSGSIPQSLKRFPS-S---AFVGNSIS  218 (625)
Q Consensus       195 ~l~g~~p~~l~~~~~-~---~~~~n~~~  218 (625)
                      +++ .+|..+..++. +   .+.+|.+.
T Consensus       364 ~l~-~lp~~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          364 QIT-EIPANFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             EEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred             ccc-cccHhhhhhcccCcEEEccCCcCc
Confidence            998 88887776655 3   44555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.55  E-value=3.4e-15  Score=142.00  Aligned_cols=142  Identities=18%  Similarity=0.328  Sum_probs=114.0

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCC-CCCcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT-LPDFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~l  145 (625)
                      +++.|+++++++. .+|  .+..+++|++|++++|.++.  +..+..+++|++|+|++|++++. ++.+..+++|++|+|
T Consensus        45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  119 (197)
T 4ezg_A           45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI  119 (197)
T ss_dssp             TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred             CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence            4778899999888 555  38899999999999997764  34788999999999999999874 447889999999999


Q ss_pred             CCccCCCCCCCCccccccccceeccccc-ccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNS-LSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNS  216 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~  216 (625)
                      ++|++++..|..+..+++|++|+|++|+ ++ .+|.. .+++|+.|++++|++++ ++ .+..++.   +.+.+|.
T Consensus       120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            9999998778888999999999999998 55 44543 78899999999999985 44 4555554   4445555

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.55  E-value=1.2e-15  Score=156.14  Aligned_cols=87  Identities=17%  Similarity=0.162  Sum_probs=39.3

Q ss_pred             CCCCccEEEecCCCCCccCCccc--ccccccccccccccccCCCCCCcccc-----cccceecCCCccCCCCCCCCcccc
Q 006922           89 RLSALKILSLRSNVITGYFPSDF--INLKSLCYLYLQFNNFSGTLPDFSVW-----KNLTIINLSDNGFNGTIPRSLSNL  161 (625)
Q Consensus        89 ~l~~L~~L~l~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~l-----~~L~~L~ls~N~l~~~~p~~l~~l  161 (625)
                      ++++|++|+|++|.+++.+|..+  ..+++|++|+|++|++++.++.+..+     ++|++|+|++|++++..|..++.+
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            34444444444444444444443  44444444444444444442123333     444444444444444444444444


Q ss_pred             ccccceeccccccc
Q 006922          162 TQLEALYLANNSLS  175 (625)
Q Consensus       162 ~~L~~L~l~~N~l~  175 (625)
                      ++|++|+|++|++.
T Consensus       173 ~~L~~L~Ls~N~l~  186 (312)
T 1wwl_A          173 PALSTLDLSDNPEL  186 (312)
T ss_dssp             SSCCEEECCSCTTC
T ss_pred             CCCCEEECCCCCcC
Confidence            44444444444443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.54  E-value=5.8e-15  Score=162.04  Aligned_cols=151  Identities=26%  Similarity=0.309  Sum_probs=105.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCc--cCCcccccccccccccccccccCCCCC--Ccccccccc
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITG--YFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLT  141 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~  141 (625)
                      ..++.|+|++|.+++.+|. .++.+++|++|+|++|.+++  .+|..+.++++|++|+|++|++++.+|  .+..+++|+
T Consensus       324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            3567777777777776665 37777788888888887775  445667777788888888888776555  366777788


Q ss_pred             eecCCCccCCCCCCCCccccccccceecccccccccCCC-C-CCCCCcEEEcccCCCccccccc-cccCCC---CcccCC
Q 006922          142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-L-NLPNLQQLNLANNNLSGSIPQS-LKRFPS---SAFVGN  215 (625)
Q Consensus       142 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p~~-l~~~~~---~~~~~n  215 (625)
                      .|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|. . .+++|+.|+|++|+|+ .+|.. +..++.   +.+.+|
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N  478 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN  478 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence            888888877776666554  57778888888777 4443 2 6777888888888887 45554 544443   456677


Q ss_pred             CCCCCC
Q 006922          216 SISFDE  221 (625)
Q Consensus       216 ~~~~~~  221 (625)
                      ++.|.+
T Consensus       479 ~~~c~c  484 (520)
T 2z7x_B          479 PWDCSC  484 (520)
T ss_dssp             CBCCCH
T ss_pred             CCcccC
Confidence            777654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.54  E-value=1.4e-14  Score=168.37  Aligned_cols=161  Identities=19%  Similarity=0.177  Sum_probs=130.8

Q ss_pred             CCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccC-CcccccccccccccccccccCCCCC-
Q 006922           55 HWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYF-PSDFINLKSLCYLYLQFNNFSGTLP-  132 (625)
Q Consensus        55 ~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p-  132 (625)
                      +|..|-+  -..+++.|+|++|.+++..+. .|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..| 
T Consensus        15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            4666666  225688999999999876554 5999999999999999666555 7789999999999999999998777 


Q ss_pred             CcccccccceecCCCccCCCCCCCC--ccccccccceecccccccccCCC--C-CCCCCcEEEcccCCCcccccccccc-
Q 006922          133 DFSVWKNLTIINLSDNGFNGTIPRS--LSNLTQLEALYLANNSLSGKIPD--L-NLPNLQQLNLANNNLSGSIPQSLKR-  206 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~L~l~~N~l~g~~p~~l~~-  206 (625)
                      .|..+++|++|+|++|.+++.+|..  +.++++|++|+|++|.+++..+.  . .+++|+.|+|++|.+++..|..+.. 
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            6899999999999999999877665  89999999999999999887653  2 7899999999999999888877654 


Q ss_pred             ----CCCCcccCCCCC
Q 006922          207 ----FPSSAFVGNSIS  218 (625)
Q Consensus       207 ----~~~~~~~~n~~~  218 (625)
                          +..+.+.+|.+.
T Consensus       172 ~~~~L~~L~L~~n~l~  187 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLY  187 (844)
T ss_dssp             HHCSSCCCEECCSBSC
T ss_pred             cCCccceEECCCCccc
Confidence                344455555543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.54  E-value=6.6e-15  Score=161.95  Aligned_cols=153  Identities=22%  Similarity=0.377  Sum_probs=119.2

Q ss_pred             CCCCCCCCCC----CCCce-EeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccc
Q 006922           45 NWNESTSVCN----HWTGV-KCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCY  119 (625)
Q Consensus        45 ~w~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  119 (625)
                      +|..+..+|.    .|.|+ .|..  .+++.|+|++|++++ +|+. +  +++|++|+|++|.|+. +|   ..+++|++
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~~-ip---~~l~~L~~  104 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALIS-LP---ELPASLEY  104 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCSC-CC---CCCTTCCE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCcc-cc---cccCCCCE
Confidence            5765666673    49999 7875  368899999999997 7765 4  3889999999999995 67   45789999


Q ss_pred             ccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccc
Q 006922          120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       120 L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~  199 (625)
                      |+|++|+|++ +|.+..  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ 
T Consensus       105 L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-  174 (571)
T 3cvr_A          105 LDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-  174 (571)
T ss_dssp             EECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-
T ss_pred             EEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-
Confidence            9999999997 555544  89999999999986 666   57889999999999987 555 67889999999999886 


Q ss_pred             cccccc-cCCCCcccCCCCC
Q 006922          200 IPQSLK-RFPSSAFVGNSIS  218 (625)
Q Consensus       200 ~p~~l~-~~~~~~~~~n~~~  218 (625)
                      +|. +. ++..+.+.+|.+.
T Consensus       175 lp~-l~~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          175 LPE-LPESLEALDVSTNLLE  193 (571)
T ss_dssp             CCC-CCTTCCEEECCSSCCS
T ss_pred             cch-hhCCCCEEECcCCCCC
Confidence            666 43 3444555666544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.54  E-value=2.2e-15  Score=136.36  Aligned_cols=123  Identities=26%  Similarity=0.241  Sum_probs=75.9

Q ss_pred             eEEEEEcCCCCcc-cccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           67 RVVAVRLPGVGFS-GLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~-g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      +++.|++++|+++ +.+|+ .++.+++|++|+|++|.+++.  ..+.++++|++|+|++|++++.+|. +..+++|++|+
T Consensus        18 ~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             cCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            4566666666666 55554 366666666777766666654  4566666666666666666665553 34466666666


Q ss_pred             CCCccCCCC-CCCCccccccccceecccccccccCC---C-C-CCCCCcEEEcc
Q 006922          145 LSDNGFNGT-IPRSLSNLTQLEALYLANNSLSGKIP---D-L-NLPNLQQLNLA  192 (625)
Q Consensus       145 ls~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p---~-~-~l~~L~~L~l~  192 (625)
                      +++|++++. .+..+..+++|++|++++|.+++..+   . . .+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666642 23556666666666666666665544   1 1 45666666654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.53  E-value=7.9e-15  Score=162.73  Aligned_cols=141  Identities=24%  Similarity=0.287  Sum_probs=73.7

Q ss_pred             eEEEEEcCCCCcccccC-cccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--Cccccccccee
Q 006922           67 RVVAVRLPGVGFSGLIP-PNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTII  143 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L  143 (625)
                      .++.|++++|.+++... +..+..+++|++|++++|.+.+..+ .+..+++|++|++++|.+.+..|  .+..+++|++|
T Consensus       348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  426 (570)
T 2z63_A          348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  426 (570)
T ss_dssp             TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred             CCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence            45566666666654320 1235555666666666665555332 25555555555555555554443  34555555555


Q ss_pred             cCCCccCCCCCCCCccccccccceeccccccc-ccCCCC--CCCCCcEEEcccCCCccccccccccCC
Q 006922          144 NLSDNGFNGTIPRSLSNLTQLEALYLANNSLS-GKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP  208 (625)
Q Consensus       144 ~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~  208 (625)
                      ++++|++++..|..+..+++|++|+|++|.++ +.+|..  .+++|+.|+|++|++++..|..+..++
T Consensus       427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  494 (570)
T 2z63_A          427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS  494 (570)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhccc
Confidence            55555555555555555555555555555554 334432  455555555555555544454444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.53  E-value=3e-15  Score=135.40  Aligned_cols=124  Identities=21%  Similarity=0.259  Sum_probs=108.1

Q ss_pred             CCCCccEEEecCCCCC-ccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccce
Q 006922           89 RLSALKILSLRSNVIT-GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL  167 (625)
Q Consensus        89 ~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  167 (625)
                      ..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            4578999999999999 78898999999999999999999977 889999999999999999998788888889999999


Q ss_pred             ecccccccccC--CCC-CCCCCcEEEcccCCCccccc---cccccCCCCccc
Q 006922          168 YLANNSLSGKI--PDL-NLPNLQQLNLANNNLSGSIP---QSLKRFPSSAFV  213 (625)
Q Consensus       168 ~l~~N~l~~~~--p~~-~l~~L~~L~l~~N~l~g~~p---~~l~~~~~~~~~  213 (625)
                      ++++|++++..  ... .+++|+.|++++|++++..+   ..+..++++...
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  145 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL  145 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEE
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccc
Confidence            99999999742  233 78999999999999997655   467777776543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.53  E-value=2.1e-14  Score=160.37  Aligned_cols=110  Identities=22%  Similarity=0.245  Sum_probs=99.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l  145 (625)
                      .+..|+|++|.+.+..+ ..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.+++.++. |+.+++|++|+|
T Consensus        76 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           76 QVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence            57789999999997544 4699999999999999999998888899999999999999999976665 689999999999


Q ss_pred             CCccCCCCCCCCccccccccceeccccccccc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGK  177 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~  177 (625)
                      ++|.|++..|..|+.+++|++|+|++|.+++.
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            99999988888999999999999999998763

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.53  E-value=1.4e-14  Score=160.68  Aligned_cols=144  Identities=20%  Similarity=0.234  Sum_probs=126.3

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      ..++.|+|++|++++.. +..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..| .|..+++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCCEEC-TTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccCccC-hhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            35889999999998754 4469999999999999999999888899999999999999999998776 689999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccc-cCCCC--CCCCCcEEEcccCCCccccccccccCCCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSG-KIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS  210 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~  210 (625)
                      +++|++++..+..++.+++|++|+|++|.+++ .+|..  .+++|+.|++++|++++..|..++.+..+
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  175 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM  175 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence            99999997666679999999999999999987 45653  79999999999999998777777665544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.53  E-value=4.2e-14  Score=147.76  Aligned_cols=157  Identities=22%  Similarity=0.272  Sum_probs=125.1

Q ss_pred             CCCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccc-cccccccccccccccC
Q 006922           50 TSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFNNFS  128 (625)
Q Consensus        50 ~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~  128 (625)
                      ...|  -....|..+     .+++.+++|.. +|.. +  ...++.|+|++|+|++..+..|. ++++|++|+|++|+|+
T Consensus         9 ~~~C--p~~C~C~~~-----~l~c~~~~l~~-iP~~-~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~   77 (361)
T 2xot_A            9 VVSC--PANCLCASN-----ILSCSKQQLPN-VPQS-L--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN   77 (361)
T ss_dssp             CTTC--CTTCEEETT-----EEECCSSCCSS-CCSS-C--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC
T ss_pred             CCCC--CCCCEECCC-----EEEeCCCCcCc-cCcc-C--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC
Confidence            3456  356778642     47888999885 6654 3  34689999999999998888787 9999999999999999


Q ss_pred             CCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcccccccc-
Q 006922          129 GTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSL-  204 (625)
Q Consensus       129 ~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l-  204 (625)
                      +..+ .|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..  .+++|+.|+|++|+|++..+..+ 
T Consensus        78 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~  157 (361)
T 2xot_A           78 FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK  157 (361)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC
T ss_pred             ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhc
Confidence            8776 5999999999999999999777778999999999999999999887753  78999999999999995333333 


Q ss_pred             --ccCCC---CcccCCCC
Q 006922          205 --KRFPS---SAFVGNSI  217 (625)
Q Consensus       205 --~~~~~---~~~~~n~~  217 (625)
                        ..++.   +.+.+|.+
T Consensus       158 ~~~~l~~L~~L~L~~N~l  175 (361)
T 2xot_A          158 DGNKLPKLMLLDLSSNKL  175 (361)
T ss_dssp             ----CTTCCEEECCSSCC
T ss_pred             CcccCCcCCEEECCCCCC
Confidence              33444   44445543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.52  E-value=3.2e-15  Score=172.01  Aligned_cols=149  Identities=20%  Similarity=0.309  Sum_probs=128.6

Q ss_pred             CeEEEEEcCCCCccc-----------------ccCccccc--CCCCccEEEecCCCCCccCCcccccccccccccccccc
Q 006922           66 KRVVAVRLPGVGFSG-----------------LIPPNTIS--RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g-----------------~~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~  126 (625)
                      ..++.|+|++|.++|                 .+|+. ++  +|++|++|+|++|.+.+.+|..|.++++|+.|+|++|+
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence            358889999999999                 47775 77  99999999999999999999999999999999999998


Q ss_pred             -cCC-CCC-Cccccc-------ccceecCCCccCCCCCCC--CccccccccceecccccccccCCCC-CCCCCcEEEccc
Q 006922          127 -FSG-TLP-DFSVWK-------NLTIINLSDNGFNGTIPR--SLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLAN  193 (625)
Q Consensus       127 -l~~-~~p-~~~~l~-------~L~~L~ls~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~  193 (625)
                       ++| .+| .++.++       +|+.|+|++|+|+ .+|.  .++++++|+.|+|++|+++ .+|.. .+++|+.|+|++
T Consensus       527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~  604 (876)
T 4ecn_A          527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY  604 (876)
T ss_dssp             TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred             CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence             998 676 455554       9999999999999 8898  8999999999999999999 77754 788999999999


Q ss_pred             CCCccccccccccCCC----CcccCCCCC
Q 006922          194 NNLSGSIPQSLKRFPS----SAFVGNSIS  218 (625)
Q Consensus       194 N~l~g~~p~~l~~~~~----~~~~~n~~~  218 (625)
                      |+++ .+|..+..++.    +.+.+|.+.
T Consensus       605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~  632 (876)
T 4ecn_A          605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLK  632 (876)
T ss_dssp             SCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred             Cccc-cchHHHhhccccCCEEECcCCCCC
Confidence            9999 89987776665    445556544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.52  E-value=9.1e-15  Score=135.12  Aligned_cols=124  Identities=21%  Similarity=0.247  Sum_probs=107.7

Q ss_pred             CCCCccEEEecCCCCC-ccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccce
Q 006922           89 RLSALKILSLRSNVIT-GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEAL  167 (625)
Q Consensus        89 ~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  167 (625)
                      ..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            4578999999999998 77898899999999999999999977 889999999999999999998788888889999999


Q ss_pred             ecccccccccC--CCC-CCCCCcEEEcccCCCccccc---cccccCCCCccc
Q 006922          168 YLANNSLSGKI--PDL-NLPNLQQLNLANNNLSGSIP---QSLKRFPSSAFV  213 (625)
Q Consensus       168 ~l~~N~l~~~~--p~~-~l~~L~~L~l~~N~l~g~~p---~~l~~~~~~~~~  213 (625)
                      +|++|++++..  +.. .+++|+.|++++|++++..+   ..+..++.+...
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  152 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL  152 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence            99999999754  233 78999999999999996554   367777766544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.52  E-value=9.5e-15  Score=143.28  Aligned_cols=151  Identities=16%  Similarity=0.172  Sum_probs=124.3

Q ss_pred             CeEEEEEcCCCC-cccccCcccccCCCCccEEEecC-CCCCccCCcccccccccccccccccccCCCCCCcccccccc--
Q 006922           66 KRVVAVRLPGVG-FSGLIPPNTISRLSALKILSLRS-NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT--  141 (625)
Q Consensus        66 ~~v~~l~l~~~~-l~g~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~--  141 (625)
                      .+++.|+|++|. ++ .+++..|..+++|++|+|++ |.+++..+..|.++++|++|+|++|++++ +|.+..+++|+  
T Consensus        55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L  132 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIF  132 (239)
T ss_dssp             TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSE
T ss_pred             CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccc
Confidence            468899999997 55 56776799999999999999 99999878889999999999999999997 67788888888  


Q ss_pred             -eecCCCc-cCCCCCCCCcccccccc-ceecccccccccCCCC-CCCCCcEEEcccCC-CccccccccccC-CC---Ccc
Q 006922          142 -IINLSDN-GFNGTIPRSLSNLTQLE-ALYLANNSLSGKIPDL-NLPNLQQLNLANNN-LSGSIPQSLKRF-PS---SAF  212 (625)
Q Consensus       142 -~L~ls~N-~l~~~~p~~l~~l~~L~-~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~-l~g~~p~~l~~~-~~---~~~  212 (625)
                       .|++++| ++++..+..|..+++|+ .|++++|+++...+.. ..++|+.|+|++|+ +++..+..+..+ +.   +.+
T Consensus       133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l  212 (239)
T 2xwt_C          133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDV  212 (239)
T ss_dssp             EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEEC
T ss_pred             cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEEC
Confidence             9999999 99977677799999999 9999999999443332 44789999999995 985556666655 54   444


Q ss_pred             cCCCCC
Q 006922          213 VGNSIS  218 (625)
Q Consensus       213 ~~n~~~  218 (625)
                      .+|.+.
T Consensus       213 ~~N~l~  218 (239)
T 2xwt_C          213 SQTSVT  218 (239)
T ss_dssp             TTCCCC
T ss_pred             CCCccc
Confidence            555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.52  E-value=1.8e-15  Score=154.74  Aligned_cols=134  Identities=23%  Similarity=0.275  Sum_probs=83.8

Q ss_pred             eEEEEEcCCCCcccccCcccc-cCCCCccEEEecCCCCCccCCcccccc-----cccccccccccccCCCCC-Ccccccc
Q 006922           67 RVVAVRLPGVGFSGLIPPNTI-SRLSALKILSLRSNVITGYFPSDFINL-----KSLCYLYLQFNNFSGTLP-DFSVWKN  139 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p-~~~~l~~  139 (625)
                      +++.|+|++|.+++.+|...+ +.+++|++|+|++|.+++. |..+..+     ++|++|+|++|++++..| .+..+++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            466677777777776665422 6677777777777777765 6666666     677777777777766554 5666777


Q ss_pred             cceecCCCccCCCC--CCCCc--cccccccceeccccccccc--CC-CC--CCCCCcEEEcccCCCccccc
Q 006922          140 LTIINLSDNGFNGT--IPRSL--SNLTQLEALYLANNSLSGK--IP-DL--NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       140 L~~L~ls~N~l~~~--~p~~l--~~l~~L~~L~l~~N~l~~~--~p-~~--~l~~L~~L~l~~N~l~g~~p  201 (625)
                      |++|+|++|++.+.  +|..+  ..+++|++|+|++|++++.  ++ ..  .+++|+.|+|++|++++.+|
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence            77777777776553  22222  5666666666666666631  11 11  45666666666666665553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.52  E-value=2.7e-14  Score=135.26  Aligned_cols=126  Identities=28%  Similarity=0.356  Sum_probs=107.6

Q ss_pred             cEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceeccccc
Q 006922           94 KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNS  173 (625)
Q Consensus        94 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~  173 (625)
                      +.+++++|.++. +|..+.  ++|++|+|++|+++.....|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            579999999996 676653  68999999999998544479999999999999999998888889999999999999999


Q ss_pred             ccccCCCC--CCCCCcEEEcccCCCccccccccccCC---CCcccCCCCCCCCC
Q 006922          174 LSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP---SSAFVGNSISFDEN  222 (625)
Q Consensus       174 l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~---~~~~~~n~~~~~~~  222 (625)
                      |++..|..  .+++|+.|+|++|+|++..+..+..++   .+.+.+|++.|++.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            99888753  789999999999999965555566554   46778999998764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.52  E-value=8.3e-15  Score=159.27  Aligned_cols=148  Identities=17%  Similarity=0.183  Sum_probs=86.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCc----------------ccccccccccccccccccCCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPS----------------DFINLKSLCYLYLQFNNFSGT  130 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~----------------~~~~l~~L~~L~L~~N~l~~~  130 (625)
                      .+..|+|++|.+++..|   ++.+++|++|+|++|.|++..+.                ....+++|+.|+|++|.+++.
T Consensus        59 ~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~  135 (487)
T 3oja_A           59 KLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML  135 (487)
T ss_dssp             TCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred             CCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence            35556666666655432   55555555555555555432111                001234455555555666555


Q ss_pred             CC-CcccccccceecCCCccCCCCCCCCcc-ccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCC
Q 006922          131 LP-DFSVWKNLTIINLSDNGFNGTIPRSLS-NLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFP  208 (625)
Q Consensus       131 ~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~  208 (625)
                      .| .++.+++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++..+...+++|+.|+|++|+|++. |..+..++
T Consensus       136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~  214 (487)
T 3oja_A          136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA  214 (487)
T ss_dssp             GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred             CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCC-CHhHcCCC
Confidence            44 466667777777777777766666664 5677777777777777664444677777788888877753 33355444


Q ss_pred             C---CcccCCCCC
Q 006922          209 S---SAFVGNSIS  218 (625)
Q Consensus       209 ~---~~~~~n~~~  218 (625)
                      .   +.+.+|.+.
T Consensus       215 ~L~~L~Ls~N~l~  227 (487)
T 3oja_A          215 GVTWISLRNNKLV  227 (487)
T ss_dssp             TCSEEECTTSCCC
T ss_pred             CccEEEecCCcCc
Confidence            4   344455433

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.51  E-value=1.1e-14  Score=160.98  Aligned_cols=152  Identities=20%  Similarity=0.236  Sum_probs=86.4

Q ss_pred             eEEEEEcCCCCcccccCc--ccccCCCCccEEEecCCCCCccCC--cccccccccccccccccccCCCCCCcccccccce
Q 006922           67 RVVAVRLPGVGFSGLIPP--NTISRLSALKILSLRSNVITGYFP--SDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTI  142 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~--~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~  142 (625)
                      .++.|+|++|.+.+.+|+  ..++.+++|++|+|++|.+++..+  ..+..+++|++|+|++|++++.++.+..+++|++
T Consensus       335 ~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~  414 (549)
T 2z81_A          335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRF  414 (549)
T ss_dssp             TCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCE
T ss_pred             cccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccE
Confidence            456677777777665542  235666777777777777765322  3466677777777777777643335666666666


Q ss_pred             ecCCCccCCCCCCCCc------------------cccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccc
Q 006922          143 INLSDNGFNGTIPRSL------------------SNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQS  203 (625)
Q Consensus       143 L~ls~N~l~~~~p~~l------------------~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~  203 (625)
                      |+|++|+++. +|..+                  ..+++|++|+|++|+|+ .+|.. .+++|+.|+|++|+|++.+|..
T Consensus       415 L~Ls~N~l~~-l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~  492 (549)
T 2z81_A          415 LNLSSTGIRV-VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGI  492 (549)
T ss_dssp             EECTTSCCSC-CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTG
T ss_pred             EECCCCCccc-ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHH
Confidence            6666666652 23222                  23455555555555555 33332 4555666666666666555544


Q ss_pred             cccCCC---CcccCCCCCCC
Q 006922          204 LKRFPS---SAFVGNSISFD  220 (625)
Q Consensus       204 l~~~~~---~~~~~n~~~~~  220 (625)
                      +..++.   +.+.+|++.|+
T Consensus       493 ~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          493 FDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             GGGCTTCCEEECCSSCBCCC
T ss_pred             HhcCcccCEEEecCCCccCC
Confidence            444333   34455555554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.51  E-value=1.7e-14  Score=156.58  Aligned_cols=145  Identities=26%  Similarity=0.236  Sum_probs=127.8

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      ..++.|+|++|.+++..| ..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++.+| .|..+++|+.|+
T Consensus        56 ~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  134 (477)
T 2id5_A           56 PHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE  134 (477)
T ss_dssp             TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence            468899999999997655 469999999999999999998777778999999999999999998777 689999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCC--CCCCCCcEEEcccCCCccccccccccCCCCc
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~  211 (625)
                      |++|.+++..|..|..+++|+.|+|++|++++..+.  ..+++|+.|+|++|.+++..+..+..++.+.
T Consensus       135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~  203 (477)
T 2id5_A          135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK  203 (477)
T ss_dssp             ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred             CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence            999999988888999999999999999999976554  2789999999999999987777777766543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.49  E-value=1.3e-13  Score=142.32  Aligned_cols=146  Identities=25%  Similarity=0.377  Sum_probs=96.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCC--ccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVIT--GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ++.|++++|.+.+ +++..|..+++|+.|++++|.++  +..|..+..+ +|++|++++|++++....+.  ++|+.|++
T Consensus       125 L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l  200 (332)
T 2ft3_A          125 LVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHL  200 (332)
T ss_dssp             CCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBC
T ss_pred             CCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEEC
Confidence            4444455555442 33444566666666666666664  2455555555 66666666666654322222  67888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCC---cccCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSIS  218 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~~  218 (625)
                      ++|++++..+..+..+++|+.|+|++|++++..+..  .+++|+.|+|++|+++ .+|..+..++.+   .+.+|.+.
T Consensus       201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~  277 (332)
T 2ft3_A          201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT  277 (332)
T ss_dssp             CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCC
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCC
Confidence            888888777778888888888888888888776642  6788888888888888 778777766654   44555544

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.49  E-value=2e-14  Score=136.56  Aligned_cols=127  Identities=20%  Similarity=0.276  Sum_probs=107.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .++.|++++|.+..  ++ .+..+++|++|++++|.+++..|..|..+++|++|+|++|++++..| .+..+++|++|+|
T Consensus        67 ~L~~L~l~~n~~~~--~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  143 (197)
T 4ezg_A           67 NIKDLTINNIHATN--YN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL  143 (197)
T ss_dssp             TCSEEEEESCCCSC--CG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred             CCCEEEccCCCCCc--ch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence            57889999996653  33 59999999999999999998888899999999999999999997555 6889999999999


Q ss_pred             CCcc-CCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCcc
Q 006922          146 SDNG-FNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       146 s~N~-l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g  198 (625)
                      ++|. ++ .+| .+..+++|+.|++++|++++..+-..+++|+.|++++|++.+
T Consensus       144 ~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          144 SYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred             cCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence            9998 65 566 689999999999999999975433489999999999999864

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.48  E-value=1.1e-14  Score=148.74  Aligned_cols=140  Identities=20%  Similarity=0.186  Sum_probs=99.5

Q ss_pred             EEEEEcCCCCcccccCcccc-cCCCCccEEEecCCCCCccCC----cccccccccccccccccccCCCCC-Ccccccccc
Q 006922           68 VVAVRLPGVGFSGLIPPNTI-SRLSALKILSLRSNVITGYFP----SDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLT  141 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~-~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~  141 (625)
                      ++.|+|.+|.+.+..|...+ ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++++.++ .+..+++|+
T Consensus        93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  172 (310)
T 4glp_A           93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT  172 (310)
T ss_dssp             CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred             eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence            77778888888877776522 778888888888888877555    344567788888888888877665 577788888


Q ss_pred             eecCCCccCCCC--C--CCCccccccccceecccccccccCCC---C--CCCCCcEEEcccCCCccccccccccC
Q 006922          142 IINLSDNGFNGT--I--PRSLSNLTQLEALYLANNSLSGKIPD---L--NLPNLQQLNLANNNLSGSIPQSLKRF  207 (625)
Q Consensus       142 ~L~ls~N~l~~~--~--p~~l~~l~~L~~L~l~~N~l~~~~p~---~--~l~~L~~L~l~~N~l~g~~p~~l~~~  207 (625)
                      +|+|++|++.+.  +  +..+..+++|++|+|++|+++...+.   .  .+++|+.|+|++|+|++.+|..+..+
T Consensus       173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            888888887642  2  22346777888888888888632221   1  56788888888888887777665544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.48  E-value=6.1e-14  Score=141.87  Aligned_cols=143  Identities=26%  Similarity=0.369  Sum_probs=109.2

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..++.|+|++|.+++.. +  +..+++|++|+|++|.+++ +| .+..+++|++|+|++|++++ ++.+..+++|+.|++
T Consensus        68 ~~L~~L~L~~n~l~~~~-~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~~~l~~l~~L~~L~l  141 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTDIK-P--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYL  141 (291)
T ss_dssp             TTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEEC
T ss_pred             CCCCEEEccCCccCCCc-c--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-ChhhcCCCCCCEEEc
Confidence            35778888888888643 2  8888888888888888886 33 48888888888888888885 477888888888889


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      ++|++++.  ..+..+++|+.|+|++|++++..+-..+++|+.|+|++|++++ +|. +..++.   +.+.+|++.
T Consensus       142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEE
T ss_pred             cCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCccc
Confidence            88888854  5678888888899998888877664478888889999988874 443 555544   344455543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.48  E-value=4.5e-14  Score=156.52  Aligned_cols=139  Identities=26%  Similarity=0.247  Sum_probs=112.8

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..++.|+|++|.+++. ++..|+++++|++|+|++|.|++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISEL-RMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC-PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCC-CGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC-CCTTCSEEEC
T ss_pred             CCcCEEECCCCCcccc-ChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc-ccccCCEEEC
Confidence            3578899999998864 4556899999999999999999888888999999999999999998 55644 7889999999


Q ss_pred             CCccCCC-CCCCCccccccccceecccccccccCCCCCCCCC--cEEEcccCCC--ccccccccccCC
Q 006922          146 SDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNL--QQLNLANNNL--SGSIPQSLKRFP  208 (625)
Q Consensus       146 s~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L--~~L~l~~N~l--~g~~p~~l~~~~  208 (625)
                      ++|++++ .+|..|+++++|++|+|++|++++. .-..+++|  +.|++++|++  ++..|..+..+.
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~  195 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN  195 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC-chhhhhhceeeEEEeecccccccccCcccccccC
Confidence            9999986 3467889999999999999998752 21245555  9999999999  888888777654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.48  E-value=1e-13  Score=141.36  Aligned_cols=143  Identities=25%  Similarity=0.385  Sum_probs=105.9

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      .+++.|+|++|.+.+. ++  +..+++|++|+|++|.+++. | .+..+++|++|+|++|++++ ++.+..+++|+.|++
T Consensus        63 ~~L~~L~L~~n~i~~~-~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l  136 (308)
T 1h6u_A           63 NNLIGLELKDNQITDL-AP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYL  136 (308)
T ss_dssp             TTCCEEECCSSCCCCC-GG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGGGTTCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCCC-hh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chhhcCCCCCCEEEC
Confidence            3577888888888754 33  88888888888888888863 3 58888888888888888875 455888888888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      ++|++++..+  +..+++|+.|+|++|++++..+-..+++|+.|+|++|++++..+  +..++.   +.+.+|.+.
T Consensus       137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             CSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCC
T ss_pred             CCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccC
Confidence            8888875433  77888888888888888865553477888888888888875443  444443   445555544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.47  E-value=1.2e-13  Score=145.72  Aligned_cols=110  Identities=22%  Similarity=0.254  Sum_probs=96.8

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l  145 (625)
                      +++.|+|++|.+.+. ++..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+. |..+++|++|+|
T Consensus        70 ~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  148 (390)
T 3o6n_A           70 QVELLNLNDLQIEEI-DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  148 (390)
T ss_dssp             CCSEEECTTSCCCEE-CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCcEEECCCCccccc-ChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence            577899999998864 455699999999999999999998888899999999999999999965554 688999999999


Q ss_pred             CCccCCCCCCCCccccccccceeccccccccc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGK  177 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~  177 (625)
                      ++|++++..|..+..+++|++|++++|++++.
T Consensus       149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            99999988788899999999999999998753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.47  E-value=1.8e-14  Score=147.73  Aligned_cols=146  Identities=21%  Similarity=0.180  Sum_probs=99.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Cc-ccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DF-SVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~-~~l~~L~~L~l  145 (625)
                      +..|++++|.+++..    ...+++|++|+|++|.+++..|..+..+++|++|+|++|++++..+ .+ ..+++|++|+|
T Consensus       101 L~~L~l~~n~l~~~~----~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L  176 (317)
T 3o53_A          101 IETLHAANNNISRVS----CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (317)
T ss_dssp             CCEEECCSSCCSEEE----ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             cCEEECCCCccCCcC----ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence            445555666665432    2346778888888888887767777778888888888888876554 33 35777888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFD  220 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~  220 (625)
                      ++|++++. |. ...+++|++|+|++|++++.++.. .+++|+.|+|++|+|+ .+|..+..++.   +.+.+|++.|+
T Consensus       177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence            88887744 32 234777888888888887665554 6777888888888887 56666655444   45566776654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.47  E-value=7.6e-14  Score=138.98  Aligned_cols=142  Identities=24%  Similarity=0.283  Sum_probs=106.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++.+|+++. ++  .++.+++|+.|+|++|.|++..|  +.++++|++|+|++|++++ +|.+.. ++|+.|+|+
T Consensus        42 ~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~  114 (263)
T 1xeu_A           42 GVQNFNGDNSNIQS-LA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLD  114 (263)
T ss_dssp             TCSEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECC
T ss_pred             cCcEEECcCCCccc-ch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc-CcccEEEcc
Confidence            47778888888874 44  48888899999999998887544  8888889999999998886 444444 888899999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      +|++++. + .+..+++|+.|+|++|++++..+-..+++|+.|+|++|++++.  ..+..++.   +.+.+|++.+
T Consensus       115 ~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          115 NNELRDT-D-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             SSCCSBS-G-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             CCccCCC-h-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            9988853 3 5888888999999999888753223788888999999988865  44555544   3455565443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.47  E-value=5.3e-14  Score=155.31  Aligned_cols=118  Identities=19%  Similarity=0.220  Sum_probs=72.4

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      +..|+|++|++++ +| . |+.|++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +|.++.+++|+.|+|++
T Consensus       443 L~~L~Ls~n~l~~-lp-~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LC-H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCN  517 (567)
T ss_dssp             CSEEECTTSCCSS-CC-C-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCS
T ss_pred             ceEEEecCCCCCC-Cc-C-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCC
Confidence            4446666666665 43 2 666666666666666666 356666666666666666666665 44666666666666666


Q ss_pred             ccCCCCC-CCCccccccccceecccccccccCCCC-----CCCCCcEEE
Q 006922          148 NGFNGTI-PRSLSNLTQLEALYLANNSLSGKIPDL-----NLPNLQQLN  190 (625)
Q Consensus       148 N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~L~  190 (625)
                      |+|++.. |..++.+++|+.|+|++|.|++.+|..     .+++|+.|+
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            6666554 666666666666666666666655532     255666554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.47  E-value=1.4e-13  Score=141.81  Aligned_cols=147  Identities=24%  Similarity=0.334  Sum_probs=97.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCC--ccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVIT--GYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ++.|++++|.+.+ +++..+.++++|+.|++++|.+.  +..+..+.++++|++|++++|.++.....+.  ++|+.|++
T Consensus       123 L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l  199 (330)
T 1xku_A          123 LQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHL  199 (330)
T ss_dssp             CCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEEC
T ss_pred             ccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEEC
Confidence            4445555555543 33444667777777777777775  3556667777777777777777764332332  67777788


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCC---cccCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSIS  218 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~~  218 (625)
                      ++|++++..|..+..+++|+.|+|++|.+++..+..  .+++|+.|+|++|+++ .+|..+..++.+   .+.+|.+.
T Consensus       200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~  276 (330)
T 1xku_A          200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  276 (330)
T ss_dssp             TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence            888777766777777888888888888887766642  6777888888888887 677766665543   44455543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.46  E-value=1.1e-13  Score=128.13  Aligned_cols=103  Identities=27%  Similarity=0.362  Sum_probs=74.6

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecCCCcc
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNG  149 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~  149 (625)
                      +++++++++. +|.. +  .++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+. |..+++|++|+|++|+
T Consensus        14 l~~s~n~l~~-ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           14 VDCSGKSLAS-VPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             EECTTSCCSS-CCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcCc-cCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            4444555553 5543 3  37888888888888887788888888888888888888866663 5777888888888888


Q ss_pred             CCCCCCCCccccccccceeccccccccc
Q 006922          150 FNGTIPRSLSNLTQLEALYLANNSLSGK  177 (625)
Q Consensus       150 l~~~~p~~l~~l~~L~~L~l~~N~l~~~  177 (625)
                      |++..+..|..+++|+.|+|++|.++..
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            8765555677777777777777766643

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.46  E-value=6.6e-15  Score=167.54  Aligned_cols=138  Identities=24%  Similarity=0.295  Sum_probs=117.7

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      ..+..|+|++|.+. .+|+. +..|++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+| .|+.+++|++|+
T Consensus       224 ~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~  299 (727)
T 4b8c_D          224 QLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY  299 (727)
T ss_dssp             CCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred             CCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence            46888999999998 78776 679999999999999999 68999999999999999999999 555 799999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCCCC--CC-CCCcEEEcccCCCccccccccccCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NL-PNLQQLNLANNNLSGSIPQSLKRFP  208 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l-~~L~~L~l~~N~l~g~~p~~l~~~~  208 (625)
                      |++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..  .+ ..+..|+|++|.++|.+|..+..+.
T Consensus       300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~  365 (727)
T 4b8c_D          300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE  365 (727)
T ss_dssp             CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred             CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence            9999998 78999999999999999999999988863  11 1223578999999999998776553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.45  E-value=1.3e-13  Score=140.77  Aligned_cols=144  Identities=27%  Similarity=0.452  Sum_probs=120.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      .+++.|+|++|.+.+. +  .+..+++|++|+|++|.+++ +| .+..+++|++|+|++|++++..+ +..+++|+.|+|
T Consensus        85 ~~L~~L~L~~n~l~~~-~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l  158 (308)
T 1h6u_A           85 TKITELELSGNPLKNV-S--AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSI  158 (308)
T ss_dssp             CSCCEEECCSCCCSCC-G--GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCCc-h--hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEc
Confidence            4689999999999863 3  49999999999999999998 44 39999999999999999986544 889999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      ++|++++..+  +..+++|+.|+|++|++++..+-..+++|+.|+|++|++++..|  +..++.   +.+.+|++.+
T Consensus       159 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          159 GNAQVSDLTP--LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             cCCcCCCChh--hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            9999996443  89999999999999999976664488999999999999996554  555554   4555666543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.45  E-value=1.2e-13  Score=139.70  Aligned_cols=141  Identities=30%  Similarity=0.438  Sum_probs=118.9

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      +++.|++.++++... +  .+..+++|++|+|++|.+++..+  +.++++|++|+|++|++++ +|.+..+++|++|+|+
T Consensus        47 ~L~~L~l~~~~i~~~-~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~  120 (291)
T 1h6t_A           47 SIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLE  120 (291)
T ss_dssp             TCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECT
T ss_pred             cccEEEccCCCcccC-h--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECC
Confidence            478899999998754 3  38999999999999999998544  9999999999999999986 6779999999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCCC---cccCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPSS---AFVGNSIS  218 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~~---~~~~n~~~  218 (625)
                      +|++++.  ..+..+++|+.|+|++|++++. +.. .+++|+.|+|++|++++..|  +..++.+   .+.+|.+.
T Consensus       121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          121 HNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             TSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            9999863  4688999999999999999976 443 78999999999999997655  6666554   45556543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.45  E-value=2.8e-14  Score=146.21  Aligned_cols=143  Identities=17%  Similarity=0.132  Sum_probs=116.7

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      ..++.|+|++|.+++.      ...++|++|++++|.+++..+.   .+++|++|+|++|++++..+ .+..+++|++|+
T Consensus        80 ~~L~~L~Ls~n~l~~l------~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  150 (317)
T 3o53_A           80 STLRTLDLNNNYVQEL------LVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD  150 (317)
T ss_dssp             TTCCEEECCSSEEEEE------EECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred             CCCCEEECcCCccccc------cCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence            4688899999998853      2348999999999999986544   36789999999999998777 688899999999


Q ss_pred             CCCccCCCCCCCCc-cccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          145 LSDNGFNGTIPRSL-SNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       145 ls~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      |++|++++..+..+ ..+++|++|+|++|.+++..+...+++|+.|+|++|++++ +|..+..++.   +.+.+|.+.
T Consensus       151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~  227 (317)
T 3o53_A          151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV  227 (317)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred             CCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc
Confidence            99999998777776 4789999999999999977555578999999999999995 5555666554   455566554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.45  E-value=3.4e-14  Score=147.93  Aligned_cols=151  Identities=21%  Similarity=0.245  Sum_probs=125.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--Cccccccccee
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTII  143 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L  143 (625)
                      ..++.|+|++|.+++.. +..|+++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+  .+..+++|++|
T Consensus        76 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           76 VNLQALVLTSNGINTIE-EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCCCEEECCCCccCccC-HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence            46889999999999754 4569999999999999999998655559999999999999999996554  58899999999


Q ss_pred             cCCCc-cCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccc----cccCCCCcccCCC
Q 006922          144 NLSDN-GFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQS----LKRFPSSAFVGNS  216 (625)
Q Consensus       144 ~ls~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~----l~~~~~~~~~~n~  216 (625)
                      ++++| .+++..+..+..+++|++|++++|++++..|..  .+++|+.|++++|+++ .+|..    +.++..+.+.+|.
T Consensus       155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~  233 (353)
T 2z80_A          155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD  233 (353)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCB
T ss_pred             ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCc
Confidence            99999 577666788999999999999999999987764  7899999999999996 45543    2344445666665


Q ss_pred             CC
Q 006922          217 IS  218 (625)
Q Consensus       217 ~~  218 (625)
                      +.
T Consensus       234 l~  235 (353)
T 2z80_A          234 LD  235 (353)
T ss_dssp             CT
T ss_pred             cc
Confidence            44

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.45  E-value=1.3e-13  Score=153.14  Aligned_cols=143  Identities=27%  Similarity=0.375  Sum_probs=119.0

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..+..|+|++|.+.+..+   +..|++|+.|+|++|.|++ +| .+..+++|+.|+|++|++++ ++.+..+++|+.|+|
T Consensus        65 ~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~L  138 (605)
T 1m9s_A           65 PNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYL  138 (605)
T ss_dssp             TTCCEEECTTSCCCCCGG---GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEEC
T ss_pred             CCCCEEEeeCCCCCCChh---hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEEC
Confidence            358889999999987543   8999999999999999997 44 78999999999999999985 578899999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      ++|+|++.  ..+..+++|+.|+|++|.|++.+|-..+++|+.|+|++|+|++ +| .+..++.   +.+.+|++.
T Consensus       139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEE
T ss_pred             CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCc
Confidence            99999865  5788999999999999999988775588999999999999986 34 4555554   445555543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.44  E-value=4.1e-14  Score=155.29  Aligned_cols=139  Identities=26%  Similarity=0.281  Sum_probs=117.8

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      .+++.|+|++|.+.+. ++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISEL-WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH-PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCC-CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC-CCCCCSEEEC
T ss_pred             ccccEEECCCCccccc-ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc-ccCCccEEec
Confidence            4688899999999864 4456999999999999999999988889999999999999999998 46654 8899999999


Q ss_pred             CCccCCC-CCCCCccccccccceecccccccccCCCCCCCCC--cEEEcccCCC--ccccccccccCC
Q 006922          146 SDNGFNG-TIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNL--QQLNLANNNL--SGSIPQSLKRFP  208 (625)
Q Consensus       146 s~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L--~~L~l~~N~l--~g~~p~~l~~~~  208 (625)
                      ++|++++ .+|..++.+++|++|+|++|++++. .-..+++|  +.|++++|++  ++.+|..+..+.
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccchh-hccccccceeeEEEeecccccccccccccccccc
Confidence            9999987 5788999999999999999999862 11256677  9999999999  888888877765

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.44  E-value=2.8e-13  Score=125.40  Aligned_cols=106  Identities=24%  Similarity=0.277  Sum_probs=94.0

Q ss_pred             ccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceeccc
Q 006922           93 LKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLAN  171 (625)
Q Consensus        93 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~  171 (625)
                      .+.|++++|.|+. +|..+.  ++|++|+|++|+|++..| .|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4789999999997 776663  899999999999998877 589999999999999999977777789999999999999


Q ss_pred             ccccccCCC-C-CCCCCcEEEcccCCCccccc
Q 006922          172 NSLSGKIPD-L-NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       172 N~l~~~~p~-~-~l~~L~~L~l~~N~l~g~~p  201 (625)
                      |+|++..+. + .+++|+.|+|++|+++...+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            999987775 3 78999999999999986544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.44  E-value=5.8e-16  Score=147.44  Aligned_cols=142  Identities=29%  Similarity=0.372  Sum_probs=117.6

Q ss_pred             eEEEEEcCCCCcccccCc-----ccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-Cccccccc
Q 006922           67 RVVAVRLPGVGFSGLIPP-----NTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNL  140 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~-----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L  140 (625)
                      .++.+++..+.+.|.+|+     ..++.+++|++|+|++|.+++ +| .+.++++|++|+|++|+++. +| .+..+++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcC
Confidence            455666777777777664     248999999999999999998 67 89999999999999999994 55 46667999


Q ss_pred             ceecCCCccCCCCCCCCccccccccceecccccccccCC--C-CCCCCCcEEEcccCCCccccccc----------cccC
Q 006922          141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP--D-LNLPNLQQLNLANNNLSGSIPQS----------LKRF  207 (625)
Q Consensus       141 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p--~-~~l~~L~~L~l~~N~l~g~~p~~----------l~~~  207 (625)
                      ++|+|++|++++ +| .+..+++|+.|+|++|++++..+  . ..+++|+.|++++|++++.+|..          +..+
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l  173 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL  173 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence            999999999996 55 68899999999999999986433  2 37899999999999999887763          6777


Q ss_pred             CCCccc
Q 006922          208 PSSAFV  213 (625)
Q Consensus       208 ~~~~~~  213 (625)
                      +.+...
T Consensus       174 ~~L~~L  179 (198)
T 1ds9_A          174 PNLKKL  179 (198)
T ss_dssp             SSCSEE
T ss_pred             CCcEEE
Confidence            776543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.43  E-value=2e-13  Score=142.00  Aligned_cols=99  Identities=20%  Similarity=0.280  Sum_probs=64.1

Q ss_pred             CCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCc-cccccccccc-
Q 006922           51 SVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPS-DFINLKSLCY-  119 (625)
Q Consensus        51 ~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~-  119 (625)
                      |.| .|..|.|++.+         ..++.|+|++|+++ .+|++.|.+|++|++|+|++|.+.+.+|. .|.++++|.+ 
T Consensus         7 C~C-~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~   84 (350)
T 4ay9_X            7 CHC-SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI   84 (350)
T ss_dssp             SEE-ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEE
T ss_pred             cEe-eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhh
Confidence            455 79999998642         35788999999998 57877899999999999999998664443 3455544432 


Q ss_pred             ccccccccCCCCC-CcccccccceecCCCccCC
Q 006922          120 LYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFN  151 (625)
Q Consensus       120 L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~  151 (625)
                      ++++.|+++...| .|..+++|++|++++|+|+
T Consensus        85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~  117 (350)
T 4ay9_X           85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK  117 (350)
T ss_dssp             EEEEETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred             hcccCCcccccCchhhhhccccccccccccccc
Confidence            3334444443333 2444444444444444443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.43  E-value=1.9e-13  Score=127.34  Aligned_cols=113  Identities=23%  Similarity=0.329  Sum_probs=100.3

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      ..++.|+|++|++.+ +++..|+.+++|++|+|++|.|++..+..|.++++|++|+|++|++++.++. +..+++|++|+
T Consensus        28 ~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             TTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            358899999999985 5666689999999999999999987777789999999999999999987774 78999999999


Q ss_pred             CCCccCCCCCCCCccccccccceecccccccccCC
Q 006922          145 LSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP  179 (625)
Q Consensus       145 ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p  179 (625)
                      |++|+|++..+..+..+++|++|+|++|.+++..|
T Consensus       107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99999996666667899999999999999987655

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=4.9e-13  Score=124.25  Aligned_cols=104  Identities=27%  Similarity=0.379  Sum_probs=80.1

Q ss_pred             EEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecCCCc
Q 006922           70 AVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDN  148 (625)
Q Consensus        70 ~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N  148 (625)
                      .++++++++. .+|.. +.  ++|++|+|++|.|++..|..|.++++|++|+|++|+|++.++. |..+++|++|+|++|
T Consensus        16 ~l~~~~n~l~-~iP~~-~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAG-IP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             EEECCSSCCS-SCCSC-CC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCCC-ccCCC-cC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            4677777774 56654 43  7889999999999988888888888888888888888876654 577888888888888


Q ss_pred             cCCCCCCCCccccccccceeccccccccc
Q 006922          149 GFNGTIPRSLSNLTQLEALYLANNSLSGK  177 (625)
Q Consensus       149 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~  177 (625)
                      +|++..+..|..+++|+.|+|++|.++..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            88855555577777777777777777643

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.41  E-value=8.7e-14  Score=129.63  Aligned_cols=125  Identities=20%  Similarity=0.280  Sum_probs=90.4

Q ss_pred             eEEEEEcCCCCcccccCcccccCCC-CccEEEecCCCCCccCCcccccccccccccccccccCCCCCCc-ccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLS-ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDF-SVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~  144 (625)
                      .++.|+|++|+++. ++ . +..+. +|++|+|++|.|++.  ..|..+++|++|+|++|++++..+.+ ..+++|++|+
T Consensus        20 ~L~~L~l~~n~l~~-i~-~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   94 (176)
T 1a9n_A           20 RDRELDLRGYKIPV-IE-N-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   94 (176)
T ss_dssp             SCEEEECTTSCCCS-CC-C-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CceEEEeeCCCCch-hH-H-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence            47778888888774 43 2 44444 888888888888875  46778888888888888887655553 7778888888


Q ss_pred             CCCccCCCCCCC--CccccccccceecccccccccCCC----C-CCCCCcEEEcccCCCc
Q 006922          145 LSDNGFNGTIPR--SLSNLTQLEALYLANNSLSGKIPD----L-NLPNLQQLNLANNNLS  197 (625)
Q Consensus       145 ls~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~----~-~l~~L~~L~l~~N~l~  197 (625)
                      |++|+|+ .+|.  .+..+++|+.|++++|.++...+.    . .+++|+.|++++|.+.
T Consensus        95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            8888885 4555  677778888888888888754332    2 6778888888888765

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.40  E-value=8.3e-13  Score=122.70  Aligned_cols=103  Identities=22%  Similarity=0.282  Sum_probs=91.2

Q ss_pred             cEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccc
Q 006922           94 KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANN  172 (625)
Q Consensus        94 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N  172 (625)
                      +.+++++|.++. +|..+.  ++|+.|+|++|+|++.+| .|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            689999999975 777664  899999999999998877 6899999999999999999766666799999999999999


Q ss_pred             cccccCCC-C-CCCCCcEEEcccCCCccc
Q 006922          173 SLSGKIPD-L-NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       173 ~l~~~~p~-~-~l~~L~~L~l~~N~l~g~  199 (625)
                      +|++.++. + .+++|+.|+|++|+++..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            99987775 3 789999999999999843

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.39  E-value=3.4e-13  Score=139.80  Aligned_cols=145  Identities=23%  Similarity=0.314  Sum_probs=103.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..+..|++++|.+.+. ++  +..+++|+.|++++|.+.+..+  +..+++|++|+|++|++++..+ +..+++|++|++
T Consensus       177 ~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l  250 (347)
T 4fmz_A          177 TDLYSLSLNYNQIEDI-SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEI  250 (347)
T ss_dssp             TTCSEEECTTSCCCCC-GG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred             CCCCEEEccCCccccc-cc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEEC
Confidence            3577888888888753 22  7778888888888888876443  7778888888888888875444 777788888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      ++|.+++.  ..+..+++|+.|++++|++++. +.. .+++|+.|++++|++++..|..+..++.   +.+.+|.+..
T Consensus       251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  325 (347)
T 4fmz_A          251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD  325 (347)
T ss_dssp             CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred             CCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence            88887753  3577777888888888887764 332 6777888888888887777766665554   3445555443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.39  E-value=8.1e-13  Score=145.32  Aligned_cols=117  Identities=26%  Similarity=0.395  Sum_probs=76.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|+|++|.++ .+|    +.+++|++|+|++|.|++ +|. +.+  +|++|+|++|+|++ +|.  .+++|+.|+|+
T Consensus        81 ~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls  148 (571)
T 3cvr_A           81 QITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINAD  148 (571)
T ss_dssp             TCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECC
T ss_pred             CCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCC
Confidence            4677777777777 455    346777777777777776 555 554  77777777777776 444  56677777777


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCcccccc
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQ  202 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~  202 (625)
                      +|+|++ +|.   .+++|+.|+|++|+|++ +|... ++|+.|+|++|+|+ .+|.
T Consensus       149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~-~lp~  197 (571)
T 3cvr_A          149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE-SLPA  197 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS-SCCC
T ss_pred             CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC-chhh
Confidence            777764 454   35566667777776665 33333 56666666666666 4554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.39  E-value=1.9e-13  Score=127.27  Aligned_cols=124  Identities=18%  Similarity=0.156  Sum_probs=102.4

Q ss_pred             cccCCCCccEEEecCCCCCccCCccccccc-ccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccc
Q 006922           86 TISRLSALKILSLRSNVITGYFPSDFINLK-SLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQL  164 (625)
Q Consensus        86 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L  164 (625)
                      .+.++.+|+.|+|++|.++. +|. +..+. +|++|+|++|.+++. +.+..+++|++|+|++|+|++..+..+..+++|
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            37788999999999999996 454 66665 999999999999975 889999999999999999996544445999999


Q ss_pred             cceecccccccccCC--CC-CCCCCcEEEcccCCCccccccc----cccCCCCccc
Q 006922          165 EALYLANNSLSGKIP--DL-NLPNLQQLNLANNNLSGSIPQS----LKRFPSSAFV  213 (625)
Q Consensus       165 ~~L~l~~N~l~~~~p--~~-~l~~L~~L~l~~N~l~g~~p~~----l~~~~~~~~~  213 (625)
                      ++|+|++|+++...+  .. .+++|+.|++++|+++ .+|..    +..++.+...
T Consensus        91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L  145 (176)
T 1a9n_A           91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  145 (176)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence            999999999975433  22 7899999999999998 56664    7777766544

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.39  E-value=5.1e-13  Score=138.58  Aligned_cols=113  Identities=19%  Similarity=0.252  Sum_probs=89.4

Q ss_pred             CCCC-CCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecC-CCCCccCCccccccccccccccccc
Q 006922           48 ESTS-VCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRS-NVITGYFPSDFINLKSLCYLYLQFN  125 (625)
Q Consensus        48 ~~~~-~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N  125 (625)
                      +..| .| .|.+|.|++.           |+|++ +|+  |..+++|+.|+|++ |.|++..|..|.+|++|+.|+|++|
T Consensus         2 p~~c~~C-~~~~v~~~~~-----------n~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N   66 (347)
T 2ifg_A            2 PDACCPH-GSSGLRCTRD-----------GALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS   66 (347)
T ss_dssp             CSSSCCS-SSSCEECCSS-----------CCCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSS
T ss_pred             CCcCccc-cCCEEEcCCC-----------CCCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCC
Confidence            4455 56 6888888652           14553 665  89999999999996 9999988888999999999999999


Q ss_pred             ccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccc
Q 006922          126 NFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG  176 (625)
Q Consensus       126 ~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~  176 (625)
                      +|++.+| .|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|.+..
T Consensus        67 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             CCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             ccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            9998777 578899999999999999865555555554 8888888887763

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.39  E-value=4.7e-13  Score=148.71  Aligned_cols=141  Identities=30%  Similarity=0.444  Sum_probs=119.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .+..|+|+++++.. ++  .|..|++|+.|+|++|.|++..|  +..+++|+.|+|++|++++ +|.+..+++|+.|+|+
T Consensus        44 ~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls  117 (605)
T 1m9s_A           44 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLE  117 (605)
T ss_dssp             TCCCCBCTTCCCCC-CT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECT
T ss_pred             CCCEEECcCCCCCC-Ch--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEec
Confidence            46778898888875 34  38999999999999999998554  9999999999999999985 6789999999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      +|+|++.  ..+..+++|+.|+|++|+|++. +.. .+++|+.|+|++|+|++..|  +..++.   +.+.+|.+.
T Consensus       118 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~  188 (605)
T 1m9s_A          118 HNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  188 (605)
T ss_dssp             TSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence            9999863  4689999999999999999976 443 89999999999999997766  666555   455566544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.39  E-value=8.3e-13  Score=142.24  Aligned_cols=138  Identities=20%  Similarity=0.163  Sum_probs=87.8

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++.+|...+.++   ++.+++|+.|++++|.+++ +|  +..+++|+.|++++|++++.  .++.+++|+.|+++
T Consensus       149 ~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls  220 (457)
T 3bz5_A          149 QLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCS  220 (457)
T ss_dssp             TCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECC
T ss_pred             cCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECc
Confidence            46677777776666652   6777777777777777776 44  66777777777777777754  36667777777777


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCC----------CCcEEEcccCCCcccccc-ccccCCCCcccCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP----------NLQQLNLANNNLSGSIPQ-SLKRFPSSAFVGN  215 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~----------~L~~L~l~~N~l~g~~p~-~l~~~~~~~~~~n  215 (625)
                      +|++++ +|  +..+++|+.|++++|++++..+. .++          +|+.|++++|.+.|.+|. .+.++..+.+.+|
T Consensus       221 ~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n  296 (457)
T 3bz5_A          221 SNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHN  296 (457)
T ss_dssp             SSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTC
T ss_pred             CCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCC
Confidence            777775 45  66777777777777777765432 222          344555555555555552 1233333444444


Q ss_pred             C
Q 006922          216 S  216 (625)
Q Consensus       216 ~  216 (625)
                      .
T Consensus       297 ~  297 (457)
T 3bz5_A          297 T  297 (457)
T ss_dssp             T
T ss_pred             c
Confidence            3

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.38  E-value=6.3e-13  Score=143.77  Aligned_cols=124  Identities=31%  Similarity=0.385  Sum_probs=74.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .+..|++.+|.+.+.  + .+..+++|+.|++++|.+++..|  +..+++|++|+|++|.+++..+ +..+++|+.|+|+
T Consensus       222 ~L~~L~l~~n~l~~~--~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~  295 (466)
T 1o6v_A          222 NLDELSLNGNQLKDI--G-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELN  295 (466)
T ss_dssp             TCCEEECCSSCCCCC--G-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECC
T ss_pred             CCCEEECCCCCcccc--h-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcC
Confidence            466667777666642  1 36666666666666666665433  6666666666666666665433 5566666666666


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCcc
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g  198 (625)
                      +|++++..+  +..+++|+.|+|++|++++..|...+++|+.|++++|++++
T Consensus       296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCC
Confidence            666664333  55566666666666666655543355556666666666554

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.38  E-value=5.2e-13  Score=144.40  Aligned_cols=144  Identities=29%  Similarity=0.380  Sum_probs=121.0

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..+..|++.+|.+.+..+   +..+++|+.|++++|.+++..+  +..+++|+.|+|++|++++..+ +..+++|+.|+|
T Consensus       243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L  316 (466)
T 1o6v_A          243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTL  316 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEEC
T ss_pred             CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEEC
Confidence            358889999999987643   8999999999999999998544  8899999999999999997555 889999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISF  219 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~  219 (625)
                      ++|++++..|  +..+++|+.|++++|++++...-..+++|+.|++++|++++..|  +..++.   +.+.+|.+..
T Consensus       317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             cCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            9999998766  78999999999999999986333489999999999999998887  555554   4555666543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.38  E-value=6.7e-13  Score=132.11  Aligned_cols=124  Identities=22%  Similarity=0.334  Sum_probs=108.1

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..++.|+|++|.+++. ++  +..+++|+.|+|++|++++ +|. +.. ++|+.|+|++|++++ ++.+..+++|+.|+|
T Consensus        63 ~~L~~L~L~~N~i~~~-~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~~l~~l~~L~~L~L  135 (263)
T 1xeu_A           63 TNLKELHLSHNQISDL-SP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TDSLIHLKNLEILSI  135 (263)
T ss_dssp             TTCCEEECCSSCCCCC-GG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SGGGTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCCC-hh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-ChhhcCcccccEEEC
Confidence            4688999999999874 33  9999999999999999998 443 333 999999999999996 577999999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCC-CCCCCCcEEEcccCCCccc
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-LNLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~l~~L~~L~l~~N~l~g~  199 (625)
                      ++|+|++. + .+..+++|+.|+|++|++++. +. ..+++|+.|++++|++++.
T Consensus       136 s~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          136 RNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence            99999964 4 689999999999999999987 43 3889999999999999855

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.36  E-value=2.6e-12  Score=138.24  Aligned_cols=127  Identities=27%  Similarity=0.446  Sum_probs=82.5

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++++|.+++ ++.  +  .++|++|++++|.+++ +| .|+++++|++|++++|++++ +|..  ..+|++|+++
T Consensus       112 ~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~  181 (454)
T 1jl5_A          112 SLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAG  181 (454)
T ss_dssp             TCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECC
T ss_pred             CCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECc
Confidence            34555555555553 221  1  1577888888888876 66 57778888888888888775 4432  2477777888


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS  209 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~  209 (625)
                      +|++++ +| .++.+++|+.|++++|++++ +|.. .++|+.|++++|+++ .+|. +..++.
T Consensus       182 ~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~-~~~l~~  238 (454)
T 1jl5_A          182 NNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE-LQNLPF  238 (454)
T ss_dssp             SSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC-CTTCTT
T ss_pred             CCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc-cCCCCC
Confidence            887775 45 57777777777777777775 3332 356777777777776 5663 544444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.34  E-value=5.3e-13  Score=138.35  Aligned_cols=144  Identities=26%  Similarity=0.412  Sum_probs=119.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..+..+++.+|.+.+..+   +..+++|+.|++++|.+++..+  +..+++|++|++++|.+++ ++.+..+++|+.|++
T Consensus       199 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l  272 (347)
T 4fmz_A          199 TSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNV  272 (347)
T ss_dssp             TTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEEC
T ss_pred             CccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEc
Confidence            357889999999886533   8899999999999999997544  8999999999999999986 578899999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccc-cccccCCCCcccCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIP-QSLKRFPSSAFVGNSI  217 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p-~~l~~~~~~~~~~n~~  217 (625)
                      ++|++++.  ..+..+++|+.|+|++|++++..|..  .+++|+.|+|++|++++..| ..+.++..+.+.+|++
T Consensus       273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI  345 (347)
T ss_dssp             CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred             cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence            99999864  45889999999999999999877763  78999999999999998777 2333444456666654

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.34  E-value=3.5e-12  Score=137.33  Aligned_cols=137  Identities=18%  Similarity=0.146  Sum_probs=99.8

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINL  145 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l  145 (625)
                      ..++.|+|++|.+++ ++   ++.+++|++|++++|.+++. +  ++++++|++|++++|+..+.+ .+..+++|+.|++
T Consensus       106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~l  177 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDC  177 (457)
T ss_dssp             TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEEC
T ss_pred             CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-ccccCCcCCEEEC
Confidence            357889999999987 43   88999999999999999884 3  778888888888888665555 4677788888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSI  217 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~  217 (625)
                      ++|++++ +|  +..+++|+.|++++|++++. +-..+++|+.|++++|++++ +|  +..++.   +.+.+|.+
T Consensus       178 s~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          178 SFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             CSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred             CCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence            8888875 44  67777777777777777764 33367777777777777776 45  444443   34444543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.34  E-value=1.1e-12  Score=144.74  Aligned_cols=105  Identities=27%  Similarity=0.386  Sum_probs=74.4

Q ss_pred             CccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecc
Q 006922           92 ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA  170 (625)
Q Consensus        92 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~  170 (625)
                      .|+.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+| .++.+++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            45677777777776 554 777777777777777777 444 67777777777777777775 56 67777777777777


Q ss_pred             cccccccC-CCC--CCCCCcEEEcccCCCccccc
Q 006922          171 NNSLSGKI-PDL--NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       171 ~N~l~~~~-p~~--~l~~L~~L~l~~N~l~g~~p  201 (625)
                      +|+|++.+ |..  .+++|+.|+|++|+|++.+|
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            77777764 542  67777777777777775544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.33  E-value=4.5e-13  Score=144.19  Aligned_cols=143  Identities=19%  Similarity=0.166  Sum_probs=67.1

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc-------------ccccccccccCCCCC
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL-------------CYLYLQFNNFSGTLP  132 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~p  132 (625)
                      .++..++++++++ |.+|++ |++|++|++|++++|.+.|.+|..++++.+|             ++|++++|.+++. |
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p   87 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-P   87 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-C
T ss_pred             ccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-C
Confidence            4577788888888 788765 8888888888888888888888888777654             6677777766652 2


Q ss_pred             CcccccccceecCCCccCCCCCCCCcc----------------cc-ccccceecccccccccCCCC-CCCCCcEEEcccC
Q 006922          133 DFSVWKNLTIINLSDNGFNGTIPRSLS----------------NL-TQLEALYLANNSLSGKIPDL-NLPNLQQLNLANN  194 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~~~~p~~l~----------------~l-~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N  194 (625)
                      .+  .++|+.|++++|++++ +|..+.                .+ ++|++|++++|++++ +|.. .+++|+.|++++|
T Consensus        88 ~~--~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N  163 (454)
T 1jl5_A           88 EL--PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNN  163 (454)
T ss_dssp             SC--CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSS
T ss_pred             CC--cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCC
Confidence            21  2445555555555553 333210                01 345555555555554 3332 4555555555555


Q ss_pred             CCccccccccccCCCCcccCCC
Q 006922          195 NLSGSIPQSLKRFPSSAFVGNS  216 (625)
Q Consensus       195 ~l~g~~p~~l~~~~~~~~~~n~  216 (625)
                      ++++ +|..+.++..+.+.+|.
T Consensus       164 ~l~~-lp~~~~~L~~L~L~~n~  184 (454)
T 1jl5_A          164 SLKK-LPDLPPSLEFIAAGNNQ  184 (454)
T ss_dssp             CCSC-CCCCCTTCCEEECCSSC
T ss_pred             cCcc-cCCCcccccEEECcCCc
Confidence            5553 44444444444444444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.32  E-value=6.3e-13  Score=147.92  Aligned_cols=150  Identities=20%  Similarity=0.327  Sum_probs=95.1

Q ss_pred             CCCCCCCCCCCCCce--------EeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccc
Q 006922           45 NWNESTSVCNHWTGV--------KCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKS  116 (625)
Q Consensus        45 ~w~~~~~~c~~w~gv--------~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  116 (625)
                      .|....++| .|.|.        .|..  ..++.|++++++++ .+|.. +.  ++|+.|+|++|.|+. +|.   .+++
T Consensus        14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~--~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~~-lp~---~l~~   82 (622)
T 3g06_A           14 AWRRAAPAE-ESRGRAAVVQKMRACLN--NGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA---LPPE   82 (622)
T ss_dssp             HHHHTCCGG-GHHHHHHHHHHHHHHHH--HCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCSC-CCC---CCTT
T ss_pred             HHHhcCCcc-hhccccccCcccccccC--CCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCCC-CCC---cCCC
Confidence            465444444 78663        2332  34777888888887 66654 43  788888888888885 554   4678


Q ss_pred             cccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCC
Q 006922          117 LCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL  196 (625)
Q Consensus       117 L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l  196 (625)
                      |++|+|++|++++ +|.  .+++|++|+|++|+|++ +|.   .+++|+.|+|++|++++ +|. .+++|++|+|++|++
T Consensus        83 L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l  153 (622)
T 3g06_A           83 LRTLEVSGNQLTS-LPV--LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQL  153 (622)
T ss_dssp             CCEEEECSCCCSC-CCC--CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCC
T ss_pred             CCEEEcCCCcCCc-CCC--CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcC
Confidence            8888888888874 443  56777788888887774 444   34566677777777665 333 246666666666666


Q ss_pred             ccccccccccCCCCcccCC
Q 006922          197 SGSIPQSLKRFPSSAFVGN  215 (625)
Q Consensus       197 ~g~~p~~l~~~~~~~~~~n  215 (625)
                      ++ +|..+..+..+.+.+|
T Consensus       154 ~~-l~~~~~~L~~L~L~~N  171 (622)
T 3g06_A          154 AS-LPALPSELCKLWAYNN  171 (622)
T ss_dssp             SC-CCCCCTTCCEEECCSS
T ss_pred             CC-cCCccCCCCEEECCCC
Confidence            63 4444444444434333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.22  E-value=1e-11  Score=128.78  Aligned_cols=104  Identities=19%  Similarity=0.195  Sum_probs=91.4

Q ss_pred             cEEEecCC-CCCccCCcccccccccccccccc-cccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecc
Q 006922           94 KILSLRSN-VITGYFPSDFINLKSLCYLYLQF-NNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA  170 (625)
Q Consensus        94 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~  170 (625)
                      ..+++++| .|++ +|. |..+++|+.|+|++ |+|++.++ .|..+++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 8997 787 99999999999996 99998776 69999999999999999999888899999999999999


Q ss_pred             cccccccCCCC-CCCCCcEEEcccCCCccc
Q 006922          171 NNSLSGKIPDL-NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       171 ~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~  199 (625)
                      +|+|++.++.. ....|+.|+|++|+|...
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCC
Confidence            99999876653 333499999999999743

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.21  E-value=4.3e-11  Score=133.14  Aligned_cols=52  Identities=25%  Similarity=0.393  Sum_probs=23.3

Q ss_pred             ccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCCCcccCCC
Q 006922          162 TQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNS  216 (625)
Q Consensus       162 ~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~  216 (625)
                      ++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|..+.++..+.+.+|.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp-~~l~~L~~L~Ls~N~L~-~lp~~~~~L~~L~Ls~N~  272 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP-VLPSELKELMVSGNRLT-SLPMLPSGLLSLSVYRNQ  272 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC-CCCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSC
T ss_pred             CCCCEEEccCCccCc-CC-CCCCcCcEEECCCCCCC-cCCcccccCcEEeCCCCC
Confidence            345555555555554 22 23344555555555554 344333333334444443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.21  E-value=3.1e-13  Score=139.43  Aligned_cols=126  Identities=22%  Similarity=0.232  Sum_probs=72.8

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCcc-CCcccccccccccccccccccCCCCC-Ccccccccceec
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGY-FPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIIN  144 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~  144 (625)
                      .++.++++++.+.+..+.  +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+ .++.+++|++|+
T Consensus        71 ~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           71 GVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             cceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            456666666666655443  45566666666666666544 55556666666666666666654443 455566666666


Q ss_pred             CCCc-cCCCC-CCCCccccccccceecccc-ccccc-CCCC--CCC-CCcEEEcccC
Q 006922          145 LSDN-GFNGT-IPRSLSNLTQLEALYLANN-SLSGK-IPDL--NLP-NLQQLNLANN  194 (625)
Q Consensus       145 ls~N-~l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~-~p~~--~l~-~L~~L~l~~N  194 (625)
                      |++| .+++. ++..+..+++|++|+|++| .+++. ++..  .++ +|+.|+|++|
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            6666 45542 4444555666666666666 55532 2221  445 5666666655

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.19  E-value=5.6e-13  Score=140.47  Aligned_cols=133  Identities=23%  Similarity=0.334  Sum_probs=77.3

Q ss_pred             CeEEEEEcCCCCccc----ccCcccccCCCCccEEEecCCCCCccCCccc----ccc---------cccccccccccccC
Q 006922           66 KRVVAVRLPGVGFSG----LIPPNTISRLSALKILSLRSNVITGYFPSDF----INL---------KSLCYLYLQFNNFS  128 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g----~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~l~  128 (625)
                      .+++.|+|++|.+++    .++. .+..+++|++|+|++|.|++..+..+    ..+         ++|++|+|++|+++
T Consensus        94 ~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A           94 PKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             TTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence            346677777777765    3433 36667777777777777654322222    223         66777777777665


Q ss_pred             -CCCC----CcccccccceecCCCccCC--C---CCCCCccccccccceeccccccc----ccCCCC--CCCCCcEEEcc
Q 006922          129 -GTLP----DFSVWKNLTIINLSDNGFN--G---TIPRSLSNLTQLEALYLANNSLS----GKIPDL--NLPNLQQLNLA  192 (625)
Q Consensus       129 -~~~p----~~~~l~~L~~L~ls~N~l~--~---~~p~~l~~l~~L~~L~l~~N~l~----~~~p~~--~l~~L~~L~l~  192 (625)
                       +.++    .+..+++|+.|+|++|+|+  |   ..|..+..+++|+.|+|++|.++    +.+|..  .+++|+.|+|+
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~  252 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  252 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence             3333    2445566666666666665  2   23445666666666666666664    333321  45666666666


Q ss_pred             cCCCccc
Q 006922          193 NNNLSGS  199 (625)
Q Consensus       193 ~N~l~g~  199 (625)
                      +|++++.
T Consensus       253 ~n~i~~~  259 (386)
T 2ca6_A          253 DCLLSAR  259 (386)
T ss_dssp             TCCCCHH
T ss_pred             CCCCchh
Confidence            6666544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.19  E-value=4.6e-13  Score=138.11  Aligned_cols=140  Identities=18%  Similarity=0.251  Sum_probs=68.3

Q ss_pred             CCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCC--CCccEEEecCCCCCccCCcccccccccccccccccccCC
Q 006922           52 VCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRL--SALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG  129 (625)
Q Consensus        52 ~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  129 (625)
                      .|..|.++.|+.  ..+..++++++.+.    +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++
T Consensus        35 vc~~W~~~~~~~--~~~~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           35 VCKRWYRLASDE--SLWQTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SCHHHHHHHTCS--TTSSEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHhcCc--hhheeeccccccCC----HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            343455555542  12344555555444    2234444  5555555555555554332 3445555555555555543


Q ss_pred             C-CC-CcccccccceecCCCccCCCCCCCCccccccccceecccc-ccccc-CCCC--CCCCCcEEEcccC-CCcc
Q 006922          130 T-LP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANN-SLSGK-IPDL--NLPNLQQLNLANN-NLSG  198 (625)
Q Consensus       130 ~-~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~-~p~~--~l~~L~~L~l~~N-~l~g  198 (625)
                      . +| .+..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++. ++..  .+++|+.|++++| .+++
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~  183 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE  183 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence            2 33 3444555555555555555444445555555555555555 34431 2221  3455555555555 5543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.18  E-value=6e-13  Score=140.23  Aligned_cols=152  Identities=17%  Similarity=0.266  Sum_probs=108.9

Q ss_pred             CeEEEEEcCCC---CcccccCccc------ccCCCCccEEEecCCCCCc----cCCcccccccccccccccccccCCCCC
Q 006922           66 KRVVAVRLPGV---GFSGLIPPNT------ISRLSALKILSLRSNVITG----YFPSDFINLKSLCYLYLQFNNFSGTLP  132 (625)
Q Consensus        66 ~~v~~l~l~~~---~l~g~~~~~~------~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p  132 (625)
                      ..++.|+|++|   .+++.+|...      +..+++|++|+|++|.|++    .+|..+.++++|++|+|++|.+++..+
T Consensus        60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~  139 (386)
T 2ca6_A           60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG  139 (386)
T ss_dssp             TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred             CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence            35777888874   5566666542      4788899999999998887    466678888899999999998864322


Q ss_pred             -C----cccc---------cccceecCCCccCC-CCCC---CCccccccccceeccccccc--c---cCC-CC-CCCCCc
Q 006922          133 -D----FSVW---------KNLTIINLSDNGFN-GTIP---RSLSNLTQLEALYLANNSLS--G---KIP-DL-NLPNLQ  187 (625)
Q Consensus       133 -~----~~~l---------~~L~~L~ls~N~l~-~~~p---~~l~~l~~L~~L~l~~N~l~--~---~~p-~~-~l~~L~  187 (625)
                       .    +..+         ++|++|+|++|+++ +.+|   ..+..+++|+.|+|++|+++  |   .+| .. .+++|+
T Consensus       140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~  219 (386)
T 2ca6_A          140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK  219 (386)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred             HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence             1    3333         78899999999887 3444   35667888999999999887  3   344 32 678889


Q ss_pred             EEEcccCCCc----cccccccccCCCC---cccCCCC
Q 006922          188 QLNLANNNLS----GSIPQSLKRFPSS---AFVGNSI  217 (625)
Q Consensus       188 ~L~l~~N~l~----g~~p~~l~~~~~~---~~~~n~~  217 (625)
                      .|+|++|.++    +.+|..+..++.+   .+.+|.+
T Consensus       220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i  256 (386)
T 2ca6_A          220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL  256 (386)
T ss_dssp             EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             EEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence            9999999886    6677776666554   4445543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=8.1e-11  Score=116.79  Aligned_cols=135  Identities=16%  Similarity=0.103  Sum_probs=105.6

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEecccc-CChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .++.|+.+.||++... ++.+++|+..... .....+.+|++++..+. +..+.++++++...+..++||||++|.++.+
T Consensus        21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   99 (263)
T 3tm0_A           21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence            4677888999999754 6899999987532 23457899999999884 6778889999988888999999999999877


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--------------------------------------------  444 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  444 (625)
                      .+...          .....++.+++++++.||...                                            
T Consensus       100 ~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A          100 EYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             HCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             ccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence            64211          123468889999999999811                                            


Q ss_pred             ------------CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          445 ------------GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       445 ------------~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                                  .+.++|+|+++.||+++++..+.|+||+.+..
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                        13489999999999998765567999997654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.16  E-value=2.7e-12  Score=134.00  Aligned_cols=136  Identities=21%  Similarity=0.272  Sum_probs=80.9

Q ss_pred             eEEEEEcCCCCcccccCc---ccccCCC-CccEEEecCCCCCccCCcccccc-----cccccccccccccCCCCCC----
Q 006922           67 RVVAVRLPGVGFSGLIPP---NTISRLS-ALKILSLRSNVITGYFPSDFINL-----KSLCYLYLQFNNFSGTLPD----  133 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~---~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~----  133 (625)
                      .++.|+|++|.+++.-+.   +.+..++ +|++|+|++|.|++..+..+..+     ++|++|+|++|++++..+.    
T Consensus        23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            366677777776643220   3466666 67777777777776656556554     6777777777777655442    


Q ss_pred             -cccc-cccceecCCCccCCCCCCCCccc-----cccccceecccccccccCCC----C--CCC-CCcEEEcccCCCccc
Q 006922          134 -FSVW-KNLTIINLSDNGFNGTIPRSLSN-----LTQLEALYLANNSLSGKIPD----L--NLP-NLQQLNLANNNLSGS  199 (625)
Q Consensus       134 -~~~l-~~L~~L~ls~N~l~~~~p~~l~~-----l~~L~~L~l~~N~l~~~~p~----~--~l~-~L~~L~l~~N~l~g~  199 (625)
                       +..+ ++|++|+|++|+|++..+..+..     .++|++|+|++|.+++....    .  .++ +|+.|+|++|++++.
T Consensus       103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~  182 (362)
T 3goz_A          103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK  182 (362)
T ss_dssp             HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence             3333 66777777777776544433322     24677777777777642221    1  233 677777777777655


Q ss_pred             ccc
Q 006922          200 IPQ  202 (625)
Q Consensus       200 ~p~  202 (625)
                      .+.
T Consensus       183 ~~~  185 (362)
T 3goz_A          183 NCA  185 (362)
T ss_dssp             CHH
T ss_pred             hHH
Confidence            543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.12  E-value=5e-12  Score=131.96  Aligned_cols=146  Identities=24%  Similarity=0.176  Sum_probs=113.0

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC----ccccccc-ccccccccccccCCCCC-Ccccc-----cc
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP----SDFINLK-SLCYLYLQFNNFSGTLP-DFSVW-----KN  139 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p-~~~~l-----~~  139 (625)
                      .+|+.++++|.+|. .+...++|++|+|++|.|++..+    ..+..++ +|++|+|++|++++..+ .+..+     ++
T Consensus         3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            57888999998865 46666779999999999998766    6778888 99999999999987655 45544     89


Q ss_pred             cceecCCCccCCCCCCCCccc----c-ccccceecccccccccCCCC------C-CCCCcEEEcccCCCcccc----ccc
Q 006922          140 LTIINLSDNGFNGTIPRSLSN----L-TQLEALYLANNSLSGKIPDL------N-LPNLQQLNLANNNLSGSI----PQS  203 (625)
Q Consensus       140 L~~L~ls~N~l~~~~p~~l~~----l-~~L~~L~l~~N~l~~~~p~~------~-l~~L~~L~l~~N~l~g~~----p~~  203 (625)
                      |++|+|++|++++..+..+..    + ++|++|+|++|++++..+..      . .++|+.|+|++|++++..    +..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            999999999999776665444    3 89999999999998765531      2 369999999999998533    333


Q ss_pred             cc----cCCCCcccCCCC
Q 006922          204 LK----RFPSSAFVGNSI  217 (625)
Q Consensus       204 l~----~~~~~~~~~n~~  217 (625)
                      +.    ++..+.+.+|.+
T Consensus       162 l~~~~~~L~~L~Ls~n~l  179 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNL  179 (362)
T ss_dssp             HHTSCTTCCEEECTTSCG
T ss_pred             HhcCCccccEeeecCCCC
Confidence            33    344455556654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.11  E-value=1.4e-10  Score=120.46  Aligned_cols=140  Identities=15%  Similarity=0.117  Sum_probs=106.6

Q ss_pred             eEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--Cccc
Q 006922           59 VKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSV  136 (625)
Q Consensus        59 v~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~  136 (625)
                      .+|+.  ..   ++-++++|+ .+|.+ +  .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|  .|..
T Consensus         7 C~C~~--~~---v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~   77 (350)
T 4ay9_X            7 CHCSN--RV---FLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN   77 (350)
T ss_dssp             SEEET--TE---EEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred             cEeeC--CE---EEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence            56764  22   455677887 56754 4  3689999999999998666789999999999999999988776  4788


Q ss_pred             ccccce-ecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEccc-CCCccccccccccC
Q 006922          137 WKNLTI-INLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLAN-NNLSGSIPQSLKRF  207 (625)
Q Consensus       137 l~~L~~-L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~-N~l~g~~p~~l~~~  207 (625)
                      +++|+. +.+++|+|+...|..|..+++|++|++++|++++..+..  ...++..|++.+ |+++...+..+..+
T Consensus        78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~  152 (350)
T 4ay9_X           78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL  152 (350)
T ss_dssp             CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred             chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence            888765 677789999877889999999999999999998766543  445667777755 45653333344433

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1.7e-10  Score=113.97  Aligned_cols=129  Identities=9%  Similarity=0.080  Sum_probs=97.8

Q ss_pred             ccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc--eecceeEEEecCceEEEEEeccCCChhhhh
Q 006922          333 GKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN--VVELKAYYYSKDEKLMVYDYYSLGSVSAML  410 (625)
Q Consensus       333 g~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  410 (625)
                      +.|..+.||++...+|..+++|+....  ....+.+|++++..+.+.+  +.+++++....+..++||||++|.++.  .
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~  104 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S  104 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence            356669999998777888999997654  2356889999998886444  455888888777889999999998884  2


Q ss_pred             ccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 006922          411 HSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN----------------------------------------------  444 (625)
Q Consensus       411 ~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------------  444 (625)
                      ..        .+   ...++.++++.|+.||...                                              
T Consensus       105 ~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          105 SH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             SC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             Cc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            11        11   2356777888888888643                                              


Q ss_pred             ---------CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          445 ---------GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       445 ---------~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                               ...++|+|++|.||+++.+..+.|+|||.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11299999999999998776667999998764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.11  E-value=4.1e-13  Score=127.59  Aligned_cols=128  Identities=22%  Similarity=0.299  Sum_probs=106.1

Q ss_pred             ccCCCCccEEEecCCCCCccCCc------ccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPS------DFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSN  160 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~  160 (625)
                      +.....++.++++.|.++|.+|.      .|.++++|++|+|++|++++ +|.+..+++|++|+|++|+++ .+|..+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhc
Confidence            56677888889999999988887      89999999999999999997 669999999999999999999 67888888


Q ss_pred             cccccceecccccccccCCCC-CCCCCcEEEcccCCCccccc-cccccCCC---CcccCCCC
Q 006922          161 LTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIP-QSLKRFPS---SAFVGNSI  217 (625)
Q Consensus       161 l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p-~~l~~~~~---~~~~~n~~  217 (625)
                      +++|+.|+|++|++++. |.. .+++|+.|+|++|++++..+ ..+..++.   +.+.+|++
T Consensus        92 ~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l  152 (198)
T 1ds9_A           92 ADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             HHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred             CCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence            89999999999999974 443 67899999999999985322 35555554   44455554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.05  E-value=6.4e-13  Score=131.10  Aligned_cols=160  Identities=18%  Similarity=0.175  Sum_probs=111.9

Q ss_pred             CCCCCCceEeCCCCCeEEEEEcCC---CCcccccCcccccCCCCccEEEecCCCCCccCCc-cccccccccc--cccccc
Q 006922           52 VCNHWTGVKCSEDGKRVVAVRLPG---VGFSGLIPPNTISRLSALKILSLRSNVITGYFPS-DFINLKSLCY--LYLQFN  125 (625)
Q Consensus        52 ~c~~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~--L~L~~N  125 (625)
                      .| +|.|+.|+.++.+|..+..++   .++.|.+.++.+..|..  .|...+|..++.++- .|...+.|..  ++++.|
T Consensus        77 l~-~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N  153 (267)
T 3rw6_A           77 LK-AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN  153 (267)
T ss_dssp             HH-HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred             HH-hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence            35 799999998777887776665   45667777766655554  344455555544432 2556666776  778888


Q ss_pred             ccC---CCCC-CcccccccceecCCCccCCC--CCCCCccccccccceecccccccccCCCCCCC--CCcEEEcccCCCc
Q 006922          126 NFS---GTLP-DFSVWKNLTIINLSDNGFNG--TIPRSLSNLTQLEALYLANNSLSGKIPDLNLP--NLQQLNLANNNLS  197 (625)
Q Consensus       126 ~l~---~~~p-~~~~l~~L~~L~ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~--~L~~L~l~~N~l~  197 (625)
                      +..   +.++ ....+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.-.-..+.  +|+.|+|++|+++
T Consensus       154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred             HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence            543   2222 12467899999999999997  55677788999999999999998752211233  8999999999999


Q ss_pred             ccccc-------ccccCCCCcccC
Q 006922          198 GSIPQ-------SLKRFPSSAFVG  214 (625)
Q Consensus       198 g~~p~-------~l~~~~~~~~~~  214 (625)
                      +.+|.       .+..+|++..++
T Consensus       234 ~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          234 DTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             cccCcchhHHHHHHHHCcccCeEC
Confidence            87763       366788776554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=1.1e-09  Score=113.98  Aligned_cols=141  Identities=17%  Similarity=0.221  Sum_probs=106.0

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEec--ccc--CChHHHHHHHHHHHcCC--CCceecceeEEEec---CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLK--DVN--VGKRDFEQQMEIVGSIR--HENVVELKAYYYSK---DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~  400 (625)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|++++..+.  +..+.+++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            34789999999999875 4678888776  332  22457889999999886  45678888888766   458999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN------------------------------------  444 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------  444 (625)
                      +++..+.+...       ..++..++..++.++++.|+.||...                                    
T Consensus       123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99988754221       12678888999999999999999831                                    


Q ss_pred             -------------------CCCceecCCCCCCEEeCCCCC--eeEeccccccccc
Q 006922          445 -------------------GGKLVHGNIKSSNIFLNSQQY--GCVSDLGLTTITS  478 (625)
Q Consensus       445 -------------------~~~ivHrDlk~~NIll~~~~~--~kl~DfGla~~~~  478 (625)
                                         .+.++|+|+++.||+++.++.  +.|+||+.+....
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                               245999999999999997753  5899999987643

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.95  E-value=1.1e-11  Score=133.42  Aligned_cols=153  Identities=19%  Similarity=0.114  Sum_probs=115.0

Q ss_pred             CeEEEEEcCCCCcccc----cCcccccCCCCccEEEecCCCCCcc----CCcccccccccccccccccccCCCCC-Ccc-
Q 006922           66 KRVVAVRLPGVGFSGL----IPPNTISRLSALKILSLRSNVITGY----FPSDFINLKSLCYLYLQFNNFSGTLP-DFS-  135 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~-  135 (625)
                      ..++.|+|++|.+.+.    +.+..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++..+ .+. 
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            4588899999988754    2233345689999999999999864    56677789999999999999865332 222 


Q ss_pred             ----cccccceecCCCccCCCC----CCCCccccccccceecccccccccCCCC-------CCCCCcEEEcccCCCcc--
Q 006922          136 ----VWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKIPDL-------NLPNLQQLNLANNNLSG--  198 (625)
Q Consensus       136 ----~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~-------~l~~L~~L~l~~N~l~g--  198 (625)
                          ..++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++..+..       ..++|+.|+|++|++++  
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~  386 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS  386 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence                236899999999999865    4566777899999999999988653321       26789999999999986  


Q ss_pred             --ccccccccCCC---CcccCCCCC
Q 006922          199 --SIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       199 --~~p~~l~~~~~---~~~~~n~~~  218 (625)
                        .+|..+..++.   +.+.+|.+.
T Consensus       387 ~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          387 CSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             HHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             HHHHHHHHHhCCCccEEECCCCCCC
Confidence              77877665554   455666644

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.90  E-value=1.7e-11  Score=131.96  Aligned_cols=151  Identities=19%  Similarity=0.209  Sum_probs=113.8

Q ss_pred             eEEEEEcCCCCcccc----cCcccccCCCCccEEEecCCCCCccC-----CcccccccccccccccccccCCC----CC-
Q 006922           67 RVVAVRLPGVGFSGL----IPPNTISRLSALKILSLRSNVITGYF-----PSDFINLKSLCYLYLQFNNFSGT----LP-  132 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~----~~~~~~~~l~~L~~L~l~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p-  132 (625)
                      +++.|+|++|++++.    ++. .+..+++|++|+|++|.+++..     +..+..+++|++|+|++|.++..    ++ 
T Consensus       200 ~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~  278 (461)
T 1z7x_W          200 QLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR  278 (461)
T ss_dssp             CCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             CceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence            688999999999863    443 4788999999999999987532     22334689999999999999863    33 


Q ss_pred             CcccccccceecCCCccCCCCCCCCccc-----cccccceeccccccccc----CCCC--CCCCCcEEEcccCCCccccc
Q 006922          133 DFSVWKNLTIINLSDNGFNGTIPRSLSN-----LTQLEALYLANNSLSGK----IPDL--NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~~~~p~~l~~-----l~~L~~L~l~~N~l~~~----~p~~--~l~~L~~L~l~~N~l~g~~p  201 (625)
                      .+..+++|++|+|++|.+++..+..+..     .++|+.|+|++|.+++.    ++..  .+++|+.|+|++|++++..+
T Consensus       279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  358 (461)
T 1z7x_W          279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV  358 (461)
T ss_dssp             HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred             HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence            4677899999999999997544433432     26999999999999865    2322  57899999999999987655


Q ss_pred             cccc--------cCCCCcccCCCCC
Q 006922          202 QSLK--------RFPSSAFVGNSIS  218 (625)
Q Consensus       202 ~~l~--------~~~~~~~~~n~~~  218 (625)
                      ..+.        .+..+.+.+|.+.
T Consensus       359 ~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          359 RELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHHHHcCCCCceEEEECCCCCCC
Confidence            5443        4555666666543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.80  E-value=2.3e-09  Score=108.81  Aligned_cols=181  Identities=16%  Similarity=0.178  Sum_probs=118.7

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCc--eecceeEEEecC---ceEEEEEeccCC
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHEN--VVELKAYYYSKD---EKLMVYDYYSLG  404 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~~~g  404 (625)
                      .++.|.+..||+..    ..+++|+-... .....+.+|++++..+ .+..  +.+.+.+....+   ..++||++++|.
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            47889999999863    56888876532 2235788999999887 3333  333444433322   347899999998


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN----------------------------------------  444 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------  444 (625)
                      ++......       .++..++..++.++++.++.||...                                        
T Consensus       102 ~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          102 PLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             ECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88653321       2667778888888888888888611                                        


Q ss_pred             ---------------CCCceecCCCCCCEEeCC--CCCeeEecccccccccccccccccCCCc---CCccccC------C
Q 006922          445 ---------------GGKLVHGNIKSSNIFLNS--QQYGCVSDLGLTTITSALAPVIARAAGY---RAPEVTD------S  498 (625)
Q Consensus       445 ---------------~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~y---~aPE~~~------~  498 (625)
                                     .+.++|+|+++.||+++.  ...+.|+||+.+........ ......+   ..|+...      +
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcC
Confidence                           134899999999999998  45678999998875432111 0111111   1222110      0


Q ss_pred             --------CCCCCccchhhhHHHHHHHHhCCCCC
Q 006922          499 --------RKATQASDVYSFGVVLLEILTGKSPI  524 (625)
Q Consensus       499 --------~~~~~~~DvwS~Gvil~elltG~~p~  524 (625)
                              .+.....+.|++|.++|++.+|+.+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    01122368999999999999998876

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.73  E-value=1.2e-10  Score=121.61  Aligned_cols=107  Identities=22%  Similarity=0.166  Sum_probs=47.3

Q ss_pred             CCccEEEecCCCCCccCCccc-ccccccccccccccccCCCCC-Cc-----ccccccceecCCCccCCC----CCCCCcc
Q 006922           91 SALKILSLRSNVITGYFPSDF-INLKSLCYLYLQFNNFSGTLP-DF-----SVWKNLTIINLSDNGFNG----TIPRSLS  159 (625)
Q Consensus        91 ~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p-~~-----~~l~~L~~L~ls~N~l~~----~~p~~l~  159 (625)
                      ++|+.|+|++|.|+......+ ..+++|+.|+|++|.++.... .+     ...++|+.|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            455555555555543211111 234455555555555542111 11     123445555555555542    1222234


Q ss_pred             ccccccceecccccccccC----CC--CCCCCCcEEEcccCCCc
Q 006922          160 NLTQLEALYLANNSLSGKI----PD--LNLPNLQQLNLANNNLS  197 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~~----p~--~~l~~L~~L~l~~N~l~  197 (625)
                      .+++|++|+|++|.|++.-    ..  ...++|+.|+|++|.|+
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence            4455555555555554211    11  02345555555555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.65  E-value=4.1e-08  Score=100.65  Aligned_cols=139  Identities=15%  Similarity=0.154  Sum_probs=82.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccC---CCCC--Cc-------
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFS---GTLP--DF-------  134 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p--~~-------  134 (625)
                      .++.|+|+. ++. .|++..|.++++|+.|+|++|.+....+..|.++.++..|.+..+...   ..+.  .|       
T Consensus       102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~  179 (329)
T 3sb4_A          102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE  179 (329)
T ss_dssp             TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred             CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence            477788887 665 577778999999999999999887666666666555555554442110   0000  00       


Q ss_pred             -------------------------------------------ccccccceecCCCccCCCCCCCCccccccccceeccc
Q 006922          135 -------------------------------------------SVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLAN  171 (625)
Q Consensus       135 -------------------------------------------~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~  171 (625)
                                                                 ..+++|+.|+|++|+++..-+..|.++++|+.|+|.+
T Consensus       180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~  259 (329)
T 3sb4_A          180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH  259 (329)
T ss_dssp             EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred             eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence                                                       0155677777777777644445567777777777776


Q ss_pred             ccccccCCCC--CCCCCc-EEEcccCCCccccccccccCCC
Q 006922          172 NSLSGKIPDL--NLPNLQ-QLNLANNNLSGSIPQSLKRFPS  209 (625)
Q Consensus       172 N~l~~~~p~~--~l~~L~-~L~l~~N~l~g~~p~~l~~~~~  209 (625)
                      | ++...+..  .+++|+ .|++.+ .++..-+.++..+++
T Consensus       260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~  298 (329)
T 3sb4_A          260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDN  298 (329)
T ss_dssp             T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTT
T ss_pred             c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCcc
Confidence            6 54332221  566666 777666 555333345555444

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.61  E-value=4.2e-10  Score=117.51  Aligned_cols=141  Identities=20%  Similarity=0.190  Sum_probs=105.1

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccc-----ccccccccccccccccCCC----CC-Ccc
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDF-----INLKSLCYLYLQFNNFSGT----LP-DFS  135 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p-~~~  135 (625)
                      ..++.|+|++|.++..-.......+++|+.|+|++|.|+......+     ...++|++|+|++|.++..    ++ .+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4699999999998754333334457789999999999985433333     2457899999999998642    22 346


Q ss_pred             cccccceecCCCccCCCC----CCCCccccccccceecccccccccC----CCC--CCCCCcEEEcccCCCccccccccc
Q 006922          136 VWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKI----PDL--NLPNLQQLNLANNNLSGSIPQSLK  205 (625)
Q Consensus       136 ~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~----p~~--~l~~L~~L~l~~N~l~g~~p~~l~  205 (625)
                      ..++|++|+|++|.|++.    ++..+..+++|+.|+|++|.|++.-    ...  ..++|+.|+|++|.|+..-...+.
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            788999999999999752    3455677789999999999997532    111  468899999999999865555554


Q ss_pred             c
Q 006922          206 R  206 (625)
Q Consensus       206 ~  206 (625)
                      .
T Consensus       261 ~  261 (372)
T 3un9_A          261 D  261 (372)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.44  E-value=1.3e-07  Score=96.81  Aligned_cols=129  Identities=15%  Similarity=0.110  Sum_probs=91.5

Q ss_pred             ccCcccccC--------CCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccC-
Q 006922           81 LIPPNTISR--------LSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGF-  150 (625)
Q Consensus        81 ~~~~~~~~~--------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l-  150 (625)
                      .||+..|.+        +++|+.|+|.+ .++..-+..|.++++|+.|+|+.|.+....+ .|..+.++..+.++.+.. 
T Consensus        83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~  161 (329)
T 3sb4_A           83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY  161 (329)
T ss_dssp             EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH
T ss_pred             ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh
Confidence            466677888        99999999999 8888777889999999999999999874444 577777777776655221 


Q ss_pred             ---CCCCCCCc--------------------------------------------------cccccccceeccccccccc
Q 006922          151 ---NGTIPRSL--------------------------------------------------SNLTQLEALYLANNSLSGK  177 (625)
Q Consensus       151 ---~~~~p~~l--------------------------------------------------~~l~~L~~L~l~~N~l~~~  177 (625)
                         ...-...|                                                  ..+++|+.|+|++|+++..
T Consensus       162 ~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I  241 (329)
T 3sb4_A          162 RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTI  241 (329)
T ss_dssp             HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEE
T ss_pred             hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCccee
Confidence               00000001                                                  0267999999999999855


Q ss_pred             CCCC--CCCCCcEEEcccCCCccccccccccCCCCc
Q 006922          178 IPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       178 ~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~  211 (625)
                      .+..  .+++|+.|+|.+| ++..-+.++..++++.
T Consensus       242 ~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          242 PDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence            4443  7899999999998 7643345666666554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.36  E-value=1.3e-07  Score=93.06  Aligned_cols=111  Identities=24%  Similarity=0.275  Sum_probs=70.7

Q ss_pred             cccccCcccccCCCCccE--EEecCCCCC---ccCCcccccccccccccccccccCC--CCC-CcccccccceecCCCcc
Q 006922           78 FSGLIPPNTISRLSALKI--LSLRSNVIT---GYFPSDFINLKSLCYLYLQFNNFSG--TLP-DFSVWKNLTIINLSDNG  149 (625)
Q Consensus        78 l~g~~~~~~~~~l~~L~~--L~l~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p-~~~~l~~L~~L~ls~N~  149 (625)
                      .++.+.-+.|...+.|..  ++++.|...   +.++....++++|+.|+|++|+|++  .+| .+..+++|+.|+|++|+
T Consensus       128 ~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~  207 (267)
T 3rw6_A          128 SQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNE  207 (267)
T ss_dssp             TTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSC
T ss_pred             hccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCc
Confidence            334444333555555665  667777433   2222222457788888888888876  333 24577888888888888


Q ss_pred             CCCCCCCCccccc--cccceecccccccccCCCC---------CCCCCcEEE
Q 006922          150 FNGTIPRSLSNLT--QLEALYLANNSLSGKIPDL---------NLPNLQQLN  190 (625)
Q Consensus       150 l~~~~p~~l~~l~--~L~~L~l~~N~l~~~~p~~---------~l~~L~~L~  190 (625)
                      |++.  ..+..+.  +|++|+|++|.+++.+|+.         .+++|+.||
T Consensus       208 i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          208 LKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             CCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             cCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            8754  3344444  7888888888888777631         577887776

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.30  E-value=1.2e-08  Score=113.44  Aligned_cols=113  Identities=18%  Similarity=0.147  Sum_probs=62.6

Q ss_pred             ccCCCCccEEEecCCCCCccCCccccc-cccccccccc----ccccCCCCCC------cccccccceecCCCc--cCCCC
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFIN-LKSLCYLYLQ----FNNFSGTLPD------FSVWKNLTIINLSDN--GFNGT  153 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~~p~------~~~l~~L~~L~ls~N--~l~~~  153 (625)
                      +..+++|++|+++.|.+++..+..+.. +++|+.|+|+    .|++++.+.+      +..+++|+.|+|++|  .+++.
T Consensus       374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~  453 (592)
T 3ogk_B          374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL  453 (592)
T ss_dssp             HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH
T ss_pred             HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH
Confidence            345677777777777776655445544 6667777775    5556543211      344666666666532  24443


Q ss_pred             CCCCcc-ccccccceeccccccccc-CCC--CCCCCCcEEEcccCCCccc
Q 006922          154 IPRSLS-NLTQLEALYLANNSLSGK-IPD--LNLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       154 ~p~~l~-~l~~L~~L~l~~N~l~~~-~p~--~~l~~L~~L~l~~N~l~g~  199 (625)
                      .+..+. .+++|+.|+|++|++++. ++.  ..+++|+.|+|++|++++.
T Consensus       454 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~  503 (592)
T 3ogk_B          454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER  503 (592)
T ss_dssp             HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred             HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence            333332 255666666666666541 222  1456666666666666543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.28  E-value=3e-06  Score=85.73  Aligned_cols=135  Identities=18%  Similarity=0.184  Sum_probs=90.9

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCC---ceecceeEEE-ecCceEEEEEeccCCCh
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE---NVVELKAYYY-SKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g~L  406 (625)
                      .++.|....||+.    |..+++|+-.. ......+.+|++++..+.+.   .+.+.+.++. ..+..++||||++|..+
T Consensus        26 ~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           26 SLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             ecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            4778888899988    56788887432 12235788999999988642   3455666664 34567899999999887


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-------------------------------------------  443 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------  443 (625)
                      ......       .++...+..++.++++.|+.||..                                           
T Consensus       101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            653211       133444445555555555555542                                           


Q ss_pred             --------------CCCCceecCCCCCCEEeCC---CCCe-eEecccccccc
Q 006922          444 --------------NGGKLVHGNIKSSNIFLNS---QQYG-CVSDLGLTTIT  477 (625)
Q Consensus       444 --------------~~~~ivHrDlk~~NIll~~---~~~~-kl~DfGla~~~  477 (625)
                                    ..+.++|+|+++.||+++.   ++.+ .|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2234699999999999987   4554 79999987654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.26  E-value=7.2e-08  Score=107.05  Aligned_cols=139  Identities=12%  Similarity=0.036  Sum_probs=89.4

Q ss_pred             eEEEEEcCCCC-cccccCcccccCCCCccEEEecCCCCCcc----CCcccccccccccccccccccCCCC----C-Cccc
Q 006922           67 RVVAVRLPGVG-FSGLIPPNTISRLSALKILSLRSNVITGY----FPSDFINLKSLCYLYLQFNNFSGTL----P-DFSV  136 (625)
Q Consensus        67 ~v~~l~l~~~~-l~g~~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p-~~~~  136 (625)
                      .++.|+|.++. ++..-.+..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++..    + -+..
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            37888887765 22111112244788999999999988764    3334567788999999999887432    2 2456


Q ss_pred             ccccceecCCCccCCCCCCCCccccccccceecccccccc---cCCC--CCCCCCcEEEcccCCCccccccccccC
Q 006922          137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG---KIPD--LNLPNLQQLNLANNNLSGSIPQSLKRF  207 (625)
Q Consensus       137 l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~---~~p~--~~l~~L~~L~l~~N~l~g~~p~~l~~~  207 (625)
                      +++|+.|+|++|.+.+ +|..+..+++|+.|+++.+....   ..+.  ..+++|+.|+++++.. +.+|..+..+
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~  292 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFA  292 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGG
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhc
Confidence            7889999999988875 56677788888888887533221   1111  1456777777776533 3455544433

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=4.2e-06  Score=82.81  Aligned_cols=135  Identities=16%  Similarity=0.193  Sum_probs=93.6

Q ss_pred             cccCCce-eEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          332 LGKGTFG-MAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       332 lg~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +..|..| .||+.... ++..+++|+-...  ...++.+|++.|+.+. +--+.++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3445554 68987744 5678899976542  2356888999888774 3346778899998899999999999988766


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--------------------------------------------  444 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  444 (625)
                      ......         .....+..++++.|+.||...                                            
T Consensus       110 ~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          110 VLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            543211         122345555556666665421                                            


Q ss_pred             -----------CCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          445 -----------GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       445 -----------~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                                 .+.++|+|+.+.|||++.++.+-|+||+.+...
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                       113799999999999998776779999977643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=5.6e-06  Score=85.56  Aligned_cols=78  Identities=10%  Similarity=0.062  Sum_probs=55.7

Q ss_pred             Hc-ccCCceeEEEEEEc-------CCcEEEEEEecccc---C-ChHHHHHHHHHHHcCC-C--CceecceeEEEec---C
Q 006922          331 VL-GKGTFGMAYKAILE-------DGTTVVVKRLKDVN---V-GKRDFEQQMEIVGSIR-H--ENVVELKAYYYSK---D  392 (625)
Q Consensus       331 ~l-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---~  392 (625)
                      .| +.|....+|+....       ++..+++|+-....   . ....+.+|++++..+. +  -.+.+++.++.+.   +
T Consensus        27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g  106 (357)
T 3ats_A           27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG  106 (357)
T ss_dssp             EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred             ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence            46 78889999998754       26788888765432   1 2356888999888874 3  3466777777654   3


Q ss_pred             ceEEEEEeccCCChhh
Q 006922          393 EKLMVYDYYSLGSVSA  408 (625)
Q Consensus       393 ~~~lv~e~~~~g~L~~  408 (625)
                      ..++||||++|..+.+
T Consensus       107 ~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          107 TPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SCEEEEECCCCBCCCB
T ss_pred             CceEEEEecCCCChhh
Confidence            5689999999877654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.12  E-value=9.3e-08  Score=89.29  Aligned_cols=112  Identities=13%  Similarity=0.121  Sum_probs=81.1

Q ss_pred             cccCCCCccEEEecCC-CCCcc----CCcccccccccccccccccccCCC----CC-CcccccccceecCCCccCCCC--
Q 006922           86 TISRLSALKILSLRSN-VITGY----FPSDFINLKSLCYLYLQFNNFSGT----LP-DFSVWKNLTIINLSDNGFNGT--  153 (625)
Q Consensus        86 ~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~ls~N~l~~~--  153 (625)
                      .+...++|++|+|++| .|...    +...+...++|++|+|++|.+...    +. .+...++|++|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4677888999999998 88632    223455668899999999988632    11 244557899999999998753  


Q ss_pred             --CCCCccccccccceec--ccccccccC----CCC--CCCCCcEEEcccCCCc
Q 006922          154 --IPRSLSNLTQLEALYL--ANNSLSGKI----PDL--NLPNLQQLNLANNNLS  197 (625)
Q Consensus       154 --~p~~l~~l~~L~~L~l--~~N~l~~~~----p~~--~l~~L~~L~l~~N~l~  197 (625)
                        +...+...++|++|+|  ++|.|+..-    ...  ..++|+.|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              3456677788999999  789887421    111  4578999999999885

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.05  E-value=1.2e-07  Score=105.18  Aligned_cols=63  Identities=16%  Similarity=0.140  Sum_probs=30.5

Q ss_pred             ccccccceecCCCccCCCCCCCCccc-cccccceecccccccccCCC---CCCCCCcEEEcccCCCcc
Q 006922          135 SVWKNLTIINLSDNGFNGTIPRSLSN-LTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       135 ~~l~~L~~L~ls~N~l~~~~p~~l~~-l~~L~~L~l~~N~l~~~~p~---~~l~~L~~L~l~~N~l~g  198 (625)
                      ..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++....   ..+++|+.|+|++|++++
T Consensus       429 ~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          429 EHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             HHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             hhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            3445555555544 443332223332 45566666666655432221   135556666666666643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.98  E-value=2.6e-05  Score=79.80  Aligned_cols=141  Identities=16%  Similarity=0.190  Sum_probs=80.5

Q ss_pred             cccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCC-----CCceecce-e--EEEecCceEEEEEeccC
Q 006922          332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-----HENVVELK-A--YYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~~~~  403 (625)
                      |+.|..+.||+....+| .+++|+....   ......|++++..+.     .|.++... |  +....+..++||+|++|
T Consensus        40 l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           40 IQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             CC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             ccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            56677889999987655 5889988752   334445555555442     34444311 1  12345677899999998


Q ss_pred             CChh--------------hhhccccCCC---------CccCCHHHHH-------------------------------HH
Q 006922          404 GSVS--------------AMLHSERGEG---------RIPLDWDTRM-------------------------------RI  429 (625)
Q Consensus       404 g~L~--------------~~l~~~~~~~---------~~~l~~~~~~-------------------------------~i  429 (625)
                      ..+.              ..+|......         ...-.|....                               .+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            6543              1122211100         0112343211                               11


Q ss_pred             HHHHHHHHHHHHh----------cCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          430 AIGAARGIARIHA----------ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       430 ~~~ia~~l~~LH~----------~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ...+.+++++|+.          ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1123446666763          1234599999999999998888999999997653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.98  E-value=3e-07  Score=101.94  Aligned_cols=122  Identities=22%  Similarity=0.257  Sum_probs=75.4

Q ss_pred             cCCCCccEEEecCCCCCccCCcccc-ccccccccccccc-ccCCC-CCC-cccccccceecCCCccCCCCCCCCc----c
Q 006922           88 SRLSALKILSLRSNVITGYFPSDFI-NLKSLCYLYLQFN-NFSGT-LPD-FSVWKNLTIINLSDNGFNGTIPRSL----S  159 (625)
Q Consensus        88 ~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~-~~~l~~L~~L~ls~N~l~~~~p~~l----~  159 (625)
                      ..+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++. +..+++|++|+|++|.+++..+..+    .
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~  181 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD  181 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence            4567788888888877765555554 5778888888777 44321 333 2367778888888887765433333    3


Q ss_pred             ccccccceecccccccccCCC-----C--CCCCCcEEEcccCCCccccccccccCCCCc
Q 006922          160 NLTQLEALYLANNSLSGKIPD-----L--NLPNLQQLNLANNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~~p~-----~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~  211 (625)
                      .+++|+.|+|++|.  +.+..     .  .+++|+.|+|++|...+.+|..+.+++.+.
T Consensus       182 ~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~  238 (594)
T 2p1m_B          182 TYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLE  238 (594)
T ss_dssp             TCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCS
T ss_pred             cCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcce
Confidence            55678888888776  12221     1  357788888887733223666555555543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.95  E-value=9.2e-07  Score=91.52  Aligned_cols=110  Identities=14%  Similarity=0.162  Sum_probs=61.0

Q ss_pred             cccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCC-CCc--ccccccceecCCC--ccCCCC-----CC
Q 006922           86 TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTL-PDF--SVWKNLTIINLSD--NGFNGT-----IP  155 (625)
Q Consensus        86 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~--~~l~~L~~L~ls~--N~l~~~-----~p  155 (625)
                      .+..+++|+.|+|++|.-.. ++. + .+++|+.|+|..|.++... ..+  ..+++|+.|+|+.  |...+.     +.
T Consensus       167 ll~~~P~L~~L~L~g~~~l~-l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~  243 (362)
T 2ra8_A          167 VLDAMPLLNNLKIKGTNNLS-IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR  243 (362)
T ss_dssp             HHHTCTTCCEEEEECCBTCB-CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred             HHhcCCCCcEEEEeCCCCce-ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence            35667778888887763111 232 3 2677777777766654211 122  2567777777642  221111     01


Q ss_pred             CCc--cccccccceecccccccccCCC-----CCCCCCcEEEcccCCCcc
Q 006922          156 RSL--SNLTQLEALYLANNSLSGKIPD-----LNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       156 ~~l--~~l~~L~~L~l~~N~l~~~~p~-----~~l~~L~~L~l~~N~l~g  198 (625)
                      ..+  ..+++|+.|+|++|.+.+..+.     ..+++|+.|+|+.|.|++
T Consensus       244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            112  2456777777777776542211     146677777777777765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.81  E-value=9.4e-07  Score=82.40  Aligned_cols=110  Identities=14%  Similarity=0.093  Sum_probs=82.1

Q ss_pred             CeEEEEEcCCC-Cccccc---CcccccCCCCccEEEecCCCCCcc----CCcccccccccccccccccccCCC----C-C
Q 006922           66 KRVVAVRLPGV-GFSGLI---PPNTISRLSALKILSLRSNVITGY----FPSDFINLKSLCYLYLQFNNFSGT----L-P  132 (625)
Q Consensus        66 ~~v~~l~l~~~-~l~g~~---~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~-p  132 (625)
                      ..++.|+|++| ++...-   -...+...++|++|+|++|.|...    +...+...++|++|+|++|.+...    + .
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            45888999998 775321   122467789999999999999742    233345567899999999999752    1 2


Q ss_pred             CcccccccceecC--CCccCCCC----CCCCccccccccceeccccccc
Q 006922          133 DFSVWKNLTIINL--SDNGFNGT----IPRSLSNLTQLEALYLANNSLS  175 (625)
Q Consensus       133 ~~~~l~~L~~L~l--s~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~  175 (625)
                      .+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            4667789999999  88999753    2334556689999999999985

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.75  E-value=5.3e-05  Score=79.57  Aligned_cols=124  Identities=19%  Similarity=0.227  Sum_probs=84.4

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .+..+.|+.+ +. .|+...|.++++|+.++|..| ++..-...|.+ .+|+.++|. |.++..-+ .|..+++|+.+++
T Consensus       204 ~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l  278 (401)
T 4fdw_A          204 GIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTT  278 (401)
T ss_dssp             CCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEE
T ss_pred             ccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEe
Confidence            4667777744 43 567778889999999999875 56555566766 778888884 44542222 5778888888888


Q ss_pred             CCccCC-----CCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCc
Q 006922          146 SDNGFN-----GTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLS  197 (625)
Q Consensus       146 s~N~l~-----~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~  197 (625)
                      .+|.+.     ..-+..|..|++|+.++|.+ .++..-...  .+++|+.++|..| ++
T Consensus       279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~  335 (401)
T 4fdw_A          279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VT  335 (401)
T ss_dssp             ESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred             CCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-cc
Confidence            887764     23355778888888888884 455332322  6778888888554 54

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.74  E-value=8.5e-05  Score=77.88  Aligned_cols=73  Identities=8%  Similarity=0.093  Sum_probs=48.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc--------CChHHHHHHHHHHHcCCC--Ccee-cceeEEEecCceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN--------VGKRDFEQQMEIVGSIRH--ENVV-ELKAYYYSKDEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~lv  397 (625)
                      +.||.|.++.||++... +++.++||......        .....+..|.+++..+..  +..+ +++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            35899999999999754 47889999865321        123456778888877632  3333 44433  44567899


Q ss_pred             EEeccCC
Q 006922          398 YDYYSLG  404 (625)
Q Consensus       398 ~e~~~~g  404 (625)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.67  E-value=1.2e-05  Score=83.13  Aligned_cols=138  Identities=13%  Similarity=0.145  Sum_probs=90.0

Q ss_pred             CeEEEEEcCCCCccc-ccC------cccccCCCCccEEEecCCCCC---------ccCCcccccccccccccccccccCC
Q 006922           66 KRVVAVRLPGVGFSG-LIP------PNTISRLSALKILSLRSNVIT---------GYFPSDFINLKSLCYLYLQFNNFSG  129 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g-~~~------~~~~~~l~~L~~L~l~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~  129 (625)
                      .+|+.|.+...++.| ...      .+++..+++|+.|.+..+.+.         +.+...+..+++|+.|+|++|.-. 
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence            357777777666553 210      123567899999999876542         113334567789999999988311 


Q ss_pred             CCCCcccccccceecCCCccCCCCCCCCcc--ccccccceeccc--cccccc---------CCCCCCCCCcEEEcccCCC
Q 006922          130 TLPDFSVWKNLTIINLSDNGFNGTIPRSLS--NLTQLEALYLAN--NSLSGK---------IPDLNLPNLQQLNLANNNL  196 (625)
Q Consensus       130 ~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~--~l~~L~~L~l~~--N~l~~~---------~p~~~l~~L~~L~l~~N~l  196 (625)
                      .++.+ .+++|+.|+|..|.++...-..+.  .+++|+.|+|+.  |...+.         +....+++|+.|+|++|.+
T Consensus       186 ~l~~~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i  264 (362)
T 2ra8_A          186 SIGKK-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE  264 (362)
T ss_dssp             BCCSC-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred             eeccc-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence            33444 388999999999988643323333  688999999863  332221         1112578999999999999


Q ss_pred             ccccccccc
Q 006922          197 SGSIPQSLK  205 (625)
Q Consensus       197 ~g~~p~~l~  205 (625)
                      +...+..+.
T Consensus       265 ~~~~~~~la  273 (362)
T 2ra8_A          265 QNVVVEMFL  273 (362)
T ss_dssp             HHHHHHHHH
T ss_pred             chHHHHHHH
Confidence            865554443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.66  E-value=0.00012  Score=76.88  Aligned_cols=64  Identities=17%  Similarity=0.172  Sum_probs=28.8

Q ss_pred             cCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCC
Q 006922           82 IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSD  147 (625)
Q Consensus        82 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~  147 (625)
                      |++..|.++.+|+.++|++|.++......|. ..+|+.+.|..| ++..-. .|..+++|+.+++.+
T Consensus       171 I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          171 LKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             ECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             ehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence            3344455555555555555555543333333 345555555422 221111 344455555555544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.61  E-value=0.00027  Score=71.29  Aligned_cols=138  Identities=15%  Similarity=0.141  Sum_probs=90.8

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCC---CCceecceeEEEecCceEEEEEeccCCChh
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR---HENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .|+.|....+|+... ++..+++|+-...  ....+..|++.|..+.   ...+.++++++...+..++||||+++..+.
T Consensus        43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~  119 (312)
T 3jr1_A           43 KLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK  119 (312)
T ss_dssp             EECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred             EeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence            478899999999886 4678888987643  2456888988888773   356788888888888899999999987653


Q ss_pred             h-----------hhccccC-CC----------------CccCCHHHHH---HHHH----------------HHHH-HHHH
Q 006922          408 A-----------MLHSERG-EG----------------RIPLDWDTRM---RIAI----------------GAAR-GIAR  439 (625)
Q Consensus       408 ~-----------~l~~~~~-~~----------------~~~l~~~~~~---~i~~----------------~ia~-~l~~  439 (625)
                      .           .+|.... ..                .-.-+|....   ++..                .+.. ....
T Consensus       120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~  199 (312)
T 3jr1_A          120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT  199 (312)
T ss_dssp             TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence            1           2333221 00                0012565432   1111                1111 1123


Q ss_pred             HHh-cCCCCceecCCCCCCEEeCCCCCeeEeccc
Q 006922          440 IHA-ANGGKLVHGNIKSSNIFLNSQQYGCVSDLG  472 (625)
Q Consensus       440 LH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfG  472 (625)
                      |.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            321 2245699999999999999887 8899974

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.30  E-value=0.0017  Score=65.72  Aligned_cols=143  Identities=15%  Similarity=0.106  Sum_probs=82.7

Q ss_pred             cccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCC--ceecceeE-----EEecCceEEEEEeccCC
Q 006922          332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHE--NVVELKAY-----YYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~g  404 (625)
                      ++ |....||+....+|+.+++|+..........+..|..++..+...  .+.+++..     ....+..++||+|++|.
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~  112 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  112 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence            55 777789988877787899999875444556777788877766421  23334432     12245567899999885


Q ss_pred             Chhh--------------hhccccCC----CCccCCHHHH----HHH---------------HHHHHHHHHHHHhc----
Q 006922          405 SVSA--------------MLHSERGE----GRIPLDWDTR----MRI---------------AIGAARGIARIHAA----  443 (625)
Q Consensus       405 ~L~~--------------~l~~~~~~----~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~~----  443 (625)
                      .+..              .+|.....    .....++...    ..+               ...+.+.++.+...    
T Consensus       113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  192 (328)
T 1zyl_A          113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  192 (328)
T ss_dssp             ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            5421              11211110    1112233211    000               11111223333321    


Q ss_pred             CCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       444 ~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      ....++|+|+++.||+++ + .+.|+||+.+...
T Consensus       193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             SCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            233489999999999998 4 8899999877643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.29  E-value=0.0009  Score=70.62  Aligned_cols=76  Identities=8%  Similarity=0.112  Sum_probs=48.6

Q ss_pred             CCCceecCCCCCCEEeCCCCCeeEeccccccccccccc---ccc-cCCCcCCccccCCC---CCCCccchhhhHHHHHHH
Q 006922          445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP---VIA-RAAGYRAPEVTDSR---KATQASDVYSFGVVLLEI  517 (625)
Q Consensus       445 ~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~~~-~~~~y~aPE~~~~~---~~~~~~DvwS~Gvil~el  517 (625)
                      .+.++|+|+++.|||++.++ ++++||+.+........   ... -...|.+|+.....   ......++.+....+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            34599999999999998876 99999998876542211   000 01235666654321   112345566888888887


Q ss_pred             HhCC
Q 006922          518 LTGK  521 (625)
Q Consensus       518 ltG~  521 (625)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.27  E-value=0.0015  Score=65.05  Aligned_cols=73  Identities=18%  Similarity=0.205  Sum_probs=52.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCC---ceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHE---NVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.+|.|..+.||+....||+.|.+|+-..... ....|..|++.|..+.-.   .+.+++++    +..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            34789999999999999999999998764432 234688899988877421   23344443    23578999998765


Q ss_pred             h
Q 006922          406 V  406 (625)
Q Consensus       406 L  406 (625)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.15  E-value=0.0012  Score=66.19  Aligned_cols=70  Identities=10%  Similarity=0.041  Sum_probs=42.9

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCce-ecceeEEEecCceEEEEEec-cCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-VELKAYYYSKDEKLMVYDYY-SLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~L  406 (625)
                      +.|+.|....+|+.     ..+++|+.........+..+|+.++..+....+ .+++++  +.+.-++|+||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            34788999999998     558888876532222344667777776643233 344443  344467899999 55444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.0016  Score=67.38  Aligned_cols=143  Identities=11%  Similarity=0.131  Sum_probs=82.4

Q ss_pred             HcccCCceeEEEEEEc--------CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc-eecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILE--------DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN-VVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .|..|-...+|+....        +++.+++|+.........++.+|.++++.+.-.. ..++++++.+    .+||||+
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i  132 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI  132 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence            3666778888998864        2578999986443334566778999888774222 3456655533    3999999


Q ss_pred             cCCChhhh-----------------hccccCCCCccCC--HHHHHHHHHHHHH-------------------HHHHH---
Q 006922          402 SLGSVSAM-----------------LHSERGEGRIPLD--WDTRMRIAIGAAR-------------------GIARI---  440 (625)
Q Consensus       402 ~~g~L~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------~l~~L---  440 (625)
                      +|..+...                 +|........+..  |.+..++..++..                   .+.+|   
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            98665421                 1211111111122  4555555443321                   22333   


Q ss_pred             -HhcC-CCCceecCCCCCCEEeCCC----CCeeEecccccccc
Q 006922          441 -HAAN-GGKLVHGNIKSSNIFLNSQ----QYGCVSDLGLTTIT  477 (625)
Q Consensus       441 -H~~~-~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~~~  477 (625)
                       .... ...++|+|+.+.||+++.+    +.+.++||..+...
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence             2222 2358999999999999876    68999999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.92  E-value=0.0041  Score=62.69  Aligned_cols=144  Identities=8%  Similarity=0.064  Sum_probs=80.2

Q ss_pred             HcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCc--eecceeE------EEecCceEEEEEecc
Q 006922          331 VLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN--VVELKAY------YYSKDEKLMVYDYYS  402 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~~  402 (625)
                      .|+.|....+|+....+| .+++|+.... .....+..|++++..+....  +.+++..      ....+..+++|+|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            367788889999987665 6788988752 22345667777776653211  2223211      122356789999999


Q ss_pred             CCChhh--------------hhccccCC---C----CccCCHHHHHH------------HHHHHHHHHHHHHhcC----C
Q 006922          403 LGSVSA--------------MLHSERGE---G----RIPLDWDTRMR------------IAIGAARGIARIHAAN----G  445 (625)
Q Consensus       403 ~g~L~~--------------~l~~~~~~---~----~~~l~~~~~~~------------i~~~ia~~l~~LH~~~----~  445 (625)
                      |..+..              .+|.....   .    .....|.....            +...+.+.+++++...    .
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            865421              12221110   0    00112433111            1112445556665421    2


Q ss_pred             CCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       446 ~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3589999999999998876567999997654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.92  E-value=0.0021  Score=67.93  Aligned_cols=71  Identities=10%  Similarity=0.134  Sum_probs=47.9

Q ss_pred             HcccCCceeEEEEEEcC--------CcEEEEEEeccccCChHHHHHHHHHHHcCCCCce-ecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-VELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  401 (625)
                      .|+.|....+|+....+        +..+++|+.... .....+.+|..++..+...++ .++++.+.+    .+|+||+
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l  154 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  154 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence            47788889999998753        578999988432 111556678888887753333 456655432    3899999


Q ss_pred             cCCCh
Q 006922          402 SLGSV  406 (625)
Q Consensus       402 ~~g~L  406 (625)
                      ++.++
T Consensus       155 ~G~~l  159 (429)
T 1nw1_A          155 PSRPL  159 (429)
T ss_dssp             CEEEC
T ss_pred             CCccc
Confidence            87444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.85  E-value=9.2e-05  Score=67.58  Aligned_cols=34  Identities=9%  Similarity=-0.012  Sum_probs=17.6

Q ss_pred             CccEEEecCCCCCccCCccccccccccccccccc
Q 006922           92 ALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN  125 (625)
Q Consensus        92 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N  125 (625)
                      .|+.|||+++.++..--..+.++++|+.|+|+++
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            4566666666554322223445555555555555

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.0056  Score=65.05  Aligned_cols=72  Identities=7%  Similarity=0.101  Sum_probs=46.9

Q ss_pred             HcccCCceeEEEEEEcC-CcEEEEEEeccccCChHHHHHHHHHHHcCCCCce-ecceeEEEecCceEEEEEeccCCCh
Q 006922          331 VLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-VELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .|+.|-...+|+....+ +..+++|+.........+..+|..++..+...++ .++++++.  +  .+||||+++.++
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            47788889999998765 5788888875432222234688888888864444 45666652  2  359999987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.80  E-value=0.0024  Score=65.98  Aligned_cols=72  Identities=8%  Similarity=0.072  Sum_probs=42.7

Q ss_pred             HcccCCceeEEEEEEcC---------CcEEEEEEeccccCChHHHHHHHHHHHcCCCCce-ecceeEEEecCceEEEEEe
Q 006922          331 VLGKGTFGMAYKAILED---------GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-VELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  400 (625)
                      .++.|..-.+|+....+         +..+++|+.........+...|.+++..+...++ .++++..    .-++||||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e~  115 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEEW  115 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEEE
Confidence            36778888999988654         2678888775432211234678887777743333 3555443    23689999


Q ss_pred             ccCCCh
Q 006922          401 YSLGSV  406 (625)
Q Consensus       401 ~~~g~L  406 (625)
                      +++..+
T Consensus       116 i~G~~l  121 (369)
T 3c5i_A          116 LYGDPL  121 (369)
T ss_dssp             CCSEEC
T ss_pred             ecCCcC
Confidence            987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.79  E-value=0.0063  Score=61.76  Aligned_cols=143  Identities=13%  Similarity=0.091  Sum_probs=71.6

Q ss_pred             cccCCcee-EEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCC--CceecceeEEEecCceEEEEEeccCCChhh
Q 006922          332 LGKGTFGM-AYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH--ENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       332 lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      |+.|+... +|+....+|..+++|.-....  ..++..|++++..+..  -.+.+++.+...  .-++|||++.+..+.+
T Consensus        26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~l~~  101 (333)
T 3csv_A           26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDALFTE  101 (333)
T ss_dssp             --------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCBHHH
T ss_pred             CCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcchHH
Confidence            44454443 667765446777777544321  1345566776666532  234455655332  2378999987766544


Q ss_pred             hhccc---------------------cCCCCccCCHHHHH-------H-------------HHHHHHHHHHHHHh---cC
Q 006922          409 MLHSE---------------------RGEGRIPLDWDTRM-------R-------------IAIGAARGIARIHA---AN  444 (625)
Q Consensus       409 ~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~~l~~LH~---~~  444 (625)
                      .+...                     .......++.....       .             ....+.+.++.+..   ..
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            33211                     00000111111100       0             00111222233311   12


Q ss_pred             CCCceecCCCCCCEEeCCC----CCeeEeccccccccc
Q 006922          445 GGKLVHGNIKSSNIFLNSQ----QYGCVSDLGLTTITS  478 (625)
Q Consensus       445 ~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~~~~  478 (625)
                      .+.++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            3459999999999999875    678999999887543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.38  E-value=0.00036  Score=63.60  Aligned_cols=84  Identities=12%  Similarity=0.072  Sum_probs=60.3

Q ss_pred             ccccccccccccccCC-CCCCcccccccceecCCCcc-CCCCCCCCcccc----ccccceeccccc-ccc--cCCCCCCC
Q 006922          114 LKSLCYLYLQFNNFSG-TLPDFSVWKNLTIINLSDNG-FNGTIPRSLSNL----TQLEALYLANNS-LSG--KIPDLNLP  184 (625)
Q Consensus       114 l~~L~~L~L~~N~l~~-~~p~~~~l~~L~~L~ls~N~-l~~~~p~~l~~l----~~L~~L~l~~N~-l~~--~~p~~~l~  184 (625)
                      -.+|+.|||+++.++. .+..+..+++|+.|+|++|. |+..--..+..+    ++|++|+|+++. ++.  ...-..++
T Consensus        60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~  139 (176)
T 3e4g_A           60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR  139 (176)
T ss_dssp             CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred             CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence            3579999999999864 24467889999999999995 764322234432    479999999974 763  11112689


Q ss_pred             CCcEEEcccCC-Cc
Q 006922          185 NLQQLNLANNN-LS  197 (625)
Q Consensus       185 ~L~~L~l~~N~-l~  197 (625)
                      +|+.|+|+++. ++
T Consensus       140 ~L~~L~L~~c~~It  153 (176)
T 3e4g_A          140 NLKYLFLSDLPGVK  153 (176)
T ss_dssp             TCCEEEEESCTTCC
T ss_pred             CCCEEECCCCCCCC
Confidence            99999999985 44

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.24  E-value=0.0052  Score=53.12  Aligned_cols=34  Identities=32%  Similarity=0.472  Sum_probs=15.5

Q ss_pred             cccceecccccccccCCCC--CCCCCcEEEcccCCC
Q 006922          163 QLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNL  196 (625)
Q Consensus       163 ~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l  196 (625)
                      +|+.|+|++|+|+...+..  .+++|+.|+|++|.+
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            3444455555444332221  344555555555544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.22  E-value=0.03  Score=56.89  Aligned_cols=33  Identities=15%  Similarity=0.278  Sum_probs=28.3

Q ss_pred             CCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       446 ~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            358999999999999988889999998776543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.16  E-value=0.005  Score=53.23  Aligned_cols=54  Identities=20%  Similarity=0.252  Sum_probs=29.4

Q ss_pred             EEEecCCCCC-ccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccC
Q 006922           95 ILSLRSNVIT-GYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGF  150 (625)
Q Consensus        95 ~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l  150 (625)
                      .++.+++.++ ..+|..+.  .+|++|+|++|+|+...+ .|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            6677777776 23554332  346666666666653333 345555555555555554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=95.94  E-value=0.014  Score=60.34  Aligned_cols=102  Identities=17%  Similarity=0.163  Sum_probs=42.6

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCcccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE  165 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~  165 (625)
                      +....+|+.+.+..+ +.......|.++..|+.+.+..+ ++..-. .|..+.+|+.+.+.++ ++..-...|..+++|+
T Consensus       213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence            444555555555433 22223334445555555555443 221111 2444444555544332 2212223444455555


Q ss_pred             ceecccccccccCCCC--CCCCCcEEEc
Q 006922          166 ALYLANNSLSGKIPDL--NLPNLQQLNL  191 (625)
Q Consensus       166 ~L~l~~N~l~~~~p~~--~l~~L~~L~l  191 (625)
                      .+.+.+|.++..-...  ++.+|+.+.|
T Consensus       290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~l  317 (379)
T 4h09_A          290 KVVMDNSAIETLEPRVFMDCVKLSSVTL  317 (379)
T ss_dssp             EEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             cccccccccceehhhhhcCCCCCCEEEc
Confidence            5555544444222211  3444555544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=95.74  E-value=0.0098  Score=61.91  Aligned_cols=109  Identities=17%  Similarity=0.328  Sum_probs=77.6

Q ss_pred             cCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--CcccccccceecCCCccCCCCCCCCcc
Q 006922           82 IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTIINLSDNGFNGTIPRSLS  159 (625)
Q Consensus        82 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~ls~N~l~~~~p~~l~  159 (625)
                      +....|.++..|+.+.+..+..+ .-...|.++.+|+.+.+. +.++ .++  .|..+.+|+.++|.+| ++..-..+|.
T Consensus       256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~  331 (394)
T 4gt6_A          256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFA  331 (394)
T ss_dssp             ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred             cccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence            34456888889999988765543 445678888889988886 3444 333  5888889999998765 5534456788


Q ss_pred             ccccccceecccccccccCCC---CCCCCCcEEEcccCCC
Q 006922          160 NLTQLEALYLANNSLSGKIPD---LNLPNLQQLNLANNNL  196 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~~p~---~~l~~L~~L~l~~N~l  196 (625)
                      +|++|+.+.|.++ ++ .+..   .++++|+.+++.+|..
T Consensus       332 ~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          332 GCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             TCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred             CCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence            8899999988655 54 3443   2788899999888754

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.54  E-value=0.00068  Score=63.01  Aligned_cols=86  Identities=15%  Similarity=0.088  Sum_probs=47.4

Q ss_pred             ccCCCCccEEEecCC-CCCcc----CCcccccccccccccccccccCCC----CC-CcccccccceecCCCccCCCC---
Q 006922           87 ISRLSALKILSLRSN-VITGY----FPSDFINLKSLCYLYLQFNNFSGT----LP-DFSVWKNLTIINLSDNGFNGT---  153 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~ls~N~l~~~---  153 (625)
                      +.+-+.|+.|+|++| .|...    +-..+..-+.|+.|+|++|++...    +. .+..-+.|+.|+|++|.|...   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            445677888888875 66521    112233446677777777777521    11 133445677777777777532   


Q ss_pred             -CCCCccccccccceecccc
Q 006922          154 -IPRSLSNLTQLEALYLANN  172 (625)
Q Consensus       154 -~p~~l~~l~~L~~L~l~~N  172 (625)
                       +-..+..-+.|+.|+|++|
T Consensus       117 ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHhhCCceeEEECCCC
Confidence             1122333345666666543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.35  E-value=0.095  Score=48.99  Aligned_cols=99  Identities=10%  Similarity=0.086  Sum_probs=64.6

Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      -+|.+.|....    .+++++++..++.|.+++|.-+-.... + ..+=+.|..|++..+|.+...+ ..+.        
T Consensus        33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence            37888887654    379999999999999998876622111 1 1233456889999999887764 2111        


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT  519 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt  519 (625)
                       .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1122367888764 355678899999999999887

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.00  E-value=0.048  Score=56.61  Aligned_cols=107  Identities=18%  Similarity=0.135  Sum_probs=48.4

Q ss_pred             cCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccc--------------------cCCCCC--Ccccccc
Q 006922           82 IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNN--------------------FSGTLP--DFSVWKN  139 (625)
Q Consensus        82 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~--------------------l~~~~p--~~~~l~~  139 (625)
                      +....+.....|+.+.+..|... .....|.++..|+.+.+..+.                    ++ .++  .|..+.+
T Consensus       244 i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~i~-~I~~~aF~~c~~  321 (394)
T 4fs7_A          244 LGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDSVK-FIGEEAFESCTS  321 (394)
T ss_dssp             ECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTTCC-EECTTTTTTCTT
T ss_pred             cccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccccc-eechhhhcCCCC
Confidence            33445666666666666655432 223334444444444443332                    22 121  3445555


Q ss_pred             cceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcc
Q 006922          140 LTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLA  192 (625)
Q Consensus       140 L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~  192 (625)
                      |+.++|.++ ++..-..+|.+|++|+.+.+..| ++..-...  ++.+|+.+++.
T Consensus       322 L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          322 LVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             CCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             CCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            555555433 33222344555555555555444 33211111  44555555543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=94.82  E-value=0.047  Score=56.64  Aligned_cols=103  Identities=12%  Similarity=0.158  Sum_probs=62.0

Q ss_pred             CCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC-
Q 006922          103 ITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-  181 (625)
Q Consensus       103 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-  181 (625)
                      ++..-...|.++.+|+.+.+..+..+-.--.|..+.+|+.+.+. +.++..-...|.++.+|+.++|.+| ++..-... 
T Consensus       253 v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF  330 (394)
T 4gt6_A          253 VARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF  330 (394)
T ss_dssp             EEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred             ceEcccceeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence            33334456777788888888665443111257777888888885 4455344557788888888888755 44222221 


Q ss_pred             -CCCCCcEEEcccCCCccccc-cccccCCC
Q 006922          182 -NLPNLQQLNLANNNLSGSIP-QSLKRFPS  209 (625)
Q Consensus       182 -~l~~L~~L~l~~N~l~g~~p-~~l~~~~~  209 (625)
                       ++.+|+.+.|..+ ++ .|+ .++..+.+
T Consensus       331 ~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~  358 (394)
T 4gt6_A          331 AGCEQLERIAIPSS-VT-KIPESAFSNCTA  358 (394)
T ss_dssp             TTCTTCCEEEECTT-CC-BCCGGGGTTCTT
T ss_pred             hCCCCCCEEEECcc-cC-EEhHhHhhCCCC
Confidence             6778888887544 54 332 34544443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=94.67  E-value=0.037  Score=57.50  Aligned_cols=87  Identities=17%  Similarity=0.189  Sum_probs=68.8

Q ss_pred             cCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--CcccccccceecCCCccCCCCCCCCcc
Q 006922           82 IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTIINLSDNGFNGTIPRSLS  159 (625)
Q Consensus        82 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~ls~N~l~~~~p~~l~  159 (625)
                      ++...+..+.+|+.+.+..+ ++..-...|.++.+|+.++|..+ ++ .+.  .|..+.+|+.+++..| ++..-..+|.
T Consensus       288 i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~  363 (394)
T 4fs7_A          288 VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ  363 (394)
T ss_dssp             ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred             eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence            44556778888999998765 66656678999999999999754 54 343  6889999999999877 6645567899


Q ss_pred             ccccccceecccc
Q 006922          160 NLTQLEALYLANN  172 (625)
Q Consensus       160 ~l~~L~~L~l~~N  172 (625)
                      +|++|+.+++..|
T Consensus       364 ~C~~L~~i~lp~~  376 (394)
T 4fs7_A          364 GCINLKKVELPKR  376 (394)
T ss_dssp             TCTTCCEEEEEGG
T ss_pred             CCCCCCEEEECCC
Confidence            9999999999766

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=94.58  E-value=0.042  Score=56.59  Aligned_cols=133  Identities=20%  Similarity=0.242  Sum_probs=92.7

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--CcccccccceecC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l  145 (625)
                      +..+.++.+ + ..+....+.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ +. .++  .|..+.+|+.+.+
T Consensus       219 l~~i~~~~~-~-~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l  293 (379)
T 4h09_A          219 LKKITITSG-V-TTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVM  293 (379)
T ss_dssp             CSEEECCTT-C-CEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEE
T ss_pred             cceeeeccc-e-eEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccc
Confidence            444555433 2 2355566888999999999876 66556677888999999998755 33 233  5888999999999


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC---CCCCCcEEEcccCCCccccccccccCCCCcccCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNS  216 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~  216 (625)
                      .+|.++..-..+|.++.+|+.+.|.++ ++ .+...   ++.+|+.+.+.         ..+..+..-+|.|..
T Consensus       294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip---------~~v~~I~~~aF~~c~  356 (379)
T 4h09_A          294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYP---------KSITLIESGAFEGSS  356 (379)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCC---------TTCCEECTTTTTTSS
T ss_pred             cccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEEC---------CccCEEchhHhhCCC
Confidence            999888555678999999999999765 54 33432   67778777653         334444455565543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.39  E-value=0.17  Score=52.94  Aligned_cols=142  Identities=10%  Similarity=0.116  Sum_probs=82.9

Q ss_pred             HcccCCceeEEEEEEcC--------CcEEEEEEeccccCChHHHHHHHHHHHcCCCCc-eecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN-VVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  401 (625)
                      .+..|-...+|+....+        +..+++|+.........+..+|.+++..+...+ ..++++.+    .-++||||+
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~efI  152 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEFI  152 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEECC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEEe
Confidence            36667788899888653        578888886543222234567888877774323 34455433    237899999


Q ss_pred             cCCChhhh-----------------hccccC------C--CCccCCHHHHHHHHHHH-------------------HHHH
Q 006922          402 SLGSVSAM-----------------LHSERG------E--GRIPLDWDTRMRIAIGA-------------------ARGI  437 (625)
Q Consensus       402 ~~g~L~~~-----------------l~~~~~------~--~~~~l~~~~~~~i~~~i-------------------a~~l  437 (625)
                      ++..+...                 +|....      .  ...+--|.+..++..++                   ...+
T Consensus       153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~  232 (424)
T 3mes_A          153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI  232 (424)
T ss_dssp             CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred             CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence            98664320                 111100      0  11122344443333222                   2223


Q ss_pred             HHHHhc---------------------CCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          438 ARIHAA---------------------NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       438 ~~LH~~---------------------~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      .+|...                     ....++|+|+.+.||+ +.++.+.++||..+...
T Consensus       233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            333211                     1234899999999999 78889999999988653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.99  E-value=0.0041  Score=57.71  Aligned_cols=84  Identities=13%  Similarity=0.044  Sum_probs=57.1

Q ss_pred             CeEEEEEcCCC-Ccccc---cCcccccCCCCccEEEecCCCCCccC----CcccccccccccccccccccCCCC-----C
Q 006922           66 KRVVAVRLPGV-GFSGL---IPPNTISRLSALKILSLRSNVITGYF----PSDFINLKSLCYLYLQFNNFSGTL-----P  132 (625)
Q Consensus        66 ~~v~~l~l~~~-~l~g~---~~~~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~-----p  132 (625)
                      ..++.|+|+++ ++...   .-.+.+..=..|+.|+|++|.|...-    -..+..=+.|+.|+|++|+|...-     .
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~  120 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR  120 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence            45888999875 55321   01223666789999999999998322    122334478999999999997421     1


Q ss_pred             CcccccccceecCCCcc
Q 006922          133 DFSVWKNLTIINLSDNG  149 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~  149 (625)
                      .+..-+.|+.|+|++|.
T Consensus       121 aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A          121 STLVTQSIVEFKADNQR  137 (197)
T ss_dssp             HTTTTCCCSEEECCCCS
T ss_pred             HHhhCCceeEEECCCCc
Confidence            35556779999998764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.01  E-value=0.17  Score=33.92  Aligned_cols=9  Identities=22%  Similarity=0.143  Sum_probs=3.6

Q ss_pred             Hhhhhhccc
Q 006922          271 IVACCVRKK  279 (625)
Q Consensus       271 ~~~~~~~~~  279 (625)
                      ++++++||+
T Consensus        31 ~~~~~RRr~   39 (44)
T 2ks1_B           31 IGLFMRRRH   39 (44)
T ss_dssp             HHHHHHTTT
T ss_pred             HHHHhhhhH
Confidence            334444433

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=90.95  E-value=0.13  Score=33.35  Aligned_cols=31  Identities=10%  Similarity=0.138  Sum_probs=16.7

Q ss_pred             ccccceeeehhhhHHHHHHHHHHHHHhhhhhc
Q 006922          246 RIGETTLLGIVIAASVLGLLAFLFLIVACCVR  277 (625)
Q Consensus       246 ~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~~  277 (625)
                      ..+..++.+++++.++.++++.. +++++|+|
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~-l~~~~~rr   37 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLG-ILVFRSRR   37 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHH-HHHHHHCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHH-HHHHHeec
Confidence            34556777777776655444333 33444433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=90.55  E-value=0.17  Score=33.84  Aligned_cols=10  Identities=20%  Similarity=0.145  Sum_probs=4.0

Q ss_pred             Hhhhhhcccc
Q 006922          271 IVACCVRKKR  280 (625)
Q Consensus       271 ~~~~~~~~~~  280 (625)
                      ++++++||++
T Consensus        30 ~~~~~RRRr~   39 (44)
T 2l2t_A           30 FAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHTTCS
T ss_pred             HHHHhhhhhh
Confidence            3344444433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.86  E-value=0.99  Score=46.71  Aligned_cols=30  Identities=20%  Similarity=0.357  Sum_probs=25.3

Q ss_pred             ceecCCCCCCEEe------CCCCCeeEecccccccc
Q 006922          448 LVHGNIKSSNIFL------NSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       448 ivHrDlk~~NIll------~~~~~~kl~DfGla~~~  477 (625)
                      ++|+|+.+.|||+      +++..+.++||..|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            5799999999999      45667999999988754

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=85.13  E-value=0.49  Score=31.60  Aligned_cols=7  Identities=14%  Similarity=0.581  Sum_probs=2.8

Q ss_pred             eeehhhh
Q 006922          252 LLGIVIA  258 (625)
Q Consensus       252 ~~~i~i~  258 (625)
                      +++.+++
T Consensus        14 Ia~~vVG   20 (44)
T 2jwa_A           14 IISAVVG   20 (44)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            3334444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	625
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-43
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-42
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-41
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-37
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-05
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-12
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	2e-05
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.001

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-50
 Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E LG G FG  +       T V VK LK  ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           +++   ++ +Y   GS+   L +  G   I L  +  + +A   A G+A I   N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTI----TSALAPVIARAAGYRAPEVTDSRKATQAS 505
           H +++++NI ++      ++D GL  +                 + APE  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFG++L EI+T G+ P       E++  +   + +VR +   E              
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------------- 237

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
              E+ Q+   C    P+ RP    +  V+E+
Sbjct: 238 ---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-48
 Identities = 49/274 (17%), Positives = 105/274 (38%), Gaps = 29/274 (10%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + +G G FG+ +     +   V +K +++  + + DF ++ E++  + H  +V+L     
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
            +    +V+++   G     L       R     +T + + +    G   +       ++
Sbjct: 71  EQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVI 123

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTI----TSALAPVIARAAGYRAPEVTDSRKATQAS 505
           H ++ + N  +   Q   VSD G+T          +        + +PEV    + +  S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           DV+SFGV++ E+ + GK P       E+V  +     + +    +               
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------------- 229

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
               + QI   C    P+ RP    ++R +  + 
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 5e-48
 Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + +GKG FG         G  V VK +K+ +   + F  +  ++  +RH N+V+L     
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 390 SKDEKL-MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            +   L +V +Y + GS+   L S    GR  L  D  ++ ++     +  +   N    
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVY 508
           VH ++ + N+ ++      VSD GLT   S+          + APE    +K +  SDV+
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184

Query: 509 SFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEMV 567
           SFG++L EI + G+ P       ++V  V                  +  +    +    
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------KGYKMDAPDGCPP 227

Query: 568 EMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND 601
            + ++  +C       RP    +   +E+++ ++
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 9e-48
 Identities = 64/282 (22%), Positives = 120/282 (42%), Gaps = 33/282 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + +G G+FG  YK        V VK L          + F+ ++ ++   RH N++    
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
           Y  +  +  +V  +    S+   LH          +    + IA   A+G+  +HA +  
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS-- 124

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAGYRAPEV---TDS 498
            ++H ++KS+NIFL+      + D GL T+ S  +       ++ +  + APEV    D 
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
              +  SDVY+FG+VL E++TG+ P         ++    +  +V   + +         
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN 600
            P        M ++   C+ +  D+RP  P ++  IE +  +
Sbjct: 238 CPK------AMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 60/299 (20%), Positives = 107/299 (35%), Gaps = 33/299 (11%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           E +GKG FG  ++     G  V VK            E ++     +RHEN++   A   
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 390 SKDEKL----MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +       +V DY+  GS+   L+      R  +  +  +++A+  A G+A +H    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 446 G-----KLVHGNIKSSNIFLNSQQYGCVSDLGL-------TTITSALAPVIARAAGYRAP 493
           G      + H ++KS NI +      C++DLGL       T               Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 494 EVTDSR------KATQASDVYSFGVVLLEILTGKSPIHTTGGDEL----VHLVRWVHSVV 543
           EV D        ++ + +D+Y+ G+V  EI    S        +L    +         +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
           R+    +     +       E +  M +I   C       R     + + +  +   + 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 51/273 (18%), Positives = 104/273 (38%), Gaps = 29/273 (10%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
           + LG G FG+           V +K +K+ ++ + +F ++ +++ ++ HE +V+L     
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
            +    ++ +Y + G +   L   R            + +       +  + +      +
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FL 122

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTI----TSALAPVIARAAGYRAPEVTDSRKATQAS 505
           H ++ + N  +N Q    VSD GL+          +        +  PEV    K +  S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 506 DVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           D+++FGV++ EI + GK P       E    +     + R    +E              
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------------- 228

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
              ++  I  SC     D+RP    ++  I +V
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-44
 Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 42/300 (14%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYY 389
             LG+G FG  +       T V +K LK   +    F Q+ +++  +RHE +V+L A   
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 81

Query: 390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLV 449
           S++   +V +Y S GS   +L   +GE    L     + +A   A G+A +   N    V
Sbjct: 82  SEEPIYIVTEYMSKGS---LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135

Query: 450 HGNIKSSNIFLNSQQYGCVSDLGLTTITSA----LAPVIARAAGYRAPEVTDSRKATQAS 505
           H +++++NI +       V+D GL  +                 + APE     + T  S
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

Query: 506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE 565
           DV+SFG++L E+ T     +   G     ++  V                  R P   E 
Sbjct: 196 DVWSFGILLTELTTKGRVPY--PGMVNREVLDQV--------------ERGYRMPCPPEC 239

Query: 566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESSTPPPPVAGEN 625
              +  +   C  + P++RP    +   +E+                 +ST P    GEN
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF---------------TSTEPQYQPGEN 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (390), Expect = 4e-43
 Identities = 53/278 (19%), Positives = 106/278 (38%), Gaps = 27/278 (9%)

Query: 330 EVLGKGTFGMAYKAILED-GTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             LG G +G  Y+ + +    TV VK LK+  +   +F ++  ++  I+H N+V+L    
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             +    ++ ++ + G++   L       R  +     + +A   +  +  +   N    
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---F 136

Query: 449 VHGNIKSSNIFLNSQQYGCVSDLG----LTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
           +H ++ + N  +       V+D G    +T  T            + APE     K +  
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           SDV++FGV+L EI T     +   G +L  +   +                  R    E 
Sbjct: 197 SDVWAFGVLLWEIATYGMSPY--PGIDLSQVYELLEKD--------------YRMERPEG 240

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
              ++ ++  +C    P  RP   ++ +  E +    S
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 47/287 (16%), Positives = 102/287 (35%), Gaps = 16/287 (5%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK--DVNVGKRDFEQQMEIVGSIRHENVVELKA 386
             LG G  G+ +K      G  +  K +        +    ++++++       +V    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            +YS  E  +  ++   GS+  +L          +      +++I   +G+  +   +  
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK- 125

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQAS 505
            ++H ++K SNI +NS+    + D G++  +  ++A        Y +PE       +  S
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 506 DVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV--FDVELLRYPNIE 563
           D++S G+ L+E+  G+ PI      EL  +          E           L  Y    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKM---PDVVRVIENVRPNDSENRPS 607
              + + ++    V   P + P      +    +      +   R  
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (386), Expect = 2e-42
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 39/289 (13%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVE 383
           +V+G G FG      L    +    V +K LK       +RDF  +  I+G   H NV+ 
Sbjct: 32  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L+         +++ ++   GS+ + L    G           + +  G A G+  +   
Sbjct: 92  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM 147

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--------TSALAPVIARAAGYRAPEV 495
           N    VH ++ + NI +NS     VSD GL+          T   A        + APE 
Sbjct: 148 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
              RK T ASDV+S+G+V+ E+++ G+ P       ++++ +                  
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------------- 247

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSE 603
           +  R P   +    + Q+ + C  +  + RPK   +V  ++ +  N + 
Sbjct: 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 53/275 (19%), Positives = 110/275 (40%), Gaps = 31/275 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELK 385
             +G G++G   K     DG  +V K L   ++    K+    ++ ++  ++H N+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 386 AYYYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
                +      +V +Y   G +++++     E R  LD +  +R+       +   H  
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 444 NGG--KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEVTDS 498
           + G   ++H ++K +N+FL+ +Q   + D GL  I    ++ A        Y +PE  + 
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
               + SD++S G +L E+     P       EL   +R               + +  R
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR---------------EGKFRR 233

Query: 559 YP-NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            P    +E+ E++      +      RP + +++ 
Sbjct: 234 IPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-41
 Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 37/297 (12%)

Query: 316 NYAFDLEDLLRASAEVLGKGTFGMAYKAILED----GTTVVVKRLKDVN--VGKRDFEQQ 369
           +       L+    EV+G+G FG  Y   L D         VK L  +        F  +
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78

Query: 370 MEIVGSIRHENVVELKAYYYSKDEK-LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMR 428
             I+    H NV+ L       +   L+V  Y   G     L +              + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIG 134

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-------TSALA 481
             +  A+G+  + +    K VH ++ + N  L+ +    V+D GL          +    
Sbjct: 135 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS 541
                   + A E   ++K T  SDV+SFGV+L E++T  +P +         +  ++  
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQ 249

Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
             R           LL+     + + E   + + C     + RP   ++V  I  + 
Sbjct: 250 GRR-----------LLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIF 292

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 2e-41
 Identities = 59/269 (21%), Positives = 98/269 (36%), Gaps = 32/269 (11%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQM----EIVGSIRHENVVEL 384
             LGKG FG  Y A   +    + +K L    + K   E Q+    EI   +RH N++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
             Y++      ++ +Y  LG+V   L           D           A  ++  H+  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR 126

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT-ITSALAPVIARAAGYRAPEVTDSRKATQ 503
              ++H +IK  N+ L S     ++D G +    S+    +     Y  PE+ + R   +
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
             D++S GV+  E L GK P       E    +  V     +  T    D          
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD---------- 233

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                   +    +   P QRP + +V+ 
Sbjct: 234 --------LISRLLKHNPSQRPMLREVLE 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 3e-41
 Identities = 61/302 (20%), Positives = 116/302 (38%), Gaps = 46/302 (15%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLK--DVNVGKRDFEQQMEIVGSI-RHEN 380
           + LG G FG   +A        +   TV VK LK       +     +++++  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG-------------EGRIPLDWDTRM 427
           +V L          L++ +Y   G +   L  +R              +  + LD +  +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAP 482
             +   A+G+A + + N    +H ++ + NI L   +   + D GL           +  
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSV 542
                  + APE   +   T  SDV+S+G+ L E+ +  S  +       + +    + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-----MPVDSKFYKM 260

Query: 543 VREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDS 602
           ++E +          R  + E    EM  I  +C    P +RP    +V++IE    ++S
Sbjct: 261 IKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI-SES 309

Query: 603 EN 604
            N
Sbjct: 310 TN 311

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 3e-41
 Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 53/300 (17%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENV 381
             +G+G FG  ++A        E  T V VK LK+      + DF+++  ++    + N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGE-------------------GRIPLD 422
           V+L           ++++Y + G ++  L S                       G  PL 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 423 WDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----T 477
              ++ IA   A G+A +        VH ++ + N  +       ++D GL+        
Sbjct: 139 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 478 SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLV 536
                  A    +  PE     + T  SDV+++GVVL EI + G  P +    +E+++ V
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255

Query: 537 RWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           R               D  +L  P  E   +E+  +   C  ++P  RP    + R+++ 
Sbjct: 256 R---------------DGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-41
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 37/287 (12%)

Query: 330 EVLGKGTFGMAYKAILEDGT-----TVVVKRLKD--VNVGKRDFEQQMEIVGSIRHENVV 382
           +V+G G FG  YK +L+  +      V +K LK       + DF  +  I+G   H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L+         +++ +Y   G++   L  + G           + +  G A G+  +  
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 128

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI------TSALAPVIARAAGYRAPEVT 496
            N    VH ++ + NI +NS     VSD GL+ +       +           + APE  
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 497 DSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
             RK T ASDV+SFG+V+ E++T     +         +++ +               + 
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAI--------------NDG 229

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDS 602
            R P   +    + Q+ M C  +   +RPK  D+V +++  +R  DS
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-41
 Identities = 57/273 (20%), Positives = 115/273 (42%), Gaps = 32/273 (11%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVVELK 385
             +G+G+F   YK +  E    V    L+D  + K +   F+++ E++  ++H N+V   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 386 AYYYS----KDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
             + S    K   ++V +  + G++   L   +      +             +G+  +H
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTI-TSALAPVIARAAGYRAPEVTDSR 499
                 ++H ++K  NIF+        + DLGL T+  ++ A  +     + APE+ +  
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-E 187

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
           K  ++ DVY+FG+ +LE+ T + P           + R V S V+     +V   E+   
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPEV--- 242

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                      +I   C+ +  D+R  + D++ 
Sbjct: 243 ----------KEIIEGCIRQNKDERYSIKDLLN 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (378), Expect = 7e-41
 Identities = 56/288 (19%), Positives = 116/288 (40%), Gaps = 30/288 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD-FEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++      G     K +   +   ++   ++++ +  +RH  +V L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           +   +E +M+Y++ S G +   +  E       +  D  +       +G+  +H  N   
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN--- 144

Query: 448 LVHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA--LAPVIARAAGYRAPEVTDSRKATQ 503
            VH ++K  NI   +++   +   D GLT          V    A + APEV + +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            +D++S GV+   +L+G SP      DE +  V+           +  ++++   +  I 
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-----------SCDWNMDDSAFSGIS 253

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR---VIENVRPNDSENRPSS 608
           E+  + ++     ++  P+ R  +   +    +     P      PSS
Sbjct: 254 EDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 8e-41
 Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 38/289 (13%)

Query: 319 FDLEDLLRASAEVLGKGTFGMAYKAIL---EDGTTVVVKRLKDVN--VGKRDFEQQMEIV 373
              ++LL A  E LG G FG   + +    +    V +K LK         +  ++ +I+
Sbjct: 5   LKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63

Query: 374 GSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGA 433
             + +  +V L     + +  ++V +    G +   L  +R      +       +    
Sbjct: 64  HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQV 118

Query: 434 ARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP------VIARA 487
           + G+  +   N    VH ++ + N+ L ++ Y  +SD GL+    A              
Sbjct: 119 SMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREE 546
             + APE  + RK +  SDV+S+GV + E L+ G+ P       +   ++ ++    R E
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMAFIEQGKRME 232

Query: 547 WTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
              E                 E+  +   C +   + RP    V + + 
Sbjct: 233 CPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 52/271 (19%), Positives = 110/271 (40%), Gaps = 33/271 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK----DVNVGKRDFEQQMEIVGSIRHENVVEL 384
             +G G+FG  Y A  + +   V +K++       N   +D  +++  +  +RH N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           +  Y  +    +V +Y    +   +   ++     PL       +  GA +G+A +H+ N
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV---TDSRKA 501
              ++H ++K+ NI L+      + D G  +I +     +     + APEV    D  + 
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG-TPYWMAPEVILAMDEGQY 191

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
               DV+S G+  +E+   K P+     + +  L     +           +   L+  +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIAQN-----------ESPALQSGH 238

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
             E     +    SC+ ++P  RP    +++
Sbjct: 239 WSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-40
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 39/284 (13%)

Query: 330 EVLGKGTFGMAYKAILE----DGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENV 381
           E LG G+FG+  +   +       +V VK LK   + +     DF +++  + S+ H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           + L     +   K MV +   LGS+   L   +G         T  R A+  A G+  + 
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI------TSALAPVIARAAGYRAPEV 495
           +      +H ++ + N+ L ++    + D GL            +         + APE 
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 496 TDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
             +R  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 229

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR 598
           E  R P  E+   ++  + + C    P+ RP    +   +   +
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 7e-40
 Identities = 56/279 (20%), Positives = 100/279 (35%), Gaps = 39/279 (13%)

Query: 331 VLGKGTFGMAYKAILED---GTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVEL 384
            LG G FG   K   +      TV VK LK+       K +   +  ++  + +  +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
                  +  ++V +   LG ++  L   R      +     + +    + G+  +  +N
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN 127

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA------LAPVIARAAGYRAPEVTDS 498
               VH ++ + N+ L +Q Y  +SD GL+    A                + APE  + 
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 499 RKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
            K +  SDV+SFGV++ E  + G+ P     G E+  ++                     
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------- 227

Query: 558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN 596
           R         EM  +   C     + RP    V   + N
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-39
 Identities = 53/298 (17%), Positives = 104/298 (34%), Gaps = 38/298 (12%)

Query: 330 EVLGKGTFGMAYKAILEDG---TTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVE 383
           +V+G+G FG   KA ++         +KR+K+       RDF  ++E++  +  H N++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLH-----------SERGEGRIPLDWDTRMRIAIG 432
           L      +    +  +Y   G++   L            +        L     +  A  
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 433 AARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--TSALAPVIARAAGY 490
            ARG+  +        +H ++ + NI +       ++D GL+          +      +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 491 RAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE 550
            A E  +    T  SDV+S+GV+L EI++     +   G     L   +    R E    
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGYRLEKPLN 250

Query: 551 VFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSS 608
             D              E+  +   C    P +RP    ++  +  +         ++
Sbjct: 251 CDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-38
 Identities = 50/273 (18%), Positives = 103/273 (37%), Gaps = 32/273 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAY 387
             LG G FG  YKA   E       K +   +     D+  +++I+ S  H N+V+L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           +Y ++   ++ ++ + G+V A++         PL       +       +  +H      
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNK--- 130

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEV-----TDSR 499
           ++H ++K+ NI         ++D G++   +          G   + APEV     +  R
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
                +DV+S G+ L+E+   + P H      ++        + + E         L + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------IAKSEP------PTLAQP 238

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                   + L+    C+ +  D R     +++
Sbjct: 239 SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 1e-37
 Identities = 54/272 (19%), Positives = 99/272 (36%), Gaps = 32/272 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL--KDVNVGKRDFEQQMEIVGSIRHENVVELKA 386
           + LG+G +G    A+       V VK +  K       + ++++ I   + HENVV+   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
           +    + + +  +Y S G +   +  + G     +      R       G+  +H     
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEV-TDSRK 500
            + H +IK  N+ L+ +    +SD GL T+        L   +     Y APE+      
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
             +  DV+S G+VL  +L G+        D       W                    + 
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN-----------PWK 230

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
            I+   + +L      +V  P  R  +PD+ +
Sbjct: 231 KIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  140 bits (355), Expect = 1e-37
 Identities = 56/306 (18%), Positives = 120/306 (39%), Gaps = 36/306 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRL-KDVNVGKRDFEQQMEIVGSIRHENVVELKAY 387
           E LG G FG+ ++ +    G   V K +     + K   + ++ I+  + H  ++ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           +  K E +++ ++ S G +   + +E       +     +     A  G+  +H  +   
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS--- 147

Query: 448 LVHGNIKSSNIFLNSQQYG--CVSDLGLTTI--TSALAPVIARAAGYRAPEVTDSRKATQ 503
           +VH +IK  NI   +++     + D GL T      +  V    A + APE+ D      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE 563
            +D+++ GV+   +L+G SP       E +  V+       E+            + ++ 
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-----------AFSSVS 256

Query: 564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR---------VIENVRPNDSENRPSSGNKSES 614
            E  + ++   + + + P +R  + D +           + +  P+   N+     K + 
Sbjct: 257 PEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKY 313

Query: 615 STPPPP 620
           +  P P
Sbjct: 314 ADWPAP 319

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-37
 Identities = 54/279 (19%), Positives = 106/279 (37%), Gaps = 36/279 (12%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDV--NVGKRDFEQQMEIVGSIRHENVVE 383
             +G+G FG  ++ I          V +K  K+   +  +  F Q+   +    H ++V+
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           L     +++   ++ +  +LG     L S     +  LD  + +  A   +  +A + + 
Sbjct: 73  LIGVI-TENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI----TSALAPVIARAAGYRAPEVTDSR 499
                VH +I + N+ ++S     + D GL+      T   A        + APE  + R
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 500 KATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
           + T ASDV+ FGV + EIL  G  P      ++++  +                     R
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-----------------R 227

Query: 559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
            P        +  +   C    P +RP+  ++   +  +
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 53/298 (17%), Positives = 104/298 (34%), Gaps = 50/298 (16%)

Query: 330 EVLGKGTFGMAYKAILED------GTTVVVKRLKDV--NVGKRDFEQQMEIVGSI-RHEN 380
           +VLG G FG    A             V VK LK+   +  +     +++++  +  HEN
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 381 VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG------------------EGRIPLD 422
           +V L           ++++Y   G +   L S+R                   E    L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 423 WDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----T 477
           ++  +  A   A+G+  +   +    VH ++ + N+ +   +   + D GL         
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 478 SALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVR 537
             +         + APE       T  SDV+S+G++L EI +     +  G     +  +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PGIPVDANFYK 278

Query: 538 WVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE 595
            + +  + +      +              E+  I  SC      +RP  P++   + 
Sbjct: 279 LIQNGFKMDQPFYATE--------------EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 6e-37
 Identities = 47/268 (17%), Positives = 106/268 (39%), Gaps = 29/268 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD-FEQQMEIVGSIRHENVVELKAY 387
           E +G+G  G  Y A+ +  G  V ++++      K++    ++ ++   ++ N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 388 YYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGK 447
           Y   DE  +V +Y + GS++ ++          +D      +     + +  +H+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 448 LVHGNIKSSNIFLNSQQYGCVSDLGLT---TITSALAPVIARAAGYRAPEVTDSRKATQA 504
           ++H +IKS NI L       ++D G     T   +    +     + APEV   +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
            D++S G++ +E++ G+ P         ++L+            A     EL     +  
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------ATNGTPELQNPEKLSA 244

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
              + L     C+    ++R    ++++
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-36
 Identities = 46/296 (15%), Positives = 117/296 (39%), Gaps = 29/296 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           E LG+G FG+ ++ +      T + K +K     +   ++++ I+   RH N++ L   +
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            S +E +M++++ S   +   +++        L+    +         +  +H+ N   +
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN---I 123

Query: 449 VHGNIKSSNIFLNSQQYGCV--SDLGLTTITSA--LAPVIARAAGYRAPEVTDSRKATQA 504
            H +I+  NI   +++   +   + G            ++  A  Y APEV      + A
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
           +D++S G ++  +L+G +P       +++  +        EE            +  I  
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-----------AFKEISI 232

Query: 565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR---VIENVRPNDSENRPSSGNKSESSTP 617
           E ++ +      +V+    R    + ++   + + +    ++   +  ++    T 
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTL 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 38/302 (12%)

Query: 330 EVLGKGTFGMAYKAIL-----EDGTTVVVKRLKDVNVGK--RDFEQQMEIVGSIRHENVV 382
           +VLG G FG  YK +      +    V +K L++    K  ++   +  ++ S+ + +V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L     +   +L +      G     L     E +  +     +   +  A+G+  +  
Sbjct: 75  RLLGICLTSTVQL-ITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTD 497
                LVH ++ + N+ + + Q+  ++D GL  +         A        + A E   
Sbjct: 130 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 498 SRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
            R  T  SDV+S+GV + E++T G  P       E+  ++                  + 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----------------KG 229

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKSESST 616
            R P      +++  I + C +   D RPK  +++     +  +        G++     
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289

Query: 617 PP 618
            P
Sbjct: 290 SP 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 58/293 (19%), Positives = 105/293 (35%), Gaps = 38/293 (12%)

Query: 330 EVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENV 381
             LG+G+FGM Y+ +       E  T V +K + +      + +F  +  ++      +V
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERG-----EGRIPLDWDTRMRIAIGAARG 436
           V L          L++ +  + G + + L S R          P      +++A   A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 437 IARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYR 491
           +A ++A      VH ++ + N  +       + D G+T                    + 
Sbjct: 146 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEV 551
           +PE       T  SDV+SFGVVL EI T     +   G     ++R+V      +     
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--GLSNEQVLRFVMEGGLLDKPDNC 260

Query: 552 FDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIEN-VRPNDSE 603
            D               + ++   C    P  RP   +++  I+  + P   E
Sbjct: 261 PD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 63/296 (21%), Positives = 103/296 (34%), Gaps = 48/296 (16%)

Query: 330 EVLGKGTFGMAYKAIL--------EDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSI-RH 378
           + LG+G FG    A             T V VK LK         D   +ME++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEG-----------RIPLDWDTRM 427
           +N++ L           ++ +Y S G++   L + R  G              L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 428 RIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-----QYGCVSDLGLTTITSALAP 482
             A   ARG+  + +      +H ++ + N+ +            ++             
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHS 541
                  + APE    R  T  SDV+SFGV+L EI T G SP      +EL  L++  H 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH- 254

Query: 542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                           R         E+  +   C   +P QRP    +V  ++ +
Sbjct: 255 ----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 41/271 (15%), Positives = 96/271 (35%), Gaps = 36/271 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVEL 384
           ++LG+G+F     A  L       +K L+  ++ K +      ++ +++  + H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +   ++      Y   G +   +           D              +  +H   
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG 128

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI-----TSALAPVIARAAGYRAPEVTDSR 499
              ++H ++K  NI LN   +  ++D G   +       A A      A Y +PE+   +
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
            A ++SD+++ G ++ +++ G  P        +   +  +     E++  +  D  L+  
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD--LVE- 242

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                            +V    +R    ++
Sbjct: 243 ---------------KLLVLDATKRLGCEEM 258

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 6e-34
 Identities = 73/321 (22%), Positives = 130/321 (40%), Gaps = 40/321 (12%)

Query: 330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           +V+G G+FG+ Y+A L + G  V +K++      KR   ++++I+  + H N+V L+ ++
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 389 YSKDEK------LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
           YS  EK       +V DY          H  R +    L             R +A IH+
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIHS 140

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTITSALAPVIARAA--GYRAP-EVTDS 498
                + H +IK  N+ L+       + D G         P ++      YRAP  +  +
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHT-TGGDELVHLVRWVHSVVREEWTAEVFDVELL 557
              T + DV+S G VL E+L G+      +G D+LV +++ + +  RE+      +    
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 558 RYPNIEEEMV----------EMLQIAMSCVVRMPDQRPKMPDVVR-------VIENVRPN 600
           ++P I+              E + +    +   P  R    +             NV+  
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317

Query: 601 DSENRPSSGNKSE---SSTPP 618
           +  + P+  N +    SS PP
Sbjct: 318 NGRDTPALFNFTTQELSSNPP 338

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 45/273 (16%), Positives = 96/273 (35%), Gaps = 29/273 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
           +VLG G  G   +           +K L+D    +R+ E         +  ++V +   Y
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVY 74

Query: 389 YSKDEK----LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
            +        L+V +    G + + +      G           I       I  +H+ N
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-----VIARAAGYRAPEVTDSR 499
              + H ++K  N+   S++   +  L                       Y APEV    
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
           K  ++ D++S GV++  +L G  P ++  G  +   ++    + + E+           +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP-------EW 241

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
             + EE+  +++   + +   P QR  + + + 
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 44/294 (14%)

Query: 330 EVLGKGTFGMAYKAI------LEDGTTVVVKRLKD--VNVGKRDFEQQMEIVGSIRHE-N 380
           + LG+G FG   +A            TV VK LK+   +   R    +++I+  I H  N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 381 VVELKAYYYSKDEKLM-VYDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMR 428
           VV L          LM + ++   G++S  L S+R E            +  L  +  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 429 IAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAA 488
            +   A+G+  + +      +H ++ + NI L+ +    + D GL          + +  
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 489 -----GYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV 543
                 + APE    R  T  SDV+SFGV+L EI +  +  +       V +       +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRL 250

Query: 544 REEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
           +E            R    +    EM Q  + C    P QRP   ++V  + N+
Sbjct: 251 KEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  123 bits (309), Expect = 5e-32
 Identities = 51/278 (18%), Positives = 105/278 (37%), Gaps = 37/278 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVEL 384
           E+LG G     + A  L     V VK L+            F ++ +   ++ H  +V +
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 385 KAYYYSKDEKL----MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
                ++        +V +Y    ++  ++H+E      P+     + +   A + +   
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL------TTITSALAPVIARAAGYRAPE 494
           H      ++H ++K +NI +++     V D G+      +  +      +   A Y +PE
Sbjct: 128 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 495 VTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
                     SDVYS G VL E+LTG+ P        + +        VRE+        
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------HVREDPIP----- 233

Query: 555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
              R+  +  ++  ++   +  + + P+ R +    +R
Sbjct: 234 PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMR 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (308), Expect = 3e-31
 Identities = 48/266 (18%), Positives = 95/266 (35%), Gaps = 33/266 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQ-------MEIVGSIRHENV 381
            ++G+G FG  Y     + G    +K L    +  +  E         + +V +     +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           V +   +++ D+   + D  + G +   L                   A     G+  +H
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL-TTITSALAPVIARAAGYRAPEV-TDSR 499
                 +V+ ++K +NI L+   +  +SDLGL    +           GY APEV     
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
               ++D +S G +L ++L G SP       +   + R   ++  E              
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------ 229

Query: 560 PNIEEEMVEMLQIAMSCVVRMPDQRP 585
            +   E+  +L+     + R  ++R 
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRL 252

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-31
 Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 35/272 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQME-----IVGSIRHENVVE 383
           ++LGKG+FG  + A   +      +K LK   V   D  +        +  +  H  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 384 LKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA 443
           +   + +K+    V +Y + G +   + S         D       A     G+  +H+ 
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122

Query: 444 NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRK 500
               +V+ ++K  NI L+   +  ++D G+               G   Y APE+   +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 501 ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP 560
              + D +SFGV+L E+L G+SP H    +EL H +R  +         E  D       
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD------- 232

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                      + +   VR P++R  +   +R
Sbjct: 233 -----------LLVKLFVREPEKRLGVRGDIR 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (302), Expect = 7e-31
 Identities = 46/271 (16%), Positives = 99/271 (36%), Gaps = 30/271 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD--FEQQMEIVGSIRHENVVELKA 386
           +VLG G F     A        V +K +    +  ++   E ++ ++  I+H N+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
            Y S     ++    S G +   +  +              R+       +      +  
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAV---KYLHDL 126

Query: 447 KLVHGNIKSSNIFLNSQQYGC---VSDLGLTTI--TSALAPVIARAAGYRAPEVTDSRKA 501
            +VH ++K  N+   S        +SD GL+ +    ++        GY APEV   +  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
           ++A D +S GV+   +L G  P +     +L   +               ++ +   + +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-----------YEFDSPYWDD 235

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
           I +   + ++     + + P++R      ++
Sbjct: 236 ISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-30
 Identities = 54/277 (19%), Positives = 104/277 (37%), Gaps = 36/277 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK-------DVNVGKRDFEQQMEIVGSIRHENV 381
           E LG G F +  K      G     K +K          V + D E+++ I+  I+H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIH 441
           + L   Y +K + +++ +  + G +   L  +       L  +           G+  +H
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130

Query: 442 AANGGKLVHGNIKSSNIFLNSQQYG----CVSDLGLTTI--TSALAPVIARAAGYRAPEV 495
           +     + H ++K  NI L  +        + D GL            I     + APE+
Sbjct: 131 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
            +       +D++S GV+   +L+G SP       E +  V  V+    +E+        
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY-------- 239

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
              + N      + ++     +V+ P +R  + D ++
Sbjct: 240 ---FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (300), Expect = 1e-30
 Identities = 39/282 (13%), Positives = 80/282 (28%), Gaps = 32/282 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             +G G+FG  Y    +  G  V +K    V         + +I   ++    +    + 
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
            ++ +  ++       S+  + +             T + +A      I  IH+ N    
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---F 124

Query: 449 VHGNIKSSNIFLNSQQYGCV---SDLG----------LTTITSALAPVIARAAGYRAPEV 495
           +H ++K  N  +   + G +    D G             I       +   A Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 496 TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE 555
               + ++  D+ S G VL+    G  P               +           +    
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC--- 241

Query: 556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                    E    L     C     D +P    + ++  N+
Sbjct: 242 ----KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 54/281 (19%), Positives = 112/281 (39%), Gaps = 26/281 (9%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKA 386
           E +G+GT+G+ YKA    G T  +K+++     +       +++ I+  ++H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
             ++K   ++V+++        +   E       L+  T     +    GIA  H     
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR-- 120

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEV-TDSRKAT 502
            ++H ++K  N+ +N +    ++D GL                   YRAP+V   S+K +
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 503 QASDVYSFGVVLLEILTGKSPIH-TTGGDELVHLVRWVHSVVREEW----TAEVFDVELL 557
              D++S G +  E++ G       +  D+L+ + R + +   + W        +D    
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 558 RYPNIEEEMV------EMLQIAMSCVVRMPDQRPKMPDVVR 592
            Y  +  E          + +    +   P+QR      + 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  118 bits (296), Expect = 3e-30
 Identities = 46/281 (16%), Positives = 97/281 (34%), Gaps = 42/281 (14%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR----------- 377
           E+LG+G   +  + I         VK +     G    E+  E+  +             
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 378 HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
           H N+++LK  Y +     +V+D    G +   L       ++ L      +I       I
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVI 123

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--TSALAPVIARAAGYRAPEV 495
             +H  N   +VH ++K  NI L+      ++D G +           +     Y APE+
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 496 ------TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA 549
                  +     +  D++S GV++  +L G  P        ++ ++            +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-----------S 229

Query: 550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
             +      + +  + + +++      +V  P +R    + 
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 43/261 (16%), Positives = 94/261 (36%), Gaps = 31/261 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVEL 384
             LG G+FG  +      +G    +K LK   V +         +  ++  + H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
              +    +  M+ DY     +                       A      +  +H+ +
Sbjct: 70  WGTFQDAQQIFMIMDY-----IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
              +++ ++K  NI L+   +  ++D G       +   +     Y APEV  ++   ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE 564
            D +SFG+++ E+L G +P + +   +    +                + EL   P   E
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---------------NAELRFPPFFNE 226

Query: 565 EMVEMLQIAMSCVVRMPDQRP 585
           ++ ++L      + R   QR 
Sbjct: 227 DVKDLLS---RLITRDLSQRL 244

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 49/296 (16%), Positives = 97/296 (32%), Gaps = 28/296 (9%)

Query: 330 EVLGKGTFGMAYKA--ILEDGTTVVVKRLKDVNVGKRDFEQQ------MEIVGSIRHENV 381
             +G+G +G  +KA  +   G  V +KR++     +            +  + +  H NV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 382 VELKAYYYSKDEKLMVYDYYSLGSVS-AMLHSERGEGRIPLDWDTRMRIAIGAARGIARI 440
           V L                     V   +           +  +T   +     RG+  +
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 441 HAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA--AGYRAPEVTDS 498
           H+     +VH ++K  NI + S     ++D GL  I S    + +      YRAPEV   
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR 558
                  D++S G +  E+   K     +   + +  +  V  +  EE       +    
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 559 YPNIEEEMV---------EMLQIAMSCVVRMPDQRPKMPDV-----VRVIENVRPN 600
           + +   + +             + + C+   P +R            + +E  + N
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-29
 Identities = 53/289 (18%), Positives = 115/289 (39%), Gaps = 34/289 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKA 386
             +G+G +GM   A    +   V +K++         +   ++++I+   RHEN++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 387 YYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGG 446
              +   + M   Y     + A L+         L  D          RG+  IH+AN  
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN-- 129

Query: 447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI------TSALAPVIARAAGYRAPEV-TDSR 499
            ++H ++K SN+ LN+     + D GL  +       +           YRAPE+  +S+
Sbjct: 130 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188

Query: 500 KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
             T++ D++S G +L E+L+ +         + ++ +  +     +E    + +++   Y
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248

Query: 560 ----------------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                           PN + + +++L      +   P +R ++   + 
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-29
 Identities = 49/285 (17%), Positives = 111/285 (38%), Gaps = 36/285 (12%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLK---DVNVGKRDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G+ YKA     G  V +K+++   +         +++ ++  + H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
              +++++  +V+++        M  S        +             +G+A  H+   
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI---TSALAPVIARAAGYRAPEV-TDSRKA 501
             ++H ++K  N+ +N++    ++D GL                   YRAPE+    +  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY-- 559
           + A D++S G +  E++T ++     G  E+  L R   ++   +         +  Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFP--GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 560 --------------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                         P ++E+   +L      +   P++R      
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 41/284 (14%), Positives = 79/284 (27%), Gaps = 34/284 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYY 388
             +G+G+FG+ ++   L +   V +K              +      +     +    Y+
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 389 YSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKL 448
             +    ++     LG     L    G         T    A      +  IH  +   L
Sbjct: 70  GQEGLHNVLVIDL-LGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 449 VHGNIKSSNIFLNSQQYG-----CVSDLGL----------TTITSALAPVIARAAGYRAP 493
           V+ +IK  N  +            V D G+            I       ++  A Y + 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 494 EVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
                R+ ++  D+ + G V +  L G  P               +    +     E+  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC- 241

Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV 597
                     EE  + +  A +      D  P    +  +   V
Sbjct: 242 ------AGFPEEFYKYMHYARN---LAFDATPDYDYLQGLFSKV 276

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 55/282 (19%), Positives = 106/282 (37%), Gaps = 28/282 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELK 385
           + +G G +G    A+    G  V +K+L      +   +   +++ ++  +RHENV+ L 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +   +      D+Y +         +  +    L  D    +     +G+  IHAA  
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGI 142

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEV-TDSRKATQA 504
              +H ++K  N+ +N      + D GL     +          YRAPEV  +  + TQ 
Sbjct: 143 ---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY----- 559
            D++S G ++ E++TGK+    +   + +  +  V      E+   +   E   Y     
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 560 -----------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                       N     V +L+     +V   +QR    + 
Sbjct: 260 ELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEA 298

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-28
 Identities = 49/284 (17%), Positives = 109/284 (38%), Gaps = 29/284 (10%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK------RDFEQQMEIVGSIRHENVV 382
           + LG+G F   YKA        V +K++K  +  +      R   ++++++  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 383 ELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
            L   +  K    +V+D+     +   L     +  + L         +   +G+  +H 
Sbjct: 64  GLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEV-TDS 498
                ++H ++K +N+ L+      ++D GL     +             YRAPE+   +
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 499 RKATQASDVYSFGVVLLEILTGKSPIH-TTGGDELVHLVRWVHSVVREEW---TAEVFDV 554
           R      D+++ G +L E+L     +   +  D+L  +   + +   E+W    +    V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 555 ELLRYPNIEEEMV------EMLQIAMSCVVRMPDQRPKMPDVVR 592
               +P I    +      ++L +     +  P  R      ++
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  113 bits (284), Expect = 3e-28
 Identities = 45/255 (17%), Positives = 95/255 (37%), Gaps = 21/255 (8%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK----RDFEQQMEIVGSIRHENVVEL 384
           + LG G+FG        E G    +K L    V K         +  I+ ++    +V+L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           +  +       MV +Y + G + + L                   A         +H+ +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQA 504
              L++ ++K  N+ ++ Q Y  V+D G           +       APE+  S+   +A
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKA 218

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV--ELL----- 557
            D ++ GV++ E+  G  P       ++   +          +++++ D+   LL     
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 558 -RYPNIEEEMVEMLQ 571
            R+ N++  + ++  
Sbjct: 279 KRFGNLKNGVNDIKN 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-27
 Identities = 40/276 (14%), Positives = 90/276 (32%), Gaps = 44/276 (15%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD-------FEQQMEIVGSIR--HE 379
            +LG G FG  Y  I + D   V +K ++   +              ++ ++  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            V+ L  ++   D  +++ +            +ERG     L  +            +  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGC-VSDLGLTTI-TSALAPVIARAAGYRAPEVTD 497
            H      ++H +IK  NI ++  +    + D G   +    +         Y  PE   
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182

Query: 498 SRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL 556
             +   +++ V+S G++L +++ G  P                          E+   ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH---------------------DEEIIRGQV 221

Query: 557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR 592
                +  E   +++    C+   P  RP   ++  
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 52/267 (19%), Positives = 99/267 (37%), Gaps = 36/267 (13%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD----FEQQMEIVGSIRHENVVEL 384
           ++LGKGTFG          G    +K L+   +  +D       +  ++ + RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 385 KAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN 444
           K  + + D    V +Y + G +   L             +            +  +H+ +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 445 GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAG---YRAPEVTDSRKA 501
              +V+ +IK  N+ L+   +  ++D GL     +    +    G   Y APEV +    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP- 560
            +A D +  GVV+ E++ G+ P +    + L  L+                    +R+P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------------IRFPR 226

Query: 561 NIEEEMVEMLQIAMSCVVRMPDQRPKM 587
            +  E   +L      + + P QR   
Sbjct: 227 TLSPEAKSLLA---GLLKKDPKQRLGG 250

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-25
 Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 28/282 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVN---VGKRDFEQQMEIVGSIRHENVVELK 385
             +G G +G    A   + G  V VK+L       +  +   +++ ++  ++HENV+ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +          D Y +  +     +   + +  L  D    +     RG+  IH+A+ 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADI 142

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVT-DSRKATQA 504
              +H ++K SN+ +N      + D GL   T            YRAPE+  +     Q 
Sbjct: 143 ---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199

Query: 505 SDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY----- 559
            D++S G ++ E+LTG++    T   + + L+  +      E   ++       Y     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259

Query: 560 -----------PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDV 590
                             V++L+     +V   D+R      
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQA 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 43/283 (15%), Positives = 105/283 (37%), Gaps = 28/283 (9%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELK 385
           E +G+GT+G  +KA   E    V +KR++  +  +       +++ ++  ++H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
              +S  +  +V+++                    LD +          +G+   H+ N 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI----TSALAPVIARAAGYRAPEVTDSRKA 501
             ++H ++K  N+ +N      +++ GL           +  +          +  ++  
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 502 TQASDVYSFGVVLLEILTGKSPI--HTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY 559
           + + D++S G +  E+     P+       D+L  + R + +   E+W +     +   Y
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 560 PNIEEEMV----------EMLQIAMSCVVRMPDQRPKMPDVVR 592
           P                     +  + +   P QR    + ++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 7e-25
 Identities = 52/290 (17%), Positives = 97/290 (33%), Gaps = 32/290 (11%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELK 385
             +G+GTFG  +KA   + G  V +K++   N  +       ++++I+  ++HENVV L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 386 AYYYSKDEKLMVYD---YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA 442
               +K           Y         L        +        R+      G+  IH 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 443 ANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA-------AGYRAPEV 495
                ++H ++K++N+ +       ++D GL    S                  YR PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 496 -TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV 554
               R      D++  G ++ E+ T    +        + L+  +   +  E    V + 
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 555 ELLRYPNIEEEMV--------------EMLQIAMSCVVRMPDQRPKMPDV 590
           EL     + +                   L +    +V  P QR    D 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 2e-23
 Identities = 48/340 (14%), Positives = 107/340 (31%), Gaps = 58/340 (17%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHEN-------- 380
             LG G F   + A  + + T V +K ++   V     E +++++  +   +        
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 381 ---VVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGI 437
              +++L  ++  K    +            +L   +      +      +I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 438 ARIHAANGGKLVHGNIKSSNIFLNSQQYGC------VSDLGLTTITSALAPVIARAAGYR 491
             +H   G  ++H +IK  N+ +             ++DLG             +   YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 492 APEVTDSRKATQASDVYSFGVVLLEILTGKSP-------IHTTGGDELVHLVRWVHSVVR 544
           +PEV         +D++S   ++ E++TG           +T   D +  ++  +  +  
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 545 EEWTAEVF-----------------------DVELLRYPNIEEEMVEMLQIAMSCVVRMP 581
                  +                       DV   +Y   ++E  E+       +   P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 582 DQRPKMPDV--------VRVIENVRPNDSENRPSSGNKSE 613
            +R     +           +E +R  D E   S  +   
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPG 356

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.4 bits (239), Expect = 2e-22
 Identities = 48/286 (16%), Positives = 110/286 (38%), Gaps = 22/286 (7%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAY 387
             LG+G +   ++AI + +   VVVK LK V   K+  +++++I+ ++R   N++ L   
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98

Query: 388 YYSKDEKL--MVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
                 +   +V+++ +      +           L             + +   H+   
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 446 GKLVHGNIKSSNIFLNSQQYG-CVSDLGLTTITSALAPVIARAAG--YRAPEVTDSRKA- 501
             ++H ++K  N+ ++ +     + D GL            R A   ++ PE+    +  
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 502 TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN 561
             + D++S G +L  ++  K P    G D    LVR    +  E+    +    +   P 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPS 607
             + +    +      V   +Q    P+ +  ++ +   D ++R +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 1e-21
 Identities = 48/272 (17%), Positives = 97/272 (35%), Gaps = 38/272 (13%)

Query: 330 EVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVNVGKRD-----FEQQMEIVGSIRHE- 379
           +VLG G +G  +        + G    +K LK   + ++         + +++  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 380 NVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIAR 439
            +V L   + ++ +  ++ DY + G +   L       R                  +  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144

Query: 440 IHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGL----TTITSALAPVIARAAGYRAPEV 495
           +H      +++ +IK  NI L+S  +  ++D GL        +  A        Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 496 --TDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
                    +A D +S GV++ E+LTG SP    G       +              +  
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-----------RRILK 250

Query: 554 VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP 585
            E      +     +++Q     +++ P +R 
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRL 279

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.7 bits (216), Expect = 3e-19
 Identities = 49/188 (26%), Positives = 69/188 (36%), Gaps = 31/188 (16%)

Query: 32  LDFVNN-----LPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNT 86
           L   NN      P     N +E +   N    +        +  + L     S L P   
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--- 258

Query: 87  ISRLSALKILSLRSNVITGYFP--------------------SDFINLKSLCYLYLQFNN 126
           +S L+ L  L L +N I+   P                    S   NLK+L YL L FNN
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318

Query: 127 FSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNL 186
            S   P  S    L  +  ++N    +   SL+NLT +  L   +N +S   P  NL  +
Sbjct: 319 ISDISP-VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANLTRI 375

Query: 187 QQLNLANN 194
            QL L + 
Sbjct: 376 TQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.0 bits (188), Expect = 1e-15
 Identities = 39/152 (25%), Positives = 54/152 (35%), Gaps = 28/152 (18%)

Query: 78  FSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW 137
            S + P   ++ L     LSL  N +         +L +L  L L  N  S  L   S  
Sbjct: 209 ISDITPLGILTNL---DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGL 262

Query: 138 KNLTIINLSDNGFNGTIP--------------------RSLSNLTQLEALYLANNSLSGK 177
             LT + L  N  +   P                      +SNL  L  L L  N++S  
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322

Query: 178 IPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
            P  +L  LQ+L  ANN +S     SL    +
Sbjct: 323 SPVSSLTKLQRLFFANNKVSD--VSSLANLTN 352

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 4e-08
 Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLN 190
            D +         L       T+  S ++L Q+  L      +   I  +  L NL Q+N
Sbjct: 17  TD-TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQIN 72

Query: 191 LANNNLSGSIP 201
            +NN L+   P
Sbjct: 73  FSNNQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 7e-08
 Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 5/88 (5%)

Query: 103 ITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLT 162
           I   F      L       L   N + T+   +    +T +     G   +I   +  L 
Sbjct: 12  INQIFTDT--ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIK-SID-GVEYLN 66

Query: 163 QLEALYLANNSLSGKIPDLNLPNLQQLN 190
            L  +  +NN L+   P  NL  L  + 
Sbjct: 67  NLTQINFSNNQLTDITPLKNLTKLVDIL 94

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 4e-05
 Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 2/86 (2%)

Query: 118 CYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK 177
                  +N    +   +   NL  +  ++N  +   P     LT L+ L L  N L   
Sbjct: 177 LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI 234

Query: 178 IPDLNLPNLQQLNLANNNLSGSIPQS 203
               +L NL  L+LANN +S   P S
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLS 260

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 6e-19
 Identities = 43/230 (18%), Positives = 87/230 (37%), Gaps = 11/230 (4%)

Query: 330 EVLGKGTFGMAYKAI-LEDGTTVVVKRLKDVNVGKRD---FEQQMEIVGSIRHENVVELK 385
           + +G G  G+   A        V +K+L      +       +++ ++  + H+N++ L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 386 AYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANG 445
             +  +       D Y +  +  M  +     ++ LD +    +      GI  +H+A  
Sbjct: 83  NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140

Query: 446 GKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI--TSALAPVIARAAGYRAPEVTDSRKATQ 503
              +H ++K SNI + S     + D GL     TS +         YRAPEV       +
Sbjct: 141 ---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197

Query: 504 ASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFD 553
             D++S G ++ E++  K         +  + V         E+  ++  
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.4 bits (207), Expect = 2e-18
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 7/162 (4%)

Query: 26  EDKEALLDFVNNLPHSRSL-NWNESTSVCNH-WTGVKCSEDGK--RVVAVRLPGVGFSGL 81
           +DK+ALL    +L +  +L +W  +T  CN  W GV C  D +  RV  + L G+     
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 82  IP-PNTISRLSALKILSLRSNV-ITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWK 138
            P P++++ L  L  L +     + G  P     L  L YLY+   N SG +PD  S  K
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD 180
            L  ++ S N  +GT+P S+S+L  L  +    N +SG IPD
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.8 bits (182), Expect = 3e-15
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNN 195
            KNL  ++L +N   GT+P+ L+ L  L +L ++ N+L G+IP   NL        ANN 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 196 LSGSIP 201
                P
Sbjct: 303 CLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 22/52 (42%), Positives = 28/52 (53%), Gaps = 4/52 (7%)

Query: 168 YLANNSLSGKIPD--LNLPNLQQLNLANNNLSGSIPQS--LKRFPSSAFVGN 215
            L NN + G +P     L  L  LN++ NNL G IPQ   L+RF  SA+  N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 16/51 (31%), Positives = 23/51 (45%)

Query: 98  LRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDN 148
           LR+N I G  P     LK L  L + FNN  G +P     +   +   ++N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.4 bits (142), Expect = 3e-10
 Identities = 23/66 (34%), Positives = 30/66 (45%), Gaps = 2/66 (3%)

Query: 115 KSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNS 173
           K+L  L L+ N   GTLP   +  K L  +N+S N   G IP    NL + +    ANN 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 174 LSGKIP 179
                P
Sbjct: 303 CLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 14/80 (17%), Positives = 26/80 (32%), Gaps = 2/80 (2%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFI 112
            +    +      K +  + L      G +P   +++L  L  L++  N + G  P    
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQ-GG 288

Query: 113 NLKSLCYLYLQFNNFSGTLP 132
           NL+         N      P
Sbjct: 289 NLQRFDVSAYANNKCLCGSP 308

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (166), Expect = 2e-13
 Identities = 33/126 (26%), Positives = 49/126 (38%), Gaps = 2/126 (1%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNL 140
           +P +T   L  L  L L  N I+      F  L SL  L L  N  +   P  F     L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLP-NLQQLNLANNNLSGS 199
             + L  N  +     +L+ L  L+ L L +N          L   LQ+   +++ +  S
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 200 IPQSLK 205
           +PQ L 
Sbjct: 264 LPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (114), Expect = 8e-07
 Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 3/95 (3%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT 141
           + P+    L  L  L L +N ++         L++L YL L  N +        +W  L 
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSG 176
               S +    ++P+ L+         LA N L G
Sbjct: 252 KFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (114), Expect = 1e-06
 Identities = 23/105 (21%), Positives = 36/105 (34%), Gaps = 3/105 (2%)

Query: 103 ITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVW-KNLTIINLSDNGFNGTIPRSLSNL 161
           +    P+ F  L  L  L+L         P        L  + L DN        +  +L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 162 TQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSL 204
             L  L+L  N +S         L +L +L L  N ++   P + 
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (113), Expect = 1e-06
 Identities = 35/180 (19%), Positives = 56/180 (31%), Gaps = 38/180 (21%)

Query: 61  CSEDGKRVVAVRLPGVGFSGL---IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL 117
           C    +  V    P  G   +   IP  +       + + L  N I+    + F   ++L
Sbjct: 6   CVCYNEPKVTTSCPQQGLQAVPVGIPAAS-------QRIFLHGNRISHVPAASFRACRNL 58

Query: 118 CYLYLQFNNFSGTL--------------------------PDFSVWKNLTIINLSDNGFN 151
             L+L  N  +                               F     L  ++L   G  
Sbjct: 59  TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

Query: 152 GTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS 209
              P     L  L+ LYL +N+L     D   +L NL  L L  N +S    ++ +   S
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 66.6 bits (161), Expect = 1e-12
 Identities = 41/168 (24%), Positives = 61/168 (36%), Gaps = 18/168 (10%)

Query: 51  SVCN-HWTGVKCSEDGKRVVAVRLP---------GVGFSGLIPPNTISRLSALKILSLRS 100
             C  H   V+CS+ G   V   LP             +  I       L  L  L L +
Sbjct: 6   FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILIN 64

Query: 101 NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSN 160
           N I+   P  F  L  L  LYL  N     LP+  + K L  + + +N          + 
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLK-ELPE-KMPKTLQELRVHENEITKVRKSVFNG 122

Query: 161 LTQLEALYLAN--NSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSL 204
           L Q+  + L       SG        +  L  + +A+ N++ +IPQ L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 169

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 13/125 (10%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSV-WKNL 140
           IP        +L  L L  N IT    +    L +L  L L FN+ S           +L
Sbjct: 165 IPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--------LNLPNLQQLNLA 192
             ++L++N     +P  L++   ++ +YL NN++S    +            +   ++L 
Sbjct: 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280

Query: 193 NNNLS 197
           +N + 
Sbjct: 281 SNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.9 bits (141), Expect = 5e-10
 Identities = 25/96 (26%), Positives = 39/96 (40%), Gaps = 2/96 (2%)

Query: 115 KSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNS 173
                L LQ N  +     DF   KNL  + L +N  +   P + + L +LE LYL+ N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 174 LSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
           L   +P+     LQ+L +  N ++            
Sbjct: 91  LKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 18/75 (24%), Positives = 31/75 (41%), Gaps = 3/75 (4%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNN 195
            +  +++L +N           NL  L  L L NN +S   P     L  L++L L+ N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 196 LSGSIPQSLKRFPSS 210
           L   +P+ + +    
Sbjct: 91  LK-ELPEKMPKTLQE 104

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.7 bits (125), Expect = 5e-08
 Identities = 37/179 (20%), Positives = 55/179 (30%), Gaps = 9/179 (5%)

Query: 37  NLPHSRSLNWNESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLI---PPNTISRLSAL 93
            LP        E     N  T V+ S        + +                   +  L
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152

Query: 94  KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNG 152
             + +    IT           SL  L+L  N  +           NL  + LS N  + 
Sbjct: 153 SYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209

Query: 153 TIPRSLSNLTQLEALYLANNSLSGKIPD-LNLPNLQQLNLANNNLSGSIPQSLKRFPSS 210
               SL+N   L  L+L NN L        +   +Q + L NNN+S +I  +    P  
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGY 267

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.0 bits (118), Expect = 3e-07
 Identities = 34/153 (22%), Positives = 50/153 (32%), Gaps = 29/153 (18%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN---------------- 125
           I P   + L  L+ L L  N +          L+ L     +                  
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 126 -------NFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK 177
                    SG     F   K L+ I ++D     TIP+ L     L  L+L  N ++  
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKV 186

Query: 178 IPDL--NLPNLQQLNLANNNLSGSIPQSLKRFP 208
                  L NL +L L+ N++S     SL   P
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 60.5 bits (146), Expect = 8e-12
 Identities = 30/122 (24%), Positives = 47/122 (38%), Gaps = 10/122 (8%)

Query: 94  KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGT 153
           ++L L    +T         L  + +L L  N      P  +  + L ++  SDN     
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-- 56

Query: 154 IPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNLS---GSIPQSLKRF 207
               ++NL +L+ L L NN L          + P L  LNL  N+L    G   +  +  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 208 PS 209
           PS
Sbjct: 117 PS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 21/110 (19%), Positives = 40/110 (36%), Gaps = 10/110 (9%)

Query: 87  ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS 146
           + +L  +  L L  N +    P+    L+ L  L    +N    +   +    L  + L 
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ-ASDNALENVDGVANLPRLQELLLC 73

Query: 147 DNGFNGT-IPRSLSNLTQLEALYLANNSLSGKIPDL------NLPNLQQL 189
           +N    +   + L +  +L  L L  NSL      +       LP++  +
Sbjct: 74  NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 8e-06
 Identities = 26/112 (23%), Positives = 40/112 (35%), Gaps = 29/112 (25%)

Query: 142 IINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNL-------------- 186
           +++L+      T+   L  L  +  L L++N L    P L  L  L              
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 187 --------QQLNLANNNL-SGSIPQSLKRFPSSAFV---GNSISFDENLAPR 226
                   Q+L L NN L   +  Q L   P    +   GNS+  +E +  R
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.5 bits (140), Expect = 3e-10
 Identities = 18/62 (29%), Positives = 27/62 (43%), Gaps = 2/62 (3%)

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNL 191
              +    LT +   DN  +   P  L++L  L  ++L NN +S   P  N  NL  + L
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL 224

Query: 192 AN 193
            N
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 3/65 (4%)

Query: 107 FPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA 166
             +   NL  L  L    N  S  +   +   NL  ++L +N  +   P  L+N + L  
Sbjct: 165 DLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 167 LYLAN 171
           + L N
Sbjct: 222 VTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 19/65 (29%), Positives = 31/65 (47%)

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL 196
                +  LS      +    L+NL++L  L   +N +S   P  +LPNL +++L NN +
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207

Query: 197 SGSIP 201
           S   P
Sbjct: 208 SDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 12/60 (20%), Positives = 23/60 (38%), Gaps = 4/60 (6%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
            N   I    +    T+  + ++L  +  L      ++  I  +  L NL  L L +N +
Sbjct: 19  ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 3/38 (7%), Positives = 14/38 (36%)

Query: 160 NLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
            L     +    ++++  +   +L  +  L+     ++
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT 54

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 60.2 bits (144), Expect = 3e-10
 Identities = 20/74 (27%), Positives = 38/74 (51%), Gaps = 8/74 (10%)

Query: 134 FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLAN 193
             +  +L  +N+S+N     +P     L +L     + N L+ ++P+L   NL+QL++  
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL-PQNLKQLHVEY 333

Query: 194 NNLSG--SIPQSLK 205
           N L     IP+S++
Sbjct: 334 NPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.5 bits (142), Expect = 4e-10
 Identities = 21/96 (21%), Positives = 34/96 (35%), Gaps = 9/96 (9%)

Query: 98  LRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRS 157
              N  +    S      SL  L +  N     LP       L  +  S N     +P  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA-EVPEL 322

Query: 158 LSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLAN 193
             NL Q   L++  N L  + PD+   +++ L + +
Sbjct: 323 PQNLKQ---LHVEYNPLR-EFPDI-PESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 3e-06
 Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 3/70 (4%)

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNL 196
              L       N  +  I         LE L ++NN L  ++P L  P L++L  + N+L
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL-PPRLERLIASFNHL 316

Query: 197 SGSIPQSLKR 206
           +  +P+  + 
Sbjct: 317 A-EVPELPQN 325

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 7e-06
 Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 6/61 (9%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           +    + L++ G + ++P    +L     L  + NSL+ ++P+L   +L+ L + NNNL 
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPEL-PQSLKSLLVDNNNLK 91

Query: 198 G 198
            
Sbjct: 92  A 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 3/64 (4%)

Query: 162 TQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDE 221
            Q   L L N  LS  +P+L  P+L+ L  + N+L+  +P+  +   S     N++    
Sbjct: 38  RQAHELELNNLGLS-SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 222 NLAP 225
           +L P
Sbjct: 95  DLPP 98

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 56.7 bits (136), Expect = 6e-10
 Identities = 26/203 (12%), Positives = 57/203 (28%), Gaps = 33/203 (16%)

Query: 330 EVLGKGTFGMAYKAILEDGTTVVVKRLK-----------DVNVGKRDFEQQMEIVGSIRH 378
           +++G+G     +    E     VVK  K             + G   F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 379 ENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIA 438
             + +L+          +   Y   G+   M   +  E       +    +       +A
Sbjct: 66  RALQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117

Query: 439 RIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARAAGYRAPEVTD- 497
           + +      +VHG++   N+ ++ +    + D   +                   +V + 
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGE-----EGWREILERDVRNI 168

Query: 498 ----SRKATQASDVYSFGVVLLE 516
               SR      D+ S    +L+
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.4 bits (139), Expect = 1e-09
 Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 11/83 (13%)

Query: 134 FSVWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKIPDL-------N 182
                 L ++ L+D   + +    +  +L     L  L L+NN L               
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 183 LPNLQQLNLANNNLSGSIPQSLK 205
              L+QL L +   S  +   L+
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 8e-09
 Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 14/102 (13%)

Query: 106 YFPSDFINLKSLCYLYLQFNNFSGT----LPD-FSVWKNLTIINLSDNGFNGTIPRSLS- 159
                      L  L+L   + S +    L        +L  ++LS+N         L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 160 ----NLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
                   LE L L +   S ++ D     LQ L     +L 
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDR----LQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 9e-09
 Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 7/73 (9%)

Query: 139 NLTIINLSDNGFNGT-IPRSLSNLTQLEALYLANNSLSGK----IPDL--NLPNLQQLNL 191
           ++  +++     +       L  L Q + + L +  L+      I       P L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 192 ANNNLSGSIPQSL 204
            +N L       +
Sbjct: 63  RSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 1e-08
 Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 16/97 (16%)

Query: 112 INLKSLCYLYLQFNNFSGT-LPD-FSVWKNLTIINLSDNGFNG----TIPRSLSNLTQLE 165
           ++++SL    +Q    S     +   + +   ++ L D G        I  +L     L 
Sbjct: 2   LDIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 166 ALYLANNSLSGKIPDL-------NLPNLQQLNLANNN 195
            L L +N L                  +Q+L+L N  
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 3e-06
 Identities = 17/97 (17%), Positives = 31/97 (31%), Gaps = 20/97 (20%)

Query: 91  SALKILSLRSNVITG----YFPSDFINLKSLCYLYLQFNNFSG--------TLPDFSVWK 138
           S L++L L    ++        +  +   SL  L L  N            ++       
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG--C 426

Query: 139 NLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLS 175
            L  + L D  ++  +        +L+AL     SL 
Sbjct: 427 LLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 5e-05
 Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 6/74 (8%)

Query: 137 WKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL------NLPNLQQLN 190
              ++   L D G            + L  L+LA+  +S               +L++L+
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403

Query: 191 LANNNLSGSIPQSL 204
           L+NN L  +    L
Sbjct: 404 LSNNCLGDAGILQL 417

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 3e-07
 Identities = 12/67 (17%), Positives = 24/67 (35%), Gaps = 3/67 (4%)

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNL 191
            D   +      NL        +  + + L  ++ +   N+ +        LPN+ +L L
Sbjct: 19  SD-DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFL 75

Query: 192 ANNNLSG 198
             N L+ 
Sbjct: 76  NGNKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 5/83 (6%)

Query: 103 ITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLT 162
           I   F  D           L+  + +  +   +   ++  I  +++         +  L 
Sbjct: 14  IKQIFSDD--AFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLP 68

Query: 163 QLEALYLANNSLSGKIPDLNLPN 185
            +  L+L  N L+   P  NL N
Sbjct: 69  NVTKLFLNGNKLTDIKPLANLKN 91

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 4e-05
 Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 4/77 (5%)

Query: 118 CYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK 177
                  NN    +   S    L  ++L DN  +  +P  L+ LT+L+ LYL+ N +S  
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD- 192

Query: 178 IPDL-NLPNLQQLNLAN 193
           +  L  L NL  L L +
Sbjct: 193 LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 28/165 (16%), Positives = 53/165 (32%), Gaps = 45/165 (27%)

Query: 86  TISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD------------ 133
           T + L+++  +   ++ I          L ++  L+L  N  +   P             
Sbjct: 41  TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98

Query: 134 -----------------------------FSVWKNLTIINLSDNGFNGTIPRSLSNLTQL 164
                                          +     + +L       T    LS LT+L
Sbjct: 99  ENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL 158

Query: 165 EALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
           + L L +N +S  +P   L  LQ L L+ N++S  +  +L    +
Sbjct: 159 DTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKN 201

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 4e-07
 Identities = 28/124 (22%), Positives = 41/124 (33%), Gaps = 13/124 (10%)

Query: 79  SGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYL---QFNNFSGTLPDFS 135
            GL     +   +   +L+ RS++          N+  L  L L   +            
Sbjct: 30  KGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQ 88

Query: 136 VWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---------NLPNL 186
              NL I+NLS N              +LE L+L  NSLS    D            P L
Sbjct: 89  KAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKL 148

Query: 187 QQLN 190
            +L+
Sbjct: 149 LRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 9e-06
 Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 6/93 (6%)

Query: 120 LYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIP 179
             L       + PD        ++N   +    T+     N+ +L +L L+NN L     
Sbjct: 25  QALDLKGLR-SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDD 82

Query: 180 D----LNLPNLQQLNLANNNLSGSIPQSLKRFP 208
                   PNL+ LNL+ N L         +  
Sbjct: 83  MSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 1e-06
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 2/76 (2%)

Query: 113 NLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANN 172
            + S   +     N +  LP   + K+ TI++LS+N        +L   T+L  L L   
Sbjct: 8   KVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 173 SLSGKIPDLNLPNLQQ 188
            L+    D  LP L  
Sbjct: 66  ELTKLQVDGTLPVLGT 81

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 21/96 (21%), Positives = 29/96 (30%), Gaps = 2/96 (2%)

Query: 103 ITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLT-IINLSDNGFNGTIPRSLSNL 161
           +T         L  L  LYL+ N      P           ++L++N         L+ L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 162 TQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
             L+ L L  NSL            L    L  N  
Sbjct: 172 ENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 7e-05
 Identities = 14/65 (21%), Positives = 22/65 (33%), Gaps = 5/65 (7%)

Query: 133 DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLN 190
           + S   +   +N         +P  L   T +  L+L+ N L        +    L QLN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 191 LANNN 195
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 12/51 (23%), Positives = 17/51 (33%)

Query: 101 NVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFN 151
           N +T         L++L  L LQ N+       F     L    L  N + 
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 3e-04
 Identities = 15/72 (20%), Positives = 26/72 (36%), Gaps = 5/72 (6%)

Query: 82  IPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGT--LPDFSVW-- 137
           +P   ++ L  L  L L+ N +    P  F     L + +L  N +     +  F  W  
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQ 221

Query: 138 KNLTIINLSDNG 149
            N   + +   G
Sbjct: 222 DNAENVYVWKQG 233

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 8/53 (15%), Positives = 19/53 (35%), Gaps = 1/53 (1%)

Query: 157 SLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
            +S +     +     +L+  +P     +   L+L+ N L      +L  +  
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTR 56

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 1e-06
 Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 9/93 (9%)

Query: 118 CYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPR-SLSNLTQLEALYLANNSLSG 176
             L+L  N              L  +NLSDN     +P       +    L ++   +  
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215

Query: 177 KIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS 209
            +P   L NL++L   +         +LK+ P+
Sbjct: 216 -LPSYGLENLKKLRARSTY-------NLKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 4e-05
 Identities = 12/54 (22%), Positives = 18/54 (33%), Gaps = 8/54 (14%)

Query: 134 FSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQ 187
           F       I+++S    +      L NL +L A    N           LP L+
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK--------KLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 6e-04
 Identities = 12/53 (22%), Positives = 15/53 (28%), Gaps = 3/53 (5%)

Query: 80  GLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP 132
             +P +     S   IL +    I         NLK L        N    LP
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.4 bits (108), Expect = 5e-06
 Identities = 18/101 (17%), Positives = 33/101 (32%), Gaps = 15/101 (14%)

Query: 137 WKNLTIINLSDNGFNGTIPRSLSN------LTQLEALYLANNSLSGKIPDL-------NL 183
           W NL  + L+D   +     ++ +         L+ L L  N +               +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 184 PNLQQLNLANNNLS--GSIPQSLKRFPSSAFVGNSISFDEN 222
           P+L  L L  N  S    +   ++   S+   G     D+ 
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 342

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 9/82 (10%), Positives = 34/82 (41%), Gaps = 10/82 (12%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGK----IPDL--NLPNLQQLNL 191
           K+L +  ++      ++   L     ++ + L+ N++  +    + +   +  +L+    
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 192 ANN---NLSGSIPQSLKRFPSS 210
           ++     +   IP++L+    +
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQA 88

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (101), Expect = 2e-05
 Identities = 12/78 (15%), Positives = 26/78 (33%), Gaps = 1/78 (1%)

Query: 131 LPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLN 190
              ++       ++L        I    + L Q +A+  ++N +        L  L+ L 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLL 69

Query: 191 LANNNLSGSIPQSLKRFP 208
           + NN +        +  P
Sbjct: 70  VNNNRICRIGEGLDQALP 87

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 43.5 bits (101), Expect = 2e-05
 Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 8/67 (11%)

Query: 131 LPDFSVWKNLTIINLSDNGFNGTIPR------SLSNLTQLEALYLANNSLSGKIPDL-NL 183
           +  F   K++          +G IP       +LS L   + L L+ N++  KI  L  +
Sbjct: 11  IRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGM 69

Query: 184 PNLQQLN 190
            NL+ L+
Sbjct: 70  ENLRILS 76

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 13/60 (21%), Positives = 20/60 (33%), Gaps = 12/60 (20%)

Query: 153 TIPRSLSNL---TQLEALYLANNSLSGKIPDL--------NLPNLQQLNLANNNLSGSIP 201
           TI  ++        + A       L G IP +         L   + L L+ NN+   I 
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 1e-04
 Identities = 15/62 (24%), Positives = 24/62 (38%), Gaps = 4/62 (6%)

Query: 138 KNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNL 196
                  L       T+  S ++L Q+  L      +   I  +  L NL Q+N +NN L
Sbjct: 18  AEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 74

Query: 197 SG 198
           + 
Sbjct: 75  TD 76

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 4e-04
 Identities = 6/51 (11%), Positives = 15/51 (29%), Gaps = 2/51 (3%)

Query: 147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS 197
           D   N       + L +     L   +++  +   +L  +  L      + 
Sbjct: 5   DTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK 53

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.3 bits (90), Expect = 5e-04
 Identities = 22/85 (25%), Positives = 39/85 (45%), Gaps = 2/85 (2%)

Query: 106 YFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE 165
              +D   LK+L  L     + +      ++    ++  L+ +    T  + L+NLT LE
Sbjct: 116 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLE 175

Query: 166 ALYLANNSLSGKIPDL-NLPNLQQL 189
            L +++N +S  I  L  L NL+ L
Sbjct: 176 RLDISSNKVSD-ISVLAKLTNLESL 199

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 2e-04
 Identities = 17/99 (17%), Positives = 33/99 (33%), Gaps = 4/99 (4%)

Query: 132 PDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQ 188
           PD       + +  + +G        L     L  LY+ N      +       L  L+ 
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 189 LNLANNNLSGSIPQSLKRFPSSAFVGNSISFDENLAPRA 227
           L +  + L    P +    P  + +  S +  E+L+ + 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKT 99

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 3e-04
 Identities = 28/149 (18%), Positives = 49/149 (32%), Gaps = 14/149 (9%)

Query: 53  CNHWTGVKCSEDGKRVVAVRLPGVG-----------FSGLIPPNTISRLSALKILSLRSN 101
            +  +G++C+ DG       LPG                 +    +  L  L+ L++  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 102 VITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTI-PRSLSN 160
            +    P  F     L  L L FN             +L  + LS N  + +   R L  
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 161 LTQLEALYLANNSL--SGKIPDLNLPNLQ 187
             +     +    L   G+ P  ++PN  
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 9e-04
 Identities = 7/65 (10%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD-LNLPNLQQLNLANNNLSGS 199
             ++L+    +  +   L +   + A     + +   + +  +   +Q ++L+N+ +  S
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 200 IPQSL 204
               +
Sbjct: 62  TLHGI 66

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 27/185 (14%), Positives = 52/185 (28%), Gaps = 48/185 (25%)

Query: 51  SVCN-HWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSN----VITG 105
           ++C+   T V C+  G + +            IP +T         L L  N    + + 
Sbjct: 4   AMCHCEGTTVDCTGRGLKEIPRD---------IPLHT-------TELLLNDNELGRISSD 47

Query: 106 YFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLE 165
                  +L  L     Q         + +       +   +N       +    L QL+
Sbjct: 48  GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG--ENKIKEISNKMFLGLHQLK 105

Query: 166 ALYLANNSLSGKIPDL--NLPNLQ-----------------------QLNLANNNLSGSI 200
            L L +N +S  +P    +L +L                        + +L         
Sbjct: 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165

Query: 201 PQSLK 205
           P  ++
Sbjct: 166 PSKVR 170

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	625
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.69
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.64
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.56
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.55
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.55
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.49
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.47
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.46
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.42
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.36
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.35
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.32
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.31
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.24
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.19
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.17
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.17
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.16
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.16
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.12
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.12
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.1
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.95
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.89
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.62
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.24
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.07
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.03
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.91
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.74
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.12
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.84
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.27
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.16
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.13
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.73

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=416.53  Aligned_cols=247  Identities=21%  Similarity=0.400  Sum_probs=199.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|...+..++||||+++|+|.++
T Consensus        11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~   90 (263)
T d1sm2a_          11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   90 (263)
T ss_dssp             EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHH
Confidence            56999999999999998899999999988777778999999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +....    ..++|..+..++.|+|+||+|||+.+   |+||||||+|||+++++.+||+|||+++......    ....
T Consensus        91 l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          91 LRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             HHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             hhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            87543    24899999999999999999999998   9999999999999999999999999998764322    2345


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      ||..|+|||++.+..|+.++|||||||++|||+| |++||......+   ..+.+....      ...        .+..
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~~------~~~--------~p~~  226 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGF------RLY--------KPRL  226 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHTC------CCC--------CCTT
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHhcC------CCC--------Cccc
Confidence            7888999999999999999999999999999999 566665433222   222222110      011        1112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      +..++.+++.+||+.||++||||+||++.|++++++
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            234677888999999999999999999999998653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=409.05  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||+++|++.+ +..++||||+++|+|.++
T Consensus        19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~   97 (272)
T d1qpca_          19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF   97 (272)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             EEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHH
Confidence            5699999999999999888999999998877777889999999999999999999998754 567999999999999998


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....   ..++|..+.+|+.||++||+|||+++   |+||||||+||||++++.+||+|||+|+......    ....
T Consensus        98 ~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (272)
T d1qpca_          98 LKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (272)
T ss_dssp             TTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             HhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence            765432   24899999999999999999999988   9999999999999999999999999998775332    2345


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEE  565 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  565 (625)
                      ++..|||||++.+..++.++|||||||++|||+||..|+.....  ..+....+.   ...           ..+.+...
T Consensus       172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~---~~~-----------~~~~p~~~  235 (272)
T d1qpca_         172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE---RGY-----------RMVRPDNC  235 (272)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH---TTC-----------CCCCCTTC
T ss_pred             CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHH---hcC-----------CCCCcccC
Confidence            77889999999988999999999999999999996555433221  122222221   110           00111122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          566 MVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       566 ~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ..++.+++.+||+.||++||||+||++.|+.+
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            34677888899999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-51  Score=413.89  Aligned_cols=247  Identities=26%  Similarity=0.450  Sum_probs=194.5

Q ss_pred             hHcccCCceeEEEEEEc-CC---cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DG---TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      ++||+|+||+||+|... +|   ..||||++.....  ..+.|.+|+++|++++|||||+++|+|...+..++|||||++
T Consensus        32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~  111 (299)
T d1jpaa_          32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN  111 (299)
T ss_dssp             EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence            57999999999999964 33   3689998875433  235799999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccc-
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAP-  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  482 (625)
                      |+|.+++.....    .++|.++.+++.|+|+||+|||+++   |+||||||+||||+.++.+||+|||+|+....... 
T Consensus       112 g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         112 GSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             EEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            999998876432    4899999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             -------ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          483 -------VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       483 -------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                             ...+|..|||||.+.+..++.++|||||||++|||+| |+.||.+....+....   +.   .+.        
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~---i~---~~~--------  250 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA---IE---QDY--------  250 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HH---TTC--------
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH---HH---cCC--------
Confidence                   1245778999999999999999999999999999998 8999976554333222   11   111        


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                         ..+...+...++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       251 ---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 ---RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               1112223345677888999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=402.28  Aligned_cols=244  Identities=20%  Similarity=0.325  Sum_probs=207.2

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhhh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSAM  409 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  409 (625)
                      +.||+|+||+||+|+.++++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||||+++|+|..+
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~   89 (258)
T d1k2pa_          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY   89 (258)
T ss_dssp             CCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHH
T ss_pred             EEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHh
Confidence            56999999999999998889999999998777788999999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----cccc
Q 006922          410 LHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVIA  485 (625)
Q Consensus       410 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~~  485 (625)
                      +.....    .+++..+.+++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......    ....
T Consensus        90 ~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          90 LREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             HHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             hhcccc----CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            765543    4899999999999999999999998   9999999999999999999999999998654322    1235


Q ss_pred             cCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          486 RAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       486 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      +|..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+.       ...  ..        +.+..
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~--~~--------~~p~~  225 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGL--RL--------YRPHL  225 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC--CC--------CCCTT
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCC--CC--------CCccc
Confidence            6778999999998999999999999999999998 899998765444332221       110  01        11122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                      ...++.+++.+||+.||++|||++|+++.|.++
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            234677888899999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-50  Score=409.02  Aligned_cols=250  Identities=20%  Similarity=0.323  Sum_probs=206.3

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      +.||+|+||+||+|... +|+.||||+++......++|.+|++++++++|||||+++++|.+.+..++||||+++|+|.+
T Consensus        23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~  102 (287)
T d1opja_          23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD  102 (287)
T ss_dssp             EETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHH
Confidence            56999999999999965 58999999998777777889999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      ++....   ...++|..+..|+.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+......    ...
T Consensus       103 ~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_         103 YLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             HHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             Hhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            997643   235899999999999999999999998   9999999999999999999999999998765432    123


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .++..|+|||++.+..|+.++|||||||++|||++|..||.....  .....+.+.    .+..          .+....
T Consensus       177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~----~~~~----------~~~~~~  240 (287)
T d1opja_         177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLE----KDYR----------MERPEG  240 (287)
T ss_dssp             EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHH----TTCC----------CCCCTT
T ss_pred             cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHh----cCCC----------CCCCcc
Confidence            467789999999999999999999999999999997766643322  122222211    1110          011112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                      ...++.+++.+||+.||++|||++||++.|+.+..+.
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            2346778888999999999999999999999886653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=405.73  Aligned_cols=249  Identities=25%  Similarity=0.418  Sum_probs=196.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|+.+  ..||||+++.....   .+.|.+|++++.+++|||||++++++.. +..++||||+++|+|
T Consensus        14 ~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L   90 (276)
T d1uwha_          14 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSL   90 (276)
T ss_dssp             SEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEH
T ss_pred             EEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCH
Confidence            57999999999999864  46999999754332   3678999999999999999999998754 568999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~  481 (625)
                      .+++.....    .++|..+..++.|+|+||+|||+++   ||||||||+|||++.++.+||+|||+|+.....     .
T Consensus        91 ~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          91 YHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             HHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             HHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            999975432    4899999999999999999999997   999999999999999999999999999876432     2


Q ss_pred             cccccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 PVIARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                      ....||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+....+..  ...+.    .+.    ..+....
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~----~~~----~~p~~~~  233 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVG----RGY----LSPDLSK  233 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----HTS----CCCCGGG
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHh----cCC----CCCcchh
Confidence            23568889999999864   35899999999999999999999999865433221  11111    111    1111111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      .  ......++.+++.+||+.||++||||+||++.|+.++++
T Consensus       234 ~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         234 V--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             S--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            0  112234677888899999999999999999999988753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=403.14  Aligned_cols=243  Identities=21%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             HcccCCceeEEEEEEc---CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          331 VLGKGTFGMAYKAILE---DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      .||+|+||+||+|...   ++..||||+++....  ..+.|.+|+++|++++|||||+++|++.. +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            3999999999999753   356899999976432  23679999999999999999999999865 56899999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----  481 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----  481 (625)
                      |.+++...+.    .+++..+.+++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+......    
T Consensus        95 L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  167 (285)
T d1u59a_          95 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  167 (285)
T ss_dssp             HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence            9998865432    4899999999999999999999998   9999999999999999999999999998764322    


Q ss_pred             --cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          482 --PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       482 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        ....+|..|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+.       .+.          +
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~----------~  230 (285)
T d1u59a_         168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK----------R  230 (285)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTC----------C
T ss_pred             cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC----------C
Confidence              22356778999999998899999999999999999998 999998765444332221       111          0


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                      .+.+.....++.+++.+||+.+|++||||.+|++.|+.+.
T Consensus       231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111223346778899999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=401.99  Aligned_cols=242  Identities=23%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             hHcccCCceeEEEEEEc---CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE---DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|.+.   .++.||||+++....+   .+.+.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            35999999999999854   2468999999754322   3579999999999999999999999865 567899999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc--
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA--  481 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~--  481 (625)
                      |+|.+++....     .++|..+.+++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999997643     4999999999999999999999998   9999999999999999999999999998764321  


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ....||..|||||.+.+..++.++|||||||++|||+| |+.||.+....+....+   .    .+.         
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i---~----~~~---------  227 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---E----KGE---------  227 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H----TTC---------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH---H----cCC---------
Confidence                22357788999999998899999999999999999998 99999875543322221   1    110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                       +.+.+.....++.+++.+||+.||++||||+||++.|+..
T Consensus       228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence             0111122334677888999999999999999999988754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-50  Score=396.75  Aligned_cols=238  Identities=23%  Similarity=0.365  Sum_probs=199.5

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|+.. +|+.||+|++...    ....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~   90 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   90 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            357999999999999964 6899999999743    22346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-cc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-AP  482 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-~~  482 (625)
                      |+|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus        91 g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          91 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             CcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            99999997643     3899999999999999999999998   999999999999999999999999999876543 34


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+....+      .+...            +.+
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~------------~~p  224 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRVEF------------TFP  224 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTTCC------------CCC
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------HcCCC------------CCC
Confidence            457899999999999999999999999999999999999999765433322211      11110            001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .....++.+++.+||+.||++|||++|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            112235667788999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=396.02  Aligned_cols=240  Identities=21%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+|+.||||+++....  ..+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L   90 (271)
T d1nvra_          11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL   90 (271)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence            5799999999999996 4699999999975432  235789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-----c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-----A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-----~  481 (625)
                      .+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....     .
T Consensus        91 ~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          91 FDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             GGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99997532     4899999999999999999999998   999999999999999999999999999876322     2


Q ss_pred             cccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ....||+.|||||++.+..+ +.++||||+||++|||+||+.||......... .....    .....          .+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~----~~~~~----------~~  227 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EKKTY----------LN  227 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH----TTCTT----------ST
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh----cCCCC----------CC
Confidence            34578999999999988776 57899999999999999999999765432211 11110    00000          00


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11112235667788999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=398.49  Aligned_cols=239  Identities=18%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||+++|+|.
T Consensus        26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~  105 (293)
T d1yhwa1          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (293)
T ss_dssp             EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence            5699999999999995 579999999997553 34567999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++...      .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....   ....
T Consensus       106 ~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            987653      3899999999999999999999998   999999999999999999999999999876432   2345


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+...      ........         ..+....
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~~---------~~~~~~~  241 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP---------ELQNPEK  241 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSC---------CCSSGGG
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCCC---------CCCCccc
Confidence            68999999999999999999999999999999999999997644322111      11111110         0111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...++.+++.+||+.||++|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2345677888999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=398.01  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=195.0

Q ss_pred             hHcccCCceeEEEEEEcCC-----cEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILEDG-----TTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ++||+|+||+||+|.++..     ..||||+++.....  ..+|.+|++++.+++|||||+++|++.+.+..++||||+.
T Consensus        13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~   92 (283)
T d1mqba_          13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME   92 (283)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecc
Confidence            5799999999999986532     47999999754332  3568999999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|++.+.+.....    .++|.++.+++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+|+...... 
T Consensus        93 ~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          93 NGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             TEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             cCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            9999988875432    4999999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             -----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 -----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                           ....||..|||||++.+..++.++|||||||++|||+||..|+......  .+..+.+.    .+.         
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~----~~~---------  230 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN----DGF---------  230 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH----TTC---------
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHh----ccC---------
Confidence                 1234677899999999999999999999999999999965555432221  12222221    110         


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                       +.+.......++.+++.+||+.+|++||||.||++.|+++.+.
T Consensus       231 -~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 -RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence             1112222345678889999999999999999999999987654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=397.75  Aligned_cols=248  Identities=25%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      .+.||+|+||+||+|..++++.||||+++......+.|.+|+.++++++|||||+++|+|. .++.++||||+++|+|..
T Consensus        22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~  100 (285)
T d1fmka3          22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD  100 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred             eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhh
Confidence            4579999999999999988889999999877777788999999999999999999999985 466899999999999999


Q ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc----ccc
Q 006922          409 MLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA----PVI  484 (625)
Q Consensus       409 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~----~~~  484 (625)
                      ++.....   ..++|.++..++.||++||+|||+++   |+||||||+|||+++++++||+|||+|+......    ...
T Consensus       101 ~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3         101 FLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             HHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             hhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence            8876432   24899999999999999999999998   9999999999999999999999999998764322    224


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .+|..|+|||++....++.++|||||||++|||+||..|+.....  ..+....+..   ..           ..+....
T Consensus       175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~---~~-----------~~~~~~~  238 (285)
T d1fmka3         175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER---GY-----------RMPCPPE  238 (285)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT---TC-----------CCCCCTT
T ss_pred             cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHh---cC-----------CCCCCcc
Confidence            578889999999999999999999999999999996665543322  2222222221   10           0111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          565 EMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ...++.+++.+||+.||++||+|++|+++|+....
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            33467788889999999999999999999988664

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=397.94  Aligned_cols=245  Identities=20%  Similarity=0.325  Sum_probs=187.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEe--cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYS--KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|+. .+|+.||||+++......   +.+.+|++++++++|||||++++++.+  .+..++||||+++
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~   89 (269)
T d2java1          10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   89 (269)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence            5799999999999995 479999999998764433   458899999999999999999999865  4568999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN--GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      |+|.+++..... ....+++..+..++.|++.||+|||+++  ..+|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        90 g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          90 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             EEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            999999875432 1235899999999999999999999975  235999999999999999999999999999876532 


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        .....||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+....   +.    ......        
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~---i~----~~~~~~--------  233 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IR----EGKFRR--------  233 (269)
T ss_dssp             -------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HH----HTCCCC--------
T ss_pred             CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH---HH----cCCCCC--------
Confidence              2345789999999999999999999999999999999999999976543332221   11    111110        


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+  .....++.+++.+||+.||.+|||++|+++
T Consensus       234 ~~--~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 IP--YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC--cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            01  112235677888999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=397.64  Aligned_cols=241  Identities=20%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++|||||++++++.+.+..++||||+++|+|.
T Consensus        18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~   97 (288)
T d2jfla1          18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD   97 (288)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence            5699999999999996 4689999999976533 3467999999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APVI  484 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~  484 (625)
                      +++.....    ++++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....   ....
T Consensus        98 ~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          98 AVMLELER----PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             HHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred             HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence            98865432    4999999999999999999999998   999999999999999999999999999765432   2345


Q ss_pred             ccCCCcCCccccC-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          485 ARAAGYRAPEVTD-----SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       485 ~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .||+.|||||++.     ...|+.++|||||||++|||+||+.||.+....+....+      ..... .        ..
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~~~~-~--------~~  235 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AKSEP-P--------TL  235 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HHSCC-C--------CC
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcCCC-C--------CC
Confidence            7899999999983     456899999999999999999999999876544432211      11111 0        01


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      +.......++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111222346677888999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=392.66  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=195.3

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||.||+|... |+.||||+++.. ...+.+.+|++++++++|||||+++|+|.+ .+..++||||+++|+|.
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~   89 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   89 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence            367999999999999985 789999999764 345789999999999999999999999865 45689999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccccccC
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVIARA  487 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  487 (625)
                      +++....   ...++|..+++|+.|++.||+|||+.+   |+||||||+|||++.++.+|++|||+++..........++
T Consensus        90 ~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~  163 (262)
T d1byga_          90 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  163 (262)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCcccccc
Confidence            9997643   225899999999999999999999987   9999999999999999999999999999877666666788


Q ss_pred             CCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHHHH
Q 006922          488 AGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEEEM  566 (625)
Q Consensus       488 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  566 (625)
                      ..|+|||++.+..++.++|||||||++|||+| |+.||......+..   .++.    .+.          +.+......
T Consensus       164 ~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i~----~~~----------~~~~~~~~~  226 (262)
T d1byga_         164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE----KGY----------KMDAPDGCP  226 (262)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHT----TTC----------CCCCCTTCC
T ss_pred             ccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHH----cCC----------CCCCCccCC
Confidence            89999999988899999999999999999999 78888765444332   2221    111          111112223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          567 VEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       567 ~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      .++.+++.+||..||++||||.|+++.|++++.
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            467788889999999999999999999998864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-49  Score=401.95  Aligned_cols=193  Identities=20%  Similarity=0.341  Sum_probs=171.5

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|.. .+|+.||+|+++.....  .+.+.+|++++++++|||||+++++|.+.+..++||||+++|+|
T Consensus        12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L   91 (322)
T d1s9ja_          12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL   91 (322)
T ss_dssp             EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence            5699999999999995 47899999999754322  46789999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCEEeCCCCCeeEecccccccccc-ccccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAA-NGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA-LAPVI  484 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~~  484 (625)
                      .+++.+..     .+++..+..++.|++.||+|||++ +   |+||||||+|||++.++.+||+|||+|+.... .....
T Consensus        92 ~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  163 (322)
T d1s9ja_          92 DQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  163 (322)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence            99997653     389999999999999999999985 6   99999999999999999999999999987643 23456


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCc
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGD  530 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~  530 (625)
                      .||+.|||||++.+..|+.++||||+||++|||++|+.||...+..
T Consensus       164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            8999999999999999999999999999999999999999875543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=388.18  Aligned_cols=241  Identities=23%  Similarity=0.410  Sum_probs=192.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEe----cCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYS----KDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|... +++.||+|++......   .+.+.+|++++++++|||||++++++.+    ....++||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            35999999999999964 6889999999765433   3568899999999999999999999875    24578999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCCeeEeccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN-SQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~  480 (625)
                      ++|+|.+++....     .+++..+..++.|+++||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+.....
T Consensus        95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999997653     4899999999999999999999874 4599999999999997 4789999999999876443


Q ss_pred             -ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 -APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                       .....||+.|||||++.+ .++.++|||||||++|||+||+.||......+  ...+.+    ..+.....++      
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i----~~~~~~~~~~------  235 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSGVKPASFD------  235 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTTCCCGGGG------
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHH----HcCCCCcccC------
Confidence             345679999999999875 59999999999999999999999997543221  111111    1111110011      


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         .....++.+++.+||+.||++|||++|+++
T Consensus       236 ---~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence               011234667888999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=401.60  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             HhHcccCCceeEEEEEEcC-C-----cEEEEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAILED-G-----TTVVVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|+... +     ..||||++....  .....+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus        42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (325)
T d1rjba_          42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  121 (325)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence            4679999999999998542 2     369999987542  2346789999999998 89999999999999999999999


Q ss_pred             eccCCChhhhhccccCC------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 006922          400 YYSLGSVSAMLHSERGE------------------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~  461 (625)
                      |+++|+|.++++..+..                  ....++|..+..++.|+++||+|||+++   ||||||||+|||++
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~  198 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT  198 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence            99999999999765421                  1235899999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhH
Q 006922          462 SQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHL  535 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~  535 (625)
                      .++.+||+|||+|+......     ....+|+.|||||.+.+..|+.++|||||||++|||+| |+.||.+....+..  
T Consensus       199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~--  276 (325)
T d1rjba_         199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--  276 (325)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--
T ss_pred             cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            99999999999998764332     23456888999999999999999999999999999998 89999876544322  


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIE  595 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~  595 (625)
                      .+.+    ..+.          +.+.+.....++.+++.+||+.||++||||+||++.|.
T Consensus       277 ~~~~----~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         277 YKLI----QNGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHH----HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH----hcCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1111    1111          01111222346778888999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-48  Score=395.66  Aligned_cols=239  Identities=20%  Similarity=0.360  Sum_probs=194.9

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++.....    .+.+.+|++++++++|||||++++++.+.+..++|||||++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            35799999999999995 57899999999765432    24688999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |++..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus       100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~  170 (309)
T d1u5ra_         100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NS  170 (309)
T ss_dssp             EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CC
T ss_pred             CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-Cc
Confidence            99976665432     4899999999999999999999998   999999999999999999999999999877554 34


Q ss_pred             cccCCCcCCccccCC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          484 IARAAGYRAPEVTDS---RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      ..||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+....+..      ........ ...     . ..
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~~~~-~~~-----~-~~  237 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNES-PAL-----Q-SG  237 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC-CCC-----S-CT
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCCC-CCC-----C-CC
Confidence            579999999999854   46899999999999999999999999764432211      11111111 000     0 01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                         ....++.+++.+||+.||++|||++|+++
T Consensus       238 ---~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         238 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               11235677888999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=391.97  Aligned_cols=238  Identities=16%  Similarity=0.295  Sum_probs=196.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|.. .+|+.||||+++...    ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g   92 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN   92 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence            36799999999999996 479999999997532    2346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---  480 (625)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.....   
T Consensus        93 g~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          93 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999887653     4899999999999999999999998   999999999999999999999999999876432   


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        .....||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+....      ......       ..  
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~~~-------~~--  229 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK------IIKLEY-------DF--  229 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHTTCC-------CC--
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH------HHcCCC-------CC--
Confidence              2235689999999999999999999999999999999999999976543322211      111110       00  


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       +  .....++.+++.+||+.||++|||++|+++
T Consensus       230 -p--~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 -P--EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -C--TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -C--ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             1  112235667888999999999999999754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-48  Score=394.70  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=202.7

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|+..      +++.||||+++.....  .++|.+|++++++++||||++++++|...+..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~   97 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY   97 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence            356999999999999853      3578999999764332  36799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccC-------------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 006922          401 YSLGSVSAMLHSERG-------------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN  461 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~  461 (625)
                      +++|+|.+++.....                   .....++|..+..|+.|++.||+|||+++   ||||||||+|||++
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld  174 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVG  174 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEEC
Confidence            999999999975422                   12234899999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCcchhhH
Q 006922          462 SQQYGCVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGK-SPIHTTGGDELVHL  535 (625)
Q Consensus       462 ~~~~~kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~-~p~~~~~~~~~~~~  535 (625)
                      .++.+||+|||+|+......     ....++..|+|||.+.+..|+.++|||||||++|||++|. +||......+... 
T Consensus       175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~-  253 (301)
T d1lufa_         175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-  253 (301)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-
T ss_pred             CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH-
Confidence            99999999999998654321     2345677899999999999999999999999999999985 6776654433322 


Q ss_pred             HHHHHHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          536 VRWVHSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       536 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                        .+.    .+...          +.......++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus       254 --~v~----~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         254 --YVR----DGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --HHH----TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --HHH----cCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              221    11110          1112233467888999999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-47  Score=390.64  Aligned_cols=241  Identities=20%  Similarity=0.330  Sum_probs=183.2

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|+.. +|+.||||++.....  ..+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus        15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L   94 (307)
T d1a06a_          15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL   94 (307)
T ss_dssp             EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            57999999999999964 689999999976432  235688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCCeeEeccccccccccc--c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN---SQQYGCVSDLGLTTITSAL--A  481 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~--~  481 (625)
                      .+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||+.   .++.+||+|||+|+.....  .
T Consensus        95 ~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          95 FDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             HHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             HHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            99997543     4999999999999999999999998   99999999999995   5789999999999876433  2


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+....      ......     ...   .+.
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~~~-----~~~---~~~  232 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------ILKAEY-----EFD---SPY  232 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHTTCC-----CCC---TTT
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HhccCC-----CCC---Ccc
Confidence            345789999999999999999999999999999999999999976543322211      111110     000   011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ......++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1112235677888999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=394.71  Aligned_cols=245  Identities=21%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             hHcccCCceeEEEEEEc-CCc----EEEEEEecccc--CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGT----TVVVKRLKDVN--VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ++||+|+||+||+|... +|+    .||+|+++...  ...+.+.+|++++++++|||||+++|+|.+. ..++++||+.
T Consensus        15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~   93 (317)
T d1xkka_          15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP   93 (317)
T ss_dssp             EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEecc
Confidence            67999999999999854 444    68999987542  3357899999999999999999999999864 5778899999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+.+....    ..++|..+.+++.|||+||+|||+++   |+||||||+|||++.++.+||+|||+|+...... 
T Consensus        94 ~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          94 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             TCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             CCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999887643    24899999999999999999999997   9999999999999999999999999998764322 


Q ss_pred             ----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccccc
Q 006922          482 ----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVEL  556 (625)
Q Consensus       482 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  556 (625)
                          ....||..|+|||++.+..|+.++|||||||++|||+| |+.||......+....+.   .   +.          
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~---~~----------  230 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K---GE----------  230 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---H---TC----------
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c---CC----------
Confidence                22357889999999999999999999999999999999 899998766555433322   1   10          


Q ss_pred             cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          557 LRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       557 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       +.+.+.....++.+++.+||+.||.+|||+.||++.|+.+..
T Consensus       231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence             111122233467788899999999999999999999988754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=383.44  Aligned_cols=246  Identities=21%  Similarity=0.371  Sum_probs=191.9

Q ss_pred             HhHcccCCceeEEEEEEcC----CcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILED----GTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .+.||+|+||+||+|....    +..||||+++.....  .+.+.+|++++++++|||||++++++. .+..++||||++
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~   90 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT   90 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence            3579999999999998542    457899998754332  356899999999999999999999985 467899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|++.+++.....    .+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+|+.....  
T Consensus        91 ~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          91 LGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             TEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             CCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            9999998765432    4899999999999999999999998   999999999999999999999999999876432  


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhccccccccccccc
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELL  557 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  557 (625)
                        .....+|+.|+|||.+.+..++.++|||||||++|||+| |++||......+....+.      ....          
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------~~~~----------  227 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER----------  227 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC----------
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC----------
Confidence              223456788999999999999999999999999999998 899998766544432221      1110          


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          558 RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       558 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                       .+.......++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus       228 -~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         228 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             01112223467788889999999999999999999988753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=390.70  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=196.3

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecC----ceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKD----EKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||+++++|.+.+    ..++|||||++|+
T Consensus         9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~   87 (303)
T d1vjya_           9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS   87 (303)
T ss_dssp             EEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred             EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCC
Confidence            5699999999999987 5899999999754322222334455556789999999999998754    5789999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAAN-----GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      |.+++++.      .++|..+.+++.|+|.||+|+|+..     .++|+||||||+||||+.++.+||+|||+++.....
T Consensus        88 L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          88 LFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            99999864      3899999999999999999999741     235999999999999999999999999999876432


Q ss_pred             -------ccccccCCCcCCccccCCCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCcchh--------hHHHHH
Q 006922          481 -------APVIARAAGYRAPEVTDSRK------ATQASDVYSFGVVLLEILTGKSPIHTTGGDELV--------HLVRWV  539 (625)
Q Consensus       481 -------~~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--------~~~~~~  539 (625)
                             .....||+.|+|||++....      ++.++|||||||++|||+||..||......+..        ......
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence                   22356899999999987542      577999999999999999999887543322111        011112


Q ss_pred             HHHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          540 HSVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       540 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                      ......+.    .++.........+....+.+++.+||+.||++||||.||++.|+++..+
T Consensus       242 ~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         242 RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            22221111    1111111111234556788999999999999999999999999988654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-47  Score=386.58  Aligned_cols=238  Identities=18%  Similarity=0.291  Sum_probs=200.9

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.++++++|||||++++++.+.+..++||||+++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g   88 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   88 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence            36799999999999996 46999999999753    22346789999999999999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPV  483 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  483 (625)
                      |+|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+........
T Consensus        89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             ccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            99999887654     3788899999999999999999998   999999999999999999999999999998777777


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+....+      .....         ...+.. 
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~---------~~p~~~-  224 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAEL---------RFPPFF-  224 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCCC---------CCCTTS-
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------HcCCC---------CCCCCC-
Confidence            88999999999999999999999999999999999999999765433322211      11110         001112 


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                        ..++.+++.+|+..||.+||     |++|+++
T Consensus       225 --s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              23566778899999999996     8999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-47  Score=393.72  Aligned_cols=244  Identities=22%  Similarity=0.364  Sum_probs=199.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|.. .+|+.||||++..... ..+.+.+|++++.+++|||||++++++.+.+..++|||||++|+|
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  110 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  110 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence            36799999999999996 4799999999976533 346688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCCeeEecccccccccccc--c
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS--QQYGCVSDLGLTTITSALA--P  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~--~  482 (625)
                      .+++....    ..+++..+..|+.||+.||+|||+++   ||||||||+|||++.  ++.+||+|||+|+......  .
T Consensus       111 ~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         111 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             HHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99986543    24999999999999999999999998   999999999999964  5789999999998775432  3


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+....+      ....+.   .+...     .
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~---~~~~~-----~  249 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWN---MDDSA-----F  249 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCC---SCCGG-----G
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC---CCccc-----c
Confidence            457899999999999999999999999999999999999999765433322211      111110   00000     0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      .....++.+++.+||+.||++|||++|+++.
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112356778889999999999999999873

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=383.31  Aligned_cols=244  Identities=25%  Similarity=0.421  Sum_probs=188.8

Q ss_pred             hHcccCCceeEEEEEEc--CC--cEEEEEEeccccC--C--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE--DG--TTVVVKRLKDVNV--G--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~--~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      +.||+|+||+||+|+..  ++  ..||||+++....  .  .++|.+|++++++++|||||+++|+|.+ +..++||||+
T Consensus        14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~   92 (273)
T d1u46a_          14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELA   92 (273)
T ss_dssp             EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeee
Confidence            56999999999999853  22  3789999975422  1  2578999999999999999999999965 4678999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA  481 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  481 (625)
                      ++|++.+++.....    .+++..+..++.|+|+||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        93 ~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          93 PLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             TTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             cCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            99999998876532    4999999999999999999999988   9999999999999999999999999999764322


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+...   +   ..+...       
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---~---i~~~~~-------  232 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---K---IDKEGE-------  232 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H---HHTSCC-------
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---H---HHhCCC-------
Confidence                  12346678999999999999999999999999999998 899997654433322   1   112211       


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENV  597 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~  597 (625)
                         ..+.......++.+++.+||+.||++||||.||++.|++.
T Consensus       233 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               0111122234677888899999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=381.00  Aligned_cols=242  Identities=22%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccC-------ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV-------GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++....       ..+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   94 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999996 4799999999975421       246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----CeeEeccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ----YGCVSDLGLTTI  476 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~  476 (625)
                      |++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+|++|||+|+.
T Consensus        95 ~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          95 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence            99999999997653     4999999999999999999999998   99999999999999877    499999999987


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                      ....  .....+|..|+|||++.+..++.++|||||||++|||+||+.||.+....+....+.      ....  . +..
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~~--~-~~~  237 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVNY--E-FED  237 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TTCC--C-CCH
T ss_pred             cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH------hcCC--C-CCc
Confidence            6432  334568889999999999999999999999999999999999998654333222111      1100  0 000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ...  +   ....++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~--~---~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         238 EYF--S---NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHH--T---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhc--C---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000  1   11235667888999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=383.19  Aligned_cols=248  Identities=22%  Similarity=0.336  Sum_probs=197.2

Q ss_pred             hHcccCCceeEEEEEEcCC----cEEEEEEeccccC--ChHHHHHHHHHHHcCCCCceecceeEEEe-cCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILEDG----TTVVVKRLKDVNV--GKRDFEQQMEIVGSIRHENVVELKAYYYS-KDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  402 (625)
                      ++||+|+||+||+|.+.++    ..||||+++....  ..++|.+|++++++++|||||+++|++.. ++..++|||||+
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            5699999999999996432    3689999975432  23679999999999999999999999876 457899999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA-  481 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~-  481 (625)
                      +|+|.+++.....    .+++..+.+++.|+++||.|+|+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus       113 ~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         113 HGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             cCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999876432    4788999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             ------cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          482 ------PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       482 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                            ....+|..|+|||.+....++.++||||||+++|||+||+.||......  .+...++   ..+..   .    
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~~---~----  253 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGRR---L----  253 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTCC---C----
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCCC---C----
Confidence                  1235678899999999999999999999999999999987777543211  1111111   11110   0    


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPN  600 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~  600 (625)
                          ..+.....++.+++.+||+.||++||+|.||++.|+.+...
T Consensus       254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                11112234677888999999999999999999999999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=385.25  Aligned_cols=237  Identities=22%  Similarity=0.294  Sum_probs=197.9

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccc----cCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDV----NVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|+. .+|+.||||++++.    ....+.+.+|+++|++++|||||++++++.+.+..++||||+++|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg   90 (337)
T d1o6la_          11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   90 (337)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence            5799999999999995 57999999999753    223466889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---cc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---LA  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~  481 (625)
                      +|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+....   ..
T Consensus        91 ~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          91 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             BHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             chhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            9999988754     3889999999999999999999998   99999999999999999999999999987543   23


Q ss_pred             cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCC
Q 006922          482 PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPN  561 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  561 (625)
                      ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+..+.+.      ... .           +.
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------~~~-~-----------~~  224 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEE-I-----------RF  224 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-C-----------CC
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------cCC-C-----------CC
Confidence            34678999999999999999999999999999999999999998755433322211      111 0           00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          562 IEEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       562 ~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      +.....++.+++.+||+.||++||+     ++|+++
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1112235667788999999999995     777775

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-46  Score=387.98  Aligned_cols=243  Identities=22%  Similarity=0.368  Sum_probs=198.5

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEecccc-CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      .+.||+|+||+||+|.. .+|+.||||+++... .+.+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  113 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  113 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence            35799999999999995 479999999997653 2345688999999999999999999999999999999999999999


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCCeeEeccccccccccc--cc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLN--SQQYGCVSDLGLTTITSAL--AP  482 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~--~~  482 (625)
                      .+.+....    ..+++.++..|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|+.....  ..
T Consensus       114 ~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         114 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            98876532    24899999999999999999999998   99999999999998  5789999999999887543  23


Q ss_pred             ccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCc
Q 006922          483 VIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNI  562 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  562 (625)
                      ...+|+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+....+      ......   +..  ...+. 
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~~---~~~--~~~~~-  254 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCDWE---FDE--DAFSS-  254 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHCCCC---CCS--STTTT-
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC---CCc--ccccC-
Confidence            457889999999999999999999999999999999999999765433322211      111100   000  00111 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          563 EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       563 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ...++.+++.+||+.||.+|||+.|+++
T Consensus       255 --~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         255 --VSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              2235667888999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=383.89  Aligned_cols=253  Identities=22%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             HhHcccCCceeEEEEEEc-CCc--EEEEEEecccc--CChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEEecc
Q 006922          329 AEVLGKGTFGMAYKAILE-DGT--TVVVKRLKDVN--VGKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      .++||+|+||+||+|.+. +|.  .||||+++...  ...+.+.+|++++.++ +|||||+++|+|.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            367999999999999964 444  57888886432  2346799999999998 79999999999999999999999999


Q ss_pred             CCChhhhhcccc-----------CCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecc
Q 006922          403 LGSVSAMLHSER-----------GEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDL  471 (625)
Q Consensus       403 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df  471 (625)
                      +|+|.++++...           ......++|..+.+++.|+|+||.|+|+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence            999999997542           112345899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccc--cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          472 GLTTITSALA--PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGK-SPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       472 Gla~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      |+++......  ....+|..|+|||.+....++.++|||||||++|||++|. +||......+.   .+.+    ..+. 
T Consensus       172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~i----~~~~-  243 (309)
T d1fvra_         172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL----PQGY-  243 (309)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHG----GGTC-
T ss_pred             cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHHH----HhcC-
Confidence            9998764332  2345788899999999999999999999999999999965 56755433222   2211    1110 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                               +.+.......++.+++.+||+.||++||||+||++.|+++.++.
T Consensus       244 ---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         244 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                     01111122346777888999999999999999999999987543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-46  Score=386.24  Aligned_cols=237  Identities=17%  Similarity=0.225  Sum_probs=200.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEecccc----CChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVN----VGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLG  404 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  404 (625)
                      +.||+|+||+||+|+. .+|+.||||+++...    ...+.+.+|+++++.++|||||++++++...+..++||||+.+|
T Consensus        47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g  126 (350)
T d1rdqe_          47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence            5799999999999996 479999999997432    23356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccccccc
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALAPVI  484 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  484 (625)
                      +|..++....     .+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.........
T Consensus       127 ~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~  198 (350)
T d1rdqe_         127 EMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             chhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence            9999997653     3899999999999999999999998   9999999999999999999999999999887776777


Q ss_pred             ccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcHH
Q 006922          485 ARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIEE  564 (625)
Q Consensus       485 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  564 (625)
                      .||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+.   ...+   .....            .....
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i---~~~~~------------~~p~~  260 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKI---VSGKV------------RFPSH  260 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HHCCC------------CCCTT
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHHH---hcCCC------------CCCcc
Confidence            899999999999999999999999999999999999999976432222   2111   11110            00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006922          565 EMVEMLQIAMSCVVRMPDQRP-----KMPDVVR  592 (625)
Q Consensus       565 ~~~~l~~l~~~Cl~~~P~~RP-----s~~ev~~  592 (625)
                      ...++.+++.+||+.||.+|+     |++|+++
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            223566788899999999994     8999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=382.30  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=204.0

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEe
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDY  400 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  400 (625)
                      .+.||+|+||+||+|.+.      +++.||||+++.....  ...|.+|++++++++|||||+++|+|...+..++||||
T Consensus        25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~  104 (308)
T d1p4oa_          25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  104 (308)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence            467999999999999853      3578999999764322  24588999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccccC-----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccc
Q 006922          401 YSLGSVSAMLHSERG-----EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTT  475 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~  475 (625)
                      +++|+|.+++.....     .....++|..+.+++.|+|+||+|||+++   |+||||||+|||++.++++||+|||+|+
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccce
Confidence            999999999875431     12235799999999999999999999987   9999999999999999999999999998


Q ss_pred             cccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          476 ITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTG-KSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       476 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ......     ....+++.|+|||.+.+..++.++|||||||++|||+|| +.||......+....+      .....  
T Consensus       182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------~~~~~--  253 (308)
T d1p4oa_         182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------MEGGL--  253 (308)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------HTTCC--
T ss_pred             eccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhCCC--
Confidence            764332     223567889999999999999999999999999999997 5777654433322211      11111  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006922          550 EVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPND  601 (625)
Q Consensus       550 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~  601 (625)
                               .+........+.+++.+||+.+|++||||+||++.|++..+..
T Consensus       254 ---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         254 ---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                     0111122346788888999999999999999999998886643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-47  Score=383.84  Aligned_cols=252  Identities=27%  Similarity=0.344  Sum_probs=189.9

Q ss_pred             HhHcccCCceeEEEEEEc------CCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecC-ceEEEE
Q 006922          329 AEVLGKGTFGMAYKAILE------DGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKD-EKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  398 (625)
                      .+.||+|+||+||+|...      +++.||||+++....  ..+.+.+|++++.++ +|+|||.+++++...+ ..++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            357999999999999853      246899999975432  235677888888776 6899999999987654 689999


Q ss_pred             EeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCee
Q 006922          399 DYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGC  467 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~k  467 (625)
                      ||+++|+|.++++.....           ....++|.++..++.|+++||+|||+++   |+||||||+|||+++++.+|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence            999999999999764321           1234899999999999999999999998   99999999999999999999


Q ss_pred             Eecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHH
Q 006922          468 VSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTG-KSPIHTTGGDELVHLVRWVHS  541 (625)
Q Consensus       468 l~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~  541 (625)
                      |+|||+|+......     ....||..|||||.+.+..++.++|||||||++|||+|| +.||......+..  ...+. 
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~--~~~~~-  251 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK-  251 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--HHHHH-
T ss_pred             EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--HHHHh-
Confidence            99999998654322     234678889999999999999999999999999999996 5678655433221  11111 


Q ss_pred             HhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          542 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       542 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                         .+...          +.......++.+++.+||+.||++|||++||++.|+++.+
T Consensus       252 ---~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         252 ---EGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ---HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               11100          1111223467788899999999999999999999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=380.69  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=196.8

Q ss_pred             HhHcccCCceeEEEEEEcC--------CcEEEEEEeccccCC--hHHHHHHHHHHHcC-CCCceecceeEEEecCceEEE
Q 006922          329 AEVLGKGTFGMAYKAILED--------GTTVVVKRLKDVNVG--KRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  397 (625)
                      .+.||+|+||.||+|+...        +..||||+++.....  ..++.+|...+.++ +|||||+++++|.+++..++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            3579999999999998532        357999999765432  36788898888888 899999999999999999999


Q ss_pred             EEeccCCChhhhhccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          398 YDYYSLGSVSAMLHSERGE-----------GRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |||+++|+|.+++......           ....+++.++++++.|++.||+|||+.+   ||||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence            9999999999999765421           1235899999999999999999999998   9999999999999999999


Q ss_pred             eEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      ||+|||+++......     ....++..|+|||.+.+..|+.++|||||||++|||+| |++||.+....+.   .+.+.
T Consensus       175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---~~~i~  251 (299)
T d1fgka_         175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---FKLLK  251 (299)
T ss_dssp             EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH
T ss_pred             EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---HHHHH
Confidence            999999998764332     23457788999999999999999999999999999998 7888876543322   22221


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVR  598 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~  598 (625)
                          .+..          .+.......++.+++.+||+.||.+|||+.||++.|+++.
T Consensus       252 ----~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         252 ----EGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----TTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                1110          0111112245778888999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-45  Score=370.21  Aligned_cols=247  Identities=20%  Similarity=0.311  Sum_probs=194.7

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----hHHHHHHHHHHHcCCCCceecceeEEEecCc----eEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----KRDFEQQMEIVGSIRHENVVELKAYYYSKDE----KLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~  400 (625)
                      +.||+|+||+||+|.. .+|+.||||+++.....    .+.+.+|++++++++|||||++++++...+.    .++||||
T Consensus        13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~   92 (277)
T d1o6ya_          13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY   92 (277)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence            5799999999999995 57999999999765332    2468899999999999999999999987543    7899999


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +++++|.+++....     .+++.++..++.|++.||+|||+++   |+||||||+|||++.++..+++|||.++.....
T Consensus        93 ~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          93 VDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             CCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             CCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence            99999999887653     4899999999999999999999998   999999999999999999999999998754321


Q ss_pred             ------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 ------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            .....||+.|||||++.+..++.++||||+||++|||+||+.||......+..      ...+......    +
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~----~  234 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP----P  234 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC----G
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCCC----C
Confidence                  23346899999999999999999999999999999999999999764432221      1122221110    0


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRP-KMPDVVRVIENVR  598 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~ev~~~L~~~~  598 (625)
                      .. ..+..   ..++.+++.+|++.||++|| |++|+...|.+++
T Consensus       235 ~~-~~~~~---s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 SA-RHEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GG-TSSSC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ch-hccCC---CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            00 11112   23566777899999999999 8999999998774

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=377.10  Aligned_cols=252  Identities=17%  Similarity=0.272  Sum_probs=191.6

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC------hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG------KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  402 (625)
                      ++||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|++++++++|||||++++++...+..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999995 46999999999754321      2468899999999999999999999999999999999999


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      ++++..+....     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            98877666433     24888899999999999999999998   999999999999999999999999999876432  


Q ss_pred             -ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhc---cccccccc--
Q 006922          481 -APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVRE---EWTAEVFD--  553 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d--  553 (625)
                       .....+|..|+|||++.. ..|+.++|||||||++|||+||+.||......+..   ..+......   ........  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence             223468899999998864 56799999999999999999999999765433322   222221111   00000000  


Q ss_pred             --ccccCCCC-c-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 --VELLRYPN-I-----EEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 --~~~~~~~~-~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        ......+. .     .....++.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              00000000 0     011245778888999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=380.23  Aligned_cols=241  Identities=20%  Similarity=0.303  Sum_probs=192.1

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcC-CCCceecceeEEEe----cCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSI-RHENVVELKAYYYS----KDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~  403 (625)
                      ++||+|+||+||+|+. .+|+.||||+++.    ...+.+|++++.++ +|||||+++++|.+    ....++|||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999995 5799999999975    35678899987654 89999999999876    3568999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccccccc
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~  480 (625)
                      |+|.+++....   ...+++.++..|+.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|+.....
T Consensus        94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC
Confidence            99999997542   235899999999999999999999998   999999999999986   457999999999876432


Q ss_pred             --ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccC
Q 006922          481 --APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLR  558 (625)
Q Consensus       481 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  558 (625)
                        .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+   ...+...        . ..
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~--------~-~~  235 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMG--------Q-YE  235 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC--------S-SS
T ss_pred             CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcC--------C-CC
Confidence              34457899999999999999999999999999999999999999765543322111   1000000        0 01


Q ss_pred             CCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          559 YPN--IEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       559 ~~~--~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .+.  ......++.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111  1223456788889999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=379.60  Aligned_cols=243  Identities=20%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             HhHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCChh
Q 006922          329 AEVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      .+.||+|+||+||+|... +|+.||||+++........+.+|+++|..++|||||++++++.+.+..++||||+++|+|.
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~   89 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence            357999999999999964 6899999999876555567889999999999999999999999999999999999999999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC--CCeeEeccccccccccc--ccc
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ--QYGCVSDLGLTTITSAL--APV  483 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DfGla~~~~~~--~~~  483 (625)
                      +++....    ..+++.++..++.|++.||+|||+++   |+||||||+|||++.+  ..+||+|||+++.....  ...
T Consensus        90 ~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence            9997543    24899999999999999999999998   9999999999999854  47999999999876543  234


Q ss_pred             cccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCCCcH
Q 006922          484 IARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYPNIE  563 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  563 (625)
                      ..+++.|+|||.+.+..|+.++||||+||++|||++|+.||......+....      .......   ++...  .+.  
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~------i~~~~~~---~~~~~--~~~--  229 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYT---FDEEA--FKE--  229 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCC---CCHHH--HTT--
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCC---CChhh--ccC--
Confidence            5678899999999999999999999999999999999999976543332221      1111100   00000  011  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          564 EEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       564 ~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                       ...++.+++.+|+..||++|||++|+++
T Consensus       230 -~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         230 -ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1234667788999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-45  Score=368.96  Aligned_cols=242  Identities=19%  Similarity=0.335  Sum_probs=196.4

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCC----------hHHHHHHHHHHHcCC-CCceecceeEEEecCceEE
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG----------KRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLM  396 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  396 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++.....          .+.+.+|++++++++ |||||++++++.+++..++
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            36799999999999996 57999999999764322          135789999999997 9999999999999999999


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ||||+++|+|.+++....     .+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence            999999999999997643     4899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccc--ccccccCCCcCCccccC------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTD------SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT  548 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  548 (625)
                      ....  .....||..|+|||.+.      ...++.++||||+||++|||+||+.||......+....+      ..+...
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i------~~~~~~  233 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------MSGNYQ  233 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH------HhCCCC
Confidence            6542  33456889999999874      345788999999999999999999999865432222111      111110


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 AEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                        .      ..+.......++.+++.+||+.||++|||++||++
T Consensus       234 --~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 --F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --C------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0      00111122346677888999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=377.22  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             HhHcccCCceeEEEEEE------cCCcEEEEEEeccccC--ChHHHHHHHHHHHcC-CCCceecceeEEEecCceEEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL------EDGTTVVVKRLKDVNV--GKRDFEQQMEIVGSI-RHENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      .+.||+|+||+||+|+.      .+++.||||+++....  ....+.+|+.++.++ +|||||+++++|.+.+..++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            35799999999999985      2467899999986533  235688999999999 69999999999999999999999


Q ss_pred             eccCCChhhhhccccC-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCe
Q 006922          400 YYSLGSVSAMLHSERG-------------EGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYG  466 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~  466 (625)
                      |+++|+|.++++....             .....+++..+.+++.||++||+|||+++   |+||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence            9999999999986542             12335899999999999999999999998   9999999999999999999


Q ss_pred             eEecccccccccccc-----cccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 006922          467 CVSDLGLTTITSALA-----PVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILT-GKSPIHTTGGDELVHLVRWVH  540 (625)
Q Consensus       467 kl~DfGla~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  540 (625)
                      |++|||+++......     ....+|+.|+|||.+.+..++.++|||||||++|||+| |++||......+...  +.+.
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~--~~i~  262 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY--KMIK  262 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH--HHHH
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH--HHHh
Confidence            999999998765332     22457788999999999999999999999999999999 666665544433221  1111


Q ss_pred             HHhhcccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          541 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       541 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ...+              .........++.+++.+||+.||++||||+||+++|+++..
T Consensus       263 ~~~~--------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         263 EGFR--------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC--------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            1110              01111223467788889999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=377.34  Aligned_cols=237  Identities=24%  Similarity=0.372  Sum_probs=194.0

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccc----cCChHHHHHHHHHHH-cCCCCceecceeEEEecCceEEEEEeccC
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDV----NVGKRDFEQQMEIVG-SIRHENVVELKAYYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  403 (625)
                      +.||+|+||+||+|... +|+.||||++++.    ....+.+..|..++. .++|||||++++++.+++..++||||+++
T Consensus         8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~   87 (320)
T d1xjda_           8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG   87 (320)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence            57999999999999964 6999999999753    223355677777665 68999999999999999999999999999


Q ss_pred             CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc---c
Q 006922          404 GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA---L  480 (625)
Q Consensus       404 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~  480 (625)
                      |+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....   .
T Consensus        88 g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          88 GDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999998654     3889999999999999999999998   99999999999999999999999999986543   2


Q ss_pred             ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCCC
Q 006922          481 APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRYP  560 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  560 (625)
                      .....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+..+....+.      ...       +.   .+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~~-------~~---~p  223 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MDN-------PF---YP  223 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------CC---CC
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC-------CC---CC
Confidence            234578999999999999999999999999999999999999998654333222211      111       00   01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006922          561 NIEEEMVEMLQIAMSCVVRMPDQRPKMP-DVVR  592 (625)
Q Consensus       561 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-ev~~  592 (625)
                        .....++.+++.+||..||++||++. |+++
T Consensus       224 --~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              11223567788899999999999995 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.3e-45  Score=378.65  Aligned_cols=240  Identities=20%  Similarity=0.259  Sum_probs=192.5

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEecccc----CChHHHHH---HHHHHHcCCCCceecceeEEEecCceEEEEEec
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVN----VGKRDFEQ---QMEIVGSIRHENVVELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  401 (625)
                      ++||+|+||+||+|+.. +|+.||||++....    .....+.+   |+++++.++|||||++++++.+.+..++||||+
T Consensus        10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~   89 (364)
T d1omwa3          10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   89 (364)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence            57999999999999964 69999999996432    12233444   467777888999999999999999999999999


Q ss_pred             cCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc-
Q 006922          402 SLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL-  480 (625)
Q Consensus       402 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-  480 (625)
                      ++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+..... 
T Consensus        90 ~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          90 NGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             CSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             CCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            9999999997653     3889999999999999999999998   999999999999999999999999999876543 


Q ss_pred             ccccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccccccCC
Q 006922          481 APVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVELLRY  559 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  559 (625)
                      .....||+.|+|||++. +..|+.++|||||||++|||+||+.||......+.......   ....         .....
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~---------~~~~~  229 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM---------AVELP  229 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSSC---------CCCCC
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccC---------CCCCC
Confidence            34457999999999986 45689999999999999999999999987655443322211   0000         00001


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          560 PNIEEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       560 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                      ...   ..++.+++.+||+.||++|||     ++|+++
T Consensus       230 ~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         230 DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            112   235677788999999999999     577764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=367.63  Aligned_cols=255  Identities=17%  Similarity=0.243  Sum_probs=190.9

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|.. .+|+.||||+++....   ..+.+.+|++++++++|||||++++++.+.+..++||||+.++.
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~   87 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL   87 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCch
Confidence            5799999999999995 5799999999975432   24678999999999999999999999999999999999998654


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---cc
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---AP  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~  482 (625)
                      +. ++....   ...+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+.....   ..
T Consensus        88 ~~-~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          88 KK-FMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             HH-HHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             hh-hhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            44 443222   124899999999999999999999998   999999999999999999999999999876432   23


Q ss_pred             ccccCCCcCCccccCCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh--ccccccccc-----c
Q 006922          483 VIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR--EEWTAEVFD-----V  554 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d-----~  554 (625)
                      ...||..|+|||.+.... ++.++||||+||++|||++|+.||.+.+..+...  ........  +.....+..     .
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhcccccccccccc
Confidence            347889999999876655 5789999999999999999999997654322211  11111100  000010000     0


Q ss_pred             cccC--CCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006922          555 ELLR--YPNIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV  593 (625)
Q Consensus       555 ~~~~--~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~  593 (625)
                      ....  .....    ....++.+++.+|++.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000  00000    112456778889999999999999999873

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-44  Score=361.11  Aligned_cols=255  Identities=19%  Similarity=0.258  Sum_probs=193.1

Q ss_pred             hHcccCCceeEEEEEEcCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCCh
Q 006922          330 EVLGKGTFGMAYKAILEDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGSV  406 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  406 (625)
                      +.||+|+||+||+|+..+|+.||||+++....   ..+.+.+|+.+|++++|||||++++++.+.+..+++|||+.++.+
T Consensus         8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~   87 (286)
T d1ob3a_           8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK   87 (286)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred             cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence            56999999999999998999999999976432   246799999999999999999999999999999999999998777


Q ss_pred             hhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc---ccc
Q 006922          407 SAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL---APV  483 (625)
Q Consensus       407 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~  483 (625)
                      ..+.....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||.+......   ...
T Consensus        88 ~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          88 KLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             HHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            76665432     4999999999999999999999998   999999999999999999999999999876432   223


Q ss_pred             cccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc-----ccccc
Q 006922          484 IARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF-----DVELL  557 (625)
Q Consensus       484 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----d~~~~  557 (625)
                      ..+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+....+................     +....
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            4577889999998654 56899999999999999999999997654332222111110000000000000     00000


Q ss_pred             C-CC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          558 R-YP-----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       558 ~-~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      . .+     .......++.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 00     01112245678888999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=360.35  Aligned_cols=231  Identities=16%  Similarity=0.335  Sum_probs=187.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC-------hHHHHHHHHHHHcCC--CCceecceeEEEecCceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG-------KRDFEQQMEIVGSIR--HENVVELKAYYYSKDEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||||+++.....       ...+.+|++++++++  |||||++++++.+.+..++|||
T Consensus        10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e   89 (273)
T d1xwsa_          10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE   89 (273)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence            5799999999999995 57999999999754221       234678999999986  8999999999999999999999


Q ss_pred             eccC-CChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CCeeEecccccccc
Q 006922          400 YYSL-GSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQ-QYGCVSDLGLTTIT  477 (625)
Q Consensus       400 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~  477 (625)
                      |+.+ +++.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.+ +.+||+|||+|+..
T Consensus        90 ~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          90 RPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             CCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence            9976 57777776543     4899999999999999999999998   9999999999999854 78999999999876


Q ss_pred             ccc-ccccccCCCcCCccccCCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccccccccc
Q 006922          478 SAL-APVIARAAGYRAPEVTDSRKA-TQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDVE  555 (625)
Q Consensus       478 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  555 (625)
                      ... .....||..|+|||++.+..+ +.++||||+||++|||+||+.||....     +       ..+...   .+.  
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~~~---~~~--  224 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRGQV---FFR--  224 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHCCC---CCS--
T ss_pred             ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhhccc---CCC--
Confidence            433 344678999999999876665 577999999999999999999996421     1       111110   000  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          556 LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       556 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                          +...   .++.+++.+||+.||++|||++|+++
T Consensus       225 ----~~~s---~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         225 ----QRVS---SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCC---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                1122   35667778999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=361.00  Aligned_cols=261  Identities=18%  Similarity=0.251  Sum_probs=191.5

Q ss_pred             hHcccCCceeEEEEEE-cC-CcEEEEEEeccccC---ChHHHHHHHHHHHcC---CCCceecceeEEEe-----cCceEE
Q 006922          330 EVLGKGTFGMAYKAIL-ED-GTTVVVKRLKDVNV---GKRDFEQQMEIVGSI---RHENVVELKAYYYS-----KDEKLM  396 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~l  396 (625)
                      +.||+|+||+||+|+. .+ ++.||||+++....   ....+.+|+++++.+   +||||++++++|..     ....++
T Consensus        13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~   92 (305)
T d1blxa_          13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   92 (305)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence            5799999999999996 34 67799999975422   234577788777665   79999999999864     246789


Q ss_pred             EEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          397 VYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       397 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      +|||++++++........    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          93 VFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            999999987765544322    24899999999999999999999998   99999999999999999999999999986


Q ss_pred             cccc--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh-hccccccccc
Q 006922          477 TSAL--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVV-REEWTAEVFD  553 (625)
Q Consensus       477 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d  553 (625)
                      ....  .....||+.|+|||++.+..|+.++||||+||++|||+||+.||...+..+....+....... ...+......
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            5432  345678999999999999999999999999999999999999998654333222221111000 0011000000


Q ss_pred             ccc-----cCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          554 VEL-----LRY---PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       554 ~~~-----~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                      ...     ...   .........+.+++.+|++.||++|||++|+++.  ++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            000     000   0011112356677889999999999999999863  5444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=363.72  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=191.4

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  399 (625)
                      +.||+|+||+||+|.. .+|+.||||+++......   +.+.+|+++|++++|||||+++++|...+      +.++|||
T Consensus        24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  103 (346)
T d1cm8a_          24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP  103 (346)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence            5699999999999995 469999999998654332   46889999999999999999999997654      5699999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+ +.+|..+.+..      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+|+....
T Consensus       104 ~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         104 FM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence            99 55777776543      3999999999999999999999998   99999999999999999999999999998877


Q ss_pred             cccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccc----------
Q 006922          480 LAPVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWT----------  548 (625)
Q Consensus       480 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  548 (625)
                      ......+|..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+..............+..          
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence            7777789999999999865 45689999999999999999999999765433222211111100000000          


Q ss_pred             -----ccccccccc-CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006922          549 -----AEVFDVELL-RYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENVRP  599 (625)
Q Consensus       549 -----~~~~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~~~  599 (625)
                           .+....... ..+..   ..++.+++.+|+..||++|||+.|+++.  ++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNA---SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTC---CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhccCCcccccchHHhccCC---CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                 000000000 00111   2356678889999999999999999974  666543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-42  Score=350.89  Aligned_cols=264  Identities=14%  Similarity=0.142  Sum_probs=206.6

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCC-CceecceeEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH-ENVVELKAYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|+.. +|+.||||++.... ....+.+|++++..++| +|++.+++++......++||||+ +++|.
T Consensus        11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~   88 (293)
T d1csna_          11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   88 (293)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence            56999999999999954 68999999886532 34568889999999965 89999999999999999999998 67999


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----CCCeeEeccccccccccc--
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS-----QQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~--  480 (625)
                      +++.....    .+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+.....  
T Consensus        89 ~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          89 DLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            88875432    4899999999999999999999998   999999999999975     568999999999875321  


Q ss_pred             --------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          481 --------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       481 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                              .....||+.|||||++.+..++.++|||||||++|||+||+.||..............+..........+  
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~--  239 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE--  239 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH--
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH--
Confidence                    2234689999999999999999999999999999999999999987655444333332222111111010  


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRPNDSENRPSSGNKS  612 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  612 (625)
                         +.  +..   ..++.+++..|+..+|++||+++.+.+.|+++..+........++|+
T Consensus       240 ---l~--~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         240 ---LC--AGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             ---HT--TTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             ---hc--CCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence               00  111   23577788899999999999999999999887554444444445554

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-42  Score=352.38  Aligned_cols=251  Identities=16%  Similarity=0.155  Sum_probs=189.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecce-eEEEecCceEEEEEeccCCChh
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELK-AYYYSKDEKLMVYDYYSLGSVS  407 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e~~~~g~L~  407 (625)
                      +.||+|+||+||+|+. .+|+.||||++.... ....+..|++++..++|+|++..+ +++...+..++||||+. +++.
T Consensus        13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~   90 (299)
T d1ckia_          13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLE   90 (299)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred             EEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchh
Confidence            5699999999999995 568999999987543 345688999999999877766555 45566778889999985 4666


Q ss_pred             hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCCeeEeccccccccccc----
Q 006922          408 AMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNS---QQYGCVSDLGLTTITSAL----  480 (625)
Q Consensus       408 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~----  480 (625)
                      ..+....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.....    
T Consensus        91 ~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          91 DLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             hhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            6554432    24899999999999999999999998   999999999999864   457999999999876432    


Q ss_pred             ------ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccccc
Q 006922          481 ------APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVFDV  554 (625)
Q Consensus       481 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  554 (625)
                            .....||+.|||||.+.+..++.++|||||||++|||+||+.||......+..................     
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----  238 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----  238 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH-----
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh-----
Confidence                  123468999999999999999999999999999999999999998765444333222111110000000     


Q ss_pred             cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006922          555 ELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRVIENVRP  599 (625)
Q Consensus       555 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~L~~~~~  599 (625)
                      ..  .+   ....++.+++..||+.+|++||+++++.+.|+.+..
T Consensus       239 ~~--~~---~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         239 VL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HH--TT---TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             Hh--cc---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            00  01   112457788889999999999999999999987643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=352.96  Aligned_cols=255  Identities=20%  Similarity=0.262  Sum_probs=189.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccC---ChHHHHHHHHHHHcCCCCceecceeEEEe--------cCceEEE
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNV---GKRDFEQQMEIVGSIRHENVVELKAYYYS--------KDEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~lv  397 (625)
                      +.||+|+||+||+|+. .+|+.||||++.....   ..+.+.+|+++|++++||||+++++++..        .+..++|
T Consensus        16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv   95 (318)
T d3blha1          16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV   95 (318)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence            5799999999999995 5799999999865422   23678899999999999999999999865        3457899


Q ss_pred             EEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccc
Q 006922          398 YDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       398 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      |||++++.+........     .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          96 FDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeec
Confidence            99999887765544322     3788899999999999999999998   999999999999999999999999999765


Q ss_pred             ccc-------ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 006922          478 SAL-------APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTA  549 (625)
Q Consensus       478 ~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  549 (625)
                      ...       .....+|..|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+.............
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            421       1234688899999998754 68999999999999999999999997654433333222221111111111


Q ss_pred             ccccccc--------cCCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          550 EVFDVEL--------LRYPNIEEE------MVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       550 ~~~d~~~--------~~~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......        .......+.      ..++.+++.+|++.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1100000        000111111      234678899999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=360.10  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=189.7

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCChHHHHHHHHHHHcCCCCceecceeEEEecC------ceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENVVELKAYYYSKD------EKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~~~  402 (625)
                      ++||+|+||+||+|+.. +|+.||||+++...   ....+|+++|++++|||||+++++|....      ..++||||++
T Consensus        26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~  102 (350)
T d1q5ka_          26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  102 (350)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred             eEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence            57999999999999964 69999999997643   23457999999999999999999986532      4689999998


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccc-
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSAL-  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~-  480 (625)
                      ++.+..+.....  ....+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++..... 
T Consensus       103 ~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         103 ETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             CccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            765444433222  1235899999999999999999999998   99999999999999875 8999999999876432 


Q ss_pred             -ccccccCCCcCCccccCC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-----HHhhccccccccc
Q 006922          481 -APVIARAAGYRAPEVTDS-RKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVH-----SVVREEWTAEVFD  553 (625)
Q Consensus       481 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~d  553 (625)
                       .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....     ..+... .....+
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~-~~~~~~  256 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTE  256 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CC---C
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh-ccchhh
Confidence             334568889999998764 578999999999999999999999997654332221111000     000000 000000


Q ss_pred             ccccC---CC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006922          554 VELLR---YP----NIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENVRP  599 (625)
Q Consensus       554 ~~~~~---~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~~~  599 (625)
                      .....   .+    .......++.+++.+|+..||++|||+.|+++  .++++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00000   00    00112235677888999999999999999986  4666644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-42  Score=354.33  Aligned_cols=258  Identities=19%  Similarity=0.256  Sum_probs=189.0

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC--hHHHHHHHHHHHcCCCCceecceeEEEecC----ceEEEEEecc
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG--KRDFEQQMEIVGSIRHENVVELKAYYYSKD----EKLMVYDYYS  402 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~  402 (625)
                      +.||+|+||+||+|.. .+|+.||||+++.....  .+.+.+|+++|.+++||||+++++++....    ..+++++|+.
T Consensus        14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~   93 (345)
T d1pmea_          14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM   93 (345)
T ss_dssp             EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred             EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence            5799999999999985 57999999999764322  356889999999999999999999997643    2355667778


Q ss_pred             CCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc--
Q 006922          403 LGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL--  480 (625)
Q Consensus       403 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~--  480 (625)
                      +|+|.+++...      .+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+.....  
T Consensus        94 ~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          94 GADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             CCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            99999999753      3899999999999999999999998   999999999999999999999999999865432  


Q ss_pred             ----ccccccCCCcCCccccC-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccc-----
Q 006922          481 ----APVIARAAGYRAPEVTD-SRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAE-----  550 (625)
Q Consensus       481 ----~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  550 (625)
                          .....++..|+|||++. +..++.++||||+||++|||++|+.||......+.......+...........     
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence                23345788899999984 45678999999999999999999999976543322221111100000000000     


Q ss_pred             ----cc-cccccCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006922          551 ----VF-DVELLRYPNIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IENV  597 (625)
Q Consensus       551 ----~~-d~~~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~~~  597 (625)
                          .. .+.. ......    ....++.+++.+|++.||++|||++|+++.  +++.
T Consensus       245 ~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         245 ARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                00 0000 000000    011356788889999999999999999874  4443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=341.69  Aligned_cols=253  Identities=17%  Similarity=0.244  Sum_probs=193.8

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCC---hHHHHHHHHHHHcCCCCceecceeEEEecCceEEEEEeccCCC
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVG---KRDFEQQMEIVGSIRHENVVELKAYYYSKDEKLMVYDYYSLGS  405 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  405 (625)
                      +.||+|+||+||+|+. .+|+.||||+++.....   ...+.+|+.+++.++||||+++++++.+.+..++|+|++.+++
T Consensus         8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~   87 (292)
T d1unla_           8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL   87 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred             eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence            5799999999999995 57899999999755332   3678899999999999999999999999999999999999999


Q ss_pred             hhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccccc---c
Q 006922          406 VSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSALA---P  482 (625)
Q Consensus       406 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~---~  482 (625)
                      +..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......   .
T Consensus        88 l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          88 KKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             HHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             ccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            988776543     4789999999999999999999998   9999999999999999999999999998765332   2


Q ss_pred             ccccCCCcCCccccCCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcc---cccc---ccc--
Q 006922          483 VIARAAGYRAPEVTDSRK-ATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREE---WTAE---VFD--  553 (625)
Q Consensus       483 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~d--  553 (625)
                      ...++..|+|||.+.... ++.++||||+||++|||++|+.||.....  ..+....+.......   ....   ..+  
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            234566799999987654 68999999999999999999999754332  222222222221110   0000   000  


Q ss_pred             ------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          554 ------VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       554 ------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                            ...............+.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000000011112235677888999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=345.88  Aligned_cols=242  Identities=20%  Similarity=0.302  Sum_probs=193.4

Q ss_pred             HhHcccCCceeEEEEEE----cCCcEEEEEEecccc-----CChHHHHHHHHHHHcCCC-CceecceeEEEecCceEEEE
Q 006922          329 AEVLGKGTFGMAYKAIL----EDGTTVVVKRLKDVN-----VGKRDFEQQMEIVGSIRH-ENVVELKAYYYSKDEKLMVY  398 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  398 (625)
                      .+.||+|+||+||+|+.    .+|+.||||+++...     ...+.+.+|++++.+++| |||+++++++.+.+..++||
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            36799999999999984    248899999997532     234678899999999976 89999999999999999999


Q ss_pred             EeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccc
Q 006922          399 DYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITS  478 (625)
Q Consensus       399 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~  478 (625)
                      ||+.+|+|.+++....     .+.......++.|++.||+|+|+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999998764     2678889999999999999999998   9999999999999999999999999998764


Q ss_pred             cc----ccccccCCCcCCccccCCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 006922          479 AL----APVIARAAGYRAPEVTDSR--KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF  552 (625)
Q Consensus       479 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (625)
                      ..    .....+++.|+|||.+.+.  .++.++||||+||++|||+||+.||......+....+...  .....      
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~~------  252 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKSE------  252 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHCC------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cccCC------
Confidence            32    2235678889999998654  4688999999999999999999999876654443332211  11110      


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006922          553 DVELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPK-----MPDVVR  592 (625)
Q Consensus       553 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~ev~~  592 (625)
                            .+.......++.+++.+||+.||++|||     ++|+++
T Consensus       253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  0111123346777888999999999995     678764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=342.63  Aligned_cols=249  Identities=18%  Similarity=0.257  Sum_probs=189.7

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC-CCceecceeEEEec--CceEEEEEeccCC
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-HENVVELKAYYYSK--DEKLMVYDYYSLG  404 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~g  404 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++..  ..+.+.+|+++|.+++ ||||+++++++...  ...++||||++++
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~  117 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  117 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence            36799999999999996 57999999999753  3567899999999995 99999999999754  4689999999999


Q ss_pred             ChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-CeeEeccccccccccc--c
Q 006922          405 SVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQ-YGCVSDLGLTTITSAL--A  481 (625)
Q Consensus       405 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~--~  481 (625)
                      +|....+        .+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.....  .
T Consensus       118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            9877643        3899999999999999999999998   99999999999998765 5899999999876532  3


Q ss_pred             cccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---------c---ccc
Q 006922          482 PVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVR---------E---EWT  548 (625)
Q Consensus       482 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~---~~~  548 (625)
                      ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||........ .... +.....         .   ...
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~-i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVR-IAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHH-HHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH-HHHH-HHHHHCCchhhhhhhhcccccC
Confidence            345678889999997764 579999999999999999999999976543211 1111 111100         0   000


Q ss_pred             ccccc----------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          549 AEVFD----------VELLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       549 ~~~~d----------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      ....+          ..............++.+++.+|+..||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000          000011111222346778888999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=348.67  Aligned_cols=259  Identities=20%  Similarity=0.277  Sum_probs=192.2

Q ss_pred             hHcccCCceeEEEEEE-cCCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEec-----CceEEEEEe
Q 006922          330 EVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSK-----DEKLMVYDY  400 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  400 (625)
                      +.||+|+||+||+|+. .+|+.||||+++....+.   +.+.+|++++++++|||||++++++...     ...+++++|
T Consensus        24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~  103 (348)
T d2gfsa1          24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  103 (348)
T ss_dssp             EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence            5799999999999995 579999999998654332   4678999999999999999999998643     344677888


Q ss_pred             ccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEeccccccccccc
Q 006922          401 YSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSAL  480 (625)
Q Consensus       401 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  480 (625)
                      +.+|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++......
T Consensus       104 ~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1         104 LMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc
Confidence            8999999998643      3899999999999999999999998   999999999999999999999999999887766


Q ss_pred             ccccccCCCcCCccccCCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhcccccccc-------
Q 006922          481 APVIARAAGYRAPEVTDSR-KATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHSVVREEWTAEVF-------  552 (625)
Q Consensus       481 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  552 (625)
                      .....++..|+|||.+.+. .++.++||||+||++|||++|+.||.+.+.......+.........+......       
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            6666788889999987665 46889999999999999999999997654332222221111000000000000       


Q ss_pred             cccccCCC--CcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006922          553 DVELLRYP--NIE----EEMVEMLQIAMSCVVRMPDQRPKMPDVVR--VIENV  597 (625)
Q Consensus       553 d~~~~~~~--~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~--~L~~~  597 (625)
                      .......+  ...    ....++.+++.+|+..||.+|||+.|+++  .+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00000000  000    11235677888999999999999999987  45544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=346.61  Aligned_cols=252  Identities=18%  Similarity=0.253  Sum_probs=183.1

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccccCCh---HHHHHHHHHHHcCCCCceecceeEEEec------CceEEEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDVNVGK---RDFEQQMEIVGSIRHENVVELKAYYYSK------DEKLMVYD  399 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  399 (625)
                      +.||+|+||+||+|... +|+.||||+++......   ..+.+|+.++++++|||||+++++|...      ...++|||
T Consensus        23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E  102 (355)
T d2b1pa1          23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME  102 (355)
T ss_dssp             EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence            57999999999999954 69999999998654433   4588999999999999999999999643      57899999


Q ss_pred             eccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEecccccccccc
Q 006922          400 YYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTITSA  479 (625)
Q Consensus       400 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~  479 (625)
                      |+.++.+. .+..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+++....
T Consensus       103 y~~~~l~~-~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         103 LMDANLCQ-VIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CCSEEHHH-HHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ccchHHHH-hhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence            99775554 4432       2889999999999999999999998   99999999999999999999999999887643


Q ss_pred             c--ccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHH----------------HHH
Q 006922          480 L--APVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRW----------------VHS  541 (625)
Q Consensus       480 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~----------------~~~  541 (625)
                      .  .....+|..|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..                ...
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            2  2345688899999999999999999999999999999999999976543222111110                000


Q ss_pred             Hhhcccc------cccccccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006922          542 VVREEWT------AEVFDVELLRY--PNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVR  592 (625)
Q Consensus       542 ~~~~~~~------~~~~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~  592 (625)
                      .......      ...+.......  ........++.+++.+|+..||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000      00000000000  011234567888999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-37  Score=322.57  Aligned_cols=264  Identities=17%  Similarity=0.246  Sum_probs=191.0

Q ss_pred             HhHcccCCceeEEEEEE-cCCcEEEEEEeccccCChHHHHHHHHHHHcCC-----------CCceecceeEEEec--Cce
Q 006922          329 AEVLGKGTFGMAYKAIL-EDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR-----------HENVVELKAYYYSK--DEK  394 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~--~~~  394 (625)
                      .+.||+|+||+||+|+. .+|+.||||+++......+.+.+|++++..++           |+||+++++++...  ...
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~   97 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV   97 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence            36799999999999995 57999999999876544567788998887764           57899999988653  456


Q ss_pred             EEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCEEeCCCCC------ee
Q 006922          395 LMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHA-ANGGKLVHGNIKSSNIFLNSQQY------GC  467 (625)
Q Consensus       395 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIll~~~~~------~k  467 (625)
                      +++|+++..+..........  ....+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.      ++
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence            67777766554433332222  22347889999999999999999998 65   999999999999987654      89


Q ss_pred             EecccccccccccccccccCCCcCCccccCCCCCCCccchhhhHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH---Hhh
Q 006922          468 VSDLGLTTITSALAPVIARAAGYRAPEVTDSRKATQASDVYSFGVVLLEILTGKSPIHTTGGDELVHLVRWVHS---VVR  544 (625)
Q Consensus       468 l~DfGla~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~---~~~  544 (625)
                      ++|||.+...........+|..|+|||++....++.++||||+||+++||++|+.||.................   .+.
T Consensus       173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg  252 (362)
T d1q8ya_         173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  252 (362)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence            99999998877666667899999999999999999999999999999999999999976443221111111110   000


Q ss_pred             c---------cccccccccc------------------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HH
Q 006922          545 E---------EWTAEVFDVE------------------LLRYPNIEEEMVEMLQIAMSCVVRMPDQRPKMPDVVRV--IE  595 (625)
Q Consensus       545 ~---------~~~~~~~d~~------------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev~~~--L~  595 (625)
                      .         ......++..                  ............++.+++.+|+..||.+|||++|+++.  ++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~  332 (362)
T d1q8ya_         253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK  332 (362)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence            0         0000000000                  00122345667788999999999999999999999873  54


Q ss_pred             hh
Q 006922          596 NV  597 (625)
Q Consensus       596 ~~  597 (625)
                      +.
T Consensus       333 ~~  334 (362)
T d1q8ya_         333 DT  334 (362)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=4.2e-30  Score=261.74  Aligned_cols=204  Identities=34%  Similarity=0.579  Sum_probs=157.2

Q ss_pred             CChhHHHHHHHHHHhCCCCCCC-CCCCCCCCCC-CCCceEeCCCC--CeEEEEEcCCCCcccc--cCcccccCCCCccEE
Q 006922           23 EPVEDKEALLDFVNNLPHSRSL-NWNESTSVCN-HWTGVKCSEDG--KRVVAVRLPGVGFSGL--IPPNTISRLSALKIL   96 (625)
Q Consensus        23 ~~~~~~~~ll~~~~~~~~~~~~-~w~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~g~--~~~~~~~~l~~L~~L   96 (625)
                      |.++|++||++||+++.+...+ +|..++++|. .|.||+|+..+  .||+.|+|++++++|.  +|+ .|++|++|++|
T Consensus         3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L   81 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL   81 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred             CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccccc
Confidence            7899999999999999654444 8987777774 59999998754  4899999999999984  666 59999999999


Q ss_pred             EecC-CCCCccCCcccccccccccccccccccCCCCC-------------------------CcccccccceecCCCccC
Q 006922           97 SLRS-NVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-------------------------DFSVWKNLTIINLSDNGF  150 (625)
Q Consensus        97 ~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-------------------------~~~~l~~L~~L~ls~N~l  150 (625)
                      +|++ |+++|.+|..|++|++|++|+|++|++.+.++                         .+..+++|+.+++++|.+
T Consensus        82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l  161 (313)
T d1ogqa_          82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence            9997 89999999999999999999999998875433                         234445555555555555


Q ss_pred             CCCCCC-----------------------------------------------------------------------Ccc
Q 006922          151 NGTIPR-----------------------------------------------------------------------SLS  159 (625)
Q Consensus       151 ~~~~p~-----------------------------------------------------------------------~l~  159 (625)
                      ++.+|.                                                                       .++
T Consensus       162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~  241 (313)
T d1ogqa_         162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG  241 (313)
T ss_dssp             EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            443332                                                                       223


Q ss_pred             ccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccc--cccCCCCcccCCCCCCCCCCCCCC
Q 006922          160 NLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQS--LKRFPSSAFVGNSISFDENLAPRA  227 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~--l~~~~~~~~~~n~~~~~~~~~~~~  227 (625)
                      .+++|+.|+|++|+|+|.+|..  .+++|+.|+|++|+|+|.+|+.  +.++..+.+.+|+.+||.|+++|.
T Consensus       242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence            3456667888888888888763  6788888888888888888863  445556677888888888877663

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=6.6e-23  Score=192.34  Aligned_cols=161  Identities=13%  Similarity=0.104  Sum_probs=118.2

Q ss_pred             HhHcccCCceeEEEEEEcCCcEEEEEEeccccCC-------------------hHHHHHHHHHHHcCCCCceecceeEEE
Q 006922          329 AEVLGKGTFGMAYKAILEDGTTVVVKRLKDVNVG-------------------KRDFEQQMEIVGSIRHENVVELKAYYY  389 (625)
Q Consensus       329 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~h~niv~l~~~~~  389 (625)
                      .+.||+|+||+||+|...+|+.||||+++.....                   .....+|...+.++.|.+++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence            4679999999999999888999999987632110                   12245678889999999998877653 


Q ss_pred             ecCceEEEEEeccCCChhhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCCeeEe
Q 006922          390 SKDEKLMVYDYYSLGSVSAMLHSERGEGRIPLDWDTRMRIAIGAARGIARIHAANGGKLVHGNIKSSNIFLNSQQYGCVS  469 (625)
Q Consensus       390 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIll~~~~~~kl~  469 (625)
                         ..+++|||+++..+..            +++....+++.|+++|++|||+++   |+||||||+|||++++ .++|+
T Consensus        84 ---~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 ---GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ---TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             ---CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence               3479999999865433            223345678999999999999998   9999999999999865 48899


Q ss_pred             cccccccccccccccccCCCcCC------ccccCCCCCCCccchhhhHHHHH
Q 006922          470 DLGLTTITSALAPVIARAAGYRA------PEVTDSRKATQASDVYSFGVVLL  515 (625)
Q Consensus       470 DfGla~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DvwS~Gvil~  515 (625)
                      |||.|+........     .|..      .|. ..+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            99999876532211     0111      011 1356788999999765443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.5e-19  Score=169.30  Aligned_cols=135  Identities=27%  Similarity=0.353  Sum_probs=92.5

Q ss_pred             CCCCCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccC-Ccccccccccccccccccc
Q 006922           48 ESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYF-PSDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        48 ~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~  126 (625)
                      +..|.| .|..|.|++            ++|+ .+|++ +  .+++++|+|++|.|++.+ +..|.++++|+.|+|++|+
T Consensus         3 P~~C~C-~~~~v~Cs~------------~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~   65 (192)
T d1w8aa_           3 PAMCHC-EGTTVDCTG------------RGLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ   65 (192)
T ss_dssp             CTTSEE-ETTEEECTT------------SCCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSC
T ss_pred             CCCCEE-cCCEEEEeC------------CCcC-ccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccc
Confidence            445555 577777754            3444 45543 2  256777777777776533 4556777777777777777


Q ss_pred             cCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccc
Q 006922          127 FSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGS  199 (625)
Q Consensus       127 l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~  199 (625)
                      +.+.++ .+..+++|+.|+|++|+|+...|..|.++++|++|+|++|+|++..++.  .+++|++|+|++|.+...
T Consensus        66 i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             cccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            776655 5667777777777777777666667777777777777777777766653  677777777777777643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=3.7e-17  Score=160.98  Aligned_cols=159  Identities=25%  Similarity=0.236  Sum_probs=115.7

Q ss_pred             eEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCC
Q 006922           59 VKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSG  129 (625)
Q Consensus        59 v~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  129 (625)
                      |.|++.+         ..++.|+|++|.+++ +|+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++
T Consensus        15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~   91 (266)
T d1p9ag_          15 VNCDKRNLTALPPDLPKDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS   91 (266)
T ss_dssp             EECTTSCCSSCCSCCCTTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS
T ss_pred             EEccCCCCCeeCcCcCcCCCEEECcCCcCCC-cCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc
Confidence            7886532         357889999999985 566679999999999999999986 44 36788999999999999987


Q ss_pred             CCCCcccccccceecCCCccCCC------------------------CCCCCccccccccceecccccccccCCCC--CC
Q 006922          130 TLPDFSVWKNLTIINLSDNGFNG------------------------TIPRSLSNLTQLEALYLANNSLSGKIPDL--NL  183 (625)
Q Consensus       130 ~~p~~~~l~~L~~L~ls~N~l~~------------------------~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l  183 (625)
                      ..+.+..+++|+.|++++|.+..                        ..+..+..+++|+.|++++|+|++..+..  .+
T Consensus        92 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l  171 (266)
T d1p9ag_          92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL  171 (266)
T ss_dssp             CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC
T ss_pred             cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccc
Confidence            66666666666666666655543                        33344455667777777777777666543  57


Q ss_pred             CCCcEEEcccCCCccccccccccCCC---CcccCCCCCCCC
Q 006922          184 PNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFDE  221 (625)
Q Consensus       184 ~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~~  221 (625)
                      ++|+.|+|++|+|+ .+|..+..++.   +.+.||+|.|++
T Consensus       172 ~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             TTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             cccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            77888888888887 67766555443   456678887775

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.64  E-value=5.6e-16  Score=144.52  Aligned_cols=155  Identities=20%  Similarity=0.226  Sum_probs=116.1

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      .++.|+|++|.+++.+++..|.++++|+.|+|++|.+.+..+..|..+++|++|+|++|+++...| .|..+++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            467788888888877777778888888888888888888888888888888888888888886666 4788888888888


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccccccccCCCCcccCCCCCCCC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQSLKRFPSSAFVGNSISFDE  221 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~~n~~~~~~  221 (625)
                      ++|+|++..|..|..+++|++|+|++|.+....+.. -...++.+.+..|.++...|..+..+.-+.+..|.+.|..
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~~  186 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCC
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChhhcCCEeeecCHhhCcCCC
Confidence            888888777777888888888888888876543321 1123555667777777777776666555555556666643

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=4.5e-15  Score=147.27  Aligned_cols=155  Identities=26%  Similarity=0.287  Sum_probs=128.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLS  146 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls  146 (625)
                      +..+....++....+++..|.++++|++|++++|.+....+..+..+.+|+.+++++|++++..+ .|..+++|+.|+++
T Consensus        82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~  161 (284)
T d1ozna_          82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH  161 (284)
T ss_dssp             CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccc
Confidence            33444444444445667779999999999999999988777888899999999999999997666 57888999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCccccccccccCCC---CcccCCCCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSISFDE  221 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~~~~  221 (625)
                      +|+|++..+..|..+++|+.|++++|++++..|..  .+++|+.|++++|++++..|..+..+++   +.+.+|++.|++
T Consensus       162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C  241 (284)
T d1ozna_         162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             cCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence            99999877888999999999999999999888864  7889999999999999887777776554   566789988875


Q ss_pred             C
Q 006922          222 N  222 (625)
Q Consensus       222 ~  222 (625)
                      .
T Consensus       242 ~  242 (284)
T d1ozna_         242 R  242 (284)
T ss_dssp             G
T ss_pred             c
Confidence            3

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.55  E-value=6.7e-15  Score=147.51  Aligned_cols=80  Identities=28%  Similarity=0.353  Sum_probs=69.2

Q ss_pred             CCCCCCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccc
Q 006922           47 NESTSVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSL  117 (625)
Q Consensus        47 ~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  117 (625)
                      |+..|.| .|.+|.|++.+         ..++.|+|++|+++ .+|+..|.++++|++|++++|.+....|..|.++++|
T Consensus         4 ~p~~c~c-~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L   81 (305)
T d1xkua_           4 CPFRCQC-HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL   81 (305)
T ss_dssp             CCTTCEE-ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             CCCCCEe-cCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence            4667777 79999998642         34778999999987 4666679999999999999999999888899999999


Q ss_pred             ccccccccccC
Q 006922          118 CYLYLQFNNFS  128 (625)
Q Consensus       118 ~~L~L~~N~l~  128 (625)
                      +.|++++|+++
T Consensus        82 ~~L~l~~n~l~   92 (305)
T d1xkua_          82 ERLYLSKNQLK   92 (305)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEecccCCccC
Confidence            99999999876

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=9.2e-15  Score=144.99  Aligned_cols=162  Identities=23%  Similarity=0.312  Sum_probs=112.8

Q ss_pred             CCCCCCC--CCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC--------
Q 006922           48 ESTSVCN--HWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP--------  108 (625)
Q Consensus        48 ~~~~~c~--~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------  108 (625)
                      +..|.|.  .|.-|.|++.+         ..++.|+|++|+++ .+|+..|.++++|++|++++|.+....+        
T Consensus         3 p~~C~C~~~~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~   81 (284)
T d1ozna_           3 PGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL   81 (284)
T ss_dssp             CTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCCCEEcCCCCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhcccccccccccccccccccccccccccc
Confidence            3455552  35568998643         23578999999997 5777789999999999999998875433        


Q ss_pred             -----------------cccccccccccccccccccCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecc
Q 006922          109 -----------------SDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLA  170 (625)
Q Consensus       109 -----------------~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~  170 (625)
                                       ..|.++++|++|++++|.+....+ .+....+|+.+++++|+|++..+..|..+++|+.|+|+
T Consensus        82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~  161 (284)
T d1ozna_          82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH  161 (284)
T ss_dssp             CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccc
Confidence                             345556677777777777765444 45566677777777777775555666777777777777


Q ss_pred             cccccccCCCC--CCCCCcEEEcccCCCccccccccccCCCC
Q 006922          171 NNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKRFPSS  210 (625)
Q Consensus       171 ~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~~~~~  210 (625)
                      +|++++..+..  .+++|+.|++++|++++..|..+..++++
T Consensus       162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L  203 (284)
T d1ozna_         162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL  203 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             cCcccccchhhhccccccchhhhhhccccccChhHhhhhhhc
Confidence            77777655543  56777777777777776667666665543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.49  E-value=4e-15  Score=149.83  Aligned_cols=132  Identities=31%  Similarity=0.421  Sum_probs=107.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCc-cEEEecCCCCCc-----------------------cCCcccccccccccccc
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSAL-KILSLRSNVITG-----------------------YFPSDFINLKSLCYLYL  122 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L-~~L~l~~N~l~~-----------------------~~p~~~~~l~~L~~L~L  122 (625)
                      .+..+++.+|.+.|.+|.. +..+..+ +.+++++|++++                       .+|..+..+++|+.|++
T Consensus       150 ~L~~l~l~~n~l~~~ip~~-~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~  228 (313)
T d1ogqa_         150 NLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL  228 (313)
T ss_dssp             TCCEEECCSSCCEEECCGG-GGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEEC
T ss_pred             ccceeeccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3556677777777776654 5555444 555555555554                       44555566778999999


Q ss_pred             cccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCC-Cccc
Q 006922          123 QFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNN-LSGS  199 (625)
Q Consensus       123 ~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~-l~g~  199 (625)
                      ++|.+++.+|.+..+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|.. .+++|+.+++++|+ ++|.
T Consensus       229 ~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             CSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred             ccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCC
Confidence            99999999999999999999999999999999999999999999999999999999986 78999999999998 5654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=6.1e-14  Score=137.56  Aligned_cols=139  Identities=22%  Similarity=0.268  Sum_probs=108.7

Q ss_pred             eCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCccccccc
Q 006922           61 CSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNL  140 (625)
Q Consensus        61 C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L  140 (625)
                      |+... ....++.++++|+ .+|++ +.  ++|++|+|++|.|++..+..|.++++|++|+|++|+|+ .+|.++.+++|
T Consensus         6 ~~~~~-~~~~v~C~~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L   79 (266)
T d1p9ag_           6 VSKVA-SHLEVNCDKRNLT-ALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVL   79 (266)
T ss_dssp             EECST-TCCEEECTTSCCS-SCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTC
T ss_pred             EcccC-CCeEEEccCCCCC-eeCcC-cC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccccccccc
Confidence            54432 3455799999999 47765 43  57999999999999977788999999999999999998 56778899999


Q ss_pred             ceecCCCccCCCCCCCCccccccccceecccccccccCCCC--CCCCCcEEEcccCCCcccccccccc
Q 006922          141 TIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL--NLPNLQQLNLANNNLSGSIPQSLKR  206 (625)
Q Consensus       141 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~L~l~~N~l~g~~p~~l~~  206 (625)
                      ++|+|++|++++ .+..+..+++|+.|++++|.+.+..+..  .+.++..|++++|.+++..+..+..
T Consensus        80 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~  146 (266)
T d1p9ag_          80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP  146 (266)
T ss_dssp             CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred             cccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccc
Confidence            999999999984 5778888999999999999887654432  5566667777777666444443333

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.46  E-value=8e-14  Score=119.57  Aligned_cols=101  Identities=20%  Similarity=0.260  Sum_probs=56.5

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccC
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGF  150 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l  150 (625)
                      |+|++|+++ .++  .++.+++|++|++++|.|+. +|..|..+++|+.|++++|+++. +|.+..+++|+.|++++|+|
T Consensus         3 L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           3 LHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EECTTSCCS-SCC--CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCC
T ss_pred             EEcCCCCCC-CCc--ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cCccccccccCeEECCCCcc
Confidence            556666665 232  25566666666666666654 44456666666666666666653 34555666666666666666


Q ss_pred             CCCC-CCCccccccccceecccccccc
Q 006922          151 NGTI-PRSLSNLTQLEALYLANNSLSG  176 (625)
Q Consensus       151 ~~~~-p~~l~~l~~L~~L~l~~N~l~~  176 (625)
                      +... ...+..+++|+.|++++|+++.
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            5321 1234555555566666655553

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=4.3e-14  Score=127.47  Aligned_cols=124  Identities=19%  Similarity=0.165  Sum_probs=97.5

Q ss_pred             ccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           87 ISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        87 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      +.+...|++|+|++|+|+. +|..+..+++|+.|+|++|+++ .++.+..+++|++|++++|+++...+..+..+++|+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            6778889999999999987 4666678899999999999998 4577888999999999999998544444577899999


Q ss_pred             eecccccccccCC--C-CCCCCCcEEEcccCCCcccccc----ccccCCCCccc
Q 006922          167 LYLANNSLSGKIP--D-LNLPNLQQLNLANNNLSGSIPQ----SLKRFPSSAFV  213 (625)
Q Consensus       167 L~l~~N~l~~~~p--~-~~l~~L~~L~l~~N~l~g~~p~----~l~~~~~~~~~  213 (625)
                      |+|++|+++....  . ..+++|+.|++++|+++ ..|.    .+..+|.+...
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~L  144 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  144 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             ceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCee
Confidence            9999999875321  2 26889999999999987 3442    46677776544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.42  E-value=1.3e-13  Score=118.32  Aligned_cols=101  Identities=27%  Similarity=0.394  Sum_probs=87.6

Q ss_pred             cEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCCccCCCCCCCCccccccccceeccccc
Q 006922           94 KILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNS  173 (625)
Q Consensus        94 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~  173 (625)
                      ++|+|++|+|+. ++ .+..+++|++|++++|+++...+.++.+++|+.|++++|+|++ +| .+..+++|+.|++++|+
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            589999999995 44 5999999999999999999655579999999999999999984 45 58999999999999999


Q ss_pred             ccccCCC---CCCCCCcEEEcccCCCcc
Q 006922          174 LSGKIPD---LNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       174 l~~~~p~---~~l~~L~~L~l~~N~l~g  198 (625)
                      ++.....   ..+++|+.|++++|+++.
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            9865432   278999999999999973

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.36  E-value=6.9e-13  Score=125.00  Aligned_cols=135  Identities=27%  Similarity=0.378  Sum_probs=83.6

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|+|++|.+++ ++  .++.+++|++|++++|+|++ +| .+.++++|+.|++++|.+. .++.+..+++|+.++++
T Consensus        69 ~L~~L~L~~n~i~~-l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~  142 (210)
T d1h6ta2          69 NVTKLFLNGNKLTD-IK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG  142 (210)
T ss_dssp             TCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECC
T ss_pred             CCCEEeCCCccccC-cc--ccccCccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence            35666666666664 22  25666677777777776665 33 3666667777777766665 34556666667777777


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCCCc
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPSSA  211 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~  211 (625)
                      +|.+++  +..+..+++|+.+++++|++++..+-..+++|+.|+|++|+|+ .+| .+..++++.
T Consensus       143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~  203 (210)
T d1h6ta2         143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLD  203 (210)
T ss_dssp             SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCS
T ss_pred             cccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCC
Confidence            776653  2345566677777777777765433336677777777777776 344 355555443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.35  E-value=9.5e-13  Score=122.89  Aligned_cols=122  Identities=25%  Similarity=0.406  Sum_probs=53.3

Q ss_pred             EEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCCC
Q 006922           68 VVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLSD  147 (625)
Q Consensus        68 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls~  147 (625)
                      ++.|+|++|.+++. ++  ++++++|+.|++++|.+.. ++ .+.++++|+.|++++|.+.. ++.+..+++|+.|++++
T Consensus        64 L~~L~Ls~N~l~~~-~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~-~~~~~~l~~L~~L~l~~  137 (199)
T d2omxa2          64 LTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSS  137 (199)
T ss_dssp             CCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCS
T ss_pred             cCcCccccccccCc-cc--ccCCccccccccccccccc-cc-cccccccccccccccccccc-ccccchhhhhHHhhhhh
Confidence            44444444444432 11  4444444444444444443 12 24444444444444444432 22344444455555555


Q ss_pred             ccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCc
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS  197 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~  197 (625)
                      |++.. ++ .+..+++|+.|++++|++++..+-..+++|+.|++++|+++
T Consensus       138 n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         138 NTISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             SCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             hhhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC
Confidence            54432 12 24444455555555555443322224445555555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.35  E-value=1.1e-12  Score=122.54  Aligned_cols=141  Identities=25%  Similarity=0.368  Sum_probs=113.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++.++++.. +.  .++.+++|++|+|++|+|++..|  +.++++|++|++++|.+. .++.+..+++|+.|+++
T Consensus        41 ~l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~l~~l~~L~~L~l~  114 (199)
T d2omxa2          41 QVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLF  114 (199)
T ss_dssp             TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGGGTTCTTCSEEECC
T ss_pred             CCCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccccccccccccccccc
Confidence            47789999999874 43  38899999999999999998543  999999999999999987 45678899999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSI  217 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~  217 (625)
                      +|.+...  ..+..+++|+.|++++|++.....-..+++|+.|++++|++++. + .++.+++   +.+.+|.+
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKV  184 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCC
Confidence            9998753  34788999999999999997543234789999999999999854 3 2444444   45555553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=1.7e-12  Score=115.93  Aligned_cols=112  Identities=20%  Similarity=0.216  Sum_probs=74.6

Q ss_pred             CCCCCCCCCCceEeCCCCCeEEEEEcCCCCcccccCcccccCCCCccEEEecCC-CCCccCCcccccccccccccccccc
Q 006922           48 ESTSVCNHWTGVKCSEDGKRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSN-VITGYFPSDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        48 ~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~N~  126 (625)
                      +..+.|+.+.+|+|+..+            +. .+|. .+..+++|+.|++++| .|+...+..|.++++|+.|+|++|+
T Consensus         2 P~~C~c~~~~~l~c~~~~------------~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~   67 (156)
T d2ifga3           2 PDACCPHGSSGLRCTRDG------------AL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG   67 (156)
T ss_dssp             CSSSCCSSSSCEECCSSC------------CC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSC
T ss_pred             cCCCCcCCCCeEEecCCC------------Cc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccc
Confidence            455666667888886532            22 2333 3777888899999765 4887666778888888888888888


Q ss_pred             cCCCCC-CcccccccceecCCCccCCCCCCCCccccccccceecccccc
Q 006922          127 FSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSL  174 (625)
Q Consensus       127 l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l  174 (625)
                      |+...| .|..+++|++|+|++|+|+ .+|..+....+|+.|+|++|.+
T Consensus        68 l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          68 LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             CCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred             cCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcc
Confidence            876555 4777777777777777777 4444332333455566655555

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.31  E-value=2.2e-12  Score=121.49  Aligned_cols=142  Identities=29%  Similarity=0.410  Sum_probs=115.3

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++.++.+... +  .+..+++|++|+|++|.|++. + .+.++++|+.|++++|++++ +|.+..+++|+.|+++
T Consensus        47 ~L~~L~l~~~~i~~l-~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          47 SIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLE  120 (210)
T ss_dssp             TCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECT
T ss_pred             CccEEECcCCCCCCc-h--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cccccccccccccccc
Confidence            477889999988753 3  288999999999999999984 3 47899999999999999985 6778999999999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCccccccccccCCC---CcccCCCCC
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKRFPS---SAFVGNSIS  218 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~---~~~~~n~~~  218 (625)
                      +|.+.. + ..+..+++|+.++++.|.+++..+...+++|+.+++++|++++..|  +..++.   +.+.+|.+.
T Consensus       121 ~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         121 HNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             TSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             cccccc-c-cccccccccccccccccccccccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCC
Confidence            999873 3 3688899999999999999865444578999999999999986433  444444   555566543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=1.8e-12  Score=116.64  Aligned_cols=120  Identities=21%  Similarity=0.237  Sum_probs=99.5

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceec
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIIN  144 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~  144 (625)
                      .++..|+|++|+++. ++ ..+..+++|+.|+|++|.|+.. + .|..+++|++|+|++|+++...+. +..+++|+.|+
T Consensus        18 ~~lr~L~L~~n~I~~-i~-~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          18 VRDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TSCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CcCcEEECCCCCCCc-cC-ccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence            357889999999985 44 4568899999999999999974 3 589999999999999999976665 56799999999


Q ss_pred             CCCccCCCCCC-CCccccccccceecccccccccCCC------CCCCCCcEEE
Q 006922          145 LSDNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPD------LNLPNLQQLN  190 (625)
Q Consensus       145 ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~------~~l~~L~~L~  190 (625)
                      +++|+|+..-. ..+..+++|++|++++|.++.. |.      ..+++|+.||
T Consensus        94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~-~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEET
T ss_pred             eccccccccccccccccccccchhhcCCCccccc-cchHHHHHHHCCCcCeeC
Confidence            99999984321 3678899999999999999754 43      1688999887

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.19  E-value=1.4e-13  Score=128.45  Aligned_cols=124  Identities=27%  Similarity=0.339  Sum_probs=99.5

Q ss_pred             ccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCC-cccccccceecCCCccCCCCCCCCcccccc
Q 006922           85 NTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPD-FSVWKNLTIINLSDNGFNGTIPRSLSNLTQ  163 (625)
Q Consensus        85 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~  163 (625)
                      ..++.|++|++|+|++|+|+. ++ .+.++++|+.|+|++|+++ .+|. +..+++|+.|++++|+++. ++ .+..+++
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~  116 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN  116 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHH
T ss_pred             hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccc
Confidence            458899999999999999996 44 5999999999999999998 4554 4456789999999999984 33 4888999


Q ss_pred             ccceecccccccccCC--C-CCCCCCcEEEcccCCCccccccc----------cccCCCCccc
Q 006922          164 LEALYLANNSLSGKIP--D-LNLPNLQQLNLANNNLSGSIPQS----------LKRFPSSAFV  213 (625)
Q Consensus       164 L~~L~l~~N~l~~~~p--~-~~l~~L~~L~l~~N~l~g~~p~~----------l~~~~~~~~~  213 (625)
                      |+.|+|++|+++....  . ..+++|+.|+|++|+++...+..          +..+|++..+
T Consensus       117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~L  179 (198)
T d1m9la_         117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL  179 (198)
T ss_dssp             SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEE
T ss_pred             ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEe
Confidence            9999999999985422  2 37899999999999997554432          4556666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.17  E-value=3.3e-11  Score=115.68  Aligned_cols=99  Identities=20%  Similarity=0.307  Sum_probs=65.1

Q ss_pred             CCCCCCCceEeCCCC---------CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC-cccccccccccc
Q 006922           51 SVCNHWTGVKCSEDG---------KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP-SDFINLKSLCYL  120 (625)
Q Consensus        51 ~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L  120 (625)
                      |.| .+..|.|++.+         ..++.|+|++|.++ .+|+..|.++++|++|+|++|.+...+| ..|.+++++++|
T Consensus         6 C~C-~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l   83 (242)
T d1xwdc1           6 CHC-SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI   83 (242)
T ss_dssp             EEE-CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred             CCC-cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence            556 68889997542         25788999999987 5777779999999999999998876443 345555555555


Q ss_pred             cccc-cccCCCCC-CcccccccceecCCCccCC
Q 006922          121 YLQF-NNFSGTLP-DFSVWKNLTIINLSDNGFN  151 (625)
Q Consensus       121 ~L~~-N~l~~~~p-~~~~l~~L~~L~ls~N~l~  151 (625)
                      ++.. |++....+ .|..+++|+.|++++|+++
T Consensus        84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             EEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred             cccccccccccccccccccccccccccchhhhc
Confidence            5432 34443333 2445555555555555443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.17  E-value=1.8e-11  Score=125.63  Aligned_cols=128  Identities=32%  Similarity=0.418  Sum_probs=83.2

Q ss_pred             CeEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-------------
Q 006922           66 KRVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-------------  132 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-------------  132 (625)
                      ..+..+++.+|.++. ++  .+..+++|+.|++++|.+++..  .+..+++|+.|++++|++++..+             
T Consensus       219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~  293 (384)
T d2omza2         219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELN  293 (384)
T ss_dssp             TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCcccccccccccccc
Confidence            356778888888875 22  4788889999999999988744  37788888888888888875432             


Q ss_pred             --------CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCccccc
Q 006922          133 --------DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIP  201 (625)
Q Consensus       133 --------~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p  201 (625)
                              .+..+++++.|++++|++++..  .+..+++|++|+|++|+|++ ++.. .+++|+.|+|++|+|++..|
T Consensus       294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred             ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence                    1333445566666666665432  25556666666666666654 2222 55666666666666664433

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=2.6e-11  Score=108.04  Aligned_cols=108  Identities=18%  Similarity=0.123  Sum_probs=90.3

Q ss_pred             CCCCccEEEecCCCCCccCCcccccccccccccccccc-cCCCCC-CcccccccceecCCCccCCCCCCCCccccccccc
Q 006922           89 RLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNN-FSGTLP-DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEA  166 (625)
Q Consensus        89 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~  166 (625)
                      .......++.+++.+.. .|..+..+++|++|++++|+ ++...+ .|..+++|+.|+|++|+|+...|..|..+++|++
T Consensus         6 ~c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CCSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CcCCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            34445678889988886 67889999999999998775 775444 6999999999999999999777888999999999


Q ss_pred             eecccccccccCCCC-CCCCCcEEEcccCCCc
Q 006922          167 LYLANNSLSGKIPDL-NLPNLQQLNLANNNLS  197 (625)
Q Consensus       167 L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~  197 (625)
                      |+|++|+|+...+.. ...+|+.|+|++|+|.
T Consensus        85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             eeccCCCCcccChhhhccccccccccCCCccc
Confidence            999999999655543 5557999999999995

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.16  E-value=4.8e-11  Score=118.80  Aligned_cols=149  Identities=23%  Similarity=0.274  Sum_probs=104.2

Q ss_pred             EEEEEcCCCCccc-ccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC-CcccccccceecC
Q 006922           68 VVAVRLPGVGFSG-LIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP-DFSVWKNLTIINL  145 (625)
Q Consensus        68 v~~l~l~~~~l~g-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l  145 (625)
                      ...++...+.... ......+..+++|+.+++++|.++. +|..+  +++|+.|++++|..++..+ .+..++.++.|++
T Consensus       126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~  202 (305)
T d1xkua_         126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL  202 (305)
T ss_dssp             CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             ccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence            3345554443221 2223457888888899998888875 44433  5788888898888887666 5778888888899


Q ss_pred             CCccCCCCCCCCccccccccceecccccccccCCCC-CCCCCcEEEcccCCCcccccc-cc---------ccCCCCcccC
Q 006922          146 SDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL-NLPNLQQLNLANNNLSGSIPQ-SL---------KRFPSSAFVG  214 (625)
Q Consensus       146 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~L~l~~N~l~g~~p~-~l---------~~~~~~~~~~  214 (625)
                      ++|++++..+..+..+++|++|+|++|+|+...+.. .+++|+.|+|++|+|+ .++. .+         ..+..+.+.+
T Consensus       203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~  281 (305)
T d1xkua_         203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFS  281 (305)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCS
T ss_pred             ccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCC
Confidence            988888777778888888999999999888543333 6888899999998887 3432 21         2233355667


Q ss_pred             CCCCCC
Q 006922          215 NSISFD  220 (625)
Q Consensus       215 n~~~~~  220 (625)
                      |++.+.
T Consensus       282 N~~~~~  287 (305)
T d1xkua_         282 NPVQYW  287 (305)
T ss_dssp             SSSCGG
T ss_pred             CcCccC
Confidence            776543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.12  E-value=8.4e-11  Score=111.72  Aligned_cols=57  Identities=18%  Similarity=0.288  Sum_probs=29.6

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFS  128 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  128 (625)
                      .++.|++++|.+.+..   .+..+++|++|++++|.++. ++ .+..+++|+.|++++|...
T Consensus        64 ~L~~L~ls~n~i~~~~---~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~  120 (227)
T d1h6ua2          64 NLIGLELKDNQITDLA---PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT  120 (227)
T ss_dssp             TCCEEECCSSCCCCCG---GGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC
T ss_pred             CCcEeecCCceeeccc---cccccccccccccccccccc-cc-ccccccccccccccccccc
Confidence            3555555555555422   15555555555555555553 22 3555555555555555544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.12  E-value=7e-11  Score=112.28  Aligned_cols=143  Identities=26%  Similarity=0.384  Sum_probs=107.5

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .++.|++.+++++. ++  .+..|++|+.|++++|.+++..|  +..+++|++|++++|.++ .++.+..+++|+.++++
T Consensus        42 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~  115 (227)
T d1h6ua2          42 GITTLSAFGTGVTT-IE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLT  115 (227)
T ss_dssp             TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECT
T ss_pred             CcCEEECCCCCCCc-ch--hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccccccccccccccccc
Confidence            47889999999884 43  38999999999999999997543  889999999999999987 56677788888888888


Q ss_pred             CccCCCCCC--------------------CCccccccccceecccccccccCCCCCCCCCcEEEcccCCCcccccccccc
Q 006922          147 DNGFNGTIP--------------------RSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLSGSIPQSLKR  206 (625)
Q Consensus       147 ~N~l~~~~p--------------------~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~g~~p~~l~~  206 (625)
                      +|...+..+                    ..+..+++|+.|++++|.+++..+-..+++|+.|+|++|++++ +|. ++.
T Consensus       116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~  193 (227)
T d1h6ua2         116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP-LAS  193 (227)
T ss_dssp             TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGG-GGG
T ss_pred             cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC-Chh-hcC
Confidence            877664211                    1245567788899998888765544478889999999998875 443 444


Q ss_pred             CCC---CcccCCCC
Q 006922          207 FPS---SAFVGNSI  217 (625)
Q Consensus       207 ~~~---~~~~~n~~  217 (625)
                      +++   +.+.+|.+
T Consensus       194 l~~L~~L~Ls~N~l  207 (227)
T d1h6ua2         194 LPNLIEVHLKNNQI  207 (227)
T ss_dssp             CTTCCEEECTTSCC
T ss_pred             CCCCCEEECcCCcC
Confidence            444   44455543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.10  E-value=5.2e-11  Score=122.19  Aligned_cols=123  Identities=33%  Similarity=0.428  Sum_probs=97.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCC--------------------cccccccccccccccccc
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFP--------------------SDFINLKSLCYLYLQFNN  126 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~  126 (625)
                      .+..+++.+|.+++..   .++.+++|+.|++++|.+++..+                    ..+..+++++.|+|++|+
T Consensus       242 ~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~  318 (384)
T d2omza2         242 NLTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN  318 (384)
T ss_dssp             TCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred             ccchhccccCccCCCC---cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence            4566777777776542   26667777777777776664321                    235667899999999999


Q ss_pred             cCCCCCCcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCC
Q 006922          127 FSGTLPDFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNN  195 (625)
Q Consensus       127 l~~~~p~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~  195 (625)
                      +++. +.+..+++|+.|++++|+|++ ++ .+.++++|++|+|++|++++.+|-..+++|+.|+|++|.
T Consensus       319 l~~l-~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         319 ISDI-SPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA  384 (384)
T ss_dssp             CSCC-GGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCEE
T ss_pred             CCCC-cccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCCc
Confidence            9965 458899999999999999985 44 699999999999999999988775689999999999983

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.95  E-value=4.2e-12  Score=118.17  Aligned_cols=124  Identities=26%  Similarity=0.354  Sum_probs=100.9

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .+..|+|++|+++ .++  .|..|++|+.|+|++|.|+. +|..+..+++|+.|++++|+++. ++.+..+++|+.|+|+
T Consensus        49 ~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~  123 (198)
T d1m9la_          49 ACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMS  123 (198)
T ss_dssp             TCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSEEEES
T ss_pred             ccceeECcccCCC-Ccc--cccCCccccChhhccccccc-ccccccccccccccccccccccc-cccccccccccccccc
Confidence            5789999999988 454  38999999999999999986 56656667899999999999984 5678889999999999


Q ss_pred             CccCCCCCC-CCccccccccceecccccccccCCCC------------CCCCCcEEEcccCCCc
Q 006922          147 DNGFNGTIP-RSLSNLTQLEALYLANNSLSGKIPDL------------NLPNLQQLNLANNNLS  197 (625)
Q Consensus       147 ~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~------------~l~~L~~L~l~~N~l~  197 (625)
                      +|+|+.... ..+..+++|+.|+|++|.+....+..            .+++|+.||  +..++
T Consensus       124 ~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            999984321 35788999999999999998665542            478888876  44443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=2.1e-09  Score=102.67  Aligned_cols=132  Identities=16%  Similarity=0.107  Sum_probs=100.3

Q ss_pred             EEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCC--CcccccccceecCC-C
Q 006922           71 VRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLP--DFSVWKNLTIINLS-D  147 (625)
Q Consensus        71 l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~ls-~  147 (625)
                      ++..+.+++ .+|++ +  .+++++|+|++|.|+...+..|.++++|++|+|++|.+...++  .|..+++++.|++. .
T Consensus        13 i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          13 FLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            444566777 67764 3  2579999999999998767789999999999999999987665  47889999999876 4


Q ss_pred             ccCCCCCCCCccccccccceecccccccccCCCC---CCCCCcEEEcccCCCcccccccccc
Q 006922          148 NGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDL---NLPNLQQLNLANNNLSGSIPQSLKR  206 (625)
Q Consensus       148 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~L~l~~N~l~g~~p~~l~~  206 (625)
                      |.+....+..|..+++|+.|++++|.+....+..   .+..+..+..+++.+...-+..+..
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~  150 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG  150 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred             ccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccc
Confidence            6788777888999999999999999998654432   3455556666777776333344433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.62  E-value=7.6e-08  Score=96.43  Aligned_cols=115  Identities=28%  Similarity=0.369  Sum_probs=87.7

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      .+..|+|++++++ .+|+    .+++|++|+|++|+|+. +|..+   .+|+.|++++|+++ .++++.  ++|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~-~l~~lp--~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK-ALSDLP--PLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-CCCSCC--TTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccc-hhhhhc--ccccccccc
Confidence            3667899999997 4664    25789999999999995 67654   57888899999887 344332  469999999


Q ss_pred             CccCCCCCCCCccccccccceecccccccccCCCCCCCCCcEEEcccCCCc
Q 006922          147 DNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPDLNLPNLQQLNLANNNLS  197 (625)
Q Consensus       147 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~L~l~~N~l~  197 (625)
                      +|.++ .+|. ++.+++|+.|++++|.++.....  ...+..+.+.++...
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred             ccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhcccccc
Confidence            99998 5664 67889999999999988754433  456777887777664

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.56  E-value=2.5e-07  Score=92.53  Aligned_cols=76  Identities=20%  Similarity=0.287  Sum_probs=62.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCcccccccccccccccccccCCCCCCcccccccceecCC
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFNNFSGTLPDFSVWKNLTIINLS  146 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ls  146 (625)
                      +++.|+|++|+++ .+|..    +.+|+.|++++|+++. ++. +  .+.|++|+|++|.+. .+|.++.+++|+.|+++
T Consensus        59 ~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~-~lp~~~~l~~L~~L~l~  128 (353)
T d1jl5a_          59 HLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVD  128 (353)
T ss_dssp             TCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECC
T ss_pred             CCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhh-h--ccccccccccccccc-cccchhhhccceeeccc
Confidence            5788999999998 66642    5689999999999985 332 2  246999999999998 56778889999999999


Q ss_pred             CccCCC
Q 006922          147 DNGFNG  152 (625)
Q Consensus       147 ~N~l~~  152 (625)
                      +|.++.
T Consensus       129 ~~~~~~  134 (353)
T d1jl5a_         129 NNSLKK  134 (353)
T ss_dssp             SSCCSC
T ss_pred             cccccc
Confidence            999874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=1.6e-08  Score=98.98  Aligned_cols=146  Identities=22%  Similarity=0.198  Sum_probs=84.4

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCccCCccccccccccccccccc-ccCCC-CCC-ccccccccee
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITGYFPSDFINLKSLCYLYLQFN-NFSGT-LPD-FSVWKNLTII  143 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~-~~~l~~L~~L  143 (625)
                      ++..|+|+++.+++......+..+++|++|+|+++.++...+..+..+++|++|+|+++ .++.. +.. ...+++|++|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence            46666776666554433344566677777777776666555555666666666666663 34310 111 2234455555


Q ss_pred             cCCCc-cCC----------------------------CC-CCCCccccccccceecccc-cccccCCC-C-CCCCCcEEE
Q 006922          144 NLSDN-GFN----------------------------GT-IPRSLSNLTQLEALYLANN-SLSGKIPD-L-NLPNLQQLN  190 (625)
Q Consensus       144 ~ls~N-~l~----------------------------~~-~p~~l~~l~~L~~L~l~~N-~l~~~~p~-~-~l~~L~~L~  190 (625)
                      +++++ .++                            .. +...+.++++|++|+|++| .+++.... . .+++|++|+
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~  206 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  206 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence            55442 222                            10 1111234678999999885 46644332 2 678899999


Q ss_pred             ccc-CCCccccccccccCCCCcc
Q 006922          191 LAN-NNLSGSIPQSLKRFPSSAF  212 (625)
Q Consensus       191 l~~-N~l~g~~p~~l~~~~~~~~  212 (625)
                      |++ +.+++.....+++++++..
T Consensus       207 L~~C~~i~~~~l~~L~~~~~L~~  229 (284)
T d2astb2         207 LSRCYDIIPETLLELGEIPTLKT  229 (284)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             CCCCCCCChHHHHHHhcCCCCCE
Confidence            998 5777666666777666543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=2.9e-08  Score=88.41  Aligned_cols=66  Identities=24%  Similarity=0.280  Sum_probs=37.4

Q ss_pred             ccccccceecCCCccCCCC--CCCCccccccccceecccccccccCCC--CCCCCCcEEEcccCCCcccc
Q 006922          135 SVWKNLTIINLSDNGFNGT--IPRSLSNLTQLEALYLANNSLSGKIPD--LNLPNLQQLNLANNNLSGSI  200 (625)
Q Consensus       135 ~~l~~L~~L~ls~N~l~~~--~p~~l~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~L~l~~N~l~g~~  200 (625)
                      ..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|.++...+.  ....+|+.|++++|+++...
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            3456666666666666532  123345566666666666666643221  13345667777777776443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.07  E-value=1.3e-05  Score=76.45  Aligned_cols=131  Identities=16%  Similarity=0.110  Sum_probs=88.4

Q ss_pred             CCceeEEEEEEcCCcEEEEEEecccc-CChHHHHHHHHHHHcCC-CCceecceeEEEecCceEEEEEeccCCChhhhhcc
Q 006922          335 GTFGMAYKAILEDGTTVVVKRLKDVN-VGKRDFEQQMEIVGSIR-HENVVELKAYYYSKDEKLMVYDYYSLGSVSAMLHS  412 (625)
Q Consensus       335 G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  412 (625)
                      ++.+.||+... +++.+++|+..... .....+.+|...+..+. +--+.+++.+....+..++||+++++.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34468998864 46677888876543 23456788888877663 43456778888888889999999999887654432


Q ss_pred             ccCCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 006922          413 ERGEGRIPLDWDTRMRIAIGAARGIARIHAAN------------------------------------------------  444 (625)
Q Consensus       413 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------------  444 (625)
                      .       ..   ...++.++++.++.||+..                                                
T Consensus       104 ~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (263)
T d1j7la_         104 E-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF  173 (263)
T ss_dssp             C-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred             c-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence            1       11   2223444555555555321                                                


Q ss_pred             --------CCCceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          445 --------GGKLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       445 --------~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                              .+.++|+|+.+.|||+++++..-|+||+.+..
T Consensus       174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                    11279999999999998776667999997764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.03  E-value=4.3e-07  Score=80.53  Aligned_cols=79  Identities=30%  Similarity=0.295  Sum_probs=36.7

Q ss_pred             ccccccccccccccccCCCCC---CcccccccceecCCCccCCCCCCCCccccccccceecccccccccCCC--------
Q 006922          112 INLKSLCYLYLQFNNFSGTLP---DFSVWKNLTIINLSDNGFNGTIPRSLSNLTQLEALYLANNSLSGKIPD--------  180 (625)
Q Consensus       112 ~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~--------  180 (625)
                      ..+++|++|+|++|+++..-+   .+..+++|+.|+|++|+|+..-+-......+|+.|++++|.++....+        
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence            344555555555555543211   133455555555555555522111112223455566666665544332        


Q ss_pred             -CCCCCCcEEE
Q 006922          181 -LNLPNLQQLN  190 (625)
Q Consensus       181 -~~l~~L~~L~  190 (625)
                       ..+|+|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
Confidence             1456666554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.91  E-value=3.3e-07  Score=95.00  Aligned_cols=61  Identities=15%  Similarity=0.111  Sum_probs=29.2

Q ss_pred             eEEEEEcCCCCcccccCcccccCCCCccEEEecCCCCCc----cCCccccccccccccccccccc
Q 006922           67 RVVAVRLPGVGFSGLIPPNTISRLSALKILSLRSNVITG----YFPSDFINLKSLCYLYLQFNNF  127 (625)
Q Consensus        67 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l  127 (625)
                      .++.||++++++++.--.+.+..+++|++|+|++|.|+.    .+...+..+++|++|||++|.+
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i   67 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL   67 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence            355555555555543212234445555555555555541    1222334445555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.81  E-value=3.5e-07  Score=91.74  Aligned_cols=153  Identities=18%  Similarity=0.232  Sum_probs=102.7

Q ss_pred             CeEEEEEcCCCCcc--------cccC----cccccCCCCccEEEecCCCCCcc----CCcccccccccccccccccccCC
Q 006922           66 KRVVAVRLPGVGFS--------GLIP----PNTISRLSALKILSLRSNVITGY----FPSDFINLKSLCYLYLQFNNFSG  129 (625)
Q Consensus        66 ~~v~~l~l~~~~l~--------g~~~----~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  129 (625)
                      ..++.|++.+|.+.        ..+.    .......+.|+.|++++|.++..    +...+...++|+.|+|++|+++.
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  200 (344)
T d2ca6a1         121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  200 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence            35788899888751        1110    11134677899999999988732    22234567889999999999863


Q ss_pred             C-----C-CCcccccccceecCCCccCCCC----CCCCccccccccceecccccccccC--------CCCCCCCCcEEEc
Q 006922          130 T-----L-PDFSVWKNLTIINLSDNGFNGT----IPRSLSNLTQLEALYLANNSLSGKI--------PDLNLPNLQQLNL  191 (625)
Q Consensus       130 ~-----~-p~~~~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~--------p~~~l~~L~~L~l  191 (625)
                      .     + ..+...++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.-        .....+.|+.|++
T Consensus       201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l  280 (344)
T d2ca6a1         201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  280 (344)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence            1     1 2467788999999999998632    3445677889999999999987421        1113467999999


Q ss_pred             ccCCCccc----ccccc----ccCCCCcccCCCCC
Q 006922          192 ANNNLSGS----IPQSL----KRFPSSAFVGNSIS  218 (625)
Q Consensus       192 ~~N~l~g~----~p~~l----~~~~~~~~~~n~~~  218 (625)
                      ++|+++..    +...+    ..+..+.+.||.+.
T Consensus       281 s~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            99998642    22222    23445566666654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.75  E-value=5.2e-05  Score=71.70  Aligned_cols=74  Identities=4%  Similarity=-0.017  Sum_probs=52.8

Q ss_pred             ccCC-ceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCC--CCceecceeEEEecCceEEEEEeccCCChhh
Q 006922          333 GKGT-FGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIR--HENVVELKAYYYSKDEKLMVYDYYSLGSVSA  408 (625)
Q Consensus       333 g~G~-~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  408 (625)
                      ..|. .+.||+....++..+++|.-....  ..++..|++.++.+.  .-.+.+++++..+.+..++||+++++.++.+
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            3444 367899988778888889765432  345777888777663  2335667888888888999999998866543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.74  E-value=5.2e-07  Score=93.45  Aligned_cols=108  Identities=20%  Similarity=0.310  Sum_probs=80.4

Q ss_pred             CCccEEEecCCCCCcc-CCcccccccccccccccccccCC----CCC-CcccccccceecCCCccCCCC----CCCCcc-
Q 006922           91 SALKILSLRSNVITGY-FPSDFINLKSLCYLYLQFNNFSG----TLP-DFSVWKNLTIINLSDNGFNGT----IPRSLS-  159 (625)
Q Consensus        91 ~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~ls~N~l~~~----~p~~l~-  159 (625)
                      .+|+.||+++|++++. +..-+..+++|+.|+|++|.++.    .+. .+..+++|+.|||++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999852 12345678999999999998862    122 356788999999999998631    222332 


Q ss_pred             ccccccceeccccccccc----CCC--CCCCCCcEEEcccCCCcc
Q 006922          160 NLTQLEALYLANNSLSGK----IPD--LNLPNLQQLNLANNNLSG  198 (625)
Q Consensus       160 ~l~~L~~L~l~~N~l~~~----~p~--~~l~~L~~L~l~~N~l~g  198 (625)
                      ...+|+.|+|++|++++.    ++.  ..+++|+.|+|++|.++.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            235799999999999753    222  267899999999999974

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.64  E-value=2.9e-06  Score=84.78  Aligned_cols=133  Identities=21%  Similarity=0.283  Sum_probs=96.8

Q ss_pred             CeEEEEEcCCCCcccc----cCcccccCCCCccEEEecCCCCC--c--cCCc---------ccccccccccccccccccC
Q 006922           66 KRVVAVRLPGVGFSGL----IPPNTISRLSALKILSLRSNVIT--G--YFPS---------DFINLKSLCYLYLQFNNFS  128 (625)
Q Consensus        66 ~~v~~l~l~~~~l~g~----~~~~~~~~l~~L~~L~l~~N~l~--~--~~p~---------~~~~l~~L~~L~L~~N~l~  128 (625)
                      .+++.|+|.+|.+...    +. ..+...++|+.|++++|.+.  +  .+..         .....+.|+.|++++|+++
T Consensus        93 ~~L~~L~L~~n~i~~~~~~~l~-~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~  171 (344)
T d2ca6a1          93 PKLHTVRLSDNAFGPTAQEPLI-DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  171 (344)
T ss_dssp             TTCCEEECCSCCCCTTTHHHHH-HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCcccccccccccccccccchh-hhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence            4588899999988653    22 23668899999999999873  1  1111         1234678999999999886


Q ss_pred             CCC----C-CcccccccceecCCCccCCCC-----CCCCccccccccceeccccccccc----CCC--CCCCCCcEEEcc
Q 006922          129 GTL----P-DFSVWKNLTIINLSDNGFNGT-----IPRSLSNLTQLEALYLANNSLSGK----IPD--LNLPNLQQLNLA  192 (625)
Q Consensus       129 ~~~----p-~~~~l~~L~~L~ls~N~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~----~p~--~~l~~L~~L~l~  192 (625)
                      ..-    . .+...++|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +..  ..+++|+.|+|+
T Consensus       172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls  251 (344)
T d2ca6a1         172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  251 (344)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence            321    1 245678899999999998742     345677889999999999998632    111  157889999999


Q ss_pred             cCCCccc
Q 006922          193 NNNLSGS  199 (625)
Q Consensus       193 ~N~l~g~  199 (625)
                      +|.|++.
T Consensus       252 ~n~i~~~  258 (344)
T d2ca6a1         252 DCLLSAR  258 (344)
T ss_dssp             TCCCCHH
T ss_pred             cCccCch
Confidence            9999754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.60  E-value=2.2e-06  Score=83.35  Aligned_cols=151  Identities=20%  Similarity=0.206  Sum_probs=101.0

Q ss_pred             CeEEEEEcCCC-CcccccCcccccCCCCccEEEecCC-CCCcc-CCccccc-cccccccccccc--ccCC-CCCC-cccc
Q 006922           66 KRVVAVRLPGV-GFSGLIPPNTISRLSALKILSLRSN-VITGY-FPSDFIN-LKSLCYLYLQFN--NFSG-TLPD-FSVW  137 (625)
Q Consensus        66 ~~v~~l~l~~~-~l~g~~~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~-~~p~-~~~l  137 (625)
                      .+++.|+|+++ +++..--...+..+++|++|+++++ .++.. +...+.. .++|+.|++++.  .++. .+.. +..+
T Consensus        95 ~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~  174 (284)
T d2astb2          95 SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC  174 (284)
T ss_dssp             TTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHC
T ss_pred             CCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccc
Confidence            45888999885 5542211122467899999999984 55421 2222333 468999999864  3332 1222 3567


Q ss_pred             cccceecCCCc-cCCCCCCCCccccccccceeccc-ccccccCCC--CCCCCCcEEEcccCCCccccccccccCCCCccc
Q 006922          138 KNLTIINLSDN-GFNGTIPRSLSNLTQLEALYLAN-NSLSGKIPD--LNLPNLQQLNLANNNLSGSIPQSLKRFPSSAFV  213 (625)
Q Consensus       138 ~~L~~L~ls~N-~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~--~~l~~L~~L~l~~N~l~g~~p~~l~~~~~~~~~  213 (625)
                      ++|++|++++| .+++.....+..+++|++|+|++ +.+++....  ..+++|+.|+++++--.+.++.....+|.+.+.
T Consensus       175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i~  254 (284)
T d2astb2         175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQIN  254 (284)
T ss_dssp             TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSEES
T ss_pred             ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcccccc
Confidence            89999999986 58877778889999999999999 467653332  268999999999883333444444567777654


Q ss_pred             CCC
Q 006922          214 GNS  216 (625)
Q Consensus       214 ~n~  216 (625)
                      .+.
T Consensus       255 ~~~  257 (284)
T d2astb2         255 CSH  257 (284)
T ss_dssp             CCC
T ss_pred             Ccc
Confidence            433

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.31  E-value=0.00052  Score=69.19  Aligned_cols=74  Identities=9%  Similarity=0.084  Sum_probs=46.4

Q ss_pred             hHcccCCceeEEEEEEc-CCcEEEEEEeccc--------cCChHHHHHHHHHHHcCC-C--CceecceeEEEecCceEEE
Q 006922          330 EVLGKGTFGMAYKAILE-DGTTVVVKRLKDV--------NVGKRDFEQQMEIVGSIR-H--ENVVELKAYYYSKDEKLMV  397 (625)
Q Consensus       330 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  397 (625)
                      +.||.|....||+.... +++.++||.-...        .........|.+.+..+. +  ..+.+++.  .+.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence            34899999999999865 4678999965321        112234556777776552 2  23444443  355667899


Q ss_pred             EEeccCCC
Q 006922          398 YDYYSLGS  405 (625)
Q Consensus       398 ~e~~~~g~  405 (625)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.12  E-value=0.00094  Score=65.35  Aligned_cols=137  Identities=15%  Similarity=0.109  Sum_probs=80.5

Q ss_pred             eEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCCCce-----ecce--eEEEecCceEEEEEeccCCChhh---
Q 006922          339 MAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-----VELK--AYYYSKDEKLMVYDYYSLGSVSA---  408 (625)
Q Consensus       339 ~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lv~e~~~~g~L~~---  408 (625)
                      .||++...+|+.+++|+.+....+.+++..|.+.+..+....+     +..-  ......+..+.++++++|..+..   
T Consensus        37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~  116 (325)
T d1zyla1          37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNI  116 (325)
T ss_dssp             EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCH
T ss_pred             eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCH
Confidence            7999999999999999998776677888889988877642211     1111  12234556788999988644321   


Q ss_pred             -----------hhccc----cCCCCccCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCCcee
Q 006922          409 -----------MLHSE----RGEGRIPLDWDT-------------------RMRIAIGAARGIARIHAA----NGGKLVH  450 (625)
Q Consensus       409 -----------~l~~~----~~~~~~~l~~~~-------------------~~~i~~~ia~~l~~LH~~----~~~~ivH  450 (625)
                                 .+|..    ....+..+++..                   +..+...+.+.++.+...    ....+||
T Consensus       117 ~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liH  196 (325)
T d1zyla1         117 DQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLH  196 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECC
T ss_pred             HHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeec
Confidence                       11111    101111222211                   111222223333333332    1335899


Q ss_pred             cCCCCCCEEeCCCCCeeEecccccccc
Q 006922          451 GNIKSSNIFLNSQQYGCVSDLGLTTIT  477 (625)
Q Consensus       451 rDlk~~NIll~~~~~~kl~DfGla~~~  477 (625)
                      +|+.+.|||++++  ..++||+-+...
T Consensus       197 gDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         197 GDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             SSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             CCCCcccEEEeCC--ceEEechhcccC
Confidence            9999999999743  458999977643

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.84  E-value=3.8e-05  Score=67.88  Aligned_cols=88  Identities=15%  Similarity=0.083  Sum_probs=47.3

Q ss_pred             cCCCCccEEEecCC-CCCcc----CCcccccccccccccccccccCCC-CC----CcccccccceecCCCccCCCC----
Q 006922           88 SRLSALKILSLRSN-VITGY----FPSDFINLKSLCYLYLQFNNFSGT-LP----DFSVWKNLTIINLSDNGFNGT----  153 (625)
Q Consensus        88 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-~p----~~~~l~~L~~L~ls~N~l~~~----  153 (625)
                      .+.++|+.|+|+++ .++..    +-..+...++|++|+|++|.+... ..    .+...+.|+.|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            34567777777763 45421    111244456677777777766421 11    133446677777777776532    


Q ss_pred             CCCCccccccccceeccccccc
Q 006922          154 IPRSLSNLTQLEALYLANNSLS  175 (625)
Q Consensus       154 ~p~~l~~l~~L~~L~l~~N~l~  175 (625)
                      +-..+...++|++|+|++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence            1123444456666666666543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.27  E-value=0.0078  Score=60.22  Aligned_cols=72  Identities=11%  Similarity=0.132  Sum_probs=47.9

Q ss_pred             HcccCCceeEEEEEEcCC--------cEEEEEEeccccCChHHHHHHHHHHHcCCCCce-ecceeEEEecCceEEEEEec
Q 006922          331 VLGKGTFGMAYKAILEDG--------TTVVVKRLKDVNVGKRDFEQQMEIVGSIRHENV-VELKAYYYSKDEKLMVYDYY  401 (625)
Q Consensus       331 ~lg~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  401 (625)
                      .|+.|-.=.+|+....++        ..|.+++.-. .....+..+|..+++.+.-.++ .++++++.    -.+|+||+
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~efi  123 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEYI  123 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECCC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEEe
Confidence            477788889999886543        4566666553 3334567788888887753344 45666653    26899999


Q ss_pred             cCCChh
Q 006922          402 SLGSVS  407 (625)
Q Consensus       402 ~~g~L~  407 (625)
                      ++..+.
T Consensus       124 ~g~~l~  129 (395)
T d1nw1a_         124 PSRPLS  129 (395)
T ss_dssp             CEEECC
T ss_pred             ccccCC
Confidence            875543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.16  E-value=0.00026  Score=62.25  Aligned_cols=86  Identities=13%  Similarity=0.032  Sum_probs=59.7

Q ss_pred             CeEEEEEcCCCC-cccccC---cccccCCCCccEEEecCCCCCccC----CcccccccccccccccccccCCCC-----C
Q 006922           66 KRVVAVRLPGVG-FSGLIP---PNTISRLSALKILSLRSNVITGYF----PSDFINLKSLCYLYLQFNNFSGTL-----P  132 (625)
Q Consensus        66 ~~v~~l~l~~~~-l~g~~~---~~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~-----p  132 (625)
                      ..++.|+|++++ ++..--   ...+...++|+.|+|++|.+....    ...+...++|++|+|++|.++..-     .
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence            458889998643 432110   123667788999999999987321    223445678999999999987421     1


Q ss_pred             CcccccccceecCCCccCC
Q 006922          133 DFSVWKNLTIINLSDNGFN  151 (625)
Q Consensus       133 ~~~~l~~L~~L~ls~N~l~  151 (625)
                      .+...++|+.|+|++|.+.
T Consensus        95 aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSC
T ss_pred             HHHhCCcCCEEECCCCcCC
Confidence            3566788999999999875

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.33  E-value=0.00043  Score=60.62  Aligned_cols=109  Identities=14%  Similarity=0.128  Sum_probs=58.3

Q ss_pred             cCCCCccEEEecC-CCCCcc----CCcccccccccccccccccccCCCCC-----CcccccccceecCCCccCCCC----
Q 006922           88 SRLSALKILSLRS-NVITGY----FPSDFINLKSLCYLYLQFNNFSGTLP-----DFSVWKNLTIINLSDNGFNGT----  153 (625)
Q Consensus        88 ~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~ls~N~l~~~----  153 (625)
                      .+.++|++|+|++ |.++..    +-..+...++|++|+|++|.++..--     .+...++|+.|++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            4556777777776 445421    11223455667777777776653110     234456677777777776532    


Q ss_pred             CCCCccccccccceec--cccccccc----CCCC--CCCCCcEEEcccCCC
Q 006922          154 IPRSLSNLTQLEALYL--ANNSLSGK----IPDL--NLPNLQQLNLANNNL  196 (625)
Q Consensus       154 ~p~~l~~l~~L~~L~l--~~N~l~~~----~p~~--~l~~L~~L~l~~N~l  196 (625)
                      +-..+...++|+.++|  ++|.+...    +...  ..++|+.|+++.|..
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            1234455566665333  45555421    1111  456777777766654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.13  E-value=0.092  Score=50.08  Aligned_cols=143  Identities=8%  Similarity=0.052  Sum_probs=71.5

Q ss_pred             cccCCceeEEEEEEcCCcEEEEEEeccccCChHHHHHHHHHHHcCCC-----Cceecc-ee--EEEecCceEEEEEeccC
Q 006922          332 LGKGTFGMAYKAILEDGTTVVVKRLKDVNVGKRDFEQQMEIVGSIRH-----ENVVEL-KA--YYYSKDEKLMVYDYYSL  403 (625)
Q Consensus       332 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-----~niv~l-~~--~~~~~~~~~lv~e~~~~  403 (625)
                      |..|---+.|+....+|+ +++|+.... .+.++...|++++..+.+     |..+.. -|  +.........++.+..+
T Consensus        26 i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g  103 (316)
T d2ppqa1          26 IAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG  103 (316)
T ss_dssp             ECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred             CCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence            456666788998877665 888988653 234556667777766532     222211 11  11223455667777665


Q ss_pred             CChhhh--------------hccccCC----CCccC--CH----------------HHHHHHHHHHHHHHHHHHhcC-CC
Q 006922          404 GSVSAM--------------LHSERGE----GRIPL--DW----------------DTRMRIAIGAARGIARIHAAN-GG  446 (625)
Q Consensus       404 g~L~~~--------------l~~~~~~----~~~~l--~~----------------~~~~~i~~~ia~~l~~LH~~~-~~  446 (625)
                      ......              ++.....    .....  .|                ......+......+.-.+... ..
T Consensus       104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~  183 (316)
T d2ppqa1         104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA  183 (316)
T ss_dssp             BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred             ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence            433211              1100000    00000  00                011112222222222222211 23


Q ss_pred             CceecCCCCCCEEeCCCCCeeEeccccccc
Q 006922          447 KLVHGNIKSSNIFLNSQQYGCVSDLGLTTI  476 (625)
Q Consensus       447 ~ivHrDlk~~NIll~~~~~~kl~DfGla~~  476 (625)
                      ++||+|+.++||+++.+...-|.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            599999999999999887778999997753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.73  E-value=0.004  Score=54.10  Aligned_cols=110  Identities=13%  Similarity=0.050  Sum_probs=72.7

Q ss_pred             CeEEEEEcCCC-CcccccC---cccccCCCCccEEEecCCCCCccC----CcccccccccccccccccccCCCC-----C
Q 006922           66 KRVVAVRLPGV-GFSGLIP---PNTISRLSALKILSLRSNVITGYF----PSDFINLKSLCYLYLQFNNFSGTL-----P  132 (625)
Q Consensus        66 ~~v~~l~l~~~-~l~g~~~---~~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~-----p  132 (625)
                      ..++.|+|.++ .++...-   ...+...++|++|+|++|.++...    -..+...++|+.|++++|.+...-     .
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            35777888763 4432210   123567899999999999987422    123455688999999999886421     2


Q ss_pred             Cccccccccee--cCCCccCCC----CCCCCccccccccceeccccccc
Q 006922          133 DFSVWKNLTII--NLSDNGFNG----TIPRSLSNLTQLEALYLANNSLS  175 (625)
Q Consensus       133 ~~~~l~~L~~L--~ls~N~l~~----~~p~~l~~l~~L~~L~l~~N~l~  175 (625)
                      .+...++|+.+  ++++|.+..    .+...+...++|+.|+++.|...
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            46667888864  556777753    23344567788999999877643